Citrus Sinensis ID: 006785
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 631 | 2.2.26 [Sep-21-2011] | |||||||
| Q8VYY5 | 565 | Receptor-like serine/thre | yes | no | 0.868 | 0.969 | 0.517 | 1e-171 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.453 | 0.375 | 0.478 | 1e-67 | |
| Q6R2J8 | 703 | Protein STRUBBELIG-RECEPT | no | no | 0.608 | 0.546 | 0.387 | 8e-67 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.458 | 0.424 | 0.473 | 6e-66 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.456 | 0.406 | 0.470 | 1e-65 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.456 | 0.401 | 0.468 | 7e-65 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.451 | 0.397 | 0.455 | 1e-64 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.451 | 0.383 | 0.456 | 2e-64 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.448 | 0.434 | 0.452 | 7e-64 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.453 | 0.402 | 0.454 | 2e-63 |
| >sp|Q8VYY5|NCRK_ARATH Receptor-like serine/threonine-protein kinase NCRK OS=Arabidopsis thaliana GN=NCRK PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 601 bits (1549), Expect = e-171, Method: Compositional matrix adjust.
Identities = 328/634 (51%), Positives = 412/634 (64%), Gaps = 86/634 (13%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MK++V+ A L+ LI IQ+ G N+ CTC SS G++S+IL+ NCS SC+
Sbjct: 1 MKMRVETALAILLVLISIQQCY-------GGVSNYTCTCFSS--GNRSDILESNCSTSCN 51
Query: 61 CSPVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVVV 120
C P +W C+C A+G P +A +++CF SC C++G+ K +++S K+V+
Sbjct: 52 CRP----DRDQWVCLCPANGFPVIAIGGSNSSCFTSCNCSAGATKSSKK--QYLSRKLVI 105
Query: 121 IVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKESC-NSATNLISHRITSVPET 179
++LL C +L ++AFL ++CY+ RK KF ++ +SSD+ES +S+ NLI+ + +
Sbjct: 106 VILLFCGVLISLAFLASMICYICRKDKFSGQTPSVSSDRESSWHSSANLINRKSSVSQSK 165
Query: 180 RVEVVSPIDLATGCFLKTT--FCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGS 237
S GCF + FC SK TIHG I +FSY+ LE AT+KFS ++++G GGS
Sbjct: 166 ISISSS----VAGCFFQNASLFCVSKPETIHGAIFQFSYTELEQATNKFSSNSVIGHGGS 221
Query: 238 SYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297
S VYRGQL DG+ A+KR T G + D++F TEV++LSRLHH HVVPL+GYCSEF GK
Sbjct: 222 SCVYRGQLKDGKTAAIKRLNTPKGDDTDTLFSTEVELLSRLHHYHVVPLIGYCSEFHGKH 281
Query: 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 357
A RLLVFE+M G+LRDCLDG L E M W+ R+++A+GAARGLEYLHEAAAPRILHRD+K
Sbjct: 282 AERLLVFEYMSYGSLRDCLDGELGEKMTWNIRISVALGAARGLEYLHEAAAPRILHRDVK 341
Query: 358 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFGYFAPEYAMVGRASLMS 416
S+NILLDEN +AKITDLGMAK L +DGL S SSSP +QGTFGYFAPEYA+ G AS MS
Sbjct: 342 STNILLDENWHAKITDLGMAKCLSSDGLQSGSSSPTTGLQGTFGYFAPEYAIAGCASQMS 401
Query: 417 DVFSFGVVLLELITGRQPIHR-SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPK 475
DVFSFGVVLLELITGR+PI + S KGEESLV+WA PRLQDS VI ELPDPRL G F +
Sbjct: 402 DVFSFGVVLLELITGRKPIQKPSNNKGEESLVIWAVPRLQDSKRVIEELPDPRLNGKFAE 461
Query: 476 EEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD-KSRRRNISLNLFQIFSAGGMEK 534
EEMQIMAYLAKECL LDP++RPTM EVVQILSTI PD SRRRN +N
Sbjct: 462 EEMQIMAYLAKECLLLDPESRPTMREVVQILSTITPDTSSRRRNFPINY----------- 510
Query: 535 EPSIERPDNLFETLIESEELKKATSFGSPRCSQAVDTDITLNTRSNSKEEDTVSTEYMEK 594
L +S E KK + G R S S +E+
Sbjct: 511 -------------LFQSNEKKKESKVGWSRGG------------SKSGQEE--------- 536
Query: 595 LLLLTSEVRSSRAPDIETVDLTEPRFESFCMKNV 628
ETVDLTEPRFESFC+ NV
Sbjct: 537 ----------------ETVDLTEPRFESFCLPNV 554
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 258 bits (658), Expect = 1e-67, Method: Compositional matrix adjust.
Identities = 144/301 (47%), Positives = 191/301 (63%), Gaps = 15/301 (4%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
FSY L AT+ FS N++G+GG VY+G L D R+VAVK+ K GG D F EVD
Sbjct: 418 FSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGG-QGDREFKAEVD 476
Query: 274 MLSRLHHCHVVPLVGYC-SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 332
+SR+HH +++ +VGYC SE R RLL+++++PN NL L G++W TRV I
Sbjct: 477 TISRVHHRNLLSMVGYCISENR-----RLLIYDYVPNNNLYFHLHAAGTPGLDWATRVKI 531
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS- 391
A GAARGL YLHE PRI+HRDIKSSNILL+ N +A ++D G+AK L D C++
Sbjct: 532 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAK-LALD----CNTHI 586
Query: 392 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 451
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ S G+ESLV WA
Sbjct: 587 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWAR 646
Query: 452 PRLQDSGTV--ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
P L ++ + L DP+L ++ EM M A C++ RP MS++V+ ++
Sbjct: 647 PLLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAFDSL 706
Query: 510 A 510
A
Sbjct: 707 A 707
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6R2J8|SRF8_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 8 OS=Arabidopsis thaliana GN=SRF8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 255 bits (651), Expect = 8e-67, Method: Compositional matrix adjust.
Identities = 162/418 (38%), Positives = 236/418 (56%), Gaps = 34/418 (8%)
Query: 102 GSVSGVKASGKHISSKVVVIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKES 161
GS SGK +S VV ++ + + I L+L LC K K +R S +S +
Sbjct: 273 GSEEKSSDSGKGLSGGVVTGIVFGSLFVAGIIALVLYLCL--HKKKRKVRGSTRASQRSL 330
Query: 162 CNSATNLISHRITSVPETRVEVVSPI-DLATGCFLKTTFCRSKTWTIHGTIIR------- 213
S T V E RV+ V+ + DL + K T R +G+I R
Sbjct: 331 PLSGT-------PEVQEQRVKSVASVADLKSSPAEKVTVDRVMK---NGSISRIRSPITA 380
Query: 214 --FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLT 270
++ S+L+ AT+ FS NI+G+G VYR + +G+I+A+K+ + FL
Sbjct: 381 SQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFPNGKIMAIKKIDNAALSLQEEDNFLE 440
Query: 271 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMN--WDT 328
V +SRL H ++VPL GYC+E RLLV+E++ NGNL D L MN W+
Sbjct: 441 AVSNMSRLRHPNIVPLAGYCTE----HGQRLLVYEYVGNGNLDDTLHTNDDRSMNLTWNA 496
Query: 329 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 388
RV +A+G A+ LEYLHE P I+HR+ KS+NILLDE LN ++D G+A L +
Sbjct: 497 RVKVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEELNPHLSDSGLAA-LTPNTERQV 555
Query: 389 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 448
S+ ++ G+FGY APE+A+ G ++ SDV++FGVV+LEL+TGR+P+ S T+ E+SLV
Sbjct: 556 ST---QVVGSFGYSAPEFALSGIYTVKSDVYTFGVVMLELLTGRKPLDSSRTRAEQSLVR 612
Query: 449 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
WATP+L D +S++ DP L G +P + + A + C+Q +P+ RP MSEVVQ L
Sbjct: 613 WATPQLHDI-DALSKMVDPSLNGMYPAKSLSRFADIIALCIQPEPEFRPPMSEVVQQL 669
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 252 bits (644), Expect = 6e-66, Method: Compositional matrix adjust.
Identities = 141/298 (47%), Positives = 183/298 (61%), Gaps = 9/298 (3%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
FSY L T FS N++G+GG VY+G L+DGR VAVK+ K GG + F EV+
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKI-GGSQGEREFKAEVE 385
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
++SR+HH H+V LVGYC RLLV++++PN L L M W+TRV +A
Sbjct: 386 IISRVHHRHLVTLVGYCI----SEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVA 441
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393
GAARG+ YLHE PRI+HRDIKSSNILLD + A + D G+AK + L + S+
Sbjct: 442 AGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVST-- 499
Query: 394 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 453
R+ GTFGY APEYA G+ S +DV+S+GV+LLELITGR+P+ S G+ESLV WA P
Sbjct: 500 RVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPL 559
Query: 454 LQDS--GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
L + EL DPRL +F EM M A C++ RP MS+VV+ L T+
Sbjct: 560 LGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTL 617
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 251 bits (641), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 142/302 (47%), Positives = 192/302 (63%), Gaps = 14/302 (4%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
FSY L AT+ FS N++G+GG VY+G L DGR+VAVK+ K GG D F EV+
Sbjct: 365 FSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGG-QGDREFKAEVE 423
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
LSR+HH H+V +VG+C G R RLL+++++ N +L L G ++W TRV IA
Sbjct: 424 TLSRIHHRHLVSIVGHC--ISGDR--RLLIYDYVSNNDLYFHLHGE-KSVLDWATRVKIA 478
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS-P 392
GAARGL YLHE PRI+HRDIKSSNILL++N +A+++D G+A RL D C++
Sbjct: 479 AGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLA-RLALD----CNTHIT 533
Query: 393 ARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 452
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ S G+ESLV WA P
Sbjct: 534 TRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARP 593
Query: 453 RLQDSGTV--ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510
+ + L DP+L G++ + EM M A C++ RP M ++V+ ++A
Sbjct: 594 LISHAIETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFESLA 653
Query: 511 PD 512
+
Sbjct: 654 AE 655
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 248 bits (634), Expect = 7e-65, Method: Compositional matrix adjust.
Identities = 140/299 (46%), Positives = 184/299 (61%), Gaps = 11/299 (3%)
Query: 212 IRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTE 271
I F+Y L T+ F S +VG+GG VY+G L +G+ VA+K+ K+ F E
Sbjct: 356 IHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYRE-FKAE 414
Query: 272 VDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA 331
V+++SR+HH H+V LVGYC R L++EF+PN L L G + + W RV
Sbjct: 415 VEIISRVHHRHLVSLVGYCI----SEQHRFLIYEFVPNNTLDYHLHGKNLPVLEWSRRVR 470
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 391
IAIGAA+GL YLHE P+I+HRDIKSSNILLD+ A++ D G+A RL S+
Sbjct: 471 IAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLA-RLNDTAQSHIST- 528
Query: 392 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 451
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ S GEESLV WA
Sbjct: 529 --RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWAR 586
Query: 452 PRLQDS--GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508
PRL ++ ISE+ DPRL+ D+ + E+ M A C++ RP M +VV+ L T
Sbjct: 587 PRLIEAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRALDT 645
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 248 bits (632), Expect = 1e-64, Method: Compositional matrix adjust.
Identities = 139/305 (45%), Positives = 187/305 (61%), Gaps = 20/305 (6%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
F+Y L AT+ FS +N++GQGG YV++G L +G+ VAVK+ K +G + F EV
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLK-EGSSQGEREFQAEVG 400
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
++SR+HH H+V LVGYC A RLLV+EF+PN L L G M W +R+ IA
Sbjct: 401 IISRVHHRHLVALVGYCI----ADAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRLKIA 456
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393
+G+A+GL YLHE P+I+HRDIK+SNIL+D AK+ D G+AK + +D S+
Sbjct: 457 VGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAK-IASDTNTHVST--- 512
Query: 394 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 453
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+PI + + SLV WA P
Sbjct: 513 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPL 572
Query: 454 LQDSGTVISELP------DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL- 506
L +SEL D +L ++ KEEM M A C++ RP M +V ++L
Sbjct: 573 LNQ----VSELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLE 628
Query: 507 STIAP 511
I+P
Sbjct: 629 GNISP 633
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 247 bits (631), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 137/300 (45%), Positives = 190/300 (63%), Gaps = 15/300 (5%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
F+ S LE ATD+FS ++G+GG VY+G + DG VAVK T+ N D F+ EV+
Sbjct: 337 FTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLL-TRDNQNRDREFIAEVE 395
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAI 332
MLSRLHH ++V L+G C E R R L++E + NG++ L EG ++WD R+ I
Sbjct: 396 MLSRLHHRNLVKLIGICIEGR----TRCLIYELVHNGSVESHLH----EGTLDWDARLKI 447
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP 392
A+GAARGL YLHE + PR++HRD K+SN+LL+++ K++D G+A R +G S+
Sbjct: 448 ALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA-REATEGSQHIST-- 504
Query: 393 ARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 452
R+ GTFGY APEYAM G + SDV+S+GVVLLEL+TGR+P+ S GEE+LV WA P
Sbjct: 505 -RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARP 563
Query: 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512
L + + +L DP L G + ++M +A +A C+ + RP M EVVQ L I D
Sbjct: 564 LLANR-EGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALKLIYND 622
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 245 bits (626), Expect = 7e-64, Method: Compositional matrix adjust.
Identities = 134/296 (45%), Positives = 184/296 (62%), Gaps = 13/296 (4%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
F+Y L AT+ FS +N++GQGG YV++G L G+ VAVK+ K G + F EV+
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSG-QGEREFQAEVE 326
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
++SR+HH H+V L+GYC RLLV+EF+PN NL L G M W TR+ IA
Sbjct: 327 IISRVHHRHLVSLIGYCM----AGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIA 382
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393
+G+A+GL YLHE P+I+HRDIK+SNIL+D AK+ D G+AK + +D S+
Sbjct: 383 LGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAK-IASDTNTHVST--- 438
Query: 394 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP- 452
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ + ++SLV WA P
Sbjct: 439 RVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPL 498
Query: 453 --RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
R + G L D ++ ++ +EEM M A C++ RP MS++V+ L
Sbjct: 499 LNRASEEGD-FEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRAL 553
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 243 bits (621), Expect = 2e-63, Method: Compositional matrix adjust.
Identities = 136/299 (45%), Positives = 185/299 (61%), Gaps = 13/299 (4%)
Query: 213 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEV 272
F+Y L T+ FS NI+G+GG VY+G+L DG++VAVK+ K G D F EV
Sbjct: 340 HFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSG-QGDREFKAEV 398
Query: 273 DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 332
+++SR+HH H+V LVGYC + RLL++E++PN L L G + W RV I
Sbjct: 399 EIISRVHHRHLVSLVGYCI----ADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRI 454
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP 392
AIG+A+GL YLHE P+I+HRDIKS+NILLD+ A++ D G+AK + + +
Sbjct: 455 AIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDS----TQTHVS 510
Query: 393 ARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 452
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ + GEESLV WA P
Sbjct: 511 TRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARP 570
Query: 453 RLQ---DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508
L ++G SEL D RL+ + + E+ M A C++ RP M +VV+ L +
Sbjct: 571 LLHKAIETGD-FSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDS 628
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 631 | ||||||
| 297746278 | 635 | unnamed protein product [Vitis vinifera] | 1.0 | 0.993 | 0.683 | 0.0 | |
| 359478364 | 628 | PREDICTED: receptor-like serine/threonin | 0.988 | 0.993 | 0.678 | 0.0 | |
| 255578119 | 625 | kinase, putative [Ricinus communis] gi|2 | 0.985 | 0.995 | 0.662 | 0.0 | |
| 224106790 | 563 | predicted protein [Populus trichocarpa] | 0.817 | 0.916 | 0.706 | 0.0 | |
| 224132516 | 532 | predicted protein [Populus trichocarpa] | 0.778 | 0.922 | 0.724 | 0.0 | |
| 356542635 | 612 | PREDICTED: receptor-like serine/threonin | 0.960 | 0.990 | 0.591 | 0.0 | |
| 351727637 | 612 | protein kinase family protein precursor | 0.960 | 0.990 | 0.588 | 0.0 | |
| 449456024 | 614 | PREDICTED: receptor-like serine/threonin | 0.961 | 0.988 | 0.585 | 0.0 | |
| 147834997 | 1324 | hypothetical protein VITISV_037547 [Viti | 0.828 | 0.395 | 0.652 | 0.0 | |
| 351725463 | 610 | protein kinase family protein precursor | 0.961 | 0.995 | 0.596 | 0.0 |
| >gi|297746278|emb|CBI16334.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 870 bits (2249), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/635 (68%), Positives = 508/635 (80%), Gaps = 4/635 (0%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MKL V+V ACLI L+ IQ S+CD LS+ S W CTCSS+ QG Q+ IL NCS SCD
Sbjct: 1 MKLPVEVALACLISLLGIQLSLCDVLSDTSNINKWTCTCSSANQGSQNYILAGNCSTSCD 60
Query: 61 CSPVGGSSEG-KWTCICAADGLPKVAANSYDTTCFASCTCTSGSVS-GVKASGKHISSKV 118
CSP GG S G +WTCICAADG PKVA++S T+CF +C CTSGS + A KHISSKV
Sbjct: 61 CSPAGGGSTGDRWTCICAADGFPKVASDSGHTSCFTACNCTSGSPNEDAPARRKHISSKV 120
Query: 119 VVIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVP 177
VVI+LLLCV+LTT AFL VLCYVYRK K ++ V SSDKE SCNSATNLISH+I SVP
Sbjct: 121 VVIILLLCVVLTTFAFLASVLCYVYRKEKCPIQPPVFSSDKETSCNSATNLISHKINSVP 180
Query: 178 ETRVEVVSPIDLATGCFLK-TTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGG 236
E+RV++ SPI+ TGCF K ++ RSKT TIH TI++FSY LE+AT+KFS SN++G GG
Sbjct: 181 ESRVDIGSPINSLTGCFHKASSLFRSKTGTIHETIVQFSYYELENATNKFSNSNLIGVGG 240
Query: 237 SSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296
SSYVY GQL DG+ VAVKR KT+GGP+AD VFLTE+++LSRLHHCHVVPL+GYCSE +GK
Sbjct: 241 SSYVYCGQLKDGKTVAVKRLKTKGGPDADLVFLTEIELLSRLHHCHVVPLLGYCSESQGK 300
Query: 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 356
A RLLVFE+M NGNLRDCLDG + M+W TRV+IA+GAARGLEYLHEAAAPRILHRD+
Sbjct: 301 HAQRLLVFEYMLNGNLRDCLDGDSGKNMDWATRVSIALGAARGLEYLHEAAAPRILHRDV 360
Query: 357 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMS 416
KS+NILLDEN AKITDLGMAKRL+ADGLPSCS+SPARMQGTFGYFAPEYA+VGRAS MS
Sbjct: 361 KSTNILLDENWRAKITDLGMAKRLRADGLPSCSNSPARMQGTFGYFAPEYAIVGRASPMS 420
Query: 417 DVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKE 476
DVFSFGVVLLELI+GR+PIH+S KGEESLV+WATPRLQDSG V+SELPDP LKG+FP+E
Sbjct: 421 DVFSFGVVLLELISGRKPIHKSTNKGEESLVIWATPRLQDSGRVMSELPDPHLKGNFPEE 480
Query: 477 EMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNLFQIFSAGGMEKEP 536
EMQIMA+LAKECL LDPDARPTMSE+VQILSTIAPDKSRRRNI +N FQ S M+ E
Sbjct: 481 EMQIMAFLAKECLLLDPDARPTMSEIVQILSTIAPDKSRRRNIPVNFFQRLSPHSMKSEA 540
Query: 537 SIERPDNLFETLIESEELKKATSFGSPRCSQAVDTDITLNTRSNSKEEDTVSTEYMEKLL 596
+ PD E+ ++ E + T+ + RCS +D D TL + + +VS EY+E+L+
Sbjct: 541 HMLIPDKKSESPVDVELRRAGTNKWTDRCSLPLDIDRTLCIGDSQTKAVSVSAEYIERLI 600
Query: 597 LLTSEVRSSRAPDIETVDLTEPRFESFCMKNVNSP 631
++TS RS R P ETVDLTEPRFESFCM N SP
Sbjct: 601 IMTSNARSWRGPADETVDLTEPRFESFCMANGRSP 635
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359478364|ref|XP_002282467.2| PREDICTED: receptor-like serine/threonine-protein kinase NCRK-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 858 bits (2217), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 431/635 (67%), Positives = 504/635 (79%), Gaps = 11/635 (1%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MKL V+V ACLI L+ IQ S+C G W CTCSS+ QG Q+ IL NCS SCD
Sbjct: 1 MKLPVEVALACLISLLGIQLSLC-------GLNKWTCTCSSANQGSQNYILAGNCSTSCD 53
Query: 61 CSPVGGSSEG-KWTCICAADGLPKVAANSYDTTCFASCTCTSGSVS-GVKASGKHISSKV 118
CSP GG S G +WTCICAADG PKVA++S T+CF +C CTSGS + A KHISSKV
Sbjct: 54 CSPAGGGSTGDRWTCICAADGFPKVASDSGHTSCFTACNCTSGSPNEDAPARRKHISSKV 113
Query: 119 VVIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVP 177
VVI+LLLCV+LTT AFL VLCYVYRK K ++ V SSDKE SCNSATNLISH+I SVP
Sbjct: 114 VVIILLLCVVLTTFAFLASVLCYVYRKEKCPIQPPVFSSDKETSCNSATNLISHKINSVP 173
Query: 178 ETRVEVVSPIDLATGCFLK-TTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGG 236
E+RV++ SPI+ TGCF K ++ RSKT TIH TI++FSY LE+AT+KFS SN++G GG
Sbjct: 174 ESRVDIGSPINSLTGCFHKASSLFRSKTGTIHETIVQFSYYELENATNKFSNSNLIGVGG 233
Query: 237 SSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296
SSYVY GQL DG+ VAVKR KT+GGP+AD VFLTE+++LSRLHHCHVVPL+GYCSE +GK
Sbjct: 234 SSYVYCGQLKDGKTVAVKRLKTKGGPDADLVFLTEIELLSRLHHCHVVPLLGYCSESQGK 293
Query: 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 356
A RLLVFE+M NGNLRDCLDG + M+W TRV+IA+GAARGLEYLHEAAAPRILHRD+
Sbjct: 294 HAQRLLVFEYMLNGNLRDCLDGDSGKNMDWATRVSIALGAARGLEYLHEAAAPRILHRDV 353
Query: 357 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMS 416
KS+NILLDEN AKITDLGMAKRL+ADGLPSCS+SPARMQGTFGYFAPEYA+VGRAS MS
Sbjct: 354 KSTNILLDENWRAKITDLGMAKRLRADGLPSCSNSPARMQGTFGYFAPEYAIVGRASPMS 413
Query: 417 DVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKE 476
DVFSFGVVLLELI+GR+PIH+S KGEESLV+WATPRLQDSG V+SELPDP LKG+FP+E
Sbjct: 414 DVFSFGVVLLELISGRKPIHKSTNKGEESLVIWATPRLQDSGRVMSELPDPHLKGNFPEE 473
Query: 477 EMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNLFQIFSAGGMEKEP 536
EMQIMA+LAKECL LDPDARPTMSE+VQILSTIAPDKSRRRNI +N FQ S M+ E
Sbjct: 474 EMQIMAFLAKECLLLDPDARPTMSEIVQILSTIAPDKSRRRNIPVNFFQRLSPHSMKSEA 533
Query: 537 SIERPDNLFETLIESEELKKATSFGSPRCSQAVDTDITLNTRSNSKEEDTVSTEYMEKLL 596
+ PD E+ ++ E + T+ + RCS +D D TL + + +VS EY+E+L+
Sbjct: 534 HMLIPDKKSESPVDVELRRAGTNKWTDRCSLPLDIDRTLCIGDSQTKAVSVSAEYIERLI 593
Query: 597 LLTSEVRSSRAPDIETVDLTEPRFESFCMKNVNSP 631
++TS RS R P ETVDLTEPRFESFCM N SP
Sbjct: 594 IMTSNARSWRGPADETVDLTEPRFESFCMANGRSP 628
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578119|ref|XP_002529929.1| kinase, putative [Ricinus communis] gi|223530559|gb|EEF32437.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 847 bits (2189), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 420/634 (66%), Positives = 497/634 (78%), Gaps = 12/634 (1%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MKLQV+V ACL+GLIWIQ+ +C G NW CTCS S QG+Q+ + K NCS SCD
Sbjct: 1 MKLQVEVALACLVGLIWIQQGLC-------GLNNWTCTCSLSSQGNQTYV-KSNCSTSCD 52
Query: 61 CSPV-GGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVV 119
C+PV GGS + W C CAADGLP++A+ S+D+TCF +C CTSGSV+ + KH S KVV
Sbjct: 53 CNPVAGGSKDSTWGCTCAADGLPRIASGSHDSTCFTACNCTSGSVAQAQEKRKHFSGKVV 112
Query: 120 VIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVPE 178
VI+LLLCVILTT+AFL + CYVYRK +S + SD+E S SATNLISH+ +S+ E
Sbjct: 113 VIILLLCVILTTLAFLASITCYVYRKDNCPFQSPIFISDRETSYTSATNLISHKASSLLE 172
Query: 179 TRVEVVSPIDLATGCFLKTTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSS 238
T V + + ++ GCF + F R + I+GTI+RFSYS LEHAT FS SN++G GGSS
Sbjct: 173 TGVSIDTHLNPMPGCF-RRAFYRGSSDIINGTIVRFSYSELEHATKNFSNSNLIGLGGSS 231
Query: 239 YVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298
YVYRGQL +G+ VA+KR QGGP+ADS+F EV++LSRLHHCHVVPL+G CSEF+GK +
Sbjct: 232 YVYRGQLRNGKTVAIKRLNAQGGPDADSLFSKEVEVLSRLHHCHVVPLLGCCSEFQGKHS 291
Query: 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 358
RLLVFE+MPNGNLRDCLDG+ E M W+TRVAIAIGAARGLEYLHEAAAPRILHRD+KS
Sbjct: 292 KRLLVFEYMPNGNLRDCLDGISGESMKWETRVAIAIGAARGLEYLHEAAAPRILHRDVKS 351
Query: 359 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDV 418
+NILLDEN AKITDLGMAKRLKADG+PS SSSPARMQGTFGYFAPEYAMVGRASLMSDV
Sbjct: 352 TNILLDENWGAKITDLGMAKRLKADGVPSSSSSPARMQGTFGYFAPEYAMVGRASLMSDV 411
Query: 419 FSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEM 478
FSFGVVLLELI+GRQPIH+S KGEESLVLWATPRLQDS V+SELPD RLKG+FP+EEM
Sbjct: 412 FSFGVVLLELISGRQPIHKSTNKGEESLVLWATPRLQDSRRVVSELPDQRLKGNFPEEEM 471
Query: 479 QIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNLFQIFSAGGMEKEPSI 538
QIMAYLAKECL LDPDARPTM E+VQILSTIAPDKSRRRNI +NLFQ+ M+ E I
Sbjct: 472 QIMAYLAKECLLLDPDARPTMREIVQILSTIAPDKSRRRNIPVNLFQMSFTRSMKMESHI 531
Query: 539 ERPDNLFETLIESEELKKATSFG-SPRCSQAVDTDITLNTRSNSKEEDTVSTEYMEKLLL 597
++ NL E +++ EL++ +S S S +D + TL+ R + E DTVS+EYME+L+L
Sbjct: 532 QKSGNLVEGSVDAAELRRESSAKQSALGSLPLDVEHTLSVRQKTMEVDTVSSEYMERLIL 591
Query: 598 LTSEVRSSRAPDIETVDLTEPRFESFCMKNVNSP 631
LTS+ RS R D E VDLTEPRFESF M N P
Sbjct: 592 LTSKARSWRVTDEEAVDLTEPRFESFRMANAKFP 625
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106790|ref|XP_002314286.1| predicted protein [Populus trichocarpa] gi|222850694|gb|EEE88241.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 742 bits (1916), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/528 (70%), Positives = 434/528 (82%), Gaps = 12/528 (2%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MKLQ+KV A LIGLIWIQ++ +SG W CTCS+S QG+QS I K NCS SCD
Sbjct: 1 MKLQLKVALAFLIGLIWIQQA-------KSGINKWTCTCSASYQGNQSYI-KSNCSTSCD 52
Query: 61 CSPVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVVV 120
CSP G G WTC C++DGLPKVA DTTCF +C CTSG+ + + KH SSK+V+
Sbjct: 53 CSP--GMPGGMWTCTCSSDGLPKVATGIQDTTCFTACNCTSGTWFLWQYTRKHFSSKIVL 110
Query: 121 IVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVPET 179
++LLLCVILTT+AFL + CY+YRK K ++S V SD+E SCNSATNLISHR +SV ET
Sbjct: 111 VILLLCVILTTLAFLASITCYLYRKDKCLVQSPVFLSDRERSCNSATNLISHRASSVSET 170
Query: 180 RVEVVSPIDLATGCFLKTTF-CRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSS 238
++ V SPI+ +GCF K +F CRSKT I G +I F+YS LEHAT+KFS SN++G GGSS
Sbjct: 171 KIRVDSPINPISGCFRKASFLCRSKTEIIQGNLILFTYSELEHATNKFSHSNLIGLGGSS 230
Query: 239 YVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298
YVY GQL DGR VAVKR K QGGP+AD +F TEV++L++LHHCHVVPL+GYCS+F+GK +
Sbjct: 231 YVYHGQLKDGRTVAVKRLKAQGGPDADFLFSTEVELLAKLHHCHVVPLLGYCSKFQGKFS 290
Query: 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 358
RLLVFE+MPNGNLRDCLDGVL E MNW TRV IAIGAARGLEYLHE+AAPRILHRD+KS
Sbjct: 291 ERLLVFEYMPNGNLRDCLDGVLGEKMNWQTRVTIAIGAARGLEYLHESAAPRILHRDVKS 350
Query: 359 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDV 418
+NIL+DEN AKITDLGMAKRL+ DG+PS SSPARMQGTFGYFAPEYAM+GRAS MSDV
Sbjct: 351 TNILMDENWRAKITDLGMAKRLRGDGVPSSPSSPARMQGTFGYFAPEYAMIGRASPMSDV 410
Query: 419 FSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEM 478
FSFGVVLLELITGRQPIH+S KGEESLVLWATP LQDSG V+ ELPDPRLKG+FP+EE+
Sbjct: 411 FSFGVVLLELITGRQPIHKSTNKGEESLVLWATPLLQDSGLVLLELPDPRLKGNFPEEEL 470
Query: 479 QIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNLFQI 526
QIMAYLAKECL LDPDARP+M EVVQILSTIAP+KS+RRNI + LFQ+
Sbjct: 471 QIMAYLAKECLLLDPDARPSMGEVVQILSTIAPEKSKRRNIPVKLFQV 518
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224132516|ref|XP_002328308.1| predicted protein [Populus trichocarpa] gi|222837823|gb|EEE76188.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 737 bits (1902), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/497 (72%), Positives = 416/497 (83%), Gaps = 6/497 (1%)
Query: 31 GQKNWKCTCSSSLQGDQSNILKLNCSRSCDCSPVGGSSEGKWTCICAADGLPKVAANSYD 90
G NW CTCS+S QG+QS K NCS SCDC+ G S G WTC C+ DGLPKVAA S D
Sbjct: 1 GINNWTCTCSASYQGNQS-YTKSNCSTSCDCT--GRQSRGTWTCTCSTDGLPKVAAGSQD 57
Query: 91 TTCFASCTCTSGSVSGVKASGKHISSKVVVIVLLLCVILTTIAFLMLVLCYVYRKGKFHL 150
TTCF +C CTSGS++ +A+ KHISSK+VV V+LLCVILTT+AFL Y+ RK K +
Sbjct: 58 TTCFTACNCTSGSLTDAQATRKHISSKIVV-VILLCVILTTLAFLASTTWYLCRKDKCPI 116
Query: 151 RSSVISSDKE-SCNSATNLISHRITSVPETRVEVVSPIDLATGCFLKTTF-CRSKTWTIH 208
+S SD+E SCNSATNLISHR +SV ET++ V SPI+ +GCF K +F CRSKT IH
Sbjct: 117 QSPTFLSDRETSCNSATNLISHRASSVSETKIRVDSPINPISGCFRKASFLCRSKTEIIH 176
Query: 209 GTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVF 268
GT+I F+YS LEHATDKFS SN++G GGSSYVYRGQL DG VAVKR K QGG +AD +F
Sbjct: 177 GTLICFAYSELEHATDKFSHSNLIGLGGSSYVYRGQLKDGTTVAVKRLKAQGGTDADLLF 236
Query: 269 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT 328
EV++L++LHHCHVVPL+GYCSEFRGK + RLLVFE+MPNGNLRDCLDG++ E MNW T
Sbjct: 237 SREVELLAKLHHCHVVPLLGYCSEFRGKLSERLLVFEYMPNGNLRDCLDGIMGENMNWQT 296
Query: 329 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 388
RV IAIGAARGLEYLHEAAAPRILHRD+KS+NIL+DE AKITDLGMAKRL+ADG+PS
Sbjct: 297 RVTIAIGAARGLEYLHEAAAPRILHRDVKSTNILMDELWRAKITDLGMAKRLRADGVPSS 356
Query: 389 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 448
SSSPARMQGTFGYFAPEYAM+GRASLMSDVFSFGVVLLE+ITGRQPIH++ K EESLVL
Sbjct: 357 SSSPARMQGTFGYFAPEYAMIGRASLMSDVFSFGVVLLEVITGRQPIHKTTNKVEESLVL 416
Query: 449 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508
WATP LQDS VISELPDPRLKG+FP+EE+QIMAYLAKECL +DPD+RP+MSEVVQILST
Sbjct: 417 WATPLLQDSRRVISELPDPRLKGNFPEEELQIMAYLAKECLLMDPDSRPSMSEVVQILST 476
Query: 509 IAPDKSRRRNISLNLFQ 525
IAP+KS+RRNI ++LFQ
Sbjct: 477 IAPEKSKRRNIPVSLFQ 493
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356542635|ref|XP_003539772.1| PREDICTED: receptor-like serine/threonine-protein kinase NCRK-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1901), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/637 (59%), Positives = 464/637 (72%), Gaps = 31/637 (4%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MK Q+K+ A +I L+WIQ S CD+ SE S W+C CS QG+QS L NCS+SCD
Sbjct: 1 MKPQLKIALALVISLLWIQHSFCDENSETSSLNKWRCRCS--FQGNQSYSLA-NCSKSCD 57
Query: 61 CSPVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVVV 120
C S WTC+C ++G P+VAA+ + CF++C CT G+VS S KH+SSK+VV
Sbjct: 58 CHSDSEESASVWTCVCDSNGFPQVAADGRSSNCFSTCNCTWGTVSRPGGSKKHVSSKIVV 117
Query: 121 IVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHR--ITSVP 177
++LL+CVI TT+AFL+ ++C+VYRK + ++S + S+DKE S S TNLISHR +SVP
Sbjct: 118 VILLICVICTTMAFLVSLICHVYRKDRCTIQSPIFSTDKETSSGSTTNLISHRSGASSVP 177
Query: 178 ETRVEVVSPIDLATGCFLKTTFC-RSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGG 236
ET+ + SPI TGCF K +F S T HG I FS + LE+AT+ FS SN++G GG
Sbjct: 178 ETKYAINSPIYHITGCFQKASFLFGSPKETYHGNIFPFSLAELENATENFSSSNLIGVGG 237
Query: 237 SSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296
SSYVY G+L DG VAVKR K QGGP ADS F E+++L+RLHHCH+VPL+GYCSE +GK
Sbjct: 238 SSYVYLGRLKDGSNVAVKRLKDQGGPEADSAFFKEIELLARLHHCHLVPLLGYCSELKGK 297
Query: 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 356
RLLVF++M NGNLRDCLDGV + ++W TRV IAIGAARGLEYLHEAAAPRILHRD+
Sbjct: 298 HVQRLLVFDYMANGNLRDCLDGVSGKHIDWATRVMIAIGAARGLEYLHEAAAPRILHRDV 357
Query: 357 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMS 416
KS+NILLDEN AKITDLGMAK L++D LPSCS+SPARMQGTFGYFAPEYA+VGRASL S
Sbjct: 358 KSTNILLDENWQAKITDLGMAKNLRSDDLPSCSNSPARMQGTFGYFAPEYAIVGRASLES 417
Query: 417 DVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKE 476
DVFSFGVVLLELI+GR PIH+S K EESLV+WATPR QDS VI+EL DP+LKG+FP+E
Sbjct: 418 DVFSFGVVLLELISGRHPIHKSTGK-EESLVIWATPRFQDSRRVITELVDPQLKGNFPEE 476
Query: 477 EMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKS-RRRNISLNLFQIFSAGGMEKE 535
E+Q+MAYLAKECL LDPD RPTMSEVVQILS+I+P KS RRRNI +LFQ E
Sbjct: 477 EVQVMAYLAKECLLLDPDTRPTMSEVVQILSSISPGKSRRRRNIPASLFQ---------E 527
Query: 536 PSIERPDNLFETLIESEELKKATSFGSP-RCSQAVDTDITLNTRSNSKEEDTVSTEYMEK 594
P ++++ ++A P S + D L+ + +K ED +S EYME
Sbjct: 528 PE------------DAQKQRQAPPSKFPTHSSMPIYNDHNLSVENKNKAEDALSAEYMES 575
Query: 595 LLLLTSEVRSSRAPDIETVDLTEPRFESFCMKNVNSP 631
L+LLTS+ S A + E VDLTEPRFESFC+ N N P
Sbjct: 576 LILLTSKSDGSCASEEEIVDLTEPRFESFCITNGNVP 612
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351727637|ref|NP_001235120.1| protein kinase family protein precursor [Glycine max] gi|223452424|gb|ACM89539.1| protein kinase family protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 729 bits (1881), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/637 (58%), Positives = 462/637 (72%), Gaps = 31/637 (4%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MK Q+K+ A ++ L+WIQ+S CD+ S+ S W+C CS QG+QS L NCS+SCD
Sbjct: 1 MKPQLKIALALVVSLLWIQQSFCDETSDTSSLNKWRCRCS--FQGNQSYSLA-NCSKSCD 57
Query: 61 CSPVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVVV 120
C S WTC+C ++G P+VAA+ + + CF +C CT G+ S S KH+SSK+VV
Sbjct: 58 CFSDSEESASVWTCVCDSNGFPQVAADGHSSNCFNACNCTWGTFSRPGGSKKHVSSKIVV 117
Query: 121 IVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHR--ITSVP 177
++LL+CVI TT+AFL+ ++C+VYRK + + S + S DKE S S TNLISHR +SVP
Sbjct: 118 VILLICVICTTMAFLVSLICHVYRKDRCTIHSPIFSMDKETSSGSTTNLISHRSGTSSVP 177
Query: 178 ETRVEVVSPIDLATGCFLKTTFC-RSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGG 236
ET+ + SPI TGCF K +F + T HG I FS + LE+AT+ FS SN++G GG
Sbjct: 178 ETKYAMNSPIYHITGCFQKASFFFGNPKETYHGNIFPFSLAELENATENFSSSNLIGVGG 237
Query: 237 SSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296
SSYVY G+L DG VAVKR K QGG ADS F E+++L+RLHHCH+VPL+GYCSE +GK
Sbjct: 238 SSYVYLGRLKDGSNVAVKRLKDQGGSEADSAFFKEIELLARLHHCHLVPLLGYCSELKGK 297
Query: 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 356
RLLVF++M NGNLRDCLDGV + ++W TRV IAIGAARGLEYLHEAAAPRILHRD+
Sbjct: 298 HVQRLLVFDYMANGNLRDCLDGVSGKHVDWATRVMIAIGAARGLEYLHEAAAPRILHRDV 357
Query: 357 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMS 416
KS+NILLDEN AKITDLGMAK L++D LPSCS+SPARMQGTFGYFAPEYA+VGRASL S
Sbjct: 358 KSTNILLDENWQAKITDLGMAKNLRSDDLPSCSNSPARMQGTFGYFAPEYAIVGRASLES 417
Query: 417 DVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKE 476
DVFSFGVVLLELI+GR PIH+S K EESLV+WATPRLQDS VI EL DP+LKG+FP+E
Sbjct: 418 DVFSFGVVLLELISGRHPIHKSTGK-EESLVIWATPRLQDSRRVIRELVDPQLKGNFPEE 476
Query: 477 EMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKS-RRRNISLNLFQIFSAGGMEKE 535
E+QIMAYLAKECL LDPD RPTMSEVVQIL +I+P KS RRRNI +LFQ E
Sbjct: 477 EVQIMAYLAKECLLLDPDTRPTMSEVVQILLSISPGKSRRRRNIPASLFQ---------E 527
Query: 536 PSIERPDNLFETLIESEELKKATSFGSP-RCSQAVDTDITLNTRSNSKEEDTVSTEYMEK 594
P ++E+ +++T P S + D L+ + +K ED VS E ME
Sbjct: 528 PE------------DAEKQRQSTPSKFPTHSSLPIYNDHNLSVENKNKAEDAVSAENMES 575
Query: 595 LLLLTSEVRSSRAPDIETVDLTEPRFESFCMKNVNSP 631
L+LLTS+ SRA + E VDLTEPRFESFC+ N N+P
Sbjct: 576 LILLTSKSDGSRASEEEIVDLTEPRFESFCITNGNAP 612
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449456024|ref|XP_004145750.1| PREDICTED: receptor-like serine/threonine-protein kinase NCRK-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 726 bits (1873), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/635 (58%), Positives = 459/635 (72%), Gaps = 28/635 (4%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
M+ QV TF L+G I +Q+ IC S+ S NW C C S Q +Q L NCS SC
Sbjct: 1 MRHQVAATFLSLVGFILLQQVICADTSDFSTSGNWTCRCFSPHQENQGLTLGPNCSTSCS 60
Query: 61 CSP-VGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVV 119
C+ V GS WTC+C+ DG PKV AN+ D+ CF SC CT G + + S +HISS VV
Sbjct: 61 CTQDVEGSR--LWTCMCSTDGFPKVVANNRDSNCFTSCNCTYGLLPELPYSKRHISSNVV 118
Query: 120 VIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVPE 178
VI+L LCVI+ T+AF +LV+CY+ ++ K +R+ +IS DK+ S NS TNLISHR +S P+
Sbjct: 119 VIILSLCVIIITVAFFILVVCYLCQRDKCRVRAPIISLDKQISYNSLTNLISHRSSSTPD 178
Query: 179 TRVEVVSPIDLATGCF-LKTTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGS 237
++V + SP++ GCF + R+K+ ++ G II+FSYS LE+AT+KFS S++VG+GGS
Sbjct: 179 SKVMMDSPVNNIKGCFFMNQCLLRTKSRSLCGIIIQFSYSELENATEKFSSSHLVGRGGS 238
Query: 238 SYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297
S+VYRG+L DGR VAVKR QGGP+ D +FLTE+ +LSRL+HCHVVPL+GYC+E RGK
Sbjct: 239 SFVYRGELRDGRTVAVKRLNIQGGPDVDYLFLTEIQLLSRLNHCHVVPLLGYCTESRGKH 298
Query: 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 357
RLLV+E+MP GNLRDCLDG + M+W TRV IA+GAARGLEYLHEAAAPRILHRD+K
Sbjct: 299 TERLLVYEYMPKGNLRDCLDGASGKKMDWSTRVTIALGAARGLEYLHEAAAPRILHRDVK 358
Query: 358 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSD 417
S+NILLD++ AKITDLGMA RL+ D LPSCSSSPARMQGTFGYFAPEYA+VGRASL SD
Sbjct: 359 STNILLDKDWRAKITDLGMATRLRGDDLPSCSSSPARMQGTFGYFAPEYAIVGRASLKSD 418
Query: 418 VFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEE 477
VFSFGVVLLELITG+ PIH+S KGEESL +WA PRLQ+S VI+ELPDP L G FP+EE
Sbjct: 419 VFSFGVVLLELITGQHPIHKSAGKGEESLAIWAAPRLQNSRRVITELPDPHLDGTFPEEE 478
Query: 478 MQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNLFQIFSAGGMEKEPS 537
MQIMAYLAKECL LDPDARPTM+EVVQ+LS I PDKSRR NIS N+FQ+ + ME++ S
Sbjct: 479 MQIMAYLAKECLLLDPDARPTMTEVVQVLSNITPDKSRRNNISANVFQVSQSLMMERQAS 538
Query: 538 IERPDNLFETLIESEELKKATSFGSPRCSQAVDTDITLNTRSNSKEEDTVSTEYMEKLLL 597
+ + R S +D D +L N +D VS E M+ L+
Sbjct: 539 SRKWLD--------------------RYSLPLDIDRSL-CADNYGNQDIVSFENMKTLVP 577
Query: 598 LTSEVRSSR--APDIETVDLTEPRFESFCMKNVNS 630
TS+ + R PD ETVDLTEPRFESFC+ NV S
Sbjct: 578 FTSKGNNLRVQGPDDETVDLTEPRFESFCIVNVKS 612
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147834997|emb|CAN61381.1| hypothetical protein VITISV_037547 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 725 bits (1872), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/567 (65%), Positives = 430/567 (75%), Gaps = 44/567 (7%)
Query: 109 ASGKHISSKVVVIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATN 167
A KHISSKVVVI+LLLCV+LTT AFL VLCYVYRK K ++ V SSDKE SCNSATN
Sbjct: 758 ARRKHISSKVVVIILLLCVVLTTFAFLASVLCYVYRKEKCPIQPPVFSSDKETSCNSATN 817
Query: 168 LISHRITSVPETRVEVVSPIDLATGCFLK-TTFCRSKTWTIHGTIIRFSYSALEHATDKF 226
LISH+I SVPE+RV++ SPI+ TGCF K ++ RSKT TIH TI++FSY LE+AT+KF
Sbjct: 818 LISHKINSVPESRVDIGSPINSLTGCFHKASSLFRSKTGTIHETIVQFSYYELENATNKF 877
Query: 227 SGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEV-------------- 272
S SN++G GGSSYVY GQL DG+ VAVKR KT+GGP+AD VFLTEV
Sbjct: 878 SNSNLIGVGGSSYVYCGQLKDGKTVAVKRLKTKGGPDADLVFLTEVLHHSAIIFNLFVEH 937
Query: 273 ----------------------------DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304
++LSRLHHCHVVPL+GYCSE +GK A RLLVF
Sbjct: 938 SFVASVIMGGVRTTEHSWRFYTMLLCQIELLSRLHHCHVVPLLGYCSESQGKHAQRLLVF 997
Query: 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 364
E+M NGNLRDCLDG + M+W TRV+IA+GAARGLEYLHEAAAPRILHRD+KS+NILLD
Sbjct: 998 EYMLNGNLRDCLDGDSGKNMDWATRVSIALGAARGLEYLHEAAAPRILHRDVKSTNILLD 1057
Query: 365 ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVV 424
EN AKITDLGMAKRL+ADGLPSCS+SPARMQGTFGYFAPEYA+VGRAS MSDVFSFGVV
Sbjct: 1058 ENWRAKITDLGMAKRLRADGLPSCSNSPARMQGTFGYFAPEYAIVGRASPMSDVFSFGVV 1117
Query: 425 LLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYL 484
LLELI+GR+PIH+S KGEESLV+WATPRLQDSG V+SELPDP LKG+FP+EEMQIMA+L
Sbjct: 1118 LLELISGRKPIHKSTNKGEESLVIWATPRLQDSGRVMSELPDPHLKGNFPEEEMQIMAFL 1177
Query: 485 AKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNLFQIFSAGGMEKEPSIERPDNL 544
AKECL LDPDARPTMSE+VQILSTIAPDKSRRRNI +N FQ S M+ E + PD
Sbjct: 1178 AKECLLLDPDARPTMSEIVQILSTIAPDKSRRRNIPVNFFQRLSPHSMKSEAHMLIPDKK 1237
Query: 545 FETLIESEELKKATSFGSPRCSQAVDTDITLNTRSNSKEEDTVSTEYMEKLLLLTSEVRS 604
E+ ++ E + T+ + RCS +D D TL + +VS EY+E+L+++TS RS
Sbjct: 1238 SESPVDVELRRAGTNKWTDRCSLPLDIDRTLCIGDXQTKAVSVSAEYIERLIIMTSNARS 1297
Query: 605 SRAPDIETVDLTEPRFESFCMKNVNSP 631
R P ETVDLTEPRFESFCM N SP
Sbjct: 1298 WRGPADETVDLTEPRFESFCMANGRSP 1324
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351725463|ref|NP_001237605.1| protein kinase family protein precursor [Glycine max] gi|223452292|gb|ACM89474.1| protein kinase family protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 717 bits (1850), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/634 (59%), Positives = 459/634 (72%), Gaps = 27/634 (4%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MK Q+ V A +I L+ IQ S CD+ S+ +G WKC CSS LQG++ L NCS+SCD
Sbjct: 1 MKPQLNVAVALVISLLCIQHSFCDEPSD-TGLNKWKCRCSS-LQGNKIYSLA-NCSKSCD 57
Query: 61 CSPVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVVV 120
C P + WTC C +G PKV A+ ++ +CF +C CT G+V S K ISSK+VV
Sbjct: 58 CHPDAEENASIWTCECDPNGFPKVTADVHNLSCFNACNCTWGTVRKPLGSKKQISSKIVV 117
Query: 121 IVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVPET 179
I L +CVI TTIAFL V+C+VYR+ K ++S +ISSDKE S +S TNLISHR +SVPET
Sbjct: 118 IFLSICVICTTIAFLTSVVCHVYRRDKGPIQSPMISSDKETSYSSTTNLISHRTSSVPET 177
Query: 180 RVEVVSPIDLATGCFLKTTFC-RSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSS 238
+V + SPI TGCF K S+ T HG II+FS++ LE+AT+ FS SN++G GGSS
Sbjct: 178 KVAITSPISHITGCFQKAALLFGSQRETFHGNIIQFSFAELENATENFSTSNLIGLGGSS 237
Query: 239 YVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298
YVYRG+L DG VAVKR K Q GP ADS F TE+++LSRLHHCH+VPLVGYCSE +GK
Sbjct: 238 YVYRGRLKDGSNVAVKRIKDQRGPEADSEFFTEIELLSRLHHCHLVPLVGYCSELKGKNV 297
Query: 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 358
RLLVFE+M NGNLRD LDG+L + M+W TRV IA+GAARGLEYLHEAAAPRILHRD+KS
Sbjct: 298 QRLLVFEYMTNGNLRDRLDGILGQKMDWSTRVTIALGAARGLEYLHEAAAPRILHRDVKS 357
Query: 359 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDV 418
+NILLD+N AKITDLGMAK L+AD PSCS SPARMQGTFGYFAPEYA+VGRASL SDV
Sbjct: 358 TNILLDKNWQAKITDLGMAKNLRADDHPSCSDSPARMQGTFGYFAPEYAIVGRASLESDV 417
Query: 419 FSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEM 478
FSFGVVLLELI+GRQPIH+S K EESLV+WAT RLQDS ++EL DP+L G+FP+EE+
Sbjct: 418 FSFGVVLLELISGRQPIHKSAGK-EESLVIWATSRLQDSRRALTELADPQLNGNFPEEEL 476
Query: 479 QIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKS-RRRNISLNLFQIFSAGGMEKEPS 537
QIMAYLAKECL LDPD RPTMSEVVQILS+I+P KS RRR I ++ FQ
Sbjct: 477 QIMAYLAKECLLLDPDTRPTMSEVVQILSSISPGKSRRRRTIPVSPFQ------------ 524
Query: 538 IERPDNLFETLIESEELKKATSFGSPRCSQAVDTDITLNTRSNSKEEDTVSTEYMEKLLL 597
P++L E + + F S R +D D L+ + +K+ TVS+E+++ L+L
Sbjct: 525 --EPEDL-----EKQRQAPPSIFPS-RNLLPLDIDHNLHVGNENKDVHTVSSEHLKSLML 576
Query: 598 LTSEVRSSRAPDIETVDLTEPRFESFCMKNVNSP 631
TS+ S A D E VDLTEPRFESF M N N P
Sbjct: 577 FTSKGESWHASDEEMVDLTEPRFESFYMINDNFP 610
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 631 | ||||||
| TAIR|locus:2062824 | 565 | NCRK [Arabidopsis thaliana (ta | 0.819 | 0.915 | 0.553 | 9e-156 | |
| TAIR|locus:2132168 | 725 | AT4G02010 [Arabidopsis thalian | 0.508 | 0.442 | 0.457 | 7.2e-68 | |
| TAIR|locus:2028756 | 762 | PERK10 "proline-rich extensin- | 0.456 | 0.377 | 0.475 | 6.9e-63 | |
| TAIR|locus:2026925 | 708 | PERK9 "proline-rich extensin-l | 0.491 | 0.437 | 0.446 | 4.8e-62 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.458 | 0.424 | 0.473 | 7.9e-62 | |
| TAIR|locus:2019938 | 718 | PERK11 "proline-rich extensin- | 0.503 | 0.442 | 0.450 | 1.3e-61 | |
| TAIR|locus:2038992 | 744 | ALE2 "Abnormal Leaf Shape 2" [ | 0.451 | 0.383 | 0.453 | 1.3e-61 | |
| TAIR|locus:2099009 | 400 | AT3G58690 [Arabidopsis thalian | 0.492 | 0.777 | 0.431 | 1.3e-61 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.448 | 0.437 | 0.462 | 1.9e-60 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.448 | 0.434 | 0.456 | 3.1e-60 |
| TAIR|locus:2062824 NCRK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1452 (516.2 bits), Expect = 9.0e-156, Sum P(2) = 9.0e-156
Identities = 301/544 (55%), Positives = 380/544 (69%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MK++V+ A L+ LI IQ+ C G N+ CTC SS G++S+IL+ NCS SC+
Sbjct: 1 MKMRVETALAILLVLISIQQ--C-----YGGVSNYTCTCFSS--GNRSDILESNCSTSCN 51
Query: 61 CSPVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTXXXXXXXXXXXXHISSKXXX 120
C P +W C+C A+G P +A +++CF SC C+ ++S K
Sbjct: 52 CRP----DRDQWVCLCPANGFPVIAIGGSNSSCFTSCNCSAGATKSSKKQ--YLSRKLVI 105
Query: 121 XXXXXXXXXXXXAFLMLVLCYVYRKGKFHLRSSVISSDKESC-NSATNLISHRITSVPET 179
AFL ++CY+ RK KF ++ +SSD+ES +S+ NLI+ + +SV ++
Sbjct: 106 VILLFCGVLISLAFLASMICYICRKDKFSGQTPSVSSDRESSWHSSANLINRK-SSVSQS 164
Query: 180 RVEVVSPIDLATGCFLKTT--FCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGS 237
++ + S + GCF + FC SK TIHG I +FSY+ LE AT+KFS ++++G GGS
Sbjct: 165 KISISSSV---AGCFFQNASLFCVSKPETIHGAIFQFSYTELEQATNKFSSNSVIGHGGS 221
Query: 238 SYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297
S VYRGQL DG+ A+KR T G + D++F TEV++LSRLHH HVVPL+GYCSEF GK
Sbjct: 222 SCVYRGQLKDGKTAAIKRLNTPKGDDTDTLFSTEVELLSRLHHYHVVPLIGYCSEFHGKH 281
Query: 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 357
A RLLVFE+M G+LRDCLDG L E M W+ R+++A+GAARGLEYLHEAAAPRILHRD+K
Sbjct: 282 AERLLVFEYMSYGSLRDCLDGELGEKMTWNIRISVALGAARGLEYLHEAAAPRILHRDVK 341
Query: 358 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFGYFAPEYAMVGRASLMS 416
S+NILLDEN +AKITDLGMAK L +DGL S SSSP +QGTFGYFAPEYA+ G AS MS
Sbjct: 342 STNILLDENWHAKITDLGMAKCLSSDGLQSGSSSPTTGLQGTFGYFAPEYAIAGCASQMS 401
Query: 417 DVFSFGVVLLELITGRQPIHR-SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPK 475
DVFSFGVVLLELITGR+PI + S KGEESLV+WA PRLQDS VI ELPDPRL G F +
Sbjct: 402 DVFSFGVVLLELITGRKPIQKPSNNKGEESLVIWAVPRLQDSKRVIEELPDPRLNGKFAE 461
Query: 476 EEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD-KSRRRNISLNLFQIFSAGGMEK 534
EEMQIMAYLAKECL LDP++RPTM EVVQILSTI PD SRRRN +N +F + +K
Sbjct: 462 EEMQIMAYLAKECLLLDPESRPTMREVVQILSTITPDTSSRRRNFPINY--LFQSNEKKK 519
Query: 535 EPSI 538
E +
Sbjct: 520 ESKV 523
|
|
| TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 689 (247.6 bits), Expect = 7.2e-68, P = 7.2e-68
Identities = 157/343 (45%), Positives = 207/343 (60%)
Query: 172 RITSVPETRVEVVSPIDLATGCFLKTTFCRSKTWTIHGTIIRF-SYSALEHATDKFSGSN 230
R P+ E V P +L G F + H RF SY L+ AT F ++
Sbjct: 333 REEKAPDPHKEAVKPRNLDAGSFGGSL--------PHPASTRFLSYEELKEATSNFESAS 384
Query: 231 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
I+G+GG VYRG L DG VA+K+ T GGP D F E+DMLSRLHH ++V LVGY
Sbjct: 385 ILGEGGFGKVYRGILADGTAVAIKKL-TSGGPQGDKEFQVEIDMLSRLHHRNLVKLVGYY 443
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMN----WDTRVAIAIGAARGLEYLHEA 346
S R + LL +E +PNG+L L G L G+N WDTR+ IA+ AARGL YLHE
Sbjct: 444 SS-RDS-SQHLLCYELVPNGSLEAWLHGPL--GLNCPLDWDTRMKIALDAARGLAYLHED 499
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
+ P ++HRD K+SNILL+ N NAK+ D G+AK+ +G + S+ R+ GTFGY APEY
Sbjct: 500 SQPSVIHRDFKASNILLENNFNAKVADFGLAKQAP-EGRGNHLST--RVMGTFGYVAPEY 556
Query: 407 AMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 466
AM G + SDV+S+GVVLLEL+TGR+P+ S G+E+LV W P L+D + EL D
Sbjct: 557 AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWTRPVLRDKDR-LEELVD 615
Query: 467 PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
RL+G +PKE+ + +A C+ + RPTM EVVQ L +
Sbjct: 616 SRLEGKYPKEDFIRVCTIAAACVAPEASQRPTMGEVVQSLKMV 658
|
|
| TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 642 (231.1 bits), Expect = 6.9e-63, P = 6.9e-63
Identities = 144/303 (47%), Positives = 192/303 (63%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
FSY L AT+ FS N++G+GG VY+G L D R+VAVK+ K GG D F EVD
Sbjct: 418 FSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGG-QGDREFKAEVD 476
Query: 274 MLSRLHHCHVVPLVGYC-SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 332
+SR+HH +++ +VGYC SE R RLL+++++PN NL L G++W TRV I
Sbjct: 477 TISRVHHRNLLSMVGYCISENR-----RLLIYDYVPNNNLYFHLHAAGTPGLDWATRVKI 531
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS- 391
A GAARGL YLHE PRI+HRDIKSSNILL+ N +A ++D G+AK L D C++
Sbjct: 532 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAK-LALD----CNTHI 586
Query: 392 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 451
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ S G+ESLV WA
Sbjct: 587 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWAR 646
Query: 452 PRLQDSGTV--ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
P L ++ + L DP+L ++ EM M A C++ RP MS++V+ ++
Sbjct: 647 PLLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAFDSL 706
Query: 510 APD 512
A +
Sbjct: 707 AEE 709
|
|
| TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 634 (228.2 bits), Expect = 4.8e-62, P = 4.8e-62
Identities = 145/325 (44%), Positives = 200/325 (61%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
FSY L AT+ FS N++G+GG VY+G L DGR+VAVK+ K GG D F EV+
Sbjct: 365 FSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGG-QGDREFKAEVE 423
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
LSR+HH H+V +VG+C G R RLL+++++ N +L L G ++W TRV IA
Sbjct: 424 TLSRIHHRHLVSIVGHC--ISGDR--RLLIYDYVSNNDLYFHLHGEK-SVLDWATRVKIA 478
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS-P 392
GAARGL YLHE PRI+HRDIKSSNILL++N +A+++D G+A RL D C++
Sbjct: 479 AGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLA-RLALD----CNTHIT 533
Query: 393 ARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 452
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ S G+ESLV WA P
Sbjct: 534 TRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARP 593
Query: 453 RLQDSGTV--ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510
+ + L DP+L G++ + EM M A C++ RP M ++V+ ++A
Sbjct: 594 LISHAIETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFESLA 653
Query: 511 PDKSRRRNISLNLFQIFSAGGMEKE 535
+ + L ++F++ E
Sbjct: 654 AE-DLTNGMRLGESEVFNSAQQSAE 677
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 632 (227.5 bits), Expect = 7.9e-62, P = 7.9e-62
Identities = 141/298 (47%), Positives = 183/298 (61%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
FSY L T FS N++G+GG VY+G L+DGR VAVK+ K GG + F EV+
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKI-GGSQGEREFKAEVE 385
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
++SR+HH H+V LVGYC RLLV++++PN L L M W+TRV +A
Sbjct: 386 IISRVHHRHLVTLVGYCIS----EQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVA 441
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393
GAARG+ YLHE PRI+HRDIKSSNILLD + A + D G+AK + L + S+
Sbjct: 442 AGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVST-- 499
Query: 394 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 453
R+ GTFGY APEYA G+ S +DV+S+GV+LLELITGR+P+ S G+ESLV WA P
Sbjct: 500 RVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPL 559
Query: 454 LQDS--GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
L + EL DPRL +F EM M A C++ RP MS+VV+ L T+
Sbjct: 560 LGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTL 617
|
|
| TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 630 (226.8 bits), Expect = 1.3e-61, P = 1.3e-61
Identities = 150/333 (45%), Positives = 200/333 (60%)
Query: 212 IRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTE 271
I F+Y L T+ F S +VG+GG VY+G L +G+ VA+K+ K+ F E
Sbjct: 356 IHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYRE-FKAE 414
Query: 272 VDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA 331
V+++SR+HH H+V LVGYC R L++EF+PN L L G + + W RV
Sbjct: 415 VEIISRVHHRHLVSLVGYCIS----EQHRFLIYEFVPNNTLDYHLHGKNLPVLEWSRRVR 470
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 391
IAIGAA+GL YLHE P+I+HRDIKSSNILLD+ A++ D G+A RL D S S+
Sbjct: 471 IAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLA-RLN-DTAQSHIST 528
Query: 392 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 451
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ S GEESLV WA
Sbjct: 529 --RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWAR 586
Query: 452 PRLQDS---GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508
PRL ++ G ISE+ DPRL+ D+ + E+ M A C++ RP M +VV+ L T
Sbjct: 587 PRLIEAIEKGD-ISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRALDT 645
Query: 509 IAPDKSRRRN-ISLNLFQIFSAGGMEKEPSIER 540
D S N + + +++ +G E I R
Sbjct: 646 -RDDLSDLTNGVKVGQSRVYDSGQYSNEIRIFR 677
|
|
| TAIR|locus:2038992 ALE2 "Abnormal Leaf Shape 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 630 (226.8 bits), Expect = 1.3e-61, P = 1.3e-61
Identities = 136/300 (45%), Positives = 190/300 (63%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
F+ S LE ATD+FS ++G+GG VY+G + DG VAVK T+ N D F+ EV+
Sbjct: 337 FTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLL-TRDNQNRDREFIAEVE 395
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAI 332
MLSRLHH ++V L+G C E R R L++E + NG++ L EG ++WD R+ I
Sbjct: 396 MLSRLHHRNLVKLIGICIEGR----TRCLIYELVHNGSVESHLH----EGTLDWDARLKI 447
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP 392
A+GAARGL YLHE + PR++HRD K+SN+LL+++ K++D G+A+ +G S+
Sbjct: 448 ALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA-TEGSQHIST-- 504
Query: 393 ARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 452
R+ GTFGY APEYAM G + SDV+S+GVVLLEL+TGR+P+ S GEE+LV WA P
Sbjct: 505 -RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARP 563
Query: 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512
L + + +L DP L G + ++M +A +A C+ + RP M EVVQ L I D
Sbjct: 564 LLANREG-LEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALKLIYND 622
|
|
| TAIR|locus:2099009 AT3G58690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 630 (226.8 bits), Expect = 1.3e-61, P = 1.3e-61
Identities = 142/329 (43%), Positives = 203/329 (61%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
F++ L AT FS SN+VG GG VYRG L DGR VA+K G + F EV+
Sbjct: 75 FTFKQLHSATGGFSKSNVVGNGGFGLVYRGVLNDGRKVAIK-LMDHAGKQGEEEFKMEVE 133
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDT 328
+LSRL +++ L+GYCS+ + +LLV+EFM NG L++ L G + ++W+T
Sbjct: 134 LLSRLRSPYLLALLGYCSD----NSHKLLVYEFMANGGLQEHLYLPNRSGSVPPRLDWET 189
Query: 329 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 388
R+ IA+ AA+GLEYLHE +P ++HRD KSSNILLD N NAK++D G+AK + +D
Sbjct: 190 RMRIAVEAAKGLEYLHEQVSPPVIHRDFKSSNILLDRNFNAKVSDFGLAK-VGSDKAGGH 248
Query: 389 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 448
S+ R+ GT GY APEYA+ G + SDV+S+GVVLLEL+TGR P+ GE LV
Sbjct: 249 VST--RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDMKRATGEGVLVS 306
Query: 449 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508
WA P+L D V+ ++ DP L+G + +E+ +A +A C+Q + D RP M++VVQ +
Sbjct: 307 WALPQLADRDKVV-DIMDPTLEGQYSTKEVVQVAAIAAMCVQAEADYRPLMADVVQ---S 362
Query: 509 IAPDKSRRRNISLNLFQIFSAGGMEKEPS 537
+ P RR+ S L S+ + + P+
Sbjct: 363 LVPLVRNRRSAS-KLSGCSSSFSLARSPN 390
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 619 (223.0 bits), Expect = 1.9e-60, P = 1.9e-60
Identities = 137/296 (46%), Positives = 185/296 (62%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
F+Y L AT+ FS +N++GQGG YV++G L G+ VAVK+ K G + F EV+
Sbjct: 263 FTYEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEVAVKQLKVGSG-QGEREFQAEVE 321
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
++SR+HH H+V LVGYC G A RLLV+EF+PN NL L G M W TR+ IA
Sbjct: 322 IISRVHHRHLVSLVGYC--IAG--AKRLLVYEFVPNNNLELHLHGEGRPTMEWSTRLKIA 377
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393
+G+A+GL YLHE P+I+HRDIK+SNIL+D AK+ D G+AK + +D S+
Sbjct: 378 LGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAK-IASDTNTHVST--- 433
Query: 394 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP- 452
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ + ++SLV WA P
Sbjct: 434 RVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPL 493
Query: 453 --RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
R + G L D ++ + +EEM M A C++ RP MS++V+ L
Sbjct: 494 LNRASEQGD-FEGLADAKMNNGYDREEMARMVACAAACVRHSARRRPRMSQIVRAL 548
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 617 (222.3 bits), Expect = 3.1e-60, P = 3.1e-60
Identities = 135/296 (45%), Positives = 185/296 (62%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
F+Y L AT+ FS +N++GQGG YV++G L G+ VAVK+ K G + F EV+
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSG-QGEREFQAEVE 326
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
++SR+HH H+V L+GYC G RLLV+EF+PN NL L G M W TR+ IA
Sbjct: 327 IISRVHHRHLVSLIGYC--MAG--VQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIA 382
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393
+G+A+GL YLHE P+I+HRDIK+SNIL+D AK+ D G+AK + +D S+
Sbjct: 383 LGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAK-IASDTNTHVST--- 438
Query: 394 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP- 452
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ + ++SLV WA P
Sbjct: 439 RVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPL 498
Query: 453 --RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
R + G L D ++ ++ +EEM M A C++ RP MS++V+ L
Sbjct: 499 LNRASEEGD-FEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRAL 553
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q8VYY5 | NCRK_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5173 | 0.8684 | 0.9699 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00024559001 | SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (580 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 631 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-46 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-40 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-27 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-21 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-20 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-18 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 8e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 6e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.001 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.001 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.002 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 6e-49
Identities = 78/278 (28%), Positives = 119/278 (42%), Gaps = 66/278 (23%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G+GG VY + G+ VA+K K + + L E+++L +L+H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 350
+ LV E+ G+L+D L ++ D + I + GLEYLH
Sbjct: 61 EDENH----LYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHSN---G 112
Query: 351 ILHRDIKSSNILLDE-NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE-YAM 408
I+HRD+K NILLD N K+ D G++K L +D + + GT Y APE
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-----IVGTPAYMAPEVLLG 167
Query: 409 VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 468
G S SD++S GV+L EL P L+D
Sbjct: 168 KGYYSEKSDIWSLGVILYEL-----------------------PELKD------------ 192
Query: 469 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
L ++ LQ DP+ RP+ E+++ L
Sbjct: 193 ---------------LIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 2e-46
Identities = 96/282 (34%), Positives = 130/282 (46%), Gaps = 39/282 (13%)
Query: 231 IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVG 288
+G G VY+ + G+IVAVK K + D E+ +L RL H ++V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG--MNWDTRVAIAIGAARGLEYLHEA 346
F K + LV E+ G+L D L G ++ D IA+ RGLEYLH
Sbjct: 66 A---FEDKDHL-YLVMEYCEGGDLFD----YLSRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ-GTFGYFAPE 405
I+HRD+K NILLDEN KI D G+AK SSS GT Y APE
Sbjct: 118 ---GIIHRDLKPENILLDENGVVKIADFGLAK------KLLKSSSSLTTFVGTPWYMAPE 168
Query: 406 YAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 464
+ G DV+S GV+L EL+TG+ P ++ + D +I +
Sbjct: 169 VLLGGNGYGPKVDVWSLGVILYELLTGKPP--------------FSGENILDQLQLIRRI 214
Query: 465 PDPRLKGDFPK--EEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
P L+ D PK + L K+CL DP RPT E++Q
Sbjct: 215 LGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 6e-44
Identities = 86/283 (30%), Positives = 128/283 (45%), Gaps = 55/283 (19%)
Query: 240 VYRGQLTDG-----RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 294
VY+G L VAVK K FL E ++ +L H ++V L+G C+E
Sbjct: 15 VYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-- 72
Query: 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHR 354
+ M +V E+MP G+L D L + ++ ++ A+ ARG+EYL +HR
Sbjct: 73 EEPLM--IVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHR 127
Query: 355 DIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARMQGTFGYFAPEYAMVGRA 412
D+ + N L+ ENL KI+D G+++ L D P R + APE G+
Sbjct: 128 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR------WMAPESLKEGKF 181
Query: 413 SLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQDSGTVISE 463
+ SDV+SFGV+L E+ T G +P + + KG RL
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGY---------RL--------P 224
Query: 464 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
P + P E + L +C DP+ RPT SE+V+IL
Sbjct: 225 KPP-----NCPPE----LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 7e-43
Identities = 78/289 (26%), Positives = 118/289 (40%), Gaps = 57/289 (19%)
Query: 230 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
+G+G VY + G++VA+K K + L E+ +L +L H ++V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGA--ARGLEYLH 344
E K + V E+ G+L D L G L E A LEYLH
Sbjct: 65 VF-EDEDKLYL---VMEYCEGGDLFDLLKKRGRLSE------DEARFYLRQILSALEYLH 114
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 404
I+HRD+K NILLDE+ + K+ D G+A++L + GT Y AP
Sbjct: 115 SK---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT------TFVGTPEYMAP 165
Query: 405 EYAMVGRASLMSDVFSFGVVLLELITGRQP---------IHRSITKGEESLVLWATPRLQ 455
E + D++S GV+L EL+TG+ P + + I K +
Sbjct: 166 EVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKP----------- 214
Query: 456 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
P P + D E ++ ++ L DP+ R T E +Q
Sbjct: 215 ---------PFPPPEWDISPEAKDLI----RKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 7e-43
Identities = 85/286 (29%), Positives = 123/286 (43%), Gaps = 62/286 (21%)
Query: 240 VYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 294
VY+G+L VAVK K FL E ++ +L H +VV L+G C+E
Sbjct: 15 VYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTE-- 72
Query: 295 GKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351
+V E+M G+L L L + ++ A+ ARG+EYL
Sbjct: 73 --EEPLYIVMEYMEGGDLLSYLRKNRPKL----SLSDLLSFALQIARGMEYLESK---NF 123
Query: 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARMQGTFGYFAPEYAMV 409
+HRD+ + N L+ ENL KI+D G+++ L D P R + APE
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR------WMAPESLKE 177
Query: 410 GRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQDSGTV 460
G+ + SDV+SFGV+L E+ T G QP + + G RL
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGY---------RL------ 222
Query: 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
P + P E +M +C DP+ RPT SE+V+IL
Sbjct: 223 --PQPP-----NCPPELYDLM----LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 2e-42
Identities = 87/302 (28%), Positives = 130/302 (43%), Gaps = 66/302 (21%)
Query: 230 NIVGQG--GSSYVYRGQLTDG----RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
+G+G G VY+G+L VAVK K FL E ++ +L H +V
Sbjct: 1 KKLGEGAFGE--VYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNV 58
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNL-------RDCLDGVLVEGMNWDTRVAIAIGA 336
V L+G C+E LV E+M G+L R ++ ++ AI
Sbjct: 59 VRLLGVCTE----EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS---PA 393
A+G+EYL + +HRD+ + N L+ E+L KI+D G+++ + D + P
Sbjct: 115 AKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI 171
Query: 394 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEE 444
R + APE G + SDV+SFGV+L E+ T G P + + KG
Sbjct: 172 R------WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY- 224
Query: 445 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
RL P+ P E ++M C QLDP+ RPT SE+V+
Sbjct: 225 --------RL--------PKPE-----YCPDELYELM----LSCWQLDPEDRPTFSELVE 259
Query: 505 IL 506
L
Sbjct: 260 RL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 5e-40
Identities = 88/298 (29%), Positives = 131/298 (43%), Gaps = 71/298 (23%)
Query: 233 GQG--GSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
G+G G VY+G L VAVK K FL E ++ +L H ++V
Sbjct: 8 GEGAFGE--VYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEY 342
L+G C++ G+ +V E+MP G+L D L L + +A+ A+G+EY
Sbjct: 66 LLGVCTQ--GEPLY--IVTEYMPGGDLLDFLRKHGEKL----TLKDLLQMALQIAKGMEY 117
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
L +HRD+ + N L+ ENL KI+D G+++ + D R +G G
Sbjct: 118 LESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY-------YRKRGG-GKL 166
Query: 403 -----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVL 448
APE G+ + SDV+SFGV+L E+ T G QP + + G
Sbjct: 167 PIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGY----- 221
Query: 449 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
RL PR + P E ++M +C DP+ RPT SE+V+ L
Sbjct: 222 ----RL------------PRPENC-PDELYELM----LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 7e-39
Identities = 81/282 (28%), Positives = 120/282 (42%), Gaps = 38/282 (13%)
Query: 230 NIVGQGGSSYVYRGQLTD-GRIVAVK--RFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
++G+G VY D G ++AVK +++ E+ +LS L H ++V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEAL-EREIRILSSLQHPNIVRY 64
Query: 287 VGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGMNWDTRV-AIAIGAARGLEY 342
G R + L +F E++ G+L L G L E + R I GL Y
Sbjct: 65 YGSE---RDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IRKYTRQI--LEGLAY 116
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
LH I+HRDIK +NIL+D + K+ D G AKRL + S ++GT +
Sbjct: 117 LHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS---VRGTPYWM 170
Query: 403 APEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462
APE +D++S G ++E+ TG+ P G L+ + I
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSE---LGNPMAALYKIGSSGEP-PEIP 226
Query: 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
E K DF L K CL+ DP RPT E++Q
Sbjct: 227 EHLSEEAK-DF----------LRK-CLRRDPKKRPTADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 77/277 (27%), Positives = 121/277 (43%), Gaps = 44/277 (15%)
Query: 232 VGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G+GG VY+ G+ VA+K K + + + + E+ +L + H ++V Y
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKI-INEIQILKKCKHPNIVKY--YG 64
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 350
S + +V EF G+L+D L + + + +GLEYLH
Sbjct: 65 SYLKKDELW--IVMEFCSGGSLKDLLKS-TNQTLTESQIAYVCKELLKGLEYLHSN---G 118
Query: 351 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR--MQGTFGYFAPEYAM 408
I+HRDIK++NILL + K+ D G++ +L S + AR M GT + APE
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQL--------SDTKARNTMVGTPYWMAPEVIN 170
Query: 409 VGRASLMSDVFSFGVVLLELITGRQPIHRS-ITKGEESLVLWAT---PRLQDSGTVISEL 464
+D++S G+ +EL G+ P K L AT P L++ E
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA---LFKIATNGPPGLRN-----PEK 222
Query: 465 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 501
K DF K+CLQ +P+ RPT +
Sbjct: 223 WSDEFK-DF-----------LKKCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 84/295 (28%), Positives = 131/295 (44%), Gaps = 32/295 (10%)
Query: 229 SNIVGQG--GSSYVYRGQLTD---GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
+G+G G + R G VAVK G S F E+++L L H ++
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 343
V G E G R++RL + E++P+G+LRD L + +N + + +G++YL
Sbjct: 69 VKYKG-VCEKPGGRSLRL-IMEYLPSGSLRDYLQR-HRDQINLKRLLLFSSQICKGMDYL 125
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG----LPSCSSSPARMQGTF 399
R +HRD+ + NIL++ KI+D G+AK L D + SP
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF----- 177
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459
++APE + S SDV+SFGV L EL T P E L + + Q T
Sbjct: 178 -WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPA---EFLRMIGIAQGQMIVT 233
Query: 460 VISEL--PDPRLK--GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510
+ EL RL P E +M K C + +P RP+ ++++ I+ +
Sbjct: 234 RLLELLKEGERLPRPPSCPDEVYDLM----KLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (298), Expect = 3e-29
Identities = 95/396 (23%), Positives = 149/396 (37%), Gaps = 39/396 (9%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRL-HHCHVVPLVG 288
+G+G VY + D ++VA+K + + V FL E+ +L+ L H ++V L
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLEYLHEAA 347
+ + LV E++ G+L D L + +G ++ + I LEYLH
Sbjct: 66 FFQDEGSL----YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK- 120
Query: 348 APRILHRDIKSSNILLDENLN-AKITDLGMAKRLKADGLPSCSSSPARMQ-GTFGYFAPE 405
I+HRDIK NILLD + K+ D G+AK L G S + GT GY APE
Sbjct: 121 --GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 406 YAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462
+ + AS SD++S G+ L EL+TG P S L +I
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL----------KIIL 228
Query: 463 ELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPDARPTMSEVVQI-------LSTIAP 511
ELP P L ++++ A + L DP R + S + L
Sbjct: 229 ELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDL 288
Query: 512 DKSRRRNISLNLFQIFSAGGMEKEPSIERPDNLFETLIESEELKKATSFGSPRCSQAVDT 571
+ + S L S+ L + + S ++
Sbjct: 289 SDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNS 348
Query: 572 DITLNTRSNSKEEDTVSTEYMEKLLLLTSEVRSSRA 607
L + ++SK L+S R +
Sbjct: 349 SSLLLSTASSKRSSLPKISARSSPSSLSSSSRQQAS 384
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 83/278 (29%), Positives = 130/278 (46%), Gaps = 38/278 (13%)
Query: 233 GQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG-YC 290
GQG S VY+ + G+I A+K+ G L E+ L +VV G +
Sbjct: 10 GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY 69
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVA-IAIGAARGLEYLHEAA 347
E G+ + +V E+M G+L D L G + E + +A IA +GL+YLH
Sbjct: 70 KE--GEIS---IVLEYMDGGSLADLLKKVGKIPEPV-----LAYIARQILKGLDYLHTKR 119
Query: 348 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA 407
I+HRDIK SN+L++ KI D G++K L + L C++ GT Y +PE
Sbjct: 120 --HIIHRDIKPSNLLINSKGEVKIADFGISKVL-ENTLDQCNTF----VGTVTYMSPE-R 171
Query: 408 MVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 466
+ G + S +D++S G+ LLE G+ P + +Q I + P
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGKFPF-----LPPGQPSFFEL--MQ----AICDGPP 220
Query: 467 PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
P L + E + +++ CLQ DP RP+ +E++Q
Sbjct: 221 PSLPAEEFSPEFR--DFISA-CLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 75/281 (26%), Positives = 124/281 (44%), Gaps = 44/281 (15%)
Query: 225 KFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCH 282
+ +++G+G VY+G L G VA+K+ + + E+D+L L H +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAA-RG 339
+V +G ++ ++ E+ NG+LR + G E + VA+ + +G
Sbjct: 61 IVKYIGS---IETSDSL-YIILEYAENGSLRQIIKKFGPFPE-----SLVAVYVYQVLQG 111
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
L YLHE ++HRDIK++NIL ++ K+ D G+A +L S GT
Sbjct: 112 LAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV-----VGTP 163
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459
+ APE + AS SD++S G ++EL+TG P + L
Sbjct: 164 YWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYY----------------DLNPMAA 207
Query: 460 V--ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT 498
+ I + P L E + +L +C Q DP+ RPT
Sbjct: 208 LFRIVQDDHPPLPEGISPE---LKDFL-MQCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 79/298 (26%), Positives = 130/298 (43%), Gaps = 55/298 (18%)
Query: 232 VGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
+G+G V+ G+ D +VAVK K +A F E ++L+ H ++V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDTR-------VAIA 333
G C+E G + +VFE+M +G+L L D ++ + + IA
Sbjct: 73 FYGVCTE--GDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393
+ A G+ YL A+ +HRD+ + N L+ +L KI D GM++ + ++
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVY-------TTDYY 178
Query: 394 RMQGT----FGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVL 448
R+ G + PE M + + SDV+SFGVVL E+ T G+QP + ++ E +
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY-GLSNEEVIECI 237
Query: 449 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
G + L PR P E IM C + DP R + ++ + L
Sbjct: 238 -------TQGRL---LQRPR---TCPSEVYDIM----LGCWKRDPQQRINIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 83/275 (30%), Positives = 124/275 (45%), Gaps = 39/275 (14%)
Query: 248 GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 307
G +VAVK K + G S + E+++L L+H ++V G CSE GK L+ E++
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK--GLQLIMEYV 90
Query: 308 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 367
P G+LRD L +N + A G+ YLH + +HRD+ + N+LLD +
Sbjct: 91 PLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDR 144
Query: 368 NAKITDLGMAK---------RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDV 418
KI D G+AK R++ DG SP ++A E + S SDV
Sbjct: 145 LVKIGDFGLAKAVPEGHEYYRVREDG-----DSPVF------WYAVECLKENKFSYASDV 193
Query: 419 FSFGVVLLELITGRQPIHRSITKGEESL----VLWATPRLQDSGTVISELPDPRLKGDFP 474
+SFGV L EL+T K EE + RL + LP P+ + P
Sbjct: 194 WSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPK---NCP 250
Query: 475 KEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
+E +M K C + + RPT ++ IL +
Sbjct: 251 QEVYILM----KNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 81/298 (27%), Positives = 117/298 (39%), Gaps = 64/298 (21%)
Query: 229 SNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPL 286
N +G G VY L G ++AVK + Q P E+ +L L H ++V
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV-- 62
Query: 287 VGYCSEFRGKRAMR--LLVF-EFMPNGNLRDCLDGVLVEGMNWDTRV--AIAIGAARGLE 341
++ G R + +F E+ G L + +L G D V + GL
Sbjct: 63 -----KYYGVEVHREKVYIFMEYCSGGTLEE----LLEHGRILDEHVIRVYTLQLLEGLA 113
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
YLH I+HRDIK +NI LD N K+ D G A +LK + + GT Y
Sbjct: 114 YLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT-MGEEVQSLAGTPAY 169
Query: 402 FAPE------YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA----- 450
APE GRA +D++S G V+LE+ TG++P + +
Sbjct: 170 MAPEVITGGKGKGHGRA---ADIWSLGCVVLEMATGKRPWSELDNE-------FQIMFHV 219
Query: 451 ----TPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
P +PD K+ CL+ DP RPT SE++Q
Sbjct: 220 GAGHKP----------PIPDSLQLSPEGKD-------FLDRCLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 77/275 (28%), Positives = 131/275 (47%), Gaps = 28/275 (10%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+G+G VY+G L VAVK ++ P+ FL E ++L + H ++V L+G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351
+ + +V E +P G+L L + + +++ AA G+EYL +
Sbjct: 63 Q----KQPIYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLE---SKNC 114
Query: 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR 411
+HRD+ + N L+ EN KI+D GM+ R + G+ + S Q + APE GR
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMS-REEEGGIYTVSD--GLKQIPIKWTAPEALNYGR 171
Query: 412 ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKG 471
+ SDV+S+G++L E + + ++ + T +SG +P P+L
Sbjct: 172 YTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERIESG---YRMPAPQL-- 219
Query: 472 DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
P+E ++M +C DP+ RP+ SE+ L
Sbjct: 220 -CPEEIYRLM----LQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 83/290 (28%), Positives = 129/290 (44%), Gaps = 59/290 (20%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+G+G V G G+ VAVK K A + FL E +++ L H ++V L+G
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTA-AQA-FLAEASVMTTLRHPNLVQLLGVV- 69
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351
+G +V E+M G+L D L + ++ A+ G+EYL E
Sbjct: 70 -LQGNPLY--IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NF 123
Query: 352 LHRDIKSSNILLDENLNAKITDLGMAK--RLKADG--LPSCSSSPARMQGTFGYFAPEYA 407
+HRD+ + N+L+ E+L AK++D G+AK D LP + APE
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP------------VKWTAPEAL 171
Query: 408 MVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPR--LQDSGTVIS-- 462
+ S SDV+SFG++L E+ + GR P PR L+D +
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPY----------------PRIPLKDVVPHVEKG 215
Query: 463 ---ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
E P+ P E ++M K+C +LDP RPT ++ + L+ I
Sbjct: 216 YRMEAPE-----GCPPEVYKVM----KDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 89/272 (32%), Positives = 127/272 (46%), Gaps = 42/272 (15%)
Query: 233 GQGGSSYVYRGQLTDGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
G G V+ G VAVK K G P A FL E ++ +L H +V L C
Sbjct: 15 GAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEA---FLQEAQIMKKLRHDKLVQLYAVC 70
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCL-DGVLVEG--MNWDTRVAIAIGAARGLEYLHEAA 347
SE +V E+M G+L D L G EG + V +A A G+ YL
Sbjct: 71 SE----EEPIYIVTEYMSKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLESR- 122
Query: 348 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA 407
+HRD+ + NIL+ ENL KI D G+A+ ++ D + + ++ T APE A
Sbjct: 123 --NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAA 176
Query: 408 MVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 466
GR ++ SDV+SFG++L E++T GR P + +T E VL R G +P
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVP-YPGMTNRE---VLEQVER----GY---RMPR 225
Query: 467 PRLKGDFPKEEMQIMAYLAKECLQLDPDARPT 498
P + P+E +M +C DP+ RPT
Sbjct: 226 PP---NCPEELYDLM----LQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 80/282 (28%), Positives = 119/282 (42%), Gaps = 36/282 (12%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH 279
E ++F+ +G G V+ G + VA+K K+ F EV L RL
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD-FQKEVQALKRLR 60
Query: 280 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--A 337
H H++ L CS ++ E M G+L L EG I + A
Sbjct: 61 HKHLISLFAVCSVGEPV----YIITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVA 114
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD-GLPSCSSSPARMQ 396
G+ YL E +HRD+ + NIL+ E+L K+ D G+A+ +K D L S P +
Sbjct: 115 EGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK-- 169
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456
+ APE A G S SDV+SFG++L E+ T Q + + E
Sbjct: 170 ----WTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE-------VYDQIT 218
Query: 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT 498
+G +P P P+E +IM EC +P+ RP+
Sbjct: 219 AGY---RMPCP---AKCPQEIYKIM----LECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 78/285 (27%), Positives = 126/285 (44%), Gaps = 40/285 (14%)
Query: 226 FSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCHV 283
F N +G+G V++ + D R+ A+K+ + + E +L++L ++
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 343
+ Y F K + + V E+ NG+L L + D I GL +L
Sbjct: 62 IR---YYESFLDKGKLNI-VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL 117
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFGYF 402
H + +ILHRDIKS N+ LD N KI DLG+AK L S +++ A + GT Y
Sbjct: 118 H---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL------SDNTNFANTIVGTPYYL 168
Query: 403 APEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462
+PE + SDV++ GVVL E TG+ P + G +I
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD-----------------ANNQGALIL 211
Query: 463 ELPDPRLKGDFP---KEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
++ ++G FP + Q +A L +CL D RP ++++
Sbjct: 212 KI----IRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 82/295 (27%), Positives = 130/295 (44%), Gaps = 58/295 (19%)
Query: 230 NIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
++G G V RG+L VA+K K FLTE ++ + H +++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG---MNWDTRVAIAIGAARGLEY 342
L G + + + M ++ E+M NG LD L E V + G A G++Y
Sbjct: 70 LEGVVT--KSRPVM--IITEYMENG----SLDKFLRENDGKFTVGQLVGMLRGIASGMKY 121
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK-ADGLPSCSS--SPARMQGTF 399
L E +HRD+ + NIL++ NL K++D G+++RL+ ++ + P R
Sbjct: 122 LSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR----- 173
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSG 458
+ APE + + SDV+SFG+V+ E+++ G +P W QD
Sbjct: 174 -WTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP-------------YWDMSN-QD-- 216
Query: 459 TVISE------LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507
VI LP P D P Q+M +C Q D + RPT S++V L
Sbjct: 217 -VIKAVEDGYRLPPPM---DCPSALYQLM----LDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 72/291 (24%), Positives = 124/291 (42%), Gaps = 60/291 (20%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVF-LTEVDMLSRLHHCHVVPLVGY 289
+G+G VY + +DG++ +K + L EV +L +L+H +++ Y
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNII---KY 64
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG--------MNWDTRVAIAIGAARGLE 341
F K + +V E+ G+L + EG ++W ++ +A L+
Sbjct: 65 YESFEEKGKL-CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA------LK 117
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
YLH +ILHRDIK NI L N K+ D G++K L + + + + GT Y
Sbjct: 118 YLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST-VDLAKT----VVGTPYY 169
Query: 402 FAPE------YAMVGRASLMSDVFSFGVVLLELITGRQPI-HRSITKGEESLVLWATPRL 454
+PE Y + SD++S G VL EL T + P ++ L L
Sbjct: 170 LSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHPFEGENL----LELAL------ 213
Query: 455 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505
++ P + + E + L LQ DP+ RP++++++Q
Sbjct: 214 ----KILKGQYPP-IPSQYSSE----LRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 68/227 (29%), Positives = 112/227 (49%), Gaps = 37/227 (16%)
Query: 232 VGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
+G+G VY+G+LT VA+K K P F E +++S L H ++V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVEGMNWDTRVA 331
L+G C+ K ++FE++ +G+L + L D + ++ +
Sbjct: 73 LLGVCT----KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL-KAD--GLPSC 388
IAI A G+EYL ++ +HRD+ + N L+ E L KI+D G+++ + AD + S
Sbjct: 129 IAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 389 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
S P R + PE + G+ + SD++SFGVVL E+ + G QP
Sbjct: 186 SLLPVR------WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 4e-23
Identities = 75/314 (23%), Positives = 121/314 (38%), Gaps = 74/314 (23%)
Query: 230 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRLHHCHVVPLV 287
+G+G VY+ + G +VA+K+ + + + + E+ +L +L H ++V L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 288 G-YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR-------- 338
S+ +G M VFE+M + D L G+L V +
Sbjct: 65 EIVTSKGKGSIYM---VFEYMDH----D-LTGLLDS-----PEVKFTESQIKCYMKQLLE 111
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
GL+YLH ILHRDIK SNIL++ + K+ D G+A+ ++ R+ T
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN---RVI-T 164
Query: 399 FGYFAPE-------YAMVGRASLMSDVFSFGVVLLELITGRQPIHR-------------- 437
Y PE Y G D++S G +L EL G+ PI +
Sbjct: 165 LWYRPPELLLGATRY---GPE---VDMWSVGCILAELFLGK-PIFQGSTELEQLEKIFEL 217
Query: 438 --SITK----GEESLVLWATPRLQDS-GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQ 490
S T G L + + + + E K + L + L
Sbjct: 218 CGSPTDENWPGVSKLPWFENLKPKKPYKRRLRE----FFKHLIDPSALD----LLDKLLT 269
Query: 491 LDPDARPTMSEVVQ 504
LDP R + + +Q
Sbjct: 270 LDPKKRISADQALQ 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 4e-23
Identities = 82/270 (30%), Positives = 121/270 (44%), Gaps = 36/270 (13%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+G G V+ G + VAVK K G FL E ++ +L H ++ L C+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKP--GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351
+V E M G+L + L G + + +A A G+ YL A
Sbjct: 72 ----LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNY 124
Query: 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMV 409
+HRD+ + N+L+ EN K+ D G+A+ +K D AR F + APE A+
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKED------IYEAREGAKFPIKWTAPEAALY 178
Query: 410 GRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 468
R S+ SDV+SFG++L E++T GR P + +T E VL + +P P
Sbjct: 179 NRFSIKSDVWSFGILLTEIVTYGRMP-YPGMTNAE---VLQQVDQGY-------RMPCPP 227
Query: 469 LKGDFPKEEMQIMAYLAKECLQLDPDARPT 498
PKE IM +C + DPD RPT
Sbjct: 228 ---GCPKELYDIML----DCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 5e-23
Identities = 84/264 (31%), Positives = 123/264 (46%), Gaps = 29/264 (10%)
Query: 248 GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 307
G +VAVK+ + F E+++L L H ++V G C G+R +RL V E++
Sbjct: 33 GEVVAVKKLQ-HSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLRL-VMEYL 89
Query: 308 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 367
P G+LRD L E ++ + A +G+EYL + R +HRD+ + NIL++
Sbjct: 90 PYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYL---GSKRYVHRDLATRNILVESEN 145
Query: 368 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLE 427
KI D G+ K L D P + ++APE + S+ SDV+SFGVVL E
Sbjct: 146 RVKIGDFGLTKVLPQDKEYYKVREPG--ESPIFWYAPESLTESKFSVASDVWSFGVVLYE 203
Query: 428 LIT----GRQP---IHRSI--TKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEM 478
L T P R + K + +V L+++G LP P P E
Sbjct: 204 LFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG----RLPAPP---GCPAEIY 256
Query: 479 QIMAYLAKECLQLDPDARPTMSEV 502
IM KEC DP RP+ SE+
Sbjct: 257 AIM----KECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 5e-23
Identities = 75/296 (25%), Positives = 128/296 (43%), Gaps = 58/296 (19%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
+ + +G+G S VY+ G+ VA+K+ + + + + E+ ++ H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK--QNKELIINEILIMKDCKHP 75
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA-RGL 340
++V +V E+M G+L D + V MN + ++A +GL
Sbjct: 76 NIVDYYD-SYLVGD---ELWVVMEYMDGGSLTDIITQNFVR-MN-EPQIAYVCREVLQGL 129
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
EYLH + ++HRDIKS NILL ++ + K+ D G A +L + S + GT
Sbjct: 130 EYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-----SKRNSVVGTPY 181
Query: 401 YFAPEYAMVGRASLMS---DVFSFGVVLLELITG-----RQPIHRSI----TKGEESLVL 448
+ APE V + D++S G++ +E+ G R+P R++ TKG
Sbjct: 182 WMAPE---VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG------ 232
Query: 449 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
P L++ E D +L K CL DP+ RP+ E++Q
Sbjct: 233 --IPPLKNPEKWSPEFKD----------------FLNK-CLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 78/283 (27%), Positives = 116/283 (40%), Gaps = 32/283 (11%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
+K + +G+G V + +L G I A+K T P+ L E+++ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--IAIGAARGL 340
+V G + + + E+ G+L V G +V IA +GL
Sbjct: 61 IVKYYGAFLD--ESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGL 118
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
YLH +I+HRDIK SNILL K+ D G++ L +S GT
Sbjct: 119 SYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-------VNSLAGTFTGTSF 168
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460
Y APE S+ SDV+S G+ LLE+ R P +GE L + +
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF---PPEGEPPLGPI------ELLSY 219
Query: 461 ISELPDPRLKGDFPKEEMQI-----MAYLAKECLQLDPDARPT 498
I +P+P LK + I K+CL+ DP RPT
Sbjct: 220 IVNMPNPELKDE---PGNGIKWSEEFKDFIKQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 80/308 (25%), Positives = 127/308 (41%), Gaps = 51/308 (16%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKT-QGGPNADSVFLTEVDMLSRLHHC 281
+K+ +VG+G V + + G IVA+K+FK + + L EV +L +L H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 282 HVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 340
++V L +R RL LVFE++ L + L+ G+ D + + +
Sbjct: 61 NIVNLKEAF-----RRKGRLYLVFEYVER-TLLELLE-ASPGGLPPDAVRSYIWQLLQAI 113
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
Y H + I+HRDIK NIL+ E+ K+ D G A+ L+A + A T
Sbjct: 114 AYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA----TRW 166
Query: 401 YFAPE----YAMVGRASLMSDVFSFGVVLLELITGR---------------QPIHRSITK 441
Y APE G+ DV++ G ++ EL+ G Q +
Sbjct: 167 YRAPELLVGDTNYGKP---VDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP 223
Query: 442 GEESLVLWATPRLQDSGTVISELPDP-----RLKGDFPKEEMQIMAYLAKECLQLDPDAR 496
+ L + PR +G E P R G + + K CL++DP R
Sbjct: 224 SHQEL-FSSNPRF--AGVAFPEPSQPESLERRYPGKVSSPALDFL----KACLRMDPKER 276
Query: 497 PTMSEVVQ 504
T E++Q
Sbjct: 277 LTCDELLQ 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 82/309 (26%), Positives = 132/309 (42%), Gaps = 72/309 (23%)
Query: 231 IVGQGGSSYVYRGQLT-DGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
++G G VY+G +G VA+K + + P A+ L E +++ + H HVV
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNL-------RDCLDGVLVEGMNWDTRVAIAIGAAR 338
L+G C + L+ + MP G L +D + + +NW ++A +
Sbjct: 74 LLGICL---SSQVQ--LITQLMPLGCLLDYVRNHKDNIGSQYL--LNWCVQIA------K 120
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG---LPSCSSSPARM 395
G+ YL E R++HRD+ + N+L+ + KITD G+AK L D P +
Sbjct: 121 GMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK- 176
Query: 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESL 446
+ A E + + SDV+S+GV + EL+T G +P I + KGE
Sbjct: 177 -----WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE--- 228
Query: 447 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
LP P P + + L K C +D ++RPT E++
Sbjct: 229 ----------------RLPQP------PICTIDVYMVLVK-CWMIDAESRPTFKELINEF 265
Query: 507 STIAPDKSR 515
S +A D R
Sbjct: 266 SKMARDPQR 274
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 75/265 (28%), Positives = 110/265 (41%), Gaps = 41/265 (15%)
Query: 251 VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNG 310
VAVK K + FL E ++++L H +V L+G C K +LV E P G
Sbjct: 26 VAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC-----KGEPLMLVMELAPLG 80
Query: 311 NLRDCLDG----VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 366
L L + + +VA G+ YL +HRD+ + N+LL
Sbjct: 81 PLLKYLKKRREIPVSDLKELAHQVA------MGMAYLESK---HFVHRDLAARNVLLVNR 131
Query: 367 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMVGRASLMSDVFSFGVV 424
AKI+D GM++ L A A G + ++APE G+ S SDV+S+GV
Sbjct: 132 HQAKISDFGMSRALGAGS----DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVT 187
Query: 425 LLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYL 484
L E + + + KG E + + +SG LP P P+E IM
Sbjct: 188 LWEAFSYGAKPYGEM-KGAEVI------AMLESG---ERLPRPEE---CPQEIYSIM--- 231
Query: 485 AKECLQLDPDARPTMSEVVQILSTI 509
C + P+ RPT SE+
Sbjct: 232 -LSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 82/285 (28%), Positives = 119/285 (41%), Gaps = 57/285 (20%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
G G S V + G+I+AVK + + L E+D+L H C+ +VG+
Sbjct: 10 GAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDIL---HKCNSPYIVGFYG 66
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNW-DTRV--AIAIGAARGLEYLHEAAA 348
F + + + E+M G LD +L E R+ IA+ +GL YLHE
Sbjct: 67 AFYNNGDISICM-EYMDGG----SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH- 120
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRL---KADGLPSCSS--SPARMQGTFGYFA 403
+I+HRD+K SNIL++ K+ D G++ +L A SS +P R+QG Y
Sbjct: 121 -KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGN-DY-- 176
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 463
S+ SD++S G+ L+EL TGR P P +
Sbjct: 177 ---------SVKSDIWSLGLSLIELATGRFPY---------------PPENDPPDGIFEL 212
Query: 464 L------PDPRL-KGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 501
L P PRL G F + CL DP RP+ E
Sbjct: 213 LQYIVNEPPPRLPSGKFSPD----FQDFVNLCLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 2e-21
Identities = 86/278 (30%), Positives = 127/278 (45%), Gaps = 37/278 (13%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+GQG V+ G VA+K K G FL E ++ +L H +VPL S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKP--GTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351
E +V EFM G+L D L + + V +A A G+ Y+
Sbjct: 72 E-----EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NY 123
Query: 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMV 409
+HRD++++NIL+ +NL KI D G+A RL D + AR F + APE A+
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLA-RLIED-----NEYTARQGAKFPIKWTAPEAALY 177
Query: 410 GRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 468
GR ++ SDV+SFG++L EL+T GR P + + V + G +P P+
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV--------ERGY---RMPCPQ 226
Query: 469 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
P+ ++M K C + DPD RPT + L
Sbjct: 227 ---GCPESLHELM----KLCWKKDPDERPTFEYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 74/226 (32%), Positives = 109/226 (48%), Gaps = 36/226 (15%)
Query: 269 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNW 326
LTE ++LSR++H +V L + + F+ + + LV E+ P G L L G E
Sbjct: 41 LTERNILSRINHPFIVKL--HYA-FQTEEKL-YLVLEYAPGGELFSHLSKEGRFSEE--- 93
Query: 327 DTRVAIA-IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385
R A I A LEYLH I++RD+K NILLD + + K+TD G+AK L ++G
Sbjct: 94 RARFYAAEIVLA--LEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG- 147
Query: 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHR 437
++ GT Y APE + D +S GV+L E++TG+ P I+
Sbjct: 148 SRTNT----FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYE 203
Query: 438 SITKGEESLVLWATPRLQDSGTVISEL----PDPRLKGDFPKEEMQ 479
I K + +P +D +IS L P RL G EE++
Sbjct: 204 KILKDPLRFPEFLSPEARD---LISGLLQKDPTKRL-GSGGAEEIK 245
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 83/311 (26%), Positives = 120/311 (38%), Gaps = 83/311 (26%)
Query: 232 VGQGGSSYVYRGQL-------TDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCH 282
+GQG VY G + R VA+K + FL E ++ + H
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETR-VAIK--TVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL----------DGV----LVEGMNWDT 328
VV L+G S G+ + +V E M G+L+ L G+ L + +
Sbjct: 71 VVRLLGVVS--TGQPTL--VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM-- 124
Query: 329 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RL 380
A A G+ YL + +HRD+ + N ++ E+L KI D GM + R
Sbjct: 125 ----AAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177
Query: 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 439
GL P R + APE G + SDV+SFGVVL E+ T QP
Sbjct: 178 GGKGL-----LPVR------WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY---- 222
Query: 440 TKG---EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDAR 496
+G EE L + G + D P+ + L + C Q +P R
Sbjct: 223 -QGLSNEEVL------KFVIDGGHL----------DLPENCPDKLLELMRMCWQYNPKMR 265
Query: 497 PTMSEVVQILS 507
PT E+V L
Sbjct: 266 PTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 5e-21
Identities = 79/287 (27%), Positives = 122/287 (42%), Gaps = 58/287 (20%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRLHHCHVVPLVG 288
G+G VY+ + L+D + A+K D+V E+ +L+ ++H +++
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV--NEIRILASVNHPNII---S 63
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNL------RDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
Y F + +V E+ P G+L R ++ E W I I RGL+
Sbjct: 64 YKEAFLDGNKL-CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLRGLQA 118
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ-GTFGY 401
LHE +ILHRD+KS+NILL N KI DLG++K LK + A+ Q GT Y
Sbjct: 119 LHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK--------KNMAKTQIGTPHY 167
Query: 402 FAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460
APE GR S SD++S G +L E+ T P
Sbjct: 168 MAPE-VWKGRPYSYKSDIWSLGCLLYEMATFAPPFE---------------------ARS 205
Query: 461 ISELPDPRLKGDFPK---EEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
+ +L +G +P Q + + LQ+ P RP +++
Sbjct: 206 MQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 7e-21
Identities = 89/313 (28%), Positives = 150/313 (47%), Gaps = 63/313 (20%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHC 281
+K+ +VG+G V + + + G+IVA+K+F +++ + + E+ ML +L H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 282 HVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDC------LDGVLVEGMNWDTRVAIAI 334
++V L+ +R RL LVFEF+ + L D LD V +
Sbjct: 61 NLVNLIEVF-----RRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQI------ 109
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
RG+E+ H + I+HRDIK NIL+ ++ K+ D G A+ L A G + A
Sbjct: 110 --LRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVA- 162
Query: 395 MQGTFGYFAPEYAM----VGRASLMSDVFSFGVVLLELITGRQP----------IHRSIT 440
T Y APE + GRA D+++ G ++ E++TG +P ++ I
Sbjct: 163 ---TRWYRAPELLVGDTKYGRA---VDIWAVGCLVTEMLTG-EPLFPGDSDIDQLYH-II 214
Query: 441 KGEESLVLWATPRLQD--------SGTVISELPDPR-LKGDFPKEEMQIMAYLAKECLQL 491
K +L PR Q+ +G + E+ + L+ FPK ++ LAK+CL++
Sbjct: 215 KCLGNL----IPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLS-GLVLDLAKQCLRI 269
Query: 492 DPDARPTMSEVVQ 504
DPD RP+ S+++
Sbjct: 270 DPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 78/288 (27%), Positives = 118/288 (40%), Gaps = 46/288 (15%)
Query: 232 VGQGGSSYVYRGQLTD--GRI--VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLV 287
+G G V RG+ + G++ VAVK K+ + FL E ++ L H +++ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 288 GYCSEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGMNWDTRVAIAIGAARGLEYL 343
G M +V E P G+L D L G + D V IA G+ YL
Sbjct: 63 GVV---LTHPLM--MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA----NGMRYL 113
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
R +HRD+ + NILL + KI D G+ + L + ++ F + A
Sbjct: 114 ESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE--DHYVMEEHLKVPFAWCA 168
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELIT-GRQP-IHRSITKGEESL--VLWATPRLQDSGT 459
PE S SDV+ FGV L E+ T G +P S G + L + RL
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS---GSQILKKIDKEGERL----- 220
Query: 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507
E P+ P++ +M +C +P RPT + + + L
Sbjct: 221 ---ERPE-----ACPQDIYNVM----LQCWAHNPADRPTFAALREFLP 256
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 84/270 (31%), Positives = 122/270 (45%), Gaps = 37/270 (13%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+G G V+ G VAVK K G + FL E ++ +L H +V L S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKP--GTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351
E +V E+M G+L D L + V +A A G+ Y+
Sbjct: 72 E-----EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NY 123
Query: 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMV 409
+HRD++S+NIL+ + L KI D G+A RL D + AR F + APE A+
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLA-RLIED-----NEYTARQGAKFPIKWTAPEAALY 177
Query: 410 GRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 468
GR ++ SDV+SFG++L EL+T GR P + + E VL R +P P
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVP-YPGMNNRE---VLEQVERGY-------RMPCP- 225
Query: 469 LKGDFPKEEMQIMAYLAKECLQLDPDARPT 498
D P ++M +C + DP+ RPT
Sbjct: 226 --QDCPISLHELML----QCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 2e-20
Identities = 70/206 (33%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+GQG V+ G VA+K K G + FL E ++ +L H +V L S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351
E +V E+M G+L D L G + + + V +A A G+ Y+
Sbjct: 72 E-----EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 123
Query: 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMV 409
+HRD++++NIL+ ENL K+ D G+A RL D + AR F + APE A+
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLA-RLIED-----NEYTARQGAKFPIKWTAPEAALY 177
Query: 410 GRASLMSDVFSFGVVLLELIT-GRQP 434
GR ++ SDV+SFG++L EL T GR P
Sbjct: 178 GRFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 79/282 (28%), Positives = 121/282 (42%), Gaps = 38/282 (13%)
Query: 230 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFK-TQGGPNADSVFLTEVDMLSRLHHCHVVPLV 287
++G G ++ VY L + VA+KR + + D + EV +S+ +H +VV
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDEL-RKEVQAMSQCNHPNVVKY- 64
Query: 288 GYCSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDTRVAIAIGAARGLEY 342
Y S F + LV ++ G+L D + G L E + +GLEY
Sbjct: 65 -YTS-FVVGDEL-WLVMPYLSGGSLLDIMKSSYPRGGLDE----AIIATVLKEVLKGLEY 117
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR--MQGTFG 400
LH +HRDIK+ NILL E+ + KI D G++ L G + R GT
Sbjct: 118 LHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGG---DRTRKVRKTFVGTPC 171
Query: 401 YFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459
+ APE +D++SFG+ +EL TG P + + L+L LQ+
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSK--YPPMKVLML----TLQNDP- 224
Query: 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 501
L + K ++++ CLQ DP RPT E
Sbjct: 225 --PSLETGADYKKYSKSFRKMIS----LCLQKDPSKRPTAEE 260
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 59/172 (34%), Positives = 79/172 (45%), Gaps = 23/172 (13%)
Query: 269 LTEVDMLSRLHHCHVVP-LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMN 325
L E +L L+H P LV F+ + M LV + + G+LR L E
Sbjct: 48 LNERRILQELNH----PFLVNLWYSFQDEENM-YLVVDLLLGGDLRYHLSQKVKFSEEQ- 101
Query: 326 WDTRVAIA-IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384
+ I I A LEYLH I+HRDIK NILLDE + ITD +A ++ D
Sbjct: 102 --VKFWICEIVLA--LEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154
Query: 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
L + +S GT GY APE S+ D +S GV E + G++P
Sbjct: 155 LTTSTS------GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 4e-20
Identities = 78/287 (27%), Positives = 122/287 (42%), Gaps = 55/287 (19%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+G G V+ G+ VA+K + +G + D F+ E ++ +L H ++V L G C+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDD-FIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
+ R +V E+M NG L + L G L G W + + +EYL
Sbjct: 70 KQRPIF----IVTEYMANGCLLNYLRERKGKL--GTEWLLDMCSDV--CEAMEYLESNG- 120
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT---FGYFAPE 405
+HRD+ + N L+ E+ K++D G+A R D + S QGT + PE
Sbjct: 121 --FIHRDLAARNCLVGEDNVVKVSDFGLA-RYVLDDQYTSS------QGTKFPVKWAPPE 171
Query: 406 YAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTV--IS 462
R S SDV+SFGV++ E+ + G+ P R +S V +S
Sbjct: 172 VFDYSRFSSKSDVWSFGVLMWEVFSEGKMPY----------------ERFSNSEVVESVS 215
Query: 463 E---LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
L P+L P E IM C P+ RP +++ L
Sbjct: 216 AGYRLYRPKLA---PTEVYTIM----YSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 81/304 (26%), Positives = 125/304 (41%), Gaps = 54/304 (17%)
Query: 233 GQGGS-SYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
G GGS S V + G ++A K + L E+ ++ H C +V +
Sbjct: 16 GNGGSVSKVKH--IPTGTVMAKKVVHIGAKSSVRKQILRELQIM---HECRSPYIVSFYG 70
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG--MNWDTRVAIAIGAARGLEYLHEAAAP 349
F + + + EFM G+L D + +G + + IA+ GL YL+
Sbjct: 71 AFLNENNI-CMCMEFMDCGSL----DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH-- 123
Query: 350 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV 409
RI+HRDIK SNIL++ K+ D G++ L +S GT Y +PE
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGEL-------INSIADTFVGTSTYMSPERIQG 176
Query: 410 GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV--------- 460
G+ ++ SDV+S G+ ++EL G+ P +A + D G
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFP--------------FAFSNIDDDGQDDPMGILDLL 222
Query: 461 --ISELPDPRL-KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRR 517
I + P PRL DFP + + CL DP RPT ++ + I R
Sbjct: 223 QQIVQEPPPRLPSSDFP----EDLRDFVDACLLKDPTERPTPQQLCAMPPFI--QALRAS 276
Query: 518 NISL 521
N+ L
Sbjct: 277 NVDL 280
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 5e-20
Identities = 89/288 (30%), Positives = 127/288 (44%), Gaps = 56/288 (19%)
Query: 232 VGQGGSSYVYRG-QLTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
+G G VY G L DG AVK Q G A E+ +LS+L H ++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 287 VGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGM--NWDTRVAIAIGAARGLE 341
+G E L +F E +P G+L L G E + + TR + GLE
Sbjct: 68 LGTERE-----EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLY-TRQILL-----GLE 116
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA-DGLPSCSSSPARMQGTFG 400
YLH +HRDIK +NIL+D N K+ D GMAK++ S SP M
Sbjct: 117 YLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWM----- 168
Query: 401 YFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459
APE G L +D++S G +LE+ TG+ P + E ++ R ++
Sbjct: 169 --APEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL----EGVAAVFKIGRSKE--- 219
Query: 460 VISELPD---PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
+ +PD K DF I+ +CLQ DP RPT +E+++
Sbjct: 220 -LPPIPDHLSDEAK-DF------IL-----KCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 82/299 (27%), Positives = 132/299 (44%), Gaps = 45/299 (15%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTDG-----RIVAVKRFKTQGGPNADSVFLTEVDMLSRL 278
D+ + S+++ +G ++ G L D V VK K ++ L E +L L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 279 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNL----RDCLDGVLVEGMNWDTR--VAI 332
H +++P++ C E +++ +M GNL + C G T+ V +
Sbjct: 66 SHQNILPILHVCIEDGEPP---FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHM 122
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL---KADGLPSCS 389
AI A G+ YLH+ ++H+DI + N ++DE L KITD +++ L L
Sbjct: 123 AIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE 179
Query: 390 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVL 448
+ P + + A E + S SDV+SFGV+L EL+T G+ P + I E + L
Sbjct: 180 NRPVK------WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP-YVEIDPFEMAAYL 232
Query: 449 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507
RL P E +MA C LDP+ RP+ S++VQ L+
Sbjct: 233 KDGYRLAQPINC-------------PDELFAVMAC----CWALDPEERPSFSQLVQCLT 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 8e-20
Identities = 75/282 (26%), Positives = 132/282 (46%), Gaps = 43/282 (15%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+G G V+ G + R VA+K + G ++ F+ E ++ +L H +V L G C+
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIRE--GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
E R+ LVFEFM +G L D L G + +T + + + G+ YL +
Sbjct: 70 E----RSPICLVFEFMEHGCLSDYLRAQRGKFSQ----ETLLGMCLDVCEGMAYLESSN- 120
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PARMQGTFGYFAPEY 406
++HRD+ + N L+ EN K++D GM + + D S + + P + + +PE
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK------WSSPEV 172
Query: 407 AMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465
+ S SDV+SFGV++ E+ + G+ P + + + E + A RL
Sbjct: 173 FSFSKYSSKSDVWSFGVLMWEVFSEGKTP-YENRSNSEVVETINAGFRLY---------- 221
Query: 466 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507
PRL + ++M + C + P+ RP+ S ++ L+
Sbjct: 222 KPRLA---SQSVYELMQH----CWKERPEDRPSFSLLLHQLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 9e-20
Identities = 75/210 (35%), Positives = 107/210 (50%), Gaps = 23/210 (10%)
Query: 236 GSSYVYRGQLTDGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293
G ++ + + T G I A+K K N LTE D+LS+ +VV L Y S F
Sbjct: 7 GRVFLAKKKST-GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL--YYS-F 62
Query: 294 RGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIA-IGAARGLEYLHEAAAPR 350
+GK+ + LV E++P G+L L+ G L E + R+ IA I A LEYLH
Sbjct: 63 QGKKNL-YLVMEYLPGGDLASLLENVGSLDEDV---ARIYIAEIVLA--LEYLHSNG--- 113
Query: 351 ILHRDIKSSNILLDENLNAKITDLGMAK---RLKADGLPSCSSSPARMQGTFGYFAPEYA 407
I+HRD+K NIL+D N + K+TD G++K + L R+ GT Y APE
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE-V 172
Query: 408 MVGRA-SLMSDVFSFGVVLLELITGRQPIH 436
++G+ S D +S G +L E + G P H
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPPFH 202
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 22/218 (10%)
Query: 232 VGQGGSSYVYRGQLTD-GRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
+G+GG V Q+ G++ A K R K + G + + L E +L ++ +V
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKG---EQMALNEKKILEKVSSRFIVS 57
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 345
L Y E + LV M G+L+ + V G + A GLE+LH+
Sbjct: 58 L-AYAFETKDDLC---LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ 113
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 405
RI++RD+K N+LLD++ N +I+DLG+A LK GT GY APE
Sbjct: 114 R---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG------GKKIKGRAGTPGYMAPE 164
Query: 406 YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 443
D F+ G L E+I GR P + K E
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 1e-19
Identities = 75/288 (26%), Positives = 133/288 (46%), Gaps = 30/288 (10%)
Query: 230 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
N++ +G Y+G+ + +G VK + +S+ +E+ + +L H ++V L+G
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEIN-----DVNSIPSSEIADMGKLQHPNIVKLIG 750
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
C +G L+ E++ NL + L ++W+ R IAIG A+ L +LH +
Sbjct: 751 LCRSEKGA----YLIHEYIEGKNLSEVL-----RNLSWERRRKIAIGIAKALRFLHCRCS 801
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 408
P ++ ++ I++D + L + L D SS+ Y APE
Sbjct: 802 PAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA---------YVAPETRE 851
Query: 409 VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 468
+ SD++ FG++L+EL+TG+ P S+V WA R S + DP
Sbjct: 852 TKDITEKSDIYGFGLILIELLTGKSPADAE-FGVHGSIVEWA--RYCYSDCHLDMWIDPS 908
Query: 469 LKGDFPKEEMQIMAY--LAKECLQLDPDARPTMSEVVQILSTIAPDKS 514
++GD + +I+ LA C DP ARP ++V++ L + + S
Sbjct: 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956
|
Length = 968 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 57/296 (19%)
Query: 232 VGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
+G+ +Y+G L ++VA+K K P F E +++ LHH ++V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---------------DGVLVEGMNWDTRVA 331
+G ++ ++FE++ G+L + L DG + ++ +
Sbjct: 73 LGVVTQ----EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 391
IAI A G+EYL ++ +H+D+ + NIL+ E L+ KI+DLG+++ + S+
Sbjct: 129 IAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY-------SAD 178
Query: 392 PARMQGT----FGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESL 446
R+Q + PE M G+ S SD++SFGVVL E+ + G QP + +E +
Sbjct: 179 YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG--FSNQEVI 236
Query: 447 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 502
+ +L LP D P M L EC Q P RP ++
Sbjct: 237 EMVRKRQL---------LPCSE---DCPPR----MYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 3e-19
Identities = 76/278 (27%), Positives = 133/278 (47%), Gaps = 39/278 (14%)
Query: 231 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
I+G+G V +G+ T G+ VAVK K A FL E ++++LHH ++V L+G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 350
G +V E M GNL + L ++ + ++ A G+EYL + +
Sbjct: 69 LH-NGLY----IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKK 120
Query: 351 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG 410
++HRD+ + NIL+ E+ AK++D G+A R+ + G+ + S P + + APE
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLA-RVGSMGVDN-SKLPVK------WTAPEALKHK 172
Query: 411 RASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRL 469
+ S SDV+S+GV+L E+ + GR P P++ S + E +
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAPY----------------PKM--SLKEVKECVEKGY 214
Query: 470 KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507
+ + P+ + L C + +P RP+ ++ + L
Sbjct: 215 RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 4e-19
Identities = 79/289 (27%), Positives = 120/289 (41%), Gaps = 39/289 (13%)
Query: 230 NIVGQGGSSYVYRGQLTDG----RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
++G+G VY G L D AVK FL E ++ H +V+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG--AARGLEYL 343
L+G C G L+V +M +G+LR+ + E N + I G A+G+EYL
Sbjct: 61 LLGICLPSEG---SPLVVLPYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYL 114
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT---FG 400
A+ + +HRD+ + N +LDE+ K+ D G+A+ D S G
Sbjct: 115 ---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR----DIYDKEYYSVHNHTGAKLPVK 167
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460
+ A E + + SDV+SFGV+L EL+T P + + + ++ L R
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR------- 220
Query: 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
L P D E M C P+ RPT SE+V + I
Sbjct: 221 ---LLQPEYCPDPLYEVML-------SCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-19
Identities = 81/280 (28%), Positives = 128/280 (45%), Gaps = 33/280 (11%)
Query: 232 VGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G+G V+ G+L D VAVK + P+ + FL E +L + H ++V L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI--GAARGLEYLHEAAA 348
++ K+ + +V E + G D L + EG + I + AA G+EYL +
Sbjct: 63 TQ---KQPI-YIVMELVQGG---DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---S 112
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 408
+HRD+ + N L+ E KI+D GM+ R + DG+ +S+ Q + APE
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMS-REEEDGV--YASTGGMKQIPVKWTAPEALN 169
Query: 409 VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 468
GR S SDV+SFG++L E+ L A P S E +
Sbjct: 170 YGRYSSESDVWSFGILLW-----------------EAFSLGAVPYANLSNQQTREAIEQG 212
Query: 469 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508
++ P+ + L + C + DP RP+ S V Q L +
Sbjct: 213 VRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 82/298 (27%), Positives = 136/298 (45%), Gaps = 50/298 (16%)
Query: 231 IVGQGGSSYVYRG-QLTDGRIV----AVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
++G G VY+G + +G V A+K GP A+ F+ E +++ + H H+V
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNL-------RDCLDGVLVEGMNWDTRVAIAIGAAR 338
L+G C LV + MP+G L +D + L+ +NW ++A +
Sbjct: 74 LLGVCLS-----PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLL--LNWCVQIA------K 120
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
G+ YL E R++HRD+ + N+L+ + KITD G+A+ L+ D ++ +M
Sbjct: 121 GMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE-KEYNADGGKM--P 174
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 457
+ A E + + SDV+S+GV + EL+T G +P T+ P L +
Sbjct: 175 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--------EIPDLLEK 226
Query: 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSR 515
G LP P P + + + K C +D D+RP E+ S +A D R
Sbjct: 227 G---ERLPQP------PICTIDVYMVMVK-CWMIDADSRPKFKELAAEFSRMARDPQR 274
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 72/279 (25%), Positives = 121/279 (43%), Gaps = 35/279 (12%)
Query: 235 GGSSY--VYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
GG Y VY G VAVK K + FL E ++ + H ++V L+G C+
Sbjct: 15 GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351
+ ++ EFM GNL D L + +N + +A + +EYL
Sbjct: 73 ----REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 125
Query: 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR 411
+HRD+ + N L+ EN K+ D G+++ + D ++ A + + APE +
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTAPESLAYNK 181
Query: 412 ASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLK 470
S+ SDV++FGV+L E+ T G P + L + EL + +
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSP--------------YPGIDLSQ----VYELLEKGYR 223
Query: 471 GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
+ P+ + L + C Q +P RP+ +E+ Q T+
Sbjct: 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 4e-18
Identities = 73/278 (26%), Positives = 127/278 (45%), Gaps = 37/278 (13%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+G G V+ G VA+K K G + FL E +++ +L H +V L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQ--GSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351
+ ++ E+M NG+L D L + + + +A A G+ ++
Sbjct: 72 -----QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NY 123
Query: 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMV 409
+HRD++++NIL+ E L KI D G+A+ ++ + AR F + APE
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDN------EYTAREGAKFPIKWTAPEAINY 177
Query: 410 GRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 468
G ++ SDV+SFG++L E++T GR P + +T E V+ R +P P
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIP-YPGMTNPE---VIQNLERGY-------RMPRPD 226
Query: 469 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
+ P+E ++M + C + P+ RPT + +L
Sbjct: 227 ---NCPEELYELM----RLCWKEKPEERPTFEYLRSVL 257
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 71/271 (26%), Positives = 129/271 (47%), Gaps = 29/271 (10%)
Query: 248 GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 307
G VAVK K + G N + E+++L L+H ++V G C+E G ++L + EF+
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE-DGGNGIKL-IMEFL 90
Query: 308 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 367
P+G+L++ L +N ++ A+ +G++YL + + +HRD+ + N+L++
Sbjct: 91 PSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEH 146
Query: 368 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLE 427
KI D G+ K ++ D + + ++APE + + + SDV+SFGV L E
Sbjct: 147 QVKIGDFGLTKAIETD--KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYE 204
Query: 428 LIT----GRQPIHRSI-----TKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEM 478
L+T P+ + T G+ ++ RL LP P + P+E
Sbjct: 205 LLTYCDSESSPMTLFLKMIGPTHGQMTVT-----RLVRVLEEGKRLPRP---PNCPEEVY 256
Query: 479 QIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
Q+M ++C + P R T +++ I
Sbjct: 257 QLM----RKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 5e-18
Identities = 74/283 (26%), Positives = 123/283 (43%), Gaps = 40/283 (14%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKT--QGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
+G+G S VY+ L DGR+VA+K+ + A L E+D+L +L H +V+
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIK--- 66
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCL------DGVLVEGMNWDTRVAIAIGAARGLEY 342
Y + F + +V E G+L + ++ E W V + LE+
Sbjct: 67 YLASFI-ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEH 121
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
+H RI+HRDIK +N+ + K+ DLG+ + + + S + GT Y
Sbjct: 122 MHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-----LVGTPYYM 173
Query: 403 APEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462
+PE + SD++S G +L E+ + P G++ L I
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKM-------NLYSLCKKIE 221
Query: 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505
+ P L D EE++ L C+ DP+ RP +S V+Q+
Sbjct: 222 KCDYPPLPADHYSEELR---DLVSRCINPDPEKRPDISYVLQV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 5e-18
Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 38/230 (16%)
Query: 231 IVGQGGSSYVYRGQL-TDGRIVAVK----RFKTQGGPNADSVFLTEVDMLSRL-HHCHVV 284
I+G+G S V + + A+K R + V E ++L+RL H ++
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEK-KVKYVK-IEKEVLTRLNGHPGII 65
Query: 285 PLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--ARGLE 341
L Y + F+ + L V E+ PNG L L + G + D + A LE
Sbjct: 66 KL--YYT-FQDEE--NLYFVLEYAPNGEL---LQYIRKYG-SLDEKCTRFYAAEILLALE 116
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS--------CSSSPA 393
YLH I+HRD+K NILLD++++ KITD G AK L + P S
Sbjct: 117 YLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 394 RMQGTFGYF-------APEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
+ + F F +PE A SD+++ G ++ +++TG+ P
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 75/308 (24%), Positives = 125/308 (40%), Gaps = 70/308 (22%)
Query: 231 IVGQGGSSYVYRGQLT--DGRI--VAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCHVVP 285
I+G+G V GQL+ DG VAVK K ++ FL+E + H +V+
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 286 LVGYC--SEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGMNWDTRVAIAIGAARG 339
L+G C + K +++ FM +G+L L G L E + T + + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
+EYL + +HRD+ + N +L E++ + D G++K++
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI------------------- 163
Query: 400 GYFAPEYAMVGRASLM------------------SDVFSFGVVLLELITGRQPIHRSITK 441
++ +Y GR + M SDV++FGV + E+ T Q + +
Sbjct: 164 --YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN 221
Query: 442 GEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 501
E L RL+ + EL D L C + DP RPT ++
Sbjct: 222 HEIYDYLRHGNRLKQPEDCLDELYD-----------------LMYSCWRADPKDRPTFTK 264
Query: 502 VVQILSTI 509
+ ++L I
Sbjct: 265 LREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-18
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 20/201 (9%)
Query: 231 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
++G+G V++G L D VAVK K FL+E +L + H ++V L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 291 SEFRGKRAMRLLVFEFMPNGN----LRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
++ R +V E +P G+ LR D + + + V A+ AA G+ YL
Sbjct: 62 TQ----RQPIYIVMELVPGGDFLSFLRKKKDELKTKQL-----VKFALDAAAGMAYLE-- 110
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
+ +HRD+ + N L+ EN KI+D GM+ R + DG+ SS Q + APE
Sbjct: 111 -SKNCIHRDLAARNCLVGENNVLKISDFGMS-RQEDDGI---YSSSGLKQIPIKWTAPEA 165
Query: 407 AMVGRASLMSDVFSFGVVLLE 427
GR S SDV+S+G++L E
Sbjct: 166 LNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 7e-18
Identities = 85/293 (29%), Positives = 129/293 (44%), Gaps = 44/293 (15%)
Query: 232 VGQGGSSYVYRGQLTDGRIVA---VKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
+G G V G+ G A VK + P+ +FL EV L+H +V+ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGM-NWDTRVAIAIGAARGLEYLHE 345
C E LLV EF P G+L++ L + +V M D +A A GL +LH+
Sbjct: 63 QCIE----SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMA-KRLKADGLPS--CSSSPARMQGTFGYF 402
A +H D+ N L +L+ KI D G+A ++ D + C + P R +
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR------WL 169
Query: 403 APEYAMVGRASLM-------SDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRL 454
APE + L+ S+++S GV + EL T QP + VL R
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP----YPDLSDEQVLKQVVRE 225
Query: 455 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507
QD +LP P+L + ++M + C LDP+ RPT EV ++L+
Sbjct: 226 QD-----IKLPKPQLDLKYSDRWYEVMQF----CW-LDPETRPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 86/288 (29%), Positives = 124/288 (43%), Gaps = 70/288 (24%)
Query: 247 DGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304
D +VAVK K P A F E ++L+ L H H+V G C G ++VF
Sbjct: 34 DKMLVAVKALKD---PTLAARKDFQREAELLTNLQHEHIVKFYGVC----GDGDPLIMVF 86
Query: 305 EFMPNGNLRDCLDG------VLVEG--------MNWDTRVAIAIGAARGLEYLHEAAAPR 350
E+M +G+L L +LV+G + + IA A G+ YL A+
Sbjct: 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQH 143
Query: 351 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG----TFGYFAPEY 406
+HRD+ + N L+ NL KI D GM++ + S+ R+ G + PE
Sbjct: 144 FVHRDLATRNCLVGANLLVKIGDFGMSRDVY-------STDYYRVGGHTMLPIRWMPPES 196
Query: 407 AMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISE-- 463
M + + SDV+SFGV+L E+ T G+QP W Q S T + E
Sbjct: 197 IMYRKFTTESDVWSFGVILWEIFTYGKQP--------------W----FQLSNTEVIECI 238
Query: 464 -----LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
L PR+ PKE IM C Q +P R + E+ +IL
Sbjct: 239 TQGRVLERPRV---CPKEVYDIML----GCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 84/296 (28%), Positives = 133/296 (44%), Gaps = 59/296 (19%)
Query: 232 VGQGGSSYVYRGQL------TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
+G+G V+ + D +VAVK K + +A F E ++L+ L H H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTVLQHQHIVR 71
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEG--------MNWDTRVAI 332
G C+E R L+VFE+M +G+L L D ++ G + +AI
Sbjct: 72 FYGVCTEGR----PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP 392
A A G+ YL A+ +HRD+ + N L+ + L KI D GM++ + S+
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY-------STDY 177
Query: 393 ARMQG----TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR-SITKGEESL 446
R+ G + PE + + + SD++SFGVVL E+ T G+QP ++ S T+ E +
Sbjct: 178 YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237
Query: 447 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 502
T EL PR P E IM + C Q +P R + ++
Sbjct: 238 ------------TQGRELERPR---TCPPEVYAIM----QGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 77/292 (26%), Positives = 116/292 (39%), Gaps = 61/292 (20%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
G+G V + + + G I+AVKR + L ++D+ R C Y
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP------YTV 63
Query: 292 EFRGKRAMRLLVFEFMPNGNLRD-CLD----GVLVEGMNWDTRV--AIAIGAARGLEYLH 344
F G V+ M + D LD V +G+ + IA+ + LEYLH
Sbjct: 64 TFYGALFREGDVWICM---EVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLG--------MAKRLKADGLPSCSSSPARMQ 396
++HRD+K SN+L++ N K+ D G +AK + A P
Sbjct: 121 SKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP---------- 168
Query: 397 GTFGYFAPEY---AMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 452
Y APE + + + SDV+S G+ ++EL TGR P W TP
Sbjct: 169 ----YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS-----------WKTP 213
Query: 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
Q V E P P+L + E Q +CL+ + RP E++Q
Sbjct: 214 FQQLKQVV--EEPSPQLPAEKFSPEFQ---DFVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 72/263 (27%), Positives = 116/263 (44%), Gaps = 36/263 (13%)
Query: 248 GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 307
G VAVK K A FL E ++++L H ++V L+G E +G +V E+M
Sbjct: 29 GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVEEKGGL---YIVTEYM 82
Query: 308 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 367
G+L D L + D + ++ +EYL A +HRD+ + N+L+ E+
Sbjct: 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDN 139
Query: 368 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLE 427
AK++D G+ K +A P + + APE + S SDV+SFG++L E
Sbjct: 140 VAKVSDFGLTK--EASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWSFGILLWE 191
Query: 428 LIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAK 486
+ + GR P R K PR++ K D P ++ + K
Sbjct: 192 IYSFGRVPYPRIPLKD-------VVPRVEKG-----------YKMDAPDGCPPVVYDVMK 233
Query: 487 ECLQLDPDARPTMSEVVQILSTI 509
+C LD RP+ ++ + L I
Sbjct: 234 QCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 69/286 (24%), Positives = 123/286 (43%), Gaps = 41/286 (14%)
Query: 231 IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADS-----VFLTEVDMLSRLHHCHVV 284
+G G S Y+ + + G ++AVK+ +++ E+ +++RL+H H++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGLEY 342
++G E + L E+M G++ L G E + + RGL Y
Sbjct: 67 RMLGATCE----DSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI----INYTEQLLRGLSY 118
Query: 343 LHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
LHE +I+HRD+K +N+L+D +I D G A RL A ++ GT +
Sbjct: 119 LHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK-GTGAGEFQGQLLGTIAF 174
Query: 402 FAPEY---AMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458
APE GR+ DV+S G V++E+ T + P W + +
Sbjct: 175 MAPEVLRGEQYGRS---CDVWSVGCVIIEMATAKPP--------------WNAEKHSNHL 217
Query: 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
+I ++ P+ + + CL+L P+ RP E+++
Sbjct: 218 ALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 87/315 (27%), Positives = 140/315 (44%), Gaps = 67/315 (21%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHC 281
+K+ + +G+G V++ + + G+IVA+K+F +++ P + L E+ ML +L H
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFM-----------PNGNLRDCLDGVLVEGMNWDTRV 330
++V L+ FR KR + L VFE+ P G + L++ + W T
Sbjct: 61 NLVNLI---EVFRRKRKLHL-VFEYCDHTVLNELEKNPRG-----VPEHLIKKIIWQT-- 109
Query: 331 AIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 390
+ + + H +HRD+K NIL+ + K+ D G A+ L G
Sbjct: 110 ------LQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY 160
Query: 391 SPARMQGTFGYFAPEYAMVGRASLMS--DVFSFGVVLLELITGRQPI--HRS-------I 439
R Y APE +VG DV++ G V EL+TG QP+ +S I
Sbjct: 161 VATRW-----YRAPEL-LVGDTQYGPPVDVWAIGCVFAELLTG-QPLWPGKSDVDQLYLI 213
Query: 440 TKGEESLVLWATPRLQD--------SGTVISELPDPR--LKGDFPKEEMQIMAYLAKECL 489
K L+ PR Q G I E P+ R L+ FP +++L K CL
Sbjct: 214 RKTLGDLI----PRHQQIFSTNQFFKGLSIPE-PETREPLESKFPNISSPALSFL-KGCL 267
Query: 490 QLDPDARPTMSEVVQ 504
Q+DP R + E+++
Sbjct: 268 QMDPTERLSCEELLE 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-17
Identities = 84/305 (27%), Positives = 138/305 (45%), Gaps = 52/305 (17%)
Query: 225 KFSGSNIVGQGGSSYVYRG-QLTDG---RI-VAVKRFKTQGGPNADSVFLTEVDMLSRLH 279
+F ++G G VY+G + +G +I VA+K + P A+ L E +++ +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 280 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGM-NWDTRVAIAI 334
+ HV L+G C + L+ + MP G L D + D + + + NW ++A
Sbjct: 68 NPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA--- 119
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
+G+ YL E R++HRD+ + N+L+ + KITD G+AK L AD
Sbjct: 120 ---KGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD------EKEYH 167
Query: 395 MQG---TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWA 450
+G + A E + + SDV+S+GV + EL+T G +P + I E S +L
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP-YDGIPASEISSILEK 226
Query: 451 TPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510
RL P P P + + + K C +D D+RP E++ S +A
Sbjct: 227 GERL----------PQP------PICTIDVYMIMVK-CWMIDADSRPKFRELIIEFSKMA 269
Query: 511 PDKSR 515
D R
Sbjct: 270 RDPQR 274
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 84/303 (27%), Positives = 136/303 (44%), Gaps = 60/303 (19%)
Query: 231 IVGQGGSSYVYRG-QLTDG---RI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
++G G VY+G + DG +I VA+K + P A+ L E +++ + +V
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNL----RDCLDGVLVEGM-NWDTRVAIAIGAARGL 340
L+G C + LV + MP G L R+ D + + + NW ++A +G+
Sbjct: 74 LLGICLT-----STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIA------KGM 122
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK-------ADGLPSCSSSPA 393
YL E R++HRD+ + N+L+ + KITD G+A+ L ADG P
Sbjct: 123 SYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG----GKVPI 175
Query: 394 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATP 452
+ + A E + R + SDV+S+GV + EL+T G +P + + P
Sbjct: 176 K------WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY--------DGIPAREIP 221
Query: 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512
L + G LP P P + + + K C +D + RP E+V S +A D
Sbjct: 222 DLLEKG---ERLPQP------PICTIDVYMIMVK-CWMIDSECRPRFRELVDEFSRMARD 271
Query: 513 KSR 515
SR
Sbjct: 272 PSR 274
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 81/299 (27%), Positives = 135/299 (45%), Gaps = 52/299 (17%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G+G + VY+G+ T G IVA+K S + E+ ++ L H ++V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL---- 63
Query: 291 SEFRGKRAMRLLVFEFMPN---------GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 341
+ +LVFE+M G R LD V+ + +G+
Sbjct: 64 HDVIHTENKLMLVFEYMDKDLKKYMDTHGV-RGALDPNTVKSFTYQL--------LKGIA 114
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
+ HE R+LHRD+K N+L+++ K+ D G+A +A G+P + S + T Y
Sbjct: 115 FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLA---RAFGIPVNTFSNEVV--TLWY 166
Query: 402 FAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPIHRSITKGEESLV----LWATPRLQD 456
AP+ + R S D++S G ++ E+ITGR P+ T E+ L+ + TP +
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR-PLFPG-TNNEDQLLKIFRIMGTPT-ES 223
Query: 457 SGTVISELPDPRLKGDFPKEEMQIMAY-----------LAKECLQLDPDARPTMSEVVQ 504
+ IS+LP+ K FP+ Q + L LQL+P+ R + + +Q
Sbjct: 224 TWPGISQLPE--YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 4e-17
Identities = 69/207 (33%), Positives = 100/207 (48%), Gaps = 31/207 (14%)
Query: 247 DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 306
D +VAVK K NA F E ++L+ L H H+V G C E G ++VFE+
Sbjct: 34 DKILVAVKTLK-DASDNARKDFHREAELLTNLQHEHIVKFYGVCVE--GDPL--IMVFEY 88
Query: 307 MPNGNLRDCL-----DGVLVEGMNWDTRVA------IAIGAARGLEYLHEAAAPRILHRD 355
M +G+L L D VL+ N + IA A G+ YL A+ +HRD
Sbjct: 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRD 145
Query: 356 IKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG----TFGYFAPEYAMVGR 411
+ + N L+ ENL KI D GM++ + S+ R+ G + PE M +
Sbjct: 146 LATRNCLVGENLLVKIGDFGMSRDVY-------STDYYRVGGHTMLPIRWMPPESIMYRK 198
Query: 412 ASLMSDVFSFGVVLLELIT-GRQPIHR 437
+ SDV+S GVVL E+ T G+QP ++
Sbjct: 199 FTTESDVWSLGVVLWEIFTYGKQPWYQ 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 4e-17
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 33/213 (15%)
Query: 231 IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLT---EVDMLSRLHHCHVVPL 286
+G+G VY+ + G IVA+K+ + + + T E+ +L L H ++V L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIR--LDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
+ +R + LVFE+ +L+ LD ++ + +I RGL Y H
Sbjct: 64 LDVI---HTERKL-YLVFEYCDM-DLKKYLD-KRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE- 405
RILHRD+K NIL++ + K+ D G+A +A G+P + + + T Y APE
Sbjct: 118 ---RILHRDLKPQNILINRDGVLKLADFGLA---RAFGIPLRTYTHEVV--TLWYRAPEI 169
Query: 406 ------YAMVGRASLMSDVFSFGVVLLELITGR 432
Y S D++S G + E+ITG+
Sbjct: 170 LLGSKHY------STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 67/231 (29%), Positives = 102/231 (44%), Gaps = 44/231 (19%)
Query: 230 NIVGQGGSSYVYRGQLTD------GRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
N +G G VY G TD G I VAVK + FL E ++S +H +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVE-----GMNWDTRVAIAIGAA 337
+V L+G C + ++ E M G+L L VE + + I + A
Sbjct: 61 IVKLLGVCLL----NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNA-----KITDLGMAK--------RLKADG 384
+G YL + +HRD+ + N L+ E KI D G+A+ R + +G
Sbjct: 117 KGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
L P R + APE + G+ + SDV+SFGV++ E++T G+QP
Sbjct: 174 L-----LPVR------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 65/221 (29%), Positives = 114/221 (51%), Gaps = 33/221 (14%)
Query: 231 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADS---------VFLTEVDMLSRLHH 280
++G G VY G + G ++AVK+ + +A S E+ +L L H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPS-VSASSKDRKRSMLDALAREIALLKELQH 65
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGM--NWDTRVAIAIG 335
++V +G + A L +F E++P G++ L+ G E + N+ ++
Sbjct: 66 ENIVQYLGSSLD-----ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL---- 116
Query: 336 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR- 394
+GL YLH I+HRDIK +NIL+D KI+D G++K+L+A+ L S ++ AR
Sbjct: 117 --KGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSL-STKTNGARP 170
Query: 395 -MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
+QG+ + APE + +D++S G +++E++TG+ P
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 73/291 (25%), Positives = 127/291 (43%), Gaps = 32/291 (10%)
Query: 229 SNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVF-LTEVDMLSRL---HHCHV 283
+G+G VY+ + L GR VA+K+ + + L E+ +L +L H ++
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 284 VPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
V L+ C R R ++L LVFE + + +L L G+ +T + RG+++
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD-GLPSCSSSPARMQGTFGY 401
LH + RI+HRD+K NIL+ + KI D G+A+ + L S T Y
Sbjct: 123 LH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV-------TLWY 172
Query: 402 FAPEYAMVGRASLMS--DVFSFGVVLLELITGRQPIHRSITKGE---ESLVLWATPRLQD 456
APE + ++S + D++S G + EL R+P+ R ++ + + + P ++
Sbjct: 173 RAPEVLL--QSSYATPVDMWSVGCIFAELFR-RRPLFRGTSEADQLDKIFDVIGLPSEEE 229
Query: 457 SGTVISELPD---PRLKGDFPKEEMQIMAY---LAKECLQLDPDARPTMSE 501
+S F +I L K+ L +P R + E
Sbjct: 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFE 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 77/279 (27%), Positives = 128/279 (45%), Gaps = 39/279 (13%)
Query: 230 NIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
I+G G VY+ L RI+AVK ++E+++L + C ++G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEIL---YKCDSPYIIG 63
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNL---RDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 345
+ F + + + EFM G+L R + VL R+A+A+ +GL YL
Sbjct: 64 FYGAFFVENRISICT-EFMDGGSLDVYRKIPEHVL-------GRIAVAV--VKGLTYLW- 112
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 405
+ +ILHRD+K SN+L++ K+ D G++ +L +S GT Y APE
Sbjct: 113 --SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-------VNSIAKTYVGTNAYMAPE 163
Query: 406 YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465
+ + SDV+S G+ +EL GR P + I K + SL+ LQ ++ E P
Sbjct: 164 RISGEQYGIHSDVWSLGISFMELALGRFP-YPQIQKNQGSLM-----PLQLLQCIVDEDP 217
Query: 466 DPRLK-GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 503
P L G F ++ + + +C++ P RP ++
Sbjct: 218 -PVLPVGQFSEKFVHFIT----QCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 79/287 (27%), Positives = 133/287 (46%), Gaps = 45/287 (15%)
Query: 231 IVGQGGSSYVYRGQL-TDGR---IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
++G G V+RG L GR VA+K K FL+E ++ + H +++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYL 343
G ++F K AM ++ E+M NG L L DG V + G A G++YL
Sbjct: 72 EGVVTKF--KPAM--IITEYMENGALDKYLRDHDGEFSSYQ----LVGMLRGIAAGMKYL 123
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
+ +HRD+ + NIL++ NL K++D G+++ L+ D + ++S ++ + A
Sbjct: 124 SDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTA 178
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462
PE + + SDV+SFG+V+ E+++ G +P W + I+
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERP-------------YWDMSN-HEVMKAIN 224
Query: 463 E---LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
+ LP P D P Q+M +C Q D RP ++V +L
Sbjct: 225 DGFRLPAPM---DCPSAVYQLML----QCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 9e-17
Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV------FLTEVDMLSRLHHCHV 283
++G+G VY G G+++AVK+ + N + EVD+L L H ++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTS-NVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGLE 341
V +G C + + EF+P G++ L+ G L E + I G A
Sbjct: 65 VQYLGTCLD----DNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA---- 116
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFG 400
YLH ++HRDIK +N++L N K+ D G A+RL GL S+ + M GT
Sbjct: 117 YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 435
+ APE SD++S G + E+ TG+ P+
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 76/287 (26%), Positives = 116/287 (40%), Gaps = 51/287 (17%)
Query: 231 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV------FLTEVDMLSRLHHCHV 283
++GQG VY D GR +AVK+ P++ E+ +L L H +
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPF--DPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 284 VPLVGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGL 340
V G C L +F E+MP G+++D L G L E + I G+
Sbjct: 67 VQYYG-CLRDDET----LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGV 117
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
EYLH I+HRDIK +NIL D N K+ D G +KRL+ + GT
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS--VTGTPY 172
Query: 401 YFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457
+ +PE GR +DV+S G ++E++T + P WA +
Sbjct: 173 WMSPEVISGEGYGRK---ADVWSVGCTVVEMLTEKPP--------------WAEFEAMAA 215
Query: 458 GTVISELP-DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 503
I+ P +P+L P + + RP+ E++
Sbjct: 216 IFKIATQPTNPQL----PSHVSPDARNFLRRTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 79/325 (24%), Positives = 142/325 (43%), Gaps = 56/325 (17%)
Query: 230 NIVGQGGSSYVYRGQLT-DGRIV--AVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVP 285
+++G+G V R + DG + A+K K N F E+++L +L HH +++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVA 331
L+G C R + E+ P GNL D L V + +
Sbjct: 68 LLGACE----NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 391
A A G++YL E + +HRD+ + N+L+ ENL +KI D G+++ + +
Sbjct: 124 FASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL 180
Query: 392 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 451
P R + A E + SDV+SFGV+L E+++ L T
Sbjct: 181 PVR------WMAIESLNYSVYTTKSDVWSFGVLLWEIVS-----------------LGGT 217
Query: 452 PRLQDSGTVISELPDPRLKG---DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508
P G +EL + +G + P+ + L ++C + P RP +++ LS
Sbjct: 218 PY---CGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR 274
Query: 509 IAPDKSRRRNISLNLFQIFSAGGME 533
+ ++R+ +++ LF+ F+ G++
Sbjct: 275 ML--EARKAYVNMALFENFTYAGID 297
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 73/293 (24%), Positives = 122/293 (41%), Gaps = 51/293 (17%)
Query: 231 IVGQGGSSYVYRG-QLTDGRIVAVKRF---KTQGGPNAD------SVFLTEVDMLSRLHH 280
++G+G VY +T G ++AVK+ T G + +E++ L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL------DGVLVEGMNWDTRVAIAI 334
++V +G F + E++P G++ CL + LV
Sbjct: 68 LNIVQYLG----FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV------ 117
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
GL YLH ILHRD+K+ N+L+D + KI+D G++K K+D + +
Sbjct: 118 --LEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK--KSDDIYD-NDQNMS 169
Query: 395 MQGTFGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 452
MQG+ + APE S D++S G V+LE+ GR+P W+
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP--------------WSDE 215
Query: 453 R-LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
+ + ++ P + D + C ++PD RPT E++Q
Sbjct: 216 EAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 82/336 (24%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 216 YSALEHATDKFSGSNIVGQGGSSYVYRGQL-TDG-RI-VAVKRFKTQGGPNADSVFLTEV 272
Y LE KF +++G+G V + ++ DG R+ A+KR K + F E+
Sbjct: 1 YPVLEWNDIKFQ--DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGEL 58
Query: 273 DMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV---------- 321
++L +L HH +++ L+G C R L E+ P+GNL D L V
Sbjct: 59 EVLCKLGHHPNIINLLGACEH----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 114
Query: 322 ----EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377
++ + A ARG++YL + + +HRD+ + NIL+ EN AKI D G++
Sbjct: 115 NSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 171
Query: 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437
+ + + P R + A E + SDV+S+GV+L E+++ +
Sbjct: 172 RGQEVYVKKTMGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 225
Query: 438 SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP 497
+T E L RL+ E+ D L ++C + P RP
Sbjct: 226 GMTCAELYEKLPQGYRLEKPLNCDDEVYD-----------------LMRQCWREKPYERP 268
Query: 498 TMSEVVQILSTIAPDKSRRRNISLNLFQIFSAGGME 533
+ ++++ L+ + + R+ ++ L++ F+ G++
Sbjct: 269 SFAQILVSLNRML--EERKTYVNTTLYEKFTYAGID 302
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 73/288 (25%), Positives = 116/288 (40%), Gaps = 45/288 (15%)
Query: 230 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLT-EVDMLSRLHHCHVVPLV 287
+G+G V + + +DG+I+ K + L EV++L L H ++V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV--- 62
Query: 288 GYCSEFRGKRAMRL-LVFEFMPNGNL----RDC--LDGVLVEGMNWD--TRVAIAIGAAR 338
Y + L +V E+ G+L + C + E W T++ +A
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA----- 117
Query: 339 GLEYLH--EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
L H +LHRD+K +NI LD N N K+ D G+AK L D SS
Sbjct: 118 -LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-----SSFAKTYV 171
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456
GT Y +PE SD++S G ++ EL P + + L
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT---ARNQLQLA--------- 219
Query: 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
+ I E R+ + E +++ K L +DPD RP+ E++Q
Sbjct: 220 --SKIKEGKFRRIPYRYSSELNEVI----KSMLNVDPDKRPSTEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 7e-16
Identities = 70/279 (25%), Positives = 121/279 (43%), Gaps = 40/279 (14%)
Query: 231 IVGQG--GSSYVYRGQLTDGRIVAVKRFK-TQGGPNADSVFLTEVDMLSRLHHCHVVPLV 287
++G+G G + +YR + D +V K T+ L E+ +LS L H +++
Sbjct: 7 VLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNII--- 62
Query: 288 GYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLH 344
Y + F + L+ E+ G L D + G L E + + + Y+H
Sbjct: 63 AYYNHFMDDNTL-LIEMEYANGGTLYDKIVRQKGQLFEE---EMVLWYLFQIVSAVSYIH 118
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 404
+A ILHRDIK+ NI L + K+ D G++K L ++ S + GT Y +P
Sbjct: 119 KAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE-----YSMAETVVGTPYYMSP 170
Query: 405 EYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 464
E + + SD+++ G VL EL+T + R+ ++ +Q + T +
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLT----LKRTFDATNPLNLVVKI--VQGNYTPV--- 221
Query: 465 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 503
+ E + ++ LQ DP+ RPT EV+
Sbjct: 222 -----VSVYSSELISLV----HSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 8e-16
Identities = 81/309 (26%), Positives = 128/309 (41%), Gaps = 50/309 (16%)
Query: 206 TIHGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNA 264
TI G + LE+ + +G G VY+ + G ++AVK+ + G
Sbjct: 4 TIDGQKYPADLNDLENLGE-------IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE 56
Query: 265 DSVFLTEVDMLSRLHHC-HVVPLVGY-CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV- 321
+ L ++D++ + H C ++V GY ++ M L+ CLD +L
Sbjct: 57 NKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM----------STCLDKLLKR 106
Query: 322 --EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379
+ D + + + L YL E ++HRD+K SNILLD + N K+ D G++ R
Sbjct: 107 IQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGR 164
Query: 380 LKADGLPSCSSSPARMQGTFGYFAPEY----AMVGRASLMSDVFSFGVVLLELITGRQPI 435
L D S + R G Y APE + + +DV+S G+ L+EL TG+ P
Sbjct: 165 L-VD-----SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPY 218
Query: 436 HRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDA 495
T+ E VL T I + P L + + CL D
Sbjct: 219 KNCKTEFE---VL----------TKILQEEPPSLPPN--EGFSPDFCSFVDLCLTKDHRK 263
Query: 496 RPTMSEVVQ 504
RP E++Q
Sbjct: 264 RPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 232 VGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNA----DSVFLTEVDMLSRLHHCHVVPL 286
+G+G + VY+ GRIVA+K+ K A + L E+ +L L H +++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
+ F K + L VFEFM +L + + D + + + RGLEYLH
Sbjct: 68 L---DVFGHKSNINL-VFEFME-TDLEKVIKDKSIVLTPADIK-SYMLMTLRGLEYLHSN 121
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG---TFGYFA 403
ILHRD+K +N+L+ + K+ D G+A+ S S +M T Y A
Sbjct: 122 W---ILHRDLKPNNLLIASDGVLKLADFGLAR--------SFGSPNRKMTHQVVTRWYRA 170
Query: 404 PEYAMVGRA-SLMSDVFSFGVVLLELITGR 432
PE R + D++S G + EL+
Sbjct: 171 PELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 28/195 (14%)
Query: 250 IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309
+VAVK + A + FL E+ ++SRL + +++ L+G C ++ E+M N
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCV----SDDPLCMITEYMEN 101
Query: 310 GNLRDCLDGVLVEG----------MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359
G+L L +E ++ + +A+ A G++YL A+ +HRD+ +
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATR 158
Query: 360 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG----TFGYFAPEYAMVGRASLM 415
N L+ + KI D GM++ L S R+QG + A E ++G+ +
Sbjct: 159 NCLVGNHYTIKIADFGMSRNLY-------SGDYYRIQGRAVLPIRWMAWESILLGKFTTA 211
Query: 416 SDVFSFGVVLLELIT 430
SDV++FGV L E+ T
Sbjct: 212 SDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 73/287 (25%), Positives = 125/287 (43%), Gaps = 57/287 (19%)
Query: 231 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
+G+G VY+ G++VA+K + + E+ +L + ++V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYG- 65
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWD-TRVAIAI---GAARGLEYLHE 345
S F K +V E+ G++ D +++ N T IA +GLEYLH
Sbjct: 66 -SYF--KNTDLWIVMEYCGAGSVSD-----IMKITNKTLTEEEIAAILYQTLKGLEYLH- 116
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ---GTFGYF 402
+ + +HRDIK+ NILL+E AK+ D G++ +L + + A+ GT +
Sbjct: 117 --SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL--------TDTMAKRNTVIGTPFWM 166
Query: 403 APEYAMVGRASLMSDVFSFGVVLLELITGRQP---IH--RSITKGEESLVLWATPRLQDS 457
APE + +D++S G+ +E+ G+ P IH R+I
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI------------------ 208
Query: 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
+I P P L P++ K+CL DP+ RP+ +++Q
Sbjct: 209 -FMIPNKPPPTLSD--PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 35/201 (17%)
Query: 250 IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309
+VAVK + NA + FL EV +LSRL +++ L+G C + ++ E+M N
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD----EDPLCMITEYMEN 103
Query: 310 GNLRDCLDG-VLVEG----------------MNWDTRVAIAIGAARGLEYLHEAAAPRIL 352
G+L L L + +++ + + +A+ A G++YL ++ +
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFV 160
Query: 353 HRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG----TFGYFAPEYAM 408
HRD+ + N L+ ENL KI D GM++ L A R+QG + A E +
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSRNLYA-------GDYYRIQGRAVLPIRWMAWECIL 213
Query: 409 VGRASLMSDVFSFGVVLLELI 429
+G+ + SDV++FGV L E++
Sbjct: 214 MGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 76/300 (25%), Positives = 124/300 (41%), Gaps = 69/300 (23%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
+ F+ +G+G VY+ ++VA+K + + E+ LS+ +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 283 VVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIAI---GAA 337
+ G S +G +L ++ E+ G+ D L G L E IA
Sbjct: 61 ITKYYG--SFLKG---SKLWIIMEYCGGGSCLDLLKPGKLDET-------YIAFILREVL 108
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ- 396
GLEYLHE +HRDIK++NILL E + K+ D G++ +L +S+ ++
Sbjct: 109 LGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQL--------TSTMSKRNT 157
Query: 397 --GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP---IH--RSITKGEESLVLW 449
GT + APE +D++S G+ +EL G P +H R VL
Sbjct: 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---------VL- 207
Query: 450 ATPRLQDSGTVISELPDPRLKGD-FPKEEMQIMAYLAKE----CLQLDPDARPTMSEVVQ 504
+I + P L+G+ F K K+ CL DP RP+ E+++
Sbjct: 208 ---------FLIPKNNPPSLEGNKFSKP--------FKDFVSLCLNKDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 75/289 (25%), Positives = 131/289 (45%), Gaps = 46/289 (15%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
+G+G VY+ + G +VA+K+ + T+G P S + E+ +L L+H ++V L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHPNIVKL 64
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
+ + LVFEF+ + +L+ +D + G+ + +GL + H
Sbjct: 65 L----DVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH-- 117
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
+ R+LHRD+K N+L++ K+ D G+A +A G+P + + + T Y APE
Sbjct: 118 -SHRVLHRDLKPQNLLINTEGAIKLADFGLA---RAFGVPVRTYTHEVV--TLWYRAPEI 171
Query: 407 AMVGR-ASLMSDVFSFGVVLLELITGRQ--PIHRSI--------TKGEESLVLWATPRLQ 455
+ + S D++S G + E++T R P I T G V+W
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG---- 227
Query: 456 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
++ LPD K FPK Q + + LD D R +S+++
Sbjct: 228 -----VTSLPD--YKPSFPKWARQDFSKVVP---PLDEDGRDLLSQMLH 266
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 78/284 (27%), Positives = 129/284 (45%), Gaps = 50/284 (17%)
Query: 235 GGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
G +Y VY+ + + G +VA+K K + G + + + E+ ML H ++V G S
Sbjct: 12 GSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEII-QQEISMLKECRHPNIVAYFG--S 68
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351
R + +V E+ G+L+D V ++ + +GL YLHE
Sbjct: 69 YLRRDKLW--IVMEYCGGGSLQDIYQ-VTRGPLSELQIAYVCRETLKGLAYLHET---GK 122
Query: 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ---GTFGYFAPEYAM 408
+HRDIK +NILL E+ + K+ D G++ +L A + A+ + GT + APE A
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTA--------TIAKRKSFIGTPYWMAPEVAA 174
Query: 409 V---GRASLMSDVFSFGVVLLELITGRQP---IH--RSITKGEESLVLWATPRLQDSGTV 460
V G D+++ G+ +EL + P +H R L+ +
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR---------ALFLISK------- 218
Query: 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
S P P+LK D K ++ K+CL DP RPT ++++Q
Sbjct: 219 -SNFPPPKLK-DKEKWSPVFHDFI-KKCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 73/280 (26%), Positives = 124/280 (44%), Gaps = 40/280 (14%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLVGY 289
+G G V+ G + VAVK K P SV FL E +++ L H +V L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK----PGTMSVQAFLEEANLMKTLQHDKLVRLYAV 69
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 349
+ K ++ E+M G+L D L + + + A G+ Y+
Sbjct: 70 VT----KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK--- 122
Query: 350 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYA 407
+HRD++++N+L+ E+L KI D G+A+ ++ + AR F + APE
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN------EYTAREGAKFPIKWTAPEAI 176
Query: 408 MVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 466
G ++ SDV+SFG++L E++T G+ P + ++ + L R+
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIP-YPGMSNSDVMSALQRGYRM------------ 223
Query: 467 PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
PR++ + P E IM K C + + RPT + +L
Sbjct: 224 PRME-NCPDELYDIM----KTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 69/268 (25%), Positives = 113/268 (42%), Gaps = 40/268 (14%)
Query: 250 IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309
+V VK + N S F E+DM +L H +VV L+G C E ++ E+
Sbjct: 37 LVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE----AEPHYMILEYTDL 92
Query: 310 GNLRDCL-------DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNIL 362
G+L+ L + + ++ +VA+ A G+++L A R +HRD+ + N L
Sbjct: 93 GDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCL 149
Query: 363 LDENLNAKITDLGMAKRLKADGLPSCSSS--PARMQGTFGYFAPEYAMVGRASLMSDVFS 420
+ K++ L ++K + ++ P R + APE S SDV+S
Sbjct: 150 VSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR------WLAPEAVQEDDFSTKSDVWS 203
Query: 421 FGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQ 479
FGV++ E+ T G P ++ E L ELP P P +
Sbjct: 204 FGVLMWEVFTQGELP-FYGLSDEE---------VLNRLQAGKLELPVPE---GCPSRLYK 250
Query: 480 IMAYLAKECLQLDPDARPTMSEVVQILS 507
+M C ++P RP+ SE+V L
Sbjct: 251 LMT----RCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 82/291 (28%), Positives = 135/291 (46%), Gaps = 51/291 (17%)
Query: 231 IVGQGGSSYVYRGQLT-DGR---IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
++G G V RG+L G+ VA+K K+ FL+E ++ + H +++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR-VAIAIGAARGLEYLHE 345
G ++ R +++ EFM NG L L +G + V + G A G++YL E
Sbjct: 71 EGVVTKSRPV----MIITEFMENGALDSFLR--QNDGQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL-PSCSSS-----PARMQGTF 399
+HRD+ + NIL++ NL K++D G+++ L+ D P+ +SS P R
Sbjct: 125 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR----- 176
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSG 458
+ APE + + SDV+S+G+V+ E+++ G +P W QD
Sbjct: 177 -WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-------------YWDMSN-QDVI 221
Query: 459 TVISE---LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
I + LP P D P Q+M +C Q D +ARP ++V L
Sbjct: 222 NAIEQDYRLPPPM---DCPTALHQLML----DCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 7e-15
Identities = 71/281 (25%), Positives = 120/281 (42%), Gaps = 55/281 (19%)
Query: 250 IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309
+VAVK K + + + F E +++ H ++V L+G C+ + M LL FE+M
Sbjct: 37 MVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV---GKPMCLL-FEYMAY 92
Query: 310 GNL----RDCLDGVLVEGMNWDTR----------------VAIAIGAARGLEYLHEAAAP 349
G+L R + + + IA A G+ YL E
Sbjct: 93 GDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER--- 149
Query: 350 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS---PARMQGTFGYFAPEY 406
+ +HRD+ + N L+ EN+ KI D G+++ + + S + P R + PE
Sbjct: 150 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR------WMPPES 203
Query: 407 AMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465
R + SDV+++GVVL E+ + G QP + E ++ + G V+S P
Sbjct: 204 IFYNRYTTESDVWAYGVVLWEIFSYGMQPYY---GMAHEEVIYYVR-----DGNVLS-CP 254
Query: 466 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
D + P E +M + C P RP+ + + +IL
Sbjct: 255 D-----NCPLELYNLM----RLCWSKLPSDRPSFASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 7e-15
Identities = 76/282 (26%), Positives = 129/282 (45%), Gaps = 54/282 (19%)
Query: 243 GQLTDGRI---------VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293
G++ GR+ VA+K K FL+E ++ + H +++ L G +
Sbjct: 18 GEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-- 75
Query: 294 RGKRAMRLLVFEFMPNGNLRDCL---DG--VLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
+ K M +V E+M NG+L L DG +++ V + G A G++YL +
Sbjct: 76 KSKPVM--IVTEYMENGSLDAFLRKHDGQFTVIQ------LVGMLRGIASGMKYLSDMGY 127
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 408
+HRD+ + NIL++ NL K++D G+++ L+ D P + + + + APE
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDD--PEAAYTTRGGKIPIRWTAPEAIA 182
Query: 409 VGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISE---L 464
+ + SDV+S+G+V+ E+++ G +P W QD I E L
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERP-------------YWEMSN-QDVIKAIEEGYRL 228
Query: 465 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
P P D P Q+M +C Q D + RP ++V IL
Sbjct: 229 PAPM---DCPAALHQLML----DCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 8e-15
Identities = 76/301 (25%), Positives = 126/301 (41%), Gaps = 56/301 (18%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
+G+G VY+ + G IVA+K+ K ++G P L E+ +L L+H +++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA---LREIKLLKELNHPNIIKL 63
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
+ FR K + LVFEFM + +L + G+ + +GL + H
Sbjct: 64 L---DVFRHKGDL-YLVFEFM-DTDLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ----GTFGYF 402
ILHRD+K N+L++ K+ D G+A+ SP R T Y
Sbjct: 118 ---GILHRDLKPENLLINTEGVLKLADFGLARSF---------GSPVRPYTHYVVTRWYR 165
Query: 403 APE--YAMVGRASLMSDVFSFGVVLLELITGRQPIH--RS----ITKGEESLVLWATPRL 454
APE G ++ + D++S G + EL++ R P+ +S + K +L TP
Sbjct: 166 APELLLGDKGYSTPV-DIWSVGCIFAELLSRR-PLFPGKSEIDQLFKIFRTL---GTPDP 220
Query: 455 QDSGTVISELPDPRLKGDFPKEEMQ----IMAYLAKECLQL-------DPDARPTMSEVV 503
+ + L K FPK+ + + + L L DP R T + +
Sbjct: 221 EVW-PKFTSLARN-YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQAL 278
Query: 504 Q 504
Sbjct: 279 A 279
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 77/297 (25%), Positives = 127/297 (42%), Gaps = 48/297 (16%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLT----EVDM 274
E+ D+ ++G+G VY + L+ +A+K P DS ++ E+ +
Sbjct: 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEI-----PERDSRYVQPLHEEIAL 58
Query: 275 LSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLVEGMNWDTRVA 331
S L H ++V +G SE + E +P G+L L G L + N T +
Sbjct: 59 HSYLKHRNIVQYLGSDSE----NGFFKIFMEQVPGGSLSALLRSKWGPLKD--NEQTIIF 112
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-KITDLGMAKRLKADGLPSCSS 390
GL+YLH+ +I+HRDIK N+L++ KI+D G +KRL G+ C+
Sbjct: 113 YTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA--GINPCTE 167
Query: 391 SPARMQGTFGYFAPEYAMVGRASL--MSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 448
+ GT Y APE G +D++S G ++E+ TG+ P GE +
Sbjct: 168 T---FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE---LGEPQAAM 221
Query: 449 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAY-LAKECLQLDPDARPTMSEVVQ 504
+ + E+P E + A C + DPD R + +++Q
Sbjct: 222 FKVGMFKIH----PEIP----------ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 71/220 (32%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 232 VGQGGSSYVYRGQL-TDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
+G+GG V Q+ G++ A K R K + G V E +L+++H +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV---EKRILAKVHSRFIVS 57
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA--RGLEYL 343
L F+ K + LV M G+LR + V E + A A GLE+L
Sbjct: 58 LA---YAFQTKTDL-CLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
H+ RI++RD+K N+LLD + N +I+DLG+A LK DG S GT G+ A
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELK-DG----QSKTKGYAGTPGFMA 165
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 443
PE D F+ GV L E+I R P K E
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 81/313 (25%), Positives = 125/313 (39%), Gaps = 69/313 (22%)
Query: 233 GQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVF----LTEVDMLSRLHHCHVVPL- 286
G+G VY+ Q+ GR+VA+K+ N F L E+ +L +L H +VVPL
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILMH---NEKDGFPITALREIKILKKLKHPNVVPLI 73
Query: 287 ---VGYCSEFRGKRAMRLLVFEFM----------PNGNLRD----CLDGVLVEGMNWDTR 329
V + + KR +V +M P+ L + C L+EG+N
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGIN---- 129
Query: 330 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 389
YLHE ILHRDIK++NIL+D KI D G+A R P+
Sbjct: 130 ------------YLHEN---HILHRDIKAANILIDNQGILKIADFGLA-RPYDGPPPNPK 173
Query: 390 SSPAR-------MQGTFGYFAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPIHRSITK 441
+ T Y PE + R + D++ G V E+ T R PI + +
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR-PILQGKSD 232
Query: 442 GEESLVLWA---TPRLQDSGTVISELP---DPRLKGDFP-------KEEMQIMAYLAKEC 488
++ +++ TP +++ LP ++P + L +
Sbjct: 233 IDQLHLIFKLCGTPT-EETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKL 291
Query: 489 LQLDPDARPTMSE 501
L LDP R T S+
Sbjct: 292 LSLDPYKRLTASD 304
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRLH---HCHVVPL 286
+G G VY+ + G VA+K + Q + + + EV +L RL H ++V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 287 VGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 345
+ C+ R R ++ LVFE + + +LR LD V G+ +T + RGL++LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH- 125
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 405
A I+HRD+K NIL+ K+ D G+A+ + SC + + T Y APE
Sbjct: 126 --ANCIVHRDLKPENILVTSGGQVKLADFGLAR------IYSCQMALTPVVVTLWYRAPE 177
Query: 406 YAMVGRASLMSDVFSFGVVLLELITGRQPI 435
+ + D++S G + E+ R+P+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 81/309 (26%), Positives = 126/309 (40%), Gaps = 61/309 (19%)
Query: 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV--FLTEVDML 275
L T F ++G+G VY+ + G++VA+K D E ++L
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNIL 56
Query: 276 SRL-HHCHVVPLVG--YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGM----NWDT 328
+ +H ++ G G LV E G++ D + G+ +G W
Sbjct: 57 RKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-- 114
Query: 329 RVA-IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP- 386
+A I RGL YLHE +++HRDIK NILL +N K+ D G++ +L +
Sbjct: 115 -IAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR 170
Query: 387 -SCSSSPARMQGTFGYFAPEYAMVG---RASL--MSDVFSFGVVLLELITGRQP---IH- 436
+ +P M APE AS SDV+S G+ +EL G+ P +H
Sbjct: 171 NTFIGTPYWM-------APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP 223
Query: 437 -RSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDA 495
R+ L+ PR P P LK P+ + ECL + +
Sbjct: 224 MRA---------LFKIPR----------NPPPTLKS--PENWSKKFNDFISECLIKNYEQ 262
Query: 496 RPTMSEVVQ 504
RP M E+++
Sbjct: 263 RPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 83/309 (26%), Positives = 127/309 (41%), Gaps = 57/309 (18%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRGQLTD---GRI---VAVKRFKTQGGPNADSVFLTEVD 273
E + +K + +GQG VY G D G VAVK FL E
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR---- 329
++ HVV L+G S K L+V E M +G+L+ L + E N R
Sbjct: 62 VMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 117
Query: 330 ----VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK------- 378
+ +A A G+ YL+ A + +HRD+ + N ++ + KI D GM +
Sbjct: 118 LQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 174
Query: 379 -RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437
R GL P R + APE G + SD++SFGVVL E+ + + ++
Sbjct: 175 YRKGGKGL-----LPVR------WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ 223
Query: 438 SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP 497
++ E+ L + D G + D P + + L + C Q +P RP
Sbjct: 224 GLSN-EQVLKF-----VMDGGYL-----------DQPDNCPERVTDLMRMCWQFNPKMRP 266
Query: 498 TMSEVVQIL 506
T E+V +L
Sbjct: 267 TFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 76/287 (26%), Positives = 125/287 (43%), Gaps = 68/287 (23%)
Query: 251 VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309
VAVK K S ++E++M+ + H +++ L+G C++ G +V E+ +
Sbjct: 45 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-EGPL---YVVVEYAAH 100
Query: 310 GNLRDCL--------------DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 355
GNLRD L E + V+ A ARG+E+L A+ + +HRD
Sbjct: 101 GNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRD 157
Query: 356 IKSSNILLDENLNAKITDLGMAK--------RLKADG-LPSCSSSPARMQGTFGYFAPEY 406
+ + N+L+ E+ KI D G+A+ R +G LP + APE
Sbjct: 158 LAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLP------------VKWMAPE- 204
Query: 407 AMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465
A+ R + SDV+SFGV+L E+ T L +P G + EL
Sbjct: 205 ALFDRVYTHQSDVWSFGVLLWEIFT-----------------LGGSPY---PGIPVEELF 244
Query: 466 DPRLKG---DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
+G + P+ Q + +L ++C P RPT ++V+ L +
Sbjct: 245 KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 71/256 (27%), Positives = 113/256 (44%), Gaps = 45/256 (17%)
Query: 275 LSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG----MNWDTRV 330
L LH C+ +VG+ F + + + E M G+L D VL + N ++
Sbjct: 50 LKVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSL----DQVLKKAGRIPENILGKI 104
Query: 331 AIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 390
+IA+ RGL YL E I+HRD+K SNIL++ K+ D G++ +L + S ++
Sbjct: 105 SIAV--LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMAN 156
Query: 391 SPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL---- 446
S GT Y +PE ++ SD++S G+ L+E+ GR PI K E++
Sbjct: 157 S---FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRP 213
Query: 447 ---VLWATPRLQDSGTV--------ISEL-------PDPRLKGDFPKEEMQIMAYLAKEC 488
SG I EL P P+L +E Q ++ K C
Sbjct: 214 VSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQ--DFVDK-C 270
Query: 489 LQLDPDARPTMSEVVQ 504
L+ +P R + E+ +
Sbjct: 271 LKKNPKERADLKELTK 286
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 77/287 (26%), Positives = 128/287 (44%), Gaps = 60/287 (20%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
+G+G VY+ + G IVA+K+ + +G P S + E+ +L L+H ++V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVP---STAIREISLLKELNHPNIVRL 63
Query: 287 --VGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 343
V + +L LVFEF+ + +L+ +D + G++ + +G+ Y
Sbjct: 64 LDVVHSEN-------KLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG------ 397
H + R+LHRD+K N+L+D K+ D G+A +A G+P ++
Sbjct: 116 H---SHRVLHRDLKPQNLLIDREGALKLADFGLA---RAFGVP--------VRTYTHEVV 161
Query: 398 TFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESL--------VL 448
T Y APE + R S D++S G + E++ R + G+ + L
Sbjct: 162 TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-----RRPLFPGDSEIDQLFRIFRTL 216
Query: 449 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDA 495
TP +D ++ LPD K FPK Q L+K LD D
Sbjct: 217 -GTPD-EDVWPGVTSLPD--YKPTFPKWARQ---DLSKVVPNLDEDG 256
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 32/218 (14%)
Query: 231 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNAD------SVFLTEVDMLSRLHHCHV 283
++GQG VY D GR +A K + Q P + S E+ +L L H +
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAK--QVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGLE 341
V G C R ++ + + + E+MP G+++D L G L E + I G+
Sbjct: 67 VQYYG-CLRDRAEKTLTIFM-EYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGMS 120
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK-----ADGLPSCSSSPARMQ 396
YLH + I+HRDIK +NIL D N K+ D G +KRL+ G+ S + +P M
Sbjct: 121 YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM- 176
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
+PE +DV+S G ++E++T + P
Sbjct: 177 ------SPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 68/287 (23%), Positives = 128/287 (44%), Gaps = 45/287 (15%)
Query: 225 KFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
K++ +GQG S V+ + G+ VA+K+ Q P + + + E+ ++ L + ++
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKE-LIINEILVMKELKNPNI 78
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD-----CLDGVLVEGMNWDTRVAIAIGAAR 338
V + S G +V E++ G+L D C+D + A+ +
Sbjct: 79 VNFLD--SFLVGDEL--FVVMEYLAGGSLTDVVTETCMDEAQI--------AAVCRECLQ 126
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
LE+LH A +++HRDIKS N+LL + + K+TD G ++ + S + M GT
Sbjct: 127 ALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVGT 178
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP-IHRSITKGEESLVLWATPRLQDS 457
+ APE D++S G++ +E++ G P ++ + + + TP LQ+
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN- 237
Query: 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
P++ I CL++D + R + E++Q
Sbjct: 238 ----------------PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 83/320 (25%), Positives = 138/320 (43%), Gaps = 59/320 (18%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF----LTEVDM 274
+ DKF +G+G VY+ + D G +VA+K+ + N F + E+ +
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLD---NEKEGFPITAIREIKI 59
Query: 275 LSRLHHCHVVPLVGYCS------EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGM---N 325
L +L+H ++V L + +F+ + LVFE+M + L G+L G+ +
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHD-----LMGLLESGLVHFS 114
Query: 326 WDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385
D + GL Y H+ LHRDIK SNILL+ K+ D G+A+ ++
Sbjct: 115 EDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSE-- 169
Query: 386 PSCSSSPARMQGTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQPIHRSITKGE 443
S P + ++ P ++G R DV+S G +L EL T ++PI ++ +
Sbjct: 170 ---ESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQA---NQ 222
Query: 444 ESLVLWATPRLQDSGTV-----ISELP-----------DPRLKGDF---PKEEMQIMAYL 484
E L RL S + +LP RL+ +F P + ++ ++
Sbjct: 223 ELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHM 282
Query: 485 AKECLQLDPDARPTMSEVVQ 504
L LDP R T E +
Sbjct: 283 ----LTLDPSKRCTAEEALN 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 72/287 (25%), Positives = 116/287 (40%), Gaps = 42/287 (14%)
Query: 231 IVGQGGSSYVYRG---QLTDGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
+G+G VY+G + +I VAVK K P+ FL E ++ + H H+V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
+G +E +V E P G LR L V ++ + + + + L YL
Sbjct: 73 IGVITE-----NPVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAYLE-- 124
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
+ R +HRDI + N+L+ K+ D G+++ L+ + S ++ + APE
Sbjct: 125 -SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK----WMAPES 179
Query: 407 AMVGRASLMSDVFSFGVVLLE-LITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465
R + SDV+ FGV + E L+ G +P VI +
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKPFQ------------GVKNN-----DVIGRIE 222
Query: 466 DPRLKGD-FPKEEM--QIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
G+ P + L +C DP RP +E+ LS I
Sbjct: 223 ----NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 72/285 (25%), Positives = 122/285 (42%), Gaps = 53/285 (18%)
Query: 231 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
++G+G VYRG + GR+VA+K + S EV +LS+L + Y
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 290 C-SEFRGKRAMRLLVFEFMPNGNLRD-----CLDGVLVEGMNWDTRVAIAIGAARGLEYL 343
S +G R ++ E+ G++R + + + + VA L+Y+
Sbjct: 68 YGSYLKGPRLW--IIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVA--------LKYI 117
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
H+ ++HRDIK++NIL+ N K+ D G+A L SS + GT + A
Sbjct: 118 HKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLN-----QNSSKRSTFVGTPYWMA 169
Query: 404 PEYAMVGRA-SLMSDVFSFGVVLLELITGRQPI-----HRSITKGEESLVLWATPRLQDS 457
PE G+ +D++S G+ + E+ TG P R++ +S PRL+D+
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS----KPPRLEDN 225
Query: 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 502
G + K + +A CL +P R + E+
Sbjct: 226 G--------------YSKLLREFVAA----CLDEEPKERLSAEEL 252
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 76/246 (30%), Positives = 114/246 (46%), Gaps = 40/246 (16%)
Query: 231 IVGQGGSSYVYRGQLTD-GRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLH--HCH 282
I+G+GG VY + D G++ A+K R K + G +++ L E MLS + C
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG---ETLALNERIMLSLVSTGDCP 57
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGL 340
+ + Y K + + + M G+L L GV E + R A GL
Sbjct: 58 FIVCMSYAFHTPDKLS---FILDLMNGGDLHYHLSQHGVFSEA---EMRF-YAAEIILGL 110
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS---PARMQG 397
E++H +++RD+K +NILLDE+ + +I+DLG+A C S P G
Sbjct: 111 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA----------CDFSKKKPHASVG 157
Query: 398 TFGYFAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPI--HRSITKGE-ESLVLWATPR 453
T GY APE G A S D FS G +L +L+ G P H++ K E + + L
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 217
Query: 454 LQDSGT 459
L DS +
Sbjct: 218 LPDSFS 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-14
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 29/203 (14%)
Query: 241 YRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300
+RGQ VA+K K G ++ F+ E ++ +L H +V L G C+ K+
Sbjct: 25 WRGQYD----VAIKMIKE--GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT----KQRPI 74
Query: 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI---AIGAARGLEYLHEAAAPRILHRDIK 357
+V E+M NG CL L E + G+ YL + + +HRD+
Sbjct: 75 YIVTEYMSNG----CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLA 127
Query: 358 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PARMQGTFGYFAPEYAMVGRASLM 415
+ N L+D+ K++D G+++ + D S S P R + PE + + S
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR------WSPPEVLLYSKFSSK 181
Query: 416 SDVFSFGVVLLELIT-GRQPIHR 437
SDV++FGV++ E+ + G+ P R
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 73/279 (26%), Positives = 122/279 (43%), Gaps = 57/279 (20%)
Query: 251 VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNG 310
VA+K + + G + + L H ++V L+G C A LV + P G
Sbjct: 39 VAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-----ASLQLVTQLSPLG 93
Query: 311 NL-------RDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 363
+L RD LD + +NW ++A +G+ YL E R++HR++ + NILL
Sbjct: 94 SLLDHVRQHRDSLDPQRL--LNWCVQIA------KGMYYLEEH---RMVHRNLAARNILL 142
Query: 364 DENLNAKITDLGMAKRLKADG---LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFS 420
+ +I D G+A L D S +P + + A E + GR + SDV+S
Sbjct: 143 KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK------WMALESILFGRYTHQSDVWS 196
Query: 421 FGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGD-FPKEEM 478
+GV + E+++ G +P +A R E+PD KG+ + ++
Sbjct: 197 YGVTVWEMMSYGAEP--------------YAGMRPH-------EVPDLLEKGERLAQPQI 235
Query: 479 -QIMAYLAK-ECLQLDPDARPTMSEVVQILSTIAPDKSR 515
I Y+ +C +D + RPT E+ + +A D R
Sbjct: 236 CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPR 274
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 69/277 (24%), Positives = 118/277 (42%), Gaps = 55/277 (19%)
Query: 251 VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNG 310
VAVK K + L+E ++L +++H HV+ L G CS+ LL+ E+ G
Sbjct: 33 VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ----DGPLLLIVEYAKYG 88
Query: 311 NLR----------------------DCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
+LR LD + ++ A +RG++YL E
Sbjct: 89 SLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM-- 146
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEY 406
+++HRD+ + N+L+ E KI+D G+++ + + S R +G + A E
Sbjct: 147 -KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE-----DSYVKRSKGRIPVKWMAIES 200
Query: 407 AMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465
+ SDV+SFGV+L E++T G P G L+ L +G
Sbjct: 201 LFDHIYTTQSDVWSFGVLLWEIVTLGGNPY-----PGIAPERLFN---LLKTG------- 245
Query: 466 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 502
+ + P+ + M L C + +PD RPT +++
Sbjct: 246 ---YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 7e-14
Identities = 71/298 (23%), Positives = 126/298 (42%), Gaps = 40/298 (13%)
Query: 226 FSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHH 280
F+ ++G+G V QL + VAVK K ++D FL E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 281 CHVVPLVGYC--SEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGMNWDTRVAIAI 334
+V+ L+G S +G+ + +++ FM +G+L L G + T V I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSS- 391
A G+EYL ++ +HRD+ + N +L+EN+ + D G++K++ + C+S
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 392 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 451
P + + A E + SDV++FGV + E++T Q + + E L
Sbjct: 178 PVK------WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG 231
Query: 452 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
RL+ P + ++ + L +C +P RP+ + L I
Sbjct: 232 NRLKQ-----------------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 67/278 (24%), Positives = 116/278 (41%), Gaps = 37/278 (13%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+G G V+ VAVK K G + FL E +++ L H +V L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351
+ ++ EFM G+L D L + + A G+ ++ +
Sbjct: 72 -----KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 123
Query: 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMV 409
+HRD++++NIL+ +L KI D G+A+ ++ + AR F + APE
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDN------EYTAREGAKFPIKWTAPEAINF 177
Query: 410 GRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 468
G ++ SDV+SFG++L+E++T GR P + ++ E L R+ EL +
Sbjct: 178 GSFTIKSDVWSFGILLMEIVTYGRIP-YPGMSNPEVIRALERGYRMPRPENCPEELYNIM 236
Query: 469 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
+ C + P+ RPT + +L
Sbjct: 237 M-----------------RCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 76/274 (27%), Positives = 122/274 (44%), Gaps = 42/274 (15%)
Query: 249 RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 308
+VAVK + NA FL EV +LSRL ++ L+G C+ ++ E+M
Sbjct: 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDP----PLCMIMEYME 102
Query: 309 NGNL------RDCLDGVLVEGMN---WDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359
NG+L L + T + +A A G+ YL +HRD+ +
Sbjct: 103 NGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR 159
Query: 360 NILLDENLNAKITDLGMAKRL------KADGLPSCSSSPARMQGTFGYFAPEYAMVGRAS 413
N L+ +N KI D GM++ L + G P R + A E ++G+ +
Sbjct: 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPL---PIR------WMAWESVLLGKFT 210
Query: 414 LMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGD 472
SDV++FGV L E++T R+ + +T ++ ++ A +D G I LP P
Sbjct: 211 TKSDVWAFGVTLWEILTLCREQPYEHLT--DQQVIENAGHFFRDDGRQIY-LPRPPN--- 264
Query: 473 FPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
PK+ ++M EC + D + RPT E+ L
Sbjct: 265 CPKDIYELM----LECWRRDEEDRPTFREIHLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 65/219 (29%), Positives = 101/219 (46%), Gaps = 20/219 (9%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRIV-AVKRFKTQGGPNADSVFLTEVDMLSRL 278
E D F + +G G V + Q ++ A K + P + + E L L
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRE---LQVL 57
Query: 279 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRV--AIAIGA 336
H C+ +VG+ F + + + E M G+L D VL E + ++I
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSL----DQVLKEAKRIPEEILGKVSIAV 112
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
RGL YL E +I+HRD+K SNIL++ K+ D G++ +L + S ++S
Sbjct: 113 LRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANS---FV 163
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 435
GT Y +PE S+ SD++S G+ L+EL GR PI
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 69/278 (24%), Positives = 120/278 (43%), Gaps = 41/278 (14%)
Query: 232 VGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G+G + V + GR VAVK+ + + +F EV ++ H ++V + Y
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF-NEVVIMRDYQHPNIVEM--YS 83
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 350
S G +V EF+ G L D V MN + + + + L +LH A
Sbjct: 84 SYLVGDELW--VVMEFLEGGALTDI---VTHTRMNEEQIATVCLAVLKALSFLH---AQG 135
Query: 351 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR--MQGTFGYFAPEYAM 408
++HRDIKS +ILL + K++D G ++ + P R + GT + APE +
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE-------VPRRKSLVGTPYWMAPE--V 186
Query: 409 VGRASLMS--DVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 466
+ R + D++S G++++E++ G P + P LQ + I +
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPP-------------YFNEPPLQ-AMKRIRDNLP 232
Query: 467 PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
P+LK + + L DP R T +E++
Sbjct: 233 PKLKN--LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-14
Identities = 64/235 (27%), Positives = 96/235 (40%), Gaps = 38/235 (16%)
Query: 231 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNA--DSVFLTEVDMLSRLHHCHVVPLV 287
++G+GG VY R VA+K+ + N FL E + + L H +VP+
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 288 GYCSEFRGKRAMRLLVFEFMP---NGNLRDCLDGV---------LVEGMNWDTRVAIAIG 335
CS+ V+ MP L+ L V L E + ++I
Sbjct: 69 SICSDGD-------PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK 121
Query: 336 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR----------LKADGL 385
+EY+H +LHRD+K NILL I D G A + D
Sbjct: 122 ICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 386 PSCSSS---PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437
C SS P ++ GT Y APE + AS +D+++ GV+L +++T P R
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233
|
Length = 932 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 31/219 (14%)
Query: 230 NIVGQGGSSYVYRGQLT-DGRIV--AVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVP 285
+++G+G V + ++ DG + A+KR K + F E+++L +L HH +++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVA 331
L+G C R L E+ P+GNL D L V ++ +
Sbjct: 61 LLGACE----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 391
A ARG++YL + + +HRD+ + NIL+ EN AKI D G+++ + +
Sbjct: 117 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 173
Query: 392 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 430
P R + A E + SDV+S+GV+L E+++
Sbjct: 174 PVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 69/222 (31%), Positives = 107/222 (48%), Gaps = 22/222 (9%)
Query: 226 FSGSNIVGQGGSSYVYRGQL-TDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLH 279
F ++G+GG V Q+ G++ A K R K + G +S+ L E +L +++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG---ESMALNEKQILEKVN 58
Query: 280 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 339
VV L Y E K A+ LV M G+L+ + + G V A G
Sbjct: 59 SRFVVSL-AYAYE--TKDAL-CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG 114
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
LE LH+ RI++RD+K NILLD++ + +I+DLG+A +P + R+ GT
Sbjct: 115 LEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVH-----VPEGQTIKGRV-GTV 165
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITK 441
GY APE R + D ++ G +L E+I G+ P + K
Sbjct: 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 71/301 (23%), Positives = 117/301 (38%), Gaps = 73/301 (24%)
Query: 230 NIVGQ-GGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
I+G+ G ++ VY+ Q G A K + + + F+ E+D+LS H ++V
Sbjct: 8 EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED-FMVEIDILSECKHPNIVG 66
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVE---GMNWDTRVAIAIGAARGLEY 342
L + K + + EF G LD +++E G+ + L +
Sbjct: 67 LYEAYF-YENKLWILI---EFCDGG----ALDSIMLELERGLTEPQIRYVCRQMLEALNF 118
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ------ 396
LH +++HRD+K+ NILL + + K+ D G++ + K+ +Q
Sbjct: 119 LHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-----------LQKRDTFI 164
Query: 397 GTFGYFAPEYAMVGRAS-----LMSDVFSFGVVLLELITGRQPIHR--------SITKGE 443
GT + APE +D++S G+ L+EL P H I K E
Sbjct: 165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE 224
Query: 444 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 503
P L S D +L CL DPD RPT +E++
Sbjct: 225 -------PPTLDQPSKWSSSFND----------------FLKS-CLVKDPDDRPTAAELL 260
Query: 504 Q 504
+
Sbjct: 261 K 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 69/282 (24%), Positives = 121/282 (42%), Gaps = 38/282 (13%)
Query: 226 FSGSNIVGQGGSSYVYRGQLTDGR---IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
F+ +G+G V++G D R +VA+K + + E+ +LS+ +
Sbjct: 6 FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
V G S +G + ++ E++ G+ D L + T + + +GL+Y
Sbjct: 64 VTKYYG--SYLKGTKLW--IIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDY 116
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
LH + + +HRDIK++N+LL E + K+ D G+A +L + + GT +
Sbjct: 117 LH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-----FVGTPFWM 168
Query: 403 APEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462
APE +D++S G+ +EL G P + VL+ P+
Sbjct: 169 APEVIQQSAYDSKADIWSLGITAIELAKGEPP----NSDMHPMRVLFLIPK--------- 215
Query: 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
P L G+F K + + CL DP RPT E+++
Sbjct: 216 -NNPPTLTGEFSKPFKEFI----DACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 90/328 (27%), Positives = 143/328 (43%), Gaps = 41/328 (12%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYR-GQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL 278
E D F + +G G V++ G I+A K + P + + E L L
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRE---LQVL 57
Query: 279 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGA 336
H C+ +VG+ F + + + E M G+L L G + E + +V+IA+
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQIL--GKVSIAV-- 112
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
+GL YL E +I+HRD+K SNIL++ K+ D G++ +L + S ++S
Sbjct: 113 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANS---FV 163
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456
GT Y +PE S+ SD++S G+ L+E+ GR PI K E +++ P D
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE--LMFGCPVEGD 221
Query: 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS--EVVQILSTIAPDKS 514
+ P PR G + +Y PD+RP M+ E++ + P K
Sbjct: 222 PAESETS-PRPRPPG------RPLSSY--------GPDSRPPMAIFELLDYIVNEPPPKL 266
Query: 515 RRRNISLNLFQIFSAGGMEKEPSIERPD 542
FQ F + K P+ ER D
Sbjct: 267 PSGVFGAE-FQDFVNKCLIKNPA-ERAD 292
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 77/291 (26%), Positives = 122/291 (41%), Gaps = 53/291 (18%)
Query: 231 IVGQGGSSYVYRG--QLTDGR--IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
I+G G + RG +L R VA+ + FL E L + H ++V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYL 343
G + RG M +V E+M NG L L +G LV G + G A G++YL
Sbjct: 72 EGVIT--RGNTMM--IVTEYMSNGALDSFLRKHEGQLVAGQLMG----MLPGLASGMKYL 123
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS--SPARMQGTFGY 401
E +H+ + + +L++ +L KI+ + K++ + + S SP +
Sbjct: 124 SEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL------W 174
Query: 402 FAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPI----HRSITKGEESLVLWATPRLQD 456
APE S SDV+SFG+V+ E+++ G +P + + K E
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF--------- 225
Query: 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507
LP PR + P Q+M +C Q + RP S++ ILS
Sbjct: 226 ------RLPAPR---NCPNLLHQLML----DCWQKERGERPRFSQIHSILS 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 72/278 (25%), Positives = 124/278 (44%), Gaps = 50/278 (17%)
Query: 251 VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309
VAVK K+ S ++E++M+ + H +++ L+G C++ ++ E+
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ----DGPLYVIVEYASK 108
Query: 310 GNLRDCL--------------DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 355
GNLR+ L V E +++ V+ A ARG+EYL A+ + +HRD
Sbjct: 109 GNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRD 165
Query: 356 IKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SL 414
+ + N+L+ E+ KI D G+A+ + ++ R+ + APE A+ R +
Sbjct: 166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYK-KTTNGRL--PVKWMAPE-ALFDRIYTH 221
Query: 415 MSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKG--- 471
SDV+SFGV+L E+ T L +P G + EL +G
Sbjct: 222 QSDVWSFGVLLWEIFT-----------------LGGSPY---PGVPVEELFKLLKEGHRM 261
Query: 472 DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
D P + + ++C P RPT ++V+ L I
Sbjct: 262 DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 67/282 (23%), Positives = 125/282 (44%), Gaps = 35/282 (12%)
Query: 225 KFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
K++ +GQG S VY + G+ VA+++ Q P + + + E+ ++ + ++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNPNI 79
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 343
V Y + + +V E++ G+L D V M+ A+ + LE+L
Sbjct: 80 V---NYLDSYLVGDEL-WVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQALEFL 132
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
H + +++HRDIKS NILL + + K+TD G ++ + S + M GT + A
Sbjct: 133 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVGTPYWMA 184
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELITGRQP-IHRSITKGEESLVLWATPRLQDSGTVIS 462
PE D++S G++ +E+I G P ++ + + + TP LQ+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN------ 238
Query: 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
P++ I CL +D + R + E++Q
Sbjct: 239 -----------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 66/282 (23%), Positives = 125/282 (44%), Gaps = 35/282 (12%)
Query: 225 KFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
K++ +GQG S VY + G+ VA+K+ Q P + + + E+ ++ + ++
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKE-LIINEILVMRENKNPNI 78
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 343
V Y + + +V E++ G+L D V M+ A+ + L++L
Sbjct: 79 V---NYLDSYLVGDEL-WVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQALDFL 131
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
H + +++HRDIKS NILL + + K+TD G ++ + S + M GT + A
Sbjct: 132 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVGTPYWMA 183
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELITGRQP-IHRSITKGEESLVLWATPRLQDSGTVIS 462
PE D++S G++ +E++ G P ++ + + + TP LQ+
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN------ 237
Query: 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
P+ + CL++D D R + E++Q
Sbjct: 238 -----------PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 79/254 (31%), Positives = 116/254 (45%), Gaps = 41/254 (16%)
Query: 231 IVGQGGSSYVYRGQLTD-GRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLH--HCH 282
I+G+GG VY + D G++ A+K R K + G +++ L E MLS + C
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG---ETLALNERIMLSLVSTGDCP 57
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGL 340
+ + Y K + + M G+L L GV E + R A GL
Sbjct: 58 FIVCMTYAFHTPDKLC---FILDLMNGGDLHYHLSQHGVFSEK---EMRF-YATEIILGL 110
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
E++H +++RD+K +NILLDE+ + +I+DLG+A P GT G
Sbjct: 111 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-------KKKPHASVGTHG 160
Query: 401 YFAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459
Y APE G A S D FS G +L +L+ G P + TK + + R+ + T
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-----DRM--TLT 213
Query: 460 VISELPD---PRLK 470
V ELPD P LK
Sbjct: 214 VNVELPDSFSPELK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 83/311 (26%), Positives = 139/311 (44%), Gaps = 47/311 (15%)
Query: 251 VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309
VAVK K S ++E++M+ + H +++ L+G C++ + +LV E+
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ---DGPLYVLV-EYASK 102
Query: 310 GNLRDCLDGVLVEGMNW--DT------------RVAIAIGAARGLEYLHEAAAPRILHRD 355
GNLR+ L GM++ DT V+ A ARG+EYL A+ + +HRD
Sbjct: 103 GNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRD 159
Query: 356 IKSSNILLDENLNAKITDLGMAKRL-KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-S 413
+ + N+L+ E+ KI D G+A+ + D ++ ++ + APE A+ R +
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVK----WMAPE-ALFDRVYT 214
Query: 414 LMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDF 473
SDV+SFGV+L E+ T + I E +L R+ EL
Sbjct: 215 HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHEL--------- 265
Query: 474 PKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNL-FQIFSAGGM 532
IM +EC P RPT ++V+ L + S + L++ F+ +S G
Sbjct: 266 ----YMIM----RECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSVPFEQYSPGCP 317
Query: 533 EKEPSIERPDN 543
+ S D+
Sbjct: 318 DSPSSCSSGDD 328
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 75/285 (26%), Positives = 124/285 (43%), Gaps = 40/285 (14%)
Query: 225 KFSGSNIVGQG--GSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHC 281
K+ +VG+G G ++ R D ++V +K+ + + E +L L H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 341
+++ Y F +A+ ++V E+ P G L + + ++ DT + + L
Sbjct: 60 NII---EYYENFLEDKAL-MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH 115
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLN-AKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
++H ILHRD+K+ NILLD++ KI D G++K L S S + GT
Sbjct: 116 HVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL------SSKSKAYTVVGTPC 166
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460
Y +PE + SD+++ G VL EL S+ + E+ L A SGT
Sbjct: 167 YISPELCEGKPYNQKSDIWALGCVLYELA--------SLKRAFEAANLPALVLKIMSGTF 218
Query: 461 --ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 503
IS+ P L+ L L LDP RP +S+++
Sbjct: 219 APISDRYSPDLR------------QLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 73/285 (25%), Positives = 128/285 (44%), Gaps = 41/285 (14%)
Query: 225 KFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
K++ +GQG S VY + G+ VA+K+ Q P + + + E+ ++ H ++
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKE-LIINEILVMRENKHPNI 78
Query: 284 VPLVG---YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARG 339
V + E +V E++ G+L D V+ E M+ A+ +
Sbjct: 79 VNYLDSYLVGDEL-------WVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQA 127
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
LE+LH + +++HRDIKS NILL + + K+TD G ++ + S + M GT
Sbjct: 128 LEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVGTP 179
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459
+ APE D++S G++ +E++ G P +L L AT +GT
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE--NPLRALYLIAT-----NGT 232
Query: 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
P L+ P++ I CL++D + R + E++Q
Sbjct: 233 -------PELQN--PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 232 VGQGGSSYVYRGQL-TDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
+G+GG V Q+ G++ A K R K + G + + L E ++L +++ +V
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSG---EKMALLEKEILEKVNSPFIVN 57
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 345
L Y E + LV M G+L+ + V G+ + + + G+ +LH
Sbjct: 58 L-AYAFE---SKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS 113
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 405
I++RD+K N+LLD+ N +++DLG+A LK DG + GT GY APE
Sbjct: 114 M---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELK-DGKTITQRA-----GTNGYMAPE 164
Query: 406 YAMVGRASLMSDVFSFGVVLLELITGRQP 434
S D F+ G + E++ GR P
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 82/291 (28%), Positives = 122/291 (41%), Gaps = 40/291 (13%)
Query: 232 VGQGGSSYVYRGQLTDGRI---VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
+G G V G++ G V VK + FL E L H +++ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV-EGMNWDTRV--AIAIGAARGLEYLHE 345
C+E LLV EF P G+L+ L E M D +A A GL +LH+
Sbjct: 63 QCTEV----TPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAK-RLKADGLPSCSSSPARMQGTFGYFAP 404
+H D+ N LL +L KI D G++ + K D +P ++ + AP
Sbjct: 119 N---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY----VTPDQLWVPLRWIAP 171
Query: 405 EYA-------MVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQD 456
E +V + S+V+S GV + EL G QP +R ++ + VL T R Q
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP-YRHLSDEQ---VLTYTVREQQ 227
Query: 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507
+LP PRLK ++M + L P+ RP+ EV +LS
Sbjct: 228 -----LKLPKPRLKLPLSDRWYEVMQFCW-----LQPEQRPSAEEVHLLLS 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 75/283 (26%), Positives = 124/283 (43%), Gaps = 44/283 (15%)
Query: 233 GQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 292
G GS Y + T G +A+K + + + + + E+D+L H V P Y +
Sbjct: 12 GNYGSVYKVLHRPT-GVTMAMKEIRLELDESKFNQIIMELDIL---HKA-VSP---YIVD 63
Query: 293 FRGKRAMRLLVF---EFMPNGNLRDCLDG-VLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
F G + V+ E+M G+L G V EG+ D I +GL++L E
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH- 122
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ-GTFGYFAPEYA 407
I+HRD+K +N+L++ N K+ D G++ L A S A+ G Y APE
Sbjct: 123 -NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--------SLAKTNIGCQSYMAPERI 173
Query: 408 MVGRA------SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 461
G ++ SDV+S G+ +LE+ GR P E ++A +L I
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY-----PPETYANIFA--QLS----AI 222
Query: 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
+ P L + + + +CL P+ RPT +++++
Sbjct: 223 VDGDPPTLPSGYSDDAQDFV----AKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 43/140 (30%), Positives = 68/140 (48%), Gaps = 24/140 (17%)
Query: 302 LVFEFMPNGNLRDCLDGVLVEGM-----NWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 356
LV E++ G DC L++ + +W + + G+E LH+ I+HRDI
Sbjct: 74 LVMEYLNGG---DC--ASLIKTLGGLPEDWAKQYIAEV--VLGVEDLHQRG---IIHRDI 123
Query: 357 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMS 416
K N+L+D+ + K+TD G+++ +GL + GT Y APE + MS
Sbjct: 124 KPENLLIDQTGHLKLTDFGLSR----NGL-----ENKKFVGTPDYLAPETILGVGDDKMS 174
Query: 417 DVFSFGVVLLELITGRQPIH 436
D +S G V+ E + G P H
Sbjct: 175 DWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 37/219 (16%)
Query: 240 VYRGQL---TDG---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293
VY+G L G + VA+K K + F E M SRL H ++V L+G +
Sbjct: 21 VYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-- 78
Query: 294 RGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVEGMNWDTRVAIAIGAARG 339
K ++F + + +L + L D + + V I A G
Sbjct: 79 --KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAG 136
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG---LPSCSSSPARMQ 396
+E+L ++ ++H+D+ + N+L+ + LN KI+DLG+ + + A L S P R
Sbjct: 137 MEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR-- 191
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+ +PE M G+ S+ SD++S+GVVL E+ + G QP
Sbjct: 192 ----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 53/194 (27%), Positives = 95/194 (48%), Gaps = 27/194 (13%)
Query: 250 IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309
+VAVK + NA + FL E+ ++SRL +++ L+ C ++ E+M N
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCIT----SDPLCMITEYMEN 103
Query: 310 GNLRDCLDGVLVEG---------MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 360
G+L L + +++ T + +A A G++YL ++ +HRD+ + N
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRN 160
Query: 361 ILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG----TFGYFAPEYAMVGRASLMS 416
L+ +N KI D GM++ L S R+QG + + E ++G+ + S
Sbjct: 161 CLVGKNYTIKIADFGMSRNLY-------SGDYYRIQGRAVLPIRWMSWESILLGKFTTAS 213
Query: 417 DVFSFGVVLLELIT 430
DV++FGV L E++T
Sbjct: 214 DVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 226 FSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQ--GGPNADSVFLTEVDMLSRLHHCH 282
F ++G+GG V Q+ G++ A KR + + +S+ L E +L +++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
VV L + K A+ LV M G+L+ + + G + + A GLE
Sbjct: 62 VVNLA---YAYETKDAL-CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLED 117
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
LH ++RD+K NILLD+ + +I+DLG+A + +P S R+ GT GY
Sbjct: 118 LHREN---TVYRDLKPENILLDDYGHIRISDLGLAVK-----IPEGESIRGRV-GTVGYM 168
Query: 403 APEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
APE R +L D + G ++ E+I G+ P
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 8e-13
Identities = 56/211 (26%), Positives = 85/211 (40%), Gaps = 30/211 (14%)
Query: 232 VGQGGSSYVYR-GQLTDGRIVAVKRF----KTQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
+G+G V++ G VA+K+ G PN L E+ L H +VV L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPN---QALREIKALQACQHPYVVKL 64
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR----GLEY 342
+ F +LV E+MP+ L VL + A R G+ Y
Sbjct: 65 L---DVFPHGSGF-VLVMEYMPSD-----LSEVLRDEERPLPE-AQVKSYMRMLLKGVAY 114
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
+H I+HRD+K +N+L+ + KI D G+A+ + S A T Y
Sbjct: 115 MHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA----TRWYR 167
Query: 403 APEYAMVGRA-SLMSDVFSFGVVLLELITGR 432
APE R D+++ G + EL+ G
Sbjct: 168 APELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 8e-13
Identities = 56/172 (32%), Positives = 77/172 (44%), Gaps = 31/172 (18%)
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCL-DGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 347
Y + F+ K+ + +L E+ G L L D L + + R IA EYLH
Sbjct: 59 YRT-FKDKKYIYML-MEYCLGGELWTILRDRGLFD--EYTARFYIA-CVVLAFEYLHNRG 113
Query: 348 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS---CSSSPARMQGTFGYFAP 404
I++RD+K N+LLD N K+ D G AK+LK G + C GT Y AP
Sbjct: 114 ---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLK-SGQKTWTFC--------GTPEYVAP 161
Query: 405 EYAMVGRASLMSDVFSFGVVLLELITGRQP----------IHRSITKGEESL 446
E + D +S G++L EL+TGR P I+ I KG L
Sbjct: 162 EIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKL 213
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 79/283 (27%), Positives = 125/283 (44%), Gaps = 51/283 (18%)
Query: 233 GQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV---FLTEVDMLSRLHHCHVVPLVGY 289
G GG+ Y + T GR+ A+K G + D+V E+++L ++H +VV
Sbjct: 85 GAGGTVYKVIHRPT-GRLYALKVIY---GNHEDTVRRQICREIEILRDVNHPNVVK---- 136
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 349
C + ++ EFM G+L +G + + VA I G+ YLH
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSL----EGTHIADEQFLADVARQI--LSGIAYLHRR--- 187
Query: 350 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY--- 406
I+HRDIK SN+L++ N KI D G++ R+ A + C+SS GT Y +PE
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVS-RILAQTMDPCNSS----VGTIAYMSPERINT 242
Query: 407 -----AMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 461
A G A D++S GV +LE GR P +G+ WA+ +
Sbjct: 243 DLNHGAYDGYA---GDIWSLGVSILEFYLGRFPFGVG-RQGD-----WASLM---CAICM 290
Query: 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
S+ P+ P + + CLQ +P R + +++Q
Sbjct: 291 SQPPEA------PATASREFRHFISCCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 232 VGQGGSSYVYRGQ--LTDGRIVAVKRFKTQ----GGPNADSVFLTEVDMLSRLHHCHVVP 285
+G+G V++ + GR VA+KR + Q G P + + + L H +VV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 286 LVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH 344
L C+ R R +L LVFE + + +L LD V G+ +T + RGL++LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 404
+ R++HRD+K NIL+ + K+ D G+A+ + S + + T Y AP
Sbjct: 128 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR------IYSFQMALTSVVVTLWYRAP 178
Query: 405 EYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437
E + + D++S G + E+ R+P+ R
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFR 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 231 IVGQGGSSYVYRGQL-TDGRIVAVKRF--KTQGGPNADSVFLTEVDMLSRLHHCHVVPLV 287
++G+GG V Q+ G++ A K+ K +++ L E +L +++ VV L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 65
Query: 288 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 347
Y E K A+ LV M G+L+ + + G + + V A GLE LH
Sbjct: 66 AYAYE--TKDAL-CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE- 121
Query: 348 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ-GTFGYFAPEY 406
RI++RD+K NILLD+ + +I+DLG+A + R + GT GY APE
Sbjct: 122 --RIVYRDLKPENILLDDYGHIRISDLGLAVEIP-------EGETIRGRVGTVGYMAPEV 172
Query: 407 AMVGRASLMSDVFSFGVVLLELITGRQP 434
R + D + G ++ E+I G+ P
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 72/288 (25%), Positives = 121/288 (42%), Gaps = 55/288 (19%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+G G V+ G+ VA+K G ++ F+ E ++ +L H +V L G C+
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE--GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
+ + +V EFM NG L + L G L + D +++ G+EYL +
Sbjct: 70 Q----QKPLYIVTEFMENGCLLNYLRQRQGKLSK----DMLLSMCQDVCEGMEYLERNS- 120
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 408
+HRD+ + N L+ K++D GM + + D SSS A+ + PE
Sbjct: 121 --FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD--EYTSSSGAKF--PVKWSPPEVFN 174
Query: 409 VGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQDSGT 459
+ S SDV+SFGV++ E+ T G+ P + I++G
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF---------------- 218
Query: 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507
L P+L E M C P+ RPT +E+++ ++
Sbjct: 219 ---RLYRPKLASMTVYEVMY-------SCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 70/285 (24%), Positives = 126/285 (44%), Gaps = 44/285 (15%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
+G+G S VYR L DG VA+K+ + AD + E+D+L +L+H +V+
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCI--KEIDLLKQLNHPNVIK- 66
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDG------VLVEGMNWDTRVAIAIGAARGL 340
Y + F + + V E G+L + ++ E W V + L
Sbjct: 67 --YYASFIEDNELNI-VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SAL 119
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
E++H + R++HRDIK +N+ + K+ DLG+ + S +++ + GT
Sbjct: 120 EHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-----SKTTAAHSLVGTPY 171
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460
Y +PE + SD++S G +L E+ + P + + + L++ +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY------GDKMNLYSLCK------K 219
Query: 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505
I + P L D EE++ L C+ DP+ RP ++ V +
Sbjct: 220 IEQCDYPPLPSDHYSEELR---QLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 66/221 (29%), Positives = 99/221 (44%), Gaps = 34/221 (15%)
Query: 226 FSGSNIVGQG--GSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHC 281
F+ +G G G+ Y R T +VA+K+ G + + + EV L +L H
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRT-NEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 282 HVVPLVGYCSEFRG---KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 338
+ + E++G + LV E+ G+ D L+ V + + AI GA +
Sbjct: 76 NTI-------EYKGCYLREHTAWLVMEYCL-GSASDILE-VHKKPLQEVEIAAICHGALQ 126
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQG 397
GL YLH + +HRDIK+ NILL E K+ D G A + SPA G
Sbjct: 127 GLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLV----------SPANSFVG 173
Query: 398 TFGYFAPE--YAM-VGRASLMSDVFSFGVVLLELITGRQPI 435
T + APE AM G+ DV+S G+ +EL + P+
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 62/283 (21%), Positives = 122/283 (43%), Gaps = 36/283 (12%)
Query: 231 IVGQGGSSYVYRGQLTDGRIVAVKRFK--TQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
++ + + +Y+G + + V ++ FK +G + E+ L R+ +++ + G
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AA 347
+ + L+ E+ G LR+ LD + +++ T++ +AI +GL L++
Sbjct: 86 FIIDIVDDLPRLSLILEYCTRGYLREVLD--KEKDLSFKTKLDMAIDCCKGLYNLYKYTN 143
Query: 348 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA 407
P ++++ S + L+ EN KI G+ K L SS P + YF+ +
Sbjct: 144 KP---YKNLTSVSFLVTENYKLKIICHGLEKIL--------SSPPFKNVNFMVYFSYKML 192
Query: 408 --MVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465
+ ++ D++S GVVL E+ TG+ P TK L +I++
Sbjct: 193 NDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL-------------IINKNN 239
Query: 466 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508
+L D P + + + C D RP + E++ LS
Sbjct: 240 SLKLPLDCP----LEIKCIVEACTSHDSIKRPNIKEILYNLSL 278
|
Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 80/307 (26%), Positives = 132/307 (42%), Gaps = 59/307 (19%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRI-------VAVKRFKTQGGPNADSVFLTEV 272
E A +K + S +GQG VY G + G + VA+K FL E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60
Query: 273 DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR--- 329
++ + HVV L+G S+ + L++ E M G+L+ L + E N +
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPT----LVIMELMTRGDLKSYLRSLRPEMENNPVQAPP 116
Query: 330 -----VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK------ 378
+ +A A G+ YL+ A + +HRD+ + N ++ E+ KI D GM +
Sbjct: 117 SLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173
Query: 379 --RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
R GL P R + +PE G + SDV+SFGVVL E+ T + +
Sbjct: 174 YYRKGGKGL-----LPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 222
Query: 437 RSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDAR 496
+ ++ E+ L R G ++ + PD + P ++M + C Q +P R
Sbjct: 223 QGMSN-EQVL------RFVMEGGLL-DKPD-----NCPDMLFELM----RMCWQYNPKMR 265
Query: 497 PTMSEVV 503
P+ E++
Sbjct: 266 PSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 27/212 (12%)
Query: 230 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKT---QGGPNADSVFLTEVDMLSRLHHCHVVP 285
N +G+G VYR + T G IVA+K+ + + G S L E+ +L L H ++V
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS--LREITLLLNLRHPNIVE 70
Query: 286 LVGYCSEFRGKRAMRL-LVFEFMPN--GNLRDCLDGVLVEGMNWDTRV-AIAIGAARGLE 341
L GK + LV E+ +L D + E ++V + + RGL+
Sbjct: 71 LKEVVV---GKHLDSIFLVMEYCEQDLASLLDNMPTPFSE-----SQVKCLMLQLLRGLQ 122
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
YLHE I+HRD+K SN+LL + KI D G+A+ GLP+ +P + T Y
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY---GLPAKPMTPKVV--TLWY 174
Query: 402 FAPEYAMVGRASLMS-DVFSFGVVLLELITGR 432
APE + + D+++ G +L EL+ +
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 34/219 (15%)
Query: 231 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNAD------SVFLTEVDMLSRLHHCHV 283
++GQG VY D GR +AVK + Q P + + E+ +L L H +
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVK--QVQFDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 284 VPLVGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGL 340
V G R L +F E MP G+++D L G L E + I G+
Sbjct: 67 VQYYGC---LRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGV 119
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK-----ADGLPSCSSSPARM 395
YLH + I+HRDIK +NIL D N K+ D G +KRL+ G+ S + +P M
Sbjct: 120 SYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176
Query: 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
+PE +D++S G ++E++T + P
Sbjct: 177 -------SPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 26/201 (12%)
Query: 251 VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNG 310
VA+K K + + + E +++ +L + ++V ++G C + +LV E G
Sbjct: 25 VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-----EAEALMLVMEMASGG 79
Query: 311 NLRDCL----DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 366
L L D + V + V + + G++YL +HRD+ + N+LL
Sbjct: 80 PLNKFLSGKKDEITVSNV-----VELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQ 131
Query: 367 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMVGRASLMSDVFSFGVV 424
AKI+D G++K L AD S AR G + ++APE + S SDV+S+G+
Sbjct: 132 HYAKISDFGLSKALGADD----SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGIT 187
Query: 425 LLELIT-GRQPIHRSITKGEE 444
+ E + G++P + KG E
Sbjct: 188 MWEAFSYGQKPYKK--MKGPE 206
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 77/302 (25%), Positives = 116/302 (38%), Gaps = 59/302 (19%)
Query: 230 NIVGQGGSSYVYRGQLTDGRI------VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
+G G VY G VAVK +S FL E ++S+ +H ++
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR---------VAIAI 334
V L+G E R R ++ E M G+L+ L E R + A
Sbjct: 72 VRLIGVSFE----RLPRFILLELMAGGDLKS----FLRENRPRPERPSSLTMKDLLFCAR 123
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMAKRLKADGLPSCSSS 391
A+G +YL E +HRDI + N LL AKI D GMA+ + +S
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY-------RAS 173
Query: 392 PARMQGT----FGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESL 446
R G + PE + G + +DV+SFGV+L E+ + G P + T E
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP-YPGRTNQEVME 232
Query: 447 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
+ RL P P +IM +C Q P+ RP + +++ +
Sbjct: 233 FVTGGGRLDPP----KGCPGPV---------YRIMT----DCWQHTPEDRPNFATILERI 275
Query: 507 ST 508
Sbjct: 276 QY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 63/265 (23%), Positives = 112/265 (42%), Gaps = 43/265 (16%)
Query: 251 VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309
VAVK K + ++E+ ++S L +H ++V L+G C+ L++ E+
Sbjct: 68 VAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT----IGGPILVITEYCCY 123
Query: 310 GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 369
G+L + L + + ++ + A+G+ +L A+ +HRD+ + N+LL
Sbjct: 124 GDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIV 180
Query: 370 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELI 429
KI D G+A+ + D AR+ + APE + SDV+S+G++L E+
Sbjct: 181 KICDFGLARDIMNDS-NYVVKGNARL--PVKWMAPESIFNCVYTFESDVWSYGILLWEIF 237
Query: 430 TGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDF--------PKEEMQIM 481
+ L + P G + +K + P E IM
Sbjct: 238 S-----------------LGSNPY---PGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIM 277
Query: 482 AYLAKECLQLDPDARPTMSEVVQIL 506
K C DP RPT ++VQ++
Sbjct: 278 ----KTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG-Y 289
VG G VY+ + L G + AVK K + G + S+ E+ M+ HC++V G Y
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDF-SLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA-IAIGAARGLEYLHEAAA 348
S R + E+ G+L+D V G + ++A + +GL YLH
Sbjct: 76 LS-----REKLWICMEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 408
+HRDIK +NILL +N + K+ D G+A ++ A + GT + APE A
Sbjct: 128 ---MHRDIKGANILLTDNGDVKLADFGVAAKITA-----TIAKRKSFIGTPYWMAPEVAA 179
Query: 409 V---GRASLMSDVFSFGVVLLELITGRQPI 435
V G + + D+++ G+ +EL + P+
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 33/188 (17%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
RGL+Y+H A ++HRD+K SN+L++E+ +I D GMA+ L SSSP +
Sbjct: 118 RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL--------SSSPTEHKY 166
Query: 398 -------TFGYFAPEYAMV-GRASLMSDVFSFGVVLLELI------TGRQPIHR-----S 438
T Y APE + + D++S G + E++ G+ +H+ S
Sbjct: 167 FMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILS 226
Query: 439 ITKGEESLVLWAT--PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDAR 496
+ VL R++ + FPK + + L++ LQ DP+ R
Sbjct: 227 VLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQ-MLQFDPEER 285
Query: 497 PTMSEVVQ 504
T+ + +Q
Sbjct: 286 ITVEQALQ 293
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 72/277 (25%), Positives = 122/277 (44%), Gaps = 48/277 (17%)
Query: 251 VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309
VAVK K S ++E++M+ + H +++ L+G C++ ++ E+
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ----DGPLYVIVEYASK 105
Query: 310 GNLRDCLDG--------------VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 355
GNLR+ L V E M + V+ ARG+EYL A+ + +HRD
Sbjct: 106 GNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRD 162
Query: 356 IKSSNILLDENLNAKITDLGMAKRL-KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-S 413
+ + N+L+ EN KI D G+A+ + D ++ ++ + APE A+ R +
Sbjct: 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVK----WMAPE-ALFDRVYT 217
Query: 414 LMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGD 472
SDV+SFGV++ E+ T G P + I E +L R+ +EL
Sbjct: 218 HQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLLKEGHRMDKPANCTNEL-------- 268
Query: 473 FPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
+ ++C P RPT ++V+ L I
Sbjct: 269 ---------YMMMRDCWHAIPSHRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 69/281 (24%), Positives = 121/281 (43%), Gaps = 36/281 (12%)
Query: 226 FSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 284
F+ +G+G VY+G +VA+K + + E+ +LS+ ++
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA-RGLEYL 343
G S +G + ++ E++ G+ D L +E +T +A + +GL+YL
Sbjct: 66 RYYG--SYLKGTKLW--IIMEYLGGGSALDLLKPGPLE----ETYIATILREILKGLDYL 117
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
H + R +HRDIK++N+LL E + K+ D G+A +L + + GT + A
Sbjct: 118 H---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-----FVGTPFWMA 169
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 463
PE +D++S G+ +EL G P + VL+ P+
Sbjct: 170 PEVIKQSAYDFKADIWSLGITAIELAKGEPP----NSDLHPMRVLFLIPKNS-------- 217
Query: 464 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
P L+G + K + CL DP RPT E+++
Sbjct: 218 --PPTLEGQYSKP----FKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 71/284 (25%), Positives = 128/284 (45%), Gaps = 42/284 (14%)
Query: 226 FSGSNIVGQGGSSYVYRGQLTDGR---IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
F+ +G+G V++G D R +VA+K + + E+ +LS+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIAIGAA-RGL 340
V G S + + ++ E++ G+ D L+ G L E T++A + +GL
Sbjct: 64 VTKYYG--SYLKDTKLW--IIMEYLGGGSALDLLEPGPLDE-----TQIATILREILKGL 114
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
+YLH + + +HRDIK++N+LL E+ K+ D G+A +L + GT
Sbjct: 115 DYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-----NTFVGTPF 166
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460
+ APE +D++S G+ +EL G +P H + + VL+ P+
Sbjct: 167 WMAPEVIKQSAYDSKADIWSLGITAIELAKG-EPPHSELHPMK---VLFLIPKNN----- 217
Query: 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
P L+G++ K + + CL +P RPT E+++
Sbjct: 218 -----PPTLEGNYSKP----LKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 75/276 (27%), Positives = 119/276 (43%), Gaps = 37/276 (13%)
Query: 232 VGQGGSSYV-YRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G+G + V + G+ VAVK+ + + +F EV ++ HH +VV + Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-NEVVIMRDYHHENVVDM--YN 86
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 350
S G +V EF+ G L D V MN + + + R L YLH
Sbjct: 87 SYLVGDELW--VVMEFLEGGALTDI---VTHTRMNEEQIATVCLSVLRALSYLHNQG--- 138
Query: 351 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR--MQGTFGYFAPEYAM 408
++HRDIKS +ILL + K++D G ++ + P R + GT + APE
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE-------VPKRKSLVGTPYWMAPEVIS 191
Query: 409 VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 468
D++S G++++E+I G P + P LQ + LP PR
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMIDGEPP-------------YFNEPPLQAMRRIRDNLP-PR 237
Query: 469 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
+K D K + +L L +P R T E++Q
Sbjct: 238 VK-DSHKVSSVLRGFL-DLMLVREPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 80/301 (26%), Positives = 130/301 (43%), Gaps = 44/301 (14%)
Query: 218 ALEHATDKFSGSNIVGQGGSSYVYR-GQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLS 276
+L TD + +G+G VY+ DG + AVK + D E ++L
Sbjct: 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQ 73
Query: 277 RL-HHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--I 332
L +H +VV G + +L LV E G++ + + G+L+ G D + I
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP 392
GA GL++LH RI+HRD+K +NILL K+ D G++ +L + L +S
Sbjct: 134 LYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV- 189
Query: 393 ARMQGTFGYFAPE---------YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 443
GT + APE Y+ R DV+S G+ +EL G P+
Sbjct: 190 ----GTPFWMAPEVIACEQQYDYSYDARC----DVWSLGITAIELGDGDPPLFDM----H 237
Query: 444 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 503
L+ PR P P L P++ + + +CL D +ARP+++ ++
Sbjct: 238 PVKTLFKIPR----------NPPPTLLH--PEKWCRSFNHFISQCLIKDFEARPSVTHLL 285
Query: 504 Q 504
+
Sbjct: 286 E 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 6e-12
Identities = 80/318 (25%), Positives = 126/318 (39%), Gaps = 90/318 (28%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGY 289
+G G VY + G +VA+K+ K + + + L EV L +L H ++V L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK-- 64
Query: 290 CSE-FRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR--------G 339
E FR L VFE+M GNL M + R G
Sbjct: 65 --EVFREND--ELYFVFEYM-EGNLYQL--------MKDRKGKPFSESVIRSIIYQILQG 111
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP-ARMQGT 398
L ++H+ HRD+K N+L+ KI D G+A+ ++ S P T
Sbjct: 112 LAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIR-------SRPPYTDYVST 161
Query: 399 FGYFAPEYAMVGRASLMS---DVFSFGVVLLELITGRQP----------IHRSITKGEES 445
Y APE ++ R++ S D+++ G ++ EL T R P +++ I
Sbjct: 162 RWYRAPE--ILLRSTSYSSPVDIWALGCIMAELYTLR-PLFPGSSEIDQLYK-ICS---- 213
Query: 446 LVLWATPRLQD------------------SGTVISEL-PDPRLKGDFPKEEMQIMAYLAK 486
VL TP QD + T + +L P+ E + ++ K
Sbjct: 214 -VL-GTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNA------SPEAIDLI----K 261
Query: 487 ECLQLDPDARPTMSEVVQ 504
+ L+ DP RPT S+ +Q
Sbjct: 262 DMLRWDPKKRPTASQALQ 279
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 22/218 (10%)
Query: 226 FSGSNIVGQGGSSYVYRGQL-TDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLH 279
F ++G+GG V Q+ G++ A K R K + G +++ L E +L +++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG---EAMALNEKRILEKVN 58
Query: 280 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 339
VV L Y E K A+ LV M G+L+ + + G + + A G
Sbjct: 59 SRFVVSL-AYAYE--TKDAL-CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG 114
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
LE L RI++RD+K NILLD+ + +I+DLG+A + +P + R+ GT
Sbjct: 115 LEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQ-----IPEGETVRGRV-GTV 165
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437
GY APE + + D + G ++ E+I G+ P +
Sbjct: 166 GYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 79/319 (24%), Positives = 125/319 (39%), Gaps = 68/319 (21%)
Query: 221 HATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVF----LTEVDML 275
K+ +GQG V++ + +IVA+K+ + N F L E+ +L
Sbjct: 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLME---NEKEGFPITALREIKIL 65
Query: 276 SRLHHCHVVPLVGYC----SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA 331
L H +VV L+ C + + + LVFEF + +L L V+
Sbjct: 66 QLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVK-FTLSEIKK 123
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 391
+ GL Y+H +ILHRD+K++NIL+ ++ K+ D G+A+ S +S
Sbjct: 124 VMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSL----SKNSK 176
Query: 392 PARMQG---TFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHR---------- 437
P R T Y PE + R D++ G ++ E+ T R PI +
Sbjct: 177 PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQHQLTL 235
Query: 438 ------SITK----GEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAY---- 483
SIT G + L L+ ELP +G K + ++ Y
Sbjct: 236 ISQLCGSITPEVWPGVDKLELFKK----------MELP----QGQKRKVKERLKPYVKDP 281
Query: 484 ----LAKECLQLDPDARPT 498
L + L LDP R
Sbjct: 282 HALDLIDKLLVLDPAKRID 300
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 60/174 (34%), Positives = 84/174 (48%), Gaps = 30/174 (17%)
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS-CSSSPARM 395
ARG+E+L A+ + +HRD+ + NILL EN KI D G+A+ + D P AR+
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD--PDYVRKGSARL 238
Query: 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRL 454
+ APE + SDV+SFGV+L E+ + G P + + EE RL
Sbjct: 239 --PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP-YPGVQINEE-----FCQRL 290
Query: 455 QDSGTVIS--ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
+D GT + E P + IM C Q DP RPT S +V+IL
Sbjct: 291 KD-GTRMRAPENATPEIYR--------IML----ACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 30/217 (13%)
Query: 231 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADS----VFLTEVDMLSRLHHCHVVP 285
++G+G VY D GR +AVK+ S E+ +L L H +V
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 286 LVGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGLEY 342
G C R +L +F E+MP G+++D L G L E + I +G+ Y
Sbjct: 69 YYG-C--LRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----QGVSY 121
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK-----ADGLPSCSSSPARMQG 397
LH + I+HRDIK +NIL D N K+ D G +KR++ G+ S + +P M
Sbjct: 122 LH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM-- 176
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
+PE +DV+S ++E++T + P
Sbjct: 177 -----SPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 72/276 (26%), Positives = 127/276 (46%), Gaps = 37/276 (13%)
Query: 232 VGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G+G + V + + G++VAVK+ + + +F EV ++ H +VV + Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEM--YN 84
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 350
S G +V EF+ G L D V MN + A+ + + L LH A
Sbjct: 85 SYLVGDELW--VVMEFLEGGALTDI---VTHTRMNEEQIAAVCLAVLKALSVLH---AQG 136
Query: 351 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG 410
++HRDIKS +ILL + K++D G ++ + +P S + GT + APE ++
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKS----LVGTPYWMAPE--LIS 189
Query: 411 RASLMS--DVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 468
R D++S G++++E++ G P + P L+ + LP P+
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGEPP-------------YFNEPPLKAMKMIRDNLP-PK 235
Query: 469 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
LK + K + +L + L DP R T +E+++
Sbjct: 236 LK-NLHKVSPSLKGFLDR-LLVRDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 78/313 (24%), Positives = 124/313 (39%), Gaps = 65/313 (20%)
Query: 223 TDKFSGSNIVGQGGSSYV--YRGQLTDGRIVAVKR----FKTQGGPNADSVFLTEVDMLS 276
T+++ VG G V R QLT G+ VA+K+ F T A + E+ +L
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPV--LAKRTY-RELKLLK 64
Query: 277 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--IAI 334
L H +++ L F V E + R L+ + +
Sbjct: 65 HLRHENIISL---SDIFISPLEDIYFVTELLGTDLHR------LLTSRPLEKQFIQYFLY 115
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
RGL+Y+H A ++HRD+K SNIL++EN + KI D G+A+ +
Sbjct: 116 QILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR-----------IQDPQ 161
Query: 395 MQG---TFGYFAPEYAMV-GRASLMSDVFSFGVVLLELIT------GRQPIHR--SITKG 442
M G T Y APE + + + D++S G + E++ G+ +++ IT
Sbjct: 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITD- 220
Query: 443 EESLVLWATPRLQDSGTVISE--------LP--DPR-LKGDFPKEEMQIMAYLAKECLQL 491
L TP T+ SE LP +P F + + L K L
Sbjct: 221 -----LLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEK-MLVF 274
Query: 492 DPDARPTMSEVVQ 504
DP R + +E +
Sbjct: 275 DPQKRISAAEALA 287
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 71/276 (25%), Positives = 122/276 (44%), Gaps = 46/276 (16%)
Query: 251 VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309
VAVK K + ++E++++ + H +++ L+G C++ ++ E+
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ----EGPLYVIVEYAAK 102
Query: 310 GNLRDCL------------DGVLV--EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 355
GNLR+ L D V E +++ V+ A ARG+EYL + R +HRD
Sbjct: 103 GNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL---ESRRCIHRD 159
Query: 356 IKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SL 414
+ + N+L+ E+ KI D G+A+ + +S R+ + APE A+ R +
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARGVHDIDYYK-KTSNGRL--PVKWMAPE-ALFDRVYTH 215
Query: 415 MSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDF 473
SDV+SFG+++ E+ T G P + I E +L R+ EL
Sbjct: 216 QSDVWSFGILMWEIFTLGGSP-YPGIPVEELFKLLREGHRMDKPSNCTHEL--------- 265
Query: 474 PKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
L +EC P RPT ++V+ L +
Sbjct: 266 --------YMLMRECWHAVPTQRPTFKQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 67/238 (28%), Positives = 98/238 (41%), Gaps = 58/238 (24%)
Query: 232 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVD-------MLSRLHHCHV 283
+G G V + G+ A+K V L +V+ +L + H
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKA-----KIVKLKQVEHVLNEKRILQSIRH--- 60
Query: 284 VP-LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIA-IGAARG 339
P LV F+ + LV E++P G L L G E + R A + A
Sbjct: 61 -PFLVNLYGSFQDDSNL-YLVMEYVPGGELFSHLRKSGRFPEPV---ARFYAAQVVLA-- 113
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
LEYLH I++RD+K N+LLD + KITD G AKR+K C GT
Sbjct: 114 LEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC--------GTP 162
Query: 400 GYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 443
Y APE Y G+A D ++ G+++ E++ G P I+ I +G+
Sbjct: 163 EYLAPEIILSKGY---GKA---VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 61/237 (25%), Positives = 95/237 (40%), Gaps = 48/237 (20%)
Query: 231 IVGQGGSSYVYRGQL----TDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVV 284
++G+G V L G++ A+K + + + E D+L+ +V
Sbjct: 8 VIGRGAFGEV---WLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIV 64
Query: 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIA-IGAARGLE 341
L Y S F+ + + LV E+MP G+L + L V E R IA + A L+
Sbjct: 65 KL--YYS-FQDEEHL-YLVMEYMPGGDLMNLLIRKDVFPEET---ARFYIAELVLA--LD 115
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG----------------- 384
+H+ +HRDIK NIL+D + + K+ D G+ K++
Sbjct: 116 SVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 385 -LPSCSSSPARMQ------GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
L R GT Y APE L D +S GV+L E++ G P
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 40/109 (36%), Positives = 56/109 (51%), Gaps = 15/109 (13%)
Query: 331 AIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 390
IA+ + L YL E +I+HRD+K SNILLD N N K+ D G++ +L
Sbjct: 111 KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV--------D 160
Query: 391 SPARMQ--GTFGYFAPEYAMVGRAS---LMSDVFSFGVVLLELITGRQP 434
S A+ + G Y APE + SDV+S G+ L E+ TG+ P
Sbjct: 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 69/230 (30%), Positives = 114/230 (49%), Gaps = 28/230 (12%)
Query: 232 VGQGGSSYVYRG--QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
+G+G + V++G +LT +VA+K + + A + EV +L L H ++V L
Sbjct: 13 LGEGTYATVFKGRSKLT-ENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAI-GAARGLEYLHEA 346
+R + L VFE++ + +L+ LD G L+ N V I + RGL Y H+
Sbjct: 72 ---IHTERCLTL-VFEYLDS-DLKQYLDNCGNLMSMHN----VKIFMFQLLRGLSYCHKR 122
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
+ILHRD+K N+L++E K+ D G+A +A +P+ + S + T Y P+
Sbjct: 123 ---KILHRDLKPQNLLINEKGELKLADFGLA---RAKSVPTKTYSNEVV--TLWYRPPD- 173
Query: 407 AMVGRASLMS--DVFSFGVVLLELITGRQPIHRSITKGEESLV--LWATP 452
++G + D++ G +L E+ TGR S K E L+ L TP
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTP 223
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 72/258 (27%), Positives = 118/258 (45%), Gaps = 38/258 (14%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
+G+G VY+G+ G+IVA+K+ + +G P S + E+ +L L H ++V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVP---STAIREISLLKELQHPNIVCL 64
Query: 287 VGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRV-AIAIGAARGLEYLH 344
+ RL L+FEF+ + +L+ LD + V + +G+ + H
Sbjct: 65 QDVLMQ-----ESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG----TFG 400
+ R+LHRD+K N+L+D K+ D G+A +A G+ P R+ T
Sbjct: 119 ---SRRVLHRDLKPQNLLIDNKGVIKLADFGLA---RAFGI------PVRVYTHEVVTLW 166
Query: 401 YFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIH--RSITKGEESLVLWATPRLQDS 457
Y APE + R S D++S G + E+ T + H I + + TP +D
Sbjct: 167 YRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPT-EDV 225
Query: 458 GTVISELPDPRLKGDFPK 475
++ LPD K FPK
Sbjct: 226 WPGVTSLPD--YKNTFPK 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 4e-11
Identities = 70/288 (24%), Positives = 116/288 (40%), Gaps = 36/288 (12%)
Query: 226 FSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHV 283
F +VG G VY+G+ + G++ A+K G + + E++ML + HH ++
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNI 65
Query: 284 VPLVGYCSEFR--GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 341
G + G LV EF G++ D + + + I RGL
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
+LH+ +++HRDIK N+LL EN K+ D G++ +L GT +
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-----RTVGRRNTFIGTPYW 177
Query: 402 FAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456
APE SD++S G+ +E+ G P + L+ PR
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP----LCDMHPMRALFLIPR--- 230
Query: 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
P PRLK ++ Q + CL + RPT ++++
Sbjct: 231 -------NPAPRLKSKKWSKKFQ---SFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 72/280 (25%), Positives = 117/280 (41%), Gaps = 43/280 (15%)
Query: 232 VGQGGSSYVYRG---QLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLV 287
+G G V +G + VAVK K P L E +++ +L + ++V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 288 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLVEGMNWDTRVAIAIGAARGLEYLH 344
G C + M LV E G L L V + + + + G++YL
Sbjct: 63 GIC---EAESWM--LVMELAELGPLNKFLQKNKHVTEKNI-----TELVHQVSMGMKYLE 112
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYF 402
E +HRD+ + N+LL AKI+D G++K L AD + A+ G + ++
Sbjct: 113 ET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE----NYYKAKTHGKWPVKWY 165
Query: 403 APEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462
APE + S SDV+SFGV++ E + Q ++ + E + ++ + R+
Sbjct: 166 APECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM-------- 217
Query: 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 502
E P P E M L K C D RP + V
Sbjct: 218 ECPQ-----RCPPE----MYDLMKLCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 61/189 (32%), Positives = 85/189 (44%), Gaps = 42/189 (22%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
RGL+Y+H A I+HRD+K SNI ++E+ KI D G+A R D M G
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLA-RHTDD----------EMTG 174
Query: 398 ---TFGYFAPEYAMVGRASLMS-----DVFSFGVVLLELITGRQ--PIHRSITKGEESLV 447
T Y APE M+ M D++S G ++ EL+TG+ P I + + +
Sbjct: 175 YVATRWYRAPE-IMLNW---MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMN 230
Query: 448 LWATPR--------LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQ----LDPDA 495
L TP + + I LP K DF KE LA + L+ LDPD
Sbjct: 231 LVGTPDEELLQKISSESARNYIQSLP-QMPKKDF-KEVFSGANPLAIDLLEKMLVLDPDK 288
Query: 496 RPTMSEVVQ 504
R T +E +
Sbjct: 289 RITAAEALA 297
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 69/226 (30%), Positives = 96/226 (42%), Gaps = 29/226 (12%)
Query: 224 DKFSGSNIVGQG--GSSYVYRGQLTDGRIVAVKRFKTQ--GGPNADSVFLTEVDMLSRLH 279
F ++VG+G G V R + T G I A+K K S F E D+LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT-GDIYAMKVMKKSVLLAQETVSFFEEERDILSI-S 58
Query: 280 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGA 336
+ +P + Y F+ K + LV E+ P G+L L + E M
Sbjct: 59 NSPWIPQLQYA--FQDKDNL-YLVMEYQPGGDLLSLLNRYEDQFDEDM-------AQFYL 108
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
A + +H +HRDIK N+L+D + K+ D G A RL A+ + + S P
Sbjct: 109 AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN-SKLPV--- 164
Query: 397 GTFGYFAPEY--AMVGRASLMSDV----FSFGVVLLELITGRQPIH 436
GT Y APE M G V +S GV+ E+I GR P H
Sbjct: 165 GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 63/240 (26%), Positives = 105/240 (43%), Gaps = 41/240 (17%)
Query: 271 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLV---EGM 324
E +LS+L H ++V Y + G+ + +V F G+L L G L+ + +
Sbjct: 49 EAQLLSQLKHPNIV---AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVV 105
Query: 325 NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384
W ++A+A L+YLHE ILHRD+K+ N+ L K+ DLG+A+ L+
Sbjct: 106 EWFVQIAMA------LQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE--- 153
Query: 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE 444
+ + + GT Y +PE + SDV++ G + E+ T + H K
Sbjct: 154 --NQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK---HAFNAKDMN 208
Query: 445 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
SLV I E P + D+ E + L L P+ RP++ +++
Sbjct: 209 SLVY-----------RIIEGKLPPMPKDYSPE----LGELIATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G G VY+ + + G + A+K K + G + V E+ M+ H ++V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFA-VVQQEIIMMKDCKHSNIVAYFG-- 73
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA-IAIGAARGLEYLHEAAAP 349
S R R + EF G+L+D V G ++++A ++ +GL YLH
Sbjct: 74 SYLR--RDKLWICMEFCGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKGK- 127
Query: 350 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV 409
+HRDIK +NILL +N + K+ D G++ ++ A + GT + APE A V
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVSAQITA-----TIAKRKSFIGTPYWMAPEVAAV 180
Query: 410 GRA---SLMSDVFSFGVVLLELITGRQPI 435
R + + D+++ G+ +EL + P+
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 58/183 (31%), Positives = 90/183 (49%), Gaps = 20/183 (10%)
Query: 271 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRV 330
E D+L+ ++H +V L Y + GK L+ +F+ G+L L E M + V
Sbjct: 48 ERDILAEVNHPFIVKL-HYAFQTEGKL---YLILDFLRGGDLFTRLSK---EVMFTEEDV 100
Query: 331 AIAIGA-ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 389
+ A L++LH I++RD+K NILLDE + K+TD G++K D
Sbjct: 101 KFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAY 156
Query: 390 SSPARMQGTFGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 447
S GT Y APE +V R + +D +SFGV++ E++TG P K +++
Sbjct: 157 S----FCGTVEYMAPE--VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210
Query: 448 LWA 450
L A
Sbjct: 211 LKA 213
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 9e-11
Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 12/99 (12%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
RGL+YLH A ++HRD+K SNIL++ N + KI D G+A+ + D +
Sbjct: 114 RGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE-----DEKGFLTE 165
Query: 398 ---TFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGR 432
T Y APE + R + D++S G + EL+T +
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 77/302 (25%), Positives = 137/302 (45%), Gaps = 41/302 (13%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ--LTDGRIVAVKRFK-TQGGPNADSVFLTEVDMLSRLHH 280
D++ +G+G VY+ + +T+ +A+K+ + Q S + E+ +L + H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTN-ETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 281 CHVVPL--VGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 337
++V L V + + RL LVFE++ + +L+ +D N
Sbjct: 61 GNIVRLQDVVHSEK-------RLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQIL 112
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNA-KITDLGMAKRLKADGLPSCSSSPARMQ 396
RG+ Y H + R+LHRD+K N+L+D NA K+ D G+A +A G+P + + +
Sbjct: 113 RGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLA---RAFGIPVRTFTHEVV- 165
Query: 397 GTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQ--PIHRSITKGEESLVLWATPR 453
T Y APE + R S D++S G + E++ + P I + + + TP
Sbjct: 166 -TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPN 224
Query: 454 LQDSGTVISELPDPRLKGDFPKEEMQIMAY-----------LAKECLQLDPDARPTMSEV 502
+++ ++ LPD K FPK + +A L + L+LDP R T
Sbjct: 225 -EETWPGVTSLPD--YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAA 281
Query: 503 VQ 504
++
Sbjct: 282 LE 283
|
Length = 294 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 58/182 (31%), Positives = 85/182 (46%), Gaps = 40/182 (21%)
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS-CSSSPARM 395
ARG+E+L A+ + +HRD+ + NILL EN KI D G+A+ + D P AR+
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD--PDYVRKGDARL 237
Query: 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 455
+ APE + SDV+SFGV+L E+ + L A+P
Sbjct: 238 --PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS-----------------LGASPY-- 276
Query: 456 DSGTVISELPDPRLKG-------DFPKEEM-QIMAYLAKECLQLDPDARPTMSEVVQILS 507
G I E RLK ++ E+ IM +C +P+ RPT SE+V+IL
Sbjct: 277 -PGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIML----DCWHNNPEDRPTFSELVEILG 331
Query: 508 TI 509
+
Sbjct: 332 DL 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 73/289 (25%), Positives = 120/289 (41%), Gaps = 35/289 (12%)
Query: 232 VGQGGSSYVYRGQLT-DGRI--VAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCHVVPLV 287
+G+G V GQL D I VAVK K ++ FL+E + H +V+ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 288 GYC---SEFRGKRAMRLLVFEFMPNGNLRDCLD----GVLVEGMNWDTRVAIAIGAARGL 340
G C E G + +++ FM +G+L L G + + V A G+
Sbjct: 67 GVCLQTVESEGYPS-PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
EYL ++ +HRD+ + N +L+EN+N + D G++K++ +G A+M
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI-YNGDYYRQGRIAKM--PVK 179
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460
+ A E + SDV+SFGV + E+ T Q + + E L RL+
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ---- 235
Query: 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
P + + + L C L+P RP+ + L
Sbjct: 236 -------------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 47/170 (27%), Positives = 79/170 (46%), Gaps = 24/170 (14%)
Query: 271 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNL----RDCLDGVLVEGM-- 324
E +L+++ H ++V + F + +V E+ G+L + + E
Sbjct: 48 EAVLLAKMKHPNIV---AFKESFEADGHL-YIVMEYCDGGDLMQKIKLQRGKLFPEDTIL 103
Query: 325 NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384
W ++ + G++++HE R+LHRDIKS NI L +N K+ D G A+ L + G
Sbjct: 104 QWFVQMCL------GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154
Query: 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
+C+ GT Y PE + SD++S G +L EL T + P
Sbjct: 155 AYACT-----YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 67/283 (23%), Positives = 123/283 (43%), Gaps = 40/283 (14%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKT--QGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
+G+G S VYR L D + VA+K+ + A + E+D+L +L+H +V+
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIK--- 66
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCL------DGVLVEGMNWDTRVAIAIGAARGLEY 342
Y F + + V E G+L + ++ E W V + +E+
Sbjct: 67 YLDSFIEDNELNI-VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SAVEH 121
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
+H + R++HRDIK +N+ + K+ DLG+ + + +++ + GT Y
Sbjct: 122 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-----TTAAHSLVGTPYYM 173
Query: 403 APEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462
+PE + SD++S G +L E+ + P + G++ + + I
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY-----GDKMNLFSLCQK-------IE 221
Query: 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505
+ P L + E+++ L C+ DPD RP + V QI
Sbjct: 222 QCDYPPLPTEHYSEKLR---ELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 25/231 (10%)
Query: 217 SALEHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDML 275
SAL F +VG G VY+G+ + G++ A+K + + E++ML
Sbjct: 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEINML 66
Query: 276 SRL-HHCHVVPLVGYCSEFR--GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 332
+ HH ++ G + G LV EF G++ D + + D I
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYI 126
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP 392
RGL +LH A +++HRDIK N+LL EN K+ D G++ +L +
Sbjct: 127 CREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--------DRTV 175
Query: 393 ARMQ---GTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPI 435
R GT + APE SD++S G+ +E+ G P+
Sbjct: 176 GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 66/220 (30%), Positives = 96/220 (43%), Gaps = 32/220 (14%)
Query: 226 FSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCH 282
F G + +G G VY +VAVK+ G + + EV L +L H +
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 283 VVPLVGYCSEFRG---KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 339
+ E++G K LV E+ G+ D L+ V + + AI GA +G
Sbjct: 83 TI-------EYKGCYLKEHTAWLVMEYCL-GSASDLLE-VHKKPLQEVEIAAITHGALQG 133
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGT 398
L YLH ++HRDIK+ NILL E K+ D G A + SSPA GT
Sbjct: 134 LAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK----------SSPANSFVGT 180
Query: 399 FGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPI 435
+ APE + G+ DV+S G+ +EL + P+
Sbjct: 181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 62/219 (28%), Positives = 106/219 (48%), Gaps = 25/219 (11%)
Query: 232 VGQGGSSYVYRG--QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
+G+G + VY+G +LTD +VA+K + + A + EV +L L H ++V L
Sbjct: 14 LGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL--- 69
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGLEYLHEAA 347
+ LVFE++ + +L+ LD G + N + + RGL Y H
Sbjct: 70 -HDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLL---RGLNYCHRR- 123
Query: 348 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA 407
++LHRD+K N+L++E K+ D G+A +A +P+ + S + T Y P+
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLA---RAKSIPTKTYSNEVV--TLWYRPPD-I 175
Query: 408 MVGRA--SLMSDVFSFGVVLLELITGRQPIHRSITKGEE 444
++G S D++ G + E+ TGR P+ T E+
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGR-PLFPGSTVEEQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 27/225 (12%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKT----QGGPNADSVFLTEVDMLSRL 278
D + +G+G VY+ + G++VA+K+ + +G P L E+ +L L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIP---PTALREISLLQML 57
Query: 279 HHC-HVVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGV---LVEGMNWDTRVAI 332
++V L V + E GK LVFE++ + +L+ +D + T +
Sbjct: 58 SESIYIVRLLDVEHVEEKNGK-PSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-KITDLGMAKRLKADGLPSCSSS 391
+G+ + H+ ++HRD+K N+L+D+ KI DLG+ +A +P S +
Sbjct: 116 MYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLG---RAFSIPVKSYT 169
Query: 392 PARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPI 435
+ T Y APE + S D++S G + E+ +QP+
Sbjct: 170 HEIV--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPL 211
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 34/213 (15%)
Query: 232 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLVG 288
VGQGG V+ + D G IVA+KR K + V LTE D+L+ +V L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAI-----AIGAARGLE 341
Y F+ + L E++P G+ R L+ GVL E R + A+ A
Sbjct: 68 Y--AFQDDEYL-YLAMEYVPGGDFRTLLNNLGVLSED---HARFYMAEMFEAVDA----- 116
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
LHE +HRD+K N L+D + + K+TD G++K G+ + ++S + G+ Y
Sbjct: 117 -LHELG---YIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANS---VVGSPDY 164
Query: 402 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
APE D +S G +L E + G P
Sbjct: 165 MAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 52/176 (29%), Positives = 84/176 (47%), Gaps = 26/176 (14%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
GL++LH I++RD+K NILLD + + KI D GM K +C+ GT
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-----FCGT 159
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH--------RSITKGEESLVLWA 450
Y APE + + + D +SFGV+L E++ G+ P H +SI W
Sbjct: 160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWL 219
Query: 451 TPRLQDSGTVISEL----PDPRL--KGDFPKEEM-QIMAYLAKECLQLDPDARPTM 499
T +D ++ +L P+ RL KGD + + + + A E +++P +P +
Sbjct: 220 TREAKD---ILVKLFVREPERRLGVKGDIRQHPFFREIDWSALEEREIEPPFKPKV 272
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 232 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G G VY+ + + G + A K +T+ + ++ E+++L+ +H ++V L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YMVEIEILATCNHPYIVKLLG-A 77
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 350
+ GK ++ EF P G +D +++E T I + + LE L + +
Sbjct: 78 FYWDGKLW---IMIEFCPGG----AVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 351 ILHRDIKSSNILLDENLNAKITDLGM-AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV 409
I+HRD+K+ N+LL + + K+ D G+ AK +K L S GT + APE M
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQRRDS----FIGTPYWMAPEVVMC 184
Query: 410 GRAS-----LMSDVFSFGVVLLELITGRQPIH 436
+D++S G+ L+E+ P H
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 216
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-10
Identities = 49/174 (28%), Positives = 80/174 (45%), Gaps = 21/174 (12%)
Query: 268 FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL--VFEFMPNGNLRDCL--DGVLVEG 323
F E + +RL+H ++V L+ G+ LL VFE++P LR+ L DG L G
Sbjct: 25 FRRETALCARLYHPNIVALLD-----SGEAPPGLLFAVFEYVPGRTLREVLAADGALPAG 79
Query: 324 MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRL 380
+ + L H I+HRD+K NI++ +AK+ D G+ L
Sbjct: 80 ----ETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL 132
Query: 381 KA--DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 432
D + + + GT Y APE + SD++++G++ LE +TG+
Sbjct: 133 PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 73/319 (22%), Positives = 121/319 (37%), Gaps = 51/319 (15%)
Query: 233 GQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFL-TEVDMLSRLHHCHVVPLVGYCS 291
++ + + T +VAVK+ D L E+ +L H +++P Y +
Sbjct: 11 EDLMIVHLAKHKPT-NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP---YVT 66
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI---GAARGLEYLHEAAA 348
F + +V M G+ D L EG+ +AIA L+Y+H
Sbjct: 67 SFIVDSEL-YVVSPLMAYGSCEDLLKTHFPEGLP---ELAIAFILKDVLNALDYIHSKG- 121
Query: 349 PRILHRDIKSSNILLDENLNAKITDL----GMAKRLKADGLPSCSSSPARMQGTFGYFAP 404
+HR +K+S+ILL + ++ L M K K + P + +P
Sbjct: 122 --FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD--FPKSSVKNLPWLSP 177
Query: 405 EYAMVGRASLM-----SDVFSFGVVLLELITGRQP---IHRSITKGEESLVLWATPRLQD 456
E V + +L SD++S G+ EL G P + + E+ V P L D
Sbjct: 178 E---VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK--VRGTVPCLLD 232
Query: 457 SGTVI---SELPDPRLKGDFPKEEMQIMAY-----------LAKECLQLDPDARPTMSEV 502
T + R + P + + CLQ DP++RP+ S
Sbjct: 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSAS-- 290
Query: 503 VQILSTIAPDKSRRRNISL 521
Q+L+ + +RRN SL
Sbjct: 291 -QLLNHSFFKQCKRRNTSL 308
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 56/222 (25%), Positives = 107/222 (48%), Gaps = 33/222 (14%)
Query: 225 KFSGSNIVGQG--GSSYVYRGQLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHC 281
++ +G+G G Y+ + + +D +K P + EV +L+++ H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLVEG---MNWDTRVAIAIG 335
++V + + F+ + +V E+ G+L ++ GVL ++W ++++
Sbjct: 60 NIV---TFFASFQENGRL-FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL--- 112
Query: 336 AARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRLK--ADGLPSCSSSP 392
GL+++H+ +ILHRDIKS NI L +N + AK+ D G+A++L + +C +P
Sbjct: 113 ---GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTP 166
Query: 393 ARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
Y +PE + +D++S G VL EL T + P
Sbjct: 167 Y-------YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 35/268 (13%)
Query: 248 GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 307
GR VAVK + + +F EV ++ H +VV + Y S G+ L+ EF+
Sbjct: 46 GRQVAVKMMDLRKQQRRELLF-NEVVIMRDYQHQNVVEM--YKSYLVGEELWVLM--EFL 100
Query: 308 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 367
G L D + +N + + + L YLH + ++HRDIKS +ILL +
Sbjct: 101 QGGALTDIVSQTR---LNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDG 154
Query: 368 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLE 427
K++D G ++ D +P S + GT + APE D++S G++++E
Sbjct: 155 RVKLSDFGFCAQISKD-VPKRKS----LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIE 209
Query: 428 LITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE 487
++ G P +S V A RL+DS P P+LK + K + +L +
Sbjct: 210 MVDGEPPYF------SDSPV-QAMKRLRDS-------PPPKLK-NAHKISPVLRDFLER- 253
Query: 488 CLQLDPDARPTMSEVVQ---ILSTIAPD 512
L +P R T E++ +L T P+
Sbjct: 254 MLTREPQERATAQELLDHPFLLQTGLPE 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 58/177 (32%), Positives = 89/177 (50%), Gaps = 30/177 (16%)
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS-CSSSPARM 395
A+G+E+L A+ + +HRD+ + NILL EN KI D G+A+ + D P AR+
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD--PDYVRKGDARL 243
Query: 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRL 454
+ APE ++ SDV+SFGV+L E+ + G P + + EE RL
Sbjct: 244 --PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCR-----RL 295
Query: 455 QDSGTVISELPDPRLKG-DFPKEEM-QIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
++ GT R++ D+ EM Q M +C +P RPT SE+V+ L +
Sbjct: 296 KE-GT--------RMRAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 71/286 (24%), Positives = 122/286 (42%), Gaps = 50/286 (17%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+G G VY+ Q + ++A + ++ E+D+L+ H ++V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL---D 69
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE---YLHEAAA 348
F + + +L+ EF G +D V++E T I + + LE YLHE
Sbjct: 70 AFYYENNLWILI-EFCAGG----AVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN-- 122
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 408
+I+HRD+K+ NIL + + K+ D G++ + + S GT + APE M
Sbjct: 123 -KIIHRDLKAGNILFTLDGDIKLADFGVSAK-NTRTIQRRDS----FIGTPYWMAPEVVM 176
Query: 409 VGRAS-----LMSDVFSFGVVLLELITGRQPIH-----RSITKGEESLVLWATPRLQDSG 458
+ +DV+S G+ L+E+ P H R + K +S P L
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS----EPPTLAQPS 232
Query: 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
SE D +L K+CL+ + DAR T ++++Q
Sbjct: 233 RWSSEFKD----------------FL-KKCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 37/96 (38%), Positives = 51/96 (53%), Gaps = 8/96 (8%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
RGL+YLH A ILHRDIK N+L++ N KI D G+A+ + D S + +
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEVV-- 166
Query: 398 TFGYFAPEYAMVGRASLMS-DVFSFGVVLLELITGR 432
T Y APE M R + D++S G + EL+ R
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 69/257 (26%), Positives = 125/257 (48%), Gaps = 30/257 (11%)
Query: 232 VGQGGSSYVYRG--QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
+G+G + V++G +LT+ +VA+K + + A + EV +L L H ++V L
Sbjct: 14 LGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL--- 69
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAI-GAARGLEYLHEA 346
+ LVFE++ + +L+ +D G ++ N V I + RGL Y H
Sbjct: 70 -HDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHN----VKIFLYQILRGLAYCHRR 123
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
++LHRD+K N+L++E K+ D G+A +A +P+ + S + T Y P+
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLA---RAKSVPTKTYSNEVV--TLWYRPPD- 174
Query: 407 AMVGRA--SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV--LWATPRLQDSGTVIS 462
++G + S D++ G + E+ +GR S + E L+ L TP +++ IS
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPT-EETWPGIS 233
Query: 463 ELPDPRLKGDFPKEEMQ 479
+ + +FPK + Q
Sbjct: 234 SNDEFK-NYNFPKYKPQ 249
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 8e-10
Identities = 80/310 (25%), Positives = 130/310 (41%), Gaps = 52/310 (16%)
Query: 226 FSGSNIVGQG--GSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHC 281
F+ +G G G+ Y R T+ +VA+K+ G + + + EV L R+ H
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHP 85
Query: 282 HVVPLVGYCSEFRG---KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 338
+ + E++G + LV E+ G+ D L+ V + + AI GA +
Sbjct: 86 NSI-------EYKGCYLREHTAWLVMEYCL-GSASDLLE-VHKKPLQEVEIAAITHGALQ 136
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
GL YLH + ++HRDIK+ NILL E K+ D G A S +S GT
Sbjct: 137 GLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSA---------SIASPANSFVGT 184
Query: 399 FGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 455
+ APE + G+ DV+S G+ +EL + P+ + A L
Sbjct: 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN----------MNAMSALY 234
Query: 456 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSR 515
I++ P L+ + E CLQ P RPT E+++ + + + R
Sbjct: 235 H----IAQNESPTLQSN---EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL---RER 284
Query: 516 RRNISLNLFQ 525
+ ++L Q
Sbjct: 285 PETVLIDLIQ 294
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 39/124 (31%), Positives = 52/124 (41%), Gaps = 19/124 (15%)
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
EYLH I++RD+K N+LLD + K+TD G AK++ C GT
Sbjct: 132 EYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC--------GTPE 180
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWATP 452
Y APE D ++ GV+L E I G P I+ I G W
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDG 240
Query: 453 RLQD 456
R +D
Sbjct: 241 RARD 244
|
Length = 329 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 37/101 (36%), Positives = 56/101 (55%), Gaps = 14/101 (13%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK-RLKADGLPS--CSSSPARM 395
GL++LH+ I++RD+K N+LLD++ + KI D GM K + +G S C
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC------- 157
Query: 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
GT Y APE + + D +SFGV+L E++ G+ P H
Sbjct: 158 -GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
D + +G+G + VY+G+ +G++VA+K + Q + E +L L H +
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
+V L + + LVFE++ + +L +D G++ + RGL Y
Sbjct: 65 IVLL----HDIIHTKETLTLVFEYV-HTDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSY 118
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
+H+ ILHRD+K N+L+ + K+ D G+A +A +PS + S + T Y
Sbjct: 119 IHQR---YILHRDLKPQNLLISDTGELKLADFGLA---RAKSVPSHTYSNEVV--TLWYR 170
Query: 403 APEYAMVGRA--SLMSDVFSFGVVLLELITG 431
P+ ++G S D++ G + +E+I G
Sbjct: 171 PPD-VLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 35/97 (36%), Positives = 48/97 (49%), Gaps = 9/97 (9%)
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
L++LH+ I++RDIK NILLD + +TD G++K A+ S GT
Sbjct: 118 LDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS----FCGTI 170
Query: 400 GYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQP 434
Y APE G D +S GV+ EL+TG P
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 80/331 (24%), Positives = 129/331 (38%), Gaps = 84/331 (25%)
Query: 232 VGQGGSSYVYRGQL---TDGRIVAVKRFKTQGGPNADSVFLT-----EVDMLSRLHHCHV 283
+G+G VY+ + DG+ A+K+FK G ++ E+ +L L H +V
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFK---GDKEQYTGISQSACREIALLRELKHENV 64
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR-VAIAIGAA----- 337
V LV E K L+F++ + D L + + + + ++I +
Sbjct: 65 VSLVEVFLEHADKSVY--LLFDYAEH-------D--LWQIIKFHRQAKRVSIPPSMVKSL 113
Query: 338 -----RGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGLPSC 388
G+ YLH +LHRD+K +NIL+ E KI DLG+A+ A P
Sbjct: 114 LWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170
Query: 389 SSSPARMQGTFGYFAPEYAMVGRASLMS-DVFSFGVVLLELIT------GRQ-------P 434
P + T Y APE + R + D+++ G + EL+T GR+ P
Sbjct: 171 DLDPVVV--TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNP 228
Query: 435 IHR----SITKGEESLVLWATPRLQDSGTVISELPD-PRLKGDFPKEE---------MQI 480
R I + VL TP +D + +P+ L DF + M+
Sbjct: 229 FQRDQLERIFE-----VL-GTPTEKDWPDIKK-MPEYDTLMKDFKTKTYPSNSLAKWMEK 281
Query: 481 MAYLAKECLQL-------DPDARPTMSEVVQ 504
+ L DP R T E ++
Sbjct: 282 HKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 51/164 (31%), Positives = 75/164 (45%), Gaps = 32/164 (19%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
LE+LH+ I++RDIK NILLD N + +TD G++K D + S GT
Sbjct: 117 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS----FCGT 169
Query: 399 FGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456
Y AP+ G D +S GV++ EL+TG P GE++ + R+
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF---TVDGEKNSQAEISRRILK 226
Query: 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQL----DPDAR 496
S +P +P+E M+ LAK+ +Q DP R
Sbjct: 227 S--------EP----PYPQE----MSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 2e-09
Identities = 47/184 (25%), Positives = 82/184 (44%), Gaps = 24/184 (13%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ- 396
+ L+Y+H ++HRD+K SNILL+ + K+ D G+A+ L L +P
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVLTDY 172
Query: 397 -GTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 453
T Y APE ++G R + D++S G +L E++ G+ + T + ++
Sbjct: 173 VATRWYRAPE-ILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231
Query: 454 L--QD--------SGTVISELPDPR---LKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 500
+D + T++ LP L PK + L K+ L +P+ R T
Sbjct: 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALD-LLKKLLVFNPNKRLTAE 290
Query: 501 EVVQ 504
E ++
Sbjct: 291 EALE 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 48/165 (29%), Positives = 70/165 (42%), Gaps = 29/165 (17%)
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFGY 401
+H + ++HRDIKS+NILL N K+ D G +K A + S R GT Y
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAA----TVSDDVGRTFCGTPYY 211
Query: 402 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 461
APE S +D+FS GV+L EL+T ++P G +
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF---------------------DGENM 250
Query: 462 SELPDPRLKGDF---PKEEMQIMAYLAKECLQLDPDARPTMSEVV 503
E+ L G + P M + L DP RP+ S+++
Sbjct: 251 EEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
GL++LH I++RD+K N++LD + + KI D GM K G + + GT
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKE-NVFG----DNRASTFCGT 159
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
Y APE + + D +SFGV+L E++ G+ P H
Sbjct: 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 36/101 (35%), Positives = 51/101 (50%), Gaps = 14/101 (13%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
GL++LHE I++RD+K N+LLD + KI D GM K G + + GT
Sbjct: 108 GLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-----VTTSTFCGT 159
Query: 399 FGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
Y APE Y G A D ++ GV+L E++ G+ P
Sbjct: 160 PDYIAPEILSYQPYGPA---VDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 50/167 (29%), Positives = 76/167 (45%), Gaps = 27/167 (16%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
G+ Y+H+ RILHRD+K+ NI L NL KI D G+++ L + SC + GT
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL----MGSCDLATT-FTGT 168
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458
Y +PE SD++S G +L E+ H + S+VL
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLA---HAFEGQNFLSVVL---------- 215
Query: 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505
I E P P L + ++ IM + L DP RP+ +E+++
Sbjct: 216 -RIVEGPTPSLPETYSRQLNSIMQSM----LNKDPSLRPSAAEILRN 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 32/214 (14%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLVG 288
+G G VY + + + +VA+K+ G + + + EV L +L H + +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI---- 78
Query: 289 YCSEFRG---KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 345
++RG + LV E+ G+ D L+ V + + A+ GA +GL YLH
Sbjct: 79 ---QYRGCYLREHTAWLVMEYCL-GSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFGYFAP 404
++HRD+K+ NILL E K+ D G A + +PA GT + AP
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----------APANXFVGTPYWMAP 180
Query: 405 EYAMV---GRASLMSDVFSFGVVLLELITGRQPI 435
E + G+ DV+S G+ +EL + P+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 38/109 (34%), Positives = 55/109 (50%), Gaps = 30/109 (27%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
RGL+Y+H A +LHRD+K SN+LL+ N + KI D G+A+ + S M
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR--------TTSEKGDFMTE 167
Query: 398 ---TFGYFAPEYAMVGRASLMS--------DVFSFGVVLLELITGRQPI 435
T Y APE L++ DV+S G + EL+ GR+P+
Sbjct: 168 YVVTRWYRAPEL-------LLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 35/101 (34%), Positives = 52/101 (51%), Gaps = 14/101 (13%)
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
A GL +LH I++RD+K N++LD + KI D GM K G + +
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-----FC 162
Query: 397 GTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP 434
GT Y APE Y G++ D ++FGV+L E++ G+ P
Sbjct: 163 GTPDYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 36/185 (19%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
+GL+Y+H A I+HRD+K N+ ++E+ KI D G+A++ + + M G
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ-----------TDSEMTG 174
Query: 398 ---TFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPI---HRSITKGEESLVLWA 450
T Y APE + + D++S G ++ E++TG+ P+ H + + E + +
Sbjct: 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK-PLFKGHDHLDQLMEIMKVTG 233
Query: 451 TP------RLQ--DSGTVISELPDPRLKGDF----PKEEMQIMAYLAKECLQLDPDARPT 498
TP +LQ D+ + +LP R K DF P + L K L LD ++R T
Sbjct: 234 TPSKEFVQKLQSEDAKNYVKKLPRFR-KKDFRSLLPNANPLAVNVLEK-MLVLDAESRIT 291
Query: 499 MSEVV 503
+E +
Sbjct: 292 AAEAL 296
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 58/230 (25%), Positives = 103/230 (44%), Gaps = 31/230 (13%)
Query: 231 IVGQG--GSSYVYRGQLTDGRIVAVKRF-KTQGGPNADSVFL-TEVDMLSRLHHCHVVPL 286
++G+G G + R + T ++ A+K K + +DS F E D+++ + VV L
Sbjct: 50 VIGRGAFGEVQLVRHKSTR-KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNW----DTRVAIAIGAARGLEY 342
F+ R + +V E+MP G+L + + V W V +A+ A + +
Sbjct: 109 F---YAFQDDRYL-YMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVLALDAIHSMGF 163
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
+H RD+K N+LLD++ + K+ D G ++ +G+ C ++ GT Y
Sbjct: 164 IH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA----VGTPDYI 210
Query: 403 APEYAMV----GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 448
+PE G D +S GV L E++ G P + G S ++
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 23/107 (21%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
RGL+Y+H A +LHRD+K SN+LL+ N + KI D G+A+ + P
Sbjct: 117 RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR----------IADPEHDHT 163
Query: 398 TF--------GYFAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPI 435
F Y APE + + + D++S G +L E+++ R P+
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 18/154 (11%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
L+YLH +I++RD+K N++LD++ + KITD G+ K D +++ GT
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-----AATMKTFCGT 158
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT---PRL- 454
Y APE D + GVV+ E++ GR P + + L+L PR
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTL 218
Query: 455 -QDSGTVISEL----PDPRLKGDFPKEEMQIMAY 483
D+ +++S L P+ RL G P + +IM +
Sbjct: 219 SADAKSLLSGLLIKDPNKRLGGG-PDDAKEIMRH 251
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 44/228 (19%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTDGR-IVAVKRFK-TQGGPNADSVFLTEVDMLSRLHHC 281
+KF +VG+G V + + + + IVA+K+FK ++ L E+ ML L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEF-----------MPNGNLRDCLDGV---LVEGMNWD 327
++V L FR +R LVFE+ MPNG + + L++ ++W
Sbjct: 61 NIVELK---EAFR-RRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW- 115
Query: 328 TRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS 387
H+ I+HRDIK N+L+ N K+ D G A+ L
Sbjct: 116 ---------------CHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE----G 153
Query: 388 CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 435
+++ T Y +PE + D++S G +L EL G QP+
Sbjct: 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG-QPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 67/303 (22%), Positives = 130/303 (42%), Gaps = 63/303 (20%)
Query: 150 LRSSVISSDKESCNSATNLISHRITSVPETRVEVVSPIDLATGC------FLKTTFCRSK 203
L+S+ SS+K++ S ++SH P + ++L C ++ T +CR
Sbjct: 75 LKSTARSSEKQALMSELKIMSHL---GPHLNI-----VNLLGACTKGGPIYIITEYCR-- 124
Query: 204 TWTIHGTII----RFSYSALEHATDK-------FSGSNIVGQGGSSYVYRGQLTDGRIVA 252
+G ++ R ++ L++ DK SG + S+V G +DG +
Sbjct: 125 ----YGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMD 180
Query: 253 VKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNL 312
+ + + + ++ DM + + + Y S + +++P+
Sbjct: 181 MSK-------DESADYVPMQDMKGTVKYADIES-SNYESPYD----------QYLPSAPE 222
Query: 313 RDCLDGVLVEG--MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 370
R D ++ E +++ V + A G+E+L A+ +HRD+ + N+L+ E K
Sbjct: 223 RTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVK 279
Query: 371 ITDLGMAKRLKADGLPSCSSSPARMQGTF---GYFAPEYAMVGRASLMSDVFSFGVVLLE 427
I D G+A+ + D S+ TF + APE + +SDV+SFG++L E
Sbjct: 280 ICDFGLARDIMRD------SNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWE 333
Query: 428 LIT 430
+ T
Sbjct: 334 IFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 46/163 (28%)
Query: 302 LVFEFMPNGNLRDCLDGVLVEGMNWD----------TRVAIAIGAARGLEYLHEAAAPRI 351
+V E+MP G+L + + N+D V +A+ A + ++H
Sbjct: 120 MVMEYMPGGDLVNLMS-------NYDIPEKWARFYTAEVVLALDAIHSMGFIH------- 165
Query: 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM--- 408
RD+K N+LLD++ + K+ D G ++ A+G+ C ++ GT Y +PE
Sbjct: 166 --RDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA----VGTPDYISPEVLKSQG 219
Query: 409 ----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 447
GR D +S GV L E++ G P + +SLV
Sbjct: 220 GDGYYGRE---CDWWSVGVFLYEMLVGDTPFY------ADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 53/187 (28%), Positives = 80/187 (42%), Gaps = 37/187 (19%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
GL+Y+H A +LHRD+K N+L++ + KI D G+A+ S +P G
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR--------GFSENPGENAG 164
Query: 398 -------TFGYFAPEYAMVGRASLMS--DVFSFGVVLLELITGRQPI------------- 435
T Y APE M+ S DV+S G +L EL+ GR+P+
Sbjct: 165 FMTEYVATRWYRAPE-IMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLNQI 222
Query: 436 -HRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPD 494
T EE+L +P+ Q+ + +P + FP + L K L DP
Sbjct: 223 LQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEK-LLAFDPT 281
Query: 495 ARPTMSE 501
R ++ E
Sbjct: 282 KRISVEE 288
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 44/168 (26%), Positives = 79/168 (47%), Gaps = 25/168 (14%)
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
L YLH+ RI+HRD+ +NI+L E+ ITD G+AK+ + + S + GT
Sbjct: 126 LRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE------SKLTSVVGTI 177
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459
Y PE +DV++FG +L ++ T + P + +T L +
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFY-------------STNMLSLATK 224
Query: 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507
++ + +P +G + + + + CL D +ARP + +V ++S
Sbjct: 225 IVEAVYEPLPEGMYS----EDVTDVITSCLTPDAEARPDIIQVSAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 232 VGQGGSSYVYRGQLTD-GRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
+G+G V++ + + IVA+KR + +G P S L E+ +L L H ++V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKELKHKNIVRL 64
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
Y K+ LVFE+ + +L+ D + ++ + + +GL + H
Sbjct: 65 --YDVLHSDKKLT--LVFEYC-DQDLKKYFDSCNGD-IDPEIVKSFMFQLLKGLAFCHSH 118
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
+LHRD+K N+L+++N K+ D G+A +A G+P S + T Y P+
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLA---RAFGIPVRCYSAEVV--TLWYRPPD- 169
Query: 407 AMVGRASLMS---DVFSFGVVLLELITGRQPI 435
+ G A L S D++S G + EL +P+
Sbjct: 170 VLFG-AKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 36/97 (37%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL-PSCSSSPARMQG 397
L YLHE I++RD+K N+LLD + K+TD GM K +GL P ++S G
Sbjct: 108 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDTTS--TFCG 158
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
T Y APE D ++ GV++ E++ GR P
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 3e-08
Identities = 72/280 (25%), Positives = 115/280 (41%), Gaps = 67/280 (23%)
Query: 266 SVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNG----NLRDCLDGVL 320
S + EV+++ L H ++V Y F K +L ++ EF G N++ C +
Sbjct: 57 SQLVIEVNVMRELKHKNIVR---YIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYK--M 111
Query: 321 VEGMNWDTRVAIAIGAARGLEYLHEAA----APRILHRDIKSSNILLD------------ 364
+ V I L Y H R+LHRD+K NI L
Sbjct: 112 FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171
Query: 365 -ENLN----AKITDLGMAKRLKADGLP-SCSSSPARMQGTFGYFAPEYAMVGRASL--MS 416
NLN AKI D G++K + + + SC +P Y++PE + S S
Sbjct: 172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPY-------YWSPELLLHETKSYDDKS 224
Query: 417 DVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL---PDPRLKGDF 473
D+++ G ++ EL +G+ P H++ + +ISEL PD +KG
Sbjct: 225 DMWALGCIIYELCSGKTPFHKA----------------NNFSQLISELKRGPDLPIKGK- 267
Query: 474 PKEEMQIMAYLAKECLQLDPDARPTMSEVV--QILSTIAP 511
+E+ I L K L L RP+ + + QI+ + P
Sbjct: 268 -SKELNI---LIKNLLNLSAKERPSALQCLGYQIIKNVGP 303
|
Length = 1021 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 3e-08
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 57/218 (26%)
Query: 240 VYRGQ-LTDGRIVAVKRFKTQGGPNADSVF----LTEVDMLSRLHHCHVVPL----VG-- 288
VYR + G IVA+K+ K + F L E+++L +L H ++V + VG
Sbjct: 21 VYRARDKKTGEIVALKKLKME---KEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN 77
Query: 289 ----YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA----IAIGAARGL 340
Y +V E++ + +L+ L+E M + + + G+
Sbjct: 78 LDKIY------------MVMEYVEH-DLKS-----LMETMKQPFLQSEVKCLMLQLLSGV 119
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR----MQ 396
+LH+ ILHRD+K+SN+LL+ KI D G+A+ SP + +
Sbjct: 120 AHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY---------GSPLKPYTQLV 167
Query: 397 GTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQ 433
T Y APE + S D++S G + EL+T +
Sbjct: 168 VTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 71/292 (24%), Positives = 117/292 (40%), Gaps = 43/292 (14%)
Query: 232 VGQGGSSYVYRGQLTDGRIVA---VKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
+G G V ++ VA VK K + FL + D L H +++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT----RVAIAIGAARGLEYLH 344
C E LLVFE+ G+L+ L N R+A I A G+ ++H
Sbjct: 63 QCVE----AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA--GVTHMH 116
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMA-KRLKADGLPSCSSSPARMQGTFGYFA 403
+ LH D+ N L +L K+ D G+ R K D + + ++ + A
Sbjct: 117 KH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----WLA 169
Query: 404 PEYAMVGRASLM-------SDVFSFGVVLLELI-TGRQPIHRSITKGEESLVLWATPRLQ 455
PE L+ S+V++ GV L EL QP ++ E VL + Q
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS-HLSDRE---VLNHVIKDQ 225
Query: 456 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507
+L P+L+ + + +++ + C L P+ R T EV ++L+
Sbjct: 226 Q-----VKLFKPQLELPYSERWYEVLQF----CW-LSPEKRATAEEVHRLLT 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
L +LHE I++RD+K N+LLD + K+TD GM K G + + GT
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-----DTTSTFCGTP 160
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
Y APE D ++ GV++ E++ GR P
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 60/257 (23%), Positives = 98/257 (38%), Gaps = 44/257 (17%)
Query: 188 DLATGCFLKTTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVY----RG 243
L+ + C + + + +++R Y+ L T G V+ G
Sbjct: 66 SLSPQTDVCQEPCETTSSSDPASVVRMQYNILSSLT----------PGSEGEVFVCTKHG 115
Query: 244 QLTDGRIV--AVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301
+++ AV KT G E+D+L + H ++ L+ +R K
Sbjct: 116 DEQRKKVIVKAVTGGKTPG---------REIDILKTISHRAIINLI---HAYRWKS---- 159
Query: 302 LVFEFMP--NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359
V MP +L +D + + + I L YLH I+HRD+K+
Sbjct: 160 TVCMVMPKYKCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTE 214
Query: 360 NILLDENLNAKITDLGMAKRLKA-DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDV 418
NI LDE NA + D G A +L A P C GT +PE + +D+
Sbjct: 215 NIFLDEPENAVLGDFGAACKLDAHPDTPQCYG----WSGTLETNSPELLALDPYCAKTDI 270
Query: 419 FSFGVVLLELITGRQPI 435
+S G+VL E+ +
Sbjct: 271 WSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 50/193 (25%), Positives = 89/193 (46%), Gaps = 25/193 (12%)
Query: 264 ADSVFL-TEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVE 322
+DS F E D+++ + VV L +C+ F+ + + +V E+MP G+L + + V
Sbjct: 85 SDSAFFWEERDIMAFANSPWVVQL--FCA-FQDDKYL-YMVMEYMPGGDLVNLMSNYDVP 140
Query: 323 ---GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379
+ V +A+ A +H ++HRD+K N+LLD++ + K+ D G +
Sbjct: 141 EKWAKFYTAEVVLALDA------IHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191
Query: 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMV----GRASLMSDVFSFGVVLLELITGRQPI 435
+ G+ C ++ GT Y +PE G D +S GV L E++ G P
Sbjct: 192 MDETGMVRCDTA----VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
Query: 436 HRSITKGEESLVL 448
+ G S ++
Sbjct: 248 YADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 10/97 (10%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL-PSCSSSPARMQG 397
L +LHE I++RD+K N+LLD + + K+TD GM K +GL P ++S G
Sbjct: 108 ALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK----EGLGPGDTTST--FCG 158
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
T Y APE D ++ GV++ E++ GR P
Sbjct: 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 20/103 (19%)
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
L YLH +++RD+K N++LD++ + KITD G+ K +DG ++ GT
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-----ATMKTFCGTP 159
Query: 400 GYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
Y APE Y GRA D + GVV+ E++ GR P +
Sbjct: 160 EYLAPEVLEDNDY---GRA---VDWWGLGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 18/152 (11%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
L+YLH + +++RD+K N++LD++ + KITD G+ K DG ++ GT
Sbjct: 107 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-----ATMKTFCGT 159
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL---- 454
Y APE D + GVV+ E++ GR P + + L+L R
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL 219
Query: 455 -QDSGTVISEL----PDPRLKG--DFPKEEMQ 479
++ +++S L P RL G D KE MQ
Sbjct: 220 SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
+ GL +LH I++RD+K N++LD + KI D GM K DG+ + +
Sbjct: 111 SVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT-----FC 162
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
GT Y APE D +++GV+L E++ G+ P
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 20/103 (19%)
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ--- 396
LEYLH + +++RDIK N++LD++ + KITD G+ K +DG A M+
Sbjct: 108 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--------ATMKTFC 156
Query: 397 GTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIH 436
GT Y APE GRA D + GVV+ E++ GR P +
Sbjct: 157 GTPEYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 59/211 (27%), Positives = 89/211 (42%), Gaps = 33/211 (15%)
Query: 302 LVFEFMPNGNLRDCLDGVLVEG--MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359
LV E G++ D + G L G M I A GL++LH + +HRD+K +
Sbjct: 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGN 153
Query: 360 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMS--- 416
NILL K+ D G++ +L + L +S GT + APE + L S
Sbjct: 154 NILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-----GTPFWMAPE-VIACEQQLDSTYD 207
Query: 417 ---DVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDF 473
DV+S G+ +EL G P + L+ PR P P L
Sbjct: 208 ARCDVWSLGITAIELGDGDPP----LADLHPMRALFKIPR----------NPPPTLHQ-- 251
Query: 474 PKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
P+ ++CL D + RPT+S+++Q
Sbjct: 252 PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 68/243 (27%), Positives = 110/243 (45%), Gaps = 33/243 (13%)
Query: 231 IVGQGGSSYVYRGQLTDG----RIVAVKRFKTQG-GPNADSVFLT--EVDMLSRLHHCHV 283
++G+GG V++ + G +I A+K K N T E ++L + H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGLE 341
V L+ Y + GK L+ E++ G L L+ G+ +E DT + LE
Sbjct: 63 VDLI-YAFQTGGKL---YLILEYLSGGELFMHLEREGIFME----DTACFYLSEISLALE 114
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
+LH+ I++RD+K NILLD + K+TD G+ K +G + GT Y
Sbjct: 115 HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-----TVTHTFCGTIEY 166
Query: 402 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI---HR-----SITKGEESLVLWATPR 453
APE M D +S G ++ +++TG P +R I KG+ +L + TP
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPE 226
Query: 454 LQD 456
+D
Sbjct: 227 ARD 229
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 25/168 (14%)
Query: 271 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMN--W 326
E +L + H ++ L + +E +R + +L E++P G L L G +
Sbjct: 51 EKRVLKEVSHPFIIRL--FWTE-HDQRFLYML-MEYVPGGELFSYLRNSGRFSNSTGLFY 106
Query: 327 DTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 386
+ + A+ EYLH + I++RD+K NILLD+ + K+TD G AK+L+
Sbjct: 107 ASEIVCAL------EYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT 157
Query: 387 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
C GT Y APE + D ++ G+++ E++ G P
Sbjct: 158 LC--------GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 76/284 (26%), Positives = 127/284 (44%), Gaps = 38/284 (13%)
Query: 233 GQGGSSYVYRGQ--LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
G+G + VY+G+ LT ++VA+K + + A + E +L L H ++V L
Sbjct: 14 GEGSYATVYKGRSKLTG-QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTL---- 68
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 350
+ + LVFE++ + +L+ +D G++ RGL Y H+ R
Sbjct: 69 HDIIHTKKTLTLVFEYL-DTDLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQR---R 123
Query: 351 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG 410
+LHRD+K N+L+ E K+ D G+A +A +PS + S + T Y P+ +
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLA---RAKSVPSKTYSNEVV--TLWYRPPDVLLGS 178
Query: 411 RA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESL-----VLWATPRLQDSGTVISEL 464
S D++ G + E+ TGR P+ T E+ L VL TP +++ +S
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATGR-PLFPGSTDVEDQLHKIFRVL-GTPT-EETWPGVSSN 235
Query: 465 PD----------PR-LKGDFPKEEMQIMAY-LAKECLQLDPDAR 496
P+ PR L P+ + LA + LQ +P R
Sbjct: 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKR 279
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 65/240 (27%), Positives = 97/240 (40%), Gaps = 55/240 (22%)
Query: 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 365
FM G+ L EGM+ I GA RGL YLH+ +HR+IK+S+IL+
Sbjct: 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY---IHRNIKASHILISG 136
Query: 366 NLNAKITDLGMAKRLKADG--------LPSCSSSPARMQGTFGYFAPEYAM--VGRASLM 415
+ ++ L L +G P S+S + +PE + ++
Sbjct: 137 DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTS------VLPWLSPELLRQDLYGYNVK 190
Query: 416 SDVFSFGVVLLELITGRQP---IHRSIT-----KGEESLVLWAT------PRLQ------ 455
SD++S G+ EL TGR P + R+ KG L T R++
Sbjct: 191 SDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGV 250
Query: 456 DSG------------TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 503
DSG T+ SE RL+ K L + CLQ DP+ RP+ S ++
Sbjct: 251 DSGIGESVVAAGMTQTMTSE----RLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 49/194 (25%), Positives = 73/194 (37%), Gaps = 40/194 (20%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
GL YLH A RI+HRD+K+ NI +++ I DLG A+ P + + + G
Sbjct: 168 EGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ------FPVVAPAFLGLAG 218
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457
T APE + + +D++S G+VL E++ I E V L
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLK- 277
Query: 458 GTVISEL----------PDPRLKGDF---------PKEEMQIMA---------YLAKECL 489
+IS L P RL F P +L + L
Sbjct: 278 --IISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKML 335
Query: 490 QLDPDARPTMSEVV 503
D RP+ E++
Sbjct: 336 TFDAAMRPSAEEIL 349
|
Length = 357 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 51/173 (29%), Positives = 85/173 (49%), Gaps = 26/173 (15%)
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
A+G+++L A+ +HRD+ + N+LL + AKI D G+A+ + D AR+
Sbjct: 222 AQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS-NYVVKGNARL- 276
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQ 455
+ APE ++ SDV+S+G++L E+ + G+ P + I LV ++
Sbjct: 277 -PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP-YPGI------LVNSKFYKMV 328
Query: 456 DSGTVISELPDPRLKGDF-PKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507
G +S + DF P E IM K C L+P RPT S++ Q++
Sbjct: 329 KRGYQMS-------RPDFAPPEIYSIM----KMCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 52/183 (28%), Positives = 80/183 (43%), Gaps = 32/183 (17%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
RGL+Y+H A I+HRD+K SN+ ++E+ KI D G+A+ + M G
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH-----------TDDEMTG 176
Query: 398 ---TFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQ--PIHRSITKGEESLVLWAT 451
T Y APE + + D++S G ++ EL+TGR P I + + L L T
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236
Query: 452 PRL--------QDSGTVISELPD-PRLKGD--FPKEEMQIMAYLAKECLQLDPDARPTMS 500
P + + I L P++ F + L K L LD D R T +
Sbjct: 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK-MLVLDSDKRITAA 295
Query: 501 EVV 503
+ +
Sbjct: 296 QAL 298
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 14/101 (13%)
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
A GL +LH I++RD+K N++LD + KI D GM K DG+ +
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-----TTKTFC 162
Query: 397 GTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP 434
GT Y APE Y G++ D ++FGV+L E++ G+ P
Sbjct: 163 GTPDYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 61/251 (24%), Positives = 108/251 (43%), Gaps = 42/251 (16%)
Query: 232 VGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G+G + VY+G +G++VA+K + + E +L L H ++V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLL---- 68
Query: 291 SEFRGKRAMRLLVFEFMPN----------GNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 340
+ + VFE+M G L + R+ + RGL
Sbjct: 69 HDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPY-----------NVRLFM-FQLLRGL 116
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
Y+H ILHRD+K N+L+ K+ D G+A +A +PS + S + T
Sbjct: 117 AYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLA---RAKSIPSQTYSSEVV--TLW 168
Query: 401 YFAPEYAMVGRASLMS--DVFSFGVVLLELITGRQPIHRSITKGEESLV-LWATPRL--Q 455
Y P+ ++G S D++ G + +E++ G QP ++ E L +W + +
Sbjct: 169 YRPPD-VLLGATDYSSALDIWGAGCIFIEMLQG-QPAFPGVSDVFEQLEKIWTVLGVPTE 226
Query: 456 DSGTVISELPD 466
D+ +S+LP+
Sbjct: 227 DTWPGVSKLPN 237
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 57/193 (29%), Positives = 91/193 (47%), Gaps = 50/193 (25%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
GL+Y+H A I+HRD+K N+ ++E+ KI D G+A+ + A M G
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----------HADAEMTG 173
Query: 398 ---TFGYFAPEYAMVGRASLMS-----DVFSFGVVLLELITGRQPIHRSITKGEESL--- 446
T Y APE + + M D++S G ++ E++TG +++ KG++ L
Sbjct: 174 YVVTRWYRAPEVIL----NWMHYNQTVDIWSVGCIMAEMLTG-----KTLFKGKDYLDQL 224
Query: 447 --VLWAT--------PRLQD--SGTVISELPD-PR--LKGDFPKEEMQIMAYLAKECLQL 491
+L T +L+D + + I LP PR FPK Q + L K L+L
Sbjct: 225 TQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEK-MLEL 283
Query: 492 DPDARPTMSEVVQ 504
D D R T +E ++
Sbjct: 284 DVDKRLTATEALE 296
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 47/212 (22%), Positives = 90/212 (42%), Gaps = 36/212 (16%)
Query: 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 366
+ +++ L EG+ ++ ARG+E+L A+ +HRD+ + N+LL +
Sbjct: 217 SNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQG 273
Query: 367 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTF---GYFAPEYAMVGRASLMSDVFSFGV 423
KI D G+A+ + D S+ TF + APE + +SDV+S+G+
Sbjct: 274 KIVKICDFGLARDIMHD------SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 424 VLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDF----PKEEMQ 479
+L E+ + L TP G ++ ++K + P Q
Sbjct: 328 LLWEIFS-----------------LGGTPY---PGMIVDSTFYNKIKSGYRMAKPDHATQ 367
Query: 480 IMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511
+ + +C +P+ RP+ + I+ ++ P
Sbjct: 368 EVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 46/162 (28%), Positives = 70/162 (43%), Gaps = 21/162 (12%)
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
L E + +++HRD+KS+NI L K+ D G +K+ +SS GT Y
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS---FCGTPYYL 238
Query: 403 APEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462
APE R S +D++S GV+L EL+T +HR + ++ V+
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLT----LHRPFKGPSQREIM---------QQVLY 285
Query: 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
DP FP M L L +P RPT +++
Sbjct: 286 GKYDP-----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322
|
Length = 478 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 39/103 (37%), Positives = 53/103 (51%), Gaps = 15/103 (14%)
Query: 350 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY--A 407
+HRDIK N+LLD+N + ++ D G RL ADG + S+ A GT Y +PE A
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQSNVA--VGTPDYISPEILQA 177
Query: 408 M---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 447
M GR D +S GV + E++ G P + ESLV
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYGETPFY------AESLV 214
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 48/167 (28%), Positives = 83/167 (49%), Gaps = 26/167 (15%)
Query: 271 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLV---EGM 324
EV +LS + H ++V Y F + +V ++ G+L ++ GVL + +
Sbjct: 49 EVAVLSNMKHPNIVQ---YQESFE-ENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQIL 104
Query: 325 NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384
+W ++ +A L+++H+ +ILHRDIKS NI L ++ K+ D G+A+ L +
Sbjct: 105 DWFVQICLA------LKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-- 153
Query: 385 LPSCSSSPARM-QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 430
+ AR GT Y +PE + SD+++ G VL E+ T
Sbjct: 154 ----TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 55/234 (23%), Positives = 90/234 (38%), Gaps = 48/234 (20%)
Query: 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADS-------------VFLTEVDML 275
+G+G V + T G+IVA+K+ K N + L E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 276 SRLHHCHVVPLVG-YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--- 331
+ + H +++ LV Y LV + M +L+ +D R+
Sbjct: 75 NEIKHENIMGLVDVYVEG-----DFINLVMDIM-ASDLKKVVDR--------KIRLTESQ 120
Query: 332 ---IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 388
I + GL LH+ +HRD+ +NI ++ KI D G+A+R
Sbjct: 121 VKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177
Query: 389 SSSPARMQG---------TFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGR 432
S MQ T Y APE M + D++S G + EL+TG+
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 48/180 (26%), Positives = 76/180 (42%), Gaps = 42/180 (23%)
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
A+G+ +L A+ +HRD+ + NILL KI D G+A+ ++ D AR+
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS-NYVVKGNARL- 278
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP---------IHRSITKGEESL 446
+ APE + SDV+S+G++L E+ + G P ++ I +G L
Sbjct: 279 -PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML 337
Query: 447 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
+P P E IM K C DP RPT ++VQ++
Sbjct: 338 ----SPECA------------------PSEMYDIM----KSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 47/181 (25%), Positives = 77/181 (42%), Gaps = 25/181 (13%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
R L+Y+H A + HRD+K NIL + + KI D G+A+ D + +
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD--YVA 168
Query: 398 TFGYFAPEY--AMVGRASLMSDVFSFGVVLLELITGRQPIH--RSITKGEESLV-LWATP 452
T Y APE + + + D++S G + E++TG+ P+ +++ + + L TP
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLITDLLGTP 227
Query: 453 RLQDSGTVISE------------LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 500
+ V +E P P FP + + L + L DP RPT
Sbjct: 228 SPETISRVRNEKARRYLSSMRKKQPVP-FSQKFPNADPLALRLLER-LLAFDPKDRPTAE 285
Query: 501 E 501
E
Sbjct: 286 E 286
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 37/110 (33%), Positives = 54/110 (49%), Gaps = 15/110 (13%)
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
+H +HRDIK N+LLD N + ++ D G ++ DG + SS A GT Y
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--TVQSSVA--VGTPDYI 170
Query: 403 APEY--AM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 447
+PE AM +G+ D +S GV + E++ G P + ESLV
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY------AESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 69/270 (25%), Positives = 104/270 (38%), Gaps = 58/270 (21%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 280
D F ++G+G V Q D G I A+K + + V E D+L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMN-WDTRVAIAIGA 336
VV + F+ KR + L+ EF+P G++ L D + E + +AI A
Sbjct: 61 AWVVKMF---YSFQDKRNL-YLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDA 116
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK-----------ADGL 385
L ++H RDIK N+LLD + K++D G+ LK
Sbjct: 117 IHQLGFIH---------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNP 167
Query: 386 PSCSS-------------SPARMQ------GTFGYFAPEYAMVGRASLMSDVFSFGVVLL 426
PS S R Q GT Y APE M + + D +S GV++
Sbjct: 168 PSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 427 ELITGRQPI--------HRSITKGEESLVL 448
E++ G P +R + +E+LV
Sbjct: 228 EMLIGYPPFCSETPQETYRKVMNWKETLVF 257
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 9e-07
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 8/95 (8%)
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
L +LH+ I++RD+K N+LLD + K+ D GM K +G + + GT
Sbjct: 109 LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT-----STFCGTP 160
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
Y APE D ++ GV+L E++ G P
Sbjct: 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 51/208 (24%), Positives = 77/208 (37%), Gaps = 64/208 (30%)
Query: 271 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT-- 328
E D+L+ + VV L Y S F+ + + L+ E++P G++ L M DT
Sbjct: 51 ERDILAEADNPWVVKL--YYS-FQDENYL-YLIMEYLPGGDMMTLL-------MKKDTFT 99
Query: 329 ---------RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379
+AI + L Y+H RDIK N+LLD + K++D G+
Sbjct: 100 EEETRFYIAETILAIDSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCTG 150
Query: 380 LKADG---------------LPSCSSSP------------ARMQ------GTFGYFAPEY 406
LK S P R GT Y APE
Sbjct: 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEV 210
Query: 407 AMVGRASLMSDVFSFGVVLLELITGRQP 434
+ + D +S GV++ E++ G P
Sbjct: 211 FLQTGYNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 40/131 (30%), Positives = 57/131 (43%), Gaps = 22/131 (16%)
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
LE+LH+ I++RDIK NILLD + +TD G++K L GT
Sbjct: 118 LEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEF----LSEEKERTYSFCGTI 170
Query: 400 GYFAPEY--AMVGRASLMSDVFSFGVVLLELITGRQP------------IHRSITKGEES 445
Y APE G + D +S G+++ EL+TG P + R I K +
Sbjct: 171 EYMAPEIIRGKGGHGKAV-DWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP 229
Query: 446 LVLWATPRLQD 456
+ P QD
Sbjct: 230 FPSFIGPEAQD 240
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 55/233 (23%), Positives = 89/233 (38%), Gaps = 52/233 (22%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
VG+G +VY+ + DG+ K G E+ +L L H +V+ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 292 EFRGKRAMRLLVFEF-----------------------MPNGNLRDCLDGVLVEGMNWDT 328
++ L+F++ +P G ++ L +L
Sbjct: 69 SHADRKVW--LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL-------- 118
Query: 329 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADG 384
G+ YLH A +LHRD+K +NIL+ E KI D+G A+ +
Sbjct: 119 ---------DGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166
Query: 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPIH 436
P P + TF Y APE + R + D+++ G + EL+T H
Sbjct: 167 KPLADLDPVVV--TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 40/123 (32%), Positives = 56/123 (45%), Gaps = 24/123 (19%)
Query: 330 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 389
+ IAI + L Y+H RDIK NIL+D N + ++ D G +L DG +
Sbjct: 111 MVIAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQ 159
Query: 390 SSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE 444
SS A GT Y +PE G+ D +S GV + E++ G P + E
Sbjct: 160 SSVA--VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY------AE 211
Query: 445 SLV 447
SLV
Sbjct: 212 SLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 71/316 (22%), Positives = 116/316 (36%), Gaps = 89/316 (28%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYC 290
G+G S V + Q G+ A+K K L E+ L RL H +++ L+
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVL 67
Query: 291 SEFRGKRAMRL-LVFEFMPNGNL-------RDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
+ ++ RL LVFE M + NL + L V+ + + L++
Sbjct: 68 FD---RKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQL--------LKSLDH 115
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP-ARMQGTFGY 401
+H I HRDIK NIL+ +++ K+ D G + + S P T Y
Sbjct: 116 MHRNG---IFHRDIKPENILIKDDI-LKLADFGSCRGI-------YSKPPYTEYISTRWY 164
Query: 402 FAPE---------YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 452
APE M D+++ G V E+++ P+ G L
Sbjct: 165 RAPECLLTDGYYGPKM--------DIWAVGCVFFEILS-LFPLF----PGTNEL------ 205
Query: 453 RLQDSGTVISEL---PDPRLKG----------DFPKEEMQIMAYL----AKECLQL---- 491
D I ++ PD + +FP ++ + L + E L L
Sbjct: 206 ---DQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKL 262
Query: 492 ---DPDARPTMSEVVQ 504
DPD R T + ++
Sbjct: 263 LAYDPDERITAKQALR 278
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 34/197 (17%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
G+ YLH A +LHRD+K +NIL+ E KI D+G A+ + P P
Sbjct: 120 GIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 395 MQGTFGYFAPEYAMVGRASLMS-DVFSFGVVLLELITG------RQ-------PIHRSIT 440
+ TF Y APE + R + D+++ G + EL+T RQ P H
Sbjct: 177 V--TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHD-- 232
Query: 441 KGEESLVLWATPRLQDSGTVISELPD-PRLKGDFPKE---EMQIMAYLAKECLQLDPDAR 496
+ + + P +D I ++P+ P L+ DF + ++ Y+ K ++ PD++
Sbjct: 233 QLDRIFSVMGFPADKDWED-IRKMPEYPTLQKDFRRTTYANSSLIKYMEKH--KVKPDSK 289
Query: 497 PTMSEVVQILSTIAPDK 513
+ ++Q L T+ P K
Sbjct: 290 VFL--LLQKLLTMDPTK 304
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 15/101 (14%)
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK-RLKADGLPS--CSSSPARMQ 396
LE+LH+ I++RD+K NILLD + + D G++K L + + C
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC-------- 157
Query: 397 GTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIH 436
GT Y APE + + + D +S GV++ E+ G P +
Sbjct: 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY 198
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 56/192 (29%), Positives = 84/192 (43%), Gaps = 27/192 (14%)
Query: 251 VAVKRF---KTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 307
VA+KRF K D VF +E +L+ ++H V L G F+ + + LV EF+
Sbjct: 59 VAIKRFEKSKIIKQKQVDHVF-SERKILNYINHPFCVNLYG---SFKDESYL-YLVLEFV 113
Query: 308 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL--EYLHEAAAPRILHRDIKSSNILLDE 365
G L + V A L EYL I++RD+K N+LLD+
Sbjct: 114 IGGEFFT----FLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDK 166
Query: 366 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVV 424
+ K+TD G AK + C GT Y APE + VG +D ++ G+
Sbjct: 167 DGFIKMTDFGFAKVVDTRTYTLC--------GTPEYIAPEILLNVGHGK-AADWWTLGIF 217
Query: 425 LLELITGRQPIH 436
+ E++ G P +
Sbjct: 218 IYEILVGCPPFY 229
|
Length = 340 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 18/99 (18%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
RGL+Y+H A I+HRD+K SN+ ++E+ +I D G+A++ + M G
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-----------ADDEMTG 174
Query: 398 ---TFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGR 432
T Y APE + + D++S G ++ EL+ G+
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
L +LH +++RD+K NILLD + K+ D GM K +G+ + + GT
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT-----FCGTP 160
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
Y APE D ++ GV++ E++ G+ P
Sbjct: 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 34/108 (31%), Positives = 45/108 (41%), Gaps = 35/108 (32%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLN-AKITDLGMAKRLKADGLPSCSSSPARMQG 397
L LH+ I+H DIK N+L D + + D G+ K + G PSC G
Sbjct: 121 ALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKII---GTPSC------YDG 168
Query: 398 TFGYFAPE------YAMVGRASLMSDVFSF-----GVVLLELITGRQP 434
T YF+PE Y SF GV+ EL+TG+ P
Sbjct: 169 TLDYFSPEKIKGHNYD-----------VSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 11/99 (11%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
RGL+Y+H A +LHRD+K +N+ ++ E+L KI D G+A+ + P S +
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVD----PHYSHKGYLSE 177
Query: 397 G--TFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGR 432
G T Y +P + + D+++ G + E++TG+
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 30/97 (30%), Positives = 46/97 (47%), Gaps = 8/97 (8%)
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
LE LH+ +++RD+K NILLD + + D G+ K D GT
Sbjct: 106 LENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-----DDKTNTFCGTP 157
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
Y APE + + D ++ GV+L E++TG P +
Sbjct: 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY 194
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 31/96 (32%), Positives = 46/96 (47%), Gaps = 8/96 (8%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
GL+YLHE +I++RD+K N+LLD KI D G+ K G + GT
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-----DRTSTFCGT 164
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
+ APE + D + GV++ E++ G P
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 34/107 (31%), Positives = 50/107 (46%), Gaps = 14/107 (13%)
Query: 330 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 389
+A A+G YLH I++RD+K NILLD + +TD G+ K +G+ S
Sbjct: 105 IASALG------YLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK----EGIEH-S 150
Query: 390 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
+ + GT Y APE D + G VL E++ G P +
Sbjct: 151 KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 33/100 (33%), Positives = 47/100 (47%), Gaps = 8/100 (8%)
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
A L YLH I++RD+K NILLD + +TD G+ K +G+ + S +
Sbjct: 106 ASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCK----EGI-AQSDTTTTFC 157
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
GT Y APE D + G VL E++ G P +
Sbjct: 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 48/227 (21%)
Query: 233 GQGGSSYVYRGQLTDGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
G G+ Y+ R + T R A+K+ Q VF+ E D+L+ + VV + +
Sbjct: 12 GAYGAVYLVRHKETRQRF-AMKKINKQNLILRNQIQQVFV-ERDILTFAENPFVVSM--F 67
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR--------GLE 341
CS F KR + +V E++ G DC L++ + A+ + AR LE
Sbjct: 68 CS-FETKRHL-CMVMEYVEGG---DC--ATLLKNIG-----ALPVDMARMYFAETVLALE 115
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS----------- 390
YLH I+HRD+K N+L+ + K+TD G++K GL S ++
Sbjct: 116 YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI----GLMSLTTNLYEGHIEKDT 168
Query: 391 ---SPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
++ GT Y APE + D ++ G++L E + G P
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 64/246 (26%), Positives = 99/246 (40%), Gaps = 46/246 (18%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 280
+ F ++G+G V Q D G + A+K + + V E D+L
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAAR 338
VV + F+ K + L+ EF+P G++ L L E +T+ IA
Sbjct: 61 LWVVKMF---YSFQDKLNL-YLIMEFLPGGDMMTLLMKKDTLTEE---ETQFYIA-ETVL 112
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA-----------DGLPS 387
++ +H+ +HRDIK N+LLD + K++D G+ LK LPS
Sbjct: 113 AIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 388 -------CSSSPA------RMQ------GTFGYFAPEYAMVGRASLMSDVFSFGVVLLEL 428
S A R Q GT Y APE M + + D +S GV++ E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 429 ITGRQP 434
+ G P
Sbjct: 230 LIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 62/219 (28%), Positives = 94/219 (42%), Gaps = 40/219 (18%)
Query: 230 NIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
NI+G G VY D VA+K K P + E+ ++ L+H +++ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIK--KVLQDPQYKN---RELLIMKNLNHINIIFLKD 126
Query: 289 Y----CSEFRGKRAMRLLVFEFMPN---------GNLRDCLDGVLVEGMNWDTRVAIAIG 335
Y C + K +V EF+P L LV+ ++
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL------- 179
Query: 336 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-KITDLGMAKRLKADGLPSCSSSPAR 394
R L Y+H + I HRD+K N+L+D N + K+ D G AK L A G S S +R
Sbjct: 180 -CRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA-GQRSVSYICSR 234
Query: 395 MQGTFGYFAPEYAMVGRASLMS--DVFSFGVVLLELITG 431
Y APE M+G + + D++S G ++ E+I G
Sbjct: 235 F-----YRAPEL-MLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 50/203 (24%), Positives = 84/203 (41%), Gaps = 34/203 (16%)
Query: 248 GRIVAVKRFKTQGGPNADSVFL-TEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 306
G V V+R + N FL E+ + +H ++VP Y + F + +V F
Sbjct: 25 GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVP---YRATFIADNEL-WVVTSF 80
Query: 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-- 364
M G+ +D + ++GM+ I G + L+Y+H +HR +K+S+IL+
Sbjct: 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVD 137
Query: 365 -----ENLNAKITDLGMAKRLKA-DGLPSCSS------SPARMQGTF-GYFAPEYAMVGR 411
L + ++ + +RL+ P S SP +Q GY A
Sbjct: 138 GKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK------- 190
Query: 412 ASLMSDVFSFGVVLLELITGRQP 434
SD++S G+ EL G P
Sbjct: 191 ----SDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 9/94 (9%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
G+++LH A I+HRD+K SNI++ + KI D G+A R +P + T
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTSF---MMTPYVV--T 180
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 432
Y APE + D++S G ++ E+I G
Sbjct: 181 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 41/174 (23%), Positives = 67/174 (38%), Gaps = 47/174 (27%)
Query: 303 VFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 360
V +++P G++ L G+ E + R IA +E +H+ +HRDIK N
Sbjct: 79 VMDYIPGGDMMSLLIRLGIFEEDL---ARFYIA-ELTCAIESVHKMG---FIHRDIKPDN 131
Query: 361 ILLDENLNAKITDLGMAKRLK------------------------ADGLPSCSSSP---- 392
IL+D + + K+TD G+ + + C P
Sbjct: 132 ILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERR 191
Query: 393 -ARMQ---------GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
R GT Y APE + + + D +S GV+L E++ G+ P
Sbjct: 192 RKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFL 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 37/108 (34%), Positives = 52/108 (48%), Gaps = 16/108 (14%)
Query: 330 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL-PSC 388
VA AIG YLH + I++RD+K NILLD + +TD G+ K +G+ P
Sbjct: 105 VASAIG------YLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK----EGVEPEE 151
Query: 389 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
++S GT Y APE D + G VL E++ G P +
Sbjct: 152 TTST--FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 33/101 (32%), Positives = 46/101 (45%), Gaps = 10/101 (9%)
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR-LKADGLPSCSSSPARM 395
A L YLH I++RD+K NILLD + +TD G+ K ++ +G S
Sbjct: 106 ASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST------F 156
Query: 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
GT Y APE D + G VL E++ G P +
Sbjct: 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 35/132 (26%), Positives = 60/132 (45%), Gaps = 22/132 (16%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
G+++LH A I+HRD+K SNI++ + KI D G+A+ + + +P + T
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM----MTPYVV--T 185
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458
Y APE + D++S G ++ EL+ G S++ T +
Sbjct: 186 RYYRAPEVILGMGYKENVDIWSVGCIMGELVKG-------------SVIFQGTDHIDQWN 232
Query: 459 TVISELPDPRLK 470
VI +L P +
Sbjct: 233 KVIEQLGTPSAE 244
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 30/137 (21%), Positives = 55/137 (40%), Gaps = 17/137 (12%)
Query: 231 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGY 289
++ G ++ VY D V +K ++ + EV +L L + VP V
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYV-LKINPSR---EKGADREREVAILQLLARKGLPVPKVLA 60
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 349
E G L+ E+ ++G ++ ++ + + IA A L LH+
Sbjct: 61 SGESDGWSY---LLMEW---------IEGETLDEVSEEEKEDIAEQLAELLAKLHQLPLL 108
Query: 350 RILHRDIKSSNILLDEN 366
+ H D+ NIL+D+
Sbjct: 109 VLCHGDLHPGNILVDDG 125
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 50/200 (25%), Positives = 75/200 (37%), Gaps = 51/200 (25%)
Query: 269 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGM 324
LTE ++L+ L H + L Y S F+ + + LV ++ P G L L L E
Sbjct: 49 LTEQEILATLDHPFLPTL--YAS-FQTETYL-CLVMDYCPGGELFRLLQRQPGKCLSE-- 102
Query: 325 NWDTRVAIAIGAAR---GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD------LG 375
AA LEYLH I++RD+K NILL E+ + ++D
Sbjct: 103 -----EVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154
Query: 376 MAKRLKADGLPSCSSSPARMQ------------------GTFGYFAPEYAMVGRASLMS- 416
+ + L S + GT Y APE V
Sbjct: 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE---VISGDGHGS 211
Query: 417 --DVFSFGVVLLELITGRQP 434
D ++ G++L E++ G P
Sbjct: 212 AVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 71/298 (23%), Positives = 113/298 (37%), Gaps = 65/298 (21%)
Query: 233 GQGGSSYVYRGQL---TDGRIVA-------VKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
GQG + +Y+G L +D IV V + ++ + F T ++S+L H H
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFET-ASLMSQLSHKH 62
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGMNWDTRVAIAIGAAR 338
+V L G C R ++V E++ G L L + V ++W ++ +A A
Sbjct: 63 LVKLYGVCV-----RDENIMVEEYVKFGPLDVFLHREKNNV---SLHW--KLDVAKQLAS 112
Query: 339 GLEYLHEAAAPRILHRDIKSSNILL-DENLN------AKITDLGMAKRLKADGLPSCSSS 391
L YL + +++H ++ NIL+ LN K++D G+P S
Sbjct: 113 ALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD---------PGIPITVLS 160
Query: 392 PARMQGTFGYFAPEYAMVGRASLMS--DVFSFGVVLLELITGRQPIHRSITKGEESLVLW 449
+ APE G+ASL D +SFG LLE I S E
Sbjct: 161 REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLE-ICSNGEEPLSTLSSSEKE--- 216
Query: 450 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507
R + L A L +C DP RP+ +++ L+
Sbjct: 217 ---RFYQDQHRLPMPDCAEL------------ANLINQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 8e-04
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 9/94 (9%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
G+++LH A I+HRD+K SNI++ + KI D G+A+ S +P + T
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMTPYVV--T 188
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 432
Y APE + D++S G ++ E+I G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 31/103 (30%), Positives = 47/103 (45%), Gaps = 7/103 (6%)
Query: 330 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 389
+AI R ++YLHE RI+HRDIK+ NI ++ + + D G A + +
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA----CFPVDINA 237
Query: 390 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 432
+ GT APE D++S G+VL E+ T
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 27/94 (28%), Positives = 43/94 (45%), Gaps = 13/94 (13%)
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP-ARMQGT 398
L+ LH I+ RD+ +NILLD+ + ++T ++ SC M
Sbjct: 98 LDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVE----DSCDGEAVENM--- 147
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 432
Y APE + + D +S G +L EL+TG+
Sbjct: 148 --YCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 25/82 (30%), Positives = 41/82 (50%), Gaps = 17/82 (20%)
Query: 302 LVFEFMPNGNLRDCLDGVLVEGMNWD------TRVAIAIGAARGLEYLHEAAAPRILHRD 355
L+ EF+P G+L L + +D TR +A +E +H+ +HRD
Sbjct: 78 LIMEFLPGGDLMTML-------IKYDTFSEDVTRFYMA-ECVLAIEAVHKLG---FIHRD 126
Query: 356 IKSSNILLDENLNAKITDLGMA 377
IK NIL+D + K++D G++
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 31/111 (27%), Positives = 54/111 (48%), Gaps = 14/111 (12%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
G+++LH A I+HRD+K SNI++ + KI D G+A+ S +P + T
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMTPYVV--T 181
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 449
Y APE + D++S G ++ E++ H+ + G + + W
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-----HKILFPGRDYIDQW 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 33/143 (23%), Positives = 55/143 (38%), Gaps = 43/143 (30%)
Query: 352 LHRDIKSSNILLDENLNAKITDLGMAKRLK------------------------------ 381
+HRDIK NIL+D + + K+TD G+ +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 382 ---ADGLPSCSSSPARMQ---------GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELI 429
D L AR GT Y APE + + + D +S GV+L E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 430 TGRQP-IHRSITKGEESLVLWAT 451
G+ P + ++ + + ++ W T
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQT 265
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 13/81 (16%)
Query: 302 LVFEFMPNGNLRDCLD--GVLVEGM--NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 357
LV E++ G+++ L G E M + + VA+A L+YLH I+HRD+K
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALA------LDYLHRHG---IIHRDLK 131
Query: 358 SSNILLDENLNAKITDLGMAK 378
N+L+ + K+TD G++K
Sbjct: 132 PDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 631 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.59 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.39 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.36 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.22 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.19 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.18 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.13 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.07 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.07 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.03 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.02 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.98 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.88 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.87 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.8 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.79 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.67 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.56 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.55 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.39 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.33 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.3 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.29 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.26 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.25 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.1 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.1 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.07 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.04 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.99 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.88 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.76 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.75 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.66 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.65 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.63 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.44 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.36 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.33 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.24 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.07 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.0 | |
| KOG1219 | 4289 | consensus Uncharacterized conserved protein, conta | 96.95 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.79 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.79 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.66 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.64 | |
| PLN02236 | 344 | choline kinase | 96.57 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.48 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.08 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.06 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.92 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.86 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.74 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.7 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.58 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.52 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.44 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.4 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 95.2 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.09 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.06 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.19 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.06 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-55 Score=461.71 Aligned_cols=289 Identities=53% Similarity=0.892 Sum_probs=253.0
Q ss_pred eeeeecHHHHHHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEE
Q 006785 210 TIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289 (631)
Q Consensus 210 ~~~~~s~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~ 289 (631)
....|+|.+|..||++|+..+.||+|+||.||+|.+.+|+.||||++....... ..+|.+|+.+|.+++|||+|+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 356799999999999999999999999999999999999999999988765543 4559999999999999999999999
Q ss_pred eeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCe
Q 006785 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 369 (631)
Q Consensus 290 ~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 369 (631)
|.+... .++||||||++|+|.++|+......++|..|++||.++|+||+|||+...|+||||||||+|||||+++++
T Consensus 140 C~e~~~---~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 140 CLEGGE---HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EecCCc---eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 997331 58999999999999999987543379999999999999999999999988899999999999999999999
Q ss_pred EEeccCceeeccc-CCCCCCCCCCccc-ccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhh
Q 006785 370 KITDLGMAKRLKA-DGLPSCSSSPARM-QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 447 (631)
Q Consensus 370 kL~DFGla~~~~~-~~~~~~~~~~~~~-~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~ 447 (631)
||+|||||+.... ... .... .||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+......+..++
T Consensus 217 KlsDFGLa~~~~~~~~~------~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~ 290 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTS------VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLV 290 (361)
T ss_pred EccCccCcccCCccccc------eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHH
Confidence 9999999966543 211 1111 7999999999999999999999999999999999999998876655666688
Q ss_pred hhcccccccccccccccCCCCCC-CCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 448 LWATPRLQDSGTVISELPDPRLK-GDFPK-EEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
.|..+.+.+. .+.++.|+.+. ..++. .....+..++.+|++.+|..||+|.||++.|..+.
T Consensus 291 ~w~~~~~~~~--~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 291 EWAKPLLEEG--KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHHHHHCc--chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 8987776665 68899999987 66664 57777999999999999999999999999996554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=409.42 Aligned_cols=258 Identities=33% Similarity=0.513 Sum_probs=210.3
Q ss_pred ccceeeeeCceEEEEEEECCCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEee
Q 006785 228 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 306 (631)
Q Consensus 228 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~ 306 (631)
..+.||+|+||+||+|.++....||||++..... ......|.+|+.+|.+++|||||+|+|+|.+... .+.+||||
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~---~~~iVtEy 121 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG---SLCIVTEY 121 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC---ceEEEEEe
Confidence 3556999999999999997544599999986532 2225579999999999999999999999987321 57999999
Q ss_pred CCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC-CeEEeccCceeecccCCC
Q 006785 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKRLKADGL 385 (631)
Q Consensus 307 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kL~DFGla~~~~~~~~ 385 (631)
+++|+|.++|.......+++..++.++.|||+||+|||+++. ||||||||+||||+.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999987545679999999999999999999999863 99999999999999997 99999999998765432
Q ss_pred CCCCCCCcccccCCCCCCchhhh--cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccc
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAM--VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 463 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~--~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (631)
.......||+.|||||++. ...|+.|+|||||||+||||+||+.||........ ...
T Consensus 199 ----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~-----------------~~~ 257 (362)
T KOG0192|consen 199 ----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV-----------------ASA 257 (362)
T ss_pred ----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH-----------------HHH
Confidence 1223367999999999999 56899999999999999999999999976544111 111
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 464 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 464 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
+.....+..+|..++..+..|+.+||+.||..||++.+|+..|+.+...
T Consensus 258 v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 258 VVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 1111222233444556688999999999999999999999999987543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=424.76 Aligned_cols=262 Identities=29% Similarity=0.452 Sum_probs=221.9
Q ss_pred cCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
.+....+.||+|.||.||+|+.. +.+.||||.++.....+...+|.+|+++|..|+|||||+|+|+|.+ +
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~----~ 561 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE----G 561 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc----C
Confidence 33444678999999999999854 2468999999998888788899999999999999999999999998 5
Q ss_pred ceEEEEEeeCCCCChHhhhhccc--------cCC----CCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVL--------VEG----MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 365 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~--------~~~----l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~ 365 (631)
+.++||+|||..|||.+||+... +.. |+..+.+.||.|||.||+||-++. +|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceecc
Confidence 67899999999999999996422 122 889999999999999999999998 999999999999999
Q ss_pred CCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccc
Q 006785 366 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEE 444 (631)
Q Consensus 366 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~ 444 (631)
+..|||+||||++.....++.... .+..-.++|||||.+..++||++||||||||+|||+++ |+.||++....+
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~---~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-- 713 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVR---GNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-- 713 (774)
T ss_pred ceEEEecccccchhhhhhhhhccc---CCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH--
Confidence 999999999999987766554321 12234689999999999999999999999999999999 999998765432
Q ss_pred hhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006785 445 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513 (631)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 513 (631)
++..+....+ ...|+.++..++.||..||+.+|.+||++.||-..|.......
T Consensus 714 ---------------VIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 714 ---------------VIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred ---------------HHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 2333333334 4678888888999999999999999999999999998775443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=406.47 Aligned_cols=256 Identities=30% Similarity=0.449 Sum_probs=213.1
Q ss_pred CccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~ 304 (631)
.+...+.||+|.||.||.|.++....||||.++.... ..+.|.+|+++|++|+|+|||+|+|+|.. ...+||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m--~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~----~~piyIVt 280 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM--SPEAFLREAQIMKKLRHEKLVKLYGVCTK----QEPIYIVT 280 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc--ChhHHHHHHHHHHhCcccCeEEEEEEEec----CCceEEEE
Confidence 3444678999999999999998888999999987532 33459999999999999999999999986 34689999
Q ss_pred eeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCC
Q 006785 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (631)
Q Consensus 305 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~ 384 (631)
|||+.|+|.+||+......+...+.+.++.|||.||+||++++ +|||||.++||||+++..+||+|||||+...++.
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 9999999999998756667999999999999999999999998 9999999999999999999999999999555443
Q ss_pred CCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccccccccc
Q 006785 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISE 463 (631)
Q Consensus 385 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (631)
+.. .....-...|+|||.+..+.++.|||||||||+||||+| |+.||....... +-+
T Consensus 358 Y~~----~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e------------------v~~ 415 (468)
T KOG0197|consen 358 YTA----SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE------------------VLE 415 (468)
T ss_pred eee----cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH------------------HHH
Confidence 321 122234578999999999999999999999999999999 889986543221 111
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 464 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 464 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
.+....+.+.|..++..+.+||..||+.+|++|||+..+...|+.+..
T Consensus 416 ~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 416 LLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred HHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 222223334566677779999999999999999999999999887753
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=376.68 Aligned_cols=255 Identities=30% Similarity=0.426 Sum_probs=212.2
Q ss_pred ecHHHHHHHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeee
Q 006785 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 292 (631)
Q Consensus 214 ~s~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 292 (631)
+++.+|+. .+.||+|..|+|||+.++ +++.+|+|.+.....+...+++.+|++++++.+||+||.++|.|..
T Consensus 76 i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 45555554 678999999999999987 4899999999777667777889999999999999999999999986
Q ss_pred ccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHh-cCCCceeecCCCCCCeeecCCCCeEE
Q 006785 293 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKI 371 (631)
Q Consensus 293 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlKp~NILl~~~~~~kL 371 (631)
.. . ...|+||||++|||.+++... +.+++...-.|+.+|++||.|||+ ++ ||||||||+||||+..|++||
T Consensus 149 ~~--~-~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKi 220 (364)
T KOG0581|consen 149 NG--E-EISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKI 220 (364)
T ss_pred CC--c-eEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEe
Confidence 22 1 589999999999999999864 569999999999999999999996 66 999999999999999999999
Q ss_pred eccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcc
Q 006785 372 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 451 (631)
Q Consensus 372 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~ 451 (631)
+|||.++.+... ....++||..|||||.+.+..|+.++||||||++++|+.+|+.||..........+
T Consensus 221 cDFGVS~~lvnS-------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~----- 288 (364)
T KOG0581|consen 221 CDFGVSGILVNS-------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIF----- 288 (364)
T ss_pred ccccccHHhhhh-------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHH-----
Confidence 999999887643 34567899999999999999999999999999999999999999965411111100
Q ss_pred cccccccccccccC---CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 452 PRLQDSGTVISELP---DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 452 ~~~~~~~~~~~~~~---~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..+..+. .|.+... .++.+++.++..||++||.+||++.|+++.
T Consensus 289 -------~Ll~~Iv~~ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 289 -------ELLCAIVDEPPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -------HHHHHHhcCCCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1122222 2333322 255669999999999999999999999874
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=374.80 Aligned_cols=275 Identities=27% Similarity=0.422 Sum_probs=214.8
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc--CCCCCcceeEEeeeccCC
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL--HHCHVVPLVGYCSEFRGK 296 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~g~~~~~~~~ 296 (631)
.....++....+.||+|.||.||+|.|+ |+.||||++..... ..|.+|.+|.+.+ +|+||+.|++.-....+.
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE----~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE----RSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch----hhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 3445566777899999999999999996 88999999976532 3377888887754 999999999988777777
Q ss_pred cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHh-----cCCCceeecCCCCCCeeecCCCCeEE
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-----AAAPRILHRDIKSSNILLDENLNAKI 371 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivHrDlKp~NILl~~~~~~kL 371 (631)
-.++|||++|.+.|||.|||.+ ..++....++++..+|.||+|||- +|.|.|.|||||+.|||+..++.+.|
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 7899999999999999999987 458999999999999999999995 67789999999999999999999999
Q ss_pred eccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCC------CCcccchhhHHHHHHHHHhC----------CCCC
Q 006785 372 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR------ASLMSDVFSFGVVLLELITG----------RQPI 435 (631)
Q Consensus 372 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~------~s~ksDVwSlGviL~eLltG----------~~P~ 435 (631)
+|+|||-....+.. ...-.....+||.+|||||++...- .-..+||||||.|+||+..+ ++||
T Consensus 358 ADLGLAv~h~~~t~-~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTD-TIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred eeceeeEEecccCC-cccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 99999987765431 1122345568999999999986432 23468999999999999863 5777
Q ss_pred CCccccccchhhhhcccccccccccc-cccCCCCCCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 436 HRSITKGEESLVLWATPRLQDSGTVI-SELPDPRLKGD-FPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
+...+.. |.+.+..+++ .+-.+|.+... ...+....|.+||+.||..+|..|.|+-.|.+.|.++..
T Consensus 437 yd~Vp~D---------Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 437 YDVVPSD---------PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ccCCCCC---------CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 6544332 1122211111 11112222222 234667789999999999999999999999999998864
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=375.25 Aligned_cols=202 Identities=28% Similarity=0.466 Sum_probs=180.0
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
..+|...+.||+|+||+||+|+++. +..||||.+.... .++..+.+..|+.+|+.|+|||||+|++++.. ++.+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~----~~~i 84 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED----DDFI 84 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec----CCeE
Confidence 3567778889999999999999864 8999999998764 45556668999999999999999999999886 6689
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCC------CCeEEecc
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN------LNAKITDL 374 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~------~~~kL~DF 374 (631)
|||||||.||||.+||+.. +.+++.++..++.|+|.||++||+++ ||||||||.||||+.. -.+||+||
T Consensus 85 ~lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred EEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 9999999999999999875 46999999999999999999999999 9999999999999764 45899999
Q ss_pred CceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCcc
Q 006785 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (631)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~ 439 (631)
|+|+.+.... ...+..|++.|||||++...+|+.|+|+||+|+|||++++|+.||+...
T Consensus 160 GfAR~L~~~~------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 160 GFARFLQPGS------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred chhhhCCchh------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 9999887542 3456789999999999999999999999999999999999999997544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=387.87 Aligned_cols=249 Identities=27% Similarity=0.458 Sum_probs=212.9
Q ss_pred cCccccceeeeeCceEEEEEEE-CCCcEEEEEEeccC--CCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQ--GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
..|...+.||+|||..||.++. ..|+.||+|++... ..+...+...+||+|.+.|+|||||+++++|.+ ..+.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED----s~nV 93 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED----SNNV 93 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec----CCce
Confidence 4577789999999999999998 67999999999764 233455668999999999999999999999987 6788
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|||.|+|.+++|..+++++ +.+++.++..+..||+.||.|||+.+ |+|||||..|+||+++.++||+|||||..+
T Consensus 94 YivLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l 168 (592)
T KOG0575|consen 94 YIVLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQL 168 (592)
T ss_pred EEEEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeee
Confidence 9999999999999999843 67999999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
..++ ....+..|||.|.|||++.....+..+||||+|||+|-||.|++||+.....+-...+
T Consensus 169 e~~~-----Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I------------- 230 (592)
T KOG0575|consen 169 EYDG-----ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI------------- 230 (592)
T ss_pred cCcc-----cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH-------------
Confidence 7653 4556789999999999999999999999999999999999999999765333221111
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.... -.+|...+....+||..+|+.||.+|||+.+|+..
T Consensus 231 ----k~~~--Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 231 ----KLNE--YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ----HhcC--cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1000 12344555668899999999999999999999963
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-46 Score=372.66 Aligned_cols=255 Identities=25% Similarity=0.317 Sum_probs=204.4
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC------hHHHHHHHHHHHHhcCCCCCcceeEEeeecc
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN------ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 294 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 294 (631)
..+.|.+.+.||+|+||.|-+|..+ +|+.||||+++...... ......+|+++|++|+|||||++++++..
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-- 247 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-- 247 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec--
Confidence 4567778899999999999999865 59999999998653222 12225799999999999999999999986
Q ss_pred CCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCC---CCeEE
Q 006785 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN---LNAKI 371 (631)
Q Consensus 295 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~---~~~kL 371 (631)
....||||||++||+|.+++-++ +.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||
T Consensus 248 --~ds~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 248 --PDSSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred --CCceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEe
Confidence 55679999999999999999654 44777778899999999999999999 9999999999999766 67999
Q ss_pred eccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCC---CCcccchhhHHHHHHHHHhCCCCCCCccccccchhhh
Q 006785 372 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 448 (631)
Q Consensus 372 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~---~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~ 448 (631)
+|||||+..... ....++.||+.|.|||++.... +..++|+||+||+||-+++|.+||........ +
T Consensus 321 tDFGlAK~~g~~------sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l-- 390 (475)
T KOG0615|consen 321 TDFGLAKVSGEG------SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--L-- 390 (475)
T ss_pred cccchhhccccc------eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--H--
Confidence 999999987643 3566789999999999998654 34588999999999999999999975433220 0
Q ss_pred hcccccccccccccccCCCCCC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 449 WATPRLQDSGTVISELPDPRLK--GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
...+...+.. .....+.+++..+|+.+||..||++|||+.|+++.-+
T Consensus 391 ------------~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 391 ------------KEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred ------------HHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 0111111111 1233456677899999999999999999999987543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=369.89 Aligned_cols=274 Identities=28% Similarity=0.415 Sum_probs=202.9
Q ss_pred ccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc--CCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 228 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL--HHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 228 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
..++||+|.||.||||.++ ++.||||++... ..+.|.+|-+|.+.. +|+||++|+++-.........++||++
T Consensus 214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hHHHhhcCccceeehhhcc-CceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 3567999999999999996 699999999754 334488888887764 899999999876554444567899999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcC------CCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA------APRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
|.+.|+|.+||..+ .++|....+|+..+++||+|||+.- .|+|+|||||++||||.+|+++.|+|||||.+
T Consensus 289 fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 289 FHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred eccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 99999999999874 4899999999999999999999743 46899999999999999999999999999999
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCC-C-----CcccchhhHHHHHHHHHhCCCCCCC-ccccccc--hhhhhc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGR-A-----SLMSDVFSFGVVLLELITGRQPIHR-SITKGEE--SLVLWA 450 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~-----s~ksDVwSlGviL~eLltG~~P~~~-~~~~~~~--~~~~~~ 450 (631)
+..+.-. ......+||.+|||||++.+.- + -.+.||||+|.|||||+++..-++. ..+.-+. ....-.
T Consensus 366 ~~p~~~~---~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 366 LEPGKPQ---GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred ecCCCCC---cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 8754322 2334478999999999997643 2 2368999999999999996543321 1000000 001111
Q ss_pred cccccccc-ccccccCCCCCCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 451 TPRLQDSG-TVISELPDPRLKGDFP-KEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 451 ~~~~~~~~-~~~~~~~~~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
.|.+.+.. .++++-.+|.+....- ...+..+.+.+..||..||+.|.|+.-+.+.+..+...
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 22222211 1222223333322111 13356789999999999999999999999998877543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=390.61 Aligned_cols=263 Identities=24% Similarity=0.384 Sum_probs=219.1
Q ss_pred CccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
...+.++||.|.||.||+|.++- ...||||.++.....+.+.+|+.|..||.+++||||++|.|+... ....
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk----s~Pv 705 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK----SKPV 705 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec----Ccee
Confidence 34567899999999999999863 457999999998888888889999999999999999999999886 4567
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
+||+|||++|+|+.||+.+.++ |.+.+++.++.+||.||+||-+++ +|||||.++|||++.+..+||+||||+|.+
T Consensus 706 MIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeec
Confidence 9999999999999999987654 999999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
.++.- . ........-..+|.|||.+..++++.+||||||||++||.++ |..||-....++-
T Consensus 782 edd~~-~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV---------------- 843 (996)
T KOG0196|consen 782 EDDPE-A-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---------------- 843 (996)
T ss_pred ccCCC-c-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH----------------
Confidence 65431 1 111111112479999999999999999999999999999888 9999865433221
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCccc
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSR 515 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 515 (631)
+.. .....+.+.|.+++..|.+||..||++|-.+||.+.||+..|++++.+...
T Consensus 844 -Ika-Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S 897 (996)
T KOG0196|consen 844 -IKA-IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS 897 (996)
T ss_pred -HHH-HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence 111 112223344666777799999999999999999999999999999866543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=352.91 Aligned_cols=257 Identities=25% Similarity=0.366 Sum_probs=204.5
Q ss_pred CccccceeeeeCceEEEEEEE-CCCcEEEEEEeccC-CCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+|.+++.||+|.||+|||+.. .+|..||.|.++-. -+.+..+....|+.+|++|+|||||++++.- +......++|
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~--f~~~~evlni 97 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHS--FIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHh--hhccchhhHH
Confidence 466678899999999999974 57999999998844 2334556699999999999999999998732 2223445899
Q ss_pred EEeeCCCCChHhhhhcc--ccCCCCHHHHHHHHHHHHhhhHHHHhcCCCc--eeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 303 VFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPR--ILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
|||||..|||.+.++.. ..+.+++.++++++.|+++||.++|+.- ++ |+||||||.||+|+.+|.+||+||||++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHh
Confidence 99999999999999643 2345999999999999999999999842 33 9999999999999999999999999999
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
.+.... ......+|||.||+||.+.+..|+.||||||+||++|||+.-+.||.+..- ..+
T Consensus 177 ~l~s~~-----tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~---~~L------------ 236 (375)
T KOG0591|consen 177 FLSSKT-----TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL---LSL------------ 236 (375)
T ss_pred Hhcchh-----HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH---HHH------------
Confidence 887542 334567899999999999999999999999999999999999999976421 010
Q ss_pred ccccccCCCCCCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 459 TVISELPDPRLKGDFP-KEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
-.++..-.. .++| ...+..+..|+..|+..||+.||+.-.+++.+.
T Consensus 237 --~~KI~qgd~-~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 237 --CKKIEQGDY-PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred --HHHHHcCCC-CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 011111111 1234 556777999999999999999999655555443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=373.70 Aligned_cols=252 Identities=29% Similarity=0.494 Sum_probs=213.7
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
|++..+....++.||.|+.|.||+|+++ ++.||||+++.. =..+|+.|++|+||||+.|.|+|.. ..
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtq----sP 185 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQ----SP 185 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecC----Cc
Confidence 4444444555788999999999999996 788999998753 2468999999999999999999997 66
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
.++||||||+.|.|...|+.. +.+.....+.+..+||.||.|||.+. |||||||+-||||..+..+||+|||.++
T Consensus 186 cyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~ 260 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSK 260 (904)
T ss_pred eeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchH
Confidence 889999999999999999864 56889999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
.+... .....+.||..|||||++...+.++|+|||||||||||||||..||..... ..+.|.
T Consensus 261 e~~~~------STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIwG-------- 322 (904)
T KOG4721|consen 261 ELSDK------STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIWG-------- 322 (904)
T ss_pred hhhhh------hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEEe--------
Confidence 76542 334567899999999999999999999999999999999999999964332 222232
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
+-...|....|..+++-+.-|++.||+..|..||++++|+..|+-..+
T Consensus 323 -----VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 323 -----VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred -----ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 233444556677777889999999999999999999999999885544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=354.03 Aligned_cols=243 Identities=28% Similarity=0.357 Sum_probs=201.3
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
.+.|+++++||+|+||.||.++.++ ++.+|+|++++..-. ........|..+|.+++||.||+++-.+.+ ...
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt----~~k 99 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT----EEK 99 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc----CCe
Confidence 3568889999999999999998665 999999999865322 335568899999999999999999876654 668
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
+|||+||+.||.|..+|++. ..+++..+.-++..|+.||.|||+.+ ||||||||+|||||++|+++|+||||++.
T Consensus 100 LylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~ 174 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKE 174 (357)
T ss_pred EEEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchh
Confidence 89999999999999999864 45899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
....+ ....+++||+.|||||++.+..|+..+|.||+|+++|||++|.+||..........
T Consensus 175 ~~~~~-----~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~-------------- 235 (357)
T KOG0598|consen 175 DLKDG-----DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYD-------------- 235 (357)
T ss_pred cccCC-----CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHH--------------
Confidence 65443 23455899999999999999999999999999999999999999997654332211
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP 497 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 497 (631)
.+....+ ...|........+++++.|..||++|.
T Consensus 236 ---~I~~~k~-~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 236 ---KILKGKL-PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---HHhcCcC-CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1111111 112233445588999999999999996
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=365.00 Aligned_cols=270 Identities=26% Similarity=0.386 Sum_probs=220.6
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
.+.+.+...+.++||+|-||.|.+.....+..||||+++..+......+|.+|+++|.+|+||||++|+|+|.. ++
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~----De 608 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ----DD 608 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec----CC
Confidence 34456777788999999999999999988899999999998888888899999999999999999999999997 55
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
.+++|+|||++|+|.+||.+.....+.-...++|+.|||.||+||.+.+ +|||||.++|||+|.++++||+|||+++
T Consensus 609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccc
Confidence 7799999999999999998765444566777889999999999999998 9999999999999999999999999999
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh--CCCCCCCccccccchhhhhccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT--GRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt--G~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
-+...++. ....+.+-.++|||+|.+..++++.++|||+||++|||+++ ...||........ +......+..
T Consensus 686 ~lysg~yy---~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~ 759 (807)
T KOG1094|consen 686 NLYSGDYY---RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRD 759 (807)
T ss_pred ccccCCce---eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCC
Confidence 77655432 22334556789999999999999999999999999999876 7889865443221 1111111111
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
.+ +......|..+++.+.++|..||..+-.+||+++++...|.+.
T Consensus 760 ~~--------~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 760 QG--------RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CC--------cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11 1111223455666688999999999999999999999988754
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=369.92 Aligned_cols=265 Identities=27% Similarity=0.424 Sum_probs=206.7
Q ss_pred HHhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeec
Q 006785 221 HATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 293 (631)
Q Consensus 221 ~a~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 293 (631)
...++|.+.+.||+|+||.||+|.+. +++.||||+++..........+.+|+.+|..+ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 34567888999999999999999742 35789999998654444556699999999999 899999999988642
Q ss_pred cCCcceEEEEEeeCCCCChHhhhhccc-----------------------------------------------------
Q 006785 294 RGKRAMRLLVFEFMPNGNLRDCLDGVL----------------------------------------------------- 320 (631)
Q Consensus 294 ~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------- 320 (631)
....++||||+++|+|.+++....
T Consensus 84 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 84 ---NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 335799999999999999996421
Q ss_pred -------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCc
Q 006785 321 -------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393 (631)
Q Consensus 321 -------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 393 (631)
...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........ ....
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~---~~~~ 234 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---VRKG 234 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcch---hccc
Confidence 134788899999999999999999998 999999999999999999999999999865432110 1112
Q ss_pred ccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccccccccccCCCCCCCC
Q 006785 394 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGD 472 (631)
Q Consensus 394 ~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 472 (631)
...+++.|+|||++.+..++.++||||||++||||++ |..||........... . +..-....
T Consensus 235 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~------~-------~~~~~~~~---- 297 (338)
T cd05102 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ------R-------LKDGTRMR---- 297 (338)
T ss_pred CCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH------H-------HhcCCCCC----
Confidence 3346788999999999999999999999999999997 9999965332111000 0 00000111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 473 FPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 473 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
.+...+..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 298 ~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 298 APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 122233458899999999999999999999999997753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=358.22 Aligned_cols=259 Identities=29% Similarity=0.452 Sum_probs=206.4
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
.+|...+.||+|+||+||++...+ |+..|||.+....... .+.+.+|+.+|++|+|||||+++|....... ..+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~--~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSREN--DEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccC--eeeEe
Confidence 345667889999999999999765 8999999987664333 4558999999999999999999997544222 36899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC-CCCeEEeccCceeecc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKRLK 381 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kL~DFGla~~~~ 381 (631)
.|||+++|+|.+++.+... .+++..+..++.||+.||+|||+++ ||||||||+||||+. ++.+||+|||++....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999999988654 6999999999999999999999999 999999999999999 7999999999998776
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCC-CCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
... ........++||+.|||||++..+. ...++|||||||++.||+||+.||...... ....
T Consensus 170 ~~~--~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~--~~~~------------- 232 (313)
T KOG0198|consen 170 SKG--TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE--AEAL------------- 232 (313)
T ss_pred ccc--ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch--HHHH-------------
Confidence 411 1122344578999999999999643 445999999999999999999999653110 0000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
..+......+.+|...+....+++.+|+..+|+.|||+.++++...
T Consensus 233 -~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 233 -LLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred -HHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 0111111112455566677999999999999999999999998643
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=368.51 Aligned_cols=271 Identities=28% Similarity=0.452 Sum_probs=214.7
Q ss_pred ecHHHHHHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeee
Q 006785 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 292 (631)
Q Consensus 214 ~s~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 292 (631)
.+..+|++..+++.+...||+|.||+||+|.|.. .||||+++... .++..+.|++|+.++++-+|.||+-|.|||..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 4446777778888889999999999999999963 39999998653 34455679999999999999999999999985
Q ss_pred ccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEe
Q 006785 293 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 372 (631)
Q Consensus 293 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~ 372 (631)
. .+.||+.+|+|-+|+.+|+... ..|+..+.+.||.|||+||.|||.++ |||||||+.||+|.++++|||+
T Consensus 460 ----p-~~AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIg 530 (678)
T KOG0193|consen 460 ----P-PLAIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIG 530 (678)
T ss_pred ----C-ceeeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEe
Confidence 3 3499999999999999998654 45999999999999999999999998 9999999999999999999999
Q ss_pred ccCceeecccCCCCCCCCCCcccccCCCCCCchhhhc---CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh
Q 006785 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 449 (631)
Q Consensus 373 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~---~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~ 449 (631)
||||+.....- ..........|..-|||||+++. .+|+..+||||||+++|||++|..||.... . + .+.|
T Consensus 531 DFGLatvk~~w---~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-~-d--qIif 603 (678)
T KOG0193|consen 531 DFGLATVKTRW---SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-R-D--QIIF 603 (678)
T ss_pred cccceeeeeee---ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-h-h--heEE
Confidence 99999754322 11122233458889999999973 568999999999999999999999997221 1 1 1111
Q ss_pred cccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 450 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
...+ +. ..+.+. .....+++.|.+|+..||..++++||.+.+|+..|..+.+.
T Consensus 604 mVGr----G~-----l~pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 604 MVGR----GY-----LMPDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred Eecc----cc-----cCccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 1110 10 011111 12234556699999999999999999999999988887763
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=340.10 Aligned_cols=267 Identities=25% Similarity=0.390 Sum_probs=207.2
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
+.|+.+.++|+|+||.|||++.++ |+.||||++..... +...+..++|+++|++|+|+|+|.|+.+|.. ...++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr----krklh 77 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR----KRKLH 77 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh----cceeE
Confidence 356677889999999999999876 99999999986544 4445558899999999999999999988875 55789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
||+|||+. ++.+-|... ..+++...+.+++.|++.|+.|+|+++ +|||||||+||||+.++.+||+|||+|+.+.
T Consensus 78 LVFE~~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 78 LVFEYCDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLS 152 (396)
T ss_pred EEeeecch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhc
Confidence 99999965 555556553 356999999999999999999999998 9999999999999999999999999999886
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccc----
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD---- 456 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~---- 456 (631)
.. ....+..+.|..|.|||.+.+ ..|+..+||||+||++.||++|.+-|.+..+-.....+......+..
T Consensus 153 ~p-----gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~ 227 (396)
T KOG0593|consen 153 AP-----GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQS 227 (396)
T ss_pred CC-----cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHH
Confidence 43 234567789999999999987 78999999999999999999999988765543332222222111110
Q ss_pred ---cccccccc--CCCCCCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 457 ---SGTVISEL--PDPRLKGDF---PKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 457 ---~~~~~~~~--~~~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
.......+ +.+.-.... -+.....+.+|++.||+.||++|++-+|++.
T Consensus 228 iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 228 IFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 01111111 111111111 1233456889999999999999999999986
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=393.98 Aligned_cols=263 Identities=28% Similarity=0.427 Sum_probs=214.9
Q ss_pred cCccccceeeeeCceEEEEEEECC--Cc----EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD--GR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~--g~----~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
.+.+..+.||+|.||.||.|...+ |. .||||.++.....+...+|++|..+|+.++|||||+++|+|.+ .
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~----~ 767 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD----S 767 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC----C
Confidence 344557889999999999998654 43 4999999988777888889999999999999999999999987 4
Q ss_pred ceEEEEEeeCCCCChHhhhhccc-----cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEe
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVL-----VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 372 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~ 372 (631)
...+|++|||++|||..||++.. ...++..+.+.++.|||+|++||++++ +|||||.++|+||+....+||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEc
Confidence 45699999999999999998652 244899999999999999999999998 9999999999999999999999
Q ss_pred ccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcc
Q 006785 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWAT 451 (631)
Q Consensus 373 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~ 451 (631)
|||||+.....++...... ..-..+|||||.+..+.++.|+|||||||+|||++| |..||.......-...+.
T Consensus 845 DFGlArDiy~~~yyr~~~~---a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~--- 918 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGE---AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL--- 918 (1025)
T ss_pred ccchhHhhhhchheeccCc---cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH---
Confidence 9999996555443322111 223478999999999999999999999999999999 888886443221111000
Q ss_pred cccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcc
Q 006785 452 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKS 514 (631)
Q Consensus 452 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 514 (631)
... +.+.|..++..+.+||..||+.+|++||++..|++.+..+.+...
T Consensus 919 -------------~gg--RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 919 -------------EGG--RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred -------------hCC--ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 011 224566677779999999999999999999999998888765543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=346.73 Aligned_cols=265 Identities=25% Similarity=0.377 Sum_probs=213.1
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.+.|.....||.|..++||+|+.. .+..||||++.-+......+.+.+|+..|+.++||||++++..|.. +..+|
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv----~~~LW 100 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV----DSELW 100 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe----cceeE
Confidence 356778899999999999999854 5899999999877666666779999999999999999999988886 66889
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||.||.+||+.+.+......++++..+..|..++++||.|||.+| .||||||+.||||+.+|.+||+|||.+..+.
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 9999999999999998887788999999999999999999999999 9999999999999999999999999987776
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhh--cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAM--VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~--~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
..+ .........++||+.|||||++. ...|+.|+||||||++..||.+|..||....+-..........+....
T Consensus 178 ~~G-~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~--- 253 (516)
T KOG0582|consen 178 DSG-DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL--- 253 (516)
T ss_pred ccC-ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc---
Confidence 655 22222226789999999999965 356999999999999999999999999765432211111100000000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
-..+..+-.......+.+++..||+.||.+|||+.++++
T Consensus 254 ------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 ------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 001111112233446899999999999999999999997
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=360.88 Aligned_cols=251 Identities=26% Similarity=0.414 Sum_probs=209.6
Q ss_pred hcCccccceeeeeCceEEEEEEE-CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
...|....+||+|..|.||.|.. .+++.||||++..... ...+.+++|+.+|+..+|+|||+++..|.. ...+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q-~~keLilnEi~Vm~~~~H~NiVnfl~Sylv----~deLW 346 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ-PKKELLLNEILVMRDLHHPNIVNFLDSYLV----GDELW 346 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC-CchhhhHHHHHHHHhccchHHHHHHHHhcc----cceeE
Confidence 35677778899999999999975 4588999999986543 334458999999999999999999988776 46789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+|||||+||+|.|.+... .+++.++..|+.++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+.
T Consensus 347 VVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred EEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 999999999999998764 3899999999999999999999999 9999999999999999999999999998876
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
... ......+||+.|||||++....|+.|.||||||++.+||+-|.+||....+-.. ...+.
T Consensus 421 ~~~-----~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA-------lyLIa------ 482 (550)
T KOG0578|consen 421 EEQ-----SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-------LYLIA------ 482 (550)
T ss_pred ccc-----CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH-------HHHHh------
Confidence 553 355678999999999999999999999999999999999999999964222111 11111
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.--.|.+ ..++..+..+.+|+.+||+.|+++|+++.|+++.
T Consensus 483 -~ng~P~l--k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 483 -TNGTPKL--KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -hcCCCCc--CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1111222 2456667789999999999999999999999973
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=348.32 Aligned_cols=250 Identities=23% Similarity=0.381 Sum_probs=200.7
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCC--hHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEee
Q 006785 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 306 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~ 306 (631)
...||+|++|.||+|++ +|+.||||+++...... ..+.|.+|+.+|++++||||++++|++.+........++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 35799999999999998 58999999997643222 1356889999999999999999999987633334577999999
Q ss_pred CCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhc-CCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCC
Q 006785 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 307 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 385 (631)
+++|+|.+++... +.+++...+.++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++.....
T Consensus 104 ~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-- 176 (283)
T PHA02988 104 CTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-- 176 (283)
T ss_pred CCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc--
Confidence 9999999999764 4589999999999999999999985 6 889999999999999999999999998765322
Q ss_pred CCCCCCCcccccCCCCCCchhhhc--CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccc
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 463 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~--~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (631)
.....||..|+|||++.+ ..++.++|||||||++|||++|+.||............ ...
T Consensus 177 ------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i-------------~~~ 237 (283)
T PHA02988 177 ------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI-------------INK 237 (283)
T ss_pred ------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH-------------Hhc
Confidence 123458899999999976 68999999999999999999999999754322111100 000
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 464 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 464 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
...+ ..+...+..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus 238 ~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 238 NNSL----KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CCCC----CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 0111 12223345689999999999999999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=355.32 Aligned_cols=255 Identities=27% Similarity=0.370 Sum_probs=207.6
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC--hHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~ 298 (631)
..+|...+.||+|+|++||+|+.. .++.||||++.....-. ...-...|-++|.+| .||.|++|+--|.+ ..
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD----~~ 147 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD----EE 147 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec----cc
Confidence 467888999999999999999865 48999999987542211 122367899999999 99999999877765 56
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
.+|+|+||+++|+|.++|+.. +.|++.....++.+|+.||+|||++| ||||||||+|||||.|++++|+|||.|+
T Consensus 148 sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 789999999999999999875 56999999999999999999999999 9999999999999999999999999999
Q ss_pred ecccCCCC-----C---CCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhc
Q 006785 379 RLKADGLP-----S---CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA 450 (631)
Q Consensus 379 ~~~~~~~~-----~---~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~ 450 (631)
.+...... . .......++||..|.+||++.....+..+|||+||||||.|+.|++||....+..
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl-------- 294 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL-------- 294 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH--------
Confidence 88654322 0 0111255899999999999999999999999999999999999999997543211
Q ss_pred ccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 451 TPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
...++.+ +.-.+|+..++...+|+++.|..||.+|+|..+|.+.
T Consensus 295 ---------iFqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 295 ---------IFQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ---------HHHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 0111111 1123444455668899999999999999999998764
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=349.74 Aligned_cols=269 Identities=28% Similarity=0.379 Sum_probs=205.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
.+.|+..++||+|.||.||+|+.. +|+.||+|++..+... ....-..+||.||++|+||||++|.+...+.. ...+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~--~~si 193 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL--SGSI 193 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC--CceE
Confidence 345666788999999999999864 5999999999876533 33344679999999999999999999988742 3578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|||+|||+ -||.-++.... -.|+..++..++.|++.||+|+|.++ |+|||||.+|||||++|.+||+|||||+++
T Consensus 194 YlVFeYMd-hDL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 194 YLVFEYMD-HDLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEEeccc-chhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 99999995 59988886532 34999999999999999999999999 999999999999999999999999999988
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhh--hhcccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV--LWATPRLQDS 457 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~--~~~~~~~~~~ 457 (631)
..... ...+..+-|+.|.|||.+.+. .|+...|+||.||||.||+.|++.|.+..+-.+...+ .-..+. .+.
T Consensus 269 ~~~~~----~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~-e~~ 343 (560)
T KOG0600|consen 269 TPSGS----APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPT-EDY 343 (560)
T ss_pred cCCCC----cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCC-hhc
Confidence 76542 234566789999999999875 6999999999999999999999999876543321111 111111 111
Q ss_pred cccccccCCCCCC---CCC-------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 458 GTVISELPDPRLK---GDF-------PKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 458 ~~~~~~~~~~~l~---~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
+. ..+++..... ..+ -...+....+|+..+|.+||++|.|+.++++
T Consensus 344 W~-~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 344 WP-VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cc-cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11 1112211000 000 1112234678899999999999999999986
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=356.86 Aligned_cols=267 Identities=26% Similarity=0.381 Sum_probs=225.2
Q ss_pred HHHHHHhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC
Q 006785 217 SALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 295 (631)
Q Consensus 217 ~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 295 (631)
+.|+--..+.....+||.|.||.||.|.|+. .-.||||.++.+. -..++|+.|..+|+.++|||+|+|+|+|..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~--- 334 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH--- 334 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhcc---
Confidence 5566666667778899999999999999986 6789999998764 345669999999999999999999999986
Q ss_pred CcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccC
Q 006785 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 375 (631)
Q Consensus 296 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFG 375 (631)
....|||+|||..|+|.+||++.....++....+.+|.||+.||+||..++ +|||||.++|+|+.++..+||+|||
T Consensus 335 -EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 335 -EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFG 410 (1157)
T ss_pred -CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccc
Confidence 556799999999999999999887777888899999999999999999988 9999999999999999999999999
Q ss_pred ceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccc
Q 006785 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRL 454 (631)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~ 454 (631)
|++....+.+.. .....-.+.|.|||-+....++.|+|||+|||+||||.| |-.||.+..-.
T Consensus 411 LsRlMtgDTYTA----HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS------------- 473 (1157)
T KOG4278|consen 411 LSRLMTGDTYTA----HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------------- 473 (1157)
T ss_pred hhhhhcCCceec----ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-------------
Confidence 999987665432 222234578999999999999999999999999999999 88888542211
Q ss_pred ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcc
Q 006785 455 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKS 514 (631)
Q Consensus 455 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 514 (631)
.+..++....+.+-|+.++..+.+||+.||+.+|.+||++.|+-+.|+.++.+.+
T Consensus 474 -----qVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS 528 (1157)
T KOG4278|consen 474 -----QVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS 528 (1157)
T ss_pred -----HHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence 1223333344445567777779999999999999999999999999999986654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=365.90 Aligned_cols=265 Identities=28% Similarity=0.405 Sum_probs=211.5
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEECC--C--cE-EEEEEecc--CCCCChHHHHHHHHHHHHhcCCCCCcceeEEee
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTD--G--RI-VAVKRFKT--QGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~--g--~~-vAVK~l~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 291 (631)
|+...++....++||+|+||.||+|+++. + .. ||||..+. ........+|.+|.++|+.++|||||+|+|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 44445566667899999999999998753 2 23 89999885 244556677999999999999999999999998
Q ss_pred eccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEE
Q 006785 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 371 (631)
Q Consensus 292 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL 371 (631)
. ...+|+|||+|+||+|.+||+... ..++..+++.++.++|.||+|||+++ +|||||.++|+|++.++.+||
T Consensus 232 ~----~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKI 303 (474)
T KOG0194|consen 232 L----EEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKI 303 (474)
T ss_pred C----CCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEe
Confidence 7 557799999999999999998753 35999999999999999999999998 999999999999999999999
Q ss_pred eccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhc
Q 006785 372 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWA 450 (631)
Q Consensus 372 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~ 450 (631)
+||||++....-.. ......-..+|+|||.+..+.|+.++|||||||++||+++ |..||.......-
T Consensus 304 SDFGLs~~~~~~~~-----~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v------- 371 (474)
T KOG0194|consen 304 SDFGLSRAGSQYVM-----KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV------- 371 (474)
T ss_pred CccccccCCcceee-----ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH-------
Confidence 99999876531110 0101134578999999999999999999999999999999 8889875443211
Q ss_pred ccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006785 451 TPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513 (631)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 513 (631)
...+.....+...|...+..+..++..||..+|++||+|.++.+.|..+....
T Consensus 372 ----------~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 372 ----------KAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred ----------HHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 11111112222334455566888999999999999999999999999886544
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=348.43 Aligned_cols=248 Identities=25% Similarity=0.402 Sum_probs=212.1
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
.|+..+.||+|.||.||+|.+. .++.||+|++.-.......+++.+|+.+|..++++||.+++|.+.. +..++++
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~----g~~Lwii 89 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK----GTKLWII 89 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee----cccHHHH
Confidence 4555678999999999999875 4899999999988777778889999999999999999999999887 5678999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
||||.||++.+.|... ..+++..+..|..+++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+-.....
T Consensus 90 Mey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeech
Confidence 9999999999999753 33588888889999999999999998 999999999999999999999999999887654
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 463 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (631)
. ....+++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+.... ..+.+
T Consensus 165 ~-----~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl--------------flIpk 225 (467)
T KOG0201|consen 165 V-----KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL--------------FLIPK 225 (467)
T ss_pred h-----hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE--------------EeccC
Confidence 3 2346789999999999999889999999999999999999999998654331100 12334
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 464 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 464 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
-..|.+.+.+.. .|.+|+..||+.||+.||++.++++
T Consensus 226 ~~PP~L~~~~S~----~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 226 SAPPRLDGDFSP----PFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCCCccccccCH----HHHHHHHHHhhcCcccCcCHHHHhh
Confidence 445666654444 4899999999999999999999996
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=351.39 Aligned_cols=269 Identities=26% Similarity=0.344 Sum_probs=210.1
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCCcceeEEeeeccCCcce
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~ 299 (631)
.-++|...++||.|.||.||+|+-. +|..||||+++..-..-.+-.=++|++.|++|+ |||||+|..++.+. ...
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~---~~~ 84 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDN---DRI 84 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhcc---Cce
Confidence 3467788899999999999999854 589999999987644433333579999999998 99999999988873 228
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
+|+||||| ..+|+++++.+ .+.|++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+||||||.
T Consensus 85 L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 85 LYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred EeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence 99999999 57999999876 678999999999999999999999999 99999999999999888999999999998
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhh-cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhh--hhccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV--LWATPRLQD 456 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~--~~~~~~~~~ 456 (631)
.... ...+..+.|..|.|||++. .+.|+.+.||||+|+|++||.+-++-|.+..+-.+...+ ....|....
T Consensus 160 v~Sk------pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~ 233 (538)
T KOG0661|consen 160 VRSK------PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDS 233 (538)
T ss_pred cccC------CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcccc
Confidence 7642 3456678999999999886 678999999999999999999998888765433222111 112222111
Q ss_pred cc--cc--------ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 457 SG--TV--------ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 457 ~~--~~--------~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.. .. +.......+..-+|. .+....+|+.+|+..||++|||+.|.++.
T Consensus 234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 234 WPEGYNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred chhHHHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 10 00 111111111112233 55668899999999999999999999984
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=351.57 Aligned_cols=249 Identities=25% Similarity=0.342 Sum_probs=204.2
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC----CChHHHHHHHHHHHHhcC-CCCCcceeEEeeeccC
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG----PNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRG 295 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~----~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 295 (631)
..++|...+.||+|+||.|++|... +|+.||||++..... ......+.+|+.++++++ ||||++++.++..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t--- 91 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT--- 91 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec---
Confidence 4567888999999999999999764 589999997765411 123445678999999998 9999999999876
Q ss_pred CcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCC-CCeEEecc
Q 006785 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDL 374 (631)
Q Consensus 296 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kL~DF 374 (631)
...+|+||||+.||+|.+++.. ...+.+.++..++.|++.|++|||+++ |+||||||+|||++.+ +++||+||
T Consensus 92 -~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 92 -PTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred -CCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecc
Confidence 4568999999999999999987 356899999999999999999999999 9999999999999999 99999999
Q ss_pred Cceeecc-cCCCCCCCCCCcccccCCCCCCchhhhcCC-C-CcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcc
Q 006785 375 GMAKRLK-ADGLPSCSSSPARMQGTFGYFAPEYAMVGR-A-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 451 (631)
Q Consensus 375 Gla~~~~-~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~ 451 (631)
|++.... .+ .......||+.|+|||++.+.. | +.++||||+||+||.|++|+.||+.........
T Consensus 166 G~s~~~~~~~------~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~------ 233 (370)
T KOG0583|consen 166 GLSAISPGED------GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYR------ 233 (370)
T ss_pred ccccccCCCC------CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHH------
Confidence 9999873 22 3456678999999999999866 6 589999999999999999999998632211110
Q ss_pred cccccccccccccCCCCCCCCCCHHH-HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 452 PRLQDSGTVISELPDPRLKGDFPKEE-MQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 452 ~~~~~~~~~~~~~~~~~l~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
.+.... ..+|... +..+..|+.+||..||.+|+++.+|++
T Consensus 234 -----------ki~~~~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 234 -----------KIRKGE--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred -----------HHhcCC--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 111111 1233333 566899999999999999999999984
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=345.87 Aligned_cols=263 Identities=27% Similarity=0.410 Sum_probs=200.2
Q ss_pred cCccccceeeeeCceEEEEEEECC-----------------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcce
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-----------------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 286 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 286 (631)
++|...+.||+|+||.||++.+.+ +..||||.+...........|.+|+.+|.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 567788999999999999997532 347999999865444445669999999999999999999
Q ss_pred eEEeeeccCCcceEEEEEeeCCCCChHhhhhccc-----------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCC
Q 006785 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL-----------------VEGMNWDTRVAIAIGAARGLEYLHEAAAP 349 (631)
Q Consensus 287 ~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 349 (631)
++++.+ ....++||||+++|+|.+++.... ...++|..+..++.||+.||.|||+.+
T Consensus 85 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-- 158 (304)
T cd05096 85 LGVCVD----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-- 158 (304)
T ss_pred EEEEec----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--
Confidence 999876 346799999999999999985421 123788999999999999999999998
Q ss_pred ceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHH
Q 006785 350 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELI 429 (631)
Q Consensus 350 ~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLl 429 (631)
|+||||||+|||++.++.+||+|||+++........ .......++..|+|||++..+.++.++||||||+++|||+
T Consensus 159 -ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 159 -FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY---RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred -ccccCcchhheEEcCCccEEECCCccceecccCcee---EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHH
Confidence 999999999999999999999999999865432211 1122334678999999999899999999999999999998
Q ss_pred h--CCCCCCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 430 T--GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 430 t--G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
+ +..||......... ......+.... . ......+..++..+.+|+.+||+.||++|||+.+|.+.|.
T Consensus 235 ~~~~~~p~~~~~~~~~~---~~~~~~~~~~~---~-----~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 235 MLCKEQPYGELTDEQVI---ENAGEFFRDQG---R-----QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HccCCCCCCcCCHHHHH---HHHHHHhhhcc---c-----cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 7 56777643221110 00000000000 0 0000112223345889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=358.31 Aligned_cols=260 Identities=25% Similarity=0.378 Sum_probs=203.0
Q ss_pred hcCccccceeeeeCceEEEEEEE------CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccC
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQL------TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRG 295 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 295 (631)
.++|.+.+.||+|+||.||+|.+ .++..||||+++..........+.+|+.+|..+ +||||+++++++..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~--- 110 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV--- 110 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc---
Confidence 45688889999999999999974 236689999998655445556689999999999 89999999999876
Q ss_pred CcceEEEEEeeCCCCChHhhhhccc-------------------------------------------------------
Q 006785 296 KRAMRLLVFEFMPNGNLRDCLDGVL------------------------------------------------------- 320 (631)
Q Consensus 296 ~~~~~~lV~E~~~~gsL~~~l~~~~------------------------------------------------------- 320 (631)
....++||||+++|+|.+++....
T Consensus 111 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 111 -GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred -CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 456799999999999999986421
Q ss_pred ------------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 321 ------------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 321 ------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 124789999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
.... .......++..|+|||++.+..++.++||||||+++|||++ |..||........ ...+ +
T Consensus 267 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~~~-----------~ 330 (375)
T cd05104 267 DSNY---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FYKM-----------I 330 (375)
T ss_pred cccc---cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HHHH-----------H
Confidence 3211 11122335678999999999999999999999999999998 8888864322110 0000 0
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
..-..+ ..+...+..+.+|+.+||+.||++||++.+|++.|++.
T Consensus 331 ~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 331 KEGYRM----LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HhCccC----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 000000 11112234588999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=341.94 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=199.5
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
|...+.||+|+||.||++... +|+.||||.+..... ......+.+|+.+|++++|+||+++++++.+ ....++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~----~~~~~l 77 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET----KDALCL 77 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc----CCeEEE
Confidence 667789999999999999864 689999999865422 2233457899999999999999999998875 457899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++.....
T Consensus 78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 999999999998886544456899999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
.. ......||+.|+|||++.+..++.++|||||||+||||++|+.||............. .
T Consensus 155 ~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~-------------~ 215 (285)
T cd05631 155 GE------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD-------------R 215 (285)
T ss_pred CC------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH-------------H
Confidence 21 1223468999999999999999999999999999999999999997543221110000 0
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-----MSEVVQ 504 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 504 (631)
.+... ...++...+..+.+|+.+||+.||.+||+ +.++++
T Consensus 216 ~~~~~--~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 216 RVKED--QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred Hhhcc--cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 00000 01123334455889999999999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=338.53 Aligned_cols=256 Identities=23% Similarity=0.356 Sum_probs=203.6
Q ss_pred cCccccceeeeeCceEEEEEEEC----CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
++|++.+.||+|+||.||+|.++ .+..||+|+++..........|.+|+.++++++||||++++|++.. ...
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~ 80 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR----GNT 80 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec----CCC
Confidence 46778899999999999999764 3678999999876544555679999999999999999999999875 456
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.++++|||++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccc
Confidence 799999999999999997642 45899999999999999999999998 99999999999999999999999998765
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
...... .......++..|+|||.+.+..++.++||||||+++||+++ |..||........ ...
T Consensus 157 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~~--------- 220 (266)
T cd05064 157 DKSEAI----YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IKA--------- 220 (266)
T ss_pred ccccch----hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHH---------
Confidence 432211 11112345678999999999999999999999999999875 9999965432110 000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
+.+.... ..+...+..+.+++.+||+.+|++||++.+|++.|..+
T Consensus 221 --~~~~~~~----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 221 --VEDGFRL----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --HHCCCCC----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0000011 12233445588999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=357.85 Aligned_cols=263 Identities=24% Similarity=0.380 Sum_probs=204.9
Q ss_pred HHhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeec
Q 006785 221 HATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 293 (631)
Q Consensus 221 ~a~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 293 (631)
...++|...+.||+|+||.||+|++. ++..||||+++..........+.+|+.+++.+ +|+||+++++++..
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~- 113 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH- 113 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC-
Confidence 33457888999999999999999752 24579999998665445556689999999999 89999999999876
Q ss_pred cCCcceEEEEEeeCCCCChHhhhhccc-----------------------------------------------------
Q 006785 294 RGKRAMRLLVFEFMPNGNLRDCLDGVL----------------------------------------------------- 320 (631)
Q Consensus 294 ~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------- 320 (631)
....++||||+++|+|.+++....
T Consensus 114 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 114 ---GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ---CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 456799999999999999985421
Q ss_pred ---------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCC
Q 006785 321 ---------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 321 ---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 385 (631)
...+++.+++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence 124788999999999999999999998 99999999999999999999999999986543211
Q ss_pred CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccccccccc
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 464 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (631)
. .......++..|+|||++....++.++||||||+++|||++ |+.||............ +...
T Consensus 268 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~-------------~~~~ 331 (374)
T cd05106 268 Y---VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM-------------VKRG 331 (374)
T ss_pred e---eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH-------------HHcc
Confidence 0 11122335678999999998999999999999999999997 99999653321110000 0000
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 465 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 465 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
..+ ..+...+..+.+++.+||+.||++|||+.+|++.|.++.
T Consensus 332 ~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 332 YQM----SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cCc----cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 011 111122345889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=316.57 Aligned_cols=266 Identities=24% Similarity=0.351 Sum_probs=205.7
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC-hHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
++|...+.||+|.||.||+|++. +|+.||||+++.....+ .....++|++.|+.++|+||+.|++++.. ...+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~----~~~l~ 77 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH----KSNLS 77 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC----CCceE
Confidence 35666788999999999999865 59999999998654332 23347899999999999999999999876 55679
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
||+|||+ .+|...++... ..++..++..++.++++||+|||.+. |+||||||.|+|++.+|.+||+|||+|+.+.
T Consensus 78 lVfEfm~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 78 LVFEFMP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFG 152 (318)
T ss_pred EEEEecc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccC
Confidence 9999994 69999997643 55899999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchh--hhhccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL--VLWATPRLQDSG 458 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~--~~~~~~~~~~~~ 458 (631)
.... .....+-|..|.|||.+.+ ..|+..+|+||.|||+.||+-|.+-|.+..+-++... .....|.-. .+
T Consensus 153 ~p~~-----~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~-~W 226 (318)
T KOG0659|consen 153 SPNR-----IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPD-QW 226 (318)
T ss_pred CCCc-----ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcc-cC
Confidence 5432 2233478999999999986 4599999999999999999988766654433222211 112222211 11
Q ss_pred cccc---------ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 459 TVIS---------ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 459 ~~~~---------~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..+. ..+.+.+..-++ .......+|+..+|..||.+|+++.|+++.
T Consensus 227 P~~~~lpdY~~~~~~P~~~~~~lf~-aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 227 PEMTSLPDYVKIQQFPKPPLNNLFP-AASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccccccHHHHhcCCCCccccccc-cccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1122 233333333333 334446899999999999999999999874
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=341.56 Aligned_cols=265 Identities=24% Similarity=0.349 Sum_probs=209.3
Q ss_pred HHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-------------ChHHHHHHHHHHHHhcCCCCCcce
Q 006785 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-------------NADSVFLTEVDMLSRLHHCHVVPL 286 (631)
Q Consensus 221 ~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l 286 (631)
...++|.+.+.||+|.||.|-+|... +++.||||++...... ...+...+||.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999865 5999999999643210 112458899999999999999999
Q ss_pred eEEeeeccCCcceEEEEEeeCCCCChHhhhhccccCC-CCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC
Q 006785 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 365 (631)
Q Consensus 287 ~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~ 365 (631)
+.+..+.. ...+|||+|||..|.+...=. ... ++..++..++.+++.||+|||.++ ||||||||+|+||++
T Consensus 174 iEvLDDP~--s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 174 IEVLDDPE--SDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSS 245 (576)
T ss_pred EEeecCcc--cCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcC
Confidence 99887654 457899999999998765432 233 899999999999999999999999 999999999999999
Q ss_pred CCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCC----CCcccchhhHHHHHHHHHhCCCCCCCcccc
Q 006785 366 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR----ASLMSDVFSFGVVLLELITGRQPIHRSITK 441 (631)
Q Consensus 366 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~----~s~ksDVwSlGviL~eLltG~~P~~~~~~~ 441 (631)
+|++||+|||.+..+...............+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||......
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 9999999999998774432222122334578999999999987643 477899999999999999999999653221
Q ss_pred ccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 442 GEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
. ...+|....+..+-.+++...+.+|++++|.+||+.|.+..+|....+...
T Consensus 326 ~-----------------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 326 E-----------------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred H-----------------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 1 123334333433333345667999999999999999999999988776543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=323.88 Aligned_cols=237 Identities=27% Similarity=0.338 Sum_probs=201.0
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|+..+.||.|+||.|.+++.+. |..+|+|++....- .+..+...+|..+|+.+.||.++++.+-+.+ ...+
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d----~~~l 119 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD----NSNL 119 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc----CCeE
Confidence 456778999999999999999764 89999999986532 2233447789999999999999999988876 5688
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
||||||++||.|..+|++. +.++...+.-+|.+|+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+..
T Consensus 120 ymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRV 194 (355)
T ss_pred EEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEe
Confidence 9999999999999999875 56999999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
... .-+..|||.|+|||.+....++..+|.|||||++|||+.|.+||........
T Consensus 195 ~~r--------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i----------------- 249 (355)
T KOG0616|consen 195 SGR--------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI----------------- 249 (355)
T ss_pred cCc--------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH-----------------
Confidence 643 3456799999999999999999999999999999999999999976544211
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDAR 496 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 496 (631)
..++....+ .+|......+.+|+...|+.|-.+|
T Consensus 250 Y~KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 250 YEKILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 122222222 2555566668999999999998888
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=338.25 Aligned_cols=257 Identities=27% Similarity=0.447 Sum_probs=204.7
Q ss_pred cCccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
++|+..+.||+|+||.||+|.... ...||+|.++..........|.+|+.++++++||||+++++++.. .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~----~ 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK----E 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC----C
Confidence 357778899999999999998643 257999999765544455668999999999999999999998875 4
Q ss_pred ceEEEEEeeCCCCChHhhhhcccc--------------CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeee
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 363 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl 363 (631)
...+++|||+++|+|.+++..... ..+++.++..++.|++.||+|||+.+ ++||||||+||++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~ 157 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLV 157 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEE
Confidence 467999999999999999965321 44889999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccc
Q 006785 364 DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKG 442 (631)
Q Consensus 364 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~ 442 (631)
++++.++|+|||+++........ .......+++.|+|||++....++.++||||||+++|||++ |..||.......
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~ 234 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADYY---RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE 234 (283)
T ss_pred cCCCcEEECCCcceeeccccccc---cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 99999999999999865432211 11223456889999999998899999999999999999998 999997543221
Q ss_pred cchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006785 443 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508 (631)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 508 (631)
.... +..- .....+...+..+.+|+.+||+.||++||++.+|++.|..
T Consensus 235 ~~~~--------------i~~~----~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VIEM--------------IRSR----QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHH--------------HHcC----CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1000 0000 0111233444568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=352.31 Aligned_cols=249 Identities=25% Similarity=0.336 Sum_probs=206.8
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
-|..++.||.|+-|.|-+|++. +|+.+|||++.... .......+.+|+-+|+.|.||||++|++++.. ..++|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~----~~~ly 88 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN----KQHLY 88 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc----CceEE
Confidence 4666788999999999999875 59999999997652 11222347899999999999999999999886 67899
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+|.||++||-|+++|-.. +++.+.++.+++.||+.|+.|+|..+ |+||||||+|+|||.++++||+|||+|..-.
T Consensus 89 lvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred EEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 999999999999999764 56999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
.+. ...+.+|++.|.|||++.+.+| +.++||||.|||||.||||++||++..... +
T Consensus 164 ~gk------lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~---L-------------- 220 (786)
T KOG0588|consen 164 PGK------LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV---L-------------- 220 (786)
T ss_pred CCc------cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH---H--------------
Confidence 543 3455679999999999999887 889999999999999999999997432211 1
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
+.++... ..+.|...+.+.++|+.+|+..||..|.|++||++.-.
T Consensus 221 LlKV~~G--~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 221 LLKVQRG--VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred HHHHHcC--cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 1111111 11345556666899999999999999999999998533
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=353.96 Aligned_cols=263 Identities=24% Similarity=0.384 Sum_probs=206.8
Q ss_pred HhcCccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCCcceeEEeeecc
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFR 294 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 294 (631)
..++|.+.+.||+|+||.||+|.+.. +..||||++.........+.|.+|+++|+++. ||||+++++++.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-- 112 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-- 112 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence 35678889999999999999998632 34799999976555455567999999999995 9999999999875
Q ss_pred CCcceEEEEEeeCCCCChHhhhhccc------------------------------------------------------
Q 006785 295 GKRAMRLLVFEFMPNGNLRDCLDGVL------------------------------------------------------ 320 (631)
Q Consensus 295 ~~~~~~~lV~E~~~~gsL~~~l~~~~------------------------------------------------------ 320 (631)
....||||||+++|+|.++|....
T Consensus 113 --~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 113 --SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred --CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 456899999999999999985421
Q ss_pred ----------------------------------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCC
Q 006785 321 ----------------------------------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 360 (631)
Q Consensus 321 ----------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~N 360 (631)
...+++.+++.++.|++.||+|||+.+ |+||||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~N 267 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHh
Confidence 124788899999999999999999998 9999999999
Q ss_pred eeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCcc
Q 006785 361 ILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 439 (631)
Q Consensus 361 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~ 439 (631)
||++.++.+||+|||+++........ .......+++.|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNY---VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccc---cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 99999999999999999876432211 11223457788999999998899999999999999999997 999986532
Q ss_pred ccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 440 TKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
........ +..-..+ ..+...+..+.+++.+||+.+|++||++.+|.+.|..+.+
T Consensus 345 ~~~~~~~~-------------~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 345 VDSTFYNK-------------IKSGYRM----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred hhHHHHHH-------------HhcCCCC----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 21110000 0000011 1222334558899999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=343.56 Aligned_cols=260 Identities=27% Similarity=0.414 Sum_probs=204.4
Q ss_pred cCccccceeeeeCceEEEEEEECC-Cc----EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~----~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
.+|+..+.||+|+||.||+|++.. +. .||||+++..........|.+|+.+++.++||||++++|+|.. .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-----~ 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----S 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-----C
Confidence 458888999999999999998643 33 4899999765444555679999999999999999999999874 2
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..++|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccc
Confidence 4589999999999999997643 45899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
........ .......++..|+|||++....++.++||||||+++|||++ |+.||.......... .
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~---~-------- 223 (316)
T cd05108 158 LLGADEKE---YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS---I-------- 223 (316)
T ss_pred cccCCCcc---eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH---H--------
Confidence 76543211 01112234678999999999999999999999999999998 999986432211000 0
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 513 (631)
+...... ..+..+...+..++.+||..+|++||++.+++..|..+..+.
T Consensus 224 ---~~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 224 ---LEKGERL----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ---HhCCCCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 0000000 111222344788999999999999999999999998886554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=348.00 Aligned_cols=264 Identities=28% Similarity=0.425 Sum_probs=206.0
Q ss_pred HhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeecc
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFR 294 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 294 (631)
..++|.+.+.||+|+||.||+|.+. .++.||+|+++..........+..|+.++.++ +|+||++++++|...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~- 83 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP- 83 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-
Confidence 4467888999999999999999642 25789999998654444445688999999999 899999999988642
Q ss_pred CCcceEEEEEeeCCCCChHhhhhccc------------------------------------------------------
Q 006785 295 GKRAMRLLVFEFMPNGNLRDCLDGVL------------------------------------------------------ 320 (631)
Q Consensus 295 ~~~~~~~lV~E~~~~gsL~~~l~~~~------------------------------------------------------ 320 (631)
....+++|||+++|+|.+++....
T Consensus 84 --~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 84 --GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred --CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 346789999999999999985421
Q ss_pred -----cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCccc
Q 006785 321 -----VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 395 (631)
Q Consensus 321 -----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~ 395 (631)
...++|..+..++.||+.||+|||+.+ |+||||||+|||+++++.++|+|||+++.+...... ......
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~---~~~~~~ 235 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---VRKGDA 235 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcch---hhccCC
Confidence 125899999999999999999999998 999999999999999999999999999876432211 112234
Q ss_pred ccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccccccccccCCCCCCCCCC
Q 006785 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFP 474 (631)
Q Consensus 396 ~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 474 (631)
.++..|+|||++.+..++.++|||||||+||||++ |..||........ ... .+.....+ ..+
T Consensus 236 ~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~-----------~~~~~~~~----~~~ 298 (337)
T cd05054 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCR-----------RLKEGTRM----RAP 298 (337)
T ss_pred CCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHH-----------HHhccCCC----CCC
Confidence 56778999999999999999999999999999998 9999864322110 000 00000011 112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 475 KEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 475 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
......+.+++.+||+.+|++||++.+|++.|..+..
T Consensus 299 ~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 299 EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 2233458899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=342.79 Aligned_cols=201 Identities=28% Similarity=0.421 Sum_probs=175.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.++|+..+.||+|+||.||+++.. +|..||+|++...........+.+|+++|++++||||+++++++.. ....+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 79 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS----DGEIS 79 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE----CCEEE
Confidence 467888999999999999999976 4889999999765444445669999999999999999999999876 45789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||++....
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred EEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 999999999999999754 45899999999999999999999853 39999999999999999999999999987654
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~ 438 (631)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 156 DS-------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred cc-------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 32 123346999999999999999999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=345.42 Aligned_cols=243 Identities=25% Similarity=0.316 Sum_probs=195.6
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEee
Q 006785 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 306 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~ 306 (631)
+.||+|+||.||+++.. +|+.||||+++... .......+.+|+.+|++++||||+++++++.. ....|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~----~~~~~lv~e~ 76 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT----HDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc----CCEEEEEEeC
Confidence 36999999999999875 58999999997532 22334457899999999999999999998875 5578999999
Q ss_pred CCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCC
Q 006785 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 386 (631)
Q Consensus 307 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 386 (631)
+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-- 149 (323)
T cd05571 77 ANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-- 149 (323)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--
Confidence 9999999998753 45899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccCC
Q 006785 387 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 466 (631)
Q Consensus 387 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (631)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||............. . .+
T Consensus 150 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~-------------~--~~ 211 (323)
T cd05571 150 ---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-------------M--EE 211 (323)
T ss_pred ---CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH-------------c--CC
Confidence 12334579999999999999999999999999999999999999996532211100000 0 01
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006785 467 PRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 505 (631)
Q Consensus 467 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 505 (631)
. .+|......+.+|+.+||+.||++|| ++.++++.
T Consensus 212 ~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 212 I----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred C----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1 12333445588999999999999999 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=336.59 Aligned_cols=251 Identities=31% Similarity=0.514 Sum_probs=193.5
Q ss_pred ccceeeeeCceEEEEEEEC-----CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 228 GSNIVGQGGSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 228 ~~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
..+.||.|.||.||+|.+. .+..|+||+++........+.|.+|++.+++++||||++++|++.. ....++
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~----~~~~~l 78 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE----NEPLFL 78 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES----SSSEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc----cccccc
Confidence 3578999999999999987 2678999999765444456779999999999999999999999984 334799
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++|+|.++|.......+++.++..|+.||+.||.|||+.+ ++|+||+++|||++.++.+||+|||++.....
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence 999999999999998864566999999999999999999999998 99999999999999999999999999987632
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
.... .......+...|+|||.+....++.++||||||+++|||++ |+.||.......... . +
T Consensus 156 ~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~--~-----~------- 218 (259)
T PF07714_consen 156 KSKY---KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIE--K-----L------- 218 (259)
T ss_dssp SSSE---EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHH--H-----H-------
T ss_pred cccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--c-----c-------
Confidence 2111 11122346788999999999999999999999999999999 788886542211000 0 0
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 506 (631)
.+.... ..+..++..+.+++..||..+|++||++.+|++.|
T Consensus 219 ~~~~~~----~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 219 KQGQRL----PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HTTEET----TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccccc----eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 000001 12222344588999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=346.14 Aligned_cols=246 Identities=26% Similarity=0.400 Sum_probs=206.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
++|.+.+.||+|.||.||||+-+ +.+.||+|.+.+.. ..+....+.+|++|+++|+|||||.++.+|.. ...+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt----~~~~~ 77 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET----SAHLW 77 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc----cceEE
Confidence 45777888999999999999865 48999999987653 33455668999999999999999999988765 66889
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+|+||+.| +|..+|... ..+++..+..|+.+++.||.|||+.+ |+|||+||.||||+.++++|++|||+|+...
T Consensus 78 vVte~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 78 VVTEYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMS 151 (808)
T ss_pred EEehhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcc
Confidence 99999965 999999764 45999999999999999999999998 9999999999999999999999999999766
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
... ...+.+.|||.|||||.+.++.|+..+|+||+||||||+++|++||....... .+
T Consensus 152 ~~t-----~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~-----------------Lv 209 (808)
T KOG0597|consen 152 TNT-----SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ-----------------LV 209 (808)
T ss_pred cCc-----eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH-----------------HH
Confidence 532 34456779999999999999999999999999999999999999996432110 01
Q ss_pred cccC-CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 462 SELP-DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 462 ~~~~-~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
..|. ++. ..|...+..+..++...|.+||..|.+..+++.
T Consensus 210 ~~I~~d~v---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 210 KSILKDPV---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHHhcCCC---CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1111 111 234566777999999999999999999999885
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=340.04 Aligned_cols=246 Identities=24% Similarity=0.319 Sum_probs=198.9
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|...+.||+|+||.||+|... +|+.||||++.... .......+.+|+.++++++||||+++++++.+ ....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~ 76 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD----QRFL 76 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc----CCeE
Confidence 36788899999999999999976 58999999986432 12234458899999999999999999987765 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+++|+|.+++... +.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~ 151 (291)
T cd05612 77 YMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL 151 (291)
T ss_pred EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence 9999999999999999754 45899999999999999999999998 999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...........
T Consensus 152 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~-------------- 209 (291)
T cd05612 152 RDR--------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEK-------------- 209 (291)
T ss_pred cCC--------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------------
Confidence 422 1234689999999999988899999999999999999999999965332111000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-----MSEVVQI 505 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 505 (631)
+.... ..++......+.+|+.+||+.||.+||+ +.++++.
T Consensus 210 ---i~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 210 ---ILAGK--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---HHhCC--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 00000 0122223445889999999999999995 8877754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=355.59 Aligned_cols=258 Identities=27% Similarity=0.401 Sum_probs=215.9
Q ss_pred cceeeeeCceEEEEEEEC-C----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 229 SNIVGQGGSSYVYRGQLT-D----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~-~----g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
.++||.|+||+||+|.|- . .-+||||++.....++...+|+.|+.+|.+|+|||+++|+|+|.. ..+.||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~-----s~~qlv 775 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCML-----STLQLV 775 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhccc-----chHHHH
Confidence 578999999999999873 2 457999999988888888889999999999999999999999985 236899
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
++|++.|.|.+|++... ..+.....+.+..|||+||.|||++. +|||||..+||||..-..+||+|||+++.+..+
T Consensus 776 tq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999998743 45889999999999999999999998 999999999999999999999999999988766
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccccccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
..... .....-.+.|||-|.+....|+.++|||||||++|||+| |..|+++....+. .
T Consensus 852 ~~ey~---~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI------------------~ 910 (1177)
T KOG1025|consen 852 EKEYS---APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI------------------P 910 (1177)
T ss_pred ccccc---ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh------------------h
Confidence 53221 111223578999999999999999999999999999999 9999976543321 1
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcccc
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRR 516 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 516 (631)
.+.....+...|+.+...+..++.+||..|++.||+++++...+..++.+....
T Consensus 911 dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqry 964 (1177)
T KOG1025|consen 911 DLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRY 964 (1177)
T ss_pred HHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceE
Confidence 122222223456677777889999999999999999999999999998776543
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=329.10 Aligned_cols=255 Identities=23% Similarity=0.379 Sum_probs=204.7
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
.++|+..+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.. ....++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTK----EEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC----CCCcEE
Confidence 35688889999999999999998888899999986532 234568999999999999999999988765 456799
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 999999999999997655566899999999999999999999998 99999999999999999999999999987653
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
... .......++..|+|||++....++.++||||||+++|+|++ |+.||........ ... +
T Consensus 156 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~-----------~ 217 (261)
T cd05072 156 NEY----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSA-----------L 217 (261)
T ss_pred Cce----eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHH-----------H
Confidence 221 11122346778999999998899999999999999999998 9999864322110 000 0
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 508 (631)
...........++ ..+.+++.+||..+|++||++.++.+.|+.
T Consensus 218 ~~~~~~~~~~~~~----~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 218 QRGYRMPRMENCP----DELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HcCCCCCCCCCCC----HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0001111111233 448889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=330.54 Aligned_cols=255 Identities=27% Similarity=0.404 Sum_probs=203.9
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
.+|...+.||+|+||.||+|.+.+ ++.||+|++... ......+.+|++++++++|+||+++++++.. ....++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l 79 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR----EPPFYI 79 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcC----CCCcEE
Confidence 457778899999999999998764 889999998753 2334568999999999999999999998875 456799
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++++|.+++.......+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 999999999999997655556899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
.... ......++..|+|||++.+..++.++||||||+++|||++ |..||.......... .+
T Consensus 157 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~--------------~~ 218 (263)
T cd05052 157 DTYT----AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE--------------LL 218 (263)
T ss_pred ceee----ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--------------HH
Confidence 3211 1112234678999999999999999999999999999998 889986432111000 00
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
.....+ ..+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 219 ~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 219 EKGYRM----ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HCCCCC----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 000111 22233345588999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.46 Aligned_cols=246 Identities=25% Similarity=0.318 Sum_probs=198.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|.+.+.||+|+||.||+|++. +++.||||++.... .......+.+|+.+|++++||||+++++++.. ....
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~ 93 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD----ENRV 93 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc----CCEE
Confidence 56788899999999999999986 48999999987532 22334558899999999999999999998876 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168 (329)
T ss_pred EEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence 9999999999999999754 45889999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 169 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---------------- 224 (329)
T PTZ00263 169 PDR--------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY---------------- 224 (329)
T ss_pred CCC--------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH----------------
Confidence 432 12346999999999999999999999999999999999999999643221100
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-----MSEVVQI 505 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 505 (631)
..+....+ .+|......+.+|+.+||+.||.+||+ +.+++..
T Consensus 225 -~~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 225 -EKILAGRL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -HHHhcCCc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 00000000 112223345889999999999999997 5666653
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=334.06 Aligned_cols=268 Identities=23% Similarity=0.298 Sum_probs=199.9
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
++|.+.+.||+|+||.||+++++ +++.||||++..... ......+.+|+.+++.++||||+++++++.. ....|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 76 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR----RGKLY 76 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec----CCEEE
Confidence 36888999999999999999986 488999999975432 2334558899999999999999999998865 45789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||++++.|..+... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 77 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 151 (287)
T cd07848 77 LVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLS 151 (287)
T ss_pred EEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccc
Confidence 99999998777655432 245899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccc-----
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD----- 456 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~----- 456 (631)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..................+..
T Consensus 152 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07848 152 EGSN----ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKL 227 (287)
T ss_pred cccc----ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHh
Confidence 3211 1123456899999999999888999999999999999999999999753321111000000000000
Q ss_pred --ccccccccCCCCCC------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 457 --SGTVISELPDPRLK------GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 457 --~~~~~~~~~~~~l~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
..........+... .......+..+.+|+.+||+.||++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 228 FYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000001100 0111223456899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=356.47 Aligned_cols=275 Identities=22% Similarity=0.271 Sum_probs=217.4
Q ss_pred hcCccccceeeeeCceEEEEEEECCC-cEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCCcceeEE-eeec--cCCc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTDG-RIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGY-CSEF--RGKR 297 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~g-~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~-~~~~--~~~~ 297 (631)
..++++.+.|.+|||+.||.|.+..+ ..||+|++-.. .........+||++|++|+ |+|||.+++. .... .+..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 34566788999999999999998775 99999999876 5566677999999999995 9999999983 3222 2224
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
.+.+|.||||.||.|-|+++.+....|++.++++|+.++++|+++||... |+|||||||-+||||+.+++.||||||.|
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence 67899999999999999998877777999999999999999999999985 67999999999999999999999999998
Q ss_pred eecccCCCCC--C--CCCCcccccCCCCCCchhhh---cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhc
Q 006785 378 KRLKADGLPS--C--SSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA 450 (631)
Q Consensus 378 ~~~~~~~~~~--~--~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~ 450 (631)
......-... . ........-|+.|.|||++. +...++|+|||+|||+||-|+....||+....
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------- 263 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------- 263 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence 6432211000 0 00011123689999999885 66789999999999999999999999975321
Q ss_pred ccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcccccccC
Q 006785 451 TPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNIS 520 (631)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~ 520 (631)
..|.......+-.+..+..|..||..||+.||++||++.||+..+..++.......++.
T Consensus 264 -----------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 264 -----------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred -----------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 11222222222234667789999999999999999999999999998887655444444
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=341.93 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=201.9
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|.+.+.||+|+||.||+|++.+ ++.||||++..... ......+.+|++++..++||||+++++++.. ....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~----~~~~ 76 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD----DEYL 76 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc----CCEE
Confidence 368889999999999999999864 89999999975421 2334558899999999999999999998875 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 77 ~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~ 151 (333)
T cd05600 77 YLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGI 151 (333)
T ss_pred EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence 9999999999999999753 45899999999999999999999998 999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccch-hhhhcccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES-LVLWATPRLQDSGT 459 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~-~~~~~~~~~~~~~~ 459 (631)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... +..|..
T Consensus 152 ~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------- 215 (333)
T cd05600 152 VT--------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE-------- 215 (333)
T ss_pred cc--------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc--------
Confidence 43 1234569999999999999999999999999999999999999997543221111 001100
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+..+... ......+..+.+|+.+||..+|.+||++.++++.
T Consensus 216 ---~~~~~~~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 216 ---TLQRPVYD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ---cccCCCCC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00011100 0001234458889999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=333.68 Aligned_cols=266 Identities=23% Similarity=0.354 Sum_probs=199.0
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++|...+.||.|+||.||+|..+ +++.||+|+++..........+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~l 80 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT----ERCLTL 80 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC----CCeEEE
Confidence 46888899999999999999876 5899999999765444444557899999999999999999998865 457899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||++ |+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 v~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 81 VFEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred EEeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 999996 5999988653 234789999999999999999999998 99999999999999999999999999976543
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhc--c------cc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA--T------PR 453 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~--~------~~ 453 (631)
.. .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||............... . +.
T Consensus 156 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07871 156 PT-----KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG 230 (288)
T ss_pred CC-----ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc
Confidence 21 12233468999999998875 56899999999999999999999999654322211111000 0 00
Q ss_pred cccccccccccCCCCCCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 454 LQDSGTVISELPDPRLKG----DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 454 ~~~~~~~~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
+... ........+.... .........+.+|+.+||+.||.+|||+.|+++
T Consensus 231 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 231 ITSN-EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cccc-hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000 0000111111100 001112345789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=328.72 Aligned_cols=256 Identities=27% Similarity=0.393 Sum_probs=204.8
Q ss_pred HhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
..++|+..+.||+|+||.||+|.+.+++.||||.++... .....|.+|+.++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 77 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL----EEPIY 77 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEec----CCCee
Confidence 346688889999999999999998778899999987543 234558999999999999999999998775 44679
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++...
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 9999999999999997655456899999999999999999999998 9999999999999999999999999998775
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
..... .......+..|+|||++.+..++.++||||||+++|||++ |+.||.......... .
T Consensus 155 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~--~------------ 216 (261)
T cd05068 155 EDIYE----AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ--Q------------ 216 (261)
T ss_pred CCccc----ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--H------------
Confidence 32211 1111223468999999998899999999999999999999 999986432211000 0
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 508 (631)
+..... ...+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 217 ~~~~~~----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 217 VDQGYR----MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHcCCC----CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 000000 11122334558899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=331.79 Aligned_cols=256 Identities=26% Similarity=0.400 Sum_probs=203.5
Q ss_pred cCccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
++|.+.+.||+|+||.||+|.+.+ +..||||.++.....+....|.+|+++|++++|+||+++++++.. .
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~ 80 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE----G 80 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec----C
Confidence 457778899999999999998643 478999999866544455679999999999999999999999876 4
Q ss_pred ceEEEEEeeCCCCChHhhhhccc------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVL------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 365 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~ 365 (631)
...++||||+++++|.+++.... ...+++.++..++.|++.||.|||+.+ ++||||||+||+++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~ 157 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGY 157 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcC
Confidence 56899999999999999996532 234789999999999999999999998 999999999999999
Q ss_pred CCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccc
Q 006785 366 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEE 444 (631)
Q Consensus 366 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~ 444 (631)
++.++|+|||+++........ .......+++.|+|||++.+..++.++||||||+++|||++ |..||.........
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~ 234 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYY---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI 234 (280)
T ss_pred CCeEEECCcccceecccCcce---ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999999765432211 11223346788999999999999999999999999999998 99998654322111
Q ss_pred hhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 445 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
. .. .....+ ..+...+..+.+++.+||+.||++||++.||++.|.
T Consensus 235 ~---~~-----------~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 E---CI-----------TQGRLL----QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H---HH-----------HcCCcC----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 0 00 000000 112223345889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=327.37 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=199.9
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
++|+..+.||+|+||.||++.++++..+|+|.+.... .....|.+|+.+|++++||||+++++++.. ....++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ----QKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEcc----CCCEEEE
Confidence 4577788999999999999999888899999886442 223468999999999999999999998875 4567999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
|||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 78 TEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 99999999999997543 35899999999999999999999998 999999999999999999999999998865432
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccccccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
... ......++..|+|||++.+..++.++||||||+++|||++ |+.||........ .... ... .
T Consensus 154 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~i----~~~----~ 218 (256)
T cd05114 154 EYT----SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEMI----SRG----F 218 (256)
T ss_pred cee----ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH----HCC----C
Confidence 211 1122335678999999988889999999999999999999 8999864322111 0000 000 0
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
... .+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 219 ~~~-------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 219 RLY-------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCC-------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 001 11122345889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=340.34 Aligned_cols=243 Identities=26% Similarity=0.326 Sum_probs=195.0
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEee
Q 006785 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 306 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~ 306 (631)
+.||+|+||.||++... +|+.||||++.... .......+.+|+.+|+.++||||+++++++.. ....|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~lv~Ey 76 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT----KDRLCFVMEY 76 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc----CCEEEEEEeC
Confidence 36999999999999875 58999999997542 22334568899999999999999999988775 5578999999
Q ss_pred CCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCC
Q 006785 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 386 (631)
Q Consensus 307 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 386 (631)
+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-- 149 (328)
T cd05593 77 VNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-- 149 (328)
T ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--
Confidence 9999999988653 45899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccCC
Q 006785 387 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 466 (631)
Q Consensus 387 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (631)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||............. ...
T Consensus 150 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~---------------~~~ 211 (328)
T cd05593 150 ---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL---------------MED 211 (328)
T ss_pred ---cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc---------------cCC
Confidence 12234569999999999999999999999999999999999999996432211000000 001
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006785 467 PRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 505 (631)
Q Consensus 467 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 505 (631)
. .+|...+..+.+|+.+||+.||.+|| ++.++++.
T Consensus 212 ~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 212 I----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred c----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1 12233345588999999999999997 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=332.77 Aligned_cols=259 Identities=27% Similarity=0.403 Sum_probs=201.9
Q ss_pred HHhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeecc
Q 006785 221 HATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 294 (631)
Q Consensus 221 ~a~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 294 (631)
.+.++|+..+.||+|+||.||+|.+. .+..||||++...........|.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-- 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-- 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--
Confidence 35678999999999999999999753 2567999998654333344568999999999999999999998865
Q ss_pred CCcceEEEEEeeCCCCChHhhhhccc--------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCC
Q 006785 295 GKRAMRLLVFEFMPNGNLRDCLDGVL--------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 366 (631)
Q Consensus 295 ~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~ 366 (631)
....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|||++++
T Consensus 81 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 81 --GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 155 (277)
T ss_pred --CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCC
Confidence 456799999999999999996532 123688899999999999999999998 9999999999999999
Q ss_pred CCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccch
Q 006785 367 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEES 445 (631)
Q Consensus 367 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~ 445 (631)
+.++|+|||+++......... ......+++.|+|||++.+..++.++||||||+++|||++ |..||..........
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~ 232 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYR---KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232 (277)
T ss_pred CCEEECCCCCccccCCcceee---cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999987654322111 1112345788999999998899999999999999999999 688886432211000
Q ss_pred hhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 446 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
.. .....+ ..+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 233 ~~--------------~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 233 FV--------------MEGGLL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HH--------------HcCCcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 00 000000 112223345889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=329.84 Aligned_cols=256 Identities=27% Similarity=0.406 Sum_probs=207.5
Q ss_pred HhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
...+|+..+.||.|+||.||+|.+.++..+|+|.+..... .....+..|+.+++.++|+||+++++++.. ....+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~ 78 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSV----GEPVY 78 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEec----CCCeE
Confidence 4456888899999999999999998899999999876532 234568999999999999999999998875 45679
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++|+|.+++.......+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++....
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcC
Confidence 9999999999999998765566899999999999999999999998 9999999999999999999999999997664
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
.... ......++..|+|||++....++.++||||||+++|+|++ |+.||.......... ..
T Consensus 156 ~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~---~~---------- 217 (261)
T cd05148 156 EDVY-----LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYD---QI---------- 217 (261)
T ss_pred Cccc-----cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHH---HH----------
Confidence 3221 1123346778999999998899999999999999999998 899986433211100 00
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 508 (631)
. .......+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus 218 -~----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 218 -T----AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -H----hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 0 001111223334558899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=331.04 Aligned_cols=271 Identities=24% Similarity=0.364 Sum_probs=198.6
Q ss_pred cCccccceeeeeCceEEEEEEEC--CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhc---CCCCCcceeEEeeecc-CC
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT--DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRL---HHCHVVPLVGYCSEFR-GK 296 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l~~~~~~-~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~-~~ 296 (631)
++|.+.+.||+|+||.||+|+.. +++.||||+++..... .....+.+|+.+++.+ +||||+++++++.... ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999863 4788999998754322 2233467788887776 6999999999986422 12
Q ss_pred cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCc
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGl 376 (631)
....++||||++ ++|.+++.......+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 446899999995 69999997655556899999999999999999999998 99999999999999999999999999
Q ss_pred eeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhh-hcc-c--
Q 006785 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL-WAT-P-- 452 (631)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~-~~~-~-- 452 (631)
++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||............. ... +
T Consensus 157 ~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~ 230 (290)
T cd07862 157 ARIYSFQ------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 230 (290)
T ss_pred eEeccCC------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence 9865432 12234568999999999998899999999999999999999999997543321111100 000 0
Q ss_pred -ccccccccccccCCCCCCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 453 -RLQDSGTVISELPDPRLKG---DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 453 -~~~~~~~~~~~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
.+............+.... .........+.+|+.+||+.||++|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000000000000000000 011123345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=339.43 Aligned_cols=242 Identities=24% Similarity=0.285 Sum_probs=192.0
Q ss_pred eeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeCC
Q 006785 232 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 308 (631)
Q Consensus 232 LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~ 308 (631)
||+|+||.||+|...+ ++.||||++.... .......+.+|+.+|.+++||||+++++++.. ....|+||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~ 76 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS----PEKLYLVLAFIN 76 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec----CCeEEEEEcCCC
Confidence 6999999999998764 8899999987432 22334558899999999999999999988875 457899999999
Q ss_pred CCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCC
Q 006785 309 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 388 (631)
Q Consensus 309 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 388 (631)
+|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---- 147 (312)
T cd05585 77 GGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD---- 147 (312)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC----
Confidence 99999999753 45899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccCCCC
Q 006785 389 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 468 (631)
Q Consensus 389 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (631)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+....
T Consensus 148 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~-----------------~~~~~~~ 209 (312)
T cd05585 148 -DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY-----------------RKILQEP 209 (312)
T ss_pred -CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHH-----------------HHHHcCC
Confidence 1223456999999999999999999999999999999999999999643221100 0000000
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006785 469 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506 (631)
Q Consensus 469 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 506 (631)
..++......+.+|+.+||..||.+||++..+.+.|
T Consensus 210 --~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 210 --LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred --CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 112333445588999999999999998654443433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=326.90 Aligned_cols=257 Identities=26% Similarity=0.408 Sum_probs=204.4
Q ss_pred cCccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
++|+..+.||+|+||.||+|.+.. ...||||.++..........|.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 79 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK----SRP 79 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec----CCc
Confidence 568888999999999999998753 458999998766555555679999999999999999999998865 456
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.++|+|||+++.
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 80 VMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhc
Confidence 799999999999999997643 35899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||........ ...
T Consensus 156 ~~~~~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~---~~~--------- 220 (266)
T cd05033 156 LEDSEAT---YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV---IKA--------- 220 (266)
T ss_pred ccccccc---eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH---HHH---------
Confidence 7521110 01112335678999999998899999999999999999998 9999854322110 000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
+..... ...+...+..+.+|+.+||+.+|++||++.+|++.|..+
T Consensus 221 --~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 221 --VEDGYR----LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --HHcCCC----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000000 011222334588999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=331.74 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=201.1
Q ss_pred cCccccceeeeeCceEEEEEEE-----CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
+.|+..+.||+|+||.||+|.+ .++..||+|.+...........|.+|+.++++++||||+++++++.. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~ 80 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ----EQ 80 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec----CC
Confidence 4567788999999999999985 24678999999865444444568999999999999999999998765 44
Q ss_pred eEEEEEeeCCCCChHhhhhccc---------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVL---------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 363 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl 363 (631)
..|+||||+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili 157 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILI 157 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEE
Confidence 6799999999999999985321 134789999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccc
Q 006785 364 DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKG 442 (631)
Q Consensus 364 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~ 442 (631)
++++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~ 234 (283)
T cd05090 158 GEQLHVKISDLGLSREIYSADYY---RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE 234 (283)
T ss_pred cCCCcEEeccccccccccCCcce---ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 99999999999999876433211 11223346778999999988889999999999999999998 988986432211
Q ss_pred cchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006785 443 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508 (631)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 508 (631)
.... +...... ..+...+..+.+++.+||+.||++||++.+|.+.|..
T Consensus 235 ~~~~--------------~~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEM--------------VRKRQLL----PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHH--------------HHcCCcC----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 0000 0000001 1122233458889999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=330.21 Aligned_cols=259 Identities=25% Similarity=0.405 Sum_probs=201.2
Q ss_pred cCccccceeeeeCceEEEEEEECC-Cc----EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~----~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
++|...+.||+|+||.||+|.+.. ++ .+++|.+...........+..|+.+++++.||||+++++++.. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-----~ 81 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-----A 81 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-----C
Confidence 456778899999999999998743 44 4788887654444444568888999999999999999998742 3
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..++|+||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccce
Confidence 4689999999999999997532 45899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
........ .......++..|+|||++.++.++.++||||||+++|||++ |+.||............ ..
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~--------~~ 226 (279)
T cd05111 158 LLYPDDKK---YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL--------EK 226 (279)
T ss_pred eccCCCcc---cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--------HC
Confidence 76433211 11223457789999999998999999999999999999998 99998654321111100 00
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
+ .....+. .+ ...+..++.+||..+|++|||+.++++.|..+..+
T Consensus 227 ~---~~~~~~~---~~----~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 227 G---ERLAQPQ---IC----TIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred C---CcCCCCC---CC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 0 0011111 12 23467889999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=343.29 Aligned_cols=248 Identities=26% Similarity=0.375 Sum_probs=192.4
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
+|...+.||+|+||.||+|++. +++.||||++...........+.+|+++++.++|+||+++++++.. ....++|
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv 150 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH----NGEIQVL 150 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc----CCeEEEE
Confidence 3445688999999999999876 5899999999765444445668999999999999999999998865 4578999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
|||+++|+|.+.. ...+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 151 ~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 151 LEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred EecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 9999999987532 2567788899999999999999998 999999999999999999999999999876432
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhc-----CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~-----~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
. .......||..|+|||++.. ...+.++|||||||++|||++|+.||..............
T Consensus 222 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~--------- 287 (353)
T PLN00034 222 M-----DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA--------- 287 (353)
T ss_pred c-----ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH---------
Confidence 1 11233569999999998742 3346789999999999999999999963221111110000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+.....+ ..+......+.+|+.+||+.||++||++.|+++.
T Consensus 288 --~~~~~~~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 288 --ICMSQPP----EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --HhccCCC----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000011 1222334558999999999999999999999885
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=339.81 Aligned_cols=243 Identities=26% Similarity=0.318 Sum_probs=194.5
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEee
Q 006785 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 306 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~ 306 (631)
+.||+|+||.||++... +|+.||+|++.... .......+.+|+.+++.++||||+++++++.. ....|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~----~~~~~lv~E~ 76 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT----HDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec----CCEEEEEEeC
Confidence 36999999999999875 58999999997542 22334457889999999999999999998875 4578999999
Q ss_pred CCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCC
Q 006785 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 386 (631)
Q Consensus 307 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 386 (631)
+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-- 149 (323)
T cd05595 77 ANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-- 149 (323)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--
Confidence 9999999988653 45899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccCC
Q 006785 387 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 466 (631)
Q Consensus 387 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (631)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||............. . ..
T Consensus 150 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~-------------~--~~ 211 (323)
T cd05595 150 ---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-------------M--EE 211 (323)
T ss_pred ---CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh-------------c--CC
Confidence 12234569999999999999999999999999999999999999996432211100000 0 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006785 467 PRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 505 (631)
Q Consensus 467 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 505 (631)
. .+|...+..+.+|+.+||+.||.+|| ++.++++.
T Consensus 212 ~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 212 I----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred C----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1 12223344588999999999999998 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=378.29 Aligned_cols=263 Identities=26% Similarity=0.498 Sum_probs=205.9
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
...|...+.||+|+||.||+|++. ++..||||++...... ...|+++|++++|||||+++|+|.+ ....|
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~----~~~~~ 759 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRS----EKGAY 759 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEc----CCCCE
Confidence 345777889999999999999974 6899999998754321 2356899999999999999999976 34679
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++|+|.++++. ++|..+..|+.|+|+||+|||....++|+||||||+||+++.++.+++. ||.+....
T Consensus 760 lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~ 833 (968)
T PLN00113 760 LIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC 833 (968)
T ss_pred EEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence 99999999999999963 7999999999999999999996655569999999999999999888876 66654332
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
.+ ....||+.|+|||++.+..++.++|||||||++|||++|+.||+..... ......|........ ..
T Consensus 834 ~~---------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~--~~ 901 (968)
T PLN00113 834 TD---------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDC--HL 901 (968)
T ss_pred cC---------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCcc--ch
Confidence 11 1235889999999999999999999999999999999999999543221 223333433222111 12
Q ss_pred cccCCCCCCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 462 SELPDPRLKG--DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 462 ~~~~~~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
....++.+.. ..+......+.+++.+||+.||++||+|.||++.|+.+...
T Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred hheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 3334444433 23455666788999999999999999999999999988653
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=329.21 Aligned_cols=270 Identities=29% Similarity=0.386 Sum_probs=204.3
Q ss_pred cccceeeeeCceEEEEEEE-----CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 227 SGSNIVGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 227 ~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
...+.||+|+||+||++.. .++..||+|.++..........|.+|+++|++++||||+++++++.... ....+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~~~ 84 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG--GKGLQ 84 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--CceEE
Confidence 7788999999999988653 3578999999976544444566899999999999999999999886532 34679
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++|+|.+++.. ..+++.++..++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||+++...
T Consensus 85 lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 99999999999999965 34899999999999999999999998 9999999999999999999999999998664
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
..... ........++..|+|||.+....++.++||||||+++|||++|..||.......... ..+....... ..+
T Consensus 159 ~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~--~~~ 233 (283)
T cd05080 159 EGHEY--YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM-IGPKQGQMTV--VRL 233 (283)
T ss_pred Ccchh--hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhh-hcccccccch--hhh
Confidence 32210 011122345677999999988889999999999999999999999986433211100 0000000000 001
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
....+.......+...+..+.+++..||+.+|++|||+.+|++.|..+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 111111111223334455689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=338.08 Aligned_cols=257 Identities=24% Similarity=0.345 Sum_probs=202.1
Q ss_pred HhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
-.++|..+..||+|+||.||+++-++ |..+|+|+++.... .......+.|-.+|....+|.||+|+-.|.+ ..
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD----~~ 214 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD----KE 214 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC----CC
Confidence 35788899999999999999998765 99999999986532 2334458889999999999999999977765 67
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
++||||||++|||+..+|... ..|++..+..++.+++.|++-||+.| +|||||||+|+|||..|++||+||||+.
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred eeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccc
Confidence 899999999999999999764 56899999999999999999999999 9999999999999999999999999986
Q ss_pred ecccC----------------------CCCC---CCC-----------------CCcccccCCCCCCchhhhcCCCCccc
Q 006785 379 RLKAD----------------------GLPS---CSS-----------------SPARMQGTFGYFAPEYAMVGRASLMS 416 (631)
Q Consensus 379 ~~~~~----------------------~~~~---~~~-----------------~~~~~~Gt~~Y~APE~~~~~~~s~ks 416 (631)
-+... ..+. ... .....+|||-|||||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 43210 0000 000 00124699999999999999999999
Q ss_pred chhhHHHHHHHHHhCCCCCCCccccccc-hhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCC
Q 006785 417 DVFSFGVVLLELITGRQPIHRSITKGEE-SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDA 495 (631)
Q Consensus 417 DVwSlGviL~eLltG~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~ 495 (631)
|.||||+|+||||.|.+||....+..-. .+..|... +..| -......+..+||.+|+. ||++
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~-----------l~fP-----~~~~~s~eA~DLI~rll~-d~~~ 432 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET-----------LKFP-----EEVDLSDEAKDLITRLLC-DPEN 432 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh-----------ccCC-----CcCcccHHHHHHHHHHhc-CHHH
Confidence 9999999999999999999876654321 22233211 1111 111223558889999999 9999
Q ss_pred CCC---HHHHHH
Q 006785 496 RPT---MSEVVQ 504 (631)
Q Consensus 496 RPs---~~evl~ 504 (631)
|.- +.||.+
T Consensus 433 RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 433 RLGSKGAEEIKK 444 (550)
T ss_pred hcCcccHHHHhc
Confidence 975 666644
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=331.76 Aligned_cols=267 Identities=23% Similarity=0.363 Sum_probs=197.8
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.++|.+.+.||+|+||.||+|... +++.||||++...........+.+|+.+++.++||||+++++++.. ....+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~ 79 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT----KETLT 79 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec----CCeEE
Confidence 367888999999999999999986 5899999999765433334457899999999999999999998875 45789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+ .++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 80 lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 80 LVFEYV-HTDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred EEEECC-CcCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 999999 57888888653 245899999999999999999999998 9999999999999999999999999987543
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccch-hhh--hcccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES-LVL--WATPRLQDS 457 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~-~~~--~~~~~~~~~ 457 (631)
... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......... ... ...+.. ..
T Consensus 155 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~ 228 (303)
T cd07869 155 VPS-----HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNE-DT 228 (303)
T ss_pred CCC-----ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCCh-hh
Confidence 221 12233468999999998875 458899999999999999999999997532211000 000 000000 00
Q ss_pred ccccc---ccCCCCCCCCCCH---------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 458 GTVIS---ELPDPRLKGDFPK---------EEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 458 ~~~~~---~~~~~~l~~~~~~---------~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
..... ...........+. .....+.+|+.+||+.||.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 229 WPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 0000000000000 01234788999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=319.46 Aligned_cols=270 Identities=24% Similarity=0.302 Sum_probs=207.2
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChH-HHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~-~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
++|+.++.|++|+||.||+|+++ +++.||+|+++........ -.-++||.+|.+++|||||.+..+..-.. -+.+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~--~d~iy 153 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN--MDKIY 153 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc--cceee
Confidence 44666889999999999999976 4899999999866433321 23689999999999999999998876433 34589
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
||||||+ -||..+++... ++|...++..+..|+++|++|||.+. |+|||||++|+|+++.|.+||+||||||.+.
T Consensus 154 ~VMe~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 154 IVMEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eeHHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999995 59999998754 67999999999999999999999999 9999999999999999999999999999886
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchh--hhhcccc-----
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL--VLWATPR----- 453 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~--~~~~~~~----- 453 (631)
.. ....+..+-|..|.|||.+.+. .|++..|+||+|||+.||+++++-|.+...-.+... .....|.
T Consensus 229 sp-----~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 229 SP-----LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred CC-----cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence 54 2345667899999999999875 599999999999999999999988876543322111 1111111
Q ss_pred ---ccccc--ccccccCCCCCCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 454 ---LQDSG--TVISELPDPRLKGDFPKE-EMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 454 ---~~~~~--~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..... ....+.+...++..++.. ..+.-.+|+..+|..||.+|.|+.+.++.
T Consensus 304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 10000 001111112233333332 44557789999999999999999999874
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=341.04 Aligned_cols=246 Identities=24% Similarity=0.294 Sum_probs=198.5
Q ss_pred cCccccceeeeeCceEEEEEEECC--CcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD--GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~--g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
++|...+.||+|+||.||+|.++. +..||||++.... .......+.+|+.+++.++||||+++++++.+ ...
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~----~~~ 105 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD----ESY 105 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe----CCE
Confidence 468888999999999999998653 3689999986432 22334568899999999999999999999876 557
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 89999999999999999754 45899999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 181 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~-------------- 238 (340)
T PTZ00426 181 VDTR--------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ-------------- 238 (340)
T ss_pred cCCC--------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH--------------
Confidence 5321 234569999999999999889999999999999999999999997532211000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 505 (631)
.+..... .+|......+.+++.+||+.||.+|+ ++.++++.
T Consensus 239 ---~i~~~~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 239 ---KILEGII--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---HHhcCCC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0000000 12222334578899999999999995 78888654
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=336.97 Aligned_cols=201 Identities=27% Similarity=0.419 Sum_probs=174.2
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.++|++.+.||+|+||.||++.+. ++..+|+|++...........+.+|+++++.++||||+++++++.. ....+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 79 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS----DGEIS 79 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE----CCEEE
Confidence 467888999999999999999986 4889999998765444445568999999999999999999999886 45789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++|+|.+++... ..+++..+..++.+++.||.|||+.+ +|+||||||+|||++.++.+||+|||++....
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 999999999999999753 45889999999999999999999752 29999999999999999999999999987653
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~ 438 (631)
.. ......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 156 DS-------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hh-------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 32 112346899999999999888999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=325.85 Aligned_cols=255 Identities=24% Similarity=0.386 Sum_probs=204.7
Q ss_pred HhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
..+.|.+.+.||+|+||.||+|..++++.||+|.+..... ....|.+|+.++++++|+||+++++++. ....+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT-----QEPIY 76 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc-----cCCcE
Confidence 3467888999999999999999988899999999875432 3356899999999999999999998764 23579
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++++|.+++.......+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 9999999999999997655556899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
..... ......++..|+|||++....++.++||||||+++|||++ |+.||.......... .
T Consensus 154 ~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~----------- 215 (260)
T cd05067 154 DNEYT----AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ---N----------- 215 (260)
T ss_pred CCCcc----cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH---H-----------
Confidence 32211 1122346778999999998899999999999999999999 999996433211100 0
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 508 (631)
+...... ..+...+..+.+++.+||..+|++||++.+++..|..
T Consensus 216 ~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 216 LERGYRM----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHcCCCC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0000011 1122223458999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=330.79 Aligned_cols=259 Identities=25% Similarity=0.402 Sum_probs=202.9
Q ss_pred CccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
+|.+.+.||+|+||.||+|... ....+|+|.+...........+.+|+.+++.++||||+++++.+.. ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ----DG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec----CC
Confidence 3667889999999999999863 2357999988765444445568999999999999999999998875 44
Q ss_pred eEEEEEeeCCCCChHhhhhccc----------------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCC
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVL----------------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 356 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl 356 (631)
..++||||+.+|+|.+++.... ...+++.+++.++.|++.||+|||+.+ |+||||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~di 153 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDL 153 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhh
Confidence 6799999999999999986421 134889999999999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCC
Q 006785 357 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPI 435 (631)
Q Consensus 357 Kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~ 435 (631)
||+|||+++++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||
T Consensus 154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 230 (290)
T cd05045 154 AARNVLVAEGRKMKISDFGLSRDVYEEDSY---VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230 (290)
T ss_pred hhheEEEcCCCcEEeccccccccccCccch---hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999865432211 01122345678999999988889999999999999999998 99998
Q ss_pred CCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 436 HRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
....... +..+ +.+. .....+...+..+.+++..||+.+|++||++.++++.|+++..
T Consensus 231 ~~~~~~~---~~~~-----------~~~~----~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 231 PGIAPER---LFNL-----------LKTG----YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCCCHHH---HHHH-----------HhCC----CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 6432211 1110 0000 0111222333458899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=323.86 Aligned_cols=259 Identities=24% Similarity=0.330 Sum_probs=205.2
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|.+.+.||+|+||.||+|+.. +++.||||.+.... .......|.+|+++++.++||||+++++++.. ....
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 77 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE----DNEL 77 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE----CCeE
Confidence 56888999999999999999875 58999999886432 23334458899999999999999999998876 4577
Q ss_pred EEEEeeCCCCChHhhhhccc--cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 301 LLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~ 154 (267)
T cd08228 78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccce
Confidence 99999999999999885422 234789999999999999999999998 9999999999999999999999999988
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
...... .......|++.|+|||++.+..++.++||||||+++|||++|+.||........ ....
T Consensus 155 ~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-~~~~---------- 218 (267)
T cd08228 155 FFSSKT-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-SLCQ---------- 218 (267)
T ss_pred eccchh-----HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH-HHHH----------
Confidence 764321 111234588999999999988899999999999999999999999864322110 0000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
.+.....+. ..+...+..+.+++.+||+.+|++||++.+|++.|.++
T Consensus 219 -~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 219 -KIEQCDYPP---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -HHhcCCCCC---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 001111111 11223445689999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=329.63 Aligned_cols=253 Identities=25% Similarity=0.381 Sum_probs=200.4
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
+|+..+.||+|+||+||++... +++.||||++..... ......+.+|+.++++++||||+++++++.. ....+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 76 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET----KDALC 76 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC----CCeEE
Confidence 3677889999999999999875 589999999875322 2223457889999999999999999998865 45789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++|+|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIP 153 (285)
T ss_pred EEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 9999999999999886544456999999999999999999999998 9999999999999999999999999998754
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
... ......|++.|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 154 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~------------- 214 (285)
T cd05605 154 EGE------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE------------- 214 (285)
T ss_pred CCC------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH-------------
Confidence 321 1123468999999999998899999999999999999999999997532211100000
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 505 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 505 (631)
..+. .....++...+..+.+|+.+||+.||.+|| ++.++++.
T Consensus 215 ~~~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 215 RRVK--EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHhh--hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0000 001122334455688999999999999999 78888664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=309.41 Aligned_cols=271 Identities=25% Similarity=0.355 Sum_probs=211.1
Q ss_pred hcCccccceeeeeCceEEEEEE-ECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC-CcceE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG-KRAMR 300 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~~~~ 300 (631)
.++|.+.+.||+|||.-||+++ ..++..+|+|++.... .+..+..++|++..++++||||++++++...... .....
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 3567788999999999999998 4568999999998765 4556668999999999999999999988865443 35578
Q ss_pred EEEEeeCCCCChHhhhhccccC--CCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVE--GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
||+++|...|+|.+.++....+ .+++.+.++|+.+|++||++||+.. |+++||||||.|||+.+.+.++|.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999765433 4999999999999999999999986 569999999999999999999999999987
Q ss_pred ecccCCCCC----CCCCCcccccCCCCCCchhhhc---CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcc
Q 006785 379 RLKADGLPS----CSSSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 451 (631)
Q Consensus 379 ~~~~~~~~~----~~~~~~~~~Gt~~Y~APE~~~~---~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~ 451 (631)
...-.-... ....+....-|..|.|||.+.- ...++++|||||||+||+|+.|..||+.....+..-
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl------ 251 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL------ 251 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE------
Confidence 643211000 0011223346899999998863 457999999999999999999999997544332211
Q ss_pred cccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 452 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 452 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
...+..+.+..+-....+..+.+|+++|++.||.+||++.+++..+..+.
T Consensus 252 ---------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 252 ---------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11122222211111224556999999999999999999999999887664
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=344.59 Aligned_cols=243 Identities=22% Similarity=0.336 Sum_probs=202.3
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~ 298 (631)
.++|..+++||+|.||.|+++..+. ++.+|||++++... .+..+..+.|..|+... +||.+++|+..+.. ..
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT----~~ 442 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT----KE 442 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc----CC
Confidence 4678999999999999999999874 88999999997643 23344578888888877 69999999988775 67
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
++|+||||+.||++..+.+. +.|++..+.-+|..|+.||.|||+++ ||+||||.+|||||.+|++||+||||++
T Consensus 443 ~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred eEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 89999999999995554442 45999999999999999999999999 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
.....+ ....++.||+.|||||++.+..|+..+|.|||||+||||+.|..||.+..+.+-...+.
T Consensus 517 e~m~~g-----~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~---------- 581 (694)
T KOG0694|consen 517 EGMGQG-----DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV---------- 581 (694)
T ss_pred ccCCCC-----CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh----------
Confidence 654322 35567899999999999999999999999999999999999999998654432211111
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM 499 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 499 (631)
.. ...+|..++.+...|++++|..+|++|.-+
T Consensus 582 -------~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 582 -------ND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -------cC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 00 013566667778899999999999999866
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=336.91 Aligned_cols=272 Identities=23% Similarity=0.335 Sum_probs=197.5
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC-CcceEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG-KRAMRL 301 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~~~~~ 301 (631)
+|++.+.||+|+||.||+|+.. +|+.||||++.... .......+.+|+.++++++||||+++++++..... .....|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999875 58999999987432 22233458899999999999999999998864321 223579
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+ +++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 999999 57999988753 45899999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhc--CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhh-hh-cccc----
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-LW-ATPR---- 453 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~--~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~~-~~~~---- 453 (631)
..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||............ .. ..+.
T Consensus 155 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 155 NDTPT--AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccCc--cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 32111 112234579999999999875 67899999999999999999999999653221100000 00 0000
Q ss_pred --ccc--ccccccccCC---CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 454 --LQD--SGTVISELPD---PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 454 --~~~--~~~~~~~~~~---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+.. ....+..+.. ..+...++ .....+.+++.+||+.||++|||+.++++.
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFP-NADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcC-CCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000 0000000000 00000011 123447889999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=331.70 Aligned_cols=263 Identities=27% Similarity=0.422 Sum_probs=206.0
Q ss_pred HHHhcCccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeee
Q 006785 220 EHATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 292 (631)
Q Consensus 220 ~~a~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 292 (631)
+...++|+..+.||+|+||.||++.+.+ ...+|+|++...........+.+|++++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 3345668888999999999999998642 3689999988654444455688999999999 89999999998875
Q ss_pred ccCCcceEEEEEeeCCCCChHhhhhcc--------------ccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCC
Q 006785 293 FRGKRAMRLLVFEFMPNGNLRDCLDGV--------------LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 358 (631)
Q Consensus 293 ~~~~~~~~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp 358 (631)
....++||||+++|+|.++++.. ....+++..++.++.|++.||.|||+.+ |+||||||
T Consensus 88 ----~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp 160 (293)
T cd05053 88 ----EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAA 160 (293)
T ss_pred ----CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccce
Confidence 44679999999999999999642 2345899999999999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 006785 359 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 437 (631)
Q Consensus 359 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~ 437 (631)
+|||+++++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 237 (293)
T cd05053 161 RNVLVTEDHVMKIADFGLARDIHHIDYY---RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237 (293)
T ss_pred eeEEEcCCCeEEeCccccccccccccce---eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence 9999999999999999999876543211 11122235678999999998899999999999999999998 8899864
Q ss_pred ccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 438 SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
......... +.. ......+......+.+|+.+||..||++|||+.++++.|..+.
T Consensus 238 ~~~~~~~~~--------------~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 238 IPVEELFKL--------------LKE----GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCHHHHHHH--------------HHc----CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 322110000 000 0011122233445889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=324.24 Aligned_cols=254 Identities=28% Similarity=0.439 Sum_probs=202.9
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
.++|++.+.||+|+||.||+|.+.++..||+|.+..... ....|.+|+.++++++|+|++++++++.+ ...++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-----~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVSE-----EPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEECC-----CCcEE
Confidence 356788899999999999999988888899999876433 23458999999999999999999988642 34689
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++++|.+++.......+++.++..++.+++.||+|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 999999999999997654556899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
.... ......++..|+|||++....++.++||||||+++|||++ |..||....... .... +
T Consensus 155 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~-----------~ 216 (260)
T cd05070 155 NEYT----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQ-----------V 216 (260)
T ss_pred cccc----cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH-----------H
Confidence 3211 1122235678999999988899999999999999999999 888986432111 0000 0
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 508 (631)
... .....+...+..+.+|+.+||..+|++|||+.++.+.|..
T Consensus 217 ~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 217 ERG----YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HcC----CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 000 0111223334558899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=339.93 Aligned_cols=258 Identities=29% Similarity=0.487 Sum_probs=217.0
Q ss_pred cCccccceeeeeCceEEEEEEECC---C--cEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD---G--RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~---g--~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
......++||.|-||.||+|...+ | -.||||.-+.+..++..+.|+.|..+|+.++||||++|+|+|.+ .
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-----~ 463 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-----Q 463 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-----c
Confidence 344556889999999999998653 2 36999999988888888889999999999999999999999985 3
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..|||||+++.|.|..||+.+. ..++..+...++.||..+|+|||+.. +|||||..+|||+....-+||+||||++
T Consensus 464 P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhh
Confidence 5699999999999999998643 55899999999999999999999988 9999999999999999999999999999
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
.+.++.+...+ ...-.+.|||||.+...+++.+||||-|||.+||++. |..||+......
T Consensus 540 ~~ed~~yYkaS----~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD--------------- 600 (974)
T KOG4257|consen 540 YLEDDAYYKAS----RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD--------------- 600 (974)
T ss_pred hccccchhhcc----ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc---------------
Confidence 98877654322 2234678999999999999999999999999999988 999997654332
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
++..+. ..-+.++|+.++..+..|+.+||..+|.+||++.++...|..+...
T Consensus 601 --VI~~iE-nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 601 --VIGHIE-NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred --eEEEec-CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 111111 1112346667777799999999999999999999999999887653
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=325.89 Aligned_cols=248 Identities=22% Similarity=0.332 Sum_probs=206.7
Q ss_pred cCccccceeeeeCceEEEEEEE-CCCcEEEEEEeccCCCCCh--HHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNA--DSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
.+|++.+.||+|.||.|-+|.. ..|+.||||.++.+..... ...+.+|++||+.|+||||+.++.+|.. .+.+
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN----kdKI 128 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN----KDKI 128 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC----CceE
Confidence 4667778899999999999976 5699999999987644333 3347899999999999999999988764 6678
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
.|||||..+|.|+||+... +.|++.++..++.||..|+.|+|.++ ++|||||.+|||||+|+++||+||||+..+
T Consensus 129 vivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhh
Confidence 9999999999999999875 56999999999999999999999998 999999999999999999999999999887
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
... ....++.|++-|.+||++.+.+| ++.+|-|||||+||-|+.|..||++......
T Consensus 204 ~~~------kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l---------------- 261 (668)
T KOG0611|consen 204 ADK------KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL---------------- 261 (668)
T ss_pred ccc------cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH----------------
Confidence 654 34567899999999999998887 7899999999999999999999987544321
Q ss_pred cccccCCCCCCC-CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 460 VISELPDPRLKG-DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 460 ~~~~~~~~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
+..+.....+. ..| ....-||++||..||++|.|+.+|...-+
T Consensus 262 -vrQIs~GaYrEP~~P----SdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 262 -VRQISRGAYREPETP----SDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred -HHHhhcccccCCCCC----chHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 11222211111 122 22566899999999999999999987654
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=328.47 Aligned_cols=261 Identities=27% Similarity=0.402 Sum_probs=207.3
Q ss_pred hcCccccceeeeeCceEEEEEEECC-----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
.++|...+.||+|+||.||+|.+.+ +..|++|++...........+.+|+.++++++|+||+++++++... .
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~ 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED---G 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC---C
Confidence 4678888999999999999999765 7889999987655555566689999999999999999999988653 3
Q ss_pred ceEEEEEeeCCCCChHhhhhcccc------CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEE
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLV------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 371 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL 371 (631)
...+++++|+++|+|.+++..... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEE
Confidence 456999999999999999965322 35899999999999999999999998 999999999999999999999
Q ss_pred eccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhc
Q 006785 372 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWA 450 (631)
Q Consensus 372 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~ 450 (631)
+|||+++.+....... ......++..|+|||++.+..++.++||||||+++||+++ |+.||....... ...+.
T Consensus 159 ~d~g~~~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~ 232 (280)
T cd05043 159 TDNALSRDLFPMDYHC---LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYL 232 (280)
T ss_pred CCCCCcccccCCceEE---eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHH
Confidence 9999998654332111 1122346778999999998889999999999999999999 999996532211 11110
Q ss_pred ccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 451 TPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
. ..........++ ..+.+++.+||..||++|||+.++++.|..+.
T Consensus 233 ~-----------~~~~~~~~~~~~----~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 233 K-----------DGYRLAQPINCP----DELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred H-----------cCCCCCCCCcCC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0 000111111223 45889999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=337.55 Aligned_cols=243 Identities=26% Similarity=0.325 Sum_probs=193.9
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEee
Q 006785 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 306 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~ 306 (631)
+.||+|+||.||++... +|+.||||++.... .......+..|++++..++||||+++++++.. ....|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~----~~~~~lv~E~ 76 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT----HDRLCFVMEY 76 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc----CCEEEEEEeC
Confidence 36999999999999875 58999999997542 22334457889999999999999999988775 5578999999
Q ss_pred CCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHh-cCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCC
Q 006785 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 307 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 385 (631)
+++|+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~- 150 (325)
T cd05594 77 ANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG- 150 (325)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-
Confidence 9999999988653 458999999999999999999997 67 9999999999999999999999999987543221
Q ss_pred CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccC
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (631)
.......||+.|+|||++.+..++.++||||||++||||++|+.||............. ..
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~---------------~~ 211 (325)
T cd05594 151 ----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL---------------ME 211 (325)
T ss_pred ----cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh---------------cC
Confidence 12234569999999999999999999999999999999999999996533211111000 00
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006785 466 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 505 (631)
Q Consensus 466 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 505 (631)
.. .+|......+.+|+.+||+.||++|+ ++.++++.
T Consensus 212 ~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 212 EI----RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CC----CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 01 12222334588999999999999996 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=324.22 Aligned_cols=255 Identities=28% Similarity=0.436 Sum_probs=203.2
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
.++|.+.+.||+|+||.||+|.+.+...||||++..... ....|.+|++++++++||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-----~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-----EPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEECC-----CCcEE
Confidence 356888899999999999999987777899999975332 23468999999999999999999987642 34689
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 999999999999997654456899999999999999999999998 99999999999999999999999999987653
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
.... ......++..|+|||+..+..++.++||||||+++|||++ |..||........... +
T Consensus 155 ~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~--------------~ 216 (262)
T cd05071 155 NEYT----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ--------------V 216 (262)
T ss_pred cccc----cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH--------------H
Confidence 3211 1122346778999999988899999999999999999999 8888854322110000 0
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
...... ..+...+..+.+|+.+||+.+|++||++.++++.|+..
T Consensus 217 ~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 217 ERGYRM----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred hcCCCC----CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 000000 11233445588999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=345.42 Aligned_cols=265 Identities=23% Similarity=0.370 Sum_probs=205.8
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCCcceeEEee
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCS 291 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~ 291 (631)
++...++|.+.+.||+|+||.||+|++.+ +..||||+++..........+.+|+.+|.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 34445667778999999999999998642 46899999986544444556899999999997 999999999987
Q ss_pred eccCCcceEEEEEeeCCCCChHhhhhcccc--------------------------------------------------
Q 006785 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLV-------------------------------------------------- 321 (631)
Q Consensus 292 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------- 321 (631)
. ....++||||+++|+|.++|+....
T Consensus 112 ~----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 112 K----GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred c----CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 6 3467999999999999999964311
Q ss_pred ----------------------------------------------CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecC
Q 006785 322 ----------------------------------------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 355 (631)
Q Consensus 322 ----------------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD 355 (631)
..+++..++.++.|++.||+|||+.+ |+|||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrd 264 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRD 264 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCccc
Confidence 23678889999999999999999988 99999
Q ss_pred CCCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCC
Q 006785 356 IKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434 (631)
Q Consensus 356 lKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P 434 (631)
|||+|||+++++.+||+|||+++........ .......+++.|+|||++....++.++||||||+++|||++ |..|
T Consensus 265 lkp~NiLl~~~~~~kL~DfGla~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P 341 (401)
T cd05107 265 LAARNVLICEGKLVKICDFGLARDIMRDSNY---ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP 341 (401)
T ss_pred CCcceEEEeCCCEEEEEecCcceeccccccc---ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999865432211 11123357889999999998889999999999999999998 8889
Q ss_pred CCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 435 IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
|............ +.. ......|...+..+.+|+.+||..+|.+||++.+|++.|+.+.
T Consensus 342 ~~~~~~~~~~~~~-------------~~~----~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 342 YPELPMNEQFYNA-------------IKR----GYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCCCCchHHHHHH-------------HHc----CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 8543221110000 000 0011122233455899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.08 Aligned_cols=243 Identities=26% Similarity=0.364 Sum_probs=193.5
Q ss_pred ceeeeeCceEEEEEEEC----CCcEEEEEEeccCC---CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 230 NIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+.||+|+||.||+++.. .++.||||+++... .......+..|+.+|+.++||||+++++++.. ....|+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~----~~~~~l 77 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT----GGKLYL 77 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec----CCeEEE
Confidence 57999999999999753 47899999987532 22233457889999999999999999998875 457899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++|+|.+++... ..+.+..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 78 ILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred EEeCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 99999999999999753 45788999999999999999999998 99999999999999999999999999875433
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......... .
T Consensus 153 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~-----------------~ 210 (323)
T cd05584 153 EG-----TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI-----------------D 210 (323)
T ss_pred CC-----CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH-----------------H
Confidence 21 1223356999999999999888999999999999999999999999653321100 0
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 505 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 505 (631)
.+.... ...|...+..+.+|+.+||+.+|++|| ++.++++.
T Consensus 211 ~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 211 KILKGK--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HHHcCC--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 111110 012233344588999999999999999 78887663
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=328.26 Aligned_cols=257 Identities=27% Similarity=0.405 Sum_probs=200.8
Q ss_pred hcCccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCC
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 296 (631)
+++|.+.+.||+|+||.||+|.+.+ +..||+|.+...........|.+|+.++++++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE---- 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----
Confidence 4678889999999999999998753 568999988765444445569999999999999999999998875
Q ss_pred cceEEEEEeeCCCCChHhhhhcccc-----CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC---C
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLV-----EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL---N 368 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~---~ 368 (631)
....++||||+++++|.+++..... ..+++..++.++.||+.||+|||+.+ ++||||||+|||++.++ .
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~ 157 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRV 157 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcc
Confidence 3456999999999999999965432 24899999999999999999999998 99999999999998654 5
Q ss_pred eEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhh
Q 006785 369 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLV 447 (631)
Q Consensus 369 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~ 447 (631)
+||+|||+++......... .......+..|+|||++.+..++.++|||||||++|||++ |..||............
T Consensus 158 ~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~ 234 (277)
T cd05036 158 AKIADFGMARDIYRASYYR---KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV 234 (277)
T ss_pred eEeccCccccccCCcccee---cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 8999999998763322110 1112234568999999999999999999999999999997 99998653322111100
Q ss_pred hhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 448 LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
.... ....+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 235 --------------~~~~----~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 --------------TGGG----RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --------------HcCC----cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0000 01122233445889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.52 Aligned_cols=253 Identities=25% Similarity=0.311 Sum_probs=196.2
Q ss_pred CccccceeeeeCceEEEEEEEC----CCcEEEEEEeccCC---CCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCC
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGK 296 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 296 (631)
+|++.+.||+|+||.||+++.. +++.||+|++.... .......+..|+.++..+ +|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT---- 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec----
Confidence 4778899999999999999753 58899999986431 222334578899999999 69999999988765
Q ss_pred cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCc
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGl 376 (631)
....++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~ 151 (332)
T cd05614 77 EAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGL 151 (332)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcC
Confidence 45789999999999999999653 45899999999999999999999998 99999999999999999999999999
Q ss_pred eeecccCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccc
Q 006785 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 455 (631)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 455 (631)
++.+..... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||..............
T Consensus 152 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~------ 221 (332)
T cd05614 152 SKEFLSEEK----ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR------ 221 (332)
T ss_pred CccccccCC----CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH------
Confidence 986543221 122345799999999998865 478999999999999999999999964322111110000
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006785 456 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 505 (631)
Q Consensus 456 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 505 (631)
.+.. .++. ++...+..+.+++.+||+.||++|| ++.++++.
T Consensus 222 ----~~~~-~~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 222 ----RILK-CDPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ----HHhc-CCCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0000 1111 2233344588999999999999999 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=321.76 Aligned_cols=249 Identities=28% Similarity=0.438 Sum_probs=196.0
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeCC
Q 006785 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 308 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~ 308 (631)
+.||+|+||.||+|.+. +++.||+|.+...........|.+|++++++++||||+++++++.. ....++||||++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~ 76 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ----KQPIYIVMELVQ 76 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC----CCCeEEEEeecc
Confidence 36899999999999875 5899999988755444445669999999999999999999999875 446799999999
Q ss_pred CCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCC
Q 006785 309 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 388 (631)
Q Consensus 309 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 388 (631)
+++|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 77 ~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-- 150 (252)
T cd05084 77 GGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA-- 150 (252)
T ss_pred CCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccc--
Confidence 99999999753 245899999999999999999999998 999999999999999999999999998764422110
Q ss_pred CCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccccccccccCCC
Q 006785 389 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDP 467 (631)
Q Consensus 389 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (631)
.......++..|+|||.+.++.++.++||||||+++|||++ |..||............ ..
T Consensus 151 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~--------------~~---- 211 (252)
T cd05084 151 -STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI--------------EQ---- 211 (252)
T ss_pred -ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH--------------Hc----
Confidence 00111123567999999999999999999999999999998 88888543221110000 00
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 468 RLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 468 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
......+...+..+.+|+.+||+.+|++|||+.+|++.|.
T Consensus 212 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 212 GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 0011122233455889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.11 Aligned_cols=260 Identities=23% Similarity=0.357 Sum_probs=204.8
Q ss_pred hcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccC
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRG 295 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 295 (631)
.++|...+.||+|+||.||+|.+. .+..||||+++........+.+.+|+.+++++ +||||+++++++..
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--- 110 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI--- 110 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec---
Confidence 356888999999999999999752 24579999987654444456689999999999 89999999998875
Q ss_pred CcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccC
Q 006785 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 375 (631)
Q Consensus 296 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFG 375 (631)
....|+||||+++|+|.+++.......+++.++..++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||
T Consensus 111 -~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 111 -GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred -CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence 446799999999999999997654444899999999999999999999998 9999999999999999999999999
Q ss_pred ceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccc
Q 006785 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRL 454 (631)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~ 454 (631)
+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||......... ...
T Consensus 187 ~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~~~----- 256 (302)
T cd05055 187 LARDIMNDSNY---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--YKL----- 256 (302)
T ss_pred ccccccCCCce---eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--HHH-----
Confidence 99865432210 11122346788999999999999999999999999999998 99998643321110 000
Q ss_pred ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 455 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 455 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
+.....+ ..+...+..+.+++.+||..+|++||++.++++.|.++
T Consensus 257 ------~~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 257 ------IKEGYRM----AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ------HHcCCcC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0000001 11122234588999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=323.45 Aligned_cols=252 Identities=23% Similarity=0.359 Sum_probs=199.3
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
++|...+.||+|+||.||+|.+.++..+|||.+.... .....|.+|+.++++++||||+++++++.+ ....++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK----QRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc----CCCcEEE
Confidence 3467788999999999999998777789999987543 223568999999999999999999999865 3457999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.....
T Consensus 78 ~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 78 TEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 99999999999997643 35899999999999999999999998 999999999999999999999999998865432
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccccccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
.. .......++..|+|||++.+..++.++||||||+++|||++ |..||............ .
T Consensus 154 ~~----~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~--------------~ 215 (256)
T cd05113 154 EY----TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV--------------S 215 (256)
T ss_pred ce----eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH--------------h
Confidence 21 11112335678999999998889999999999999999998 99998643321100000 0
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
....+ ..+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 216 ~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 216 QGLRL----YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred cCCCC----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00000 011112345889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=325.94 Aligned_cols=260 Identities=26% Similarity=0.406 Sum_probs=204.0
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCc----EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
++|...+.||+|+||+||+|.+. +|+ .||||++...........+.+|+.+++.++|+||+++++++.. .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~ 81 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-----S 81 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----C
Confidence 56777899999999999999864 344 4899999766555556678999999999999999999998864 2
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..+++|||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCcee
Confidence 4589999999999999997542 45899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||....... ...+
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~-------- 223 (279)
T cd05109 158 LLDIDETE---YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDL-------- 223 (279)
T ss_pred ecccccce---eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH--------
Confidence 76532211 01112235678999999998899999999999999999998 889986432111 0000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 513 (631)
+.....+ ..+...+..+.+++.+||+.||++||++.++++.|..+....
T Consensus 224 ---~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 224 ---LEKGERL----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ---HHCCCcC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0000001 111223345889999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=322.01 Aligned_cols=249 Identities=25% Similarity=0.407 Sum_probs=196.3
Q ss_pred eeeeCceEEEEEEEC---CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeCC
Q 006785 232 VGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 308 (631)
Q Consensus 232 LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~ 308 (631)
||+|+||.||+|.+. .+..||||++.........+.|.+|+.++++++||||+++++++.. ...++||||++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-----~~~~lv~e~~~ 77 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-----EALMLVMEMAS 77 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-----CCeEEEEEeCC
Confidence 899999999999864 3567999999766544445669999999999999999999998742 35699999999
Q ss_pred CCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCC
Q 006785 309 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 388 (631)
Q Consensus 309 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 388 (631)
+|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++..........
T Consensus 78 ~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~- 152 (257)
T cd05115 78 GGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY- 152 (257)
T ss_pred CCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccce-
Confidence 99999999753 245899999999999999999999998 9999999999999999999999999998654332111
Q ss_pred CCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccccccccccCCC
Q 006785 389 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDP 467 (631)
Q Consensus 389 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (631)
.......++..|+|||++....++.++||||||+++|||++ |..||............ .....
T Consensus 153 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~--------------~~~~~- 216 (257)
T cd05115 153 -KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI--------------EQGKR- 216 (257)
T ss_pred -eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH--------------HCCCC-
Confidence 11112234678999999988889999999999999999996 99999654321110000 00001
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 468 RLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 468 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
...+...+..+.+++.+||..+|++||++.+|.+.|..+
T Consensus 217 ---~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 217 ---LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 112333345588999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=341.26 Aligned_cols=256 Identities=22% Similarity=0.316 Sum_probs=197.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|++.+.||+|+||.||+|+.. +|+.||||++.... .......+.+|+.+|..++||||+++++++.. ....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~----~~~~ 76 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD----ENYL 76 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc----CCeE
Confidence 46888999999999999999976 48999999997532 12333457889999999999999999998876 5678
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++..+
T Consensus 77 ~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 77 YLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred EEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceec
Confidence 9999999999999999753 45899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCCCC---------------------------------CCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHH
Q 006785 381 KADGLPSCS---------------------------------SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLE 427 (631)
Q Consensus 381 ~~~~~~~~~---------------------------------~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~e 427 (631)
......... .......||+.|+|||++....++.++|||||||++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 231 (364)
T cd05599 152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231 (364)
T ss_pred cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHH
Confidence 322110000 00112469999999999999999999999999999999
Q ss_pred HHhCCCCCCCccccccch-hhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHH
Q 006785 428 LITGRQPIHRSITKGEES-LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT---MSEVV 503 (631)
Q Consensus 428 LltG~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl 503 (631)
|++|..||.......... ...|. ..+..+. ....+..+.+|+.+|+. +|.+|++ +.+++
T Consensus 232 l~~G~~Pf~~~~~~~~~~~i~~~~-----------~~~~~~~-----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll 294 (364)
T cd05599 232 MLVGYPPFCSDNPQETYRKIINWK-----------ETLQFPD-----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIK 294 (364)
T ss_pred hhcCCCCCCCCCHHHHHHHHHcCC-----------CccCCCC-----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHh
Confidence 999999997543221100 00000 0000000 01123447788899986 9999998 88886
Q ss_pred HH
Q 006785 504 QI 505 (631)
Q Consensus 504 ~~ 505 (631)
+.
T Consensus 295 ~h 296 (364)
T cd05599 295 SH 296 (364)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=320.34 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=198.5
Q ss_pred CccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~ 304 (631)
+|++.+.||+|+||.||+|.++++..+|||++..... ....|.+|+++++.++||||+++++++.. ....++||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~ 78 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTK----QRPIFIVT 78 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcC----CCceEEEE
Confidence 4667889999999999999988778899999864322 23458899999999999999999998765 45679999
Q ss_pred eeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCC
Q 006785 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (631)
Q Consensus 305 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~ 384 (631)
||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 79 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 79 EYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred ecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 9999999999997543 35899999999999999999999998 9999999999999999999999999998654322
Q ss_pred CCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccccccccc
Q 006785 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISE 463 (631)
Q Consensus 385 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (631)
.. ......++..|+|||++.+..++.++||||||+++|||++ |+.||.......... .+..
T Consensus 155 ~~----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~--------------~~~~ 216 (256)
T cd05059 155 YT----SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE--------------SVSA 216 (256)
T ss_pred cc----ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH--------------HHHc
Confidence 11 1112234568999999999999999999999999999999 899986432211100 0001
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006785 464 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506 (631)
Q Consensus 464 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 506 (631)
.... ..+...+..+.+++.+||..+|++|||+.++++.|
T Consensus 217 ~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 217 GYRL----YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCcC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1111 11222344588999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=338.36 Aligned_cols=263 Identities=27% Similarity=0.407 Sum_probs=203.0
Q ss_pred hcCccccceeeeeCceEEEEEEE------CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccC
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQL------TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRG 295 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 295 (631)
.++|.+.+.||+|+||.||+|.+ .+++.||||+++..........+.+|+.+|.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC--
Confidence 46788899999999999999974 247899999998654444455688999999999 789999999988642
Q ss_pred CcceEEEEEeeCCCCChHhhhhccc-------------------------------------------------------
Q 006785 296 KRAMRLLVFEFMPNGNLRDCLDGVL------------------------------------------------------- 320 (631)
Q Consensus 296 ~~~~~~lV~E~~~~gsL~~~l~~~~------------------------------------------------------- 320 (631)
....++||||+++|+|.+++....
T Consensus 84 -~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 84 -GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred -CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 346789999999999999986421
Q ss_pred ----------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCCCC
Q 006785 321 ----------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 390 (631)
Q Consensus 321 ----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 390 (631)
...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......... .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---~ 236 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---V 236 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcch---h
Confidence 123688899999999999999999998 999999999999999999999999999865332110 1
Q ss_pred CCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccccccccccCCCCC
Q 006785 391 SPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRL 469 (631)
Q Consensus 391 ~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 469 (631)
......++..|+|||++.+..++.++||||||+++|||++ |..||........... .+......
T Consensus 237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-------------~~~~~~~~-- 301 (343)
T cd05103 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR-------------RLKEGTRM-- 301 (343)
T ss_pred hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHH-------------HHhccCCC--
Confidence 1122345678999999998899999999999999999997 8999864322111000 00000001
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 470 KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 470 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
..+......+.+++..||+.+|++||++.+|++.|..+..
T Consensus 302 --~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 302 --RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred --CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1111122348889999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=324.56 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=201.7
Q ss_pred HHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccC--C
Q 006785 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRG--K 296 (631)
Q Consensus 221 ~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~--~ 296 (631)
.+++.|+..+.||+|+||.||+|.+. +++.||||++.... .....+..|+.+++++ +|+||+++++++..... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 45677888899999999999999875 48899999987543 3344588999999999 79999999999875332 1
Q ss_pred cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCc
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGl 376 (631)
....|+||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 346899999999999999998654456899999999999999999999998 99999999999999999999999999
Q ss_pred eeecccCCCCCCCCCCcccccCCCCCCchhhh-----cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcc
Q 006785 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 451 (631)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~ 451 (631)
+....... .......|+..|+|||++. ...++.++|||||||++|||++|+.||............
T Consensus 158 ~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~---- 228 (272)
T cd06637 158 SAQLDRTV-----GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---- 228 (272)
T ss_pred ceeccccc-----ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH----
Confidence 87654321 1223456899999999986 345788999999999999999999999643221111000
Q ss_pred cccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 452 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 452 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
.....+.. .+...+..+.+|+.+||..+|.+|||+.++++
T Consensus 229 ----------~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 ----------PRNPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ----------hcCCCCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00000111 11122345889999999999999999999976
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=340.16 Aligned_cols=256 Identities=24% Similarity=0.323 Sum_probs=201.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|.+.+.||+|+||.||+|... +|+.||||+++... .......+.+|++++..++||||+++++++.+ ....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~ 76 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD----EEHL 76 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec----CCeE
Confidence 36888999999999999999976 58999999997532 22344568899999999999999999988775 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 151 (350)
T cd05573 77 YLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKM 151 (350)
T ss_pred EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence 9999999999999999764 56899999999999999999999998 999999999999999999999999999866
Q ss_pred ccCCC------------------------CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCC
Q 006785 381 KADGL------------------------PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436 (631)
Q Consensus 381 ~~~~~------------------------~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~ 436 (631)
..... ...........||+.|+|||++.+..++.++|||||||+||||++|+.||.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~ 231 (350)
T cd05573 152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231 (350)
T ss_pred cccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCC
Confidence 44320 000012234569999999999999999999999999999999999999997
Q ss_pred Cccccccch-hhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 006785 437 RSITKGEES-LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-MSEVVQI 505 (631)
Q Consensus 437 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 505 (631)
......... +..|. ..+..+.. ...+..+.+|+.+||. ||.+||+ +.++++.
T Consensus 232 ~~~~~~~~~~i~~~~-----------~~~~~p~~-----~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 232 SDTLQETYNKIINWK-----------ESLRFPPD-----PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCHHHHHHHHhccC-----------CcccCCCC-----CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 543211100 00000 00001110 1123458889999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=334.27 Aligned_cols=245 Identities=22% Similarity=0.330 Sum_probs=191.7
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHH---HhcCCCCCcceeEEeeeccCCcce
Q 006785 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDML---SRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
|.+.+.||+|+||.||+|.+. +|+.||||+++... .......+.+|+.++ +.++||||+++++++.. ...
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~----~~~ 76 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT----EDH 76 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc----CCE
Confidence 566789999999999999875 48999999997532 222334566776665 56689999999998875 557
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.|+||||+++|+|..++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 77 ~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05589 77 VCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKE 150 (324)
T ss_pred EEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence 8999999999999988864 45899999999999999999999998 99999999999999999999999999875
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 151 ~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~-------------- 211 (324)
T cd05589 151 GMGFG-----DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD-------------- 211 (324)
T ss_pred CCCCC-----CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH--------------
Confidence 33211 12234579999999999999999999999999999999999999996532211100
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQ 504 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 504 (631)
.+.... ..+|...+..+.+++.+||+.||.+|| ++.++++
T Consensus 212 ---~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 212 ---SIVNDE--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---HHHhCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 000000 012223344578899999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.43 Aligned_cols=262 Identities=26% Similarity=0.402 Sum_probs=204.6
Q ss_pred hcCccccceeeeeCceEEEEEEEC--------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeec
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 293 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 293 (631)
.++|.+.+.||+|+||.||++... ++..+|+|.++..........+.+|+.+++++ +||||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~- 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence 356888999999999999999753 23579999998654444455688999999999 89999999999876
Q ss_pred cCCcceEEEEEeeCCCCChHhhhhcccc--------------CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCC
Q 006785 294 RGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359 (631)
Q Consensus 294 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~ 359 (631)
....|+||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.+ ++||||||+
T Consensus 96 ---~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~ 169 (307)
T cd05098 96 ---DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 169 (307)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHH
Confidence 4567999999999999999975321 24899999999999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCc
Q 006785 360 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (631)
Q Consensus 360 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~ 438 (631)
|||++.++.+||+|||+++........ .......+++.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYY---KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchh---hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 999999999999999998765432111 11112234578999999998889999999999999999998 88888543
Q ss_pred cccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 439 ITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
........ +... .....+...+..+.+|+.+||..+|++||++.+|++.|..+...
T Consensus 247 ~~~~~~~~--------------~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 247 PVEELFKL--------------LKEG----HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred CHHHHHHH--------------HHcC----CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 21110000 0000 01122333445688999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=328.62 Aligned_cols=256 Identities=25% Similarity=0.362 Sum_probs=200.1
Q ss_pred CccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
.|.+.+.||+|+||.||+|.+.+ +..||||+++..........|.+|+.++..++||||+++++++.. ..
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~----~~ 81 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK----EQ 81 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----CC
Confidence 35567889999999999998642 578999999865443344568899999999999999999999875 44
Q ss_pred eEEEEEeeCCCCChHhhhhccc--------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeec
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 364 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~ 364 (631)
..++++||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVF 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEec
Confidence 6799999999999999985211 134889999999999999999999998 99999999999999
Q ss_pred CCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccc
Q 006785 365 ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGE 443 (631)
Q Consensus 365 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~ 443 (631)
+++.+||+|||+++........ .......+++.|+|||++..+.++.++||||||+++|||++ |..||........
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred CCCceEecccccccccccchhe---eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999998865432211 11122346789999999998899999999999999999998 8888864322110
Q ss_pred chhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006785 444 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508 (631)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 508 (631)
. ..+.+.. ....+...+..+.+|+..||+.+|++||++.+|++.|+.
T Consensus 236 ~-----------------~~i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 I-----------------EMIRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H-----------------HHHHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 0 0011110 011233344558899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=321.90 Aligned_cols=253 Identities=30% Similarity=0.440 Sum_probs=202.2
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
++|.+.+.||+|+||.||+|.+.++..+|+|++.... .....|.+|+.++++++|+|++++++++.. ...++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-----EPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-----CCcEEE
Confidence 4577788999999999999998777789999886543 233558999999999999999999988642 346899
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
|||+++|+|.+++.......+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||+++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 99999999999997655456899999999999999999999998 999999999999999999999999999876433
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccccccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
... ......++..|+|||++.+..++.++||||||+++|||++ |..||......... .+ +.
T Consensus 156 ~~~----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~-----------~~ 217 (260)
T cd05069 156 EYT----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL---EQ-----------VE 217 (260)
T ss_pred ccc----ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH-----------HH
Confidence 211 1122346778999999998899999999999999999999 89998653321110 00 00
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 508 (631)
....+ ..+...+..+.+++.+||..||++||++.+|++.|+.
T Consensus 218 ~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 218 RGYRM----PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cCCCC----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00011 1223344568999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=306.48 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=210.2
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|.+.+.||+|-||.||.|+.+ ++-.||+|++..... .....++.+|++|-+.|+||||+++++++.+ ....
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd----~~ri 97 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD----SKRI 97 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec----ccee
Confidence 56888999999999999999875 478999999875421 2233458999999999999999999999987 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
||++||.++|.|...|+......++......+..|+|.||.|+|..+ ||||||||+|+|++.++.+||+|||-+...
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999999777777999999999999999999999988 999999999999999999999999998654
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
. ........||.-|++||+..+..++..+|+|++|++.||++.|.+||....... .
T Consensus 175 p-------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-----------------t 230 (281)
T KOG0580|consen 175 P-------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-----------------T 230 (281)
T ss_pred C-------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-----------------H
Confidence 3 234567889999999999999999999999999999999999999997544221 1
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
..++..-.+ .+|...+....+++.+|+..+|.+|.+..|+++.-+
T Consensus 231 YkrI~k~~~--~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 231 YKRIRKVDL--KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred HHHHHHccc--cCCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 111211111 233445556889999999999999999999987643
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=341.51 Aligned_cols=262 Identities=21% Similarity=0.277 Sum_probs=195.8
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
..+|.+.+.||+|+||.||++.+. .++.||||.... ..+.+|+++|++|+||||+++++++.. ....+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~----~~~~~ 159 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTY----NKFTC 159 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEE----CCeeE
Confidence 367999999999999999999875 489999997542 237899999999999999999999875 45779
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+|||++ +++|..++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 160 lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 160 LILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred EEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 999999 57999988653 45899999999999999999999998 9999999999999999999999999997543
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccc-----hh--hhh--cc-
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE-----SL--VLW--AT- 451 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~-----~~--~~~--~~- 451 (631)
... ........||+.|+|||++.+..++.++||||||++||||++|+.||......... .+ ... ..
T Consensus 234 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~ 309 (391)
T PHA03212 234 DIN----ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTH 309 (391)
T ss_pred ccc----ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCC
Confidence 211 11223457999999999999999999999999999999999999887543211100 00 000 00
Q ss_pred c-ccc-ccccccc--------c-cCCCCCCCCC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 452 P-RLQ-DSGTVIS--------E-LPDPRLKGDF--PKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 452 ~-~~~-~~~~~~~--------~-~~~~~l~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+ .+. .....+. . ...+...... ....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 310 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 310 PNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 000 0000000 0 0001000000 01234568899999999999999999999863
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=329.62 Aligned_cols=261 Identities=27% Similarity=0.409 Sum_probs=204.3
Q ss_pred hcCccccceeeeeCceEEEEEEEC--------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeec
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 293 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 293 (631)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+...........+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~- 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec-
Confidence 456777899999999999999742 24579999987654444556689999999999 89999999998875
Q ss_pred cCCcceEEEEEeeCCCCChHhhhhccc--------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCC
Q 006785 294 RGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359 (631)
Q Consensus 294 ~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~ 359 (631)
....|+||||+++|+|.+++.... ...+++.++..++.||+.||.|||+.+ |+||||||+
T Consensus 93 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 166 (304)
T cd05101 93 ---DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR 166 (304)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccc
Confidence 456799999999999999996532 134789999999999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCc
Q 006785 360 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (631)
Q Consensus 360 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~ 438 (631)
|||+++++.+||+|||+++........ .......+++.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYY---KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred eEEEcCCCcEEECCCccceeccccccc---ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999876433211 11122346778999999998889999999999999999998 78887543
Q ss_pred cccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 439 ITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
........ +..... ...+...+..+.+|+.+||+.+|++||++.++++.|.++..
T Consensus 244 ~~~~~~~~--------------~~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 244 PVEELFKL--------------LKEGHR----MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred CHHHHHHH--------------HHcCCc----CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 22110000 000000 01122334558889999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=320.02 Aligned_cols=260 Identities=23% Similarity=0.335 Sum_probs=205.7
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|+..+.||+|+||.||+|... ++..+|||.+..... ......|.+|+.+++.++|+||+++++++.+ ....
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~ 77 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE----DNEL 77 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe----CCeE
Confidence 46777889999999999999864 689999998865322 2233568899999999999999999999876 4578
Q ss_pred EEEEeeCCCCChHhhhhcc--ccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 301 LLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~ 154 (267)
T cd08229 78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhh
Confidence 9999999999999998642 2245899999999999999999999998 9999999999999999999999999987
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
...... .......|+..|+|||++.+..++.++||||||+++|+|++|..||.......... .
T Consensus 155 ~~~~~~-----~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~----------- 217 (267)
T cd08229 155 FFSSKT-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL-C----------- 217 (267)
T ss_pred ccccCC-----cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHH-h-----------
Confidence 654322 11223468899999999998889999999999999999999999986432111000 0
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
..+.....+.+ .+...+..+.+++.+||+.+|++|||+.+|++.+.++.
T Consensus 218 ~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 218 KKIEQCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred hhhhcCCCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 00111111111 11234456889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=320.98 Aligned_cols=248 Identities=27% Similarity=0.383 Sum_probs=195.2
Q ss_pred eeeeeCceEEEEEEEC---CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEee
Q 006785 231 IVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 306 (631)
Q Consensus 231 ~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~ 306 (631)
.||+|+||.||+|.++ ++..+|||+++.... ......|..|+.+++.++||||+++++++.. ...++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-----ESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCcEEEEec
Confidence 5899999999999753 478999999875432 2344568999999999999999999998742 356899999
Q ss_pred CCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCC
Q 006785 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 386 (631)
Q Consensus 307 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 386 (631)
+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||.|||++.++.+||+|||+++........
T Consensus 77 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 77 AELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 9999999999753 45899999999999999999999998 999999999999999999999999999876433211
Q ss_pred CCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccccccccccC
Q 006785 387 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465 (631)
Q Consensus 387 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (631)
. .......++..|+|||.+....++.++||||||+++|||++ |+.||........ ... +....
T Consensus 152 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~-----------i~~~~ 215 (257)
T cd05116 152 Y--KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV---TQM-----------IESGE 215 (257)
T ss_pred e--eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH-----------HHCCC
Confidence 0 11122335678999999988889999999999999999998 9999965322110 000 00000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006785 466 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508 (631)
Q Consensus 466 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 508 (631)
.+ ..|...+..+.+|+.+||+.||++||++.+|.+.|..
T Consensus 216 ~~----~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 216 RM----ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CC----CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11 1223334558899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=322.17 Aligned_cols=259 Identities=24% Similarity=0.346 Sum_probs=197.9
Q ss_pred cccceeeeeCceEEEEEEECC-Cc--EEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC--CcceE
Q 006785 227 SGSNIVGQGGSSYVYRGQLTD-GR--IVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRAMR 300 (631)
Q Consensus 227 ~~~~~LG~G~fG~Vy~~~~~~-g~--~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~~~~ 300 (631)
.+.+.||+|+||.||+|.+.+ +. .||||.++... .......|.+|+.+++.++|+||+++++++..... .....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999999765 33 69999887542 23334568999999999999999999998854322 12356
Q ss_pred EEEEeeCCCCChHhhhhcc----ccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCc
Q 006785 301 LLVFEFMPNGNLRDCLDGV----LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGl 376 (631)
++||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999987421 1234899999999999999999999998 99999999999999999999999999
Q ss_pred eeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccc
Q 006785 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQ 455 (631)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~ 455 (631)
++........ .......+++.|+|||++....++.++||||||+++|||++ |+.||........... +.
T Consensus 159 ~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-------~~ 228 (272)
T cd05075 159 SKKIYNGDYY---RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY-------LR 228 (272)
T ss_pred ccccCcccce---ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HH
Confidence 9876433211 11122346678999999999999999999999999999999 7888864322110000 00
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 456 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 456 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
...... .+...+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 229 -------~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 229 -------QGNRLK----QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -------cCCCCC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000001 1122334588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=318.18 Aligned_cols=251 Identities=23% Similarity=0.289 Sum_probs=203.1
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
+|++.+.||+|+||.||++... +++.+|+|.++........+.+.+|+.+++.++|+||+++++++.. ....|+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 76 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA----DGHLYIV 76 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE----CCEEEEE
Confidence 4677899999999999999876 4889999998755444455668899999999999999999998875 5578999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
|||+++|+|.+++.......+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++.....
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 99999999999987655556899999999999999999999998 999999999999999999999999999876433
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 463 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (631)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|..||........... +..
T Consensus 154 ~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~--------------~~~ 214 (255)
T cd08219 154 GA-----YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK--------------VCQ 214 (255)
T ss_pred cc-----ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH--------------Hhc
Confidence 21 12345688999999999988899999999999999999999999964322110000 000
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 464 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 464 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
... ...+...+..+.+|+.+||+.||++||++.+|+..
T Consensus 215 ~~~----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 215 GSY----KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCC----CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 000 01223334458899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.98 Aligned_cols=254 Identities=22% Similarity=0.299 Sum_probs=199.2
Q ss_pred HHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 221 ~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
...++|...+.||+|+||.||+++.. +++.||||++.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~----~ 115 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD----D 115 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec----C
Confidence 34578899999999999999999876 48899999986431 12233447889999999999999999988775 5
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
...|+||||+++|+|.+++... .++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~ 189 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccce
Confidence 5789999999999999998653 4788889999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcC----CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG----RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 453 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~----~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~ 453 (631)
......... ......||+.|+|||++... .++.++|||||||+||||++|+.||..........
T Consensus 190 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~-------- 257 (370)
T cd05596 190 MKMDANGMV----RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS-------- 257 (370)
T ss_pred eeccCCCcc----cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHH--------
Confidence 876433211 12345699999999998653 47899999999999999999999996533211100
Q ss_pred cccccccccccCCCCCCCCCC--HHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 006785 454 LQDSGTVISELPDPRLKGDFP--KEEMQIMAYLAKECLQLDPDA--RPTMSEVVQI 505 (631)
Q Consensus 454 ~~~~~~~~~~~~~~~l~~~~~--~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 505 (631)
.+........+| ...+..+.+|+..||+.+|.+ ||++.++++.
T Consensus 258 ---------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 258 ---------KIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---------HHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 010000000111 123455888999999999987 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=327.67 Aligned_cols=263 Identities=27% Similarity=0.397 Sum_probs=203.8
Q ss_pred HHHhcCccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeec
Q 006785 220 EHATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293 (631)
Q Consensus 220 ~~a~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 293 (631)
+...++|++.+.||+|+||.||+|..++ +..||||.+...........+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 80 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK- 80 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence 3456789999999999999999997542 458999998755444444568899999999999999999998765
Q ss_pred cCCcceEEEEEeeCCCCChHhhhhccc--------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC
Q 006785 294 RGKRAMRLLVFEFMPNGNLRDCLDGVL--------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 365 (631)
Q Consensus 294 ~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~ 365 (631)
....++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++
T Consensus 81 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~ 154 (288)
T cd05061 81 ---GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAH 154 (288)
T ss_pred ---CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcC
Confidence 346799999999999999996422 123577889999999999999999998 999999999999999
Q ss_pred CCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccc
Q 006785 366 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEE 444 (631)
Q Consensus 366 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~ 444 (631)
++.++|+|||+++........ .......++..|+|||.+.++.++.++||||||+++|||++ |..||.........
T Consensus 155 ~~~~~L~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~ 231 (288)
T cd05061 155 DFTVKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 231 (288)
T ss_pred CCcEEECcCCccccccccccc---cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999865432211 11122345678999999999999999999999999999999 78888643221100
Q ss_pred hhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 445 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
. .+.+... ...+...+..+.+++.+||+.+|++|||+.++++.|....
T Consensus 232 ~-----------------~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 232 K-----------------FVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred H-----------------HHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 0 0000000 0112222345899999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=333.00 Aligned_cols=249 Identities=23% Similarity=0.333 Sum_probs=192.9
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
+.||+|+||.||++++. +++.||||+++... .......+.+|..++..+ +||||+++++++.. ....|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~----~~~~~lv~e 76 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT----ESRLFFVIE 76 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc----CCEEEEEEe
Confidence 36999999999999876 48899999997542 223344578899999998 79999999998875 557899999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCC
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 385 (631)
|+++|+|.+++... +.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 150 (329)
T cd05588 77 FVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG- 150 (329)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC-
Confidence 99999999988653 45999999999999999999999998 9999999999999999999999999987532211
Q ss_pred CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccc--cchhhhhcccccccccccccc
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKG--EESLVLWATPRLQDSGTVISE 463 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 463 (631)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......+. ...
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~----------~~~ 216 (329)
T cd05588 151 ----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL----------FQV 216 (329)
T ss_pred ----CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHH----------HHH
Confidence 12234579999999999999999999999999999999999999996422111 00000000 000
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 006785 464 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT------MSEVVQ 504 (631)
Q Consensus 464 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~ 504 (631)
+..... ..|...+..+.+++.+||+.||.+||+ +.++++
T Consensus 217 ~~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 217 ILEKQI--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHcCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 111110 122333445889999999999999998 556654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=316.12 Aligned_cols=251 Identities=29% Similarity=0.360 Sum_probs=203.1
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+|...+.||+|+||.||+|... +++.|++|.+.... .......+.+|++++++++||||+++++++.+ ....|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l 76 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD----KGKLNI 76 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc----CCEEEE
Confidence 4677789999999999999875 48999999987532 33445568999999999999999999998876 457899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++++|.+++.......+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++....
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~ 153 (256)
T cd08529 77 VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD 153 (256)
T ss_pred EEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence 999999999999998754567999999999999999999999998 99999999999999999999999999887654
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
.. .......|++.|+|||++.+..++.++||||||+++|||++|+.||....... .... +.
T Consensus 154 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~-----------~~ 214 (256)
T cd08529 154 NT-----NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LILK-----------II 214 (256)
T ss_pred cc-----chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHH-----------HH
Confidence 32 11233468899999999999999999999999999999999999996443211 0000 00
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
....+ ..+......+.+++.+||+.+|++||++.++++.
T Consensus 215 ~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 215 RGVFP----PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred cCCCC----CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 00011 1222334558999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=316.92 Aligned_cols=259 Identities=24% Similarity=0.355 Sum_probs=206.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccC--CCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ--GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|+..+.||+|+||.||+|... +|+.||+|.++.. ........+.+|++++++++|+|++++++++.. ....
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~----~~~~ 77 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE----NNEL 77 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec----CCeE
Confidence 57888999999999999999987 6899999988643 222334568999999999999999999999876 4577
Q ss_pred EEEEeeCCCCChHhhhhcc--ccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 301 LLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
++||||+++|+|.+++... ....+++.++..++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~ 154 (267)
T cd08224 78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceee
Confidence 9999999999999998643 2244899999999999999999999998 9999999999999999999999999987
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
...... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||....... ...
T Consensus 155 ~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~--------- 216 (267)
T cd08224 155 FFSSKT-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSL--------- 216 (267)
T ss_pred eccCCC-----cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH----HHH---------
Confidence 654321 11223468899999999998889999999999999999999999985432110 000
Q ss_pred ccccccCCCCCCCCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 459 TVISELPDPRLKGDFPK-EEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
...+... .....+. ..+..+.+++.+||..+|++||++.+|++.|..+.
T Consensus 217 --~~~~~~~-~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 217 --CKKIEKC-DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --HhhhhcC-CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0000000 0011122 34455889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=339.89 Aligned_cols=256 Identities=21% Similarity=0.300 Sum_probs=194.4
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.|...+.||+|+||+||+|+.. +++.||||++.... .......+.+|+.+|++++||||+++++++.+ ...+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~----~~~~~ 77 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD----KDNLY 77 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec----CCEEE
Confidence 5778899999999999999875 48899999997542 22334568899999999999999999999876 55789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 78 lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~ 152 (381)
T cd05626 78 FVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFR 152 (381)
T ss_pred EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccc
Confidence 999999999999999754 45899999999999999999999998 9999999999999999999999999986432
Q ss_pred cCCCCC------------------------------------------CCCCCcccccCCCCCCchhhhcCCCCcccchh
Q 006785 382 ADGLPS------------------------------------------CSSSPARMQGTFGYFAPEYAMVGRASLMSDVF 419 (631)
Q Consensus 382 ~~~~~~------------------------------------------~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVw 419 (631)
...... .........||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (381)
T cd05626 153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232 (381)
T ss_pred cccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcccee
Confidence 110000 00011235799999999999988899999999
Q ss_pred hHHHHHHHHHhCCCCCCCccccccc-hhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHH--hcccCCCCC
Q 006785 420 SFGVVLLELITGRQPIHRSITKGEE-SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE--CLQLDPDAR 496 (631)
Q Consensus 420 SlGviL~eLltG~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~--cl~~dP~~R 496 (631)
||||++|||++|+.||......... ....|.. .+..+. ...++ ..+.+|+.+ |+..++..|
T Consensus 233 SlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-----------~~~~~~-~~~~s----~~~~dli~~ll~~~~~~~~R 296 (381)
T cd05626 233 SVGVILFEMLVGQPPFLAPTPTETQLKVINWEN-----------TLHIPP-QVKLS----PEAVDLITKLCCSAEERLGR 296 (381)
T ss_pred ehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccc-----------ccCCCC-CCCCC----HHHHHHHHHHccCcccccCC
Confidence 9999999999999999754322111 0000000 000000 01123 346677776 455666679
Q ss_pred CCHHHHHHH
Q 006785 497 PTMSEVVQI 505 (631)
Q Consensus 497 Ps~~evl~~ 505 (631)
|++.++++.
T Consensus 297 ~~~~~~l~h 305 (381)
T cd05626 297 NGADDIKAH 305 (381)
T ss_pred CCHHHHhcC
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=324.42 Aligned_cols=246 Identities=26% Similarity=0.367 Sum_probs=192.5
Q ss_pred eeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeCC
Q 006785 232 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 308 (631)
Q Consensus 232 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~ 308 (631)
||+|+||+||++... +++.||||.+...... .....+..|+.+++.++|+||+++.+++.. ....++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~----~~~~~lv~e~~~ 76 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT----KTDLCLVMTIMN 76 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC----CCeEEEEEeCCC
Confidence 699999999999875 5899999998754221 223457889999999999999999988765 456899999999
Q ss_pred CCChHhhhhcc--ccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCC
Q 006785 309 NGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 386 (631)
Q Consensus 309 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 386 (631)
+|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 77 ~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-- 151 (280)
T cd05608 77 GGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-- 151 (280)
T ss_pred CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC--
Confidence 99999887532 2345899999999999999999999998 9999999999999999999999999997654332
Q ss_pred CCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccCC
Q 006785 387 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 466 (631)
Q Consensus 387 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (631)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||........... ....+..
T Consensus 152 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~-------------~~~~~~~ 215 (280)
T cd05608 152 ---SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE-------------LKQRILN 215 (280)
T ss_pred ---ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH-------------HHHhhcc
Confidence 122345689999999999999999999999999999999999999964322111000 0001111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006785 467 PRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQ 504 (631)
Q Consensus 467 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 504 (631)
.. ..++...+..+.+++.+||+.||++|| ++.++++
T Consensus 216 ~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 216 DS--VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cC--CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 10 012333445588999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=317.34 Aligned_cols=248 Identities=29% Similarity=0.444 Sum_probs=197.5
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeCCC
Q 006785 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~~ 309 (631)
++||+|+||.||+|...+++.||+|++...........|.+|+++++.++||||+++++++.. ....++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ----RQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec----CCccEEEEECCCC
Confidence 368999999999999888999999998765444444568999999999999999999999875 3467999999999
Q ss_pred CChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCCC
Q 006785 310 GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 389 (631)
Q Consensus 310 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 389 (631)
++|.+++.... ..+++..+..++.+++.+|.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 77 ~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~---- 148 (250)
T cd05085 77 GDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY---- 148 (250)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc----
Confidence 99999986543 35899999999999999999999998 99999999999999999999999999875433211
Q ss_pred CCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccccccccccCCCC
Q 006785 390 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 468 (631)
Q Consensus 390 ~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (631)
.......++..|+|||++..+.++.++||||||+++||+++ |..||........... +......
T Consensus 149 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~--------------~~~~~~~- 213 (250)
T cd05085 149 SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ--------------VEKGYRM- 213 (250)
T ss_pred ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--------------HHcCCCC-
Confidence 11112234678999999998899999999999999999998 9999864322110000 0000011
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 469 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 469 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
..+...+..+.+++.+||..+|++||++.++++.|.
T Consensus 214 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 214 ---SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 112233455889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=331.10 Aligned_cols=239 Identities=23% Similarity=0.338 Sum_probs=188.3
Q ss_pred ceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 230 NIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
+.||+|+||.||+|+..+ ++.||||.++... .......+..|..++..+ +||||+++++++.. ....|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~----~~~~~lv~e 76 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT----KEHLFFVME 76 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc----CCEEEEEEc
Confidence 369999999999998764 8899999987532 122334456677777755 89999999988765 457899999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCC
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 385 (631)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~- 150 (316)
T cd05592 77 YLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE- 150 (316)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-
Confidence 99999999998753 45899999999999999999999998 9999999999999999999999999997653321
Q ss_pred CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccC
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (631)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||............ .. .
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i--------------~~-~ 211 (316)
T cd05592 151 ----GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI--------------LN-D 211 (316)
T ss_pred ----CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH--------------Hc-C
Confidence 1223456999999999999989999999999999999999999999754321100000 00 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 006785 466 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 501 (631)
Q Consensus 466 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 501 (631)
.+ .+|......+.+|+.+||+.||.+||++.+
T Consensus 212 ~~----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 212 RP----HFPRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CC----CCCCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 11 122233445788999999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=325.44 Aligned_cols=257 Identities=28% Similarity=0.412 Sum_probs=203.3
Q ss_pred hcCccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCC
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 296 (631)
.++|.+.+.||+|+||.||+|.+++ +..||+|.+...........+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---- 80 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST---- 80 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC----
Confidence 4678888999999999999998753 468999998765444445568999999999999999999999876
Q ss_pred cceEEEEEeeCCCCChHhhhhccc--------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCC
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVL--------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 368 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 368 (631)
....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~ 157 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLT 157 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCC
Confidence 356799999999999999996532 123789999999999999999999998 999999999999999999
Q ss_pred eEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhh
Q 006785 369 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLV 447 (631)
Q Consensus 369 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~ 447 (631)
+||+|||+++........ .......++..|+|||.+..+.++.++||||||+++|||++ |..||............
T Consensus 158 ~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 234 (277)
T cd05032 158 VKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234 (277)
T ss_pred EEECCcccchhhccCccc---ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH
Confidence 999999999866443221 11223346789999999998889999999999999999998 89998543221110000
Q ss_pred hhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 448 LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
.....+ ..|...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 235 --------------~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 --------------IDGGHL----DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred --------------hcCCCC----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 000011 122223455889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=326.62 Aligned_cols=259 Identities=26% Similarity=0.393 Sum_probs=203.1
Q ss_pred cCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
.+|...+.||+|+||.||+|+.. ++..+++|.+.... ......|.+|++++++++|+||+++++++.. .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGD----G 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc----C
Confidence 35677889999999999999753 35579999886542 2333568999999999999999999999875 4
Q ss_pred ceEEEEEeeCCCCChHhhhhccc--------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeee
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 363 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl 363 (631)
...++||||+++++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~ 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLV 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEE
Confidence 56799999999999999996532 134899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccc
Q 006785 364 DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKG 442 (631)
Q Consensus 364 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~ 442 (631)
+.++.++|+|||++......... .......++..|+|||++.+..++.++||||||+++|||++ |+.||.......
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 233 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYY---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 233 (291)
T ss_pred ccCCcEEECCCCcccccCCCcee---ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999765432211 11223456789999999999999999999999999999999 999986543211
Q ss_pred cchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 443 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
... .. ..-..+. .+...+..+.+++.+||+.+|++||++.+|++.|..+.+
T Consensus 234 ~~~--~~------------~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 234 VIE--CI------------TQGRVLE----RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHH--HH------------hCCCCCC----CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 100 00 0000001 112233458899999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=327.54 Aligned_cols=258 Identities=26% Similarity=0.427 Sum_probs=200.6
Q ss_pred cCccccceeeeeCceEEEEEEECC-C--cEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcce
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-G--RIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g--~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 299 (631)
++|++.+.||+|+||.||+|.+++ + ..+++|.++..........|.+|+.++.++ +||||+++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----~~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN----RGY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc----CCc
Confidence 568888999999999999998754 3 357899887544334445689999999999 79999999998875 446
Q ss_pred EEEEEeeCCCCChHhhhhccc--------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC
Q 006785 300 RLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 365 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~ 365 (631)
.++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~ 154 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGE 154 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECC
Confidence 799999999999999996532 124889999999999999999999998 999999999999999
Q ss_pred CCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccc
Q 006785 366 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEE 444 (631)
Q Consensus 366 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~ 444 (631)
++.+||+|||++....... .......+..|+|||++....++.++||||||+++|||++ |..||.........
T Consensus 155 ~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~ 228 (297)
T cd05089 155 NLASKIADFGLSRGEEVYV------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY 228 (297)
T ss_pred CCeEEECCcCCCcccccee------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999999986432110 0111123567999999998889999999999999999997 99999643321100
Q ss_pred hhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 445 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
. .+. .......+...+..+.+|+.+||+.+|.+||++.++++.|..+...
T Consensus 229 ~-----------------~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 229 E-----------------KLP-QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred H-----------------HHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0 000 0011112223344588999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=332.49 Aligned_cols=238 Identities=24% Similarity=0.310 Sum_probs=189.8
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
+.||+|+||.||+|+.+ +++.||||++.... .......+..|..++..+ +||||+++++++.. ....|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~----~~~~~iv~E 76 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT----PDRLFFVME 76 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc----CCEEEEEEc
Confidence 36999999999999976 48899999987532 223345578899999877 79999999998875 557899999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCC
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 385 (631)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 y~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~- 150 (320)
T cd05590 77 FVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG- 150 (320)
T ss_pred CCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-
Confidence 99999999998754 45899999999999999999999998 9999999999999999999999999987643221
Q ss_pred CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccC
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (631)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .+.
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~-----------------~i~ 209 (320)
T cd05590 151 ----KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFE-----------------AIL 209 (320)
T ss_pred ----CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH-----------------HHh
Confidence 12234569999999999999999999999999999999999999996543211100 000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006785 466 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 500 (631)
Q Consensus 466 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 500 (631)
... ...+...+..+.+|+.+||+.||.+||++.
T Consensus 210 ~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 210 NDE--VVYPTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred cCC--CCCCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 000 011222344588999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=350.68 Aligned_cols=264 Identities=25% Similarity=0.281 Sum_probs=205.9
Q ss_pred HHHHHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC
Q 006785 218 ALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 295 (631)
Q Consensus 218 ~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 295 (631)
+.+...++|.+.+.||+|+||+||+|+.. +|+.||||++..... ......+.+|+.++..++|+|++++...+.....
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 34445678999999999999999999864 589999999875432 2334558899999999999999998877654221
Q ss_pred ----CcceEEEEEeeCCCCChHhhhhccc--cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCe
Q 006785 296 ----KRAMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 369 (631)
Q Consensus 296 ----~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 369 (631)
....+++||||+++|+|.++|.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence 1124689999999999999996432 345899999999999999999999998 9999999999999999999
Q ss_pred EEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh
Q 006785 370 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 449 (631)
Q Consensus 370 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~ 449 (631)
||+|||+++.+..... ........||+.|+|||++.+..++.++||||||++||||++|+.||...........
T Consensus 183 kL~DFGls~~~~~~~~---~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~--- 256 (496)
T PTZ00283 183 KLGDFGFSKMYAATVS---DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK--- 256 (496)
T ss_pred EEEecccCeecccccc---ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH---
Confidence 9999999987643211 1122345799999999999999999999999999999999999999964322110000
Q ss_pred cccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 450 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
....... ..+...+..+.+|+.+||+.||.+||++.++++.
T Consensus 257 ----------~~~~~~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 ----------TLAGRYD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ----------HhcCCCC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0000001 1233344558899999999999999999999864
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=332.29 Aligned_cols=243 Identities=21% Similarity=0.295 Sum_probs=192.6
Q ss_pred ceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 230 NIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
+.||+|+||.||+|+... ++.||||++.... .......+..|.+++..+ +||||+++++++.. ....|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~----~~~~~lv~E 76 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT----KDRLFFVME 76 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc----CCeEEEEEe
Confidence 369999999999998764 7899999987532 223344577899999876 89999999999875 457899999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCC
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 385 (631)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 77 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~- 150 (321)
T cd05591 77 YVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG- 150 (321)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-
Confidence 99999999998754 45899999999999999999999998 9999999999999999999999999987643221
Q ss_pred CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccC
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (631)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .+.
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~-----------------~i~ 209 (321)
T cd05591 151 ----VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE-----------------SIL 209 (321)
T ss_pred ----ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHH-----------------HHH
Confidence 12234569999999999999899999999999999999999999997543221100 000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 006785 466 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-------TMSEVVQI 505 (631)
Q Consensus 466 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~ 505 (631)
.... ..|...+..+.+|+..||+.||++|| ++.++++.
T Consensus 210 ~~~~--~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 210 HDDV--LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred cCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 0000 11222334588999999999999999 67777653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=329.23 Aligned_cols=258 Identities=26% Similarity=0.442 Sum_probs=200.1
Q ss_pred cCccccceeeeeCceEEEEEEECC-Cc--EEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcce
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GR--IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~--~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 299 (631)
++|++.+.||+|+||.||+|.+++ +. .+|+|.++..........|.+|++++.++ +||||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~----~~~ 82 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----RGY 82 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC----CCC
Confidence 467778999999999999998753 44 46888776544444455688999999999 89999999999865 456
Q ss_pred EEEEEeeCCCCChHhhhhccc--------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC
Q 006785 300 RLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 365 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~ 365 (631)
.|+||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGE 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecC
Confidence 799999999999999996432 124789999999999999999999998 999999999999999
Q ss_pred CCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccc
Q 006785 366 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEE 444 (631)
Q Consensus 366 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~ 444 (631)
++.+||+|||++...... .......++..|+|||++....++.++||||||+++|||+| |..||........
T Consensus 160 ~~~~kl~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~- 232 (303)
T cd05088 160 NYVAKIADFGLSRGQEVY------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL- 232 (303)
T ss_pred CCcEEeCccccCcccchh------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH-
Confidence 999999999998643211 01111234678999999988889999999999999999998 9999864322110
Q ss_pred hhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 445 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
.. .+.. ......+...+..+.+|+.+||+.+|++||++.++++.|..+...
T Consensus 233 --~~--------------~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 233 --YE--------------KLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred --HH--------------HHhc-CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 00 0000 000011222334588999999999999999999999999877544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=345.59 Aligned_cols=268 Identities=22% Similarity=0.293 Sum_probs=195.6
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeecc----CCc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR----GKR 297 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~ 297 (631)
..+|...+.||+|+||.||+|... +++.||||++.... ....+|+.+|+.++||||+++++++.... ...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 467999999999999999999875 48999999886432 12457999999999999999998864321 123
Q ss_pred ceEEEEEeeCCCCChHhhhhcc--ccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC-CeEEecc
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDL 374 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kL~DF 374 (631)
..+++||||++ ++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 35789999996 5787777532 2345899999999999999999999998 99999999999998664 6999999
Q ss_pred CceeecccCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhh--hhcc
Q 006785 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV--LWAT 451 (631)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~--~~~~ 451 (631)
|+|+.+.... ......||+.|+|||++.+. .++.++|||||||+||||++|.+||............ ....
T Consensus 216 Gla~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 289 (440)
T PTZ00036 216 GSAKNLLAGQ------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT 289 (440)
T ss_pred ccchhccCCC------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 9998764321 12335689999999998764 6899999999999999999999999754322111000 0000
Q ss_pred cccccc---cccc-----cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 452 PRLQDS---GTVI-----SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 452 ~~~~~~---~~~~-----~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+..... .... ..+....+...+|...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000000 0000 00111111112333344568899999999999999999999863
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=320.90 Aligned_cols=253 Identities=28% Similarity=0.409 Sum_probs=191.8
Q ss_pred eeeeeCceEEEEEEECC---CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeC
Q 006785 231 IVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 307 (631)
Q Consensus 231 ~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~ 307 (631)
.||+|+||.||+|.+.+ +..+|+|.++..........|.+|+.++++++||||+++++++.+ ....++||||+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~ 77 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE----VTPYLLVMEFC 77 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC----CCCcEEEEECC
Confidence 58999999999998653 467999998766544445568999999999999999999998875 34679999999
Q ss_pred CCCChHhhhhccc---cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCC
Q 006785 308 PNGNLRDCLDGVL---VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (631)
Q Consensus 308 ~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~ 384 (631)
++|+|.+++.... ....++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 9999999996532 123678888899999999999999998 9999999999999999999999999987543322
Q ss_pred CCCCCCCCcccccCCCCCCchhhhcC-------CCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccc
Q 006785 385 LPSCSSSPARMQGTFGYFAPEYAMVG-------RASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 385 ~~~~~~~~~~~~Gt~~Y~APE~~~~~-------~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
.. .......|+..|+|||++... .++.++||||||+++|||++ |+.||.......... +.. .
T Consensus 155 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~~~---~- 224 (269)
T cd05087 155 YY---VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---YTV---R- 224 (269)
T ss_pred ee---ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---HHh---h-
Confidence 11 112234578899999988642 35889999999999999996 999996433221100 000 0
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
.....+..+.+....+ ..+.+++..|| .+|++|||+.+|++.|.
T Consensus 225 --~~~~~~~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 225 --EQQLKLPKPRLKLPLS----DRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred --cccCCCCCCccCCCCC----hHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0011222333322233 34778899999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=320.43 Aligned_cols=256 Identities=29% Similarity=0.432 Sum_probs=205.2
Q ss_pred HhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
..++|.+.+.||+|+||.||+|.+++++.||||.+..... ....+.+|+.++++++|+||+++++++.. ....+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 77 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSE----EEPIY 77 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeec----CCceE
Confidence 4567888999999999999999988888999999875432 33568999999999999999999998765 45679
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++++|.+++.......+++.++..++.+++.||.|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceecc
Confidence 9999999999999998765556999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
.... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||........ ...
T Consensus 155 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~----------- 216 (261)
T cd05034 155 DDEY----TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---LEQ----------- 216 (261)
T ss_pred chhh----hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH-----------
Confidence 3211 11112235678999999998899999999999999999999 9999854322110 000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 508 (631)
+...... ..+...+..+.+++.+||..+|++||++.++++.|+.
T Consensus 217 ~~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 217 VERGYRM----PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHcCCCC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0000000 1112223458899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=327.08 Aligned_cols=264 Identities=23% Similarity=0.353 Sum_probs=200.0
Q ss_pred hcCccccceeeeeCceEEEEEEECC---------------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCccee
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD---------------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLV 287 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~---------------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 287 (631)
.++|.+.+.||+|+||.||++.... ...||||++...........|.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578888999999999999987532 2359999997654444556699999999999999999999
Q ss_pred EEeeeccCCcceEEEEEeeCCCCChHhhhhcccc----------CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCC
Q 006785 288 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV----------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 357 (631)
Q Consensus 288 g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK 357 (631)
+++.. ....++||||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|||||
T Consensus 84 ~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlk 156 (295)
T cd05097 84 GVCVS----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLA 156 (295)
T ss_pred EEEcC----CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccC
Confidence 99865 4567999999999999999854311 13789999999999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh--CCCCC
Q 006785 358 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT--GRQPI 435 (631)
Q Consensus 358 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt--G~~P~ 435 (631)
|+|||+++++.+||+|||++......... .......++..|+|||++..+.++.++||||||+++|||++ |..||
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~ 233 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233 (295)
T ss_pred hhhEEEcCCCcEEecccccccccccCcce---eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999765432211 11122345778999999998999999999999999999998 56777
Q ss_pred CCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 436 HRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
............ ......... ... . ..+...+..+.+|+.+||+.||++||++.+|++.|.
T Consensus 234 ~~~~~~~~~~~~---~~~~~~~~~---~~~-~----~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 234 SLLSDEQVIENT---GEFFRNQGR---QIY-L----SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred cccChHHHHHHH---HHhhhhccc---ccc-C----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 543221100000 000000000 000 0 111122345899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=331.95 Aligned_cols=242 Identities=23% Similarity=0.297 Sum_probs=191.4
Q ss_pred CccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCC-CCcceeEEeeeccCCcceE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHC-HVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~~~~ 300 (631)
+|.+.+.||+|+||.||+|+..+ ++.||||++.... .......+..|..++..+.|+ +|+++++++.. ....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----~~~~ 76 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----MDRL 76 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc----CCEE
Confidence 47778999999999999998764 7899999987532 223345588899999999665 57788877765 4578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 77 YFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 9999999999999998754 45899999999999999999999998 999999999999999999999999998753
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 152 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~--------------- 211 (324)
T cd05587 152 IFGG-----KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ--------------- 211 (324)
T ss_pred CCCC-----CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH---------------
Confidence 2211 12234569999999999999999999999999999999999999996533211100
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM 499 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 499 (631)
.+... ...+|...+..+.+++.+||..||.+|++.
T Consensus 212 --~i~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 212 --SIMEH--NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --HHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00000 011222334458899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=331.54 Aligned_cols=244 Identities=24% Similarity=0.325 Sum_probs=189.9
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
+.||+|+||.||+|... +++.||+|+++... .......+.+|+.++.++ +||||+++++++.. ....|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~----~~~~~lv~E 76 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT----ESRLFFVIE 76 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe----CCEEEEEEe
Confidence 46999999999999876 48899999997542 223344577899998877 89999999998876 557899999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCC
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 385 (631)
|+++|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~- 150 (329)
T cd05618 77 YVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG- 150 (329)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-
Confidence 99999999988653 45899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCcccccc--chhhhhcccccccccccccc
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE--ESLVLWATPRLQDSGTVISE 463 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 463 (631)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .....+. ...
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~----------~~~ 216 (329)
T cd05618 151 ----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL----------FQV 216 (329)
T ss_pred ----CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHH----------HHH
Confidence 122345799999999999999999999999999999999999999963211110 0000000 000
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006785 464 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM 499 (631)
Q Consensus 464 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 499 (631)
+.... ..+|......+.+|+.+||+.||.+||++
T Consensus 217 i~~~~--~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 217 ILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HhcCC--CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11110 12333344558899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=317.79 Aligned_cols=250 Identities=28% Similarity=0.420 Sum_probs=199.8
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
++|...+.||+|+||.||++... |..||+|.+.... ..+.|.+|+.++++++|+|++++++++... ....++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~lv 78 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE---KGGLYIV 78 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC---CCceEEE
Confidence 46778899999999999999875 7889999986432 244689999999999999999999986542 3457999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
|||+++++|.+++.......+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999997655455899999999999999999999998 999999999999999999999999998765332
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccccccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
. ....++..|+|||++....++.++||||||+++|||++ |+.||....... .... +.
T Consensus 156 ~--------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~-----------~~ 213 (256)
T cd05082 156 Q--------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR-----------VE 213 (256)
T ss_pred C--------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-----------Hh
Confidence 1 12234578999999998889999999999999999998 999985422111 0000 00
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
....+ ..+...+..+.+++.+||+.+|++|||+.++++.|..+
T Consensus 214 ~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 214 KGYKM----DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred cCCCC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00011 12223344588999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=323.34 Aligned_cols=259 Identities=28% Similarity=0.407 Sum_probs=203.0
Q ss_pred cCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
++|.+.+.||+|+||.||++... ++..+|+|.+.... ......|.+|++++++++||||+++++++.. .
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVE----G 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec----C
Confidence 56788899999999999999752 24569999886542 2344568999999999999999999999875 4
Q ss_pred ceEEEEEeeCCCCChHhhhhccc-----------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCC
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVL-----------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 366 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~ 366 (631)
...++||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+|||++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence 56799999999999999996432 124899999999999999999999998 9999999999999999
Q ss_pred CCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccch
Q 006785 367 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEES 445 (631)
Q Consensus 367 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~ 445 (631)
+.++|+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||..........
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~ 233 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYY---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233 (288)
T ss_pred CcEEeccCCccccccCCcee---ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999865432211 11123346788999999998899999999999999999998 899986443211000
Q ss_pred hhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 446 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
.. ............+ ..+.+|+.+||+.||.+|||+.++++.|..+..
T Consensus 234 ~i--------------~~~~~~~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 234 CI--------------TQGRVLQRPRTCP----KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HH--------------HcCCcCCCCCCCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 00 0000011111223 448999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.84 Aligned_cols=254 Identities=24% Similarity=0.296 Sum_probs=198.6
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|.+.+.||+|+||.||++... +|+.||||+++... .......+.+|+.+++.++|+||+++++++.+ ....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~----~~~~ 76 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD----KDNL 76 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec----CCeE
Confidence 46888999999999999999875 58999999997542 22344558899999999999999999988775 4578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 152 (330)
T cd05601 77 YLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARL 152 (330)
T ss_pred EEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeEC
Confidence 9999999999999999764 245899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhh------cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAM------VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 454 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~------~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~ 454 (631)
...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||.............
T Consensus 153 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~------ 222 (330)
T cd05601 153 TANKMV----NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM------ 222 (330)
T ss_pred CCCCce----eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHH------
Confidence 543211 122346899999999986 4567899999999999999999999996533211110000
Q ss_pred ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 455 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 455 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.. .... ........+..+.+|+..||. +|.+||++.++++.
T Consensus 223 -~~----~~~~----~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 223 -NF----QRFL----KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -cC----CCcc----CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00 0000 000011233447889999998 99999999998753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=323.49 Aligned_cols=247 Identities=24% Similarity=0.336 Sum_probs=192.4
Q ss_pred eeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeCC
Q 006785 232 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 308 (631)
Q Consensus 232 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~ 308 (631)
||+|+||.||++..+ +|+.||+|.+..... ......+..|++++++++||||+++++++.. ....++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~----~~~~~lv~e~~~ 76 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES----KTHLCLVMSLMN 76 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec----CCeEEEEEecCC
Confidence 699999999999875 489999999864322 1223346679999999999999999988765 457899999999
Q ss_pred CCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCC
Q 006785 309 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 388 (631)
Q Consensus 309 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 388 (631)
+|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 77 g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---- 149 (277)
T cd05607 77 GGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---- 149 (277)
T ss_pred CCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc----
Confidence 999999886655556899999999999999999999998 9999999999999999999999999998764321
Q ss_pred CCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccCCCC
Q 006785 389 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 468 (631)
Q Consensus 389 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (631)
......||..|+|||++.+..++.++|||||||++|||++|+.||............. .......
T Consensus 150 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~-------------~~~~~~~ 214 (277)
T cd05607 150 --TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK-------------RRTLEDE 214 (277)
T ss_pred --eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH-------------HHhhccc
Confidence 1123468999999999998889999999999999999999999996432211110000 0001000
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 469 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 469 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
... .....+..+.+|+.+||+.||++||++.|+++.
T Consensus 215 ~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 215 VKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred ccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 000 011223458899999999999999999877643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=331.40 Aligned_cols=242 Identities=23% Similarity=0.296 Sum_probs=192.4
Q ss_pred CccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcceE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~ 300 (631)
+|...+.||+|+||.||+|+... ++.||||++..... ......+..|..++..+ +|++|+++++++.. ....
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----~~~~ 76 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT----MDRL 76 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec----CCEE
Confidence 47778999999999999998764 78999999875421 22333467788888887 68899999988765 4578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~ 151 (323)
T cd05616 77 YFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 151 (323)
T ss_pred EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceec
Confidence 9999999999999998654 45899999999999999999999998 999999999999999999999999999754
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 152 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~--------------- 211 (323)
T cd05616 152 MWDG-----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ--------------- 211 (323)
T ss_pred CCCC-----CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHH---------------
Confidence 3221 12234569999999999999999999999999999999999999996533211100
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM 499 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 499 (631)
.+.... ..+|...+..+.+|+.+||+.||.+|++.
T Consensus 212 --~i~~~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 212 --SIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --HHHhCC--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 000000 11233344558899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=329.42 Aligned_cols=241 Identities=23% Similarity=0.359 Sum_probs=190.3
Q ss_pred ceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 230 NIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
+.||+|+||.||+|.+.+ ++.||||+++... .......+..|..++..+ +||||+++++++.+ ....|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~----~~~~~lv~e 76 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT----KENLFFVME 76 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe----CCEEEEEEe
Confidence 369999999999999764 7899999997542 122334467788888765 99999999998876 457899999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCC
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 385 (631)
|+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 y~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 150 (316)
T cd05619 77 YLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD- 150 (316)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-
Confidence 99999999999753 45899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccC
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (631)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||............. ..
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~---------------~~ 211 (316)
T cd05619 151 ----AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR---------------MD 211 (316)
T ss_pred ----CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH---------------hC
Confidence 12234569999999999999899999999999999999999999996533211000000 00
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 006785 466 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS-EVV 503 (631)
Q Consensus 466 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 503 (631)
.+. ++......+.+++.+||+.||++||++. ++.
T Consensus 212 ~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 212 NPC----YPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCC----CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 111 1222334578899999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=317.90 Aligned_cols=254 Identities=26% Similarity=0.397 Sum_probs=199.3
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++|.+.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.++++++||||+++++++.. ....|+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~----~~~~~i 83 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLS----REKLWI 83 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEe----CCEEEE
Confidence 46888899999999999999974 588999999875432 233457899999999999999999999875 457899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 84 CMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 99999999999998653 45899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhh---cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
.. .......|+..|+|||.+. ...++.++||||||+++|||++|+.||......... ..+..
T Consensus 159 ~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~~~~~-------- 223 (267)
T cd06646 159 TI-----AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FLMSK-------- 223 (267)
T ss_pred cc-----cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--eeeec--------
Confidence 21 1123346889999999884 345788999999999999999999998643221110 00000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 506 (631)
.....+... .....+..+.+++.+||..+|++||++.++++.|
T Consensus 224 --~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 224 --SNFQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --CCCCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 001111111 1112335588999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=340.42 Aligned_cols=256 Identities=21% Similarity=0.297 Sum_probs=195.1
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|.+.+.||+|+||.||++... +++.||||++.... .......+.+|+++++.++||||+++++++.+ ....
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~----~~~~ 76 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD----AQYL 76 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc----CCee
Confidence 36888899999999999999875 58999999986432 22334558899999999999999999998875 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 77 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 77 YLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999999999753 45899999999999999999999998 999999999999999999999999999743
Q ss_pred ccCCCCC----------CC--------------------------------CCCcccccCCCCCCchhhhcCCCCcccch
Q 006785 381 KADGLPS----------CS--------------------------------SSPARMQGTFGYFAPEYAMVGRASLMSDV 418 (631)
Q Consensus 381 ~~~~~~~----------~~--------------------------------~~~~~~~Gt~~Y~APE~~~~~~~s~ksDV 418 (631)
....... .. .......||+.|+|||++.+..++.++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 231 (377)
T cd05629 152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW 231 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceee
Confidence 2210000 00 00012469999999999999899999999
Q ss_pred hhHHHHHHHHHhCCCCCCCccccccch-hhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCC-
Q 006785 419 FSFGVVLLELITGRQPIHRSITKGEES-LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDAR- 496 (631)
Q Consensus 419 wSlGviL~eLltG~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R- 496 (631)
|||||+||||++|+.||.......... ...|. ..+.-+. ....+..+.+|+.+|+. +|.+|
T Consensus 232 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----------~~~~~p~-----~~~~s~~~~dli~~lL~-~~~~r~ 294 (377)
T cd05629 232 WSLGAIMFECLIGWPPFCSENSHETYRKIINWR-----------ETLYFPD-----DIHLSVEAEDLIRRLIT-NAENRL 294 (377)
T ss_pred EecchhhhhhhcCCCCCCCCCHHHHHHHHHccC-----------CccCCCC-----CCCCCHHHHHHHHHHhc-CHhhcC
Confidence 999999999999999996533211100 00000 0000010 01123447889999997 67765
Q ss_pred --CCHHHHHHH
Q 006785 497 --PTMSEVVQI 505 (631)
Q Consensus 497 --Ps~~evl~~ 505 (631)
+++.++++.
T Consensus 295 ~r~~~~~~l~h 305 (377)
T cd05629 295 GRGGAHEIKSH 305 (377)
T ss_pred CCCCHHHHhcC
Confidence 599988764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=324.66 Aligned_cols=264 Identities=27% Similarity=0.411 Sum_probs=203.2
Q ss_pred hcCccccceeeeeCceEEEEEEECC-----------------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD-----------------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 285 (631)
..+|.+.+.||+|+||.||+|.+.+ +..||+|++...........|.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3568888999999999999997643 24689999886655555667899999999999999999
Q ss_pred eeEEeeeccCCcceEEEEEeeCCCCChHhhhhccc---------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCC
Q 006785 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL---------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 356 (631)
Q Consensus 286 l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl 356 (631)
+++++.. ....++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||
T Consensus 84 ~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dl 156 (296)
T cd05051 84 LLGVCTV----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDL 156 (296)
T ss_pred EEEEEec----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---cccccc
Confidence 9999875 356799999999999999996543 125899999999999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh--CCCC
Q 006785 357 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT--GRQP 434 (631)
Q Consensus 357 Kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt--G~~P 434 (631)
||+||+++.++.++|+|||+++........ .......+++.|+|||++....++.++||||||+++|||++ |..|
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 233 (296)
T cd05051 157 ATRNCLVGKNYTIKIADFGMSRNLYSSDYY---RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233 (296)
T ss_pred chhceeecCCCceEEccccceeecccCcce---eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCC
Confidence 999999999999999999999865433211 11223456789999999998899999999999999999998 6778
Q ss_pred CCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 435 IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
|....... ............ ........+...+..+.+|+.+||+.||++|||+.+|++.|.
T Consensus 234 ~~~~~~~~---~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 234 YEHLTDQQ---VIENAGHFFRDD--------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCcChHH---HHHHHHhccccc--------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 75432111 000000000000 000001112223345899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=321.34 Aligned_cols=259 Identities=26% Similarity=0.401 Sum_probs=200.5
Q ss_pred CccccceeeeeCceEEEEEEECC-C---cEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLTD-G---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~~-g---~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
.|.+.+.||+|+||.||+|.+.. + ..||||.+...........|..|+.+++.++||||+++++++.. ....
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~ 80 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK----SRPV 80 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC----CCce
Confidence 46678899999999999998753 3 36999998765444455679999999999999999999998765 4567
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 81 MIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccc
Confidence 99999999999999997543 45899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
.................+..|+|||++....++.++||||||+++||+++ |..||....... ...+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i--------- 224 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAI--------- 224 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHH---------
Confidence 43221100000111112457999999999999999999999999999886 999986432211 11110
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
...... ..+...+..+.+++.+||+.+|++||++.+|+..|+.+
T Consensus 225 --~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 225 --EQDYRL----PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --HcCCcC----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000000 11222334588999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=319.93 Aligned_cols=259 Identities=25% Similarity=0.418 Sum_probs=202.4
Q ss_pred hcCccccceeeeeCceEEEEEEECC-C---cEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD-G---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g---~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
.++|+..+.||+|+||.||+|.+.. + ..+|||.+...........+..|++++++++|+|++++++++.. ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~ 79 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK----FK 79 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc----CC
Confidence 3467778999999999999998753 3 37999998765444445668999999999999999999999875 44
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..|+||||+++++|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccce
Confidence 6799999999999999997533 45899999999999999999999998 9999999999999999999999999997
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
......... ........+..|+|||++....++.++||||||+++|||++ |+.||...........
T Consensus 156 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~----------- 222 (268)
T cd05063 156 VLEDDPEGT--YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKA----------- 222 (268)
T ss_pred ecccccccc--eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH-----------
Confidence 664322110 11111223567999999998889999999999999999997 9999864322110000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
+.... ....+...+..+.+++.+||+.+|++||++.+|++.|.++
T Consensus 223 ---i~~~~----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 223 ---INDGF----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---HhcCC----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00000 0011122334588999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=319.21 Aligned_cols=260 Identities=25% Similarity=0.387 Sum_probs=201.0
Q ss_pred ccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC--Ccc
Q 006785 226 FSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRA 298 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~~ 298 (631)
|.+.+.||+|+||.||+|.+.. +..||||+++..... .....+.+|+.+++.++||||+++++++..... ...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999998643 367999998764332 334568999999999999999999998865332 223
Q ss_pred eEEEEEeeCCCCChHhhhhccc----cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEecc
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVL----VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 374 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DF 374 (631)
..++||||+++|+|..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 5799999999999999985421 235899999999999999999999998 999999999999999999999999
Q ss_pred CceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccc
Q 006785 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPR 453 (631)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~ 453 (631)
|+++......... ......++..|+|||++....++.++||||||+++|||++ |..||....... ...+.
T Consensus 158 g~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~--- 228 (273)
T cd05035 158 GLSKKIYSGDYYR---QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYL--- 228 (273)
T ss_pred cceeecccccccc---ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---
Confidence 9998765432211 1112235678999999988889999999999999999999 888885432211 00000
Q ss_pred cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 454 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 454 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
...... ..+...+..+.+++.+||+.||++||++.++++.|..+
T Consensus 229 --------~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 --------RHGNRL----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --------HcCCCC----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000011 12223345588999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=333.93 Aligned_cols=206 Identities=23% Similarity=0.366 Sum_probs=173.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|+..+.||+|+||+||++... +++.||||++.... .......+.+|+.++.+++|+||+++++++.+ ....
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~----~~~~ 76 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD----KLNL 76 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec----CCeE
Confidence 46888999999999999999876 48999999997532 12233457889999999999999999998875 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~ 151 (363)
T cd05628 77 YLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151 (363)
T ss_pred EEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence 9999999999999999754 45899999999999999999999998 999999999999999999999999999765
Q ss_pred ccCCCCC------------------------------CCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh
Q 006785 381 KADGLPS------------------------------CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 430 (631)
Q Consensus 381 ~~~~~~~------------------------------~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt 430 (631)
....... .........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 231 (363)
T cd05628 152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (363)
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh
Confidence 3211000 0001123579999999999999999999999999999999999
Q ss_pred CCCCCCCc
Q 006785 431 GRQPIHRS 438 (631)
Q Consensus 431 G~~P~~~~ 438 (631)
|+.||...
T Consensus 232 G~~Pf~~~ 239 (363)
T cd05628 232 GYPPFCSE 239 (363)
T ss_pred CCCCCCCC
Confidence 99999654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=337.82 Aligned_cols=256 Identities=22% Similarity=0.313 Sum_probs=198.7
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 295 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 295 (631)
+....++|+..+.||+|+||.||+++... ++.||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--- 114 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD--- 114 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc---
Confidence 44456789999999999999999999864 8899999986421 22233458899999999999999999998875
Q ss_pred CcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccC
Q 006785 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 375 (631)
Q Consensus 296 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFG 375 (631)
....|+||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 115 -~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG 187 (370)
T cd05621 115 -DKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFG 187 (370)
T ss_pred -CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecc
Confidence 56789999999999999999653 4789999999999999999999998 9999999999999999999999999
Q ss_pred ceeecccCCCCCCCCCCcccccCCCCCCchhhhcC----CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcc
Q 006785 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG----RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 451 (631)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~----~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~ 451 (631)
++........ .......||+.|+|||++... .++.++||||||++||||++|+.||.........
T Consensus 188 ~a~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~------- 256 (370)
T cd05621 188 TCMKMDETGM----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY------- 256 (370)
T ss_pred cceecccCCc----eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH-------
Confidence 9987643221 112345699999999998753 3789999999999999999999999654321110
Q ss_pred cccccccccccccCCCCCCCCCC--HHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 006785 452 PRLQDSGTVISELPDPRLKGDFP--KEEMQIMAYLAKECLQLDPDA--RPTMSEVVQI 505 (631)
Q Consensus 452 ~~~~~~~~~~~~~~~~~l~~~~~--~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 505 (631)
..+.+......+| ...+..+.+++..|+..++.+ ||++.++++.
T Consensus 257 ----------~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 257 ----------SKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ----------HHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0111100000111 123455788889999755543 8899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=329.68 Aligned_cols=241 Identities=24% Similarity=0.348 Sum_probs=190.2
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
+.||+|+||.||+|+++ +|+.||||.++.... ......+..|..++..+ +||||+++++++.. ....|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----~~~~~lv~E 76 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT----KEHLFFVME 76 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe----CCEEEEEEC
Confidence 46999999999999986 488999999975421 22334467788888765 99999999998875 557899999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCC
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 385 (631)
|+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 150 (316)
T cd05620 77 FLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD- 150 (316)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-
Confidence 99999999998753 45899999999999999999999998 9999999999999999999999999987532211
Q ss_pred CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccC
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (631)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||........... +. ..
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~--------------~~-~~ 211 (316)
T cd05620 151 ----NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFES--------------IR-VD 211 (316)
T ss_pred ----CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH--------------HH-hC
Confidence 123345799999999999999999999999999999999999999964332110000 00 00
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 006785 466 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS-EVV 503 (631)
Q Consensus 466 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 503 (631)
.+. ++......+.+|+.+||+.||++||++. +++
T Consensus 212 ~~~----~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 212 TPH----YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCC----CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 111 1222334588999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=316.83 Aligned_cols=249 Identities=29% Similarity=0.447 Sum_probs=202.2
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
++|...+.||.|+||.||+|... |+.||||.+..... ....+.+|+.++++++|+||+++++++.. ....++|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~v 78 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQ----GNPLYIV 78 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcC----CCCeEEE
Confidence 46777899999999999999875 88999999976543 45568999999999999999999999875 4567999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
|||+++++|.+++.......+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 99999999999997655456999999999999999999999998 999999999999999999999999999876322
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccccccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
. ....++..|+|||++..+.++.++||||||+++|||++ |+.||....... .... +.
T Consensus 156 ~--------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~-----------~~ 213 (256)
T cd05039 156 Q--------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPH-----------VE 213 (256)
T ss_pred c--------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH-----------Hh
Confidence 1 12234678999999998899999999999999999997 999986432111 0000 00
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 508 (631)
.... ...+...+..+.+++.+||..+|++||++.++++.|..
T Consensus 214 ~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 214 KGYR----MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred cCCC----CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0000 11122234558899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=316.94 Aligned_cols=250 Identities=28% Similarity=0.386 Sum_probs=197.7
Q ss_pred ceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 230 NIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
+.||+|+||.||+|++.. +..||+|.+...........+.+|+.+++.+.|+||+++++++.. ...++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~v~e 75 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-----EPLMLVME 75 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-----CceEEEEE
Confidence 369999999999997642 368999999866554455679999999999999999999998652 35699999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCC
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 385 (631)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.......
T Consensus 76 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 76 LAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred eCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 99999999999764 35899999999999999999999998 99999999999999999999999999987654321
Q ss_pred CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccccccccc
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 464 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (631)
.. .......++..|+|||.+....++.++||||||+++|||++ |..||....... ...+.. ..
T Consensus 151 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~-----------~~ 214 (257)
T cd05060 151 YY--RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLE-----------SG 214 (257)
T ss_pred cc--ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHH-----------cC
Confidence 11 11122234678999999998899999999999999999998 999986432211 111100 00
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 465 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 465 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
.. ...+...+..+.+++.+||..+|++||++.+|++.|..+
T Consensus 215 ~~----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 215 ER----LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred Cc----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 00 012222334588999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=317.79 Aligned_cols=258 Identities=25% Similarity=0.391 Sum_probs=202.5
Q ss_pred cCccccceeeeeCceEEEEEEEC----CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
.+|.+.+.||+|+||.||+|.+. .+..+|+|.++..........|.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 79 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK----SKP 79 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec----CCc
Confidence 45777899999999999999864 2347999998765444445679999999999999999999999865 456
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.++||||+++++|.+++.... ..+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++..
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 799999999999999997643 45899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
....... ........++..|+|||++.+..++.++||||||+++||+++ |..||........ ....
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~-------- 222 (267)
T cd05066 156 LEDDPEA--AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAI-------- 222 (267)
T ss_pred cccccce--eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHH--------
Confidence 6532210 011112234568999999998899999999999999999887 9999865432111 0000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
.+.... ..+...+..+.+++.+||+.+|++||++.++++.|..+
T Consensus 223 ---~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 223 ---EEGYRL----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---hCCCcC----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000001 11122234588999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=345.70 Aligned_cols=250 Identities=22% Similarity=0.269 Sum_probs=198.3
Q ss_pred ccccceeeeeCceEEEEEEEC-C-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLT-D-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~-~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
|...+.||+|+||.||+|... + ++.||+|.+.... ......+.+|+.+|+.++||||+++++++.. ....|||
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~----~~~~~lv 143 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKS----DDKLLLI 143 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE----CCEEEEE
Confidence 777899999999999999754 3 6778888765432 2333457889999999999999999999876 5578999
Q ss_pred EeeCCCCChHhhhhccc--cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 304 FEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
|||+++|+|.++|.... ...+++.++..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 99999999999886432 235889999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
.... ........||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 221 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~---------------- 281 (478)
T PTZ00267 221 DSVS---LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQ---------------- 281 (478)
T ss_pred Cccc---cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----------------
Confidence 3221 112334569999999999999999999999999999999999999996432211000
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
.+..... ...+...+..+.+|+.+||+.||++||++.++++
T Consensus 282 -~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 282 -QVLYGKY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -HHHhCCC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0000000 0122233455889999999999999999999975
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=329.47 Aligned_cols=242 Identities=23% Similarity=0.327 Sum_probs=192.7
Q ss_pred ceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 230 NIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
+.||+|+||.||+|.+.. ++.||||+++... .......+..|..++..+ +||||+++++++.. ....|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~----~~~~~lv~e 76 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT----KDRLFFVME 76 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc----CCEEEEEEc
Confidence 369999999999998764 7899999997532 223344578899999888 79999999998875 457899999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCC
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 385 (631)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 150 (318)
T cd05570 77 YVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG- 150 (318)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-
Confidence 99999999988754 45899999999999999999999998 9999999999999999999999999987533221
Q ss_pred CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccC
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (631)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .+.
T Consensus 151 ----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~-----------------~i~ 209 (318)
T cd05570 151 ----VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ-----------------SIL 209 (318)
T ss_pred ----CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHH-----------------HHH
Confidence 12234568999999999999999999999999999999999999996433211000 000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 006785 466 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM-----SEVVQ 504 (631)
Q Consensus 466 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 504 (631)
... ..++...+..+.+|+.+||+.||.+||++ .++++
T Consensus 210 ~~~--~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 210 EDE--VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred cCC--CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 000 01222334458899999999999999999 76654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.85 Aligned_cols=239 Identities=24% Similarity=0.312 Sum_probs=191.0
Q ss_pred ceeeeeCceEEEEEEE----CCCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEE
Q 006785 230 NIVGQGGSSYVYRGQL----TDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~ 304 (631)
+.||+|+||.||+++. .+|+.||||++..... ......+..|+++|++++||||+++++++.. ....|+||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT----EGKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc----CCEEEEEE
Confidence 5799999999999875 2589999999975422 2233447789999999999999999998875 45789999
Q ss_pred eeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCC
Q 006785 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (631)
Q Consensus 305 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~ 384 (631)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 78 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 78 DFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 999999999999653 45899999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccccc
Q 006785 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 464 (631)
Q Consensus 385 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (631)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .+
T Consensus 153 -----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~-----------------~i 210 (318)
T cd05582 153 -----KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT-----------------MI 210 (318)
T ss_pred -----CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHH-----------------HH
Confidence 12234569999999999998889999999999999999999999996532211000 00
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 006785 465 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 501 (631)
Q Consensus 465 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 501 (631)
.... ..+|...+..+.+|+.+||+.||++||++.+
T Consensus 211 ~~~~--~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 211 LKAK--LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HcCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0000 0123333455889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=319.02 Aligned_cols=253 Identities=28% Similarity=0.419 Sum_probs=189.4
Q ss_pred eeeeeCceEEEEEEECC---CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeC
Q 006785 231 IVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 307 (631)
Q Consensus 231 ~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~ 307 (631)
.||+|+||.||+|...+ ...+|+|.+...........|.+|+.+++.++|+||+++++++.. ....++||||+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~----~~~~~lv~e~~ 77 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE----SIPYLLVLEFC 77 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC----CCceEEEEEeC
Confidence 58999999999997543 457899987655444445568999999999999999999998875 45679999999
Q ss_pred CCCChHhhhhcccc---CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCC
Q 006785 308 PNGNLRDCLDGVLV---EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (631)
Q Consensus 308 ~~gsL~~~l~~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~ 384 (631)
++|+|.+++..... ...++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccch
Confidence 99999999975432 23568888999999999999999998 9999999999999999999999999987543322
Q ss_pred CCCCCCCCcccccCCCCCCchhhhc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccc
Q 006785 385 LPSCSSSPARMQGTFGYFAPEYAMV-------GRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 385 ~~~~~~~~~~~~Gt~~Y~APE~~~~-------~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
... ......+++.|+|||++.. ..++.++||||||+++|||++ |..||............. .
T Consensus 155 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~------~- 224 (269)
T cd05042 155 YYI---TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVV------R- 224 (269)
T ss_pred hee---ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh------h-
Confidence 111 1122346778999998753 356889999999999999999 788886432211000000 0
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
.....+..+.+...++ ..+..++..|| .||++|||+.+|++.|.
T Consensus 225 --~~~~~~~~~~~~~~~~----~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 225 --EQDIKLPKPQLDLKYS----DRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred --ccCccCCCCcccccCC----HHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0011222333322333 44677888898 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=321.75 Aligned_cols=252 Identities=27% Similarity=0.391 Sum_probs=198.5
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
|+..+.||+|+||.||++.+. +++.||||.+...... .....+.+|+.++++++|+|++++++.+.. ....++
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~----~~~~~l 77 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET----KDALCL 77 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec----CCEEEE
Confidence 566788999999999999876 4899999998754322 223457889999999999999999998875 457899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 999999999999996654456999999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
.. ......||..|+|||++.+..++.++||||||+++|||++|+.||.............. ...
T Consensus 155 ~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~----------~~~ 218 (285)
T cd05630 155 GQ------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER----------LVK 218 (285)
T ss_pred Cc------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh----------hhh
Confidence 21 11234689999999999999999999999999999999999999975322110000000 000
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-----MSEVVQI 505 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 505 (631)
.. .. ..+......+.+|+..||+.||++||| +.|+++.
T Consensus 219 ~~-~~----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 219 EV-QE----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hh-hh----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 00 01 112223345889999999999999999 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.14 Aligned_cols=267 Identities=24% Similarity=0.349 Sum_probs=201.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++|++.+.||+|+||.||++.+. ++..+|+|.+...........+.+|++++++++||||+++++++.. ....++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 76 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS----DGEISI 76 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee----CCEEEE
Confidence 36888999999999999999876 4888999998765433344568899999999999999999999876 557899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHh-cCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+ ++||||||+|||++.++.++|+|||++....
T Consensus 77 v~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 77 CMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred EeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 99999999999999754 458999999999999999999997 46 9999999999999999999999999987553
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc--
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT-- 459 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~-- 459 (631)
.. ......|+..|+|||++.+..++.++||||||+++|||++|+.||........................
T Consensus 152 ~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (308)
T cd06615 152 DS-------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHR 224 (308)
T ss_pred cc-------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcc
Confidence 22 123356889999999998888999999999999999999999998643321111100000000000000
Q ss_pred -----------------cccccCCCCCCCCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 460 -----------------VISELPDPRLKGDFPK-EEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 460 -----------------~~~~~~~~~l~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
....+... .....|. .....+.+|+.+||..+|++||++.+|++...
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 225 PVSGHPPDSPRPMAIFELLDYIVNE-PPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred cccCCCCCccchhhHHHHHHHHhcC-CCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 00000000 0001111 13345889999999999999999999987643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.99 Aligned_cols=264 Identities=24% Similarity=0.372 Sum_probs=200.5
Q ss_pred hcCccccceeeeeCceEEEEEEEC-----------------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-----------------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-----------------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 285 (631)
.++|++.+.||+|+||.||++.+. ++..||||++...........|.+|+.+|+.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356888999999999999998543 234699999986544445567999999999999999999
Q ss_pred eeEEeeeccCCcceEEEEEeeCCCCChHhhhhcccc---------CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCC
Q 006785 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV---------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 356 (631)
Q Consensus 286 l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl 356 (631)
+++++.. ....++||||+++|+|.+++..... ..+++.++..++.|++.||+|||+.+ |+||||
T Consensus 84 ~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl 156 (296)
T cd05095 84 LLAVCIT----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDL 156 (296)
T ss_pred EEEEEec----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccC
Confidence 9999875 4467999999999999999965321 23778899999999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh--CCCC
Q 006785 357 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT--GRQP 434 (631)
Q Consensus 357 Kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt--G~~P 434 (631)
||+|||++.++.++|+|||+++.+...... .......+++.|+|||....+.++.++||||||+++|||++ |..|
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p 233 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCcce---eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999865433211 11122335678999999988899999999999999999998 6788
Q ss_pred CCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 435 IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
|............ ...+.... ..... ..+..++..+.+|+.+||+.||++||++.+|++.|.
T Consensus 234 ~~~~~~~~~~~~~---~~~~~~~~---~~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 234 YSQLSDEQVIENT---GEFFRDQG---RQVYL-----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ccccChHHHHHHH---HHHHhhcc---ccccC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 8543221110000 00000000 00000 111223355889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=333.24 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=212.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
++|...+++|+|+||.++..+.+ ++..|++|.+.-.. .........+|+.++++++|||||.+.+.+.+ ++...+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~---~~~~l~ 80 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE---DGQLLC 80 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc---CCceEE
Confidence 46777889999999999999865 47899999987553 33334467899999999999999999998876 234489
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
|||+||+||+|.+.|....+..+++..+..++.|++.|+.|||+.. |+|||||+.||+++.+..++|+|||+|+...
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcC
Confidence 9999999999999998776667999999999999999999999887 9999999999999999999999999999887
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
... ......+||+.||.||.+.+.+|+.|+|||||||++|||++-+++|....... .+
T Consensus 158 ~~~-----~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~-----------------Li 215 (426)
T KOG0589|consen 158 PED-----SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE-----------------LI 215 (426)
T ss_pred Cch-----hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH-----------------HH
Confidence 653 23456789999999999999999999999999999999999999997543221 11
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.++.... ..+.|...+..+..|+..|+..+|+.||++.+++..
T Consensus 216 ~ki~~~~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 216 LKINRGL-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHhhcc-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1111111 224566677779999999999999999999999975
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=326.35 Aligned_cols=267 Identities=22% Similarity=0.349 Sum_probs=198.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++|...+.||+|+||.||+|... +++.||||.++..........+.+|+.++++++||||+++++++.. ....++
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 81 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT----DKSLTL 81 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee----CCeEEE
Confidence 46788899999999999999876 4889999999765444444458899999999999999999999875 457899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||++ ++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 v~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 82 VFEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred EEeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 999996 5898888653 244899999999999999999999998 99999999999999999999999999976433
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcc--------cc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT--------PR 453 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~--------~~ 453 (631)
.. .......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||................ +.
T Consensus 157 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07872 157 PT-----KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG 231 (309)
T ss_pred Cc-----cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence 21 11223468899999998865 468999999999999999999999996543321111110000 00
Q ss_pred cccccccccccCCCCCCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 454 LQDSGTVISELPDPRLKG----DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 454 ~~~~~~~~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+... ........+.... ......+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 232 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 232 ISSN-DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hcch-hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000 0000000000000 0011233457899999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=327.62 Aligned_cols=261 Identities=26% Similarity=0.416 Sum_probs=202.8
Q ss_pred hcCccccceeeeeCceEEEEEEEC--------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeec
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 293 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 293 (631)
.++|.+.+.||+|+||.||++... ....||+|+++..........+..|+.+++++ +||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ- 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc-
Confidence 456778899999999999999752 24579999988654444455688999999999 69999999998875
Q ss_pred cCCcceEEEEEeeCCCCChHhhhhccc--------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCC
Q 006785 294 RGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359 (631)
Q Consensus 294 ~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~ 359 (631)
....|+||||+++|+|.+++.... ...+++.++..++.|++.||.|||+.+ |+||||||+
T Consensus 90 ---~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~ 163 (314)
T cd05099 90 ---EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAAR 163 (314)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccce
Confidence 446799999999999999996532 134899999999999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCc
Q 006785 360 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (631)
Q Consensus 360 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~ 438 (631)
|||+++++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYY---KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccc---cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999865432111 01112234567999999999899999999999999999999 88888543
Q ss_pred cccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 439 ITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
........ +...... ..+...+..+.+++.+||+.+|++||++.++++.|..+..
T Consensus 241 ~~~~~~~~--------------~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 241 PVEELFKL--------------LREGHRM----DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred CHHHHHHH--------------HHcCCCC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 22110000 0000000 1122333458899999999999999999999999987743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=323.10 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=201.8
Q ss_pred hcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCC
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 296 (631)
.++|+..+.||+|+||.||+|.+. ++..||+|++...........|.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~---- 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV---- 79 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC----
Confidence 467888899999999999999864 4678999998765444445669999999999999999999998875
Q ss_pred cceEEEEEeeCCCCChHhhhhccc--------------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCC
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVL--------------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 356 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl 356 (631)
....++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl 156 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDL 156 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 446799999999999999996421 124788999999999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCC
Q 006785 357 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPI 435 (631)
Q Consensus 357 Kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~ 435 (631)
||+|||+++++.++|+|||++......... .......++..|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus 157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~ 233 (288)
T cd05050 157 ATRNCLVGENMVVKIADFGLSRNIYSADYY---KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233 (288)
T ss_pred cHhheEecCCCceEECccccceecccCccc---cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999998765432211 11122235678999999998999999999999999999998 88888
Q ss_pred CCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 436 HRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
.......... .+.+... ...+...+..+.+|+.+||+.+|++|||+.|+++.|+
T Consensus 234 ~~~~~~~~~~-----------------~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 234 YGMAHEEVIY-----------------YVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCCHHHHHH-----------------HHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 6432211000 0000000 0112233455889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=320.90 Aligned_cols=251 Identities=27% Similarity=0.371 Sum_probs=197.2
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
|+..+.||+|+||+||+|.+. +++.||+|.+...... .....+.+|+++|++++|+||+++.+++.. ....++
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~----~~~~~l 77 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET----KDALCL 77 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec----CCEEEE
Confidence 566788999999999999875 5899999998654221 223447889999999999999999988765 457899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05632 78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPE 154 (285)
T ss_pred EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence 999999999999887544456999999999999999999999998 99999999999999999999999999876532
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
.. ......|+..|+|||++.+..++.++||||||+++|||++|..||............. .
T Consensus 155 ~~------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~-------------~ 215 (285)
T cd05632 155 GE------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD-------------R 215 (285)
T ss_pred CC------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------------H
Confidence 21 1223468999999999998899999999999999999999999996532211111000 0
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-----MSEVVQ 504 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 504 (631)
.+... ...++...+..+.+|+..||+.||++||+ +.++++
T Consensus 216 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 216 RVLET--EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred hhhcc--ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 00000 00122233345788999999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=337.50 Aligned_cols=205 Identities=23% Similarity=0.323 Sum_probs=171.2
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.|...+.||+|+||.||+|+.. +++.||||++.... .......+.+|+.++++++||||+++++++.+ ....|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~----~~~~~ 77 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD----KDNLY 77 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe----CCEEE
Confidence 5778899999999999999875 48899999987532 12234458899999999999999999999876 55789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 78 lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~ 152 (382)
T cd05625 78 FVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (382)
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccc
Confidence 999999999999999754 45889999999999999999999998 9999999999999999999999999986432
Q ss_pred cCCCC------------------------------------------CCCCCCcccccCCCCCCchhhhcCCCCcccchh
Q 006785 382 ADGLP------------------------------------------SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVF 419 (631)
Q Consensus 382 ~~~~~------------------------------------------~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVw 419 (631)
..... ..........||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (382)
T cd05625 153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEE
Confidence 10000 000011235799999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCCc
Q 006785 420 SFGVVLLELITGRQPIHRS 438 (631)
Q Consensus 420 SlGviL~eLltG~~P~~~~ 438 (631)
||||+||||++|+.||...
T Consensus 233 SlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 233 SVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred echHHHHHHHhCCCCCCCC
Confidence 9999999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.62 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=196.9
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
+|...+.||+|+||.||+|.+. +++.||||++...........|.+|++++++++||||+++++++.. ....++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv 77 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV----ENRISIC 77 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE----CCEEEEE
Confidence 5677889999999999999864 5889999998765444445568999999999999999999999876 4567999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
|||+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 78 ~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 78 TEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred EecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 9999999997652 3688899999999999999999998 999999999999999999999999999765432
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 463 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (631)
......||..|+|||++.+..++.++||||||+++|+|++|+.||............. ... ..+..
T Consensus 149 -------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~~---~~~~~ 214 (279)
T cd06619 149 -------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL----QLL---QCIVD 214 (279)
T ss_pred -------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH----HHH---HHHhc
Confidence 1233568999999999998899999999999999999999999996532211100000 000 00000
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006785 464 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506 (631)
Q Consensus 464 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 506 (631)
...+.+. ....+..+.+++.+||+.+|++||++.++++.-
T Consensus 215 ~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 215 EDPPVLP---VGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred cCCCCCC---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 0011111 111233488999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=338.47 Aligned_cols=256 Identities=21% Similarity=0.287 Sum_probs=194.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|++.+.||+|+||.||+|+.. +++.||||++.... .......+.+|+++|++++|+||+++++.+.+ ...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~----~~~~ 76 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD----KDNL 76 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc----CCEE
Confidence 36888999999999999999875 48999999986431 12233458899999999999999999998875 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+
T Consensus 77 ~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 9999999999999999764 45889999999999999999999998 999999999999999999999999998543
Q ss_pred ccCCCC--------------------------------------CCCCCCcccccCCCCCCchhhhcCCCCcccchhhHH
Q 006785 381 KADGLP--------------------------------------SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFG 422 (631)
Q Consensus 381 ~~~~~~--------------------------------------~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlG 422 (631)
...... ..........||+.|+|||++.+..++.++||||||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 231 (376)
T cd05598 152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 231 (376)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecc
Confidence 210000 000011235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCccccccch-hhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC---C
Q 006785 423 VVLLELITGRQPIHRSITKGEES-LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP---T 498 (631)
Q Consensus 423 viL~eLltG~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---s 498 (631)
|+||||++|+.||.......... ...|.. ....+ .....+..+.+++.+|+ .+|.+|+ +
T Consensus 232 vilyell~G~~Pf~~~~~~~~~~~i~~~~~-----------~~~~~-----~~~~~s~~~~~li~~l~-~~p~~R~~~~t 294 (376)
T cd05598 232 VILYEMLVGQPPFLADTPAETQLKVINWET-----------TLHIP-----SQAKLSREASDLILRLC-CGAEDRLGKNG 294 (376)
T ss_pred ceeeehhhCCCCCCCCCHHHHHHHHhccCc-----------cccCC-----CCCCCCHHHHHHHHHHh-cCHhhcCCCCC
Confidence 99999999999997543221111 000100 00000 01112334667777766 5999999 8
Q ss_pred HHHHHHH
Q 006785 499 MSEVVQI 505 (631)
Q Consensus 499 ~~evl~~ 505 (631)
+.++++.
T Consensus 295 ~~ell~h 301 (376)
T cd05598 295 ADEIKAH 301 (376)
T ss_pred HHHHhCC
Confidence 8888764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=321.88 Aligned_cols=274 Identities=24% Similarity=0.373 Sum_probs=203.8
Q ss_pred CccccceeeeeCceEEEEEEEC-----CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
.|.+.+.||+|+||.||++++. ++..||+|.++..........+.+|+.+++.++||||+++++++.... ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG--GNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC--CCc
Confidence 4677889999999999999742 478899999876554555567999999999999999999999887532 346
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.++||||+++++|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++.
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred eEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 799999999999999996542 35899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
....... ........++..|+|||++.+..++.++||||||+++|||++++.|................ .... ...
T Consensus 159 ~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~-~~~~-~~~ 234 (284)
T cd05079 159 IETDKEY--YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTH-GQMT-VTR 234 (284)
T ss_pred cccCccc--eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccc-cccc-HHH
Confidence 6433211 11122345778899999999888999999999999999999987765322110000000000 0000 000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
.+..+.. ......+...+..+.+|+.+||+.+|++||++.++++.|+.+
T Consensus 235 ~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 235 LVRVLEE-GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHc-CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000000 001111223345689999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=319.89 Aligned_cols=270 Identities=25% Similarity=0.343 Sum_probs=197.3
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC-hHHHHHHHHHHHHhc---CCCCCcceeEEeeeccC-Ccc
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRL---HHCHVVPLVGYCSEFRG-KRA 298 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~-~~~ 298 (631)
+|.+.+.||+|+||.||+|... +|+.||+|.++...... ....+.+|+.+++++ +||||+++++++..... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999876 48999999987543222 223466788877766 69999999998865322 234
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..++||||++ ++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 6799999996 59999987655556899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccch-hhhhc-ccc---
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES-LVLWA-TPR--- 453 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~-~~~~~-~~~--- 453 (631)
...... ......||..|+|||++.+..++.++|||||||++|||++|+.||.......... ..... .+.
T Consensus 157 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07863 157 IYSCQM------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 230 (288)
T ss_pred cccCcc------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 654321 1233468999999999998899999999999999999999999986433211100 00000 000
Q ss_pred cccccccccccCCCCC---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 454 LQDSGTVISELPDPRL---KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 454 ~~~~~~~~~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
+............+.. ...........+.+|+.+||+.||++|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000000000 00111223455789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.41 Aligned_cols=275 Identities=27% Similarity=0.345 Sum_probs=200.7
Q ss_pred cCccccceeeeeCceEEEEEEEC-----CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
..|.+.+.||+|+||.||++..+ ++..||||++.... ......|.+|++++++++||||+++++++.... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--RR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC--CC
Confidence 45777889999999999999753 47899999987542 233456899999999999999999999876432 34
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence 6799999999999999996532 34899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
......... .......++..|+|||++.+..++.++||||||+++|||++|..|+............. ........
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 232 (284)
T cd05081 157 VLPQDKEYY--KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGN--DKQGQMIV 232 (284)
T ss_pred cccCCCcce--eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccc--ccccccch
Confidence 764322110 01111224456999999998899999999999999999999877754321110000000 00000000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
..+.+..........+...+..+.+|+.+||..+|++|||+.+|++.|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000000000011111223344588999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=329.01 Aligned_cols=245 Identities=23% Similarity=0.296 Sum_probs=190.4
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
+.||+|+||.||++... +++.||||++..... ......+.+|+.++.++ +||||+++++++.. ....|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e 76 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT----TSRLFLVIE 76 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe----CCEEEEEEe
Confidence 36999999999999875 478999999975422 23344588999999988 79999999998865 457899999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCC
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 385 (631)
|+++|+|.+++... +.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~- 150 (327)
T cd05617 77 YVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG- 150 (327)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-
Confidence 99999999988653 45999999999999999999999998 9999999999999999999999999987532211
Q ss_pred CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccC
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (631)
.......||+.|+|||++.+..++.++||||||++||||++|+.||.............+.. ..+.
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~----------~~~~ 216 (327)
T cd05617 151 ----DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF----------QVIL 216 (327)
T ss_pred ----CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHH----------HHHH
Confidence 12234579999999999999999999999999999999999999996432221111000000 0000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006785 466 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 500 (631)
Q Consensus 466 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 500 (631)
... ...|...+..+.+++.+||+.||.+||++.
T Consensus 217 ~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 217 EKP--IRIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred hCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 000 012223334578899999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=327.56 Aligned_cols=243 Identities=22% Similarity=0.303 Sum_probs=191.5
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcC-CCCCcceeEEeeeccCCcceE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~ 300 (631)
+|...+.||+|+||.||+|... +|+.||||++.... .......+..|..++..+. |++|+++++++.. ....
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----~~~~ 76 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT----VDRL 76 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec----CCEE
Confidence 3667889999999999999875 48999999987532 2233445788999998885 5778888887765 4578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~ 151 (323)
T cd05615 77 YFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEH 151 (323)
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecccccccc
Confidence 9999999999999998653 45899999999999999999999998 999999999999999999999999998754
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 152 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~---------------- 210 (323)
T cd05615 152 MVDG-----VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF---------------- 210 (323)
T ss_pred CCCC-----ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH----------------
Confidence 3221 1223456999999999999989999999999999999999999999754321100
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 500 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 500 (631)
..+.... ..+|...+..+.+++.+||+.+|.+|++..
T Consensus 211 -~~i~~~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 211 -QSIMEHN--VSYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -HHHHhCC--CCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 0000000 012223344578899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=315.67 Aligned_cols=255 Identities=25% Similarity=0.401 Sum_probs=193.7
Q ss_pred ceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 230 NIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
+.||+|+||.||+|.+.+ +..||||++...........+.+|+.+++.++||||+++++++... ....++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS---EGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC---CCCcEEEEe
Confidence 368999999999998642 4579999986543334455688999999999999999999987642 234689999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCC
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 385 (631)
|+.+|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 78 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 78 YMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 999999999997543 34688888999999999999999998 99999999999999999999999999976543221
Q ss_pred CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhC-CCCCCCccccccchhhhhccccccccccccccc
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITG-RQPIHRSITKGEESLVLWATPRLQDSGTVISEL 464 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (631)
.. ........++..|+|||++....++.++||||||+++|||++| .+||....... ..... ...
T Consensus 154 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~-----------~~~ 218 (262)
T cd05058 154 YS-VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYL-----------LQG 218 (262)
T ss_pred ee-ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH-----------hcC
Confidence 11 0111233467789999999888999999999999999999995 45554321110 00000 000
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 465 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 465 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
..+. .+...+..+.+++..||+.+|++||++.+|++.|+.+.
T Consensus 219 ~~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 219 RRLL----QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCC----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0011 11122345889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=317.89 Aligned_cols=250 Identities=26% Similarity=0.457 Sum_probs=194.0
Q ss_pred ceeeeeCceEEEEEEECC-Cc--EEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 230 NIVGQGGSSYVYRGQLTD-GR--IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~-g~--~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
+.||+|+||.||+|.+.+ +. .+|+|.++..........+.+|++++.++ +||||+++++++.. ....++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----~~~~~lv~e 76 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----RGYLYLAIE 76 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec----CCCceEEEE
Confidence 358999999999998754 43 57889887544444555689999999999 89999999999876 446799999
Q ss_pred eCCCCChHhhhhccc--------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEE
Q 006785 306 FMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 371 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL 371 (631)
|+++|+|.+++.... ...+++.++..++.|++.||+|||+.+ ++||||||+|||+++++.+||
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl 153 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKI 153 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEE
Confidence 999999999996432 124789999999999999999999998 999999999999999999999
Q ss_pred eccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhc
Q 006785 372 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWA 450 (631)
Q Consensus 372 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~ 450 (631)
+|||++...... ........+..|+|||++....++.++||||||+++|||++ |..||..........
T Consensus 154 ~dfgl~~~~~~~------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~----- 222 (270)
T cd05047 154 ADFGLSRGQEVY------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----- 222 (270)
T ss_pred CCCCCccccchh------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHH-----
Confidence 999998632211 01111224567999999988889999999999999999997 999996432211000
Q ss_pred ccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 451 TPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
.+.. ......+......+.+|+.+||+.+|.+|||+.++++.|..+.
T Consensus 223 ------------~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 223 ------------KLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ------------HHhC-CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0000 0000112223345889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=314.86 Aligned_cols=248 Identities=23% Similarity=0.360 Sum_probs=209.0
Q ss_pred ccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~ 304 (631)
|.++.+||+|+||.||+|.++. |+.||||.+.... ..+++..|+.+|++.+.|++|++||.|.. ...+|+||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK----~sDLWIVM 107 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFK----HSDLWIVM 107 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhcc----CCceEeeh
Confidence 6667889999999999998764 9999999987653 34568999999999999999999998775 55789999
Q ss_pred eeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCC
Q 006785 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (631)
Q Consensus 305 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~ 384 (631)
|||.-|++.+.++.+ .+++++.++..++...++||+|||... -||||||+.||||+.+|.+||+|||.|..+.+..
T Consensus 108 EYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 108 EYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred hhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 999999999999864 467999999999999999999999987 8999999999999999999999999998776432
Q ss_pred CCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccccc
Q 006785 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 464 (631)
Q Consensus 385 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (631)
....++.||+.|||||++..-.|..++||||||++..||..|++||...-+-... -.+..-
T Consensus 184 -----AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI--------------FMIPT~ 244 (502)
T KOG0574|consen 184 -----AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI--------------FMIPTK 244 (502)
T ss_pred -----HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee--------------EeccCC
Confidence 2345578999999999999999999999999999999999999998643221100 011122
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 465 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 465 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+.|.+ ..|+..+..+.++++.||.++|++|-|+.++++.
T Consensus 245 PPPTF--~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 245 PPPTF--KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCC--CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 23333 3477888999999999999999999999999874
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.22 Aligned_cols=255 Identities=23% Similarity=0.372 Sum_probs=203.2
Q ss_pred HhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
..++|...+.||+|+||.||+|.+.++..+|+|.+.... .....|.+|+.++++++|+||+++++++.+ ...+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 76 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-----EPIY 76 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-----CCeE
Confidence 346788899999999999999998778889999887532 234568999999999999999999988764 3569
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
++|||+++++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 9999999999999997655556899999999999999999999998 9999999999999999999999999998664
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
.... .......++..|+|||++....++.++||||||+++|++++ |+.||........ ..+.
T Consensus 154 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~---------- 216 (260)
T cd05073 154 DNEY----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRAL---------- 216 (260)
T ss_pred CCCc----ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH----------
Confidence 3221 11122346678999999998889999999999999999999 8999864322110 0000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 508 (631)
...... ..+...+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 217 -~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 217 -ERGYRM----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -hCCCCC----CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 000000 1112233458899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=328.96 Aligned_cols=238 Identities=24% Similarity=0.294 Sum_probs=186.3
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHH-HHHhcCCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVD-MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
+.||+|+||+||+|... +|+.||||++.... .......+..|.. +++.++||||+++++++.. ....|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~----~~~~~lv~e 76 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT----ADKLYFVLD 76 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe----CCEEEEEEc
Confidence 36999999999999976 58999999987432 1222233555555 5678899999999988875 557899999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCC
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 385 (631)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~- 150 (323)
T cd05575 77 YVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS- 150 (323)
T ss_pred CCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-
Confidence 99999999998753 45899999999999999999999998 9999999999999999999999999987543211
Q ss_pred CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccC
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (631)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||............ ...
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i-------------~~~-- 211 (323)
T cd05575 151 ----KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI-------------LNK-- 211 (323)
T ss_pred ----CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHH-------------HcC--
Confidence 1233456999999999999999999999999999999999999999653221100000 000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006785 466 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 500 (631)
Q Consensus 466 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 500 (631)
...+ +...+..+.+++.+||+.||.+||++.
T Consensus 212 ~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 212 PLRL----KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCC----CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 0111 122234588999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=314.24 Aligned_cols=254 Identities=23% Similarity=0.350 Sum_probs=201.2
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC----ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
++|...+.||+|+||.||++... +++.||||.+...... .....+.+|++++++++||||+++++++.. ..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~ 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD----DE 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc----CC
Confidence 46888999999999999999865 5899999998644221 123458899999999999999999999876 45
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||+++
T Consensus 78 ~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~ 152 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 152 (263)
T ss_pred eEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccce
Confidence 789999999999999998754 45889999999999999999999998 9999999999999999999999999997
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
........ ........|+..|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 153 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------------- 217 (263)
T cd06625 153 RLQTICSS--GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF------------- 217 (263)
T ss_pred eccccccc--cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH-------------
Confidence 65432111 011123457889999999999889999999999999999999999986432211000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
...........+......+.+++.+||..+|++|||+.++++.
T Consensus 218 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 218 ----KIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----HHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0000011112333344558899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=315.11 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=203.1
Q ss_pred cCccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
++|...+.||+|+||.||+|.+.+ ...||||...........+.|.+|+.++++++||||+++++++.. ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 80 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-----NP 80 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----CC
Confidence 457778899999999999998653 247999998765544455679999999999999999999998764 34
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.++||||+++|+|.+++.... ..+++..+..++.+++.||+|||+.+ ++|+||||+|||++.++.++|+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeee
Confidence 589999999999999997542 35899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
........ .....++..|+|||.+....++.++||||||+++|||++ |..||............
T Consensus 157 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~----------- 221 (270)
T cd05056 157 LEDESYYK----ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI----------- 221 (270)
T ss_pred ccccccee----cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-----------
Confidence 65432111 112234578999999988889999999999999999986 99999654322111000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
....... .+...+..+.+++.+||..+|++|||+.++++.|..+..
T Consensus 222 ---~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 222 ---ENGERLP----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ---HcCCcCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0000111 122334458899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=316.01 Aligned_cols=273 Identities=25% Similarity=0.342 Sum_probs=207.2
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccC-CCCChHHHHHHHHHHHHhcCCCCCcceeEEeee-ccCCcce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE-FRGKRAM 299 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~~~ 299 (631)
...|...+.||+|+||.|+.|..+ +|+.||||++... ......+.-.+|+++|+.++|+||+.++.++.. ..+.-..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 445555788999999999999876 5899999998743 233344557899999999999999999998875 3334557
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.|+|+|+| +.+|.+.++.. +.++...+..+..|+++||+|+|+.+ |+||||||+|+|++.+..+||+|||||+.
T Consensus 101 vYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence 89999999 78999999764 44899999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhh-cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc-
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS- 457 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~- 457 (631)
.... ......+..+.|..|.|||.+. ...|+...||||.||||.||++|++-|.+...-....++....+.-...
T Consensus 175 ~~~~---~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 175 LDKF---FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred cccc---CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 7643 1123456778999999999886 4679999999999999999999999887654333222222111111000
Q ss_pred ---------cccccccC---CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 458 ---------GTVISELP---DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 458 ---------~~~~~~~~---~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
...+..++ ...+...+| .......+|+.+||..||.+|+|++|.++.
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00111111 111111122 233447789999999999999999999873
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=314.44 Aligned_cols=251 Identities=27% Similarity=0.367 Sum_probs=198.6
Q ss_pred ceeeeeCceEEEEEEECC--C--cEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 230 NIVGQGGSSYVYRGQLTD--G--RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~--g--~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
+.||+|++|.||+|.+.+ + ..||||.+...........|.+|+.++++++||||+++++++.. ...++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~v~e 75 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-----HPLMMVTE 75 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-----CeEEEEEE
Confidence 368999999999998753 3 36999999876543455679999999999999999999998764 46799999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCC
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 385 (631)
|+++|+|.+++.......+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccc
Confidence 999999999997654356899999999999999999999998 99999999999999999999999999987654321
Q ss_pred CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccccccccc
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 464 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (631)
. ........++..|+|||++....++.++||||||+++|||++ |+.||............. ...
T Consensus 153 ~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-------------~~~ 217 (257)
T cd05040 153 H--YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID-------------KEG 217 (257)
T ss_pred c--eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------------hcC
Confidence 1 111123457889999999998899999999999999999999 999996432221100000 000
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 465 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 465 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
. ....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 218 ~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 218 E----RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred C----cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0 00112223445889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=352.34 Aligned_cols=265 Identities=26% Similarity=0.347 Sum_probs=203.1
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|.+.+.||+|+||.||+|.+. +|+.||||++..... ......|.+|++++++++||||+++++++.+ ....
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d----~~~l 77 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD----GDPV 77 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee----CCEE
Confidence 57888999999999999999876 489999999975422 2234568999999999999999999999876 4578
Q ss_pred EEEEeeCCCCChHhhhhccc---------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEE
Q 006785 301 LLVFEFMPNGNLRDCLDGVL---------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 371 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL 371 (631)
|+||||++||+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKL 154 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVI 154 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEE
Confidence 99999999999999986421 233677888999999999999999998 999999999999999999999
Q ss_pred eccCceeecccCCC-------------CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCc
Q 006785 372 TDLGMAKRLKADGL-------------PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (631)
Q Consensus 372 ~DFGla~~~~~~~~-------------~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~ 438 (631)
+|||+++....... ...........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 99999987622110 00011123357999999999999999999999999999999999999999653
Q ss_pred cccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhhCC
Q 006785 439 ITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-TMSEVVQILSTIAP 511 (631)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~ 511 (631)
....... . ..+..+.... .....+..+.+++.+||+.||++|| ++.++.+.|.....
T Consensus 235 ~~~ki~~----~-----------~~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 235 KGRKISY----R-----------DVILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred chhhhhh----h-----------hhccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 2211000 0 0011110000 0012234478899999999999995 66777777776644
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=312.76 Aligned_cols=250 Identities=32% Similarity=0.487 Sum_probs=201.8
Q ss_pred ceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 230 NIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
+.||+|+||.||+|.... +..||||.+...........+.+|+++++.++|+||+++++++.. ....++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE----EEPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC----CCceEEEEE
Confidence 369999999999998764 789999999876544445679999999999999999999998876 457899999
Q ss_pred eCCCCChHhhhhccc-------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 306 FMPNGNLRDCLDGVL-------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
|+++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||.+.
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~ 153 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSR 153 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccc
Confidence 999999999997642 255899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
....... ........++..|+|||.+....++.++||||||+++|||++ |..||....... ...
T Consensus 154 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~--------- 218 (262)
T cd00192 154 DVYDDDY---YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLE--------- 218 (262)
T ss_pred ccccccc---cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHH---------
Confidence 7654321 112234457889999999988899999999999999999999 699986542211 000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
.+.. ......+...+..+.+++.+||..+|.+||++.++++.|.
T Consensus 219 -----~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 219 -----YLRK-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----HHHc-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0000 0011223333456889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=314.27 Aligned_cols=267 Identities=24% Similarity=0.311 Sum_probs=219.9
Q ss_pred HHHHHHHhcCccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEE
Q 006785 216 YSALEHATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289 (631)
Q Consensus 216 ~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~ 289 (631)
..+|..-..+++...++-+|.||.||+|.|.+ .+.|-||.++..+.+-....|+.|.-++..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 45666677788888999999999999997653 456889999988888778889999999999999999999999
Q ss_pred eeeccCCcceEEEEEeeCCCCChHhhhhc------cccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeee
Q 006785 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDG------VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 363 (631)
Q Consensus 290 ~~~~~~~~~~~~lV~E~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl 363 (631)
+.+. ....+++|.++.-|+|..||.. ...+.++..+.+.++.|++.||+|||+++ +||.||.++|++|
T Consensus 356 ~ie~---~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvI 429 (563)
T KOG1024|consen 356 SIED---YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVI 429 (563)
T ss_pred Eeec---cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhccee
Confidence 9873 4467999999999999999972 22345788899999999999999999999 9999999999999
Q ss_pred cCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccc
Q 006785 364 DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKG 442 (631)
Q Consensus 364 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~ 442 (631)
|+...+||+|-.|+|.+.+.++..-... ......||+||.+....|+..+|||||||+||||+| |+.|+..-.+.+
T Consensus 430 dd~LqVkltDsaLSRDLFP~DYhcLGDn---EnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE 506 (563)
T KOG1024|consen 430 DDQLQVKLTDSALSRDLFPGDYHCLGDN---ENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE 506 (563)
T ss_pred hhheeEEeccchhccccCcccccccCCC---CCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH
Confidence 9999999999999998887766433222 235678999999999999999999999999999999 999986544332
Q ss_pred cchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 443 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
... .... + .+...|-++++++..+|..||...|++||+++|+++.|.+.
T Consensus 507 m~~-ylkd-------G----------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 507 MEH-YLKD-------G----------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred HHH-HHhc-------c----------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 111 1111 1 11123445566699999999999999999999999999865
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=315.35 Aligned_cols=256 Identities=25% Similarity=0.279 Sum_probs=206.1
Q ss_pred CccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.|..++.||.|.-|+||++.+++ +..+|+|++..... .+.......|-+||+.++||.++.||+.+.. +.+.+
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet----~~~~c 153 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET----DKYSC 153 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec----cceeE
Confidence 45567889999999999999876 68999999976532 2233347789999999999999999998875 67889
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+|||||+||+|..+++.+..+.++...+.-++..|+-||+|||-.| ||.|||||+||||.++|++-|+||.|+....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 9999999999999999888888999999999999999999999999 9999999999999999999999999976432
Q ss_pred cCC-C---------------------------C-C----------------------CCCCCcccccCCCCCCchhhhcC
Q 006785 382 ADG-L---------------------------P-S----------------------CSSSPARMQGTFGYFAPEYAMVG 410 (631)
Q Consensus 382 ~~~-~---------------------------~-~----------------------~~~~~~~~~Gt~~Y~APE~~~~~ 410 (631)
..- . . . .......++||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 100 0 0 0 00112336899999999999999
Q ss_pred CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcc
Q 006785 411 RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQ 490 (631)
Q Consensus 411 ~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~ 490 (631)
..+.++|.|+|||+||||+.|..||.+.....-... ++...+...-....+..+.+||++.|.
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N-----------------Iv~~~l~Fp~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN-----------------IVGQPLKFPEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH-----------------HhcCCCcCCCCCcchhHHHHHHHHHhc
Confidence 999999999999999999999999976554432221 221112111122455668999999999
Q ss_pred cCCCCCCC----HHHHHH
Q 006785 491 LDPDARPT----MSEVVQ 504 (631)
Q Consensus 491 ~dP~~RPs----~~evl~ 504 (631)
+||.+|.. +.||.+
T Consensus 374 KdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred cChhhhhccccchHHhhc
Confidence 99999998 777755
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=332.64 Aligned_cols=261 Identities=20% Similarity=0.274 Sum_probs=199.2
Q ss_pred HHHHHHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeec
Q 006785 217 SALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293 (631)
Q Consensus 217 ~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 293 (631)
.++....++|.+.+.||+|+||.||++..+ +++.||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~- 114 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD- 114 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-
Confidence 345555689999999999999999999986 48899999986421 12233457899999999999999999998875
Q ss_pred cCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEec
Q 006785 294 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD 373 (631)
Q Consensus 294 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~D 373 (631)
....|+||||+++|+|.+++... .++...+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 115 ---~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~D 185 (371)
T cd05622 115 ---DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD 185 (371)
T ss_pred ---CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEe
Confidence 55789999999999999998653 4788899999999999999999998 99999999999999999999999
Q ss_pred cCceeecccCCCCCCCCCCcccccCCCCCCchhhhcC----CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh
Q 006785 374 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG----RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 449 (631)
Q Consensus 374 FGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~----~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~ 449 (631)
||+++....... .......||+.|+|||++... .++.++|||||||++|||++|+.||............
T Consensus 186 fG~a~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i-- 259 (371)
T cd05622 186 FGTCMKMNKEGM----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI-- 259 (371)
T ss_pred CCceeEcCcCCc----ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHH--
Confidence 999987643321 112345699999999998753 3789999999999999999999999753321110000
Q ss_pred cccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 006785 450 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDA--RPTMSEVVQIL 506 (631)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L 506 (631)
.... ..+....+...+..+.+++..|+..++.+ ||++.++++..
T Consensus 260 -----------~~~~--~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 260 -----------MNHK--NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -----------HcCC--CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0000 00000111223445788999999844433 67888887754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.59 Aligned_cols=251 Identities=27% Similarity=0.368 Sum_probs=206.0
Q ss_pred cccceeeeeCceEEEEEEECC--Cc--EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 227 SGSNIVGQGGSSYVYRGQLTD--GR--IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 227 ~~~~~LG~G~fG~Vy~~~~~~--g~--~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
...++||+|.||.|++|.|+. |+ .||||.++.........+|++|+.+|.+|+|||+++|||+..+ ....|
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-----qp~mM 187 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-----QPAMM 187 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-----chhhH
Confidence 345789999999999999874 43 6999999987665577789999999999999999999999874 34589
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
|||+++.|+|.+.|+......|-......++.|||.||.||..++ +|||||..+|+||-....+||+||||.+.+..
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999998844455888899999999999999999988 99999999999999999999999999998765
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
..... .......-...|+|||.+..+.++.++|||+|||++|||+| |..||-+.... .+
T Consensus 265 ned~Y--vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~------------------qI 324 (1039)
T KOG0199|consen 265 NEDMY--VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI------------------QI 324 (1039)
T ss_pred CCcce--EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH------------------HH
Confidence 32111 00111123568999999999999999999999999999999 78899653321 12
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+.+|..-+..-|+.+++.++++++.||..+|++|||+..|.+.
T Consensus 325 L~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 325 LKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred HHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 22223333334577888889999999999999999999999743
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=317.48 Aligned_cols=260 Identities=26% Similarity=0.415 Sum_probs=204.0
Q ss_pred cCccccceeeeeCceEEEEEEECC-Cc----EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~----~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
.+|...+.||+|+||.||+|.+.+ |. .||+|.+...........+.+|+.++++++||||+++++++.. .
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 81 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-----S 81 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----C
Confidence 456778899999999999998653 33 6999988766554455678999999999999999999999874 3
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccc
Confidence 5799999999999999997643 34899999999999999999999988 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
........ .......++..|+|||.+....++.++||||||+++|||++ |+.||....... ....
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~-------- 223 (279)
T cd05057 158 LLDVDEKE---YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPDL-------- 223 (279)
T ss_pred cccCcccc---eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHH--------
Confidence 76532211 01111224578999999988899999999999999999998 999996533211 0000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 513 (631)
+.... ....+......+.+++.+||..+|..||++.++++.|..+..+.
T Consensus 224 ---~~~~~----~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 224 ---LEKGE----RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred ---HhCCC----CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 00000 00112222334788999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=328.44 Aligned_cols=262 Identities=26% Similarity=0.396 Sum_probs=203.9
Q ss_pred hcCccccceeeeeCceEEEEEEECC--------CcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeec
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 293 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 293 (631)
..+|.+.+.||+|+||.||+|.... +..||+|.++..........+.+|+++++++ +||||+++++++..
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 89 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-
Confidence 4567888999999999999997521 2369999988654444556789999999999 89999999999875
Q ss_pred cCCcceEEEEEeeCCCCChHhhhhccc--------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCC
Q 006785 294 RGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359 (631)
Q Consensus 294 ~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~ 359 (631)
....++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ |+||||||+
T Consensus 90 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 163 (334)
T cd05100 90 ---DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAAR 163 (334)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccc
Confidence 446799999999999999996532 234889999999999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCc
Q 006785 360 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (631)
Q Consensus 360 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~ 438 (631)
|||++.++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYY---KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred eEEEcCCCcEEECCcccceeccccccc---ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 999999999999999999865432111 11122234578999999999999999999999999999998 88888543
Q ss_pred cccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 439 ITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
........ +... ...+.+...+..+.+|+.+||+.+|++||++.++++.|..+...
T Consensus 241 ~~~~~~~~--------------~~~~----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 241 PVEELFKL--------------LKEG----HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred CHHHHHHH--------------HHcC----CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 22111000 0000 00111222334588999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=318.93 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=198.9
Q ss_pred cCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
++|...+.||+|+||.||++... ++..+|+|.+... .......|.+|+++++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTE----G 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec----C
Confidence 45666789999999999999642 3568999988754 23344569999999999999999999998875 4
Q ss_pred ceEEEEEeeCCCCChHhhhhcccc-------------CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeec
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLV-------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 364 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~ 364 (631)
...++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVG 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEc
Confidence 467999999999999999965321 24889999999999999999999998 99999999999999
Q ss_pred CCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccc
Q 006785 365 ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGE 443 (631)
Q Consensus 365 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~ 443 (631)
+++.+||+|||+++........ .......+++.|+|||++.+..++.++||||||+++|||++ |..||........
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 233 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYY---RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA 233 (280)
T ss_pred CCCCEEECCCCceeEcCCCcee---ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH
Confidence 9999999999999765432211 11122345788999999999999999999999999999998 8999864332211
Q ss_pred chhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 444 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
..... ..... ..+...+..+.+|+.+||+.||++||++.+|++.|.
T Consensus 234 ~~~~~--------------~~~~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 234 IECIT--------------QGREL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHH--------------cCccC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11000 00001 111222344889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=314.35 Aligned_cols=250 Identities=25% Similarity=0.363 Sum_probs=202.6
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++|+..+.||.|+||.||+|.+. +++.||+|.+...........+.+|+.+++.++|+||+++++++.+ ....|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~ 76 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK----GSKLWI 76 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE----CCeEEE
Confidence 35777889999999999999876 4899999999765444555668999999999999999999998876 457899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
|+||+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++....
T Consensus 77 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 77 IMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred EEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 99999999999999753 6899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
.. .......|++.|+|||++.+..++.++||||||+++|+|++|+.||.......... .+.
T Consensus 151 ~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~--------------~~~ 211 (274)
T cd06609 151 TM-----SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF--------------LIP 211 (274)
T ss_pred cc-----cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH--------------Hhh
Confidence 31 12233468899999999998889999999999999999999999996432111000 000
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
....+.+... ..+..+.+++.+||..+|++|||+.++++.
T Consensus 212 ~~~~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 212 KNNPPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred hcCCCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111111111 033448889999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=319.16 Aligned_cols=250 Identities=26% Similarity=0.413 Sum_probs=200.7
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
.+|+..+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.+++.++|+||+++++++.. ....++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~----~~~~~l 94 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLV----GDELWV 94 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEe----CCEEEE
Confidence 46788889999999999999864 5889999998765433 34568899999999999999999998875 457899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 95 v~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 95 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred eecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 9999999999999864 34799999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
.. .......|++.|+|||++.+..++.++||||||+++|+|++|+.||........ ...+.
T Consensus 169 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~~------------ 229 (296)
T cd06654 169 EQ-----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIA------------ 229 (296)
T ss_pred cc-----cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHHh------------
Confidence 21 112234688999999999988899999999999999999999999965332111 00000
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
....+. ...+......+.+++.+||..+|++||++.++++.
T Consensus 230 ~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 230 TNGTPE--LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cCCCCC--CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 000001 11223344558899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=328.44 Aligned_cols=242 Identities=22% Similarity=0.273 Sum_probs=187.3
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHH-HHHhcCCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVD-MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
+.||+|+||.||+|+.. +++.||+|++..... ......+..|.. +++.++||||+++++++.. ....|+|||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~----~~~~~lv~e 76 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT----ADKLYFVLD 76 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc----CCeEEEEEe
Confidence 36999999999999876 478899999875321 122223444444 5678899999999998875 557899999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCC
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 385 (631)
|+++|+|.+++... ..+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~- 150 (325)
T cd05602 77 YINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN- 150 (325)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-
Confidence 99999999999753 45788899999999999999999998 9999999999999999999999999997543221
Q ss_pred CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccC
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (631)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .+.
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-----------------~i~ 209 (325)
T cd05602 151 ----GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD-----------------NIL 209 (325)
T ss_pred ----CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHH-----------------HHH
Confidence 12334569999999999999999999999999999999999999996433211100 000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 466 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 466 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
.... ..+...+..+.+++.+||+.||.+||++.+.+.
T Consensus 210 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 210 NKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred hCCc--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 0000 112223345888999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=318.39 Aligned_cols=263 Identities=26% Similarity=0.408 Sum_probs=205.9
Q ss_pred cHHHHHHHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeee
Q 006785 215 SYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 292 (631)
Q Consensus 215 s~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 292 (631)
++.++..+.+.|+..+.||.|+||.||+|.+. +++.||+|++.... .....+..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 55666677889999999999999999999875 48899999986542 2334588999999999 79999999998864
Q ss_pred cc--CCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeE
Q 006785 293 FR--GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 370 (631)
Q Consensus 293 ~~--~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 370 (631)
.. ......|+||||+++|+|.+++.......+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 22 12457899999999999999997655556889999999999999999999998 99999999999999999999
Q ss_pred EeccCceeecccCCCCCCCCCCcccccCCCCCCchhhh-----cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccch
Q 006785 371 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES 445 (631)
Q Consensus 371 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~ 445 (631)
|+|||++....... .......|++.|+|||.+. ...++.++||||||+++|||++|..||..........
T Consensus 162 l~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~ 236 (282)
T cd06636 162 LVDFGVSAQLDRTV-----GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF 236 (282)
T ss_pred EeeCcchhhhhccc-----cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh
Confidence 99999987653221 1223456899999999876 3457889999999999999999999996433211110
Q ss_pred hhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 446 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
. +.....+.. .....+..+.+|+.+||+.||.+|||+.+|++
T Consensus 237 ~--------------~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 L--------------IPRNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred h--------------HhhCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 000111111 11123345889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=318.49 Aligned_cols=262 Identities=23% Similarity=0.343 Sum_probs=203.5
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++|++.+.||+|+||+||++... +|+.||+|++...........+.+|+++++.++||||+++++++.. ...+++
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~l 80 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN----ENNICM 80 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec----CCEEEE
Confidence 45677789999999999999875 4889999998765545556679999999999999999999999876 457899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHh-cCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
||||+++++|.+++... +.+++..+..++.+++.||.|||+ .+ ++||||||+||++++++.++|+|||++....
T Consensus 81 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 81 CMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred EEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 99999999999998753 458999999999999999999997 46 9999999999999999999999999987543
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||............. ..+.. .+
T Consensus 156 ~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~---~~~~~---~~ 222 (284)
T cd06620 156 NSI-------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP---MGILD---LL 222 (284)
T ss_pred hhc-------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhh---hHHHH---HH
Confidence 221 123468999999999988899999999999999999999999997543321100000 00000 00
Q ss_pred cccCCCCCCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006785 462 SELPDPRLKGDFP-KEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508 (631)
Q Consensus 462 ~~~~~~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 508 (631)
..+...... ..+ ...+..+.+|+.+||+.||++||++.|+++...-
T Consensus 223 ~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 223 QQIVQEPPP-RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred HHHhhccCC-CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 001100000 111 1234558899999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=316.27 Aligned_cols=270 Identities=25% Similarity=0.326 Sum_probs=202.2
Q ss_pred ccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCC-cceEEEE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK-RAMRLLV 303 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~~~~~lV 303 (631)
|...+++|.|+||.||+|++.. +..||||+.-.+..- -.+|+++|++++|||||+|+-++...... ..+..+|
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4456889999999999999765 789999998765332 24799999999999999999888765554 3466799
Q ss_pred EeeCCCCChHhhhhcc--ccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCC-CCeEEeccCceeec
Q 006785 304 FEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRL 380 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kL~DFGla~~~ 380 (631)
||||+ .+|.++++.. ..+.++...+.-+..||.+||.|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99996 5999999742 2355888888999999999999999988 9999999999999976 88999999999988
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccc--hhhhhcccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE--SLVLWATPRLQDS 457 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~--~~~~~~~~~~~~~ 457 (631)
..+. ......-|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+....... .......|..++.
T Consensus 177 ~~~e------pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 177 VKGE------PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred ccCC------CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 6542 2344567899999999986 46999999999999999999999988764432221 1112222222111
Q ss_pred c---ccccccCCCCCCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhhhC
Q 006785 458 G---TVISELPDPRLKGD-----FPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ--ILSTIA 510 (631)
Q Consensus 458 ~---~~~~~~~~~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~ 510 (631)
. ....+...|.+... +......+..+|+.++|+.+|.+|.++.|++. .++.+.
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 0 01111112222211 22333455889999999999999999999985 344443
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=316.15 Aligned_cols=250 Identities=27% Similarity=0.442 Sum_probs=195.8
Q ss_pred ceeeeeCceEEEEEEECC-------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 230 NIVGQGGSSYVYRGQLTD-------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~-------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+.||+|+||.||+|+..+ +..+|||.+...........|.+|+.+++.++||||+++++++.. ....++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~ 76 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL----NEPQYI 76 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC----CCCeEE
Confidence 368999999999998653 357999998765444455679999999999999999999998865 446799
Q ss_pred EEeeCCCCChHhhhhccc-----cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC-----CeEEe
Q 006785 303 VFEFMPNGNLRDCLDGVL-----VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-----NAKIT 372 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-----~~kL~ 372 (631)
||||+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++ .++|+
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~ 153 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIG 153 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEEC
Confidence 999999999999996532 233789999999999999999999988 99999999999999877 89999
Q ss_pred ccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcc
Q 006785 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWAT 451 (631)
Q Consensus 373 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~ 451 (631)
|||+++........ .......++..|+|||++.++.++.++||||||+++|||++ |+.||....... .....
T Consensus 154 dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~- 226 (269)
T cd05044 154 DFGLARDIYKSDYY---RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHV- 226 (269)
T ss_pred Cccccccccccccc---ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHH-
Confidence 99999765433211 11122346788999999999999999999999999999998 999986432211 00000
Q ss_pred cccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 452 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 452 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
. . ......+...+..+.+++.+||..+|.+||++.+|++.|.
T Consensus 227 ---~-------~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 227 ---T-------A----GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ---h-------c----CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0 0 0000122233456889999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=310.97 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=201.2
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+|++.+.||+|++|.||++... +++.||||++.... .......+.+|++++++++|+|++++++.+.. .....|+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~l 77 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG---EDGLLYI 77 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC---CCCEEEE
Confidence 4778899999999999999875 47899999987543 22334568899999999999999999887643 2346799
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++++|.+++.......+++.++..++.+++.||+|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 999999999999997655556899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
.. .......|++.|+|||++.+..++.++||||||+++|+|++|+.||.......... .. ..
T Consensus 155 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~--~~-----------~~ 216 (257)
T cd08223 155 QC-----DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY--RI-----------IE 216 (257)
T ss_pred cC-----CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH--HH-----------Hh
Confidence 22 12234568899999999999999999999999999999999999986432111000 00 00
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. ..+ ..+...+..+.+++.+||+.+|++||++.++++.
T Consensus 217 ~-~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 217 G-KLP----PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred c-CCC----CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 001 1223344568899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=327.83 Aligned_cols=270 Identities=21% Similarity=0.273 Sum_probs=198.9
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC--Cc
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KR 297 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~ 297 (631)
..++|...+.||+|+||.||++... .++.||||++.... .......+.+|+.+++.++||||+++++++..... ..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999865 48899999987543 22334568899999999999999999998864321 22
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
...|+||||++ ++|.+++.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCccc
Confidence 35799999995 577777653 3789999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh--ccc---
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATP--- 452 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~--- 452 (631)
+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.............. ..+
T Consensus 167 ~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 167 RTAGTS------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_pred ccCCCc------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 765332 122345689999999999998999999999999999999999999965332111000000 000
Q ss_pred ---ccc-------cccccccccCCCC------C--CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 453 ---RLQ-------DSGTVISELPDPR------L--KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 453 ---~~~-------~~~~~~~~~~~~~------l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+. ........+..+. . ....+......+.+|+.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000 0000000000000 0 001112234557899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=335.69 Aligned_cols=264 Identities=21% Similarity=0.263 Sum_probs=195.2
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
..+|.+.+.||+|+||.||+|.+.. ++.||||..... .+.+|+++|++|+|+||+++++++.. ....+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~-------~~~~E~~iL~~L~HpnIv~l~~~~~~----~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYA-------SSVHEARLLRRLSHPAVLALLDVRVV----GGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccccc-------CHHHHHHHHHHCCCCCCCcEEEEEEE----CCEEE
Confidence 4579999999999999999999864 789999964321 26789999999999999999998876 45679
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+|||++ .++|.+++.... ..++|.+++.|+.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 237 lv~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 237 LVLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred EEEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 999999 579999886532 45999999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCcccccc--------chhhhhcccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE--------ESLVLWATPR 453 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~--------~~~~~~~~~~ 453 (631)
.... ........||+.|+|||++.+..++.++|||||||+||||++|..|+........ ...+......
T Consensus 312 ~~~~---~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~ 388 (461)
T PHA03211 312 GSWS---TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH 388 (461)
T ss_pred cccc---cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence 3221 1122345699999999999999999999999999999999998876643221100 0001110000
Q ss_pred cccccc-----ccc-------ccCCCCC-CCCCC--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 454 LQDSGT-----VIS-------ELPDPRL-KGDFP--KEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 454 ~~~~~~-----~~~-------~~~~~~l-~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
...... ... ....+.. ...+. ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000 000 0000000 00000 0112357889999999999999999999875
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=317.90 Aligned_cols=247 Identities=24% Similarity=0.380 Sum_probs=199.1
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~ 304 (631)
|+..+.||+|+||.||+|.+. +++.||||.+...........+.+|+.++++++||||+++++++.. ....|+||
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~ 81 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK----GTKLWIIM 81 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc----CCceEEEE
Confidence 555678999999999999875 4789999998755444455668999999999999999999998875 45789999
Q ss_pred eeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCC
Q 006785 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (631)
Q Consensus 305 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~ 384 (631)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 82 EYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 99999999999864 45899999999999999999999998 9999999999999999999999999997654322
Q ss_pred CCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccccc
Q 006785 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 464 (631)
Q Consensus 385 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (631)
. ......|+..|+|||++.+..++.++||||||+++|||++|+.||......... . .+...
T Consensus 156 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~-----------~~~~~ 216 (277)
T cd06642 156 I-----KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---F-----------LIPKN 216 (277)
T ss_pred h-----hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---h-----------hhhcC
Confidence 1 122345889999999999888999999999999999999999998643221100 0 00011
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 465 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 465 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..+.+ +...+..+.+++.+||+.+|++||++.++++.
T Consensus 217 ~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 217 SPPTL----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCC----CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11222 22334458899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=327.70 Aligned_cols=270 Identities=23% Similarity=0.275 Sum_probs=197.7
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC--Cc
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KR 297 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~ 297 (631)
..++|...+.||+|+||.||++... +|..||||++.... .......+.+|+.+++.++||||+++++++..... ..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999875 48999999997542 22334558899999999999999999998864321 12
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
...|+||||++ ++|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence 35799999995 567766643 3788999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhh---------
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL--------- 448 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~--------- 448 (631)
+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 171 ~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 244 (359)
T cd07876 171 RTACTN------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE 244 (359)
T ss_pred cccccC------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHH
Confidence 754322 11233568999999999999999999999999999999999999997543211000000
Q ss_pred -----------hcccccccccccccccCCCCC---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 449 -----------WATPRLQDSGTVISELPDPRL---KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 449 -----------~~~~~~~~~~~~~~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+........+....+...... ....+......+.+|+.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000000000000000 000111123457899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=317.37 Aligned_cols=266 Identities=26% Similarity=0.356 Sum_probs=205.4
Q ss_pred cHHHHHHHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeee
Q 006785 215 SYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 292 (631)
Q Consensus 215 s~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 292 (631)
.++.+..+.++|++.+.||+|+||.||++... +++.+|+|++.... .....+..|+.+++++ +||||+++++++..
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 34566778899999999999999999999875 48899999886532 2234588999999999 79999999998864
Q ss_pred cc-CCcceEEEEEeeCCCCChHhhhhcc--ccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCe
Q 006785 293 FR-GKRAMRLLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 369 (631)
Q Consensus 293 ~~-~~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 369 (631)
.. ......++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 32 2345789999999999999988642 2245889999999999999999999998 9999999999999999999
Q ss_pred EEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhc-----CCCCcccchhhHHHHHHHHHhCCCCCCCccccccc
Q 006785 370 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE 444 (631)
Q Consensus 370 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-----~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~ 444 (631)
+|+|||+++....... ......|++.|+|||++.. ..++.++||||||+++|||++|+.||.........
T Consensus 164 kl~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~ 238 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-----RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL 238 (286)
T ss_pred EEccCCceeecccCCC-----ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH
Confidence 9999999987643221 1223468999999998753 45788999999999999999999998643221110
Q ss_pred hhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006785 445 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506 (631)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 506 (631)
. . ......+.+. .+......+.+|+.+||+.||++|||+.+|++.+
T Consensus 239 ~--~------------~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 239 F--K------------IPRNPPPTLH--QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred h--h------------ccccCCCccc--CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0 0 0000001110 1111234588999999999999999999998754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=331.35 Aligned_cols=271 Identities=24% Similarity=0.289 Sum_probs=197.6
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCC-cceEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK-RAMRL 301 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~~~~~ 301 (631)
+|+..+.||+|+||.||++... +|+.||||++.... .......+.+|+.+|+.++|+||+++++++...... ....|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999874 58999999986532 222334588999999999999999999988753211 12679
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+. ++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999995 6888887543 45899999999999999999999998 9999999999999999999999999998754
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh--cccccccc-
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPRLQDS- 457 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~~~~~- 457 (631)
.... .......+|+.|+|||++.+. .++.++||||||+++|||++|+.||.............. ..+.....
T Consensus 155 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 155 PDES----KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230 (372)
T ss_pred cCcc----ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 3221 122334688999999998874 479999999999999999999999975432211110000 00000000
Q ss_pred ------c-ccccccCC-CCCC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 458 ------G-TVISELPD-PRLK--GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 458 ------~-~~~~~~~~-~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. ........ +... ..........+.+|+.+||+.||.+|||+.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 00000000 0000 01112224458899999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=313.58 Aligned_cols=249 Identities=23% Similarity=0.333 Sum_probs=202.9
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
.|+..+.||.|+||.||+|.+. ++..||||.+...........+.+|+.+++++.||||+++++++.. ....++|
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 80 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK----GTKLWII 80 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE----CCEEEEE
Confidence 4566788999999999999875 4889999998765444455678999999999999999999999876 5578999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
|||+++|+|.+++.. ..+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 81 MEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred EecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 999999999999864 35889999999999999999999998 999999999999999999999999999776443
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 463 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (631)
.. ......++..|+|||++.+..++.++||||||+++|||++|..||..........
T Consensus 155 ~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------------------ 211 (277)
T cd06640 155 QI-----KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF------------------ 211 (277)
T ss_pred cc-----ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh------------------
Confidence 21 1223458889999999998889999999999999999999999986432211000
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006785 464 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506 (631)
Q Consensus 464 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 506 (631)
..........+...+..+.+++.+||+.+|++||++.++++.-
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 212 LIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred hhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 0000111123445566688999999999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=310.52 Aligned_cols=249 Identities=29% Similarity=0.451 Sum_probs=197.8
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeCCC
Q 006785 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~~ 309 (631)
++||.|+||.||++.+.+++.||+|++...........|.+|++++++++|+||+++++++.. ....++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ----KQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec----CCCeEEEEEcCCC
Confidence 368999999999999877999999998765444445669999999999999999999998875 4567999999999
Q ss_pred CChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCCC
Q 006785 310 GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 389 (631)
Q Consensus 310 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 389 (631)
++|.+++.... ..+++..+..++.+++.||+|||+++ ++||||||+|||++.++.++|+|||++.........
T Consensus 77 ~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~--- 149 (251)
T cd05041 77 GSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT--- 149 (251)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcce---
Confidence 99999996542 35899999999999999999999998 999999999999999999999999999765422111
Q ss_pred CCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccccccccccCCCC
Q 006785 390 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 468 (631)
Q Consensus 390 ~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (631)
.......++..|+|||++.++.++.++||||||+++|||++ |..||........... +...
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~--------------~~~~---- 211 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER--------------IESG---- 211 (251)
T ss_pred eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH--------------HhcC----
Confidence 11112234667999999998899999999999999999999 7888854332111000 0000
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 469 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 469 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
.....+...+..+.+++.+||..+|++||++.+|++.|.
T Consensus 212 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 212 YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 001122333456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=315.82 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=200.7
Q ss_pred cCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
++|+..+.||+|+||.||+|+.+ +.+.|++|.+...........|.+|++++++++|+||+++++++.+ .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~ 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE----A 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC----C
Confidence 46778889999999999999864 2467999988765443345669999999999999999999998865 4
Q ss_pred ceEEEEEeeCCCCChHhhhhcccc-------CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeE
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLV-------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 370 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 370 (631)
...++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~ 157 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVK 157 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEE
Confidence 467999999999999999975431 15899999999999999999999998 99999999999999999999
Q ss_pred EeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhh
Q 006785 371 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLW 449 (631)
Q Consensus 371 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~ 449 (631)
|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ....
T Consensus 158 l~~~~~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~ 230 (275)
T cd05046 158 VSLLSLSKDVYNSEY----YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNR 230 (275)
T ss_pred EcccccccccCcccc----cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHH
Confidence 999999875432211 12223356788999999988889999999999999999999 788885432211 0000
Q ss_pred cccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 450 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
.....+....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 231 --------------~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 --------------LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --------------HHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00000001112223345889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=312.64 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=199.9
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
++.+++++.....||+|+||.||+|.+. ++..||+|.+.... ......+.+|+.++++++|+||+++++++.. .
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~ 77 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSE----N 77 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeecc----C
Confidence 4556777777889999999999999865 47889999887543 2334568999999999999999999999876 4
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCC--CHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC-CCCeEEecc
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGM--NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDL 374 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kL~DF 374 (631)
...++||||+++++|.+++.... ..+ ++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.++|+||
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~df 153 (268)
T cd06624 78 GFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDF 153 (268)
T ss_pred CEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecc
Confidence 57899999999999999997532 234 88889999999999999999998 999999999999976 678999999
Q ss_pred CceeecccCCCCCCCCCCcccccCCCCCCchhhhcCC--CCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccc
Q 006785 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR--ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 452 (631)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~--~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 452 (631)
|++....... .......|++.|+|||++.... ++.++||||||+++|+|++|+.||........ ..+...
T Consensus 154 g~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~ 225 (268)
T cd06624 154 GTSKRLAGIN-----PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVG 225 (268)
T ss_pred hhheecccCC-----CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhh
Confidence 9987654321 1122345889999999986543 78999999999999999999999864321110 001000
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 453 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.......++......+.+++.+||+.+|.+|||+.++++.
T Consensus 226 -------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 226 -------------MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -------------hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0001112333444558899999999999999999999763
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.21 Aligned_cols=238 Identities=23% Similarity=0.274 Sum_probs=185.7
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHH-HHHhcCCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVD-MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
++||+|+||.||+|+.. +++.||||++.... .......+..|.. +++.++||||+++++++.. ....|+|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~----~~~~~lv~e 76 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT----AEKLYFVLD 76 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc----CCEEEEEEc
Confidence 36999999999999975 48999999986432 1222334555554 6788899999999988765 457899999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCC
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 385 (631)
|+++|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 150 (321)
T cd05603 77 YVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE- 150 (321)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-
Confidence 99999999988653 45889999999999999999999998 9999999999999999999999999987532211
Q ss_pred CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccC
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (631)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .+.
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-----------------~i~ 209 (321)
T cd05603 151 ----ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD-----------------NIL 209 (321)
T ss_pred ----CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHH-----------------HHh
Confidence 12234569999999999998899999999999999999999999996532211000 000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006785 466 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 500 (631)
Q Consensus 466 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 500 (631)
... ..++......+.+++.+||+.||.+||++.
T Consensus 210 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 210 HKP--LQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred cCC--CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 000 012223344588999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=321.83 Aligned_cols=260 Identities=28% Similarity=0.474 Sum_probs=201.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCc----EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
.+|...+.||+|+||.||+|.+. +|. .||+|.+...........+.+|+.+++.++||||++++|++.. .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----~ 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-----P 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----C
Confidence 45677889999999999999864 343 5799988765444445568999999999999999999998864 2
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..++++||+++|+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred CceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccc
Confidence 357999999999999998754 235899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||............ . .
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~---~-----~ 226 (303)
T cd05110 158 LLEGDEKE---YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL---E-----K 226 (303)
T ss_pred cccCcccc---cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---H-----C
Confidence 76432211 11122345778999999998999999999999999999997 89998643211111100 0 0
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 513 (631)
+ .... .+...+..+..++..||..+|++||++.++++.|..+..+.
T Consensus 227 ~---~~~~-------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 227 G---ERLP-------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred C---CCCC-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 0 0011 11112334788999999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=311.14 Aligned_cols=251 Identities=27% Similarity=0.462 Sum_probs=198.6
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
.+|+..+.||+|+||.||+|.+.++..+|||.+..... ....|.+|++++++++|||++++++++.. ....++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTE----RSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEcc----CCceEEE
Confidence 35677889999999999999987788999999875432 23458999999999999999999998765 4467999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
|||+++++|.+++.... ..+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++.....
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 78 FEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 99999999999997543 34899999999999999999999998 999999999999999999999999999865432
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccccccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
.. .......++.+|+|||++.++.++.++||||||+++|||++ |+.||....... .... +.. ..
T Consensus 154 ~~----~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~----~~~----~~ 218 (256)
T cd05112 154 QY----TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVET----INA----GF 218 (256)
T ss_pred cc----cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHH----HhC----CC
Confidence 11 11122335678999999998899999999999999999998 999986432111 0000 000 00
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 506 (631)
....+ ...+..+.+|+.+||+.+|++||++.++++.|
T Consensus 219 ~~~~~-------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 219 RLYKP-------RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCC-------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 01111 11234588999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=309.69 Aligned_cols=253 Identities=25% Similarity=0.452 Sum_probs=199.6
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC--------hHHHHHHHHHHHHhcCCCCCcceeEEeeeccC
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN--------ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 295 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 295 (631)
+|...+.||.|+||.||+|... +++.||+|.+....... ....+.+|+.++++++||||+++++++.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence 3667789999999999999875 48899999886542221 12458899999999999999999999876
Q ss_pred CcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccC
Q 006785 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 375 (631)
Q Consensus 296 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFG 375 (631)
....++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||
T Consensus 78 -~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg 151 (267)
T cd06628 78 -ADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFG 151 (267)
T ss_pred -CCccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccC
Confidence 45779999999999999999754 45899999999999999999999998 9999999999999999999999999
Q ss_pred ceeecccCCCCCC-CCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccc
Q 006785 376 MAKRLKADGLPSC-SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 454 (631)
Q Consensus 376 la~~~~~~~~~~~-~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~ 454 (631)
+++.......... ........|+..|+|||.+.+..++.++||||||+++|+|++|+.||..........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--------- 222 (267)
T cd06628 152 ISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF--------- 222 (267)
T ss_pred CCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH---------
Confidence 9987653221110 111223568899999999998889999999999999999999999996532211000
Q ss_pred ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 455 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 455 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
.+.....+. .+...+..+.+++.+||+.||.+||++.+|++
T Consensus 223 -----~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 223 -----KIGENASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -----HHhccCCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 001111122 22333455889999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=327.74 Aligned_cols=242 Identities=24% Similarity=0.275 Sum_probs=187.8
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHH-HHHhcCCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVD-MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
+.||+|+||.||+|+.. +|+.||||++.... .......+..|.. +++.++||||+++++++.. ....|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~----~~~~~lv~e 76 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT----TEKLYFVLD 76 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec----CCEEEEEEc
Confidence 36999999999999875 58999999986532 1223334556655 4677899999999988875 557899999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCC
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 385 (631)
|+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-- 149 (325)
T cd05604 77 FVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-- 149 (325)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--
Confidence 99999999988653 45899999999999999999999998 999999999999999999999999998753221
Q ss_pred CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccC
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (631)
........||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .+.
T Consensus 150 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~-----------------~~~ 209 (325)
T cd05604 150 ---SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD-----------------NIL 209 (325)
T ss_pred ---CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH-----------------HHH
Confidence 112334579999999999999999999999999999999999999996532211000 000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 466 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 466 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
...+ ..+...+..+.+++.+|++.+|.+||++.+.++
T Consensus 210 ~~~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 210 HKPL--VLRPGASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred cCCc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 0000 011122344778999999999999998864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=313.14 Aligned_cols=253 Identities=24% Similarity=0.341 Sum_probs=188.5
Q ss_pred eeeeeCceEEEEEEECCC---cEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeC
Q 006785 231 IVGQGGSSYVYRGQLTDG---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 307 (631)
Q Consensus 231 ~LG~G~fG~Vy~~~~~~g---~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~ 307 (631)
.||+|+||.||+|...++ ..+++|.+...........|.+|+.+++.++||||+++++++.. ....|+||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~----~~~~~lv~e~~ 77 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE----AIPYLLVFEYC 77 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC----CCccEEEEecC
Confidence 599999999999976443 35677777655444456679999999999999999999999875 45679999999
Q ss_pred CCCChHhhhhccc--cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCC
Q 006785 308 PNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 308 ~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 385 (631)
++|+|.+++.... ...+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.++|+|||++........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh
Confidence 9999999997532 234677788899999999999999998 99999999999999999999999999864322111
Q ss_pred CCCCCCCcccccCCCCCCchhhhc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccc
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMV-------GRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~-------~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
........|+..|+|||++.. ..++.++||||||+++|||++ |..||............. .
T Consensus 155 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~------~-- 223 (268)
T cd05086 155 ---IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVI------K-- 223 (268)
T ss_pred ---hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH------h--
Confidence 011223467899999998753 245789999999999999997 566775432211111000 0
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
.....+.++.+...++ ..+.+++..|| .+|++||++.+|++.|.
T Consensus 224 -~~~~~~~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 224 -DQQVKLFKPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred -hcccccCCCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 0111233343333333 34777889999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.40 Aligned_cols=259 Identities=27% Similarity=0.406 Sum_probs=205.1
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++|++.+.||.|+||+||+|... ++..+|+|++...........+.+|+++++.++|+||+++++.+.. ....++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~i 76 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV----GDELWL 76 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee----CCEEEE
Confidence 46888999999999999999865 5889999999765444456679999999999999999999998875 557899
Q ss_pred EEeeCCCCChHhhhhcccc-CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 303 VFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
||||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.++|+|||++....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~ 153 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLA 153 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence 9999999999999976433 45899999999999999999999998 9999999999999999999999999997765
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
...... ........|+..|+|||++... .++.++||||||+++|||++|+.||........ .....
T Consensus 154 ~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~---------- 220 (267)
T cd06610 154 DGGDRT-RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTL---------- 220 (267)
T ss_pred cCcccc-ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHh----------
Confidence 433211 0123445689999999998877 789999999999999999999999965432110 00000
Q ss_pred ccccCCCCCCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 461 ISELPDPRLKGDF-PKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 461 ~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
.. ..+.+.... ....+..+.+++.+||+.||++||++.+|++
T Consensus 221 -~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 221 -QN-DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -cC-CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00 011111111 1233455889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=309.10 Aligned_cols=249 Identities=25% Similarity=0.393 Sum_probs=202.0
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++|+..+.||.|+||.||+|.+.+ ++.||+|.+..... ...+.+|++++++++|+||+++++++.. ....|+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFK----NTDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeec----CCcEEE
Confidence 578888999999999999999875 88999999875432 5569999999999999999999999876 457899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
++||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 ~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 76 VMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred EEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 99999999999999653 245899999999999999999999998 99999999999999999999999999887643
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
.. .......|+..|+|||++.+..++.++||||||+++|+|++|+.||........... +.
T Consensus 152 ~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~--------------~~ 212 (256)
T cd06612 152 TM-----AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM--------------IP 212 (256)
T ss_pred Cc-----cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh--------------hc
Confidence 21 122334588999999999988999999999999999999999999864322111000 00
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
....+. ...+......+.+++.+||+.+|++|||+.+|++
T Consensus 213 ~~~~~~--~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 213 NKPPPT--LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred cCCCCC--CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 000011 1122334456889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=318.18 Aligned_cols=267 Identities=23% Similarity=0.364 Sum_probs=198.9
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++|...+.||+|+||.||+|..+ +++.||+|.+...........+.+|+.++++++||||+++++++.. ....++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~----~~~~~l 81 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT----EKSLTL 81 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec----CCeEEE
Confidence 46888899999999999999876 4889999998755444444557899999999999999999999875 457899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||++ ++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.++|+|||++.....
T Consensus 82 v~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 82 VFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred EEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 999996 6999988654 245899999999999999999999998 99999999999999999999999999876432
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhc--c------cc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA--T------PR 453 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~--~------~~ 453 (631)
.. .......+++.|+|||++.+ ..++.++||||||+++|||++|+.||............... . +.
T Consensus 157 ~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (301)
T cd07873 157 PT-----KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231 (301)
T ss_pred CC-----CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh
Confidence 21 11223457899999998875 45788999999999999999999999754322111000000 0 00
Q ss_pred cccccccccccCCCCCCCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 454 LQDSGTVISELPDPRLKGD----FPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 454 ~~~~~~~~~~~~~~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+... ........+..... .....+..+.+|+.+||+.||.+|||+.++++.
T Consensus 232 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 232 ILSN-EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred hhcc-ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 00000001111111 111234457899999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=324.70 Aligned_cols=253 Identities=25% Similarity=0.296 Sum_probs=209.4
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcC-CCCCcceeEEeeeccCCcc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~ 298 (631)
...|.+.+.||+|.||.||+++.+. |+.+|+|.+...... .....+.+|+.+|+++. |||||.+++++.. ..
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~----~~ 109 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED----PD 109 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc----CC
Confidence 4567778899999999999999876 999999999866433 23456899999999997 9999999999986 55
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCC----CCeEEecc
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN----LNAKITDL 374 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~----~~~kL~DF 374 (631)
..++|||++.||.|.+.+... .+++..+..++.|++.+++|||+.+ |+||||||+|+|+... +.+|++||
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 889999999999999999765 3999999999999999999999999 9999999999999533 47999999
Q ss_pred CceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccc
Q 006785 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 454 (631)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~ 454 (631)
|++...... ......+||+.|+|||++....|+..+||||+||++|.|++|..||...........+...
T Consensus 184 Gla~~~~~~------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~---- 253 (382)
T KOG0032|consen 184 GLAKFIKPG------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG---- 253 (382)
T ss_pred CCceEccCC------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC----
Confidence 999987652 2445678999999999999999999999999999999999999999765433222111111
Q ss_pred ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006785 455 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506 (631)
Q Consensus 455 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 506 (631)
+..+..+..+..+..+.+++..++..||..|+|+.++++.-
T Consensus 254 -----------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp 294 (382)
T KOG0032|consen 254 -----------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHP 294 (382)
T ss_pred -----------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence 01122223344566789999999999999999999999953
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=308.86 Aligned_cols=271 Identities=25% Similarity=0.338 Sum_probs=201.9
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCC-CcceeEEeeecc--CCcce
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCH-VVPLVGYCSEFR--GKRAM 299 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~--~~~~~ 299 (631)
.|...++||+|+||+||+|+.+ +|+.||+|++...... ..-....+|+.+|++|+|+| |++|++++.... +....
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 3444567999999999999865 5899999999865432 12223689999999999999 999999998633 12237
Q ss_pred EEEEEeeCCCCChHhhhhcccc--CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLV--EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
.++||||+ .-+|.+|++.... +.++...+..++.||++||+|||+++ |+||||||.||||+++|.+||+|||+|
T Consensus 92 l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchH
Confidence 89999999 6799999987553 46788899999999999999999999 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchh--hhhccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL--VLWATPRL 454 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~--~~~~~~~~ 454 (631)
+.+.-. .......++|..|.|||++.+. .|+...||||+|||+.||++++.-|.+..+...... .....|.-
T Consensus 168 ra~~ip-----~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 168 RAFSIP-----MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNE 242 (323)
T ss_pred HHhcCC-----cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCc
Confidence 965432 1234566899999999999876 799999999999999999999888876544221111 11111111
Q ss_pred ccccccccccCCCCC-----C--CCCCHHH---HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 455 QDSGTVISELPDPRL-----K--GDFPKEE---MQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 455 ~~~~~~~~~~~~~~l-----~--~~~~~~~---~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+.+..+..+++-.. . ..+.... .....+++.+||+.+|.+|.|+..++..
T Consensus 243 -~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 -KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred -cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11111111111110 0 0011111 1257789999999999999999999875
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.68 Aligned_cols=207 Identities=24% Similarity=0.372 Sum_probs=173.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|+..+.||+|+||.||++... +++.||||++.... .......+..|+.++..++||||+++++++.. ....
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~----~~~~ 76 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD----KRNL 76 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCEE
Confidence 36788899999999999999876 48999999997432 22334558889999999999999999998865 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||+++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 77 YLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred EEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 9999999999999999753 45899999999999999999999998 999999999999999999999999998755
Q ss_pred ccCCCCC------------------------------CCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh
Q 006785 381 KADGLPS------------------------------CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 430 (631)
Q Consensus 381 ~~~~~~~------------------------------~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt 430 (631)
....... .........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t 231 (360)
T cd05627 152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (360)
T ss_pred ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc
Confidence 3211000 0001123579999999999999999999999999999999999
Q ss_pred CCCCCCCcc
Q 006785 431 GRQPIHRSI 439 (631)
Q Consensus 431 G~~P~~~~~ 439 (631)
|+.||....
T Consensus 232 G~~Pf~~~~ 240 (360)
T cd05627 232 GYPPFCSET 240 (360)
T ss_pred CCCCCCCCC
Confidence 999997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=310.51 Aligned_cols=255 Identities=26% Similarity=0.423 Sum_probs=199.9
Q ss_pred CccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCC-----ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP-----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
+|...+.||.|+||.||+|...+++.+|||.+...... .....+.+|++++++++|+||+++++++.+ ...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~ 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD----DNT 76 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec----CCe
Confidence 46778899999999999999888999999998754221 122458899999999999999999999876 457
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 151 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARR 151 (265)
T ss_pred EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHh
Confidence 89999999999999999754 45889999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCCC-CCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 380 LKADGLP-SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 380 ~~~~~~~-~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
....... ..........|+..|+|||++.+..++.++||||||+++|+|++|+.||.......... .. .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~--~~-----~--- 221 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF--YI-----G--- 221 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH--Hh-----h---
Confidence 5321111 00112233568999999999998889999999999999999999999996432211100 00 0
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
......+.+ +......+.+++.+||+.+|++||++.++++
T Consensus 222 --~~~~~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 222 --AHRGLMPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --hccCCCCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000111112 2233445888999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=314.77 Aligned_cols=274 Identities=26% Similarity=0.362 Sum_probs=205.0
Q ss_pred CccccceeeeeCceEEEEEEEC-----CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
.|...+.||+|+||.||+|.+. ++..||||.+...........|.+|+++++.++|+||+++++++.... ...
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~--~~~ 82 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPG--GRS 82 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCC--CCc
Confidence 4566788999999999999864 368999999986544334567999999999999999999999876522 346
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 799999999999999997643 35899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
....... ........++..|+|||.+....++.++||||||+++|||++|+.|+............... . .....
T Consensus 159 ~~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~--~-~~~~~ 233 (284)
T cd05038 159 LPEDKDY--YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQ--G-QMIVT 233 (284)
T ss_pred cccCCcc--eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccc--c-cccHH
Confidence 6532111 01111234566799999999889999999999999999999999998643221100000000 0 00000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
.+.+..........+...+..+.+|+.+||+.+|++||++.+|++.|..+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00111111111112233345688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.60 Aligned_cols=256 Identities=21% Similarity=0.275 Sum_probs=193.0
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccC--CCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ--GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|.+.+.||+|+||.||+++.. +++.||||++... ........|.+|+.++..++|+||+++++++.+ ....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~ 76 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD----ENNL 76 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec----CCeE
Confidence 46888999999999999999976 4899999998642 122234458899999999999999999998875 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 77 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 152 (331)
T cd05597 77 YLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRL 152 (331)
T ss_pred EEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeec
Confidence 9999999999999999753 245899999999999999999999998 999999999999999999999999999766
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhc-----CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 455 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-----~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 455 (631)
..... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||............ .
T Consensus 153 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i-------~ 221 (331)
T cd05597 153 LADGT----VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI-------M 221 (331)
T ss_pred CCCCC----ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHH-------H
Confidence 43321 11123469999999999873 45788999999999999999999999653221110000 0
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCC--CCCCCHHHHHHH
Q 006785 456 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDP--DARPTMSEVVQI 505 (631)
Q Consensus 456 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP--~~RPs~~evl~~ 505 (631)
... .....+.....+ +..+.+++.+|+..++ ..||++.++++.
T Consensus 222 ~~~---~~~~~~~~~~~~----~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 222 NHK---EHFQFPPDVTDV----SEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cCC---CcccCCCccCCC----CHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 000 000001111112 3346777887775433 347899988875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=310.80 Aligned_cols=246 Identities=28% Similarity=0.415 Sum_probs=196.9
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
++|.+.+.||+|+||.||++.. .++.||+|.+.... ....+.+|+.++++++|||++++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILH-----NGLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-----CCcEEE
Confidence 4577889999999999999986 57889999986532 33568999999999999999999998754 235899
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
|||+++++|.+++.......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 99999999999997655456899999999999999999999998 999999999999999999999999998764321
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccccccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
......+..|+|||++.++.++.++||||||+++|||++ |+.||............ .
T Consensus 154 --------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~--------------~ 211 (254)
T cd05083 154 --------VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV--------------E 211 (254)
T ss_pred --------CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH--------------h
Confidence 111234568999999998899999999999999999998 99998643321110000 0
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
....+ ..+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 212 ~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 212 KGYRM----EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCCCC----CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 00001 112223345889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=325.61 Aligned_cols=270 Identities=21% Similarity=0.265 Sum_probs=198.5
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeecc--CCc
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKR 297 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~ 297 (631)
..++|...+.||+|+||.||++... .++.||||++.... .......+.+|+.+++.++||||+++++++.... ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999875 48899999997542 2333455889999999999999999999875422 122
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
...|+||||++ ++|.+++.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 45799999995 578777753 3789999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh--ccc---
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATP--- 452 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~--- 452 (631)
+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.. ..+
T Consensus 174 ~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (364)
T cd07875 174 RTAGTS------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 247 (364)
T ss_pred cccCCC------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 765332 122345689999999999999999999999999999999999999965432111100000 000
Q ss_pred ---ccc--------cc----cccccccCCCCC---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 453 ---RLQ--------DS----GTVISELPDPRL---KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 453 ---~~~--------~~----~~~~~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+. .. ......+....+ ...........+.+|+.+||+.||.+|||+.++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 00 000000000000 001111123457899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=307.99 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=202.8
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+|+..+.||.|+||.||.++.. +++.+++|.+.... .......+.+|+.++++++|+||+++++++.+ ....++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~~ 76 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD----DNTLLI 76 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec----CCeEEE
Confidence 4778899999999999999865 48899999987542 33445568999999999999999999999876 457899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++|+|.+++.......+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 77 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~ 153 (256)
T cd08221 77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGS 153 (256)
T ss_pred EEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence 999999999999997654456899999999999999999999998 99999999999999999999999999987644
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
... ......|++.|+|||++.+..++.++||||||+++|||++|..||..........
T Consensus 154 ~~~-----~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~----------------- 211 (256)
T cd08221 154 EYS-----MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV----------------- 211 (256)
T ss_pred ccc-----cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH-----------------
Confidence 321 2234568999999999988889999999999999999999999986432211100
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 506 (631)
.+...... ..+...+..+.+++.+||..+|++||++.++++.+
T Consensus 212 ~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 212 KIVQGNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHHcCCCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 00000000 11122334588899999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=311.80 Aligned_cols=252 Identities=26% Similarity=0.395 Sum_probs=197.0
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++|...+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.+++.++||||+++++++.. ....|+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~----~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLR----RDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEe----CCEEEE
Confidence 45677788999999999999875 488999999876532 333457899999999999999999998875 557899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++++|.+++... ..+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 84 CMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred EEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 99999999999998654 45899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhh---cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
.. .......|+..|+|||++. ...++.++|||||||++|||++|..||............. .
T Consensus 159 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~--~-------- 223 (267)
T cd06645 159 TI-----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT--K-------- 223 (267)
T ss_pred cc-----cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh--c--------
Confidence 21 1223456899999999874 4568899999999999999999999986433211110000 0
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
.....+.... ....+..+.+++.+||+.+|++||++.+|++
T Consensus 224 --~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 224 --SNFQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --cCCCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0001111110 0012234789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=315.29 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=201.8
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
..+|...+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++|+||+++++++.. ....|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLV----GDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEec----CCEEE
Confidence 367888999999999999999874 589999999875433 334558899999999999999999999875 45789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 93 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred EeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 99999999999999864 34799999999999999999999998 9999999999999999999999999987654
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
.... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||........... .
T Consensus 167 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~--------------~ 227 (297)
T cd06656 167 PEQS-----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--------------I 227 (297)
T ss_pred CCcc-----CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee--------------e
Confidence 3321 12234688999999999988899999999999999999999999964322111000 0
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.....+. ...+...+..+.+|+.+||..+|++||++.++++.
T Consensus 228 ~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 228 ATNGTPE--LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ccCCCCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000011 11223344558899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=314.49 Aligned_cols=253 Identities=25% Similarity=0.390 Sum_probs=199.1
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++|++.+.||+|+||.||++.+. +|..||+|.+...........+.+|++++++++|+||+++++++.. ....|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~l 76 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI----EGAVYM 76 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec----CCeEEE
Confidence 35777889999999999999986 5899999998765433444568999999999999999999998875 557899
Q ss_pred EEeeCCCCChHhhhhccc-cCCCCHHHHHHHHHHHHhhhHHHHhc-CCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 303 VFEFMPNGNLRDCLDGVL-VEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
||||+++++|..++.... ...+++..+..++.+++.||.|||+. + |+||||||+||+++.++.++|+|||++...
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 153 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL 153 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999999999987532 23589999999999999999999974 6 999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcC------CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVG------RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 454 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~------~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~ 454 (631)
... ......|++.|+|||.+.+. .++.++||||||+++|||++|+.||...........
T Consensus 154 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-------- 218 (286)
T cd06622 154 VAS-------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ-------- 218 (286)
T ss_pred cCC-------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH--------
Confidence 322 12234588899999988544 358899999999999999999999964322110000
Q ss_pred ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 455 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 455 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+..+... .....+......+.+++.+||+.+|++||++.+++..
T Consensus 219 ------~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 219 ------LSAIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ------HHHHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0011110 0112333455568899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=335.52 Aligned_cols=272 Identities=17% Similarity=0.201 Sum_probs=195.8
Q ss_pred cHHHHHHHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCC------CCccee
Q 006785 215 SYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC------HVVPLV 287 (631)
Q Consensus 215 s~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~------niv~l~ 287 (631)
..+++...+++|.+.+.||+|+||+||+|.+. .++.||||+++... .....+..|+.++..++|. ++++++
T Consensus 120 ~~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 120 LGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred cCCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 34455666789999999999999999999875 48899999996432 2233466788888777554 578888
Q ss_pred EEeeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHh-cCCCceeecCCCCCCeeecCC
Q 006785 288 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDEN 366 (631)
Q Consensus 288 g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlKp~NILl~~~ 366 (631)
+++.. .....++|||++ +++|.+++... ..+++..+..|+.||+.||+|||+ .+ ||||||||+|||++.+
T Consensus 198 ~~~~~---~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~ 268 (467)
T PTZ00284 198 RYFQN---ETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETS 268 (467)
T ss_pred EEEEc---CCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecC
Confidence 87764 234679999998 88999988654 458999999999999999999997 47 9999999999999876
Q ss_pred C----------------CeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh
Q 006785 367 L----------------NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 430 (631)
Q Consensus 367 ~----------------~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt 430 (631)
+ .+||+|||++..... ......||+.|+|||++.+..++.++|||||||+||||++
T Consensus 269 ~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~--------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ellt 340 (467)
T PTZ00284 269 DTVVDPVTNRALPPDPCRVRICDLGGCCDERH--------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYT 340 (467)
T ss_pred CcccccccccccCCCCceEEECCCCccccCcc--------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHh
Confidence 5 499999998754321 2234679999999999999999999999999999999999
Q ss_pred CCCCCCCccccccchhhhhcccccccc----------ccccccc--CCCCCC--------C--CC-CHHHHHHHHHHHHH
Q 006785 431 GRQPIHRSITKGEESLVLWATPRLQDS----------GTVISEL--PDPRLK--------G--DF-PKEEMQIMAYLAKE 487 (631)
Q Consensus 431 G~~P~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~--~~~~l~--------~--~~-~~~~~~~l~~li~~ 487 (631)
|+.||..................+... ....... ..+... . .. .......+.+|+.+
T Consensus 341 G~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 420 (467)
T PTZ00284 341 GKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYG 420 (467)
T ss_pred CCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHH
Confidence 999997543221111110000000000 0000000 000000 0 00 00112457799999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 006785 488 CLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 488 cl~~dP~~RPs~~evl~~ 505 (631)
||+.||.+|||+.|+++.
T Consensus 421 mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 421 LLHYDRQKRLNARQMTTH 438 (467)
T ss_pred hCCcChhhCCCHHHHhcC
Confidence 999999999999999973
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=329.71 Aligned_cols=245 Identities=29% Similarity=0.415 Sum_probs=201.1
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
|..++.||.|+||.||.|.+. +.+.||||++.-... .+...+++.|+..|.+|+|||++.+.|+|.. ....||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr----e~TaWL 103 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR----EHTAWL 103 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec----cchHHH
Confidence 555778999999999999864 588999999875432 2334568999999999999999999999986 556799
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||| -|+-.|+|.-. .+++.+.++..|..+.+.||+|||+.+ .||||||+.||||++.|.|||+|||.|....+
T Consensus 104 VMEYC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 104 VMEYC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHHHH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 99999 67888887643 367899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhh---cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
...++|||.|||||++. .+.|+-|+||||||++..||.-.++|++....-. +...+
T Consensus 179 ---------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-------ALYHI----- 237 (948)
T KOG0577|consen 179 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHI----- 237 (948)
T ss_pred ---------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-------HHHHH-----
Confidence 34578999999999985 6789999999999999999999999986532211 01111
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..--.|.+. ..+++..+..|+..||++-|.+|||..++++.
T Consensus 238 --AQNesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 238 --AQNESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred --HhcCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 111122222 35667789999999999999999999999874
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.17 Aligned_cols=270 Identities=21% Similarity=0.311 Sum_probs=195.0
Q ss_pred cceeeee--CceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEE
Q 006785 229 SNIVGQG--GSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (631)
Q Consensus 229 ~~~LG~G--~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~ 304 (631)
.++||+| +||+||++..+ +|+.||||++...... .....+.+|+.+++.++||||+++++++.. ....++||
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~----~~~~~lv~ 78 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----DNELWVVT 78 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE----CCEEEEEE
Confidence 5679999 78999999875 5899999999765332 233457789999999999999999999876 55789999
Q ss_pred eeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCC
Q 006785 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (631)
Q Consensus 305 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~ 384 (631)
||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++|||.+......+
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 9999999999997654456899999999999999999999998 9999999999999999999999998754432211
Q ss_pred CC--CCCCCCcccccCCCCCCchhhhc--CCCCcccchhhHHHHHHHHHhCCCCCCCccccccc-hhhhhcccccccc--
Q 006785 385 LP--SCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE-SLVLWATPRLQDS-- 457 (631)
Q Consensus 385 ~~--~~~~~~~~~~Gt~~Y~APE~~~~--~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~-~~~~~~~~~~~~~-- 457 (631)
.. ..........++..|+|||++.+ ..++.++||||||+++|||++|+.||......... .......+...+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTT 235 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccc
Confidence 10 00111222357788999999976 45899999999999999999999999643211100 0000000000000
Q ss_pred ---------------------cccccccC---CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 458 ---------------------GTVISELP---DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 458 ---------------------~~~~~~~~---~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+....... ...............+.+|+.+||+.||++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00000000 0000011222334568899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=329.49 Aligned_cols=262 Identities=21% Similarity=0.295 Sum_probs=196.5
Q ss_pred hcCccccceeeeeCceEEEEEEEC---CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
..+|.+.+.||+|+||.||++... .+..||||.+.... .+.+|+++|++++||||+++++++.. ...
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~----~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRW----KST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEee----CCE
Confidence 457899999999999999999754 35789999886432 25789999999999999999998875 457
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.++|||++ +++|.+++.. ...+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++..
T Consensus 161 ~~lv~e~~-~~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 161 VCMVMPKY-KCDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred EEEEehhc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 89999999 5789999843 256999999999999999999999998 99999999999999999999999999976
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccc-------
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP------- 452 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~------- 452 (631)
...... ........||+.|+|||++....++.++|||||||++|||++|+.||.................
T Consensus 235 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~ 311 (392)
T PHA03207 235 LDAHPD---TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPL 311 (392)
T ss_pred cCcccc---cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcc
Confidence 543321 1122346799999999999999999999999999999999999999975433211000000000
Q ss_pred cccccc--------ccccccCCCCCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 453 RLQDSG--------TVISELPDPRLKGDFP-----KEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 453 ~~~~~~--------~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+.... ........+.. ..+ ......+.+++.+||..||++||++.+++..
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 312 EFPQNGSTNLCKHFKQYAIVLRPPY--TIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccCCccchhHHHHHHhhcccccCCc--cccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 00000000000 001 0122347889999999999999999999875
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=350.55 Aligned_cols=261 Identities=22% Similarity=0.330 Sum_probs=200.2
Q ss_pred HHHHHhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC
Q 006785 218 ALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 295 (631)
Q Consensus 218 ~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 295 (631)
+.+...++|.+.+.||+|+||+||++.+.. +..||+|.+..... ......|..|+.+|+.|+|||||++++++....
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~- 85 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA- 85 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC-
Confidence 334456789999999999999999998764 78899999875432 233456899999999999999999999886532
Q ss_pred CcceEEEEEeeCCCCChHhhhhccc--cCCCCHHHHHHHHHHHHhhhHHHHhcCC----CceeecCCCCCCeeecC----
Q 006785 296 KRAMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAA----PRILHRDIKSSNILLDE---- 365 (631)
Q Consensus 296 ~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivHrDlKp~NILl~~---- 365 (631)
...+||||||+++|+|.++|.... ...+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 86 -~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 86 -NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred -CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 346899999999999999997532 2459999999999999999999998542 34999999999999964
Q ss_pred -------------CCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhc--CCCCcccchhhHHHHHHHHHh
Q 006785 366 -------------NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELIT 430 (631)
Q Consensus 366 -------------~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~--~~~s~ksDVwSlGviL~eLlt 430 (631)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||||||++
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT 238 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccc------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence 3348999999998654321 1234569999999999864 458999999999999999999
Q ss_pred CCCCCCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 431 GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 431 G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
|+.||.......... . .+...+...+ ... +..+.+|+..||+.+|.+||++.|+++
T Consensus 239 Gk~PF~~~~~~~qli--~-----------~lk~~p~lpi-~~~----S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 239 GKTPFHKANNFSQLI--S-----------ELKRGPDLPI-KGK----SKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCCCCcCCcHHHHH--H-----------HHhcCCCCCc-CCC----CHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 999996432211000 0 0001111000 112 345889999999999999999999984
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.52 Aligned_cols=257 Identities=24% Similarity=0.304 Sum_probs=201.8
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCC--hHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|...+.||+|+||.||+|...+ ++.||||.+....... ....+..|+++++.++|+||+++++++.. ....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 76 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT----ETYL 76 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec----CCEE
Confidence 367888999999999999998765 8999999997653332 44568899999999999999999998865 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+.+++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 77 CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQS 153 (316)
T ss_pred EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence 99999999999999997655566999999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCC------------------------CCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCC
Q 006785 381 KADGLPS------------------------CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436 (631)
Q Consensus 381 ~~~~~~~------------------------~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~ 436 (631)
....... .........||..|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 3221100 0011223568999999999998889999999999999999999999996
Q ss_pred CccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 006785 437 RSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT----MSEVVQ 504 (631)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 504 (631)
........ ..+.............+..+.+++.+||..+|++||+ +.++++
T Consensus 234 ~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 234 GSNRDETF-----------------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCchHHHH-----------------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 43321110 0000000000011113456899999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=315.75 Aligned_cols=266 Identities=26% Similarity=0.392 Sum_probs=206.2
Q ss_pred ecHHHHHHHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEee
Q 006785 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 291 (631)
Q Consensus 214 ~s~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 291 (631)
+++.++..++++|...+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++ +|||++++++++.
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 445667778899999999999999999999875 58899999986532 2334578899999999 8999999999987
Q ss_pred eccC-CcceEEEEEeeCCCCChHhhhhcc--ccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCC
Q 006785 292 EFRG-KRAMRLLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 368 (631)
Q Consensus 292 ~~~~-~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 368 (631)
.... .....|+||||+++|+|.++++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 5432 234689999999999999998642 2345899999999999999999999998 999999999999999999
Q ss_pred eEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcC-----CCCcccchhhHHHHHHHHHhCCCCCCCcccccc
Q 006785 369 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-----RASLMSDVFSFGVVLLELITGRQPIHRSITKGE 443 (631)
Q Consensus 369 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-----~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~ 443 (631)
+||+|||++........ ......|+..|+|||++... .++.++||||||+++|||++|+.||........
T Consensus 167 ~kl~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~ 241 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL-----RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT 241 (291)
T ss_pred EEEeecccchhcccccc-----cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH
Confidence 99999999886543221 11234588999999988643 368999999999999999999999864322111
Q ss_pred chhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 444 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
...+ .....+.+ ..+......+.+|+.+||+.+|++||++.++++.
T Consensus 242 --~~~~------------~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 242 --LFKI------------PRNPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred --HHHH------------hcCCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0000 00001111 1122334458999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=308.92 Aligned_cols=254 Identities=23% Similarity=0.368 Sum_probs=196.7
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC----CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG----PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
.+|...+.||+|+||.||+|... ++..||+|++..... ......+.+|+.+++.++||||+++++++.... ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 79 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA--EK 79 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC--CC
Confidence 36788899999999999999875 489999999864321 122345889999999999999999999876422 34
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..+++|||+++++|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+++
T Consensus 80 ~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 679999999999999999753 34899999999999999999999998 9999999999999999999999999987
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
........ ........++..|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~-------------- 218 (266)
T cd06651 155 RLQTICMS--GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI-------------- 218 (266)
T ss_pred cccccccc--CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH--------------
Confidence 65432111 11122345889999999999888999999999999999999999999643211100
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
...........++......+..++ .||..+|++||++.+|++
T Consensus 219 ---~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 219 ---FKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---HHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 000000011123333444567777 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=308.26 Aligned_cols=255 Identities=24% Similarity=0.339 Sum_probs=199.0
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC----CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG----PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
.+|...+.||+|+||.||+|...+ |+.||||.+..... ......+.+|+.++++++||||+++++++.+.. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~ 79 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM--ER 79 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC--Cc
Confidence 468888999999999999998754 89999998864321 122346888999999999999999999876532 24
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
.+++||||+++++|.+++... ..+++.....++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||+++
T Consensus 80 ~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 80 TLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 678999999999999998754 34788999999999999999999998 9999999999999999999999999988
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
........ ........|+..|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-------------- 218 (265)
T cd06652 155 RLQTICLS--GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI-------------- 218 (265)
T ss_pred cccccccc--ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH--------------
Confidence 65432111 11223346899999999998888999999999999999999999999643211100
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+..........|......+.+++.+||. +|++||++.+|++.
T Consensus 219 ---~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 219 ---FKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ---HHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 00000011122345555668888999985 99999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=323.59 Aligned_cols=256 Identities=20% Similarity=0.263 Sum_probs=193.7
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|.+.+.||+|+||.||+++.. +++.||||++.... .......+.+|+.++..++|+||+++++++.. ....
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~----~~~~ 76 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD----ENYL 76 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCEE
Confidence 46888999999999999999876 48899999986421 12233458889999999999999999998875 5678
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||++||+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~ 152 (331)
T cd05624 77 YLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKM 152 (331)
T ss_pred EEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeec
Confidence 99999999999999997532 45899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhc-----CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 455 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-----~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 455 (631)
..... .......||+.|+|||++.+ +.++.++||||||++||||++|+.||.............
T Consensus 153 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~------- 221 (331)
T cd05624 153 NQDGT----VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM------- 221 (331)
T ss_pred cCCCc----eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHH-------
Confidence 44321 11223469999999999875 567899999999999999999999996432211100000
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 006785 456 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDA--RPTMSEVVQI 505 (631)
Q Consensus 456 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 505 (631)
.. .....-+..... .+..+.+++.+|+..++.+ |+++.++++.
T Consensus 222 ~~---~~~~~~p~~~~~----~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 222 NH---EERFQFPSHITD----VSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cC---CCcccCCCcccc----CCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00 000101111111 2345778888888865543 4577777654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=314.93 Aligned_cols=239 Identities=24% Similarity=0.423 Sum_probs=184.5
Q ss_pred eeeeeCceEEEEEEECC-------------------------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcc
Q 006785 231 IVGQGGSSYVYRGQLTD-------------------------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285 (631)
Q Consensus 231 ~LG~G~fG~Vy~~~~~~-------------------------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 285 (631)
.||+|+||.||+|.+.. ...||||++.... ......|.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 59999999999997521 1358999886542 233445889999999999999999
Q ss_pred eeEEeeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC
Q 006785 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 365 (631)
Q Consensus 286 l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~ 365 (631)
+++++.+ ....++||||+++|+|..++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.
T Consensus 81 ~~~~~~~----~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~ 152 (274)
T cd05076 81 VHGVCVR----GSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLAR 152 (274)
T ss_pred EEEEEEe----CCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEec
Confidence 9999986 45679999999999999998653 245899999999999999999999998 999999999999976
Q ss_pred CC-------CeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHH-hCCCCCC
Q 006785 366 NL-------NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELI-TGRQPIH 436 (631)
Q Consensus 366 ~~-------~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLl-tG~~P~~ 436 (631)
.+ .+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~---------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 223 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR---------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK 223 (274)
T ss_pred cCcccCccceeeecCCccccccccc---------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcc
Confidence 43 3799999997643221 12347788999998875 56899999999999999995 6899986
Q ss_pred CccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 437 RSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
........... .. ... .+......+.+++.+||+.+|++|||+.+|++.|.
T Consensus 224 ~~~~~~~~~~~--------------~~--~~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 224 ERTPSEKERFY--------------EK--KHR----LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ccChHHHHHHH--------------Hh--ccC----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 54322110000 00 000 11111234888999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=308.34 Aligned_cols=251 Identities=22% Similarity=0.295 Sum_probs=201.4
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+|+..+.||+|+||.||++... +|+.||+|.+.... .......+.+|+.++++++||||+++++++.. ....++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~l 76 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE----NGNLYI 76 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC----CCeEEE
Confidence 4778899999999999999875 58999999987542 23334568999999999999999999998865 457899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++++|.+++.......+++.+++.++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++.....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 999999999999997654456899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||............ +.
T Consensus 154 ~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~-------------~~ 215 (256)
T cd08218 154 TVE-----LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI-------------IR 215 (256)
T ss_pred chh-----hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH-------------hc
Confidence 211 122345889999999999889999999999999999999999998643221100000 00
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.. .+ ..+......+.+++.+||+.+|++||++.+|++.
T Consensus 216 ~~-~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 216 GS-YP----PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CC-CC----CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00 01 1223334558999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=314.05 Aligned_cols=266 Identities=23% Similarity=0.347 Sum_probs=195.7
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+|+..+.||+|+||.||+|... ++..||||++..... ......+.+|+.++++++||||+++++++.. ....|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~ 76 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ----ESRLYL 76 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee----CCeEEE
Confidence 4677889999999999999875 589999999875432 2233458899999999999999999999875 457899
Q ss_pred EEeeCCCCChHhhhhcccc-CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 303 VFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
||||++ ++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 77 IFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred EEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 999996 689998865432 45899999999999999999999998 9999999999999999999999999997653
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchh----------hhhc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL----------VLWA 450 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~----------~~~~ 450 (631)
... .......+++.|+|||++.+. .++.++||||||+++|||++|+.||........... ..|.
T Consensus 153 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd07861 153 IPV-----RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWP 227 (285)
T ss_pred CCc-----ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Confidence 221 112233578999999988754 478999999999999999999999975432110000 0000
Q ss_pred ccc-cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 451 TPR-LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 451 ~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
... +.+............+. ......+..+.+++.+||+.||++|||+.+|++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 228 GVTSLPDYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred cchhhHHHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 00000000000000000 001113345789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.30 Aligned_cols=199 Identities=25% Similarity=0.350 Sum_probs=161.9
Q ss_pred cceeeeeCceEEEEEEEC---CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 229 SNIVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
.++||+|+||.||+|+.. +++.||||.+..... ...+.+|+.+|++++||||+++++++.... ....|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHA--DRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCC--CcEEEEEEe
Confidence 457999999999999865 367899999875422 234789999999999999999999886432 346799999
Q ss_pred eCCCCChHhhhhccc-------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeee----cCCCCeEEecc
Q 006785 306 FMPNGNLRDCLDGVL-------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDL 374 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl----~~~~~~kL~DF 374 (631)
|+ +++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+||
T Consensus 81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred cc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 99 568988875321 124889999999999999999999998 9999999999999 45678999999
Q ss_pred CceeecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCc
Q 006785 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (631)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~ 438 (631)
|+++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 157 G~a~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 157 GFARLFNSPLKP--LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CceeccCCCCcc--ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 999876432211 112234578999999999876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=313.48 Aligned_cols=251 Identities=24% Similarity=0.326 Sum_probs=196.0
Q ss_pred ccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~ 304 (631)
|++.+.||.|+||.||+|.+.. +..+|+|.+.... ......+.+|+++++.++||||+++++++.. ....|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~----~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYY----ENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEee----CCEEEEEE
Confidence 4566789999999999999764 7888999886542 2344568899999999999999999999876 45789999
Q ss_pred eeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCC
Q 006785 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (631)
Q Consensus 305 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~ 384 (631)
||+++++|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 82 e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 82 EFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 999999999988653 245899999999999999999999998 9999999999999999999999999987653221
Q ss_pred CCCCCCCCcccccCCCCCCchhhh-----cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 385 LPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 385 ~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
.......|++.|+|||++. ...++.++|||||||++|||++|+.||.......... ..
T Consensus 158 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~--~~---------- 220 (282)
T cd06643 158 -----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLL--KI---------- 220 (282)
T ss_pred -----cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHH--HH----------
Confidence 1223356899999999884 3457889999999999999999999986432211100 00
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 506 (631)
.....+.+ ..+...+..+.+|+.+||+.+|++||++.++++.-
T Consensus 221 --~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 221 --AKSEPPTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred --hhcCCCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 00000110 11222334588999999999999999999997643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=310.65 Aligned_cols=240 Identities=23% Similarity=0.386 Sum_probs=185.3
Q ss_pred ceeeeeCceEEEEEEECC-------------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCC
Q 006785 230 NIVGQGGSSYVYRGQLTD-------------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~-------------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 296 (631)
+.||+|+||.||+|++.+ ...||+|.+.... ......|.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~---- 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVR---- 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEec----
Confidence 358999999999998532 2358999876543 2334468899999999999999999999875
Q ss_pred cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCC-------e
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN-------A 369 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~-------~ 369 (631)
....++||||+++|+|..++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCcee
Confidence 446699999999999999886532 45899999999999999999999998 999999999999987654 8
Q ss_pred EEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhh-cCCCCcccchhhHHHHHHHHH-hCCCCCCCccccccchhh
Q 006785 370 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELI-TGRQPIHRSITKGEESLV 447 (631)
Q Consensus 370 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-~~~~s~ksDVwSlGviL~eLl-tG~~P~~~~~~~~~~~~~ 447 (631)
+++|||++...... ....++..|+|||.+. ...++.++||||||+++|||+ +|..||...........
T Consensus 152 ~l~d~g~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~- 221 (262)
T cd05077 152 KLSDPGIPITVLSR---------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF- 221 (262)
T ss_pred EeCCCCCCccccCc---------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-
Confidence 99999998654321 2235788999999887 567899999999999999998 58888754321110000
Q ss_pred hhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 448 LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
+ . . ....... ....+.+|+.+||+.||++||++.+|++.|+
T Consensus 222 -~------~------~--~~~~~~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 222 -Y------E------G--QCMLVTP----SCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -H------h------c--CccCCCC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 0 0 0000111 1245889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.07 Aligned_cols=256 Identities=20% Similarity=0.268 Sum_probs=193.7
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|.+.+.||+|+||.||+++++. ++.||+|++.... .......|.+|+.++..++|+||+++++++.. ....
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~ 76 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD----ENNL 76 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec----CCEE
Confidence 368888999999999999999765 7889999986421 12233448889999999999999999988875 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 77 ~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~ 152 (332)
T cd05623 77 YLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKL 152 (332)
T ss_pred EEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheec
Confidence 9999999999999999753 245899999999999999999999998 999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhh-----cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 455 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 455 (631)
..... .......||+.|+|||++. ...++.++|||||||+||||++|+.||.............
T Consensus 153 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~------- 221 (332)
T cd05623 153 MEDGT----VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM------- 221 (332)
T ss_pred ccCCc----ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHh-------
Confidence 43321 1122356999999999986 3468899999999999999999999996532211110000
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 006785 456 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDA--RPTMSEVVQI 505 (631)
Q Consensus 456 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 505 (631)
.. ......+.. ....+..+.+|+.+|+..+++. |+++.++++.
T Consensus 222 ~~---~~~~~~p~~----~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 222 NH---KERFQFPAQ----VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CC---CccccCCCc----cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 000111111 1123345778888888654443 6889888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=325.56 Aligned_cols=193 Identities=23% Similarity=0.301 Sum_probs=164.6
Q ss_pred HhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
...+|.+.+.||+|+||.||+|.... ++.||+|+..... ...|+.++++++||||+++++++.. ....
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~ 132 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-------TLIEAMLLQNVNHPSVIRMKDTLVS----GAIT 132 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-------cHHHHHHHHhCCCCCCcChhheEEe----CCee
Confidence 34679999999999999999999764 7889999754321 4579999999999999999999876 4567
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
++||||+ .++|.+++... ...+++..+..|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 133 ~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 133 CMVLPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred EEEEEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 9999999 57999988653 346899999999999999999999998 999999999999999999999999998753
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCC
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~ 436 (631)
... .......||+.|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 208 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 208 VVA------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred ccC------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 321 12234569999999999999999999999999999999999765553
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=306.78 Aligned_cols=254 Identities=27% Similarity=0.418 Sum_probs=202.4
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.++|...+.||.|+||.||+|... +++.+|+|.+...... ....+.+|++++++++||||+++++++.. ....|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLR----RDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEe----CCEEE
Confidence 357888899999999999999875 4788999999765332 44568999999999999999999998875 45789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
++|||+++++|.+++.... ..+++.++..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++....
T Consensus 77 l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred EEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhh
Confidence 9999999999999987532 45899999999999999999999998 9999999999999999999999999987654
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcC---CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVG---RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~---~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
... .......++..|+|||.+... .++.++||||||+++|||++|+.||.............
T Consensus 153 ~~~-----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~---------- 217 (262)
T cd06613 153 ATI-----AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS---------- 217 (262)
T ss_pred hhh-----hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----------
Confidence 321 122335688999999998776 78999999999999999999999996543221111000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
......+.+ ..+...+..+.+++.+||..+|.+|||+.+|+.
T Consensus 218 --~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 218 --KSNFPPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --hccCCCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000111111 122334556899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=306.77 Aligned_cols=252 Identities=31% Similarity=0.491 Sum_probs=200.1
Q ss_pred ccccceeeeeCceEEEEEEECC-----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
|++.+.||.|+||.||++.+.+ +..||+|++...........+..|+.++..++|+||+++++++.+ ....
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 76 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE----EEPL 76 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC----CCee
Confidence 3456789999999999998764 388999999766544456679999999999999999999998876 3577
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
+++|||+++++|.+++.......+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++...
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceec
Confidence 99999999999999997644333899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
....... .....+++.|+|||.+....++.++||||||+++|+|++ |+.||........ ...
T Consensus 154 ~~~~~~~----~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~---~~~---------- 216 (258)
T smart00219 154 YDDDYYK----KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV---LEY---------- 216 (258)
T ss_pred ccccccc----cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----------
Confidence 5442211 112237889999999988889999999999999999998 7888764221110 000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 506 (631)
+...... ..+...+..+.+++.+||..+|++|||+.++++.|
T Consensus 217 -~~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 217 -LKKGYRL----PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -HhcCCCC----CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0000001 11222344588899999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.42 Aligned_cols=257 Identities=27% Similarity=0.428 Sum_probs=202.5
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeecc--CCc
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFR--GKR 297 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~--~~~ 297 (631)
++++|++.+.||.|+||.||+|..+ +++.+++|++..... ....|.+|+.+++++ .|+||+++++++.... ...
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 5688999999999999999999985 478999999875432 345689999999999 7999999999987644 234
Q ss_pred ceEEEEEeeCCCCChHhhhhccc--cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccC
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 375 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFG 375 (631)
...++||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 56899999999999999987543 356899999999999999999999998 9999999999999999999999999
Q ss_pred ceeecccCCCCCCCCCCcccccCCCCCCchhhhc-----CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhc
Q 006785 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA 450 (631)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-----~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~ 450 (631)
++....... .......|+..|+|||++.. ..++.++||||||+++|+|++|+.||......... ..
T Consensus 159 ~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~-- 229 (275)
T cd06608 159 VSAQLDSTL-----GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL--FK-- 229 (275)
T ss_pred cceecccch-----hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH--HH--
Confidence 987654321 12233458899999998753 34688999999999999999999999643211100 00
Q ss_pred ccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 451 TPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
+.....+.+ ..+...+..+.+|+.+||..||++|||+.++++
T Consensus 230 ----------~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 ----------IPRNPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ----------hhccCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000011111 112334556889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.36 Aligned_cols=250 Identities=25% Similarity=0.417 Sum_probs=200.5
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
.+|+..+.||.|+||.||+|... +|+.||||.+..... .....+.+|+.+++.++|||++++++++.. ....|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLV----GDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEec----CceEEE
Confidence 45788899999999999999864 589999999875433 334568899999999999999999999875 457899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++++|.+++.. ..+++.++..++.+++.||+|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 94 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 94 VMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999999999864 34899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||............ ..
T Consensus 168 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~--~~----------- 229 (296)
T cd06655 168 EQS-----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--AT----------- 229 (296)
T ss_pred ccc-----cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--Hh-----------
Confidence 321 122346889999999999888999999999999999999999999654321111100 00
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
...+.+ ..+...+..+.+++.+||..||++||++.+|++.
T Consensus 230 -~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 230 -NGTPEL--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred -cCCccc--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000 1122233458889999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=305.02 Aligned_cols=250 Identities=25% Similarity=0.358 Sum_probs=199.6
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+|...+.||+|+||.||++... +++.+|||.+.... .......+.+|++++++++||||+++++.+.. ....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~l 76 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE----DKALMI 76 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec----CCEEEE
Confidence 4777899999999999999875 58899999987543 23345568999999999999999999988764 457899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC-CeEEeccCceeecc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKRLK 381 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kL~DFGla~~~~ 381 (631)
||||+++++|.+++.......+++..+..++.+++.||+|||+++ |+|+||||+||++++++ .++|+|||++....
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (256)
T cd08220 77 VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153 (256)
T ss_pred EEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence 999999999999998755556899999999999999999999998 99999999999998654 57999999998764
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
... ......|+..|+|||.+....++.++||||||+++|+|++|+.||....... ..... .
T Consensus 154 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~----------~ 214 (256)
T cd08220 154 SKS------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLKI----------M 214 (256)
T ss_pred CCc------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHHHH----------H
Confidence 321 1223468899999999998889999999999999999999999986432211 00000 0
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.. ... ..+...+..+.+++.+||+.+|++|||+.++++.
T Consensus 215 ~~-~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 215 SG-TFA----PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred hc-CCC----CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 00 000 1222234458899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=310.96 Aligned_cols=252 Identities=29% Similarity=0.473 Sum_probs=196.8
Q ss_pred ccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHH-HHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADS-VFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~-~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
|+..+.||+|+||+||+++... ++.||+|++.......... ...+|+.++++++||||+++++++.. ....++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~~~v 76 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD----DNYLYIV 76 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE----SSEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc----ccccccc
Confidence 4567899999999999999875 6789999998764333222 24569999999999999999999887 5677999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
|||+++++|.+++.. ...+++.++..++.|++.||++||+.+ |+|+||||+||++++++.++|+|||.+......
T Consensus 77 ~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~ 151 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN 151 (260)
T ss_dssp EEEETTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST
T ss_pred ccccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 999999999999983 255899999999999999999999998 999999999999999999999999998764111
Q ss_pred CCCCCCCCCcccccCCCCCCchhhh-cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh-cccccccccccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW-ATPRLQDSGTVI 461 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~-~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 461 (631)
........+|..|+|||++. +..++.++||||+|+++|+|++|..||.............. ......
T Consensus 152 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~------ 220 (260)
T PF00069_consen 152 -----NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLP------ 220 (260)
T ss_dssp -----TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHH------
T ss_pred -----ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccc------
Confidence 12233456899999999998 88899999999999999999999999976511111111000 000000
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
... .........+.+++.+||+.||++||++.++++
T Consensus 221 ----~~~---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 221 ----SSS---QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ----HHT---TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ----ccc---cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000011256899999999999999999999976
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=307.58 Aligned_cols=249 Identities=25% Similarity=0.412 Sum_probs=199.2
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC---CCCCcceeEEeeeccCCcceE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~~~~ 300 (631)
.|+..+.||+|+||.||+|.+. +++.||||.+...........+.+|+.++++++ |||++++++++.. ....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~----~~~~ 77 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK----GPRL 77 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee----CCEE
Confidence 4667788999999999999974 589999999876544455566889999999996 9999999998875 4578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
++||||+++++|.++++.. .+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++...
T Consensus 78 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred EEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 9999999999999998653 5899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
.... .......|+..|+|||++..+ .++.++||||||+++|+|++|..||..........
T Consensus 152 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------------- 212 (277)
T cd06917 152 NQNS-----SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------------- 212 (277)
T ss_pred CCCc-----cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh--------------
Confidence 5432 122334689999999988754 46899999999999999999999996432211100
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+.....+.+... ..+..+.+++.+||+.||++||++.++++.
T Consensus 213 ~~~~~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 213 LIPKSKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ccccCCCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0011111222111 133458899999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=309.45 Aligned_cols=260 Identities=28% Similarity=0.388 Sum_probs=203.2
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++|...+.||.|++|.||++.+. +++.+|+|.+...........+.+|++++++++||||+++++++.... ....++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES--SSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC--CCeEEE
Confidence 35778899999999999999985 488999999986544445566999999999999999999999986533 346799
Q ss_pred EEeeCCCCChHhhhhcc--ccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 303 VFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 99999999999987542 2345889999999999999999999998 999999999999999999999999998755
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCcccc--ccchhhhhccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITK--GEESLVLWATPRLQDSG 458 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~--~~~~~~~~~~~~~~~~~ 458 (631)
.... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .......+..
T Consensus 156 ~~~~-------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------- 221 (287)
T cd06621 156 VNSL-------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV------- 221 (287)
T ss_pred cccc-------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh-------
Confidence 3221 12345788999999999999999999999999999999999999754221 0011111100
Q ss_pred ccccccCCCCCCCCCC--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006785 459 TVISELPDPRLKGDFP--KEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 506 (631)
....+.+....+ ...+..+.+++.+||..+|.+|||+.|+++.-
T Consensus 222 ----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 222 ----NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred ----cCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 001111111111 12345688999999999999999999998843
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=310.04 Aligned_cols=268 Identities=24% Similarity=0.352 Sum_probs=198.9
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
++|+..+.||+|+||.||+|.+. +|+.||+|++..... ....+.+.+|+.+++.++|+|++++++++.. ....+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~ 76 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR----KRKLH 76 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee----CCEEE
Confidence 46788899999999999999986 489999999875432 2333458899999999999999999999876 45779
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++++|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 77 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07847 77 LVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILT 151 (286)
T ss_pred EEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecC
Confidence 999999998888876543 35899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhh-hcccccc----
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL-WATPRLQ---- 455 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~-~~~~~~~---- 455 (631)
.... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||............. .......
T Consensus 152 ~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07847 152 GPGD-----DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 226 (286)
T ss_pred CCcc-----cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 4321 1223457889999999876 557899999999999999999999996543221110000 0000000
Q ss_pred --cccccccccCCCCCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 456 --DSGTVISELPDPRLKGDFP-----KEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 456 --~~~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
...........+......+ ...+..+.+|+.+||+.+|++||++.+++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 227 IFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred hcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000000011111110001 1123558899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=312.46 Aligned_cols=252 Identities=23% Similarity=0.358 Sum_probs=197.8
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+.|++.+.||.|+||.||+|+... ++.||+|.+... .......+.+|+.+++.++||||+++++++.. ....++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYW----DGKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe----CCeEEE
Confidence 567788999999999999998865 899999998754 23345568899999999999999999998875 457899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++++|..++.+.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 87 v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 87 MIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred EEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 999999999998876532 45899999999999999999999998 99999999999999999999999999875432
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhh-----cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
.. .......+++.|+|||++. ...++.++||||||+++|||++|..||........ ....
T Consensus 163 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~-------- 227 (292)
T cd06644 163 TL-----QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKI-------- 227 (292)
T ss_pred cc-----cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHHH--------
Confidence 21 1223456889999999885 34468899999999999999999999864321110 0000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.....+.. ..+...+..+.+++.+||..+|++||++.++++.
T Consensus 228 ----~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 228 ----AKSEPPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ----hcCCCccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00001111 1122334458889999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=306.09 Aligned_cols=256 Identities=26% Similarity=0.443 Sum_probs=201.2
Q ss_pred CccccceeeeeCceEEEEEEE-CCCcEEEEEEeccCCCC-----ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 225 KFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGP-----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
+|+..+.||+|+||.||+|.. .+++.||+|.+...... .....+.+|+.++++++|+||+++++++.+ ..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~ 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE----DS 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc----CC
Confidence 477788999999999999986 45899999998743321 123568999999999999999999999875 45
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC-CeEEeccCce
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMA 377 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kL~DFGla 377 (631)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|||++
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~ 151 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAA 151 (268)
T ss_pred eEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccc
Confidence 779999999999999999753 45899999999999999999999998 99999999999998775 5999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
......... .........||..|+|||.+.+..++.++||||+|+++|+|++|..||...........
T Consensus 152 ~~~~~~~~~-~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~----------- 219 (268)
T cd06630 152 ARLAAKGTG-AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL----------- 219 (268)
T ss_pred ccccccccc-CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH-----------
Confidence 876543211 11122345689999999999888899999999999999999999999964322111110
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
+............+......+.+++.+||..+|++||++.++++
T Consensus 220 ---~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 220 ---IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---HHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00111111112344455566889999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=305.67 Aligned_cols=238 Identities=25% Similarity=0.444 Sum_probs=187.6
Q ss_pred ceeeeeCceEEEEEEECCCc-----------EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 230 NIVGQGGSSYVYRGQLTDGR-----------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~g~-----------~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
+.||+|+||.||+|.+.+.. .|++|.+...... ...|.+|+.+++.++||||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-----D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-----C
Confidence 36899999999999986432 5888887654322 4568999999999999999999999875 2
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC-------CeEE
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-------NAKI 371 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-------~~kL 371 (631)
..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+||
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEe
Confidence 3589999999999999997643 25899999999999999999999998 99999999999999887 7999
Q ss_pred eccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcC--CCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhh
Q 006785 372 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVL 448 (631)
Q Consensus 372 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~--~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~ 448 (631)
+|||++...... ....++..|+|||++... .++.++||||||+++|||++ |..||...........
T Consensus 150 ~Dfg~a~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~-- 218 (259)
T cd05037 150 SDPGIPITVLSR---------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF-- 218 (259)
T ss_pred CCCCcccccccc---------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH--
Confidence 999998765431 123467789999999876 78999999999999999999 5777754432111110
Q ss_pred hcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 449 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
+.. ......+ ....+.+++.+||..+|.+||++.+|++.|.
T Consensus 219 ~~~---------~~~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 YQD---------QHRLPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred Hhc---------CCCCCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 0000010 1145889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=315.38 Aligned_cols=199 Identities=25% Similarity=0.352 Sum_probs=161.3
Q ss_pred cceeeeeCceEEEEEEECC---CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 229 SNIVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
...||+|+||.||+|+..+ +..||+|.+.... ....+.+|+.+|++++||||+++++++.... ....++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHS--DRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccC--CCeEEEEEe
Confidence 3579999999999998753 5789999987542 2234789999999999999999999886532 446799999
Q ss_pred eCCCCChHhhhhcc-------ccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeee----cCCCCeEEecc
Q 006785 306 FMPNGNLRDCLDGV-------LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDL 374 (631)
Q Consensus 306 ~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl----~~~~~~kL~DF 374 (631)
|++ ++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 995 5888887421 1224889999999999999999999998 9999999999999 56678999999
Q ss_pred CceeecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCc
Q 006785 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (631)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~ 438 (631)
|+++........ ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 157 G~a~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 157 GFARLFNSPLKP--LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cceeccCCCccc--ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 999876543211 112234568999999999876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=311.20 Aligned_cols=239 Identities=23% Similarity=0.398 Sum_probs=185.6
Q ss_pred eeeeeCceEEEEEEECC--------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 231 IVGQGGSSYVYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 231 ~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
.||+|+||.||+|.... ...||+|.+.... ....+.|.+|+.+++.++||||+++++++.. ....++
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~----~~~~~l 76 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVC----GDESIM 76 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEe----CCCcEE
Confidence 58999999999998642 2348888875432 3344568899999999999999999999876 345699
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCC--------eEEecc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN--------AKITDL 374 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~--------~kL~DF 374 (631)
||||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. ++++||
T Consensus 77 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccc
Confidence 999999999999997643 35899999999999999999999998 999999999999987765 589999
Q ss_pred CceeecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCC-CCCCCccccccchhhhhccc
Q 006785 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGR-QPIHRSITKGEESLVLWATP 452 (631)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~-~P~~~~~~~~~~~~~~~~~~ 452 (631)
|++..... .....+++.|+|||++.+ ..++.++||||||+++|||++|. .||........... .
T Consensus 153 g~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~---- 218 (258)
T cd05078 153 GISITVLP---------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-Y---- 218 (258)
T ss_pred ccccccCC---------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-H----
Confidence 98765432 123457889999999986 45799999999999999999985 55543221110000 0
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 453 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
.. .. .+|......+.+|+.+||+.+|++|||+.++++.|+
T Consensus 219 ---------~~--~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 219 ---------ED--RH----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---------Hc--cc----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 00 122222345889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.04 Aligned_cols=269 Identities=23% Similarity=0.315 Sum_probs=197.1
Q ss_pred HHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC--C
Q 006785 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--K 296 (631)
Q Consensus 221 ~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~ 296 (631)
...++|...+.||+|+||.||+|... +++.||||++..... ......+.+|+.+|++++||||+++++++..... .
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 44678999999999999999999875 588999999875422 2233457789999999999999999988754221 1
Q ss_pred cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCc
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGl 376 (631)
....|++++++ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 24579999998 8899988764 35899999999999999999999998 99999999999999999999999999
Q ss_pred eeecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccch-hhhhc-ccc
Q 006785 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES-LVLWA-TPR 453 (631)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~-~~~~~-~~~ 453 (631)
++..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.......... ..... .+.
T Consensus 165 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07878 165 ARQADDE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236 (343)
T ss_pred ceecCCC--------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9865432 233468999999999876 568999999999999999999999996432111000 00000 000
Q ss_pred ------cccc--cccc---cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 454 ------LQDS--GTVI---SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 454 ------~~~~--~~~~---~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+... ...+ .......+.. ........+.+|+.+||+.||.+|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKK-IFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHH-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000 0000000000 000112346789999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=306.72 Aligned_cols=247 Identities=24% Similarity=0.380 Sum_probs=199.2
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~ 304 (631)
|+..+.||.|+||.||+|.+. ++..||||.+...........|.+|+.++++++||||+++++++.. ....|+||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~ 81 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK----DTKLWIIM 81 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe----CCeEEEEE
Confidence 566788999999999999875 5889999998755444445668999999999999999999999876 45789999
Q ss_pred eeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCC
Q 006785 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (631)
Q Consensus 305 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~ 384 (631)
||+++++|.+++.. ..+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 82 EYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 99999999999864 34899999999999999999999998 9999999999999999999999999987664322
Q ss_pred CCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccccc
Q 006785 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 464 (631)
Q Consensus 385 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (631)
. ......|+..|+|||++....++.++||||||+++|+|++|..||........... +...
T Consensus 156 ~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~--------------~~~~ 216 (277)
T cd06641 156 I-----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL--------------IPKN 216 (277)
T ss_pred h-----hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH--------------HhcC
Confidence 1 12234588899999999888899999999999999999999999864321110000 0001
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 465 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 465 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..+.+. ...+..+.+++.+||+.+|.+||++.++++.
T Consensus 217 ~~~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 217 NPPTLE----GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCC----cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111122 2233448889999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=311.60 Aligned_cols=253 Identities=26% Similarity=0.368 Sum_probs=199.6
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.++|.+.+.||.|+||.||+|.+. ++..||+|.+.... ......|.+|++++++++||||+++++++.. ....|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFY----ENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEec----CCeEE
Confidence 356788889999999999999875 58899999987542 2334568899999999999999999999875 45789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....
T Consensus 79 lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 79 ILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred EEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 9999999999999987532 45899999999999999999999998 9999999999999999999999999987654
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhh-----cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
... .......||+.|+|||++. ...++.++||||||+++|||++|+.||........ ...+
T Consensus 155 ~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~~------- 220 (280)
T cd06611 155 STL-----QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLKI------- 220 (280)
T ss_pred ccc-----cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHHH-------
Confidence 321 1223456899999999885 34467899999999999999999999965322110 0000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.....+.+ ..+...+..+.+++..||+.+|.+||++.++++.
T Consensus 221 -----~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 221 -----LKSEPPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -----hcCCCCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00001111 1122334458899999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=305.55 Aligned_cols=253 Identities=25% Similarity=0.319 Sum_probs=201.2
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+|++.+.||.|+||.||++... +++.||+|++..... ......+..|++++++++|+||+++++++.... ....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRS--NQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCC--CCEEEE
Confidence 4677889999999999999865 588999999875432 333456889999999999999999999876432 346799
Q ss_pred EEeeCCCCChHhhhhccc--cCCCCHHHHHHHHHHHHhhhHHHH-----hcCCCceeecCCCCCCeeecCCCCeEEeccC
Q 006785 303 VFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLH-----EAAAPRILHRDIKSSNILLDENLNAKITDLG 375 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH-----~~~~~~ivHrDlKp~NILl~~~~~~kL~DFG 375 (631)
+|||+++++|.+++.... ...+++..++.++.+++.||.||| +.+ |+|+||||+||++++++.+||+|||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g 155 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFG 155 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccc
Confidence 999999999999996532 345899999999999999999999 666 9999999999999999999999999
Q ss_pred ceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccc
Q 006785 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 455 (631)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 455 (631)
++........ ......|++.|+|||++....++.++||||||+++|+|++|+.||....... ...
T Consensus 156 ~~~~~~~~~~-----~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~------- 220 (265)
T cd08217 156 LAKILGHDSS-----FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LAS------- 220 (265)
T ss_pred ccccccCCcc-----cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHH-------
Confidence 9987654321 1223468999999999998889999999999999999999999996543111 000
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 456 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 456 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+..... ...+...+..+.+++.+||+.+|++||++.+|++.
T Consensus 221 ----~~~~~~~----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 221 ----KIKEGKF----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----HHhcCCC----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0001111 12333444568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.94 Aligned_cols=268 Identities=26% Similarity=0.410 Sum_probs=198.5
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
++|+..+.||+|+||.||+|.+++ ++.||+|++...... .....+.+|+++++.++||||+++++++.. ....|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 76 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR----KKRLY 76 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc----CCeEE
Confidence 367788999999999999999864 899999998654332 234568899999999999999999999865 55789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++++|.++.... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++....
T Consensus 77 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07846 77 LVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA 151 (286)
T ss_pred EEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeecc
Confidence 999999999998876543 34899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc---
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS--- 457 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~--- 457 (631)
... .......++..|+|||++.+ ..++.++||||||+++|||++|+.||..................+...
T Consensus 152 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07846 152 APG-----EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE 226 (286)
T ss_pred CCc-----cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHH
Confidence 432 11233458899999999875 457889999999999999999999986432211000000000000000
Q ss_pred ----cccccccCCCCCCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 458 ----GTVISELPDPRLKG-----DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 458 ----~~~~~~~~~~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.........+.... ...+..+..+.+|+.+||+.+|++||++.++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000000010000 0112234568899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=321.84 Aligned_cols=241 Identities=24% Similarity=0.254 Sum_probs=183.9
Q ss_pred eeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhc---CCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 232 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRL---HHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 232 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
||+|+||+||+|+.. +++.||||++..... ......+..|..++..+ +||||+++++++.. ....|+|||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~----~~~~~lv~e 76 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT----DSDLYLVTD 76 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec----CCeEEEEEc
Confidence 699999999999876 489999999864321 12223356677777665 69999999988875 557899999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCC
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 385 (631)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~- 150 (330)
T cd05586 77 YMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN- 150 (330)
T ss_pred CCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-
Confidence 99999999998753 45899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccccc
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 464 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (631)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||............. . .
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~-------~-----~-- 212 (330)
T cd05586 151 ----KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA-------F-----G-- 212 (330)
T ss_pred ----CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHH-------c-----C--
Confidence 122345699999999998764 48999999999999999999999996532211100000 0 0
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 006785 465 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT----MSEVVQ 504 (631)
Q Consensus 465 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 504 (631)
...+.. ......+.+++.+||+.||.+||+ +.++++
T Consensus 213 -~~~~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 213 -KVRFPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -CCCCCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 000000 112344788999999999999984 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=311.28 Aligned_cols=267 Identities=22% Similarity=0.306 Sum_probs=194.4
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+|...+.||+|+||.||+|... +|+.||+|++..... ......+.+|++++++++||||+++++++.+ ....++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~----~~~~~l 76 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS----DKKLTL 76 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc----CCceEE
Confidence 4677889999999999999976 589999999875422 2223447889999999999999999998765 457899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
|+||++ ++|.+++.... ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.++|+|||+++....
T Consensus 77 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 77 VFEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI 151 (284)
T ss_pred EEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence 999996 68888876532 45899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh--cccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPRLQDSGT 459 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~~~~~~~ 459 (631)
.. .......+++.|+|||++.+. .++.++||||||+++|||++|..|+.............. ..........
T Consensus 152 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07839 152 PV-----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP 226 (284)
T ss_pred CC-----CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhH
Confidence 21 112234578999999998764 478999999999999999999998754322110000000 0000000000
Q ss_pred cccccCCC----CCC-----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDP----RLK-----GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~----~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+....+. ... .......+..+.+|+.+||+.||.+|||+.++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000000 000 01112234568899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=309.50 Aligned_cols=252 Identities=26% Similarity=0.379 Sum_probs=192.6
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHH-HHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDM-LSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
++|++.+.||+|+||.||+|.+. +|+.||||+++..........+..|+.+ ++.++||||+++++++.. ....|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~----~~~~~ 76 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR----EGDVW 76 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec----CCcEE
Confidence 46788899999999999999876 5999999999765433344456667775 556699999999999875 45689
Q ss_pred EEEeeCCCCChHhhhhccc--cCCCCHHHHHHHHHHHHhhhHHHHhc-CCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 302 LVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
+||||++ |+|.+++.... ...+++..+..++.|++.||+|||++ + ++||||||+|||++.++.+||+|||+++
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~ 152 (283)
T cd06617 77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISG 152 (283)
T ss_pred EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence 9999995 78988886432 24589999999999999999999987 6 9999999999999999999999999988
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhc----CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV----GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 454 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~----~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~ 454 (631)
...... ......|+..|+|||++.+ ..++.++||||||+++|||++|+.||........ ....
T Consensus 153 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~------ 219 (283)
T cd06617 153 YLVDSV------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-QLKQ------ 219 (283)
T ss_pred cccccc------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-HHHH------
Confidence 654321 1123458899999998864 4468899999999999999999999854221100 0000
Q ss_pred ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 455 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 455 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
... ...+.+. ....+..+.+++.+||..+|++||++.++++.
T Consensus 220 -----~~~-~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 220 -----VVE-EPSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred -----HHh-cCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0111111 11233458899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=306.66 Aligned_cols=256 Identities=25% Similarity=0.437 Sum_probs=196.1
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--C-------hHHHHHHHHHHHHhcCCCCCcceeEEeeecc
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--N-------ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 294 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 294 (631)
+|...+.||.|+||.||+|... +|+.||||.++..... . ..+.+..|+.+++.++|||++++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 4667789999999999999865 5899999988642111 1 12357889999999999999999998875
Q ss_pred CCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEecc
Q 006785 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 374 (631)
Q Consensus 295 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DF 374 (631)
....++||||+++++|.++++.. ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+||
T Consensus 80 --~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~ 152 (272)
T cd06629 80 --EEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDF 152 (272)
T ss_pred --CCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeec
Confidence 45779999999999999999765 45899999999999999999999998 999999999999999999999999
Q ss_pred CceeecccCCCCCCCCCCcccccCCCCCCchhhhcCC--CCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccc
Q 006785 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR--ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 452 (631)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~--~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 452 (631)
|+++....... ........|+..|+|||.+.... ++.++||||||+++||+++|..||........ .....
T Consensus 153 ~~~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~-- 225 (272)
T cd06629 153 GISKKSDDIYD---NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MFKLG-- 225 (272)
T ss_pred ccccccccccc---ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HHHhh--
Confidence 99876532211 11123456889999999987654 78999999999999999999999853221110 00000
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 453 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.....+..........+..+.+++.+||..+|++||++.+|++.
T Consensus 226 ---------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 226 ---------NKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ---------ccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00001111111112234558889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=302.98 Aligned_cols=248 Identities=28% Similarity=0.426 Sum_probs=198.4
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC----CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG----PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
+|+..+.||+|+||.||+|... +++.|++|.+..... .+....+.+|+.+++.++|+||+++++++.. ...
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~ 76 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE----EDN 76 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec----CCe
Confidence 3666788999999999999986 689999999865321 2244568999999999999999999998865 457
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~ 151 (258)
T cd06632 77 LYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQ 151 (258)
T ss_pred EEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCcccee
Confidence 89999999999999999754 35899999999999999999999998 99999999999999999999999999887
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCC-CCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
..... ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||......... +...
T Consensus 152 ~~~~~------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~------ 215 (258)
T cd06632 152 VVEFS------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV----FKIG------ 215 (258)
T ss_pred ccccc------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH----HHHH------
Confidence 54332 123345889999999988766 899999999999999999999999654311100 0000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
.....+ ..+......+.+++.+||+.+|++||++.++++
T Consensus 216 ---~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 216 ---RSKELP----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---hcccCC----CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 000001 122333455888999999999999999999976
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=306.91 Aligned_cols=253 Identities=28% Similarity=0.403 Sum_probs=201.9
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
+|+..+.||.|+||.||++.++ +++.||+|++...........+.+|++++++++||||+++++++.. ....++|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~lv 77 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN----NGDISIC 77 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec----CCEEEEE
Confidence 5677788999999999999986 4899999999876544555678999999999999999999998876 4678999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHh-cCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
+||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+ ++|+||||+||++++++.++|+|||++.....
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 78 MEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred EEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 99999999999997643 568999999999999999999999 77 99999999999999999999999999876543
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
... ....++..|+|||++.+..++.++||||||+++|+|++|+.||.......... ..... .+.
T Consensus 154 ~~~-------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~--------~~~ 217 (265)
T cd06605 154 SLA-------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI-FELLQ--------YIV 217 (265)
T ss_pred HHh-------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH-HHHHH--------HHh
Confidence 211 11568899999999999899999999999999999999999996542111110 00000 000
Q ss_pred ccCCCCCCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 463 ELPDPRLKGDFPKE-EMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 463 ~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
....+. .+.. .+..+.+++..||..+|++|||+.+++..
T Consensus 218 ~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 218 NEPPPR----LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred cCCCCC----CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 011111 1111 44558899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=297.80 Aligned_cols=256 Identities=29% Similarity=0.396 Sum_probs=202.6
Q ss_pred HHHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC-------hHHHHHHHHHHHHhc-CCCCCcceeEEe
Q 006785 220 EHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-------ADSVFLTEVDMLSRL-HHCHVVPLVGYC 290 (631)
Q Consensus 220 ~~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-------~~~~~~~E~~~l~~l-~H~niv~l~g~~ 290 (631)
+....+|...+.||+|..++|-+...+ .|..+|+|++....... ..+.-.+|+.||+++ .||+|+.+.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 344567888899999999999998765 48889999986442221 122345799999999 899999999988
Q ss_pred eeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeE
Q 006785 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 370 (631)
Q Consensus 291 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 370 (631)
.. +...++|+|.|+.|.|.|||... -.++++....|+.|+..|++|||..+ ||||||||+|||+|++.++|
T Consensus 93 es----~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~ 163 (411)
T KOG0599|consen 93 ES----DAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIK 163 (411)
T ss_pred cC----cchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceE
Confidence 75 66889999999999999999865 34899999999999999999999998 99999999999999999999
Q ss_pred EeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhc------CCCCcccchhhHHHHHHHHHhCCCCCCCccccccc
Q 006785 371 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV------GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE 444 (631)
Q Consensus 371 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~------~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~ 444 (631)
|+|||+|..+..+ .......|||+|+|||.+.. ..|+..+|+|++|||+|.|+.|.+||.....--..
T Consensus 164 isDFGFa~~l~~G------ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlML 237 (411)
T KOG0599|consen 164 ISDFGFACQLEPG------EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLML 237 (411)
T ss_pred EeccceeeccCCc------hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHH
Confidence 9999999988764 34566789999999998853 35899999999999999999999999643211100
Q ss_pred hhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 445 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..+ .+ +. -.+..+-..+.+....+|+.+||+.||.+|.|+.|++..
T Consensus 238 R~I-------me-Gk-------yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 238 RMI-------ME-GK-------YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHH-------Hh-cc-------cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 000 00 00 001111123345568899999999999999999999873
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=304.80 Aligned_cols=260 Identities=24% Similarity=0.364 Sum_probs=198.0
Q ss_pred ccccceeeeeCceEEEEEEEC----CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCC--cc
Q 006785 226 FSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK--RA 298 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~--~~ 298 (631)
|.+.+.||+|+||.||+|.+. .++.||||++..... ....+.+.+|+.++++++||||+++++++...... ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999864 368899999876432 23345688999999999999999999988653221 22
Q ss_pred eEEEEEeeCCCCChHhhhhccc----cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEecc
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVL----VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 374 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DF 374 (631)
..++++||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 4578999999999998874321 124789999999999999999999998 999999999999999999999999
Q ss_pred CceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccc
Q 006785 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPR 453 (631)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~ 453 (631)
|+++........ .......+++.|++||.+....++.++||||||+++|||++ |+.||....... ...+..
T Consensus 158 g~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~-- 229 (273)
T cd05074 158 GLSKKIYSGDYY---RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLI-- 229 (273)
T ss_pred cccccccCCcce---ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHH--
Confidence 999866432211 11122345678999999998899999999999999999999 888886432211 000000
Q ss_pred cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 454 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 454 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
...... .+...+..+.+++.+||+.+|++||++.++++.|..+
T Consensus 230 ---------~~~~~~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 ---------KGNRLK----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---------cCCcCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000000 1112334588999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=310.43 Aligned_cols=267 Identities=19% Similarity=0.219 Sum_probs=190.8
Q ss_pred hcCccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHH----------HHHHHHHHHHhcCCCCCcceeE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADS----------VFLTEVDMLSRLHHCHVVPLVG 288 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~----------~~~~E~~~l~~l~H~niv~l~g 288 (631)
.++|.+.++||+|+||.||+|.+.+ +..+|+|+..........+ ....+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3678889999999999999998754 3466777644332211111 1223344556678999999999
Q ss_pred EeeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCC
Q 006785 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 368 (631)
Q Consensus 289 ~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 368 (631)
++..........+++++++ ..++.+.+... ...++..+..++.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence 8765443344668889988 45777776543 33678889999999999999999998 999999999999999999
Q ss_pred eEEeccCceeecccCCCCCC--CCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchh
Q 006785 369 AKITDLGMAKRLKADGLPSC--SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 446 (631)
Q Consensus 369 ~kL~DFGla~~~~~~~~~~~--~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~ 446 (631)
++|+|||+|+.+...+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99999999987754321110 1112234699999999999999999999999999999999999999975432211100
Q ss_pred hhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006785 447 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506 (631)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 506 (631)
.... ..+..+..+.+. ....+..+.+++..||..+|++||++.++++.|
T Consensus 245 ~~~~--------~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAKC--------DFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhHH--------HHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0000 001111111111 111235588999999999999999999999876
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=309.85 Aligned_cols=269 Identities=21% Similarity=0.291 Sum_probs=196.4
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++++|...+.||+|+||.||+|... +|..||||++...........+.+|+.+++.++|+||+++++++.. ....
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~ 78 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT----KETL 78 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec----CCeE
Confidence 3567888999999999999999875 5889999999765444444457899999999999999999998865 4578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+. ++|.+++.... ..+.+..+..++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||+++..
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 79 TFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred EEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccccc
Confidence 99999995 78877775432 45788899999999999999999998 999999999999999999999999998764
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccc------
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR------ 453 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~------ 453 (631)
.... .......+++.|+|||++.+. .++.++||||||+++|||++|+.||.......+.....|....
T Consensus 154 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07870 154 SIPS-----QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDT 228 (291)
T ss_pred CCCC-----CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhh
Confidence 3221 112234578999999988754 5788999999999999999999999754322111111110000
Q ss_pred ------cccccccccccC-CCCCCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 454 ------LQDSGTVISELP-DPRLKGDFP-KEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 454 ------~~~~~~~~~~~~-~~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
............ .+.+..... ......+.+++.+|+..||.+|||+.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 229 WPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000 000000000 001345788999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=308.93 Aligned_cols=267 Identities=23% Similarity=0.390 Sum_probs=195.0
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++|+..+.||+|+||.||+|..+ +++.||||.+...........+.+|++++++++|+||+++++++.. ....++
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~l 80 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT----KKTLTL 80 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec----CCeEEE
Confidence 56888899999999999999876 5899999998754333333447889999999999999999999875 557899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||++ ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 v~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 81 VFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred EEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 999997 59999887543 36899999999999999999999998 99999999999999999999999999875432
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcc---c------
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT---P------ 452 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~---~------ 452 (631)
.. .......++..|+|||++.+ ..++.++||||||+++|||++|+.||.............+.. +
T Consensus 156 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 156 PS-----KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred CC-----ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhh
Confidence 21 11122346889999998875 458999999999999999999999996443111000000000 0
Q ss_pred ccccc---ccc-ccccCCCCCCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 453 RLQDS---GTV-ISELPDPRLKGDFP-KEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 453 ~~~~~---~~~-~~~~~~~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
..... ... ........+....+ ......+.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 000 00000000000000 001145778999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=311.76 Aligned_cols=254 Identities=27% Similarity=0.357 Sum_probs=193.6
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCCcceeEEeeeccCCcceEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+|...+.||+|+||.||++... +++.||||.+...........+.+|+.++.++. |+||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~----~~~~~~ 80 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR----EGDCWI 80 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec----CCcEEE
Confidence 3445678999999999999875 489999999876544445556899999999995 9999999998865 446799
Q ss_pred EEeeCCCCChHhhh---hccccCCCCHHHHHHHHHHHHhhhHHHHhc-CCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 303 VFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 303 V~E~~~~gsL~~~l---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
+|||+. ++|.++. .......+++..+..++.+++.||+|||+. + |+||||||+||+++.++.++|+|||+++
T Consensus 81 ~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 156 (288)
T cd06616 81 CMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISG 156 (288)
T ss_pred EEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhH
Confidence 999985 5665543 222235689999999999999999999975 6 9999999999999999999999999997
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcC---CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVG---RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 455 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~---~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 455 (631)
...... ......|++.|+|||++... .++.++||||||+++|||++|+.||........ ...
T Consensus 157 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~-------- 221 (288)
T cd06616 157 QLVDSI------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFD-QLT-------- 221 (288)
T ss_pred HhccCC------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHH-HHh--------
Confidence 654321 11233588999999998766 689999999999999999999999964321000 000
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 456 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 456 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. ......+.+....+...+..+.+|+.+||+.+|++|||+.+|++.
T Consensus 222 ---~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 222 ---Q-VVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ---h-hcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000111222222223345568999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=342.55 Aligned_cols=267 Identities=26% Similarity=0.395 Sum_probs=213.8
Q ss_pred HHHHHhcCccccceeeeeCceEEEEEEECC--------CcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeE
Q 006785 218 ALEHATDKFSGSNIVGQGGSSYVYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVG 288 (631)
Q Consensus 218 ~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g 288 (631)
.++...+++.+.+.||+|.||.|++|.... ...||||+++........+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 455556666667799999999999997531 4579999999887777778899999999999 7999999999
Q ss_pred EeeeccCCcceEEEEEeeCCCCChHhhhhccc------------c--CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeec
Q 006785 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL------------V--EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHR 354 (631)
Q Consensus 289 ~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr 354 (631)
+|.. ....++|+||+..|+|.+||+... . ..++..+.+.++.|||.||+||++.. +|||
T Consensus 370 ~~t~----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHR 442 (609)
T KOG0200|consen 370 ACTQ----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHR 442 (609)
T ss_pred eecc----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccch
Confidence 9987 456799999999999999997654 0 12889999999999999999999998 9999
Q ss_pred CCCCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCC
Q 006785 355 DIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQ 433 (631)
Q Consensus 355 DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~ 433 (631)
||.++|||+..+..+||+|||+|+...............+ -...|||||.+....|+.|+|||||||+||||+| |..
T Consensus 443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~--LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~ 520 (609)
T KOG0200|consen 443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGT--LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGT 520 (609)
T ss_pred hhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCc--cceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCC
Confidence 9999999999999999999999997665443221111100 2356999999999999999999999999999999 888
Q ss_pred CCCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 434 PIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 434 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
||....... .+ .+......+...|..+..++..+|+.||+.+|++||++.++++.|....
T Consensus 521 PYp~~~~~~--~l---------------~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 521 PYPGIPPTE--EL---------------LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred CCCCCCcHH--HH---------------HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 885421111 00 1111122223445666677999999999999999999999999998753
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=319.49 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=202.6
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccC-CCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcceE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQ-GGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~-~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~ 300 (631)
-..|+++++||+||.+.||++...+.+.||+|++... .+.+...-|..|+.+|.+| .|.+||+|++|-.. +.++
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~----d~~l 435 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT----DGYL 435 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc----CceE
Confidence 3567788999999999999999888888999887643 4445556699999999999 69999999988664 6799
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
||||||= .-||..+|+........| .+..+..|++.++.++|++| |||.||||.|+|+-. |.+||+|||.|...
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred EEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 9999987 679999998765544556 78889999999999999999 999999999999964 58999999999988
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCC-----------CCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGR-----------ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 449 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-----------~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~ 449 (631)
..+.. +-.....+||+.||+||.+.... .++++||||+|||||+|+.|+.||..... .|
T Consensus 510 ~~DTT---sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~ 579 (677)
T KOG0596|consen 510 QPDTT---SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QI 579 (677)
T ss_pred Ccccc---ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HH
Confidence 76543 22344578999999999986322 57899999999999999999999964321 11
Q ss_pred cccccccccccccccCCCCCCCCCCHHHH-HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 450 ATPRLQDSGTVISELPDPRLKGDFPKEEM-QIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~-~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..+..+.+|...-++|.--. ..+.++|+.||..||.+||+..++++.
T Consensus 580 ---------aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 ---------AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ---------HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 13445555544333332111 128899999999999999999999873
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=324.30 Aligned_cols=244 Identities=27% Similarity=0.422 Sum_probs=201.0
Q ss_pred eeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeCCC
Q 006785 231 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309 (631)
Q Consensus 231 ~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~~ 309 (631)
+||+|.||+||.|++.+ ...+|||.+...... ..+-+.+|+.+-+.|+|.|||+++|.+.+ ..+.-|.||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr-~~QPLhEEIaLH~~LrHkNIVrYLGs~se----nGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR-EVQPLHEEIALHSTLRHKNIVRYLGSVSE----NGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccch-hhccHHHHHHHHHHHhhHhHHHHhhccCC----CCeEEEEeecCCC
Confidence 59999999999999765 567999998765433 33347899999999999999999999876 4577899999999
Q ss_pred CChHhhhhccccCCC--CHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC-CCCeEEeccCceeecccCCCC
Q 006785 310 GNLRDCLDGVLVEGM--NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKRLKADGLP 386 (631)
Q Consensus 310 gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kL~DFGla~~~~~~~~~ 386 (631)
|+|.++|+..- +++ ++.+.-.+.+||+.||.|||++. |||||||-+||||+. .|.+||+|||-++++..-
T Consensus 657 GSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--- 729 (1226)
T KOG4279|consen 657 GSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--- 729 (1226)
T ss_pred CcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC---
Confidence 99999998643 445 77888889999999999999998 999999999999964 678999999999876532
Q ss_pred CCCCCCcccccCCCCCCchhhhcCC--CCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccccc
Q 006785 387 SCSSSPARMQGTFGYFAPEYAMVGR--ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 464 (631)
Q Consensus 387 ~~~~~~~~~~Gt~~Y~APE~~~~~~--~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (631)
.....++.||..|||||++..+. |+..+|||||||++.||.||++||.......... .++
T Consensus 730 --nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM----------------FkV 791 (1226)
T KOG4279|consen 730 --NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM----------------FKV 791 (1226)
T ss_pred --CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh----------------hhh
Confidence 23456788999999999998654 8999999999999999999999997543321111 111
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 465 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 465 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
---...+++|.+.+.....++.+|+..||.+||++.++++
T Consensus 792 GmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 792 GMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 1112334678899999999999999999999999999986
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=297.58 Aligned_cols=252 Identities=23% Similarity=0.309 Sum_probs=199.7
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
+++|++.+.||+|.|+.||+.... +|+.+|+|+++... .....+.+.+|+.|-+.|+||||++|...+.+ ..+.
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~----~~~~ 85 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE----ESFH 85 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc----ccee
Confidence 466777889999999999998754 58999999887542 23345668999999999999999999976665 6688
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC---CCCeEEeccCce
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGMA 377 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~~~~kL~DFGla 377 (631)
|||+|+|.|++|..-+-.+ .-+++..+-....||+.+|.|+|.++ |||||+||.|+||-. .--+||+|||+|
T Consensus 86 ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceE
Confidence 9999999999997766433 33788888999999999999999999 999999999999943 334899999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
..+. ++ ......+|||+|||||++...+|+..+|||+.|||||-|+.|++||.+.....-
T Consensus 161 i~l~-~g-----~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl-------------- 220 (355)
T KOG0033|consen 161 IEVN-DG-----EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-------------- 220 (355)
T ss_pred EEeC-Cc-----cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH--------------
Confidence 9887 32 345667899999999999999999999999999999999999999975221110
Q ss_pred cccccccCCC--CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006785 458 GTVISELPDP--RLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506 (631)
Q Consensus 458 ~~~~~~~~~~--~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 506 (631)
...+... .+.+..-+.......+|+++||..||.+|.|+.|.++.-
T Consensus 221 ---ye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp 268 (355)
T KOG0033|consen 221 ---YEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHP 268 (355)
T ss_pred ---HHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence 0011100 111111223344588999999999999999999998753
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=305.47 Aligned_cols=253 Identities=21% Similarity=0.360 Sum_probs=197.1
Q ss_pred CccccceeeeeCceEEEEEEECC--CcEEEEEEeccCC---------CCChHHHHHHHHHHHHh-cCCCCCcceeEEeee
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLTD--GRIVAVKRFKTQG---------GPNADSVFLTEVDMLSR-LHHCHVVPLVGYCSE 292 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~~--g~~vAVK~l~~~~---------~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~ 292 (631)
+|++.+.||+|+||.||+|.+.. ++.+|||.+.... .......+.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36778889999999999999865 7889999886321 12223447788888875 699999999999875
Q ss_pred ccCCcceEEEEEeeCCCCChHhhhhcc--ccCCCCHHHHHHHHHHHHhhhHHHHh-cCCCceeecCCCCCCeeecCCCCe
Q 006785 293 FRGKRAMRLLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNA 369 (631)
Q Consensus 293 ~~~~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlKp~NILl~~~~~~ 369 (631)
....++||||+++++|.+++... ....+++..++.++.|++.||.|||+ .+ ++|+||+|+|||++.++.+
T Consensus 81 ----~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~ 153 (269)
T cd08528 81 ----NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKV 153 (269)
T ss_pred ----CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcE
Confidence 45789999999999999988542 23458999999999999999999996 56 9999999999999999999
Q ss_pred EEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh
Q 006785 370 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 449 (631)
Q Consensus 370 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~ 449 (631)
+|+|||++....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||...........
T Consensus 154 ~l~dfg~~~~~~~~~------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~--- 224 (269)
T cd08528 154 TITDFGLAKQKQPES------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK--- 224 (269)
T ss_pred EEecccceeeccccc------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHH---
Confidence 999999998754332 22345688999999999988899999999999999999999999864322110000
Q ss_pred cccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 450 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
.......+... ...+..+.+++.+||+.||++||++.|+...+.
T Consensus 225 ----------~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 225 ----------IVEAVYEPLPE----GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ----------HhhccCCcCCc----ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00000011111 122345889999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=300.07 Aligned_cols=253 Identities=30% Similarity=0.433 Sum_probs=204.9
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++|...+.||+|++|.||+|...+ ++.||||++...........+.+|+.++.+++|+|++++++++.. ....++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~l 76 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK----EGEISI 76 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc----CCeEEE
Confidence 357788999999999999999875 999999999876544455679999999999999999999999876 467899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHh-cCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 77 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~ 151 (264)
T cd06623 77 VLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLE 151 (264)
T ss_pred EEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999999764 558999999999999999999999 88 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
.... ......++..|+|||.+....++.++||||||+++|+|++|+.||.............+ +
T Consensus 152 ~~~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-----------~ 215 (264)
T cd06623 152 NTLD-----QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA-----------I 215 (264)
T ss_pred cCCC-----cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH-----------H
Confidence 4321 11245688999999999988999999999999999999999999965432111111100 0
Q ss_pred cccCCCCCCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 462 SELPDPRLKGDFPKE-EMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.....+. .+.. .+..+.+++..||..+|++||++.++++.
T Consensus 216 ~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 216 CDGPPPS----LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred hcCCCCC----CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1111111 1222 34458899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=309.70 Aligned_cols=260 Identities=20% Similarity=0.262 Sum_probs=199.5
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|...+.||+|+||.||++.... ++.||||.+..... ......+.+|+++++.++||||+++++.+.. ....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~ 76 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET----KRHL 76 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec----CCEE
Confidence 367888999999999999998764 78999999875432 2334468899999999999999999998865 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
++||||++|++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++..
T Consensus 77 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~ 151 (305)
T cd05609 77 CMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIG 151 (305)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCcccc
Confidence 9999999999999999754 45899999999999999999999998 999999999999999999999999998742
Q ss_pred ccCCCCC----------CCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhc
Q 006785 381 KADGLPS----------CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA 450 (631)
Q Consensus 381 ~~~~~~~----------~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~ 450 (631)
....... .........|+..|+|||++....++.++||||||+++|||++|..||............
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~--- 228 (305)
T cd05609 152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV--- 228 (305)
T ss_pred CcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---
Confidence 2111000 000112345788999999998888999999999999999999999999643221100000
Q ss_pred ccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006785 451 TPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508 (631)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 508 (631)
.......+.... ..+..+.+++.+||+.+|++||++.++.+.|..
T Consensus 229 ---------~~~~~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 ---------ISDDIEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ---------HhcccCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 000111111111 223448899999999999999997666666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=311.58 Aligned_cols=245 Identities=25% Similarity=0.389 Sum_probs=194.5
Q ss_pred cceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeC
Q 006785 229 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 307 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~ 307 (631)
...||+|+||.||++... ++..||||.+.... ......+.+|+.+++.++|+||+++++.+.. ....|+||||+
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~----~~~~~lv~e~~ 101 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLV----GDELWVVMEFL 101 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheec----CCeEEEEEeCC
Confidence 456999999999999875 58899999986543 3344568899999999999999999998775 45789999999
Q ss_pred CCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCC
Q 006785 308 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS 387 (631)
Q Consensus 308 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 387 (631)
++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 102 ~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--- 172 (292)
T cd06658 102 EGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--- 172 (292)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc---
Confidence 99999998854 34899999999999999999999998 9999999999999999999999999987553221
Q ss_pred CCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccCCC
Q 006785 388 CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDP 467 (631)
Q Consensus 388 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (631)
.......|+..|+|||++.+..++.++||||||+++|||++|+.||........... +.....+
T Consensus 173 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~--------------~~~~~~~ 236 (292)
T cd06658 173 --PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR--------------IRDNLPP 236 (292)
T ss_pred --ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------------HHhcCCC
Confidence 122335689999999999888899999999999999999999999864322111000 0011111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 468 RLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 468 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+.. .......+..++.+||..||.+|||+.++++.
T Consensus 237 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 237 RVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1111 11223457889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=307.37 Aligned_cols=245 Identities=26% Similarity=0.342 Sum_probs=198.1
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|+..+.||+|+||.||++.+. +++.||||.+.... .......+.+|++++++++||||+++++++.. ....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 76 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD----DSNL 76 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc----CCeE
Confidence 36788899999999999999876 48999999986532 22334568899999999999999999998875 4578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||+|+|||++.++.+||+|||++...
T Consensus 77 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 151 (290)
T cd05580 77 YLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRV 151 (290)
T ss_pred EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence 9999999999999999764 45899999999999999999999998 999999999999999999999999998875
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
... .....|++.|+|||.+.+...+.++||||||+++|+|++|+.||.........
T Consensus 152 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------- 207 (290)
T cd05580 152 KGR--------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIY---------------- 207 (290)
T ss_pred CCC--------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH----------------
Confidence 432 22345889999999998888999999999999999999999999643311000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQ 504 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 504 (631)
..+.... ..++......+.+++.+||..||.+|| ++.++++
T Consensus 208 -~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 208 -EKILEGK--VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -HHHhcCC--ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0000000 012222345588999999999999998 6777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=305.95 Aligned_cols=267 Identities=21% Similarity=0.286 Sum_probs=199.4
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+|.+.+.||+|+||.||+|.+. +|+.||||++..... ......+.+|+.++++++||||+++++++.. ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~~ 76 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH----GSGFVL 76 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec----CCeeEE
Confidence 4677889999999999999975 589999999876542 2334568999999999999999999999876 557899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+ +++|.+++.... ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 77 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 77 VMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSE 151 (286)
T ss_pred Eeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence 99999 999999987543 56999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh--c------ccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--A------TPR 453 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~------~~~ 453 (631)
... .......|+..|+|||++.+. .++.++||||||+++|||++|.+||.............. . .+.
T Consensus 152 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 152 EEP----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPG 227 (286)
T ss_pred CCC----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhh
Confidence 321 112334689999999988654 468999999999999999999877754322111000000 0 000
Q ss_pred cccccccccccCCCCCC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 454 LQDSGTVISELPDPRLK----GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 454 ~~~~~~~~~~~~~~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..... ....+..+... ..........+.+++.+||+.+|++||++.++++.
T Consensus 228 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 228 LTSLP-DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred ccCcc-hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 00000000000 00111234668999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=306.95 Aligned_cols=268 Identities=27% Similarity=0.383 Sum_probs=200.1
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
++|+..+.||+|+||.||+|.+. +++.||||+++... .......+.+|++++++++|+||+++++++.. ....+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~ 76 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR----KGRLY 76 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE----CCEEE
Confidence 36788899999999999999876 48899999987542 23334568999999999999999999999876 45789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||++++.|..++... ..+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 77 iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~ 151 (288)
T cd07833 77 LVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALR 151 (288)
T ss_pred EEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccC
Confidence 999999887776655432 44899999999999999999999998 9999999999999999999999999988765
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc---
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS--- 457 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~--- 457 (631)
.... .......++..|+|||++... .++.++||||||+++|+|++|+.||..................+...
T Consensus 152 ~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07833 152 ARPA----SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQE 227 (288)
T ss_pred CCcc----ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhh
Confidence 4321 122335688999999999887 88999999999999999999999986432211100000000000000
Q ss_pred ----ccccc--ccCCCCC----CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 458 ----GTVIS--ELPDPRL----KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 458 ----~~~~~--~~~~~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
..... +...... ...++...+..+.+|+.+||..+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 228 LFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred hcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 0000000 00122233566899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=306.23 Aligned_cols=250 Identities=25% Similarity=0.396 Sum_probs=200.2
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++|...+.||+|+||.||++... ++..||+|.+..... .....+.+|+.+++.++||||+++++++.. ....|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~----~~~~~l 93 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKHPNIVNYLDSYLV----GDELWV 93 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-hHHHHHHHHHHHHhhcCCCCeeehhheeee----CCcEEE
Confidence 67888899999999999999864 588999999865432 334568999999999999999999998876 456799
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
|+||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 94 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 94 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred EEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 9999999999999865 34789999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
... ......|++.|+|||.+....++.++||||||+++|++++|+.||............ .
T Consensus 168 ~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~--------------~ 228 (293)
T cd06647 168 EQS-----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--------------A 228 (293)
T ss_pred ccc-----ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh--------------h
Confidence 321 122346889999999998888999999999999999999999999643221110000 0
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
....+. ...+......+.+++.+||..+|++||++.+++..
T Consensus 229 ~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 229 TNGTPE--LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cCCCCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000011 11122334558899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=306.53 Aligned_cols=267 Identities=22% Similarity=0.303 Sum_probs=197.6
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC----ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
+|...+.||+|+||.||+|... +|+.||||.+...... .....+..|++++++++|+||+++++++.+ ...
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~ 76 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH----KSN 76 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec----CCE
Confidence 4677889999999999999975 5899999999765332 223447789999999999999999999876 457
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.++||||+ +|+|.+++.... ..+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||+++.
T Consensus 77 ~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~ 151 (298)
T cd07841 77 INLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS 151 (298)
T ss_pred EEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeee
Confidence 89999999 999999997643 36999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhh-hhcccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-LWATPRLQDS 457 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~~~~~~~~~~ 457 (631)
..... .......+++.|+|||.+.+ ..++.++||||||+++|||++|.+||............ ..........
T Consensus 152 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (298)
T cd07841 152 FGSPN-----RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEEN 226 (298)
T ss_pred ccCCC-----ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhh
Confidence 65432 11223356788999998865 45789999999999999999997777543321100000 0000000000
Q ss_pred cc---cccccCCCCCC-----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 458 GT---VISELPDPRLK-----GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 458 ~~---~~~~~~~~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.. ........... ..........+.+++.+||+.+|++|||+.++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00 00000000000 01112334568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=299.22 Aligned_cols=255 Identities=27% Similarity=0.414 Sum_probs=199.7
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+|...+.||+|+||.||+|... +++.||||.++..... .....+..|++++++++|+||+++++++.. ....++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~~l 76 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH----REKVYI 76 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec----CCEEEE
Confidence 4777899999999999999875 5899999998765432 345668999999999999999999998764 457899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
|+||+++++|.+++... ..+++..+..++.+++.||+|||+.+ |+|+||+|+||++++++.+||+|||++.....
T Consensus 77 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 77 FMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred EEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence 99999999999999753 34789999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCC---CCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~---~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
..... ........++..|+|||++.... ++.++||||||+++||+++|+.||.......... ..
T Consensus 152 ~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~--~~---------- 218 (264)
T cd06626 152 NTTTM-GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM--FH---------- 218 (264)
T ss_pred CCCcc-cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH--HH----------
Confidence 33211 11122346889999999998766 8999999999999999999999996432211100 00
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
+.....+.+.. .......+.+++.+||+.+|++||++.+++.
T Consensus 219 -~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 219 -VGAGHKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -HhcCCCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00001111111 1112445788999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=299.57 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=198.4
Q ss_pred CccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+|...+.||+|+||.||+|..+. |..||+|.+..... ......+.+|+++++.++|+||+++++.+.. ....++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~----~~~~~l 76 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE----NGRLFI 76 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc----CCeEEE
Confidence 47778999999999999999764 88999999865422 2334468899999999999999999998865 457899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCC-eEEeccCceeecc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN-AKITDLGMAKRLK 381 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~-~kL~DFGla~~~~ 381 (631)
|+||+++++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||||+||++++++. ++|+|||.+....
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (257)
T cd08225 77 VMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153 (257)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence 999999999999997654445899999999999999999999998 999999999999988854 6999999987664
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
... .......|++.|+|||++....++.++||||||+++|||++|..||..........
T Consensus 154 ~~~-----~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---------------- 212 (257)
T cd08225 154 DSM-----ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL---------------- 212 (257)
T ss_pred CCc-----ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH----------------
Confidence 321 11123458899999999988889999999999999999999999986432211000
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
....... ...+...+..+.+++.+||..+|++|||+.++++.
T Consensus 213 -~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 213 -KICQGYF-APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -HHhcccC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0000000 01112223458899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=309.61 Aligned_cols=245 Identities=23% Similarity=0.374 Sum_probs=194.9
Q ss_pred cceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeC
Q 006785 229 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 307 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~ 307 (631)
...||+|+||.||+|... +++.||||.+..... .....+.+|+.+++.++||||+++++++.. ....|+||||+
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~----~~~~~iv~e~~ 100 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLV----GEELWVLMEFL 100 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheee----CCeEEEEEecC
Confidence 457999999999999875 589999999865433 334568899999999999999999998875 45789999999
Q ss_pred CCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCC
Q 006785 308 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS 387 (631)
Q Consensus 308 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 387 (631)
++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 101 ~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--- 171 (297)
T cd06659 101 QGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--- 171 (297)
T ss_pred CCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc---
Confidence 99999998754 34899999999999999999999998 9999999999999999999999999987554321
Q ss_pred CCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccCCC
Q 006785 388 CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDP 467 (631)
Q Consensus 388 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (631)
.......|+..|+|||++.+..++.++||||||+++|||++|+.||.......... .. .....+
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~--~~------------~~~~~~ 235 (297)
T cd06659 172 --PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK--RL------------RDSPPP 235 (297)
T ss_pred --ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HH------------hccCCC
Confidence 11233568999999999998889999999999999999999999996432211100 00 000000
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 468 RLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 468 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.. ..+......+.+++.+||+.+|++||++.++++.
T Consensus 236 ~~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 236 KL--KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred Cc--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00 0111223447889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=299.68 Aligned_cols=254 Identities=22% Similarity=0.336 Sum_probs=199.2
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC----CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG----GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
.+|.+.+.||+|+||.||+|.+. ++..||+|.+.... .......|.+|++++++++|+||+++++++.... ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--~~ 79 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE--EK 79 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC--CC
Confidence 46788899999999999999875 48999999875321 2233456889999999999999999999876532 34
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++
T Consensus 80 ~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 678999999999999998753 34889999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
........ ........|+..|+|||++.+..++.++||||||+++|||++|+.||........ .
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~------------ 218 (264)
T cd06653 155 RIQTICMS--GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--I------------ 218 (264)
T ss_pred cccccccc--CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH--H------------
Confidence 65421110 1112335689999999999988899999999999999999999999964321110 0
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
............|......+.+++.+||+ +|..||++.+++.
T Consensus 219 ---~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 219 ---FKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---HHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 01111111123444555668999999999 5799999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=322.77 Aligned_cols=250 Identities=23% Similarity=0.357 Sum_probs=200.9
Q ss_pred ccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~ 304 (631)
|.+...||.|+||.||+|+.++ +-..|-|.+... ..+..++|+-||+||....||+||+|++.|.. .+.+||+.
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~----enkLwili 108 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYF----ENKLWILI 108 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhc----cCceEEEE
Confidence 4556679999999999998776 445566766554 34556679999999999999999999988765 55789999
Q ss_pred eeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCC
Q 006785 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (631)
Q Consensus 305 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~ 384 (631)
|||.||-+...+-. ..+.|+..++..++.|++.||.|||++. |||||||+.|||++-+|.++|+|||.+......
T Consensus 109 EFC~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t- 183 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST- 183 (1187)
T ss_pred eecCCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH-
Confidence 99999999888765 3467999999999999999999999998 999999999999999999999999998654322
Q ss_pred CCCCCCCCcccccCCCCCCchhhh-----cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 385 LPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 385 ~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
......+.|||.|||||+.. ..+|+.++||||||++|.||..+.+|-+...+-. ...
T Consensus 184 ----~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR---Vll----------- 245 (1187)
T KOG0579|consen 184 ----RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VLL----------- 245 (1187)
T ss_pred ----HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH---HHH-----------
Confidence 12344578999999999886 4679999999999999999999999976443211 000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+.+--.|.+. .|..+...+.+++++||..||..||++.++++.
T Consensus 246 KiaKSePPTLl--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 246 KIAKSEPPTLL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHhhcCCCccc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 01112223332 356677789999999999999999999999873
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=307.14 Aligned_cols=267 Identities=21% Similarity=0.327 Sum_probs=196.0
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+|+..+.||.|+||.||+|+.. +|+.||||++..... ......+.+|++++++++||||+++++++.. ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~~ 76 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT----ENKLYL 76 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc----CCcEEE
Confidence 4777889999999999999875 589999999875432 2233458899999999999999999998865 457799
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+. ++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~ 152 (284)
T cd07860 77 VFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 152 (284)
T ss_pred Eeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999995 68999987655566899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCC-CCcccchhhHHHHHHHHHhCCCCCCCccccccc-hhhhhcccc-------
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRSITKGEE-SLVLWATPR------- 453 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~-~~~~~~~~~------- 453 (631)
.. .......+++.|+|||++.+.. ++.++||||||+++|||+||+.||......... ....+....
T Consensus 153 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07860 153 PV-----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 227 (284)
T ss_pred Cc-----cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence 21 1122334788999999887644 688999999999999999999999643221100 000000000
Q ss_pred c---ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 454 L---QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 454 ~---~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. ..............+. .........+.+++.+||+.||.+|||+.++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 228 VTSLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhHHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0 0000000000000000 0011123447889999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=303.95 Aligned_cols=254 Identities=27% Similarity=0.415 Sum_probs=202.8
Q ss_pred HHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 221 ~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
..++.|+..+.||+|+||.||+|.+. ++..||+|++..... ....+.+|+++++.++|+|++++++++.. ...
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~ 89 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLV----GDE 89 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEE----CCE
Confidence 34567788889999999999999986 588999999976533 44568999999999999999999999876 457
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.|+|+||+++++|.+++.... ..+++..+..++.+++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 165 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQ 165 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhh
Confidence 899999999999999998643 36999999999999999999999988 99999999999999999999999999865
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
..... .......++..|+|||++.+..++.++||||||+++|+|++|+.||.......... ....
T Consensus 166 ~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~--~~~~-------- 230 (286)
T cd06614 166 LTKEK-----SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF--LITT-------- 230 (286)
T ss_pred hccch-----hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHh--------
Confidence 54321 11223457889999999988889999999999999999999999986432211100 0000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
... +... .+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 231 ---~~~-~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 231 ---KGI-PPLK--NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ---cCC-CCCc--chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 000 0000 111233458899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=306.67 Aligned_cols=248 Identities=27% Similarity=0.386 Sum_probs=195.1
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
..|...+.||+|+||.||+|... +++.||+|.+..... ......+.+|+++++.++||||+++++++.. ....
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~----~~~~ 90 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR----EHTA 90 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe----CCeE
Confidence 45777889999999999999875 589999999864422 2233468899999999999999999999886 4567
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||++ |+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||++...
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceec
Confidence 99999996 68877775432 45899999999999999999999998 999999999999999999999999998764
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhh---cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
... ....|+..|+|||++. ...++.++||||||+++|||++|+.||.............
T Consensus 166 ~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~--------- 227 (307)
T cd06607 166 SPA---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA--------- 227 (307)
T ss_pred CCC---------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh---------
Confidence 322 2345788999999874 4568899999999999999999999986432211000000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 506 (631)
....+.+ .+...+..+.+++.+||..+|++||++.+|+...
T Consensus 228 -----~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 228 -----QNDSPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred -----cCCCCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0000111 1223445689999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=302.52 Aligned_cols=266 Identities=24% Similarity=0.378 Sum_probs=197.6
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
+|+..+.||.|++|.||+|+.. +|..||||.++..........+.+|+.++++++|+||+++++++.. ....++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 76 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT----ENKLMLV 76 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee----CCcEEEE
Confidence 4778899999999999999986 4899999999865444444567899999999999999999999876 4567999
Q ss_pred EeeCCCCChHhhhhccc-cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 304 FEFMPNGNLRDCLDGVL-VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
|||++ ++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.....
T Consensus 77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 77 FEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGI 152 (284)
T ss_pred EecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence 99997 58999886533 235899999999999999999999998 99999999999999999999999999976533
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhh--hhccccc-----
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV--LWATPRL----- 454 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~--~~~~~~~----- 454 (631)
.. .......++..|+|||++.+. .++.++||||||+++|+|++|+.||............ .+..+..
T Consensus 153 ~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07836 153 PV-----NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPG 227 (284)
T ss_pred Cc-----cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHH
Confidence 21 112234578899999988654 5789999999999999999999999754322110000 0000000
Q ss_pred -ccc---cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 455 -QDS---GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 455 -~~~---~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
... ........+... ....+..+..+.+++.+||+.||.+||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 228 ISQLPEYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HhcCchhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 000000000000 0111223455889999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=305.43 Aligned_cols=269 Identities=23% Similarity=0.340 Sum_probs=199.2
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
++|+..+.||.|+||.||+|.+. +++.+|||.++..... .....+.+|+.++++++||||+++++++.... ....|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN--LDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC--CCcEE
Confidence 46778889999999999999986 4889999999754322 22234778999999999999999999887532 25789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++....
T Consensus 83 lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred EEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 9999996 59999887543 35899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccch-hhh---------hc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEES-LVL---------WA 450 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~-~~~---------~~ 450 (631)
... .......+++.|+|||++.+. .++.++||||||+++|||++|..||.......... ... |.
T Consensus 158 ~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 158 SPL-----KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred CCc-----cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence 431 111234578899999988754 46899999999999999999999996533211100 000 00
Q ss_pred cc-cccccc-ccccccCCCCCCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 451 TP-RLQDSG-TVISELPDPRLKGDFPKE-EMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 451 ~~-~~~~~~-~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
.. .+.... ..........+...++.. ....+.+++..||+.+|++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 000000 000111111112223322 3555889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=321.60 Aligned_cols=245 Identities=24% Similarity=0.373 Sum_probs=195.0
Q ss_pred ceeeeeCceEEEEEEECC-CcEEEEEEe---ccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 230 NIVGQGGSSYVYRGQLTD-GRIVAVKRF---KTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~-g~~vAVK~l---~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
.+||+|+|-+||||.+.. |-.||--.+ .....+...+.|..|+.+|+.|+||||++++.++.+... ....+|+|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n--~~in~iTE 123 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN--KTINFITE 123 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC--ceeeeeee
Confidence 569999999999998754 777774333 333445556779999999999999999999999887553 57889999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC-CCCeEEeccCceeecccCC
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKRLKADG 384 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kL~DFGla~~~~~~~ 384 (631)
.+..|+|..|+.+. +.++...+..++.||++||.|||++. |||||||||-+||+|+. -|.|||+|+|||......
T Consensus 124 L~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s- 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS- 199 (632)
T ss_pred cccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence 99999999999875 55889999999999999999999985 67999999999999975 578999999999887643
Q ss_pred CCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccccc
Q 006785 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 464 (631)
Q Consensus 385 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (631)
......|||.|||||++. ..|++.+||||||+.++||+|+..||..-........ ++...+
T Consensus 200 ------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYK------------KV~SGi 260 (632)
T KOG0584|consen 200 ------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYK------------KVTSGI 260 (632)
T ss_pred ------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHH------------HHHcCC
Confidence 233478999999999877 8899999999999999999999999965443322110 111111
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 465 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 465 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
....+..--. .++.+||.+|+.. ..+|||+.|+++
T Consensus 261 KP~sl~kV~d----Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 261 KPAALSKVKD----PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred CHHHhhccCC----HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1111111111 2388999999999 999999999996
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=311.55 Aligned_cols=270 Identities=21% Similarity=0.257 Sum_probs=199.8
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC--Cc
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KR 297 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~ 297 (631)
..++|+..+.||+|+||.||+|... +|+.||||++.... .......+.+|+.++++++||||+++++++..... ..
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999875 58999999986432 22334457889999999999999999998764321 12
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
...|+||||+. ++|.+++... +++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35799999995 6888887642 889999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhh----------
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV---------- 447 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~---------- 447 (631)
+...... ......||..|+|||++.+..++.++||||||+++|+|++|+.||............
T Consensus 166 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 166 RTAGTSF------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE 239 (353)
T ss_pred eeCCCCC------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 8654321 122345889999999999999999999999999999999999999643211100000
Q ss_pred ----------hhcccccccccccccccC----CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 448 ----------LWATPRLQDSGTVISELP----DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 448 ----------~~~~~~~~~~~~~~~~~~----~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+.............++. .+......+......+.+++.+||+.||.+|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000000000110 0111111122335568899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=339.07 Aligned_cols=261 Identities=28% Similarity=0.423 Sum_probs=198.6
Q ss_pred HHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeecc-----
Q 006785 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR----- 294 (631)
Q Consensus 221 ~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 294 (631)
.-..+|+..++||+||||.|||++.+ ||+.||||++.............+|+.+|++|+|||||+++..+.+..
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 44567888899999999999999876 799999999987765555566899999999999999999986664310
Q ss_pred ----------------------------------------------------------C---------------------
Q 006785 295 ----------------------------------------------------------G--------------------- 295 (631)
Q Consensus 295 ----------------------------------------------------------~--------------------- 295 (631)
+
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred -------------------------------CcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHH
Q 006785 296 -------------------------------KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH 344 (631)
Q Consensus 296 -------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH 344 (631)
....+||-||||+.-.|.++++.+.... .....++++.+|+.||.|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH
Confidence 0146789999999988888887653211 46778999999999999999
Q ss_pred hcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc----c--------CCCCCC-CCCCcccccCCCCCCchhhhcC-
Q 006785 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK----A--------DGLPSC-SSSPARMQGTFGYFAPEYAMVG- 410 (631)
Q Consensus 345 ~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~----~--------~~~~~~-~~~~~~~~Gt~~Y~APE~~~~~- 410 (631)
++| ||||||||.||+|+++..|||+|||+|.... . +..... ....+..+||..|+|||++.+.
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 999 9999999999999999999999999998722 0 001111 1244667899999999999754
Q ss_pred --CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccCCCCCCC--CCCHHHHHHHHHHHH
Q 006785 411 --RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKG--DFPKEEMQIMAYLAK 486 (631)
Q Consensus 411 --~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~--~~~~~~~~~l~~li~ 486 (631)
.|+.|+|+||+||||+||+. ||....+... .+..+.++.+.. ++.......-+.++.
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~----------------iL~~LR~g~iP~~~~f~~~~~~~e~slI~ 852 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERAS----------------ILTNLRKGSIPEPADFFDPEHPEEASLIR 852 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHHHH----------------HHHhcccCCCCCCcccccccchHHHHHHH
Confidence 49999999999999999984 5654333211 112222222222 122223333567899
Q ss_pred HhcccCCCCCCCHHHHHH
Q 006785 487 ECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 487 ~cl~~dP~~RPs~~evl~ 504 (631)
++++.||.+|||+.|+++
T Consensus 853 ~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 853 WLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHhcCCCccCCCHHHHhh
Confidence 999999999999999986
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.15 Aligned_cols=248 Identities=25% Similarity=0.312 Sum_probs=199.6
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
+|...+.||.|+||.||+|.+. ++..||+|.+..... ......+.+|++++++++||||+++++++.. ....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 76 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD----EENMY 76 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC----CCeEE
Confidence 4778899999999999999986 489999999975432 2345568999999999999999999988764 55789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~ 151 (258)
T cd05578 77 LVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVT 151 (258)
T ss_pred EEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccC
Confidence 999999999999999764 46899999999999999999999998 9999999999999999999999999987764
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
... ......|+..|+|||++....++.++||||||+++|+|++|+.||.............
T Consensus 152 ~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------------- 212 (258)
T cd05578 152 PDT------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA------------- 212 (258)
T ss_pred CCc------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH-------------
Confidence 432 1233458889999999988889999999999999999999999997543211111100
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM--SEVV 503 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl 503 (631)
.... .....+...+..+.+++.+||..||.+||++ .+++
T Consensus 213 -~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 213 -KQET--ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -Hhcc--ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0000 1112333344668899999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=321.28 Aligned_cols=276 Identities=25% Similarity=0.380 Sum_probs=204.9
Q ss_pred ccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC--CcceEEEEE
Q 006785 228 GSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRAMRLLVF 304 (631)
Q Consensus 228 ~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~~~~~lV~ 304 (631)
..+.||+|+||.||+|+.+ .|+.||||.++........+.+.+|+++|++|+|+|||+++++-.+... ......+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 3467999999999999965 5999999999988777788889999999999999999999886443220 034568999
Q ss_pred eeCCCCChHhhhhcc-ccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeec--CCCC--eEEeccCceee
Q 006785 305 EFMPNGNLRDCLDGV-LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD--ENLN--AKITDLGMAKR 379 (631)
Q Consensus 305 E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~--~~~~--~kL~DFGla~~ 379 (631)
|||.||||+..|++. ...+|++.+.+.+..+++.||.|||+++ |+||||||.||++- .+|+ .||+|||.|+.
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999999999754 2356999999999999999999999999 99999999999983 3333 69999999998
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhh-cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
+.++. ....++||..|++||.+. .+.|+..+|.|||||++||.+||..||..........-+.|....-...+
T Consensus 174 l~d~s------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 174 LDDNS------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred CCCCC------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 87653 446678999999999998 48899999999999999999999999965443321111222111111111
Q ss_pred ccccccCC---C-----CC--CCCCCHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHhhhCCC
Q 006785 459 TVISELPD---P-----RL--KGDFPKEEMQIMAYLAKECLQLDPDARP--TMSEVVQILSTIAPD 512 (631)
Q Consensus 459 ~~~~~~~~---~-----~l--~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~i~~~ 512 (631)
..+..... | .+ ...........+-..+..+|..+|.+|- .+.+....+..|...
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 10000000 0 00 1112223333455667778888888888 777777766666543
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=311.47 Aligned_cols=274 Identities=23% Similarity=0.295 Sum_probs=199.1
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC-CcceE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG-KRAMR 300 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~~~~ 300 (631)
.++|.+.+.||+|+||.||+|.+. +|+.||||.+...........+.+|+.++++++|+||+++++++..... .....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999865 5899999998754444445568899999999999999999988764321 22457
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+. ++|.+++.. +.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeec
Confidence 99999995 588888754 45899999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhh-hh-cccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-LW-ATPRLQDS 457 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~~-~~~~~~~~ 457 (631)
...... ........||..|+|||.+.+ ..++.++||||||+++|+|++|+.||............ .. ..+.....
T Consensus 157 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 157 DPEHDH--TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred cccccc--cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 432211 112234568999999998764 56899999999999999999999999643211100000 00 00000000
Q ss_pred --------cccccccCCC-CCC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 458 --------GTVISELPDP-RLK-GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 458 --------~~~~~~~~~~-~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.......... ... .......+..+.+++.+||+.+|++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000 000 00001123458899999999999999999999885
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=306.39 Aligned_cols=249 Identities=22% Similarity=0.334 Sum_probs=206.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC-hHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.-|...+.||+|.|..|-+|++- .|..||||++....... ....+.+|+..|+.++|||||+||.+... ...+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT----QTKly 93 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT----QTKLY 93 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc----cceEE
Confidence 34666788999999999999753 59999999997653322 23458899999999999999999987654 66789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeec-CCCCeEEeccCceeec
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRL 380 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~-~~~~~kL~DFGla~~~ 380 (631)
||+|+-.+|+|++||-... .++.+..+.+++.||+.|+.|+|..+ +|||||||+||.+- .-|-+||+|||++..+
T Consensus 94 LiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccC
Confidence 9999999999999996643 56999999999999999999999998 99999999999875 4577999999999887
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
.+.. ......|++.|-|||++.+..| .+++||||||||||-|++|++||+...+.+-
T Consensus 170 ~PG~------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------- 227 (864)
T KOG4717|consen 170 QPGK------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------- 227 (864)
T ss_pred CCcc------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh----------------
Confidence 7643 4556789999999999998877 5689999999999999999999976544321
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+..+.|- +...|...+.+..+||..||..||.+|.+.++|+..
T Consensus 228 -LTmImDC--KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 228 -LTMIMDC--KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred -hhhhhcc--cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 2222222 224677788889999999999999999999999864
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=301.55 Aligned_cols=245 Identities=28% Similarity=0.400 Sum_probs=191.7
Q ss_pred eeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeCC
Q 006785 232 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 308 (631)
Q Consensus 232 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~ 308 (631)
||+|+||+||++... +|+.||+|.+.... .......+..|+++|+.++||||+++++++.. ....|+||||++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~~~ 76 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET----KDDLCLVMTLMN 76 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec----CCeEEEEEecCC
Confidence 689999999999865 58999999986532 12234457889999999999999999988765 457899999999
Q ss_pred CCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCC
Q 006785 309 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 388 (631)
Q Consensus 309 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 388 (631)
+++|.+++.......+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 77 ~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---- 149 (277)
T cd05577 77 GGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---- 149 (277)
T ss_pred CCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC----
Confidence 999999997654456999999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccCCCC
Q 006785 389 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 468 (631)
Q Consensus 389 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (631)
......++..|+|||++.+..++.++||||||+++|+|++|+.||............. .....
T Consensus 150 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------------~~~~~-- 212 (277)
T cd05577 150 --KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK-------------RRTLE-- 212 (277)
T ss_pred --ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH-------------hcccc--
Confidence 1223457889999999988889999999999999999999999996543211100000 00000
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006785 469 LKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQ 504 (631)
Q Consensus 469 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 504 (631)
.....+...+..+.+++.+||+.+|.+|| ++.++++
T Consensus 213 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 213 MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 01112223345588999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=302.06 Aligned_cols=247 Identities=23% Similarity=0.372 Sum_probs=195.9
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~ 304 (631)
|...+.||+|++|.||++... +++.+|+|++.... ......+.+|+.+++.++||||+++++++.. ....++|+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~----~~~~~~v~ 95 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV----GDELWVVM 95 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEc----CCeEEEEE
Confidence 444578999999999999864 58899999986442 2334558899999999999999999998875 45779999
Q ss_pred eeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCC
Q 006785 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (631)
Q Consensus 305 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~ 384 (631)
||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 96 EFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred eccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 99999999999876 35899999999999999999999998 9999999999999999999999999887554321
Q ss_pred CCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccccc
Q 006785 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 464 (631)
Q Consensus 385 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (631)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||........... +...
T Consensus 170 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~--------------~~~~ 230 (285)
T cd06648 170 -----PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR--------------IRDN 230 (285)
T ss_pred -----cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH--------------HHhc
Confidence 112234589999999999888899999999999999999999999864322111000 0000
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 465 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 465 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
..+... .+...+..+.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 231 LPPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 111111 11113345889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=293.24 Aligned_cols=255 Identities=25% Similarity=0.385 Sum_probs=204.8
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+|...+.||+|++|.||+|... +++.|++|++..... ....+.+.+|++++++++|+||+++++.+.... ....++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE--KNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC--CCeEEE
Confidence 3677889999999999999987 589999999875532 234556899999999999999999999887521 257899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++++|.+++.... .+++..+..++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 79 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 79 FLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999999997643 6899999999999999999999988 99999999999999999999999999987765
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
.... .......++..|+|||.+.....+.++||||||+++|+|++|..||....... ... .
T Consensus 154 ~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~-------------~ 214 (260)
T cd06606 154 IETG---EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM---AAL-------------Y 214 (260)
T ss_pred cccc---ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---HHH-------------H
Confidence 4210 01233468899999999988889999999999999999999999996543110 001 1
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+.........+...+..+.+++.+||..+|++||++.++++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 215 KIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred hccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1111111122333445669999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.42 Aligned_cols=197 Identities=26% Similarity=0.324 Sum_probs=170.9
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CC-----CCcceeEEeeeccCC
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HC-----HVVPLVGYCSEFRGK 296 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g~~~~~~~~ 296 (631)
.+|.+.+.||+|.||.|.+|.+. +++.||||+++... ....+-..|+.+|..|+ |. |+|++++|+..
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f---- 259 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF---- 259 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc----
Confidence 37889999999999999999865 49999999998753 33444678999999996 43 89999999986
Q ss_pred cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCC--CCeEEecc
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN--LNAKITDL 374 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~--~~~kL~DF 374 (631)
..+.+||+|.+ .-+|.++|+.+...+++...+..|+.||+.||.+||+.+ |||+||||+||||.+- ..+||+||
T Consensus 260 r~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 260 RNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred ccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEec
Confidence 67889999999 679999999888888999999999999999999999999 9999999999999653 36999999
Q ss_pred CceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCc
Q 006785 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (631)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~ 438 (631)
|.|...... .-....+..|.|||++.+.+|+.+.||||||||+.||++|.+-|.+.
T Consensus 336 GSSc~~~q~--------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 336 GSSCFESQR--------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred ccccccCCc--------ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 999876432 12456788999999999999999999999999999999997666544
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=311.56 Aligned_cols=275 Identities=22% Similarity=0.291 Sum_probs=200.0
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccC-CCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcc
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ-GGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~ 298 (631)
..++|+..+.||+|+||.||+|.+. +|+.+|||++... ........+.+|+.+++++ +||||+++++++.... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~--~~ 82 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN--DK 82 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC--Cc
Confidence 4567888899999999999999876 4889999988643 2223334577899999999 9999999999886422 34
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..|+||||++ ++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 6799999996 6999988753 5899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccc--
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ-- 455 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~-- 455 (631)
..................||..|+|||++.+ ..++.++||||||+++|+|++|+.||....................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 7654322111122334578999999998764 5578999999999999999999999964332211100000000000
Q ss_pred --------cccccccccCCCCCC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 456 --------DSGTVISELPDPRLK--GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 456 --------~~~~~~~~~~~~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.....+..+...... .......+..+.+++.+||+.+|++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000000000 00111134568899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=300.51 Aligned_cols=243 Identities=26% Similarity=0.337 Sum_probs=186.0
Q ss_pred eeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHh---cCCCCCcceeEEeeeccCCcceEEEEE
Q 006785 231 IVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSR---LHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (631)
Q Consensus 231 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~~E~~~l~~---l~H~niv~l~g~~~~~~~~~~~~~lV~ 304 (631)
.||+|+||.||++... +++.||||.+...... .....+.+|..+++. .+||||+.+++++.. ....++||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~ 76 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT----PDKLCFIL 76 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec----CCeEEEEE
Confidence 4899999999999875 4899999998654322 222334555544443 479999999988875 44679999
Q ss_pred eeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCC
Q 006785 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (631)
Q Consensus 305 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~ 384 (631)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++.......
T Consensus 77 e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 77 DLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence 999999999998754 45899999999999999999999998 9999999999999999999999999987553221
Q ss_pred CCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccc
Q 006785 385 LPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 463 (631)
Q Consensus 385 ~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (631)
.....||..|+|||.+.. ..++.++||||||+++|||++|..||.............. ..
T Consensus 152 -------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~------------~~ 212 (279)
T cd05633 152 -------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM------------TL 212 (279)
T ss_pred -------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH------------hh
Confidence 123458999999998864 5589999999999999999999999965432211110000 00
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006785 464 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 505 (631)
Q Consensus 464 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 505 (631)
... ...+...+..+.+++.+||+.||.+|| ++.++++.
T Consensus 213 ~~~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 213 TVN----VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCC----cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 011 122333445688999999999999999 59988775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=297.89 Aligned_cols=243 Identities=26% Similarity=0.358 Sum_probs=194.7
Q ss_pred eeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeCC
Q 006785 232 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 308 (631)
Q Consensus 232 LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~ 308 (631)
||.|+||.||+++... ++.||+|++..... ......+.+|+.+++.++||||+++++++.+ ....++||||++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~ 76 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD----KKYIYMLMEYCL 76 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc----CCccEEEEecCC
Confidence 6899999999999864 89999999875432 2344568999999999999999999998765 456799999999
Q ss_pred CCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCC
Q 006785 309 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 388 (631)
Q Consensus 309 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 388 (631)
+++|.+++.+. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---- 147 (262)
T cd05572 77 GGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---- 147 (262)
T ss_pred CCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----
Confidence 99999999764 34899999999999999999999998 9999999999999999999999999998764321
Q ss_pred CCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccCCCC
Q 006785 389 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 468 (631)
Q Consensus 389 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (631)
......|+..|+|||++....++.++|+||||+++|+|++|..||.......... ...+....
T Consensus 148 --~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---------------~~~~~~~~ 210 (262)
T cd05572 148 --KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEI---------------YNDILKGN 210 (262)
T ss_pred --ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHH---------------HHHHhccC
Confidence 1223468899999999988889999999999999999999999996543211000 11111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006785 469 LKGDFPKEEMQIMAYLAKECLQLDPDARPT-----MSEVVQ 504 (631)
Q Consensus 469 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 504 (631)
....+|......+.+++.+||+.+|++||+ +.|+++
T Consensus 211 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 211 GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 111233333556899999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=314.42 Aligned_cols=250 Identities=28% Similarity=0.344 Sum_probs=207.6
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
-...|.+.+.||+|.|+.|.+|++. .+..||||.+..... ......+.+|+++|+.|+|||||+++.+... ...
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t----~~~ 129 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET----EAT 129 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee----cce
Confidence 3567888999999999999999875 489999999976533 3333458999999999999999999998875 668
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
+|+||||+.+|.|++||... ..+...++..++.|+.++++|||+++ |||||||++||||+.+.++||+|||++..
T Consensus 130 lylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~ 204 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTF 204 (596)
T ss_pred eEEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeecccccee
Confidence 99999999999999999765 33666899999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
+... .....+.|++.|.|||++.+..| ++++|+||+|++||-|+.|.+||++..-
T Consensus 205 ~~~~------~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l------------------ 260 (596)
T KOG0586|consen 205 FDYG------LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL------------------ 260 (596)
T ss_pred eccc------ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc------------------
Confidence 8643 34566789999999999988665 8899999999999999999999975322
Q ss_pred ccccccCCCCCCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 459 TVISELPDPRLKG--DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 459 ~~~~~~~~~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
.++.++.+.+ .+|........+|++++|.++|.+|+++.++.+.-+
T Consensus 261 ---k~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 261 ---KELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred ---ccccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 2222222222 123334445788999999999999999999987543
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=303.19 Aligned_cols=277 Identities=22% Similarity=0.280 Sum_probs=196.9
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC----C
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG----K 296 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----~ 296 (631)
.++|...+.||+|+||.||+|... +++.||||.+...... .....+.+|+.++++++||||+++++++..... .
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 356888999999999999999876 4899999998654322 223346789999999999999999998865321 1
Q ss_pred cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCc
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGl 376 (631)
....++||||+. ++|.+++.... ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 345799999995 58888886532 35899999999999999999999998 99999999999999999999999999
Q ss_pred eeecccCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccc
Q 006785 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 455 (631)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 455 (631)
+.......... ........++..|+|||++.+. .++.++||||||+++|||++|+.||....................
T Consensus 166 ~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 166 ARAFSLSKNSK-PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred cccccCCcccC-CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 98664332111 1122334578899999988764 478899999999999999999999865432111110000000000
Q ss_pred c----cc---ccccccCCCCC-CCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 456 D----SG---TVISELPDPRL-KGDF-----PKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 456 ~----~~---~~~~~~~~~~l-~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. .. .....+..+.- .... +......+.+|+.+||..||.+|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0 00 00000000000 0000 00012346789999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=299.57 Aligned_cols=264 Identities=23% Similarity=0.269 Sum_probs=192.9
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcceEEEE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
|...+.||+|+||.||+|... +++.||+|+++............+|+.++.++ .|+|++++++++.+.. ....++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~--~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK--TGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC--CCcEEEE
Confidence 456788999999999999875 58999999987653333333456899999999 4999999999987632 2467999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
|||++ |+|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++.....
T Consensus 79 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 79 FELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred EecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 99996 68888886532 45899999999999999999999998 999999999999999 99999999999866432
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhh-hhccc-------cc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-LWATP-------RL 454 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~~~~~-------~~ 454 (631)
. ......++..|+|||++.. +.++.++|||||||++|||++|..||............ ..... ..
T Consensus 153 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 153 P------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred C------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 1 1123457899999997654 56789999999999999999999999653321100000 00000 00
Q ss_pred ccccccccccCCCCCCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 455 QDSGTVISELPDPRLKG----DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 455 ~~~~~~~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.... ......+.... ......+..+.+|+.+||+.+|++||++.++++.
T Consensus 227 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 227 RKSR--HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccc--cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000 00000000000 0112335668999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=302.04 Aligned_cols=271 Identities=22% Similarity=0.272 Sum_probs=194.9
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccC-Ccce
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRG-KRAM 299 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~-~~~~ 299 (631)
++|+..+.||+|+||.||+|.+. +++.||||++...... .....+.+|+.+++.+ +||||+++++++..... ....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999976 5899999998754322 2334588999999999 56999999998875332 2234
Q ss_pred EEEEEeeCCCCChHhhhhccc---cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC-CCCeEEeccC
Q 006785 300 RLLVFEFMPNGNLRDCLDGVL---VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLG 375 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kL~DFG 375 (631)
.|+||||+++ +|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 8999886432 235899999999999999999999998 999999999999998 8899999999
Q ss_pred ceeecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccch-hhhh-ccc
Q 006785 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES-LVLW-ATP 452 (631)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~-~~~~-~~~ 452 (631)
+++.+.... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.......... .... ..+
T Consensus 157 ~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPV-----KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP 231 (295)
T ss_pred cceecCCCc-----cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 988654321 11122356889999998865 457999999999999999999999996532211100 0000 000
Q ss_pred ccccccccccccC----CCCCC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 453 RLQDSGTVISELP----DPRLK----GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 453 ~~~~~~~~~~~~~----~~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
.... ........ .+... ....+.....+.+++.+||..||.+||++.+++.
T Consensus 232 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQV-WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred Chhh-CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 00000000 00000 0001123455889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=301.53 Aligned_cols=266 Identities=22% Similarity=0.325 Sum_probs=195.9
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
|+..+.||.|++|.||+|.+. +|..||||++...... .....+.+|+++++.++|||++++++++.. ....|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~----~~~~~iv 76 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS----ENKLYLV 76 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc----CCeEEEE
Confidence 556788999999999999875 6999999998754322 233458899999999999999999999875 4678999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
|||+ +++|.+++.......+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~ 152 (283)
T cd07835 77 FEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVP 152 (283)
T ss_pred Eecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCC
Confidence 9999 579999997654446899999999999999999999998 999999999999999999999999998765322
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccc-hhhhhccc-------cc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEE-SLVLWATP-------RL 454 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~-~~~~~~~~-------~~ 454 (631)
. .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......... ....+... ..
T Consensus 153 ~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd07835 153 V-----RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV 227 (283)
T ss_pred c-----cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhh
Confidence 1 111223568899999987654 5789999999999999999999999654321110 00000000 00
Q ss_pred c---cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 455 Q---DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 455 ~---~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. +..........+... ......+..+.+++.+||+.+|.+|||+.++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 228 TSLPDYKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhchhhhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 000000000000000 1112223458899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=305.08 Aligned_cols=250 Identities=27% Similarity=0.387 Sum_probs=195.4
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
|...+.||+|+||.||+|+.. ++..||+|++..... ......+.+|+.++++++|||++++++++.. ....++
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~l 102 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR----EHTAWL 102 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee----CCeEEE
Confidence 566788999999999999875 589999999875422 2233458899999999999999999999876 456799
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||++ |+|.+++... ...+++.++..++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.....
T Consensus 103 v~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 103 VMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred EEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 999996 5888877543 345899999999999999999999998 99999999999999999999999999865432
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhh---cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
.....|++.|+|||++. .+.++.++||||||+++|||++|+.||.......... .+.
T Consensus 178 ---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~--~~~--------- 237 (317)
T cd06635 178 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIA--------- 237 (317)
T ss_pred ---------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH--HHH---------
Confidence 12345889999999874 4568999999999999999999999986432111000 000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
... .+. ..+...+..+.+++.+||+.+|.+||++.++++.+..+.
T Consensus 238 --~~~-~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 238 --QNE-SPT---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred --hcc-CCC---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 000 000 111233445889999999999999999999998766543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=303.70 Aligned_cols=271 Identities=25% Similarity=0.307 Sum_probs=197.3
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
.++|+..+.||+|+||.||+|.+. +|+.||+|+++..... .....+.+|+.++++++|+||+++++++.... ....
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~~ 83 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH--LDSI 83 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC--CCeE
Confidence 357888999999999999999975 4899999998754322 22234678999999999999999999886422 2467
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
++||||+. ++|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 99999995 58998887532 55899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhh-hccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL-WATPRLQDSG 458 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~-~~~~~~~~~~ 458 (631)
.... .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||............. +.........
T Consensus 159 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 159 GLPA-----KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW 233 (309)
T ss_pred CCcc-----CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 5332 11122346788999998875 457999999999999999999999996543221111100 0000000000
Q ss_pred ccc--------cccCCCCCCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 459 TVI--------SELPDPRLKG--DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 459 ~~~--------~~~~~~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
... ..+....... .........+.+++.+||+.||++|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 0000000000 0001124457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=306.74 Aligned_cols=268 Identities=24% Similarity=0.337 Sum_probs=194.8
Q ss_pred eeeee--CceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEee
Q 006785 231 IVGQG--GSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 306 (631)
Q Consensus 231 ~LG~G--~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~ 306 (631)
.||+| +||+||++.+. +|+.||||++..... ....+.+.+|+.+++.++||||+++++++.. ....++||||
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----~~~~~~v~e~ 80 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT----GSWLWVISPF 80 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec----CCceEEEEec
Confidence 46666 99999999875 599999999875432 2234568899999999999999999999876 4567999999
Q ss_pred CCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCC
Q 006785 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 386 (631)
Q Consensus 307 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 386 (631)
+.+++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+.........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99999999998755556899999999999999999999998 999999999999999999999999865433221111
Q ss_pred C--CCCCCcccccCCCCCCchhhhcC--CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhh-------hcccccc
Q 006785 387 S--CSSSPARMQGTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL-------WATPRLQ 455 (631)
Q Consensus 387 ~--~~~~~~~~~Gt~~Y~APE~~~~~--~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~-------~~~~~~~ 455 (631)
. .........++..|+|||++.+. .++.++||||||+++|||++|+.||............. +......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccc
Confidence 0 00111122356789999998764 47899999999999999999999996543211100000 0000000
Q ss_pred cc----------------cc-----cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 456 DS----------------GT-----VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 456 ~~----------------~~-----~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.. .. ....+....+....+......+.+|+.+||+.||++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 00 0001111122223344566778999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=302.65 Aligned_cols=267 Identities=22% Similarity=0.334 Sum_probs=195.1
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
++|+..+.||+|+||.||+|.++ +|+.||||++..... ......+.+|++++++++||||+++++++.. ....|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 77 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS----EKRLY 77 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec----CCeEE
Confidence 46888899999999999999876 589999999865432 2233458899999999999999999999875 45789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC-CCCeEEeccCceeec
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKRL 380 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kL~DFGla~~~ 380 (631)
+||||++ ++|.+++.......+++..+..++.||+.||+|||+.+ ++||||+|+||+++. ++.+||+|||++...
T Consensus 78 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 78 LVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred EEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 9999995 68888886544444788899999999999999999998 999999999999985 557899999999765
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhh--hhcccc----
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV--LWATPR---- 453 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~--~~~~~~---- 453 (631)
.... .......+++.|+|||++.+. .++.++||||||+++|+|++|+.||............ .+..+.
T Consensus 154 ~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (294)
T PLN00009 154 GIPV-----RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW 228 (294)
T ss_pred CCCc-----cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 4321 112234578999999988764 5789999999999999999999999654322111100 000000
Q ss_pred -----cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 454 -----LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 454 -----~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
+.+............+. ......+..+.+++.+||+.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLA-TVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccccchhhhhhcccCCCCCHH-HhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000000000000 011123345888999999999999999999986
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=309.56 Aligned_cols=276 Identities=21% Similarity=0.299 Sum_probs=202.2
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
.++|++.+.||.|+||.||+|... +|+.||+|++..... ......+.+|+.+|++++||||+++++++..........
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 467888999999999999999875 489999999875432 233455788999999999999999998876544445678
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
++||||+. |+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 6999998653 44899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhc--ccc--c-
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA--TPR--L- 454 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~--~~~--~- 454 (631)
....... ........|+..|+|||++.. ..++.++||||||+++|||++|+.||............... .+. .
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 158 SSSPTEH-KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred cccCcCC-CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 4432211 112234578999999998865 46899999999999999999999999653221110000000 000 0
Q ss_pred cc-ccccccccCC-CCCCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 455 QD-SGTVISELPD-PRLKGDF-----PKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 455 ~~-~~~~~~~~~~-~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.. ....+.+... ....... ....+..+.+++..||+.+|++||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00 0000000000 0000001 11234568999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=293.21 Aligned_cols=251 Identities=27% Similarity=0.380 Sum_probs=202.1
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+|...+.||.|+||.||++.+. ++..||+|++..... ......+.+|+++++.++|+|++++++.+.. ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~----~~~~~l 76 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE----KGKLCI 76 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec----CCEEEE
Confidence 4677889999999999999976 489999999976533 2445568899999999999999999998775 367899
Q ss_pred EEeeCCCCChHhhhhccc--cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 303 VFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||+++++|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 153 (258)
T cd08215 77 VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVL 153 (258)
T ss_pred EEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeec
Confidence 999999999999997643 356999999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
.... .......|++.|+|||.+....++.++||||||+++|+|++|+.||....... ....
T Consensus 154 ~~~~-----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~----------- 214 (258)
T cd08215 154 SSTV-----DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LALK----------- 214 (258)
T ss_pred ccCc-----ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHHH-----------
Confidence 5432 12233468899999999988889999999999999999999999986432111 0000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
......+ ..+......+.+++.+||..+|++|||+.++++.
T Consensus 215 ~~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 215 ILKGQYP----PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HhcCCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000011 1222333458899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=286.28 Aligned_cols=258 Identities=27% Similarity=0.429 Sum_probs=203.6
Q ss_pred eeecHHHHHHHhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEE
Q 006785 212 IRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGY 289 (631)
Q Consensus 212 ~~~s~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~ 289 (631)
......+|+. +..||.|..|.||++..+. |..+|||.+......++...++..++++.+- ..|.||+.+||
T Consensus 87 ~~~dindl~~-------l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~Gy 159 (391)
T KOG0983|consen 87 YQADINDLEN-------LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGY 159 (391)
T ss_pred cccChHHhhh-------HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeE
Confidence 3444555554 5679999999999998765 8999999999887777777888999988766 48999999999
Q ss_pred eeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCe
Q 006785 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 369 (631)
Q Consensus 290 ~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 369 (631)
+.. +...++.||.| ..-+..+|.. ..+++++..+-++...++.||.||.+++ .|+|||+||+|||+|+.|++
T Consensus 160 Fi~----n~dV~IcMelM-s~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~Gni 231 (391)
T KOG0983|consen 160 FIT----NTDVFICMELM-STCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNI 231 (391)
T ss_pred Eee----CchHHHHHHHH-HHHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCE
Confidence 986 44568889998 3445555543 4567899989999999999999999876 59999999999999999999
Q ss_pred EEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhc---CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchh
Q 006785 370 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 446 (631)
Q Consensus 370 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~---~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~ 446 (631)
||+|||++-++.+.. ...+..|-+.|||||.+.- ..|..++||||||+.|+||.||+.||.......+...
T Consensus 232 KlCDFGIsGrlvdSk------AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt 305 (391)
T KOG0983|consen 232 KLCDFGISGRLVDSK------AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT 305 (391)
T ss_pred Eeecccccceeeccc------ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH
Confidence 999999998876543 3345569999999999863 4689999999999999999999999976544322111
Q ss_pred hhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 447 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.++.+.+ |.+.+.. ..+..+.+++..||.+|+.+||.+.++++.
T Consensus 306 ------------kvln~eP-P~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 306 ------------KVLNEEP-PLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ------------HHHhcCC-CCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1122222 4443321 245669999999999999999999999874
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=301.93 Aligned_cols=268 Identities=19% Similarity=0.252 Sum_probs=193.5
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccC-CCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeCC
Q 006785 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 308 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~ 308 (631)
+.+|.|+++.||++.. +++.||||++... ........+.+|+++++.++|+||+++++++.. ....+++|||++
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~----~~~~~~~~e~~~ 82 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV----DSELYVVSPLMA 82 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec----CCeEEEEEeccC
Confidence 3455555655666554 5899999999765 334445569999999999999999999998875 457799999999
Q ss_pred CCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCC--
Q 006785 309 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP-- 386 (631)
Q Consensus 309 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~-- 386 (631)
+|+|.+++.......+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 999999998655556899999999999999999999998 999999999999999999999999998765432211
Q ss_pred CCCCCCcccccCCCCCCchhhhc--CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhh-------hcccccccc
Q 006785 387 SCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL-------WATPRLQDS 457 (631)
Q Consensus 387 ~~~~~~~~~~Gt~~Y~APE~~~~--~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~-------~~~~~~~~~ 457 (631)
..........++..|+|||++.. ..++.++||||||+++|||++|+.||............. +........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 11112234457889999999875 358899999999999999999999997532211000000 000000000
Q ss_pred cccccc----cCCCC----CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 458 GTVISE----LPDPR----LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 458 ~~~~~~----~~~~~----l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
...... ..++. .....+......+.+|+.+||+.||++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 00000 1112233445668899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=289.17 Aligned_cols=250 Identities=27% Similarity=0.437 Sum_probs=200.7
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
.|...+.||+|++|.||++... +++.+++|++..... .....+.+|+.+++.++|+|++++++++.. ....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLK----KDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEec----CCeEEEE
Confidence 3667789999999999999986 589999999976543 345568999999999999999999998876 4567999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
+||+++++|.+++.... ..+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 76 MEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred EecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 99999999999987642 46899999999999999999999988 999999999999999999999999998776543
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 463 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (631)
.. .....|+..|+|||++....++.++||||||+++|+|++|+.||............ ..
T Consensus 152 ~~------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--------------~~ 211 (253)
T cd05122 152 KA------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI--------------AT 211 (253)
T ss_pred cc------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH--------------Hh
Confidence 21 23456889999999999888999999999999999999999998643211110000 00
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 464 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 464 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
...+.+. .+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 212 ~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 212 NGPPGLR--NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cCCCCcC--cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0001111 011123458899999999999999999999763
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=301.67 Aligned_cols=254 Identities=27% Similarity=0.407 Sum_probs=193.8
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcceEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
++|...+.||+|+||.||+|++.+ ++.||||+++..........+..|+.++.++ .||||+++++++.+ ....|
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~ 90 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT----DSDVF 90 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec----CCeEE
Confidence 567778999999999999999875 8999999997654444445577788877777 59999999999876 45789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHh-cCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
+||||+ +++|.+++... ...+++..+..++.|++.||+|||+ .+ |+||||+|+||++++++.+||+|||++...
T Consensus 91 ~v~e~~-~~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 91 ICMELM-STCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred EEeecc-CcCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999998 45787776543 2468999999999999999999997 46 999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCC----CCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGR----ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~----~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
.... ......++..|+|||++.... ++.++||||||+++|||++|+.||.......+ ......
T Consensus 166 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~------ 232 (296)
T cd06618 166 VDSK------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE-VLTKIL------ 232 (296)
T ss_pred cCCC------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH-HHHHHh------
Confidence 4321 112235788999999987554 78999999999999999999999964221110 000000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
... .+... ........+.+|+.+||..||++||++.++++.-.
T Consensus 233 -----~~~-~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 233 -----QEE-PPSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred -----cCC-CCCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 000 00000 00112345889999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=299.29 Aligned_cols=265 Identities=26% Similarity=0.350 Sum_probs=196.5
Q ss_pred ccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCCcceeEEeeeccCCcceEEEE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
|.+.+.||+|+||+||+|...+ ++.||||++.............+|+..+++++ |+|++++++++.. ....++|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~----~~~~~lv 76 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE----NDELYFV 76 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc----CCcEEEE
Confidence 5567889999999999999864 78999999876543333334678999999998 9999999998876 5577999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
|||+ +|+|.+++.......+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 9999 889999997654456899999999999999999999998 999999999999999999999999999865432
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhh----------hhccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV----------LWATP 452 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~----------~~~~~ 452 (631)
. ......|+..|+|||++.. ..++.++||||||+++|||++|+.||............ .|...
T Consensus 153 ~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07830 153 P------PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG 226 (283)
T ss_pred C------CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhH
Confidence 1 1223458899999998754 45799999999999999999999998654321111000 00000
Q ss_pred c-cc-cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 453 R-LQ-DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 453 ~-~~-~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. +. .....+.......+....+ .....+.+++.+||+.+|++|||+.|++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 227 YKLASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhhhccccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0 00 0000000000000000011 113558899999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=295.36 Aligned_cols=267 Identities=24% Similarity=0.349 Sum_probs=196.4
Q ss_pred ccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCC-hHHHHHHHHHHHHhc---CCCCCcceeEEeeeccC-Ccce
Q 006785 226 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRL---HHCHVVPLVGYCSEFRG-KRAM 299 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~-~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~-~~~~ 299 (631)
|++.+.||+|+||.||+|+++. ++.||||+++...... ....+.+|+.+++++ +|+|++++++++..... ....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5667899999999999999875 8999999997543222 233466788877766 59999999999876432 1224
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.+++|||++ ++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 799999996 58999987654446999999999999999999999998 99999999999999999999999999977
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhh----------hh
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV----------LW 449 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~----------~~ 449 (631)
..... ......++..|+|||++.+..++.++||||||+++|||++|+.||............ .|
T Consensus 157 ~~~~~------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 157 YSFEM------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW 230 (287)
T ss_pred ccCCc------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhc
Confidence 64332 112335788999999999999999999999999999999999998653321110000 00
Q ss_pred cccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 450 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
....... ............ ..........+.+++.+||+.||.+||++.++++
T Consensus 231 ~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLP-RSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccc-hhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000 000000000000 1112234456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=299.23 Aligned_cols=269 Identities=25% Similarity=0.343 Sum_probs=197.2
Q ss_pred ccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
|.+.+.||.|+||.||+|+..+ ++.+|||++.... .......+.+|+++++.++|+|++++++++.... ....++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG--KGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC--CCcEEEE
Confidence 5567889999999999998764 8999999998653 2333455889999999999999999999987631 2578999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
|||++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 79 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 79 FEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 99996 58999886542 45899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhc-ccccccccccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA-TPRLQDSGTVI 461 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 461 (631)
.. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||............... ...........
T Consensus 154 ~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 154 NS----ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred Cc----ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence 21 11223357889999998765 45789999999999999999999999754322111100000 00000000000
Q ss_pred ccc-----CCC------CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 462 SEL-----PDP------RLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 462 ~~~-----~~~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..+ ..+ .+...+...++..+.+++.+||..+|.+||++.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000 000 00000111124568899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=294.78 Aligned_cols=245 Identities=23% Similarity=0.301 Sum_probs=186.7
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHH-hcCCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLS-RLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
+.||.|+||.||+|... +|+.||||++..... ......+..|..++. ..+|+|++++++++.. ....|+|||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e 77 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS----KDYLYLVME 77 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc----CCeEEEEEe
Confidence 46899999999999875 489999999865321 112223455555544 4589999999999875 457899999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCC
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 385 (631)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++....
T Consensus 78 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 149 (260)
T cd05611 78 YLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--- 149 (260)
T ss_pred ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc---
Confidence 99999999999754 45899999999999999999999998 99999999999999999999999999876432
Q ss_pred CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccC
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (631)
.....|+..|+|||.+.+..++.++||||||+++|||++|..||.......... .... ...
T Consensus 150 ------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~----------~~~- 210 (260)
T cd05611 150 ------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFD--NILS----------RRI- 210 (260)
T ss_pred ------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHHh----------ccc-
Confidence 123458899999999988889999999999999999999999996432211000 0000 000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 466 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 466 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
..........+..+.+++.+||+.+|++||++.++.+.|.
T Consensus 211 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 211 --NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred --CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 0000111223455889999999999999998766655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=292.76 Aligned_cols=249 Identities=27% Similarity=0.333 Sum_probs=200.2
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+|++.+.||+|+||.||+++.. +++.+|||.+.... .......+.+|+.+++.++|+||+++++++.. ....++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD----GNKLCI 76 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc----CCEEEE
Confidence 4677889999999999999865 58899999987543 22334558899999999999999999988875 457899
Q ss_pred EEeeCCCCChHhhhhccc--cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 303 VFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++...
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~ 153 (256)
T cd08530 77 VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVL 153 (256)
T ss_pred EehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhh
Confidence 999999999999986522 245899999999999999999999998 999999999999999999999999999776
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
.... .....|++.|+|||.+.+..++.++|+||||+++|||++|+.||.......... .
T Consensus 154 ~~~~-------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~--~------------ 212 (256)
T cd08530 154 KKNM-------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY--K------------ 212 (256)
T ss_pred ccCC-------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H------------
Confidence 5431 122357889999999999889999999999999999999999996433211000 0
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+... .....+......+.+++.+||..+|++||++.++++.
T Consensus 213 ~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 213 VQRG----KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HhcC----CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 0112233445668999999999999999999999763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=298.71 Aligned_cols=207 Identities=25% Similarity=0.334 Sum_probs=168.3
Q ss_pred CccccceeeeeCceEEEEEEECC---CcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLTD---GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
+|.+.+.||+|+||.||+|.... ++.||||.+.... .......+.+|+.++++++||||+++++++.... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA--DKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC--Cce
Confidence 46778899999999999999754 7899999997632 1223345788999999999999999999987632 257
Q ss_pred EEEEEeeCCCCChHhhhhccc---cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC----CCCeEEe
Q 006785 300 RLLVFEFMPNGNLRDCLDGVL---VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE----NLNAKIT 372 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~----~~~~kL~ 372 (631)
.++||||++ ++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 79 VYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred EEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEEC
Confidence 899999996 57877774322 135889999999999999999999998 999999999999999 8999999
Q ss_pred ccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCcc
Q 006785 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSI 439 (631)
Q Consensus 373 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~ 439 (631)
|||++......... ........+|..|+|||++.+. .++.++||||||+++|+|++|+.||....
T Consensus 155 Dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 155 DLGLARLFNAPLKP--LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred CCccccccCCCccc--ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 99999876443211 1122345688999999988764 57999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=302.97 Aligned_cols=250 Identities=25% Similarity=0.350 Sum_probs=202.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
.+.|..-++||+||||.||-...+ +|+.+|.|.+..... .......+.|-.+|.+++.+.||.+--.+.. .+.
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT----kd~ 259 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET----KDA 259 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC----CCc
Confidence 367888899999999999999765 499999998865422 2333457899999999999999987654443 667
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
+++|+..|+||||.-+|.+.....|++..++-++.+|+.||++||+.. ||.|||||+|||||+.|+++|+|+|||..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEe
Confidence 899999999999999998776677999999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
+.... .....+||.+|||||++.++.|+...|.|||||+||||+.|+.||.....+....-+.
T Consensus 337 i~~g~------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd----------- 399 (591)
T KOG0986|consen 337 IPEGK------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD----------- 399 (591)
T ss_pred cCCCC------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH-----------
Confidence 76543 2334489999999999999999999999999999999999999996544332110000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 500 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 500 (631)
+.+.. -...+++..++...+|....|+.||.+|.-..
T Consensus 400 --rr~~~--~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 400 --RRTLE--DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred --HHHhc--chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 00000 01235666667788899999999999997443
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=323.53 Aligned_cols=202 Identities=19% Similarity=0.228 Sum_probs=158.6
Q ss_pred HhcCccccceeeeeCceEEEEEEECC--CcEEEEEEec--------------c--CCCCChHHHHHHHHHHHHhcCCCCC
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLTD--GRIVAVKRFK--------------T--QGGPNADSVFLTEVDMLSRLHHCHV 283 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~~--g~~vAVK~l~--------------~--~~~~~~~~~~~~E~~~l~~l~H~ni 283 (631)
..++|.+.+.||+|+||+||++.++. +..+++|.+. . .........|.+|+.+|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999987642 2222222111 0 0112233458899999999999999
Q ss_pred cceeEEeeeccCCcceEEEEEeeCCCCChHhhhhccc---cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCC
Q 006785 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL---VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 360 (631)
Q Consensus 284 v~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~N 360 (631)
+++++++.. ....|+|++++ +++|.+++.... ........+..|+.|++.||+|||+++ |+||||||+|
T Consensus 226 v~l~~~~~~----~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~N 297 (501)
T PHA03210 226 LKIEEILRS----EANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLEN 297 (501)
T ss_pred CcEeEEEEE----CCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 999999876 45679999999 568888775322 112345667889999999999999998 9999999999
Q ss_pred eeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCC
Q 006785 361 ILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 435 (631)
Q Consensus 361 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~ 435 (631)
|||+.++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||+||||++|..++
T Consensus 298 ILl~~~~~vkL~DFGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 298 IFLNCDGKIVLGDFGTAMPFEKERE----AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred EEECCCCCEEEEeCCCceecCcccc----cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999987654321 1223457999999999999999999999999999999999987644
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=287.78 Aligned_cols=248 Identities=27% Similarity=0.465 Sum_probs=200.4
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+|+..+.||+|++|.||++... +++.||||.+...... .....+.+|++++++++|+|++++++++.. ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET----SDSLYI 76 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe----CCEEEE
Confidence 4677889999999999999876 4789999999765332 344568999999999999999999998875 457899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 77 v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 151 (254)
T cd06627 77 ILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLND 151 (254)
T ss_pred EEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence 99999999999999764 45899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ..+...
T Consensus 152 ~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~----~~~~~~---------- 212 (254)
T cd06627 152 VSK-----DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA----ALFRIV---------- 212 (254)
T ss_pred Ccc-----cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH----HHHHHh----------
Confidence 321 1233468899999999988888999999999999999999999986432111 011000
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
....+ ..+...+..+.+++.+||..+|++||++.+++.
T Consensus 213 ~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 213 QDDHP----PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ccCCC----CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 00011 122233455889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=293.35 Aligned_cols=242 Identities=26% Similarity=0.354 Sum_probs=185.4
Q ss_pred eeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHH---HHhcCCCCCcceeEEeeeccCCcceEEEEE
Q 006785 231 IVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDM---LSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (631)
Q Consensus 231 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~~E~~~---l~~l~H~niv~l~g~~~~~~~~~~~~~lV~ 304 (631)
.||+|+||.||+|... +++.||||.+...... .....+..|..+ ++...||||+++++++.. ....++||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~----~~~~~~v~ 76 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----PDKLSFIL 76 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec----CCEEEEEE
Confidence 3899999999999875 4889999998754222 222224445443 444589999999988775 45789999
Q ss_pred eeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCC
Q 006785 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (631)
Q Consensus 305 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~ 384 (631)
||++||+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++..+...
T Consensus 77 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~- 150 (278)
T cd05606 77 DLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 150 (278)
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc-
Confidence 999999999988653 45899999999999999999999998 999999999999999999999999998755322
Q ss_pred CCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccc
Q 006785 385 LPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 463 (631)
Q Consensus 385 ~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (631)
......|+..|+|||++..+ .++.++||||||+++|||++|+.||............. ...
T Consensus 151 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~------------~~~ 212 (278)
T cd05606 151 ------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR------------MTL 212 (278)
T ss_pred ------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH------------Hhh
Confidence 11234689999999998754 68999999999999999999999997542221111000 000
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006785 464 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQ 504 (631)
Q Consensus 464 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 504 (631)
...+ ..+...+..+.+++.+||..+|.+|| ++.++++
T Consensus 213 ~~~~----~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 213 TMAV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ccCC----CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 0111 12222345588999999999999999 9999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=298.59 Aligned_cols=275 Identities=25% Similarity=0.324 Sum_probs=198.9
Q ss_pred HHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeecc----
Q 006785 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR---- 294 (631)
Q Consensus 221 ~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 294 (631)
.+.++|++.+.||+|+||.||+|.++ +|+.||||+++.... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678899999999999999999986 489999999975432 223345788999999999999999999887533
Q ss_pred --CCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEe
Q 006785 295 --GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 372 (631)
Q Consensus 295 --~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~ 372 (631)
......++|+||+++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 112368999999975 787777654 345899999999999999999999998 9999999999999999999999
Q ss_pred ccCceeecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh-c
Q 006785 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW-A 450 (631)
Q Consensus 373 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~-~ 450 (631)
|||++........ .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............. .
T Consensus 159 dfg~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~ 234 (302)
T cd07864 159 DFGLARLYNSEES----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC 234 (302)
T ss_pred cccccccccCCcc----cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 9999987654321 11122346788999998865 4578999999999999999999999964332111100000 0
Q ss_pred cccccccccccccc-----CC------CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 451 TPRLQDSGTVISEL-----PD------PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 451 ~~~~~~~~~~~~~~-----~~------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..........+.+. .+ ...... ....+..+.+++..||+.+|.+||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000000000000 00 000000 01123458899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=303.12 Aligned_cols=272 Identities=21% Similarity=0.285 Sum_probs=195.9
Q ss_pred CccccceeeeeCceEEEEEEECC---CcEEEEEEeccCCC-CChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcce
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 299 (631)
+|...+.||+|+||.||++.... +..||||++..... ......+.+|+.+++++ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 46778899999999999998753 67899999875322 22344588999999999 699999999876544333456
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.|+++||+. ++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 789999995 7999988643 45899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhh-----------
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV----------- 447 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~----------- 447 (631)
........ ........||..|+|||++.+ ..++.++||||||+++|+|++|+.||............
T Consensus 155 ~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 155 FSENPGEN-AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred cccccccc-cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 65432211 112234578999999998865 46899999999999999999999998653311100000
Q ss_pred --hhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 448 --LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 448 --~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
.+..+................+.. ........+.+++.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000000000000000 00112345889999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=304.71 Aligned_cols=270 Identities=23% Similarity=0.337 Sum_probs=196.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC--Ccc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRA 298 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~~ 298 (631)
.++|...+.||+|+||.||+|... +|+.||||++.... .......+.+|+.+++.++||||+++++++..... ...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999875 58999999987532 22233458899999999999999999998864321 123
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..++|+||+. .+|..++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 5699999995 57777653 34899999999999999999999998 9999999999999999999999999987
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccc----
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR---- 453 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~---- 453 (631)
..... .....++..|+|||++.+ ..++.++||||||+++|||++|+.||..................
T Consensus 166 ~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07879 166 HADAE--------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE 237 (342)
T ss_pred CCCCC--------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 54321 223467889999999876 46899999999999999999999999754321111100000000
Q ss_pred ----cccc--ccc---ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhhh
Q 006785 454 ----LQDS--GTV---ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI--LSTI 509 (631)
Q Consensus 454 ----~~~~--~~~---~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i 509 (631)
+... ... ........+...++ .....+.+|+.+||+.||++||++.+++.. ++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFP-KASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhc-CCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0000 000 00000000000001 123457899999999999999999999853 5444
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=291.47 Aligned_cols=248 Identities=20% Similarity=0.234 Sum_probs=190.1
Q ss_pred HHHHHhcCcccccee--eeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeec
Q 006785 218 ALEHATDKFSGSNIV--GQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 293 (631)
Q Consensus 218 ~l~~a~~~f~~~~~L--G~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 293 (631)
+.....++|.+.+.+ |+|+||.||++..+ ++..+|+|.+....... .|+.....+ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~- 80 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTT- 80 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEec-
Confidence 344445677777776 99999999999865 58899999987542211 122222223 79999999999876
Q ss_pred cCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC-CeEEe
Q 006785 294 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKIT 372 (631)
Q Consensus 294 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kL~ 372 (631)
....|+||||+++|+|.+++... ..+++.++..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+
T Consensus 81 ---~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~ 152 (267)
T PHA03390 81 ---LKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLC 152 (267)
T ss_pred ---CCeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEe
Confidence 44789999999999999999764 36999999999999999999999998 99999999999999988 99999
Q ss_pred ccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccc
Q 006785 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 452 (631)
Q Consensus 373 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 452 (631)
|||+++..... ....|+..|+|||++.+..++.++||||||+++|||++|+.||....... .....+..
T Consensus 153 dfg~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~- 221 (267)
T PHA03390 153 DYGLCKIIGTP---------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLK- 221 (267)
T ss_pred cCccceecCCC---------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHH-
Confidence 99998765422 22358899999999998889999999999999999999999997432211 11111100
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 006785 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-MSEVVQ 504 (631)
Q Consensus 453 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 504 (631)
.. .. ....+...+..+.+++.+||+.+|.+||+ +.++++
T Consensus 222 ----------~~-~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 222 ----------RQ-QK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----------hh-cc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 00 00122234455899999999999999996 688875
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=299.16 Aligned_cols=250 Identities=26% Similarity=0.375 Sum_probs=194.1
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.|+..+.||+|+||.||+|+.. ++..||||.+.... .......+.+|+++++.++|+|++++++++.. ....+
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 91 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR----EHTAW 91 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc----CCeeE
Confidence 3566678999999999999975 48899999986432 22233458899999999999999999999876 45779
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+. |+|.+++... ...+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++....
T Consensus 92 lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 92 LVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 9999996 6888877543 245899999999999999999999998 9999999999999999999999999987653
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhh---cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
.. ....|++.|+|||++. ...++.++||||||+++|||++|..||.......... .+.
T Consensus 167 ~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~-------- 227 (308)
T cd06634 167 PA---------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIA-------- 227 (308)
T ss_pred Cc---------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH--HHh--------
Confidence 22 2345889999999975 3567889999999999999999999986432111000 000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
....+.. .+......+.+|+.+||+.+|++||++.++++.....
T Consensus 228 ----~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 228 ----QNESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred ----hcCCCCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 0000111 1122345588999999999999999999999865433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=297.50 Aligned_cols=243 Identities=24% Similarity=0.394 Sum_probs=192.7
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeCC
Q 006785 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 308 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~ 308 (631)
..||+|+||.||++... +|+.||||++.... ......+.+|+.+++.++|+|++++++++.. ....++||||++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~ 100 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLV----GDELWVVMEFLE 100 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEe----CCEEEEEEecCC
Confidence 56999999999999875 58999999986432 3345568999999999999999999998876 557899999999
Q ss_pred CCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCC
Q 006785 309 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 388 (631)
Q Consensus 309 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 388 (631)
+++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 101 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~---- 170 (292)
T cd06657 101 GGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV---- 170 (292)
T ss_pred CCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc----
Confidence 9999998754 34899999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccCCCC
Q 006785 389 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 468 (631)
Q Consensus 389 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (631)
.......|++.|+|||++....++.++||||||+++|+|++|..||........... +.....+.
T Consensus 171 -~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~--------------~~~~~~~~ 235 (292)
T cd06657 171 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM--------------IRDNLPPK 235 (292)
T ss_pred -ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------------HHhhCCcc
Confidence 112334688999999999888899999999999999999999999864321110000 00001111
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 469 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 469 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
+.. ....+..+.+++.+||+.+|.+||++.++++
T Consensus 236 ~~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 236 LKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred cCC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 100 1112334788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=295.83 Aligned_cols=252 Identities=24% Similarity=0.341 Sum_probs=193.3
Q ss_pred CccccceeeeeCceEEEEEEEC----CCcEEEEEEeccCC---CCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCC
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGK 296 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 296 (631)
+|+..+.||.|+||.||++... +|..||+|++.... .....+.+.+|+.++.++ +|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT---- 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec----
Confidence 3677889999999999999863 68999999987532 122335578899999999 69999999988765
Q ss_pred cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCc
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGl 376 (631)
....|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 151 (290)
T cd05613 77 DTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 151 (290)
T ss_pred CCeEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcc
Confidence 45779999999999999999754 45889999999999999999999998 99999999999999999999999999
Q ss_pred eeecccCCCCCCCCCCcccccCCCCCCchhhhcC--CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccc
Q 006785 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 454 (631)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~--~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~ 454 (631)
+........ .......|+..|+|||++... .++.++||||||+++|+|++|..||.......... ..
T Consensus 152 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~--~~----- 220 (290)
T cd05613 152 SKEFHEDEV----ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA--EI----- 220 (290)
T ss_pred ceecccccc----cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHH--HH-----
Confidence 987543321 112235689999999998753 46889999999999999999999985322111000 00
Q ss_pred ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006785 455 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQ 504 (631)
Q Consensus 455 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 504 (631)
...+... ...++......+.+++.+||+.+|++|| ++.+++.
T Consensus 221 ------~~~~~~~--~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 221 ------SRRILKS--EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ------HHHhhcc--CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0000000 0112333445588999999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=304.73 Aligned_cols=271 Identities=23% Similarity=0.316 Sum_probs=198.6
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC-Ccce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG-KRAM 299 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~~~ 299 (631)
.++|.+.+.||+|+||+||+|... +++.||||.+.... .......+.+|+.+++.++|+||+++++++..... ....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457888999999999999999875 58999999987532 22233457889999999999999999998765321 1235
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.|+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999995 7899988653 45899999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhh-hh-cccc---
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-LW-ATPR--- 453 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~~-~~~~--- 453 (631)
..... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||............ .. ..+.
T Consensus 158 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 158 TSEKG-----DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232 (337)
T ss_pred cCCCc-----ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 54321 11223457899999998875 56899999999999999999999999643211100000 00 0000
Q ss_pred ---cc--ccccccc---ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 454 ---LQ--DSGTVIS---ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 454 ---~~--~~~~~~~---~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.. .....+. ...++... ...+..+..+.+++.+||+.+|++|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00 0000000 00011110 0112234558899999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=298.68 Aligned_cols=277 Identities=25% Similarity=0.334 Sum_probs=197.7
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC-hHHHHHHHHHHHHhcCCCCCcceeEEeeeccC----C
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG----K 296 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----~ 296 (631)
.++|.+.+.||+|+||.||+|.+. +++.||||++....... ....+.+|++++++++||||+++++++.+... .
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467888999999999999999976 48999999986543222 22347889999999999999999988765332 2
Q ss_pred cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCc
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGl 376 (631)
...+++||||+. ++|...+... ...+++..+..++.|+++||.|||+.+ |+|+||||+|||+++++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence 446799999995 5787777643 245999999999999999999999998 99999999999999999999999999
Q ss_pred eeecccCCCCCC------CCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh
Q 006785 377 AKRLKADGLPSC------SSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 449 (631)
Q Consensus 377 a~~~~~~~~~~~------~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~ 449 (631)
++.......... ........|++.|+|||++.+. .++.++||||||+++|||++|+.||..............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 986543321110 1112334678899999988654 589999999999999999999999865432211111000
Q ss_pred --cccccc--cccccccccCCCCCCCCCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 450 --ATPRLQ--DSGTVISELPDPRLKGDFP-------KEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 450 --~~~~~~--~~~~~~~~~~~~~l~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
..+.-. .....+....+.......+ ......+.+++.+||+.||.+|||+.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000 0000000000000000011 112245889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=293.48 Aligned_cols=248 Identities=28% Similarity=0.387 Sum_probs=193.8
Q ss_pred eeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeCC
Q 006785 232 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 308 (631)
Q Consensus 232 LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~ 308 (631)
||.|+||.||++++.+ |+.||+|.+..... ......+.+|++++++++||||+++++.+.. ....|+||||++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~lv~e~~~ 76 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG----KKNLYLVMEYLP 76 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec----CcEEEEEEecCC
Confidence 6899999999999875 99999999875422 2344568899999999999999999988764 557899999999
Q ss_pred CCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCC--
Q 006785 309 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP-- 386 (631)
Q Consensus 309 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~-- 386 (631)
+++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 77 ~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 77 GGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 99999999764 36899999999999999999999998 999999999999999999999999998765432110
Q ss_pred -CCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccC
Q 006785 387 -SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465 (631)
Q Consensus 387 -~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (631)
..........++..|+|||.+.....+.++||||||+++|+|++|..||........... +.
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~-----------------~~ 214 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQN-----------------IL 214 (265)
T ss_pred ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----------------Hh
Confidence 000122335688899999999888899999999999999999999999964432111000 00
Q ss_pred CCCCCCCCCHH--HHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 466 DPRLKGDFPKE--EMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 466 ~~~l~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
.... ..+.. .+..+..++.+||+.+|.+|||+..+.+.|.
T Consensus 215 ~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 215 NGKI--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred cCCc--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0000 01111 2455889999999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=296.19 Aligned_cols=256 Identities=24% Similarity=0.316 Sum_probs=196.7
Q ss_pred CccccceeeeeCceEEEEEEEC----CCcEEEEEEeccCC---CCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCC
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGK 296 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 296 (631)
+|...+.||+|+||.||++... +++.||||.++... .......+.+|+.++.++ +||||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~---- 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT---- 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec----
Confidence 3667889999999999999753 47889999987432 122334588999999999 69999999988764
Q ss_pred cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCc
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGl 376 (631)
....++||||+++|+|.+++... ..+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~ 151 (288)
T cd05583 77 DTKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGL 151 (288)
T ss_pred CCEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcc
Confidence 45679999999999999998653 45899999999999999999999988 99999999999999999999999999
Q ss_pred eeecccCCCCCCCCCCcccccCCCCCCchhhhcCC--CCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccc
Q 006785 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR--ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 454 (631)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~--~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~ 454 (631)
++.+..... .......|+..|+|||.+.+.. .+.++||||||+++|||++|..||.......... ....
T Consensus 152 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--~~~~--- 222 (288)
T cd05583 152 SKEFLAEEE----ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS--EISR--- 222 (288)
T ss_pred ccccccccc----cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHH--HHHH---
Confidence 876543321 1122345889999999987655 7889999999999999999999985322111000 0000
Q ss_pred ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006785 455 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508 (631)
Q Consensus 455 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 508 (631)
..... .+ ..+......+.+++.+||+.+|++|||+.++.+.|..
T Consensus 223 ----~~~~~--~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 223 ----RILKS--KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ----HHHcc--CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 00000 11 1222233458899999999999999999988887764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=338.27 Aligned_cols=260 Identities=28% Similarity=0.365 Sum_probs=207.8
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEE-CCCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCC
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 296 (631)
+...+-+|.....||.|.||.||-|.. .+|...|||-++.... ......+.+|+.+|..|+|||+|+++|+-..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH---- 1305 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH---- 1305 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec----
Confidence 556677888899999999999999985 4599999998875422 3344558899999999999999999998765
Q ss_pred cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCc
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGl 376 (631)
....+|.||||++|+|.+.++.. +-.++.....+..|++.|++|||++| ||||||||.||||+.+|.+|++|||.
T Consensus 1306 Rekv~IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred HHHHHHHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccc
Confidence 45679999999999999998643 33566667778899999999999999 99999999999999999999999999
Q ss_pred eeecccCCCCCCCCCCcccccCCCCCCchhhhcCC---CCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccc
Q 006785 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 453 (631)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~---~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~ 453 (631)
|..+.... ...........||+.|||||++.+.. ...++||||+|||++||+||+.||......-...
T Consensus 1381 a~ki~~~~-~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIM-------- 1451 (1509)
T KOG4645|consen 1381 AVKIKNNA-QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIM-------- 1451 (1509)
T ss_pred eeEecCch-hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHH--------
Confidence 98876542 12223445678999999999997543 5778999999999999999999997554321111
Q ss_pred cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 454 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 454 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..+ ...-.+.+|...+..-.+++..||..||..|.++.|+++.
T Consensus 1452 --------y~V-~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1452 --------YHV-AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --------hHH-hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 111 0111224566777888999999999999999998877664
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=296.79 Aligned_cols=245 Identities=28% Similarity=0.413 Sum_probs=191.2
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
|...+.||+|+||.||+|+.. +|+.||+|++...... .....+.+|+++++.++|||++++++++.+ ....|+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 98 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK----EHTAWL 98 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe----CCEEEE
Confidence 555678999999999999875 4889999998754322 233458899999999999999999999876 457799
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+. |+|.+++... ...+++.++..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 99 v~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 99 VMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP 173 (313)
T ss_pred EEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence 999995 6888887643 245899999999999999999999998 99999999999999999999999999854321
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhh---cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
.....|+..|+|||++. ...++.++||||||+++|||++|..||.............
T Consensus 174 ---------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~----------- 233 (313)
T cd06633 174 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----------- 233 (313)
T ss_pred ---------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-----------
Confidence 22356889999999984 4568889999999999999999999986532211110000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.. ..+.. .....+..+.+|+.+||+.+|.+||++.+++..
T Consensus 234 --~~-~~~~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 234 --QN-DSPTL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --hc-CCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00111 111122348889999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=290.29 Aligned_cols=250 Identities=24% Similarity=0.321 Sum_probs=192.9
Q ss_pred CccccceeeeeCceEEEEEEECC-CcEEEEEEeccC----CCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQ----GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~----~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
+|.+.+.||+|+||.||++++.. +..+++|.++.. ........+..|+.+++.++||||+++++++.+ ...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 76 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE----RDA 76 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc----CCc
Confidence 47778899999999999998754 455666665532 122233457789999999999999999998765 446
Q ss_pred EEEEEeeCCCCChHhhhhcc--ccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 300 RLLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
.++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++ +.++|+|||++
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~ 152 (260)
T cd08222 77 FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVS 152 (260)
T ss_pred eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCce
Confidence 79999999999999988642 2345899999999999999999999998 999999999999986 46999999998
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
....... .......|++.|+|||.+.+..++.++||||||+++|+|++|..||........ ..
T Consensus 153 ~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~---~~--------- 215 (260)
T cd08222 153 RLLMGSC-----DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV---VL--------- 215 (260)
T ss_pred eecCCCc-----ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---HH---------
Confidence 7764321 122334588999999999888889999999999999999999999853221100 00
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.......+ ..+...+..+.+++.+||..+|++||++.++++.
T Consensus 216 --~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 216 --RIVEGPTP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --HHHcCCCC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 00011111 1233444568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=293.84 Aligned_cols=253 Identities=28% Similarity=0.396 Sum_probs=200.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcC-CCCCcceeEEeeeccCCcce
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~ 299 (631)
++|...+.||.|+||.||+|... +|+.||+|++.... .......+.+|++++++++ ||||+++++++.. ...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~----~~~ 76 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD----EEN 76 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC----Cce
Confidence 36788899999999999999876 58999999987532 2233455889999999998 9999999988764 457
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~ 151 (280)
T cd05581 77 LYFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKV 151 (280)
T ss_pred EEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccc
Confidence 89999999999999999764 35999999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCCCCC---------------CCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccc
Q 006785 380 LKADGLPSC---------------SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE 444 (631)
Q Consensus 380 ~~~~~~~~~---------------~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~ 444 (631)
......... ........|+..|+|||++....++.++||||||++++++++|+.||.........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 231 (280)
T cd05581 152 LDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF 231 (280)
T ss_pred cCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 654321100 01223456889999999998888999999999999999999999999654311100
Q ss_pred hhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 006785 445 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM----SEVVQ 504 (631)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~ 504 (631)
..+. .....++...+..+.+++.+||+.+|.+||++ .++++
T Consensus 232 -----------------~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 -----------------QKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -----------------HHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0000 01112233334558899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=292.00 Aligned_cols=266 Identities=23% Similarity=0.315 Sum_probs=198.3
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
|...+.||.|++|.||+|... +++.+|+|++...... .....+.+|+.++++++|+||+++++++.. ....++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~v 76 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH----KGDLYLV 76 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc----CCCEEEE
Confidence 456778999999999999875 5899999998765332 334568899999999999999999998875 4578999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
|||++ ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||.+......
T Consensus 77 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 77 FEFMD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred EeccC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 99996 58988887643 46899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhh--hcc------ccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL--WAT------PRL 454 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~--~~~------~~~ 454 (631)
. .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||............. ... ..+
T Consensus 152 ~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd05118 152 V-----RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF 226 (283)
T ss_pred c-----ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccc
Confidence 2 111234578899999998876 78999999999999999999999986533211100000 000 000
Q ss_pred ccc-cccccccCCCCC--CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 455 QDS-GTVISELPDPRL--KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 455 ~~~-~~~~~~~~~~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
... ............ ........+..+.+++.+||+.||.+||++.+++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 000000000000 011122345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=301.58 Aligned_cols=274 Identities=23% Similarity=0.314 Sum_probs=201.1
Q ss_pred HHHHHHHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeec
Q 006785 216 YSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293 (631)
Q Consensus 216 ~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 293 (631)
..++..++++|.+.+.||+|+||.||+|... +++.||||++.... .......+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 4567778899999999999999999999864 58999999987532 222334588899999999999999999988643
Q ss_pred cC--CcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEE
Q 006785 294 RG--KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 371 (631)
Q Consensus 294 ~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL 371 (631)
.. .....|++++++ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 21 123468889887 8899988864 34899999999999999999999998 999999999999999999999
Q ss_pred eccCceeecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhh-hh
Q 006785 372 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-LW 449 (631)
Q Consensus 372 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~~ 449 (631)
+|||+++..... .....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||............ ..
T Consensus 162 ~dfg~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (345)
T cd07877 162 LDFGLARHTDDE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 233 (345)
T ss_pred eccccccccccc--------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999998764321 223468899999998876 56889999999999999999999998543221100000 00
Q ss_pred cc-------cccccc--cc---cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 450 AT-------PRLQDS--GT---VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 450 ~~-------~~~~~~--~~---~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.. ..+... .. .+..+...... .........+.+++.+||+.||.+||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 000000 00 00001110000 0000123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=302.54 Aligned_cols=273 Identities=21% Similarity=0.296 Sum_probs=195.1
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCC-----
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK----- 296 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~----- 296 (631)
..+|...+.||.|+||.||+|... +|..||+|++..... .....+.+|++++++++||||+++++++......
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 367888999999999999999875 489999999876543 3445688999999999999999999876542211
Q ss_pred -----cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeec-CCCCeE
Q 006785 297 -----RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAK 370 (631)
Q Consensus 297 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~-~~~~~k 370 (631)
....|+||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++ +++.++
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 135799999996 699988864 34899999999999999999999998 99999999999997 456789
Q ss_pred EeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh
Q 006785 371 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 449 (631)
Q Consensus 371 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~ 449 (631)
|+|||+++........ ........|+..|+|||.+.. ..++.++||||||+++|||++|+.||..............
T Consensus 156 l~dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~ 233 (342)
T cd07854 156 IGDFGLARIVDPHYSH--KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233 (342)
T ss_pred ECCcccceecCCcccc--ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999765432111 111123357889999998754 5688899999999999999999999965432211111111
Q ss_pred ccccccc--ccccccc--------cCCCCC-CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 450 ATPRLQD--SGTVISE--------LPDPRL-KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 450 ~~~~~~~--~~~~~~~--------~~~~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..+.... ....... ...+.. ...........+.+|+.+||+.||.+|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000000 0000000 000000 000011233457889999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=300.03 Aligned_cols=273 Identities=24% Similarity=0.310 Sum_probs=201.0
Q ss_pred CccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeecc-CCcceEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR-GKRAMRL 301 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~~~~~ 301 (631)
+|.+.+.||.|+||.||+|+..+ ++.||||++..... ......+.+|+.+++.++|+||+++++++.... ......|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47778999999999999999764 89999999876432 334456899999999999999999999887632 1223679
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||++ ++|.+++... ..+++..+..++.+++.||+|||+.+ |+||||||.|||++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999996 5899988754 36999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh--cccc-----
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPR----- 453 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~----- 453 (631)
..... ........+|..|+|||++.+. .++.++||||||+++|+|++|+.||.............- ..+.
T Consensus 155 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 155 PDEDE--KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ccccc--cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 43210 0112334688999999999887 789999999999999999999999965432111000000 0000
Q ss_pred ---cccccccccccCCC--CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 454 ---LQDSGTVISELPDP--RLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 454 ---~~~~~~~~~~~~~~--~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.......+...... .-........+..+.+++.+||+.+|++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000000000 00000111234558899999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=310.87 Aligned_cols=264 Identities=26% Similarity=0.394 Sum_probs=217.9
Q ss_pred HHHHHHHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeec
Q 006785 216 YSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 293 (631)
Q Consensus 216 ~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 293 (631)
++.+...++.|.+.+.||.|.+|.||+++.. +++.+|||++....+. +++...|.++|+.+ +|||++.++|++...
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~--deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE--EEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc--cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 4445556778888999999999999999854 5899999998876433 34578899999998 899999999998643
Q ss_pred -cCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEe
Q 006785 294 -RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 372 (631)
Q Consensus 294 -~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~ 372 (631)
.+.++++|||||||.+||..|++++..++.+.|..+..|+..+++||.+||... ++|||||-.|||++.++.+||.
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence 345779999999999999999998877788999999999999999999999988 9999999999999999999999
Q ss_pred ccCceeecccCCCCCCCCCCcccccCCCCCCchhhhc-----CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhh
Q 006785 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 447 (631)
Q Consensus 373 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-----~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~ 447 (631)
|||++..+... .....+.+||+.|||||++.. ..|+.++|+||||++-.||--|.+|+...-+..
T Consensus 166 DFGvSaQldsT-----~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr----- 235 (953)
T KOG0587|consen 166 DFGVSAQLDST-----VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR----- 235 (953)
T ss_pred eeeeeeeeecc-----cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-----
Confidence 99999877543 234456789999999999964 347889999999999999999999986432211
Q ss_pred hhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 448 LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..+.-...|.....-|....+.+.+++..||.+|.++||++.++++.
T Consensus 236 -----------aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 236 -----------ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -----------hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 01111223333334578888999999999999999999999999863
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=290.18 Aligned_cols=265 Identities=26% Similarity=0.360 Sum_probs=196.2
Q ss_pred ccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
|+..+.||+|+||.||+|+..+ ++.||+|++.... .......+..|+.++++++|+|++++++++.. ....++|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~~v 76 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT----ERKLYLV 76 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc----CCceEEE
Confidence 4556789999999999999764 8999999998653 22334557899999999999999999998875 4578999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
|||++ ++|.+++.... ..+++..+..++.+++.||+|||+.+ |+||||+|+||++++++.++|+|||+++.....
T Consensus 77 ~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 77 FEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIP 151 (282)
T ss_pred ecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence 99997 69999997642 35899999999999999999999998 999999999999999999999999999776432
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchh----------hhhccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL----------VLWATP 452 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~----------~~~~~~ 452 (631)
.. ......++..|+|||++... .++.++||||||+++|||++|+.||........... ..|...
T Consensus 152 ~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07829 152 LR-----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226 (282)
T ss_pred cc-----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhh
Confidence 21 12223467889999998776 789999999999999999999999865332111000 000000
Q ss_pred -ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 453 -RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 453 -~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+..................++ .....+.+++..||..+|++||++.+++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 227 TKLPDYKPTFPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccccccCccchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000000000000000000111 124558999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.34 Aligned_cols=270 Identities=22% Similarity=0.308 Sum_probs=198.0
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCC
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 296 (631)
+....++|+..+.||+|+||.||+|... +|..||||++..... ......+.+|+.+|++++||||+++++++......
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3345778999999999999999999865 589999999864322 22334588999999999999999999988643211
Q ss_pred --cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEecc
Q 006785 297 --RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 374 (631)
Q Consensus 297 --~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DF 374 (631)
....++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 13468999999 7899988864 35899999999999999999999998 999999999999999999999999
Q ss_pred CceeecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccc
Q 006785 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 453 (631)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~ 453 (631)
|++...... .....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||..................
T Consensus 163 g~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (343)
T cd07880 163 GLARQTDSE--------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGT 234 (343)
T ss_pred ccccccccC--------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 998765321 223457899999999876 45889999999999999999999999643321110000000000
Q ss_pred --------ccc--ccccccccC---CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 454 --------LQD--SGTVISELP---DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 454 --------~~~--~~~~~~~~~---~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
+.. .......+. ...+ ..........+.+++.+|++.||.+|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CCHHHHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 000000000 0000 0011123345789999999999999999999985
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.62 Aligned_cols=265 Identities=23% Similarity=0.313 Sum_probs=197.1
Q ss_pred HHHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 220 EHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 220 ~~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
..++++|+..+.||.|+||.||+|... +++.||||++.... .......+..|+++++.++||||+++++++... .
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~ 82 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP---L 82 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC---C
Confidence 446788999999999999999999865 58999999886432 223345588999999999999999999988642 3
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
...++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||+|+|||+++++.++|+|||++
T Consensus 83 ~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 83 EDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred CcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccc
Confidence 3578999999 6799988864 34788889999999999999999998 999999999999999999999999998
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchh-hhhccc---
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL-VLWATP--- 452 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~-~~~~~~--- 452 (631)
...... .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||........... ..+...
T Consensus 156 ~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 227 (328)
T cd07856 156 RIQDPQ--------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD 227 (328)
T ss_pred cccCCC--------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 754321 123457889999998765 5689999999999999999999999964322110000 000000
Q ss_pred -----cccc-ccccccccCCCCCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 453 -----RLQD-SGTVISELPDPRLKGDFP-----KEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 453 -----~~~~-~~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.... ....+.... .....+ +.....+.+++.+||+.+|++||++.+++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 228 DVINTICSENTLRFVQSLP---KREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhccchhhHHHHhhcc---ccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 000000000 000111 1123568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=285.45 Aligned_cols=248 Identities=26% Similarity=0.321 Sum_probs=199.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC--hHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|..+++||+|.||.|-+++.+ .|+.+|+|+++....-. ....-+.|-.+|+..+||.+..|.-.+. ..+.+
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ----t~drl 243 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ----TQDRL 243 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc----cCceE
Confidence 45777899999999999999865 49999999998763322 2233567899999999999887764443 36688
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
++||||..||.|.-+|.+. +.+++....-+...|+.||.|||+++ ||.||||.+|.|||.+|++||+||||++.-
T Consensus 244 CFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999999999764 55898888999999999999999998 999999999999999999999999999864
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
...+ .....+.|||.|+|||++....|+..+|.|.+||++|||++|++||+......-..++.
T Consensus 319 I~~g-----~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl------------ 381 (516)
T KOG0690|consen 319 IKYG-----DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL------------ 381 (516)
T ss_pred cccc-----ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH------------
Confidence 4332 34567899999999999999999999999999999999999999997654332111111
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQ 504 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 504 (631)
..++ .+|.....+...|+...|.+||.+|. ++.||.+
T Consensus 382 ~ed~-------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 382 MEDL-------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred hhhc-------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 1111 24555556678899999999999995 4555544
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=297.40 Aligned_cols=271 Identities=23% Similarity=0.307 Sum_probs=193.9
Q ss_pred cCccc-cceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC-------------hHHHHHHHHHHHHhcCCCCCcceeE
Q 006785 224 DKFSG-SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-------------ADSVFLTEVDMLSRLHHCHVVPLVG 288 (631)
Q Consensus 224 ~~f~~-~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-------------~~~~~~~E~~~l~~l~H~niv~l~g 288 (631)
++|.. .+.||.|+||.||+|.+. +++.||||.+....... ....+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 34443 467999999999999875 58999999986542221 0124779999999999999999999
Q ss_pred EeeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCC
Q 006785 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 368 (631)
Q Consensus 289 ~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 368 (631)
++.. ....++||||+. |+|.+++... ..+++.....++.|++.||+|||+.+ |+|+||+|+||+++.++.
T Consensus 88 ~~~~----~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 88 VYVE----GDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGI 157 (335)
T ss_pred EEec----CCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCC
Confidence 9875 457899999996 6999998653 34899999999999999999999998 999999999999999999
Q ss_pred eEEeccCceeecccCCCC---------CCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCc
Q 006785 369 AKITDLGMAKRLKADGLP---------SCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (631)
Q Consensus 369 ~kL~DFGla~~~~~~~~~---------~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~ 438 (631)
++|+|||+++........ ..........+++.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999876522110 001111223468899999998764 4689999999999999999999999654
Q ss_pred cccccchhh-hh-cccc---ccccc-----ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 439 ITKGEESLV-LW-ATPR---LQDSG-----TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 439 ~~~~~~~~~-~~-~~~~---~~~~~-----~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
......... .. ..+. +.... ........+... ......+..+.+++.+||+.+|++||++.+++..
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 322111000 00 0000 00000 000000000000 0011223457899999999999999999999874
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=278.00 Aligned_cols=255 Identities=24% Similarity=0.278 Sum_probs=204.1
Q ss_pred HhcCcccc-ceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcc
Q 006785 222 ATDKFSGS-NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 222 a~~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~ 298 (631)
.+++|++. ++||-|-.|.|-....+ .|+.+|+|++.... ...+|+++--.. .|||||.++++|........
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP------KARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH------HHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 35566654 56899999999999876 48999999997542 256888876655 79999999999987766778
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC---CCCeEEeccC
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLG 375 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~~~~kL~DFG 375 (631)
.+++|||.|+||.|+..++.+..+.+++.++-.|..||+.|+.|||+.+ |.||||||+|+|... |-.+||+|||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 8999999999999999999887788999999999999999999999999 999999999999964 4568999999
Q ss_pred ceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccc
Q 006785 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 455 (631)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 455 (631)
+|+.-... ....+..-|+.|.|||++...+|+...|+||+||++|-|++|.+||+........ +
T Consensus 210 FAK~t~~~------~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais-------p--- 273 (400)
T KOG0604|consen 210 FAKETQEP------GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------P--- 273 (400)
T ss_pred cccccCCC------ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC-------h---
Confidence 99875432 2234456799999999999999999999999999999999999999754322100 0
Q ss_pred cccccccccCCCCCCCCCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006785 456 DSGTVISELPDPRLKGDFP----KEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506 (631)
Q Consensus 456 ~~~~~~~~~~~~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 506 (631)
....++.... -.+| ...++...++++.+|..+|.+|.|+.+++..-
T Consensus 274 ---gMk~rI~~gq--y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 274 ---GMKRRIRTGQ--YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred ---hHHhHhhccC--ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 0011111111 1233 34566778999999999999999999998753
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=281.02 Aligned_cols=237 Identities=30% Similarity=0.384 Sum_probs=190.4
Q ss_pred eeeeCceEEEEEEECC-CcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeCC
Q 006785 232 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 308 (631)
Q Consensus 232 LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~ 308 (631)
||.|+||.||++...+ ++.+|+|.+...... .....+..|+.++++++|+||+++++.+.. ....++||||++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~v~e~~~ 76 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT----EEKLYLVLEYAP 76 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec----CCeeEEEEecCC
Confidence 6899999999998764 899999998765332 234468899999999999999999988764 567899999999
Q ss_pred CCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCC
Q 006785 309 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 388 (631)
Q Consensus 309 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 388 (631)
+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---- 147 (250)
T cd05123 77 GGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG---- 147 (250)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC----
Confidence 99999999764 35899999999999999999999988 9999999999999999999999999998764431
Q ss_pred CCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccCCCC
Q 006785 389 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 468 (631)
Q Consensus 389 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (631)
.......++..|+|||.+.+...+.++|+||||+++|+|++|+.||....... .. ..+...
T Consensus 148 -~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~--------------~~~~~~- 208 (250)
T cd05123 148 -SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IY--------------EKILKD- 208 (250)
T ss_pred -CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HH--------------HHHhcC-
Confidence 12234468899999999988889999999999999999999999996432210 00 000000
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 006785 469 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 501 (631)
Q Consensus 469 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 501 (631)
...++...+..+.+++.+||..||++||++.+
T Consensus 209 -~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 209 -PLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred -CCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 01122233455889999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=298.69 Aligned_cols=268 Identities=24% Similarity=0.338 Sum_probs=196.8
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC--Cc
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KR 297 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~ 297 (631)
..++|...+.||+|+||.||+|+.. +++.||||++.... .......+.+|+.+++.++|||++++++++..... ..
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678889999999999999999986 48899999986532 22233457889999999999999999887654221 12
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
...++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence 3479999999 7799999875 45899999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccc---
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR--- 453 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~--- 453 (631)
...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............-....
T Consensus 166 ~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 166 RHTDDE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237 (343)
T ss_pred cccccc--------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence 765422 223457889999998865 46789999999999999999999999643321111000000000
Q ss_pred -----ccc--cccc---ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 454 -----LQD--SGTV---ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 454 -----~~~--~~~~---~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+.. .... +.....+.+.. .....+..+.+++.+||+.+|++|||+.+|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHH-HhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000 0000 00000000000 001124568899999999999999999999763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=314.92 Aligned_cols=146 Identities=26% Similarity=0.356 Sum_probs=128.7
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|.+.+.||+|+||.||+|.+. +++.||||+++.... ......+..|+.++..++||||+++++++.. ....
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~----~~~~ 79 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS----ANNV 79 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE----CCEE
Confidence 57888999999999999999986 589999999975422 2223558899999999999999999988765 4578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
||||||+.+++|.+++... ..+++..++.|+.||+.||.|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 80 ~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999999753 45889999999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=277.58 Aligned_cols=206 Identities=25% Similarity=0.342 Sum_probs=169.7
Q ss_pred cCccccceeeeeCceEEEEEEECC-----CcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
..|+....||+|.+|.||+|.-++ ...+|||+++..... .......+|+.+++.|+||||+.|..++... +
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~---d 100 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH---D 100 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc---C
Confidence 358888999999999999996432 237999999866332 2234478999999999999999999888764 4
Q ss_pred ceEEEEEeeCCCCChHhhhhcc---ccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCC----CCeE
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGV---LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN----LNAK 370 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~----~~~k 370 (631)
...+|++||.+ -+|...|+-. ..+.++...+..|+.||+.|+.|||++. |+||||||.||||..+ |.+|
T Consensus 101 ~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence 46899999995 5999988422 2345899999999999999999999999 9999999999999877 8999
Q ss_pred EeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCc
Q 006785 371 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (631)
Q Consensus 371 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~ 438 (631)
|+|||+++.+...-.+. .....++-|..|.|||.+.+. .|+.+.|||+.|||+.||++-.+-|...
T Consensus 177 IaDlGlaR~~~~plkpl--~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPL--ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred eecccHHHHhhcccccc--ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99999999887543221 234457789999999999875 5899999999999999999987777543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=279.56 Aligned_cols=261 Identities=25% Similarity=0.331 Sum_probs=198.3
Q ss_pred eeeecHHHHHHHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeE
Q 006785 211 IIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVG 288 (631)
Q Consensus 211 ~~~~s~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g 288 (631)
...|+-+.|+. +..||.|+||+|+|-.++ .|+..|||++..........+|+.|.+...+- +-||||+++|
T Consensus 58 ~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 58 LHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred ccccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 34566566665 567999999999999876 49999999999887767777799999876555 8999999999
Q ss_pred EeeeccCCcceEEEEEeeCCCCChHhhhh---ccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC
Q 006785 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 365 (631)
Q Consensus 289 ~~~~~~~~~~~~~lV~E~~~~gsL~~~l~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~ 365 (631)
.+.. ....||.||+| .-||..+-. ......+++..+-.|..-++.||.||.+.- .|||||+||+||||+.
T Consensus 131 a~F~----EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr 203 (361)
T KOG1006|consen 131 ALFS----EGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDR 203 (361)
T ss_pred hhhc----CCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEec
Confidence 8875 44579999999 567766542 222345888888899999999999998764 4999999999999999
Q ss_pred CCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhc--CCCCcccchhhHHHHHHHHHhCCCCCCCcccccc
Q 006785 366 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 443 (631)
Q Consensus 366 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~--~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~ 443 (631)
.|.+||+|||.+-.+... -..+.-.|-..|||||.+.. ..|..+|||||||++|||+.||+.||.......+
T Consensus 204 ~G~vKLCDFGIcGqLv~S------iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfe 277 (361)
T KOG1006|consen 204 HGDVKLCDFGICGQLVDS------IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFE 277 (361)
T ss_pred CCCEeeecccchHhHHHH------HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHH
Confidence 999999999998766542 12233468889999999863 3489999999999999999999999975432111
Q ss_pred -chhhhhcccccccccccccccCCCCCCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 444 -ESLVLWATPRLQDSGTVISELPDPRLKGDF-PKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 444 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
...+... -.|.+..+. ..+....|..++..|+.+|-..||.+.++.++
T Consensus 278 ql~~Vv~g--------------dpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 278 QLCQVVIG--------------DPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHHHHcC--------------CCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 0111111 111221111 12245568999999999999999999998763
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=276.50 Aligned_cols=219 Identities=20% Similarity=0.203 Sum_probs=174.6
Q ss_pred eCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeCCCCChH
Q 006785 235 GGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLR 313 (631)
Q Consensus 235 G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~~gsL~ 313 (631)
|.||.||++.+. +++.||+|++.... .+.+|...+....||||+++++++.. ....++||||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVS----EDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheec----CCeEEEEEecCCCCCHH
Confidence 899999999875 58999999987542 23455566666689999999998775 45789999999999999
Q ss_pred hhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCc
Q 006785 314 DCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393 (631)
Q Consensus 314 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 393 (631)
+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||++...... ..
T Consensus 74 ~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--------~~ 140 (237)
T cd05576 74 SHISKF--LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--------CD 140 (237)
T ss_pred HHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc--------cc
Confidence 998654 35899999999999999999999998 999999999999999999999999987655432 11
Q ss_pred ccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccCCCCCCCCC
Q 006785 394 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDF 473 (631)
Q Consensus 394 ~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 473 (631)
...++..|+|||++....++.++||||+|+++|||++|+.|+....... ..... ...
T Consensus 141 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------------~~~~~----~~~ 197 (237)
T cd05576 141 GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------------NTHTT----LNI 197 (237)
T ss_pred cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------------ccccc----cCC
Confidence 2345778999999988889999999999999999999998874321100 00000 012
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCH
Q 006785 474 PKEEMQIMAYLAKECLQLDPDARPTM 499 (631)
Q Consensus 474 ~~~~~~~l~~li~~cl~~dP~~RPs~ 499 (631)
|......+.+++.+||+.||++||++
T Consensus 198 ~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 198 PEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred cccCCHHHHHHHHHHccCCHHHhcCC
Confidence 22334458899999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=252.61 Aligned_cols=267 Identities=23% Similarity=0.335 Sum_probs=202.2
Q ss_pred CccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCCh-HHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNA-DSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+|...++||+|.+|+||+|+..+ ++.||+|+++-+...+. -...++|+-+|+.++|.|||+++++... +..+-+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs----dkkltl 78 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS----DKKLTL 78 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc----CceeEE
Confidence 35556789999999999998654 89999999986543332 2347899999999999999999987664 557789
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
|+||| ..+|..|.+... ..++...+..++.|+++||.|+|+++ +.||||||.|.||+.||+.|++|||+++.+.-
T Consensus 79 vfe~c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 79 VFEFC-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred eHHHh-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 99999 569999987643 55999999999999999999999998 99999999999999999999999999997753
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCC-CCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccc-cccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPR-LQDSGT 459 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~-~~~~~~ 459 (631)
.- ......+-|..|.+|.++.+.+ |+...|+||-|+|+.||.. |++-|.+.....+..-+.|.... -.+.+.
T Consensus 154 pv-----rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wp 228 (292)
T KOG0662|consen 154 PV-----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWP 228 (292)
T ss_pred ce-----EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCC
Confidence 21 1233446799999999998765 8999999999999999998 55555544433322222222221 123334
Q ss_pred cccccCCCCCCCCCCHH--HH-------HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKE--EM-------QIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~--~~-------~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+..++|-..-..+|.. .+ ..=++|+.+.+.-+|.+|.++++.++.
T Consensus 229 s~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 229 SMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 45555554443333321 11 123578888999999999999988763
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=316.02 Aligned_cols=258 Identities=22% Similarity=0.295 Sum_probs=202.4
Q ss_pred HHHHHHhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCCcceeEEeeec
Q 006785 217 SALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293 (631)
Q Consensus 217 ~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 293 (631)
.++.--.++|.++++||+|+||.|..++.+. ++.||+|+++.-.. ......|..|-++|..-+.+-|++|.-.|.+
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD- 146 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD- 146 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC-
Confidence 3455567889999999999999999999865 89999999976211 1223348899999998889999999866654
Q ss_pred cCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEec
Q 006785 294 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD 373 (631)
Q Consensus 294 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~D 373 (631)
..++|+|||||+||||..+|.... .+++.-+..++..|+-||.-||+.| +|||||||+|||||..|++||+|
T Consensus 147 ---~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 147 ---ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred ---ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeecc
Confidence 678999999999999999998754 5888889999999999999999999 99999999999999999999999
Q ss_pred cCceeecccCCCCCCCCCCcccccCCCCCCchhhh----c-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhh
Q 006785 374 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM----V-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 448 (631)
Q Consensus 374 FGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~----~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~ 448 (631)
||.+-....++... ....+|||-|.+||++. + +.|+..+|.||+||++|||+.|..||+...-.+-+
T Consensus 219 FGsClkm~~dG~V~----s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY---- 290 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVR----SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY---- 290 (1317)
T ss_pred chhHHhcCCCCcEE----eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH----
Confidence 99988877665432 33468999999999996 3 67999999999999999999999999753321111
Q ss_pred hcccccccccccccccCCCCCCCCCC--HHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 006785 449 WATPRLQDSGTVISELPDPRLKGDFP--KEEMQIMAYLAKECLQLDPDARPT---MSEVVQI 505 (631)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 505 (631)
.+|.+-.-...+| ...+....+||...+. +|+.|.. +.++...
T Consensus 291 -------------~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 291 -------------GKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred -------------HHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 1122111111223 2244557777776654 7888887 8777653
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=283.86 Aligned_cols=242 Identities=24% Similarity=0.316 Sum_probs=195.9
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChH--HHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcce
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNAD--SVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~--~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 299 (631)
.+|..+.+||+|+||.|.+|.-+. .+.+|||+++.+..-+.+ +--+.|-.+|... +-|.++++..++.. .+.
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT----mDR 424 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT----MDR 424 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh----hhh
Confidence 467888999999999999998664 678999999876322221 1234577777766 67788898877664 557
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
+|+||||+.||+|.-++++. ..+.+..++-+|..||-||-+||+++ ||.||||.+|||||.+|++||+|||+++.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccc
Confidence 89999999999999999865 45899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
-..++ ....++.||+.|+|||++...+|+..+|.|||||+||||+.|++||++....+-
T Consensus 500 ni~~~-----~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el---------------- 558 (683)
T KOG0696|consen 500 NIFDG-----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---------------- 558 (683)
T ss_pred cccCC-----cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH----------------
Confidence 54433 345678999999999999999999999999999999999999999986543221
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT 498 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs 498 (631)
...+.+.. -.+|...+.+...+.+..|.+.|.+|..
T Consensus 559 -F~aI~ehn--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 559 -FQAIMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -HHHHHHcc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 11111111 1356677777888999999999999953
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=283.79 Aligned_cols=262 Identities=26% Similarity=0.335 Sum_probs=198.4
Q ss_pred cCccccceeeeeCceEEEEEEE-CCCcEEEEEEeccCCCCCh------HHHHHHHHHHHHhcCCCCCcceeEEeeeccCC
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNA------DSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 296 (631)
++|-.+.+||+|||+.||+|.+ ...+.||||+-........ .....+|..|-+.|.||.||++++|+.-.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD--- 539 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD--- 539 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec---
Confidence 4666778899999999999974 4588999998654433222 22367899999999999999999998752
Q ss_pred cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeec---CCCCeEEec
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITD 373 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~---~~~~~kL~D 373 (631)
....+-|+|||+|.+|.-||... +.+++.++..|+.||+.||.||.+.. |+|||-||||.||||- .-|.+||+|
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence 34568999999999999999865 55899999999999999999999884 6799999999999994 457799999
Q ss_pred cCceeecccCCCCCC--CCCCcccccCCCCCCchhhhcC----CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhh
Q 006785 374 LGMAKRLKADGLPSC--SSSPARMQGTFGYFAPEYAMVG----RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 447 (631)
Q Consensus 374 FGla~~~~~~~~~~~--~~~~~~~~Gt~~Y~APE~~~~~----~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~ 447 (631)
|||++....+.+... ........||.+|++||.+.-+ ..+.|+||||.|||+|..+.|+.||......... .
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI--L 694 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI--L 694 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH--H
Confidence 999998876554321 1233456799999999988644 4789999999999999999999999654332111 0
Q ss_pred hhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 448 LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
.. ..+.. ..++.- +.-+........+|++||+..-++|.+..++..
T Consensus 695 qe--NTIlk----AtEVqF-----P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 695 QE--NTILK----ATEVQF-----PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hh--hchhc----ceeccC-----CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 00 00000 011111 111223445788999999999999998887754
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=269.49 Aligned_cols=269 Identities=22% Similarity=0.347 Sum_probs=203.4
Q ss_pred cHHHHHHHhcCccccceeeeeCceEEEEEE-ECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeee
Q 006785 215 SYSALEHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 292 (631)
Q Consensus 215 s~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 292 (631)
+++++-..|+ +.||+|+++.|--++ +.+|..+|||++.+. ....+....+|++++... .|+||++|+.++.+
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 3566666664 579999999999886 567999999999876 345566688999999999 79999999998876
Q ss_pred ccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCC---e
Q 006785 293 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN---A 369 (631)
Q Consensus 293 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~---~ 369 (631)
+...|||||-|.||+|..+|+.. +.|++.++.++..+|+.||.|||.+| |.||||||+|||-..-.. +
T Consensus 148 ----d~~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPv 218 (463)
T KOG0607|consen 148 ----DTRFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPV 218 (463)
T ss_pred ----cceEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCce
Confidence 66789999999999999999865 45999999999999999999999999 999999999999965443 7
Q ss_pred EEeccCceeecccC--CCCCCCCCCcccccCCCCCCchhhh-----cCCCCcccchhhHHHHHHHHHhCCCCCCCccccc
Q 006785 370 KITDLGMAKRLKAD--GLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKG 442 (631)
Q Consensus 370 kL~DFGla~~~~~~--~~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~ 442 (631)
||+||.|....... -.+.......+.+|+..|||||+.. ...|+.+.|.||||||||-|++|.+||.+.-...
T Consensus 219 KiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d 298 (463)
T KOG0607|consen 219 KICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD 298 (463)
T ss_pred eeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc
Confidence 99999997654322 1222223345578999999999874 3458999999999999999999999997654321
Q ss_pred cchhhhhccccccc--ccccccccCCCCCCCCCCHHH----HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 443 EESLVLWATPRLQD--SGTVISELPDPRLKGDFPKEE----MQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 443 ~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~~~----~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
--|.....-. .......|.+. .-++|+.. +.+..+|+...+..|+.+|.++.++++
T Consensus 299 ----CGWdrGe~Cr~CQ~~LFesIQEG--kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 299 ----CGWDRGEVCRVCQNKLFESIQEG--KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ----CCccCCCccHHHHHHHHHHHhcc--CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 0111110000 00011111111 12355433 455678899999999999999999887
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=264.31 Aligned_cols=238 Identities=31% Similarity=0.414 Sum_probs=190.5
Q ss_pred CceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeCCCCChHh
Q 006785 236 GSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD 314 (631)
Q Consensus 236 ~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~ 314 (631)
+||.||+|+..+ |+.+|+|++...........+.+|++.+++++|+|++++++++.. ....+++|||+++++|.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~~l~~e~~~~~~L~~ 76 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED----EDKLYLVMEYCDGGDLFD 76 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee----CCEEEEEEeCCCCCCHHH
Confidence 589999999875 899999999876544435679999999999999999999999876 457799999999999999
Q ss_pred hhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcc
Q 006785 315 CLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394 (631)
Q Consensus 315 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 394 (631)
++.... .+++..+..++.+++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++....... ....
T Consensus 77 ~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~------~~~~ 145 (244)
T smart00220 77 LLKKRG--RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG------LLTT 145 (244)
T ss_pred HHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc------cccc
Confidence 997643 2899999999999999999999998 9999999999999999999999999998765432 2234
Q ss_pred cccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccCCCCCCCCCC
Q 006785 395 MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFP 474 (631)
Q Consensus 395 ~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 474 (631)
..++..|+|||.+....++.++||||||+++|+|++|..||....... ....+ +..........
T Consensus 146 ~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~~--------------~~~~~~~~~~~ 209 (244)
T smart00220 146 FVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFKK--------------IGKPKPPFPPP 209 (244)
T ss_pred ccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHH--------------HhccCCCCccc
Confidence 458889999999998889999999999999999999999986531111 11100 00000000000
Q ss_pred H-HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 475 K-EEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 475 ~-~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
. ..+..+.+++.+||..+|++||++.++++
T Consensus 210 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 210 EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 0 03345888999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=281.85 Aligned_cols=246 Identities=24% Similarity=0.290 Sum_probs=194.3
Q ss_pred cceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEee
Q 006785 229 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 306 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~ 306 (631)
.+.||.|.||+||-|+++ +|+.||||++.+.. ..+....+.+|+.||..++||.||.|..-|.. .+..|+|||-
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET----~ervFVVMEK 644 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET----PERVFVVMEK 644 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC----CceEEEEehh
Confidence 478999999999999876 59999999997653 33444668999999999999999999876654 5678999999
Q ss_pred CCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCC---CCeEEeccCceeecccC
Q 006785 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN---LNAKITDLGMAKRLKAD 383 (631)
Q Consensus 307 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~---~~~kL~DFGla~~~~~~ 383 (631)
+ .|+..+.|-......+++..-.-++.||+.||.|||.++ |+|+||||+||||... -.+||+|||+|+++...
T Consensus 645 l-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 645 L-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred h-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 9 567666664444566888888889999999999999998 9999999999999644 45899999999998754
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 463 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (631)
......+||+.|+|||++....|...-|+||.|||+|--++|..||....+-. ..++.+ .-
T Consensus 721 ------sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQNA-----------aF 781 (888)
T KOG4236|consen 721 ------SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQNA-----------AF 781 (888)
T ss_pred ------hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh--HHhhcc-----------cc
Confidence 34456789999999999999999999999999999999999999995432111 111100 01
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 464 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 464 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+..+ ....+......+||...|+..-.+|.+..+.+..
T Consensus 782 MyPp----~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 782 MYPP----NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred ccCC----CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 1111 1123445557889999999999999998876653
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-33 Score=266.53 Aligned_cols=274 Identities=23% Similarity=0.319 Sum_probs=197.0
Q ss_pred ccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCC-hHHHHHHHHHHHHhcCCCCCcceeEEeeecc----CCcce
Q 006785 226 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR----GKRAM 299 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~~~ 299 (631)
|....+||+|.||.||+|+.++ |+.||+|++--+.... .-...++|+++|..|+|+|++.++..|.... +....
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 3445679999999999998765 7889998765432222 2233689999999999999999998886432 23445
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.|+||++|+ -+|.-+|.... ..++..++..++.++..||.|+|... |+|||+||.|+||+.++.+||+|||+++.
T Consensus 99 ~ylVf~~ce-hDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 99 FYLVFDFCE-HDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeHHHhh-hhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccc
Confidence 899999995 59999887643 45899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh--------c
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--------A 450 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--------~ 450 (631)
+....... ....+..+.|..|.+||.+.+ ..|+.+.|||.-|||+.||++|.+-+++........++.. .
T Consensus 174 fs~~~n~~-kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 174 FSTSKNVV-KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred eecccccC-CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 75543222 123445667999999999886 5689999999999999999999888776544322211110 0
Q ss_pred ccccccccccccccCCCCC-CCCCC--HHH------HHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006785 451 TPRLQDSGTVISELPDPRL-KGDFP--KEE------MQIMAYLAKECLQLDPDARPTMSEVVQIL 506 (631)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~l-~~~~~--~~~------~~~l~~li~~cl~~dP~~RPs~~evl~~L 506 (631)
+|..... .....+.-+.+ .+.+. ++. .+...+|+..++..||.+|+++.+++..-
T Consensus 253 WP~~d~l-pL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 253 WPNVDNL-PLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred CCCcccc-hHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 0100000 00000100000 00000 000 12467899999999999999999998653
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=299.16 Aligned_cols=264 Identities=20% Similarity=0.248 Sum_probs=170.6
Q ss_pred HhcCccccceeeeeCceEEEEEEECC-----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeee-c-c
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE-F-R 294 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~-~ 294 (631)
..++|...+.||+|+||.||+|.+.+ +..||||++..... .+.+..| .+....+.++..++..+.. . .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 45789999999999999999998754 68999999864321 1112221 1222233333332221111 1 1
Q ss_pred CCcceEEEEEeeCCCCChHhhhhccccC------------------CCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCC
Q 006785 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVE------------------GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 356 (631)
Q Consensus 295 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl 356 (631)
......++||||+++++|.+++...... ......+..++.|++.||+|||+.+ |+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcC
Confidence 2345789999999999999998643210 0123345679999999999999998 999999
Q ss_pred CCCCeeecC-CCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcC----------------------CCC
Q 006785 357 KSSNILLDE-NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG----------------------RAS 413 (631)
Q Consensus 357 Kp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~----------------------~~s 413 (631)
||+|||+++ ++.+||+|||+|+.+.... ........||+.|+|||.+... .++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~----~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGI----NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCcccccccc----ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 999999985 5789999999998654322 1223456789999999966422 234
Q ss_pred cccchhhHHHHHHHHHhCCCCCCCccccc-------cchhhhhcccccccccccccccCCCCCCC--CCCHHHHHHHHHH
Q 006785 414 LMSDVFSFGVVLLELITGRQPIHRSITKG-------EESLVLWATPRLQDSGTVISELPDPRLKG--DFPKEEMQIMAYL 484 (631)
Q Consensus 414 ~ksDVwSlGviL~eLltG~~P~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~--~~~~~~~~~l~~l 484 (631)
.++|||||||+||||+++..|++...... ......|.... .....+.+.. ...........+|
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~d~~~~~~~dL 429 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLV--------EPRASPDLRRGFEVLDLDGGAGWEL 429 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhh--------ccccchhhhhhhhhccccchHHHHH
Confidence 56799999999999999877754321100 00111111000 0000000000 0001111234589
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 006785 485 AKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 485 i~~cl~~dP~~RPs~~evl~~ 505 (631)
+.+||+.||.+|||+.++++.
T Consensus 430 i~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 430 LKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHHccCCcccCCCHHHHhCC
Confidence 999999999999999999874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=288.34 Aligned_cols=241 Identities=23% Similarity=0.289 Sum_probs=194.5
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcce
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 299 (631)
+++.|.....+|.|+|+.|-++... +++..+||++...... -.+|+.++.+. +||||+++.+++.+ ..+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-----~~~e~~~~~~~~~h~niv~~~~v~~~----~~~ 390 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-----NQDEIPISLLVRDHPNIVKSHDVYED----GKE 390 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc-----cccccchhhhhcCCCcceeecceecC----Cce
Confidence 3667777888999999999999865 4888999999766221 34677777776 89999999999886 567
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeee-cCCCCeEEeccCcee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL-DENLNAKITDLGMAK 378 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl-~~~~~~kL~DFGla~ 378 (631)
.|+|||++.|+-|.+.+.... .+. ..+..|+.+|+.++.|||++| +|||||||+|||+ ++.++++|+|||.++
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~--~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKP--EFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred eeeeehhccccHHHHHHHhcc--hhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhh
Confidence 899999999998888776532 233 778889999999999999998 9999999999999 689999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
....+- ..-.-|..|.|||++....|+.++|+||||++||+|++|+.||.......+
T Consensus 465 ~~~~~~--------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e--------------- 521 (612)
T KOG0603|consen 465 ELERSC--------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE--------------- 521 (612)
T ss_pred hCchhh--------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH---------------
Confidence 776541 122457889999999999999999999999999999999999975433210
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
....+..+ .+....+....+|+..||+.||.+||++.++...
T Consensus 522 -i~~~i~~~----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 522 -IHTRIQMP----KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -HHHhhcCC----ccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 11122222 2335556678999999999999999999999764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=287.59 Aligned_cols=264 Identities=20% Similarity=0.282 Sum_probs=182.1
Q ss_pred hcCccccceeeeeCceEEEEEEE-----------------CCCcEEEEEEeccCCCCC-------------hHHHHHHHH
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQL-----------------TDGRIVAVKRFKTQGGPN-------------ADSVFLTEV 272 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~-----------------~~g~~vAVK~l~~~~~~~-------------~~~~~~~E~ 272 (631)
.++|.+.++||+|+||.||+|.+ .+++.||||++....... ..+.+..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 57899999999999999999964 235789999987542211 111244577
Q ss_pred HHHHhcCCCCC-----cceeEEeeeccC----CcceEEEEEeeCCCCChHhhhhccc----------------------c
Q 006785 273 DMLSRLHHCHV-----VPLVGYCSEFRG----KRAMRLLVFEFMPNGNLRDCLDGVL----------------------V 321 (631)
Q Consensus 273 ~~l~~l~H~ni-----v~l~g~~~~~~~----~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~ 321 (631)
.++.+++|.++ ++++++|..... .....||||||+++|+|.++|+... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 78888876654 678888764211 1345799999999999999986421 1
Q ss_pred CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCC
Q 006785 322 EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401 (631)
Q Consensus 322 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y 401 (631)
..++|..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........ .......+|+.|
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~----~~~~~g~~tp~Y 376 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN----FNPLYGMLDPRY 376 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc----cCccccCCCcce
Confidence 12567889999999999999999998 99999999999999999999999999976533211 111123358899
Q ss_pred CCchhhhcCC----------------------CCcccchhhHHHHHHHHHhCCC-CCCCccccc------cchhhhhccc
Q 006785 402 FAPEYAMVGR----------------------ASLMSDVFSFGVVLLELITGRQ-PIHRSITKG------EESLVLWATP 452 (631)
Q Consensus 402 ~APE~~~~~~----------------------~s~ksDVwSlGviL~eLltG~~-P~~~~~~~~------~~~~~~~~~~ 452 (631)
+|||.+.... ...+.||||+||+|++|++|.. |+....... ......|.
T Consensus 377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r-- 454 (507)
T PLN03224 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR-- 454 (507)
T ss_pred eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH--
Confidence 9999875322 1234799999999999999876 664321110 00111111
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q 006785 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDP---DARPTMSEVVQI 505 (631)
Q Consensus 453 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~~ 505 (631)
....................+|+.++|..+| .+|+|+.|+++.
T Consensus 455 ----------~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 455 ----------MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ----------hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0000111111122234557889999998766 689999999874
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=270.05 Aligned_cols=266 Identities=22% Similarity=0.245 Sum_probs=198.5
Q ss_pred HhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcC--CCC----CcceeEEeeecc
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH--HCH----VVPLVGYCSEFR 294 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~--H~n----iv~l~g~~~~~~ 294 (631)
.+.+|.+...+|+|.||.|-...+.. +..||||+++.- ....+..+-|+++|.+|. .|+ +|.+.+++..
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy-- 162 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY-- 162 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc--
Confidence 47899999999999999999998654 789999999753 233445678999999993 332 4455555543
Q ss_pred CCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeec----------
Q 006785 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD---------- 364 (631)
Q Consensus 295 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~---------- 364 (631)
....+||+|.+ |-|+.++|..+...+++..++..|+.|++.+++|||+.+ ++|-||||+|||+-
T Consensus 163 --rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 163 --RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred --cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEecc
Confidence 56789999999 779999999887788999999999999999999999998 99999999999992
Q ss_pred ----------CCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCC
Q 006785 365 ----------ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434 (631)
Q Consensus 365 ----------~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P 434 (631)
.+..++|+|||.|+..... ....+.|..|.|||++.+-.++..+||||+||||+||.+|..-
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDHEH--------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceeccC--------cceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 1345899999999875432 2456789999999999999999999999999999999999998
Q ss_pred CCCccccccchhhhhccccccc---c---------------------c--ccccccCCCCCC-CCCCHHHHHHHHHHHHH
Q 006785 435 IHRSITKGEESLVLWATPRLQD---S---------------------G--TVISELPDPRLK-GDFPKEEMQIMAYLAKE 487 (631)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~~---~---------------------~--~~~~~~~~~~l~-~~~~~~~~~~l~~li~~ 487 (631)
|+.....+...........++. . + ..+.+.+.|.-. ......+...|.+|+++
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 8765533211111100000000 0 0 000111111000 01122344568999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 006785 488 CLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 488 cl~~dP~~RPs~~evl~~ 505 (631)
||..||.+|+|+.|+++.
T Consensus 389 mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 389 MLEFDPARRITLREALSH 406 (415)
T ss_pred HHccCccccccHHHHhcC
Confidence 999999999999999863
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=281.42 Aligned_cols=250 Identities=22% Similarity=0.308 Sum_probs=203.7
Q ss_pred cCccccceeeeeCceEEEEEEECCCc-EEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTDGR-IVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~g~-~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
.++.....||-|+||.|=+...+... .+|+|+++... .....+....|-.+|...+.|.||++|.-+.+ ..+.
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd----~kyv 495 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD----SKYV 495 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc----chhh
Confidence 34555667999999999999876543 48999987653 23344558899999999999999999976665 6788
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
||.||-|-||.|+..|+.+ +.|+..+..-++..++.|++|||.++ ||.|||||+|++||.+|-+||.|||+|+.+
T Consensus 496 YmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHh
Confidence 9999999999999999875 55899999999999999999999999 999999999999999999999999999988
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
.... ..-++.||+.|.|||++.+...+..+|.||||+++|||++|.+||....+-.-..++....
T Consensus 571 ~~g~------KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi--------- 635 (732)
T KOG0614|consen 571 GSGR------KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI--------- 635 (732)
T ss_pred ccCC------ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh---------
Confidence 7643 3456899999999999999999999999999999999999999998765443333222111
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-----MSEVVQI 505 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 505 (631)
. ...+|........+|+++....+|.+|.- +.+|.+.
T Consensus 636 -d-------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 636 -D-------KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred -h-------hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 1 11345555566788999999999999975 4555443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=282.36 Aligned_cols=246 Identities=30% Similarity=0.435 Sum_probs=185.4
Q ss_pred ccccceeeeeCceE-EEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcceEEEE
Q 006785 226 FSGSNIVGQGGSSY-VYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 226 f~~~~~LG~G~fG~-Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
|...+++|.|+.|+ ||+|.. +|+.||||++-.. ......+|+..|+.- .|||||++++.-. +...+||.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e----~~~~A~rEi~lL~eSD~H~NviRyyc~E~----d~qF~YIa 581 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE----FFDFAQREIQLLQESDEHPNVIRYYCSEQ----DRQFLYIA 581 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH----hHHHHHHHHHHHHhccCCCceEEEEeecc----CCceEEEE
Confidence 44456789999876 799998 4899999998643 223367999999988 8999999976433 36689999
Q ss_pred EeeCCCCChHhhhhcc--ccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC---C--CCeEEeccCc
Q 006785 304 FEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---N--LNAKITDLGM 376 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~--~~~kL~DFGl 376 (631)
.|.| .-+|.+++... ......-...+.+..|++.||++||+.+ ||||||||.||||+- + ..++|+|||+
T Consensus 582 lELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl 657 (903)
T KOG1027|consen 582 LELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGL 657 (903)
T ss_pred ehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccc
Confidence 9999 57999999763 1111222456788899999999999998 999999999999965 3 4689999999
Q ss_pred eeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhC-CCCCCCccccccchhhhhcccccc
Q 006785 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITG-RQPIHRSITKGEESLVLWATPRLQ 455 (631)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG-~~P~~~~~~~~~~~~~~~~~~~~~ 455 (631)
++.+..+... -.......||-+|+|||++.....+..+||||+||++|+.++| ..||.......... ....
T Consensus 658 sKkl~~~~sS--~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI--l~~~---- 729 (903)
T KOG1027|consen 658 SKKLAGGKSS--FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI--LTGN---- 729 (903)
T ss_pred ccccCCCcch--hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh--hcCc----
Confidence 9998765422 1225567799999999999999999999999999999999995 89996544321110 0000
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 456 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 456 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
..+..+ . ..+. + +..+||.+|++.+|..||++.+|+.
T Consensus 730 ---~~L~~L-----~-~~~d-~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 730 ---YTLVHL-----E-PLPD-C--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ---cceeee-----c-cCch-H--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 000000 0 1111 1 5789999999999999999999985
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=256.71 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=193.2
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~ 298 (631)
.++|..+++||+|++..|..++++. .+.+|+|+++..- ..+...=...|-.+...- +||.+|.|..++.. ..
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt----es 324 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT----ES 324 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc----cc
Confidence 4678999999999999999998764 7899999988652 122222245677777666 89999999887765 56
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
.+++|.||++||+|.-+++++ +.+++..+.-+...|..||.|||++| ||.||||.+|+|||..|++||+|+|+.+
T Consensus 325 rlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred eEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhh
Confidence 789999999999999888764 55999999999999999999999999 9999999999999999999999999997
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
.-..++ ....++.||+.|.|||++.+..|+..+|.|+|||+++||+.|+.||+.......... ...
T Consensus 400 e~l~~g-----d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~n---------ted 465 (593)
T KOG0695|consen 400 EGLGPG-----DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMN---------TED 465 (593)
T ss_pred cCCCCC-----cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccc---------hhH
Confidence 644332 345678999999999999999999999999999999999999999974322111100 000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT 498 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs 498 (631)
....-+....++ +|...+-....+++.-|++||.+|..
T Consensus 466 ylfqvilekqir--iprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 466 YLFQVILEKQIR--IPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred HHHHHHhhhccc--ccceeehhhHHHHHHhhcCCcHHhcC
Confidence 011111111111 23333334566788889999999853
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=268.41 Aligned_cols=209 Identities=23% Similarity=0.318 Sum_probs=169.7
Q ss_pred cCccccceeeeeCceEEEEEEE-CCCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
.-|..++.||-|+||.|.++.. +....||+|.|.+..- .........|-+||..-+.+-||+|+-.|.+ ++.+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD----kdnL 704 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD----KDNL 704 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc----CCce
Confidence 3466778899999999999964 4477899999875422 1222336789999999999999999866655 6789
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||++||++..+|-+. +-|.+..+..++..+..|+++.|..| +|||||||+|||||.+|++||+||||+.-+
T Consensus 705 YFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred EEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence 9999999999999998654 44888888889999999999999999 999999999999999999999999998643
Q ss_pred cc---------CCCCCC------------CC----------------CCcccccCCCCCCchhhhcCCCCcccchhhHHH
Q 006785 381 KA---------DGLPSC------------SS----------------SPARMQGTFGYFAPEYAMVGRASLMSDVFSFGV 423 (631)
Q Consensus 381 ~~---------~~~~~~------------~~----------------~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGv 423 (631)
.- .+.... +. .....+||+.|+|||++....|+.-.|.||.||
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV 859 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence 21 100000 00 011246999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCcccc
Q 006785 424 VLLELITGRQPIHRSITK 441 (631)
Q Consensus 424 iL~eLltG~~P~~~~~~~ 441 (631)
|||||+.|+.||......
T Consensus 860 il~em~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLADTPG 877 (1034)
T ss_pred HHHHHhhCCCCccCCCCC
Confidence 999999999999766544
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=239.69 Aligned_cols=206 Identities=27% Similarity=0.385 Sum_probs=169.4
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCC
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGK 296 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 296 (631)
++...+.......||+|++|.|-+-++. +|+..|||++......+.....++|+++..+- .-|.+|.++|....
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r---- 116 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR---- 116 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc----
Confidence 4444455556778999999999888764 69999999999876666677789999987766 89999999997664
Q ss_pred cceEEEEEeeCCCCChHhhhhccc--cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEecc
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 374 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DF 374 (631)
....|+.||.| ..||..+-.... ++.+++..+-+||..++.||.|||++- .+||||+||+||||+.+|++|++||
T Consensus 117 egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDF 193 (282)
T KOG0984|consen 117 EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDF 193 (282)
T ss_pred cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccc
Confidence 44679999999 568887765432 345889999999999999999999975 4999999999999999999999999
Q ss_pred CceeecccCCCCCCCCCCcccccCCCCCCchhhhc----CCCCcccchhhHHHHHHHHHhCCCCCCC
Q 006785 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV----GRASLMSDVFSFGVVLLELITGRQPIHR 437 (631)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~----~~~s~ksDVwSlGviL~eLltG~~P~~~ 437 (631)
|.+-.+.+.- ..+...|-..|||||.+.. ..|+-|+||||||+.++||.+++.||+.
T Consensus 194 GIsG~L~dSi------Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 194 GISGYLVDSI------AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred ccceeehhhh------HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 9998776431 1122357889999998863 3689999999999999999999999964
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=235.23 Aligned_cols=211 Identities=35% Similarity=0.541 Sum_probs=181.8
Q ss_pred eeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeCCCC
Q 006785 232 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNG 310 (631)
Q Consensus 232 LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~~g 310 (631)
||+|.+|.||++...+ ++.++||++...........+.+|+..++.+.|++++++++++.. ....+++|||++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~~~~~e~~~~~ 76 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED----ENHLYLVMEYCEGG 76 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec----CCeEEEEEecCCCC
Confidence 6899999999999865 899999999876443234569999999999999999999998875 35779999999999
Q ss_pred ChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC-CCCeEEeccCceeecccCCCCCCC
Q 006785 311 NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKRLKADGLPSCS 389 (631)
Q Consensus 311 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~ 389 (631)
+|.+++.... ..+++..+..++.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........
T Consensus 77 ~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---- 148 (215)
T cd00180 77 SLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---- 148 (215)
T ss_pred cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----
Confidence 9999997542 35899999999999999999999998 999999999999999 89999999999987654321
Q ss_pred CCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccCCCC
Q 006785 390 SSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 468 (631)
Q Consensus 390 ~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (631)
......+...|++||.+... .++.++|+|++|+++++|
T Consensus 149 -~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------- 187 (215)
T cd00180 149 -LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------- 187 (215)
T ss_pred -hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------
Confidence 12334578899999999877 889999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 469 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 469 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..+.+++..|+..+|++||++.++++.
T Consensus 188 ----------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 227889999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-31 Score=250.76 Aligned_cols=271 Identities=24% Similarity=0.306 Sum_probs=193.5
Q ss_pred cccceeeeeCceEEEEEEE-CCCcEEEEEEeccC-CCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCC-cceEEEE
Q 006785 227 SGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK-RAMRLLV 303 (631)
Q Consensus 227 ~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~~~~~lV 303 (631)
+..+-||-|+||.||...+ ++|+.||+|++..- ..-.....+.+|+++|..++|.|++..++.......+ -.++|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3457799999999999976 46999999998643 1122234588999999999999999887665321111 1245889
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
+|+| ..+|...+-. .+.++...+.-+..||++||+|||+.+ |.||||||.|.|++.|..+||+|||||+....+
T Consensus 136 TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchh
Confidence 9998 5688887753 466889999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccc--hhhhhcccccccccc-
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEE--SLVLWATPRLQDSGT- 459 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~--~~~~~~~~~~~~~~~- 459 (631)
+. ...+..+-|..|.|||.+++. .|+...||||.|+|+.||+.++.-|+...+-... .......+.++....
T Consensus 210 ~~----~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 210 DR----LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred hh----hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 32 233445678999999999975 5899999999999999999888887654332221 112233333322211
Q ss_pred -------ccccc-CCCCCCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 460 -------VISEL-PDPRLKG----DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 460 -------~~~~~-~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
.++.- ..|.+.- .-+..-..+...+...++..||+.|.+..+.+..+.
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 00100 0111110 011122233456777889999999999998877543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=260.60 Aligned_cols=198 Identities=22% Similarity=0.297 Sum_probs=168.7
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChH-------HHHHHHHHHHHhcC---CCCCcceeEEee
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNAD-------SVFLTEVDMLSRLH---HCHVVPLVGYCS 291 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~-------~~~~~E~~~l~~l~---H~niv~l~g~~~ 291 (631)
...|+..+.||.|+||.|+.|.++. ...|+||.+.+..--... -..-.|+.||+.|+ |+||++++.++.
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3458889999999999999999875 678999998765321110 01446999999997 999999999988
Q ss_pred eccCCcceEEEEEeeC-CCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeE
Q 006785 292 EFRGKRAMRLLVFEFM-PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 370 (631)
Q Consensus 292 ~~~~~~~~~~lV~E~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 370 (631)
+ +.++||+||-. ++-+|++++... ..+++.++..|+.||+.|+++||+++ |||||||-+|+.++.+|-+|
T Consensus 640 d----dd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~k 710 (772)
T KOG1152|consen 640 D----DDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVK 710 (772)
T ss_pred c----CCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEE
Confidence 6 67889999976 566999999764 45999999999999999999999999 99999999999999999999
Q ss_pred EeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCC-CcccchhhHHHHHHHHHhCCCCCC
Q 006785 371 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIH 436 (631)
Q Consensus 371 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~ 436 (631)
|+|||.|..... .....++||..|.|||++.+..| +..-|||++|++||.++....||+
T Consensus 711 lidfgsaa~~ks-------gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 711 LIDFGSAAYTKS-------GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EeeccchhhhcC-------CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999876543 23456889999999999998776 777899999999999999999985
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=247.53 Aligned_cols=135 Identities=26% Similarity=0.344 Sum_probs=119.5
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-----CC---CCcceeEEeeecc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-----HC---HVVPLVGYCSEFR 294 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~-----H~---niv~l~g~~~~~~ 294 (631)
.+|.+.++||.|.|++||++.+. +.+.||+|+.+.. +...+..+.||++|+.++ |+ +||+|++.|....
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 67889999999999999999875 4789999999864 334455789999999983 33 6999999998888
Q ss_pred CCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeee
Q 006785 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 363 (631)
Q Consensus 295 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl 363 (631)
....+++||+|++ |-+|..+|.....++++...+.+|+.||+.||.|||... +|||-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 8888999999999 889999998888889999999999999999999999876 59999999999999
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=233.18 Aligned_cols=200 Identities=30% Similarity=0.422 Sum_probs=170.5
Q ss_pred ccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~ 304 (631)
|...+.||.|++|.||++...+ ++.+|||.+...........+.+|++.+++++|+|++++++++.. ....++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~----~~~~~~v~ 76 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED----PEPLYLVM 76 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec----CCceEEEE
Confidence 4567889999999999999875 899999999865433245678999999999999999999998875 35679999
Q ss_pred eeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCC
Q 006785 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (631)
Q Consensus 305 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~ 384 (631)
||+++++|.+++..... .+++..+..++.+++.+|.+||+.+ ++|+||+|.||+++.++.++|+|||++.......
T Consensus 77 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 77 EYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred eccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 99999999999976432 1799999999999999999999998 9999999999999999999999999998775432
Q ss_pred CCCCCCCCcccccCCCCCCchhh-hcCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 006785 385 LPSCSSSPARMQGTFGYFAPEYA-MVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (631)
Q Consensus 385 ~~~~~~~~~~~~Gt~~Y~APE~~-~~~~~s~ksDVwSlGviL~eLltG~~P~~~ 437 (631)
........++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 153 ----~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 ----AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ----cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 0122345678899999998 666788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-29 Score=265.45 Aligned_cols=253 Identities=26% Similarity=0.400 Sum_probs=199.1
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.++|.....+|.|.+|.|||+++. .++..|||+++-..... .....+|+-+++..+||||+.++|.+.. ....|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-~~~iqqei~~~~dc~h~nivay~gsylr----~dklw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-FSGIQQEIGMLRDCRHPNIVAYFGSYLR----RDKLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-ccccccceeeeecCCCcChHHHHhhhhh----hcCcE
Confidence 456777889999999999999875 58999999998764433 2336789999999999999999998875 45679
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
++||||.+|+|++.-+.. .++++.++..+....++||+|||+++ -+|||||-.|||+++.+.+|++|||.+..+.
T Consensus 89 icMEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred EEEEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhh
Confidence 999999999999976543 56899999999999999999999998 8999999999999999999999999987665
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhh---cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
.. ......+.||+.|||||+.. .+.|..++|||+.|+.-.|+---++|....-+... +.....
T Consensus 164 at-----i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~--l~LmTk------- 229 (829)
T KOG0576|consen 164 AT-----IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA--LFLMTK------- 229 (829)
T ss_pred hh-----hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH--HHHhhc-------
Confidence 32 23345678999999999874 56799999999999999999887777543322111 000000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
.....|.++. +......+..|++.++.++|.+||+++.+++
T Consensus 230 ---S~~qpp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 230 ---SGFQPPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ---cCCCCCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 0111122221 2334556899999999999999999988765
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=228.09 Aligned_cols=257 Identities=20% Similarity=0.285 Sum_probs=191.6
Q ss_pred hcCccccceeeeeCceEEEEEE-ECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCCcceeEEeeeccCCcceE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~ 300 (631)
.++|++.+.+|+|-++.||.|. ..+++.++||+++.-. ...+.+|+.||..|. ||||++|+++..+.. ....
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~--Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPE--SKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCcc--ccCc
Confidence 4678889999999999999997 4568899999998643 234889999999995 999999999987754 3467
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC-CCCeEEeccCceee
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKR 379 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kL~DFGla~~ 379 (631)
.||+||+++.+...+- ..++..++.....+++.||.|+|++| |+|||+||.|++||. ...++|+|+|||.+
T Consensus 111 aLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred hhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhh
Confidence 8999999998877654 34788889999999999999999999 999999999999986 45699999999998
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh----c----
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW----A---- 450 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~----~---- 450 (631)
+.+... ....+.+..|--||.+.. ..|...-|+|||||+|..|+..+.||......... ++.. .
T Consensus 183 YHp~~e------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ-LVkIakVLGt~el 255 (338)
T KOG0668|consen 183 YHPGKE------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVKIAKVLGTDEL 255 (338)
T ss_pred cCCCce------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH-HHHHHHHhChHHH
Confidence 765432 223356677889998865 45788899999999999999999998654322111 1000 0
Q ss_pred -----------cccccc-----ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 451 -----------TPRLQD-----SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 451 -----------~~~~~~-----~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
.+.+.+ ....+.....+.-..-. ..+..+|+.+.|..|..+|||+.|.+.
T Consensus 256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~----~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLV----SPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccC----ChHHHHHHHHHHhhccccccchHHHhc
Confidence 000000 00001111111111111 244778999999999999999999875
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=240.12 Aligned_cols=267 Identities=22% Similarity=0.287 Sum_probs=199.3
Q ss_pred CccccceeeeeCceEEEEEEECCC--cEEEEEEeccCCCCChHHHHHHHHHHHHhcCC----CCCcceeEEeeeccCCcc
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLTDG--RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH----CHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~~g--~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~~~~~~~~~ 298 (631)
+|.+.+.||+|+||.||++...+. ..+|+|........... .+..|+.+|..+.+ +++..+++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~---~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGR---STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEecc---CCCc
Confidence 788899999999999999997653 58999988765433332 47889999999963 57888887663 1255
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCC-----CCeEEec
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-----LNAKITD 373 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-----~~~kL~D 373 (631)
+.|+||+.+ |.+|.++......+.++..+++.|+.|++.+|++||+.| ++||||||.|+++... ..++|.|
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEe
Confidence 779999999 899999886655577999999999999999999999999 9999999999999765 4689999
Q ss_pred cCceeecc--cCCCC--CCCCC-CcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhh
Q 006785 374 LGMAKRLK--ADGLP--SCSSS-PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 448 (631)
Q Consensus 374 FGla~~~~--~~~~~--~~~~~-~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~ 448 (631)
||+++.+. ..... ..... ...+.||.+|+++..+.+...+++.|+||+++++.|++.|..||............
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~- 249 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF- 249 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH-
Confidence 99999433 22211 11111 23467999999999999999999999999999999999999999654432211100
Q ss_pred hcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006785 449 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513 (631)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 513 (631)
.+..............+..+..++..+-..+...+|.+..+...|.......
T Consensus 250 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 250 -------------EKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred -------------HHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 0000000000011112233666666677799999999999999988775544
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=234.35 Aligned_cols=261 Identities=24% Similarity=0.337 Sum_probs=191.2
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccC-CCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC--CcceE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRAMR 300 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~~~~ 300 (631)
+|..++.+|.|.- .|.-|.+. .++.||+|++... ......+...+|..++..+.|+||++++.++..... .-...
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4555667888877 56666443 4889999988654 222333457899999999999999999998864322 13356
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||| .++|.+.+. ..++-.++..|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+|+..
T Consensus 97 y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 97 YLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhccc
Confidence 9999999 679998886 23788999999999999999999999 999999999999999999999999999875
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcc-------c-
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT-------P- 452 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~-------~- 452 (631)
..+ ...+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+.. .+.+|.. +
T Consensus 169 ~~~------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 169 DTD------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQLGTPD 237 (369)
T ss_pred Ccc------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHHhcCCC
Confidence 443 23456788999999999998889999999999999999999987775322 1111110 0
Q ss_pred -----cccccc------------ccccc-cCCCCCCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 453 -----RLQDSG------------TVISE-LPDPRLKG--DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 453 -----~~~~~~------------~~~~~-~~~~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+...+ ....+ ++|..... +.+.-......+++.+||..||++|.+++++++.
T Consensus 238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000000 00111 11111111 1112223457889999999999999999999873
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-28 Score=247.84 Aligned_cols=276 Identities=24% Similarity=0.287 Sum_probs=202.7
Q ss_pred eecHHHHHHHhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcC------CCCCcc
Q 006785 213 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH------HCHVVP 285 (631)
Q Consensus 213 ~~s~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~------H~niv~ 285 (631)
.|.+..-+....+|.+....|+|-|++|.+|.+.. |+.||||++..... ....=+.|+++|++|+ --|.++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~--M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV--MHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH--HhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 34555556667899999999999999999998764 88999999986532 2222468999999994 237888
Q ss_pred eeEEeeeccCCcceEEEEEeeCCCCChHhhhhcccc-CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeec
Q 006785 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 364 (631)
Q Consensus 286 l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~ 364 (631)
|+..|.. .++++||+|-+ ..+|.++|..... -+|....+..++.|+.-||..|...+ |+|.||||.|||++
T Consensus 499 l~r~F~h----knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVN 570 (752)
T KOG0670|consen 499 LFRHFKH----KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVN 570 (752)
T ss_pred HHHHhhh----cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEec
Confidence 8766654 67899999998 6799999976432 24888999999999999999999998 99999999999999
Q ss_pred CCCC-eEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCcccccc
Q 006785 365 ENLN-AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 443 (631)
Q Consensus 365 ~~~~-~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~ 443 (631)
+..+ +||||||.|........ +.+..+..|.|||++.+.+|+...|+||.||+||||.||+..|.+......
T Consensus 571 E~k~iLKLCDfGSA~~~~enei-------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M 643 (752)
T KOG0670|consen 571 ESKNILKLCDFGSASFASENEI-------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM 643 (752)
T ss_pred cCcceeeeccCccccccccccc-------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHH
Confidence 7654 79999999987765432 233456789999999999999999999999999999999988875543321
Q ss_pred chhhhhc---------------ccccccc---------------cccccccCCC------CCC--CCCCHH---HHHHHH
Q 006785 444 ESLVLWA---------------TPRLQDS---------------GTVISELPDP------RLK--GDFPKE---EMQIMA 482 (631)
Q Consensus 444 ~~~~~~~---------------~~~~~~~---------------~~~~~~~~~~------~l~--~~~~~~---~~~~l~ 482 (631)
..+..-. ..++... ...+.....| .+. ..+|.+ ..+.|.
T Consensus 644 Lrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~r 723 (752)
T KOG0670|consen 644 LRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLR 723 (752)
T ss_pred HHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHH
Confidence 1111000 0000000 0000001111 011 113333 345688
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 006785 483 YLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 483 ~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+|+..|+.+||++|.|..+.++.
T Consensus 724 dLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 724 DLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHHHHhccChhhcCCHHHHhcC
Confidence 99999999999999999998763
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=217.70 Aligned_cols=279 Identities=20% Similarity=0.256 Sum_probs=211.8
Q ss_pred hcCccccceeeeeCceEEEEEE-ECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCC-CCcceeEEeeeccCCcceE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC-HVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~~~~ 300 (631)
..+|...+.||.|+||.+|.|. ..+|..||||+....... .++..|..+...|+|- .|..+..|..+ ..+-
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h---pqL~yEskvY~iL~~g~GiP~i~~y~~e----~~yn 86 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH---PQLLYESKVYRILQGGVGIPHIRHYGTE----KDYN 86 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC---cchhHHHHHHHHhccCCCCchhhhhccc----cccc
Confidence 4678889999999999999997 467999999998765432 2378899999999654 56666655554 4456
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC---CeEEeccCce
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL---NAKITDLGMA 377 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~---~~kL~DFGla 377 (631)
.||||.+ |.+|.++++-. .+.++..+++-+|-|++.-++|+|.++ +|||||||+|+|..-+. .+.++|||||
T Consensus 87 vlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred eeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccch
Confidence 8999999 89999988654 356999999999999999999999999 99999999999996543 4899999999
Q ss_pred eecccCC--CCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccc
Q 006785 378 KRLKADG--LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 455 (631)
Q Consensus 378 ~~~~~~~--~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 455 (631)
+.+.+.. .+..........||.+|.+-..+.+...+.+.|+-|+|++|..+.-|..||++........... .+.
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE----kI~ 237 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE----KIS 237 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH----HHH
Confidence 9876532 2333445566889999999999999999999999999999999999999998754332111000 000
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcccccccCcchh
Q 006785 456 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNLF 524 (631)
Q Consensus 456 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~ 524 (631)
+....++-..+...+|.+ +.-.+..|-..-.++-|+..-+.+.+..+.....-.....++|-
T Consensus 238 ---EkK~s~~ie~LC~G~P~E----F~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~ 299 (341)
T KOG1163|consen 238 ---EKKMSTPIEVLCKGFPAE----FAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWT 299 (341)
T ss_pred ---HhhcCCCHHHHhCCCcHH----HHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHH
Confidence 001112222334445555 66677889999999999999999888887766655555555554
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-27 Score=223.96 Aligned_cols=250 Identities=19% Similarity=0.336 Sum_probs=182.8
Q ss_pred HhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcce
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 299 (631)
..+.|.+.+.||+|.||.+-+++++. .+.+++|.+..... ...+|.+|...--.| .|.||+.-+.+..+ ..+.
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq---t~d~ 96 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEVAFQ---TSDA 96 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHHHhh---cCce
Confidence 35678899999999999999999875 78899999876543 345699998876666 79999988765544 2447
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeee-c-CCCCeEEeccCce
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL-D-ENLNAKITDLGMA 377 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl-~-~~~~~kL~DFGla 377 (631)
+++++||++.|+|..-+.. .++.+.....++.|++.||.|+|+.+ +||||||.+|||| + +...+||+|||+.
T Consensus 97 YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred EEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccc
Confidence 7899999999999987754 45788888999999999999999998 9999999999999 2 3447999999998
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcC---C--CCcccchhhHHHHHHHHHhCCCCCCCccccccc--hhhhhc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG---R--ASLMSDVFSFGVVLLELITGRQPIHRSITKGEE--SLVLWA 450 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~---~--~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~--~~~~~~ 450 (631)
+..... .....-+..|.+||..... . ..+.+|||.||+++|.++||..||+........ ....|.
T Consensus 171 ~k~g~t--------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~ 242 (378)
T KOG1345|consen 171 RKVGTT--------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWL 242 (378)
T ss_pred cccCce--------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHh
Confidence 764321 1222345679999977532 2 477899999999999999999999854332211 111222
Q ss_pred ccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 006785 451 TPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 503 (631)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 503 (631)
... ... -|.....+.+. +..+.++-+..+|++|--..++.
T Consensus 243 ~rk-------~~~--~P~~F~~fs~~----a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 243 KRK-------NPA--LPKKFNPFSEK----ALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred ccc-------Ccc--CchhhcccCHH----HHHHHHHhcCCcccccchhHHHH
Confidence 111 111 12222233333 66677888999999994444433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=236.11 Aligned_cols=206 Identities=28% Similarity=0.433 Sum_probs=166.9
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEEC----CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeec
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 293 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 293 (631)
+....+.|...++||+|.|++||++.+. ..+.||+|.+.....+. ....|+++|..+ .+.||+++.+++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~---ri~~El~~L~~~gG~~ni~~~~~~~rn- 106 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS---RILNELEMLYRLGGSDNIIKLNGCFRN- 106 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch---HHHHHHHHHHHhccchhhhcchhhhcc-
Confidence 3445567888999999999999999754 36789999998765554 378999999999 79999999988764
Q ss_pred cCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCC-CCeEEe
Q 006785 294 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKIT 372 (631)
Q Consensus 294 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kL~ 372 (631)
.+...+|+||++.-+-.+++.. ++..++...+..+..||+++|..| ||||||||+|+|.+.. +.-.|.
T Consensus 107 ---nd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~Lv 175 (418)
T KOG1167|consen 107 ---NDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLV 175 (418)
T ss_pred ---CCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEE
Confidence 5678999999999998888764 678999999999999999999999 9999999999999754 557899
Q ss_pred ccCceeecccCC-------------CC-------CC-------------------CCCCcccccCCCCCCchhhhc-CCC
Q 006785 373 DLGMAKRLKADG-------------LP-------SC-------------------SSSPARMQGTFGYFAPEYAMV-GRA 412 (631)
Q Consensus 373 DFGla~~~~~~~-------------~~-------~~-------------------~~~~~~~~Gt~~Y~APE~~~~-~~~ 412 (631)
|||||....... .+ .. ........||++|.|||++.. ...
T Consensus 176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q 255 (418)
T KOG1167|consen 176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ 255 (418)
T ss_pred echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence 999997321100 00 00 001123469999999999974 668
Q ss_pred CcccchhhHHHHHHHHHhCCCCCCCcc
Q 006785 413 SLMSDVFSFGVVLLELITGRQPIHRSI 439 (631)
Q Consensus 413 s~ksDVwSlGviL~eLltG~~P~~~~~ 439 (631)
+.++||||.|||++-+++++.||....
T Consensus 256 ttaiDiws~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 256 TTAIDIWSAGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred CCccceeeccceeehhhccccccccCc
Confidence 999999999999999999999997543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.2e-26 Score=222.26 Aligned_cols=277 Identities=19% Similarity=0.249 Sum_probs=208.0
Q ss_pred CccccceeeeeCceEEEEEE-ECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcceEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
.|.+.++||+|+||.++.|+ +-+++.||||...... ...++..|....+.| .-+.|...+-+..+ ..+-.|
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFGqe----G~~NiL 101 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFGQE----GKYNIL 101 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeeccc----cchhhh
Confidence 57789999999999999997 4579999999876442 223477889988888 67888887754443 345589
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCC-----CCeEEeccCce
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-----LNAKITDLGMA 377 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-----~~~kL~DFGla 377 (631)
|+|++ |.||.|+.+-. .+.|+.++++.||+|++.-++|+|++. +|.|||||+|+||..- ..+.|+|||+|
T Consensus 102 VidLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccch
Confidence 99999 89999987643 467999999999999999999999998 9999999999999533 34899999999
Q ss_pred eecccCCC--CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccc
Q 006785 378 KRLKADGL--PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 455 (631)
Q Consensus 378 ~~~~~~~~--~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 455 (631)
+.+.+... +..........||.+||+-..+.+...+.+.|+-|||-+++..|-|.+||++........ ..+
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~-------kYe 249 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE-------KYE 249 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH-------HHH
Confidence 98876432 223344566789999999999999999999999999999999999999998754332111 011
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcccccccCcchh
Q 006785 456 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNLF 524 (631)
Q Consensus 456 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~ 524 (631)
..+......+-..|...+|. ++..-+...-.++.++-|+++-+...+..+.........-.++|.
T Consensus 250 KIGe~Kr~T~i~~Lc~g~P~----efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~ 314 (449)
T KOG1165|consen 250 KIGETKRSTPIEVLCEGFPE----EFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWM 314 (449)
T ss_pred HhccccccCCHHHHHhcCHH----HHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence 11111111111222333444 467777778889999999999998888877665544444444443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=222.67 Aligned_cols=276 Identities=22% Similarity=0.348 Sum_probs=204.9
Q ss_pred ccccccCCcccccceeeeecHHHHHHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccC-CCCChHHHHHHHHHH
Q 006785 196 KTTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQ-GGPNADSVFLTEVDM 274 (631)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~s~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~-~~~~~~~~~~~E~~~ 274 (631)
.+++.+.++.+..++..+|+--++. ......+|.+...|..|+|+|+ |..+++|+++.. .......+|.+|.-.
T Consensus 166 dt~wkgtktr~rdatlsr~~gid~~----~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~ 240 (448)
T KOG0195|consen 166 DTTWKGTKTRTRDATLSRYTGIDVS----SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPA 240 (448)
T ss_pred ccccccccccccccccccccCcchh----hhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcc
Confidence 3333344444444444554433221 1223446888999999999996 555777888754 233444569999999
Q ss_pred HHhcCCCCCcceeEEeeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeec
Q 006785 275 LSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHR 354 (631)
Q Consensus 275 l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr 354 (631)
|+-+.||||++++|.|.. ...+.+|..||+.|+|+..|++...-..+..++++++.++|+||+|||+.. |-|..-
T Consensus 241 lrifshpnilpvlgacns----ppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~ 315 (448)
T KOG0195|consen 241 LRIFSHPNILPVLGACNS----PPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRF 315 (448)
T ss_pred eeeecCCchhhhhhhccC----CCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhh
Confidence 999999999999999986 567799999999999999998876555788999999999999999999985 435566
Q ss_pred CCCCCCeeecCCCCeEEe--ccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCC---CCcccchhhHHHHHHHHH
Q 006785 355 DIKSSNILLDENLNAKIT--DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELI 429 (631)
Q Consensus 355 DlKp~NILl~~~~~~kL~--DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~---~s~ksDVwSlGviL~eLl 429 (631)
-|.+..++||++.+++|+ |--++-. .....-.+.||+||.+...+ .-..+|+|||+++||||.
T Consensus 316 ~lns~hvmidedltarismad~kfsfq------------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~ 383 (448)
T KOG0195|consen 316 YLNSKHVMIDEDLTARISMADTKFSFQ------------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELN 383 (448)
T ss_pred hcccceEEecchhhhheecccceeeee------------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhh
Confidence 789999999999998875 3222111 11122458899999998654 345789999999999999
Q ss_pred hCCCCCCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 430 TGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 430 tG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
|...||....+-+-. .++.-..++..+|+..+..+.+|+.-|+..||.+||.+..|+-.|+++
T Consensus 384 trevpfadlspmecg-----------------mkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 384 TREVPFADLSPMECG-----------------MKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccccccccCCchhhh-----------------hhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 999999754432211 112223344456777778899999999999999999999999999876
Q ss_pred C
Q 006785 510 A 510 (631)
Q Consensus 510 ~ 510 (631)
.
T Consensus 447 ~ 447 (448)
T KOG0195|consen 447 I 447 (448)
T ss_pred c
Confidence 3
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=269.62 Aligned_cols=205 Identities=19% Similarity=0.197 Sum_probs=141.8
Q ss_pred HhcCC-CCCcceeEEeeecc---CCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCce
Q 006785 276 SRLHH-CHVVPLVGYCSEFR---GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351 (631)
Q Consensus 276 ~~l~H-~niv~l~g~~~~~~---~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 351 (631)
+.++| +||+++++++.... .....++++|||+ +++|.++|+.. ...+++.+++.++.||++||.|||+++ |
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 34555 58888888773222 1123567889988 67999999753 345999999999999999999999998 9
Q ss_pred eecCCCCCCeeecC-------------------CCCeEEeccCceeecccCC------CCC-----CCCCCcccccCCCC
Q 006785 352 LHRDIKSSNILLDE-------------------NLNAKITDLGMAKRLKADG------LPS-----CSSSPARMQGTFGY 401 (631)
Q Consensus 352 vHrDlKp~NILl~~-------------------~~~~kL~DFGla~~~~~~~------~~~-----~~~~~~~~~Gt~~Y 401 (631)
+||||||+||||+. ++.+|++|||+++...... ... .........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4456666677665422100 000 00011124689999
Q ss_pred CCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHH
Q 006785 402 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIM 481 (631)
Q Consensus 402 ~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 481 (631)
||||++.+..++.++|||||||+||||++|..|+..... ..... .....++.... .....
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~-----------~~~~~~~~~~~-----~~~~~ 241 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSL-----------RHRVLPPQILL-----NWPKE 241 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHH-----------HHhhcChhhhh-----cCHHH
Confidence 999999999999999999999999999999888642111 00000 00011111111 11225
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 006785 482 AYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 482 ~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..++.+||+.+|.+||++.|+++.
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhc
Confidence 578889999999999999999874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-25 Score=208.54 Aligned_cols=166 Identities=19% Similarity=0.184 Sum_probs=126.3
Q ss_pred CChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCCC
Q 006785 310 GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 389 (631)
Q Consensus 310 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 389 (631)
|+|.++++.. ...+++.++..|+.|++.||.|||+++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-----
Confidence 7899999753 356999999999999999999999875 999999999999999 99998754321
Q ss_pred CCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccCCCCC
Q 006785 390 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRL 469 (631)
Q Consensus 390 ~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 469 (631)
..||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ..+. ........
T Consensus 64 -----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~-~~~~-----------~~~~~~~~ 126 (176)
T smart00750 64 -----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAIL-EILL-----------NGMPADDP 126 (176)
T ss_pred -----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHH-HHHH-----------HHhccCCc
Confidence 258999999999999999999999999999999999999996432211100 0000 00000000
Q ss_pred C-CCCCHHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 470 K-GDFPKEEMQ--IMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 470 ~-~~~~~~~~~--~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
. ...+..... .+.+++.+||..+|.+||++.++++.+..+
T Consensus 127 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 127 RDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred cccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 0 011222333 589999999999999999999999988765
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=224.91 Aligned_cols=180 Identities=23% Similarity=0.222 Sum_probs=135.3
Q ss_pred HHhcCccccceeeeeCceEEEEEEEC--CCcEEEEEEeccCC----CCChHHHHHHHHHHHHhcCCCCCcceeEEeeecc
Q 006785 221 HATDKFSGSNIVGQGGSSYVYRGQLT--DGRIVAVKRFKTQG----GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 294 (631)
Q Consensus 221 ~a~~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 294 (631)
...++|...+.||+|+||+||+|.++ +++.||||++.... .......|.+|+++|++++|+|+++.+..+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 34577899999999999999999875 47888999875331 122345589999999999999999633211
Q ss_pred CCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCC-CCCCeeecCCCCeEEec
Q 006785 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI-KSSNILLDENLNAKITD 373 (631)
Q Consensus 295 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl-Kp~NILl~~~~~~kL~D 373 (631)
...|+||||++|++|... .. .. ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|
T Consensus 91 ---~~~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred ---CCcEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence 135999999999999732 11 11 1467889999999999998 999999 99999999999999999
Q ss_pred cCceeecccCCCCCC---CCCCcccccCCCCCCchhhhcCC------CCcccchh
Q 006785 374 LGMAKRLKADGLPSC---SSSPARMQGTFGYFAPEYAMVGR------ASLMSDVF 419 (631)
Q Consensus 374 FGla~~~~~~~~~~~---~~~~~~~~Gt~~Y~APE~~~~~~------~s~ksDVw 419 (631)
||+|+.+...+.... ........+++.|+|||++...+ .+..+|-|
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 999998765432111 01124567899999999886432 33446666
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.5e-22 Score=204.15 Aligned_cols=258 Identities=31% Similarity=0.447 Sum_probs=196.1
Q ss_pred ccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCC--hHHHHHHHHHHHHhcCCC-CCcceeEEeeeccCCcceEEE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHC-HVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~--~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~~~~~l 302 (631)
|...+.||.|+||.||++... ..+++|.+....... ....|.+|+.++..+.|+ ++++++.++.. ....++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD----EGSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec----CCEEEE
Confidence 556778999999999999986 789999998765544 366799999999999888 79999988843 334799
Q ss_pred EEeeCCCCChHhhhhcccc-CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC-CeEEeccCceeec
Q 006785 303 VFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKRL 380 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kL~DFGla~~~ 380 (631)
+++|+.+++|.+++..... ..+.......+..|++.+++|+|..+ ++|||+||+||+++..+ .++++|||+++..
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence 9999999999977765321 25889999999999999999999999 99999999999999988 6999999999865
Q ss_pred ccCCCCCCC-CCCcccccCCCCCCchhhhc---CCCCcccchhhHHHHHHHHHhCCCCCCCcccc---ccchhhhhcccc
Q 006785 381 KADGLPSCS-SSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSITK---GEESLVLWATPR 453 (631)
Q Consensus 381 ~~~~~~~~~-~~~~~~~Gt~~Y~APE~~~~---~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~---~~~~~~~~~~~~ 453 (631)
......... .......||..|+|||.+.+ ..++...|+||+|++++++++|..||...... ......
T Consensus 153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~------ 226 (384)
T COG0515 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI------ 226 (384)
T ss_pred CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH------
Confidence 543321110 12356679999999999987 68899999999999999999999997544321 000000
Q ss_pred cccccccccccCCC----CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 454 LQDSGTVISELPDP----RLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 454 ~~~~~~~~~~~~~~----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+.....+ ......+......+.+++..++..+|..|.+..+....
T Consensus 227 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 227 -------ILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -------HHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0001100 00101111223457788999999999999999887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-22 Score=225.23 Aligned_cols=258 Identities=21% Similarity=0.217 Sum_probs=183.5
Q ss_pred cccceeeeeCceEEEEEEEC-CCcEEEEEEecc----C-CCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 227 SGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKT----Q-GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 227 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~----~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
...+++|.|.+|.|+..... .....+.|.+.. . ........+..|+-+-..|+|+|++..+..+.+.. ..
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~----~~ 396 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID----GI 396 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc----cc
Confidence 34678999999988877643 344445444331 1 11111112556777888899999988776665532 22
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
+-+||||++ ||..++... ..+...++..++.|++.|++|+|+.| |.|||||++|++++.++.+||+|||.+..+
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVF 470 (601)
T ss_pred hhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceee
Confidence 444999999 999998753 35888999999999999999999999 999999999999999999999999999877
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCC-cccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRAS-LMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s-~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
....... ........|+..|+|||++.+..|. ...||||.|+++..|++|+.||.......... .. ...
T Consensus 471 ~~~~e~~-~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~-----~~~--- 540 (601)
T KOG0590|consen 471 RYPWEKN-IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KT-----NNY--- 540 (601)
T ss_pred ccCcchh-hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hh-----hcc---
Confidence 6543211 1334567899999999999988874 46899999999999999999996543322110 00 000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
........-.......++.....++.++|+.+|.+|.|+.+|++.
T Consensus 541 -~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 541 -SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred -ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 000000000001223344557889999999999999999999874
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.4e-22 Score=210.52 Aligned_cols=260 Identities=22% Similarity=0.327 Sum_probs=184.0
Q ss_pred HHhcCCCCCcceeEEeeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeec
Q 006785 275 LSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHR 354 (631)
Q Consensus 275 l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr 354 (631)
|+.+.|.|+.+++|.+.+ ....++|.+||..|+|.|.+... ...++|.....+..+|+.||+|||... -..|+
T Consensus 1 l~~l~h~n~~~f~g~~~~----~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVD----GPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEec----CCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeee
Confidence 457899999999999997 36779999999999999999763 356999999999999999999999754 23999
Q ss_pred CCCCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcC-------CCCcccchhhHHHHHHH
Q 006785 355 DIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-------RASLMSDVFSFGVVLLE 427 (631)
Q Consensus 355 DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-------~~s~ksDVwSlGviL~e 427 (631)
.|++.|+++|..+.+||+|||+......... ........-..-|.|||.+... ..+.+.||||||++++|
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~---~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e 150 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAE---PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE 150 (484)
T ss_pred eeccccceeeeeEEEEechhhhccccccccc---ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence 9999999999999999999999877643100 0011111234579999988753 14778999999999999
Q ss_pred HHhCCCCCCCcccccc-chhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006785 428 LITGRQPIHRSITKGE-ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506 (631)
Q Consensus 428 LltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 506 (631)
+++...||+....... ..++.+.. . .-.....|.+.... +....+..++..||..+|+.||++.+|...+
T Consensus 151 i~~r~~~~~~~~~~~~~~eii~~~~----~---~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~ 221 (484)
T KOG1023|consen 151 ILFRSGPFDLRNLVEDPDEIILRVK----K---GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKL 221 (484)
T ss_pred HHhccCccccccccCChHHHHHHHH----h---cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhh
Confidence 9999999976433222 11222110 0 01112223222111 3333588899999999999999999999999
Q ss_pred hhhCCCcccccccCcchhhhhhcCCCCCCCCC-CCCchhHHhhhhHHH
Q 006785 507 STIAPDKSRRRNISLNLFQIFSAGGMEKEPSI-ERPDNLFETLIESEE 553 (631)
Q Consensus 507 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~e~~~~~~~ 553 (631)
..+........++...++...+....+.+..+ ++..++.++....+.
T Consensus 222 ~~~~~~~~~~~nl~D~m~~~le~Y~~nLe~~v~eRt~~l~~e~~k~d~ 269 (484)
T KOG1023|consen 222 LTINKGGSSKGNLMDSLFRMLESYADNLEKLVDERTAELEEEKKKTDT 269 (484)
T ss_pred hhhcccccccchhHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHHHHH
Confidence 98877665444666666666665555444333 334444444444443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.6e-21 Score=185.10 Aligned_cols=140 Identities=16% Similarity=0.170 Sum_probs=108.6
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCC-h-------H-----------------HHHHHHHHHHHhcCCCCC
Q 006785 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN-A-------D-----------------SVFLTEVDMLSRLHHCHV 283 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~-~-------~-----------------~~~~~E~~~l~~l~H~ni 283 (631)
...||+|+||.||+|...+|+.||||+++...... . . .....|+++|.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999998889999999997542111 1 0 112359999999988877
Q ss_pred cceeEEeeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHH-HhcCCCceeecCCCCCCee
Q 006785 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL-HEAAAPRILHRDIKSSNIL 362 (631)
Q Consensus 284 v~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDlKp~NIL 362 (631)
.....+... ..+|||||+++++|...+.. ...+++.++..++.|++.+|.|| |+.+ |+||||||+|||
T Consensus 82 ~~p~~~~~~------~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIl 150 (190)
T cd05147 82 PCPEPILLK------SHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLL 150 (190)
T ss_pred CCCcEEEec------CCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEE
Confidence 543322111 23899999998877655322 24589999999999999999999 6888 999999999999
Q ss_pred ecCCCCeEEeccCceeec
Q 006785 363 LDENLNAKITDLGMAKRL 380 (631)
Q Consensus 363 l~~~~~~kL~DFGla~~~ 380 (631)
+++ +.++|+|||+|...
T Consensus 151 i~~-~~v~LiDFG~a~~~ 167 (190)
T cd05147 151 YHD-GKLYIIDVSQSVEH 167 (190)
T ss_pred EEC-CcEEEEEccccccC
Confidence 984 78999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.8e-21 Score=187.05 Aligned_cols=177 Identities=12% Similarity=0.128 Sum_probs=135.9
Q ss_pred HHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChH--HH------HHHHHHHHHhcCCCCCcceeEEeee
Q 006785 221 HATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNAD--SV------FLTEVDMLSRLHHCHVVPLVGYCSE 292 (631)
Q Consensus 221 ~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~--~~------~~~E~~~l~~l~H~niv~l~g~~~~ 292 (631)
...++|...++||.|+||.||++.. ++..+|||.+......... .. |.+|+..+.++.|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4478999999999999999999766 5778999999765322211 12 5789999999999999999888654
Q ss_pred ccCC----cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCC
Q 006785 293 FRGK----RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 368 (631)
Q Consensus 293 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 368 (631)
.... ....+|||||++|.+|.++.. ++. ....+++.+|..||+.+ ++|||+||+||+++.++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 2211 234799999999999988732 222 24568999999999999 99999999999999988
Q ss_pred eEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHH
Q 006785 369 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELI 429 (631)
Q Consensus 369 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLl 429 (631)
++|+|||.......+.. ...++....+..++|+|+|||++.-+.
T Consensus 173 i~liDfg~~~~~~e~~a-----------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKA-----------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhh-----------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 99999998865532210 011344556778999999999988665
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.2e-20 Score=178.07 Aligned_cols=140 Identities=22% Similarity=0.226 Sum_probs=110.9
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCC---------------------h----HHHHHHHHHHHHhcCCCCC
Q 006785 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN---------------------A----DSVFLTEVDMLSRLHHCHV 283 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~---------------------~----~~~~~~E~~~l~~l~H~ni 283 (631)
.+.||+|+||.||+|.+.+|+.||||+++...... . ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999998789999999998652110 0 1124578999999999988
Q ss_pred cceeEEeeeccCCcceEEEEEeeCCCCChHhh-hhccccCCCCHHHHHHHHHHHHhhhHHHHh-cCCCceeecCCCCCCe
Q 006785 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDC-LDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNI 361 (631)
Q Consensus 284 v~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlKp~NI 361 (631)
.....+... ..+|||||++|+++... +.. ..++..+...++.+++.+|.+||+ .+ |+||||||+||
T Consensus 82 ~~p~~~~~~------~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NI 149 (190)
T cd05145 82 PVPEPILLK------KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNI 149 (190)
T ss_pred CCceEEEec------CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhE
Confidence 544433322 13899999988865443 332 347888999999999999999999 88 99999999999
Q ss_pred eecCCCCeEEeccCceeecc
Q 006785 362 LLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 362 Ll~~~~~~kL~DFGla~~~~ 381 (631)
|++ ++.++|+|||++....
T Consensus 150 ll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 150 LYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EEE-CCCEEEEEcccceecC
Confidence 999 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.6e-20 Score=175.13 Aligned_cols=190 Identities=16% Similarity=0.069 Sum_probs=140.3
Q ss_pred cccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCC---hHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcceEEE
Q 006785 227 SGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN---ADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 227 ~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~---~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
.....|++|+||+||.+.. ++..++.+.+....... ....|.+|+++|++| +|+++++++++. ..++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~--------~~~l 75 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD--------GRHL 75 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc--------CEEE
Confidence 3456899999999997765 67888888877553311 122488999999999 568899998751 2499
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCC-CCCCeeecCCCCeEEeccCceeecc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI-KSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl-Kp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+|||+.|.+|.+.+.. ....++.|++.+|+++|++| |+|||| ||.|||++.++.++|+|||+|....
T Consensus 76 vmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 76 DRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred EEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 9999999999764321 11356789999999999999 999999 7999999999999999999998654
Q ss_pred cCCCCC---CCCC-----CcccccCCCCCCchhhhcC-CCC-cccchhhHHHHHHHHHhCCCCCCC
Q 006785 382 ADGLPS---CSSS-----PARMQGTFGYFAPEYAMVG-RAS-LMSDVFSFGVVLLELITGRQPIHR 437 (631)
Q Consensus 382 ~~~~~~---~~~~-----~~~~~Gt~~Y~APE~~~~~-~~s-~ksDVwSlGviL~eLltG~~P~~~ 437 (631)
...... .... ......++.|++|+...-. ..+ ...+.++-|.-+|.++||+.|...
T Consensus 144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 322100 0000 0012367888888855432 333 567889999999999999988654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-20 Score=210.41 Aligned_cols=255 Identities=22% Similarity=0.220 Sum_probs=176.5
Q ss_pred CccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHH--HHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDM--LSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++...+.||.+.|=.|.+|+++.|. |+||++-.....-....|.++++- ...++|||.+++..+-. .....||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~----t~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLV----TDKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHH----hhHHHHH
Confidence 5666788999999999999998887 999998766544333445544443 44559999999875533 2445688
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec--
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL-- 380 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~-- 380 (631)
|-+|. .-+|.|.|.-+ .-+...+...|+.|++.||..+|..+ |+|+|||.+||||+.-.=+.|+||..-+..
T Consensus 99 vRqyv-khnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 99 VRQYV-KHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHHH-hhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccC
Confidence 88998 56899988643 22677888999999999999999999 999999999999998777899999765421
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcC-----------CCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhh
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVG-----------RASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVL 448 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-----------~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~ 448 (631)
+.+.-........+...-..|.|||.+... ..+++-||||+||++.||++ |++||.-.. +..
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~a 246 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLA 246 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHh
Confidence 111100000000011122469999987531 15778999999999999999 788875321 111
Q ss_pred hcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006785 449 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508 (631)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 508 (631)
+......+....+.++.|+ .++.|+..|++.||.+|.++++.++.-..
T Consensus 247 Yr~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred HhccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 1111001111223334333 27789999999999999999999986443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.5e-19 Score=178.23 Aligned_cols=235 Identities=20% Similarity=0.280 Sum_probs=150.3
Q ss_pred cccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCC----------CCCcceeEEeee-
Q 006785 227 SGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHH----------CHVVPLVGYCSE- 292 (631)
Q Consensus 227 ~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H----------~niv~l~g~~~~- 292 (631)
...+.||.|+|+.||.+.+.. |+.+|||++.... .....+.+.+|.-....+.+ -.++--++...-
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 335789999999999999865 8999999986543 33345567777766655432 112211111110
Q ss_pred -------ccCCcc-----eEEEEEeeCCCCChHhhhhc---cc--cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecC
Q 006785 293 -------FRGKRA-----MRLLVFEFMPNGNLRDCLDG---VL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 355 (631)
Q Consensus 293 -------~~~~~~-----~~~lV~E~~~~gsL~~~l~~---~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD 355 (631)
...... ..+++|+-+ .+||.+++.. .. ...+....++.+..|+++.+++||..| ++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecc
Confidence 000011 347788888 6799888642 11 112445566778899999999999999 99999
Q ss_pred CCCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcC--------CCCcccchhhHHHHHHH
Q 006785 356 IKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG--------RASLMSDVFSFGVVLLE 427 (631)
Q Consensus 356 lKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~--------~~s~ksDVwSlGviL~e 427 (631)
|+|+|++++.+|.++|+||+.......... ....+..|.+||..... .++.+.|.|++|+++|.
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~--------~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYR--------CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEEE--------GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCceee--------ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 999999999999999999998776543210 02345789999977542 47889999999999999
Q ss_pred HHhCCCCCCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 006785 428 LITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDAR 496 (631)
Q Consensus 428 LltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 496 (631)
|++|+.||........... ....+. +.++.+..|+..+|+.||++|
T Consensus 243 lWC~~lPf~~~~~~~~~~~----------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW----------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG----------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc----------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999975433221110 011233 556669999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=170.21 Aligned_cols=140 Identities=19% Similarity=0.232 Sum_probs=106.4
Q ss_pred cccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-----CCCCCcceeEEeeeccCCcceEE
Q 006785 227 SGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-----HHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 227 ~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
...+.||+|+||.||. .-.++.. +||++..... .....+.+|+.+++.+ .||||++++|++.+..+......
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 3457899999999996 2223444 6998875432 2345689999999999 57999999999987544333345
Q ss_pred EEEee--CCCCChHhhhhccccCCCCHHHHHHHHHHHHhhh-HHHHhcCCCceeecCCCCCCeeecC----CCCeEEecc
Q 006785 302 LVFEF--MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL-EYLHEAAAPRILHRDIKSSNILLDE----NLNAKITDL 374 (631)
Q Consensus 302 lV~E~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivHrDlKp~NILl~~----~~~~kL~DF 374 (631)
+|+|| +.+|+|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. ++.++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 89999 5579999999652 25554 35677888777 9999999 999999999999973 347999995
Q ss_pred Cce
Q 006785 375 GMA 377 (631)
Q Consensus 375 Gla 377 (631)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=175.98 Aligned_cols=202 Identities=23% Similarity=0.264 Sum_probs=142.3
Q ss_pred CCCCCcceeEEeeec-----------------------cCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHH
Q 006785 279 HHCHVVPLVGYCSEF-----------------------RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG 335 (631)
Q Consensus 279 ~H~niv~l~g~~~~~-----------------------~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 335 (631)
+|||||++.++|.+. -+....+|+||..+ .-+|.+||..+ ..+.....-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHH
Confidence 599999999887542 12345789999999 46999999753 3577778889999
Q ss_pred HHhhhHHHHhcCCCceeecCCCCCCeee--cCCCC--eEEeccCceeecccCCCCCCC-CCCcccccCCCCCCchhhhcC
Q 006785 336 AARGLEYLHEAAAPRILHRDIKSSNILL--DENLN--AKITDLGMAKRLKADGLPSCS-SSPARMQGTFGYFAPEYAMVG 410 (631)
Q Consensus 336 ia~gL~yLH~~~~~~ivHrDlKp~NILl--~~~~~--~kL~DFGla~~~~~~~~~~~~-~~~~~~~Gt~~Y~APE~~~~~ 410 (631)
++.|+.|||.+| |.|||+|++|||| |+|.. ++|+|||.+-.-...+..... +.....-|...-||||+....
T Consensus 350 lLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 999999999999 9999999999999 44443 689999987543332221111 112234478889999988643
Q ss_pred C------CCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHH
Q 006785 411 R------ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYL 484 (631)
Q Consensus 411 ~------~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l 484 (631)
+ .-.|+|.|+.|.+-||++....||+... +..+. .. ...+-.-|. .|..++..+.+|
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG---em~L~---~r-------~Yqe~qLPa----lp~~vpp~~rql 489 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG---EMLLD---TR-------TYQESQLPA----LPSRVPPVARQL 489 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccc---hheec---hh-------hhhhhhCCC----CcccCChHHHHH
Confidence 2 2458999999999999999999997621 11110 00 111212222 344445558889
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 006785 485 AKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 485 i~~cl~~dP~~RPs~~evl~ 504 (631)
+...|+.||.+|++..-...
T Consensus 490 V~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred HHHHhcCCccccCCccHHHh
Confidence 99999999999998764444
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.4e-20 Score=197.27 Aligned_cols=225 Identities=24% Similarity=0.291 Sum_probs=177.6
Q ss_pred eeeeCceEEEEEE----ECCCcEEEEEEeccCCCCCh-HHHHHHHHHHHHhcC-CCCCcceeEEeeeccCCcceEEEEEe
Q 006785 232 VGQGGSSYVYRGQ----LTDGRIVAVKRFKTQGGPNA-DSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 232 LG~G~fG~Vy~~~----~~~g~~vAVK~l~~~~~~~~-~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
+|+|.||.|++.. .+.|..+|+|.++....... ......|..++...+ ||.+|++.-.+.. +...+++++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt----~~kl~l~ld 77 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT----DGKLYLILD 77 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc----ccchhHhhh
Confidence 7899999999864 23478899998875432221 113567888898896 9999998755543 456799999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCC
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 385 (631)
|..||+|...+... ..++..........++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++.......
T Consensus 78 ~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred hcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 99999999888654 33677777778888999999999999 99999999999999999999999999987754432
Q ss_pred CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccC
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (631)
..||..|||||++. .....+|.||||++.+||+||..||... ....|+
T Consensus 153 ---------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~---------------------~~~~Il 200 (612)
T KOG0603|consen 153 ---------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD---------------------TMKRIL 200 (612)
T ss_pred ---------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH---------------------HHHHHh
Confidence 16899999999988 5677899999999999999999999641 111121
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006785 466 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM 499 (631)
Q Consensus 466 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 499 (631)
. .....|.+.......++..++..+|..|.-.
T Consensus 201 ~--~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 201 K--AELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred h--hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1 1224677888888999999999999999654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.2e-18 Score=196.40 Aligned_cols=199 Identities=22% Similarity=0.249 Sum_probs=156.7
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC---CCCCcceeEEeeeccC
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEFRG 295 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~ 295 (631)
++.-...|.+.+.||+|+||+||+|...+|+.||+|+-+.....+ |.--.+++.+|+ -+-|..+...+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~--- 765 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVF--- 765 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHcc---
Confidence 444456788899999999999999998889999999988765443 444456667776 1223333333232
Q ss_pred CcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeec-------CCCC
Q 006785 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-------ENLN 368 (631)
Q Consensus 296 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~-------~~~~ 368 (631)
.+.-+||+||.+.|+|.++++ ..+.++|...+.++.|+++.+++||..+ |||+||||+|+||. ++..
T Consensus 766 -~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 766 -QNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred -CCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccc
Confidence 334589999999999999998 3466999999999999999999999999 99999999999993 3445
Q ss_pred eEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCC
Q 006785 369 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQ 433 (631)
Q Consensus 369 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~ 433 (631)
++|+|||-+-...--. .........+|-.+--+|+..+..++...|.|-|+-+++-||.|+.
T Consensus 840 l~lIDfG~siDm~lfp---~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFP---DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEEEecccceeeeEcC---CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 8999999885432110 0123345568889999999999999999999999999999999963
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=162.37 Aligned_cols=144 Identities=20% Similarity=0.141 Sum_probs=111.5
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCC---------------------ChHHHHHHHHHHHHh
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP---------------------NADSVFLTEVDMLSR 277 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~---------------------~~~~~~~~E~~~l~~ 277 (631)
+......|...+.||+|+||.||++...+|+.||||++...... .....+..|+.++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 33333447778999999999999999888999999987643210 011126788999999
Q ss_pred cCCCC--CcceeEEeeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecC
Q 006785 278 LHHCH--VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 355 (631)
Q Consensus 278 l~H~n--iv~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD 355 (631)
+.|++ ++..++. ...++||||++|++|...... .....++.+++.++.++|+.+ |+|||
T Consensus 90 l~~~~i~v~~~~~~--------~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~D 150 (198)
T cd05144 90 LYEEGFPVPKPIDW--------NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHGD 150 (198)
T ss_pred HHHcCCCCCceeec--------CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcCC
Confidence 98874 4444432 234899999999999775431 235678889999999999988 99999
Q ss_pred CCCCCeeecCCCCeEEeccCceeecc
Q 006785 356 IKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 356 lKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
|||+||++++++.++|+|||++....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.4e-17 Score=162.06 Aligned_cols=135 Identities=20% Similarity=0.315 Sum_probs=111.0
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccCCCCCh-------HHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNA-------DSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+.||+|++|.||+|.+ +|..|+||+......... ...+.+|+.++..+.|+++.....++.. ....++
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~----~~~~~l 76 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD----PENFII 76 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe----CCCCEE
Confidence 5699999999999988 677899998764432111 1347789999999999998776666554 234589
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
||||++|++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 77 v~e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 77 VMEYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999998642 22 88899999999999999998 99999999999999 78899999998764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.7e-19 Score=184.43 Aligned_cols=178 Identities=25% Similarity=0.382 Sum_probs=132.9
Q ss_pred ceEEEEEeeCCCCChHhhhhc-cccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCc
Q 006785 298 AMRLLVFEFMPNGNLRDCLDG-VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGl 376 (631)
.++|+.|++|...+|.+||.+ ......++...+.++.|++.|++| ++ .+|||+||.||+...+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 368999999999999999964 344568899999999999999999 66 99999999999999999999999999
Q ss_pred eeecccCCCCC-CCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccc
Q 006785 377 AKRLKADGLPS-CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRL 454 (631)
Q Consensus 377 a~~~~~~~~~~-~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~ 454 (631)
........... .....+..+||..||+||.+.+..|+.|+||||||+||+||++ =..+++.....
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~------------- 469 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATL------------- 469 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhh-------------
Confidence 88765543111 1123456789999999999999999999999999999999997 23333211100
Q ss_pred ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 006785 455 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 502 (631)
Q Consensus 455 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 502 (631)
. ..-....+|....++|.+ ..|+.+++...|.+||++.++
T Consensus 470 ~---d~r~g~ip~~~~~d~p~e-----~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 470 T---DIRDGIIPPEFLQDYPEE-----YTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred h---hhhcCCCChHHhhcCcHH-----HHHHHHhcCCCcccCchHHHH
Confidence 0 001112222222334432 467889999999999944433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.9e-17 Score=165.33 Aligned_cols=146 Identities=19% Similarity=0.164 Sum_probs=111.9
Q ss_pred hcCccccceeeeeCceEEEEEE--ECCCcEEEEEEeccCCCC-------------------C----hHHHHHHHHHHHHh
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQ--LTDGRIVAVKRFKTQGGP-------------------N----ADSVFLTEVDMLSR 277 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~--~~~g~~vAVK~l~~~~~~-------------------~----~~~~~~~E~~~l~~ 277 (631)
...|.+.+.||+|+||.||+|. ..+|+.||||+++..... . ....+..|+.++.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3457888999999999999998 457999999998754210 0 11235689999999
Q ss_pred cCCCC--CcceeEEeeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecC
Q 006785 278 LHHCH--VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 355 (631)
Q Consensus 278 l~H~n--iv~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD 355 (631)
+.+.. +.+++++. ..++||||++|++|..++... ..+...+...++.|++.+|++||+.+ .|+|||
T Consensus 107 L~~~~i~~p~~~~~~--------~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~D 174 (237)
T smart00090 107 LYEAGVPVPKPIAWR--------RNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGD 174 (237)
T ss_pred HHhcCCCCCeeeEec--------CceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCC
Confidence 97533 34444321 238999999998887765322 23566677899999999999999886 499999
Q ss_pred CCCCCeeecCCCCeEEeccCceeecc
Q 006785 356 IKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 356 lKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
|||+||+++ ++.++|+|||++....
T Consensus 175 ikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 175 LSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CChhhEEEE-CCCEEEEEChhhhccC
Confidence 999999999 7899999999987543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.9e-17 Score=158.34 Aligned_cols=131 Identities=22% Similarity=0.328 Sum_probs=103.9
Q ss_pred eeeeeCceEEEEEEECCCcEEEEEEeccCCCCC-------hHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 231 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN-------ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 231 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
.||+|+||.||+|.+ +|..|+||......... ....+.+|++++..+.|+++.....++.. ....++|
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~----~~~~~lv 75 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD----PDNKTIV 75 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE----CCCCEEE
Confidence 389999999999996 57889999865432211 12347789999999988876544444433 2345899
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
|||++|++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 76 ~e~~~g~~l~~~~~~~~-----~----~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 76 MEYIEGKPLKDVIEEGN-----D----ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEECCccHHHHHhhcH-----H----HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999999999875421 1 78999999999999998 99999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.6e-17 Score=182.34 Aligned_cols=142 Identities=20% Similarity=0.316 Sum_probs=110.9
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccC--CCC-----ChHHHHHHHHHHHHhcCCCCCcceeEEee
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQ--GGP-----NADSVFLTEVDMLSRLHHCHVVPLVGYCS 291 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 291 (631)
.......|...+.||+|+||+||+|.+.+.. +++|+.... ... .....+.+|+++++.++|++++....++.
T Consensus 328 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~ 406 (535)
T PRK09605 328 EEEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV 406 (535)
T ss_pred ccccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE
Confidence 3334455567889999999999999886443 444433211 111 11245889999999999999988776665
Q ss_pred eccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEE
Q 006785 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 371 (631)
Q Consensus 292 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL 371 (631)
. ....++||||++|++|.+++. ....++.+++.+|.|||+.+ |+||||||+|||+ +++.++|
T Consensus 407 ~----~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~l 468 (535)
T PRK09605 407 D----PEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYL 468 (535)
T ss_pred e----CCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEE
Confidence 4 234589999999999999875 35678999999999999998 9999999999999 5778999
Q ss_pred eccCceee
Q 006785 372 TDLGMAKR 379 (631)
Q Consensus 372 ~DFGla~~ 379 (631)
+|||+++.
T Consensus 469 iDFGla~~ 476 (535)
T PRK09605 469 IDFGLGKY 476 (535)
T ss_pred EeCccccc
Confidence 99999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-17 Score=186.17 Aligned_cols=211 Identities=22% Similarity=0.318 Sum_probs=143.5
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
.+|..+++|-.|++|.||..+++. .+.+|+|+-+... ++ +||..+.+ ..+.
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-------il-----------Rnilt~a~----------npfv 134 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-------IL-----------RNILTFAG----------NPFV 134 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccch-------hh-----------hccccccC----------Ccce
Confidence 567788999999999999998875 6678885422210 11 12333321 1233
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
| ||-...+..... ++. +++.+++|||+.+ |+|||+||+|.||+.-|++|++|||+++....
T Consensus 135 v------gDc~tllk~~g~--lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 135 V------GDCATLLKNIGP--LPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred e------chhhhhcccCCC--Ccc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 3 455555543222 222 2277899999998 99999999999999999999999999875432
Q ss_pred CCC--------CCC--CCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccc
Q 006785 383 DGL--------PSC--SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 452 (631)
Q Consensus 383 ~~~--------~~~--~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 452 (631)
... ... ........||+.|.|||++....|+..+|.|++|+|+||.+.|..||++..+.+-...+...
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd-- 273 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD-- 273 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh--
Confidence 111 000 11234467999999999999999999999999999999999999999876544322222111
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 006785 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP 497 (631)
Q Consensus 453 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 497 (631)
++..+.-....+. +.++++.++|+.+|..|-
T Consensus 274 ----------~i~wpE~dea~p~----Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 274 ----------DIEWPEEDEALPP----EAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ----------hccccccCcCCCH----HHHHHHHHHHHhChHhhc
Confidence 1111111222333 478889999999999994
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.5e-16 Score=147.95 Aligned_cols=137 Identities=24% Similarity=0.261 Sum_probs=99.3
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCC-hHHH----------------------HHHHHHHHHhcCCC--CC
Q 006785 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN-ADSV----------------------FLTEVDMLSRLHHC--HV 283 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~-~~~~----------------------~~~E~~~l~~l~H~--ni 283 (631)
.+.||+|+||.||+|...+|+.||||++....... .... ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999987532111 1111 13566667776443 34
Q ss_pred cceeEEeeeccCCcceEEEEEeeCCCCChHhh-hhccccCCCCHHHHHHHHHHHHhhhHHHHh-cCCCceeecCCCCCCe
Q 006785 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDC-LDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNI 361 (631)
Q Consensus 284 v~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlKp~NI 361 (631)
.+.+++. ..++||||++++++... +.... .. .....++.+++.++.++|. .+ |+|+||||+||
T Consensus 82 ~~~~~~~--------~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Ni 146 (187)
T cd05119 82 PKPIDLN--------RHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNI 146 (187)
T ss_pred CceEecC--------CCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhE
Confidence 4554431 24899999998654321 21111 11 5678899999999999999 77 99999999999
Q ss_pred eecCCCCeEEeccCceeecc
Q 006785 362 LLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 362 Ll~~~~~~kL~DFGla~~~~ 381 (631)
+++ ++.++|+|||++....
T Consensus 147 li~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 147 LVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred EEE-CCcEEEEECccccccc
Confidence 999 8899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.9e-15 Score=148.30 Aligned_cols=140 Identities=16% Similarity=0.198 Sum_probs=107.0
Q ss_pred cceee-eeCceEEEEEEECCCcEEEEEEeccCC------------CCChHHHHHHHHHHHHhcCCCCC--cceeEEeeec
Q 006785 229 SNIVG-QGGSSYVYRGQLTDGRIVAVKRFKTQG------------GPNADSVFLTEVDMLSRLHHCHV--VPLVGYCSEF 293 (631)
Q Consensus 229 ~~~LG-~G~fG~Vy~~~~~~g~~vAVK~l~~~~------------~~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~ 293 (631)
...|| .||.|+||++... +..++||++.... .......+.+|+.++.+|.|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35688 8999999999885 7789999885321 01223457889999999998875 6777765432
Q ss_pred cCCcceEEEEEeeCCC-CChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEe
Q 006785 294 RGKRAMRLLVFEFMPN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 372 (631)
Q Consensus 294 ~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~ 372 (631)
.......++||||++| .+|.+++... .++.. .+.+++.+|.+||+.| |+||||||.|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2212233699999997 6999988642 34443 3568899999999999 9999999999999998899999
Q ss_pred ccCceee
Q 006785 373 DLGMAKR 379 (631)
Q Consensus 373 DFGla~~ 379 (631)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998865
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.5e-15 Score=137.20 Aligned_cols=135 Identities=21% Similarity=0.194 Sum_probs=111.5
Q ss_pred ccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCC--CCCcceeEEeeeccCCcceEEEEEe
Q 006785 228 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH--CHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 228 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
+.+.||.|.++.||++...+ ..++||....... ...+.+|+.++..++| .++++++++... ....+++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~----~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGES----DGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC----CCccEEEEE
Confidence 35679999999999999854 7899999865433 3458999999999976 588888876654 346799999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
|++++.+..+ +......++.+++.+|++||......++|+|++|+||+++..+.++++|||++..
T Consensus 74 ~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9988877654 5566778899999999999986444599999999999999988999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.9e-16 Score=175.79 Aligned_cols=257 Identities=25% Similarity=0.290 Sum_probs=186.6
Q ss_pred CccccceeeeeCceEEEEEEECC--CcEEEEEEeccCC-CCChHHHHHHHHHHHHhcC-CCCCcceeEEeeeccCCcceE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLTD--GRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~~--g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~ 300 (631)
.|...+.||+|.|+.|-...... ...+|+|.+.... ..........|..+-+.+. |+|++.+++.... ....
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~----~~~~ 96 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS----PRSY 96 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC----Cccc
Confidence 34556679999999999887633 4567777766543 2222233445777777786 9999999987665 5577
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHH-hcCCCceeecCCCCCCeeecCCC-CeEEeccCcee
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH-EAAAPRILHRDIKSSNILLDENL-NAKITDLGMAK 378 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHrDlKp~NILl~~~~-~~kL~DFGla~ 378 (631)
+++++|..++++.+.+.......++....-....|+..++.|+| +.+ +.||||||+|.+++..+ ..+++|||+|.
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence 99999999999999883222224667778889999999999999 888 99999999999999999 99999999999
Q ss_pred eccc-CCCCCCCCCCccccc-CCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccc
Q 006785 379 RLKA-DGLPSCSSSPARMQG-TFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 455 (631)
Q Consensus 379 ~~~~-~~~~~~~~~~~~~~G-t~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 455 (631)
.+.. .+.. .......| ++.|+|||...+ .......|+||.|+++.-+++|..||+......... ..|....
T Consensus 174 ~~~~~~g~~---~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-~~~~~~~-- 247 (601)
T KOG0590|consen 174 AYRNKNGAE---RSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-SSWKSNK-- 247 (601)
T ss_pred cccccCCcc---eeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-eeecccc--
Confidence 8776 4322 22334567 999999999887 466888999999999999999999997654433211 1111110
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 456 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 456 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. ................++.+++..+|..|.+.+++...
T Consensus 248 ----------~-~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 248 ----------G-RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ----------c-ccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 0 00001111222235667788888999999999988653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.2e-13 Score=150.19 Aligned_cols=148 Identities=23% Similarity=0.235 Sum_probs=104.1
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChH-------------------------------------
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNAD------------------------------------- 265 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~------------------------------------- 265 (631)
...|. .+.||.|++|.||+|++++|+.||||+.+........
T Consensus 117 F~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~ 195 (437)
T TIGR01982 117 FAEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLR 195 (437)
T ss_pred HhhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHH
Confidence 34444 3679999999999999999999999998654211000
Q ss_pred --HHHHHHHHHHHhc----CCCCCcceeEEeeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHh-
Q 006785 266 --SVFLTEVDMLSRL----HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR- 338 (631)
Q Consensus 266 --~~~~~E~~~l~~l----~H~niv~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~- 338 (631)
-+|.+|...+.++ +|.+-+.+-.++.+.. ...+|||||++|++|.+++.... ...+ +..++..++.
T Consensus 196 ~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~---~~~vLvmE~i~G~~L~~~~~~~~-~~~~---~~~ia~~~~~~ 268 (437)
T TIGR01982 196 RELDLRREAANASELGENFKNDPGVYVPEVYWDRT---SERVLTMEWIDGIPLSDIAALDE-AGLD---RKALAENLARS 268 (437)
T ss_pred HHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhc---CCceEEEEeECCcccccHHHHHh-cCCC---HHHHHHHHHHH
Confidence 0244566555555 2333344444444322 23589999999999998765321 1222 3456666665
Q ss_pred hhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 339 gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
.+..+|..| ++|+|++|.||+++.++.++++|||++..+.
T Consensus 269 ~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 269 FLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 478899988 9999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.5e-13 Score=143.87 Aligned_cols=253 Identities=21% Similarity=0.247 Sum_probs=179.3
Q ss_pred cCccccceeee--eCceEEEEEEE---CCCcEEEEEEeccCCC-CChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCC
Q 006785 224 DKFSGSNIVGQ--GGSSYVYRGQL---TDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGK 296 (631)
Q Consensus 224 ~~f~~~~~LG~--G~fG~Vy~~~~---~~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 296 (631)
..|.....+|. |.+|.||.+.. .++..+|+|+-+.... +.....=.+|+...+.+ .|+|.++....+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~---- 189 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG---- 189 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc----
Confidence 34555677999 99999999987 3588899998554322 12222235677777777 69999997666554
Q ss_pred cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHh----hhHHHHhcCCCceeecCCCCCCeeecCC-CCeEE
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR----GLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKI 371 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kL 371 (631)
....|+-+|++ +.+|..+..... ..++...+..+..+..+ ||.++|..+ ++|-|+||.||++..+ ...++
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred CCcceeeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeec
Confidence 55679999999 689998886542 33666677777777777 999999988 9999999999999999 78999
Q ss_pred eccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcc
Q 006785 372 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 451 (631)
Q Consensus 372 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~ 451 (631)
+|||+...+.............+..|...|++||.. .+.++..+|+|++|.++.+..++..+...... ..|..
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~~ 337 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN------SSWSQ 337 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC------CCccc
Confidence 999999988776644433333444688899999954 56788899999999999999988665432110 11111
Q ss_pred cccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 452 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 452 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
- ... .+..++-......+...+..+++.+|-.|++.+.+..
T Consensus 338 ~---------r~~---~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 L---------RQG---YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred c---------ccc---cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0 000 0111111122233555788899999999999887764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=9e-13 Score=130.90 Aligned_cols=209 Identities=21% Similarity=0.283 Sum_probs=140.8
Q ss_pred HHHHhcCCCCCcceeEEeeeccC-CcceEEEEEeeCCCCChHhhhhccc--cCCCCHHHHHHHHHHHHhhhHHHHhcCCC
Q 006785 273 DMLSRLHHCHVVPLVGYCSEFRG-KRAMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAP 349 (631)
Q Consensus 273 ~~l~~l~H~niv~l~g~~~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 349 (631)
.-|-.+-|-|||++..|+.+... ......++.|||.-|+|..+|++.. ...+......+++.||..||.|||+. .|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 34555679999999999876544 3456789999999999999997643 33477788889999999999999997 47
Q ss_pred ceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHH
Q 006785 350 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELI 429 (631)
Q Consensus 350 ~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLl 429 (631)
+|+|+++.-+-|++..++-+|+.----.. ....-............|-++|.|||+-.....+..+|||+||+..+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 79999999999999999888875321111 00000000001112234678999999877777888999999999999998
Q ss_pred hCCCCCCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 430 TGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 430 tG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
.+..--.......... -. ....+..+-++. =+.++.+|++..|..||+|++++.
T Consensus 277 ilEiq~tnseS~~~~e---e~------ia~~i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVE---EN------IANVIIGLENGL------------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcceeehh---hh------hhhheeeccCcc------------ccCcCcccccCCCCCCcchhhhhc
Confidence 8764322111110000 00 000011111111 134677899999999999998864
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=7.1e-12 Score=118.43 Aligned_cols=130 Identities=17% Similarity=0.086 Sum_probs=96.3
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCc-ceeEEeeeccCCcceEEEEEeeCC
Q 006785 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRLLVFEFMP 308 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~~~~~lV~E~~~ 308 (631)
+.|+.|.++.||++... +..|++|+....... ...+..|+.+++.+.+.+++ +++.+.. ...++||||++
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~--~~~~~~E~~~l~~l~~~~~~P~~~~~~~------~~~~lv~e~i~ 74 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL--LINRENEAENSKLAAEAGIGPKLYYFDP------ETGVLITEFIE 74 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCccc--ccCHHHHHHHHHHHHHhCCCCceEEEeC------CCCeEEEEecC
Confidence 56888999999999875 778999997654321 22368899999999665554 4554322 12389999999
Q ss_pred CCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcC--CCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 309 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA--APRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 309 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
|.++.+.. . ....++.+++++|+.||..+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 75 G~~l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCcccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 98876530 1 11235678999999999886 23369999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.8e-12 Score=138.65 Aligned_cols=154 Identities=18% Similarity=0.198 Sum_probs=100.0
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCC---------------------------------Ch
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGP---------------------------------NA 264 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~---------------------------------~~ 264 (631)
++.....|+. +.||.|++|.||+|++++ |+.||||+++..... +.
T Consensus 115 ~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~ 193 (537)
T PRK04750 115 VEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEF 193 (537)
T ss_pred HHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHH
Confidence 3444556776 789999999999999987 999999999754210 00
Q ss_pred HH------HHHHHHHHHHhcC----CCCCcceeEEeeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHH
Q 006785 265 DS------VFLTEVDMLSRLH----HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 334 (631)
Q Consensus 265 ~~------~~~~E~~~l~~l~----H~niv~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ 334 (631)
.. +|.+|...+.++. +.+.+.+-.++.+. ....+|||||+.|++|.++-.-. ..+.+........
T Consensus 194 ~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~---st~~VLvmE~i~G~~l~d~~~l~-~~g~d~~~la~~~- 268 (537)
T PRK04750 194 EKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY---CSETVMVMERMYGIPVSDVAALR-AAGTDMKLLAERG- 268 (537)
T ss_pred HHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc---CCCceEEEeeecCccHHhHHHHH-hcCCCHHHHHHHH-
Confidence 01 1445555555552 44455555555443 22458999999999998752111 1122222221111
Q ss_pred HHHhhhHHHHhcCCCceeecCCCCCCeeecCCC----CeEEeccCceeeccc
Q 006785 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENL----NAKITDLGMAKRLKA 382 (631)
Q Consensus 335 ~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~----~~kL~DFGla~~~~~ 382 (631)
+..-+..++..| ++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 269 -v~~~~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 269 -VEVFFTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -HHHHHHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 111233445567 99999999999999888 899999999987643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.3e-10 Score=110.07 Aligned_cols=136 Identities=18% Similarity=0.210 Sum_probs=98.6
Q ss_pred ceeeeeCceEEEEEEECC-------CcEEEEEEeccCCC---------------------CChHHHHH----HHHHHHHh
Q 006785 230 NIVGQGGSSYVYRGQLTD-------GRIVAVKRFKTQGG---------------------PNADSVFL----TEVDMLSR 277 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~-------g~~vAVK~l~~~~~---------------------~~~~~~~~----~E~~~l~~ 277 (631)
..||.|--+.||.|...+ +..+|||+.+.... ......+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 47899999863210 01122333 79999999
Q ss_pred cCC--CCCcceeEEeeeccCCcceEEEEEeeCCCCChHh-hhhccccCCCCHHHHHHHHHHHHhhhHHH-HhcCCCceee
Q 006785 278 LHH--CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD-CLDGVLVEGMNWDTRVAIAIGAARGLEYL-HEAAAPRILH 353 (631)
Q Consensus 278 l~H--~niv~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH 353 (631)
+.. -++.+++++. ..+|||||+.+..+.. .|.. ..++..+...+..+++.+|..| |..+ |||
T Consensus 83 l~~~Gv~vP~pi~~~--------~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVH 148 (197)
T cd05146 83 MQKAGIPCPEVVVLK--------KHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECN---LVH 148 (197)
T ss_pred HHHcCCCCCeEEEec--------CCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 943 5677777642 2389999997654422 2222 1244556677889999999998 8888 999
Q ss_pred cCCCCCCeeecCCCCeEEeccCceeec
Q 006785 354 RDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 354 rDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
+||++.|||+++ +.++|+|||.+-..
T Consensus 149 GDLs~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 149 ADLSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CCCCHHHEEEEC-CcEEEEECCCceeC
Confidence 999999999974 67999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.9e-10 Score=113.39 Aligned_cols=146 Identities=21% Similarity=0.233 Sum_probs=110.6
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCC--CCCcceeEEeeeccCCcceEEEEEeeC
Q 006785 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH--CHVVPLVGYCSEFRGKRAMRLLVFEFM 307 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~~~~~lV~E~~ 307 (631)
+.|+.|.++.||++...+|..++||+............+..|++++..+.+ .++.+++.+..... .....++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~-~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS-VLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC-ccCCceEEEEEe
Confidence 568999999999999877789999997654332233458899999999965 34577777654321 112458999999
Q ss_pred CCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcC----------------------------------------
Q 006785 308 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA---------------------------------------- 347 (631)
Q Consensus 308 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 347 (631)
+|.+|.+.+.. ..++..+...++.+++++|..||+..
T Consensus 83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 99988876532 34677888888889999999998531
Q ss_pred -------------CCceeecCCCCCCeeecC--CCCeEEeccCceee
Q 006785 348 -------------APRILHRDIKSSNILLDE--NLNAKITDLGMAKR 379 (631)
Q Consensus 348 -------------~~~ivHrDlKp~NILl~~--~~~~kL~DFGla~~ 379 (631)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 56689999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.5e-11 Score=130.57 Aligned_cols=250 Identities=22% Similarity=0.215 Sum_probs=176.4
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEEC--CCcEEEEEEeccCCCCChHH-HHHHHHHHHHhc-CCCCCcceeEEeeecc
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLT--DGRIVAVKRFKTQGGPNADS-VFLTEVDMLSRL-HHCHVVPLVGYCSEFR 294 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l~~~~~~~~~~-~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 294 (631)
....+.+|..+..||.|.|+.|++...+ ++..|++|.+.........+ .-+.|+.+...+ .|.+++++...+.+.+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 4445678999999999999999998644 57899999987654333222 245677777777 6888888776666533
Q ss_pred CCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCC-CCeEEec
Q 006785 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITD 373 (631)
Q Consensus 295 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kL~D 373 (631)
..|+--|||+++++...+ .....++...++.+..|++.++.++|+.. ++|+|+||+||++..+ +..++.|
T Consensus 340 ----~~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~ 410 (524)
T KOG0601|consen 340 ----QGYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGD 410 (524)
T ss_pred ----cccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccc
Confidence 447899999999988766 23355888889999999999999999888 9999999999999876 7789999
Q ss_pred cCceeecccCCCCCCCCCCcccccCCCCC--CchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcc
Q 006785 374 LGMAKRLKADGLPSCSSSPARMQGTFGYF--APEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 451 (631)
Q Consensus 374 FGla~~~~~~~~~~~~~~~~~~~Gt~~Y~--APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~ 451 (631)
||....+.... ....+.-+++ +++......+..+.|++|||.-+.|.++|..--.. .+.|.
T Consensus 411 ~~~~t~~~~~~--------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~--------~~~~~- 473 (524)
T KOG0601|consen 411 FGCWTRLAFSS--------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES--------GVQSL- 473 (524)
T ss_pred cccccccceec--------ccccccccccccchhhccccccccccccccccccccccccCcccCcc--------cccce-
Confidence 99986532211 1112233444 55555567789999999999999999988542111 01111
Q ss_pred cccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 452 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 452 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
.+..-.-+.+ +... +.+..+.+.+...++..||.+.++.....
T Consensus 474 --------~i~~~~~p~~----~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 474 --------TIRSGDTPNL----PGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred --------eeecccccCC----CchH-HhhhhhhhhhcCCccccchhhhhhcccch
Confidence 1111111111 1111 44667788889999999999988765443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.4e-09 Score=118.30 Aligned_cols=167 Identities=18% Similarity=0.255 Sum_probs=124.4
Q ss_pred ECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeCCCCChHhhhhccccCCC
Q 006785 245 LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGM 324 (631)
Q Consensus 245 ~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l 324 (631)
..++.+|.|...+.... .......+-++.|+.|+||||++++..+.. ....|||+|.+ -.|..++...
T Consensus 34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~----~~~~ylvTErV--~Pl~~~lk~l----- 101 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEE----EGTLYLVTERV--RPLETVLKEL----- 101 (690)
T ss_pred eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcc----cCceEEEeecc--ccHHHHHHHh-----
Confidence 34588888888876654 334457788999999999999999987665 55789999998 4788887653
Q ss_pred CHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCc
Q 006785 325 NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 404 (631)
Q Consensus 325 ~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~AP 404 (631)
........+.||+.||.|||+.+ .++|++|.-.-|+++..|..||++|-++........+ .....---.|..|
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~-----~~~~~~~~s~~~P 174 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP-----AKSLYLIESFDDP 174 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc-----cccchhhhcccCh
Confidence 35566677889999999999765 4999999999999999999999999988654432110 0011111235666
Q ss_pred hhhhcCCCCcccchhhHHHHHHHHHhCC
Q 006785 405 EYAMVGRASLMSDVFSFGVVLLELITGR 432 (631)
Q Consensus 405 E~~~~~~~s~ksDVwSlGviL~eLltG~ 432 (631)
+.+.... -..|.|-||+++||++.|.
T Consensus 175 ~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 175 EEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred hhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 6443222 3469999999999999983
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.5e-09 Score=107.38 Aligned_cols=145 Identities=18% Similarity=0.140 Sum_probs=103.8
Q ss_pred eeeeeCceEEEEEEECCCcEEEEEEeccCCCCC----------hHHHHHHHHHHHHhcCCC--CCcceeEEeeeccCC-c
Q 006785 231 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN----------ADSVFLTEVDMLSRLHHC--HVVPLVGYCSEFRGK-R 297 (631)
Q Consensus 231 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~----------~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~~~~-~ 297 (631)
.+-......|++..+ +|+.|.||+........ ....+.+|...+.+|... .+++++++....... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344444455777776 57889999875432111 111378999999988443 344566665432211 2
Q ss_pred ceEEEEEeeCCCC-ChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC-------CCCe
Q 006785 298 AMRLLVFEFMPNG-NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-------NLNA 369 (631)
Q Consensus 298 ~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-------~~~~ 369 (631)
..-+||||++++. +|.+++........+......++.+++..+.-||..| |+|+|++++|||++. +..+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 3468999999876 8999986433344566778899999999999999999 999999999999975 4678
Q ss_pred EEeccCceee
Q 006785 370 KITDLGMAKR 379 (631)
Q Consensus 370 kL~DFGla~~ 379 (631)
.|+||+.++.
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998753
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.7e-09 Score=98.82 Aligned_cols=144 Identities=19% Similarity=0.263 Sum_probs=101.1
Q ss_pred ccceeeeeCceEEEEEEECCCcEEEEEEeccCC--CCCh-----HHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 228 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG--GPNA-----DSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 228 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~-----~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
...+|-+|+-+.|+++.+. |+...||.-.... .+.. ...-++|..+|.++.--.|.--.-++.+.. .-
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~----~~ 85 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY----GG 85 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC----CC
Confidence 4567889999999999984 7887777543221 1111 223678999999886544443222333322 22
Q ss_pred EEEEeeCCC-CChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCC---eEEeccCc
Q 006785 301 LLVFEFMPN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN---AKITDLGM 376 (631)
Q Consensus 301 ~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~---~kL~DFGl 376 (631)
.|+|||++| .++.+++...........-...++..|-+.+.-||..+ |||+||..+||+|..++. +.++|||+
T Consensus 86 ~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgl 162 (229)
T KOG3087|consen 86 QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGL 162 (229)
T ss_pred eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecc
Confidence 799999976 48888886644333333333678888889999999999 999999999999965443 58999999
Q ss_pred eee
Q 006785 377 AKR 379 (631)
Q Consensus 377 a~~ 379 (631)
+..
T Consensus 163 s~~ 165 (229)
T KOG3087|consen 163 SSV 165 (229)
T ss_pred hhc
Confidence 754
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3e-09 Score=99.07 Aligned_cols=131 Identities=24% Similarity=0.366 Sum_probs=93.2
Q ss_pred eeeeeCceEEEEEEECCCcEEEEEEeccC--CCCChHH-----HHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 231 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQ--GGPNADS-----VFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 231 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~-----~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
.+++|+-..+|.+.+. |..+++|.=... ..+..++ .-.+|..+|.++.--.|.--+=+..+ .....|+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD----~~~~~I~ 77 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD----PDNGLIV 77 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc----CCCCEEE
Confidence 5788999999999875 444666643322 2222222 24579999998865444322222233 3345899
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
|||++|..|.++|... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 78 me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 78 MEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999999998754 2445666666778899999 99999999999998764 99999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=6.4e-11 Score=133.62 Aligned_cols=252 Identities=21% Similarity=0.251 Sum_probs=162.4
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
+.|.+.+-+-+|.|+.++.+.-.. |...++|...... .....+....+-.++-..+||-++...-- .......
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s----~~~rsP~ 879 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS----FPCRSPL 879 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC----CCCCCCc
Confidence 445556667889999999876432 4444444433211 01111112223333333344555543321 1124467
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
+||++|..+++|...|+... ..+..-.......+.++++|||... +.|||++|.|+|+..++..+++|||+....
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred chhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 99999999999999987643 3455555566667888999999886 899999999999999999999999854322
Q ss_pred cc----CCC------------------CCC----CCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCC
Q 006785 381 KA----DGL------------------PSC----SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434 (631)
Q Consensus 381 ~~----~~~------------------~~~----~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P 434 (631)
.. .+. ... ........||+.|.+||.+.+......+|.|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 10 000 000 0112335699999999999999999999999999999999999999
Q ss_pred CCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006785 435 IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 500 (631)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 500 (631)
|............ .-..+..+ ..+........+++...+..+|.+|..+.
T Consensus 1035 ~na~tpq~~f~ni------------~~~~~~~p----~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIFENI------------LNRDIPWP----EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhhhhcc------------ccCCCCCC----CCccccChhhhhhhhhhhccCchhccCcc
Confidence 9754433211100 00111111 22334445578888889999999997765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.98 E-value=5e-09 Score=100.35 Aligned_cols=126 Identities=26% Similarity=0.285 Sum_probs=82.2
Q ss_pred EEEEEEECCCcEEEEEEeccCCC------------CC--------h-----HHHHHHHHHHHHhcCCC--CCcceeEEee
Q 006785 239 YVYRGQLTDGRIVAVKRFKTQGG------------PN--------A-----DSVFLTEVDMLSRLHHC--HVVPLVGYCS 291 (631)
Q Consensus 239 ~Vy~~~~~~g~~vAVK~l~~~~~------------~~--------~-----~~~~~~E~~~l~~l~H~--niv~l~g~~~ 291 (631)
.||.|...+|..+|||+.+.... .. . .....+|++.|.++... ++.+++.+-.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~ 80 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR 80 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence 48999998899999999864311 00 0 11256799999999766 5667765421
Q ss_pred eccCCcceEEEEEeeCC--CCChHhhhhccccCCCCHHHHHHHHHHHHhhhHH-HHhcCCCceeecCCCCCCeeecCCCC
Q 006785 292 EFRGKRAMRLLVFEFMP--NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY-LHEAAAPRILHRDIKSSNILLDENLN 368 (631)
Q Consensus 292 ~~~~~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivHrDlKp~NILl~~~~~ 368 (631)
..|||||++ |..+..+.... ++......++.+++..+.. +|..| |+|+||.+.|||++++ .
T Consensus 81 --------~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 81 --------NVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp --------TEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-C
T ss_pred --------CEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-e
Confidence 289999998 55555433321 1133455667777775555 57888 9999999999999988 9
Q ss_pred eEEeccCceeec
Q 006785 369 AKITDLGMAKRL 380 (631)
Q Consensus 369 ~kL~DFGla~~~ 380 (631)
+.|+|||.+...
T Consensus 145 ~~iIDf~qav~~ 156 (188)
T PF01163_consen 145 VYIIDFGQAVDS 156 (188)
T ss_dssp EEE--GTTEEET
T ss_pred EEEEecCcceec
Confidence 999999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.88 E-value=4.2e-08 Score=103.81 Aligned_cols=218 Identities=16% Similarity=0.224 Sum_probs=151.8
Q ss_pred CceEEEEEEE-CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeCCC-CChH
Q 006785 236 GSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN-GNLR 313 (631)
Q Consensus 236 ~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~~-gsL~ 313 (631)
...+.||+.. .||..|++|+++........ .-..-+++++++.|.|||+|..++......+.-+++||+|+++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n-k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN-KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc-cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 3467899874 47999999999544322211 1245588999999999999999887444446678999999975 4777
Q ss_pred hhhhcc-------------ccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 314 DCLDGV-------------LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 314 ~~l~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
++--.. .+...++..++.++.|+..||.++|+.| +.-+-|.+++||++.+..++|+..|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeee
Confidence 654211 1123677899999999999999999999 999999999999999999999999988776
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCC-CCccccccchhhhhcccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI-HRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~-~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
..+... | +. --.+-|.=.||.+++.|.||..-- ....... .
T Consensus 444 ~~d~~~-----------------~--le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~----------------s 485 (655)
T KOG3741|consen 444 QEDPTE-----------------P--LE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQS----------------S 485 (655)
T ss_pred cCCCCc-----------------c--hh---HHhhhhHHHHHHHHHHHhhcccccccccchHH----------------H
Confidence 554210 0 11 123568889999999999996431 1000000 0
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+. .+....+.++++++......++++ -+..+++.+
T Consensus 486 ~~~---------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 486 HLT---------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHH---------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 000 122334455777788787888876 566666654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.2e-07 Score=98.01 Aligned_cols=266 Identities=15% Similarity=0.145 Sum_probs=158.5
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEe---eeccCCcceEEEEE
Q 006785 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYC---SEFRGKRAMRLLVF 304 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~---~~~~~~~~~~~lV~ 304 (631)
.+.||+|+-+.+|-.--- +. .+-|++........ .+.+..|... .||-+-.-+.+= ....+.....-+.|
T Consensus 16 gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~----aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQ----AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CccccCCccceeeecchh-hc-hhheeecCCCchHH----HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 567999999999975321 22 34476665422221 2334445555 566443311110 01111223356778
Q ss_pred eeCCCC-ChHhhhh----ccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 305 EFMPNG-NLRDCLD----GVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 305 E~~~~g-sL~~~l~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
..+++. ...++++ ++.....+|...++++..+|.+.+-||+.| .+-+|++++|+|+.+++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 887654 2333332 122233889999999999999999999999 89999999999999999999988544332
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhh-----cCCCCcccchhhHHHHHHHHHhC-CCCCCCccccccch---hhhhc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITG-RQPIHRSITKGEES---LVLWA 450 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG-~~P~~~~~~~~~~~---~~~~~ 450 (631)
...+ ....--+|...|++||.-. +..-+...|.|-|||++++|+.| +.||.+........ -...+
T Consensus 167 ~~ng------~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 167 NANG------TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred ccCC------ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 2221 1223346889999999654 33457789999999999999996 99987532111100 00001
Q ss_pred ccccccccc-cccccCCCCCCCCCC-HHHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHhhhCCC
Q 006785 451 TPRLQDSGT-VISELPDPRLKGDFP-KEEMQIMAYLAKECLQLD--PDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 451 ~~~~~~~~~-~~~~~~~~~l~~~~~-~~~~~~l~~li~~cl~~d--P~~RPs~~evl~~L~~i~~~ 512 (631)
...+....+ .....+.| ...| ...+..+..|..+|+... +.-|||++..+..|..+...
T Consensus 241 ~g~f~ya~~~~~g~~p~P---~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 241 HGRFAYASDQRRGLKPPP---RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred cceeeechhccCCCCCCC---CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 111111100 00111111 1122 122344667777887643 56899999999888776544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=6.3e-08 Score=94.81 Aligned_cols=128 Identities=27% Similarity=0.267 Sum_probs=95.1
Q ss_pred CcEEEEEEeccCCCC------ChHHHHHHHHHHHHhcCCC--CCcceeEEeeeccCCcceEEEEEeeCCCC-ChHhhhhc
Q 006785 248 GRIVAVKRFKTQGGP------NADSVFLTEVDMLSRLHHC--HVVPLVGYCSEFRGKRAMRLLVFEFMPNG-NLRDCLDG 318 (631)
Q Consensus 248 g~~vAVK~l~~~~~~------~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~~~~~~~~~lV~E~~~~g-sL~~~l~~ 318 (631)
++.+.+|.+...... -......+|...+.+|... .+.+.+++.....+.....++|+|++++. +|.+++..
T Consensus 32 ~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~ 111 (206)
T PF06293_consen 32 GRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ 111 (206)
T ss_pred ceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh
Confidence 556666654322111 1233478899988888433 45677777765433334568999999884 89999876
Q ss_pred cccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC---CeEEeccCceeec
Q 006785 319 VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL---NAKITDLGMAKRL 380 (631)
Q Consensus 319 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~---~~kL~DFGla~~~ 380 (631)
... ++......++.+++..+.-||+.| |+|+|+++.|||++.+. .+.++||+.++..
T Consensus 112 ~~~--~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 112 WEQ--LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hcc--cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 322 566778899999999999999999 99999999999998887 7999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.4e-07 Score=91.10 Aligned_cols=144 Identities=21% Similarity=0.149 Sum_probs=107.7
Q ss_pred eeeeCceEEEEEEECCCcEEEEEEeccC--CC---CChHHHHHHHHHHHHhcCC--CCCcceeEEeeeccCCcceEEEEE
Q 006785 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQ--GG---PNADSVFLTEVDMLSRLHH--CHVVPLVGYCSEFRGKRAMRLLVF 304 (631)
Q Consensus 232 LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~---~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~~~~~lV~ 304 (631)
-|+||.+.|++-... |..+-+|+-... .. +-....|.+|+..|.+|.. -.+.+.+.+.....+....-+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 477999999998874 557999986521 11 3455669999999999943 335555532222222344568999
Q ss_pred eeCCC-CChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCC--eEEeccCceee
Q 006785 305 EFMPN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN--AKITDLGMAKR 379 (631)
Q Consensus 305 E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~--~kL~DFGla~~ 379 (631)
|-++| -||.+++......+.+...+..+..+++..+.-||+.+ +.|+|+.+.|||++.++. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97743 58999886644445677888899999999999999999 999999999999986667 99999987654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.3e-07 Score=93.30 Aligned_cols=135 Identities=21% Similarity=0.184 Sum_probs=96.6
Q ss_pred ccccceeeeeCceEEEEEEECCCcEEEEEEeccCCC---------------------CChHHHHHHHHHHHHhcCCC--C
Q 006785 226 FSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG---------------------PNADSVFLTEVDMLSRLHHC--H 282 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~---------------------~~~~~~~~~E~~~l~~l~H~--n 282 (631)
..+...||-|--+.||.|...+|.++|||.=+.... ........+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345678999999999999999999999996432210 00112367899999999655 7
Q ss_pred CcceeEEeeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCee
Q 006785 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNIL 362 (631)
Q Consensus 283 iv~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NIL 362 (631)
+.+.+++ +...+||||++|-.|...- ++....-.|+..|+.-+.-+-..| |||+|+.+=||+
T Consensus 173 VP~P~~~--------nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIl 234 (304)
T COG0478 173 VPKPIAW--------NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNIL 234 (304)
T ss_pred CCCcccc--------ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEE
Confidence 7777653 2348999999887665432 122333344444555555555677 999999999999
Q ss_pred ecCCCCeEEeccCcee
Q 006785 363 LDENLNAKITDLGMAK 378 (631)
Q Consensus 363 l~~~~~~kL~DFGla~ 378 (631)
++++|.++++||--+.
T Consensus 235 V~~dg~~~vIDwPQ~v 250 (304)
T COG0478 235 VTEDGDIVVIDWPQAV 250 (304)
T ss_pred EecCCCEEEEeCcccc
Confidence 9999999999996553
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.7e-07 Score=100.27 Aligned_cols=153 Identities=20% Similarity=0.239 Sum_probs=100.7
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChH---------------------------------
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNAD--------------------------------- 265 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~--------------------------------- 265 (631)
++.....|+. +-|+.++-|.||+|++++|+.||||+.+..-.....
T Consensus 121 iee~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~ 199 (517)
T COG0661 121 IEELFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFE 199 (517)
T ss_pred HHHHHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHH
Confidence 3444455553 578999999999999999999999998754221100
Q ss_pred ------HHHHHHHHHHHhc----CCCCCcceeEEeeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHH
Q 006785 266 ------SVFLTEVDMLSRL----HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG 335 (631)
Q Consensus 266 ------~~~~~E~~~l~~l----~H~niv~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 335 (631)
-+|.+|..-+.++ ++..-+++-.++.+.. ....|+|||++|-.+.+...-.. .+++...+.....+
T Consensus 200 ~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t---~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~ 275 (517)
T COG0661 200 KRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYT---TRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVR 275 (517)
T ss_pred HHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhcc---CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHH
Confidence 0144455555554 2333334444554432 24589999999999998853222 34664444433333
Q ss_pred HHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 336 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 336 ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+. +..+-..| ++|.|..|.||+++.++.+.+.|||+...+.
T Consensus 276 ~f--~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 276 AF--LRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HH--HHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 22 23333356 9999999999999999999999999987654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=3.5e-08 Score=108.01 Aligned_cols=154 Identities=22% Similarity=0.312 Sum_probs=101.0
Q ss_pred HHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC-CCCCC---CCCCcccccCCCCCCchhhhc
Q 006785 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD-GLPSC---SSSPARMQGTFGYFAPEYAMV 409 (631)
Q Consensus 334 ~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~-~~~~~---~~~~~~~~Gt~~Y~APE~~~~ 409 (631)
.+++.||.|+|... .+||++|.|++|.++.++..||+.|+.+...... .++-. ...+.-.+-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34558999999754 6999999999999999999999999987654431 11100 011112334578999999999
Q ss_pred CCCCcccchhhHHHHHHHHHhCCCCCCCcc-ccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHh
Q 006785 410 GRASLMSDVFSFGVVLLELITGRQPIHRSI-TKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKEC 488 (631)
Q Consensus 410 ~~~s~ksDVwSlGviL~eLltG~~P~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~c 488 (631)
...+.++|+||+|+++|.+..|..+..... ......+. ...+..-...++.+.+.++.+=+.++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~---------------~~~~~~~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS---------------RNLLNAGAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh---------------hcccccccccccccCcHHHHHHHHHH
Confidence 889999999999999999996554432211 11111100 00000000112233344466677888
Q ss_pred cccCCCCCCCHHHHHH
Q 006785 489 LQLDPDARPTMSEVVQ 504 (631)
Q Consensus 489 l~~dP~~RPs~~evl~ 504 (631)
+..++.-||++.++..
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 9999999998877654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.39 E-value=6.1e-06 Score=80.93 Aligned_cols=154 Identities=23% Similarity=0.304 Sum_probs=104.5
Q ss_pred eecHHHHHHHhcCccccceee---eeCceEEEEEEECCCcEEEEEEeccCCCCCh------------------HHH----
Q 006785 213 RFSYSALEHATDKFSGSNIVG---QGGSSYVYRGQLTDGRIVAVKRFKTQGGPNA------------------DSV---- 267 (631)
Q Consensus 213 ~~s~~~l~~a~~~f~~~~~LG---~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~------------------~~~---- 267 (631)
..++..|....++..+....| .|--..||+|...++..+|||+++.....-. ...
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 345666777777777766665 5666789999988899999999975421100 000
Q ss_pred -HHHHHHHHHhcC--CCCCcceeEEeeeccCCcceEEEEEeeCCCCCh-HhhhhccccCCCCHHHHHHHHHHHHhhhHHH
Q 006785 268 -FLTEVDMLSRLH--HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNL-RDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 343 (631)
Q Consensus 268 -~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL 343 (631)
...|+.-|+++. +-.+.+-+++.. -.|||||+....+ .-.|... ++...+...+..++++.|.-|
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~~--------nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l 182 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFRN--------NVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRL 182 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeecC--------CeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHH
Confidence 345888888883 445566665432 2799999954311 1111111 123335777788888888888
Q ss_pred Hh-cCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 344 HE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 344 H~-~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
-. .+ +||+||..=|||+. ++.+.|+|||-|....
T Consensus 183 ~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 183 YKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 76 66 99999999999999 7799999999886543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=2.8e-06 Score=93.07 Aligned_cols=152 Identities=18% Similarity=0.190 Sum_probs=96.5
Q ss_pred HHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChH----------------------------------
Q 006785 220 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNAD---------------------------------- 265 (631)
Q Consensus 220 ~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~---------------------------------- 265 (631)
+.....|+ .+-||.-+.|.||+|++++|+.||||+-+..-.....
T Consensus 158 e~if~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~ 236 (538)
T KOG1235|consen 158 EDIFSEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP 236 (538)
T ss_pred HHHHHhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence 34444554 3568999999999999999999999997654221100
Q ss_pred --HHHHHHHHHHHhc----CCCC---CcceeEEeeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHH
Q 006785 266 --SVFLTEVDMLSRL----HHCH---VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA 336 (631)
Q Consensus 266 --~~~~~E~~~l~~l----~H~n---iv~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i 336 (631)
-+|.+|.+-..++ .|-+ -|.+-.++.+. .....|+||||+|..+.|.-. ....+++...+..-+.++
T Consensus 237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~---st~RVLtME~~~G~~i~Dl~~-i~~~gi~~~~i~~~l~~~ 312 (538)
T KOG1235|consen 237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL---STKRVLTMEYVDGIKINDLDA-IDKRGISPHDILNKLVEA 312 (538)
T ss_pred hhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc---CcceEEEEEecCCccCCCHHH-HHHcCCCHHHHHHHHHHH
Confidence 0144555433333 4555 12222333332 235699999999998877532 122346666555544444
Q ss_pred HhhhHHHHhcCCCceeecCCCCCCeeecC----CCCeEEeccCceeecc
Q 006785 337 ARGLEYLHEAAAPRILHRDIKSSNILLDE----NLNAKITDLGMAKRLK 381 (631)
Q Consensus 337 a~gL~yLH~~~~~~ivHrDlKp~NILl~~----~~~~kL~DFGla~~~~ 381 (631)
..-+ |=..| ++|.|-.|.||+++. ++.+.+.|||+.....
T Consensus 313 ~~~q--If~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 313 YLEQ--IFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHHH--HHhcC---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 3222 22335 999999999999983 6779999999987654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.1e-05 Score=78.39 Aligned_cols=142 Identities=14% Similarity=0.198 Sum_probs=93.0
Q ss_pred HhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHH---------HHHHHHHHHhcCCC---CCcceeEE
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV---------FLTEVDMLSRLHHC---HVVPLVGY 289 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~---------~~~E~~~l~~l~H~---niv~l~g~ 289 (631)
...+|...+++-......|.+-.. +|..+++|..+.... ...+. ..+.+..+.++... ....++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~-r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENR-RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhh-hHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 457788778887777777777766 478899998775432 12222 23344444444322 22232222
Q ss_pred eeec-cCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCC
Q 006785 290 CSEF-RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 368 (631)
Q Consensus 290 ~~~~-~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 368 (631)
.... ..-....+|||||++|..|.++.. ++. .++..++.+|.-||..| ++|+|..|.|++++++ .
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-c
Confidence 2211 111234578999999988877542 222 24556778899999999 9999999999999965 5
Q ss_pred eEEeccCceee
Q 006785 369 AKITDLGMAKR 379 (631)
Q Consensus 369 ~kL~DFGla~~ 379 (631)
++++||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.29 E-value=6.8e-06 Score=81.35 Aligned_cols=145 Identities=21% Similarity=0.236 Sum_probs=86.2
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCC--CCcceeEEeeeccCCcceEEEEEeeC
Q 006785 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC--HVVPLVGYCSEFRGKRAMRLLVFEFM 307 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~~~~~~~~~lV~E~~ 307 (631)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++.+.... ......+++|+++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~-~~~~~~~~~~~~i 77 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD-EFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET-EETSEEEEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccc-cccccceEEEEEe
Confidence 568999999999999876 68999997543 3344578999999988533 356777654332 2233579999999
Q ss_pred CCCChHh----------------hh---hccc--cCCCCHHH---------HHHH------------HHHHHh-hhHHHH
Q 006785 308 PNGNLRD----------------CL---DGVL--VEGMNWDT---------RVAI------------AIGAAR-GLEYLH 344 (631)
Q Consensus 308 ~~gsL~~----------------~l---~~~~--~~~l~~~~---------~~~i------------~~~ia~-gL~yLH 344 (631)
+|..+.. .+ +... ...+.+.. .... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9998887 11 1110 01111111 0000 111222 333443
Q ss_pred hc----CCCceeecCCCCCCeeec-CCCCeEEeccCceee
Q 006785 345 EA----AAPRILHRDIKSSNILLD-ENLNAKITDLGMAKR 379 (631)
Q Consensus 345 ~~----~~~~ivHrDlKp~NILl~-~~~~~kL~DFGla~~ 379 (631)
.. ....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 31 344699999999999999 556667999998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.26 E-value=3.8e-06 Score=80.78 Aligned_cols=102 Identities=23% Similarity=0.266 Sum_probs=83.1
Q ss_pred HHHHHHHHhcCC-CCCcceeEEeeeccCCcceEEEEEeeCCCCChHhh---hhccccCCCCHHHHHHHHHHHHhhhHHHH
Q 006785 269 LTEVDMLSRLHH-CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDC---LDGVLVEGMNWDTRVAIAIGAARGLEYLH 344 (631)
Q Consensus 269 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~gL~yLH 344 (631)
..|.-+|+.+++ +++++++|+|-. ++|.||...+++... +... ...+|..+.+||.++++.+++|+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~--------~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~ 76 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR--------FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELD 76 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC--------EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHh
Confidence 468889999965 699999999965 789999987766421 1111 22589999999999999999999
Q ss_pred hcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 345 ~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
+.....+.-.|++++|+-+++++++|++|...+-..
T Consensus 77 ~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 77 HGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 865555899999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.5e-05 Score=79.19 Aligned_cols=139 Identities=13% Similarity=0.167 Sum_probs=81.8
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCC--CcceeEEeeeccCCcceEEEEEeeC
Q 006785 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH--VVPLVGYCSEFRGKRAMRLLVFEFM 307 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~~~~~lV~E~~ 307 (631)
..||.|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++... .....+|||++
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~----~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVED----GGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEec----CCeeeeeeeec
Confidence 46899999999984 24567888876532 2233688999999986443 3566666543 33457899999
Q ss_pred CCCC-hHhhh---------------------hccccCCCCHHHHHH-HHH----------HHHh-hhHHHHhc-CCCcee
Q 006785 308 PNGN-LRDCL---------------------DGVLVEGMNWDTRVA-IAI----------GAAR-GLEYLHEA-AAPRIL 352 (631)
Q Consensus 308 ~~gs-L~~~l---------------------~~~~~~~l~~~~~~~-i~~----------~ia~-gL~yLH~~-~~~~iv 352 (631)
+|.+ +...+ +.............. +.. .+.. ...+|... ..+.++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 8864 22111 110001111111100 000 0001 12222211 124578
Q ss_pred ecCCCCCCeeecCCCCeEEeccCceee
Q 006785 353 HRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 353 HrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
|+|+.|.||++++++ +.|+||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999887 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.9e-05 Score=73.45 Aligned_cols=128 Identities=19% Similarity=0.199 Sum_probs=89.4
Q ss_pred ccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCc-ceeEEeeeccCCcceEEEEEee
Q 006785 228 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRLLVFEF 306 (631)
Q Consensus 228 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~~~~~lV~E~ 306 (631)
..+.|++|++|.||++.+. |..+|+|+-..+. ....+..|.++|..+.-.++. +++.|-.+ ++.|||
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds---~r~~l~kEakiLeil~g~~~~p~vy~yg~~--------~i~me~ 93 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS---PRRNLEKEAKILEILAGEGVTPEVYFYGED--------FIRMEY 93 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCCc---chhhHHHHHHHHHHhhhcCCCceEEEechh--------hhhhhh
Confidence 3567999999999999996 5579999876543 334589999999999877765 45554332 567999
Q ss_pred CCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCC-CCCeeecCCCCeEEeccCceee
Q 006785 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK-SSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 307 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK-p~NILl~~~~~~kL~DFGla~~ 379 (631)
+.|-.|.+.-.. .+..+...++ ..---|-..| |-|..|. |..++|-.+..+.|+||.-|+.
T Consensus 94 i~G~~L~~~~~~-----~~rk~l~~vl----E~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIG-----GDRKHLLRVL----EKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhc-----ccHHHHHHHH----HHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 998888876542 1333333333 3323344456 8999985 5555555555999999998874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.10 E-value=5.6e-07 Score=97.66 Aligned_cols=184 Identities=17% Similarity=0.122 Sum_probs=129.5
Q ss_pred cccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCC-CcceeEEeeeccCCcceEEEEEe
Q 006785 227 SGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH-VVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 227 ~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~~~~~lV~E 305 (631)
...+-+++|+.+.+||.+....+...++.+... ....-++++|.+++||| .++.++-+. .+.+.+++++
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~----~E~~~~i~~~ 314 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYD----GEDYLWIPMR 314 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCC----cccccchhhh
Confidence 334457889999999987654444446655433 22456899999999999 444443222 3567899999
Q ss_pred eCCCC-ChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCC
Q 006785 306 FMPNG-NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (631)
Q Consensus 306 ~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~ 384 (631)
++.+| +-..-... ....+...+...+...-++++++||+.. =+|+| ||+..+ +..+.+||+.+..+....
T Consensus 315 i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 315 ICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hhcCCccccccCCh-hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence 99877 22221111 1112444455566667788999999864 48999 887766 578999999987765432
Q ss_pred CCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCC
Q 006785 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 435 (631)
Q Consensus 385 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~ 435 (631)
......+|+.|+|||+.....+..+.|+|++|+--.++--|-+|-
T Consensus 386 ------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 ------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 345567999999999999999999999999998766776666554
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.07 E-value=5.2e-05 Score=89.58 Aligned_cols=83 Identities=13% Similarity=0.215 Sum_probs=58.8
Q ss_pred cceeeeeCceEEEEEEECCC---cEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCC--cceeEEeeeccCCcceEEE
Q 006785 229 SNIVGQGGSSYVYRGQLTDG---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHV--VPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~~g---~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~~~~~~~~~l 302 (631)
.+.|+.|.+..+|+....++ ..+++|+............+.+|+++|+.+. |.++ .+++++|.+... ....|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v-~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV-IGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc-CCCceE
Confidence 46788999999999887654 4678887654332233345889999999995 6765 778887765321 134689
Q ss_pred EEeeCCCCCh
Q 006785 303 VFEFMPNGNL 312 (631)
Q Consensus 303 V~E~~~~gsL 312 (631)
||||++|..+
T Consensus 122 VME~v~G~~~ 131 (822)
T PLN02876 122 IMEYLEGRIF 131 (822)
T ss_pred EEEecCCccc
Confidence 9999987653
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.04 E-value=4.8e-05 Score=76.39 Aligned_cols=138 Identities=22% Similarity=0.180 Sum_probs=82.2
Q ss_pred eeeeCc-eEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCCcceeEEeeeccCCcceEEEEEeeCCC
Q 006785 232 VGQGGS-SYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309 (631)
Q Consensus 232 LG~G~f-G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~~lV~E~~~~ 309 (631)
|-.|.. ..||+.... +..+.||+..... ...+.+|+++++.+. +--+.+++++... ....++|||+++|
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~----~~~~~lv~e~i~G 76 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSD----DGRAWLLTSAVPG 76 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEec----CCccEEEEEeeCC
Confidence 444555 789999764 4778889876542 223678999999883 4345567765543 2345899999999
Q ss_pred CChHhhh-------------------hccccC--CCC--HHHHHHHHHH--------------------HHhhhHHHHh-
Q 006785 310 GNLRDCL-------------------DGVLVE--GMN--WDTRVAIAIG--------------------AARGLEYLHE- 345 (631)
Q Consensus 310 gsL~~~l-------------------~~~~~~--~l~--~~~~~~i~~~--------------------ia~gL~yLH~- 345 (631)
.+|.... +..... ++. .......... +...+..|-.
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 8876432 111000 111 0011100000 1111122211
Q ss_pred ---cCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 346 ---AAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 346 ---~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
...+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 123568999999999999998778899999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.99 E-value=8.3e-05 Score=71.47 Aligned_cols=130 Identities=25% Similarity=0.391 Sum_probs=92.5
Q ss_pred cCccccceeeeeCc-eEEEEEEECCCcEEEEEEecc---CCC-------C----------ChHHHHHHHHHHHHhcC---
Q 006785 224 DKFSGSNIVGQGGS-SYVYRGQLTDGRIVAVKRFKT---QGG-------P----------NADSVFLTEVDMLSRLH--- 279 (631)
Q Consensus 224 ~~f~~~~~LG~G~f-G~Vy~~~~~~g~~vAVK~l~~---~~~-------~----------~~~~~~~~E~~~l~~l~--- 279 (631)
..++..+.||.|.- |.||+++.. |+.+|+|++.. ... . ....-|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67777899999999 999999994 78999999321 100 0 01123888999888884
Q ss_pred CCCC--cceeEEeeecc--------------CCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHH
Q 006785 280 HCHV--VPLVGYCSEFR--------------GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 343 (631)
Q Consensus 280 H~ni--v~l~g~~~~~~--------------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL 343 (631)
+.++ |+.+||..-.. .......||.||.+... .+... -+.+|.+-|..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~----~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIR----DIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchh----HHHHHHHHHHHH
Confidence 4466 89999985431 11234578899886543 12222 345666778889
Q ss_pred HhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 344 H~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCC---eeeccCcccccc-----CCEEEecccC
Confidence 9999 999999999997 5689999864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00026 Score=73.43 Aligned_cols=79 Identities=11% Similarity=0.061 Sum_probs=56.6
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCC---CCCcceeEEeeeccCCcceEEEEEe
Q 006785 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH---CHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
.+.||.|..+.||+....+++ ++||..+... ....|..|.+.|+.|.- -.+.++++++..... ....+||||
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~-~g~~~LVmE 93 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGN-PMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS-PGPDVLLLE 93 (297)
T ss_pred eeecCCccceeEEEEEcCCCC-EEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc-CCCeEEEEe
Confidence 467999999999999876564 6777754311 12358999999999943 367788887754221 234699999
Q ss_pred eCCCCCh
Q 006785 306 FMPNGNL 312 (631)
Q Consensus 306 ~~~~gsL 312 (631)
+++|+++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00039 Score=69.27 Aligned_cols=73 Identities=15% Similarity=0.145 Sum_probs=48.6
Q ss_pred ceeeeeCceEEEEEEECC--CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCc-ceeEEeeeccCCcceEEEEEee
Q 006785 230 NIVGQGGSSYVYRGQLTD--GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRLLVFEF 306 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~--g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~~~~~lV~E~ 306 (631)
+.|..|-...+|+....+ +..|++|+........ ....+|+.+++.+....++ ++++... -.+||||
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~--~d~~~E~~~~~~l~~~gl~P~v~~~~~--------~~~l~e~ 73 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI--IDRERELRIHKLLSKHGLAPKLYATFQ--------NGLIYEF 73 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce--ecHHHHHHHHHHHHhCCCCCeEEEEeC--------CcEEEEe
Confidence 457778889999998764 6789999776432211 1235799999998544444 4443321 1479999
Q ss_pred CCCCCh
Q 006785 307 MPNGNL 312 (631)
Q Consensus 307 ~~~gsL 312 (631)
++|-++
T Consensus 74 i~G~~l 79 (235)
T cd05157 74 IPGRTL 79 (235)
T ss_pred eCCCcC
Confidence 998776
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.0002 Score=71.48 Aligned_cols=76 Identities=17% Similarity=0.155 Sum_probs=46.0
Q ss_pred ceeeeeCce-EEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCC---CCcceeEEeeeccCCcceEEEEEe
Q 006785 230 NIVGQGGSS-YVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC---HVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 230 ~~LG~G~fG-~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
+.|+.|+.. .||+. +..+++|..... .....+.+|.++|..|... -+.++++...... .....+++|+
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~---~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~-~~~~~~~l~~ 74 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA---GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGE-GYPWPWSVYR 74 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc---chHHHHHHHHHHHHHHhccCCCCCCceeecCCCcc-CCCcceEEEE
Confidence 456766665 59975 234777865432 1233588999999988532 3444444332211 1124589999
Q ss_pred eCCCCChH
Q 006785 306 FMPNGNLR 313 (631)
Q Consensus 306 ~~~~gsL~ 313 (631)
+++|.++.
T Consensus 75 ~i~G~~l~ 82 (235)
T cd05155 75 WLEGETAT 82 (235)
T ss_pred eecCCCCC
Confidence 99997774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.0001 Score=85.68 Aligned_cols=201 Identities=21% Similarity=0.185 Sum_probs=138.6
Q ss_pred HHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcC
Q 006785 268 FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 347 (631)
Q Consensus 268 ~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 347 (631)
...|.+.+.++.|+|++.+++|..+.....-...+..+++..-++...+... ...+..+.+.+..++..||.|+|+..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 4557777888899999999998876443332334567888888888888754 45788999999999999999999985
Q ss_pred CCceeecCCCCC---CeeecCCCCeEEe--ccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCC--Ccccchhh
Q 006785 348 APRILHRDIKSS---NILLDENLNAKIT--DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA--SLMSDVFS 420 (631)
Q Consensus 348 ~~~ivHrDlKp~---NILl~~~~~~kL~--DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~--s~ksDVwS 420 (631)
..|.-|..+ +-..+..+.+.++ ||+.+..+...... ....-+..|.+||......+ ....|+|.
T Consensus 307 ---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~------~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 307 ---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS------FSDLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred ---cceeEEecccccccccCccceeecchhhhcccccCCCcccc------hhhcCccccccccccccccchhhhhhHHHH
Confidence 666666555 5555666777777 88888766543221 11123456788887765554 44579999
Q ss_pred HHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006785 421 FGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 500 (631)
Q Consensus 421 lGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 500 (631)
+|..+..+..|..+-... ..+.+-+...... .+......|+..++++|+++.
T Consensus 378 lgll~~~~~~~~~i~~~~------------------------~~~~~~l~~~~~~----~~~d~~~~~~~~~~~~Rl~~~ 429 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKS------------------------AVPVSLLDVLSTS----ELLDALPKCLDEDSEERLSAL 429 (1351)
T ss_pred HHHHHhhhhhcCcccccc------------------------cchhhhhccccch----hhhhhhhhhcchhhhhccchh
Confidence 999999999876543111 0111111111111 366777889999999999999
Q ss_pred HHHHHHh
Q 006785 501 EVVQILS 507 (631)
Q Consensus 501 evl~~L~ 507 (631)
+++....
T Consensus 430 ~ll~~~f 436 (1351)
T KOG1035|consen 430 ELLTHPF 436 (1351)
T ss_pred hhhhchh
Confidence 9987543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.0011 Score=64.24 Aligned_cols=133 Identities=22% Similarity=0.307 Sum_probs=88.4
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCC---------------CCChHHHHHHHHHHHHhcC------CCCCccee
Q 006785 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG---------------GPNADSVFLTEVDMLSRLH------HCHVVPLV 287 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~---------------~~~~~~~~~~E~~~l~~l~------H~niv~l~ 287 (631)
...||+|+.-.||.-- +.....||+..... ......++.+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~HP--~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP--DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEECC--CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 4679999999999853 34557888877654 1122345677777776666 78899999
Q ss_pred EEeeeccCCcceEEEEEeeCCC------CChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCe
Q 006785 288 GYCSEFRGKRAMRLLVFEFMPN------GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNI 361 (631)
Q Consensus 288 g~~~~~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NI 361 (631)
|+.....+ .-+|+|.+.+ .+|.+++.. ..++. .....+. .-..||-+.+ |+.+||+|.||
T Consensus 84 G~veT~~G----~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NI 149 (199)
T PF10707_consen 84 GFVETNLG----LGLVVELIRDADGNISPTLEDYLKE---GGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNI 149 (199)
T ss_pred EEEecCCc----eEEEEEEEECCCCCcCccHHHHHHc---CCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccE
Confidence 99876443 4677777632 267777754 23554 3333333 3346677776 99999999999
Q ss_pred eecCC---C-CeEEec-cCce
Q 006785 362 LLDEN---L-NAKITD-LGMA 377 (631)
Q Consensus 362 Ll~~~---~-~~kL~D-FGla 377 (631)
++..+ . .+.|+| ||-.
T Consensus 150 v~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 150 VVQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred EEEecCCCceEEEEEeCCCCc
Confidence 99532 2 467777 4543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00031 Score=71.18 Aligned_cols=137 Identities=14% Similarity=0.074 Sum_probs=79.0
Q ss_pred eeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCC-cceeEEeeeccCCcceEEEEEeeCCCC
Q 006785 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGYCSEFRGKRAMRLLVFEFMPNG 310 (631)
Q Consensus 232 LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~~~~~lV~E~~~~g 310 (631)
+..|-.+.+|+... ++..+++|+.......-. ....+|..+++.+....+ .++++... -++||||++|.
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~i~~~~--------~~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALG-VDRQREYQILQALSALGLAPKPILVNE--------HWLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCccccccc-CcHHHHHHHHHHHHhcCCCCceEEEeC--------CEEEEEeccCc
Confidence 45577889999874 577888987654322110 125789999999954434 34544321 17899999987
Q ss_pred ChHhh-----------------hhccc--cCCCCHHHHH-HHHHH---------HHhhhHHHHhcC-----CCceeecCC
Q 006785 311 NLRDC-----------------LDGVL--VEGMNWDTRV-AIAIG---------AARGLEYLHEAA-----APRILHRDI 356 (631)
Q Consensus 311 sL~~~-----------------l~~~~--~~~l~~~~~~-~i~~~---------ia~gL~yLH~~~-----~~~ivHrDl 356 (631)
.+..- |+... ..+++..... ....+ +...++.+-... .+.++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 66421 11111 1112222111 11111 111122222211 235899999
Q ss_pred CCCCeeecCCCCeEEeccCceee
Q 006785 357 KSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 357 Kp~NILl~~~~~~kL~DFGla~~ 379 (631)
.|.||++++++ +.|+||..|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999876 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.003 Score=67.76 Aligned_cols=76 Identities=21% Similarity=0.196 Sum_probs=53.8
Q ss_pred ceeeeeCceEEEEEEECCC-cEEEEEEeccC-----C-CCChHHHHHHHHHHHHhc-C--CCCCcceeEEeeeccCCcce
Q 006785 230 NIVGQGGSSYVYRGQLTDG-RIVAVKRFKTQ-----G-GPNADSVFLTEVDMLSRL-H--HCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~g-~~vAVK~l~~~-----~-~~~~~~~~~~E~~~l~~l-~--H~niv~l~g~~~~~~~~~~~ 299 (631)
+.||.|.+..||++...+| +.|+||.-... . .+.....+..|.+.|..+ . ..++++++.+.. ..
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~------~~ 105 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE------EL 105 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC------CC
Confidence 5689999999999998877 58999985421 1 122344577888888887 2 346777876632 34
Q ss_pred EEEEEeeCCCCC
Q 006785 300 RLLVFEFMPNGN 311 (631)
Q Consensus 300 ~~lV~E~~~~gs 311 (631)
.++||||+++..
T Consensus 106 ~~lVME~L~~~~ 117 (401)
T PRK09550 106 AVTVMEDLSDHK 117 (401)
T ss_pred CEEEEecCCCcc
Confidence 589999998644
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0013 Score=68.26 Aligned_cols=139 Identities=22% Similarity=0.266 Sum_probs=82.8
Q ss_pred ceeeeeCceEEEEEEECC-------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCC-cceeEEeeeccCCcceEE
Q 006785 230 NIVGQGGSSYVYRGQLTD-------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~-------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~~~~~ 301 (631)
+.|..|-...+|+....+ ++.+++|+...... ......+|.+++..+....+ .++++++.. .
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~--------~ 73 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE--LLIDRERELVVFARLSERNLGPKLYGIFPN--------G 73 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc--ceechHHHHHHHHHHHhCCCCCceEEEeCC--------C
Confidence 345557778999988654 57899999765422 11235789999998854333 355554421 3
Q ss_pred EEEeeCCCCChHhh-----------------hhccccC-------CC--CHHHHHH------------------------
Q 006785 302 LVFEFMPNGNLRDC-----------------LDGVLVE-------GM--NWDTRVA------------------------ 331 (631)
Q Consensus 302 lV~E~~~~gsL~~~-----------------l~~~~~~-------~l--~~~~~~~------------------------ 331 (631)
+|+||++|..+... |+..... .. -|.....
T Consensus 74 ~v~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (302)
T cd05156 74 RIEEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVEL 153 (302)
T ss_pred chhheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhH
Confidence 68999988776431 1111111 00 0111100
Q ss_pred --HHHHHHhhhHHHHh------cCCCceeecCCCCCCeeecCC----CCeEEeccCcee
Q 006785 332 --IAIGAARGLEYLHE------AAAPRILHRDIKSSNILLDEN----LNAKITDLGMAK 378 (631)
Q Consensus 332 --i~~~ia~gL~yLH~------~~~~~ivHrDlKp~NILl~~~----~~~kL~DFGla~ 378 (631)
+...+..-+.+|-. .....++|+|+.+.|||++++ +.+.++||..|.
T Consensus 154 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 154 SLFLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 11122223334432 123468999999999999875 789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0016 Score=67.29 Aligned_cols=145 Identities=14% Similarity=0.104 Sum_probs=84.5
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCC--CcceeEEeee--ccCCcceEEEEE
Q 006785 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH--VVPLVGYCSE--FRGKRAMRLLVF 304 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~--~~~~~~~~~lV~ 304 (631)
.+.|..|....+|+....+ ..+++|+.... .......|+.++..|.+.. +.+++..... ........++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV----SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCCC----ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 4557778778999987654 46888987641 1234677888888884433 4454432100 000123458999
Q ss_pred eeCCCCChHh----hh----------hccc----c-----CCCCHHHHHH----------HHHHHHhhhHHHHhc----C
Q 006785 305 EFMPNGNLRD----CL----------DGVL----V-----EGMNWDTRVA----------IAIGAARGLEYLHEA----A 347 (631)
Q Consensus 305 E~~~~gsL~~----~l----------~~~~----~-----~~l~~~~~~~----------i~~~ia~gL~yLH~~----~ 347 (631)
+|++|..+.. .+ +... . ....|..... ....+...+.++... .
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999877532 00 1100 0 0122322210 111233444555431 1
Q ss_pred CCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 348 APRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 348 ~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
+..++|+|+.|.|||++++..+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 2359999999999999988777899999864
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0058 Score=63.94 Aligned_cols=144 Identities=15% Similarity=0.152 Sum_probs=76.3
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCC--CcceeEEeee--ccCCcceEEEEEe
Q 006785 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH--VVPLVGYCSE--FRGKRAMRLLVFE 305 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~--~~~~~~~~~lV~E 305 (631)
+.|+.|....+|+....+| .+++|++. .... .....|+.++..|.... +.+.+..... ........+++++
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFE-RLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEec-cCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 4566777789999987655 68889875 2111 22445666666663222 3343321000 0001234689999
Q ss_pred eCCCCChHh-----------hh---hccc---------cCCCCH-HHHHHH------------H-HHHHhhhHHHHhc--
Q 006785 306 FMPNGNLRD-----------CL---DGVL---------VEGMNW-DTRVAI------------A-IGAARGLEYLHEA-- 346 (631)
Q Consensus 306 ~~~~gsL~~-----------~l---~~~~---------~~~l~~-~~~~~i------------~-~~ia~gL~yLH~~-- 346 (631)
|++|..+.. .| +... ...+.| .....- . ..+...++.+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 998875421 11 1110 001112 111111 1 1111122233211
Q ss_pred --CCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 347 --AAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 347 --~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
-+..+||+|+.|.|||++++...-|+||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23459999999999999977556899999875
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0075 Score=62.79 Aligned_cols=146 Identities=13% Similarity=0.129 Sum_probs=82.0
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCC--CcceeEEeee--ccCCcceEEEEE
Q 006785 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH--VVPLVGYCSE--FRGKRAMRLLVF 304 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~--~~~~~~~~~lV~ 304 (631)
.+.++.|....+|+....+| .+++|+...... ......|++++..|.... +.+++..... ........++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCC---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 34567777789999876545 577888754321 223556777777774322 4444432110 000123568999
Q ss_pred eeCCCCChHh-----------h---hhccccC----------CCCHHHHHH------------HHHHHHhhhHHHHh---
Q 006785 305 EFMPNGNLRD-----------C---LDGVLVE----------GMNWDTRVA------------IAIGAARGLEYLHE--- 345 (631)
Q Consensus 305 E~~~~gsL~~-----------~---l~~~~~~----------~l~~~~~~~------------i~~~ia~gL~yLH~--- 345 (631)
+|++|..+.. . ++..... .-.|..... ....+.+.+++|..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 9998865421 1 1110000 011221110 11123344555543
Q ss_pred -cCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 346 -AAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 346 -~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..+..++|+|+.+.||++++++...|+||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223469999999999999988767899999864
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.00092 Score=68.05 Aligned_cols=145 Identities=17% Similarity=0.145 Sum_probs=97.4
Q ss_pred ecHHHHHHHhc---CccccceeeeeCceEEEEEEECCCcEEEEEEeccCC-------------------CCC--hHHHHH
Q 006785 214 FSYSALEHATD---KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-------------------GPN--ADSVFL 269 (631)
Q Consensus 214 ~s~~~l~~a~~---~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~-------------------~~~--~~~~~~ 269 (631)
+.|..|....+ -++..++||-|--+.||.+...+|++.++|.-.-.. ... .+-...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 34444444433 356678999999999999999889999988532110 000 011245
Q ss_pred HHHHHHHhcC-CC-CCcceeEEeeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcC
Q 006785 270 TEVDMLSRLH-HC-HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 347 (631)
Q Consensus 270 ~E~~~l~~l~-H~-niv~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 347 (631)
+|+..|+.|. |- -+.+.+++. ..++|||++.|-.|.+.-+- .+..++..-+ ..-+.-|..+|
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~~--------RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~l---m~~Iv~la~~G 222 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDHN--------RHCVVMELVDGYPLRQVRHV-----EDPPTLYDDL---MGLIVRLANHG 222 (465)
T ss_pred HHHHHHHHHHHcCCCCCCccccc--------ceeeHHHhhcccceeeeeec-----CChHHHHHHH---HHHHHHHHHcC
Confidence 7899999884 33 344555433 34899999999888764321 2334443333 33345566777
Q ss_pred CCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 348 APRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 348 ~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
+||+|..-=||++++++.++++||--.
T Consensus 223 ---lIHgDFNEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 223 ---LIHGDFNEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred ---ceecccchheeEEecCCCEEEeechHh
Confidence 999999999999999999999999643
|
|
| >KOG1219 consensus Uncharacterized conserved protein, contains laminin, cadherin and EGF domains [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0017 Score=78.84 Aligned_cols=52 Identities=25% Similarity=0.535 Sum_probs=36.1
Q ss_pred cCCccceEEecCCCCCCcccccccCccCCcccCCCC--CCCCCceeeeecCCCCCc
Q 006785 30 SGQKNWKCTCSSSLQGDQSNILKLNCSRSCDCSPVG--GSSEGKWTCICAADGLPK 83 (631)
Q Consensus 30 ~~~~~~~~~c~~~~~~~~~~~~~~~c~~~~~c~~~~--~~~~~~~~c~~~~~g~~~ 83 (631)
++..+|.|.|.+-|.||-=-+.-.+|. +--|.-++ .+..+.+.|.|. .|+-|
T Consensus 3881 ~~~ggy~CkCpsqysG~~CEi~~epC~-snPC~~GgtCip~~n~f~CnC~-~gyTG 3934 (4289)
T KOG1219|consen 3881 QPKGGYKCKCPSQYSGNHCEIDLEPCA-SNPCLTGGTCIPFYNGFLCNCP-NGYTG 3934 (4289)
T ss_pred CCCCceEEeCcccccCccccccccccc-CCCCCCCCEEEecCCCeeEeCC-CCccC
Confidence 446699999999999976555445674 44565544 357888999994 45554
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.012 Score=60.20 Aligned_cols=31 Identities=29% Similarity=0.478 Sum_probs=25.8
Q ss_pred CceeecCCCCCCeeecCCCC-eEEeccCceee
Q 006785 349 PRILHRDIKSSNILLDENLN-AKITDLGMAKR 379 (631)
Q Consensus 349 ~~ivHrDlKp~NILl~~~~~-~kL~DFGla~~ 379 (631)
+.++|+|+.+.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.015 Score=60.41 Aligned_cols=146 Identities=18% Similarity=0.234 Sum_probs=82.2
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEecc-CCCCChHHHHHHHHHHHHhcCC--CCCcceeEEeeeccCCcceEEEEEee
Q 006785 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKT-QGGPNADSVFLTEVDMLSRLHH--CHVVPLVGYCSEFRGKRAMRLLVFEF 306 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~-~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~~~~~lV~E~ 306 (631)
+.+-.|..-.+|..... ++.+++. ... ...........+|+.+|+.+.- --+.+.+++|.+.. ....|.||+|
T Consensus 31 ~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~--~g~pf~v~~~ 106 (321)
T COG3173 31 EEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY--LGTPFYVMEW 106 (321)
T ss_pred eeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC--CCCceEEEEE
Confidence 33433444455665554 7788888 332 2222333346788888888743 23345566666533 2356999999
Q ss_pred CCCCChHhhhhcccc-----------------------------------CC-CCHHHHHHHH--------HHHHhhhHH
Q 006785 307 MPNGNLRDCLDGVLV-----------------------------------EG-MNWDTRVAIA--------IGAARGLEY 342 (631)
Q Consensus 307 ~~~gsL~~~l~~~~~-----------------------------------~~-l~~~~~~~i~--------~~ia~gL~y 342 (631)
++|..+.+.+..... ++ ..|......+ -....-..|
T Consensus 107 veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W 186 (321)
T COG3173 107 VEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW 186 (321)
T ss_pred ecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence 988544332211000 00 0111111100 011222344
Q ss_pred HHhcC-----CCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 343 LHEAA-----APRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 343 LH~~~-----~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
|+.+. .+.++|+|+.+.|++++++.-+=|.||+++..
T Consensus 187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 44332 25799999999999999988899999999865
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.011 Score=60.81 Aligned_cols=73 Identities=25% Similarity=0.290 Sum_probs=45.4
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC---CCCCcceeEEeeeccCCcceEEEEEe
Q 006785 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
.+.|+.|....+|+.. .+++.+.||.-... ....|..|.+-|+.|. --.+.+++++... ....|||||
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~----~~~~fLlle 92 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSES----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEY----DDDAFLLLE 92 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEEGG----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-----SSCCEEEEE
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecChh----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee----cCCceEEEE
Confidence 4568889999999988 56889999987632 2234889999999883 3356678877654 223499999
Q ss_pred eCCCC
Q 006785 306 FMPNG 310 (631)
Q Consensus 306 ~~~~g 310 (631)
|++.+
T Consensus 93 ~l~~~ 97 (288)
T PF03881_consen 93 FLEMG 97 (288)
T ss_dssp -----
T ss_pred eecCC
Confidence 99876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.00031 Score=83.39 Aligned_cols=161 Identities=13% Similarity=-0.011 Sum_probs=114.2
Q ss_pred HHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeCCCCChHhhhhccccC--CCCHHHHHHHHHHHHhhhHHHHh
Q 006785 268 FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVE--GMNWDTRVAIAIGAARGLEYLHE 345 (631)
Q Consensus 268 ~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~--~l~~~~~~~i~~~ia~gL~yLH~ 345 (631)
.+.|.+.++...|+++.....-..... ...-|.+++|+.+|.+.+.|-+...+ .++..-+...-.+......-+|.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~--s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSE--STEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCC--ChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 455666666778998887654333222 33558999999999999998543322 23333333333333555555554
Q ss_pred cC--CCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHH
Q 006785 346 AA--APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGV 423 (631)
Q Consensus 346 ~~--~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGv 423 (631)
.. ...-+|++||+-|.+|..+.++|++++|+.+...+. ........+++.|++|+....-.++.++|+|..|.
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-----~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-----LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSL 1428 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCch-----HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence 32 234799999999999999999999999999843322 12234456788999999988889999999999999
Q ss_pred HHHHHHhCCCCC
Q 006785 424 VLLELITGRQPI 435 (631)
Q Consensus 424 iL~eLltG~~P~ 435 (631)
-+|++..|..+|
T Consensus 1429 ~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1429 SLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHhcccHHH
Confidence 999998888776
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.026 Score=59.75 Aligned_cols=138 Identities=17% Similarity=0.162 Sum_probs=79.8
Q ss_pred eeeeeCceEEEEEEECC-----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCc-ceeEEeeeccCCcceEEEEE
Q 006785 231 IVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRLLVF 304 (631)
Q Consensus 231 ~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~~~~~lV~ 304 (631)
.|-.|-.-.+|+..+.+ ++.|++|+...... .. -...+|..+++.+...++. ++++.+.. ..|+
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~--------g~v~ 112 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LF-FDRDDEIRTFECMSRHGQGPRLLGRFPN--------GRVE 112 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-ee-echHHHHHHHHHHHHcCCCCceEEEECC--------ceEE
Confidence 34447778899987542 36799998765432 22 1246899999998554444 56654421 2589
Q ss_pred eeCCCCChHhh-----------------hhcccc---C-CCCHHHHHHHHHH-----------------HHhhhHHH---
Q 006785 305 EFMPNGNLRDC-----------------LDGVLV---E-GMNWDTRVAIAIG-----------------AARGLEYL--- 343 (631)
Q Consensus 305 E~~~~gsL~~~-----------------l~~~~~---~-~l~~~~~~~i~~~-----------------ia~gL~yL--- 343 (631)
+|+++.+|... ++.... . ..-|.++..+..+ +...+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99987776421 111110 0 1112322222211 11112222
Q ss_pred -Hh-cCCCceeecCCCCCCeeecC-CCCeEEeccCcee
Q 006785 344 -HE-AAAPRILHRDIKSSNILLDE-NLNAKITDLGMAK 378 (631)
Q Consensus 344 -H~-~~~~~ivHrDlKp~NILl~~-~~~~kL~DFGla~ 378 (631)
.. .....++|+|+++.|||+++ ++.+.++||..+.
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 21 11235899999999999986 4679999998774
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.016 Score=60.22 Aligned_cols=137 Identities=20% Similarity=0.230 Sum_probs=92.3
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccCCC---------------------CChHHH----HHHHHHHHHhcCCCCCc
Q 006785 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG---------------------PNADSV----FLTEVDMLSRLHHCHVV 284 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~---------------------~~~~~~----~~~E~~~l~~l~H~niv 284 (631)
..|..|--..||.|.-.+|..+|||+++..-. ...+.. ...|+.-|++|+...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 34778889999999999999999999874310 000111 34688889998766644
Q ss_pred ceeEEeeeccCCcceEEEEEeeCCCCChHh--hhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCee
Q 006785 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNIL 362 (631)
Q Consensus 285 ~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~--~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NIL 362 (631)
----... ....|||+|+. ++=+- .|.. -.++...+..+-.+++.-|.-|.... ++||.||.-=|+|
T Consensus 230 ~PePIlL------k~hVLVM~FlG-rdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~L 297 (520)
T KOG2270|consen 230 CPEPILL------KNHVLVMEFLG-RDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLL 297 (520)
T ss_pred CCCceee------ecceEeeeecc-CCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhhe
Confidence 2111111 13389999994 32211 1111 23666677777888888888887665 5999999999999
Q ss_pred ecCCCCeEEeccCceee
Q 006785 363 LDENLNAKITDLGMAKR 379 (631)
Q Consensus 363 l~~~~~~kL~DFGla~~ 379 (631)
+-+ |.+.|+|.+-+..
T Consensus 298 yhd-G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 298 YHD-GKLYIIDVSQSVE 313 (520)
T ss_pred EEC-CEEEEEEcccccc
Confidence 864 5899999886643
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.11 Score=55.84 Aligned_cols=81 Identities=20% Similarity=0.179 Sum_probs=52.5
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCC------CChHHHHHHHHHHHHhcC---CCCCcceeEEeeeccCCcce
Q 006785 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG------PNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~------~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~~~ 299 (631)
.+.||.|....||+.... +..++||+-..... +.....-..|...|+.+. ..++.+++.++.+ .
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded------~ 109 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT------M 109 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC------C
Confidence 457899999999998864 55699998652111 112222345577776663 3578889988764 3
Q ss_pred EEEEEeeCCC--CChHhhh
Q 006785 300 RLLVFEFMPN--GNLRDCL 316 (631)
Q Consensus 300 ~~lV~E~~~~--gsL~~~l 316 (631)
.+++|||+++ ..|.+.|
T Consensus 110 ~vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 110 ALIGMRYLEPPHIILRKGL 128 (418)
T ss_pred CEEEEeecCCcceehhhhh
Confidence 4889999977 2444443
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.073 Score=56.11 Aligned_cols=74 Identities=22% Similarity=0.171 Sum_probs=48.1
Q ss_pred eeeeeCceEEEEEEECCC-cEEEEEEecc------CCCCChHHHHHHHHHHHHhcC--CC-CCcceeEEeeeccCCcceE
Q 006785 231 IVGQGGSSYVYRGQLTDG-RIVAVKRFKT------QGGPNADSVFLTEVDMLSRLH--HC-HVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 231 ~LG~G~fG~Vy~~~~~~g-~~vAVK~l~~------~~~~~~~~~~~~E~~~l~~l~--H~-niv~l~g~~~~~~~~~~~~ 300 (631)
.||.|....||++...+| +.|+||.-.. ...+-......-|.+.|+... -| .+.+++.|- ....
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D------~e~~ 75 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD------TEMA 75 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc------cccc
Confidence 479999999999998654 6899997431 122333334556777877662 23 455666542 3355
Q ss_pred EEEEeeCCCC
Q 006785 301 LLVFEFMPNG 310 (631)
Q Consensus 301 ~lV~E~~~~g 310 (631)
.+|||+++..
T Consensus 76 ~~vMEdL~~~ 85 (370)
T TIGR01767 76 VTVMEDLSHH 85 (370)
T ss_pred eehHhhCccc
Confidence 7999999543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.097 Score=54.38 Aligned_cols=29 Identities=24% Similarity=0.360 Sum_probs=25.0
Q ss_pred CceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 349 PRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 349 ~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45899999999999987 578999998754
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.024 Score=55.53 Aligned_cols=30 Identities=27% Similarity=0.449 Sum_probs=21.2
Q ss_pred ceeecCCCCCCeee-cCCCCeEEeccCceee
Q 006785 350 RILHRDIKSSNILL-DENLNAKITDLGMAKR 379 (631)
Q Consensus 350 ~ivHrDlKp~NILl-~~~~~~kL~DFGla~~ 379 (631)
.++|+||.+.|||+ +.++.++++||-.|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 47899999999999 8889999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.014 Score=62.96 Aligned_cols=72 Identities=19% Similarity=0.306 Sum_probs=48.6
Q ss_pred EEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeCCCCChHhhhhcc
Q 006785 240 VYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGV 319 (631)
Q Consensus 240 Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~ 319 (631)
++.|....|+.+ ..-+.- .+ ....++-...+++.+.|+|+...+.+-. +......+|||++ +.||.+++...
T Consensus 5 ~~~a~~~~~~~c-~nglpl--t~-~s~~ilgr~~~lktl~~~~l~~yl~~~r---~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 5 TFFAQEKPGDVC-SNGLPL--TP-NSIQILGRFQYLKSLQHDNLCQYLDFSR---GKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred EEehhcCCCccc-cCCCcC--CC-cHHHHhhhhHHHHhhcCccceeeEeeec---CccceEEEEehhh-ccchHHHHHhc
Confidence 456666666544 222221 12 2234677889999999999998886543 3455578999999 78999988653
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.093 Score=55.24 Aligned_cols=138 Identities=15% Similarity=0.168 Sum_probs=77.9
Q ss_pred eeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCc-ceeEEeeeccCCcceEEEEEe
Q 006785 231 IVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 231 ~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~~~~~lV~E 305 (631)
.|..|=...+|+....+ +..|++|+...... ..-...+|..+++.+..-++- ++++++.. -+|.+
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~~--------G~i~~ 90 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YVIDRERELQAIKYLSAAGFGAKLLGVFGN--------GMIQS 90 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eEechHHHHHHHHHHHhcCCCCceeEEeCC--------cEeeh
Confidence 34446677889887543 23789998765422 112246899999999655554 56655421 25899
Q ss_pred eCCCCChHh-------hh----------hcccc---CCC-CHHHHHHHHHHH----------------------HhhhHH
Q 006785 306 FMPNGNLRD-------CL----------DGVLV---EGM-NWDTRVAIAIGA----------------------ARGLEY 342 (631)
Q Consensus 306 ~~~~gsL~~-------~l----------~~~~~---~~l-~~~~~~~i~~~i----------------------a~gL~y 342 (631)
|+++..|.. .+ +.... ... -|..+..+..++ ..-+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 997766522 11 11110 001 133222222111 111111
Q ss_pred HH----hcC-CCceeecCCCCCCeeecC-CCCeEEeccCcee
Q 006785 343 LH----EAA-APRILHRDIKSSNILLDE-NLNAKITDLGMAK 378 (631)
Q Consensus 343 LH----~~~-~~~ivHrDlKp~NILl~~-~~~~kL~DFGla~ 378 (631)
+. ..+ +..++|.|+.+.|||+++ ++.++++||..|.
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 11 111 224799999999999975 5689999998874
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.042 Score=57.21 Aligned_cols=75 Identities=16% Similarity=0.174 Sum_probs=60.1
Q ss_pred cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCc
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGl 376 (631)
..+.|++|++- |++|.-. ..-.|.+.+.|+.+.+..+.-|...- ++=|||+.-.||||+ +|++-|+||-+
T Consensus 298 ~~y~yl~~kdh-gt~is~i------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred ceEEEEEEecC-Cceeeee------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeee
Confidence 55778888887 6666421 23579999999999888777776654 489999999999999 99999999999
Q ss_pred eeecc
Q 006785 377 AKRLK 381 (631)
Q Consensus 377 a~~~~ 381 (631)
+|.-.
T Consensus 368 sRl~~ 372 (488)
T COG5072 368 SRLSY 372 (488)
T ss_pred eeccc
Confidence 98543
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.16 Score=53.31 Aligned_cols=142 Identities=21% Similarity=0.336 Sum_probs=83.0
Q ss_pred eeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCC------cceeEEeeeccCCcceEEEEEe
Q 006785 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV------VPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 232 LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni------v~l~g~~~~~~~~~~~~~lV~E 305 (631)
|.+ .-..+|+....+|+. ++|+.... . ...+...|...|..|.-..| ..+=|-....-......+-|++
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-~--~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-W--TRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC-C--CHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 444 556799998877776 88988765 2 22346677888887732211 1221211111111136789999
Q ss_pred eCCCCChHh-h-----------h---h----ccc------cCCCCHHH-------------HHHHHHHHHhhhHHHHhcC
Q 006785 306 FMPNGNLRD-C-----------L---D----GVL------VEGMNWDT-------------RVAIAIGAARGLEYLHEAA 347 (631)
Q Consensus 306 ~~~~gsL~~-~-----------l---~----~~~------~~~l~~~~-------------~~~i~~~ia~gL~yLH~~~ 347 (631)
|++|..+.. - | + +.. .....|.. ......++...+..+.+.-
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999988873 1 1 0 110 01133431 0113334444555555432
Q ss_pred C-------CceeecCCCCCCeeecCCCC-eEEeccCcee
Q 006785 348 A-------PRILHRDIKSSNILLDENLN-AKITDLGMAK 378 (631)
Q Consensus 348 ~-------~~ivHrDlKp~NILl~~~~~-~kL~DFGla~ 378 (631)
. ..+||+|+.|.|||++.+.. +.+.|||-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1 12899999999999998875 8899999875
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.1 Score=54.35 Aligned_cols=30 Identities=20% Similarity=0.273 Sum_probs=27.2
Q ss_pred ceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 350 RILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 350 ~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.++|+|+.+.|+|+++++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 599999999999999998999999988753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.16 Score=61.59 Aligned_cols=145 Identities=19% Similarity=0.238 Sum_probs=79.3
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC--CCC--CcceeE----Ee-e--eccCCcc
Q 006785 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH--HCH--VVPLVG----YC-S--EFRGKRA 298 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~--H~n--iv~l~g----~~-~--~~~~~~~ 298 (631)
+.|+ |..-.+|+....+|..+++|+.+..... .....|..+|..|. ++. +.+++- -. . .......
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~---~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~ 106 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR---VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEP 106 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccch---hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCce
Confidence 3454 4568889998888889999998764322 22445566666552 223 223221 10 0 1111122
Q ss_pred eEEEEEeeCCCCChHhhh-----------------hc----c----ccCCCCHHH-----------------HHHHHHHH
Q 006785 299 MRLLVFEFMPNGNLRDCL-----------------DG----V----LVEGMNWDT-----------------RVAIAIGA 336 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l-----------------~~----~----~~~~l~~~~-----------------~~~i~~~i 336 (631)
..+-+++|++|..|.+.. +. . ..+.+.|.. ...++.++
T Consensus 107 ~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~ 186 (1013)
T PRK06148 107 RLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERF 186 (1013)
T ss_pred EEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHH
Confidence 457789999998776510 00 0 011233422 11222222
Q ss_pred HhhhH-----HHHhcCCCceeecCCCCCCeeecCCC--CeE-EeccCceee
Q 006785 337 ARGLE-----YLHEAAAPRILHRDIKSSNILLDENL--NAK-ITDLGMAKR 379 (631)
Q Consensus 337 a~gL~-----yLH~~~~~~ivHrDlKp~NILl~~~~--~~k-L~DFGla~~ 379 (631)
..... .|.. -...+||+|+.+.|||++.+. .+. |+|||-+..
T Consensus 187 ~~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 187 LARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 22221 1211 123499999999999999775 454 999998753
|
|
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.012 Score=40.38 Aligned_cols=30 Identities=27% Similarity=0.339 Sum_probs=12.4
Q ss_pred EEEEeHHHHHHHHHHHHHHHHHhhhhccCC
Q 006785 118 VVVIVLLLCVILTTIAFLMLVLCYVYRKGK 147 (631)
Q Consensus 118 ~~~ii~i~~~~l~~l~~l~~~~~~~~rr~k 147 (631)
+.+.+++++-+++++++++++++++|||+|
T Consensus 11 vaIa~~VvVPV~vI~~vl~~~l~~~~rR~k 40 (40)
T PF08693_consen 11 VAIAVGVVVPVGVIIIVLGAFLFFWYRRKK 40 (40)
T ss_pred EEEEEEEEechHHHHHHHHHHhheEEeccC
Confidence 333333333333333344444444555543
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.25 Score=53.08 Aligned_cols=74 Identities=16% Similarity=0.230 Sum_probs=45.4
Q ss_pred ceeeeeCceEEEEEEECCC--c-----EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCc-ceeEEeeeccCCcceEE
Q 006785 230 NIVGQGGSSYVYRGQLTDG--R-----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~g--~-----~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~~~~~ 301 (631)
+.|..|-...+|++...++ . .|.++..... ....-.-.+|+.+++.+...++- ++++.+.. +
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~--~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~--------g 125 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY--NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD--------F 125 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC--CceEeccHHHHHHHHHHHhCCCCCeEEEecCC--------E
Confidence 3454577889999976542 2 2444443221 11111246799999999666555 55554432 7
Q ss_pred EEEeeCCCCChH
Q 006785 302 LVFEFMPNGNLR 313 (631)
Q Consensus 302 lV~E~~~~gsL~ 313 (631)
+|+||++|-.|.
T Consensus 126 ~l~efIeGr~l~ 137 (383)
T PTZ00384 126 TIQEWVEGNTMG 137 (383)
T ss_pred EEEEEeccccCC
Confidence 999999988764
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.11 Score=50.42 Aligned_cols=152 Identities=17% Similarity=0.190 Sum_probs=90.9
Q ss_pred CceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeCCCCChHhh
Q 006785 236 GSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDC 315 (631)
Q Consensus 236 ~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~ 315 (631)
+-.+.-+++-+=| +..+|++....-.-....|..+..++.+++- |++|.. + ....+-+|.|+|-...
T Consensus 74 gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~ArmhG--ilrL~N---D---n~~~yGvIlE~Cy~~~---- 140 (308)
T PF07387_consen 74 GNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMHG--ILRLKN---D---NNYKYGVILERCYKIK---- 140 (308)
T ss_pred CceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhhh--eeEeec---C---CCceeEEEEeeccCcc----
Confidence 3344444443223 3556666554333234458889999988763 666651 1 2345568899983211
Q ss_pred hhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCccc
Q 006785 316 LDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 395 (631)
Q Consensus 316 l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~ 395 (631)
....-.|.. =+..|.-.|+. .+..+|+|-.|+||+-|..|.+||.|-+..-.
T Consensus 141 ----------i~~~N~i~a-gi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~---------------- 192 (308)
T PF07387_consen 141 ----------INFSNFITA-GIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE---------------- 192 (308)
T ss_pred ----------cchhHHHHH-hHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh----------------
Confidence 111111221 14667788954 34599999999999999999999999875321
Q ss_pred ccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCC
Q 006785 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 432 (631)
Q Consensus 396 ~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~ 432 (631)
.+..|.--| ....+.++.+=+|-.-++++....
T Consensus 193 -~~V~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 193 -NQVNMVNIE---YESLTQEAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred -heeeEEeee---ccccChHHHHHHHHHHHHHHHHHH
Confidence 011122211 234566788888877777777643
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.19 E-value=0.8 Score=48.08 Aligned_cols=73 Identities=23% Similarity=0.254 Sum_probs=45.4
Q ss_pred eCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCC--CCccee---EE-eeeccCCcceEEEEEeeCC
Q 006785 235 GGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC--HVVPLV---GY-CSEFRGKRAMRLLVFEFMP 308 (631)
Q Consensus 235 G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~---g~-~~~~~~~~~~~~lV~E~~~ 308 (631)
+.-..||+....+|..+++|+..... ........|++.+..|... .++..+ |- ... .+...+.++++++
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~--~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~---~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPER--WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHE---HQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCccc--CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEE---ECCEEEEEEeeeC
Confidence 45678999988888889999876432 2334467888888877322 222222 10 011 1235788999998
Q ss_pred CCCh
Q 006785 309 NGNL 312 (631)
Q Consensus 309 ~gsL 312 (631)
|..+
T Consensus 111 G~~~ 114 (325)
T PRK11768 111 GRAP 114 (325)
T ss_pred CCCC
Confidence 7643
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.06 E-value=0.43 Score=46.89 Aligned_cols=74 Identities=26% Similarity=0.294 Sum_probs=48.4
Q ss_pred eeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCC---CCcceeEEeeeccCCcceEEEEEeeC
Q 006785 231 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC---HVVPLVGYCSEFRGKRAMRLLVFEFM 307 (631)
Q Consensus 231 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~~~~~~~~lV~E~~ 307 (631)
.+-.|..-..|...+ +...+.||.-.. .....|..|+.-|..|.-. ++.+++.+-.. ..+.|+||||+
T Consensus 23 ~v~gG~inea~~v~d-g~~~~FvK~n~~----~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~----~~~sylVle~L 93 (286)
T COG3001 23 EVSGGDINEAWRLRD-GTDPFFVKCNQR----EQLSMFTAEADGLELLARSNTITVPKVIAVGAS----RDHSYLVLEYL 93 (286)
T ss_pred ccCCccccceeEeec-CCcceEEEecch----hhHHHHHHHHHHHHHHHhcCCccccceEEecCC----CCeeEEEEeec
Confidence 344455555565554 467789986432 2334588999888888444 45566654443 56779999999
Q ss_pred CCCChH
Q 006785 308 PNGNLR 313 (631)
Q Consensus 308 ~~gsL~ 313 (631)
+-|.+.
T Consensus 94 ~~~~~d 99 (286)
T COG3001 94 PTGPLD 99 (286)
T ss_pred cCCCCC
Confidence 987765
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 631 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-51 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-50 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-43 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-31 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-21 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-20 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-20 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-19 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-16 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-14 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-14 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-14 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-14 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-14 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 9e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 631 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-130 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-125 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-118 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-85 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-68 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 9e-62 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 5e-59 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-58 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 5e-58 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 5e-58 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-57 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 3e-57 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-56 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 3e-56 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 7e-56 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 5e-55 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 7e-55 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 5e-53 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 5e-40 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-39 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 5e-39 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 5e-39 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-38 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 8e-38 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 5e-37 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 6e-37 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 7e-37 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-36 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 6e-36 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 6e-36 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 7e-36 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-35 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-35 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 4e-35 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 5e-35 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 5e-35 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 9e-35 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-34 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-34 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-34 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-34 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-34 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-34 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-34 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 3e-34 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 3e-34 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 3e-34 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-34 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 4e-34 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 4e-34 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 5e-34 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 6e-34 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 8e-34 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 1e-33 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 4e-33 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 5e-33 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 5e-33 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 5e-33 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 8e-33 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-32 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-32 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-32 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 5e-32 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 6e-32 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-31 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-31 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-31 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-31 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 2e-31 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 4e-31 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 5e-31 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 1e-30 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-30 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-30 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-30 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 2e-30 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 3e-30 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 5e-30 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 5e-30 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 6e-30 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 8e-30 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-29 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-29 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-29 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-29 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-29 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-29 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 3e-29 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 3e-29 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-29 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 6e-29 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 7e-29 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 8e-29 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 9e-29 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 1e-28 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-28 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-28 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-28 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-27 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 3e-27 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 3e-27 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 9e-27 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-26 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 3e-26 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 3e-26 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 6e-26 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 8e-26 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-25 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 1e-25 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-25 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-25 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 3e-25 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 3e-25 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 7e-25 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 7e-25 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-24 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 4e-24 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 8e-24 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-23 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 9e-23 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-22 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 3e-21 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 8e-21 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-20 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-20 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 3e-20 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 6e-20 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 9e-20 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-19 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-19 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-19 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 3e-19 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 4e-19 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 4e-19 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 5e-19 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 7e-19 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 8e-19 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 9e-19 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-18 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-18 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 2e-18 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 3e-18 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 3e-18 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 3e-18 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 3e-18 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-18 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 4e-18 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 4e-18 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 4e-18 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 4e-18 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 5e-18 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 5e-18 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 6e-18 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 7e-18 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 7e-18 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 7e-18 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 8e-18 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 9e-18 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-17 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-17 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-17 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-17 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-17 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 3e-17 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 3e-17 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 5e-17 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 9e-06 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 5e-17 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 5e-17 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 5e-17 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-16 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-16 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 1e-16 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-16 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-16 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-16 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-16 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-16 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 3e-16 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 3e-16 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 3e-16 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 3e-16 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 4e-16 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 4e-16 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 5e-16 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 6e-16 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-15 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-15 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 2e-15 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 4e-15 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 6e-15 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-14 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 4e-14 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 5e-14 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 5e-13 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 6e-13 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 9e-13 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 9e-13 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-12 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 4e-12 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 5e-12 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 6e-12 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 6e-12 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-11 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-11 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 3e-11 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 3e-11 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 4e-11 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 4e-11 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 4e-11 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 6e-11 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 7e-11 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 9e-11 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-10 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-10 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-10 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 2e-10 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 2e-10 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-10 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-10 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-10 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 2e-10 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 4e-10 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 4e-10 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 7e-10 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-09 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-09 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 2e-08 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 4e-08 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 6e-08 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 9e-08 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-07 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 3e-07 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 4e-07 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 4e-07 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 8e-04 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 1e-06 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-05 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 5e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 384 bits (988), Expect = e-130
Identities = 117/302 (38%), Positives = 177/302 (58%), Gaps = 14/302 (4%)
Query: 209 GTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVF 268
G + RFS L+ A+D FS NI+G+GG VY+G+L DG +VAVKR K + + F
Sbjct: 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQF 74
Query: 269 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL--VEGMNW 326
TEV+M+S H +++ L G+C RLLV+ +M NG++ CL ++W
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMT----PTERLLVYPYMANGSVASCLRERPESQPPLDW 130
Query: 327 DTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 386
R IA+G+ARGL YLH+ P+I+HRD+K++NILLDE A + D G+AK L
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDT 189
Query: 387 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES- 445
++ ++GT G+ APEY G++S +DVF +GV+LLELITG++ + ++
Sbjct: 190 HVTT---AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 446 -LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
L+ W L++ + L D L+G++ EE++ + +A C Q P RP MSEVV+
Sbjct: 247 MLLDWVKGLLKEKK--LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
Query: 505 IL 506
+L
Sbjct: 305 ML 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 371 bits (955), Expect = e-125
Identities = 113/296 (38%), Positives = 162/296 (54%), Gaps = 15/296 (5%)
Query: 213 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEV 272
R LE AT+ F ++G G VY+G L DG VA+KR F TE+
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT-PESSQGIEEFETEI 86
Query: 273 DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRV 330
+ LS H H+V L+G+C E R +L++++M NGNL+ L G M+W+ R+
Sbjct: 87 ETLSFCRHPHLVSLIGFCDE----RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 331 AIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 390
I IGAARGL YLH A I+HRD+KS NILLDEN KITD G++K + + S
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK-KGTELDQTHLS 198
Query: 391 SPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA 450
+ ++GT GY PEY + GR + SDV+SFGVVL E++ R I +S+ + +L WA
Sbjct: 199 T--VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256
Query: 451 TPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
++G + ++ DP L E ++ A +CL L + RP+M +V+ L
Sbjct: 257 VE-SHNNGQ-LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 352 bits (905), Expect = e-118
Identities = 98/308 (31%), Positives = 155/308 (50%), Gaps = 26/308 (8%)
Query: 213 RFSYSALEHATDKFS------GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNA-- 264
FS+ L++ T+ F G N +G+GG VY+G + + VAVK+
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 265 -DSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-DGVLVE 322
F E+ ++++ H ++V L+G+ S+ LV+ +MPNG+L D L
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSD----GDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 323 GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382
++W R IA GAA G+ +LHE +HRDIKS+NILLDE AKI+D G+A+ +
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKG 442
+S R+ GT Y APE + G + SD++SFGVVLLE+ITG + +
Sbjct: 186 FAQTVMTS---RIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEH--RE 239
Query: 443 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 502
+ L+ + T I + D ++ D ++ M +A +CL + RP + +V
Sbjct: 240 PQLLLDIKEEIEDEEKT-IEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297
Query: 503 VQILSTIA 510
Q+L +
Sbjct: 298 QQLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 1e-85
Identities = 81/319 (25%), Positives = 125/319 (39%), Gaps = 25/319 (7%)
Query: 208 HGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV 267
H + + L + + +G V++ QL VAVK F Q
Sbjct: 8 HSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD--KQSWQ 64
Query: 268 FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWD 327
EV L + H +++ +G L+ F G+L D L ++W+
Sbjct: 65 NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWN 121
Query: 328 TRVAIAIGAARGLEYLHEAAA-------PRILHRDIKSSNILLDENLNAKITDLGMAKRL 380
IA ARGL YLHE P I HRDIKS N+LL NL A I D G+A +
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVG-----RASLMSDVFSFGVVLLELITGRQPI 435
+A + GT Y APE A L D+++ G+VL EL +
Sbjct: 182 EAGKSAGDTHGQV---GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238
Query: 436 HRSITKGEESL--VLWATPRLQD-SGTVISELPDPRLKGDFPKEE-MQIMAYLAKECLQL 491
+ + + P L+D V+ + P L+ + K M ++ +EC
Sbjct: 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298
Query: 492 DPDARPTMSEVVQILSTIA 510
D +AR + V + ++ +
Sbjct: 299 DAEARLSAGCVGERITQMQ 317
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 225 bits (574), Expect = 2e-68
Identities = 72/335 (21%), Positives = 126/335 (37%), Gaps = 34/335 (10%)
Query: 212 IRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTE 271
+ + S D ++G+G VY+G L D R VAVK F F+ E
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINE 55
Query: 272 VDM--LSRLHHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDT 328
++ + + H ++ + M LV E+ PNG+L L +W +
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVS 112
Query: 329 RVAIAIGAARGLEYLHEAAA------PRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382
+A RGL YLH P I HRD+ S N+L+ + I+D G++ RL
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 383 DGLPSCSSSPARM---QGTFGYFAPEYAM-------VGRASLMSDVFSFGVVLLELITGR 432
+ L GT Y APE A D+++ G++ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 433 QPIHRSITKGEESL----VLWATPRLQD-SGTVISELPDPRLKGDFPKEE--MQIMAYLA 485
+ + E + + P +D V E P+ + + ++ +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 486 KECLQLDPDARPTMSEVVQILSTIAPDKSRRRNIS 520
++C D +AR T + ++ + R +++S
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 9e-62
Identities = 80/286 (27%), Positives = 133/286 (46%), Gaps = 36/286 (12%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLV 287
+G G V+R + G VAVK Q +A+ V FL EV ++ RL H ++V +
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQD-FHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 288 GYCSEFRGKRAMRL-LVFEFMPNGNLRDCL-DGVLVEGMNWDTRVAIAIGAARGLEYLHE 345
G + + L +V E++ G+L L E ++ R+++A A+G+ YLH
Sbjct: 101 GAVT-----QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH- 154
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 405
P I+HR++KS N+L+D+ K+ D G++ RLKA S S+ GT + APE
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS-RLKASTFLSSKSAA----GTPEWMAPE 209
Query: 406 YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT-PRLQDSGTVISEL 464
++ SDV+SFGV+L EL T +QP W Q V +
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQP--------------WGNLNPAQVVAAVGFKC 255
Query: 465 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510
+ + + +A + + C +P RP+ + ++ +L +
Sbjct: 256 KRLEIPRNLNPQ----VAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 5e-59
Identities = 72/292 (24%), Positives = 124/292 (42%), Gaps = 56/292 (19%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
+VG+G V + + + VA+K+ +++ + F+ E+ LSR++H ++V L G
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGV-LVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
C LV E+ G+L + L G + ++ + ++G+ YLH
Sbjct: 70 CLN------PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 349 PRILHRDIKSSNILLDENLN-AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA 407
++HRD+K N+LL KI D G A ++ + +G+ + APE
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ--------THMTNNKGSAAWMAPEVF 175
Query: 408 MVGRASLMSDVFSFGVVLLELITGRQP----------IHRSITKGEESLVLWATPRLQDS 457
S DVFS+G++L E+IT R+P I ++ G R
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT---------RP--- 223
Query: 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
L + PK + L C DP RP+M E+V+I++ +
Sbjct: 224 -----PLIK-----NLPKP----IESLMTRCWSKDPSQRPSMEEIVKIMTHL 261
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-58
Identities = 63/287 (21%), Positives = 113/287 (39%), Gaps = 41/287 (14%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVG 288
+ + S +++G+ G + VK K + F E L H +V+P++G
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
C L+ +MP G+L + L ++ V A+ ARG+ +LH
Sbjct: 75 ACQSPPAPHPT--LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLE 131
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 408
P I + S ++++DE++ A+I+ + ++ G + APE A+
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG----------RMYAPAWVAPE-AL 180
Query: 409 VGRASLM----SDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA--TPRLQDSGTVIS 462
+ +D++SF V+L EL+T P +A + ++ V
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVP--------------FADLSN-MEIGMKVAL 225
Query: 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
E R P ++ L K C+ DP RP +V IL +
Sbjct: 226 E--GLRP--TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 5e-58
Identities = 69/296 (23%), Positives = 114/296 (38%), Gaps = 25/296 (8%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDM--LSRLHHCHVVPLV 287
VG+G V+RG G VAVK F ++ + + E ++ L H +++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFI 68
Query: 288 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 347
R L+ + G+L D L + ++ + + I + A GL +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 348 A-----PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
P I HRD+KS NIL+ +N I DLG+A + + GT Y
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 403 APE------YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE--ESLVLWATPRL 454
APE + D+++FG+VL E+ +V
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 455 QDSGTVISELPDPRLKGDFPKEE-MQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
V + P + + + + +A L KEC +P AR T + + L+ I
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 3e-57
Identities = 87/296 (29%), Positives = 126/296 (42%), Gaps = 53/296 (17%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV---FLTEVDMLSRLHHCHVVPL 286
I+G GG VYR G VAVK + + E + + L H +++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
G C K LV EF G L L G + + D V A+ ARG+ YLH+
Sbjct: 72 RGVCL----KEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDE 124
Query: 347 AAPRILHRDIKSSNILLDE--------NLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
A I+HRD+KSSNIL+ + N KITD G+A R ++ G
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA-REWHR------TTKMSAAGA 177
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA--TPRLQD 456
+ + APE S SDV+S+GV+L EL+TG P + L
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP--------------FRGIDG-LAV 222
Query: 457 SGTVISE---LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
+ V LP P P+ ++M ++C DP +RP+ + ++ L+TI
Sbjct: 223 AYGVAMNKLALPIPS---TCPEPFAKLM----EDCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 3e-57
Identities = 69/298 (23%), Positives = 123/298 (41%), Gaps = 53/298 (17%)
Query: 230 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV------FLTEVDMLSRLHHCH 282
+G+GG V++G+ + D +VA+K + F EV ++S L+H +
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
+V L G +V EF+P G+L L + W ++ + + A G+EY
Sbjct: 85 IVKLYGLMHN------PPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEY 137
Query: 343 LHEAAAPRILHRDIKSSNILLDE-----NLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
+ P I+HRD++S NI L + AK+ D G++ + + G
Sbjct: 138 MQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-QQSVHSVSGLL-------G 188
Query: 398 TFGYFAPEYAMVGRASL---MSDVFSFGVVLLELITGRQPIHRSITKGE---ESLVLWAT 451
F + APE + +D +SF ++L ++TG P + G+ +++
Sbjct: 189 NFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGP-FDEYSYGKIKFINMIREEG 246
Query: 452 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
R +P+ D P + + + C DP RP S +V+ LS +
Sbjct: 247 LRP--------TIPE-----DCPPR----LRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-56
Identities = 67/301 (22%), Positives = 126/301 (41%), Gaps = 33/301 (10%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDM--LSRLHHCHVVPLV 287
+G+G V+RG+ G VAVK F ++ + + E ++ L H +++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFI 102
Query: 288 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 347
++ G LV ++ +G+L D L+ + + + +A+ A GL +LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 348 A-----PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
P I HRD+KS NIL+ +N I DLG+A R + + R GT Y
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR-VGTKRYM 218
Query: 403 APE------YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT-KGEESLVLWATPRLQ 455
APE + +D+++ G+V E+ + ++ + P ++
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 456 DSGTVIS------ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
+ V+ +P+ + + +IM +EC + AR T + + LS +
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIM----RECWYANGAARLTALRIKKTLSQL 334
Query: 510 A 510
+
Sbjct: 335 S 335
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 3e-56
Identities = 67/301 (22%), Positives = 126/301 (41%), Gaps = 33/301 (10%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDM--LSRLHHCHVVPLV 287
+G+G V+ G+ G VAVK F T ++ + E ++ + H +++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFI 97
Query: 288 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 347
+ G L+ ++ NG+L D L ++ + + +A + GL +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 348 A-----PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
P I HRD+KS NIL+ +N I DLG+A + +D R+ GT Y
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRYM 213
Query: 403 APE------YAMVGRASLMSDVFSFGVVLLELITGRQPI-HRSITKGEESLVLWATPRLQ 455
PE ++ +M+D++SFG++L E+ + ++ + P +
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 456 DSGTVIS------ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
D ++ P+ + ++ M L EC +P +R T V + L+ +
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQ----MGKLMTECWAHNPASRLTALRVKKTLAKM 329
Query: 510 A 510
+
Sbjct: 330 S 330
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 7e-56
Identities = 74/288 (25%), Positives = 118/288 (40%), Gaps = 41/288 (14%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G G VY+G+ VAVK P F EV +L + H +++ +GY
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 350
+ +V ++ +L L + IA ARG++YLH A
Sbjct: 90 TA-----PQLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLH---AKS 140
Query: 351 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE---YA 407
I+HRD+KS+NI L E+ KI D G+A + G+ + APE
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS---GSILWMAPEVIRMQ 197
Query: 408 MVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA--TPRLQDSGTVISE-- 463
S SDV++FG+VL EL+TG+ P ++ R Q V
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLP--------------YSNINNRDQIIEMVGRGSL 243
Query: 464 -LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510
+++ + PK ++M ECL+ D RP+ ++ + +A
Sbjct: 244 SPDLSKVRSNCPKRMKRLM----AECLKKKRDERPSFPRILAEIEELA 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 5e-55
Identities = 72/321 (22%), Positives = 116/321 (36%), Gaps = 48/321 (14%)
Query: 230 NIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
++G+G + G ++ +K + FL EV ++ L H +V+ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT-FLKEVKVMRCLEHPNVLKFIG 74
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHE 345
+ KR + E++ G LR + D W RV+ A A G+ YLH
Sbjct: 75 VLY--KDKRLN--FITEYIKGGTLRGIIKSMDSQY----PWSQRVSFAKDIASGMAYLHS 126
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ--------- 396
I+HRD+ S N L+ EN N + D G+A+ + + +
Sbjct: 127 M---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456
G + APE DVFSFG+VL E+I PR D
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD------------YLPRTMD 231
Query: 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI------- 509
G + D + P I C LDP+ RP+ ++ L T+
Sbjct: 232 FGLNVRGFLDRYCPPNCPPSFFPIT----VRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287
Query: 510 APDKSRRRNISLNLFQIFSAG 530
P + + ++ + G
Sbjct: 288 LPLGPQLEQLDRGFWETYRRG 308
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 5e-53
Identities = 64/309 (20%), Positives = 111/309 (35%), Gaps = 45/309 (14%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLV 287
++G+G VY G+ G VA++ + N D + F EV + H +VV +
Sbjct: 39 ELIGKGRFGQVYHGRW-HGE-VAIRLIDIER-DNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 288 GYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
G C L ++ L + + ++ + IA +G+ YLH
Sbjct: 96 GACM-----SPPHLAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVKGMGYLH-- 147
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
A ILH+D+KS N+ D ITD G+ G + APE
Sbjct: 148 -AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 407 AMVGRASLM---------SDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT-PRLQD 456
SDVF+ G + EL P + T P
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP--------------FKTQPAEAI 251
Query: 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRR 516
+ + + + KE I+ C + + RPT ++++ +L + P ++RR
Sbjct: 252 IWQMGTGMKPNLSQIGMGKEISDIL----LFCWAFEQEERPTFTKLMDMLEKL-PKRNRR 306
Query: 517 RNISLNLFQ 525
+ + ++
Sbjct: 307 LSHPGHFWK 315
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-40
Identities = 77/293 (26%), Positives = 112/293 (38%), Gaps = 40/293 (13%)
Query: 233 GQG--GSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
G+G G V G +VAVK K GP S + E+D+L L+H H++
Sbjct: 40 GEGHFGK--VSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 345
G C + LV E++P G+LRD L + + A G+ YLH
Sbjct: 98 YKGCCEDAGAASLQ--LVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHA 152
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-----MQGTFG 400
+HRD+ + N+LLD + KI D G+AK +
Sbjct: 153 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY----- 204
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGT 459
APE + SDV+SFGV L EL+T E + +
Sbjct: 205 --APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262
Query: 460 VISE---LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
++ LP P P E +M K C + + RPT ++ IL T+
Sbjct: 263 LLERGERLPRPD---KCPAEVYHLM----KNCWETEASFRPTFENLIPILKTV 308
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 82/311 (26%), Positives = 118/311 (37%), Gaps = 45/311 (14%)
Query: 233 GQG--GSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
G+G GS V + G +VAVK+ + GP+ F E+ +L LH +V
Sbjct: 32 GKGNFGS--VELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEY 342
G + LV E++P+G LRD L L + + + +G+EY
Sbjct: 89 YRGVSYGPGRQSLR--LVMEYLPSGCLRDFLQRHRARL----DASRLLLYSSQICKGMEY 142
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-----MQG 397
L R +HRD+ + NIL++ + KI D G+AK L D P +
Sbjct: 143 LGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-- 197
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQD 456
APE S SDV+SFGVVL EL T + S P L
Sbjct: 198 -----APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 457 SGTVISE---LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513
++ E LP P P E ++M K C P RP+ S + L +
Sbjct: 253 LLELLEEGQRLPAPP---ACPAEVHELM----KLCWAPSPQDRPSFSALGPQLDMLWSGS 305
Query: 514 SRRRNISLNLF 524
+
Sbjct: 306 RGCETHAFTAH 316
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-39
Identities = 64/287 (22%), Positives = 114/287 (39%), Gaps = 56/287 (19%)
Query: 231 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCHVVPLVG 288
+G+G VY+G VA + + ++ F E +ML L H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGM--NWDTRVAIAIGAARGLEYLH 344
+ +LV E M +G L+ L V+ + +W ++ +GL++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI------LKGLQFLH 146
Query: 345 EAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
P I+HRD+K NI + + KI DLG+A +A + + GT + A
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-------VIGTPEFMA 198
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELITGRQP---------IHRSITKGEESLVLWATPRL 454
PE DV++FG+ +LE+ T P I+R +T G +
Sbjct: 199 PEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA-------- 249
Query: 455 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 501
++ P +K + + C++ + D R ++ +
Sbjct: 250 -----SFDKVAIPEVK-EI----------IEG-CIRQNKDERYSIKD 279
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-39
Identities = 70/299 (23%), Positives = 122/299 (40%), Gaps = 44/299 (14%)
Query: 230 NIVGQG--GSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
+G+G G V + G VAVK K + G N + E+++L L+H +
Sbjct: 27 RDLGEGHFGK--VELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARG 339
+V G C+E G L+ EF+P+G+L++ L + N ++ A+ +G
Sbjct: 85 IVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYLPKNKNKI----NLKQQLKYAVQICKG 138
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR----- 394
++YL + +HRD+ + N+L++ KI D G+ K ++ D
Sbjct: 139 MDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195
Query: 395 MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPR 453
APE M + + SDV+SFGV L EL+T +
Sbjct: 196 Y-------APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT 248
Query: 454 LQDSGTVISE---LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
+ + E LP P + P E Q+M ++C + P R + +++ +
Sbjct: 249 VTRLVNTLKEGKRLPCPP---NCPDEVYQLM----RKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 73/287 (25%), Positives = 115/287 (40%), Gaps = 61/287 (21%)
Query: 240 VYRGQLTDGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298
V+ G+L VAVK + P+ + FL E +L + H ++V L+G C+ ++
Sbjct: 130 VFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT----QKQ 185
Query: 299 MRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 356
+V E + G+ L +G + T + + AA G+EYL +HRD+
Sbjct: 186 PIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDL 239
Query: 357 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF-----APEYAMVGR 411
+ N L+ E KI+D GM++ A G APE GR
Sbjct: 240 AARNCLVTEKNVLKISDFGMSREEADG-------VYAASGGL-RQVPVKWTAPEALNYGR 291
Query: 412 ASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQDSGTVIS 462
S SDV+SFG++L E + G P + KG RL
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG---------RL-------- 334
Query: 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
P+ P ++M ++C +P RP+ S + Q L +I
Sbjct: 335 PCPE-----LCPDAVFRLM----EQCWAYEPGQRPSFSTIYQELQSI 372
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 8e-38
Identities = 73/295 (24%), Positives = 115/295 (38%), Gaps = 40/295 (13%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G+GG SYV + L DG A+KR E DM +H +++ LV YC
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--IAIGAARGLEYLHEAAA 348
RG + L+ F G L + ++ + +G + +G RGLE +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ------GTFGYF 402
HRD+K +NILL + + DLG + S +Q T Y
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH--VEGSRQALTLQDWAAQRCTISYR 210
Query: 403 APE------YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456
APE + ++ +DV+S G VL ++ G P KG +S+ L
Sbjct: 211 APELFSVQSHCVIDER---TDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVAL-------- 258
Query: 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511
V ++L P + L + +DP RP + ++ L + P
Sbjct: 259 --AVQNQLSIP-QSPRHSSA----LWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 73/300 (24%), Positives = 116/300 (38%), Gaps = 46/300 (15%)
Query: 230 NIVGQG--GSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
+G+G GS V + G +VAVK+ + F E+++L L H +
Sbjct: 47 QQLGKGNFGS--VEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDN 103
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARG 339
+V G C + L+ E++P G+LRD L + + + +G
Sbjct: 104 IVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERI----DHIKLLQYTSQICKG 157
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR----- 394
+EYL R +HRD+ + NIL++ KI D G+ K L D P
Sbjct: 158 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW 214
Query: 395 MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 454
APE + S+ SDV+SFGVVL EL T + + + ++
Sbjct: 215 Y-------APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 267
Query: 455 --QDSGTVISE---LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
++ LP P P E IM EC + + RP+ ++ + I
Sbjct: 268 IVFHLIELLKNNGRLPRPD---GCPDEIYMIM----TECWNNNVNQRPSFRDLALRVDQI 320
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-37
Identities = 73/301 (24%), Positives = 115/301 (38%), Gaps = 46/301 (15%)
Query: 233 GQGGSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLV 287
G GS V + G +VAVK+ + F E+++L L H ++V
Sbjct: 21 GNFGS--VEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 288 GYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLH 344
G C + L+ E++P G+LRD L + + + +G+EYL
Sbjct: 78 GVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERI----DHIKLLQYTSQICKGMEYLG 131
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-----MQGTF 399
R +HRD+ + NIL++ KI D G+ K L D P
Sbjct: 132 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY---- 184
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459
APE + S+ SDV+SFGVVL EL T + + + ++
Sbjct: 185 ---APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF-H 240
Query: 460 VISE------LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513
+I LP P P E IM EC + + RP+ ++ + I +
Sbjct: 241 LIELLKNNGRLPRPD---GCPDEIYMIM----TECWNNNVNQRPSFRDLALRVDQIRDNM 293
Query: 514 S 514
+
Sbjct: 294 A 294
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 77/313 (24%), Positives = 123/313 (39%), Gaps = 68/313 (21%)
Query: 230 NIVGQGGSSYVYRGQLTDGR-----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 284
++G G VY+G VA+K + P A+ L E +++ + + HV
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLE 341
L+G C L+ + MP G L D + + + + A+G+
Sbjct: 81 RLLGICLT---STVQ--LITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQIAKGMN 131
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
YL + R++HRD+ + N+L+ + KITD G+AK L A+ G
Sbjct: 132 YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-------EKEYHAEG-GK 180
Query: 402 F-----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLV 447
A E + + SDV+S+GV + EL+T G +P I + KGE
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---- 236
Query: 448 LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507
R LP P + IM ++C +D D+RP E++ S
Sbjct: 237 -----R----------LPQPP---ICTIDVYMIM----RKCWMIDADSRPKFRELIIEFS 274
Query: 508 TIAPDKSRRRNIS 520
+A D R I
Sbjct: 275 KMARDPQRYLVIQ 287
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 67/292 (22%), Positives = 112/292 (38%), Gaps = 55/292 (18%)
Query: 233 GQGGSSYVYRGQLT--DGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
G G V +G +I VA+K K + E ++ +L + ++V L+G
Sbjct: 19 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 78
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
C + M LV E G L L + + + G++YL E
Sbjct: 79 CQA---EALM--LVMEMAGGGPLHKFLVGKREEI----PVSNVAELLHQVSMGMKYLEEK 129
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
+HRD+ + N+LL AKI+D G++K L AD + S + ++APE
Sbjct: 130 ---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW--PLKWYAPEC 184
Query: 407 AMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQDS 457
+ S SDV+S+GV + E ++ G++P + I +G+ R
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---------R---- 231
Query: 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
+ P + P E +M +C + RP V Q +
Sbjct: 232 ------MECPP---ECPPELYALM----SDCWIYKWEDRPDFLTVEQRMRAC 270
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-36
Identities = 53/286 (18%), Positives = 99/286 (34%), Gaps = 49/286 (17%)
Query: 232 VGQGGSSYVYRG--QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
+ GG ++Y + +GR V +K G A ++ + E L+ + H +V + +
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 290 CSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
+V E++ +L+ L +A + L YLH
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKL----PVAEAIAYLLEILPALSYLHSI-- 201
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 408
+++ D+K NI+L E K+ DLG R+ + G + GT G+ APE
Sbjct: 202 -GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY---------LYGTPGFQAPEIVR 250
Query: 409 VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 468
++ +D+++ G L L +G + LP+
Sbjct: 251 -TGPTVATDIYTVGRTLAALTLDLPT---------------------RNGRYVDGLPEDD 288
Query: 469 LKGDFPKE-EMQIMAYLAKECLQLDPDARP-TMSEVVQILSTIAPD 512
+ + DP R T E+ L+ + +
Sbjct: 289 PVLKTYDSYGRLLRRAIDP-----DPRQRFTTAEEMSAQLTGVLRE 329
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-36
Identities = 80/312 (25%), Positives = 133/312 (42%), Gaps = 66/312 (21%)
Query: 231 IVGQGGSSYVYRGQLTDGRI-----VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
++G G VY+G L VA+K K FL E ++ + H +++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEY 342
L G S + K M ++ E+M NG L L DG + V + G A G++Y
Sbjct: 111 LEGVIS--KYKPMM--IITEYMENGALDKFLREKDGEF----SVLQLVGMLRGIAAGMKY 162
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS----PAR-MQG 397
L +HRD+ + NIL++ NL K++D G+++ L+ D + ++S P R
Sbjct: 163 LANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT-- 217
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVL 448
APE + + SDV+SFG+V+ E++T G +P + ++I G
Sbjct: 218 -----APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF----- 267
Query: 449 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508
R LP P D P Q+M +C Q + RP +++V IL
Sbjct: 268 ----R----------LPTPM---DCPSAIYQLM----MQCWQQERARRPKFADIVSILDK 306
Query: 509 IAPDKSRRRNIS 520
+ + ++
Sbjct: 307 LIRAPDSLKTLA 318
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 79/347 (22%), Positives = 131/347 (37%), Gaps = 74/347 (21%)
Query: 230 NIVGQGGSSYVYRGQLTDGR-----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 284
++G G V++G V +K + + G + + + L H H+V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLE 341
L+G C LV +++P G+L D + G L + + A+G+
Sbjct: 79 RLLGLCPG---SSLQ--LVTQYLPLGSLLDHVRQHRGAL----GPQLLLNWGVQIAKGMY 129
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS---PAR-MQG 397
YL E ++HR++ + N+LL ++ D G+A L D S P + M
Sbjct: 130 YLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM-- 184
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVL 448
A E G+ + SDV+S+GV + EL+T G +P + + KGE
Sbjct: 185 -----ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE----- 234
Query: 449 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508
R L P+ + +M +C +D + RPT E+ +
Sbjct: 235 ----R----------LAQPQ---ICTIDVYMVM----VKCWMIDENIRPTFKELANEFTR 273
Query: 509 IAPDKSRRRNISLNLFQIFSAGGMEKEPSIERPDNLFETLIESEELK 555
+A D R I S G+ P P L +E EL+
Sbjct: 274 MARDPPRYLVIKRE-----SGPGIAPGPE---PHGLTNKKLEEVELE 312
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 70/321 (21%), Positives = 127/321 (39%), Gaps = 65/321 (20%)
Query: 220 EHATDKFSGSN-----IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
H DK G + ++G GG V++ + DG+ +KR K N + EV
Sbjct: 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN---NEKA--EREVK 56
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRL------------LVFEFMPNGNLRDCLD---- 317
L++L H ++V G F + EF G L ++
Sbjct: 57 ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116
Query: 318 GVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377
L + + + + +G++Y+H ++++RD+K SNI L + KI D G+
Sbjct: 117 EKLDKVLALE----LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLV 169
Query: 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437
LK DG R +GT Y +PE D+++ G++L EL+
Sbjct: 170 TSLKNDGK------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF- 222
Query: 438 SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP 497
++ ++L D + F K+E ++ ++ L P+ RP
Sbjct: 223 ------------------ETSKFFTDLRDGIISDIFDKKEKTLL----QKLLSKKPEDRP 260
Query: 498 TMSEVVQ--ILSTIAPDKSRR 516
SE+++ + +P+K+ R
Sbjct: 261 NTSEILRTLTVWKKSPEKNER 281
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 81/310 (26%), Positives = 131/310 (42%), Gaps = 67/310 (21%)
Query: 230 NIVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
I+G G S V G+L VA+K K FL+E ++ + H +++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEY 342
L G + RG+ AM +V E+M NG+L L DG V + G G+ Y
Sbjct: 115 LEGVVT--RGRLAM--IVTEYMENGSLDTFLRTHDGQF----TIMQLVGMLRGVGAGMRY 166
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-----MQG 397
L + +HRD+ + N+L+D NL K++D G+++ L+ D + +++ +
Sbjct: 167 LSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-- 221
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVL 448
APE S SDV+SFGVV+ E++ G +P + S+ +G
Sbjct: 222 -----APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY----- 271
Query: 449 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508
R LP P P Q+M +C D RP S++V +L
Sbjct: 272 ----R----------LPAPM---GCPHALHQLM----LDCWHKDRAQRPRFSQIVSVLDA 310
Query: 509 I--APDKSRR 516
+ +P+ R
Sbjct: 311 LIRSPESLRA 320
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 74/302 (24%), Positives = 118/302 (39%), Gaps = 65/302 (21%)
Query: 230 NIVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
++G+G VY G L D AVK S FLTE ++ H +V+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEY 342
L+G C G L+V +M +G+LR+ + + + A+G++Y
Sbjct: 91 LLGICLRSEGS---PLVVLPYMKHGDLRNFIRNETHNPTVK----DLIGFGLQVAKGMKY 143
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
L A+ + +HRD+ + N +LDE K+ D G+A+ + + G
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-------DKEYYSVHNKTGAK 193
Query: 403 ------APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLV 447
A E + + SDV+SFGV+L EL+T G P I + +G
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR---- 249
Query: 448 LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507
R L P P ++M +C + RP+ SE+V +S
Sbjct: 250 -----R----------LLQPE---YCPDPLYEVM----LKCWHPKAEMRPSFSELVSRIS 287
Query: 508 TI 509
I
Sbjct: 288 AI 289
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 78/344 (22%), Positives = 136/344 (39%), Gaps = 64/344 (18%)
Query: 230 NIVGQGGSSYVYRGQLTDGR-----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 284
++G G VY+G VA+K + P A+ L E +++ + + HV
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLE 341
L+G C + L+ + MP G L D + + + + A+G+
Sbjct: 81 RLLGICLT-----STVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQIAKGMN 131
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS---PARMQGT 398
YL + R++HRD+ + N+L+ + KITD G+AK L A+ + P +
Sbjct: 132 YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK---- 184
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLW 449
+ A E + + SDV+S+GV + EL+T G +P I + KGE
Sbjct: 185 --WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------ 236
Query: 450 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
R LP P + IM +C +D D+RP E++ S +
Sbjct: 237 ---R----------LPQPP---ICTIDVYMIM----VKCWMIDADSRPKFRELIIEFSKM 276
Query: 510 APDKSRRRNISLNLFQIFSAGGMEKEPSIERPDNLFETLIESEE 553
A D R I + + + + +++++E
Sbjct: 277 ARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADE 320
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 67/285 (23%), Positives = 107/285 (37%), Gaps = 41/285 (14%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
+ VG+G V+R + G AVK+ + + E+ + L
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE------ELVACAGLSSP 110
Query: 282 HVVPLVGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAA- 337
+VPL G + G + +F E + G+L + G L E R +G A
Sbjct: 111 RIVPLYG--AVREGPW---VNIFMELLEGGSLGQLIKQMGCLPE-----DRALYYLGQAL 160
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
GLEYLH RILH D+K+ N+LL + A + D G A L+ DGL + +
Sbjct: 161 EGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456
GT + APE M D++S ++L ++ G P + +
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY----FRGPLCLKIAS--- 270
Query: 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 501
P + Q + +E L+ +P R + E
Sbjct: 271 -----EPPPIREIPPSCAPLTAQAI----QEGLRKEPVHRASAME 306
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 9e-35
Identities = 75/313 (23%), Positives = 122/313 (38%), Gaps = 61/313 (19%)
Query: 230 NIVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
++G+G VY G L D AVK S FLTE ++ H +V+
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR--VAIAIGAARGLEYL 343
L+G C G L+V +M +G+LR+ + E N + + + A+G+++L
Sbjct: 155 LLGICLRSEGS---PLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF- 402
A+ + +HRD+ + N +LDE K+ D G+A+ + T
Sbjct: 209 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-----DKEFDSVH-NKTGAKLP 259
Query: 403 ----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLW 449
A E + + SDV+SFGV+L EL+T G P I + +G
Sbjct: 260 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR------ 313
Query: 450 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
L P P ++M +C + RP+ SE+V +S I
Sbjct: 314 -------------RLLQPE---YCPDPLYEVM----LKCWHPKAEMRPSFSELVSRISAI 353
Query: 510 APDKSRRRNISLN 522
+ +N
Sbjct: 354 FSTFIGEHYVHVN 366
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 70/311 (22%), Positives = 113/311 (36%), Gaps = 69/311 (22%)
Query: 230 NIVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSV-FLTEVDMLSRLHHCHVV 284
I+G+G V G L VAVK K + FL+E + H +V+
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 285 PLVGYCSEFRGKRAMRLLV-FEFMPNGNL----RDCLDGVLVEGMNWDTRVAIAIGAARG 339
L+G C E + + +V FM G+L + + T + + A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGLPSCSSS 391
+EYL + LHRD+ + N +L +++ + D G++K R
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK-----M 211
Query: 392 PAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITK 441
P + + A E + SDV++FGV + E+ T G P ++ +
Sbjct: 212 PVKWI-------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264
Query: 442 GEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 501
G RL + P+ D E +IM C + DP RPT S
Sbjct: 265 GH---------RL--------KQPE-----DCLDELYEIM----YSCWRTDPLDRPTFSV 298
Query: 502 VVQILSTIAPD 512
+ L +
Sbjct: 299 LRLQLEKLLES 309
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 73/298 (24%), Positives = 116/298 (38%), Gaps = 64/298 (21%)
Query: 231 IVGQGGSSYVYRGQLTDGRI----VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
I+G+G VY G T+ + VAVK K + F++E ++ L H H+V L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYL 343
+G E ++ E P G L L L T V ++ + + YL
Sbjct: 79 IGIIEE-----EPTWIIMELYPYGELGHYLERNKNSL----KVLTLVLYSLQICKAMAYL 129
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFG 400
+HRDI NIL+ K+ D G+++ ++ + S + P + M
Sbjct: 130 ESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----- 181
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWAT 451
+PE R + SDV+ F V + E+++ G+QP + + KG+
Sbjct: 182 --SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-------- 231
Query: 452 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
R LP P P +M C DP RP +E+V LS +
Sbjct: 232 -R----------LPKPD---LCPPVLYTLM----TRCWDYDPSDRPRFTELVCSLSDV 271
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 1e-34
Identities = 79/307 (25%), Positives = 132/307 (42%), Gaps = 53/307 (17%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
+ A E + +GQG V+ G VA+K K G + FL E
Sbjct: 174 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQ 231
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
++ +L H +V L SE + +V E+M G+L D L G + + V +A
Sbjct: 232 VMKKLRHEKLVQLYAVVSE---EPIY--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 286
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS-- 391
A G+ Y+ +HRD++++NIL+ ENL K+ D G+A+ ++ + + +
Sbjct: 287 AQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 343
Query: 392 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKG 442
P + + APE A+ GR ++ SDV+SFG++L EL T GR P + + +G
Sbjct: 344 PIK------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397
Query: 443 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 502
R +P P + P+ +M +C + +P+ RPT +
Sbjct: 398 Y---------R----------MPCPP---ECPESLHDLM----CQCWRKEPEERPTFEYL 431
Query: 503 VQILSTI 509
L
Sbjct: 432 QAFLEDY 438
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 71/293 (24%), Positives = 119/293 (40%), Gaps = 53/293 (18%)
Query: 233 GQGGSSYVYRGQLTDGRI---VAVKRFKT-QGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
G G+ V +G ++ VAVK K P L E +++ +L + ++V ++G
Sbjct: 28 GNFGT--VKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 85
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
C + M LV E G L L + + + + G++YL E+
Sbjct: 86 ICE---AESWM--LVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES-- 136
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 408
+HRD+ + N+LL AKI+D G++K L+AD + + + ++APE
Sbjct: 137 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW--PVKWYAPECIN 193
Query: 409 VGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQDSGT 459
+ S SDV+SFGV++ E + G++P + + KGE R
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE---------R------ 238
Query: 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512
+ P P+E +M C D + RP + V L D
Sbjct: 239 ----MGCPA---GCPREMYDLM----NLCWTYDVENRPGFAAVELRLRNYYYD 280
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 77/312 (24%), Positives = 132/312 (42%), Gaps = 65/312 (20%)
Query: 230 NIVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
+VG G V G+L VA+K K FL E ++ + H +++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEY 342
L G + + K M +V E+M NG+L L D V + G A G++Y
Sbjct: 111 LEGVVT--KSKPVM--IVTEYMENGSLDSFLRKHDAQF----TVIQLVGMLRGIASGMKY 162
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS----PAR-MQG 397
L + +HRD+ + NIL++ NL K++D G+ + L+ D + ++ P R
Sbjct: 163 LSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT-- 217
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVL 448
+PE + + SDV+S+G+VL E+++ G +P + +++ +G
Sbjct: 218 -----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY----- 267
Query: 449 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508
R LP P D P Q+M +C Q D + RP ++V IL
Sbjct: 268 ----R----------LPPPM---DCPAALYQLM----LDCWQKDRNNRPKFEQIVSILDK 306
Query: 509 IAPDKSRRRNIS 520
+ + + I+
Sbjct: 307 LIRNPGSLKIIT 318
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 70/309 (22%), Positives = 117/309 (37%), Gaps = 70/309 (22%)
Query: 230 NIVGQGGSSYVYRGQLTDG----RIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCHVV 284
++G+G V QL VAVK K ++D FL E + H HV
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 285 PLVGYCSEFRGKRAMR--LLVFEFMPNGN----LRDCLDGVLVEGMNWDTRVAIAIGAAR 338
LVG R K + +++ FM +G+ L G + T V + A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGLPSCSS 390
G+EYL ++ +HRD+ + N +L E++ + D G+++ R
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK----- 200
Query: 391 SPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSIT 440
P + + A E ++ SDV++FGV + E++T G+ P I+ +
Sbjct: 201 LPVKWL-------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253
Query: 441 KGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 500
G RL + P + +E +M +C DP RP+ +
Sbjct: 254 GGN---------RL--------KQPP-----ECMEEVYDLM----YQCWSADPKQRPSFT 287
Query: 501 EVVQILSTI 509
+ L I
Sbjct: 288 CLRMELENI 296
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 72/300 (24%), Positives = 119/300 (39%), Gaps = 61/300 (20%)
Query: 230 NIVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
++G+G VY G+ D A+K FL E ++ L+H +V+
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR--VAIAIGAARGLEYL 343
L+G G + ++ +M +G+L + N + ++ + ARG+EYL
Sbjct: 87 LIGIMLPPEG---LPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYL 140
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF- 402
A + +HRD+ + N +LDE+ K+ D G+A+ + + Q
Sbjct: 141 ---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR------EYYSVQQHRHARLP 191
Query: 403 ----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLW 449
A E R + SDV+SFGV+L EL+T G P + + +G
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR------ 245
Query: 450 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
R LP P P Q+M ++C + DP RPT +V + I
Sbjct: 246 ---R----------LPQPE---YCPDSLYQVM----QQCWEADPAVRPTFRVLVGEVEQI 285
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-34
Identities = 71/297 (23%), Positives = 123/297 (41%), Gaps = 53/297 (17%)
Query: 230 NIVGQGGSSYVYRGQLTDGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
+ +G G VY G + VAVK K FL E ++ + H ++V L+G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
C+ ++ EFM GNL D L + ++ + +A + +EYL +
Sbjct: 284 VCTR--EPPFY--IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-- 337
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF--APEY 406
+HR++ + N L+ EN K+ D G+++ + D + A F APE
Sbjct: 338 -NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHAGAKFPIKWTAPES 390
Query: 407 AMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQDS 457
+ S+ SDV++FGV+L E+ T G P ++ + K R+
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---------RM--- 438
Query: 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKS 514
P P++ ++M + C Q +P RP+ +E+ Q T+ + S
Sbjct: 439 -------ERPE---GCPEKVYELM----RACWQWNPSDRPSFAEIHQAFETMFQESS 481
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 68/316 (21%), Positives = 119/316 (37%), Gaps = 61/316 (19%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
Y + E + +G G V G+ VA+K K G ++ F+ E
Sbjct: 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAK 71
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRV 330
++ L H +V L G C+ K+ ++ E+M NG L + L +
Sbjct: 72 VMMNLSHEKLVQLYGVCT----KQRPIFIITEYMANGCLLNYLREMRHRF----QTQQLL 123
Query: 331 AIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 390
+ +EYL + + LHRD+ + N L+++ K++D G+++ + D S
Sbjct: 124 EMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180
Query: 391 S--PAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRS 438
S P R PE M + S SD+++FGV++ E+ + G+ P
Sbjct: 181 SKFPVRWS-------PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 233
Query: 439 ITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT 498
I +G R L P ++ IM C D RPT
Sbjct: 234 IAQGL---------R----------LYRPH---LASEKVYTIM----YSCWHEKADERPT 267
Query: 499 MSEVVQILSTIAPDKS 514
++ + + ++S
Sbjct: 268 FKILLSNILDVMDEES 283
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-34
Identities = 75/295 (25%), Positives = 124/295 (42%), Gaps = 61/295 (20%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
+G G V+ G + VA+K + G ++ F+ E +++ +L H +V L G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
C ++A LV EFM +G L D L G+ +T + + + G+ YL
Sbjct: 72 CL----EQAPICLVTEFMEHGCLSDYLRTQRGLF----AAETLLGMCLDVCEGMAYL--- 120
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFGYFA 403
++HRD+ + N L+ EN K++D GM + + D S + + P + +
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA-------S 173
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRL 454
PE R S SDV+SFGV++ E+ + G+ P + I+ G R
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---------R- 223
Query: 455 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
L PR QIM C + P+ RP S +++ L+ I
Sbjct: 224 ---------LYKPR---LASTHVYQIM----NHCWRERPEDRPAFSRLLRQLAEI 262
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 73/298 (24%), Positives = 129/298 (43%), Gaps = 55/298 (18%)
Query: 230 NIVGQGGSSYVYRGQLTDGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
+ +G G VY G + VAVK K + + FL E ++ + H ++V L+G
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 76
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
C+ R ++ EFM GNL D L + ++ + +A + +EYL
Sbjct: 77 VCT--REPPFY--IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EK 129
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFGYFAPE 405
+HRD+ + N L+ EN K+ D G+++ + D + + + P + APE
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT-------APE 182
Query: 406 YAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQD 456
+ S+ SDV++FGV+L E+ T G P ++ + K R+
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---------RM-- 231
Query: 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKS 514
E P+ P++ ++M + C Q +P RP+ +E+ Q T+ + S
Sbjct: 232 ------ERPE-----GCPEKVYELM----RACWQWNPSDRPSFAEIHQAFETMFQESS 274
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-34
Identities = 66/292 (22%), Positives = 112/292 (38%), Gaps = 55/292 (18%)
Query: 233 GQGGSSYVYRGQLT--DGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
G G V +G +I VA+K K + E ++ +L + ++V L+G
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
C + M LV E G L L + + + G++YL E
Sbjct: 405 CQA---EALM--LVMEMAGGGPLHKFLVGKREEI----PVSNVAELLHQVSMGMKYLEEK 455
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
+HR++ + N+LL AKI+D G++K L AD + S + ++APE
Sbjct: 456 ---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW--PLKWYAPEC 510
Query: 407 AMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQDS 457
+ S SDV+S+GV + E ++ G++P + I +G+ R
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---------R---- 557
Query: 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
+ P + P E +M +C + RP V Q +
Sbjct: 558 ------MECPP---ECPPELYALM----SDCWIYKWEDRPDFLTVEQRMRAC 596
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-34
Identities = 73/301 (24%), Positives = 113/301 (37%), Gaps = 64/301 (21%)
Query: 231 IVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
+G+G V++G VA+K K + FL E + + H H+V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYL 343
+G +E ++ E G LR L L + + A + L YL
Sbjct: 82 IGVITE---NPVW--IIMELCTLGELRSFLQVRKYSLDLA----SLILYAYQLSTALAYL 132
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFG 400
R +HRDI + N+L+ N K+ D G+++ ++ S P + M
Sbjct: 133 ESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----- 184
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWAT 451
APE R + SDV+ FGV + E++ G +P + I GE
Sbjct: 185 --APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------- 234
Query: 452 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511
R LP P + P +M +C DP RP +E+ LSTI
Sbjct: 235 -R----------LPMPP---NCPPTLYSLM----TKCWAYDPSRRPRFTELKAQLSTILE 276
Query: 512 D 512
+
Sbjct: 277 E 277
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-34
Identities = 66/294 (22%), Positives = 113/294 (38%), Gaps = 61/294 (20%)
Query: 231 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G G V G+ VAVK K G ++ F E + +L H +V G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKE--GSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 347
S K +V E++ NG L + L L + + G+ +L
Sbjct: 73 S----KEYPIYIVTEYISNGCLLNYLRSHGKGL----EPSQLLEMCYDVCEGMAFL---E 121
Query: 348 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFGYFAP 404
+ + +HRD+ + N L+D +L K++D GM + + D S + P + AP
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS-------AP 174
Query: 405 EYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQ 455
E + S SDV++FG+++ E+ + G+ P + +++G R
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH---------R-- 223
Query: 456 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
L P QIM C P+ RPT +++ + +
Sbjct: 224 --------LYRPH---LASDTIYQIM----YSCWHELPEKRPTFQQLLSSIEPL 262
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 6e-34
Identities = 69/297 (23%), Positives = 124/297 (41%), Gaps = 53/297 (17%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
+ +G G V+ VAVK K G + FL E +++ L H +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLAEANVMKTLQHDKL 245
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 343
V L ++ + ++ EFM G+L D L + + A G+ ++
Sbjct: 246 VKLHAVVTK---EPIY--IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PARMQGTFGY 401
+ +HRD++++NIL+ +L KI D G+A+ ++ + + + P + +
Sbjct: 301 EQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK------W 351
Query: 402 FAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATP 452
APE G ++ SDV+SFG++L+E++T GR P + R++ +G
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY--------- 402
Query: 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
R +P P + P+E IM C + P+ RPT + +L
Sbjct: 403 R----------MPRPE---NCPEELYNIM----MRCWKNRPEERPTFEYIQSVLDDF 442
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 8e-34
Identities = 79/308 (25%), Positives = 132/308 (42%), Gaps = 53/308 (17%)
Query: 213 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEV 272
+ A E + +GQG V+ G VA+K K G + FL E
Sbjct: 256 GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEA 313
Query: 273 DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 332
++ +L H +V L SE + +V E+M G+L D L G + + V +
Sbjct: 314 QVMKKLRHEKLVQLYAVVSE---EPIY--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 368
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS- 391
A A G+ Y+ +HRD++++NIL+ ENL K+ D G+A+ ++ + + +
Sbjct: 369 AAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 425
Query: 392 -PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITK 441
P + + APE A+ GR ++ SDV+SFG++L EL T GR P + + +
Sbjct: 426 FPIK------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479
Query: 442 GEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 501
G R +P P + P+ +M +C + +P+ RPT
Sbjct: 480 GY---------R----------MPCPP---ECPESLHDLM----CQCWRKEPEERPTFEY 513
Query: 502 VVQILSTI 509
+ L
Sbjct: 514 LQAFLEDY 521
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 78/304 (25%), Positives = 113/304 (37%), Gaps = 59/304 (19%)
Query: 231 IVGQGGSSYVYRGQLTDGRI----VAVKRFK--TQGGPNADSVFLTEVDMLSRLHHCHVV 284
+G G V RG+ VAVK K P A F+ EV+ + L H +++
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLE 341
L G +V E P G+L D L G T A+ A G+
Sbjct: 85 RLYGVVLT---PPMK--MVTELAPLGSLLDRLRKHQGHF----LLGTLSRYAVQVAEGMG 135
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
YL R +HRD+ + N+LL KI D G+ + L + ++ F +
Sbjct: 136 YLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV--PFAW 190
Query: 402 FAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP---------IHRSITKGEESLVLWAT 451
APE S SD + FGV L E+ T G++P +H+ +GE
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE-------- 242
Query: 452 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511
RL P P D P++ +M +C P+ RPT + L P
Sbjct: 243 -RL----------PRPE---DCPQDIYNVM----VQCWAHKPEDRPTFVALRDFLLEAQP 284
Query: 512 DKSR 515
R
Sbjct: 285 TDMR 288
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-33
Identities = 71/282 (25%), Positives = 114/282 (40%), Gaps = 59/282 (20%)
Query: 240 VYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299
V G G VAVK K A FL E ++++L H ++V L+G E +G
Sbjct: 209 VMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVEEKGGL-- 262
Query: 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359
+V E+M G+L D L + D + ++ +EYL +HRD+ +
Sbjct: 263 -YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAAR 318
Query: 360 NILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFGYFAPEYAMVGRASLMS 416
N+L+ E+ AK++D G+ K + + + P + APE + S S
Sbjct: 319 NVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWT-------APEALREKKFSTKS 367
Query: 417 DVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQDSGTVISELPDP 467
DV+SFG++L E+ + GR P + + KG + + P
Sbjct: 368 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------K----------MDAP 408
Query: 468 RLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
P +M K C LD RPT ++ + L I
Sbjct: 409 D---GCPPAVYDVM----KNCWHLDAATRPTFLQLREQLEHI 443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 78/316 (24%), Positives = 122/316 (38%), Gaps = 65/316 (20%)
Query: 230 NIVGQG--GSSYVYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
+GQG G VY G VA+K FL E ++ +
Sbjct: 31 RELGQGSFGM--VYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------DGVLVEGMNWDTRVAIA 333
HVV L+G S + L++ E M G+L+ L + ++ + + +A
Sbjct: 89 HVVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGL 385
A G+ YL A + +HRD+ + N ++ E+ KI D GM + R GL
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201
Query: 386 PSCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGE 443
P R M +PE G + SDV+SFGVVL E+ T QP ++ +
Sbjct: 202 -----LPVRWM-------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ-GLSNEQ 248
Query: 444 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 503
VL R G + L P + P ++M + C Q +P RP+ E++
Sbjct: 249 ---VL----RFVMEGGL---LDKPD---NCPDMLFELM----RMCWQYNPKMRPSFLEII 291
Query: 504 QILSTIAPDKSRRRNI 519
+ R +
Sbjct: 292 SSIKEEMEPGFREVSF 307
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 66/287 (22%), Positives = 118/287 (41%), Gaps = 34/287 (11%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLVG 288
+G GG S V+ + L D R VAVK + + F E + L+H +V +
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG--MNWDTRVAIAIGAARGLEYLHEA 346
+ +V E++ LRD ++ M + + A + L + H+
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRD----IVHTEGPMTPKRAIEVIADACQALNFSHQN 135
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
I+HRD+K +NI++ K+ D G+A+ + G ++ + GT Y +PE
Sbjct: 136 ---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA--VIGTAQYLSPEQ 190
Query: 407 AMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 466
A SDV+S G VL E++TG P G+ + + A +++ +
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPPF-----TGDSPVSV-AYQHVRE------DPIP 238
Query: 467 PR-LKGDFPKE-EMQIMAYLAKECLQLDPDARP-TMSEVVQILSTIA 510
P + + ++ LAK +P+ R T +E+ L +
Sbjct: 239 PSARHEGLSADLDAVVLKALAK-----NPENRYQTAAEMRADLVRVH 280
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 67/301 (22%), Positives = 121/301 (40%), Gaps = 42/301 (13%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 280
F +G+G S VYR L DG VA+K+ + +A + + E+D+L +L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL------DGVLVEGMNWDTRVAIAI 334
+V+ Y + F + +V E G+L + ++ E W +
Sbjct: 92 PNVI---KYYASFIEDNEL-NIVLELADAGDLSRMIKHFKKQKRLIPERTVWK----YFV 143
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
LE++H R++HRDIK +N+ + K+ DLG+ + S ++ A
Sbjct: 144 QLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF------SSKTTAAH 194
Query: 395 -MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 453
+ GT Y +PE + SD++S G +L E+ + P + SL
Sbjct: 195 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLYSLCK----- 248
Query: 454 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513
+ P + +E + L C+ DP+ RP ++ V + +
Sbjct: 249 -----KIEQCDYPPLPSDHYSEE----LRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299
Query: 514 S 514
+
Sbjct: 300 A 300
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-33
Identities = 73/292 (25%), Positives = 121/292 (41%), Gaps = 59/292 (20%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
+G+G V G G VAVK K A FL E ++++L H ++V L+G
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGV 82
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 349
E +G +V E+M G+L D L + D + ++ +EYL
Sbjct: 83 IVEEKGGL---YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGN 136
Query: 350 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFGYFAPEY 406
+HRD+ + N+L+ E+ AK++D G+ K + + + P + APE
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWT-------APEA 185
Query: 407 AMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQDS 457
+ S SDV+SFG++L E+ + GR P + + KG ++
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------KM--- 233
Query: 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
+ PD P ++M K C LD RP+ ++ + L I
Sbjct: 234 -----DAPD-----GCPPAVYEVM----KNCWHLDAAMRPSFLQLREQLEHI 271
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 63/290 (21%), Positives = 107/290 (36%), Gaps = 40/290 (13%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG-- 288
+G+GG V+ + D A+KR + A + EV L++L H +V
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 289 -----YCSEFRGKRAMRL-LVFEFMPNGNLRDCLDG-VLVEGMNWDTRVAIAIGAARGLE 341
+ L + + NL+D ++G +E + I + A +E
Sbjct: 73 LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ----- 396
+LH ++HRD+K SNI + K+ D G+ + D +P
Sbjct: 133 FLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 397 --GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 454
GT Y +PE S D+FS G++L EL ++ T+ E L
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL------LYPFSTQMERVRTL------ 237
Query: 455 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
T + L P L E ++ ++ L P RP +++
Sbjct: 238 ----TDVRNLKFPPLFTQKYPCEYVMV----QDMLSPSPMERPEAINIIE 279
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 70/292 (23%), Positives = 129/292 (44%), Gaps = 55/292 (18%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
+G G V+ G VAVK K G + FL E +++ +L H +V L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 349
+ + + ++ E+M NG+L D L + + + +A A G+ ++
Sbjct: 77 VT----QEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EER 128
Query: 350 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFGYFAPEY 406
+HRD++++NIL+ + L+ KI D G+A+ ++ + + + P + APE
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT-------APEA 181
Query: 407 AMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQDS 457
G ++ SDV+SFG++L E++T GR P + +++ +G R+
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---------RM--- 229
Query: 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
PD + P+E Q+M + C + P+ RPT + +L
Sbjct: 230 -----VRPD-----NCPEELYQLM----RLCWKERPEDRPTFDYLRSVLEDF 267
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 78/286 (27%), Positives = 125/286 (43%), Gaps = 39/286 (13%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLVG 288
+G GG S VY + VA+K +++ F EV S+L H ++V ++
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLEYLHEAA 347
E LV E++ L + ++ G ++ DT + G+++ H+
Sbjct: 79 VDEE----DDCYYLVMEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDM- 130
Query: 348 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA 407
RI+HRDIK NIL+D N KI D G+AK L L + + GT YF+PE A
Sbjct: 131 --RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL----TQTNHVLGTVQYFSPEQA 184
Query: 408 MVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDP 467
+D++S G+VL E++ G P G E+ V A +QD +P+
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPF-----NG-ETAVSIAIKHIQD------SVPNV 232
Query: 468 --RLKGDFPKE-EMQIMAYLAKECLQLDPDARP-TMSEVVQILSTI 509
++ D P+ I+ K D R T+ E+ LS++
Sbjct: 233 TTDVRKDIPQSLSNVILRATEK-----DKANRYKTIQEMKDDLSSV 273
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-32
Identities = 62/288 (21%), Positives = 109/288 (37%), Gaps = 33/288 (11%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFL-TEVDMLSRLHHC 281
+ + +G G + + +DG+I+ K A+ L +EV++L L H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 282 HVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--AR 338
++V Y + L +V E+ G+L + E D + +
Sbjct: 66 NIV---RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 339 GLEYLHE--AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
L+ H +LHRD+K +N+ LD N K+ D G+A+ L D + +
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-----FV 177
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456
GT Y +PE + SD++S G +L EL P ++ L
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT---AFSQKELAG-------- 226
Query: 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
I E R+ + E + + L L RP++ E+++
Sbjct: 227 ---KIREGKFRRIPYRYSDE----LNEIITRMLNLKDYHRPSVEEILE 267
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 69/295 (23%), Positives = 107/295 (36%), Gaps = 43/295 (14%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPL-- 286
VG+GG VY + RIVA+K + E RL HVVP+
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLEYLHE 345
G E G + + +L L +G + VAI L+ H
Sbjct: 102 FG---EIDG---QLYVDMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHA 152
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 405
A HRD+K NIL+ + A + D G+A + L + GT Y APE
Sbjct: 153 A---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL----TQLGNTVGTLYYMAPE 205
Query: 406 YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465
A+ +D+++ VL E +TG P G++ V+ A + +P
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPPYQ-----GDQLSVMGA--HINQ------AIP 252
Query: 466 DPR-LKGDFPKE-EMQIMAYLAKECLQLDPDAR-PTMSEVVQILSTIAPDKSRRR 517
P ++ P + I +AK +P+ R T ++ + R
Sbjct: 253 RPSTVRPGIPVAFDAVIARGMAK-----NPEDRYVTCGDLSAAAHAALATADQDR 302
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 81/301 (26%), Positives = 123/301 (40%), Gaps = 68/301 (22%)
Query: 240 VYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293
V+ + + +VAVK K A F E ++L+ L H H+V G C
Sbjct: 31 VFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-- 87
Query: 294 RGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDTR---------VAIAIGAARG 339
++VFE+M +G+L L D +++ + IA A G
Sbjct: 88 --DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASG 145
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGLPSCSSS 391
+ YL A+ +HRD+ + N L+ NL KI D GM++ R+ +
Sbjct: 146 MVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM-----L 197
Query: 392 PAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLW 449
P R M PE M + + SDV+SFGV+L E+ T G+QP ++ E V+
Sbjct: 198 PIRWM-------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-WFQLSNTE---VI- 245
Query: 450 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
G V L PR PKE +M C Q +P R + E+ +IL +
Sbjct: 246 ---ECITQGRV---LERPR---VCPKEVYDVM----LGCWQREPQQRLNIKEIYKILHAL 292
Query: 510 A 510
Sbjct: 293 G 293
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 72/295 (24%), Positives = 124/295 (42%), Gaps = 59/295 (20%)
Query: 240 VYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293
VY+G L VA+K K + F E + +RL H +VV L+G +
Sbjct: 25 VYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT-- 82
Query: 294 RGKRAMRLLVFEFMPNGNLRDCL--------DGVLVEGMNWDTR------VAIAIGAARG 339
K ++F + +G+L + L G + + V + A G
Sbjct: 83 --KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAG 140
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
+EYL ++ ++H+D+ + N+L+ + LN KI+DLG+ + + ++ ++ G
Sbjct: 141 MEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY-------AADYYKLLGN- 189
Query: 400 GYF-----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPR 453
APE M G+ S+ SD++S+GVVL E+ + G QP + + + V+
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-YCGYSNQD---VV----E 241
Query: 454 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508
+ + V LP P D P +M EC P RP ++ L
Sbjct: 242 MIRNRQV---LPCPD---DCPAWVYALM----IECWNEFPSRRPRFKDIHSRLRA 286
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 74/307 (24%), Positives = 118/307 (38%), Gaps = 61/307 (19%)
Query: 230 NIVGQGGSSYVYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
+G G VY GQ++ VAVK + FL E ++S+ +H ++
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDTRVAIAIGAAR 338
V +G + R ++ E M G+L+ L + + +A A
Sbjct: 96 VRCIGVSL----QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMAK--------RLKADGLPS 387
G +YL +HRDI + N LL AKI D GMA+ R +
Sbjct: 152 GCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM-- 206
Query: 388 CSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEES 445
P + M PE M G + +D +SFGV+L E+ + G P + S + E
Sbjct: 207 ---LPVKWM-------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQE-- 253
Query: 446 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505
VL SG + P+ + P +IM +C Q P+ RP + +++
Sbjct: 254 -VL----EFVTSGGR---MDPPK---NCPGPVYRIM----TQCWQHQPEDRPNFAIILER 298
Query: 506 LSTIAPD 512
+ D
Sbjct: 299 IEYCTQD 305
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 83/311 (26%), Positives = 128/311 (41%), Gaps = 67/311 (21%)
Query: 233 GQGGSSYVYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
G+G V+ + + +VAVK K + +A F E ++L+ L H H+V
Sbjct: 50 GEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTMLQHQHIVRF 108
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDTR--------VAIA 333
G C+ + L+VFE+M +G+L L D L+ G +A+A
Sbjct: 109 FGVCT----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGL 385
A G+ YL A +HRD+ + N L+ + L KI D GM++ R+ +
Sbjct: 165 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 386 PSCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGE 443
P R M PE + + + SDV+SFGVVL E+ T G+QP ++ E
Sbjct: 222 -----LPIRWM-------PPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-WYQLSNTE 268
Query: 444 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 503
+ G L PR P E IM + C Q +P R ++ +V
Sbjct: 269 ---AI----DCITQGRE---LERPR---ACPPEVYAIM----RGCWQREPQQRHSIKDVH 311
Query: 504 QILSTIAPDKS 514
L +A
Sbjct: 312 ARLQALAQAPP 322
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 77/311 (24%), Positives = 129/311 (41%), Gaps = 60/311 (19%)
Query: 233 GQG--GSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHV 283
G+G G V R VAVK K + ++E+ +L + HH +V
Sbjct: 36 GRGAFGQ--VIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVEGMNWDTR 329
V L+G C++ G +++ EF GNL L + + + + +
Sbjct: 94 VNLLGACTKPGGPL---MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 330 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG---LP 386
+ + A+G+E+L A+ + +HRD+ + NILL E KI D G+A+ + D
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 387 SCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEE 444
+ P + M APE ++ SDV+SFGV+L E+ + G P + + EE
Sbjct: 208 GDARLPLKWM-------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEE 259
Query: 445 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
L++ + P E Q M +C +P RPT SE+V+
Sbjct: 260 FCRR-----LKEGTR----MRAPD---YTTPEMYQTM----LDCWHGEPSQRPTFSELVE 303
Query: 505 ILSTIAPDKSR 515
L + ++
Sbjct: 304 HLGNLLQANAQ 314
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 4e-31
Identities = 72/304 (23%), Positives = 115/304 (37%), Gaps = 62/304 (20%)
Query: 231 IVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
+G+G V++G VA+K K + FL E + + H H+V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYL 343
+G +E ++ E G LR L L + + A + L YL
Sbjct: 457 IGVITE---NPVW--IIMELCTLGELRSFLQVRKFSLDLA----SLILYAYQLSTALAYL 507
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PARMQGTFGY 401
R +HRDI + N+L+ N K+ D G+++ ++ S P + +
Sbjct: 508 ESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK------W 558
Query: 402 FAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATP 452
APE R + SDV+ FGV + E++ G +P + I GE
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE--------- 609
Query: 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512
R LP P + P +M +C DP RP +E+ LSTI +
Sbjct: 610 R----------LPMPP---NCPPTLYSLM----TKCWAYDPSRRPRFTELKAQLSTILEE 652
Query: 513 KSRR 516
+ +
Sbjct: 653 EKLQ 656
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 66/352 (18%), Positives = 128/352 (36%), Gaps = 47/352 (13%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVF-LTEVDMLSRLHHC 281
+K+ +G+G + DGR +K + + EV +L+ + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGMNWDTRVAIAIGAA 337
++V Y F ++ +V ++ G+L + + E D +
Sbjct: 84 NIV---QYRESFEENGSL-YIVMDYCEGGDLFKRINAQKGVLFQEDQILD----WFVQIC 135
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
L+++H+ +ILHRDIKS NI L ++ ++ D G+A+ L + + + G
Sbjct: 136 LALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-----CIG 187
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457
T Y +PE + SD+++ G VL EL T + ++LVL
Sbjct: 188 TPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE---AGSMKNLVL--------- 235
Query: 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE------VVQILSTIAP 511
I P + + + + L + + +P RP+++ + + +
Sbjct: 236 --KIISGSFPPVSLHYSYD----LRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLS 289
Query: 512 DKSRRRNISLNLFQIFSAGGMEKEPSIERPDNLFETLIESEELKKATSFGSP 563
+ L F F + N + + K A +G P
Sbjct: 290 PQLIAEEFCLKTFSKFGS-QPIPAKRPASGQNSISVMPAQKITKPAAKYGIP 340
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 77/341 (22%), Positives = 142/341 (41%), Gaps = 80/341 (23%)
Query: 230 NIVGQGGSSYVYRGQLTDG---RIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVP 285
+++G+G V + ++ A+KR K + F E+++L +L HH +++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL------DGVLVEGMNWDTR--------VA 331
L+G C R L E+ P+GNL D L + + T +
Sbjct: 91 LLGACE----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK-----RLKADGLP 386
A ARG++YL + + +HRD+ + NIL+ EN AKI D G+++ K G
Sbjct: 147 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR- 202
Query: 387 SCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IH 436
P R M A E + SDV+S+GV+L E+++ G P ++
Sbjct: 203 ----LPVRWM-------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251
Query: 437 RSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDAR 496
+ +G R L P + E +M ++C + P R
Sbjct: 252 EKLPQGY---------R----------LEKPL---NCDDEVYDLM----RQCWREKPYER 285
Query: 497 PTMSEVVQILSTIAPDKSRRRNISLNLFQIFSAGGMEKEPS 537
P+ ++++ L+ + + R+ ++ L++ F+ G++
Sbjct: 286 PSFAQILVSLNRML--EERKTYVNTTLYEKFTYAGIDCSAE 324
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 70/308 (22%), Positives = 120/308 (38%), Gaps = 65/308 (21%)
Query: 240 VYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 292
V VAVK K+ + ++E+ ++S L H ++V L+G C+
Sbjct: 62 VVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT- 120
Query: 293 FRGKRAMRLLVFEFMPNGNLRDCL----------DGVLVEGMNWDTR--VAIAIGAARGL 340
L++ E+ G+L + L + TR + + A+G+
Sbjct: 121 ---HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGM 177
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGLPSCSSSP 392
+L A+ +HRD+ + N+LL AKI D G+A+ +K + P
Sbjct: 178 AFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR-----LP 229
Query: 393 AR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWA 450
+ M APE ++ SDV+S+G++L E+ + G P + I +
Sbjct: 230 VKWM-------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP-YPGILVNSKFY---- 277
Query: 451 TPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510
+L G + P PK IM + C L+P RPT ++ L A
Sbjct: 278 --KLVKDGYQ---MAQPA---FAPKNIYSIM----QACWALEPTHRPTFQQICSFLQEQA 325
Query: 511 PDKSRRRN 518
+ R R+
Sbjct: 326 QEDRRERD 333
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 74/307 (24%), Positives = 119/307 (38%), Gaps = 61/307 (19%)
Query: 230 NIVGQGGSSYVYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
+G G VY GQ++ VAVK + FL E ++S+ +H ++
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTR--VAIAIGAAR 338
V +G + R ++ E M G+L+ L + + + +A A
Sbjct: 137 VRCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMAK--------RLKADGLPS 387
G +YL +HRDI + N LL AKI D GMA+ R +
Sbjct: 193 GCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM-- 247
Query: 388 CSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEES 445
P + M PE M G + +D +SFGV+L E+ + G P + S + E
Sbjct: 248 ---LPVKWM-------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQE-- 294
Query: 446 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505
VL SG + P+ + P +IM +C Q P+ RP + +++
Sbjct: 295 -VL----EFVTSGGR---MDPPK---NCPGPVYRIM----TQCWQHQPEDRPNFAIILER 339
Query: 506 LSTIAPD 512
+ D
Sbjct: 340 IEYCTQD 346
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 63/288 (21%), Positives = 97/288 (33%), Gaps = 47/288 (16%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRL-HH 280
F + +G G V++ + DGR+ AVKR + D L EV ++ H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 281 CHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLD---GVLVEGMNWDTRVAIAIGA 336
V L + G L L E +L+ + L E W
Sbjct: 117 PCCVRL--EQAWEEGGI---LYLQTELC-GPSLQQHCEAWGASLPEAQVWG----YLRDT 166
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
L +LH ++H D+K +NI L K+ D G+ L G +
Sbjct: 167 LLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV------QE 217
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456
G Y APE + G +DVFS G+ +LE+ + H
Sbjct: 218 GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMELPH-------------------- 256
Query: 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
G +L L +F + + L+ DP R T ++
Sbjct: 257 GGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 59/317 (18%), Positives = 112/317 (35%), Gaps = 81/317 (25%)
Query: 233 GQGGSSYVYRGQLTDGRI--------VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 284
GQG + +++G + V +K + N F M+S+L H H+V
Sbjct: 17 GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD-KAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLE 341
G C +LV EF+ G+L L + N ++ +A A +
Sbjct: 76 LNYGVCV----CGDENILVQEFVKFGSLDTYLKKNKNCI----NILWKLEVAKQLAAAMH 127
Query: 342 YLHEAAAPRILHRDIKSSNILLD--------ENLNAKITDLGMAKRLKADGLPSCSSSPA 393
+L ++H ++ + NILL K++D G++ + +
Sbjct: 128 FL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI---LQERI 181
Query: 394 R-MQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELIT-GRQP--------IHRSITKG 442
+ PE + +L +D +SFG L E+ + G +P +
Sbjct: 182 PWV-------PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234
Query: 443 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 502
+LP P+ E ++ C+ +PD RP+ +
Sbjct: 235 H-------------------QLPAPK-----AAELANLI----NNCMDYEPDHRPSFRAI 266
Query: 503 VQILSTI-APDKSRRRN 518
++ L+++ PD R +
Sbjct: 267 IRDLNSLFTPDLVPRGS 283
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 69/295 (23%), Positives = 115/295 (38%), Gaps = 59/295 (20%)
Query: 240 VYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 292
V VAVK K ++E+ +LS L +H ++V L+G C+
Sbjct: 39 VVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT- 97
Query: 293 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR----------------VAIAIGA 336
L++ E+ G+L + L + T ++ +
Sbjct: 98 ---IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQV 154
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG---LPSCSSSPA 393
A+G+ +L A+ +HRD+ + NILL KI D G+A+ +K D + + P
Sbjct: 155 AKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 211
Query: 394 R-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWAT 451
+ M APE + SDV+S+G+ L EL + G P + + +
Sbjct: 212 KWM-------APESIFNCVYTFESDVWSYGIFLWELFSLGSSP-YPGMPVDSKFY----- 258
Query: 452 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
++ G + P P E IM K C DP RPT ++VQ++
Sbjct: 259 -KMIKEGFR---MLSPE---HAPAEMYDIM----KTCWDADPLKRPTFKQIVQLI 302
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 65/350 (18%), Positives = 127/350 (36%), Gaps = 52/350 (14%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRL-HHC-HVVPL 286
+G GGSS V++ +I A+K + N + E+ L++L H ++ L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--ARGLEYLH 344
Y + + +V E N +L L + + D + + +H
Sbjct: 122 YDY---EITDQYI-YMVMEC-GNIDLNS----WLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 404
+ I+H D+K +N L+ + K+ D G+A +++ D S G Y P
Sbjct: 173 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV---GAVNYMPP 225
Query: 405 E-----------YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 453
E + S SDV+S G +L + G+ P +
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--------------FQQ-- 269
Query: 454 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ---ILSTIA 510
+ + + + + DP + +FP + + + K CL+ DP R ++ E++ +
Sbjct: 270 IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 329
Query: 511 PDKSRRRNISLNLFQIFS-AGGMEKEPSIERPDNLFETLIESEELKKATS 559
P + + + + G+ SI + E ++S
Sbjct: 330 PVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSS 379
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 68/313 (21%), Positives = 121/313 (38%), Gaps = 75/313 (23%)
Query: 240 VYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293
V++ + +VAVK K + + + F E +++ + ++V L+G C+
Sbjct: 63 VFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA-- 120
Query: 294 RGKRAMRLLVFEFMPNGNLRDCL--------DGVLVEGMNWDTR--------------VA 331
L+FE+M G+L + L + ++ R +
Sbjct: 121 --VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLC 178
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKAD 383
IA A G+ YL + + +HRD+ + N L+ EN+ KI D G+++ + +
Sbjct: 179 IARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGN 235
Query: 384 GLPSCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITK 441
P R M PE R + SDV+++GVVL E+ + G QP + +
Sbjct: 236 DA-----IPIRWM-------PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP-YYGMAH 282
Query: 442 GEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 501
E V+ G + L P + P E +M + C P RP+
Sbjct: 283 EE---VI----YYVRDGNI---LACPE---NCPLELYNLM----RLCWSKLPADRPSFCS 325
Query: 502 VVQILSTIAPDKS 514
+ +IL +
Sbjct: 326 IHRILQRMCERAE 338
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 6e-30
Identities = 64/318 (20%), Positives = 113/318 (35%), Gaps = 50/318 (15%)
Query: 223 TDKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVFL-TEVDMLSRL 278
+ ++G+G V + G V V+R + N FL E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 279 HHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 337
+H ++VP + L +V FM G+ +D + ++GMN I G
Sbjct: 84 NHPNIVPY--RATFIADNE---LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL 138
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARM 395
+ L+Y+H +HR +K+S+IL+ + ++ L + + G P
Sbjct: 139 KALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 396 QGTFGYFAPEYAMVGRASLM-----SDVFSFGVVLLELITGRQP---------------- 434
+ +PE V + +L SD++S G+ EL G P
Sbjct: 196 VKVLPWLSPE---VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 252
Query: 435 ----IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE--- 487
+ + T E L + + + +SG S + +
Sbjct: 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHH 312
Query: 488 ----CLQLDPDARPTMSE 501
CLQ +PDARP+ S
Sbjct: 313 FVEQCLQRNPDARPSAST 330
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 72/321 (22%), Positives = 125/321 (38%), Gaps = 78/321 (24%)
Query: 240 VYRGQLTDGR--------IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYC 290
V + VAVK K S ++E++M+ + H +++ L+G C
Sbjct: 51 VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVEGMNWDTRVAIAIGA 336
+ + ++ E+ GNLR+ L + V E M + V+
Sbjct: 111 T----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQL 166
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
ARG+EYL A+ + +HRD+ + N+L+ EN KI D G+A+ + +
Sbjct: 167 ARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID--------YYKK 215
Query: 397 GTFGYF-----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKG 442
T G APE + SDV+SFGV++ E+ T G P + + + +G
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 443 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 502
R+ + P + E +M ++C P RPT ++
Sbjct: 276 H---------RM--------DKPA-----NCTNELYMMM----RDCWHAVPSQRPTFKQL 309
Query: 503 VQILSTIAPDKSRRRNISLNL 523
V+ L I + + L+
Sbjct: 310 VEDLDRILTLTTNEEYLDLSQ 330
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 60/291 (20%), Positives = 113/291 (38%), Gaps = 48/291 (16%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRL--HHCHVVPL 286
+G GGSS V++ +I A+K + N + E+ L++L H ++ L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--ARGLEYLH 344
Y + + +V E N +L L + + D + + +H
Sbjct: 94 YDY---EITDQYI-YMVMECG-NIDLNS----WLKKKKSIDPWERKSYWKNMLEAVHTIH 144
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 404
+ I+H D+K +N L+ + K+ D G+A +++ D S GT Y P
Sbjct: 145 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV---GTVNYMPP 197
Query: 405 E-----------YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 453
E + S SDV+S G +L + G+ P +
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--------------FQQ-- 241
Query: 454 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
+ + + + + DP + +FP + + + K CL+ DP R ++ E++
Sbjct: 242 IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 71/307 (23%), Positives = 121/307 (39%), Gaps = 78/307 (25%)
Query: 240 VYRGQLTDGR--------IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYC 290
V + VAVK K S ++E++M+ + H +++ L+G C
Sbjct: 97 VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVEGMNWDTRVAIAIGA 336
+ + ++ E+ GNLR+ L + V E M + V+
Sbjct: 157 T----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQL 212
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
ARG+EYL A+ + +HRD+ + N+L+ EN KI D G+A+ + +
Sbjct: 213 ARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID--------YYKK 261
Query: 397 GTFGYF-----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKG 442
T G APE + SDV+SFGV++ E+ T G P + + + +G
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 321
Query: 443 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 502
R+ + P + E +M ++C P RPT ++
Sbjct: 322 H---------RM--------DKPA-----NCTNELYMMM----RDCWHAVPSQRPTFKQL 355
Query: 503 VQILSTI 509
V+ L I
Sbjct: 356 VEDLDRI 362
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 69/280 (24%), Positives = 120/280 (42%), Gaps = 42/280 (15%)
Query: 231 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
++G+G VY G L++ +A+K + + + E+ + L H ++V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPL-HEEIALHKHLKHKNIVQYLGS 87
Query: 290 CSEFRGKRAMRLLVF-EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA-RGLEYLHEAA 347
SE + +F E +P G+L L + + + GL+YLH+
Sbjct: 88 FSE-----NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN- 141
Query: 348 APRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
+I+HRDIK N+L++ + KI+D G +KRL G+ C+ + GT Y APE
Sbjct: 142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL--AGINPCTET---FTGTLQYMAPEI 194
Query: 407 AMVGR--ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 464
G +D++S G ++E+ TG+ P + GE ++ V E+
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL---GEPQAAMFKVGM----FKVHPEI 247
Query: 465 PD---PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 501
P+ K F +C + DPD R ++
Sbjct: 248 PESMSAEAK-AF-----------ILKCFEPDPDKRACAND 275
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 66/350 (18%), Positives = 128/350 (36%), Gaps = 52/350 (14%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRL--HHCHVVPL 286
+G GGSS V++ +I A+K + N + E+ L++L H ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--ARGLEYLH 344
Y + + +V E N +L L + + D + + +H
Sbjct: 75 YDY---EITDQYI-YMVMEC-GNIDLNS----WLKKKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 404
+ I+H D+K +N L+ + K+ D G+A +++ D S GT Y P
Sbjct: 126 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV---GTVNYMPP 178
Query: 405 E-----------YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 453
E + S SDV+S G +L + G+ P +
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ----------------Q 222
Query: 454 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ---ILSTIA 510
+ + + + + DP + +FP + + + K CL+ DP R ++ E++ +
Sbjct: 223 IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282
Query: 511 PDKSRRRNISLNLFQIF-SAGGMEKEPSIERPDNLFETLIESEELKKATS 559
P + + + + G+ SI + E ++S
Sbjct: 283 PVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSS 332
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 77/363 (21%), Positives = 128/363 (35%), Gaps = 66/363 (18%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
+ S+I+GQG ++ V+RG+ G + A+K F V + E ++L +L+H +
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT---RVAIAIGA--A 337
+V L + E ++L+ EF P G+L VL E N + +
Sbjct: 69 IVKL--FAIEEETTTRHKVLIMEFCPCGSLYT----VLEEPSNAYGLPESEFLIVLRDVV 122
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGL--PSCSSS 391
G+ +L E I+HR+IK NI+ D K+TD G A+ L+ D
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--- 176
Query: 392 PARMQGTFGYFAPEYAMVGRASLMS----------DVFSFGVVLLELITGRQP------- 434
GT Y P+ M RA L D++S GV TG P
Sbjct: 177 -----GTEEYLHPD--MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229
Query: 435 -----IHRSITKGEESLVLWATPRLQDSGTVIS-ELPDPRLKGDFPKEEMQIMAYLAKEC 488
+ I G+ S + + ++ S ++P + + +
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLT---PVLANI 286
Query: 489 LQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNLFQIFSAGGMEKEPSIERPDNLFETL 548
L+ D + + S I + + +FS M N
Sbjct: 287 LEADQEKCWGFDQFFAETSDI---------LHRMVIHVFSLQQMTAHKIYIHSYNTATIF 337
Query: 549 IES 551
E
Sbjct: 338 HEL 340
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 73/312 (23%), Positives = 129/312 (41%), Gaps = 69/312 (22%)
Query: 233 GQG--GSSYVYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 284
G+G G V + + VAVK K P+ L+E ++L +++H HV+
Sbjct: 32 GEGEFGK--VVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL----------------------DGVLVE 322
L G CS + LL+ E+ G+LR L D
Sbjct: 90 KLYGACS----QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 323 GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382
+ ++ A ++G++YL A +++HRD+ + NIL+ E KI+D G+++ +
Sbjct: 146 ALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 383 DG---LPSCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 437
+ S P + M A E + SDV+SFGV+L E++T G P +
Sbjct: 203 EDSYVKRSQGRIPVKWM-------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-YP 254
Query: 438 SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP 497
I + L +G + P + +E ++M +C + +PD RP
Sbjct: 255 GIPPER---LF----NLLKTGHR---MERPD---NCSEEMYRLM----LQCWKQEPDKRP 297
Query: 498 TMSEVVQILSTI 509
+++ + L +
Sbjct: 298 VFADISKDLEKM 309
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 69/289 (23%), Positives = 120/289 (41%), Gaps = 52/289 (17%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
+ F+ +G+G V++G ++VA+K + + E+ +LS+
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-DGVLVEGMNWDTRVAIAI---GAA 337
+V Y S + + ++ E++ G+ D L G L E IA
Sbjct: 81 YVTKY--YGSYLKDTKLW--IIMEYLGGGSALDLLEPGPLDETQ-------IATILREIL 129
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
+GL+YLH + +HRDIK++N+LL E+ K+ D G+A +L + + G
Sbjct: 130 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-----FVG 181
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP---IH--RSITKGEESLVLWATP 452
T + APE +D++S G+ +EL G P +H + VL+ P
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---------VLFLIP 232
Query: 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 501
+ P L+G++ K + + CL +P RPT E
Sbjct: 233 K----------NNPPTLEGNYSKP----LKEFVEACLNKEPSFRPTAKE 267
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 34/311 (10%), Positives = 79/311 (25%), Gaps = 69/311 (22%)
Query: 231 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV---------------------- 267
++GQ G V P ++++
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 268 -----FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM--PNGNLRDCLDGVL 320
F+ D++ ++ + E R ++ M + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRL--DERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 202
Query: 321 VEG--MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378
+ R+ + + R L LH ++H ++ +I+LD+ +T
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-----SLMSDVFSFGVVLLELITGRQ 433
R A + A G+ + D ++ G+ + +
Sbjct: 260 RDGASAVSPIGRGF----APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 434 PIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDP 493
P G + + +P P + L + L+
Sbjct: 316 PNTDDAALGGSEWIFRSCKN----------IPQP-------------VRALLEGFLRYPK 352
Query: 494 DARPTMSEVVQ 504
+ R + ++
Sbjct: 353 EDRLLPLQAME 363
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 70/314 (22%), Positives = 119/314 (37%), Gaps = 57/314 (18%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
+ S+I+GQG ++ V+RG+ G + A+K F V + E ++L +L+H +
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT---RVAIAIGA--A 337
+V L + E ++L+ EF P G+L VL E N + +
Sbjct: 69 IVKL--FAIEEETTTRHKVLIMEFCPCGSLYT----VLEEPSNAYGLPESEFLIVLRDVV 122
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGL--PSCSSS 391
G+ +L E I+HR+IK NI+ D K+TD G A+ L+ D
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--- 176
Query: 392 PARMQGTFGYFAPEYAMVGRASLMS----------DVFSFGVVLLELITGRQP------- 434
GT Y P+ M RA L D++S GV TG P
Sbjct: 177 -----GTEEYLHPD--MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229
Query: 435 -----IHRSITKGEESLVLWATPRLQDSGTVIS-ELPDPRLKGDFPKEEMQIMAYLAKEC 488
+ I G+ S + + ++ S ++P + ++ +
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVS---CSLSRGLQVLLTPVLANI 286
Query: 489 LQLDPDARPTMSEV 502
L+ D + +
Sbjct: 287 LEADQEKCWGFDQF 300
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 67/313 (21%), Positives = 108/313 (34%), Gaps = 65/313 (20%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
F ++GQG V + + D R A+K+ + S L+EV +L+ L+H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQ 62
Query: 282 HVVPLVG-YCSEFRGKRAMRL--------LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 332
+VV + + M + E+ NG L D ++ R
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYD----LIHSENLNQQRDEY 118
Query: 333 A-----IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS 387
I L Y+H I+HRD+K NI +DE+ N KI D G+AK +
Sbjct: 119 WRLFRQI--LEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 388 CSSSPARMQ---------GTFGYFAPE-YAMVGRASLMSDVFSFGVVLLELITG------ 431
S GT Y A E G + D++S G++ E+I
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGME 233
Query: 432 RQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQL 491
R I + + P + K E +I+ + +
Sbjct: 234 RVNILKKLRSVSIE-------------------FPPDFDDNKMKVEKKII----RLLIDH 270
Query: 492 DPDARPTMSEVVQ 504
DP+ RP ++
Sbjct: 271 DPNKRPGARTLLN 283
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 66/308 (21%), Positives = 114/308 (37%), Gaps = 64/308 (20%)
Query: 240 VYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 292
V VAVK K + + ++E+ M+++L H ++V L+G C+
Sbjct: 61 VMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT- 119
Query: 293 FRGKRAMRLLVFEFMPNGNLRDCL---------DGVLVEGMNWDTR------------VA 331
L+FE+ G+L + L D + E +
Sbjct: 120 ---LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLC 176
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL---PSC 388
A A+G+E+L +HRD+ + N+L+ KI D G+A+ + +D
Sbjct: 177 FAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGN 233
Query: 389 SSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESL 446
+ P + M APE G ++ SDV+S+G++L E+ + G P + I
Sbjct: 234 ARLPVKWM-------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-YPGIPVDANFY 285
Query: 447 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
+L +G + P +E IM + C D RP+ + L
Sbjct: 286 ------KLIQNGFK---MDQPF---YATEEIYIIM----QSCWAFDSRKRPSFPNLTSFL 329
Query: 507 STIAPDKS 514
D
Sbjct: 330 GCQLADAE 337
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-29
Identities = 71/311 (22%), Positives = 123/311 (39%), Gaps = 86/311 (27%)
Query: 240 VYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYC 290
V + VAVK K+ S ++E++M+ + H +++ L+G C
Sbjct: 85 VVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR--------------VAIAIGA 336
+ + ++ E+ GNLR+ L G+ + V+ A
Sbjct: 145 T----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQV 200
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGLPSC 388
ARG+EYL A+ + +HRD+ + N+L+ E+ KI D G+A+ + +G
Sbjct: 201 ARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR--- 254
Query: 389 SSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRS 438
P + M APE + SDV+SFGV+L E+ T G P + +
Sbjct: 255 --LPVKWM-------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305
Query: 439 ITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT 498
+ +G R+ + P + E +M ++C P RPT
Sbjct: 306 LKEGH---------RM--------DKPS-----NCTNELYMMM----RDCWHAVPSQRPT 339
Query: 499 MSEVVQILSTI 509
++V+ L I
Sbjct: 340 FKQLVEDLDRI 350
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 68/312 (21%), Positives = 106/312 (33%), Gaps = 72/312 (23%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRL-H 279
T +F +G G V++ DG I A+KR K + D L EV + L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 280 HCHVVPLVGYCSEFRGKRAMRLLVF-EFMPNGNLRDCL------DGVLVEGMNWDTRVAI 332
H HVV + + +L+ E+ G+L D + E D +
Sbjct: 70 HSHVVRY--FSAWAEDDH---MLIQNEYCNGGSLADAISENYRIMSYFKEAELKD----L 120
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-------------------LNAKITD 373
+ RGL Y+H ++H DIK SNI + + KI D
Sbjct: 121 LLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 374 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGR 432
LG R+ SSP +G + A E +D+F+ + ++
Sbjct: 178 LGHVTRI---------SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
Query: 433 QPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLD 492
PR D I + PR+ +E L K + D
Sbjct: 229 PL-----------------PRNGDQWHEIRQGRLPRIPQVLSQE----FTELLKVMIHPD 267
Query: 493 PDARPTMSEVVQ 504
P+ RP+ +V+
Sbjct: 268 PERRPSAMALVK 279
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-28
Identities = 86/339 (25%), Positives = 131/339 (38%), Gaps = 43/339 (12%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL--VGY 289
G GG YV R G VA+K+ + + P + E+ ++ +L+H +VV V
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDTRVAIA-IGAARGLEYL 343
+ + LL E+ G+LR L L EG R ++ I +A L YL
Sbjct: 83 GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG---PIRTLLSDISSA--LRYL 137
Query: 344 HEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
HE RI+HRD+K NI+L + L KI DLG AK L L C+ GT
Sbjct: 138 HEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--CTEF----VGTLQ 188
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH--------RSITKGEESLVLWATP 452
Y APE + ++ D +SFG + E ITG +P + + + +
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248
Query: 453 RLQDSGTVISELPDP-RLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511
L + S LP P L G + + + + L R T + + A
Sbjct: 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM----LMWHQRQRGTDPQNPNVGCFQAL 304
Query: 512 DKSRRRNISLNLFQIFSAGGMEKEPSIERPDNLFETLIE 550
D +SL L + + + + L
Sbjct: 305 DS----ILSLKLLSVMNMVSGRVHTYPVTENENLQNLKS 339
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 1e-28
Identities = 41/305 (13%), Positives = 73/305 (23%), Gaps = 52/305 (17%)
Query: 231 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLV 287
+ G S V+ + A+K F + + +RL
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 288 GYCSEFRGKRAMRL----------------------LVFEFMP--NGNLRDCLDGVLVEG 323
A+ + L+ L LD V V
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 324 MNWDTRVAIAIGA--ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381
+ + A R L ++H N+ + + + D+ ++
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQPIHRSI 439
G S Y E+ A + + + G+ + + P
Sbjct: 246 TRGPASS--------VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 440 TKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM 499
+ W P L+ GT DF K L L D R
Sbjct: 298 PGIKG---SWKRPSLRVPGTDSLAFGSCTPLPDFVKT-------LIGRFLNFDRRRRLLP 347
Query: 500 SEVVQ 504
E ++
Sbjct: 348 LEAME 352
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 77/292 (26%), Positives = 123/292 (42%), Gaps = 36/292 (12%)
Query: 224 DKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
D + ++G G ++ V VA+KR + + L E+ +S+ HH +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 283 VVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTR---VAIAI---G 335
+V Y S L LV + + G++ D + ++ +G + IA
Sbjct: 75 IVSY--YTSFVVKDE---LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 336 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 395
GLEYLH+ +HRD+K+ NILL E+ + +I D G++ L G + +
Sbjct: 130 VLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 396 QGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 454
GT + APE R +D++SFG+ +EL TG P H K VL T +
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH----KYPPMKVLMLTLQ- 241
Query: 455 QDSGTVISELPDPRLKGDFPKEEM-----QIMAYLAKECLQLDPDARPTMSE 501
P L+ +EM + + CLQ DP+ RPT +E
Sbjct: 242 ---------NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE 284
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 64/296 (21%), Positives = 106/296 (35%), Gaps = 53/296 (17%)
Query: 225 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHV 283
F +++G G + + D R VAVKR + AD EV +L H +V
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR----EVQLLRESDEHPNV 80
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 343
+ +C+E R + + E L++ ++ + + + GL +L
Sbjct: 81 IRY--FCTEK--DRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHL 134
Query: 344 HEAAAPRILHRDIKSSNILLDE-----NLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
H I+HRD+K NIL+ + A I+D G+ K+L S GT
Sbjct: 135 HSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV--PGT 189
Query: 399 FGYFAPEY---AMVGRASLMSDVFSFGVVLLELITGRQP-------IHRSITKGEESLVL 448
G+ APE + D+FS G V +I+ +I G SL
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL-- 247
Query: 449 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
L + L ++ + +DP RP+ V++
Sbjct: 248 ---DCLHPEKHEDVIARE-----------------LIEKMIAMDPQKRPSAKHVLK 283
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 68/302 (22%), Positives = 120/302 (39%), Gaps = 51/302 (16%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGY 289
+ +GG ++VY Q + GR A+KR + ++ + EV + +L H ++V
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI-IQEVCFMKKLSGHPNIVQFCSA 94
Query: 290 CSEFR---GKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLEYLHE 345
S + L+ + G L + L + G ++ DT + I R ++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ-------GT 398
P I+HRD+K N+LL K+ D G A + S S+ + T
Sbjct: 155 QKPP-IIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 399 FGYFAPEYAMVGRASLM-----SDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 453
Y PE ++ S D+++ G +L L + P E+ L
Sbjct: 214 PMYRTPE--IIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF-------EDGAKL----- 259
Query: 454 LQDSGTVISELPDPRLKGDF--PKEEMQ--IMAYLAKECLQLDPDARPTMSEVVQILSTI 509
I + G + P + Q + L + LQ++P+ R +++EVV L I
Sbjct: 260 ------RI-------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306
Query: 510 AP 511
A
Sbjct: 307 AA 308
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 69/279 (24%), Positives = 110/279 (39%), Gaps = 39/279 (13%)
Query: 232 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC-HVVPLVGY 289
+G+G V + + G+I+AVKR + L ++D+ R C V Y
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTF--Y 72
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRV--AIAIGAARGLEYLHEAA 347
+ FR + E M + +L V+ +G + IA+ + LE+LH
Sbjct: 73 GALFREGDVW--ICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 348 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE-- 405
++HRD+K SN+L++ K+ D G++ L + G Y APE
Sbjct: 130 --SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD------DVAKDIDAGCKPYMAPERI 181
Query: 406 --YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 463
S+ SD++S G+ ++EL R P W TP + E
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYDS-----------WGTP--FQQLKQVVE 228
Query: 464 LPDPRLKGD-FPKEEMQIMAYLAKECLQLDPDARPTMSE 501
P P+L D F E +CL+ + RPT E
Sbjct: 229 EPSPQLPADKFSAE----FVDFTSQCLKKNSKERPTYPE 263
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 70/295 (23%), Positives = 123/295 (41%), Gaps = 57/295 (19%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
K++ +GQG S VY + G+ VA+++ Q P + + E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII-NEILVMRENKNP 77
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIAI---GAA 337
++V + S G +V E++ G+L D + + EG IA
Sbjct: 78 NIVNYLD--SYLVGDELW--VVMEYLAGGSLTDVVTETCMDEGQ-------IAAVCRECL 126
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
+ LE+LH +++HRDIKS NILL + + K+TD G ++ + S + M G
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVG 178
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS--------ITKGEESLVLW 449
T + APE D++S G++ +E+I G P I
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-------N 231
Query: 450 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
TP LQ+ + + D +L + CL++D + R + E++Q
Sbjct: 232 GTPELQNPEKLSAIFRD----------------FLNR-CLEMDVEKRGSAKELLQ 269
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 68/295 (23%), Positives = 113/295 (38%), Gaps = 57/295 (19%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
+G+G + V + GR VAVK + + +F EV ++ H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF-NEVVIMRDYQHF 102
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIAI---GAA 337
+VV + S G+ ++ EF+ G L D + L E IA
Sbjct: 103 NVVEMYK--SYLVGEELW--VLMEFLQGGALTDIVSQVRLNEEQ-------IATVCEAVL 151
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
+ L YLH A ++HRDIKS +ILL + K++D G ++ D + G
Sbjct: 152 QALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD-----VPKRKSLVG 203
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP---IH-----RSITKGEESLVLW 449
T + APE + D++S G++++E++ G P + +
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD-------S 256
Query: 450 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
P+L++S V L D +L + L DP R T E++
Sbjct: 257 PPPKLKNSHKVSPVLRD----------------FLER-MLVRDPQERATAQELLD 294
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-26
Identities = 78/318 (24%), Positives = 122/318 (38%), Gaps = 74/318 (23%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCH 282
+ I+G G S V GR VAVKR + + L E+ +L+ H +
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML----IDFCDIALMEIKLLTESDDHPN 70
Query: 283 VVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLD--GVLVEGM-NWDTRVAIAI--GA 336
V+ YCSE L + E N NL+D ++ V E + I++
Sbjct: 71 VIRY--YCSE---TTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLD-------------ENLNAKITDLGMAKRLKAD 383
A G+ +LH +I+HRD+K NIL+ ENL I+D G+ K+L +
Sbjct: 125 ASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 384 GLPSCSSSPARMQ---GTFGYFAPE-------YAMVGRASLMSDVFSFGVVLLELITGRQ 433
SS + GT G+ APE R + D+FS G V +++ +
Sbjct: 182 Q----SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 434 P-------IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAK 486
+I +G SL + +I+E D L
Sbjct: 238 HPFGDKYSRESNIIRGIFSLDEMKCLHDRS---LIAEATD-----------------LIS 277
Query: 487 ECLQLDPDARPTMSEVVQ 504
+ + DP RPT +V++
Sbjct: 278 QMIDHDPLKRPTAMKVLR 295
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 3e-26
Identities = 40/318 (12%), Positives = 89/318 (27%), Gaps = 82/318 (25%)
Query: 231 IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV---------------------- 267
++GQ G V P ++++
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 268 -----FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD----- 317
F+ D++ ++ + E R ++ M NL+ +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLD--ERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH 196
Query: 318 GVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377
+ + R+ + + R L LH ++H ++ +I+LD+ +T
Sbjct: 197 SSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 378 KRLKADGLPSCSSSPARMQGTFGYFAPEY--------AMVGRASLMS---DVFSFGVVLL 426
R + + G+ PE R +LM+ D ++ G+V+
Sbjct: 254 VRD---------GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 427 ELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAK 486
+ PI + G + R + P+ L +
Sbjct: 305 WIWCADLPITKDAALGGSEWIF-------------------RSCKNIPQPVRA----LLE 341
Query: 487 ECLQLDPDARPTMSEVVQ 504
L+ + R + ++
Sbjct: 342 GFLRYPKEDRLLPLQAME 359
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 72/290 (24%), Positives = 113/290 (38%), Gaps = 66/290 (22%)
Query: 233 GQGGSSYVYRGQLTD-GRIVAVK-RFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
G+GG + + D + A K K+ P+ E+ + L H HVV G+
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 347
F + +V E +L + L E + R G +YLH
Sbjct: 110 ---FEDNDFV-FVVLELCRRRSLLELHKRRKALTE---PEAR-YYLRQIVLGCQYLHRN- 160
Query: 348 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP---SCSSSPARMQGTFGYFAP 404
R++HRD+K N+ L+E+L KI D G+A +++ DG C GT Y AP
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--------GTPNYIAP 210
Query: 405 EYAMVGRA--SLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWATPRL 454
E ++ + S DV+S G ++ L+ G+ P + I K E S+ P
Sbjct: 211 E--VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA 268
Query: 455 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
L ++ LQ DP ARPT++E++
Sbjct: 269 AS---------------------------LIQKMLQTDPTARPTINELLN 291
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 72/307 (23%), Positives = 124/307 (40%), Gaps = 48/307 (15%)
Query: 213 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTE 271
SAL F +VG G VY+G+ + G++ A+K G + E
Sbjct: 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE--IKQE 70
Query: 272 VDMLSRL-HHCHVVPLVG-YCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDT 328
++ML + HH ++ G + + +L LV EF G++ D + + +
Sbjct: 71 INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW 130
Query: 329 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 388
I RGL +LH+ +++HRDIK N+LL EN K+ D G++ +L
Sbjct: 131 IAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 187
Query: 389 SSSPARMQGTFGYFAPEYAMVGRASLMS-----DVFSFGVVLLELITGRQP---IH--RS 438
+ GT + APE + D++S G+ +E+ G P +H R
Sbjct: 188 T-----FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR- 241
Query: 439 ITKGEESLVLWATPRLQDSGTVISELPDPRLKG-DFPKEEMQIMAYLAKECLQLDPDARP 497
L+ +I P PRLK + K+ +++ CL + RP
Sbjct: 242 --------ALF----------LIPRNPAPRLKSKKWSKK---FQSFIES-CLVKNHSQRP 279
Query: 498 TMSEVVQ 504
++++
Sbjct: 280 ATEQLMK 286
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 69/290 (23%), Positives = 120/290 (41%), Gaps = 47/290 (16%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
+ F +G+G VY+ G+IVA+K+ + + E+ ++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL---QEIIKEISIMQQCDSP 84
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD---CLDGVLVEGMNWDTRVAIAI---G 335
HVV G S F+ +V E+ G++ D + L E IA
Sbjct: 85 HVVKYYG--SYFKNTDLW--IVMEYCGAGSVSDIIRLRNKTLTEDE-------IATILQS 133
Query: 336 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 395
+GLEYLH R +HRDIK+ NILL+ +AK+ D G+A +L + +
Sbjct: 134 TLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-----V 185
Query: 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL-VLWATPRL 454
GT + APE + ++D++S G+ +E+ G+ P + ++
Sbjct: 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYA-----DIHPMRAIF----- 235
Query: 455 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
+I P P + P+ K+CL P+ R T ++++Q
Sbjct: 236 -----MIPTNPPPTFRK--PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 44/292 (15%), Positives = 85/292 (29%), Gaps = 65/292 (22%)
Query: 232 VGQGGSSYVYRGQLTD---GRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPL 286
G ++ D R VA+ QG D + L+ LSR+ V +
Sbjct: 39 HGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
+ RA L+V E++ G+L++ D + + A + H A
Sbjct: 97 LDVVHT----RAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRA 148
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
+ S + + + + +
Sbjct: 149 G---VALSIDHPSRVRVSIDGDVVL-------------------------AYPATMPD-- 178
Query: 407 AMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 466
A+ D+ G L L+ R P+ + G S + A + +
Sbjct: 179 -----ANPQDDIRGIGASLYALLVNRWPLPEA---GVRSGLAPAERDTAG------QPIE 224
Query: 467 PR-LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRR 517
P + D P + ++ +A +Q D R S ++ ++ R
Sbjct: 225 PADIDRDIPFQ----ISAVAARSVQGDGGIRSA-STLLNLMQQATAVADRTE 271
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 72/290 (24%), Positives = 113/290 (38%), Gaps = 66/290 (22%)
Query: 233 GQGGSSYVYRGQLTD-GRIVAVK-RFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
G+GG + + D + A K K+ P+ E+ + L H HVV G+
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 83
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 347
F + +V E +L + L E + R G +YLH
Sbjct: 84 ---FEDNDFV-FVVLELCRRRSLLELHKRRKALTE---PEAR-YYLRQIVLGCQYLHRN- 134
Query: 348 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP---SCSSSPARMQGTFGYFAP 404
R++HRD+K N+ L+E+L KI D G+A +++ DG C GT Y AP
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--------GTPNYIAP 184
Query: 405 EYAMVGRA--SLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWATPRL 454
E ++ + S DV+S G ++ L+ G+ P + I K E S+ P
Sbjct: 185 E--VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA 242
Query: 455 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
L ++ LQ DP ARPT++E++
Sbjct: 243 AS---------------------------LIQKMLQTDPTARPTINELLN 265
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 60/302 (19%), Positives = 115/302 (38%), Gaps = 64/302 (21%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
+ + +G G VY+ + G + A K +T+ + ++ E+++L+ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVEIEILATCDHP 76
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD---CLDGVLVEGMNWDTRVAIAI---G 335
++V L+G + + + ++ EF P G + LD L E I +
Sbjct: 77 YIVKLLG--AYYHDGKLW--IMIEFCPGGAVDAIMLELDRGLTEPQ-------IQVVCRQ 125
Query: 336 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 395
L +LH RI+HRD+K+ N+L+ + ++ D G++ + S
Sbjct: 126 MLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-----F 177
Query: 396 QGTFGYFAPEYAMVGRASLMS-----DVFSFGVVLLELITGRQP---IH-----RSITKG 442
GT + APE M D++S G+ L+E+ P ++ I K
Sbjct: 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS 237
Query: 443 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 502
+ P L E D +L L +P+ RP+ +++
Sbjct: 238 D-------PPTLLTPSKWSVEFRD----------------FLKI-ALDKNPETRPSAAQL 273
Query: 503 VQ 504
++
Sbjct: 274 LE 275
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 48/309 (15%), Positives = 103/309 (33%), Gaps = 63/309 (20%)
Query: 233 GQGGSSYVYRGQLTDGRIVAVK--------RFKTQGGPNADSVFLT--------EVDMLS 276
QG + + + + A+K + + N D + + E+ +++
Sbjct: 40 NQGKFNKIILCEKD-NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 277 RLHHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIA 333
+ + + + G + +++E+M N ++ + VL + + +
Sbjct: 99 DIKNEYCLTCEGI---ITNYD--EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153
Query: 334 IGAAR----GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP-SC 388
+ Y+H I HRD+K SNIL+D+N K++D G ++ + + S
Sbjct: 154 KCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR 211
Query: 389 SSSPARMQGTFGYFAPEYAMV----GRASLMSDVFSFGVVLLELITGRQP---------I 435
GT+ + PE D++S G+ L + P +
Sbjct: 212 --------GTYEFMPPE--FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261
Query: 436 HRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDA 495
+I P ++ +F E K L+ +P
Sbjct: 262 FNNIRTKNIEY-----PLDRNHFLYPLTNKKSTCSNNFLSNEDID---FLKLFLRKNPAE 313
Query: 496 RPTMSEVVQ 504
R T + ++
Sbjct: 314 RITSEDALK 322
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 67/302 (22%), Positives = 112/302 (37%), Gaps = 53/302 (17%)
Query: 232 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G G V++ G ++A K + P + + E+ +L + ++V Y
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF--YG 98
Query: 291 SEFRGKR---AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRV--AIAIGAARGLEYLHE 345
+ + M E M G LD VL + ++ ++I +GL YL E
Sbjct: 99 AFYSDGEISICM-----EHMDGG----SLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFGYFAP 404
+I+HRD+K SNIL++ K+ D G++ +L S A GT Y +P
Sbjct: 150 KH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--------IDSMANSFVGTRSYMSP 199
Query: 405 EYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 464
E S+ SD++S G+ L+E+ GR PI K E +
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259
Query: 465 PDPRLKGDF-----PKEEMQIMAYLAKE--------------------CLQLDPDARPTM 499
P L P +++ Y+ E CL +P R +
Sbjct: 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 319
Query: 500 SE 501
+
Sbjct: 320 KQ 321
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 73/293 (24%), Positives = 111/293 (37%), Gaps = 71/293 (24%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVK-RFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
G+G + VYR + + G VA+K K EV + +L H ++ L Y
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79
Query: 290 CSEFRGKRAMRL-LVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIA-IGAARGLEYLH 344
F + LV E NG + L E + R + I G+ YLH
Sbjct: 80 ---FEDSN--YVYLVLEMCHNGEMNRYLKNRVKPFSE---NEARHFMHQI--ITGMLYLH 129
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP---SCSSSPARMQGTFGY 401
ILHRD+ SN+LL N+N KI D G+A +LK C GT Y
Sbjct: 130 SH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--------GTPNY 178
Query: 402 FAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWAT 451
+PE + R+ L SDV+S G + L+ GR P + + + + +
Sbjct: 179 ISPE--IATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLS 236
Query: 452 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
+D +I +L L+ +P R ++S V+
Sbjct: 237 IEAKD---LIHQL------------------------LRRNPADRLSLSSVLD 262
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 72/285 (25%), Positives = 110/285 (38%), Gaps = 47/285 (16%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC-HVVPLVGY 289
+G+G V + G+I+AVKR ++ L ++D++ R C ++V Y
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF--Y 87
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRV-------AIAIGAARGLEY 342
+ FR + E M + D + V I + + L +
Sbjct: 88 GALFREGDCW--ICMELM-ST----SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
L E +I+HRDIK SNILLD + N K+ D G++ +L S + R G Y
Sbjct: 141 LKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD------SIAKTRDAGCRPYM 192
Query: 403 APEYAMVGRA----SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR--LQD 456
APE + + SDV+S G+ L EL TGR P + W + L
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK-----------WNSVFDQLT- 240
Query: 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 501
+ + P+L +E CL D RP E
Sbjct: 241 ---QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 68/279 (24%), Positives = 112/279 (40%), Gaps = 40/279 (14%)
Query: 232 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC-HVVPLVGY 289
+G G V++ + G ++AVK+ + G + L ++D++ + H C ++V +
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQC--F 90
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 349
+ + E M G + L + + + + + L YL E
Sbjct: 91 GTFITNTDVF--IAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH-- 144
Query: 350 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV 409
++HRD+K SNILLDE K+ D G++ RL + R G Y APE
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD------DKAKDRSAGCAAYMAPERIDP 198
Query: 410 GRA-----SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 464
+ +DV+S G+ L+EL TG+ P T E VL T + +
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE---VL----------TKVLQE 245
Query: 465 PDPRLKGD--FPKEEMQIMAYLAKECLQLDPDARPTMSE 501
P L G F + K+CL D RP ++
Sbjct: 246 EPPLLPGHMGFSGD----FQSFVKDCLTKDHRKRPKYNK 280
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 72/297 (24%), Positives = 109/297 (36%), Gaps = 65/297 (21%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFL--TEVDMLSRLH 279
FS +G G VY + + + +VA+K+ G + + EV L +L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 280 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD---CLDGVLVEGMNWDTRVAIAI-- 334
H + + G R A LV E+ G+ D L E IA
Sbjct: 113 HPNTIQYRG--CYLREHTAW--LVMEYCL-GSASDLLEVHKKPLQEVE-------IAAVT 160
Query: 335 -GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG----MAKRLKADGLPSCS 389
GA +GL YLH ++HRD+K+ NILL E K+ D G MA
Sbjct: 161 HGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---------- 207
Query: 390 SSPARMQGTFGYFAPEYAMVGRAS---LMSDVFSFGVVLLELITGRQPIHRSITKGEESL 446
GT + APE + DV+S G+ +EL + P+ ++
Sbjct: 208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-----NMNAM 259
Query: 447 -VLWATPRLQDSGTVISELPDPRLK-GDFPKEEMQIMAYLAKECLQLDPDARPTMSE 501
L+ I++ P L+ G + + ++ CLQ P RPT
Sbjct: 260 SALY----------HIAQNESPALQSGHWSEY---FRNFVDS-CLQKIPQDRPTSEV 302
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 73/298 (24%), Positives = 113/298 (37%), Gaps = 66/298 (22%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKR-FKTQ-GGPNADSVFLTEVDMLSRLHH 280
+ F +G+G VY + I+A+K FK Q + EV++ S L H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 281 CHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAA 337
+++ L GY F R+ L+ E+ P G + L E T I A
Sbjct: 69 PNILRLYGY---FHDAT--RVYLILEYAPLGTVYRELQKLSKFDE---QRTATYIT-ELA 119
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP-SCSSSPARMQ 396
L Y H R++HRDIK N+LL KI D G + + C
Sbjct: 120 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-------- 168
Query: 397 GTFGYFAPEYAMVGRAS--LMSDVFSFGVVLLELITGRQP--------IHRSITKGEESL 446
GT Y PE M+ D++S GV+ E + G+ P ++ I++ E +
Sbjct: 169 GTLDYLPPE--MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 226
Query: 447 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
+ T +D +IS L L+ +P RP + EV++
Sbjct: 227 PDFVTEGARD---LISRL------------------------LKHNPSQRPMLREVLE 257
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 45/237 (18%), Positives = 85/237 (35%), Gaps = 32/237 (13%)
Query: 276 SRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIAI 334
R+ VG K + + + NL+D ++ +E + I I
Sbjct: 113 RRMDPFSTKNTVGQLQPSSPKVYL-YIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI 171
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
A +E+LH ++HRD+K SNI + K+ D G+ + D +P
Sbjct: 172 QIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 395 MQ-------GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 447
GT Y +PE S D+FS G++L EL+ E +
Sbjct: 229 AYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM------ERVRI 282
Query: 448 LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
+ +++ + P ++ + ++ L P RP +++++
Sbjct: 283 I---TDVRN-----LKFPLL------FTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-23
Identities = 73/373 (19%), Positives = 130/373 (34%), Gaps = 75/373 (20%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLH 279
+D++ G ++G+G V G+ AVK + L EV +L +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 280 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--IAIGAA 337
H +++ L + + + LV E G L D ++ + A I
Sbjct: 85 HPNIMKLYEFFED----KGYFYLVGEVYTGGELFD----EIISRKRFSEVDAARIIRQVL 136
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
G+ Y+H+ +I+HRD+K N+LL ++ N +I D G++ +A
Sbjct: 137 SGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS------KKMKD 187
Query: 395 MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 454
GT Y APE + G DV+S GV+L L++G P + + V
Sbjct: 188 KIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKY-- 244
Query: 455 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPDARPTMSEVVQ------ 504
F + + ++ AK+ L P R + + +
Sbjct: 245 -----------------TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287
Query: 505 -ILSTIAPDKSRRRNISLNL--FQIFS----------AGGMEKEPSIERPDNLFETL--- 548
I+ D N LN+ FQ + + + +F +
Sbjct: 288 YTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELTAIFHKMDKN 347
Query: 549 ----IESEELKKA 557
++ EL +
Sbjct: 348 GDGQLDRAELIEG 360
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 71/312 (22%), Positives = 114/312 (36%), Gaps = 48/312 (15%)
Query: 202 SKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRF-KTQ 259
+ T F S H ++ + +G G V A+K KT
Sbjct: 15 YFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS 74
Query: 260 GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGV 319
+++S L EV +L L H +++ L + + KR L V E G L D
Sbjct: 75 VSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED---KRNYYL-VMECYKGGELFD----E 126
Query: 320 LVEGMNWDTRVAIAI--GAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDL 374
++ M ++ A I G+ YLH+ I+HRD+K N+LL +++ KI D
Sbjct: 127 IIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDF 183
Query: 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
G++ + GT Y APE + + DV+S GV+L L+ G P
Sbjct: 184 GLSAVFENQ------KKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236
Query: 435 IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQ 490
+ V + K F E + ++ AK+ LQ
Sbjct: 237 FGGQTDQEILRKVE-------------------KGKYTFDSPEWKNVSEGAKDLIKQMLQ 277
Query: 491 LDPDARPTMSEV 502
D R + +
Sbjct: 278 FDSQRRISAQQA 289
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 73/301 (24%), Positives = 117/301 (38%), Gaps = 89/301 (29%)
Query: 233 GQGGSSYVYRG--QLTDGRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
G+G + V LT GR VA+K KTQ P + EV ++ L+H ++V L +
Sbjct: 24 GKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAAR--------G 339
E L+ E+ G + D L G + E AR
Sbjct: 81 --EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE------------ARSKFRQIVSA 126
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARMQG 397
++Y H+ RI+HRD+K+ N+LLD ++N KI D G + G C + P
Sbjct: 127 VQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP----- 178
Query: 398 TFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 443
Y APE Y G DV+S GV+L L++G P + + +G+
Sbjct: 179 ---YAAPELFQGKKYD--GPE---VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230
Query: 444 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 503
+ + + ++ L K L L+P R T+ +++
Sbjct: 231 YRIPFYMSTDCEN---------------------------LLKRFLVLNPIKRGTLEQIM 263
Query: 504 Q 504
+
Sbjct: 264 K 264
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 8e-21
Identities = 68/300 (22%), Positives = 112/300 (37%), Gaps = 70/300 (23%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKR-FKTQ-GGPNADSVFLTEVDMLSRLHH 280
D F +G+G VY + + I+A+K FK+Q + E+++ S L H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 281 CHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGA- 336
+++ + Y F ++ R+ L+ EF P G L L G E + +
Sbjct: 74 PNILRMYNY---FHDRK--RIYLMLEFAPRGELYKELQKHGRFDE------QRSATFMEE 122
Query: 337 -ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP-SCSSSPAR 394
A L Y HE +++HRDIK N+L+ KI D G + + C
Sbjct: 123 LADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC------ 173
Query: 395 MQGTFGYFAPEYAMVGRAS--LMSDVFSFGVVLLELITGRQP--------IHRSITKGEE 444
GT Y PE M+ + D++ GV+ E + G P HR I +
Sbjct: 174 --GTLDYLPPE--MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL 229
Query: 445 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
+ + +D +IS+L L+ P R + V++
Sbjct: 230 KFPPFLSDGSKD---LISKL------------------------LRYHPPQRLPLKGVME 262
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 75/331 (22%), Positives = 119/331 (35%), Gaps = 74/331 (22%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
F ++G G S V+ Q G++ A+K K S+ E+ +L ++ H
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE-NEIAVLKKIKHE 66
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAARG 339
++V L + LV + + G L D GV E D + I
Sbjct: 67 NIVTLEDI---YESTTHY-YLVMQLVSGGELFDRILERGVYTEK---DASLVIQQ-VLSA 118
Query: 340 LEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
++YLHE I+HRD+K N+L +EN ITD G++K + M
Sbjct: 119 VKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----------NGIMS 165
Query: 397 ---GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEES 445
GT GY APE S D +S GV+ L+ G P + I +G
Sbjct: 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY- 224
Query: 446 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPDARPTMSE 501
+F ++ AK+ L+ DP+ R T +
Sbjct: 225 --------------------------EFESPFWDDISESAKDFICHLLEKDPNERYTCEK 258
Query: 502 VVQ---ILSTIAPDKSRRRNISLNLFQIFSA 529
+ I A + ++SL + + A
Sbjct: 259 ALSHPWIDGNTALHRDIYPSVSLQIQK-NFA 288
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 71/318 (22%), Positives = 117/318 (36%), Gaps = 72/318 (22%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLT---EVDMLSRLH 279
K+ +GQG V++ + G+ VA+K+ + + +T E+ +L L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLK 74
Query: 280 HCHVVPL----VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG 335
H +VV L S + + LVF+F + D L G+L + V +
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----D-LAGLL-------SNVLVKFT 122
Query: 336 AA----------RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385
+ GL Y+H +ILHRD+K++N+L+ + K+ D G+A+ L
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF---SL 176
Query: 386 PSCSSSPARMQG---TFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPI------ 435
+S P R T Y PE + R D++ G ++ E+ T PI
Sbjct: 177 AK-NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PIMQGNTE 234
Query: 436 ----HR------SIT----KGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIM 481
SIT ++ L+ L ++K
Sbjct: 235 QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKG-------QKRKVKDRLKAYVRDPY 287
Query: 482 AY-LAKECLQLDPDARPT 498
A L + L LDP R
Sbjct: 288 ALDLIDKLLVLDPAQRID 305
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-20
Identities = 66/303 (21%), Positives = 101/303 (33%), Gaps = 61/303 (20%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV------------FL 269
+ + +G G V + A+K K
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 270 TEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDT 328
E+ +L L H +++ L + LV EF G L + ++ +D
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFED-----KKYFYLVTEFYEGGELFE----QIINRHKFDE 145
Query: 329 RVAIAIGA--ARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKAD 383
A I G+ YLH+ I+HRDIK NILL + LN KI D G++ D
Sbjct: 146 CDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202
Query: 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 443
GT Y APE + + + DV+S GV++ L+ G P +
Sbjct: 203 ------YKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI 255
Query: 444 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPDARPTM 499
V + K F + + ++ AKE L D + R T
Sbjct: 256 IKKVE-------------------KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTA 296
Query: 500 SEV 502
E
Sbjct: 297 EEA 299
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 6e-20
Identities = 65/306 (21%), Positives = 115/306 (37%), Gaps = 48/306 (15%)
Query: 208 HGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD- 265
H + R + ++++ ++G+G V + + AVK N D
Sbjct: 6 HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65
Query: 266 SVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMN 325
S L EV++L +L H +++ L + + + V E G L D +++
Sbjct: 66 STILREVELLKKLDHPNIMKLFEILED---SSSFYI-VGELYTGGELFD----EIIKRKR 117
Query: 326 WDTRVA--IAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRL 380
+ A I G+ Y+H+ I+HRD+K NILL +++ + KI D G++
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
Query: 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 440
+ + GT Y APE + G DV+S GV+L L++G P +
Sbjct: 175 QQNTKMK------DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 441 KGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPDAR 496
V F + + ++ AK+ L P R
Sbjct: 228 YDILKRVETGKY-------------------AFDLPQWRTISDDAKDLIRKMLTFHPSLR 268
Query: 497 PTMSEV 502
T ++
Sbjct: 269 ITATQC 274
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 9e-20
Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 29/225 (12%)
Query: 222 ATDKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVF----LTEVDM 274
AT ++ +G G +Y VY+ + G VA+K + G + EV +
Sbjct: 7 ATSRYEPVAEIGVG--AYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 275 LSRLH---HCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRV 330
L RL H +VV L+ C+ R R +++ LVFE + +LR LD G+ +T
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123
Query: 331 AIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 390
+ RGL++LH I+HRD+K NIL+ K+ D G+A+ S
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY---------S 171
Query: 391 SPARMQG---TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 432
+ T Y APE + + D++S G + E+ +
Sbjct: 172 YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 74/299 (24%), Positives = 112/299 (37%), Gaps = 76/299 (25%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVK---RFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL-- 286
G+G V AVK + K + PN ++ E+ +L RL H +V+ L
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD 73
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR-------- 338
V Y E + +V E+ G +++ LD V + A
Sbjct: 74 VLYNEE----KQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQ--------AHGYFCQLID 120
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA---KRLKADGLPSCSSSPARM 395
GLEYLH + I+H+DIK N+LL KI+ LG+A AD C +S
Sbjct: 121 GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT--CRTS---- 171
Query: 396 QGTFGYFAPEYAMVGR--ASLMSDVFSFGVVLLELITGRQPIH--------RSITKGEES 445
QG+ + PE A + D++S GV L + TG P +I KG +
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA 231
Query: 446 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
+ P L D L K L+ +P R ++ ++ Q
Sbjct: 232 IPGDCGPPLSD---------------------------LLKGMLEYEPAKRFSIRQIRQ 263
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 70/298 (23%), Positives = 106/298 (35%), Gaps = 82/298 (27%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVKR------FKTQGGPNADSVFLTEVDMLSRLHHC--HV 283
G GG VY G ++D VA+K PN V + EV +L ++ V
Sbjct: 52 GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFSGV 110
Query: 284 VPLVGYCSEFRGKRAMRLLVFEF-MPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAAR-- 338
+ L+ ++ + +L+ E P +L D + G L E + AR
Sbjct: 111 IRLL----DWFERPDSFVLILERPEPVQDLFDFITERGALQEEL------------ARSF 154
Query: 339 ------GLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRLKADGL--PSCS 389
+ + H +LHRDIK NIL+D N K+ D G LK D +
Sbjct: 155 FWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD- 209
Query: 390 SSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIH--RSITKGEESL 446
GT Y PE+ R + V+S G++L +++ G P I +G+
Sbjct: 210 -------GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF 262
Query: 447 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
+ Q L + CL L P RPT E+
Sbjct: 263 RQRVSSECQH---------------------------LIRWCLALRPSDRPTFEEIQN 293
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 66/327 (20%), Positives = 117/327 (35%), Gaps = 82/327 (25%)
Query: 232 VGQGGSSYVYRGQ---LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
VG+G +VY+ + D + A+K+ + G + E+ +L L H +V+ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA---CREIALLRELKHPNVISLQK 85
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA----------R 338
++ L+F++ + +L + + + + +
Sbjct: 86 VFLSHADRKVW--LLFDYAEH-DLWHIIK---FHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNA----KITDLGMAKRLKADGLPSCSSSPAR 394
G+ YLH +LHRD+K +NIL+ KI D+G A RL L +
Sbjct: 140 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA-RLFNSPLKPLADLDPV 195
Query: 395 MQGTFGYFAPE-------YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 447
+ TF Y APE Y + D+++ G + EL+T PI + +
Sbjct: 196 VV-TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE-PIF----HCRQEDI 243
Query: 448 LWATPRLQDS--------GT-------VISELPD-PRLKGDFPKEEMQIMAY-------- 483
+ P D G I ++P+ L DF + +
Sbjct: 244 KTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHK 303
Query: 484 ---------LAKECLQLDPDARPTMSE 501
L ++ L +DP R T +
Sbjct: 304 VKPDSKAFHLLQKLLTMDPIKRITSEQ 330
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 81/317 (25%), Positives = 127/317 (40%), Gaps = 57/317 (17%)
Query: 222 ATDKFSGS---------NIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTE 271
+TD FSG +++G+G + V L + AVK + Q G VF E
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF-RE 60
Query: 272 VDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDT 328
V+ML + H +V+ L+ + E LVFE M G++ E
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEE----EDRFYLVFEKMRGGSILSHIHKRRHFNE------ 110
Query: 329 RVAIAI--GAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKAD 383
A + A L++LH I HRD+K NIL ++ KI D + +K +
Sbjct: 111 LEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167
Query: 384 GLPSCSSSPARMQ--GTFGYFAPEYAMVGRASLMS--------DVFSFGVVLLELITGRQ 433
G S S+P + G+ Y APE V A D++S GV+L L++G
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPE---VVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
Query: 434 PIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKG--DFPKEEMQIMAYLAKE---- 487
P A P Q+ L + +G +FP ++ ++ AK+
Sbjct: 225 PFVGRCGSDCGWDRGEACPACQN------MLFESIQEGKYEFPDKDWAHISCAAKDLISK 278
Query: 488 CLQLDPDARPTMSEVVQ 504
L D R + ++V+Q
Sbjct: 279 LLVRDAKQRLSAAQVLQ 295
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 77/340 (22%), Positives = 122/340 (35%), Gaps = 81/340 (23%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLS 276
D + ++G+G S V R G+ AVK +F + G + + + E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK-REASICH 81
Query: 277 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT---RVAIA 333
L H H+V L+ S M +VFEFM +L ++ VA
Sbjct: 82 MLKHPHIVELLETYSS----DGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASH 134
Query: 334 IGAAR----GLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLP 386
R L Y H+ I+HRD+K +LL + + K+ G+A +L G
Sbjct: 135 Y--MRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-- 187
Query: 387 SCSSSPARMQ---GTFGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQP------- 434
GT + APE +V R DV+ GV+L L++G P
Sbjct: 188 ------LVAGGRVGTPHFMAPE--VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER 239
Query: 435 IHRSITKGEESLV--LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLD 492
+ I KG+ + W+ ISE K+ L + L LD
Sbjct: 240 LFEGIIKGKYKMNPRQWSH---------ISES---------AKD-------LVRRMLMLD 274
Query: 493 PDARPTMSEVVQ---ILSTIAPDKSRRRNISLNLFQIFSA 529
P R T+ E + + ++ + F+A
Sbjct: 275 PAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNA 314
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 5e-19
Identities = 72/316 (22%), Positives = 114/316 (36%), Gaps = 84/316 (26%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-----RFKTQGGPNADSV--FLTEVDM 274
D++ S +G G V + + VA++ +F AD TE+++
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 275 LSRLHHCHVVPLVGYCSE---FRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTR 329
L +L+H ++ + + + +V E M G L D + L E +
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYY--------IVLELMEGGELFDKVVGNKRLKEA---TCK 242
Query: 330 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLP 386
++YLHE I+HRD+K N+LL +E+ KITD G +K L L
Sbjct: 243 -LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 298
Query: 387 S--CSSSPARMQGTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP------- 434
C GT Y APE + D +S GV+L ++G P
Sbjct: 299 RTLC--------GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 350
Query: 435 --IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----C 488
+ IT G K +F E ++ A +
Sbjct: 351 VSLKDQITSG---------------------------KYNFIPEVWAEVSEKALDLVKKL 383
Query: 489 LQLDPDARPTMSEVVQ 504
L +DP AR T E ++
Sbjct: 384 LVVDPKARFTTEEALR 399
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 7e-19
Identities = 56/336 (16%), Positives = 86/336 (25%), Gaps = 88/336 (26%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV----FLTEVDMLSR 277
K+ +GQG V + I A+K + TEV ++ +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 278 LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD-------------------CLDG 318
LHH ++ L + LV E G+L D
Sbjct: 85 LHHPNIARLYEVYED----EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 319 VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR----------------ILHRDIKSSNIL 362
E +I E I HRDIK N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 363 L--DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE--YAMVGRASLMSDV 418
+++ K+ D G++K GT + APE D
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLN-NGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259
Query: 419 FSFGVVLLELITGRQP--------IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLK 470
+S GV+L L+ G P + K
Sbjct: 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNK---------------------------K 292
Query: 471 GDFPKEEMQIMAYLAKE----CLQLDPDARPTMSEV 502
F +++ LA++ L + D R
Sbjct: 293 LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-19
Identities = 82/315 (26%), Positives = 132/315 (41%), Gaps = 73/315 (23%)
Query: 224 DKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVF----LTEVDMLS 276
+K+ +VG+G SY V + + GRIVA+K+F + D + + E+ +L
Sbjct: 25 EKYENLGLVGEG--SYGMVMKCRNKDTGRIVAIKKFLES---DDDKMVKKIAMREIKLLK 79
Query: 277 RLHHCHVVPLVGYCSE-FRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 334
+L H ++V L+ E + K+ R LVFEF+ + + D L+ + G+++
Sbjct: 80 QLRHENLVNLL----EVCKKKK--RWYLVFEFVDH-TILDDLE-LFPNGLDYQVVQKYLF 131
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
G+ + H I+HRDIK NIL+ ++ K+ D G A R A A
Sbjct: 132 QIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFA-RTLAAPGEVYDDEVA- 186
Query: 395 MQGTFGYFAPE-------YAM-VGRASLMSDVFSFGVVLLELITGR----------Q--- 433
T Y APE Y V DV++ G ++ E+ G Q
Sbjct: 187 ---TRWYRAPELLVGDVKYGKAV-------DVWAIGCLVTEMFMGEPLFPGDSDIDQLYH 236
Query: 434 -------PIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAK 486
I R + ++A RL + L+ +PK ++ LAK
Sbjct: 237 IMMCLGNLIPR-HQELFNKNPVFAGVRLPEI------KEREPLERRYPKLSEVVID-LAK 288
Query: 487 ECLQLDPDARPTMSE 501
+CL +DPD RP +E
Sbjct: 289 KCLHIDPDKRPFCAE 303
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 9e-19
Identities = 62/301 (20%), Positives = 97/301 (32%), Gaps = 88/301 (29%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVK---RFKTQGGPNADSVFLT----EVDMLSRLHHCHVV 284
G G +V+ + V VK + K + L E+ +LSR+ H +++
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92
Query: 285 PLVGYCSEFRGKRAMRLLVFEFMPNGN-LRDCLD--GVLVEGMNWDTRVAIAIGAAR--- 338
++ + + LV E +G L +D L E + A
Sbjct: 93 KVL----DIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL------------ASYIF 136
Query: 339 -----GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSS 391
+ YL I+HRDIK NI++ E+ K+ D G A L+ L C
Sbjct: 137 RQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--- 190
Query: 392 PARMQGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQPIH--RSITKGE 443
GT Y APE Y G +++S GV L L+ P +
Sbjct: 191 -----GTIEYCAPEVLMGNPYR--GPE---LEMWSLGVTLYTLVFEENPFCELEETVEAA 240
Query: 444 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 503
+ L L LQ P+ R T+ ++V
Sbjct: 241 IHPPYLVSKELMS---------------------------LVSGLLQPVPERRTTLEKLV 273
Query: 504 Q 504
Sbjct: 274 T 274
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 73/405 (18%), Positives = 135/405 (33%), Gaps = 96/405 (23%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHH 280
T+++ +G+G S V R ++ G+ A T+ D E + L H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAI--GA 336
++V L SE L+F+ + G L + E A
Sbjct: 70 PNIVRLHDSISE----EGHHYLIFDLVTGGELFEDIVAREYYSE------ADASHCIQQI 119
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPA 393
+ + H+ ++HR++K N+LL + K+ D G+A ++ +
Sbjct: 120 LEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--------Q 168
Query: 394 RMQ---GTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IH 436
GT GY +PE Y G+ D+++ GV+L L+ G P ++
Sbjct: 169 AWFGFAGTPGYLSPEVLRKDPY---GKP---VDLWACGVILYILLVGYPPFWDEDQHRLY 222
Query: 437 RSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLD 492
+ I G DFP E + AK+ L ++
Sbjct: 223 QQIKAG---------------------------AYDFPSPEWDTVTPEAKDLINKMLTIN 255
Query: 493 PDARPTMSEVVQ---ILSTIAPDKSRRRNISLNLFQIFSAGGMEK-EPSIERPDNLFETL 548
P R T +E ++ I R +++ + F+A K + +I
Sbjct: 256 PSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNA--RRKLKGAILTVMLATRNF 313
Query: 549 IESEELKKATSFGSPRCSQAVDTDITLNTRSNSKEEDTVSTEYME 593
++ + Q ++ + S +K D T +
Sbjct: 314 SVRKQEIIKVTE------QLIEAISNGDFESYTKMCDPGMTAFEP 352
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 66/304 (21%), Positives = 118/304 (38%), Gaps = 71/304 (23%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
D + +G G V+R + GR+ K T + +V E+ ++++LHH
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV-KNEISIMNQLHHP 108
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR--- 338
++ L F K M +L+ EF+ G L D + E I R
Sbjct: 109 KLINLHDA---FEDKYEM-VLILEFLSGGEL---FDRIAAEDYKMSEAEVINY--MRQAC 159
Query: 339 -GLEYLHEAAAPRILHRDIKSSNILL--DENLNAKITDLGMAKRLKADGLPSCSSSPARM 395
GL+++HE I+H DIK NI+ + + KI D G+A +L D +
Sbjct: 160 EGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV------T 210
Query: 396 QGTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEE 444
T + APE VG +D+++ GV+ L++G P +++ + +
Sbjct: 211 TATAEFAAPEIVDREPVGFY---TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD- 266
Query: 445 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPDARPTMS 500
W +F ++ ++ AK+ LQ +P R T+
Sbjct: 267 ----W----------------------EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVH 300
Query: 501 EVVQ 504
+ ++
Sbjct: 301 DALE 304
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 66/294 (22%), Positives = 124/294 (42%), Gaps = 39/294 (13%)
Query: 224 DKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
+ + + +G+G + VY+G +VA+K + + A + EV +L L H +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 283 VVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 340
+V L + ++++ LVFE++ +L+ LD +N RGL
Sbjct: 62 IVTLHDI-----IHTEKSL-TLVFEYLDK-DLKQYLDDCGN-IINMHNVKLFLFQLLRGL 113
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
Y H ++LHRD+K N+L++E K+ D G+A +A +P+ + + T
Sbjct: 114 AYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA---RAKSIPTKTYDNEVV--TLW 165
Query: 401 YFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA---TPRLQD 456
Y P+ + S D++ G + E+ TGR P+ T E+ ++ TP +
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFIFRILGTPTEET 224
Query: 457 -SGTVISELPDPRLKGDFPKEEMQIMAY-----------LAKECLQLDPDARPT 498
G I + + ++PK + + L + LQ + R +
Sbjct: 225 WPG--ILSNEEFK-TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS 275
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 38/238 (15%), Positives = 76/238 (31%), Gaps = 35/238 (14%)
Query: 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEV 272
+ + +++G+G + VY D + +K K P + +
Sbjct: 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-PANPWEFYIGTQLM 118
Query: 273 DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLVEGMNWDTR 329
+ L + F+ LV E G L + ++ + M
Sbjct: 119 ERLKPSMQHMFMKFY-SAHLFQNGSV---LVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 330 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL-----------DENLNAKITDLGMAK 378
++ A+ +E +H+ I+H DIK N +L D + + DLG +
Sbjct: 175 ISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRAS--LMSDVFSFGVVLLELITGRQP 434
+K + ++ T G+ E M+ D F + ++ G
Sbjct: 232 DMKLFPKGTIFTAKC---ETSGFQCVE--MLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 68/327 (20%), Positives = 106/327 (32%), Gaps = 111/327 (33%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVK---------------RFKTQGGPNADSVFLTEVDMLS 276
G+G V D A+K R +G A + +
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 277 R----------LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-DGVLVEGMN 325
+ L H +VV L +VFE + G + + L E
Sbjct: 82 QVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED-- 137
Query: 326 WDTRVAIAIGAAR--------GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377
AR G+EYLH +I+HRDIK SN+L+ E+ + KI D G++
Sbjct: 138 ----------QARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 378 KRLK-ADGLPSCSS-SPARMQGTFGYFAPE--------YAMVGRASLMSDVFSFGVVLLE 427
K +D L S + +PA + APE ++ G+A DV++ GV L
Sbjct: 185 NEFKGSDALLSNTVGTPA-------FMAPESLSETRKIFS--GKA---LDVWAMGVTLYC 232
Query: 428 LITGRQP--------IHRSITKGEESLVLWA--TPRLQDSGTVISELPDPRLKGDFPKEE 477
+ G+ P +H I L+D
Sbjct: 233 FVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKD--------------------- 271
Query: 478 MQIMAYLAKECLQLDPDARPTMSEVVQ 504
L L +P++R + E+
Sbjct: 272 ------LITRMLDKNPESRIVVPEIKL 292
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 66/307 (21%), Positives = 106/307 (34%), Gaps = 98/307 (31%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVKR------FKTQGGPNADSVFLTEVDMLSRLH----HC 281
G+GG V+ G LTD VA+K ++ + L EV +L ++ H
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGGHP 98
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD-----GVLVEGMNWDTRVAIAIGA 336
V+ L+ ++ + +LV E +D D G L EG
Sbjct: 99 GVIRLL----DWFETQEGFMLVLERPLPA--QDLFDYITEKGPLGEGP------------ 140
Query: 337 AR--------GLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGL-- 385
+R +++ H ++HRDIK NIL+D AK+ D G L D
Sbjct: 141 SRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYT 196
Query: 386 PSCSSSPARMQGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQPIH--R 437
GT Y PE Y + V+S G++L +++ G P +
Sbjct: 197 DFD--------GTRVYSPPEWISRHQYH--ALP---ATVWSLGILLYDMVCGDIPFERDQ 243
Query: 438 SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP 497
I + E +P L + CL P +RP
Sbjct: 244 EILEAELHFPAHVSPDCCA---------------------------LIRRCLAPKPSSRP 276
Query: 498 TMSEVVQ 504
++ E++
Sbjct: 277 SLEEILL 283
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 75/313 (23%), Positives = 112/313 (35%), Gaps = 76/313 (24%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV--------FLTEVD 273
+ + I+G+G SS V R + AVK GG + + L EVD
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 274 MLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRV 330
+L ++ H +++ L LVF+ M G L D L E +TR
Sbjct: 76 ILRKVSGHPNIIQLKDTYET----NTFFFLVFDLMKKGELFDYLTEKVTLSEK---ETRK 128
Query: 331 AI-AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS-- 387
+ A+ + LH+ I+HRD+K NILLD+++N K+TD G + +L
Sbjct: 129 IMRAL--LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV 183
Query: 388 CSSSPARMQGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP------- 434
C GT Y APE D++S GV++ L+ G P
Sbjct: 184 C--------GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 235
Query: 435 -IHRSITKGEESLVL--WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQL 491
+ R I G W S+ K+ L L +
Sbjct: 236 LMLRMIMSGNYQFGSPEWDD---------YSDT---------VKD-------LVSRFLVV 270
Query: 492 DPDARPTMSEVVQ 504
P R T E +
Sbjct: 271 QPQKRYTAEEALA 283
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 3e-18
Identities = 81/305 (26%), Positives = 141/305 (46%), Gaps = 61/305 (20%)
Query: 224 DKFSGSNIVGQGGSSY--VYRGQLTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSR 277
+K+ VG+G +Y VY+ + + GRIVA+KR + +G P S + E+ +L
Sbjct: 21 EKYQKLEKVGEG--TYGVVYKAKDSQGRIVALKRIRLDAEDEGIP---STAIREISLLKE 75
Query: 278 LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 337
LHH ++V L+ +R + LVFEFM +L+ LD + + +
Sbjct: 76 LHHPNIVSLI---DVIHSERCL-TLVFEFMEK-DLKKVLD---------ENKTGLQDSQI 121
Query: 338 --------RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 389
RG+ + H+ RILHRD+K N+L++ + K+ D G+A +A G+P S
Sbjct: 122 KIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLA---RAFGIPVRS 175
Query: 390 SSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 448
+ + T Y AP+ M + S D++S G + E+ITG+ P+ +T ++ +
Sbjct: 176 YTHEVV--TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKI 232
Query: 449 WA---TPRLQD-SGTVISELPDPRLKGDFPKEEMQIMAY-----------LAKECLQLDP 493
++ TP ++ + ELP + + F E + + L L DP
Sbjct: 233 FSILGTPNPREWPQ--VQELPLWK-QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDP 289
Query: 494 DARPT 498
+ R +
Sbjct: 290 NKRIS 294
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 4e-18
Identities = 76/315 (24%), Positives = 122/315 (38%), Gaps = 73/315 (23%)
Query: 224 DKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVF----LTEVDMLS 276
+K+ +G+G SY V++ + G+IVA+K+F D V L E+ ML
Sbjct: 3 EKYEKIGKIGEG--SYGVVFKCRNRDTGQIVAIKKFLES---EDDPVIKKIALREIRMLK 57
Query: 277 RLHHCHVVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 334
+L H ++V L V FR KR + LVFE+ + + LD G+ +I
Sbjct: 58 QLKHPNLVNLLEV-----FRRKRRL-HLVFEYCDH-TVLHELD-RYQRGVPEHLVKSITW 109
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
+ + + H+ +HRD+K NIL+ ++ K+ D G A RL A
Sbjct: 110 QTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFA-RLLTGPSDYYDDEVA- 164
Query: 395 MQGTFGYFAPE-------YAMVGRASLMSDVFSFGVVLLELITGR----------QPIHR 437
T Y +PE Y DV++ G V EL++G Q ++
Sbjct: 165 ---TRWYRSPELLVGDTQY------GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ-LYL 214
Query: 438 SITK-----------GEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAK 486
I K + ++ ++ D L+ FP + L
Sbjct: 215 -IRKTLGDLIPRHQQVFSTNQYFSGVKIPDP------EDMEPLELKFPNISYPALGLLKG 267
Query: 487 ECLQLDPDARPTMSE 501
CL +DP R T +
Sbjct: 268 -CLHMDPTERLTCEQ 281
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 4e-18
Identities = 69/299 (23%), Positives = 107/299 (35%), Gaps = 84/299 (28%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVK---RFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
G G V G+ G VAVK R K + + E+ L H H++ L
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK-REIQNLKLFRHPHIIKL-- 76
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAAR-------- 338
Y + +V E++ G L D C G + E AR
Sbjct: 77 Y--QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM------------EARRLFQQILS 122
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARMQ 396
++Y H ++HRD+K N+LLD ++NAKI D G++ + SC SP
Sbjct: 123 AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-GSPN--- 175
Query: 397 GTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEES 445
Y APE ++ A D++S GV+L L+ G P + + I G
Sbjct: 176 ----YAAPE--VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY 229
Query: 446 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
+ + + L LQ+DP R T+ ++ +
Sbjct: 230 IPEYLNRSVAT---------------------------LLMHMLQVDPLKRATIKDIRE 261
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 4e-18
Identities = 77/299 (25%), Positives = 137/299 (45%), Gaps = 50/299 (16%)
Query: 224 DKFSGSNIVGQGGSSY--VYRGQLTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSR 277
+K+ G +G+G +Y VY+ Q G A+K+ + +G P S + E+ +L
Sbjct: 2 EKYHGLEKIGEG--TYGVVYKAQNNYGETFALKKIRLEKEDEGIP---STTIREISILKE 56
Query: 278 LHHCHVVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG 335
L H ++V L V K+ + +LVFE + +L+ LD V G+ T + +
Sbjct: 57 LKHSNIVKLYDV-----IHTKKRL-VLVFEHLDQ-DLKKLLD-VCEGGLESVTAKSFLLQ 108
Query: 336 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 395
G+ Y H+ R+LHRD+K N+L++ KI D G+A +A G+P + +
Sbjct: 109 LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLA---RAFGIPVRKYTHEIV 162
Query: 396 QGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA---T 451
T Y AP+ M + S D++S G + E++ G P+ +++ ++ + ++ T
Sbjct: 163 --TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT-PLFPGVSEADQLMRIFRILGT 219
Query: 452 PRLQD-SGTVISELPDPRLKGDFPKEEMQIMAY-----------LAKECLQLDPDARPT 498
P ++ ++ELP +F E L + L+LDP+ R T
Sbjct: 220 PNSKNWPN--VTELPK--YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT 274
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 4e-18
Identities = 68/299 (22%), Positives = 122/299 (40%), Gaps = 48/299 (16%)
Query: 224 DKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLS 276
K+ +G+G +Y V++ + IVA+KR + +G P S L E+ +L
Sbjct: 2 QKYEKLEKIGEG--TYGTVFKAKNRETHEIVALKRVRLDDDDEGVP---SSALREICLLK 56
Query: 277 RLHHCHVVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 334
L H ++V L V + + LVFEF +L+ D ++ + +
Sbjct: 57 ELKHKNIVRLHDV-----LHSDKKL-TLVFEFCDQ-DLKKYFDSCNG-DLDPEIVKSFLF 108
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
+GL + H +LHRD+K N+L++ N K+ + G+A +A G+P S
Sbjct: 109 QLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLA---RAFGIPVRCYSAEV 162
Query: 395 MQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA--- 450
+ T Y P+ + S D++S G + EL +P+ ++ ++
Sbjct: 163 V--TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220
Query: 451 TPRLQD-SGTVISELPD----------PRLKGDFPKEEMQIMAYLAKECLQLDPDARPT 498
TP + +++LPD L PK L + L+ +P R +
Sbjct: 221 TPTEEQWPS--MTKLPDYKPYPMYPATTSLVNVVPKLNATGRD-LLQNLLKCNPVQRIS 276
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-18
Identities = 65/235 (27%), Positives = 103/235 (43%), Gaps = 54/235 (22%)
Query: 223 TDKFSGSNIVGQGGSSY--VYRGQLTDGRIVAVKRFKTQGGPNADSVF-LTEVDMLSRLH 279
++ ++G G S+ V++ +L + VA+K+ D F E+ ++ +
Sbjct: 39 EIAYTNCKVIGNG--SFGVVFQAKLVESDEVAIKKVL------QDKRFKNRELQIMRIVK 90
Query: 280 HCHVVPLVGY-CSEFRGKRAMRL-LVFEFMP---------NGNLRDCLDGVLVEGMNWDT 328
H +VV L + S K + L LV E++P L+ + +L++ +
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 329 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-KITDLGMAKRLKADGLPS 387
R L Y+H I HRDIK N+LLD K+ D G AK L A G P+
Sbjct: 151 --------LRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA-GEPN 198
Query: 388 ----CSSSPARMQGTFGYFAPEYAMVGRASLMS---DVFSFGVVLLELITGRQPI 435
CS R Y APE + G A+ + D++S G V+ EL+ G QP+
Sbjct: 199 VSYICS----RY-----YRAPE-LIFG-ATNYTTNIDIWSTGCVMAELMQG-QPL 241
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 78/303 (25%), Positives = 128/303 (42%), Gaps = 42/303 (13%)
Query: 221 HATDKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR 277
++ +F +G G +Y VY+G T G VA+K K S + E+ ++
Sbjct: 2 SSSSQFKQLEKLGNG--TYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKE 59
Query: 278 LHHCHVVPL--VGYCSEFRGKRAMRLLVFEFMPN---GNLRDCLDGVLVEGMNWDTRVAI 332
L H ++V L V + + LVFEFM N + G G+ +
Sbjct: 60 LKHENIVRLYDV-----IHTENKL-TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF 113
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP 392
+GL + HE +ILHRD+K N+L+++ K+ D G+A +A G+P + S
Sbjct: 114 QWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA---RAFGIPVNTFSS 167
Query: 393 ARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA- 450
+ T Y AP+ M R S D++S G +L E+ITG+ P+ E+ +++
Sbjct: 168 EVV--TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK-PLFPGTNDEEQLKLIFDI 224
Query: 451 --TP---------RLQDSGTVISELPDPRLKGDFPKEEMQIMAY----LAKECLQLDPDA 495
TP +L I + P L+ + + LQL+PD
Sbjct: 225 MGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDM 284
Query: 496 RPT 498
R +
Sbjct: 285 RLS 287
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 71/329 (21%), Positives = 117/329 (35%), Gaps = 83/329 (25%)
Query: 220 EHATDKFSGSNIVGQGGSSY--VYRGQLTD-GRIVAVKR-FKTQGGPNADSVF----LTE 271
D+F + GQG ++ V G+ G VA+K+ D F L
Sbjct: 19 RKEMDRFQVERMAGQG--TFGTVQLGKEKSTGMSVAIKKVI-------QDPRFRNRELQI 69
Query: 272 VDMLSRLHHCHVVPL--VGYCSEFRGKRAMRL-LVFEFMP---------NGNLRDCLDGV 319
+ L+ LHH ++V L Y R +R + L +V E++P + +
Sbjct: 70 MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPI 129
Query: 320 LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAK 378
L++ + R + LH + + HRDIK N+L++ + K+ D G AK
Sbjct: 130 LIKVFLFQL--------IRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180
Query: 379 RLKADGLPS----CSSSPARMQGTFGYFAPEYAMVGRASLMS---DVFSFGVVLLELITG 431
+L P+ CS R Y APE + G + D++S G + E++ G
Sbjct: 181 KLSPSE-PNVAYICS----RY-----YRAPEL-IFG-NQHYTTAVDIWSVGCIFAEMMLG 228
Query: 432 R------QPIH--RSITKGEESLVLWATPRLQDSGTVIS---ELPDPRLKG-----DFPK 475
I + VL P + + ++ KG F
Sbjct: 229 EPIFRGDNSAGQLHEIVR-----VL-GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSD 282
Query: 476 EEMQIMA---YLAKECLQLDPDARPTMSE 501
++ L LQ P+ R E
Sbjct: 283 HSLKDAKEAYDLLSALLQYLPEERMKPYE 311
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 7e-18
Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 51/234 (21%)
Query: 223 TDKFSGSNIVGQGGSSY--VYRGQLTD-GRIVAVKRFKTQGGPNADSVF-LTEVDMLSRL 278
++ + ++G G S+ VY+ +L D G +VA+K+ D F E+ ++ +L
Sbjct: 53 EVSYTDTKVIGNG--SFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRKL 104
Query: 279 HHCHVVPLVGY-CSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG- 335
HC++V L + S K + L LV +++P + + + +
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARH------YSRAKQTLPVIY 157
Query: 336 -------AARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-KITDLGMAKRLKADGLPS 387
R L Y+H I HRDIK N+LLD + K+ D G AK+L P+
Sbjct: 158 VKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PN 213
Query: 388 ----CSSSPARMQGTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQPI 435
CS R Y APE + G + DV+S G VL EL+ G QPI
Sbjct: 214 VSYICS----RY-----YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 7e-18
Identities = 72/281 (25%), Positives = 117/281 (41%), Gaps = 39/281 (13%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF--LTEVDMLSRLHH 280
D F ++G+GG V+ Q+ G++ A K+ + + E +L+++H
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 281 CHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--A 337
+V L Y F K L LV M G++R + V + + AI A
Sbjct: 245 RFIVSLA-YA--FETKT--DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
GLE+LH+ I++RD+K N+LLD++ N +I+DLG+A LKA + G
Sbjct: 300 SGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-----TKTKGYAG 351
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP------------IHRSITKGEES 445
T G+ APE + D F+ GV L E+I R P + + + + +
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT 411
Query: 446 LVLWATPRLQDSGTVISEL----PDPRLKGDFPKEEMQIMA 482
+P +D L P+ RL G +
Sbjct: 412 YPDKFSPASKD---FCEALLQKDPEKRL-GFRDGSCDGLRT 448
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 7e-18
Identities = 68/319 (21%), Positives = 123/319 (38%), Gaps = 70/319 (21%)
Query: 208 HGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD- 265
H + R + ++++ ++G+G V + + AVK N D
Sbjct: 6 HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65
Query: 266 SVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMN 325
S L EV++L +L H +++ L + + +V E G L D +++
Sbjct: 66 STILREVELLKKLDHPNIMKLFEILED----SSSFYIVGELYTGGELFD----EIIKRKR 117
Query: 326 WDTRVA--IAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRL 380
+ A I G+ Y+H+ I+HRD+K NILL +++ + KI D G++
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
Query: 381 KADGLPSCSSSPARMQ---GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--- 434
+ + +M+ GT Y APE + G DV+S GV+L L++G P
Sbjct: 175 QQNT---------KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYG 224
Query: 435 -----IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE-- 487
I + + G K F + + ++ AK+
Sbjct: 225 KNEYDILKRVETG---------------------------KYAFDLPQWRTISDDAKDLI 257
Query: 488 --CLQLDPDARPTMSEVVQ 504
L P R T ++ ++
Sbjct: 258 RKMLTFHPSLRITATQCLE 276
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 8e-18
Identities = 52/176 (29%), Positives = 77/176 (43%), Gaps = 32/176 (18%)
Query: 269 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNW 326
E+ ++ L H +V L Y F+ + M +V + + G+LR L + E
Sbjct: 63 FKELQIMQGLEHPFLVNLW-YS--FQDEEDM-FMVVDLLLGGDLRYHLQQNVHFKEE--- 115
Query: 327 DTRVAIA-IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385
++ I + A L+YL RI+HRD+K NILLDE+ + ITD +A L +
Sbjct: 116 TVKLFICELVMA--LDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170
Query: 386 PS--CSSSPARMQGTFGYFAPEYAMVGRASLMS-----DVFSFGVVLLELITGRQP 434
+ GT Y APE M D +S GV EL+ GR+P
Sbjct: 171 ITTMA--------GTKPYMAPE--MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 9e-18
Identities = 55/305 (18%), Positives = 112/305 (36%), Gaps = 72/305 (23%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL 278
+ +K+ + +G+G V+R + + + K K +G E+ +L+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL--VKKEISILNIA 58
Query: 279 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 338
H +++ L F + +++FEF+ ++ + + + R ++
Sbjct: 59 RHRNILHLHES---FESMEEL-VMIFEFISGLDI---FERINTSAFELNEREIVSY--VH 109
Query: 339 ----GLEYLHEAAAPRILHRDIKSSNILL--DENLNAKITDLGMAKRLKADGLPSCSSSP 392
L++LH I H DI+ NI+ + KI + G A++LK
Sbjct: 110 QVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---- 162
Query: 393 ARMQGTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITK 441
+ Y+APE + +V A +D++S G ++ L++G P I +I
Sbjct: 163 --LFTAPEYYAPEVHQHDVVSTA---TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217
Query: 442 GEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPDARP 497
E + F +E + ++ A + L + +R
Sbjct: 218 AE-----Y----------------------TFDEEAFKEISIEAMDFVDRLLVKERKSRM 250
Query: 498 TMSEV 502
T SE
Sbjct: 251 TASEA 255
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 65/346 (18%), Positives = 116/346 (33%), Gaps = 93/346 (26%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLS 276
D + +G G + V + + + G A K + + + EV +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 277 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAI 334
++ H +V+ L + + + +L+ E + G L D L E A
Sbjct: 71 QVLHHNVITLHDV---YENRTDV-VLILELVSGGELFDFLAQKESLSE--------EEAT 118
Query: 335 GAAR----GLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGLP 386
+ G+ YLH +I H D+K NI+L + K+ D G+A ++
Sbjct: 119 SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-- 173
Query: 387 SCSSSPARMQGTFG---YFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP------ 434
+ FG + APE Y +G +D++S GV+ L++G P
Sbjct: 174 -------EFKNIFGTPEFVAPEIVNYEPLGLE---ADMWSIGVITYILLSGASPFLGDTK 223
Query: 435 --IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----C 488
+IT + DF +E + LAK+
Sbjct: 224 QETLANITSVS-----Y----------------------DFDEEFFSHTSELAKDFIRKL 256
Query: 489 LQLDPDARPTMSEV-----VQILSTIAPDKSRRRNISLNLFQIFSA 529
L + R T+ E + + R ++L F+
Sbjct: 257 LVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYV 302
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 62/293 (21%), Positives = 105/293 (35%), Gaps = 54/293 (18%)
Query: 228 GSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVP 285
++G G + V G+ A+K EVD + H+V
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PKARQEVDHHWQASGGPHIVC 86
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT-----RVAIAIGAARGL 340
++ + L++ E M G L + G T + IG A +
Sbjct: 87 ILDVYENMHHGKRCLLIIMECMEGGEL---FSRIQERGDQAFTEREAAEIMRDIGTA--I 141
Query: 341 EYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
++LH I HRD+K N+L +++ K+TD G AK + L +P
Sbjct: 142 QFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPC---Y 191
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457
T Y APE + D++S GV++ L+ G P ++ S
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP-------------FYSNTGQAIS 238
Query: 458 GTVISELPDPRLKG--DFPKEEMQIMAYLAKE----CLQLDPDARPTMSEVVQ 504
+ + G FP E ++ AK+ L+ DP R T+++ +
Sbjct: 239 PGMKRRI----RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 66/346 (19%), Positives = 117/346 (33%), Gaps = 93/346 (26%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV-----FLTEVDMLS 276
D + +G G + V + + + G A K K + + EV +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 277 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAI 334
++ H +++ L + + + +L+ E + G L D L E A
Sbjct: 71 QVLHPNIITLHDV---YENRTDV-VLILELVSGGELFDFLAQKESLSE--------EEAT 118
Query: 335 GAAR----GLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGLP 386
+ G+ YLH +I H D+K NI+L + K+ D G+A ++
Sbjct: 119 SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-- 173
Query: 387 SCSSSPARMQGTFG---YFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP------ 434
+ FG + APE Y +G +D++S GV+ L++G P
Sbjct: 174 -------EFKNIFGTPEFVAPEIVNYEPLGLE---ADMWSIGVITYILLSGASPFLGDTK 223
Query: 435 --IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----C 488
+IT + DF +E + LAK+
Sbjct: 224 QETLANITAVS-----Y----------------------DFDEEFFSQTSELAKDFIRKL 256
Query: 489 LQLDPDARPTMSEV-----VQILSTIAPDKSRRRNISLNLFQIFSA 529
L + R T+ E + + T R ++L F+
Sbjct: 257 LVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYV 302
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 33/224 (14%)
Query: 224 DKFSGSNIVGQGGSSY--VYRGQ--LTDGRIVAVKRFK----TQGGPNADSVFLTEVDML 275
++ +G+G +Y V++ + GR VA+KR + +G P + EV +L
Sbjct: 11 QQYECVAEIGEG--AYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP---LSTIREVAVL 65
Query: 276 SRLH---HCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVA 331
L H +VV L C+ R R +L LVFE + +L LD V G+ +T
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 391
+ RGL++LH R++HRD+K NIL+ + K+ D G+A+ S
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---------SF 172
Query: 392 PARMQG---TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 432
+ T Y APE + + D++S G + E+ +
Sbjct: 173 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 69/228 (30%), Positives = 104/228 (45%), Gaps = 31/228 (13%)
Query: 231 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLV 287
I+G+G S V + R A+K + + + V E D++SRL H V L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 95
Query: 288 GYCSEFRGKRAMRL-LVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIA-IGAARGLEYL 343
Y + F+ +L + NG L + G E TR A I +A LEYL
Sbjct: 96 -YFT-FQDDE--KLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAEIVSA--LEYL 146
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
H I+HRD+K NILL+E+++ +ITD G AK L + + ++S GT Y +
Sbjct: 147 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS---FVGTAQYVS 200
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 443
PE A SD+++ G ++ +L+ G P I + I K E
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 248
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 74/323 (22%), Positives = 117/323 (36%), Gaps = 59/323 (18%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
+D F + +G+G +S VYR Q + A+K K + TE+ +L RL H
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT---VDKKIVRTEIGVLLRLSHP 108
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAI-AIGAAR 338
+++ L LV E + G L D G E D A+ I
Sbjct: 109 NIIKLKEIFET----PTEISLVLELVTGGELFDRIVEKGYYSER---DAADAVKQI--LE 159
Query: 339 GLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPARM 395
+ YLHE I+HRD+K N+L + KI D G++K ++ L +
Sbjct: 160 AVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK------TV 210
Query: 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 455
GT GY APE D++S G++ L+ G +P +
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFY------------------- 251
Query: 456 DSGTVISELPDPRLKG--DFPKEEMQIMAYLAKE----CLQLDPDARPTMSEVVQ---IL 506
+ L F ++ AK+ + LDP R T + +Q +
Sbjct: 252 -DERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310
Query: 507 STIAPDKSRRRNISLNLFQIFSA 529
A + + Q F+A
Sbjct: 311 GKAANFVH--MDTAQKKLQEFNA 331
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 70/352 (19%), Positives = 118/352 (33%), Gaps = 84/352 (23%)
Query: 209 GTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-S 266
G F +A +D + +G+G S V R T G A K T+ D
Sbjct: 14 GRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ 73
Query: 267 VFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNW 326
E + +L H ++V L E + LVF+ + G L + +V +
Sbjct: 74 KLEREARICRKLQHPNIVRLHDSIQE----ESFHYLVFDLVTGGELFE----DIVAREFY 125
Query: 327 DTRVAIAIGA--ARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLK 381
A + Y H I+HR++K N+LL + K+ D G+A +
Sbjct: 126 SEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182
Query: 382 ADGLPSCSSSPARMQ---GTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGR 432
GT GY +PE Y + D+++ GV+L L+ G
Sbjct: 183 DSE---------AWHGFAGTPGYLSPEVLKKDPY---SKP---VDIWACGVILYILLVGY 227
Query: 433 QP--------IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYL 484
P ++ I G D+P E +
Sbjct: 228 PPFWDEDQHRLYAQIKAG---------------------------AYDYPSPEWDTVTPE 260
Query: 485 AKE----CLQLDPDARPTMSEVVQ---ILSTIAPDKSRRRNISLNLFQIFSA 529
AK L ++P R T + ++ I + + R +++ + F+A
Sbjct: 261 AKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNA 312
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 5e-17
Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 330 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 389
+ + A+G+E+L A+ + +HRD+ + NILL E KI D G+A+ + D
Sbjct: 196 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252
Query: 390 SS---PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEES 445
P + + APE ++ SDV+SFGV+L E+ + G P + + EE
Sbjct: 253 GDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEF 305
Query: 446 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEM-QIMAYLAKECLQLDPDARPTMSEVVQ 504
RL++ + P D+ EM Q M +C +P RPT SE+V+
Sbjct: 306 C-----RRLKEGTR----MRAP----DYTTPEMYQTM----LDCWHGEPSQRPTFSELVE 348
Query: 505 ILSTIAPDKSR 515
L + ++
Sbjct: 349 HLGNLLQANAQ 359
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 9e-06
Identities = 25/94 (26%), Positives = 40/94 (42%), Gaps = 10/94 (10%)
Query: 230 NIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCH 282
+G+G V R VAVK K + ++E+ +L + HH +
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL 316
VV L+G C++ G +++ EF GNL L
Sbjct: 88 VVNLLGACTKPGGP---LMVIVEFCKFGNLSTYL 118
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 74/312 (23%), Positives = 116/312 (37%), Gaps = 75/312 (24%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-------RFKTQGGPNADSVFLTEVDM 274
K+ +++G+G SS V R G AVK R + E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 275 LSRLH-HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVA 331
L ++ H H++ L+ + LVF+ M G L D L E +TR
Sbjct: 153 LRQVAGHPHIITLIDSYES----SSFMFLVFDLMRKGELFDYLTEKVALSEK---ETRSI 205
Query: 332 I-AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS--C 388
+ ++ + +LH I+HRD+K NILLD+N+ +++D G + L+ C
Sbjct: 206 MRSL--LEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC 260
Query: 389 SSSPARMQGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP-------- 434
GT GY APE D+++ GV+L L+ G P
Sbjct: 261 --------GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL 312
Query: 435 IHRSITKGEESLVL--WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLD 492
+ R I +G+ W S K+ L LQ+D
Sbjct: 313 MLRMIMEGQYQFSSPEWDD---------RSST---------VKD-------LISRLLQVD 347
Query: 493 PDARPTMSEVVQ 504
P+AR T + +Q
Sbjct: 348 PEARLTAEQALQ 359
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 5e-17
Identities = 69/301 (22%), Positives = 105/301 (34%), Gaps = 84/301 (27%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
G+G V VAVK + +++ E+ + L+H +VV Y
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNHENVVKF--Y- 71
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAAR--------GL 340
R + ++ L E+ G L D D + E A+ G+
Sbjct: 72 -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP------------DAQRFFHQLMAGV 118
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP-----SCSSSPARM 395
YLH I HRDIK N+LLDE N KI+D G+A + + C
Sbjct: 119 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------- 168
Query: 396 QGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQPIH---------RSITKGE 443
GT Y APE ++ R + DV+S G+VL ++ G P + +
Sbjct: 169 -GTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225
Query: 444 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 503
L W I P L + L +P AR T+ ++
Sbjct: 226 TYLNPWKK---------ID--SAPLA--------------LLHKILVENPSARITIPDIK 260
Query: 504 Q 504
+
Sbjct: 261 K 261
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 73/317 (23%), Positives = 116/317 (36%), Gaps = 86/317 (27%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-----RFKTQGGPNADSV--FLTEVDM 274
D++ S +G G V + + VA+K +F AD TE+++
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 275 LSRLHHCHVVPLVGYCSE---FRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTR 329
L +L+H ++ + + + +V E M G L D + L E +
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDYY--------IVLELMEGGELFDKVVGNKRLKEA---TCK 117
Query: 330 VAI-AIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGL 385
+ + ++YLHE I+HRD+K N+LL +E+ KITD G +K L L
Sbjct: 118 LYFYQM--LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 386 --PSCSSSPARMQGTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP------ 434
C GT Y APE + D +S GV+L ++G P
Sbjct: 173 MRTLC--------GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224
Query: 435 ---IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE---- 487
+ IT G K +F E ++ A +
Sbjct: 225 QVSLKDQITSG---------------------------KYNFIPEVWAEVSEKALDLVKK 257
Query: 488 CLQLDPDARPTMSEVVQ 504
L +DP AR T E ++
Sbjct: 258 LLVVDPKARFTTEEALR 274
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-16
Identities = 70/272 (25%), Positives = 115/272 (42%), Gaps = 38/272 (13%)
Query: 231 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF--LTEVDMLSRLHHCHVVPLV 287
++G+GG V Q+ G++ A K+ + + L E +L +++ VV L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 288 GYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
Y + K L LV M G+L+ + + G V A GLE LH
Sbjct: 251 -YA--YETKD--ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
RI++RD+K NILLD++ + +I+DLG+A + +G GT GY APE
Sbjct: 306 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQTIKG-----RVGTVGYMAPEV 356
Query: 407 AMVGRASLMSDVFSFGVVLLELITGRQP------------IHRSITKGEESLVLWATPRL 454
R + D ++ G +L E+I G+ P + R + + E +P+
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA 416
Query: 455 QDSGTVISEL----PDPRLKGDFPKEEMQIMA 482
+ + S+L P RL G ++
Sbjct: 417 RS---LCSQLLCKDPAERL-GCRGGSAREVKE 444
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 71/302 (23%), Positives = 117/302 (38%), Gaps = 71/302 (23%)
Query: 225 KFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
S + I+G G V++ + G +A K KT+G + + V E+ ++++L H ++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEV-KNEISVMNQLDHANL 148
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR----G 339
+ L F K + +LV E++ G L D ++ E N I + G
Sbjct: 149 IQLYDA---FESKNDI-VLVMEYVDGGEL---FDRIIDESYNLTELDTILF--MKQICEG 199
Query: 340 LEYLHEAAAPRILHRDIKSSNILL--DENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
+ ++H+ ILH D+K NIL + KI D G+A+R K G
Sbjct: 200 IRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV------NFG 250
Query: 398 TFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESL 446
T + APE Y V +D++S GV+ L++G P +I
Sbjct: 251 TPEFLAPEVVNYDFVSFP---TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACR--- 304
Query: 447 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPDARPTMSEV 502
W D EE Q ++ AKE L + R + SE
Sbjct: 305 --W----------------------DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEA 340
Query: 503 VQ 504
++
Sbjct: 341 LK 342
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 66/301 (21%), Positives = 102/301 (33%), Gaps = 84/301 (27%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
G+G V VAVK + +++ E+ + L+H +VV Y
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNHENVVKF--Y- 71
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAAR--------GL 340
R + ++ L E+ G L D D + E A+ G+
Sbjct: 72 -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP------------DAQRFFHQLMAGV 118
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP-----SCSSSPARM 395
YLH I HRDIK N+LLDE N KI+D G+A + + C
Sbjct: 119 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------- 168
Query: 396 QGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 452
GT Y APE ++ R + DV+S G+VL ++ G P
Sbjct: 169 -GTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD---------------- 209
Query: 453 RLQDSGTVISELPDPRLKGDFPKEEMQIM--AYLAKEC-------LQLDPDARPTMSEVV 503
E D + + + L +P AR T+ ++
Sbjct: 210 ---QPSDSCQEYSD-WKEKKT-----YLNPWKKIDSAPLALLHKILVENPSARITIPDIK 260
Query: 504 Q 504
+
Sbjct: 261 K 261
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 61/333 (18%), Positives = 112/333 (33%), Gaps = 90/333 (27%)
Query: 233 GQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRL-HHCHVVPLVGY 289
G+G + V + + G+ A K K + + L E+ +L V+ L
Sbjct: 38 GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRD-CLD---GVLVEGMNWDTRVAIAIGAAR----GLE 341
+ + +L+ E+ G + CL ++ E I + G+
Sbjct: 98 ---YENTSEI-ILILEYAAGGEIFSLCLPELAEMVSE--------NDVIRLIKQILEGVY 145
Query: 342 YLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
YLH+ I+H D+K NILL + KI D GM++++ ++
Sbjct: 146 YLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---------ELREI 193
Query: 399 FG---YFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEE 444
G Y APE Y + A +D+++ G++ L+T P + +I++
Sbjct: 194 MGTPEYLAPEILNYDPITTA---TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN- 249
Query: 445 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPDARPTMS 500
D+ +E ++ LA + L +P+ RPT
Sbjct: 250 ----V----------------------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAE 283
Query: 501 EVVQ----ILSTIAPDKSRRRNISLNLFQIFSA 529
+ S + Q S
Sbjct: 284 ICLSHSWLQQWDFENLFHPEETSSSSQTQDHSV 316
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 63/310 (20%), Positives = 109/310 (35%), Gaps = 77/310 (24%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL 278
+H D + +G G V+R + G A K T + ++V E+ +S L
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV-RKEIQTMSVL 211
Query: 279 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 338
H +V L F M ++++EFM G L + V E A+ R
Sbjct: 212 RHPTLVNLHDA---FEDDNEM-VMIYEFMSGGEL---FEKVADEHNKMSEDEAVEY--MR 262
Query: 339 ----GLEYLHEAAAPRILHRDIKSSNILL--DENLNAKITDLGMAKRLKADGLPSCSSSP 392
GL ++HE +H D+K NI+ + K+ D G+ L
Sbjct: 263 QVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-------- 311
Query: 393 ARMQGTFG---YFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRS 438
++ T G + APE VG +D++S GV+ L++G P R+
Sbjct: 312 -SVKVTTGTAEFAAPEVAEGKPVGYY---TDMWSVGVLSYILLSGLSPFGGENDDETLRN 367
Query: 439 ITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPD 494
+ + W + ++ K+ L DP+
Sbjct: 368 VKSCD-----W----------------------NMDDSAFSGISEDGKDFIRKLLLADPN 400
Query: 495 ARPTMSEVVQ 504
R T+ + ++
Sbjct: 401 TRMTIHQALE 410
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 74/302 (24%), Positives = 111/302 (36%), Gaps = 90/302 (29%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVK---RFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
G G V G+ G VAVK R K + + E+ L H H++ L
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR-REIQNLKLFRHPHIIKL-- 81
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAAR-------- 338
Y + + +V E++ G L D C +G L E +R
Sbjct: 82 Y--QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK------------ESRRLFQQILS 127
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARMQ 396
G++Y H ++HRD+K N+LLD ++NAKI D G++ + SC SP
Sbjct: 128 GVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-GSPN--- 180
Query: 397 GTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKG 442
Y APE YA G D++S GV+L L+ G P + + I G
Sbjct: 181 ----YAAPEVISGRLYA--GPE---VDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG 231
Query: 443 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 502
+ P + L K LQ+DP R T+ ++
Sbjct: 232 IFYTPQYLNPSVIS---------------------------LLKHMLQVDPMKRATIKDI 264
Query: 503 VQ 504
+
Sbjct: 265 RE 266
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 2e-16
Identities = 69/316 (21%), Positives = 115/316 (36%), Gaps = 88/316 (27%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLS 276
D + +G G + V + Q G+ A K R + + EV++L
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 277 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAI 334
+ H +++ L F K + +L+ E + G L D L L E A
Sbjct: 64 EIRHPNIITLHDI---FENKTDV-VLILELVSGGELFDFLAEKESLTE--------DEAT 111
Query: 335 GAAR----GLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGLP 386
+ G+ YLH RI H D+K NI+L N K+ D G+A +++A
Sbjct: 112 QFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN-- 166
Query: 387 SCSSSPARMQGTFG---YFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP------ 434
+ FG + APE Y +G +D++S GV+ L++G P
Sbjct: 167 -------EFKNIFGTPEFVAPEIVNYEPLGLE---ADMWSIGVITYILLSGASPFLGETK 216
Query: 435 --IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----C 488
+I+ + DF +E + LAK+
Sbjct: 217 QETLTNISAVN-----Y----------------------DFDEEYFSNTSELAKDFIRRL 249
Query: 489 LQLDPDARPTMSEVVQ 504
L DP R T+++ ++
Sbjct: 250 LVKDPKRRMTIAQSLE 265
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 49/172 (28%), Positives = 84/172 (48%), Gaps = 38/172 (22%)
Query: 224 DKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNA-DSVFLT---EVDMLS 276
++ + +G+G + VY+ + +IVA+K+ K A D + T E+ +L
Sbjct: 10 KRYEKLDFLGEG--QFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 67
Query: 277 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA 336
L H +++ L+ F K + LVF+FM D L+ ++ + + + +
Sbjct: 68 ELSHPNIIGLLDA---FGHKSNI-SLVFDFME----TD-LEVII-KDNS------LVLTP 111
Query: 337 A----------RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378
+ +GLEYLH+ ILHRD+K +N+LLDEN K+ D G+AK
Sbjct: 112 SHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 3e-16
Identities = 76/286 (26%), Positives = 115/286 (40%), Gaps = 52/286 (18%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF--LTEVDMLSRLHH 280
+ FS I+G+GG VY + D G++ A+K + L E MLS +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 281 CH---VVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIA- 333
+V + Y K L + + M G+L L GV E D R A
Sbjct: 249 GDCPFIVCMS-YAFHTPDK----LSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAE 300
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS-CSSSP 392
I GLE++H +++RD+K +NILLDE+ + +I+DLG+A +
Sbjct: 301 I--ILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---- 351
Query: 393 ARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQP-----------IHRSIT 440
GT GY APE G A +D FS G +L +L+ G P I R
Sbjct: 352 ----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407
Query: 441 KGEESLVLWATPRLQDSGTVISEL----PDPRLKGDFPKEEMQIMA 482
L +P L+ ++ L + RL G + ++
Sbjct: 408 TMAVELPDSFSPELRS---LLEGLLQRDVNRRL-GCLGRGAQEVKE 449
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 69/302 (22%), Positives = 105/302 (34%), Gaps = 91/302 (30%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVK---RFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
G+G V + VA+K R + V E+ L L H H++ L
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE-REISYLKLLRHPHIIKL-- 74
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAAR-------- 338
Y + ++V E+ G L D + E R
Sbjct: 75 Y--DVITTPTDIVMVIEYA-GGELFDYIVEKKRMTED------------EGRRFFQQIIC 119
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARMQ 396
+EY H +I+HRD+K N+LLD+NLN KI D G++ + SC SP
Sbjct: 120 AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-GSPN--- 172
Query: 397 GTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKG 442
Y APE YA G DV+S G+VL ++ GR P + + +
Sbjct: 173 ----YAAPEVINGKLYA--GPE---VDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC 223
Query: 443 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 502
+ + +P Q L + + DP R T+ E+
Sbjct: 224 VYVMPDFLSPGAQS---------------------------LIRRMIVADPMQRITIQEI 256
Query: 503 VQ 504
+
Sbjct: 257 RR 258
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 73/360 (20%), Positives = 126/360 (35%), Gaps = 98/360 (27%)
Query: 209 GTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-----RFKTQGGP 262
GT+ R E+ D + +G G + V + + + G A K R K+
Sbjct: 1 GTVFR-----QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRG 55
Query: 263 NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVL 320
+ EV +L + H +V+ L + K + +L+ E + G L D L L
Sbjct: 56 VSREDIEREVSILKEIQHPNVITLHEV---YENKTDV-ILILELVAGGELFDFLAEKESL 111
Query: 321 VEGMNWDTRVAIAIGAAR----GLEYLHEAAAPRILHRDIKSSNILL----DENLNAKIT 372
E A + G+ YLH +I H D+K NI+L KI
Sbjct: 112 TE--------EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKII 160
Query: 373 DLGMAKRLKADGLPSCSSSPARMQGTFG---YFAPE---YAMVGRASLMSDVFSFGVVLL 426
D G+A ++ + FG + APE Y +G +D++S GV+
Sbjct: 161 DFGLAHKIDFGN---------EFKNIFGTPEFVAPEIVNYEPLGLE---ADMWSIGVITY 208
Query: 427 ELITGRQP--------IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEM 478
L++G P +++ + +F E
Sbjct: 209 ILLSGASPFLGDTKQETLANVSAVN-----Y----------------------EFEDEYF 241
Query: 479 QIMAYLAKE----CLQLDPDARPTMSEV-----VQILSTIAPDKSRRRNISLNLFQIFSA 529
+ LAK+ L DP R T+ + ++ T + +++ F+ F+A
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFAA 301
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 61/318 (19%), Positives = 103/318 (32%), Gaps = 66/318 (20%)
Query: 208 HGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADS 266
H + R + D F +G G V+ + + G +K
Sbjct: 6 HHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME 65
Query: 267 VFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNW 326
E+++L L H +++ + F M + V E G L + + G
Sbjct: 66 QIEAEIEVLKSLDHPNIIKIFEV---FEDYHNMYI-VMETCEGGELLERIVSAQARGKAL 121
Query: 327 DTRVAIAI--GAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLK 381
+ L Y H ++H+D+K NIL + KI D G+A+ K
Sbjct: 122 SEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178
Query: 382 ADGLPSCSSSPARMQ---GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP---- 434
+D GT Y APE + D++S GVV+ L+TG P
Sbjct: 179 SD---------EHSTNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGT 228
Query: 435 ----IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE--- 487
+ + T E ++ E + A +
Sbjct: 229 SLEEVQQKATYKEP---------------------------NYAVECRPL-TPQAVDLLK 260
Query: 488 -CLQLDPDARPTMSEVVQ 504
L DP+ RP+ ++V+
Sbjct: 261 QMLTKDPERRPSAAQVLH 278
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 68/306 (22%), Positives = 122/306 (39%), Gaps = 58/306 (18%)
Query: 224 DKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLS 276
D++ +G+G +Y VY+ VA+KR + +G P + EV +L
Sbjct: 34 DRYRRITKLGEG--TYGEVYKAIDTVTNETVAIKRIRLEHEEEGVP---GTAIREVSLLK 88
Query: 277 RLHHCHVVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 334
L H +++ L V + L+FE+ N +L+ +D ++ +
Sbjct: 89 ELQHRNIIELKSV-----IHHNHRL-HLIFEYAEN-DLKKYMD--KNPDVSMRVIKSFLY 139
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-----KITDLGMAKRLKADGLPSCS 389
G+ + H R LHRD+K N+LL + + KI D G+A +A G+P
Sbjct: 140 QLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA---RAFGIPIRQ 193
Query: 390 SSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 448
+ + T Y PE + R S D++S + E++ P+ ++ ++ +
Sbjct: 194 FTHEII--TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT-PLFPGDSEIDQLFKI 250
Query: 449 WA---TPRLQD-SGTVISELPDPRLKGDFPKEEMQIMAY------------LAKECLQLD 492
+ P G ++ LPD K FPK + + L L++D
Sbjct: 251 FEVLGLPDDTTWPG--VTALPD--WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMD 306
Query: 493 PDARPT 498
P R +
Sbjct: 307 PVKRIS 312
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 85/368 (23%), Positives = 131/368 (35%), Gaps = 80/368 (21%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HH 280
TD + +G G S R AVK + E+++L R H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK----SKRDPT-EEIEILLRYGQH 75
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGA-- 336
+++ L + +V E M G L D E R A A+
Sbjct: 76 PNIITLKDVYDD----GKYVYVVTELMKGGELLDKILRQKFFSE------REASAVLFTI 125
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILL-DENLNA---KITDLGMAKRLKADGLPSCSSSP 392
+ +EYLH ++HRD+K SNIL DE+ N +I D G AK+L+A+ +P
Sbjct: 126 TKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTP 180
Query: 393 ARMQGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 446
T + APE Y A D++S GV+L ++TG P E
Sbjct: 181 C---YTANFVAPEVLERQGY---DAA---CDIWSLGVLLYTMLTGYTPFANGPDDTPE-- 229
Query: 447 VLWATPRLQDSGTVISELPDPRLKG--DFPKEEMQIMAYLAKE----CLQLDPDARPTMS 500
E+ G ++ AK+ L +DP R T +
Sbjct: 230 ----------------EILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAA 273
Query: 501 EVVQ----ILSTIAPDKSRRRNISLNLFQ-----IFSAGGMEKEPSIERPDNLFETLIES 551
V++ + P R + +L + +SA + P +E TL +
Sbjct: 274 LVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAATYSALNRNQSPVLEPVGR--STLAQR 331
Query: 552 EELKKATS 559
+KK TS
Sbjct: 332 RGIKKITS 339
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 6e-16
Identities = 57/297 (19%), Positives = 100/297 (33%), Gaps = 58/297 (19%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
++ N +G+G V Q A K+ + D E++++ L H
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK-QEIEIMKSLDHP 66
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--IAIGAARG 339
+++ L + LV E G L + +V + A I
Sbjct: 67 NIIRLYETFED----NTDIYLVMELCTGGELFE----RVVHKRVFRESDAARIMKDVLSA 118
Query: 340 LEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
+ Y H+ + HRD+K N L + K+ D G+A R K M+
Sbjct: 119 VAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---------MMR 166
Query: 397 ---GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 453
GT Y +P+ + G D +S GV++ L+ G P
Sbjct: 167 TKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPPFS----------------- 208
Query: 454 LQDSGTVISELPDPRLKG--DFPKEEMQIMAYLAKE----CLQLDPDARPTMSEVVQ 504
SE+ +G FP+++ ++ A+ L P R T + ++
Sbjct: 209 ----APTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 1e-15
Identities = 65/311 (20%), Positives = 103/311 (33%), Gaps = 83/311 (26%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHH 280
+D + +G+G S V R T G A K T+ D E + +L H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAI-AIGAA 337
++V L E + LVF+ + G L + E D I I
Sbjct: 65 PNIVRLHDSIQE----ESFHYLVFDLVTGGELFEDIVAREFYSEA---DASHCIQQI--L 115
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
+ Y H I+HR++K N+LL + K+ D G+A +
Sbjct: 116 ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---------A 163
Query: 395 MQ---GTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHR 437
GT GY +PE Y + D+++ GV+L L+ G P ++
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPY---SKP---VDIWACGVILYILLVGYPPFWDEDQHRLYA 217
Query: 438 SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDP 493
I G D+P E + AK L ++P
Sbjct: 218 QIKAG---------------------------AYDYPSPEWDTVTPEAKSLIDSMLTVNP 250
Query: 494 DARPTMSEVVQ 504
R T + ++
Sbjct: 251 KKRITADQALK 261
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 64/307 (20%), Positives = 99/307 (32%), Gaps = 96/307 (31%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
G G + +VAVK + ++V E+ L H ++V
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQ-REIINHRSLRHPNIVRF--K- 82
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAAR--------GL 340
E ++ E+ G L + C G E AR G+
Sbjct: 83 -EVILTPTHLAIIMEYASGGELYERICNAGRFSED------------EARFFFQQLLSGV 129
Query: 341 EYLHEAAAPRILHRDIKSSNILLDEN--LNAKITDLGMAKRLKADGLP--SCSSSPARMQ 396
Y H + +I HRD+K N LLD + KI D G +K P +
Sbjct: 130 SYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-------- 178
Query: 397 GTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 453
GT Y APE ++ R ++DV+S GV L ++ G P
Sbjct: 179 GTPAYIAPE--VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE----------------- 219
Query: 454 LQDSGTVISELPDPRLKGDFPKEEMQIMA---------YLAKEC-------LQLDPDARP 497
DP D+ K +I++ ++ EC DP R
Sbjct: 220 ------------DPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRI 267
Query: 498 TMSEVVQ 504
++ E+
Sbjct: 268 SIPEIKT 274
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 62/288 (21%), Positives = 107/288 (37%), Gaps = 53/288 (18%)
Query: 233 GQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYC 290
G+G S + + AVK + ++ E+ L H ++V L
Sbjct: 20 GEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--ARGLEYLHEAAA 348
+ + LV E + G L + + + ++ A I + ++H+
Sbjct: 76 HD----QLHTFLVMELLNGGEL---FERIKKKK-HFSETEASYIMRKLVSAVSHMHDV-- 125
Query: 349 PRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLP---SCSSSPARMQGTFGYF 402
++HRD+K N+L ++NL KI D G A+ D P C T Y
Sbjct: 126 -GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC--------FTLHYA 176
Query: 403 APEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462
APE D++S GV+L +++G+ P + R + T
Sbjct: 177 APELLNQNGYDESCDLWSLGVILYTMLSGQVP-------------FQSHDR-SLTCTSAV 222
Query: 463 ELPDPRLKG--DFPKEEMQIMAYLAKE----CLQLDPDARPTMSEVVQ 504
E+ KG F E + ++ AK+ L +DP+ R MS +
Sbjct: 223 EIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 67/316 (21%), Positives = 107/316 (33%), Gaps = 63/316 (19%)
Query: 233 GQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYC 290
G G + V + A+K + EV++ R H+V +V
Sbjct: 71 GLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVY 124
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT-----RVAIAIGAARGLEYLHE 345
R L+V E + G L + G T + +IG A ++YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEA--IQYLHS 179
Query: 346 AAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPARMQ---GTF 399
I HRD+K N+L N K+TD G AK + + T
Sbjct: 180 I---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---------SLTTPCYTP 227
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459
Y APE + D++S GV++ L+ G P ++ L S
Sbjct: 228 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP-------------FYSNHGLAIS-- 272
Query: 460 VISELPDPRLKG--DFPKEEMQIMAYLAKE----CLQLDPDARPTMSEVVQ----ILSTI 509
+ G +FP E ++ K L+ +P R T++E + + ST
Sbjct: 273 --PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330
Query: 510 APDKSRRRNISLNLFQ 525
P + L +
Sbjct: 331 VPQTPLHTSRVLKEDK 346
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 30/217 (13%)
Query: 231 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLV 287
++G+G V +L + ++ A+K F E D+L + L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL- 139
Query: 288 GYCSEFRGKRAMRL-LVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIA-IGAARGLEY 342
+ + F+ L LV ++ G+L L + L E M R +A + A ++
Sbjct: 140 -HYA-FQDDN--NLYLVMDYYVGGDLLTLLSKFEDRLPEEM---ARFYLAEMVIA--IDS 190
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
+H+ +HRDIK NIL+D N + ++ D G +L DG S GT Y
Sbjct: 191 VHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV----AVGTPDYI 243
Query: 403 APE-----YAMVGRASLMSDVFSFGVVLLELITGRQP 434
+PE GR D +S GV + E++ G P
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 59/247 (23%), Positives = 93/247 (37%), Gaps = 42/247 (17%)
Query: 231 IVGQG--GSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPL 286
++G+G V + + T G++ A+K V F E D+L + L
Sbjct: 68 VIGRGAFSEVAVVKMKQT-GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 287 VGYCSEFRGKRAMRL-LVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIA-IGAARGLE 341
+ + F+ + L LV E+ G+L L + M R +A I A ++
Sbjct: 127 --HFA-FQDEN--YLYLVMEYYVGGDLLTLLSKFGERIPAEM---ARFYLAEIVMA--ID 176
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
+H +HRDIK NILLD + ++ D G +L+ADG GT Y
Sbjct: 177 SVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV----AVGTPDY 229
Query: 402 FAPE-------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESL 446
+PE G D ++ GV E+ G+ P + I +E L
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL 289
Query: 447 VLWATPR 453
L
Sbjct: 290 SLPLVDE 296
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 74/346 (21%), Positives = 125/346 (36%), Gaps = 92/346 (26%)
Query: 219 LEHATDKFSGSNIVGQGGSSY--VYRGQLTD-GRIVAVKRFKTQGGPNADSVF-LTEVDM 274
LE ++ K+S +G G S+ V + G+ A+K+ D + E+D+
Sbjct: 2 LETSSKKYSLGKTLGTG--SFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDI 53
Query: 275 LSRLHHCHVVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT---- 328
+ L H +++ L Y + + + G + +N
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 329 ------------RVAIAIGAA-----------------RGLEYLHEAAAPRILHRDIKSS 359
+V + + R + ++H I HRDIK
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQ 170
Query: 360 NILLDENLNA-KITDLGMAKRLKADGLPS----CSSSPARMQGTFGYFAPEYAMVGRASL 414
N+L++ N K+ D G AK+L PS CS R Y APE M+G A+
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICS----RF-----YRAPEL-MLG-ATE 218
Query: 415 MS---DVFSFGVVLLELITGRQPIHRSITKGEESL--------VLWATPRLQDSGTVISE 463
+ D++S G V ELI G +P+ GE S+ ++ TP + +
Sbjct: 219 YTPSIDLWSIGCVFGELILG-KPLF----SGETSIDQLVRIIQIM-GTPTKEQMIRMNPH 272
Query: 464 LPD---PRLKGD-----FPKEEMQIMAYLAKECLQLDPDARPTMSE 501
+ P LK P+ + L ++ L+ +PD R E
Sbjct: 273 YTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYE 318
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 58/247 (23%), Positives = 101/247 (40%), Gaps = 37/247 (14%)
Query: 231 IVGQG--GSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPL 286
++G+G G + R + T ++ A+K F E D+++ + VV L
Sbjct: 76 VIGRGAFGEVQLVRHKST-RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 287 VGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIA-IGAARGLEYL 343
+ + F+ R L +V E+MP G+L + + + E R A + A L+ +
Sbjct: 135 --FYA-FQDDR--YLYMVMEYMPGGDLVNLMSNYDVPEKW---ARFYTAEVVLA--LDAI 184
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
H +HRD+K N+LLD++ + K+ D G ++ +G+ C + GT Y +
Sbjct: 185 HSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT----AVGTPDYIS 237
Query: 404 PE----YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWAT 451
PE G D +S GV L E++ G P + I + SL
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 297
Query: 452 PRLQDSG 458
+
Sbjct: 298 NDISKEA 304
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 56/312 (17%), Positives = 110/312 (35%), Gaps = 53/312 (16%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF----LTEVDMLSR 277
++ +G G V R VA+K+ P + E+ ++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL---SRPFQNQTHAKRAYRELVLMKC 117
Query: 278 LHHCHVVPLVGYCSEFRGKRAMR--LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG 335
++H +++ L+ + + + LV E M + L V+ ++ + +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA----N-LCQVIQMELDHERMSYLLYQ 172
Query: 336 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 395
G+++LH A I+HRD+K SNI++ + KI D G+A+ + M
Sbjct: 173 MLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---------M 220
Query: 396 QG---TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQ--PIHRSITKGEESLVLWA 450
T Y APE + D++S G ++ E++ + P I + + +
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 280
Query: 451 TPRLQDSGTV-------ISELPDPR---LKGDFPKEEMQIMAYLAKEC-----------L 489
TP + + + P FP + K L
Sbjct: 281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 340
Query: 490 QLDPDARPTMSE 501
+DP R ++ +
Sbjct: 341 VIDPAKRISVDD 352
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 63/335 (18%), Positives = 107/335 (31%), Gaps = 109/335 (32%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HH 280
D + +G+G S V+ +T+ V VK K P E+ +L L
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----PVKKKKIKREIKILENLRGG 90
Query: 281 CHVVPL---VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDG------------VLVEGMN 325
+++ L V LVFE + N + + +L
Sbjct: 91 PNIITLADIVKDPVSRT-----PALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL----- 140
Query: 326 WDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADG 384
+ L+Y H I+HRD+K N+++D E+ ++ D G+A+
Sbjct: 141 ------------KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE------ 179
Query: 385 LPSCSSSPAR-MQG---TFGYFAPE---------YAMVGRASLMSDVFSFGVVLLELITG 431
P + + + PE Y++ D++S G +L +I
Sbjct: 180 ----FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFR 227
Query: 432 RQP-------IH--RSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPK------- 475
++P I K VL T L D + DPR +
Sbjct: 228 KEPFFHGHDNYDQLVRIAK-----VL-GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 281
Query: 476 ----EEMQIMAY-----LAKECLQLDPDARPTMSE 501
E Q + + L+ D +R T E
Sbjct: 282 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 316
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 9e-13
Identities = 57/319 (17%), Positives = 108/319 (33%), Gaps = 67/319 (21%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF----LTEVDMLSR 277
++ +G G V R VA+K+ P + E+ ++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL---SRPFQNQTHAKRAYRELVLMKC 80
Query: 278 LHHCHVVPLVGYCSEFRGKRAMR--LLVFEFMPNGNLRDC-LDGVLVEGMNWDTRVAIAI 334
++H +++ L+ + + + +V E M D L V+ ++ + +
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM------DANLCQVIQMELDHERMSYLLY 134
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
G+++LH A I+HRD+K SNI++ + KI D G+A+ +
Sbjct: 135 QMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--------- 182
Query: 395 MQG---TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQ------PIH--RSITKGE 443
M T Y APE + D++S G ++ E+I G I + +
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE-- 240
Query: 444 ESLVLWATPRLQDSGTV-------ISELPD-PR--LKGDFPKEEMQIMAYLAKEC----- 488
TP + + + P + FP + K
Sbjct: 241 ----QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQAR 296
Query: 489 ------LQLDPDARPTMSE 501
L +D R ++ E
Sbjct: 297 DLLSKMLVIDASKRISVDE 315
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 50/162 (30%), Positives = 70/162 (43%), Gaps = 29/162 (17%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
LE+LH+ I++RDIK NILLD N + +TD G++K AD GT
Sbjct: 171 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD----FCGT 223
Query: 399 FGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQP------------IHRSITKGEE 444
Y AP+ G + D +S GV++ EL+TG P I R I K E
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 283
Query: 445 SLVLWATPRLQDSGTVISEL----PDPRLKGDFPKEEMQIMA 482
+ +D +I L P RL G P++ +I
Sbjct: 284 PYPQEMSALAKD---LIQRLLMKDPKKRL-GCGPRDADEIKE 321
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 62/326 (19%), Positives = 106/326 (32%), Gaps = 76/326 (23%)
Query: 221 HATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKR-FKTQGGPNADSVF---------LT 270
++ + G V G ++G VA+KR F T ++ L
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 271 EVDMLSRLHHCHVVPLV-----GYCSEFRGKRAMRLLVFEFMPNGNLRDC-LDGVLVEGM 324
E+ +L+ HH +++ L LV E M L V+ +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKL----YLVTELM------RTDLAQVIHDQR 128
Query: 325 NWDTRVAIA-----IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379
+ I I GL LHEA ++HRD+ NILL +N + I D +A+
Sbjct: 129 IVISPQHIQYFMYHI--LLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLARE 183
Query: 380 LKADGLPSCSSSPARMQG---TFGYFAPEYAMVGRASLMS--DVFSFGVVLLELITGRQ- 433
AD Y APE ++ D++S G V+ E+ +
Sbjct: 184 DTADA---------NKTHYVTHRWYRAPE-LVMQFKGFTKLVDMWSAGCVMAEMFNRKAL 233
Query: 434 -----PIH--RSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAY--- 483
+ I + + TP+++D S L+ +
Sbjct: 234 FRGSTFYNQLNKIVE------VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVP 287
Query: 484 --------LAKECLQLDPDARPTMSE 501
L + L+ +P R + +
Sbjct: 288 TADPVALDLIAKMLEFNPQRRISTEQ 313
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 68/312 (21%), Positives = 116/312 (37%), Gaps = 61/312 (19%)
Query: 221 HATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF----LTEVDML 275
+ VG G V G VA+K+ P +F E+ +L
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL---SRPFQSEIFAKRAYRELLLL 77
Query: 276 SRLHHCHVVPLVGYCSEFRGKRAMR--LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
+ H +V+ L+ + R LV FM +L+ + E + +
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSE----EKIQYLV 132
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393
+GL+Y+H A ++HRD+K N+ ++E+ KI D G+A+ A+
Sbjct: 133 YQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE---------- 179
Query: 394 RMQG---TFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQ------PIH--RSIT 440
M G T Y APE ++ + D++S G ++ E++TG+ + I
Sbjct: 180 -MTGYVVTRWYRAPE-VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 237
Query: 441 KGEESLVLWATPRLQDSGTVISE--------LPDPR---LKGDFPKEEMQIMAYLAKECL 489
K + P + + + LP FP+ Q L K L
Sbjct: 238 K------VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEK-ML 290
Query: 490 QLDPDARPTMSE 501
+LD D R T ++
Sbjct: 291 ELDVDKRLTAAQ 302
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 66/347 (19%), Positives = 107/347 (30%), Gaps = 92/347 (26%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVK------RFKTQGGPNADSVFLTEV 272
E D++ +++G+G V + + VA+K F Q EV
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA--------QIEV 101
Query: 273 DMLSRL--------HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGM 324
+L + ++ V L + FR + VFE + + NL D L G+
Sbjct: 102 RLLELMNKHDTEMKYYI--VHLKRH-FMFRNHLCL---VFEML-SYNLYDLLRNTNFRGV 154
Query: 325 NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA--KITDLGMAKRLKA 382
+ + A L +L I+H D+K NILL + KI D G +
Sbjct: 155 SLNLTRKFAQQMCTALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSS----- 208
Query: 383 DGLPSCSSSPAR---MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR------- 432
C +Q F Y +PE + L D++S G +L+E+ TG
Sbjct: 209 -----CQLGQRIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262
Query: 433 ------------------------------------QPIHRSITKGEESLVLWATPRLQD 456
+ G+ T +L +
Sbjct: 263 EVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHN 322
Query: 457 SGTVISELPDPRLKGDFPKEEMQIMAY--LAKECLQLDPDARPTMSE 501
V + P R G+ + + L L DP R
Sbjct: 323 ILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYY 369
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 51/202 (25%), Positives = 81/202 (40%), Gaps = 37/202 (18%)
Query: 269 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNG----NLRDCLDGVLVEG 323
L E +L ++ +V L F+ L +V E++ G +LR G E
Sbjct: 89 LNEKRILQAVNFPFLVKLEFS---FKDNS--NLYMVMEYVAGGEMFSHLRRI--GRFSEP 141
Query: 324 MNWDTRVAIA-IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382
R A I EYLH +++RD+K N+L+D+ ++TD G AKR+K
Sbjct: 142 H---ARFYAAQIVLT--FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP-------- 434
C GT APE + + D ++ GV++ E+ G P
Sbjct: 194 RTWTLC--------GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
Query: 435 IHRSITKGEESLVLWATPRLQD 456
I+ I G+ + L+D
Sbjct: 246 IYEKIVSGKVRFPSHFSSDLKD 267
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 6e-12
Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 36/162 (22%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
L +LH+ I++RD+K NI+L+ + K+TD G+ K DG + + GT
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-----FCGT 184
Query: 399 FGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEE 444
Y APE + RA D +S G ++ +++TG P I K +
Sbjct: 185 IEYMAPEILMRSGH---NRA---VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL 238
Query: 445 SLVLWATPRLQDSGTVISEL----PDPRLKGDFPKEEMQIMA 482
+L + T +D ++ +L RL G P + ++ A
Sbjct: 239 NLPPYLTQEARD---LLKKLLKRNAASRL-GAGPGDAGEVQA 276
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 45/162 (27%), Positives = 71/162 (43%), Gaps = 36/162 (22%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
L++LH I++RD+K NILLDE + K+TD G++K + S GT
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-----FCGT 189
Query: 399 FGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEE 444
Y APE + ++ +D +SFGV++ E++TG P I K +
Sbjct: 190 VEYMAPEVVNRRGH---TQS---ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL 243
Query: 445 SLVLWATPRLQDSGTVISEL----PDPRLKGDFPKEEMQIMA 482
+ + +P Q ++ L P RL G P +I
Sbjct: 244 GMPQFLSPEAQS---LLRMLFKRNPANRL-GAGPDGVEEIKR 281
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 47/162 (29%), Positives = 70/162 (43%), Gaps = 35/162 (21%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
L+YLH +++RD+K N++LD++ + KITD G+ K DG + GT
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-----FCGT 312
Query: 399 FGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEE 444
Y APE Y GRA D + GVV+ E++ GR P + I E
Sbjct: 313 PEYLAPEVLEDNDY---GRA---VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 366
Query: 445 SLVLWATPRLQDSGTVISEL----PDPRLKGDFPKEEMQIMA 482
P + ++S L P RL G ++ +IM
Sbjct: 367 RFPRTLGPEAKS---LLSGLLKKDPKQRL-GGGSEDAKEIMQ 404
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 42/165 (25%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ-- 396
LEYLH +++RDIK N++LD++ + KITD G+ K +DG A M+
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--------ATMKTF 165
Query: 397 -GTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITK 441
GT Y APE Y GRA D + GVV+ E++ GR P + I
Sbjct: 166 CGTPEYLAPEVLEDNDY---GRA---VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219
Query: 442 GEESLVLWATPRLQDSGTVISEL----PDPRLKGDFPKEEMQIMA 482
E +P + +++ L P RL G P + ++M
Sbjct: 220 EEIRFPRTLSPEAKS---LLAGLLKKDPKQRL-GGGPSDAKEVME 260
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 53/188 (28%), Positives = 79/188 (42%), Gaps = 46/188 (24%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
RGL+Y+H A I+HRD+K SN+ ++E+ KI D G+A+ + M G
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-----------HTADEMTG 188
Query: 398 ---TFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQ------PIH--RSITKGEE 444
T Y APE M+ + D++S G ++ EL+TGR I + I +
Sbjct: 189 YVATRWYRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR--- 244
Query: 445 SLVLWATPRLQDSGTVISE--------LPD-PR--LKGDFPKEEMQIMAYLAKECLQLDP 493
L TP + + SE L P+ F + L K L LD
Sbjct: 245 ---LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK-MLVLDS 300
Query: 494 DARPTMSE 501
D R T ++
Sbjct: 301 DKRITAAQ 308
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 45/195 (23%), Positives = 77/195 (39%), Gaps = 46/195 (23%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
R ++ LH + ++HRD+K SN+L++ N + K+ D G+A+ + + + +
Sbjct: 123 RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 398 TFGYF------APEYAMVGRASLMS--------DVFSFGVVLLELIT------GRQPIH- 436
+ APE +++ DV+S G +L EL GR H
Sbjct: 180 V-EFVATRWYRAPEV-------MLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ 231
Query: 437 -RSITK------GEESLVLWATPRLQDSGTVISELPDPR---LKGDFPKEEMQIMAYLAK 486
I + L +PR ++ I LP L+ FP+ + + L +
Sbjct: 232 LLLIFGIIGTPHSDNDLRCIESPRARE---YIKSLPMYPAAPLEKMFPRVNPKGIDLLQR 288
Query: 487 ECLQLDPDARPTMSE 501
L DP R T E
Sbjct: 289 -MLVFDPAKRITAKE 302
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 4e-11
Identities = 57/238 (23%), Positives = 97/238 (40%), Gaps = 57/238 (23%)
Query: 269 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNG----NLRDCLDGVLVEG 323
E MLS + H ++ + + + F+ + ++ ++ +++ G LR
Sbjct: 54 NDERLMLSIVTHPFIIRM--WGT-FQDAQ--QIFMIMDYIEGGELFSLLRKS--QRFPNP 106
Query: 324 MNWDTRVAIA-IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382
+ + A + A LEYLH I++RD+K NILLD+N + KITD G AK +
Sbjct: 107 V---AKFYAAEVCLA--LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158
Query: 383 DGLPSCSSSPARMQGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP-- 434
C GT Y APE Y ++ D +SFG+++ E++ G P
Sbjct: 159 VTYTLC--------GTPDYIAPEVVSTKPY---NKS---IDWWSFGILIYEMLAGYTPFY 204
Query: 435 ------IHRSITKGEESLVLWATPRLQDSGTVISEL--PDP--RLKGDFPKEEMQIMA 482
+ I E + ++D ++S L D RL G+ +
Sbjct: 205 DSNTMKTYEKILNAELRFPPFFNEDVKD---LLSRLITRDLSQRL-GNLQNGTEDVKN 258
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 40/212 (18%), Positives = 78/212 (36%), Gaps = 54/212 (25%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
+ ++YLH +LHRD+K SNILL+ + K+ D G+++ + + + +
Sbjct: 120 KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 398 TFGYFAPEYAMVG-------RA--SLMS--------DVFSFGVVLLELITGRQ------P 434
T + + + RA L+ D++S G +L E++ G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236
Query: 435 IH--RSITK-----GEESLVLWATPRLQDSGTVISELP-----------------DPRLK 470
++ I E + +P + +I L L
Sbjct: 237 MNQLERIIGVIDFPSNEDVESIQSPFAKT---MIESLKEKVEIRQSNKRDIFTKWKNLLL 293
Query: 471 GDFPKEEMQIMAY-LAKECLQLDPDARPTMSE 501
PK + A L + LQ +P+ R + ++
Sbjct: 294 KINPKADCNEEALDLLDKLLQFNPNKRISAND 325
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 45/185 (24%), Positives = 75/185 (40%), Gaps = 34/185 (18%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
RGL+Y+H A +LHRD+K SN+LL+ + KI D G+A+ D +
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD-----HDHTGFLTE 190
Query: 398 ---TFGYFAPEYAMVGRASLMS--DVFSFGVVLLELITGRQ------PIH--RSITK--- 441
T Y APE M+ D++S G +L E+++ R + I
Sbjct: 191 YVATRWYRAPE-IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 249
Query: 442 --GEESLVLWATPRLQDSGTVISELPD-PR--LKGDFPKEEMQIMAYLAKECLQLDPDAR 496
+E L + ++ + LP + FP + + + L K L +P R
Sbjct: 250 SPSQEDLNCIINLKARN---YLLSLPHKNKVPWNRLFPNADSKALDLLDK-MLTFNPHKR 305
Query: 497 PTMSE 501
+ +
Sbjct: 306 IEVEQ 310
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 67/311 (21%), Positives = 114/311 (36%), Gaps = 58/311 (18%)
Query: 221 HATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF----LTEVDML 275
+ VG G V G VA+K+ P +F E+ +L
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL---YRPFQSELFAKRAYRELRLL 78
Query: 276 SRLHHCHVVPLVGYCSEFRGKRAMR--LLVFEFMPNGNLRDC-LDGVL-VEGMNWDTRVA 331
+ H +V+ L+ + LV FM L ++ E + D
Sbjct: 79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM------GTDLGKLMKHEKLGEDRIQF 132
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 391
+ +GL Y+H A I+HRD+K N+ ++E+ KI D G+A++ ++
Sbjct: 133 LVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-------- 181
Query: 392 PARMQG---TFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQ------PIH--RS 438
M G T Y APE ++ R + D++S G ++ E+ITG+ + +
Sbjct: 182 ---MTGYVVTRWYRAPE-VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 237
Query: 439 ITK-----GEESLVLWATPRLQDSGTVISELPDPR---LKGDFPKEEMQIMAYLAKECLQ 490
I K E + + ++ + LP+ + L K L
Sbjct: 238 IMKVTGTPPAEFVQRLQSDEAKN---YMKGLPELEKKDFASILTNASPLAVNLLEK-MLV 293
Query: 491 LDPDARPTMSE 501
LD + R T E
Sbjct: 294 LDAEQRVTAGE 304
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 9e-11
Identities = 62/298 (20%), Positives = 101/298 (33%), Gaps = 76/298 (25%)
Query: 224 DKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHC 281
D S ++G G + V + A+K + EV++ R
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCP 71
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT-----RVAIAIGA 336
H+V +V R L+V E + G L + G T + +IG
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGL-PSCSSSP 392
A ++YLH I HRD+K N+L N K+TD G AK + SC
Sbjct: 129 A--IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYDKSC---- 179
Query: 393 ARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 452
D++S GV++ L+ G P ++
Sbjct: 180 ------------------------DMWSLGVIMYILLCGYPP-------------FYSNH 202
Query: 453 RLQDSGTVISELPDPRLKG--DFPKEEMQIMAYLAKE----CLQLDPDARPTMSEVVQ 504
L S + + + G +FP E ++ K L+ +P R T++E +
Sbjct: 203 GLAISPGMKTRI----RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 42/156 (26%), Positives = 67/156 (42%), Gaps = 24/156 (15%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
GL +L I++RD+K N++LD + KI D GM K DG+ + + GT
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-----FCGT 505
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWA 450
Y APE D ++FGV+L E++ G+ P + +SI + +
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSM 565
Query: 451 TPRLQDSGTVISEL----PDPRLKGDFPKEEMQIMA 482
+ ++ + L P RL G P+ E I
Sbjct: 566 SK---EAVAICKGLMTKHPGKRL-GCGPEGERDIKE 597
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 42/156 (26%), Positives = 65/156 (41%), Gaps = 24/156 (15%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
GL +L I++RD+K N++LD + KI D GM K DG+ + + GT
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-----FCGT 184
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWA 450
Y APE D ++FGV+L E++ G+ P + +SI + +
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSM 244
Query: 451 TPRLQDSGTVISEL----PDPRLKGDFPKEEMQIMA 482
+ + L P RL G P+ E I
Sbjct: 245 SKEAVA---ICKGLMTKHPGKRL-GCGPEGERDIKE 276
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 33/102 (32%), Positives = 50/102 (49%), Gaps = 20/102 (19%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
L +LH+ I++RD+K N+LLD + K+ D GM K +G+ + + GT
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-----FCGT 187
Query: 399 FGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP 434
Y APE Y G A D ++ GV+L E++ G P
Sbjct: 188 PDYIAPEILQEMLY---GPA---VDWWAMGVLLYEMLCGHAP 223
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 70/343 (20%), Positives = 115/343 (33%), Gaps = 91/343 (26%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVK------RFKTQGGPNADSVFLTEV 272
+H ++ ++G+G V + + VA+K RF Q E+
Sbjct: 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA--------AEEI 144
Query: 273 DMLSRL------HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNW 326
+L L + +V+ ++ FR M FE + + NL + + +G +
Sbjct: 145 RILEHLRKQDKDNTMNVIHMLEN-FTFRNHICM---TFELL-SMNLYELIKKNKFQGFSL 199
Query: 327 DTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA--KITDLGMAKRLKADG 384
A + L+ LH+ RI+H D+K NILL + + K+ D G
Sbjct: 200 PLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG--------- 247
Query: 385 LPSCSSSPAR------MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR------ 432
SS +Q F Y APE + R + D++S G +L EL+TG
Sbjct: 248 ----SSCYEHQRVYTYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302
Query: 433 --------------QPIHRSITKG---------EESLVLWATPRLQDSGTVISELPDPRL 469
P + + + L D V++ R
Sbjct: 303 DEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRG 362
Query: 470 KGDFPKEEMQIMAYLAKE-----------CLQLDPDARPTMSE 501
K P E + L CL+ DP R T +
Sbjct: 363 KLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 39/188 (20%), Positives = 72/188 (38%), Gaps = 40/188 (21%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
RGL+Y+H A +LHRD+K +N+ ++ E+L KI D G+A+ + S +
Sbjct: 131 RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH-----YSHKGHLS 182
Query: 397 G---TFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQ------PIH--RSITKGE 443
T Y +P ++ + D+++ G + E++TG+ + + I +
Sbjct: 183 EGLVTKWYRSPR-LLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE-- 239
Query: 444 ESLVLWATPRLQDSGTV-------ISELPDPR---LKGDFPKEEMQIMAYLAKECLQLDP 493
+D + I L P + + +L + L P
Sbjct: 240 ----SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQ-ILTFSP 294
Query: 494 DARPTMSE 501
R T E
Sbjct: 295 MDRLTAEE 302
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 33/105 (31%), Positives = 43/105 (40%), Gaps = 26/105 (24%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS---CSSSPARM 395
L YLH I++RD+K NILLD + +TD G+ K + C
Sbjct: 151 ALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC------- 200
Query: 396 QGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP 434
GT Y APE Y R D + G VL E++ G P
Sbjct: 201 -GTPEYLAPEVLHKQPY---DRT---VDWWCLGAVLYEMLYGLPP 238
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 62/365 (16%), Positives = 114/365 (31%), Gaps = 110/365 (30%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G G S V+ + + VA+K K+ ++ E+ +L + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD--EIRLLKSVRNSD-------- 94
Query: 291 SEFRGKRAMRLLVFEFM---PNG------------NLRDCLDGVLVEGMNWDTRVAIAIG 335
+ + L+ +F NG +L + +G+ I
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 336 AARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSP 392
+GL+YLH RI+H DIK NILL ++ + + +R A + S
Sbjct: 155 VLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 393 ARMQG--------------------------------------TFGYFAPEYAMVGRA-S 413
A T Y + E ++G +
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLE-VLIGSGYN 271
Query: 414 LMSDVFSFGVVLLELITGR--------------------------QPIHRSITKGEESLV 447
+D++S + EL TG + + I G+ S
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKE 331
Query: 448 LWATPRLQDSGTV--ISELPDPRL------KGDFPKEEMQIMAYLAKECLQLDPDARPTM 499
+ G + I++L L K ++ +EE L+L P+ R T
Sbjct: 332 FF-----TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATA 386
Query: 500 SEVVQ 504
+E ++
Sbjct: 387 AECLR 391
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 36/105 (34%), Positives = 50/105 (47%), Gaps = 26/105 (24%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS---CSSSPARM 395
L YLHE I++RD+K N+LLD + K+TD GM K G + C
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC------- 171
Query: 396 QGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP 434
GT Y APE Y G + D ++ GV++ E++ GR P
Sbjct: 172 -GTPNYIAPEILRGEDY---GFS---VDWWALGVLMFEMMAGRSP 209
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 36/99 (36%), Positives = 54/99 (54%), Gaps = 14/99 (14%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR-LKADGLPS--CSSSPARM 395
GL++LH I++RD+K NILLD++ + KI D GM K + D + C
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC------- 179
Query: 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
GT Y APE + + + D +SFGV+L E++ G+ P
Sbjct: 180 -GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 36/105 (34%), Positives = 50/105 (47%), Gaps = 26/105 (24%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS---CSSSPARM 395
L YLHE I++RD+K N+LLD + K+TD GM K G + C
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC------- 214
Query: 396 QGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP 434
GT Y APE Y G + D ++ GV++ E++ GR P
Sbjct: 215 -GTPNYIAPEILRGEDY---GFS---VDWWALGVLMFEMMAGRSP 252
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.7 bits (146), Expect = 4e-10
Identities = 37/224 (16%), Positives = 63/224 (28%), Gaps = 57/224 (25%)
Query: 200 CRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVK--RFK 257
C K + FS+ T+K +G+G V++ D VA+K +
Sbjct: 5 CSQKG------PVPFSHCL---PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIE 54
Query: 258 TQGGPNADS-----VFLTEVDML-----------------SRLHHCHVV------PLVGY 289
N L E+ + L+ H V L+
Sbjct: 55 GPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKA 114
Query: 290 CSEFRGKRAMRL------------LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 337
+ + +V EF G L+ + + + T +I
Sbjct: 115 WDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLT 171
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381
L + R HRD+ N+LL + K+ K
Sbjct: 172 ASLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSST 213
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 64/325 (19%), Positives = 112/325 (34%), Gaps = 74/325 (22%)
Query: 231 IVGQGGSSYVYRGQ-LTDGRIVAVK------RFKTQGGPNADSVFLTEVDMLSRLHHC-- 281
+G G S V+ + + + VA+K + E+ +L R++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA--------EDEIKLLQRVNDADN 77
Query: 282 ---------HVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVA 331
H++ L+ + +G + + +VFE + NL + G+
Sbjct: 78 TKEDSMGANHILKLLDH-FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ 135
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE------NLNAKITDLGMAKRLKADGL 385
I+ GL+Y+H I+H DIK N+L++ + KI DLG A
Sbjct: 136 ISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193
Query: 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQ--PIHRSITKGE 443
S + Y +PE + +D++S ++ ELITG + +
Sbjct: 194 NSIQTRE--------YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245
Query: 444 ESLVLWA--------TPRLQDSGT-------------VISELPDPRL------KGDFPKE 476
+ + L +G IS+L L K F K+
Sbjct: 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 305
Query: 477 EMQIMAYLAKECLQLDPDARPTMSE 501
E + ++ LQLDP R
Sbjct: 306 EAKEISDFLSPMLQLDPRKRADAGG 330
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 26/123 (21%), Positives = 50/123 (40%), Gaps = 37/123 (30%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
G ++HE+ I+HRD+K +N LL+++ + K+ D G+A+ + ++ + + +
Sbjct: 140 LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 398 TFG-----------------YFAPEYAMVGRASLMS---------DVFSFGVVLLELITG 431
Y APE L+ D++S G + EL+
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPE--------LILLQENYTKSIDIWSTGCIFAELLNM 248
Query: 432 RQP 434
Q
Sbjct: 249 LQS 251
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 42/222 (18%), Positives = 77/222 (34%), Gaps = 54/222 (24%)
Query: 221 HATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVF----LTEVDML 275
D++ +++G G +V + R+VA+K+ D + L E+ +L
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI---LRVFEDLIDCKRILREIAIL 106
Query: 276 SRLHHCHVVPLV-----GYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTR 329
+RL+H HVV ++ +F L +V E D +
Sbjct: 107 NRLNHDHVVKVLDIVIPKDVEKFDE-----LYVVLEIAD-----------------SDFK 144
Query: 330 VAIAIGAA--------------RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 375
G++Y+H A ILHRD+K +N L++++ + K+ D G
Sbjct: 145 KLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFG 201
Query: 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSD 417
+A R S P + ++
Sbjct: 202 LA-RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTG 242
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 53/339 (15%), Positives = 105/339 (30%), Gaps = 74/339 (21%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRG--QLTDGRIVAVK------RFKTQGGPNADSVFLTE 271
+ +++ +G+G V VA+K +++ E
Sbjct: 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA--------RLE 66
Query: 272 VDMLSRL--------HHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVE 322
+++L ++ C V + F G + + FE + N + L +
Sbjct: 67 INVLKKIKEKDKENKFLC--VLMSD-WFNFHG----HMCIAFELL-GKNTFEFLKENNFQ 118
Query: 323 GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382
+A L +LHE ++ H D+K NIL + + + + K+
Sbjct: 119 PYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175
Query: 383 DGLPSC------SSSPARMQGT------FGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 430
S S++ T Y PE + + DV+S G +L E
Sbjct: 176 VKNTSIRVADFGSATFDHEHHTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEYYR 234
Query: 431 GR--------------------QPIHRSITKGEESLVLW--ATPRLQDSGTVISELPDPR 468
G I + + + ++S + +
Sbjct: 235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK 294
Query: 469 -LKGDFPKE--EMQIMAYLAKECLQLDPDARPTMSEVVQ 504
LK ++ E + L + L+ DP R T++E +
Sbjct: 295 PLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 45/212 (21%), Positives = 74/212 (34%), Gaps = 23/212 (10%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G G +Y G + G VA+K + E + + +P + +C
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVK---TKHPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 291 SEFRGKRAMRLLVFEFM-PN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
M V E + P+ +L + + T + +A +EY+H
Sbjct: 74 GAEGDYNVM---VMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMISRIEYIHSK-- 124
Query: 349 PRILHRDIKSSNILLDENLNAK---ITDLGMAKRLK--ADGLPSCSSSPARMQGTFGYFA 403
+HRD+K N L+ I D G+AK+ + + GT Y A
Sbjct: 125 -NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-A 182
Query: 404 PEYAMVGR-ASLMSDVFSFGVVLLELITGRQP 434
+G S D+ S G VL+ G P
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 38/158 (24%), Positives = 60/158 (37%), Gaps = 25/158 (15%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVK--RFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
+G G + G+ L VA+K K++ E +L +P V
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVY 71
Query: 289 YCSEFRGKRAMRLLVFEFM-PN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
Y AM V E + P+ +L D D + T + IAI +EY+H
Sbjct: 72 YFGPCGKYNAM---VLELLGPSLEDLFDLCDRT----FSLKTVLMIAIQLISRMEYVHSK 124
Query: 347 AAPRILHRDIKSSNILL--DENLNAK---ITDLGMAKR 379
+++RD+K N L+ N + I D +AK
Sbjct: 125 N---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 46/214 (21%), Positives = 78/214 (36%), Gaps = 27/214 (12%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G G +Y G + VA+K + L E + L +P V +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVK---TKHPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 291 SEFRGKRAMRLLVFEFM-PN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
+ V + + P+ +L + ++ T + +A +E++H +
Sbjct: 72 GVEGDYNVL---VMDLLGPSLEDLFNFCSR----KLSLKTVLMLADQMINRVEFVHSKS- 123
Query: 349 PRILHRDIKSSNILLDENLNAK---ITDLGMAKRLK--ADGLPSCSSSPARMQGTFGYFA 403
LHRDIK N L+ A I D G+AK+ + + + GT Y A
Sbjct: 124 --FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-A 180
Query: 404 PEYAMVGRASLMS---DVFSFGVVLLELITGRQP 434
+G S D+ S G VL+ + G P
Sbjct: 181 SVNTHLGIE--QSRRDDLESLGYVLMYFLRGSLP 212
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 42/230 (18%), Positives = 81/230 (35%), Gaps = 39/230 (16%)
Query: 232 VGQGGSSYVYRGQ---------LTDGRIVAVKRFKTQGGPNADSVFLT------EVDMLS 276
+ +Y + ++K G + F +V+
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 277 RLHHCHV--VPLVGYCSEFRGKRAMRLLVFEFMPNG-NLRDCLDGVLVEGMNWDTRVAIA 333
+L+ + +P + K R LV + G +L+ LD ++ + + +A
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDK--YRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVA 165
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT--DLGMAKRLKADG--LPSCS 389
LE+LHE +H ++ + NI +D +++T G A R G +
Sbjct: 166 CRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222
Query: 390 SSPARMQGTFGYFAPEYAMV----GRA-SLMSDVFSFGVVLLELITGRQP 434
S + +G E+ + G S SD+ S G +L+ + G P
Sbjct: 223 GSRSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 42/214 (19%), Positives = 76/214 (35%), Gaps = 25/214 (11%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G+G ++ G L + + VA+K + + E L C +P V Y
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRR---SDAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 291 SEFRGKRAMRLLVFEFM-PN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
+ + V + + P+ +L D + T A ++ +HE +
Sbjct: 75 GQEGLHNVL---VIDLLGPSLEDLLDLCGRK----FSVKTVAMAAKQMLARVQSIHEKS- 126
Query: 349 PRILHRDIKSSNILLDENLNAK-----ITDLGMAKRLK--ADGLPSCSSSPARMQGTFGY 401
+++RDIK N L+ + + D GM K + + GT Y
Sbjct: 127 --LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
Query: 402 FAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQP 434
+GR S D+ + G V + + G P
Sbjct: 185 -MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 54/294 (18%), Positives = 90/294 (30%), Gaps = 52/294 (17%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV------- 283
+G GG +Y A K + + +E+ R+
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVE--YQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 284 -------VPLVGYCSEFRGK-RAMRLLVFEFM-PN-GNLRDC-----LDGVLVEGMNWDT 328
+PL K R+ R +V E + + + VL
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQ------- 155
Query: 329 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT--DLGMAKRLKADG-- 384
+ I LEY+HE +H DIK++N+LL ++ D G++ R +G
Sbjct: 156 ---LGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
Query: 385 LPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGE 443
+ GT F A G A S SDV G +L + G+ P +++
Sbjct: 210 KQYQENPRKGHNGTI-EFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268
Query: 444 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP 497
+ + + G E Q + L D +P
Sbjct: 269 AVQTA----KTNLLDELPQSVLKWAPSGSSCCEIAQFLVC----AHSLAYDEKP 314
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 59/340 (17%), Positives = 111/340 (32%), Gaps = 76/340 (22%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRGQ--LTDGRIVAVK------RFKTQGGPNADSVFLTE 271
+ + ++ + +G+G V GR VAVK R+ +E
Sbjct: 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA--------RSE 61
Query: 272 VDMLSRL--------HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG 323
+ +L L C V ++ E G + VFE + + D +
Sbjct: 62 IQVLEHLNTTDPNSTFRC--VQMLE-WFEHHGHICI---VFELL-GLSTYDFIKENGFLP 114
Query: 324 MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383
D +A + + +LH ++ H D+K NIL ++ + + + + +
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171
Query: 384 GLPSC------SSSPAR------MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITG 431
P S++ + Y APE + S DV+S G +L+E G
Sbjct: 172 INPDIKVVDFGSATYDDEHHSTLVSTRH-YRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
Query: 432 R--------------------QPIHRSITKGE------ESLVLWATPRLQDSGTVISELP 465
I K + W +G +S
Sbjct: 231 FTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDW--DEHSSAGRYVSRAC 288
Query: 466 DPRLKGDFPKE-EMQIMAYLAKECLQLDPDARPTMSEVVQ 504
P + ++ E + + L ++ L+ DP R T+ E ++
Sbjct: 289 KPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 1e-06
Identities = 85/561 (15%), Positives = 146/561 (26%), Gaps = 155/561 (27%)
Query: 17 WIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRS----------CDCSP--- 63
++ I + + S L D K N SR + P
Sbjct: 93 FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN 152
Query: 64 -----VGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKV 118
V GS GK T + A D SY C + + + V
Sbjct: 153 VLIDGVLGS--GK-TWV-ALD-----VCLSYKVQC-----KMDFKIFWLNLKNCNSPETV 198
Query: 119 VVIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKESCNSATNLISHRITSVPE 178
+ ++ L + + RS S+ K +S + + S P
Sbjct: 199 LEMLQKLLYQID---------------PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY 243
Query: 179 TR----------VEVVSPIDLATGC-FLKTTFCRSKTWTIHGTIIRFSYSALEHATDKFS 227
+ + +L C L TT R K T + ++ +L+H + +
Sbjct: 244 ENCLLVLLNVQNAKAWNAFNL--SCKILLTT--RFKQVTDFLSAATTTHISLDHHSMTLT 299
Query: 228 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEV-DMLSRLHH-CHVVP 285
+ Y+ D R + R P S+ + D L+ + HV
Sbjct: 300 PDEVKSL-LLKYL------DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHV-- 350
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMN---------WD------- 327
C + L V E P R D V + W
Sbjct: 351 ---NCDKLTTIIESSLNVLE--PA-EYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV 404
Query: 328 --------TRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379
+ + ++ ++K + + L+ I D
Sbjct: 405 MVVVNKLHKYSLVEKQPKESTISIPS------IYLELK-VKLENEYALHRSIVD----HY 453
Query: 380 LKADGLPSCSSSPARMQGTF----GYFAPEYAMVGRASLMSDVF-SFGVVLLELITGRQP 434
S P + F G+ R +L VF F + Q
Sbjct: 454 NIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFL-------EQK 506
Query: 435 IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDF-----PKEEMQIMAYL----- 484
I T W G++++ L + + PK E + A L
Sbjct: 507 IRHDST-------AWNAS-----GSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPK 554
Query: 485 AKECLQLDPDARPTMSEVVQI 505
+E L +++I
Sbjct: 555 IEENLICSKYTD-----LLRI 570
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 8e-04
Identities = 31/229 (13%), Positives = 69/229 (30%), Gaps = 64/229 (27%)
Query: 460 VISELPDPRLKGDFP-----------KEEMQIMAYLAKECLQLDPD--ARPTMSEVVQIL 506
+ +++ ++ L K Q+DP+ +R S +++
Sbjct: 167 ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLR 226
Query: 507 STIAPDKSRR--------------RNIS----LNLFQI---------------FSAGGME 533
+ RR N+ N F + F +
Sbjct: 227 IHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT 286
Query: 534 KEPSIERPDNLFETLIESEEL-KKATS---FGSPRCSQAVDTD-ITLNTRSNSKEEDTVS 588
S++ T E + L K PR + + T+ L+ + S + +
Sbjct: 287 THISLDHHSMTL-TPDEVKSLLLKYLDCRPQDLPR--EVLTTNPRRLSIIAESIRDGLAT 343
Query: 589 TEYMEKLLL--LTSEVRSSRAPDIETVDLTEPR--FESFCM--KNVNSP 631
+ + + LT+ + SS + ++ E R F+ + + + P
Sbjct: 344 WDNWKHVNCDKLTTIIESS----LNVLEPAEYRKMFDRLSVFPPSAHIP 388
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 49/250 (19%), Positives = 80/250 (32%), Gaps = 63/250 (25%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVK------RFKTQGGPNADSVFLTEV 272
+ F +G G V Q + + + AVK ++ E
Sbjct: 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA--------KIEA 82
Query: 273 DMLSRL-------HHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGM 324
D+L ++ ++ V G + + L+FE + +L + + G
Sbjct: 83 DILKKIQNDDINNNNI--VKYHG-KFMYYD----HMCLIFEPL-GPSLYEIITRNNYNGF 134
Query: 325 NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384
+ + I + L YL + + H D+K NILLD+ K
Sbjct: 135 HIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191
Query: 385 LPSCSSSPARMQGTFG-----------------YFAPE------YAMVGRASLMSDVFSF 421
+ S FG Y APE + + SD++SF
Sbjct: 192 QIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSF 245
Query: 422 GVVLLELITG 431
G VL EL TG
Sbjct: 246 GCVLAELYTG 255
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 39/165 (23%), Positives = 66/165 (40%), Gaps = 21/165 (12%)
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKIT--DLGMAKRLKADG----LPSCSSSPA 393
LEY+HE +H DIK+SN+LL+ ++ D G+A R +G +
Sbjct: 165 LEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRC- 220
Query: 394 RMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 452
GT F A G A S D+ G +++ +TG P ++ + V +
Sbjct: 221 -HDGTI-EFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY--VRDSKI 276
Query: 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP 497
R +++ + + P + P E + M LD +P
Sbjct: 277 RYRENIASLMDKCFP--AANAPGEIAKYMET----VKLLDYTEKP 315
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 631 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.68 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.17 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.07 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.02 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.63 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.63 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.48 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.39 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.33 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.22 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.0 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.98 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.89 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.82 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.56 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.44 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.34 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.28 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.15 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.1 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.07 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.84 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.75 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.53 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.52 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.08 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.45 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 93.16 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.96 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 92.73 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 92.59 | |
| 1z6c_A | 87 | Vitamin K-dependent protein S; EGF module, blood c | 92.35 | |
| 1lmj_A | 86 | Fibrillin 1; EGF, calcium, microfibril, neonatal, | 86.32 | |
| 3h5c_B | 317 | Vitamin K-dependent protein Z; protein Z-protein Z | 85.48 | |
| 1x7a_L | 146 | Coagulation factor IX, light chain; inhibition, bl | 83.56 | |
| 1emn_A | 82 | Fibrillin; extracellular matrix, calcium-binding, | 83.53 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.17 | |
| 1aut_L | 114 | Activated protein C; serine proteinase, plasma cal | 82.67 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 82.61 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-55 Score=457.75 Aligned_cols=257 Identities=26% Similarity=0.369 Sum_probs=209.1
Q ss_pred CccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
++...+.||+|+||+||+|.+. +++.||||+++........+.|.+|+.+|++++|||||+++|+|.+ ..
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----~~ 102 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK----DQ 102 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS----SS
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE----CC
Confidence 3455788999999999999873 4688999999876666666789999999999999999999999986 44
Q ss_pred eEEEEEeeCCCCChHhhhhccc--------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeec
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 364 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~ 364 (631)
..+||||||++|+|.++|.... ...++|.+++.|+.|||.||+|||+++ ||||||||+||||+
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVY 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEEC
Confidence 6799999999999999996432 235999999999999999999999998 99999999999999
Q ss_pred CCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccc
Q 006785 365 ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGE 443 (631)
Q Consensus 365 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~ 443 (631)
+++++||+|||+|+.....+.. .......||+.|||||++.++.|+.++|||||||+||||+| |+.||........
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~---~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~ 256 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYY---KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 256 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCB---CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred CCCCEEECCcccceeccCCCce---eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999876543321 22344579999999999999999999999999999999998 8999975432211
Q ss_pred chhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 444 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
... +..-. ..+.|..++..+.+|+.+||+.||++||||.||++.|+..
T Consensus 257 ---~~~-----------i~~~~----~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 ---VEM-----------IRNRQ----VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ---HHH-----------HHTTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ---HHH-----------HHcCC----CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 100 00000 1123344455689999999999999999999999999865
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-55 Score=451.65 Aligned_cols=258 Identities=28% Similarity=0.404 Sum_probs=208.5
Q ss_pred cCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
++|.+.+.||+|+||+||+|++. +++.||||+++.. .....+.|.+|+++|++|+|||||+++|+|.+ .
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~----~ 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVE----G 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee----C
Confidence 45777899999999999999874 3788999999754 33445679999999999999999999999986 4
Q ss_pred ceEEEEEeeCCCCChHhhhhccc-----------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCC
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVL-----------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 366 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~ 366 (631)
...|||||||++|+|.++|+... ...++|.+++.|+.|||.||+|||+++ ||||||||+||||+++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCC
Confidence 56899999999999999997532 245999999999999999999999998 9999999999999999
Q ss_pred CCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccch
Q 006785 367 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEES 445 (631)
Q Consensus 367 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~ 445 (631)
+.+||+|||+|+........ .......||+.|||||++.+..|+.++|||||||+||||+| |+.||..........
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~---~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 241 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYY---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 241 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCE---EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred CcEEECCcccceecCCCCce---eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999999876543221 11233569999999999999999999999999999999999 899997543221111
Q ss_pred hhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 446 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
.+ ..-..+ ..|..++..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 242 ~i--------------~~~~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 242 CI--------------TQGRVL----QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HH--------------HHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH--------------HcCCCC----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 00 000011 123334455899999999999999999999999998764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=453.51 Aligned_cols=259 Identities=27% Similarity=0.417 Sum_probs=203.6
Q ss_pred cCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
++|.+.+.||+|+||+||+|+++ +++.||||+++.. .....+.|.+|+++|++|+|||||+++|+|.+ .
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~----~ 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTE----G 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----C
Confidence 45677889999999999999875 3789999999754 34455679999999999999999999999986 4
Q ss_pred ceEEEEEeeCCCCChHhhhhccc-------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeec
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVL-------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 364 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~ 364 (631)
..+|||||||++|+|.++|+... ..+++|.+++.|+.|||.||+|||+++ ||||||||+||||+
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEEC
Confidence 56899999999999999996532 235999999999999999999999998 99999999999999
Q ss_pred CCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccc
Q 006785 365 ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGE 443 (631)
Q Consensus 365 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~ 443 (631)
+++.+||+|||+|+........ .......||+.|||||++.+..++.++|||||||+||||+| |+.||........
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~---~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~ 269 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYY---RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269 (329)
T ss_dssp TTTEEEECCCC-------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH
T ss_pred CCCcEEEcccccceeccCCCcc---eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999999876543321 12234579999999999999999999999999999999999 8999975432211
Q ss_pred chhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 444 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
...+ ..-..+ ..|..++..+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 270 ~~~i--------------~~g~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 270 IDCI--------------TQGREL----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHH--------------HHTCCC----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHH--------------HcCCCC----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 1100 011111 2233344558899999999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-55 Score=450.13 Aligned_cols=264 Identities=27% Similarity=0.417 Sum_probs=205.1
Q ss_pred HHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 220 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 220 ~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
+...++|.+.+.||+|+||+||+|++++ .||||+++... ..+..+.|.+|+.+|++++|||||+++|++.+ .
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-----~ 104 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-----D 104 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-----C
Confidence 3345677888999999999999999753 59999997543 33445679999999999999999999999864 2
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
.+|||||||+||+|.++|.... ..++|.+++.|+.|||.||+|||+++ ||||||||+||||++++++||+|||+|+
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~ 180 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLAT 180 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCB
T ss_pred eEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCce
Confidence 4699999999999999997543 45999999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhc---CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 455 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~---~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 455 (631)
....... ........||+.|||||++.+ +.|+.++|||||||+||||+||+.||.............
T Consensus 181 ~~~~~~~---~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~------- 250 (307)
T 3omv_A 181 VKSRWSG---SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV------- 250 (307)
T ss_dssp C---------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH-------
T ss_pred ecccCCc---ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHH-------
Confidence 7643221 122345679999999999964 468999999999999999999999997543221111100
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 456 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 456 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
......|.+. ..+..++..+.+|+.+||+.||++||||.||++.|+.+.
T Consensus 251 -----~~~~~~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 251 -----GRGYASPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp -----HTTCCCCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred -----hcCCCCCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 0111122111 223344456899999999999999999999999998763
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=440.34 Aligned_cols=256 Identities=25% Similarity=0.290 Sum_probs=204.6
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+.|...+.||+|+||.||+|+++ +|+.||||+++.... +.+|+.+|++|+|||||++++++.+ ...+||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~----~~~~~i 127 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVRE----GPWVNI 127 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEE----TTEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEE----CCEEEE
Confidence 45777889999999999999986 499999999976432 3579999999999999999999886 567899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC-CeEEeccCceeecc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKRLK 381 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kL~DFGla~~~~ 381 (631)
|||||+||+|.++|+.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+|+.+.
T Consensus 128 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp EECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred EEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 99999999999999764 46999999999999999999999998 99999999999999987 59999999999876
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
.++...........+||+.|||||++.+..|+.++|||||||+||||++|+.||...........+..
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~------------ 270 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS------------ 270 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH------------
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc------------
Confidence 54332211223346799999999999999999999999999999999999999975433221111110
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
..+. ...++..++..+.+|+.+||+.||.+|||+.|+++.|....
T Consensus 271 -~~~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 271 -EPPP---IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp -SCCG---GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCC---chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 0000 00123344455889999999999999999999999887654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=450.57 Aligned_cols=271 Identities=26% Similarity=0.385 Sum_probs=218.5
Q ss_pred ecHHHHHHHhcCccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCCcce
Q 006785 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPL 286 (631)
Q Consensus 214 ~s~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l 286 (631)
+....|+...++|.+.+.||+|+||+||+|.+.. ++.||||+++........+.|.+|+.+|+++. |||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4445677778899999999999999999998653 36899999987665555667999999999995 5999999
Q ss_pred eEEeeeccCCcceEEEEEeeCCCCChHhhhhccc--------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCcee
Q 006785 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRIL 352 (631)
Q Consensus 287 ~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 352 (631)
+|+|.+. ...+|||||||++|+|.++|+... ...++|.+++.++.|||.||+|||+++ ||
T Consensus 134 ~g~~~~~---~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---ii 207 (353)
T 4ase_A 134 LGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CI 207 (353)
T ss_dssp EEEECCT---TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred EEEEEec---CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---ee
Confidence 9998752 335799999999999999996532 234899999999999999999999998 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-C
Q 006785 353 HRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-G 431 (631)
Q Consensus 353 HrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G 431 (631)
||||||+||||++++.+||+|||+|+....+... .......||+.|||||++.+..|+.++|||||||+||||+| |
T Consensus 208 HRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~---~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G 284 (353)
T 4ase_A 208 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 284 (353)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTS---EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred cCccCccceeeCCCCCEEECcchhhhhcccCCCc---eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCC
Confidence 9999999999999999999999999876543211 12234579999999999999999999999999999999998 8
Q ss_pred CCCCCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 432 RQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 432 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
+.||........... .+.+-..+ ..|..++..+.+|+.+||+.||++|||+.||++.|..+.
T Consensus 285 ~~Pf~~~~~~~~~~~-------------~i~~g~~~----~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 285 ASPYPGVKIDEEFCR-------------RLKEGTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp CCSSTTCCCSHHHHH-------------HHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHH-------------HHHcCCCC----CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 999975432211100 01111111 223334455889999999999999999999999998774
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-53 Score=438.69 Aligned_cols=281 Identities=24% Similarity=0.323 Sum_probs=204.5
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
++|.+.+.||+|+||+||+|++ +|+.||||+++... .....+..|+..+.+++|||||+++|+|.+.......+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 3467788999999999999998 58999999996532 11222345566667889999999999998755445578999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhc-----CCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-----AAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
||||++|+|.++|+. ..++|..++.++.|++.||+|||++ ..++||||||||+||||+.++++||+|||+|+
T Consensus 80 ~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999999975 3589999999999999999999986 12349999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcC------CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhh-hhcc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVG------RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-LWAT 451 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~------~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~~~~ 451 (631)
......... ........||+.|||||++.+. .++.++|||||||+||||+||+.||............ ....
T Consensus 157 ~~~~~~~~~-~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 157 RHDSATDTI-DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEETTTTEE-SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred cccCCCCce-eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 775432111 1223346799999999999754 3678999999999999999998887543221110000 0000
Q ss_pred cccccc-cccccccCCCCCCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 452 PRLQDS-GTVISELPDPRLKGDF-PKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 452 ~~~~~~-~~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
+..... ........+|.+.... +.+.+..+.+|+.+||+.||++||||.||++.|+++..
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 000000 0011112222222111 23456779999999999999999999999999998753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=430.24 Aligned_cols=252 Identities=25% Similarity=0.362 Sum_probs=199.6
Q ss_pred cccceeeeeCceEEEEEEECC-CcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEE
Q 006785 227 SGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (631)
Q Consensus 227 ~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~ 304 (631)
...+.||+|+||+||+|.+.. +..||||++.... .....+.|.+|+.+|++|+|||||++++++.........+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 345679999999999999864 8999999997543 23344569999999999999999999999876544456789999
Q ss_pred eeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC-CCCeEEeccCceeecccC
Q 006785 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 305 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kL~DFGla~~~~~~ 383 (631)
|||+||+|.++|... ..+++..+..++.||+.||+|||+++ ++||||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 184 (290)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence 999999999999764 56999999999999999999999885 35999999999999984 78999999999975432
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 463 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (631)
......+||+.|||||++.+ .|+.++|||||||+||||+||+.||......... ... ....
T Consensus 185 ------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~--~~~----------i~~~ 245 (290)
T 3fpq_A 185 ------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YRR----------VTSG 245 (290)
T ss_dssp ------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HHH----------HTTT
T ss_pred ------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH--HHH----------HHcC
Confidence 22345689999999998864 6999999999999999999999999643221110 000 0000
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 464 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 464 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
...+. ++...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~----~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 246 VKPAS----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CCCGG----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCC----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111 112223348899999999999999999999863
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-53 Score=441.98 Aligned_cols=252 Identities=22% Similarity=0.293 Sum_probs=202.0
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
++|.+.+.||+|+||+||+|++. +|+.||||++..... ....+.|.+|+.+|++|+|||||++++++.+ ...+|
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~----~~~~y 99 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE----NGSLY 99 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE----CCEEE
Confidence 57999999999999999999975 599999999976532 3345569999999999999999999999876 56789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
||||||+||+|.++|.......+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+.
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 9999999999999997655556899999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
... ......+||+.|||||++.+..|+.++|||||||+||||++|+.||...........+ .
T Consensus 177 ~~~-----~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-------------~ 238 (350)
T 4b9d_A 177 STV-----ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI-------------I 238 (350)
T ss_dssp HHH-----HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-------------H
T ss_pred CCc-----ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-------------H
Confidence 321 1123467999999999999999999999999999999999999999754322111100 0
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.. ..+. .+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 239 ~~-~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 239 SG-SFPP----VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HT-CCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cC-CCCC----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0111 222334458899999999999999999999863
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=435.31 Aligned_cols=250 Identities=23% Similarity=0.370 Sum_probs=206.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
..|+..+.||+|+||+||+|+++ +|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+ ...+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~----~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLV----GDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEE----TTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----CCEEEE
Confidence 56888999999999999999986 599999999975432 233458899999999999999999999986 567899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
|||||+||+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+..
T Consensus 149 vmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp EECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 9999999999999975 45999999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
.. ......+||+.|||||++.+..|+.++|||||||+||||++|+.||........... +.
T Consensus 223 ~~-----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~--------------i~ 283 (346)
T 4fih_A 223 EV-----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM--------------IR 283 (346)
T ss_dssp SS-----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--------------HH
T ss_pred CC-----CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH--------------HH
Confidence 32 223456899999999999999999999999999999999999999975432211110 01
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
....+.+ ..+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 284 ~~~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 284 DNLPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HSSCCCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCCCCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111111 1223344568999999999999999999999763
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=428.22 Aligned_cols=250 Identities=26% Similarity=0.358 Sum_probs=206.0
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|.+.+.||+|+||+||+|+.. +|+.||||++.... .......+.+|+++|++|+|||||++++++.+ ...+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~ 107 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD----DEKL 107 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----CCEE
Confidence 46889999999999999999975 59999999996431 22344568999999999999999999999876 5678
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|||||||+||+|.++|... +.+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 108 yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~ 182 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL 182 (311)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence 9999999999999999764 46999999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
..... .......+||+.|||||++.+..|+.++||||+||+||||++|+.||...........+.
T Consensus 183 ~~~~~---~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~------------ 247 (311)
T 4aw0_A 183 SPESK---QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII------------ 247 (311)
T ss_dssp CTTTT---CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------------
T ss_pred CCCCC---cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------------
Confidence 54321 122345689999999999999999999999999999999999999997543221111000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
.. .. .+|...+..+.+|+.+||+.||++|||+.|++.
T Consensus 248 -~~--~~----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 248 -KL--EY----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp -HT--CC----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred -cC--CC----CCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 00 01 123334455889999999999999999998743
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-51 Score=436.54 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=207.3
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.+.|+..+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+ ...+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~----~~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLV----GDELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEE----CCEEE
Confidence 356999999999999999999986 499999999976533 334458999999999999999999999986 56789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
||||||+||+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+.
T Consensus 225 iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298 (423)
T ss_dssp EEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred EEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECC
Confidence 99999999999999965 35999999999999999999999999 9999999999999999999999999999875
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
... ......+||+.|||||++.+..|+.++|||||||+||||++|+.||........... +
T Consensus 299 ~~~-----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~--------------i 359 (423)
T 4fie_A 299 KEV-----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM--------------I 359 (423)
T ss_dssp SSC-----CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--------------H
T ss_pred CCC-----ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH--------------H
Confidence 432 223456899999999999999999999999999999999999999975432211111 0
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.....+.+. .+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 360 ~~~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 360 RDNLPPRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HHSCCCCCS--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HcCCCCCCc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111111 122234458899999999999999999999873
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=414.49 Aligned_cols=247 Identities=25% Similarity=0.295 Sum_probs=189.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|++.+.||+|+||+||+|+.. +|+.||||++.... .......+.+|+.+|++++|||||++++++.+ ....
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----~~~~ 88 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS----KDEI 88 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE----CCEE
Confidence 57999999999999999999875 59999999997542 22334569999999999999999999999875 5678
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+ +|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 89 ~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 162 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIM 162 (275)
T ss_dssp EEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred EEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeec
Confidence 9999999 78999999764 46999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
.... ......||+.|||||++.+..+ +.++||||+||+||||++|+.||...........+.
T Consensus 163 ~~~~------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~----------- 225 (275)
T 3hyh_A 163 TDGN------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS----------- 225 (275)
T ss_dssp ------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----------
T ss_pred CCCC------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-----------
Confidence 4332 2345679999999999988775 689999999999999999999997532211100000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.. .+ .+|...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 226 --~~--~~----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 226 --NG--VY----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp --HT--CC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred --cC--CC----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00 01 1223334558899999999999999999999873
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=422.26 Aligned_cols=248 Identities=24% Similarity=0.311 Sum_probs=194.8
Q ss_pred cCccccceeeeeCceEEEEEEEC----CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
++|++.+.||+|+||+||+|+.. .++.||||+++.... ......+.+|+++|++++|||||++++++.+ ..
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~ 99 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT----EG 99 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE----TT
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE----CC
Confidence 46889999999999999999863 378999999864321 1122348899999999999999999999886 56
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
.+|||||||+||+|.++|... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~ 174 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK 174 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred EEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccce
Confidence 789999999999999999764 46999999999999999999999999 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
...... .......||+.|||||++.+..|+.++|||||||+||||++|+.||...........+.
T Consensus 175 ~~~~~~-----~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~---------- 239 (304)
T 3ubd_A 175 ESIDHE-----KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL---------- 239 (304)
T ss_dssp C----------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----------
T ss_pred eccCCC-----ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH----------
Confidence 754332 22345679999999999999999999999999999999999999997543221111110
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM-----SEVVQ 504 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 504 (631)
.. .+ .+|...+..+.+|+.+||+.||++|||+ +|+++
T Consensus 240 ---~~--~~----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 240 ---KA--KL----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ---HC--CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ---cC--CC----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 00 01 1233344558899999999999999984 56654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=411.78 Aligned_cols=255 Identities=23% Similarity=0.383 Sum_probs=191.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC-------
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG------- 295 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------- 295 (631)
++|++.+.||+|+||+||+|+++ +|+.||||+++........+.+.+|+.+|++|+|||||++++++.+...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45888999999999999999976 5899999999866544455679999999999999999999999875332
Q ss_pred -CcceEEEEEeeCCCCChHhhhhcccc-CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEec
Q 006785 296 -KRAMRLLVFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD 373 (631)
Q Consensus 296 -~~~~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~D 373 (631)
...++|||||||++|+|.+++..... ....+..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 13357999999999999999976432 23677889999999999999999999 99999999999999999999999
Q ss_pred cCceeecccCCCCCC-------CCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchh
Q 006785 374 LGMAKRLKADGLPSC-------SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 446 (631)
Q Consensus 374 FGla~~~~~~~~~~~-------~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~ 446 (631)
||+|+.+........ .......+||+.|||||++.+..|+.++|||||||+||||++ ||........ .
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~-~- 236 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR-T- 236 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH-H-
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH-H-
Confidence 999988754322110 112234679999999999999999999999999999999996 7753211100 0
Q ss_pred hhhcccccccccccccccCCCCCCCCCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 447 VLWATPRLQDSGTVISELPDPRLKGDFP---KEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
+..+.. ..+| ......+.+|+.+||+.||++|||+.|+++
T Consensus 237 --------------~~~~~~----~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 237 --------------LTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp --------------HHHHHT----TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------------HHHHhc----CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000000 0122 223344678999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=404.54 Aligned_cols=275 Identities=23% Similarity=0.315 Sum_probs=203.7
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCCcceeEEeeecc--CCcc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKRA 298 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~~ 298 (631)
.++|.+.+.||+|+||+||+|++. +|+.||||+++..... .....+.+|+++|+.|+|||||++++++.... ....
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 357999999999999999999975 5999999999755332 23455889999999999999999999876421 2345
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
.+|||||||+ |+|.+++... +.+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 7899999995 7899999754 56999999999999999999999999 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh--cccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPRLQ 455 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~~~ 455 (631)
.+....... .......+||+.|||||++.+. .++.++||||+||+||||++|+.||...........+.. ..+...
T Consensus 207 ~~~~~~~~~-~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 207 GLCTSPAEH-QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp CC--------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred ecccCcccc-ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 765432111 1234457899999999998875 579999999999999999999999976433221111100 000000
Q ss_pred cc--------cccccccCCCCCCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 456 DS--------GTVISELPDPRLKGD---FPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 456 ~~--------~~~~~~~~~~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.. ...+..++ +..... .....+..+.+|+.+||..||.+|||+.|+++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLP-PRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GTC-----CHHHHHHSSC-CCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HhhhhhhhhhhhhhhcCC-CcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 00000010 000000 001123457899999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=393.16 Aligned_cols=290 Identities=40% Similarity=0.694 Sum_probs=236.2
Q ss_pred eeeeecHHHHHHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEE
Q 006785 210 TIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289 (631)
Q Consensus 210 ~~~~~s~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~ 289 (631)
....|++.+++.+.++|...+.||+|+||.||+|.+.+|+.||||++...........|.+|+.+++.++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 35689999999999999999999999999999999888999999999865444334458999999999999999999999
Q ss_pred eeeccCCcceEEEEEeeCCCCChHhhhhcccc--CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC
Q 006785 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV--EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 367 (631)
Q Consensus 290 ~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~ 367 (631)
+.. ....++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+...++|+||||||+|||++.++
T Consensus 96 ~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~ 171 (326)
T 3uim_A 96 CMT----PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171 (326)
T ss_dssp ECC----SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred Eec----CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence 875 4456999999999999999976432 3499999999999999999999999222299999999999999999
Q ss_pred CeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccc--cccch
Q 006785 368 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT--KGEES 445 (631)
Q Consensus 368 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~--~~~~~ 445 (631)
.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .....
T Consensus 172 ~~kl~Dfg~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 247 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYKDT----HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247 (326)
T ss_dssp CEEECCCSSCEECCSSSS----CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB
T ss_pred CEEeccCccccccCcccc----cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchh
Confidence 999999999987654321 122334599999999999999999999999999999999999999963221 11122
Q ss_pred hhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 446 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
...|....... .....+.+..+...++...+..+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 248 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 248 LLDWVKGLLKE--KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HHHHHTTTTSS--CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHhhc--hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 22232222221 234556667777778888999999999999999999999999999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=396.78 Aligned_cols=206 Identities=21% Similarity=0.337 Sum_probs=172.0
Q ss_pred HHHHHhcCccccceeeeeCceEEEEEEEC----CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeee
Q 006785 218 ALEHATDKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 292 (631)
Q Consensus 218 ~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 292 (631)
.+....++|.+.+.||+|+||+||+|+.+ .++.||||++.... ....+.+|+++|+.+ +||||+++++++.+
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 34456788999999999999999999863 36889999986542 234578999999998 79999999998876
Q ss_pred ccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCC-CCeEE
Q 006785 293 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKI 371 (631)
Q Consensus 293 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kL 371 (631)
....||||||+++|+|.+++. .+++.++..++.|++.||+|||+++ |+||||||+|||++.+ +.+||
T Consensus 92 ----~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl 159 (361)
T 4f9c_A 92 ----NDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYAL 159 (361)
T ss_dssp ----TTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEE
T ss_pred ----CCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEE
Confidence 568899999999999999984 3899999999999999999999999 9999999999999876 78999
Q ss_pred eccCceeecccCCCCC-----------------------CCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHH
Q 006785 372 TDLGMAKRLKADGLPS-----------------------CSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLE 427 (631)
Q Consensus 372 ~DFGla~~~~~~~~~~-----------------------~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~e 427 (631)
+|||+|+......... ........+||+.|+|||++.+. .|+.++||||+||++||
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~e 239 (361)
T 4f9c_A 160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLS 239 (361)
T ss_dssp CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHH
Confidence 9999998654322100 00112345799999999999875 58999999999999999
Q ss_pred HHhCCCCCCCc
Q 006785 428 LITGRQPIHRS 438 (631)
Q Consensus 428 LltG~~P~~~~ 438 (631)
|++|+.||...
T Consensus 240 ll~G~~Pf~~~ 250 (361)
T 4f9c_A 240 LLSGRYPFYKA 250 (361)
T ss_dssp HHHTCSSSSCC
T ss_pred HHHCCCCCCCC
Confidence 99999999654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=386.77 Aligned_cols=286 Identities=39% Similarity=0.649 Sum_probs=234.7
Q ss_pred eecHHHHHHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeee
Q 006785 213 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 292 (631)
Q Consensus 213 ~~s~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 292 (631)
++++.+++.++++|...+.||+|+||.||+|.+++|+.||||++.... ......|.+|+.+++.++||||+++++++..
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 455566777889999999999999999999998889999999987653 3455679999999999999999999999875
Q ss_pred ccCCcceEEEEEeeCCCCChHhhhhccc--cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeE
Q 006785 293 FRGKRAMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 370 (631)
Q Consensus 293 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 370 (631)
....++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 107 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~k 179 (321)
T 2qkw_B 107 ----RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179 (321)
T ss_dssp ----TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEE
T ss_pred ----CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEE
Confidence 456799999999999999996543 234899999999999999999999998 99999999999999999999
Q ss_pred EeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhc
Q 006785 371 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA 450 (631)
Q Consensus 371 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~ 450 (631)
|+|||+++....... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.............|.
T Consensus 180 l~Dfg~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~ 256 (321)
T 2qkw_B 180 ITDFGISKKGTELDQ---THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256 (321)
T ss_dssp ECCCTTCEECSSSSC---CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT
T ss_pred Eeecccccccccccc---cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh
Confidence 999999987543221 11223456899999999999999999999999999999999999999765544433333332
Q ss_pred ccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 451 TPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
..... ...+..+.++.+....+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 257 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 257 VESHN--NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp HHHHT--TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhccc--cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 21111 112345556666667788889999999999999999999999999999987753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=411.72 Aligned_cols=249 Identities=26% Similarity=0.354 Sum_probs=198.7
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHH---HHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTE---VDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E---~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
++|.+.++||+|+||.||+|+.+ +|+.||||++.... .......+.+| +.+++.++|||||++++++.+ .
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~----~ 264 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----P 264 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----S
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE----C
Confidence 67999999999999999999986 49999999996431 11122223444 566777899999999999876 5
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
..+||||||++||+|.++|... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+|
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA 339 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 339 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEeccccee
Confidence 6889999999999999999764 45999999999999999999999999 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
+.+... .....+||+.|||||++.. ..|+.++|||||||+||||++|+.||..........+....
T Consensus 340 ~~~~~~-------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i------ 406 (689)
T 3v5w_A 340 CDFSKK-------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT------ 406 (689)
T ss_dssp EECSSC-------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH------
T ss_pred eecCCC-------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh------
Confidence 876543 2344689999999999975 57999999999999999999999999754332211111000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-----MSEVVQ 504 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 504 (631)
. .... .+|...+..+.+|+.+||+.||.+|++ +.||++
T Consensus 407 ----~--~~~~----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 407 ----L--TMAV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ----H--HCCC----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ----c--CCCC----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 0 0011 223334455899999999999999998 688765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=412.48 Aligned_cols=253 Identities=23% Similarity=0.275 Sum_probs=205.7
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.++|.+.+.||+|+||.||+|..+ +|+.||||++.... ....+.+.+|+.+|+.|+|||||++++++.+ ...+|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFED----DNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC----SSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE----CCEEE
Confidence 468999999999999999999986 49999999997643 2334568899999999999999999999876 56889
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCC--CCeEEeccCceee
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN--LNAKITDLGMAKR 379 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~--~~~kL~DFGla~~ 379 (631)
||||||+||+|.++|.... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 231 iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 9999999999999996532 45999999999999999999999999 9999999999999854 7899999999998
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
+.... ......||+.|||||++.+..|+.++|||||||+||||++|+.||...........+...
T Consensus 307 ~~~~~------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~--------- 371 (573)
T 3uto_A 307 LDPKQ------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC--------- 371 (573)
T ss_dssp CCTTS------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT---------
T ss_pred ccCCC------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhC---------
Confidence 75432 234567999999999999999999999999999999999999999754332111111000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+..+........+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 372 ------~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 372 ------DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ------CCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0001111112234458899999999999999999999874
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=382.84 Aligned_cols=260 Identities=27% Similarity=0.416 Sum_probs=210.5
Q ss_pred hcCccccceeeeeCceEEEEEEEC--------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeec
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 293 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 293 (631)
.++|.+.+.||+|+||.||+|.+. ++..||||+++..........+.+|+.+|+++ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS-
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc-
Confidence 467888999999999999999863 35679999998765444556799999999999 89999999999875
Q ss_pred cCCcceEEEEEeeCCCCChHhhhhccc--------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCC
Q 006785 294 RGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359 (631)
Q Consensus 294 ~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~ 359 (631)
....|+||||+++|+|.+++.... ...+++.+++.++.||+.||+|||+++ |+||||||+
T Consensus 159 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~ 232 (370)
T 2psq_A 159 ---DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 232 (370)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG
T ss_pred ---CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchh
Confidence 446799999999999999997543 134899999999999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCc
Q 006785 360 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (631)
Q Consensus 360 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~ 438 (631)
||||+.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYY---KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTT---CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred hEEECCCCCEEEccccCCcccCcccce---ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999876543221 12233457889999999999999999999999999999999 99999653
Q ss_pred cccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 439 ITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
........ +.....+ ..+..++..+.+|+.+||+.||.+||++.|+++.|+.+.
T Consensus 310 ~~~~~~~~--------------~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 310 PVEELFKL--------------LKEGHRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp CGGGHHHH--------------HHTTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHH--------------HhcCCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 32211000 0011111 223334455889999999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=374.02 Aligned_cols=276 Identities=28% Similarity=0.375 Sum_probs=210.8
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
.++|.+.+.||+|+||.||+|++. ++.||||++.... .....+..|+.+|++++||||+++++++..........++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 356888999999999999999986 7999999996532 2333467799999999999999999999875544556899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhc----------CCCceeecCCCCCCeeecCCCCeEEe
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA----------AAPRILHRDIKSSNILLDENLNAKIT 372 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------~~~~ivHrDlKp~NILl~~~~~~kL~ 372 (631)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+
T Consensus 100 v~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 9999999999999975 3489999999999999999999998 7 9999999999999999999999
Q ss_pred ccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcC-----CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhh
Q 006785 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-----RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 447 (631)
Q Consensus 373 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-----~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~ 447 (631)
|||+++........ .......||+.|+|||++.+. .++.++||||||+++|||++|+.||............
T Consensus 174 DFg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 174 DFGLALKFEAGKSA---GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp CCTTCEEECTTSCC---CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred cCCcccccccccCc---cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 99999877543321 123345799999999999863 4567889999999999999999999764432211111
Q ss_pred hh--ccccccccc-ccccccCCCCCCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 448 LW--ATPRLQDSG-TVISELPDPRLKGDF-PKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 448 ~~--~~~~~~~~~-~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
.. ..+...... ........+.+...+ +...+..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 000000000 001111122221111 2245667999999999999999999999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=373.64 Aligned_cols=266 Identities=27% Similarity=0.398 Sum_probs=203.8
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
++...++|.+.+.||+|+||+||+|++ +|+.||||++...... .....|.+|+.+|++++||||+++++++.. .
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~ 106 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ----P 106 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----T
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE----C
Confidence 334457788999999999999999987 5889999999765432 334568999999999999999999999875 4
Q ss_pred ceEEEEEeeCCCCChHhhhhcccc-CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCc
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGl 376 (631)
...++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 457999999999999999975421 23899999999999999999999885 3499999999999999999999999999
Q ss_pred eeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccc
Q 006785 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..............
T Consensus 186 a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~------- 253 (309)
T 3p86_A 186 SRLKASTF-----LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF------- 253 (309)
T ss_dssp ---------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHH-------
T ss_pred Cccccccc-----cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------
Confidence 97644321 122345799999999999999999999999999999999999999975432211111000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
..... ..+...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 254 ------~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 254 ------KCKRL----EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ------SCCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ------cCCCC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 01111 12233344588999999999999999999999999987644
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=359.49 Aligned_cols=284 Identities=33% Similarity=0.544 Sum_probs=226.1
Q ss_pred eeeecHHHHHHHhcCcccc------ceeeeeCceEEEEEEECCCcEEEEEEeccCC---CCChHHHHHHHHHHHHhcCCC
Q 006785 211 IIRFSYSALEHATDKFSGS------NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRLHHC 281 (631)
Q Consensus 211 ~~~~s~~~l~~a~~~f~~~------~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~---~~~~~~~~~~E~~~l~~l~H~ 281 (631)
...|++.++..++++|... +.||+|+||.||+|.. +++.||||++.... .......|.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3678999999999999988 8999999999999987 58899999987542 234456799999999999999
Q ss_pred CCcceeEEeeeccCCcceEEEEEeeCCCCChHhhhhccc-cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCC
Q 006785 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL-VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 360 (631)
Q Consensus 282 niv~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~N 360 (631)
||+++++++.. ....++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 91 ~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~N 163 (307)
T 2nru_A 91 NLVELLGFSSD----GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSAN 163 (307)
T ss_dssp TBCCEEEEECS----SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred CeEEEEEEEec----CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHH
Confidence 99999999875 446799999999999999997533 345999999999999999999999998 9999999999
Q ss_pred eeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccc
Q 006785 361 ILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 440 (631)
Q Consensus 361 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~ 440 (631)
||++.++.+||+|||+++........ .......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.....
T Consensus 164 ili~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 164 ILLDEAFTAKISDFGLARASEKFAQT---VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp EEECTTCCEEECCCTTCEECCSCSSC---EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred EEEcCCCcEEEeeccccccccccccc---ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 99999999999999999876432211 11234569999999998764 588999999999999999999999975433
Q ss_pred cccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 441 KGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
...... +. .........+....++.+ ...+...+..+.+++..||+.||.+|||+.+|++.|+.+.
T Consensus 240 ~~~~~~--~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 240 PQLLLD--IK-EEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp SSBTTH--HH-HHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hHHHHH--HH-HHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 221110 00 000011111222233332 2456777888999999999999999999999999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=362.68 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=206.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.++|...+.||+|+||+||+|... +|+.||||++...... ..+.+.+|+.+++.++||||+++++++.. ....|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLV----GDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-HHHHHHHHHHHHhcCCCCCCCeEeEEEEE----CCEEE
Confidence 467999999999999999999864 5899999999755333 34568999999999999999999999886 45789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++|+|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 94 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 999999999999999753 5899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 168 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~------------- 229 (297)
T 3fxz_A 168 PEQ-----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA------------- 229 (297)
T ss_dssp STT-----CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-------------
T ss_pred Ccc-----cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------------
Confidence 432 12334579999999999999999999999999999999999999996543221111000
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
....+ ....+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 230 -~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 230 -TNGTP--ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp -HHCSC--CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -hCCCC--CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00000 011233445568899999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=371.20 Aligned_cols=262 Identities=26% Similarity=0.407 Sum_probs=209.2
Q ss_pred hcCccccceeeeeCceEEEEEEEC----CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
.++|.+.+.||+|+||.||+|.+. .+..||||+++..........|.+|+.+|++++||||+++++++.+ ..
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~ 123 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR----GR 123 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG----GG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe----CC
Confidence 356888999999999999999985 3557999999876555556679999999999999999999999875 45
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..|+||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred ccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccc
Confidence 6799999999999999996542 45999999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
......... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........
T Consensus 200 ~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~----------- 266 (325)
T 3kul_A 200 VLEDDPDAA--YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS----------- 266 (325)
T ss_dssp ECC----CC--EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH-----------
T ss_pred ccccCccce--eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-----------
Confidence 765432111 11223346788999999999999999999999999999999 9999965432211110
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
+...... ..+...+..+.+|+..||+.||.+|||+.+|++.|+.+...
T Consensus 267 ---~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 267 ---VEEGYRL----PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp ---HHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---HHcCCCC----CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 0011111 12223344588999999999999999999999999988543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=364.94 Aligned_cols=263 Identities=24% Similarity=0.386 Sum_probs=208.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++|...+.||+|+||+||+|.+. +++.||||++... .......|.+|+++|++++||||+++++++.+ ....++
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~l 84 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK----DKRLNF 84 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----TTEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEec----CCeeEE
Confidence 56778899999999999999986 4899999998653 33445669999999999999999999999986 457899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++|+|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred EEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 99999999999999764 345999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCC---------CCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccc
Q 006785 383 DGLPSC---------SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 453 (631)
Q Consensus 383 ~~~~~~---------~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~ 453 (631)
...... ........||+.|+|||++.+..++.++||||||+++|||++|..||............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~------ 234 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL------ 234 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB------
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh------
Confidence 322110 01112457999999999999999999999999999999999999998653322111000
Q ss_pred cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 454 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 454 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
......+......++ ..+.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 235 ------~~~~~~~~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 235 ------NVRGFLDRYCPPNCP----PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp ------CHHHHHHHTCCTTCC----TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------hhhccccccCCCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 000111111112233 338889999999999999999999999998753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=383.73 Aligned_cols=259 Identities=27% Similarity=0.423 Sum_probs=208.1
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.++|...+.||+|+||.||+|.+. +++.||||+++..........|.+|+.+|++++||||+++++++.. ....|
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~ 188 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ----KQPIY 188 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS----SSSCE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec----CCCcE
Confidence 467788899999999999999986 6899999999765433334458999999999999999999999875 44679
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 189 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 999999999999999753 235899999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
..... .......+++.|+|||++..+.++.++||||||+++|||++ |..||...........
T Consensus 265 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~-------------- 327 (377)
T 3cbl_A 265 DGVYA---ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF-------------- 327 (377)
T ss_dssp TSEEE---CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHH--------------
T ss_pred CCcee---ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------------
Confidence 32111 11112346788999999999999999999999999999998 9999965432211100
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
+..... ...|..++..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 328 ~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 328 VEKGGR----LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp HHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCC----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 000001 1122333445889999999999999999999999998774
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=362.44 Aligned_cols=267 Identities=26% Similarity=0.369 Sum_probs=206.8
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHh--cCCCCCcceeEEeeeccCCcceE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR--LHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
.++|.+.+.||+|+||+||+|++ +|+.||||++... ....+..|.+++.. ++||||+++++++..........
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 46788999999999999999998 5899999998643 33456778888777 79999999999987755556678
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHH--------hcCCCceeecCCCCCCeeecCCCCeEEe
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH--------EAAAPRILHRDIKSSNILLDENLNAKIT 372 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrDlKp~NILl~~~~~~kL~ 372 (631)
++||||+++|+|.++++. ..+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 82 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 999999999999999964 35899999999999999999999 776 9999999999999999999999
Q ss_pred ccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcC------CCCcccchhhHHHHHHHHHhC----------CCCCC
Q 006785 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG------RASLMSDVFSFGVVLLELITG----------RQPIH 436 (631)
Q Consensus 373 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~------~~s~ksDVwSlGviL~eLltG----------~~P~~ 436 (631)
|||+++......... ........||+.|+|||++.+. .++.++||||||+++|||++| +.||.
T Consensus 156 Dfg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQL-DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCTTCEEEETTTTEE-ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eCCCeeecccccccc-cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999998765432211 1112334799999999999876 455799999999999999999 77775
Q ss_pred CccccccchhhhhcccccccccccccccCCCCCCC-CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 437 RSITKGEESLVLWATPRLQDSGTVISELPDPRLKG-DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
............... .......+.+.. ..+...+..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKV--------VCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCCHHHHHHH--------HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCcchhhhhHH--------HhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 433222111000000 000111111111 12345677899999999999999999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=362.89 Aligned_cols=263 Identities=22% Similarity=0.359 Sum_probs=213.1
Q ss_pred eeecHHHHHHHhcC----------ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCC
Q 006785 212 IRFSYSALEHATDK----------FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH 280 (631)
Q Consensus 212 ~~~s~~~l~~a~~~----------f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H 280 (631)
..|+++++..+++. |...+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+|++++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCC
Confidence 35778888888765 677789999999999999987 69999999997654 3345568999999999999
Q ss_pred CCCcceeEEeeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCC
Q 006785 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 360 (631)
Q Consensus 281 ~niv~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~N 360 (631)
|||+++++++.. ....++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 102 ~niv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~N 171 (321)
T 2c30_A 102 FNVVEMYKSYLV----GEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDS 171 (321)
T ss_dssp TTBCCEEEEEEE----TTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred CCcceEEEEEEE----CCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 999999999886 4578999999999999999875 35899999999999999999999998 9999999999
Q ss_pred eeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccc
Q 006785 361 ILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 440 (631)
Q Consensus 361 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~ 440 (631)
||++.++.+||+|||++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 172 Ill~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~ 246 (321)
T 2c30_A 172 ILLTLDGRVKLSDFGFCAQISKDV-----PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP 246 (321)
T ss_dssp EEECTTCCEEECCCTTCEECCSSS-----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred EEECCCCcEEEeeeeeeeecccCc-----cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999998765432 122345799999999999999999999999999999999999999965332
Q ss_pred cccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006785 441 KGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506 (631)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 506 (631)
..... .+.....+.+. .+...+..+.+|+.+||+.||++|||+.++++.-
T Consensus 247 ~~~~~--------------~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 247 VQAMK--------------RLRDSPPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp HHHHH--------------HHHHSSCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred HHHHH--------------HHhcCCCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 11100 01111111111 1122334588999999999999999999998753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=375.91 Aligned_cols=273 Identities=27% Similarity=0.401 Sum_probs=217.1
Q ss_pred eeecHHHHHHHhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCc
Q 006785 212 IRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVV 284 (631)
Q Consensus 212 ~~~s~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv 284 (631)
..+....++...++|.+.+.||+|+||.||+|.+. +++.||||+++..........|.+|+++|.++ +||||+
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 34556677778899999999999999999999742 36899999998765555556799999999999 899999
Q ss_pred ceeEEeeeccCCcceEEEEEeeCCCCChHhhhhcccc-------------------------------------------
Q 006785 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV------------------------------------------- 321 (631)
Q Consensus 285 ~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------- 321 (631)
++++++.+. ....++||||+++|+|.+++.....
T Consensus 90 ~~~~~~~~~---~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (359)
T 3vhe_A 90 NLLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG 166 (359)
T ss_dssp CEEEEECST---TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred eeeeeeecC---CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence 999998752 3347999999999999999975432
Q ss_pred ---------------------CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 322 ---------------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 322 ---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 243 (359)
T 3vhe_A 167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDI 243 (359)
T ss_dssp -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeee
Confidence 12899999999999999999999998 999999999999999999999999999866
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
..... ........||+.|+|||++.+..++.++||||||+++|||++ |+.||............
T Consensus 244 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~------------ 308 (359)
T 3vhe_A 244 YKDPD---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR------------ 308 (359)
T ss_dssp TSCTT---CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH------------
T ss_pred ccccc---chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHH------------
Confidence 43321 112234568999999999999999999999999999999998 99999654322111100
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
+....... .+...+..+.+|+..||+.||.+|||+.+|++.|..+.
T Consensus 309 -~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 309 -LKEGTRMR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp -HHHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHcCCCCC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 01111111 12223345889999999999999999999999998774
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=367.64 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=203.8
Q ss_pred hcCccccceeeeeCceEEEEEEE-CCCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
.++|.+.+.||+|+||.||+|.+ .+|+.||||++.... .......+.+|+.+|+.++||||+++++++.. ....
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~ 89 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET----EKTL 89 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE----CCEE
Confidence 46788999999999999999998 469999999997543 23344568899999999999999999999875 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp EEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 9999999999999999754 45999999999999999999999998 999999999999999999999999999866
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCC-cccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRAS-LMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s-~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
.... ......||+.|+|||++.+..+. .++||||||+++|||++|+.||..............
T Consensus 165 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~---------- 228 (328)
T 3fe3_A 165 TVGG------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR---------- 228 (328)
T ss_dssp SSSC------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----------
T ss_pred CCCC------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------
Confidence 5332 22345799999999999987764 899999999999999999999975432211110000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. .. ..|...+..+.+|+.+||..||.+|||+.|+++.
T Consensus 229 ---~--~~----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 229 ---G--KY----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ---C--CC----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ---C--CC----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 00 1222234458899999999999999999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=368.28 Aligned_cols=260 Identities=26% Similarity=0.416 Sum_probs=203.1
Q ss_pred cCccccceeeeeCceEEEEEEECC-Cc----EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~----~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
++|...+.||+|+||+||+|.+.. ++ .||+|.+...........|.+|+.++++++||||+++++++.. .
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 89 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----S 89 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-----S
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----C
Confidence 568888999999999999998753 44 4689988766555566779999999999999999999999875 2
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..++|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred CeEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCccee
Confidence 3689999999999999997643 45999999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
........ .......||+.|+|||++.+..++.++||||||+++|||++ |+.||............
T Consensus 166 ~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~---------- 232 (327)
T 3poz_A 166 LLGAEEKE---YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---------- 232 (327)
T ss_dssp HHTTTCC----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----------
T ss_pred EccCCccc---ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH----------
Confidence 76543221 12233457889999999999999999999999999999999 99999754322111100
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 513 (631)
.... ....+...+..+.+|+.+||+.||.+||++.++++.|..+....
T Consensus 233 ----~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 233 ----EKGE----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp ----HTTC----CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred ----HcCC----CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 0000 11122333445889999999999999999999999999886554
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=379.54 Aligned_cols=262 Identities=26% Similarity=0.405 Sum_probs=199.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC----CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
.++|.+.+.||+|+||.||+|++. ++..||||+++..........|.+|+.+|++++||||+++++++.+ ..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~ 119 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK----SK 119 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----SS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee----CC
Confidence 357888999999999999999875 4778999999866544555679999999999999999999999875 44
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..++||||+++|+|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred ceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 679999999999999999754 345999999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
......... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||............
T Consensus 196 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i---------- 263 (373)
T 2qol_A 196 VLEDDPEAA--YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV---------- 263 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH----------
T ss_pred ccccCCccc--eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----------
Confidence 765432111 11122346788999999999999999999999999999998 99999654321110000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
.. ......+...+..+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus 264 ----~~----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 264 ----DE----GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ----HT----TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----Hc----CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 00 000111223345588999999999999999999999999988644
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=353.61 Aligned_cols=258 Identities=23% Similarity=0.353 Sum_probs=209.4
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
.++|.+.+.||+|+||.||+|.++++..||||++..... ....+.+|+.++++++||||+++++++.. ....++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~l 80 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCSK----EYPIYI 80 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEECS----SSSEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEcc----CCceEE
Confidence 467888999999999999999998888999999976532 33568999999999999999999999865 456799
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++++|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp EEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred EEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecch
Confidence 99999999999999764 245899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
.... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||............
T Consensus 157 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-------------- 218 (268)
T 3sxs_A 157 DQYV----SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV-------------- 218 (268)
T ss_dssp TCEE----ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--------------
T ss_pred hhhh----cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH--------------
Confidence 3211 1223446788999999999899999999999999999999 99999654322111100
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
....... .+...+..+.+++..||+.||.+|||+.++++.|+.+...
T Consensus 219 ~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 219 SQGHRLY----RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HTTCCCC----CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HcCCCCC----CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 0000111 1112234588999999999999999999999999988644
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=360.17 Aligned_cols=264 Identities=27% Similarity=0.391 Sum_probs=205.7
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
.++|.+.+.||+|+||.||+|.+. +++.||||++...... .....|.+|+.++++++||||+++++++.. ...
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----~~~ 85 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE----DDC 85 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC----SSE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee----CCe
Confidence 367888999999999999999875 5899999998654332 233568999999999999999999999875 557
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.|+||||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKA 160 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred EEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence 89999999999999999764 45999999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... . .
T Consensus 161 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~--~----~------ 224 (294)
T 4eqm_A 161 LSETSL----TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI--K----H------ 224 (294)
T ss_dssp C-----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH--H----H------
T ss_pred cccccc----cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH--H----H------
Confidence 643321 12234569999999999999999999999999999999999999996543211100 0 0
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhhCCCc
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-TMSEVVQILSTIAPDK 513 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~~ 513 (631)
+... .+......+...+..+.+++.+||+.||.+|| ++.++.+.|..+....
T Consensus 225 -~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 225 -IQDS-VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp -HSSC-CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred -hhcc-CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 0000 00000011222334588999999999999998 9999999999876543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=370.03 Aligned_cols=268 Identities=24% Similarity=0.391 Sum_probs=213.6
Q ss_pred HHHHHhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEee
Q 006785 218 ALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291 (631)
Q Consensus 218 ~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 291 (631)
.+....++|.+.+.||+|+||.||+|++. +++.||||+++..........|.+|+.++++++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34445688999999999999999999875 348899999987655555567999999999999999999999987
Q ss_pred eccCCcceEEEEEeeCCCCChHhhhhccc----------------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCC
Q 006785 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVL----------------------VEGMNWDTRVAIAIGAARGLEYLHEAAAP 349 (631)
Q Consensus 292 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 349 (631)
. ....++||||+++|+|.+++.... ...+++.+++.++.||+.||+|||+++
T Consensus 121 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-- 194 (343)
T 1luf_A 121 V----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-- 194 (343)
T ss_dssp S----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred c----CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 5 446799999999999999997632 145899999999999999999999998
Q ss_pred ceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHH
Q 006785 350 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELI 429 (631)
Q Consensus 350 ~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLl 429 (631)
|+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||+
T Consensus 195 -ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 270 (343)
T 1luf_A 195 -FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY---KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270 (343)
T ss_dssp -CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB---C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred -eecCCCCcceEEECCCCeEEEeecCCCcccccCccc---cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHH
Confidence 999999999999999999999999999876433211 1223346889999999999999999999999999999999
Q ss_pred h-CCCCCCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006785 430 T-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508 (631)
Q Consensus 430 t-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 508 (631)
+ |..||........... +.....+ ..+...+..+.+|+.+||+.||.+||++.+|++.|..
T Consensus 271 t~g~~p~~~~~~~~~~~~--------------~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~ 332 (343)
T 1luf_A 271 SYGLQPYYGMAHEEVIYY--------------VRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 332 (343)
T ss_dssp TTTCCTTTTSCHHHHHHH--------------HHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hcCCCcCCCCChHHHHHH--------------HhCCCcC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHH
Confidence 9 9999965432111000 0000001 1222333458899999999999999999999999998
Q ss_pred hCCCc
Q 006785 509 IAPDK 513 (631)
Q Consensus 509 i~~~~ 513 (631)
+....
T Consensus 333 ~~~~~ 337 (343)
T 1luf_A 333 MCERA 337 (343)
T ss_dssp TTC--
T ss_pred HHhhh
Confidence 86543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=391.28 Aligned_cols=264 Identities=23% Similarity=0.363 Sum_probs=214.2
Q ss_pred HHHHHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCC
Q 006785 217 SALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (631)
Q Consensus 217 ~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 296 (631)
..++...++|...+.||+|+||.||+|.++++..||||+++... ...+.|.+|+.+|++++||||+++++++..
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---- 254 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---- 254 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEECS----
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC----
Confidence 34555677889999999999999999999888999999998643 345679999999999999999999998752
Q ss_pred cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCc
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGl 376 (631)
...|+||||+++|+|.++|.......+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 255 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 330 (454)
T 1qcf_A 255 -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGL 330 (454)
T ss_dssp -SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred -CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCC
Confidence 34699999999999999998654456899999999999999999999998 99999999999999999999999999
Q ss_pred eeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccc
Q 006785 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQ 455 (631)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~ 455 (631)
++....... .......+|+.|+|||++....++.++||||||++||||++ |+.||............
T Consensus 331 a~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-------- 398 (454)
T 1qcf_A 331 ARVIEDNEY----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-------- 398 (454)
T ss_dssp GGGBCCHHH----HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH--------
T ss_pred ceEcCCCce----eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------
Confidence 987643211 11122346789999999999999999999999999999999 99999653321111000
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 456 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 456 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
..... ...+..++..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 399 ------~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 399 ------ERGYR----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp ------HHTCC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred ------HcCCC----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 00001 112233345588999999999999999999999999988654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=358.65 Aligned_cols=277 Identities=23% Similarity=0.322 Sum_probs=214.7
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++|.+.+.||+|+||+||+|.+.. |+.||||++...........+.+|+++|++++||||+++++++.... ....++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~~~l 86 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT--TRHKVL 86 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT--TCCEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC--CceEEE
Confidence 567888999999999999999865 89999999986544455667899999999999999999999887532 336799
Q ss_pred EEeeCCCCChHhhhhcccc-CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeee----cCCCCeEEeccCce
Q 006785 303 VFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMA 377 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl----~~~~~~kL~DFGla 377 (631)
||||+++|+|.+++..... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999999976433 33999999999999999999999998 9999999999999 78888999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhh--------cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhh-
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAM--------VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL- 448 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~--------~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~- 448 (631)
+...... ......||+.|+|||++. +..++.++||||||+++|||++|+.||.............
T Consensus 164 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 164 RELEDDE------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp EECCTTC------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred eecCCCC------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 8765432 123356999999999986 5778999999999999999999999996433221110000
Q ss_pred -hccccccccccccccc--------CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 449 -WATPRLQDSGTVISEL--------PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 449 -~~~~~~~~~~~~~~~~--------~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
............+... ........++......+.+|+.+||+.||++|||+.|+++.......
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 0000000000000000 01112224567888889999999999999999999999998876543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=374.55 Aligned_cols=287 Identities=19% Similarity=0.250 Sum_probs=212.4
Q ss_pred hcCccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCCh----------HHHHHHHHHHHHhcCCCCCcce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNA----------DSVFLTEVDMLSRLHHCHVVPL 286 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~----------~~~~~~E~~~l~~l~H~niv~l 286 (631)
.++|.+.+.||+|+||.||+|.+.. ++.||||++........ ...+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4578889999999999999998864 47899999876431100 0113445566677789999999
Q ss_pred eEEeeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeec--
Q 006785 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-- 364 (631)
Q Consensus 287 ~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~-- 364 (631)
++++..........||||||+ +++|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESS
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecC
Confidence 999987555456789999999 99999999763 356999999999999999999999998 99999999999999
Q ss_pred CCCCeEEeccCceeecccCCCCCC--CCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccc
Q 006785 365 ENLNAKITDLGMAKRLKADGLPSC--SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKG 442 (631)
Q Consensus 365 ~~~~~kL~DFGla~~~~~~~~~~~--~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~ 442 (631)
.++.+||+|||+++.+........ ........||+.|+|||++.+..++.++||||||++||||++|+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 889999999999988765432211 112234569999999999999999999999999999999999999997533221
Q ss_pred cchhhhhcccccccccccccccCCCCCC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcccccccCc
Q 006785 443 EESLVLWATPRLQDSGTVISELPDPRLK-GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISL 521 (631)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~ 521 (631)
... ........ ..+..+.++.+. ..+| ..+.+|+..||..||.+||++.+|++.|..+............
T Consensus 269 ~~~--~~~~~~~~---~~~~~~~~~~~~~~~~~----~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~ 339 (364)
T 3op5_A 269 KYV--RDSKIRYR---ENIASLMDKCFPAANAP----GEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKL 339 (364)
T ss_dssp HHH--HHHHHHHH---HCHHHHHHHHSCTTCCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred HHH--HHHHHHhh---hhHHHHHHHhcccccCH----HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCcc
Confidence 110 00000000 001111111111 1233 3488999999999999999999999999988755444433333
Q ss_pred ch
Q 006785 522 NL 523 (631)
Q Consensus 522 ~~ 523 (631)
+|
T Consensus 340 dw 341 (364)
T 3op5_A 340 DL 341 (364)
T ss_dssp CC
T ss_pred ce
Confidence 33
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=380.50 Aligned_cols=255 Identities=27% Similarity=0.393 Sum_probs=208.1
Q ss_pred HHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 220 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 220 ~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
+...++|...+.||+|+||.||+|.++ |+.||||+++... ..+.|.+|+.+|++++||||+++++++.+. ...
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~ 261 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE---KGG 261 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECT---TSC
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcC---CCc
Confidence 344577888999999999999999985 7899999998653 345699999999999999999999998752 236
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.|+||||+++|+|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 799999999999999998754445899999999999999999999998 99999999999999999999999999985
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
.... .....+|+.|+|||++.+..++.++||||||++||||++ |+.||...........
T Consensus 339 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~------------ 398 (450)
T 1k9a_A 339 ASST--------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR------------ 398 (450)
T ss_dssp CC--------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH------------
T ss_pred cccc--------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------------
Confidence 4321 122357889999999999999999999999999999998 9999965432211100
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
+..... ...|..++..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 399 --i~~~~~----~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 399 --VEKGYK----MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp --HHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHcCCC----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 000011 1223334455889999999999999999999999998774
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=354.41 Aligned_cols=255 Identities=28% Similarity=0.420 Sum_probs=207.7
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
++|...+.||+|+||.||+|.+.+++.||||++..... ..+.+.+|+.++++++||||+++++++.+ ....++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 83 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLE----QAPICLV 83 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECS----SSSEEEE
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc--CHHHHHHHHHHHHhCCCCCEeeEEEEEec----CCceEEE
Confidence 56788899999999999999998899999999986532 34569999999999999999999999875 4567999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
|||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999999997543 45899999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccccccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
.. .......||+.|+|||++.+..++.++||||||+++|||++ |+.||........... +.
T Consensus 160 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~--------------~~ 221 (269)
T 4hcu_A 160 QY----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED--------------IS 221 (269)
T ss_dssp HH----HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH--------------HH
T ss_pred cc----ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--------------Hh
Confidence 11 11223457889999999999999999999999999999999 9999965332211000 00
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
....+ ..+...+..+.+|+.+||+.||++|||+.++++.|..+.
T Consensus 222 ~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 222 TGFRL----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp TTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCccC----CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 00111 112222345889999999999999999999999998874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=365.63 Aligned_cols=255 Identities=26% Similarity=0.321 Sum_probs=202.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.++|.+.+.||+|+||.||+|.+. +++.||||++.........+.+.+|+.+++.++||||+++++++.+ ....|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~ 81 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE----GNIQY 81 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC----SSEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec----CCeEE
Confidence 467889999999999999999986 5899999999765444444568999999999999999999999876 55789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp EEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 999999999999999754 45999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
.... ........||+.|+|||++.+..+ +.++||||||+++|||++|+.||......... ...+...
T Consensus 157 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~-------- 224 (323)
T 3tki_A 157 YNNR---ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEK-------- 224 (323)
T ss_dssp ETTE---ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHTT--------
T ss_pred cCCc---ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhcc--------
Confidence 3321 112234579999999999987765 78999999999999999999999754332111 1111100
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..........+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 225 -------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 225 -------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -------cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00001112233457889999999999999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=373.95 Aligned_cols=262 Identities=26% Similarity=0.394 Sum_probs=211.6
Q ss_pred HhcCccccceeeeeCceEEEEEEEC--------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeee
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 292 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 292 (631)
..++|.+.+.||+|+||.||+|.+. .+..||||+++..........+.+|+++++++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3467888999999999999999863 24679999998765555556799999999999 99999999999875
Q ss_pred ccCCcceEEEEEeeCCCCChHhhhhcccc--------------CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCC
Q 006785 293 FRGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 358 (631)
Q Consensus 293 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp 358 (631)
....++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.+ |+||||||
T Consensus 147 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp 219 (382)
T 3tt0_A 147 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAA 219 (382)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred ----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCc
Confidence 4457999999999999999976431 34899999999999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 006785 359 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 437 (631)
Q Consensus 359 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~ 437 (631)
+||||+.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYY---KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTT---CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ceEEEcCCCcEEEcccCccccccccccc---ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999876543211 12234467899999999999999999999999999999999 9999965
Q ss_pred ccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 438 SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
........ .+.....+. .+...+..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 297 ~~~~~~~~--------------~~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 297 VPVEELFK--------------LLKEGHRMD----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp CCHHHHHH--------------HHHTTCCCC----CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHH--------------HHHcCCCCC----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 43211100 001111111 122233458899999999999999999999999998753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=367.50 Aligned_cols=253 Identities=21% Similarity=0.312 Sum_probs=204.3
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC-----hHHHHHHHHHHHHhcCCCCCcceeEEeeeccCC
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-----ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 296 (631)
.+.|.+.+.||+|+||.||+|... +|+.||||+++...... ....+.+|+.+|+.++||||+++++++..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---- 86 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN---- 86 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe----
Confidence 567889999999999999999986 48999999997653321 34568999999999999999999999875
Q ss_pred cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC----CeEEe
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL----NAKIT 372 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~----~~kL~ 372 (631)
....|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~ 161 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLI 161 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEE
Confidence 55789999999999999999753 46999999999999999999999998 99999999999998776 79999
Q ss_pred ccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccc
Q 006785 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 452 (631)
Q Consensus 373 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 452 (631)
|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+....
T Consensus 162 DFG~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~- 234 (361)
T 2yab_A 162 DFGLAHEIEDGV------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS- 234 (361)
T ss_dssp CCSSCEECCTTC------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC-
T ss_pred ecCCceEcCCCC------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-
Confidence 999998765432 2234579999999999999999999999999999999999999997543221111000000
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 453 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..+........+..+.+|+.+||..||.+|||+.|+++.
T Consensus 235 --------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 235 --------------YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp --------------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --------------CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000000011223458899999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=386.49 Aligned_cols=264 Identities=28% Similarity=0.424 Sum_probs=209.0
Q ss_pred HHHHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 218 ALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 218 ~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
.++...++|...+.||+|+||.||+|.++++..||||+++... ...+.|.+|+.+|++++||||+++++++.+
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 250 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE----- 250 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----
Confidence 3444567788899999999999999999888889999998643 234569999999999999999999999864
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
...++||||+++|+|.++|.......+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA 327 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccc
Confidence 34699999999999999997654456999999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
+....... .......+|+.|+|||++..+.++.++||||||++||||++ |+.||...........
T Consensus 328 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~---------- 393 (452)
T 1fmk_A 328 RLIEDNEY----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---------- 393 (452)
T ss_dssp C------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----------
T ss_pred eecCCCce----ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH----------
Confidence 87654321 11223457889999999999999999999999999999999 9999965332111000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 513 (631)
+.... ....+..++..+.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus 394 ----i~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 394 ----VERGY----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp ----HHTTC----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ----HHcCC----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 00000 11223334455889999999999999999999999999886443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=375.92 Aligned_cols=262 Identities=25% Similarity=0.360 Sum_probs=209.4
Q ss_pred hcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCC
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 296 (631)
.++|.+.+.||+|+||.||+|.+. +++.||||+++..........+.+|+.++++++||||+++++++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---- 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ---- 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence 467888999999999999999853 3678999999765555555679999999999999999999999875
Q ss_pred cceEEEEEeeCCCCChHhhhhcccc-----CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC---C
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLV-----EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL---N 368 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~---~ 368 (631)
....++||||+++|+|.+++..... ..+++.+++.++.||+.||+|||+++ |+||||||+||||+.++ .
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCce
Confidence 4456999999999999999976431 34899999999999999999999998 99999999999999554 5
Q ss_pred eEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhh
Q 006785 369 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLV 447 (631)
Q Consensus 369 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~ 447 (631)
+||+|||+++....... ........||+.|+|||++.+..++.++||||||+++|||++ |..||...........
T Consensus 223 ~kL~DFG~a~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~- 298 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGY---YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF- 298 (367)
T ss_dssp EEECCCHHHHHHHHHSS---CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-
T ss_pred EEECCCccccccccccc---cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-
Confidence 99999999986543321 122334568999999999999999999999999999999998 9999965432211110
Q ss_pred hhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 448 LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
+.....+. .+...+..+.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus 299 -------------i~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 299 -------------VTSGGRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp -------------HHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -------------HHcCCCCC----CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 00001111 1223334588999999999999999999999999987544
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=388.90 Aligned_cols=263 Identities=26% Similarity=0.404 Sum_probs=214.3
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
++....+|...+.||+|+||.||+|.+.. +..||||+++... ...+.|.+|+.+|++++||||+++++++.. .
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~ 288 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR----E 288 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS----S
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEec----C
Confidence 44456778889999999999999999875 8899999997643 235669999999999999999999999876 4
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
...|+||||+++|+|.++|.......+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccc
Confidence 46799999999999999998755566999999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
+....... .......+|+.|+|||++....++.++||||||++||||++ |..||...........
T Consensus 366 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~---------- 431 (495)
T 1opk_A 366 RLMTGDTY----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---------- 431 (495)
T ss_dssp ECCTTCCE----ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH----------
T ss_pred eeccCCce----eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH----------
Confidence 87653321 11223446789999999999999999999999999999999 9999865432211000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
+.. ......+..++..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 432 ----~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 432 ----LEK----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp ----HHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred ----HHc----CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 001 111122333445588999999999999999999999999987543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=362.85 Aligned_cols=277 Identities=24% Similarity=0.320 Sum_probs=205.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC-----CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
.++|++.+.||+|+||.||+|++. +++.||||++... .......|.+|+.+|++++||||+++++++.... .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--R 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH--H
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--C
Confidence 356788899999999999999852 5889999999754 2334456899999999999999999999986532 2
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
...++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred CceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccc
Confidence 35699999999999999997643 34899999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
+........ ........||..|+|||++.+..++.++||||||+++|||++|..||....................
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-- 237 (295)
T 3ugc_A 162 KVLPQDKEF--FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI-- 237 (295)
T ss_dssp C---------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHH--
T ss_pred ccccCCcce--eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchh--
Confidence 876543211 1122234578889999999999999999999999999999999999864321100000000000000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
...+.+..........+..++..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00000000011111223344455899999999999999999999999998874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=370.21 Aligned_cols=266 Identities=23% Similarity=0.382 Sum_probs=208.0
Q ss_pred HHhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeec
Q 006785 221 HATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 293 (631)
Q Consensus 221 ~a~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 293 (631)
...++|...+.||+|+||.||+|.+. ++..||||++...........+.+|+.+|+++ +||||+++++++..
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 120 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL- 120 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee-
Confidence 34578888999999999999999862 36689999998655555556799999999999 99999999999876
Q ss_pred cCCcceEEEEEeeCCCCChHhhhhcccc---------------------CCCCHHHHHHHHHHHHhhhHHHHhcCCCcee
Q 006785 294 RGKRAMRLLVFEFMPNGNLRDCLDGVLV---------------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRIL 352 (631)
Q Consensus 294 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 352 (631)
....++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+
T Consensus 121 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iv 194 (344)
T 1rjb_A 121 ---SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CV 194 (344)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ---CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 4467999999999999999976432 23799999999999999999999998 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-C
Q 006785 353 HRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-G 431 (631)
Q Consensus 353 HrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G 431 (631)
||||||+|||++.++.+||+|||++......... .......||+.|+|||++.+..++.++||||||+++|||++ |
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 271 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY---VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 271 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS---EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccc---eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCC
Confidence 9999999999999999999999999876543211 11233457889999999999999999999999999999998 9
Q ss_pred CCCCCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 432 RQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 432 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
..||............ +.....+ ..+...+..+.+|+.+||+.||.+|||+.+|++.|..+..
T Consensus 272 ~~p~~~~~~~~~~~~~-------------~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 272 VNPYPGIPVDANFYKL-------------IQNGFKM----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CCSSTTCCCSHHHHHH-------------HHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCCcccCCcHHHHHHH-------------HhcCCCC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 9999654322111000 0011111 1222234458899999999999999999999999998865
Q ss_pred Cc
Q 006785 512 DK 513 (631)
Q Consensus 512 ~~ 513 (631)
..
T Consensus 335 ~~ 336 (344)
T 1rjb_A 335 DA 336 (344)
T ss_dssp --
T ss_pred HH
Confidence 43
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=364.25 Aligned_cols=249 Identities=26% Similarity=0.321 Sum_probs=203.6
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|...+.||+|+||.||+|+.+ +|+.||||+++... .......+.+|+.+|+.++||||+++++++.. ....
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----~~~~ 80 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT----HDRL 80 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC----SSEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe----CCEE
Confidence 57888999999999999999986 48999999997531 22334568899999999999999999999876 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||++||+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 9999999999999999754 45899999999999999999999998 999999999999999999999999999864
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 156 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~------------ 218 (337)
T 1o6l_A 156 ISDG-----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL------------ 218 (337)
T ss_dssp CCTT-----CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------------
T ss_pred ccCC-----CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHH------------
Confidence 3322 22345679999999999999999999999999999999999999996533211111000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 505 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 505 (631)
.. .. .+|...+..+.+|+.+||+.||.+|| ++.+|++.
T Consensus 219 -~~--~~----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 219 -ME--EI----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -HC--CC----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -cC--CC----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 00 01 12223345588999999999999999 89998764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=360.90 Aligned_cols=261 Identities=25% Similarity=0.390 Sum_probs=210.4
Q ss_pred HhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 295 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 295 (631)
..++|.+.+.||+|+||.||+|.+. +++.||||++...........+.+|+.+|++++||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ--- 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec---
Confidence 3567888999999999999999862 3588999999866555555679999999999999999999999875
Q ss_pred CcceEEEEEeeCCCCChHhhhhcccc----------------------CCCCHHHHHHHHHHHHhhhHHHHhcCCCceee
Q 006785 296 KRAMRLLVFEFMPNGNLRDCLDGVLV----------------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILH 353 (631)
Q Consensus 296 ~~~~~~lV~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 353 (631)
....++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+++ |+|
T Consensus 98 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH 173 (314)
T 2ivs_A 98 -DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVH 173 (314)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred -CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccc
Confidence 4467999999999999999975422 23899999999999999999999998 999
Q ss_pred cCCCCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CC
Q 006785 354 RDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GR 432 (631)
Q Consensus 354 rDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~ 432 (631)
|||||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |+
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 250 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSY---VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCE---ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred cccchheEEEcCCCCEEEccccccccccccccc---eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999876543211 11233457889999999999999999999999999999999 99
Q ss_pred CCCCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 433 QPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 433 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
.||........... +.....+. .+...+..+.+|+.+||+.||++||++.++++.|+.+.
T Consensus 251 ~p~~~~~~~~~~~~--------------~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 251 NPYPGIPPERLFNL--------------LKTGHRME----RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp CSSTTCCGGGHHHH--------------HHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHH--------------hhcCCcCC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99965432211110 01111111 22233345889999999999999999999999998874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=364.17 Aligned_cols=269 Identities=18% Similarity=0.192 Sum_probs=210.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcceE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~ 300 (631)
.++|.+.+.||+|+||.||+|+.. +|+.||||++...... ..+.+|+.+++++ +||||+++++++.. ....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~~~~----~~~~ 80 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA---PQLHLEYRFYKQLGSGDGIPQVYYFGPC----GKYN 80 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS---CCHHHHHHHHHHHCSCTTSCCEEEEEEE----TTEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch---HHHHHHHHHHHHhhCCCCCCEEEEEEec----CCcc
Confidence 367888999999999999999974 5899999998765332 2388999999999 99999999999876 4578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCC-----eEEeccC
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN-----AKITDLG 375 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~-----~kL~DFG 375 (631)
++||||+ +++|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred EEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence 9999999 99999999764 356999999999999999999999998 999999999999998887 9999999
Q ss_pred ceeecccCCCCC--CCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccc
Q 006785 376 MAKRLKADGLPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 453 (631)
Q Consensus 376 la~~~~~~~~~~--~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~ 453 (631)
+++.+....... .........||+.|+|||++.+..++.++||||||+++|||++|+.||.................
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~- 234 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD- 234 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH-
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh-
Confidence 998765432211 11123456799999999999999999999999999999999999999976432221111100000
Q ss_pred cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCccc
Q 006785 454 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSR 515 (631)
Q Consensus 454 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 515 (631)
.........+...+ + .+.+|+..||+.||.+||++.+|++.|..+......
T Consensus 235 ------~~~~~~~~~~~~~~----p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 235 ------TKRATPIEVLCENF----P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp ------HHHHSCHHHHTTTC----H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ------hhccCCHHHHhccC----h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 00000000001111 2 589999999999999999999999999987654433
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=352.40 Aligned_cols=255 Identities=33% Similarity=0.476 Sum_probs=195.9
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCC---CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG---PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
.++|...+.||+|+||.||+|.+. |+.||||++..... ....+.+.+|+++++.++||||+++++++.. ...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 80 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK----EPN 80 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC----C--
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec----CCc
Confidence 357888999999999999999985 88999999875432 2234568999999999999999999999876 446
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC--------CCCeEE
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE--------NLNAKI 371 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~--------~~~~kL 371 (631)
.++||||+++++|.+++.. +.+++..+..++.|++.||+|||+++..+|+||||||+|||++. ++.+||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred eEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 7999999999999999864 46899999999999999999999987556899999999999986 678999
Q ss_pred eccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcc
Q 006785 372 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 451 (631)
Q Consensus 372 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~ 451 (631)
+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||............
T Consensus 158 ~Dfg~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---- 226 (271)
T 3dtc_A 158 TDFGLAREWHRTT-------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV---- 226 (271)
T ss_dssp CCCCC--------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH----
T ss_pred ccCCccccccccc-------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh----
Confidence 9999998654321 22346999999999999999999999999999999999999999653321110000
Q ss_pred cccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 452 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 452 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
.........+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 227 -------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 227 -------------AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -------------HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -------------hcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 000111112233345588999999999999999999999999754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=355.29 Aligned_cols=257 Identities=22% Similarity=0.358 Sum_probs=206.0
Q ss_pred HhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
..++|...+.||+|+||.||+|.+.++..||||++..... ....+.+|++++++++||||+++++++.. ....+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~ 95 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTK----QRPIF 95 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECS----SSSEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEec----CCCeE
Confidence 3467888999999999999999998888999999986532 34568999999999999999999999875 45679
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++|+|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 96 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp EEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred EEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 9999999999999997633 45999999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
.... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........
T Consensus 172 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~-------------- 233 (283)
T 3gen_A 172 DDEY----TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-------------- 233 (283)
T ss_dssp CHHH----HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH--------------
T ss_pred cccc----ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH--------------
Confidence 3211 11223347889999999999999999999999999999998 9999975432211110
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
+....... .+...+..+.+|+.+||+.||.+|||+.++++.|..+.
T Consensus 234 ~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 234 IAQGLRLY----RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp HHTTCCCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcccCCC----CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 01111111 12222345889999999999999999999999998774
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=351.69 Aligned_cols=269 Identities=17% Similarity=0.205 Sum_probs=210.5
Q ss_pred hcCccccceeeeeCceEEEEEEE-CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcceE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~ 300 (631)
.++|.+.+.||+|+||.||+|.. .+|+.||||++....... .+.+|+.+++.+ +|+|++++++++.. ....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~e~~~~~~l~~~~~i~~~~~~~~~----~~~~ 81 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTGIPNVYYFGQE----GLHN 81 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSC---CHHHHHHHHHHTTTCTTCCCEEEEEEE----TTEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccH---HHHHHHHHHHHHhcCCCCCeEEeecCC----Ccee
Confidence 45788899999999999999996 468999999987543322 378999999999 89999999999875 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCC-----eEEeccC
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN-----AKITDLG 375 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~-----~kL~DFG 375 (631)
++||||+ +++|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 82 ~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 9999999 99999999764 345999999999999999999999998 999999999999987776 9999999
Q ss_pred ceeecccCCCCCC--CCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccc
Q 006785 376 MAKRLKADGLPSC--SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 453 (631)
Q Consensus 376 la~~~~~~~~~~~--~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~ 453 (631)
+++.......... ........||+.|+|||++.+..++.++||||||+++|||++|+.||..................
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 9987765432111 11234567999999999999999999999999999999999999999764322111111000000
Q ss_pred cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcc
Q 006785 454 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKS 514 (631)
Q Consensus 454 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 514 (631)
......+.+...++ ..+.+|+.+||+.||++||++.+|++.|..+.....
T Consensus 237 -------~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 237 -------KQSTPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp -------HHHSCHHHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred -------ccCccHHHHHhhCc----HHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 00000011111233 458899999999999999999999999998865443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=352.99 Aligned_cols=257 Identities=24% Similarity=0.369 Sum_probs=197.6
Q ss_pred hcCccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
.++|.+.+.||+|+||.||+|.+.. +..||||++.........+.|.+|+.++++++||||+++++++.+ .
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 88 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-----N 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----S
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-----C
Confidence 4678889999999999999998753 557999998865554555679999999999999999999998743 3
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..|+||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred ccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccc
Confidence 468999999999999999754 245899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
....... .......+|+.|+|||++....++.++||||||+++|||++ |..||............
T Consensus 165 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i---------- 230 (281)
T 1mp8_A 165 YMEDSTY----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI---------- 230 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----------
T ss_pred ccCcccc----cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH----------
Confidence 7654321 11223457889999999999999999999999999999997 99999754322111000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
....... .+...+..+.+++.+||+.||++|||+.++++.|..+.
T Consensus 231 ----~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 231 ----ENGERLP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp ----HTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HcCCCCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0000111 22233445889999999999999999999999998874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=361.62 Aligned_cols=260 Identities=22% Similarity=0.333 Sum_probs=202.9
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC------
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG------ 295 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------ 295 (631)
.++|.+.+.||+|+||.||+|++. +|+.||||++.........+.+.+|+.+|++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467888999999999999999986 6999999999876656666779999999999999999999999865321
Q ss_pred -----------------------------------------------CcceEEEEEeeCCCCChHhhhhcccc-CCCCHH
Q 006785 296 -----------------------------------------------KRAMRLLVFEFMPNGNLRDCLDGVLV-EGMNWD 327 (631)
Q Consensus 296 -----------------------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~ 327 (631)
.....++||||+++|+|.+++..... ....+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 12247999999999999999976432 336788
Q ss_pred HHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCC-------CCCCcccccCCC
Q 006785 328 TRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC-------SSSPARMQGTFG 400 (631)
Q Consensus 328 ~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-------~~~~~~~~Gt~~ 400 (631)
.++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.......... ........||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999998 99999999999999999999999999987754321110 112334579999
Q ss_pred CCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHH
Q 006785 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQI 480 (631)
Q Consensus 401 Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 480 (631)
|+|||++.+..++.++||||||+++|||++|..|+...... .. .......+ .........
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~-----~~-----------~~~~~~~~----~~~~~~~~~ 301 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI-----IT-----------DVRNLKFP----LLFTQKYPQ 301 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHH-----HH-----------HHHTTCCC----HHHHHHCHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHH-----HH-----------HhhccCCC----cccccCChh
Confidence 99999999999999999999999999999998775321100 00 00000000 111233455
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 481 MAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 481 l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+.+|+.+||+.||.+|||+.|+++.
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCCCCcCCCHHHHhhc
Confidence 7899999999999999999999873
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=364.84 Aligned_cols=260 Identities=23% Similarity=0.369 Sum_probs=205.1
Q ss_pred cCccccceeeeeCceEEEEEEECC-Cc----EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~----~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
++|...+.||+|+||.||+|.+.. ++ .||+|.+...........+.+|+.++++++||||+++++++.. .
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 87 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-----S 87 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-----S
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-----C
Confidence 567888999999999999998753 44 3888888655444444457899999999999999999998852 3
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccc
Confidence 579999999999999999764 245899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
........ .......||+.|+|||++.+..++.++||||||+++|||++ |+.||.............
T Consensus 164 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~--------- 231 (325)
T 3kex_A 164 LLPPDDKQ---LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE--------- 231 (325)
T ss_dssp GSCCCTTC---CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH---------
T ss_pred ccCccccc---ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH---------
Confidence 76543221 12334568889999999999999999999999999999999 999997543222111110
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 513 (631)
...... .+...+..+.+|+.+||+.||.+||++.++++.|..+....
T Consensus 232 -----~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 232 -----KGERLA----QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp -----TTCBCC----CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred -----cCCCCC----CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 000011 11112223778999999999999999999999999987654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=359.97 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=203.6
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-----ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCC
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 296 (631)
.+.|...+.||+|+||.||+|... +|+.||||++...... .....+.+|+.+|++++||||+++++++..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---- 85 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN---- 85 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe----
Confidence 356888999999999999999986 4899999999764322 134568999999999999999999999875
Q ss_pred cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC----CeEEe
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL----NAKIT 372 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~----~~kL~ 372 (631)
....++||||+++|+|.+++... ..+++.++..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 55789999999999999999753 46999999999999999999999998 99999999999998887 79999
Q ss_pred ccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccc
Q 006785 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 452 (631)
Q Consensus 373 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 452 (631)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...............
T Consensus 161 Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-- 232 (326)
T 2y0a_A 161 DFGLAHKIDFGN------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-- 232 (326)
T ss_dssp CCTTCEECCTTS------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHT--
T ss_pred ECCCCeECCCCC------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhc--
Confidence 999998765332 223456999999999999999999999999999999999999999654322111100000
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 453 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
............+..+.+|+.+||+.||.+|||+.++++.
T Consensus 233 -------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 233 -------------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -------------CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -------------CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000011223458899999999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=360.81 Aligned_cols=262 Identities=25% Similarity=0.376 Sum_probs=210.2
Q ss_pred HhcCccccceeeeeCceEEEEEEE------CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeecc
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQL------TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFR 294 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 294 (631)
..++|...+.||+|+||.||+|.+ .+++.||||++.........+.+.+|+.+++++ +||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence 346788899999999999999985 246899999998665545556799999999999 99999999999876
Q ss_pred CCcceEEEEEeeCCCCChHhhhhcccc----------------CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCC
Q 006785 295 GKRAMRLLVFEFMPNGNLRDCLDGVLV----------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 358 (631)
Q Consensus 295 ~~~~~~~lV~E~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp 358 (631)
....++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||
T Consensus 99 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp 173 (313)
T 1t46_A 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA 173 (313)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred --CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCcc
Confidence 4456999999999999999976432 24899999999999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 006785 359 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 437 (631)
Q Consensus 359 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~ 437 (631)
+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 250 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNY---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTS---EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ceEEEcCCCCEEEccccccccccccccc---eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999876543211 11233457889999999999999999999999999999999 9999965
Q ss_pred ccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 438 SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
.......... +.....+. .+...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 251 ~~~~~~~~~~-------------~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 251 MPVDSKFYKM-------------IKEGFRML----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp CCSSHHHHHH-------------HHHTCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchhHHHHH-------------hccCCCCC----CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 4322111000 01111111 12223345889999999999999999999999998775
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=351.99 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=209.6
Q ss_pred HHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 220 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 220 ~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
+...++|.+.+.||+|+||.||+|.+.++..||||++.... ...+.|.+|+++|++++||||+++++++.. ..
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~ 81 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-----EP 81 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SS
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-----CC
Confidence 33456788899999999999999999888899999997543 234569999999999999999999998753 24
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.++||||+++++|.+++.......+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 699999999999999997654446999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
...... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........
T Consensus 159 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~------------ 222 (279)
T 1qpc_A 159 IEDNEY----TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN------------ 222 (279)
T ss_dssp CSSSCE----ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH------------
T ss_pred ccCccc----ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH------------
Confidence 654321 11223457889999999998999999999999999999999 8999965332111000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
+....... .+...+..+.+|+.+||..||++|||+.++++.|+.+.
T Consensus 223 --~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 223 --LERGYRMV----RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp --HHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HhcccCCC----CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 00001111 12223345889999999999999999999999998774
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=352.08 Aligned_cols=256 Identities=23% Similarity=0.346 Sum_probs=205.5
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++|...+.||+|+||.||+|+++ ++.||||++..... ......|.+|+.++++++||||+++++++.... ....++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~~~l 86 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP--APHPTL 86 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT--SSSCEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC--CCCeEe
Confidence 56888899999999999999985 88999999986532 233456999999999999999999999987532 246799
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++|+|.+++.......+++.++..++.|++.||+|||+.+ ++|+||||||+|||++.++.++|+|||++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 999999999999998765456999999999999999999999875 3499999999999999999999999998754321
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCc---ccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASL---MSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~---ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
....||+.|+|||++.+..++. ++||||||+++|||++|+.||...........
T Consensus 166 ----------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~------------- 222 (271)
T 3kmu_A 166 ----------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK------------- 222 (271)
T ss_dssp ----------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH-------------
T ss_pred ----------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH-------------
Confidence 2346899999999998765544 79999999999999999999965432211000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
.......+. .+...+..+.+++.+||+.||++|||+.++++.|..+.
T Consensus 223 ~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 223 VALEGLRPT----IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HHHSCCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHhcCCCCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 011111222 22233445889999999999999999999999999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=356.46 Aligned_cols=269 Identities=25% Similarity=0.345 Sum_probs=200.7
Q ss_pred HhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
..++|.+.+.||+|+||+||+|++.+|+.||||++..... ......+.+|+.+|++++||||+++++++.. ....
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~ 94 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS----ERCL 94 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC----SSCE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc----CCEE
Confidence 3467888999999999999999998899999999975432 2334568999999999999999999999875 4578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
++||||++ |+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 95 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 95 TLVFEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAF 169 (311)
T ss_dssp EEEEECCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred EEEEcCCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceec
Confidence 99999996 5888888654 245999999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh-ccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW-ATPRLQDSG 458 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~-~~~~~~~~~ 458 (631)
.... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. .........
T Consensus 170 ~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 170 GIPV-----RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244 (311)
T ss_dssp TSCC-----C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred CCCc-----ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence 4321 12234568999999999876 5689999999999999999999999976443322111100 000000000
Q ss_pred ccccc----------cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 459 TVISE----------LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 459 ~~~~~----------~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
....+ .................+.+|+.+||+.||.+|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000 00000000001112345789999999999999999999987
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=356.45 Aligned_cols=270 Identities=24% Similarity=0.364 Sum_probs=190.4
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.++|...+.||+|+||.||+|... +|+.||||+++..........+.+|+.+|++++||||+++++++.. ....+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~ 79 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT----ENKLT 79 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC----TTEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE----CCeEE
Confidence 457888999999999999999875 4899999999866554455668999999999999999999999875 45789
Q ss_pred EEEeeCCCCChHhhhhccc----cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 302 LVFEFMPNGNLRDCLDGVL----VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
+||||++ |+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 155 (317)
T 2pmi_A 80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLA 155 (317)
T ss_dssp EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccc
Confidence 9999997 69999986532 235899999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh-cccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW-ATPRLQ 455 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~-~~~~~~ 455 (631)
+...... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. ......
T Consensus 156 ~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 230 (317)
T 2pmi_A 156 RAFGIPV-----NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNE 230 (317)
T ss_dssp EETTSCC-----CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCT
T ss_pred eecCCCc-----ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 8764321 12234568999999999976 4689999999999999999999999975433211110000 000000
Q ss_pred cccccccccC--CCCCC------------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 456 DSGTVISELP--DPRLK------------GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 456 ~~~~~~~~~~--~~~l~------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
........+. .+.+. ...+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp TTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000000000 00000 00011223458899999999999999999999763
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=358.14 Aligned_cols=261 Identities=26% Similarity=0.398 Sum_probs=213.1
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
++...++|.+.+.||+|+||.||+|.+.. +..||||++... ......+.+|+.++++++||||+++++++.. .
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~ 81 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR----E 81 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC--STHHHHHHHHHHHHHHCCCTTBCCEEEEECS----S
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----C
Confidence 33456778889999999999999999875 889999999754 3445669999999999999999999999875 4
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
...++||||+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLS 158 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccc
Confidence 56799999999999999998765567999999999999999999999999 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........
T Consensus 159 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~---------- 224 (288)
T 3kfa_A 159 RLMTGDTY----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---------- 224 (288)
T ss_dssp GTSCSSSS----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH----------
T ss_pred eeccCCcc----ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----------
Confidence 86653321 11233457889999999999999999999999999999999 9999865432211110
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
+...... ..+...+..+.+|+..||+.||.+|||+.++++.|..+.
T Consensus 225 ----~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 225 ----LEKDYRM----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp ----HHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HhccCCC----CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 0111111 122233345889999999999999999999999998774
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=355.73 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=194.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-------------------------ChHHHHHHHHHHHHh
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-------------------------NADSVFLTEVDMLSR 277 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-------------------------~~~~~~~~E~~~l~~ 277 (631)
++|.+.+.||+|+||.||+|... +++.||||++...... ...+.+.+|+++|++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 67888999999999999999875 4899999999754311 112458899999999
Q ss_pred cCCCCCcceeEEeeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCC
Q 006785 278 LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 357 (631)
Q Consensus 278 l~H~niv~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK 357 (631)
++||||+++++++.... ....|+||||+++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+|||||
T Consensus 93 l~h~~iv~~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPN--EDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp CCCTTBCCEEEEEECSS--SSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred CCCCCCCeEEEEEEcCC--CCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 99999999999987532 3478999999999999987653 45999999999999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCC---CCcccchhhHHHHHHHHHhCCCC
Q 006785 358 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQP 434 (631)
Q Consensus 358 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~---~s~ksDVwSlGviL~eLltG~~P 434 (631)
|+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.|
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 239 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-----LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC-----EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred HHHEEECCCCCEEEecCCCccccccccc-----cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 9999999999999999999987654321 123356999999999987655 47889999999999999999999
Q ss_pred CCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 435 IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
|............. ...........++ ..+.+|+.+||+.||++|||+.|+++
T Consensus 240 f~~~~~~~~~~~~~-------------~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 240 FMDERIMCLHSKIK-------------SQALEFPDQPDIA----EDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SCCSSHHHHHHHHH-------------HCCCCCCSSSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCccHHHHHHHHh-------------cccCCCCCccccC----HHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 96432211000000 0000000111233 44889999999999999999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=360.32 Aligned_cols=253 Identities=21% Similarity=0.250 Sum_probs=204.1
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.++|.+.+.||+|+||.||+|... +++.||+|.+... ......+.+|+.+|+.++||||+++++++.+ ....+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFES----MEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE----TTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEec----CCEEE
Confidence 468899999999999999999986 4889999998754 2344568899999999999999999999876 55789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC--CCCeEEeccCceee
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE--NLNAKITDLGMAKR 379 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~--~~~~kL~DFGla~~ 379 (631)
+||||+++|+|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 78 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 78 MIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 999999999999999753 245999999999999999999999998 999999999999987 78999999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
..... ......||+.|+|||++.+..++.++||||||+++|||++|..||...........+....
T Consensus 154 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-------- 219 (321)
T 1tki_A 154 LKPGD------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE-------- 219 (321)
T ss_dssp CCTTC------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--------
T ss_pred CCCCC------ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCC--------
Confidence 65331 2234579999999999998889999999999999999999999997543221111000000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 506 (631)
.. .........+..+.+|+.+||..||.+|||+.|+++.-
T Consensus 220 -----~~--~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 220 -----YT--FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp -----CC--CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred -----CC--CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 00 00000012234588999999999999999999999843
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=363.17 Aligned_cols=254 Identities=22% Similarity=0.286 Sum_probs=203.7
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
..++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.+|++++||||+++++++.+ ...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~ 102 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE----ESF 102 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----CCE
Confidence 4577999999999999999999986 489999999976532 2334568899999999999999999999876 557
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC---CeEEeccCc
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL---NAKITDLGM 376 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~---~~kL~DFGl 376 (631)
.|+||||+++|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 89999999999999998754 45899999999999999999999998 99999999999997654 599999999
Q ss_pred eeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccc
Q 006785 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
+....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||................
T Consensus 178 a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~----- 246 (362)
T 2bdw_A 178 AIEVNDSE------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA----- 246 (362)
T ss_dssp CBCCTTCC------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-----
T ss_pred ceEecCCc------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-----
Confidence 98765321 2234579999999999999999999999999999999999999996543211110000000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
...+. ......+..+.+|+.+||+.||++||++.++++.
T Consensus 247 -----~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 247 -----YDYPS-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -----CCCCT-----TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -----CCCCc-----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0112234458899999999999999999999874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=354.94 Aligned_cols=270 Identities=26% Similarity=0.388 Sum_probs=205.9
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc--CCCCCcceeEEeeeccCC
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL--HHCHVVPLVGYCSEFRGK 296 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~g~~~~~~~~ 296 (631)
-....++|.+.+.||+|+||.||+|+++ |+.||||++... ....+..|.+++..+ +||||+++++++......
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 3445678999999999999999999986 899999998643 233456667776655 999999999999875444
Q ss_pred cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhc--------CCCceeecCCCCCCeeecCCCC
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA--------AAPRILHRDIKSSNILLDENLN 368 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------~~~~ivHrDlKp~NILl~~~~~ 368 (631)
....++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+. + |+||||||+|||++.++.
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSC
T ss_pred CCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCC
Confidence 4678999999999999999965 3589999999999999999999988 6 999999999999999999
Q ss_pred eEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcc------cchhhHHHHHHHHHhC----------C
Q 006785 369 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLM------SDVFSFGVVLLELITG----------R 432 (631)
Q Consensus 369 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k------sDVwSlGviL~eLltG----------~ 432 (631)
+||+|||+++......... ........||+.|+|||++.+...+.+ +||||||+++|||++| +
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEV-DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp EEECCCTTCEECC----------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred EEEEeCCCceeeccccccc-cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 9999999998765432211 111234579999999999988776665 9999999999999999 5
Q ss_pred CCCCCccccccchhhhhcccccccccccccccCCCCCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 433 QPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFP-----KEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 433 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
.||............. ...+....+....+ ..++..+.+|+.+||+.||.+|||+.+|++.|+
T Consensus 260 ~p~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 327 (337)
T 3mdy_A 260 LPYHDLVPSDPSYEDM------------REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327 (337)
T ss_dssp CTTTTTSCSSCCHHHH------------HHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred ccHhhhcCCCCchhhh------------HHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence 5554322211100000 00011111112222 367778999999999999999999999999999
Q ss_pred hhCCC
Q 006785 508 TIAPD 512 (631)
Q Consensus 508 ~i~~~ 512 (631)
.+...
T Consensus 328 ~l~~~ 332 (337)
T 3mdy_A 328 KMSES 332 (337)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 88543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=365.58 Aligned_cols=249 Identities=23% Similarity=0.314 Sum_probs=198.4
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~ 298 (631)
.++|.+.+.||+|+||.||+|+.+ +|+.||||+++... .......+.+|..+|..+ +||||+++++++.. ..
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~----~~ 97 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT----PD 97 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----SS
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe----CC
Confidence 467899999999999999999976 48999999997531 122344578999999998 79999999999876 55
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..|+||||++||+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEcccccee
Confidence 789999999999999999764 45999999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.
T Consensus 173 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~---------- 237 (353)
T 3txo_A 173 EGICNG-----VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL---------- 237 (353)
T ss_dssp CSCC--------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----------
T ss_pred ecccCC-----ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH----------
Confidence 643321 22345679999999999999899999999999999999999999997543221111000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM------SEVVQ 504 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 504 (631)
... ..+|...+..+.+|+.+||+.||.+||++ .++++
T Consensus 238 -------~~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 238 -------NDE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -------HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -------cCC--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 000 01223334458899999999999999998 66665
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=360.22 Aligned_cols=261 Identities=26% Similarity=0.411 Sum_probs=208.9
Q ss_pred hcCccccceeeeeCceEEEEEEEC--------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeec
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 293 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 293 (631)
.++|.+.+.||+|+||.||+|.+. ++..||||++...........+.+|+.+++++ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc-
Confidence 467888999999999999999873 46789999998765555556799999999999 99999999999875
Q ss_pred cCCcceEEEEEeeCCCCChHhhhhcccc--------------CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCC
Q 006785 294 RGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359 (631)
Q Consensus 294 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~ 359 (631)
....++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.+ |+||||||+
T Consensus 113 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~ 186 (334)
T 2pvf_A 113 ---DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 186 (334)
T ss_dssp ---SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred ---CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccc
Confidence 4467999999999999999976431 24899999999999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCc
Q 006785 360 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (631)
Q Consensus 360 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~ 438 (631)
|||++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYY---KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSE---ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eEEEcCCCCEEEccccccccccccccc---cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 999999999999999999876543211 11233457889999999999999999999999999999999 99999653
Q ss_pred cccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 439 ITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
........ +.....+. .+...+..+.+|+.+||+.||.+|||+.++++.|..+..
T Consensus 264 ~~~~~~~~--------------~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 264 PVEELFKL--------------LKEGHRMD----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp CHHHHHHH--------------HHHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHH--------------HhcCCCCC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 32111000 00011111 122233458899999999999999999999999998754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=366.16 Aligned_cols=263 Identities=25% Similarity=0.378 Sum_probs=196.7
Q ss_pred CccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
.|...+.||+|+||.||+|.+.+ +..||||.++..........|.+|+.+|++++||||+++++++.+. ....
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~---~~~~ 166 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---EGSP 166 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC---SSCC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC---CCCe
Confidence 35567899999999999998642 2468999998665555667799999999999999999999987642 3356
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
++||||+++|+|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 167 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccc
Confidence 8999999999999999753 345899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
....... ........+|+.|+|||++.+..++.++||||||+++|||++ |.+||............
T Consensus 243 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~------------ 309 (373)
T 3c1x_A 243 YDKEFDS-VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL------------ 309 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH------------
T ss_pred ccccccc-ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH------------
Confidence 4432111 112233457889999999999999999999999999999999 66677543222111100
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 513 (631)
....... .+..++..+.+++.+||+.||++|||+.++++.|..+....
T Consensus 310 --~~~~~~~----~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 310 --LQGRRLL----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp --HTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred --HcCCCCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 0000111 12223345889999999999999999999999999876443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=360.78 Aligned_cols=268 Identities=26% Similarity=0.391 Sum_probs=213.3
Q ss_pred HHHHHHhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEe
Q 006785 217 SALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290 (631)
Q Consensus 217 ~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 290 (631)
++++...++|.+.+.||+|+||.||+|.+. +++.||||++...........|.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 445556788999999999999999999864 36889999998665545556699999999999999999999998
Q ss_pred eeccCCcceEEEEEeeCCCCChHhhhhccc--------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCee
Q 006785 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVL--------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNIL 362 (631)
Q Consensus 291 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NIL 362 (631)
.. ....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+++ |+||||||+|||
T Consensus 98 ~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIl 170 (322)
T 1p4o_A 98 SQ----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCM 170 (322)
T ss_dssp CS----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEE
T ss_pred cc----CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEE
Confidence 75 446699999999999999996532 134799999999999999999999998 999999999999
Q ss_pred ecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCcccc
Q 006785 363 LDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITK 441 (631)
Q Consensus 363 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~ 441 (631)
++.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 247 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 247 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCE---EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred EcCCCeEEECcCcccccccccccc---ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH
Confidence 999999999999999866433211 11123357889999999999999999999999999999999 88998653321
Q ss_pred ccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 442 GEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
...... .....+ ..+...+..+.+|+.+||+.||.+|||+.++++.|..+...
T Consensus 248 ~~~~~~--------------~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 248 QVLRFV--------------MEGGLL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp HHHHHH--------------HTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHHHHH--------------HcCCcC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 110000 000001 11223334588999999999999999999999999987653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=357.77 Aligned_cols=275 Identities=23% Similarity=0.360 Sum_probs=207.1
Q ss_pred cCccccceeeeeCceEEEEEEE-----CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
+.|...+.||+|+||.||+|++ .+++.||||++...........+.+|+.+|++++||||+++++++.... ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~ 98 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG--GN 98 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----C
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC--Cc
Confidence 4477789999999999999984 3589999999986655556677999999999999999999999987632 24
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 6799999999999999996532 45999999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccc-c
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD-S 457 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~-~ 457 (631)
........ ........||..|+|||++.+..++.++||||||+++|||++|..|+.......... ..+.... .
T Consensus 175 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~ 248 (302)
T 4e5w_A 175 AIETDKEY--YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKM----IGPTHGQMT 248 (302)
T ss_dssp ECCTTCCE--EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH----HCSCCGGGH
T ss_pred cccCCCcc--eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhc----cCCcccccC
Confidence 76543211 112234568889999999999999999999999999999999999875322110000 0000000 0
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
...+............+...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 249 VTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 00000000011111223334455899999999999999999999999998763
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=390.08 Aligned_cols=264 Identities=28% Similarity=0.420 Sum_probs=213.5
Q ss_pred HHHHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 218 ALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 218 ~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
.++...++|.+.+.||+|+||.||+|.++++..||||+++... ...+.|.+|+.+|++++||||+++++++.+
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----- 333 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE----- 333 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-----
Confidence 3445567788899999999999999999888889999998653 234569999999999999999999999864
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
...||||||+++|+|.++|.......+++.+++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 34699999999999999997654456999999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
+....... .......+|..|+|||++....++.++||||||++||||++ |+.||...........
T Consensus 411 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~---------- 476 (535)
T 2h8h_A 411 RLIEDNEY----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---------- 476 (535)
T ss_dssp TTCCCHHH----HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH----------
T ss_pred eecCCCce----ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----------
Confidence 86543211 11123347789999999999999999999999999999999 9999965432111000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 513 (631)
+..... ...+..++..+.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus 477 ----i~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 477 ----VERGYR----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp ----HHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred ----HHcCCC----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 000001 1122334455889999999999999999999999999886543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=347.91 Aligned_cols=268 Identities=21% Similarity=0.309 Sum_probs=201.2
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
++|...+.||+|+||+||+|.+. +|+.||||++..... ......+.+|+.++++++||||+++++++.. ....+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 77 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS----DKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----TTEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe----CCEEE
Confidence 57888999999999999999986 489999999976533 3344668999999999999999999999876 55789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++ +|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 78 lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 78 LVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence 99999964 666666543 255999999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCC-CCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh--ccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPRLQDSG 458 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~~~~~~ 458 (631)
... .......||+.|+|||++.+.. ++.++||||||+++|||++|..||.............. .........
T Consensus 153 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~ 227 (292)
T 3o0g_A 153 IPV-----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp SCC-----SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred Ccc-----ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhh
Confidence 321 2233456899999999998765 89999999999999999999888654322111100000 000000000
Q ss_pred ccccccC---------CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 459 TVISELP---------DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 459 ~~~~~~~---------~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
....... ............+..+.+|+.+||+.||++|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000000 0001111222344558899999999999999999999873
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=357.67 Aligned_cols=271 Identities=24% Similarity=0.353 Sum_probs=197.2
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEECC-C---cEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeec
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTD-G---RIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~-g---~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 293 (631)
+....++|.+.+.||+|+||.||+|.+.. + ..||||+++... .......|.+|+.++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 33446789999999999999999998754 3 279999997653 233456699999999999999999999998763
Q ss_pred cCC--cceEEEEEeeCCCCChHhhhhcccc----CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC
Q 006785 294 RGK--RAMRLLVFEFMPNGNLRDCLDGVLV----EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 367 (631)
Q Consensus 294 ~~~--~~~~~lV~E~~~~gsL~~~l~~~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~ 367 (631)
... ....++||||+++|+|.+++..... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCC
Confidence 221 1234899999999999999964321 24899999999999999999999998 99999999999999999
Q ss_pred CeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchh
Q 006785 368 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESL 446 (631)
Q Consensus 368 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~ 446 (631)
.+||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...........
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~ 251 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYY---RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251 (323)
T ss_dssp CEEECCCCC--------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred CEEEeeccccccccccccc---cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 9999999999876543221 11223457889999999999999999999999999999999 8999975433211110
Q ss_pred hhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006785 447 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513 (631)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 513 (631)
. ...... ..+...+..+.+|+.+||+.||++|||+.++++.|+.+....
T Consensus 252 ~--------------~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 252 L--------------IGGNRL----KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp H--------------HTTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred H--------------hcCCCC----CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 0 000011 112233345889999999999999999999999999886443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=357.67 Aligned_cols=272 Identities=27% Similarity=0.402 Sum_probs=215.6
Q ss_pred eecHHHHHHHhcCccccceeeeeCceEEEEEEE------CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcc
Q 006785 213 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQL------TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVP 285 (631)
Q Consensus 213 ~~s~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~ 285 (631)
.+....++...++|.+.+.||+|+||.||+|.+ .+++.||||++...........+.+|+.++.++ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 345556666778999999999999999999985 246899999998765545556799999999999 7999999
Q ss_pred eeEEeeeccCCcceEEEEEeeCCCCChHhhhhcccc--------------CCCCHHHHHHHHHHHHhhhHHHHhcCCCce
Q 006785 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351 (631)
Q Consensus 286 l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 351 (631)
+++++... ....++||||+++|+|.+++..... ..+++..+..++.|++.||.|||+.+ |
T Consensus 96 ~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i 169 (316)
T 2xir_A 96 LLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C 169 (316)
T ss_dssp EEEEECCT---TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EEEEEecC---CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 99998752 3357999999999999999976432 12789999999999999999999998 9
Q ss_pred eecCCCCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-
Q 006785 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT- 430 (631)
Q Consensus 352 vHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt- 430 (631)
+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++
T Consensus 170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~ 246 (316)
T 2xir_A 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246 (316)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTS---EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ccccCccceEEECCCCCEEECCCccccccccCccc---eeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999866433211 11233567899999999999999999999999999999998
Q ss_pred CCCCCCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 431 GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 431 G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
|+.||............ +........ +...+..+.+++.+||+.||.+|||+.+|++.|..+.
T Consensus 247 g~~p~~~~~~~~~~~~~-------------~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 247 GASPYPGVKIDEEFCRR-------------LKEGTRMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp SCCSSTTCCCSHHHHHH-------------HHHTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCcccchhHHHHHH-------------hccCccCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 99999654322111000 001111111 2222344889999999999999999999999998874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=360.13 Aligned_cols=261 Identities=26% Similarity=0.420 Sum_probs=203.9
Q ss_pred hcCccccceeeeeCceEEEEEEECC-Cc----EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~----~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
.++|.+.+.||+|+||.||+|.+.. ++ .||+|.+...........+.+|+.++++++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----
Confidence 3678889999999999999998753 44 4688888766566667779999999999999999999999875
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
...++|++|+.+|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 89 STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp SSEEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred CCceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 23689999999999999997643 45999999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
+........ .......||+.|+|||++.+..++.++||||||+++|||++ |+.||...........
T Consensus 165 ~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~---------- 231 (327)
T 3lzb_A 165 KLLGAEEKE---YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------- 231 (327)
T ss_dssp ------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH----------
T ss_pred eEccCcccc---ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH----------
Confidence 876443211 12223457889999999999999999999999999999999 9999975433211110
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 513 (631)
+...... ..+...+..+.+|+.+||+.||.+||++.++++.|..+....
T Consensus 232 ----~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 232 ----LEKGERL----PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp ----HHTTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred ----HHcCCCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 0011111 122233445889999999999999999999999999887554
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=366.22 Aligned_cols=263 Identities=22% Similarity=0.351 Sum_probs=209.9
Q ss_pred HhcCccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeecc
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFR 294 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 294 (631)
..++|...+.||+|+||.||+|.+.. ...||||++...........+.+|+.+|+++ +||||+++++++..
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 121 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH-- 121 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec--
Confidence 35778889999999999999998753 2489999998765555566799999999999 89999999999875
Q ss_pred CCcceEEEEEeeCCCCChHhhhhccc------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCee
Q 006785 295 GKRAMRLLVFEFMPNGNLRDCLDGVL------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNIL 362 (631)
Q Consensus 295 ~~~~~~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NIL 362 (631)
....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||
T Consensus 122 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 122 --GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred --CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 446799999999999999996532 235899999999999999999999998 999999999999
Q ss_pred ecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCcccc
Q 006785 363 LDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITK 441 (631)
Q Consensus 363 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~ 441 (631)
++.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 273 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNY---IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTS---EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred ECCCCeEEECccccccccccccce---eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence 999999999999999876543211 11233457889999999999999999999999999999999 89998654322
Q ss_pred ccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 442 GEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
...... +.....+. .+...+..+.+|+..||+.||.+|||+.+|++.|..+..
T Consensus 274 ~~~~~~-------------~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 274 SKFYKL-------------VKDGYQMA----QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHHHH-------------HHHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHH-------------HhcCCCCC----CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 111000 00001111 122223458899999999999999999999999987753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=352.62 Aligned_cols=262 Identities=27% Similarity=0.438 Sum_probs=195.3
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.++|.+.+.||+|+||.||+|++. ..||||+++.... ......|.+|+.+|++++||||+++++++. ....+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 95 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-----APQLA 95 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SSSCE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-----CCccE
Confidence 467888999999999999999864 3599999976533 233456999999999999999999999754 23469
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 96 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999999996542 45999999999999999999999998 9999999999999999999999999997654
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhh---cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
.... ........||+.|+|||++. ...++.++||||||+++|||++|+.||..............
T Consensus 172 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--------- 239 (289)
T 3og7_A 172 RWSG---SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG--------- 239 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHH---------
T ss_pred cccc---cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhc---------
Confidence 3211 12233456999999999986 66789999999999999999999999975432211100000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
.....+.+ ......++..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 240 ---~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 240 ---RGSLSPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp ---HTSCCCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ---ccccCcch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 00001111 01122333458999999999999999999999999998754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=358.42 Aligned_cols=255 Identities=25% Similarity=0.287 Sum_probs=201.5
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccC----CCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ----GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
.++|.+.+.||+|+||.||+|... +|+.||||++... ......+.+.+|+.+++.++||||+++++++.+ .
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~ 98 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS----D 98 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE----T
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe----C
Confidence 456888999999999999999875 5899999998632 122235569999999999999999999999876 5
Q ss_pred ceEEEEEeeCCCCChHhhhhccc--cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCC---eEEe
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN---AKIT 372 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~---~kL~ 372 (631)
...|+||||+++|+|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEEC
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEe
Confidence 57899999999999998886432 234899999999999999999999998 999999999999987655 9999
Q ss_pred ccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccc
Q 006785 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 452 (631)
Q Consensus 373 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 452 (631)
|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .......
T Consensus 176 Dfg~a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~i~~~ 247 (351)
T 3c0i_A 176 GFGVAIQLGESGL-----VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL---FEGIIKG 247 (351)
T ss_dssp CCTTCEECCTTSC-----BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHH---HHHHHHT
T ss_pred cCcceeEecCCCe-----eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHH---HHHHHcC
Confidence 9999987654321 1234579999999999999999999999999999999999999997532110 0000000
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 453 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.. ...+.... ..+..+.+|+.+||+.||++|||+.++++.
T Consensus 248 ~~---------~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 248 KY---------KMNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp CC---------CCCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CC---------CCCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 00000001 123458899999999999999999999873
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=358.65 Aligned_cols=247 Identities=23% Similarity=0.278 Sum_probs=193.8
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 299 (631)
.++|+..+.||+|+||+||+|.+. +|+.||||++..... ......+..|+..+.++ +||||+++++++.+ ...
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~----~~~ 131 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE----GGI 131 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe----CCE
Confidence 367999999999999999999987 699999999875432 22333466677666666 99999999999976 557
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.++||||+ +++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred EEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeee
Confidence 89999999 78999998764 346999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
..... ......||+.|+|||++.+ .++.++||||||+++|||++|..|+...... ...
T Consensus 207 ~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----~~~---------- 264 (311)
T 3p1a_A 207 LGTAG------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW-----QQL---------- 264 (311)
T ss_dssp CC------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH-----HHH----------
T ss_pred cccCC------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----HHH----------
Confidence 64332 2233469999999998875 7999999999999999999997766432110 000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
......+ .++...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 265 -~~~~~~~----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 265 -RQGYLPP----EFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp -TTTCCCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -hccCCCc----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 0000011 1111223458899999999999999999999873
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=349.63 Aligned_cols=267 Identities=25% Similarity=0.400 Sum_probs=198.4
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++|...+.||+|+||.||+|...+|+.||||++..... ......+.+|+.++++++||||+++++++.. ....++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 77 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT----KKRLVL 77 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC----SSCEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc----CCeEEE
Confidence 46888999999999999999998899999999975432 2233568899999999999999999999875 457899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||++ ++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 78 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 78 VFEHLD-QDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp EEECCS-EEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred EEEecC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 999996 49999987542 45899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh--cccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPRLQDSGT 459 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~~~~~~~ 459 (631)
.. .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. ..+.. ....
T Consensus 153 ~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~ 226 (288)
T 1ob3_A 153 PV-----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS-KNWP 226 (288)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT-TTST
T ss_pred cc-----cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCCh-hhch
Confidence 21 12234468999999999976 4589999999999999999999999975432211100000 00000 0000
Q ss_pred cccccC--CCCCC-------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELP--DPRLK-------GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~--~~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
...+.. ++.+. .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 00000 01112233458899999999999999999999863
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=370.22 Aligned_cols=255 Identities=21% Similarity=0.265 Sum_probs=203.0
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
..++|.+.+.||+|+||.||+|... +|+.||+|++...... .....+.+|+.+|++++||||+++++++.+ ...
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~ 84 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE----EGH 84 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC----SSE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE----CCE
Confidence 4577999999999999999999875 5899999999765322 234558999999999999999999999875 567
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeec---CCCCeEEeccCc
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLGM 376 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~---~~~~~kL~DFGl 376 (631)
.|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 89999999999999999764 45999999999999999999999998 99999999999998 467899999999
Q ss_pred eeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccc
Q 006785 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
+....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||................
T Consensus 160 a~~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~----- 229 (444)
T 3soa_A 160 AIEVEGEQ-----QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA----- 229 (444)
T ss_dssp CBCCCTTC-----CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-----
T ss_pred eEEecCCC-----ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-----
Confidence 98765432 12234579999999999999999999999999999999999999996543221111000000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.....+ .....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 230 -----~~~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 230 -----YDFPSP-----EWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -----CCCCTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----CCCCcc-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 001111 111223458899999999999999999999984
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=350.17 Aligned_cols=256 Identities=27% Similarity=0.474 Sum_probs=202.1
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChH------HHHHHHHHHHHhcCCCCCcceeEEeeeccC
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNAD------SVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 295 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 295 (631)
.++|...+.||+|+||.||+|.+. +++.||||++......... ..|.+|+.++++++||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 94 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--- 94 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT---
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC---
Confidence 367888899999999999999985 5899999998755333221 568999999999999999999998854
Q ss_pred CcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCC-----eE
Q 006785 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN-----AK 370 (631)
Q Consensus 296 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~-----~k 370 (631)
.. ++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||||+|||++.++. +|
T Consensus 95 -~~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 95 -PP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -TT--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -CC--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEE
Confidence 22 7999999999999988654 346999999999999999999999885 34999999999999988776 99
Q ss_pred EeccCceeecccCCCCCCCCCCcccccCCCCCCchhhh--cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhh
Q 006785 371 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM--VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 448 (631)
Q Consensus 371 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~--~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~ 448 (631)
|+|||+++.... ......||+.|+|||++. ...++.++||||||+++|||++|+.||.............
T Consensus 170 l~Dfg~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 241 (287)
T 4f0f_A 170 VADFGLSQQSVH--------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241 (287)
T ss_dssp ECCCTTCBCCSS--------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH
T ss_pred eCCCCccccccc--------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH
Confidence 999999975432 223456999999999984 4567899999999999999999999996543221110000
Q ss_pred hcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 449 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
.......+. .+...+..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus 242 -----------~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 242 -----------IREEGLRPT----IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -----------HHHSCCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -----------HhccCCCCC----CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 001111122 2333345589999999999999999999999999754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=360.22 Aligned_cols=247 Identities=24% Similarity=0.293 Sum_probs=200.6
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|.+.+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.+|+.++||||+++++++.. ....
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~ 84 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT----PTDI 84 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----CCEE
Confidence 67888999999999999999974 58999999986431 12223458999999999999999999999876 4578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
++||||+ +|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 85 ~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp EEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred EEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 9999999 78999998654 45999999999999999999999999 999999999999999999999999999866
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
.... ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........
T Consensus 159 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------- 216 (336)
T 3h4j_B 159 TDGN------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------- 216 (336)
T ss_dssp TTSB------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------
T ss_pred cCCc------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------
Confidence 4432 2234569999999999987775 7899999999999999999999965322110
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
...+... ....|...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 217 -~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 217 -FKKVNSC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -BCCCCSS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -HHHHHcC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0011100 011233344558899999999999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=348.65 Aligned_cols=262 Identities=26% Similarity=0.368 Sum_probs=203.6
Q ss_pred cCccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
.+|...+.||+|+||.||+|.+.+ ...||||.+...........+.+|+.++++++||||+++++++.+. ...
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~ 101 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---EGS 101 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS---SSC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC---CCc
Confidence 346778899999999999998643 2369999998765555566799999999999999999999987652 345
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.++||||+++|+|.+++... ...+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred eEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 68999999999999999753 345899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhC-CCCCCCccccccchhhhhccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITG-RQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG-~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
........ ........||+.|+|||.+.+..++.++||||||+++|||++| .+||.......... ..
T Consensus 178 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~-~~---------- 245 (298)
T 3f66_A 178 MYDKEYYS-VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-YL---------- 245 (298)
T ss_dssp CSCGGGCB-C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH-HH----------
T ss_pred ccccchhc-cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH-HH----------
Confidence 65432211 1223345688999999999999999999999999999999995 45554322211100 00
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
....... .+...+..+.+++.+||+.||++|||+.++++.|..+..
T Consensus 246 ---~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 246 ---LQGRRLL----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp ---HTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---hcCCCCC----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0001111 112223458899999999999999999999999998753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=361.97 Aligned_cols=253 Identities=22% Similarity=0.249 Sum_probs=192.1
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.++|.+.+.||+|+||.||+++.. +++.||||++...... ...+.+|+.++++++||||+++++++.. ....+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~ 92 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILT----PTHLA 92 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEee----CCEEE
Confidence 467888999999999999999986 5899999999765332 3458899999999999999999999876 55789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCC--eEEeccCceee
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN--AKITDLGMAKR 379 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~--~kL~DFGla~~ 379 (631)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++.
T Consensus 93 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 93 IIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 999999999999999653 45999999999999999999999998 999999999999987766 99999999975
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcc-cchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLM-SDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k-sDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
.... .......||+.|+|||++.+..++.+ +||||||+++|||++|+.||............
T Consensus 168 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~----------- 230 (361)
T 3uc3_A 168 SVLH------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT----------- 230 (361)
T ss_dssp -------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH-----------
T ss_pred cccc------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH-----------
Confidence 4322 12234569999999999988887655 89999999999999999999754332211100
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+..+.............+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 231 --~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 231 --IQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp --HHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred --HHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 000101110000111223458899999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=347.10 Aligned_cols=257 Identities=25% Similarity=0.390 Sum_probs=204.2
Q ss_pred hcCccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
.++|...+.||+|+||.||+|.+.+ +..||||++...........|.+|+.++++++||||+++++++.+ .
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~ 85 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-----E 85 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----S
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----C
Confidence 4678888999999999999998643 346999999876555556679999999999999999999998753 2
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..|+||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred CCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCc
Confidence 348999999999999999764 345899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||............
T Consensus 162 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~---------- 227 (281)
T 3cc6_A 162 YIEDEDY----YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL---------- 227 (281)
T ss_dssp CC-------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH----------
T ss_pred ccccccc----cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH----------
Confidence 7654321 11223457889999999999999999999999999999998 99999643322111100
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
....... .+...+..+.+|+.+||..||++||++.++++.|+.+.
T Consensus 228 ----~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 228 ----EKGDRLP----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp ----HHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----hcCCCCC----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 0000111 12222345889999999999999999999999998774
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=347.08 Aligned_cols=255 Identities=25% Similarity=0.429 Sum_probs=208.3
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeecc------
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR------ 294 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 294 (631)
...+|...+.||+|+||.||+|.+. +|+.||||++.... ..+.+|++++++++||||+++++++....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 3467888999999999999999986 69999999997543 23789999999999999999999885421
Q ss_pred ------CCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCC
Q 006785 295 ------GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 368 (631)
Q Consensus 295 ------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 368 (631)
......++||||+++|+|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 12446799999999999999998665567999999999999999999999998 999999999999999999
Q ss_pred eEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhh
Q 006785 369 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 448 (631)
Q Consensus 369 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~ 448 (631)
+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|||++|..|+......
T Consensus 161 ~kl~Dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~------- 227 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF------- 227 (284)
T ss_dssp EEECCCTTCEESSCCS------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHH-------
T ss_pred EEECcchhheeccccc------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHH-------
Confidence 9999999998765432 123346999999999999999999999999999999999999987432100
Q ss_pred hcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006785 449 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513 (631)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 513 (631)
...+....+...++ ..+.+|+.+||+.||.+|||+.++++.|..+....
T Consensus 228 ------------~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 228 ------------FTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp ------------HHHHHTTCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred ------------HHHhhcccccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 00011111112233 34788999999999999999999999999886543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=357.62 Aligned_cols=272 Identities=29% Similarity=0.394 Sum_probs=209.0
Q ss_pred ccccceeeeeCceEEEEEEEC-----CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
|.+.+.||+|+||.||++.+. +++.||||++...........|.+|+++|++++||||+++++++.... ....
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~~ 110 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG--AASL 110 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--TTEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC--CceE
Confidence 377899999999999998753 588999999987655555667999999999999999999999987632 3478
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
++||||+++|+|.+++... .+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 111 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999999753 4899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......... ...+...... ...
T Consensus 185 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~--~~~ 259 (318)
T 3lxp_A 185 PEGHEY--YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE-LIGIAQGQMT--VLR 259 (318)
T ss_dssp CTTCSE--EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSCCHHHH--HHH
T ss_pred cccccc--cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh-hhcccccchh--HHH
Confidence 543211 01223345888999999999999999999999999999999999998643221000 0000000000 000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
+.+..........+...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 01111111112223334455899999999999999999999999998774
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=364.59 Aligned_cols=250 Identities=28% Similarity=0.372 Sum_probs=201.2
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|.+.+.||+|+||.||++.... ++.||||++.... .......+.+|+.+|+.++||||+++++++.. ....
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~~ 90 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD----EEDM 90 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe----CCEE
Confidence 568889999999999999999764 8999999986431 22334568899999999999999999999876 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||++||+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp EEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 9999999999999999763 45999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhc---CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~---~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
.... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||................
T Consensus 166 ~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~------ 233 (384)
T 4fr4_A 166 PRET------QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE------ 233 (384)
T ss_dssp CTTC------CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH------
T ss_pred cCCC------ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh------
Confidence 5332 2344679999999999874 458999999999999999999999997543222111111000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-MSEVVQ 504 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 504 (631)
.... .+|...+..+.+|+.+||+.||.+||+ +.+|++
T Consensus 234 ------~~~~----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 234 ------TTVV----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ------HCCC----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ------hccc----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0001 123334455899999999999999998 666654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=364.87 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=197.2
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~ 298 (631)
.++|.+.+.||+|+||.||+|+.+. ++.||||+++... .......+.+|..+|.++ +||||+++++++.. ..
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~----~~ 126 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT----ES 126 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC----SS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE----CC
Confidence 3578889999999999999999864 8899999997542 122233478999999887 89999999999875 55
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 201 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceee
Confidence 789999999999999999764 45999999999999999999999999 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||............. ..
T Consensus 202 ~~~~~~-----~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~--------~~ 268 (396)
T 4dc2_A 202 EGLRPG-----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT--------ED 268 (396)
T ss_dssp CCCCTT-----CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CC--------HH
T ss_pred ecccCC-----CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhh--------HH
Confidence 633221 22345679999999999999999999999999999999999999996432111000000 00
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM 499 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 499 (631)
.....+.... ..+|...+..+.+|+.+||+.||.+||++
T Consensus 269 ~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 269 YLFQVILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHHHHhccc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 0000000000 12233344558899999999999999995
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=354.53 Aligned_cols=246 Identities=26% Similarity=0.302 Sum_probs=201.7
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|.+.+.||+|+||.||+|+.. +|+.||||+++... .......+.+|+.+++.++||||+++++++.+ ....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~----~~~~ 81 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD----AQQI 81 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC----SSEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe----CCEE
Confidence 56888999999999999999986 59999999997531 12334558899999999999999999999875 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV 156 (318)
T ss_dssp EEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceec
Confidence 9999999999999999764 45899999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.
T Consensus 157 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~------------ 216 (318)
T 1fot_A 157 PDV--------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL------------ 216 (318)
T ss_dssp SSC--------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------------
T ss_pred CCc--------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH------------
Confidence 432 234579999999999999999999999999999999999999996543211110000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 505 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 505 (631)
.. .. .+|...+..+.+|+.+||..||.+|| ++.++++.
T Consensus 217 -~~--~~----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 217 -NA--EL----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp -HC--CC----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -hC--CC----CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 00 01 12223344588999999999999999 88888753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=361.75 Aligned_cols=276 Identities=22% Similarity=0.325 Sum_probs=205.6
Q ss_pred hcCccccceeeee--CceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 223 TDKFSGSNIVGQG--GSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 223 ~~~f~~~~~LG~G--~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
.++|.+.+.||+| +||.||+|+.. +|+.||||++..... ......+.+|+.+|+.++||||+++++++.. ..
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~ 99 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----DN 99 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TT
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE----CC
Confidence 3568889999999 99999999986 599999999976532 2334558889999999999999999999986 55
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..|+||||+++|+|.+++.......+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccce
Confidence 7899999999999999998765567999999999999999999999998 9999999999999999999999999987
Q ss_pred ecccCCC--CCCCCCCcccccCCCCCCchhhhc--CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh-cccc
Q 006785 379 RLKADGL--PSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW-ATPR 453 (631)
Q Consensus 379 ~~~~~~~--~~~~~~~~~~~Gt~~Y~APE~~~~--~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~-~~~~ 453 (631)
.....+. ...........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. ..+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 256 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence 6543221 111122334579999999999987 6789999999999999999999999975432221110000 0000
Q ss_pred cccccc-----------------cccc-----cCCC----CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 454 LQDSGT-----------------VISE-----LPDP----RLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 454 ~~~~~~-----------------~~~~-----~~~~----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+.+... .... ...+ ......+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000000 0000 0000 00011223344568999999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=355.10 Aligned_cols=250 Identities=25% Similarity=0.334 Sum_probs=193.2
Q ss_pred hcCccccceeeeeCceEEEEEEE----CCCcEEEEEEeccCCC---CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQL----TDGRIVAVKRFKTQGG---PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 295 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 295 (631)
.++|.+.+.||+|+||.||+++. .+|+.||||+++.... ......+.+|+.+|+.++||||+++++++..
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 92 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT--- 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC---
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc---
Confidence 35688899999999999999987 3689999999976421 2233457899999999999999999999876
Q ss_pred CcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccC
Q 006785 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 375 (631)
Q Consensus 296 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFG 375 (631)
....|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 93 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg 166 (327)
T 3a62_A 93 -GGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFG 166 (327)
T ss_dssp -SSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCS
T ss_pred -CCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCC
Confidence 45789999999999999999754 45899999999999999999999998 9999999999999999999999999
Q ss_pred ceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccc
Q 006785 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 455 (631)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 455 (631)
+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 167 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~------- 234 (327)
T 3a62_A 167 LCKESIHDG-----TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL------- 234 (327)
T ss_dssp CC---------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-------
T ss_pred cccccccCC-----ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------
Confidence 997644322 12234579999999999999999999999999999999999999997543211100000
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006785 456 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 505 (631)
Q Consensus 456 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 505 (631)
.. .. .+|...+..+.+|+.+||+.||.+|| ++.++++.
T Consensus 235 ------~~--~~----~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 235 ------KC--KL----NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ------HT--CC----CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ------hC--CC----CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 00 01 12223345588999999999999999 77888764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=344.56 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=206.9
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
++|...+.||+|+||.||+|.+.+++.||||++..... ..+.+.+|++++++++||||+++++++.. ....++|
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 81 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLE----QAPICLV 81 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECS----SSSCEEE
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcc----CCCeEEE
Confidence 56788899999999999999998889999999986532 33568999999999999999999999875 4467999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp ECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999999999764 245899999999999999999999998 999999999999999999999999999865432
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccccccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
.. .......||+.|+|||++.+..++.++||||||+++|||++ |+.||........... +.
T Consensus 158 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~--------------i~ 219 (267)
T 3t9t_A 158 QY----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED--------------IS 219 (267)
T ss_dssp HH----HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH--------------HH
T ss_pred cc----cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH--------------Hh
Confidence 11 11223457889999999999999999999999999999999 8999865332111000 00
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
....+ ..+...+..+.+|+.+||+.||++||++.++++.|..+.
T Consensus 220 ~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 220 TGFRL----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp TTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCcC----CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00011 112222345889999999999999999999999998874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=364.34 Aligned_cols=259 Identities=24% Similarity=0.289 Sum_probs=195.2
Q ss_pred hcCcccc-ceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcce
Q 006785 223 TDKFSGS-NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 223 ~~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 299 (631)
.++|.+. +.||+|+||+||+|.+. +|+.||||++... ..+.+|+.++.++ +||||+++++++.........
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 3456665 68999999999999976 4899999999632 3478899988555 899999999998754444567
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC---CCCeEEeccCc
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGM 376 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~~~~kL~DFGl 376 (631)
.||||||++||+|.+++.......+++.++..|+.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 899999999999999998755556999999999999999999999998 999999999999987 78899999999
Q ss_pred eeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccc
Q 006785 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............. ..+..
T Consensus 211 a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---~~i~~ 281 (400)
T 1nxk_A 211 AKETTSHN------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---TRIRM 281 (400)
T ss_dssp CEECC-----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH---HHHHH
T ss_pred ccccCCCC------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH---HHHHc
Confidence 98754321 2234578999999999999999999999999999999999999997543221100000 00000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
+ ......+ .....+..+.+|+.+||+.||++|||+.++++.-.
T Consensus 282 -~--~~~~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 282 -G--QYEFPNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp -T--CCCCCTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred -C--cccCCCc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 0 0001111 11223345889999999999999999999998544
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=346.83 Aligned_cols=258 Identities=25% Similarity=0.359 Sum_probs=207.0
Q ss_pred cCccccc-eeeeeCceEEEEEEEC---CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 224 DKFSGSN-IVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 224 ~~f~~~~-~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
++|.+.+ .||+|+||.||+|.+. ++..||||+++..........+.+|+.++++++||||+++++++. ...
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~ 83 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-----AEA 83 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----SSS
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-----CCC
Confidence 3455555 8999999999999864 578899999987655555667999999999999999999999984 235
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred cEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceee
Confidence 79999999999999999753 345999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
....... ........||+.|+|||++.+..++.++||||||+++|||++ |+.||...........
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~------------ 225 (287)
T 1u59_A 160 LGADDSY--YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF------------ 225 (287)
T ss_dssp CTTCSCE--ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH------------
T ss_pred eccCcce--eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH------------
Confidence 6543211 111223457899999999998899999999999999999998 9999965432211100
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
+.....+ ..+...+..+.+|+..||+.||.+||++.++++.|+.+.
T Consensus 226 --i~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 226 --IEQGKRM----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp --HHTTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HhcCCcC----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0011111 122333455889999999999999999999999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=344.76 Aligned_cols=278 Identities=19% Similarity=0.261 Sum_probs=212.8
Q ss_pred hcCccccceeeeeCceEEEEEEE-CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.++|.+.+.||+|+||.||+|+. .+|+.||||++...... ..+.+|+.+++.++|++++..+.++... ....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~---~~~~~ 81 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAE---GDYNV 81 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEE---TTEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCC---CCceE
Confidence 46789999999999999999997 46999999998765332 2488999999999999888777766542 45779
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeee---cCCCCeEEeccCcee
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAK 378 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl---~~~~~~kL~DFGla~ 378 (631)
+||||+ +++|.+++... ...+++.++..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 82 lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 999999 99999999743 246999999999999999999999998 9999999999999 488899999999998
Q ss_pred ecccCCCCCC--CCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhh-hcccccc
Q 006785 379 RLKADGLPSC--SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL-WATPRLQ 455 (631)
Q Consensus 379 ~~~~~~~~~~--~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~-~~~~~~~ 455 (631)
.......... ........||+.|+|||++.+..++.++||||||+++|||++|+.||............. .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-- 234 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-- 234 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH--
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc--
Confidence 7765432110 112345679999999999999999999999999999999999999997543221111100 00000
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcccccccCcch
Q 006785 456 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNL 523 (631)
Q Consensus 456 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~ 523 (631)
...+.+.+...++ ..+.+|+.+||+.||.+|||+.+|++.|..+...........++|
T Consensus 235 ------~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw 292 (296)
T 3uzp_A 235 ------MSTPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW 292 (296)
T ss_dssp ------HHSCHHHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGG
T ss_pred ------cCCchHHHHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccc
Confidence 0000001112233 448899999999999999999999999998865554433333333
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=357.71 Aligned_cols=263 Identities=25% Similarity=0.390 Sum_probs=202.8
Q ss_pred hcCccccceeeeeCceEEEEEEECC-----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
.++|...+.||+|+||.||+|.+.. +..||||+++..........|.+|+.++++++||||+++++++.. .
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~ 118 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK----Y 118 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----S
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec----C
Confidence 3567778999999999999998653 246999999866544455669999999999999999999999865 4
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
...++||||+++|+|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred CCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcc
Confidence 5679999999999999999753 245999999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
+........ ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........
T Consensus 195 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~---------- 262 (333)
T 1mqb_A 195 RVLEDDPEA--TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA---------- 262 (333)
T ss_dssp ------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----------
T ss_pred hhhcccccc--ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHH----------
Confidence 876543211 111223346889999999999999999999999999999999 9999964332111000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 513 (631)
+...... ..+...+..+.+|+.+||+.||.+||++.++++.|..+....
T Consensus 263 ----~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 263 ----INDGFRL----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp ----HHTTCCC----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ----HHCCCcC----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 0000011 112233445889999999999999999999999999876443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=364.85 Aligned_cols=279 Identities=23% Similarity=0.316 Sum_probs=215.6
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++|.+.+.||+|+||.||+|.+.. |+.||||++...........+.+|+++|++++||||+++++++.... ....++
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~~~l 86 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT--TRHKVL 86 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT--TCCEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC--CCeeEE
Confidence 467888999999999999999865 89999999986544455567899999999999999999999987533 336799
Q ss_pred EEeeCCCCChHhhhhcccc-CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeee----cCCCCeEEeccCce
Q 006785 303 VFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMA 377 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl----~~~~~~kL~DFGla 377 (631)
||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 9999999999999976432 33999999999999999999999998 9999999999999 77888999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhc--------CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhh-
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV--------GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL- 448 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~--------~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~- 448 (631)
+...... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||.............
T Consensus 164 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 164 RELEDDE------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp EECCCGG------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred eEccCCC------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 8765432 1223569999999999875 567889999999999999999999996433221110000
Q ss_pred -hcccccccccccccc--------cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006785 449 -WATPRLQDSGTVISE--------LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513 (631)
Q Consensus 449 -~~~~~~~~~~~~~~~--------~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 513 (631)
............+.. .........++......+.+++.+||+.||++||++.++++.+..+....
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 000000000000000 00111122456778888999999999999999999999999998886543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=356.72 Aligned_cols=265 Identities=24% Similarity=0.335 Sum_probs=198.8
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC--hHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
.++|.+.+.||+|+||.||+|.+. +++.||||++....... ....|.+|+.++++++||||+++++++.........
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 467888999999999999999974 58999999998653322 234688999999999999999999998775544456
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.|+||||+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 79999999999999999754 45899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
....... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 166 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~----------- 232 (311)
T 3ork_A 166 IADSGNS--VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV----------- 232 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-----------
T ss_pred ccccccc--cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh-----------
Confidence 6543211 112234569999999999999999999999999999999999999996543221100000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH-HHhhh
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ-ILSTI 509 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~-~L~~i 509 (631)
.....+. .......+..+.+|+.+||+.||++||+..++++ .|..+
T Consensus 233 --~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 233 --REDPIPP--SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp --HCCCCCH--HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --cCCCCCc--ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0000000 0001112345889999999999999997766654 44433
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=372.61 Aligned_cols=266 Identities=19% Similarity=0.248 Sum_probs=208.7
Q ss_pred ecHHHHHHHhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEe
Q 006785 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290 (631)
Q Consensus 214 ~s~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 290 (631)
+.+.++....++|.+.+.||+|+||+||+|++++ ++.||||++.... .......+.+|+.++..++||||+++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3455666778899999999999999999999875 8899999986421 111122388999999999999999999998
Q ss_pred eeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeE
Q 006785 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 370 (631)
Q Consensus 291 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 370 (631)
.+ ....|+||||++||+|.++|... ...+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+|
T Consensus 144 ~~----~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vk 215 (437)
T 4aw2_A 144 QD----DNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIR 215 (437)
T ss_dssp EC----SSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred ee----CCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEE
Confidence 76 55789999999999999999763 245999999999999999999999998 99999999999999999999
Q ss_pred EeccCceeecccCCCCCCCCCCcccccCCCCCCchhhh-----cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccch
Q 006785 371 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES 445 (631)
Q Consensus 371 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~ 445 (631)
|+|||+++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||..........
T Consensus 216 L~DFGla~~~~~~~~----~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~ 291 (437)
T 4aw2_A 216 LADFGSCLKLMEDGT----VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 291 (437)
T ss_dssp ECCCTTCEECCTTSC----EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred EcchhhhhhcccCCC----cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHH
Confidence 999999987654321 1123357999999999997 4668999999999999999999999997543221111
Q ss_pred hhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 006785 446 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDA--RPTMSEVVQI 505 (631)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 505 (631)
.+... ...+..|.....++ ..+.+|+.+||..+|++ ||++.|+++.
T Consensus 292 ~i~~~----------~~~~~~p~~~~~~s----~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 292 KIMNH----------KERFQFPTQVTDVS----ENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHHTH----------HHHCCCCSSCCCSC----HHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hhhhc----------cccccCCcccccCC----HHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 11000 00111122112233 44888999999888888 9999999874
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=360.23 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=197.5
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCC--CCCcceeEEeeeccCCcce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHH--CHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~~~ 299 (631)
.++|.+.+.||+|+||.||++...+++.||||++..... ......|.+|+.+|++++| |||+++++++.. ...
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~----~~~ 83 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----DQY 83 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----SSE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee----CCE
Confidence 356888999999999999999998899999999975532 2334568999999999976 999999999876 557
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.|+|||+ .+|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccc
Confidence 8999995 589999999764 56899999999999999999999998 99999999999997 56899999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhh
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-----------GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 448 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-----------~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~ 448 (631)
...... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||........
T Consensus 157 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----- 228 (343)
T 3dbq_A 157 MQPDTT---SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----- 228 (343)
T ss_dssp C---------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----
T ss_pred cCcccc---cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-----
Confidence 654321 112234579999999999875 6789999999999999999999999964322110
Q ss_pred hcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 449 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
.+..+.++.....++...+..+.+|+.+||+.||.+|||+.++++...
T Consensus 229 -----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 229 -----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp -----------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred -----------HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 011111222222233333345889999999999999999999997543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=345.56 Aligned_cols=273 Identities=19% Similarity=0.262 Sum_probs=207.7
Q ss_pred HhcCccccceeeeeCceEEEEEEE-CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
..++|.+.+.||+|+||.||+|.. .+++.||||++....... .+.+|+.+++.++|++++..++++... ....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~e~~~l~~l~~~~~i~~~~~~~~~---~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP---QLHIESKIYKMMQGGVGIPTIRWCGAE---GDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CC---CHHHHHHHHHHHTTSTTCCCEEEEEEE---TTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccch---HHHHHHHHHHHhcCCCCCCeeeeecCC---CCce
Confidence 457899999999999999999997 458999999876543322 378999999999999888887777542 4577
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeee---cCCCCeEEeccCce
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMA 377 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl---~~~~~~kL~DFGla 377 (631)
++||||+ +++|.+++... ...+++.++..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 9999999 99999999753 245999999999999999999999998 9999999999999 78899999999999
Q ss_pred eecccCCCCC--CCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh-ccccc
Q 006785 378 KRLKADGLPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW-ATPRL 454 (631)
Q Consensus 378 ~~~~~~~~~~--~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~-~~~~~ 454 (631)
+......... .........||+.|+|||++.+..++.++||||||+++|||++|+.||.............. .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence 8876543211 01223456799999999999999999999999999999999999999975433221111000 00000
Q ss_pred ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCccccc
Q 006785 455 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRR 517 (631)
Q Consensus 455 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 517 (631)
....+.+...++ ..+.+|+..||+.||++|||+.+|++.|..+........
T Consensus 236 --------~~~~~~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~ 286 (296)
T 4hgt_A 236 --------STPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp --------HSCHHHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred --------cchhhhhhccCC----HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence 000000111223 458899999999999999999999999998875554333
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=361.58 Aligned_cols=249 Identities=22% Similarity=0.344 Sum_probs=201.2
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCc
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 297 (631)
..++|.+.+.||+|+||.||+|+.+ +|+.||||+++... .......+..|..+|..+ +||||+++++++.. .
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~----~ 90 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT----K 90 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC----S
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe----C
Confidence 4578999999999999999999986 48999999997531 123344578899999987 99999999999876 5
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
...|+||||++||+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhh
Confidence 5789999999999999999764 45899999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..............
T Consensus 166 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~-------- 232 (345)
T 1xjd_A 166 KENMLGD-----AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-------- 232 (345)
T ss_dssp BCCCCTT-----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------
T ss_pred hhcccCC-----CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh--------
Confidence 8643221 123456799999999999999999999999999999999999999975432211110000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS-EVV 503 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 503 (631)
..+ .+|...+..+.+|+.+||+.||.+||++. +|+
T Consensus 233 -------~~~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 233 -------DNP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -------CCC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -------CCC----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 011 12223344588999999999999999987 554
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=345.39 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=197.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++|.+.+.||+|+||.||++... ++..||||++...........+.+|+++|++++||||+++++++.. ....++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~l 97 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED----YHNMYI 97 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec----CCeEEE
Confidence 56888899999999999999975 4899999999876555556779999999999999999999999875 557899
Q ss_pred EEeeCCCCChHhhhhcc--ccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeee---cCCCCeEEeccCce
Q 006785 303 VFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMA 377 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl---~~~~~~kL~DFGla 377 (631)
||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 99999999999998543 2356999999999999999999999998 9999999999999 45678999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
....... ......||+.|+|||++. +.++.++||||||+++|||++|+.||.............+..+.
T Consensus 175 ~~~~~~~------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---- 243 (285)
T 3is5_A 175 ELFKSDE------HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN---- 243 (285)
T ss_dssp CC----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----
T ss_pred eecCCcc------cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcc----
Confidence 8665432 223456999999999875 57899999999999999999999999754322111111110000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
........+ ..+.+|+.+||+.||.+|||+.|+++
T Consensus 244 --------~~~~~~~~~----~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 244 --------YAVECRPLT----PQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --------CCC--CCCC----HHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --------cccccCcCC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000011223 34788999999999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=358.89 Aligned_cols=246 Identities=22% Similarity=0.289 Sum_probs=202.3
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|...+.||+|+||.||+|+.. +|+.||||++.... .......+.+|+.+|+.++||||+++++++.+ ....
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~ 116 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD----NSNL 116 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc----CCEE
Confidence 57888999999999999999986 58999999986431 12334568899999999999999999999875 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 117 ~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceec
Confidence 9999999999999999764 45899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.
T Consensus 192 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~------------ 251 (350)
T 1rdq_E 192 KGR--------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV------------ 251 (350)
T ss_dssp SSC--------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------------
T ss_pred cCC--------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH------------
Confidence 432 234579999999999999999999999999999999999999997543211110000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-----MSEVVQI 505 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 505 (631)
.. .. .+|...+..+.+|+.+||+.||.+||+ +.+|++.
T Consensus 252 -~~--~~----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 252 -SG--KV----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -HC--CC----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -cC--CC----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 00 01 122233445889999999999999998 7887653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=350.98 Aligned_cols=254 Identities=28% Similarity=0.498 Sum_probs=196.9
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
++|.+.+.||+|+||.||+|++. ++.||||++... .....|.+|+.+|++++||||+++++++.+ ..++|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~lv 77 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLN------PVCLV 77 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTT------TTEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC------CcEEE
Confidence 56778899999999999999985 788999998643 345669999999999999999999998763 25899
Q ss_pred EeeCCCCChHhhhhcccc-CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCC-eEEeccCceeecc
Q 006785 304 FEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN-AKITDLGMAKRLK 381 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~-~kL~DFGla~~~~ 381 (631)
|||+++|+|.+++..... ..+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 999999999999975432 24789999999999999999999932223999999999999998887 7999999997654
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||......... ..+. .
T Consensus 158 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~----------~ 217 (307)
T 2eva_A 158 TH--------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWA----------V 217 (307)
T ss_dssp ---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HHHH----------H
T ss_pred cc--------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HHHH----------H
Confidence 22 12345999999999999999999999999999999999999999643221110 0110 0
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
.....+.....++ ..+.+|+.+||+.||.+|||+.++++.|..+..
T Consensus 218 ~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 218 HNGTRPPLIKNLP----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp HTTCCCCCBTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred hcCCCCCcccccC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 0111112222333 448899999999999999999999999998753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=385.67 Aligned_cols=257 Identities=24% Similarity=0.350 Sum_probs=202.5
Q ss_pred Cccccc-eeeeeCceEEEEEEEC---CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 225 KFSGSN-IVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 225 ~f~~~~-~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++.+.+ .||+|+||.||+|.+. ++..||||+++........+.|.+|+++|++++||||+++++++.. ...
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----~~~ 410 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----EAL 410 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-----SSE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-----CCe
Confidence 344444 7999999999999874 4678999999876555566779999999999999999999999864 247
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
++||||+++|+|.++|... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 411 ~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp EEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred EEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 9999999999999999754 345999999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
...... ........+|+.|+|||++....++.++||||||++||||++ |+.||...........
T Consensus 487 ~~~~~~--~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~------------- 551 (613)
T 2ozo_A 487 GADDSY--YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF------------- 551 (613)
T ss_dssp C----------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH-------------
T ss_pred cCCCce--eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-------------
Confidence 433211 111122346789999999999999999999999999999998 9999975432211110
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
+..... ...+..++..+.+|+..||+.||++||++.+|++.|..+.
T Consensus 552 -i~~~~~----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 552 -IEQGKR----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp -HHTTCC----CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -HHcCCC----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 001011 1223334455889999999999999999999999998764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=358.21 Aligned_cols=252 Identities=24% Similarity=0.294 Sum_probs=188.6
Q ss_pred HhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
..++|.+.+.||+|+||.||+|++.. ++.||||++.... ..+.+.+|+.+|++++||||+++++++.. ....
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~ 123 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFET----PTEI 123 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEEC----SSEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEec----CCeE
Confidence 46789999999999999999999874 8899999998643 23458899999999999999999999875 4578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC---CCCeEEeccCce
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGMA 377 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~~~~kL~DFGla 377 (631)
++||||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 124 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp EEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred EEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 9999999999999999754 45899999999999999999999998 999999999999975 889999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ... +..
T Consensus 199 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~-----i~~- 265 (349)
T 2w4o_A 199 KIVEHQV------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM-FRR-----ILN- 265 (349)
T ss_dssp --------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH-HHH-----HHT-
T ss_pred cccCccc------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH-HHH-----HHh-
Confidence 8764321 123456999999999999999999999999999999999999999653322100 000 000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. ............+..+.+|+.+||+.||++|||+.++++.
T Consensus 266 -----~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 266 -----C--EYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -----T--CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----C--CCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0000011112233458899999999999999999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=372.80 Aligned_cols=250 Identities=26% Similarity=0.314 Sum_probs=194.5
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccC--CCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ--GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
.++|.+.+.||+|+||.||+|... +|+.||||++... ........+.+|+.+|+.++||||+++++++.. ...
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----~~~ 222 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT----HDR 222 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE----TTE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee----CCE
Confidence 467888999999999999999975 4899999999753 223334457899999999999999999999986 557
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHh-cCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
.|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCK 297 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred EEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCce
Confidence 89999999999999999754 468999999999999999999998 77 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
...... .......||+.|+|||++.+..++.++||||||++||||++|+.||..............
T Consensus 298 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--------- 363 (446)
T 4ejn_A 298 EGIKDG-----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------- 363 (446)
T ss_dssp TTCC----------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------
T ss_pred eccCCC-----cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh---------
Confidence 643322 223446799999999999999999999999999999999999999965432211111100
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 505 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 505 (631)
. .. .+|...+..+.+|+.+||+.||.+|| ++.|+++.
T Consensus 364 ---~---~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 364 ---E---EI----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ---C---CC----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---C---CC----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 0 01 12223334588999999999999999 99999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=347.90 Aligned_cols=252 Identities=27% Similarity=0.399 Sum_probs=198.6
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
.++|.+.+.||+|+||.||+|.++ |+.||||+++... ..+.|.+|+.++++++||||+++++++.+. ....++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~l 92 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE---KGGLYI 92 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC-----CCEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC---CCceEE
Confidence 467888999999999999999885 8899999997543 345689999999999999999999987642 335799
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 999999999999997654344899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
. .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......... .+
T Consensus 170 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~--------------~~ 227 (278)
T 1byg_A 170 T--------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP--------------RV 227 (278)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH--------------HH
T ss_pred c--------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--------------HH
Confidence 2 122357889999999999999999999999999999998 999996533211100 00
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
.....+ ..+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 228 ~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 228 EKGYKM----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp TTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCC----CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 011111 122233445889999999999999999999999998773
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=358.58 Aligned_cols=210 Identities=25% Similarity=0.300 Sum_probs=181.6
Q ss_pred eeecHHHHHHHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-----CCCCcc
Q 006785 212 IRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-----HCHVVP 285 (631)
Q Consensus 212 ~~~s~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~ 285 (631)
..+++.......++|.+.+.||+|+||.||+|++. +++.||||++... ......+..|+.+++.+. ||||++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 44555555666789999999999999999999985 5899999999742 233445788999999996 999999
Q ss_pred eeEEeeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC
Q 006785 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 365 (631)
Q Consensus 286 l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~ 365 (631)
+++++.. ....++||||+ +++|.+++.......+++.++..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 101 ~~~~~~~----~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 101 YHGKFMY----YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDD 172 (360)
T ss_dssp EEEEEEE----TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESC
T ss_pred ccceeeE----CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcc
Confidence 9999886 45789999999 999999998765566999999999999999999999998 999999999999975
Q ss_pred -------------------------CCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhh
Q 006785 366 -------------------------NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFS 420 (631)
Q Consensus 366 -------------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwS 420 (631)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Diws 244 (360)
T 3llt_A 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--------HGSIINTRQYRAPEVILNLGWDVSSDMWS 244 (360)
T ss_dssp TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--------CCSCCSCGGGCCHHHHTTCCCCTTHHHHH
T ss_pred ccccccccchhcccccccccccccCCCCEEEEeccCceecCCC--------CcCccCcccccCcHHHcCCCCCCccchHH
Confidence 788999999999864322 23456999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCcc
Q 006785 421 FGVVLLELITGRQPIHRSI 439 (631)
Q Consensus 421 lGviL~eLltG~~P~~~~~ 439 (631)
||+++|||++|+.||....
T Consensus 245 lG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 245 FGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHHHHHHHSSCSCCCSS
T ss_pred HHHHHHHHHHCCCCCCCCc
Confidence 9999999999999997543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=354.38 Aligned_cols=279 Identities=25% Similarity=0.398 Sum_probs=202.6
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHH--HhcCCCCCcceeEEeeecc-CCcce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDML--SRLHHCHVVPLVGYCSEFR-GKRAM 299 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l--~~l~H~niv~l~g~~~~~~-~~~~~ 299 (631)
.++|.+.+.||+|+||.||+|++ +++.||||++... ....+..|.+++ ..++||||+++++++.... .....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 36788899999999999999987 5899999999743 223355555554 4589999999998765432 23446
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhc---------CCCceeecCCCCCCeeecCCCCeE
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA---------AAPRILHRDIKSSNILLDENLNAK 370 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------~~~~ivHrDlKp~NILl~~~~~~k 370 (631)
.++||||+++|+|.+++... .+++..+..++.|++.||+|||+. + |+||||||+||||+.++.+|
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 78999999999999999753 358999999999999999999998 7 99999999999999999999
Q ss_pred EeccCceeecccCCCCC---CCCCCcccccCCCCCCchhhhc-------CCCCcccchhhHHHHHHHHHhCCCCCCCccc
Q 006785 371 ITDLGMAKRLKADGLPS---CSSSPARMQGTFGYFAPEYAMV-------GRASLMSDVFSFGVVLLELITGRQPIHRSIT 440 (631)
Q Consensus 371 L~DFGla~~~~~~~~~~---~~~~~~~~~Gt~~Y~APE~~~~-------~~~s~ksDVwSlGviL~eLltG~~P~~~~~~ 440 (631)
|+|||+++......... .........||+.|+|||++.+ ..++.++||||||+++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999998775433211 0112234569999999999976 4567789999999999999999888754332
Q ss_pred cccchhhh----hccccccccc-ccccccCCCCCCCCC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 441 KGEESLVL----WATPRLQDSG-TVISELPDPRLKGDF--PKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 441 ~~~~~~~~----~~~~~~~~~~-~~~~~~~~~~l~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
........ ...+...... ........+.+.... ....+..+.+|+.+||+.||++|||+.|+++.|..+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 21111000 0000000000 000111112222111 234566799999999999999999999999999988643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=356.56 Aligned_cols=265 Identities=24% Similarity=0.229 Sum_probs=201.9
Q ss_pred HHHHHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccC----CCCChHHHHHHHHHHHHhcCCCCCcceeEEeee
Q 006785 218 ALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ----GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 292 (631)
Q Consensus 218 ~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 292 (631)
.+....++|.+.+.||+|+||.||+|... +++.||||++... ........+.+|+.+|++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 35667788999999999999999999875 4889999998643 234555679999999999999999999999876
Q ss_pred ccCCcceEEEEEeeCCCCChHhhhhccc--------------------------------------cCCCCHHHHHHHHH
Q 006785 293 FRGKRAMRLLVFEFMPNGNLRDCLDGVL--------------------------------------VEGMNWDTRVAIAI 334 (631)
Q Consensus 293 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------~~~l~~~~~~~i~~ 334 (631)
....++||||+++|+|.+++.... ...+++..+..++.
T Consensus 100 ----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 175 (345)
T 3hko_A 100 ----EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175 (345)
T ss_dssp ----SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred ----CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence 557899999999999999985211 11135778889999
Q ss_pred HHHhhhHHHHhcCCCceeecCCCCCCeeecCCC--CeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhc--C
Q 006785 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENL--NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV--G 410 (631)
Q Consensus 335 ~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~--~ 410 (631)
|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.+....... ........||+.|+|||++.+ .
T Consensus 176 qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~ 251 (345)
T 3hko_A 176 QIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE-YYGMTTKAGTPYFVAPEVLNTTNE 251 (345)
T ss_dssp HHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---------CCCGGGCCHHHHTCSSS
T ss_pred HHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccc-cccccccCCCccccCchhhccCCC
Confidence 9999999999998 99999999999998776 89999999998765422111 112334569999999999975 6
Q ss_pred CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcc
Q 006785 411 RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQ 490 (631)
Q Consensus 411 ~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~ 490 (631)
.++.++||||||+++|||++|+.||................. ..........+..+.+|+.+||+
T Consensus 252 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~li~~~l~ 316 (345)
T 3hko_A 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKL---------------CFENPNYNVLSPLARDLLSNLLN 316 (345)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------------CTTSGGGGGSCHHHHHHHHHHSC
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccc---------------ccCCcccccCCHHHHHHHHHHcC
Confidence 789999999999999999999999965433211111100000 00000111233458899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 006785 491 LDPDARPTMSEVVQI 505 (631)
Q Consensus 491 ~dP~~RPs~~evl~~ 505 (631)
.||.+||++.++++.
T Consensus 317 ~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 317 RNVDERFDAMRALQH 331 (345)
T ss_dssp SCTTTSCCHHHHHHS
T ss_pred CChhHCCCHHHHhcC
Confidence 999999999999873
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=345.89 Aligned_cols=262 Identities=24% Similarity=0.365 Sum_probs=204.9
Q ss_pred ccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
|...+.||+|+||.||+|.+.+ +..||||++.........+.|.+|+.++++++||||+++++++... ....+
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~ 99 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP---EGLPH 99 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS---SSCCE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC---CCCcE
Confidence 4556889999999999998643 2379999998655545556799999999999999999999998752 23448
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+.+|+|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 100 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999999763 355899999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
...... ........+|+.|+|||.+.+..++.++||||||+++|||++|..|+............ +
T Consensus 176 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~-------------~ 241 (298)
T 3pls_A 176 DREYYS-VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF-------------L 241 (298)
T ss_dssp TGGGGC-SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHH-------------H
T ss_pred CCcccc-cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHH-------------h
Confidence 332111 12233456889999999999999999999999999999999966665433222111100 0
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
....... .+...+..+.+|+.+||+.||.+|||+.++++.|..+...
T Consensus 242 ~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 242 AQGRRLP----QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp HTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcCCCCC----CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0111111 1222334588999999999999999999999999987543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=358.19 Aligned_cols=249 Identities=22% Similarity=0.296 Sum_probs=201.5
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~ 298 (631)
.++|...+.||+|+||.||+|+.+. |+.||||+++... .......+..|..+|..+ +||||+++++++.. ..
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~----~~ 94 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----MD 94 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC----SS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc----CC
Confidence 4678999999999999999999875 8899999997531 123345588999999988 89999999998875 55
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..|+||||++||+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 789999999999999999754 45999999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.
T Consensus 170 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~---------- 234 (353)
T 2i0e_A 170 ENIWDG-----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM---------- 234 (353)
T ss_dssp CCCCTT-----CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----------
T ss_pred ccccCC-----cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH----------
Confidence 643322 12344679999999999999999999999999999999999999997543211110000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-----MSEVVQ 504 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 504 (631)
.. .. .+|...+..+.+|+.+||..||.+||+ +.+|++
T Consensus 235 ---~~--~~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 235 ---EH--NV----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ---HC--CC----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ---hC--CC----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 00 01 122333455889999999999999995 466654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=360.90 Aligned_cols=253 Identities=23% Similarity=0.287 Sum_probs=203.2
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.++|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.+|+.++||||+++++++.+ ....+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFED----KYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC----SSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe----CCEEE
Confidence 467999999999999999999886 58999999997543 2234468999999999999999999999875 55789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC--CCCeEEeccCceee
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE--NLNAKITDLGMAKR 379 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~--~~~~kL~DFGla~~ 379 (631)
+||||+++|+|.+++... ...+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 125 lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp EEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEeccccee
Confidence 999999999999999753 245899999999999999999999998 999999999999974 46799999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...............
T Consensus 201 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~--------- 265 (387)
T 1kob_A 201 LNPDE------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC--------- 265 (387)
T ss_dssp CCTTS------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC---------
T ss_pred cCCCc------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------
Confidence 65432 223456999999999999999999999999999999999999999754321111000000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
....++. .....+..+.+|+.+||+.||.+|||+.++++.
T Consensus 266 --~~~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 266 --DWEFDED----AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp --CCCCCSS----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --CCCCCcc----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0001111 112233458899999999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=355.52 Aligned_cols=259 Identities=25% Similarity=0.429 Sum_probs=203.7
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcE--EEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcce
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRI--VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~--vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 299 (631)
++|...+.||+|+||.||+|.+. ++.. ||||++...........+.+|+.+++++ +||||+++++++.. ...
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----~~~ 100 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----RGY 100 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE----TTE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee----CCc
Confidence 56888899999999999999875 4554 5999998654445555689999999999 99999999999876 557
Q ss_pred EEEEEeeCCCCChHhhhhccc--------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC
Q 006785 300 RLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 365 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~ 365 (631)
.|+||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+++ |+||||||+|||++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGE 177 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECG
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcC
Confidence 899999999999999997542 235899999999999999999999998 999999999999999
Q ss_pred CCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccc
Q 006785 366 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEE 444 (631)
Q Consensus 366 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~ 444 (631)
++.+||+|||+++..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.........
T Consensus 178 ~~~~kL~Dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~ 251 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVY------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251 (327)
T ss_dssp GGCEEECCTTCEESSCEE------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred CCeEEEcccCcCcccccc------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH
Confidence 999999999999754321 11223457889999999999899999999999999999998 99999654321110
Q ss_pred hhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006785 445 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513 (631)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 513 (631)
.. +...... ..+...+..+.+|+.+||+.||.+|||+.++++.|..+....
T Consensus 252 ~~--------------~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 252 EK--------------LPQGYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp HH--------------GGGTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HH--------------hhcCCCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 00 0000111 122233345889999999999999999999999999886543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=364.19 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=196.9
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcC--CCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLH--HCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|.+.+.||+|+||.||+|...+++.||||++..... ......|.+|+.+|++++ ||||+++++++.. ....
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~----~~~~ 131 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----DQYI 131 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----SSEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec----CCEE
Confidence 45888999999999999999988899999999976532 234456899999999995 5999999999876 4568
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||| +.+++|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.+
T Consensus 132 ~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 99999 5689999999764 46899999999999999999999998 99999999999996 578999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMV-----------GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 449 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-----------~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~ 449 (631)
...... .......||+.|+|||++.+ ..++.++|||||||+||||++|+.||........ .
T Consensus 205 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-~---- 276 (390)
T 2zmd_A 205 QPDTTS---VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-K---- 276 (390)
T ss_dssp ------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-H----
T ss_pred cCCCcc---ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-H----
Confidence 543211 12234579999999999875 4689999999999999999999999964322110 0
Q ss_pred cccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006785 450 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506 (631)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 506 (631)
+..+.++.....++...+..+.+|+.+||+.||.+|||+.|+++.-
T Consensus 277 -----------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 277 -----------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp -----------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -----------HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 1111111111122222234588999999999999999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=342.40 Aligned_cols=253 Identities=22% Similarity=0.302 Sum_probs=202.9
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
.++|.+.+.||+|+||.||+|.+. +|+.||||++..... ......+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 80 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE----ESFH 80 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc----CCEE
Confidence 578999999999999999999876 489999999975432 2334568899999999999999999999875 5577
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCC---eEEeccCce
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN---AKITDLGMA 377 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~---~kL~DFGla 377 (631)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 81 ~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 9999999999999998754 45899999999999999999999998 999999999999986655 999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||................
T Consensus 156 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~------ 223 (284)
T 3kk8_A 156 IEVNDSE------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA------ 223 (284)
T ss_dssp EECCSSC------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------
T ss_pred EEcccCc------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcc------
Confidence 7765432 2234569999999999999999999999999999999999999996543221111100000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
...+.+ .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 224 ----~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 224 ----YDYPSP-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ----CCCCTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ----ccCCch-----hhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 001111 111223448899999999999999999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=356.74 Aligned_cols=273 Identities=20% Similarity=0.208 Sum_probs=201.8
Q ss_pred cCccccceeeeeCceEEEEEEEC----CCcEEEEEEeccCCCCC----------hHHHHHHHHHHHHhcCCCCCcceeEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPN----------ADSVFLTEVDMLSRLHHCHVVPLVGY 289 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~~~----------~~~~~~~E~~~l~~l~H~niv~l~g~ 289 (631)
++|.+.+.||+|+||.||+|.+. ++..||||++....... ....+.+|+.+++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56888999999999999999986 47889999987653211 11236788899999999999999999
Q ss_pred eeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC--
Q 006785 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-- 367 (631)
Q Consensus 290 ~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-- 367 (631)
+..........|+||||+ +++|.+++.... .+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCC
Confidence 987544566889999999 999999997643 6999999999999999999999998 99999999999998887
Q ss_pred CeEEeccCceeecccCCCCCC--CCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccch
Q 006785 368 NAKITDLGMAKRLKADGLPSC--SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES 445 (631)
Q Consensus 368 ~~kL~DFGla~~~~~~~~~~~--~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~ 445 (631)
.+||+|||+++.+........ ........||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 999999999987754332111 111234579999999999999999999999999999999999999996432211111
Q ss_pred hhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 446 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
.... ..........+..... ...+ +..+.+|+..||..||++||++.+|++.|+.+.
T Consensus 271 ~~~~-~~~~~~~~~~~~~~~~---~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 271 QTAK-TNLLDELPQSVLKWAP---SGSS----CCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHH-HHHHHTTTHHHHHHSC---TTSC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHH-HhhcccccHHHHhhcc---cccc----HHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 0000 0000000000000000 0022 335889999999999999999999999998764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=349.67 Aligned_cols=274 Identities=25% Similarity=0.336 Sum_probs=202.7
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC----CChHHHHHHHHHHHHhcC---CCCCcceeEEeeec
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG----PNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEF 293 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~----~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~ 293 (631)
..++|.+.+.||+|+||+||+|.+. +|+.||||++..... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4678999999999999999999974 589999999874321 122345778888888774 99999999999764
Q ss_pred cCC-cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEe
Q 006785 294 RGK-RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 372 (631)
Q Consensus 294 ~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~ 372 (631)
... ....++||||+. |+|.+++.......+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEe
Confidence 322 235799999996 69999998765556999999999999999999999999 9999999999999999999999
Q ss_pred ccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhc--
Q 006785 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA-- 450 (631)
Q Consensus 373 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~-- 450 (631)
|||+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...............
T Consensus 163 Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (308)
T 3g33_A 163 DFGLARIYSYQ------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236 (308)
T ss_dssp SCSCTTTSTTC------CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHC
T ss_pred eCccccccCCC------cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999765432 2234567999999999999999999999999999999999999999754332211111000
Q ss_pred ccc---cccccccccccCCCCCCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 451 TPR---LQDSGTVISELPDPRLKG---DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 451 ~~~---~~~~~~~~~~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+. +............+.... ......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000 000000000000000000 0111233458899999999999999999999874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=344.20 Aligned_cols=250 Identities=25% Similarity=0.400 Sum_probs=207.2
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+.|...+.||+|+||.||+|... +++.||||++...........+.+|+.++++++||||+++++++.. ....++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l 97 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK----DTKLWI 97 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec----CCeEEE
Confidence 56888899999999999999875 5899999999876655666779999999999999999999999886 457899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 98 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp EEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred EEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCc
Confidence 9999999999999965 45899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........... +.
T Consensus 172 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--------------~~ 232 (303)
T 3a7i_A 172 TQI-----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL--------------IP 232 (303)
T ss_dssp TBC-----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--------------HH
T ss_pred ccc-----ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH--------------hh
Confidence 321 12345689999999999999999999999999999999999999965322111000 01
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 506 (631)
....+.+...++. .+.+|+..||+.||.+|||+.++++..
T Consensus 233 ~~~~~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 233 KNNPPTLEGNYSK----PLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp HSCCCCCCSSCCH----HHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred cCCCCCCccccCH----HHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 1112222233443 488999999999999999999998754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.37 Aligned_cols=278 Identities=26% Similarity=0.323 Sum_probs=210.2
Q ss_pred cCccccceeeeeCceEEEEEEE-----CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
++|.+.+.||+|+||.||+|++ .+++.||||++.... ......+.+|++++++++||||+++++++.... ..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~ 99 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPG--RQ 99 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--SC
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC--Cc
Confidence 5678889999999999999985 358899999997642 334456899999999999999999999886422 45
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred eEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 6899999999999999997643 35899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
........ ........||+.|+|||++.+..++.++||||||+++|+|++|+.||............. .......
T Consensus 176 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~--~~~~~~~- 250 (327)
T 3lxl_A 176 LLPLDKDY--YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC--ERDVPAL- 250 (327)
T ss_dssp ECCTTCSE--EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHH-
T ss_pred ecccCCcc--ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccc--ccccccH-
Confidence 76543211 112233458889999999999999999999999999999999999986433211000000 0000000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 513 (631)
..+............+...+..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 0000111111112233344455899999999999999999999999999885443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=369.48 Aligned_cols=261 Identities=21% Similarity=0.295 Sum_probs=205.1
Q ss_pred HHHHHHhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeec
Q 006785 217 SALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293 (631)
Q Consensus 217 ~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 293 (631)
.++....++|.+.+.||+|+||.||+|+++. ++.||||++.... .......+.+|+.+|+.++||||+++++++.+
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~- 140 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD- 140 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-
Confidence 4455567899999999999999999999864 8999999986421 11112237899999999999999999999876
Q ss_pred cCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEec
Q 006785 294 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD 373 (631)
Q Consensus 294 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~D 373 (631)
....|+||||++||+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 141 ---~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 141 ---DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp ---SSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred ---CCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEec
Confidence 5678999999999999999975 35899999999999999999999998 99999999999999999999999
Q ss_pred cCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCC----CCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh
Q 006785 374 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR----ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 449 (631)
Q Consensus 374 FGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~----~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~ 449 (631)
||+++....... .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...........+..
T Consensus 212 FG~a~~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 287 (410)
T 3v8s_A 212 FGTCMKMNKEGM----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 287 (410)
T ss_dssp CTTCEECCTTSE----EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred cceeEeeccCCc----ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHh
Confidence 999987654321 1123457999999999998655 78999999999999999999999975432211111000
Q ss_pred cccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 006785 450 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDA--RPTMSEVVQIL 506 (631)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L 506 (631)
. ...+..|. ...+ +..+.+|+.+||..+|.+ ||++.||++.-
T Consensus 288 ~----------~~~~~~p~-~~~~----s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 288 H----------KNSLTFPD-DNDI----SKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp H----------HHHCCCCT-TCCC----CHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred c----------cccccCCC-cccc----cHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 0 00011110 0122 344889999999999988 99999998753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=350.74 Aligned_cols=253 Identities=22% Similarity=0.320 Sum_probs=203.7
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC-----hHHHHHHHHHHHHhcCCCCCcceeEEeeeccCC
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-----ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 296 (631)
.++|.+.+.||+|+||.||+|... +|+.||||++....... ....+.+|+.++++++||||+++++++..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 86 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN---- 86 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence 456888999999999999999986 48999999997653322 35669999999999999999999999875
Q ss_pred cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC----CeEEe
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL----NAKIT 372 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~----~~kL~ 372 (631)
....++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEc
Confidence 55789999999999999999753 45899999999999999999999998 99999999999999887 79999
Q ss_pred ccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccc
Q 006785 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 452 (631)
Q Consensus 373 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 452 (631)
|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.............
T Consensus 162 Dfg~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~---- 231 (321)
T 2a2a_A 162 DFGLAHEIEDGV------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT---- 231 (321)
T ss_dssp CCTTCEECCTTC------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH----
T ss_pred cCccceecCccc------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH----
Confidence 999998765432 2234569999999999999999999999999999999999999996543221110000
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 453 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.. ........+...+..+.+|+.+||+.||.+|||+.++++.
T Consensus 232 ----------~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 232 ----------SV-SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp ----------TT-CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ----------hc-ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0000000001123458899999999999999999999874
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=354.17 Aligned_cols=252 Identities=23% Similarity=0.311 Sum_probs=197.6
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCC--ChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcce
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGP--NADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 299 (631)
++|...+.||+|+||.||+|+.+. ++.||||++...... .....+.+|..++.++ +||||+++++++.. ...
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~----~~~ 84 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT----ESR 84 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----SSE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe----CCE
Confidence 568889999999999999999864 899999999765322 2334588999999988 89999999999875 557
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccc
Confidence 89999999999999999754 45999999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||............. ...
T Consensus 160 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~--------~~~ 226 (345)
T 3a8x_A 160 GLRPG-----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT--------EDY 226 (345)
T ss_dssp SCCTT-----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------C--------HHH
T ss_pred ccCCC-----CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccccc--------HHH
Confidence 43221 12344679999999999999999999999999999999999999996432111000000 000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM 499 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 499 (631)
....+.... ..+|...+..+.+|+.+||+.||.+||++
T Consensus 227 ~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 227 LFQVILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHHHHHcCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 000000000 01233344558899999999999999996
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=341.99 Aligned_cols=255 Identities=26% Similarity=0.322 Sum_probs=205.2
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.++|.+.+.||+|+||.||+|... +++.||||++...........+.+|+.+++.++||||+++++++.+ ....|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 81 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE----GNIQY 81 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----TTEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc----CCEEE
Confidence 467888999999999999999986 5899999999766555566779999999999999999999999876 55779
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp EEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 999999999999999753 45899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
.... ........||+.|+|||++.+..+ +.++||||||+++|||++|+.||......... ...+....
T Consensus 157 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~------- 225 (276)
T 2yex_A 157 YNNR---ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKK------- 225 (276)
T ss_dssp ETTE---ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHHTTC-------
T ss_pred CCcc---hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhhhcc-------
Confidence 3321 111234568999999999987665 78999999999999999999999754332111 11111000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. ........+..+.+|+.+||+.||.+|||+.++++.
T Consensus 226 ----~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 226 ----T----YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ----T----TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----c----ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0 000112233458899999999999999999999763
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=359.46 Aligned_cols=269 Identities=17% Similarity=0.238 Sum_probs=206.2
Q ss_pred cCccccceeeeeCceEEEEEEECC---------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcc---------
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD---------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP--------- 285 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~---------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~--------- 285 (631)
++|.+.+.||+|+||.||+|++.. ++.||||++.... .+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDG------RLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTS------THHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccc------hHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 568889999999999999999764 7899999997541 3889999999999999987
Q ss_pred ------eeEEeeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCC
Q 006785 286 ------LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359 (631)
Q Consensus 286 ------l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~ 359 (631)
+++++.. .....|+||||+ +++|.+++.......+++.+++.++.||+.||+|||+++ |+||||||+
T Consensus 116 ~~~i~~~~~~~~~---~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~ 188 (352)
T 2jii_A 116 LLAIPTCMGFGVH---QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAE 188 (352)
T ss_dssp TCSCCCCCEEEEE---TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGG
T ss_pred ccCccchhhcccc---CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHH
Confidence 5666554 245789999999 999999998754467999999999999999999999998 999999999
Q ss_pred CeeecCCC--CeEEeccCceeecccCCCCC--CCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCC
Q 006785 360 NILLDENL--NAKITDLGMAKRLKADGLPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 435 (631)
Q Consensus 360 NILl~~~~--~~kL~DFGla~~~~~~~~~~--~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~ 435 (631)
|||++.++ .+||+|||+++.+....... .........||+.|+|||++.+..++.++||||||++||||++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 89999999998765432211 111223457999999999999999999999999999999999999999
Q ss_pred CCccccccchhhhhcccccccccccccccCCCCCC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcc
Q 006785 436 HRSITKGEESLVLWATPRLQDSGTVISELPDPRLK-GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKS 514 (631)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 514 (631)
.............. . .+.. ....+...... ..++ ..+.+|+.+||+.||.+|||+.+|++.|..+.....
T Consensus 269 ~~~~~~~~~~~~~~-~-~~~~---~~~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 269 TNCLPNTEDIMKQK-Q-KFVD---KPGPFVGPCGHWIRPS----ETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GGGTTCHHHHHHHH-H-HHHH---SCCCEECTTSCEECCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccCCcCHHHHHHHH-H-hccC---ChhhhhhhccccCCCc----HHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 75432211111000 0 0000 00011111000 1123 448899999999999999999999999998864443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=350.08 Aligned_cols=276 Identities=25% Similarity=0.362 Sum_probs=211.4
Q ss_pred HHHHHHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHh--cCCCCCcceeEEeeec
Q 006785 216 YSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR--LHHCHVVPLVGYCSEF 293 (631)
Q Consensus 216 ~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~ 293 (631)
+..-....++|.+.+.||+|+||.||+|++ +|+.||||++... ....+.+|++++.. ++||||+++++++...
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 344455678899999999999999999998 4899999998643 34558899999988 6999999999998864
Q ss_pred cCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHH--------hcCCCceeecCCCCCCeeecC
Q 006785 294 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH--------EAAAPRILHRDIKSSNILLDE 365 (631)
Q Consensus 294 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrDlKp~NILl~~ 365 (631)
.......++||||+++|+|.+++.. ..+++.+++.++.|++.||+||| +.+ |+||||||+|||++.
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKK 182 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECT
T ss_pred CCccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECC
Confidence 4333478999999999999999975 35899999999999999999999 676 999999999999999
Q ss_pred CCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCC------CCcccchhhHHHHHHHHHhC--------
Q 006785 366 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR------ASLMSDVFSFGVVLLELITG-------- 431 (631)
Q Consensus 366 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~------~s~ksDVwSlGviL~eLltG-------- 431 (631)
++.+||+|||++.......... ........||+.|+|||++.+.. ++.++||||||+++|||++|
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTI-DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEE-EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCEEEEECCCceecccccccc-ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 9999999999998765432110 01223456999999999997653 34789999999999999999
Q ss_pred --CCCCCCccccccchhhhhcccccccccccccccCCCCCCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006785 432 --RQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGD-FPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508 (631)
Q Consensus 432 --~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 508 (631)
..||............ +.. ........+.+... .....+..+.+|+.+||+.||++|||+.+|++.|..
T Consensus 262 ~~~~p~~~~~~~~~~~~~-~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 262 DYQLPYYDLVPSDPSVEE-MRK-------VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp CCCCTTTTTSCSSCCHHH-HHH-------HHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccccCccccCcCcccHHH-HHH-------HHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 6777543322111000 000 00011111111111 123566789999999999999999999999999998
Q ss_pred hCC
Q 006785 509 IAP 511 (631)
Q Consensus 509 i~~ 511 (631)
+..
T Consensus 334 i~~ 336 (342)
T 1b6c_B 334 LSQ 336 (342)
T ss_dssp HHH
T ss_pred HHH
Confidence 753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=347.50 Aligned_cols=262 Identities=23% Similarity=0.331 Sum_probs=196.6
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|.+.+.||+|+||.||+|... +|+.||||++.... .......+.+|+.++++++||||+++++++.. ....
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~ 107 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE----DNEL 107 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----TTEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCcE
Confidence 56888999999999999999874 68999999997532 22344568999999999999999999999886 4578
Q ss_pred EEEEeeCCCCChHhhhhcc--ccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 301 LLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
++||||+++|+|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGR 184 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC----
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEecccee
Confidence 9999999999999999642 2345899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 185 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---------- 249 (310)
T 2wqm_A 185 FFSSKT-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK---------- 249 (310)
T ss_dssp -------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHH----------
T ss_pred eecCCC-----ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHH----------
Confidence 664322 12234568999999999999999999999999999999999999996432211000000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
+.....+.+. +...+..+.+|+.+||+.||.+|||+.+|++.|..+.+.
T Consensus 250 --~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 250 --IEQCDYPPLP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp --HHTTCSCCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --hhcccCCCCc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 0000011111 112234488999999999999999999999999988543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=347.76 Aligned_cols=268 Identities=24% Similarity=0.326 Sum_probs=198.5
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
++|...+.||+|+||.||+|.+.. |+.||||++...... .....+.+|+.++++++||||+++++++.. ....+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~ 78 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR----KRRLH 78 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec----CCeEE
Confidence 678899999999999999999864 899999998765332 224558899999999999999999999876 55789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 79 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp EEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 999999999999988653 45899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccc----
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD---- 456 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~---- 456 (631)
... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.....................
T Consensus 154 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
T 4agu_A 154 GPS-----DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 228 (311)
T ss_dssp -----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred Ccc-----cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccc
Confidence 322 12234568999999999986 66899999999999999999999999764432211111000000000
Q ss_pred ---ccccc--cccCCCCCCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 457 ---SGTVI--SELPDPRLKGDF---PKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 457 ---~~~~~--~~~~~~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..... ..+.++...... ....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 011111110000 01223448899999999999999999999874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=346.19 Aligned_cols=253 Identities=23% Similarity=0.372 Sum_probs=199.9
Q ss_pred hcCccccceeeeeCceEEEEEEECC-C-------cEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeecc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD-G-------RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 294 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g-------~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 294 (631)
.++|...+.||+|+||.||+|.+.. + ..||+|++.... ....+.|.+|+.++++++||||+++++++..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVC-- 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC--
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe--
Confidence 3568888999999999999998653 3 579999986542 3445669999999999999999999999876
Q ss_pred CCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCC------
Q 006785 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN------ 368 (631)
Q Consensus 295 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~------ 368 (631)
....++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 84 --~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 84 --GDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp --TTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBC
T ss_pred --CCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccc
Confidence 445699999999999999997642 34899999999999999999999999 999999999999998887
Q ss_pred --eEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccch
Q 006785 369 --AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES 445 (631)
Q Consensus 369 --~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~ 445 (631)
+||+|||++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|..|+..........
T Consensus 158 ~~~kl~Dfg~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~ 228 (289)
T 4fvq_A 158 PFIKLSDPGISITVLP---------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL 228 (289)
T ss_dssp CEEEECCCCSCTTTSC---------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred ceeeeccCcccccccC---------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH
Confidence 99999999865432 223568999999999987 779999999999999999999655543322211110
Q ss_pred hhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 446 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
... . ..+.+....+ ..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 229 ~~~-~--------------~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 229 QFY-E--------------DRHQLPAPKA----AELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HHH-H--------------TTCCCCCCSS----CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred HHh-h--------------ccCCCCCCCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 000 0 0011111122 2378899999999999999999999999988654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=344.24 Aligned_cols=248 Identities=24% Similarity=0.377 Sum_probs=199.5
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
.++|.+.+.||+|+||.||+|.+.. ++.||||++.... .......+.+|+.++++++||||+++++++.+ ...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 83 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD----ATR 83 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec----CCE
Confidence 4678889999999999999998764 7899999986431 11224458899999999999999999999875 457
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVH 158 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecccccc
Confidence 89999999999999999764 45899999999999999999999998 99999999999999999999999999865
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||............
T Consensus 159 ~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------------ 219 (279)
T 3fdn_A 159 APSS-------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI------------ 219 (279)
T ss_dssp C---------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------------
T ss_pred CCcc-------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH------------
Confidence 4332 223456899999999999999999999999999999999999999643321111100
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.. ... .++...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 220 --~~-~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 220 --SR-VEF----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --HH-TCC----CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --Hh-CCC----CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 001 1222233458899999999999999999999974
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=343.91 Aligned_cols=259 Identities=24% Similarity=0.352 Sum_probs=202.6
Q ss_pred hcCccccc-eeeeeCceEEEEEEEC---CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 223 TDKFSGSN-IVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 223 ~~~f~~~~-~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
.++|.+.+ .||+|+||.||+|.+. +++.||||+++..... .....|.+|+.+++.++||||+++++++. .
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 89 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----A 89 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----S
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-----C
Confidence 34566677 8999999999999653 3688999999865332 33566999999999999999999999983 3
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
...++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 4579999999999999999764 45899999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
.......... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........
T Consensus 165 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~---------- 232 (291)
T 1xbb_A 165 KALRADENYY--KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM---------- 232 (291)
T ss_dssp EECCTTCSEE--EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----------
T ss_pred eeeccCCCcc--cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----------
Confidence 8765432110 11222346789999999999889999999999999999999 9999975432211000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
+.....+. .+...+..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 233 ----~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 233 ----LEKGERMG----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp ----HHTTCCCC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----HHcCCCCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 01111111 223334458899999999999999999999999987743
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=351.29 Aligned_cols=261 Identities=20% Similarity=0.271 Sum_probs=204.7
Q ss_pred HHHHHHhcCcccc-ceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhc-CCCCCcceeEEeee
Q 006785 217 SALEHATDKFSGS-NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 292 (631)
Q Consensus 217 ~~l~~a~~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 292 (631)
...+...+.|.+. +.||+|+||.||+|... +|+.||||++..... ......+.+|+.++..+ +||||+++++++..
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 4455666777777 88999999999999886 489999999875432 23355689999999999 67999999999875
Q ss_pred ccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC---CCCe
Q 006785 293 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNA 369 (631)
Q Consensus 293 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~~~~ 369 (631)
....++||||+++|+|.+++.......+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+
T Consensus 101 ----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 101 ----TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp ----SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCE
T ss_pred ----CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcE
Confidence 557899999999999999997655567999999999999999999999998 999999999999987 7899
Q ss_pred EEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh
Q 006785 370 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 449 (631)
Q Consensus 370 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~ 449 (631)
||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..............
T Consensus 174 kL~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 247 (327)
T 3lm5_A 174 KIVDFGMSRKIGHAC------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ 247 (327)
T ss_dssp EECCGGGCEEC---------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEeeCccccccCCcc------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh
Confidence 999999998765332 22345699999999999999999999999999999999999999965432211110000
Q ss_pred cccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 450 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. ............+..+.+|+.+||+.||++|||+.++++.
T Consensus 248 ~---------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 248 V---------------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp T---------------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred c---------------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 0000111122234458899999999999999999999764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=365.87 Aligned_cols=265 Identities=22% Similarity=0.286 Sum_probs=206.2
Q ss_pred ecHHHHHHHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEe
Q 006785 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290 (631)
Q Consensus 214 ~s~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 290 (631)
+.+.++....++|...+.||+|+||.||+++.+ +|+.||||+++... .......+.+|..+|..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 445566667789999999999999999999986 59999999996421 111222388999999999999999999998
Q ss_pred eeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeE
Q 006785 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 370 (631)
Q Consensus 291 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 370 (631)
.+ ....|+||||++||+|.++|... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++|
T Consensus 131 ~~----~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vk 202 (412)
T 2vd5_A 131 QD----ENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIR 202 (412)
T ss_dssp EC----SSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred ee----CCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEE
Confidence 76 56789999999999999999754 246999999999999999999999998 99999999999999999999
Q ss_pred EeccCceeecccCCCCCCCCCCcccccCCCCCCchhhh-------cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccc
Q 006785 371 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-------VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 443 (631)
Q Consensus 371 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-------~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~ 443 (631)
|+|||+++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||........
T Consensus 203 L~DFGla~~~~~~~~----~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 278 (412)
T 2vd5_A 203 LADFGSCLKLRADGT----VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET 278 (412)
T ss_dssp ECCCTTCEECCTTSC----EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred EeechhheeccCCCc----cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH
Confidence 999999987654321 1123457999999999997 35689999999999999999999999975432211
Q ss_pred chhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 006785 444 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDAR---PTMSEVVQI 505 (631)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~ 505 (631)
...+... ...+..|.....++ ..+.+|+.+||. +|.+| |++.+|++.
T Consensus 279 ~~~i~~~----------~~~~~~p~~~~~~s----~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 279 YGKIVHY----------KEHLSLPLVDEGVP----EEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHHTH----------HHHCCCC----CCC----HHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHHHhc----------ccCcCCCccccCCC----HHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 1111000 00111121112233 448899999999 99998 589988753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=374.78 Aligned_cols=255 Identities=26% Similarity=0.390 Sum_probs=206.2
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
.++|...+.||+|+||.||+|... +|+.||||++.... .......+.+|+.+|+.++||||+++++++.+ ...
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----~~~ 258 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET----KDA 258 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee----CCE
Confidence 467999999999999999999986 59999999986431 12334558899999999999999999998875 557
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.|+||||++||+|.+++.......+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEeccccee
Confidence 899999999999999997655556999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............
T Consensus 336 ~~~~~------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~---------- 399 (576)
T 2acx_A 336 VPEGQ------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER---------- 399 (576)
T ss_dssp CCTTC------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH----------
T ss_pred cccCc------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH----------
Confidence 65432 12335799999999999998999999999999999999999999975432211100000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 505 (631)
.+... .. .++...+..+.+|+.+||+.||.+|| ++.||++.
T Consensus 400 ~i~~~-~~----~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 400 LVKEV-PE----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHC-CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred Hhhcc-cc----cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 00000 11 12233345588999999999999999 78888764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=353.65 Aligned_cols=253 Identities=25% Similarity=0.320 Sum_probs=199.4
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcce
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 299 (631)
..++|.+.+.||+|+||.||++..+ +|+.||||++...... +.+|+++|.++ +||||+++++++.+ ...
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~E~~~l~~~~~hp~iv~~~~~~~~----~~~ 90 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-----PTEEIEILLRYGQHPNIITLKDVYDD----GKY 90 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-----CHHHHHHHHHHTTSTTBCCEEEEEEC----SSE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-----hHHHHHHHHHhcCCCCcCeEEEEEEc----CCE
Confidence 3567899999999999999999986 4899999999765322 46789999888 89999999999875 567
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCC----CCeEEeccC
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN----LNAKITDLG 375 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~----~~~kL~DFG 375 (631)
.|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 89999999999999999754 45999999999999999999999998 9999999999998443 349999999
Q ss_pred ceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccc
Q 006785 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 455 (631)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 455 (631)
+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..........+.... .
T Consensus 166 ~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i----~ 236 (342)
T 2qr7_A 166 FAKQLRAEN-----GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI----G 236 (342)
T ss_dssp TCEECBCTT-----CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH----H
T ss_pred CcccCcCCC-----CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH----c
Confidence 998765432 1223456899999999998888999999999999999999999999753221111111000 0
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 456 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 456 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. . ...+....+...+..+.+|+.+||..||++||++.++++.
T Consensus 237 ~-----~---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 237 S-----G---KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp H-----C---CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred c-----C---CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 0 0011111222334558899999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=347.51 Aligned_cols=261 Identities=23% Similarity=0.318 Sum_probs=198.6
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
.++|.+.+.||+|+||.||+|.+. +++.||||++...... .....+.+|+.++++++||||+++++++.. ...
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----~~~ 108 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI----DGQ 108 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----TTE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee----CCe
Confidence 478999999999999999999976 5899999999754322 223568999999999999999999999876 457
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.|+||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred EEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 89999999999999999764 45899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||............ .
T Consensus 184 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~-------- 248 (309)
T 2h34_A 184 TTDEKL----TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI---N-------- 248 (309)
T ss_dssp -----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH---H--------
T ss_pred cccccc----ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh---c--------
Confidence 654321 1223456999999999999999999999999999999999999999753321100000 0
Q ss_pred cccccCCC-CCCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhhCCCc
Q 006785 460 VISELPDP-RLKGDFPKEEMQIMAYLAKECLQLDPDARP-TMSEVVQILSTIAPDK 513 (631)
Q Consensus 460 ~~~~~~~~-~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~~ 513 (631)
.....+ .....++ ..+.+|+.+||+.||++|| ++.++++.|..+....
T Consensus 249 --~~~~~~~~~~~~~~----~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 249 --QAIPRPSTVRPGIP----VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp --SCCCCGGGTSTTCC----THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred --cCCCCccccCCCCC----HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 000000 1112233 3488899999999999999 9999999999876544
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=343.12 Aligned_cols=253 Identities=24% Similarity=0.356 Sum_probs=199.9
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
|.+.+.||+|+||.||+|.+. ++..||+|++.... .......+.+|+.+|++++||||+++++++..........++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 566788999999999999875 48899999987543 2334456899999999999999999999987655556678999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeec-CCCCeEEeccCceeeccc
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~-~~~~~kL~DFGla~~~~~ 382 (631)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||||+|||++ .++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999764 45899999999999999999999875 3499999999999997 789999999999965432
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
. ......||+.|+|||++. +.++.++||||||+++|+|++|+.||............. ..
T Consensus 185 ~-------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~------------~~ 244 (290)
T 1t4h_A 185 S-------FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV------------TS 244 (290)
T ss_dssp T-------SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH------------TT
T ss_pred c-------ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHH------------hc
Confidence 2 223456999999999876 569999999999999999999999996533221110000 00
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
...... .+...+..+.+|+.+||+.||.+|||+.++++.
T Consensus 245 ~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 245 GVKPAS----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TCCCGG----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCCccc----cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 000111 111222348899999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=348.62 Aligned_cols=269 Identities=25% Similarity=0.399 Sum_probs=186.0
Q ss_pred HHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 221 ~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
...++|.+.+.||+|+||.||+|... +++.||||++...........+.+|+.++++++||||+++++++.. ...
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 87 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV----KDE 87 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES----SSC
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee----cCC
Confidence 44578999999999999999999864 5899999998765444455568999999999999999999999876 446
Q ss_pred EEEEEeeCCCCChHhhhhcc------ccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEec
Q 006785 300 RLLVFEFMPNGNLRDCLDGV------LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD 373 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~D 373 (631)
.++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 164 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIAD 164 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEe
Confidence 79999999999999999642 2244899999999999999999999998 99999999999999999999999
Q ss_pred cCceeecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccc
Q 006785 374 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 452 (631)
Q Consensus 374 FGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 452 (631)
||++...................||+.|+|||++.. ..++.++||||||+++|||++|+.||.................
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 244 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 244 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC
Confidence 999976644321111122334579999999999876 5689999999999999999999999975433221110000000
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 453 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. .......++.....++ ..+.+|+.+||+.||.+|||+.++++.
T Consensus 245 --~---~~~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 245 --P---SLETGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp --C---CTTC-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred --C---ccccccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 0001111222222334 348899999999999999999999873
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=339.15 Aligned_cols=250 Identities=28% Similarity=0.417 Sum_probs=182.1
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|.+.+.||+|+||.||+|+.. +|+.||||++.... .......+.+|+.++++++||||+++++++.. ....
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 86 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED----SNYV 86 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC----SSEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc----CCeE
Confidence 56888999999999999999974 68999999986431 12234568999999999999999999999875 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 9999999999999999764 246899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 163 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------- 221 (278)
T 3cok_A 163 KMPH-----EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------------- 221 (278)
T ss_dssp C---------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------
T ss_pred cCCC-----CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH----------------
Confidence 4321 1123356899999999999989999999999999999999999999653321110
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..+.... ...+...+..+.+|+.+||+.||++|||+.++++.
T Consensus 222 -~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 222 -NKVVLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp ---CCSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -HHHhhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0000000 01222233458899999999999999999999763
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=351.17 Aligned_cols=263 Identities=24% Similarity=0.352 Sum_probs=204.7
Q ss_pred hcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCC
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 296 (631)
.++|.+.+.||+|+||.||+|++. +++.||||++...........+.+|+.++++++||||+++++++..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 104 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ---- 104 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC----
Confidence 467888999999999999999842 4778999999765545555679999999999999999999999876
Q ss_pred cceEEEEEeeCCCCChHhhhhcccc-----CCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC---CCC
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLV-----EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLN 368 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~~~ 368 (631)
....|+||||+++|+|.+++..... ..+++.+++.++.|++.||.|||+.+ |+||||||+|||++. +..
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcce
Confidence 3456999999999999999976432 34899999999999999999999998 999999999999984 456
Q ss_pred eEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhh
Q 006785 369 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLV 447 (631)
Q Consensus 369 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~ 447 (631)
+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++ |+.||...........
T Consensus 182 ~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~- 257 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYY---RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF- 257 (327)
T ss_dssp EEECCCHHHHHHHC---------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-
T ss_pred EEECcccccccccccccc---ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH-
Confidence 999999999865433211 12234568999999999999999999999999999999998 9999865322111000
Q ss_pred hhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006785 448 LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513 (631)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 513 (631)
+.....+. .+...+..+.+|+.+||+.||.+||++.+|++.|+.+....
T Consensus 258 -------------~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 258 -------------VTSGGRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp -------------HHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred -------------HhcCCCCC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 00001111 12223345889999999999999999999999999875443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=352.96 Aligned_cols=270 Identities=25% Similarity=0.360 Sum_probs=206.7
Q ss_pred hcCccccceeeeeCceEEEEEEE-CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.++|.+.+.||+|+||.||++.. .+|+.||||++... .......+.+|+.++++++||||+++++++..........+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 45788899999999999999997 46899999998654 23345568999999999999999999999975544466789
Q ss_pred EEEeeCCCCChHhhhhcc--ccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 302 LVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
+||||+++|+|.+++... ....+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999999753 2355999999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCCCCC----CCCCcccccCCCCCCchhhhcCC---CCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccc
Q 006785 380 LKADGLPSC----SSSPARMQGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 452 (631)
Q Consensus 380 ~~~~~~~~~----~~~~~~~~Gt~~Y~APE~~~~~~---~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 452 (631)
......... ........||+.|+|||++.... ++.++||||||+++|||++|+.||.............
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---- 259 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA---- 259 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH----
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH----
Confidence 532110000 00011235799999999987554 6899999999999999999999996422111110000
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 453 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
+...... ..+...+..+.+|+.+||+.||.+|||+.++++.|..+.+.
T Consensus 260 --------~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 260 --------VQNQLSI----PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp --------HHCC--C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred --------hhccCCC----CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 0000000 11122234588999999999999999999999999988544
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=343.84 Aligned_cols=262 Identities=22% Similarity=0.298 Sum_probs=204.1
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
.++|.+.+.||+|+||.||+|... +|+.||||++..... ....+.+.+|+.++++++||||+++++++.... ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~ 82 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT--NTTL 82 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG--GTEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC--CceE
Confidence 357888999999999999999986 589999999976532 234456899999999999999999999886532 4478
Q ss_pred EEEEeeCCCCChHhhhhccc--cCCCCHHHHHHHHHHHHhhhHHHHhcCC--CceeecCCCCCCeeecCCCCeEEeccCc
Q 006785 301 LLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAA--PRILHRDIKSSNILLDENLNAKITDLGM 376 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~--~~ivHrDlKp~NILl~~~~~~kL~DFGl 376 (631)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+. .+|+||||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 99999999999999997532 2348999999999999999999999862 3499999999999999999999999999
Q ss_pred eeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccc
Q 006785 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........
T Consensus 163 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---------- 227 (279)
T 2w5a_A 163 ARILNHDT-----SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK---------- 227 (279)
T ss_dssp HHHC---C-----HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----------
T ss_pred heeecccc-----ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHH----------
Confidence 97654321 111235689999999999999999999999999999999999999975432110000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
+.....+. .+...+..+.+|+.+||+.||.+||++.+|++.+...
T Consensus 228 ----i~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 228 ----IREGKFRR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp ----HHHTCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred ----Hhhccccc----CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 00111111 1222334588999999999999999999999876543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=336.71 Aligned_cols=246 Identities=20% Similarity=0.248 Sum_probs=200.5
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.++|.+.+.||+|+||.||+|.... +..||+|++..... .....+.+|++++++++||||+++++++.. ....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFED----NTDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEec----CCeEE
Confidence 4678889999999999999999865 78999999976533 334569999999999999999999999875 55789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeee---cCCCCeEEeccCcee
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAK 378 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl---~~~~~~kL~DFGla~ 378 (631)
+||||+++++|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++.
T Consensus 83 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp EEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 999999999999998754 45899999999999999999999998 9999999999999 788899999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
...... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||................
T Consensus 158 ~~~~~~------~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------- 223 (277)
T 3f3z_A 158 RFKPGK------MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGT------- 223 (277)
T ss_dssp ECCTTS------CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------
T ss_pred eccCcc------chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-------
Confidence 765432 2233469999999998765 48999999999999999999999996543221111000000
Q ss_pred ccccccCCCCCCCCCCH----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 459 TVISELPDPRLKGDFPK----EEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
. ..+. ..+..+.+|+.+||+.||.+|||+.++++
T Consensus 224 -----~-------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 224 -----F-------TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -----C-------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -----C-------CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 1111 12345889999999999999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=357.92 Aligned_cols=247 Identities=24% Similarity=0.311 Sum_probs=193.0
Q ss_pred cceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEeeC
Q 006785 229 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 307 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E~~ 307 (631)
.+.||+|+||.||+|... +|+.||||+++... ......|.+|+.+|++++||||+++++++.. ....++||||+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~E~~ 168 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFES----KNDIVLVMEYV 168 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEEEEEEECC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEE----CCEEEEEEeCC
Confidence 568999999999999875 58999999997643 2344569999999999999999999999876 45789999999
Q ss_pred CCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeee--cCCCCeEEeccCceeecccCCC
Q 006785 308 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL--DENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 308 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl--~~~~~~kL~DFGla~~~~~~~~ 385 (631)
++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++......
T Consensus 169 ~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~- 243 (373)
T 2x4f_A 169 DGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE- 243 (373)
T ss_dssp TTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence 9999999986532 35899999999999999999999998 9999999999999 567889999999998765432
Q ss_pred CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccC
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (631)
......||+.|+|||++.+..++.++||||||+++|||++|+.||............... .. ..
T Consensus 244 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~--------~~- 307 (373)
T 2x4f_A 244 -----KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC--RW--------DL- 307 (373)
T ss_dssp -----BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CC--------CS-
T ss_pred -----ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cC--------CC-
Confidence 122346999999999999999999999999999999999999999754322111100000 00 00
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 466 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 466 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+.....+ +..+.+|+.+||+.||.+|||+.|+++.
T Consensus 308 ~~~~~~~~----~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 308 EDEEFQDI----SEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp CSGGGTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ChhhhccC----CHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00001122 3458899999999999999999999873
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=337.91 Aligned_cols=247 Identities=24% Similarity=0.313 Sum_probs=198.7
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcc
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~ 298 (631)
..++|.+.+.||+|+||.||+|.+. +++.||||++..... ......+.+|+..+..+ +||||+++++++.+ ..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~----~~ 84 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE----DD 84 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE----TT
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec----CC
Confidence 3567889999999999999999986 699999999986533 33455688999999999 99999999999876 55
Q ss_pred eEEEEEeeCCCCChHhhhhccc--cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC-----------
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE----------- 365 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~----------- 365 (631)
..++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+++ |+||||||+|||++.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~ 161 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEG 161 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccc
Confidence 7899999999999999997542 255899999999999999999999998 999999999999984
Q ss_pred --------CCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 006785 366 --------NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIH 436 (631)
Q Consensus 366 --------~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~ 436 (631)
...+||+|||++....... ...||+.|+|||++.+. .++.++||||||+++|||++|..|+.
T Consensus 162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~---------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 162 DEDDWASNKVMFKIGDLGHVTRISSPQ---------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp --------CCCEEECCCTTCEETTCSC---------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred ccccccCCceEEEEcccccccccCCcc---------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 4479999999998765322 23489999999999866 56789999999999999999987764
Q ss_pred CccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 437 RSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..... .. +.....+.+...++ ..+.+|+.+||+.||++|||+.++++.
T Consensus 233 ~~~~~-----~~------------~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 233 NGDQW-----HE------------IRQGRLPRIPQVLS----QEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp SSHHH-----HH------------HHTTCCCCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred chhHH-----HH------------HHcCCCCCCCcccC----HHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 32110 00 00111112222233 458899999999999999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=354.72 Aligned_cols=250 Identities=26% Similarity=0.381 Sum_probs=199.5
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
.+.|...+.||+|+||.||+|... +|+.||||++...... .....|.+|+.+|++++||||+++++++.. ...
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~ 128 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR----EHT 128 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE----CCe
Confidence 345888999999999999999974 6899999999754322 223468999999999999999999999876 457
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.++||||+. |+|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 129 ~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASI 203 (348)
T ss_dssp EEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred EEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence 899999996 7898888643 356999999999999999999999998 99999999999999999999999999976
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhh---cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
.... ....||+.|+|||++. .+.++.++||||||+++|||++|+.||............
T Consensus 204 ~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~--------- 265 (348)
T 1u5q_A 204 MAPA---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--------- 265 (348)
T ss_dssp SSSB---------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---------
T ss_pred cCCC---------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---------
Confidence 5432 2346999999999985 567899999999999999999999999653321110000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
.....+.+. +...+..+.+|+.+||+.||++|||+.++++...
T Consensus 266 -----~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 266 -----AQNESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp -----HHSCCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred -----HhcCCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 000011111 1122344889999999999999999999987544
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=353.52 Aligned_cols=244 Identities=24% Similarity=0.296 Sum_probs=200.9
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC-------hHHHHHHHHHHHHhcCCCCCcceeEEeeec
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-------ADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 293 (631)
..++|.+.+.||+|+||.||+|.+. +++.||||++....... ....+.+|+.+|++++||||+++++++..
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~- 100 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN- 100 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 4578999999999999999999875 58999999997653211 22247789999999999999999999875
Q ss_pred cCCcceEEEEEeeCCCC-ChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEe
Q 006785 294 RGKRAMRLLVFEFMPNG-NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 372 (631)
Q Consensus 294 ~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~ 372 (631)
....++||||+.+| +|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 101 ---~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~ 172 (335)
T 3dls_A 101 ---QGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLI 172 (335)
T ss_dssp ---SSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEEC
T ss_pred ---CCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEe
Confidence 55789999999777 999999764 45999999999999999999999998 9999999999999999999999
Q ss_pred ccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcc
Q 006785 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 451 (631)
Q Consensus 373 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~ 451 (631)
|||+++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.......
T Consensus 173 Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------- 237 (335)
T 3dls_A 173 DFGSAAYLERGK------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV--------- 237 (335)
T ss_dssp CCTTCEECCTTC------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT---------
T ss_pred ecccceECCCCC------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH---------
Confidence 999998765432 2234679999999999988776 889999999999999999999996421100
Q ss_pred cccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 452 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 452 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.... ..+...+..+.+|+.+||+.||++|||+.++++.
T Consensus 238 ----------~~~~------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 ----------EAAI------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----------TTCC------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----------hhcc------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0111123448899999999999999999999885
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=357.95 Aligned_cols=267 Identities=24% Similarity=0.347 Sum_probs=204.1
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.++|.+.+.||+|+||.||+|.+. +++.||+|++...........+.+|+.+|++++||||+++++++.. ....+
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 107 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS----DGEIS 107 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE----TTEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE----CCEEE
Confidence 367888999999999999999986 5899999999876555555679999999999999999999999886 45789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhc-CCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
+||||+++|+|.+++... ..+++..+..++.+++.||+|||+. + |+||||||+|||++.++.+||+|||++...
T Consensus 108 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp EEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 999999999999999764 4589999999999999999999996 7 999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhc-------cc-
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA-------TP- 452 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~-------~~- 452 (631)
.... .....||+.|+|||++.+..++.++||||||+++|||++|+.||............... .+
T Consensus 183 ~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3eqc_A 183 IDSM-------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255 (360)
T ss_dssp HHHC-----------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------
T ss_pred cccc-------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCC
Confidence 4321 22346999999999999999999999999999999999999999754321110000000 00
Q ss_pred cccccc-----------------ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 453 RLQDSG-----------------TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 453 ~~~~~~-----------------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.....+ ..+..+.........+...+..+.+|+.+||+.||++|||+.++++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000 00000000000000111223458899999999999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=345.29 Aligned_cols=269 Identities=23% Similarity=0.336 Sum_probs=199.5
Q ss_pred HHHHHhcCccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeee
Q 006785 218 ALEHATDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 292 (631)
Q Consensus 218 ~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 292 (631)
++....++|.+.+.||+|+||.||+|.+.. ++.||||+++.... ......|.+|+.++++++||||+++++++.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 334446778889999999999999998642 45899999976532 2334568999999999999999999999876
Q ss_pred ccCC-cceEEEEEeeCCCCChHhhhhcc----ccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC
Q 006785 293 FRGK-RAMRLLVFEFMPNGNLRDCLDGV----LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 367 (631)
Q Consensus 293 ~~~~-~~~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~ 367 (631)
.... ....++||||+++|+|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCC
Confidence 3321 22569999999999999998432 2345999999999999999999999998 99999999999999999
Q ss_pred CeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchh
Q 006785 368 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESL 446 (631)
Q Consensus 368 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~ 446 (631)
.+||+|||+++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||...........
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 261 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYY---RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY 261 (313)
T ss_dssp CEEECSCSCC-------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred cEEEeecCcceeccccccc---CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence 9999999999876543211 11233457889999999999999999999999999999999 8889865432211110
Q ss_pred hhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 447 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
. .....+. .+...+..+.+|+.+||..||.+|||+.++++.|..+.
T Consensus 262 ~--------------~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 262 L--------------LHGHRLK----QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp H--------------HTTCCCC----CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H--------------HcCCCCC----CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 0001111 12233345889999999999999999999999998874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=340.19 Aligned_cols=252 Identities=22% Similarity=0.351 Sum_probs=199.8
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-----ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCC
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 296 (631)
.++|.+.+.||+|+||.||+|... +|+.||||+++..... .....|.+|+.++++++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 79 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN---- 79 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC----
Confidence 356888999999999999999987 5899999998754322 235669999999999999999999999875
Q ss_pred cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC----CeEEe
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL----NAKIT 372 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~----~~kL~ 372 (631)
....++||||+++++|.+++... ..+++.++..++.|++.||.|||+.+ |+||||||+||+++.++ .+||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~ 154 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLI 154 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred CCeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEE
Confidence 45789999999999999999753 45899999999999999999999998 99999999999998877 79999
Q ss_pred ccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccc
Q 006785 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 452 (631)
Q Consensus 373 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 452 (631)
|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||............. .
T Consensus 155 dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~- 225 (283)
T 3bhy_A 155 DFGIAHKIEAGN------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS--A- 225 (283)
T ss_dssp CCTTCEECC--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--T-
T ss_pred ecccceeccCCC------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhH--h-
Confidence 999998764322 1234568999999999999999999999999999999999999996543211100000 0
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 453 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
. ........+...+..+.+|+.+||..||.+||++.++++
T Consensus 226 -----------~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 226 -----------V-NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp -----------T-CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----------c-ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0 000000000112345889999999999999999999997
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=358.14 Aligned_cols=246 Identities=23% Similarity=0.257 Sum_probs=190.9
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHH-HHhcCCCCCcceeEEeeeccCCcce
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDM-LSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
++|...+.||+|+||.||+|+.+. ++.||||+++.... ......+.+|..+ ++.++||||+++++++.. ...
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~----~~~ 113 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT----ADK 113 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC----SSE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe----CCE
Confidence 568889999999999999999864 88999999975432 2223346677776 567899999999999876 557
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.|+||||++||+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 89999999999999999764 45899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.
T Consensus 189 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~----------- 252 (373)
T 2r5t_A 189 NIEHN-----STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL----------- 252 (373)
T ss_dssp GBCCC-----CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHH-----------
T ss_pred cccCC-----CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-----------
Confidence 43321 23345679999999999999999999999999999999999999997543221111000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 502 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 502 (631)
.. .. .++...+..+.+|+.+||+.||.+||++.+.
T Consensus 253 --~~--~~----~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 253 --NK--PL----QLKPNITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp --HS--CC----CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred --hc--cc----CCCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 00 01 1122233458899999999999999998543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=352.07 Aligned_cols=249 Identities=21% Similarity=0.287 Sum_probs=178.0
Q ss_pred cceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCCcceeEEeeeccCCcceEEEEEee
Q 006785 229 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLVFEF 306 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~~lV~E~ 306 (631)
.+.||+|+||.||+|.+. +++.||||++... ....+.+|+.+++.+. ||||+++++++.+ ....|+||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~----~~~~~lv~e~ 87 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHD----QLHTFLVMEL 87 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----SSEEEEEECC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc----CCEEEEEEEc
Confidence 378999999999999986 4899999999643 3455889999999996 9999999999875 5578999999
Q ss_pred CCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC---CeEEeccCceeecccC
Q 006785 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL---NAKITDLGMAKRLKAD 383 (631)
Q Consensus 307 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~---~~kL~DFGla~~~~~~ 383 (631)
+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 88 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 88 LNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp CCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9999999999764 56999999999999999999999998 99999999999997665 7999999999876543
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 463 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (631)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||............. ..+..
T Consensus 163 ~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~----------~~~~~ 227 (325)
T 3kn6_A 163 N-----QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV----------EIMKK 227 (325)
T ss_dssp --------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHH----------HHHHH
T ss_pred C-----CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHH----------HHHHH
Confidence 2 12234568999999999999999999999999999999999999997543211000000 00111
Q ss_pred cCCCCCC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 464 LPDPRLK--GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 464 ~~~~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+...... .......+..+.+|+.+||+.||.+|||+.++++.
T Consensus 228 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 228 IKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 1111111 01112234568999999999999999999998753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=381.59 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=198.1
Q ss_pred ceeeeeCceEEEEEEEC---CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 230 NIVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
+.||+|+||.||+|.+. .++.||||+++.... ......|.+|+.+|++++||||+++++++.. ...++|||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~~~~lv~E 449 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----ESWMLVME 449 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-----SSEEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCEEEEEE
Confidence 47999999999999763 367899999976432 3345679999999999999999999999853 24689999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCC
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 385 (631)
|+++|+|.++|... ..+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 450 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 450 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred ccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 99999999999753 45999999999999999999999998 99999999999999999999999999987654321
Q ss_pred CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccccccccc
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 464 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (631)
. ........||+.|+|||++.+..++.++||||||++||||++ |+.||........... +...
T Consensus 525 ~--~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~--------------i~~~ 588 (635)
T 4fl3_A 525 Y--YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM--------------LEKG 588 (635)
T ss_dssp ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH--------------HHTT
T ss_pred c--cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------------HHcC
Confidence 1 112233457889999999999999999999999999999998 9999965432211110 1111
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 465 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 465 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
... ..+..++..+.+|+..||+.||++||++.+|++.|+.+.
T Consensus 589 ~~~----~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 589 ERM----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CCC----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCC----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111 223334455899999999999999999999999998763
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=365.91 Aligned_cols=248 Identities=25% Similarity=0.330 Sum_probs=202.2
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|.+.+.||+|+||.||+|++. +|+.||||++.... .......+.+|+.+|+.++||||+++++++.. ....
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----~~~~ 91 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST----PSDI 91 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----CCEE
Confidence 56888999999999999999986 59999999996431 12334568999999999999999999999876 4578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 ~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 9999999999999999753 45999999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
.... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||..........
T Consensus 167 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~-------------- 226 (476)
T 2y94_A 167 SDGE------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK-------------- 226 (476)
T ss_dssp CTTC------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH--------------
T ss_pred cccc------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH--------------
Confidence 5432 2234569999999999988765 789999999999999999999997533211100
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+.+... ..|...+..+.+|+.+||+.||.+|||+.++++.
T Consensus 227 ---~i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 227 ---KICDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ---HHHTTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---HHhcCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 0000000 1122233458899999999999999999999973
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=361.89 Aligned_cols=269 Identities=21% Similarity=0.257 Sum_probs=196.5
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeecc--CCcc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKRA 298 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~~ 298 (631)
.++|.+.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.+|+.++||||+++++++.... ....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467999999999999999999875 48999999997542 2233456889999999999999999999986532 1234
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..|+||||+++ +|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 67999999965 57776643 3899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh--ccc----
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATP---- 452 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~---- 452 (631)
..... .......||+.|+|||++.+..++.++||||||++||||++|+.||...........+.. ..+
T Consensus 213 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 213 TAGTS------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286 (464)
T ss_dssp ----C------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ecCCC------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 76432 123456799999999999999999999999999999999999999975432111100000 000
Q ss_pred --cccc------------ccccccccCCCCCCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 453 --RLQD------------SGTVISELPDPRLKGD---FPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 453 --~~~~------------~~~~~~~~~~~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+.. ............+... ........+.+|+.+||+.||++|||+.|+++.
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000000000000000 011225668999999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=350.79 Aligned_cols=264 Identities=26% Similarity=0.425 Sum_probs=201.9
Q ss_pred ecHHHHHHHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEee
Q 006785 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 291 (631)
Q Consensus 214 ~s~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 291 (631)
+++.++....++|.+.+.||+|+||.||+|.+. +|+.||||++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 344455556788999999999999999999985 58999999997543 2345689999999999 8999999999987
Q ss_pred eccC--CcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCe
Q 006785 292 EFRG--KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 369 (631)
Q Consensus 292 ~~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 369 (631)
.... .....++||||+++|+|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 6321 1357899999999999999998755567999999999999999999999998 9999999999999999999
Q ss_pred EEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhh-----cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccc
Q 006785 370 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE 444 (631)
Q Consensus 370 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~ 444 (631)
||+|||++....... .......||+.|+|||++. ...++.++||||||+++|+|++|+.||.........
T Consensus 169 kl~Dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 243 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTV-----GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243 (326)
T ss_dssp EECCCTTTC------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred EEeeCcCceecCcCc-----cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 999999987654321 1223456999999999987 567899999999999999999999999643321110
Q ss_pred hhhhhcccccccccccccccCCCCC-CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 445 SLVLWATPRLQDSGTVISELPDPRL-KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.. +.....+.+ ...++ ..+.+|+.+||..||.+||++.++++.
T Consensus 244 ~~--------------~~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 244 FL--------------IPRNPAPRLKSKKWS----KKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HH--------------HHHSCCCCCSCSCSC----HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HH--------------hhcCccccCCccccC----HHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 000011111 11233 448899999999999999999999873
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=341.67 Aligned_cols=249 Identities=26% Similarity=0.409 Sum_probs=203.1
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|...+.||+|+||.||++.+.+ ++.||+|++..... ....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~ 90 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED----NDFV 90 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc----CCEE
Confidence 567788999999999999999864 88999999875432 2344568999999999999999999999875 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
++||||+++++|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 91 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 9999999999999998754 45899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 166 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------------ 228 (294)
T 2rku_A 166 EYDG-----ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK------------ 228 (294)
T ss_dssp CSTT-----CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------------
T ss_pred ccCc-----cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh------------
Confidence 5332 12233569999999999999889999999999999999999999996543211100000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. ... ..+......+.+|+.+||+.||++|||+.++++.
T Consensus 229 --~-~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 229 --K-NEY----SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --T-TCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --h-ccC----CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 000 1122233458899999999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=362.46 Aligned_cols=256 Identities=25% Similarity=0.305 Sum_probs=192.2
Q ss_pred HHHhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC-------CChHHHHHHHHHHHHhcCCCCCcceeEEee
Q 006785 220 EHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG-------PNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291 (631)
Q Consensus 220 ~~a~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 291 (631)
....++|.+.+.||+|+||.||+|.... ++.||||++..... ......+.+|+.+|++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3457899999999999999999998764 89999999874311 111223889999999999999999999875
Q ss_pred eccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC---C
Q 006785 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL---N 368 (631)
Q Consensus 292 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~---~ 368 (631)
. ...|+||||+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++ .
T Consensus 211 ~-----~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 280 (419)
T 3i6u_A 211 A-----EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCL 280 (419)
T ss_dssp S-----SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCC
T ss_pred c-----CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcce
Confidence 3 3469999999999999998754 45999999999999999999999998 99999999999997544 5
Q ss_pred eEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhc---CCCCcccchhhHHHHHHHHHhCCCCCCCccccccch
Q 006785 369 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES 445 (631)
Q Consensus 369 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~---~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~ 445 (631)
+||+|||+++...... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||..........
T Consensus 281 ~kl~DFG~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~ 354 (419)
T 3i6u_A 281 IKITDFGHSKILGETS------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 354 (419)
T ss_dssp EEECCSSTTTSCC-----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH
T ss_pred EEEeecccceecCCCc------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH
Confidence 9999999998764321 2234679999999999853 668899999999999999999999996533221110
Q ss_pred hhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 446 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
... ..... ..........+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 355 ~~i-------------~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 355 DQI-------------TSGKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHH-------------HTTCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHH-------------hcCCC-CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000 00000 00000001123458899999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=355.85 Aligned_cols=257 Identities=25% Similarity=0.343 Sum_probs=201.0
Q ss_pred hcCccccceeeeeCceEEEEEEE----CCCcEEEEEEeccCC---CCChHHHHHHHHHHHHhc-CCCCCcceeEEeeecc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQL----TDGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFR 294 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 294 (631)
.++|.+.+.||+|+||.||+++. .+++.||||+++... .......+.+|+.+|+.+ +||||+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 130 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence 35788899999999999999987 368999999986432 112233477899999999 79999999999876
Q ss_pred CCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEecc
Q 006785 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 374 (631)
Q Consensus 295 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DF 374 (631)
....++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+||
T Consensus 131 --~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Df 203 (355)
T 1vzo_A 131 --ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDF 203 (355)
T ss_dssp --TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCS
T ss_pred --CceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeC
Confidence 45789999999999999999764 45899999999999999999999998 999999999999999999999999
Q ss_pred CceeecccCCCCCCCCCCcccccCCCCCCchhhhc--CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccc
Q 006785 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 452 (631)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~--~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 452 (631)
|+++.+..... .......||+.|+|||++.+ ..++.++||||||++||||++|+.||............. .
T Consensus 204 G~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~--~- 276 (355)
T 1vzo_A 204 GLSKEFVADET----ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--R- 276 (355)
T ss_dssp SEEEECCGGGG----GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--H-
T ss_pred CCCeecccCCC----CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHH--H-
Confidence 99987643221 12234579999999999986 347899999999999999999999996433221111000 0
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHh
Q 006785 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQILS 507 (631)
Q Consensus 453 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~ 507 (631)
.+.. ..+ .++...+..+.+|+.+||..||.+|| ++.++++...
T Consensus 277 -------~~~~-~~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 277 -------RILK-SEP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp -------HHHH-CCC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred -------HHhc-cCC----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 0000 011 12333445588999999999999999 9999987543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=352.96 Aligned_cols=281 Identities=22% Similarity=0.282 Sum_probs=204.4
Q ss_pred eecHHHHHHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCC----------hHHHHHHHHHHHHhcCCCC
Q 006785 213 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN----------ADSVFLTEVDMLSRLHHCH 282 (631)
Q Consensus 213 ~~s~~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~----------~~~~~~~E~~~l~~l~H~n 282 (631)
+....++..+.++|.+.+.||+|+||.||+|...+|+.||||++....... ....+.+|+.+|++++|||
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 344678889999999999999999999999998889999999986543221 1256899999999999999
Q ss_pred CcceeEEeeecc-CCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCe
Q 006785 283 VVPLVGYCSEFR-GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNI 361 (631)
Q Consensus 283 iv~l~g~~~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NI 361 (631)
|+++++++.... ......|+||||++ |+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 999999986543 23447899999996 7898888753 345999999999999999999999998 99999999999
Q ss_pred eecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccc
Q 006785 362 LLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSIT 440 (631)
Q Consensus 362 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~ 440 (631)
|++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.....
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 239 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239 (362)
T ss_dssp EECTTCCEEECCTTC---------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred EEcCCCCEEEEecCccccccccc------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999997544321 2234568999999999887 6789999999999999999999999975432
Q ss_pred cccchhhh--hcccc-----------cccc-cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 441 KGEESLVL--WATPR-----------LQDS-GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 441 ~~~~~~~~--~~~~~-----------~~~~-~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
........ ...+. .... ............ ...+......+.+|+.+||+.||.+|||+.|+++.
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAW-TAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCH-HHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhH-HhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 11110000 00000 0000 000000000000 00111223458899999999999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=348.91 Aligned_cols=250 Identities=26% Similarity=0.400 Sum_probs=203.8
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
.++|.+.+.||+|+||.||++.+.+ ++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~ 115 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED----NDF 115 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----CCe
Confidence 3568888999999999999999864 88999999875432 2344568999999999999999999999876 457
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.|+||||+++++|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 116 ~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 116 VFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp EEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 89999999999999998754 45899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..............
T Consensus 191 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---------- 255 (335)
T 2owb_A 191 VEYDG-----ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK---------- 255 (335)
T ss_dssp CCSTT-----CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH----------
T ss_pred cccCc-----ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc----------
Confidence 65332 122345699999999999999999999999999999999999999965332111000000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.... .+......+.+|+.+||+.||++|||+.++++.
T Consensus 256 -----~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 256 -----NEYS----IPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp -----TCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -----CCCC----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0011 122223458889999999999999999999873
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=368.19 Aligned_cols=250 Identities=27% Similarity=0.403 Sum_probs=200.8
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
.++|...+.||+|+||.||+|+.+ +|+.||||++.... .......+.+|+.+|++++||||+++++++.. ...
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----~~~ 259 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET----KTD 259 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee----CCE
Confidence 367888999999999999999986 59999999996431 12334568899999999999999999998875 557
Q ss_pred EEEEEeeCCCCChHhhhhccc--cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 300 RLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
.|+||||++||+|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla 336 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA 336 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeeccee
Confidence 899999999999999997543 345999999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 337 ~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~---------- 401 (543)
T 3c4z_A 337 VELKAGQ-----TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL---------- 401 (543)
T ss_dssp EECCTTC-----CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHH----------
T ss_pred eeccCCC-----cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHH----------
Confidence 8765432 1123457999999999999999999999999999999999999999754321110000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM 499 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 499 (631)
...+.... ..+|...+..+.+|+.+||+.||.+||++
T Consensus 402 ---~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 402 ---KQRVLEQA--VTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp ---HHHHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ---HHHHhhcc--cCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 00000000 01233344558899999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=362.79 Aligned_cols=203 Identities=23% Similarity=0.315 Sum_probs=157.2
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeecc-CCcce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR-GKRAM 299 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~~~ 299 (631)
.++|.+.+.||+|+||.||+|.+. +|+.||||++..... ......+.+|+.+|++++||||+++++++.... .....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367899999999999999999876 589999999975422 223456899999999999999999999986432 22356
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.|+||||+ +|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence 89999998 68999999753 45999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCC----------------------CCCCcccccCCCCCCchhh-hcCCCCcccchhhHHHHHHHHHhC
Q 006785 380 LKADGLPSC----------------------SSSPARMQGTFGYFAPEYA-MVGRASLMSDVFSFGVVLLELITG 431 (631)
Q Consensus 380 ~~~~~~~~~----------------------~~~~~~~~Gt~~Y~APE~~-~~~~~s~ksDVwSlGviL~eLltG 431 (631)
......... .......+||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 653221100 0123446789999999986 466799999999999999999994
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=346.57 Aligned_cols=266 Identities=24% Similarity=0.335 Sum_probs=195.2
Q ss_pred cCcccc-ceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGS-NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~ 300 (631)
+.|.+. +.||+|+||.||+|... +++.||||++.... ......+.+|+.+|.++ +||||+++++++.. ....
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~----~~~~ 86 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEE----EDRF 86 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----TTEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEee----CCEE
Confidence 556664 78999999999999865 58999999997653 34455689999999995 79999999999876 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCC---eEEeccCce
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN---AKITDLGMA 377 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~---~kL~DFGla 377 (631)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 87 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred EEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 9999999999999999764 45899999999999999999999998 999999999999988776 999999999
Q ss_pred eecccCCCCC--CCCCCcccccCCCCCCchhhhc-----CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhc
Q 006785 378 KRLKADGLPS--CSSSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA 450 (631)
Q Consensus 378 ~~~~~~~~~~--~~~~~~~~~Gt~~Y~APE~~~~-----~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~ 450 (631)
.......... .........||+.|+|||++.. ..++.++||||||+++|||++|+.||......... |.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~----~~ 237 (316)
T 2ac3_A 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG----WD 237 (316)
T ss_dssp C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC----C-
T ss_pred cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc----cc
Confidence 8664322111 0112233569999999999875 55889999999999999999999999754322100 00
Q ss_pred cccccc--ccccccccCCCCCCCCCCH----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 451 TPRLQD--SGTVISELPDPRLKGDFPK----EEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 451 ~~~~~~--~~~~~~~~~~~~l~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
...... .......+..... .++. ..+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 238 RGEACPACQNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp ---CCHHHHHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccchhHHHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000000 0000000000000 1121 123458899999999999999999999884
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=351.04 Aligned_cols=252 Identities=16% Similarity=0.187 Sum_probs=201.5
Q ss_pred HhcCccccceeeeeCceEEEEEE------ECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC---CCCCcceeEEeee
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQ------LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH---HCHVVPLVGYCSE 292 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~------~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~ 292 (631)
..++|.+.+.||+|+||.||+|. ..+++.||||++... ....+..|+.++.+++ |+||+++++++..
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 45778889999999999999994 345889999999754 2445889999999886 9999999999876
Q ss_pred ccCCcceEEEEEeeCCCCChHhhhhcc---ccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC----
Q 006785 293 FRGKRAMRLLVFEFMPNGNLRDCLDGV---LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---- 365 (631)
Q Consensus 293 ~~~~~~~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---- 365 (631)
....|+||||+++|+|.+++... ....+++.+++.|+.||+.||+|||+.+ |+||||||+||||+.
T Consensus 139 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 139 ----QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp ----SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTC
T ss_pred ----CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccC
Confidence 45679999999999999999642 2345999999999999999999999998 999999999999998
Q ss_pred -------CCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCc
Q 006785 366 -------NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (631)
Q Consensus 366 -------~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~ 438 (631)
++.+||+|||+|+....... ........||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPK---GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCT---TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred ccccccccCCEEEeeCchhhhhhccCC---CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 89999999999986543211 11223456999999999999999999999999999999999999998543
Q ss_pred cccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHhhhC
Q 006785 439 ITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDAR-PTMSEVVQILSTIA 510 (631)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~i~ 510 (631)
.... +. +... +. ..+ ....+.+++..|++.+|.+| |++.++.+.|..+.
T Consensus 289 ~~~~------~~----------~~~~----~~-~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 289 EGGE------CK----------PEGL----FR-RLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp ETTE------EE----------ECSC----CT-TCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred CCCc------ee----------echh----cc-ccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 2210 00 0000 00 011 13457789999999999999 78888888887764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=351.29 Aligned_cols=269 Identities=20% Similarity=0.260 Sum_probs=192.9
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
..++|.+.+.||+|+||+||+|... +++.||||++...... .....+.+|+.+|++++||||+++++++.. ...
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~ 107 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH----NHR 107 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE----TTE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec----CCE
Confidence 3567899999999999999999875 5899999999754322 223457899999999999999999999876 557
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeec-----CCCCeEEecc
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-----ENLNAKITDL 374 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~-----~~~~~kL~DF 374 (631)
.++||||++ |+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+||
T Consensus 108 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 108 LHLIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEEEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEEEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcC
Confidence 899999996 5999999764 45899999999999999999999998 99999999999994 4556999999
Q ss_pred CceeecccCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh--cc
Q 006785 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--AT 451 (631)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~ 451 (631)
|+++...... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||.............. ..
T Consensus 182 g~a~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 256 (329)
T 3gbz_A 182 GLARAFGIPI-----RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL 256 (329)
T ss_dssp THHHHHC----------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred CCccccCCcc-----cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCC
Confidence 9998764321 122345689999999999874 489999999999999999999999975432211110000 00
Q ss_pred ccc---------ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 452 PRL---------QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 452 ~~~---------~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+.. ..............+....+......+.+|+.+||+.||.+|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 000 000000000000000000111133558899999999999999999999873
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=349.50 Aligned_cols=268 Identities=22% Similarity=0.348 Sum_probs=193.7
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++|...+.||+|+||.||+|... +++.||||++...........+.+|+.+|++++||||+++++++.. ....++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 77 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT----EKSLTL 77 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC----SSCEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee----CCEEEE
Confidence 56888999999999999999986 5899999999755433322236689999999999999999999875 456799
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||++ |+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 78 v~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 78 VFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp EEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred Eecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 999996 6999998764 345899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh--cccc---ccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPR---LQD 456 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~---~~~ 456 (631)
.. .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. ..+. +..
T Consensus 153 ~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (324)
T 3mtl_A 153 PT-----KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 227 (324)
T ss_dssp ---------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred Cc-----cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchh
Confidence 21 12234568999999999876 5689999999999999999999999976432211111000 0000 000
Q ss_pred c--cccccccCCCCCCCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 457 S--GTVISELPDPRLKGD----FPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 457 ~--~~~~~~~~~~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. .........+..... ........+.+|+.+||+.||.+|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 000000000000000 011223457899999999999999999999873
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=338.74 Aligned_cols=247 Identities=23% Similarity=0.344 Sum_probs=201.6
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|.+.+.||+|+||.||+|... +++.||||++.... .......+.+|++++++++||||+++++++.. ....
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 89 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD----RKRI 89 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc----CCEE
Confidence 56888999999999999999986 47899999986431 12234568999999999999999999999875 4578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 9999999999999999764 45899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||............
T Consensus 165 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------------- 224 (284)
T 2vgo_A 165 PSL-------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI------------- 224 (284)
T ss_dssp SSS-------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-------------
T ss_pred ccc-------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHH-------------
Confidence 432 123356899999999999999999999999999999999999999653321110000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.. .+. .++...+..+.+|+.+||+.||.+||++.++++.
T Consensus 225 -~~-~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 225 -VN-VDL----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp -HT-TCC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred -hc-ccc----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 00 011 1222333458899999999999999999999863
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=343.80 Aligned_cols=261 Identities=26% Similarity=0.338 Sum_probs=195.9
Q ss_pred cCccccceeeeeCceEEEEEEEC--CCc--EEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT--DGR--IVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~--~g~--~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
++|.+.+.||+|+||.||+|++. +++ .||||+++... .....+.|.+|+.++++++||||+++++++...
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 93 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---- 93 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC----
Confidence 56888899999999999999864 233 69999987542 233456699999999999999999999998742
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 94 -~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 94 -PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred -CceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccc
Confidence 3689999999999999997642 45899999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
......... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||.............
T Consensus 169 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-------- 238 (291)
T 1u46_A 169 RALPQNDDH--YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID-------- 238 (291)
T ss_dssp EECCC-CCE--EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH--------
T ss_pred ccccccccc--hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHH--------
Confidence 876543211 011223457889999999999889999999999999999999 999996543221100000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
...... ..+...+..+.+++.+||..||.+|||+.++++.|..+.+.
T Consensus 239 -----~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 239 -----KEGERL----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp -----TSCCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -----ccCCCC----CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 000011 11223334588999999999999999999999999987644
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=349.20 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=204.6
Q ss_pred HHHHHHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC-------hHHHHHHHHHHHHhc-CCCCCccee
Q 006785 217 SALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-------ADSVFLTEVDMLSRL-HHCHVVPLV 287 (631)
Q Consensus 217 ~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-------~~~~~~~E~~~l~~l-~H~niv~l~ 287 (631)
.......++|.+.+.||+|+||.||+|.+. +|+.||||++....... ....+.+|+.+++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 445566788999999999999999999986 69999999997653221 134578999999999 899999999
Q ss_pred EEeeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC
Q 006785 288 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 367 (631)
Q Consensus 288 g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~ 367 (631)
+++.. ....|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 167 ~~~~~----~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~ 237 (365)
T 2y7j_A 167 DSYES----SSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNM 237 (365)
T ss_dssp EEEEB----SSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTC
T ss_pred EEEee----CCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCC
Confidence 99875 55789999999999999999753 45999999999999999999999998 99999999999999999
Q ss_pred CeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhc------CCCCcccchhhHHHHHHHHHhCCCCCCCcccc
Q 006785 368 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV------GRASLMSDVFSFGVVLLELITGRQPIHRSITK 441 (631)
Q Consensus 368 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~------~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~ 441 (631)
.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......
T Consensus 238 ~ikl~DfG~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 311 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPGE------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI 311 (365)
T ss_dssp CEEECCCTTCEECCTTC------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CEEEEecCcccccCCCc------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH
Confidence 99999999998765432 2234579999999999864 35889999999999999999999999653221
Q ss_pred ccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 442 GEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
......... .. ....+. ....+..+.+|+.+||+.||++|||+.++++.
T Consensus 312 ~~~~~i~~~--~~--------~~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 312 LMLRMIMEG--QY--------QFSSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHHHHT--CC--------CCCHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhC--CC--------CCCCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 110000000 00 000000 00123448899999999999999999999873
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=355.33 Aligned_cols=210 Identities=23% Similarity=0.335 Sum_probs=165.8
Q ss_pred HHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcC-CCCCcceeEEeeeccCCc
Q 006785 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 221 ~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 297 (631)
...++|.+.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.+|+.+. ||||+++++++.... .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--~ 83 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN--D 83 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT--S
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC--C
Confidence 45678999999999999999999875 58999999986542 2233455889999999996 999999999987532 3
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
...|+||||++ |+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 46799999996 699999875 35899999999999999999999999 999999999999999999999999999
Q ss_pred eecccCCCC----------------CCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCcc
Q 006785 378 KRLKADGLP----------------SCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (631)
Q Consensus 378 ~~~~~~~~~----------------~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~ 439 (631)
+.+...... ..........||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 876431110 00112344679999999999986 678999999999999999999999997543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=350.05 Aligned_cols=277 Identities=24% Similarity=0.323 Sum_probs=207.0
Q ss_pred hcCccccceeeeeCceEEEEEEE-----CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
.++|.+.+.||+|+||.||++.+ .+|+.||||++... .......|.+|+.++++++||||+++++++.... .
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--R 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC--C
Confidence 35678889999999999999984 35899999999764 3344566999999999999999999999886532 2
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
...++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred CceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcch
Confidence 35699999999999999997642 45899999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
+......... .......+|..|+|||++.+..++.++||||||+++|||++|..||....................
T Consensus 193 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~-- 268 (326)
T 2w1i_A 193 KVLPQDKEYY--KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI-- 268 (326)
T ss_dssp EECCSSCSEE--ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH--
T ss_pred hhcccccccc--ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh--
Confidence 8765432110 112234578889999999998999999999999999999999999864311100000000000000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
...+.+..........+...+..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 269 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00000000000111123333455889999999999999999999999998774
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=350.63 Aligned_cols=268 Identities=17% Similarity=0.212 Sum_probs=202.5
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCCh----------------HHHHHHHHHHHHhcCCCCCcce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNA----------------DSVFLTEVDMLSRLHHCHVVPL 286 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~----------------~~~~~~E~~~l~~l~H~niv~l 286 (631)
.++|.+.+.||+|+||.||+|.. +|+.||||++........ ...|.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46789999999999999999999 899999999874321111 1669999999999999999999
Q ss_pred eEEeeeccCCcceEEEEEeeCCCCChHhh------hhccccCCCCHHHHHHHHHHHHhhhHHHHh-cCCCceeecCCCCC
Q 006785 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDC------LDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSS 359 (631)
Q Consensus 287 ~g~~~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlKp~ 359 (631)
++++.. ....++||||+++|+|.++ +.......+++..+..++.|++.||.|||+ .+ |+||||||+
T Consensus 109 ~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~ 181 (348)
T 2pml_X 109 EGIITN----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPS 181 (348)
T ss_dssp SEEEES----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGG
T ss_pred EEEEee----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChH
Confidence 999876 4578999999999999999 655435679999999999999999999999 88 999999999
Q ss_pred CeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcC-CCCc-ccchhhHHHHHHHHHhCCCCCCC
Q 006785 360 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASL-MSDVFSFGVVLLELITGRQPIHR 437 (631)
Q Consensus 360 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~-ksDVwSlGviL~eLltG~~P~~~ 437 (631)
|||++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|||++|+.||..
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 254 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK-------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT-------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hEEEcCCCcEEEeccccccccccc-------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999876432 12334689999999999877 5666 99999999999999999999975
Q ss_pred ccccccc-hhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 438 SITKGEE-SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 438 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
....... .........+............+..........+..+.+|+.+||+.||.+|||+.++++.
T Consensus 255 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 255 KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp SSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 4331110 0000000000000000000000000000112234458899999999999999999999873
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=362.13 Aligned_cols=278 Identities=19% Similarity=0.253 Sum_probs=210.2
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCc-ceeEEeeeccCCcceE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMR 300 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~~~~ 300 (631)
.++|.+.+.||+|+||.||+|++. +++.||||++....... .+.+|+++++.|+|++.+ .+..++.+ ....
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~E~~il~~L~~~~~i~~i~~~~~~----~~~~ 78 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP---QLLYESKIYRILQGGTGIPNVRWFGVE----GDYN 78 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC---CHHHHHHHHHHTTTSTTCCCEEEEEEE----TTEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH---HHHHHHHHHHHhcCCCCCCeEEEEEee----CCEE
Confidence 467899999999999999999974 58999999987653322 378999999999775554 44444433 4577
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeee---cCCCCeEEeccCce
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMA 377 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl---~~~~~~kL~DFGla 377 (631)
+|||||+ +++|.+++... ...+++.+++.|+.||+.||+|||+++ |+||||||+|||| +.++.+||+|||++
T Consensus 79 ~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 9999999 99999999753 356999999999999999999999998 9999999999999 68899999999999
Q ss_pred eecccCCCCCC--CCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhc-cccc
Q 006785 378 KRLKADGLPSC--SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA-TPRL 454 (631)
Q Consensus 378 ~~~~~~~~~~~--~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~-~~~~ 454 (631)
+.+........ ........||+.|+|||++.+..++.++||||||++||||++|+.||............... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (483)
T 3sv0_A 154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (483)
T ss_dssp EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence 88765432110 12233567999999999999999999999999999999999999999764432211111100 0000
Q ss_pred ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcccccccCcchh
Q 006785 455 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNLF 524 (631)
Q Consensus 455 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~ 524 (631)
.. .+. .+...++ ..+.+|+..||+.+|++||++.+|++.|..+...........++|.
T Consensus 234 ~~---~~~-----~l~~~~p----~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~ 291 (483)
T 3sv0_A 234 AT---SIE-----ALCRGYP----TEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWT 291 (483)
T ss_dssp HS---CHH-----HHHTTSC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHH
T ss_pred cc---cHH-----HHhcCCc----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCch
Confidence 00 000 0111233 4488999999999999999999999999988665444433334443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=334.35 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=197.0
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
+|.....||+|+||.||+|.+. +++.||||++.... ......+.+|+.+++.++||||+++++++.. ....++|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv 97 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSE----NGFIKIF 97 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEE----TTEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe----CCcEEEE
Confidence 4555678999999999999975 58899999997653 3445568999999999999999999999876 4578999
Q ss_pred EeeCCCCChHhhhhccc-cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC-CCCeEEeccCceeecc
Q 006785 304 FEFMPNGNLRDCLDGVL-VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKRLK 381 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kL~DFGla~~~~ 381 (631)
|||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||++....
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 99999999999997642 234679999999999999999999998 999999999999987 8999999999998764
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCC--CCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGR--ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~--~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
... .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||.......... +..
T Consensus 175 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~-------- 238 (295)
T 2clq_A 175 GIN-----PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM---FKV-------- 238 (295)
T ss_dssp C----------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH---HHH--------
T ss_pred CCC-----CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH---Hhh--------
Confidence 321 1223456999999999997654 8999999999999999999999996432211100 000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
......+. .+...+..+.+|+.+||+.||++||++.++++.
T Consensus 239 -~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 239 -GMFKVHPE----IPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -HHHCCCCC----CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -cccccccc----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00011122 223334458899999999999999999999863
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=340.10 Aligned_cols=251 Identities=24% Similarity=0.313 Sum_probs=200.1
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.++|.+.+.||+|+||.||+++.. +|+.||||++..... .....+.+|+.++++++||||+++++++.. ....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYES----TTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEEC----SSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhccc----CCEEE
Confidence 467888999999999999999986 589999999985432 233458899999999999999999999875 45789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeee---cCCCCeEEeccCcee
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAK 378 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl---~~~~~~kL~DFGla~ 378 (631)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++.
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 83 LVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp EEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred EEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 999999999999999654 45899999999999999999999998 9999999999999 788899999999987
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 158 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~---------- 220 (304)
T 2jam_A 158 MEQNG-------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIK---------- 220 (304)
T ss_dssp CCCCB-------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH----------
T ss_pred ecCCC-------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH----------
Confidence 54321 2234569999999999999999999999999999999999999996533211100000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.... ......+...+..+.+|+.+||..||.+|||+.++++.
T Consensus 221 ---~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 221 ---EGYY--EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp ---HCCC--CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ---cCCC--CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0000 00111122233458899999999999999999999873
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=354.54 Aligned_cols=271 Identities=23% Similarity=0.323 Sum_probs=198.0
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeecc---
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--- 294 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--- 294 (631)
++...++|.+.+.||+|+||.||+|.+. +|+.||||++...... +.+|+.+|+.++||||+++++++....
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 3456788999999999999999999874 5899999998755322 347999999999999999999986532
Q ss_pred -------------------------------CCcceEEEEEeeCCCCChHhhhhcc--ccCCCCHHHHHHHHHHHHhhhH
Q 006785 295 -------------------------------GKRAMRLLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLE 341 (631)
Q Consensus 295 -------------------------------~~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~ 341 (631)
....+.++||||++ |+|.+++... ....+++..+..++.|++.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 12345899999997 6888887642 2356999999999999999999
Q ss_pred HHHhcCCCceeecCCCCCCeeec-CCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchh
Q 006785 342 YLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVF 419 (631)
Q Consensus 342 yLH~~~~~~ivHrDlKp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVw 419 (631)
|||+.+ |+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++|||
T Consensus 156 ~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 156 FIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE------PSVAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp HHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS------CCCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred HHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC------CCcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 999998 99999999999997 68899999999998765432 22345689999999998865 489999999
Q ss_pred hHHHHHHHHHhCCCCCCCccccccchhhh--hccccccc---ccccccccCCCCC-----CCCCCHHHHHHHHHHHHHhc
Q 006785 420 SFGVVLLELITGRQPIHRSITKGEESLVL--WATPRLQD---SGTVISELPDPRL-----KGDFPKEEMQIMAYLAKECL 489 (631)
Q Consensus 420 SlGviL~eLltG~~P~~~~~~~~~~~~~~--~~~~~~~~---~~~~~~~~~~~~l-----~~~~~~~~~~~l~~li~~cl 489 (631)
|||+++|||++|+.||............. ...+.... ......+..-+.+ ...++...+..+.+|+.+||
T Consensus 227 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 99999999999999997543221111000 00000000 0000001111111 11123334455889999999
Q ss_pred ccCCCCCCCHHHHHH
Q 006785 490 QLDPDARPTMSEVVQ 504 (631)
Q Consensus 490 ~~dP~~RPs~~evl~ 504 (631)
+.||.+|||+.|+++
T Consensus 307 ~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 307 RYEPDLRINPYEAMA 321 (383)
T ss_dssp CSSGGGSCCHHHHHT
T ss_pred cCChhhCCCHHHHhc
Confidence 999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=354.18 Aligned_cols=268 Identities=22% Similarity=0.235 Sum_probs=206.2
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC--------CCCCcceeEEeeec
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH--------HCHVVPLVGYCSEF 293 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~~~ 293 (631)
.++|.+.+.||+|+||.||+|+.. +++.||||++... ......+.+|+.+|+.++ |+||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 467899999999999999999875 4889999999743 233456889999999995 78899999998754
Q ss_pred cCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhc-CCCceeecCCCCCCeeecCCC-----
Q 006785 294 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENL----- 367 (631)
Q Consensus 294 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlKp~NILl~~~~----- 367 (631)
.......++||||+ +++|.+++.......+++..+..++.||+.||+|||++ + |+||||||+||||+.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 44466889999999 67787777655446699999999999999999999998 8 99999999999999775
Q ss_pred --------------------------------------------CeEEeccCceeecccCCCCCCCCCCcccccCCCCCC
Q 006785 368 --------------------------------------------NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403 (631)
Q Consensus 368 --------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~A 403 (631)
.+||+|||+++..... .....||+.|+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--------~~~~~gt~~y~a 261 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--------FTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--------SCSCCSCGGGCC
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--------CccCCCCCcccC
Confidence 7999999999876432 233468999999
Q ss_pred chhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchh-------hh--------------hccccccccccccc
Q 006785 404 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL-------VL--------------WATPRLQDSGTVIS 462 (631)
Q Consensus 404 PE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~-------~~--------------~~~~~~~~~~~~~~ 462 (631)
||++.+..++.++||||||++||||++|+.||........... .. +....+... ....
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~-~~~~ 340 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK-GDLK 340 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT-SSBS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCc-cccc
Confidence 9999999999999999999999999999999975432211000 00 000000000 0000
Q ss_pred ccCCCCC---------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 463 ELPDPRL---------KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 463 ~~~~~~l---------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+..... ....+......+.+|+.+||+.||++|||+.|+++.
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 1100000 113466777889999999999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=363.74 Aligned_cols=253 Identities=24% Similarity=0.256 Sum_probs=199.0
Q ss_pred HhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCC------------ChHHHHHHHHHHHHhcCCCCCcceeE
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGP------------NADSVFLTEVDMLSRLHHCHVVPLVG 288 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~------------~~~~~~~~E~~~l~~l~H~niv~l~g 288 (631)
..++|.+.+.||+|+||+||+|.... ++.||||++...... .....+.+|+.+|++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 35789999999999999999999864 889999999754321 33456899999999999999999999
Q ss_pred EeeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC-
Q 006785 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL- 367 (631)
Q Consensus 289 ~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~- 367 (631)
++.. ....|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 114 ~~~~----~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 114 VFED----KKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNS 184 (504)
T ss_dssp EEEC----SSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTC
T ss_pred EEEc----CCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCC
Confidence 9875 56789999999999999999754 45999999999999999999999998 99999999999998775
Q ss_pred --CeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccch
Q 006785 368 --NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES 445 (631)
Q Consensus 368 --~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~ 445 (631)
.+||+|||++....... ......||+.|+|||++. +.++.++||||||+++|+|++|..||..........
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 257 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDY------KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK 257 (504)
T ss_dssp CSSEEECCCTTCEECCTTS------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CccEEEEECCCCEEcCCCC------ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 69999999998765432 223456999999999876 568999999999999999999999997543221111
Q ss_pred hhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 446 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+..... ..........+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 258 ~i~~~~~---------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 258 KVEKGKY---------------YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHCCC---------------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHcCCC---------------CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1100000 00000001123458899999999999999999999973
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=349.36 Aligned_cols=269 Identities=27% Similarity=0.443 Sum_probs=198.8
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCC-hHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
.++|...+.||+|+||.||+|.... |+.||||++....... ....+.+|+.++++++||||+++++++.. ....
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~ 99 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK----KKRW 99 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec----CCEE
Confidence 3568889999999999999999865 8999999987653332 33457899999999999999999999876 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 100 ~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTL 174 (331)
T ss_dssp EEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceee
Confidence 9999999999998886543 45999999999999999999999998 999999999999999999999999999866
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccc-c---
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL-Q--- 455 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~-~--- 455 (631)
.... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||................... .
T Consensus 175 ~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (331)
T 4aaa_A 175 AAPG-----EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ 249 (331)
T ss_dssp --------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred cCCc-----cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Confidence 4332 122344689999999999875 78999999999999999999999997543221111000000000 0
Q ss_pred ---cccccccccCCCCCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 456 ---DSGTVISELPDPRLKGDFP-----KEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 456 ---~~~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
...........+.+....+ ...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000001111111111111 1234568999999999999999999999863
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=334.87 Aligned_cols=248 Identities=24% Similarity=0.299 Sum_probs=193.6
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|.+.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.+++.++||||+++++++.. ....
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 86 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST----PTDF 86 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec----CCeE
Confidence 57888999999999999999986 69999999986431 22334568999999999999999999999875 4578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 87 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999999999754 45899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
.... ......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||............
T Consensus 162 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~------------ 223 (276)
T 2h6d_A 162 SDGE------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI------------ 223 (276)
T ss_dssp CC-------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------------
T ss_pred CCCc------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh------------
Confidence 4322 1233468999999999987765 68999999999999999999999653221100000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
... .. ..+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 224 --~~~-~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 224 --RGG-VF----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --HHC-CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --hcC-cc----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000 00 1122233458899999999999999999999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=345.40 Aligned_cols=271 Identities=24% Similarity=0.339 Sum_probs=195.9
Q ss_pred HHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC----hHHHHHHHHHHHHhcCCCCCcceeEEeeeccC
Q 006785 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN----ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 295 (631)
Q Consensus 221 ~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 295 (631)
...++|...+.||+|+||.||+|.+. +|+.||||++....... ....+.+|+.++++++||||+++++++..
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 83 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--- 83 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC---
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee---
Confidence 34578999999999999999999976 48999999997532211 12358899999999999999999999875
Q ss_pred CcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccC
Q 006785 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 375 (631)
Q Consensus 296 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFG 375 (631)
....++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 84 -~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (346)
T 1ua2_A 84 -KSNISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFG 157 (346)
T ss_dssp -TTCCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCG
T ss_pred -CCceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecc
Confidence 4567999999975 8999887532 45899999999999999999999999 9999999999999999999999999
Q ss_pred ceeecccCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh--ccc
Q 006785 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATP 452 (631)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~ 452 (631)
+++...... .......||+.|+|||++.+. .++.++||||||+++|||++|..||.............. ..+
T Consensus 158 ~a~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~ 232 (346)
T 1ua2_A 158 LAKSFGSPN-----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 232 (346)
T ss_dssp GGSTTTSCC-----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred cceeccCCc-----ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 998764332 223345689999999999764 589999999999999999999999865432211110000 000
Q ss_pred ccccccccccccCCCCC---CCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006785 453 RLQDSGTVISELPDPRL---KGDFP-----KEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506 (631)
Q Consensus 453 ~~~~~~~~~~~~~~~~l---~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 506 (631)
. ...........+... ....+ ...+..+.+|+.+||+.||.+|||+.|+++.-
T Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 233 T-EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp C-TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred C-hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 0 000000000100000 00111 22235589999999999999999999998753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=363.96 Aligned_cols=252 Identities=24% Similarity=0.320 Sum_probs=203.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
.++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.+|++++||||+++++++.. ...
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~ 100 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED----KGY 100 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe----CCE
Confidence 467888999999999999999986 589999999975432 3445669999999999999999999999876 557
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeee---cCCCCeEEeccCc
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGM 376 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl---~~~~~~kL~DFGl 376 (631)
.|+||||+.+|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 89999999999999999754 45999999999999999999999998 9999999999999 5678899999999
Q ss_pred eeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccc
Q 006785 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+....
T Consensus 176 a~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----- 243 (484)
T 3nyv_A 176 STHFEASK------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK----- 243 (484)
T ss_dssp HHHBCCCC------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----
T ss_pred eEEccccc------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-----
Confidence 98764321 2234579999999998865 69999999999999999999999997543221111110000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. ....+.....+..+.+|+.+||+.||.+|||+.++++.
T Consensus 244 --------~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 244 --------Y--TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp --------C--CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------C--CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0 00001112334558899999999999999999999973
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=362.57 Aligned_cols=252 Identities=24% Similarity=0.312 Sum_probs=196.3
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
.++|...+.||+|+||+||+|... ++..||||++.... .......+.+|+.+|+.++||||+++++++.. ....
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~ 111 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED----KRNY 111 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----CCEE
Confidence 456888999999999999999986 58999999997543 23334568999999999999999999999876 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCC---CCeEEeccCce
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN---LNAKITDLGMA 377 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~---~~~kL~DFGla 377 (631)
|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||++
T Consensus 112 ~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999999998754 45899999999999999999999998 9999999999999764 45999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
+...... ......||+.|+|||++. +.++.++||||||+++|+|++|+.||...........+.....
T Consensus 187 ~~~~~~~------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~----- 254 (494)
T 3lij_A 187 AVFENQK------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKY----- 254 (494)
T ss_dssp EECBTTB------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-----
T ss_pred eECCCCc------cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----
Confidence 8765432 223456999999999876 5699999999999999999999999975433211111100000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
....+. ....+..+.+|+.+||+.||.+|||+.++++.
T Consensus 255 -----~~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 255 -----TFDSPE-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp -----CCCSGG-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -----CCCchh-----cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 000000 01223458899999999999999999999863
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=353.56 Aligned_cols=258 Identities=12% Similarity=0.044 Sum_probs=183.2
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHhc--CCCCCccee-------EEee
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRL--HHCHVVPLV-------GYCS 291 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~~E~~~l~~l--~H~niv~l~-------g~~~ 291 (631)
.+|...+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45778899999999999999976 5899999999875432 2334577886555555 699988755 3332
Q ss_pred eccC-------------CcceEEEEEeeCCCCChHhhhhccccCCCCHHHH------HHHHHHHHhhhHHHHhcCCCcee
Q 006785 292 EFRG-------------KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR------VAIAIGAARGLEYLHEAAAPRIL 352 (631)
Q Consensus 292 ~~~~-------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~iv 352 (631)
.... .....|+||||++ |+|.+++.... ..+.+..+ ..++.||+.||+|||+++ |+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKG---LV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Cc
Confidence 2110 0145799999998 89999997642 23566666 788899999999999998 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhc--CCCCcccchhhHHHHHHHHHh
Q 006785 353 HRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELIT 430 (631)
Q Consensus 353 HrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~--~~~s~ksDVwSlGviL~eLlt 430 (631)
||||||+||||+.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++||||||++||||++
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE--------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC--------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 9999999999999999999999999865421 114457899999999987 679999999999999999999
Q ss_pred CCCCCCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 431 GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 431 G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
|+.||.......... +..... ............+...+..+.+|+.+||+.||++|||+.++++
T Consensus 289 g~~Pf~~~~~~~~~~---~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 289 LFLPFGLVTPGIKGS---WKRPSL-------RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SSCSTTBCCTTCTTC---CCBCCT-------TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCCcCcccccc---hhhhhh-------hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999997653321110 110000 0001111111111233455889999999999999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=345.58 Aligned_cols=276 Identities=21% Similarity=0.281 Sum_probs=201.9
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC----Cc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG----KR 297 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----~~ 297 (631)
++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.+|+.++||||+++++++..... ..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57888999999999999999984 589999999865432 2334568899999999999999999999876321 13
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
...|+||||++ |+|.+.+.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 46799999996 58888876543 45999999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccc-
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ- 455 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~- 455 (631)
+......... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||....................
T Consensus 172 ~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 172 RAFSLAKNSQ-PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp EECCCCSSSS-CCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccc-ccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 8765332111 123345678999999999876 4589999999999999999999999976433211111100000000
Q ss_pred ----cc--cccccccCCCCC-CCCCCHHH-----HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 456 ----DS--GTVISELPDPRL-KGDFPKEE-----MQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 456 ----~~--~~~~~~~~~~~l-~~~~~~~~-----~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.. ......+..... ........ ...+.+|+.+||+.||.+|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00 000000000000 00001111 2347899999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.52 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=199.0
Q ss_pred HHhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 221 HATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 221 ~a~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
...++|.+.+.||+|+||.||+|.+.. |+.||||++.... ....+.+|+.++++++||||+++++++.. ...
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 98 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFK----NTD 98 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEE----TTE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEe----CCE
Confidence 345789999999999999999999864 8999999997643 23458999999999999999999999876 457
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 89999999999999999743 356999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
..... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........
T Consensus 175 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------------- 236 (314)
T 3com_A 175 LTDTM-----AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM------------- 236 (314)
T ss_dssp CBTTB-----SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------------
T ss_pred hhhhc-----cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH-------------
Confidence 65331 122345689999999999999999999999999999999999999965322111000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+.....+.+ ..+...+..+.+|+.+||..||.+|||+.++++.
T Consensus 237 -~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 237 -IPTNPPPTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp -HHHSCCCCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -HhcCCCccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000001111 1122334558899999999999999999999873
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.30 Aligned_cols=272 Identities=24% Similarity=0.363 Sum_probs=202.5
Q ss_pred HhcCccccceeeeeCceEEEEEEEC--CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhc---CCCCCcceeEEeeecc-
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT--DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRL---HHCHVVPLVGYCSEFR- 294 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~- 294 (631)
+.++|.+.+.||+|+||.||+|.+. +|+.||||++..... ......+.+|+.+++.+ +||||+++++++....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999983 588999999874322 11222367888887777 8999999999986322
Q ss_pred CCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEecc
Q 006785 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 374 (631)
Q Consensus 295 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DF 374 (631)
......++||||++ |+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecC
Confidence 13557899999997 69999998765556999999999999999999999998 999999999999999999999999
Q ss_pred CceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh--ccc
Q 006785 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATP 452 (631)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~ 452 (631)
|+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.............. ..+
T Consensus 165 g~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (326)
T 1blx_A 165 GLARIYSFQM------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238 (326)
T ss_dssp CSCCCCCGGG------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccccccCCC------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 9997654321 12234689999999999999999999999999999999999999975432211100000 000
Q ss_pred ---cccc----ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 453 ---RLQD----SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 453 ---~~~~----~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
.+.. ............ ...+....+..+.+|+.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQP-IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCC-GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccCccccccchhhhcccCcch-hhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 000000000000 00112223445889999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=376.72 Aligned_cols=250 Identities=22% Similarity=0.289 Sum_probs=203.2
Q ss_pred HhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCc
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 297 (631)
..++|.+.+.||+|+||.||+|+... ++.||||+++... .......+..|..+|..+ +||||+++++++.. .
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~----~ 414 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----M 414 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC----S
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe----C
Confidence 35689999999999999999999764 8899999987431 123345588999999988 89999999988865 5
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
..+||||||+++|+|.++|... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred CEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeeccee
Confidence 5789999999999999999764 45999999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
+...... .......||+.|+|||++.+..++.++||||||++||||++|+.||..........
T Consensus 490 ~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~------------ 552 (674)
T 3pfq_A 490 KENIWDG-----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ------------ 552 (674)
T ss_dssp EECCCTT-----CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------------
T ss_pred eccccCC-----cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHH------------
Confidence 8654332 22345679999999999999999999999999999999999999997543221111
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM-----SEVVQ 504 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 504 (631)
.+.... ..+|...+..+.+|+.+||+.||.+||++ .+|++
T Consensus 553 -----~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 553 -----SIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -----HHHSSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -----HHHhCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 111110 12333445568999999999999999997 55554
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=339.08 Aligned_cols=252 Identities=24% Similarity=0.313 Sum_probs=184.3
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHH-HHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~-~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
.++|.+.+.||+|+||.||+|... +|+.||||++........... +.++...++.++||||+++++++.. ....
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~----~~~~ 81 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR----EGDV 81 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSSE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec----cCCE
Confidence 467888999999999999999975 589999999976543333333 4445555778899999999999875 4567
Q ss_pred EEEEeeCCCCChHhhhhcc--ccCCCCHHHHHHHHHHHHhhhHHHHhc-CCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 301 LLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
++||||++ |+|.+++... ....+++..+..++.|++.||+|||++ + |+||||||+|||++.++.+||+|||++
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGIS 157 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCc
Confidence 99999996 6998887542 235699999999999999999999998 8 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhh----hcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYA----MVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 453 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~----~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~ 453 (631)
+...... ......||+.|+|||++ ....++.++||||||+++|||++|+.||.............
T Consensus 158 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----- 226 (290)
T 3fme_A 158 GYLVDDV------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV----- 226 (290)
T ss_dssp ------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHH-----
T ss_pred ccccccc------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHH-----
Confidence 8765432 12234699999999996 46678999999999999999999999996432211110000
Q ss_pred cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 454 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 454 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
+... .+.. .+...+..+.+|+.+||+.||++|||+.++++
T Consensus 227 -------~~~~-~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 227 -------VEEP-SPQL---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -------HHSC-CCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------hccC-CCCc---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0000 1111 11122344889999999999999999999987
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=344.95 Aligned_cols=264 Identities=23% Similarity=0.314 Sum_probs=188.6
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCCcceeEEeeecc----CC
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFR----GK 296 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~----~~ 296 (631)
..+|.+.+.||+|+||.||+|++. +++.||||++.... ......+.+|+.++.++. ||||+++++++.... ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 356888999999999999999975 58999999986542 334456899999999995 999999999985321 23
Q ss_pred cceEEEEEeeCCCCChHhhhhccc-cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccC
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVL-VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 375 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFG 375 (631)
....++||||+. |+|.+++.... ...+++.+++.++.|++.||+|||+.+ ++|+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 456899999994 89999986532 345999999999999999999999875 349999999999999999999999999
Q ss_pred ceeecccCCCCCC-------CCCCcccccCCCCCCchhh---hcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccch
Q 006785 376 MAKRLKADGLPSC-------SSSPARMQGTFGYFAPEYA---MVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES 445 (631)
Q Consensus 376 la~~~~~~~~~~~-------~~~~~~~~Gt~~Y~APE~~---~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~ 445 (631)
+++.......... ........||+.|+|||++ .+..++.++||||||+++|||++|+.||........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-- 261 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI-- 261 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh--
Confidence 9987654321100 0111234699999999998 566789999999999999999999999964321100
Q ss_pred hhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 446 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
.............+ ..+.+|+.+||+.||.+|||+.++++.|..+.
T Consensus 262 ---------------~~~~~~~~~~~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 262 ---------------VNGKYSIPPHDTQY----TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp -------------------CCCCTTCCSS----GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------------hcCcccCCcccccc----hHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00000001111222 23788999999999999999999999998875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=349.95 Aligned_cols=268 Identities=21% Similarity=0.296 Sum_probs=200.8
Q ss_pred HHHHHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC
Q 006785 217 SALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 295 (631)
Q Consensus 217 ~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 295 (631)
.+++...++|.+.+.||+|+||.||+|.+.+ .||||+++.... ......|.+|+.++++++||||+++++++..
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 100 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS--- 100 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC---
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec---
Confidence 3444456788999999999999999999854 499999875422 2223347899999999999999999999886
Q ss_pred CcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccC
Q 006785 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 375 (631)
Q Consensus 296 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFG 375 (631)
....++||||+++++|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+|||++ ++.+||+|||
T Consensus 101 -~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 101 -PPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp -SSCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCS
T ss_pred -CCceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecC
Confidence 44689999999999999999764 245899999999999999999999998 99999999999998 6799999999
Q ss_pred ceeecccCCCCCCCCCCcccccCCCCCCchhhhc---------CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchh
Q 006785 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV---------GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 446 (631)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~---------~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~ 446 (631)
+++..................||+.|+|||++.. ..++.++||||||+++|||++|+.||...........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 254 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9876543221111223334569999999999874 4578999999999999999999999965432211000
Q ss_pred hhhcccccccccccccccCCCCC-CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006785 447 VLWATPRLQDSGTVISELPDPRL-KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513 (631)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 513 (631)
+.....+.. ...++. .+.+|+.+||..||++|||+.++++.|..+....
T Consensus 255 --------------~~~~~~~~~~~~~~~~----~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 255 --------------MGTGMKPNLSQIGMGK----EISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp --------------HHTTCCCCCCCSSCCT----THHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred --------------hccCCCCCCCcCCCCH----HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 000011111 112333 3889999999999999999999999999886553
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=362.23 Aligned_cols=252 Identities=23% Similarity=0.287 Sum_probs=199.7
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
.++|.+.+.||+|+||+||+|... +++.||||++.... .......+.+|+.+|++++||||+++++++.. ....
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~ 96 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED----SSSF 96 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc----CCEE
Confidence 467888999999999999999986 58999999986431 22334568999999999999999999999876 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeec---CCCCeEEeccCce
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMA 377 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~---~~~~~kL~DFGla 377 (631)
|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||++
T Consensus 97 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 9999999999999998654 45999999999999999999999998 99999999999995 4567999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
+...... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+....
T Consensus 172 ~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~------ 238 (486)
T 3mwu_A 172 TCFQQNT------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK------ 238 (486)
T ss_dssp TTBCCC----------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------
T ss_pred eECCCCC------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------
Confidence 8664321 2234569999999998875 59999999999999999999999997543221111000000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. ....+.....+..+.+|+.+||+.||.+|||+.++++.
T Consensus 239 -------~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 239 -------Y--AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -------C--CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -------C--CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00000112234558899999999999999999999984
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=358.27 Aligned_cols=246 Identities=16% Similarity=0.200 Sum_probs=187.7
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccC--CCCChHHHHHHHH---HHHHhcCCCCCccee-------EE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ--GGPNADSVFLTEV---DMLSRLHHCHVVPLV-------GY 289 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~~E~---~~l~~l~H~niv~l~-------g~ 289 (631)
.++|.+.+.||+|+||.||+|.+. +|+.||||++... ......+.|.+|+ .+|++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467888999999999999999964 5999999999754 2334556789999 455556899999998 44
Q ss_pred eeeccC----------Cc---ceEEEEEeeCCCCChHhhhhcccc-----CCCCHHHHHHHHHHHHhhhHHHHhcCCCce
Q 006785 290 CSEFRG----------KR---AMRLLVFEFMPNGNLRDCLDGVLV-----EGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351 (631)
Q Consensus 290 ~~~~~~----------~~---~~~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 351 (631)
+..... .. ...||||||+ +|+|.+++..... ..+++..++.|+.||+.||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 433110 00 1378999999 6899999975321 12346888899999999999999998 9
Q ss_pred eecCCCCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcC-----------CCCcccchhh
Q 006785 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-----------RASLMSDVFS 420 (631)
Q Consensus 352 vHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-----------~~s~ksDVwS 420 (631)
+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~--------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC--------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC--------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence 9999999999999999999999999986432 1223457 999999999887 8999999999
Q ss_pred HHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006785 421 FGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 500 (631)
Q Consensus 421 lGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 500 (631)
||++||||++|+.||.......... .+.. ....++ ..+.+|+.+||+.||++|||+.
T Consensus 299 lG~il~elltg~~Pf~~~~~~~~~~-----------------~~~~--~~~~~~----~~~~~li~~~L~~dp~~Rpt~~ 355 (377)
T 3byv_A 299 LGLVIYWIWCADLPITKDAALGGSE-----------------WIFR--SCKNIP----QPVRALLEGFLRYPKEDRLLPL 355 (377)
T ss_dssp HHHHHHHHHHSSCCC------CCSG-----------------GGGS--SCCCCC----HHHHHHHHHHTCSSGGGCCCHH
T ss_pred HHHHHHHHHHCCCCCcccccccchh-----------------hhhh--hccCCC----HHHHHHHHHHcCCCchhCCCHH
Confidence 9999999999999996533221100 0000 001234 3488899999999999999999
Q ss_pred HHHH
Q 006785 501 EVVQ 504 (631)
Q Consensus 501 evl~ 504 (631)
++++
T Consensus 356 e~l~ 359 (377)
T 3byv_A 356 QAME 359 (377)
T ss_dssp HHHT
T ss_pred HHhh
Confidence 9986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.39 Aligned_cols=274 Identities=21% Similarity=0.282 Sum_probs=204.1
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeecc-CCcceE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR-GKRAMR 300 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~~~~ 300 (631)
.++|.+.+.||+|+||.||+|... +++.||||++...........+.+|+++|++++||||+++++++.... ......
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457889999999999999999876 588999999986544444567899999999999999999999986532 223467
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+. |+|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999996 699999865 35899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh--ccccccc-
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPRLQD- 456 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~~~~- 456 (631)
...... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. ..+....
T Consensus 179 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 179 DPDHDH--TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp CGGGCB--CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred CCCCCc--cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 543211 112344579999999998764 4589999999999999999999999975433221111100 0000000
Q ss_pred -------ccccccccCCCCCC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 457 -------SGTVISELPDPRLK--GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 457 -------~~~~~~~~~~~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..........+... .......+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000001100000 00011223458899999999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=355.42 Aligned_cols=199 Identities=22% Similarity=0.291 Sum_probs=172.6
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhc------CCCCCcceeEEeeeccC
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL------HHCHVVPLVGYCSEFRG 295 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~ 295 (631)
..+|.+.+.||+|+||.||+|.... ++.||||++... ......+.+|+.+++.+ +|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~--- 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF--- 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE---
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc---
Confidence 4578889999999999999998764 899999999753 23345578899998887 57799999999876
Q ss_pred CcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCC--eEEec
Q 006785 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN--AKITD 373 (631)
Q Consensus 296 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~--~kL~D 373 (631)
....++||||+. ++|.+++.......+++..+..++.||+.||+|||+.+ |+||||||+||||+.++. +||+|
T Consensus 171 -~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 171 -RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp -TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECC
T ss_pred -CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEee
Confidence 457899999995 79999998766566999999999999999999999998 999999999999999887 99999
Q ss_pred cCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCcc
Q 006785 374 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (631)
Q Consensus 374 FGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~ 439 (631)
||+++..... .....||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 246 FG~a~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 246 FGSSCYEHQR--------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CTTCEETTCC--------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccceecCCc--------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999764322 234579999999999999999999999999999999999999997543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=335.58 Aligned_cols=256 Identities=25% Similarity=0.306 Sum_probs=200.0
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC---CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
..++|.+.+.||+|+||.||++... +++.||||++.... .......+.+|+.++++++||||+++++++.... .
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~ 80 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE--K 80 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC----
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC--C
Confidence 3478999999999999999999975 58999999997531 2344567999999999999999999999985322 4
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
...++||||++++ |.+++.......+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccc
Confidence 4679999999766 888887655567999999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCC--CCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR--ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 455 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~--~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 455 (631)
......... .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||............
T Consensus 157 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i-------- 225 (305)
T 2wtk_C 157 EALHPFAAD---DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI-------- 225 (305)
T ss_dssp EECCTTCSS---CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--------
T ss_pred cccCccccc---cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHH--------
Confidence 876432211 1122346899999999987654 378999999999999999999999753221110000
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 456 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 456 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.. .... .+...+..+.+|+.+||+.||.+|||+.++++.
T Consensus 226 ------~~-~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 226 ------GK-GSYA----IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ------HH-CCCC----CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------hc-CCCC----CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0011 122233448899999999999999999999974
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=346.15 Aligned_cols=267 Identities=24% Similarity=0.315 Sum_probs=196.4
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC--Ccc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRA 298 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~~ 298 (631)
.++|...+.||+|+||.||+|.+. +|+.||||++..... ......+.+|+.+|+.++||||+++++++..... ...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467888999999999999999985 599999999965432 2234568899999999999999999999875321 123
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..|+||||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 569999999 8999999975 45899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh--cccc--
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPR-- 453 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~-- 453 (631)
..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. ..+.
T Consensus 177 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 177 QADSE--------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248 (367)
T ss_dssp ECCSS--------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccccc--------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 75432 234578999999999887 6799999999999999999999999975432211110000 0000
Q ss_pred ----cccc--cc---cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 454 ----LQDS--GT---VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 454 ----~~~~--~~---~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+... .. .+.......+. ......+..+.+|+.+||+.||.+|||+.++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000 00 00001111111 1112233458899999999999999999999884
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=339.86 Aligned_cols=258 Identities=18% Similarity=0.236 Sum_probs=198.6
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCCcceeEEeeeccCCcceEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~~ 301 (631)
++|.+.+.||+|+||.||+|... +++.||||+++.. ....+.+|+.+|++++ ||||+++++++.... ....+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~--~~~~~ 109 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPV--SRTPA 109 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT--TCCEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCC--CCceE
Confidence 67888999999999999999874 5899999999743 2456899999999996 999999999987532 34679
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC-CeEEeccCceeec
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKRL 380 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kL~DFGla~~~ 380 (631)
+||||+++++|.+++.. +++.++..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 110 lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999999998853 789999999999999999999998 99999999999999776 8999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhh-----------h
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-----------L 448 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-----------~ 448 (631)
.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||............ .
T Consensus 182 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 255 (330)
T 3nsz_A 182 HPGQ------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255 (330)
T ss_dssp CTTC------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred CCCC------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhh
Confidence 5432 2233468999999999987 67899999999999999999999999543221100000 0
Q ss_pred h---ccccccc---------ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 449 W---ATPRLQD---------SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 449 ~---~~~~~~~---------~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+ ....... ......... ....+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 256 YIDKYNIELDPRFNDILGRHSRKRWERFV----HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHTTCCCCTHHHHHHCCCCCCCGGGGC----CTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHhccccccchhhhhhhccccchhhhc----cccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 0000000 000000111 111122234568999999999999999999999873
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=351.83 Aligned_cols=208 Identities=22% Similarity=0.295 Sum_probs=168.3
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC-Ccce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG-KRAM 299 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~~~ 299 (631)
.++|.+.+.||+|+||.||+|.+.. |+.||||++...... .....+.+|+.+|++++||||+++++++..... ....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4678899999999999999999764 889999999754322 234568999999999999999999999865321 1246
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.|+||||++ |+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 899999995 6999999753 45999999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCCCC-----------------CCCCcccccCCCCCCchhh-hcCCCCcccchhhHHHHHHHHHhCCCCCC
Q 006785 380 LKADGLPSC-----------------SSSPARMQGTFGYFAPEYA-MVGRASLMSDVFSFGVVLLELITGRQPIH 436 (631)
Q Consensus 380 ~~~~~~~~~-----------------~~~~~~~~Gt~~Y~APE~~-~~~~~s~ksDVwSlGviL~eLltG~~P~~ 436 (631)
......... .......+||+.|+|||++ ....++.++|||||||+||||++|..||.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 654321100 0123456799999999986 46679999999999999999999766654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=355.02 Aligned_cols=266 Identities=24% Similarity=0.323 Sum_probs=195.6
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC--CcceEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRAMRL 301 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~~~~~ 301 (631)
+|...+.||+|+||.||+|++. +|+.||||++...... +.+|+++|++++||||+++++++..... ...+.+
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh-----HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 5777899999999999999986 4899999998754321 3579999999999999999999865332 234578
Q ss_pred EEEeeCCCCChHhhhhc--cccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCC-CCeEEeccCcee
Q 006785 302 LVFEFMPNGNLRDCLDG--VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAK 378 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kL~DFGla~ 378 (631)
+||||+++ +|.+++.. .....+++..+..++.||+.||+|||+++ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999964 77776643 22356999999999999999999999998 9999999999999965 568999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh--cccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPRLQ 455 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~~~ 455 (631)
...... ......||+.|+|||++.+. .++.++|||||||+||||++|+.||.............. ..+...
T Consensus 206 ~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 206 QLVRGE------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279 (420)
T ss_dssp ECCTTC------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred hcccCC------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 764432 22345789999999999765 799999999999999999999999975432211110000 000000
Q ss_pred ---cccccccccCCCCCCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 456 ---DSGTVISELPDPRLKG-----DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 456 ---~~~~~~~~~~~~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.......+...+.+.. .++...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0000001111111111 0122234558899999999999999999999863
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=338.75 Aligned_cols=252 Identities=21% Similarity=0.338 Sum_probs=196.9
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.++|.+.+.||+|+||.||+|.+.. ++.||+|++.... ......+.+|+.+++.++||||+++++++.. ....+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 92 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYH----DGKLW 92 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----C-CEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeee----CCeEE
Confidence 4678889999999999999999864 8999999987653 3345568999999999999999999999876 45779
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 93 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp EEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred EEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999998753 355999999999999999999999998 9999999999999999999999999976432
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhh-----cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
... .......||+.|+|||++. ...++.++||||||+++|||++|+.||.......... ..
T Consensus 169 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~------- 234 (302)
T 2j7t_A 169 KTL-----QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL--KI------- 234 (302)
T ss_dssp HHH-----HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HH-------
T ss_pred ccc-----cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH--HH-------
Confidence 211 1122346899999999984 5678999999999999999999999996543211100 00
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
.....+.. ..+...+..+.+|+.+||+.||.+|||+.++++
T Consensus 235 -----~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 235 -----AKSDPPTL--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -----HHSCCCCC--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -----hccCCccc--CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000000 112333455889999999999999999999976
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=333.39 Aligned_cols=253 Identities=26% Similarity=0.351 Sum_probs=201.5
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--------ChHHHHHHHHHHHHhcC-CCCCcceeEEee
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--------NADSVFLTEVDMLSRLH-HCHVVPLVGYCS 291 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--------~~~~~~~~E~~~l~~l~-H~niv~l~g~~~ 291 (631)
..++|.+.+.||+|+||.||+|... +|+.||||++...... .....+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3578899999999999999999986 4899999999755321 12345889999999995 999999999987
Q ss_pred eccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEE
Q 006785 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 371 (631)
Q Consensus 292 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL 371 (631)
. ....++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||
T Consensus 95 ~----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 95 T----NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp C----SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred c----CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEE
Confidence 5 56789999999999999999764 45899999999999999999999998 999999999999999999999
Q ss_pred eccCceeecccCCCCCCCCCCcccccCCCCCCchhhh------cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccch
Q 006785 372 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM------VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES 445 (631)
Q Consensus 372 ~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~------~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~ 445 (631)
+|||++....... ......||+.|+|||++. ...++.++||||||+++|||++|+.||..........
T Consensus 166 ~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 239 (298)
T 1phk_A 166 TDFGFSCQLDPGE------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR 239 (298)
T ss_dssp CCCTTCEECCTTC------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ecccchhhcCCCc------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHH
Confidence 9999998765432 223456899999999885 4568899999999999999999999996533211100
Q ss_pred hhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 446 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
... ... ...........+..+.+|+.+||+.||.+|||+.++++
T Consensus 240 ~~~-------------~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIM-------------SGN--YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHH-------------HTC--CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHh-------------cCC--cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 000 000 00000111233455889999999999999999999976
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=342.42 Aligned_cols=254 Identities=26% Similarity=0.323 Sum_probs=195.0
Q ss_pred HhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC-------CChHHHHHHHHHHHHhcCCCCCcceeEEeeec
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG-------PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 293 (631)
..++|.+.+.||+|+||.||+|.+.. ++.||||++..... ......+.+|+.+|++++||||+++++++..
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 86 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 86 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-
Confidence 35678999999999999999999764 88999999875321 1122348899999999999999999999864
Q ss_pred cCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCC---eE
Q 006785 294 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN---AK 370 (631)
Q Consensus 294 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~---~k 370 (631)
. ..|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ---~-~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 87 ---E-DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp ---S-SEEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEE
T ss_pred ---C-ceEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEE
Confidence 2 369999999999999998753 46899999999999999999999998 999999999999987665 99
Q ss_pred EeccCceeecccCCCCCCCCCCcccccCCCCCCchhhh---cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhh
Q 006785 371 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 447 (631)
Q Consensus 371 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~ 447 (631)
|+|||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||............
T Consensus 158 l~Dfg~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 231 (322)
T 2ycf_A 158 ITDFGHSKILGETS------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 231 (322)
T ss_dssp ECCCTTCEECCCCH------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHH
T ss_pred EccCccceeccccc------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHH
Confidence 99999998754321 122356899999999974 467899999999999999999999999654322111000
Q ss_pred hhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 448 LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. ..... ...+.. +...+..+.+|+.+||+.||++||++.++++.
T Consensus 232 ~-~~~~~---------~~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 232 I-TSGKY---------NFIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp H-HHTCC---------CCCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred H-HhCcc---------ccCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 0 00000 000000 01123458899999999999999999999863
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=345.67 Aligned_cols=269 Identities=22% Similarity=0.251 Sum_probs=193.6
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeecc--CCcc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKRA 298 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~~ 298 (631)
.++|...+.||+|+||.||+|... +++.||||++..... ......+.+|+.+++.++||||+++++++.... ....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 467899999999999999999875 589999999975432 233456889999999999999999999987532 1223
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..|+||||++ |+|.+++.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 6799999996 588888853 4899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhc--cc----
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA--TP---- 452 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~--~~---- 452 (631)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||............... .+
T Consensus 176 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 176 TAGTSF------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 249 (371)
T ss_dssp --------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHH
T ss_pred cccccc------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 654321 223457999999999999999999999999999999999999999754321110000000 00
Q ss_pred --ccc--------c----ccccccccCCCCCCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 453 --RLQ--------D----SGTVISELPDPRLKGD---FPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 453 --~~~--------~----~~~~~~~~~~~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+. . .+.............. .+......+.+|+.+||+.||.+|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000 0 0000000000000000 112335678999999999999999999999974
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=340.44 Aligned_cols=256 Identities=25% Similarity=0.352 Sum_probs=179.4
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHH-HHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVD-MLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
.++|...+.||+|+||.||+|... +|+.||||++...........+..|+. +++.++||||+++++++.. ....
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~----~~~~ 96 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR----EGDC 96 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC----SSEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe----CCce
Confidence 367888999999999999999985 589999999987644444445666776 6777799999999999876 4578
Q ss_pred EEEEeeCCCCChHhhhhc---cccCCCCHHHHHHHHHHHHhhhHHHHhc-CCCceeecCCCCCCeeecCCCCeEEeccCc
Q 006785 301 LLVFEFMPNGNLRDCLDG---VLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGM 376 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kL~DFGl 376 (631)
++||||++ |+|.+++.. .....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 97 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 97 WICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp EEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred EEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCC
Confidence 99999996 588888753 2235689999999999999999999998 8 99999999999999999999999999
Q ss_pred eeecccCCCCCCCCCCcccccCCCCCCchhh----hcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccc
Q 006785 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYA----MVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 452 (631)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~----~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 452 (631)
++...... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||..........
T Consensus 173 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------- 239 (327)
T 3aln_A 173 SGQLVDSI------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL------- 239 (327)
T ss_dssp SCC------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------
T ss_pred ceeccccc------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH-------
Confidence 98764321 12234699999999998 45678999999999999999999999996532211000
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 453 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. .+.....+.+........+..+.+|+.+||+.||.+|||+.++++.
T Consensus 240 --~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 240 --T----QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp --C----CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred --H----HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0 0000111111111112233458899999999999999999999863
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=341.34 Aligned_cols=256 Identities=22% Similarity=0.255 Sum_probs=177.0
Q ss_pred hcCcccc-ceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHH-HHHhcCCCCCcceeEEeeeccCCcce
Q 006785 223 TDKFSGS-NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVD-MLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 223 ~~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
.++|.+. +.||+|+||.||+|.+. +|+.||||++.... ...+|+. .++.+.||||+++++++.........
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 4667774 46999999999999987 58999999986531 1333443 45667999999999999765554567
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC---CCCeEEeccCc
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGM 376 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~~~~kL~DFGl 376 (631)
.++||||+++|+|.+++.......+++.++..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 899999999999999998765567999999999999999999999998 999999999999976 45599999999
Q ss_pred eeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccc
Q 006785 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
++..... ......||+.|+|||++....++.++||||||+++|+|++|+.||............. ..+
T Consensus 178 ~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~-- 245 (336)
T 3fhr_A 178 AKETTQN-------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRI-- 245 (336)
T ss_dssp CEEC-----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred ceecccc-------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhh--
Confidence 9865432 1234568999999999988889999999999999999999999996543221100000 000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
...............+..+.+|+.+||+.||.+|||+.++++.
T Consensus 246 ------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 246 ------RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ------hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000001111112234458899999999999999999999984
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=371.00 Aligned_cols=260 Identities=24% Similarity=0.367 Sum_probs=206.3
Q ss_pred HHHhcCccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC
Q 006785 220 EHATDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 295 (631)
Q Consensus 220 ~~a~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 295 (631)
+...++|.+.+.||+|+||.||+|.+.. +..||||+++........+.|.+|+.+|++++||||+++++++.+
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--- 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--- 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---
Confidence 3345778889999999999999998743 567999998765544555679999999999999999999999853
Q ss_pred CcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccC
Q 006785 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 375 (631)
Q Consensus 296 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFG 375 (631)
...|+||||+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 463 --~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 463 --NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred --CceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecC
Confidence 3469999999999999999754 245899999999999999999999998 9999999999999999999999999
Q ss_pred ceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccc
Q 006785 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRL 454 (631)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~ 454 (631)
+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||...........
T Consensus 537 ~a~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~-------- 604 (656)
T 2j0j_A 537 LSRYMEDSTY----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-------- 604 (656)
T ss_dssp CCCSCCC--------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH--------
T ss_pred CCeecCCCcc----eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--------
Confidence 9987644321 11223457889999999999999999999999999999997 9999965432211000
Q ss_pred ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 455 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 455 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
+.....+. .+...+..+.+|+.+||+.||.+|||+.+|++.|..+.
T Consensus 605 ------i~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 605 ------IENGERLP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp ------HHHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------HHcCCCCC----CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 00001111 22233445889999999999999999999999998874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=342.35 Aligned_cols=257 Identities=23% Similarity=0.346 Sum_probs=196.7
Q ss_pred HHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcC--CCCCcceeEEeeeccCC
Q 006785 220 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLH--HCHVVPLVGYCSEFRGK 296 (631)
Q Consensus 220 ~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~ 296 (631)
....++|.+.+.||+|+||.||++...+++.||||++..... ......+.+|+.++++++ ||||+++++++..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~---- 99 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT---- 99 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC----
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec----
Confidence 334567888999999999999999998899999999975432 234456899999999996 5999999999876
Q ss_pred cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCc
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGl 376 (631)
....++||| +.+++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++ +.+||+|||+
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred CCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccc
Confidence 457899999 5589999999764 46899999999999999999999998 999999999999965 7899999999
Q ss_pred eeecccCCCCCCCCCCcccccCCCCCCchhhhc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCccccccch
Q 006785 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-----------GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES 445 (631)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-----------~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~ 445 (631)
++....... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.........
T Consensus 173 ~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~- 248 (313)
T 3cek_A 173 ANQMQPDTT---SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK- 248 (313)
T ss_dssp SCC-----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-
T ss_pred cccccCccc---cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH-
Confidence 987654321 111234569999999999875 47889999999999999999999999643221100
Q ss_pred hhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006785 446 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506 (631)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 506 (631)
+..+.++.....++...+..+.+|+.+||+.||.+||++.++++.-
T Consensus 249 ---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 249 ---------------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp ---------------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ---------------HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 0111111111122222234588999999999999999999998743
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=342.60 Aligned_cols=276 Identities=22% Similarity=0.299 Sum_probs=201.7
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeec-cCCcceE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF-RGKRAMR 300 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~~~~ 300 (631)
.++|.+.+.||+|+||.||+|.+. +|+.||||++...........+.+|+.++++++||||+++++++... .......
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467888999999999999999986 58999999997654444455688999999999999999999987642 1123568
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+. |+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999996 699999875 45899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCC-----CCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhh--hccc
Q 006785 381 KADGLPSC-----SSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL--WATP 452 (631)
Q Consensus 381 ~~~~~~~~-----~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~--~~~~ 452 (631)
........ ........||+.|+|||++.. ..++.++||||||+++|||++|+.||............. ...+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 54321110 011233578999999998765 778999999999999999999999997543221110000 0000
Q ss_pred ccccc---------cccccccCCCCCC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 453 RLQDS---------GTVISELPDPRLK--GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 453 ~~~~~---------~~~~~~~~~~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..... ...+..+...... .......+..+.+|+.+||+.||.+|||+.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 0000000000000 00011233458899999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=348.18 Aligned_cols=267 Identities=22% Similarity=0.270 Sum_probs=195.3
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC--CcceEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRAMRL 301 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~~~~~ 301 (631)
.+|...+.||+|+||.||+|++..+..||+|++...... ..+|+++|+.++||||+++++++..... ...+.+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 457888999999999999999987777999988654322 3479999999999999999999875432 234578
Q ss_pred EEEeeCCCCChHhhhhc--cccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeec-CCCCeEEeccCcee
Q 006785 302 LVFEFMPNGNLRDCLDG--VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAK 378 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~-~~~~~kL~DFGla~ 378 (631)
+||||++++ |.+.+.. .....+++..+..++.|++.||+|||+.+ |+||||||+||||+ .++.+||+|||+++
T Consensus 115 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 999999764 4443321 22356999999999999999999999998 99999999999999 79999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhh--hcccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL--WATPRLQ 455 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~--~~~~~~~ 455 (631)
...... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||............. ...+...
T Consensus 191 ~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 191 ILIAGE------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE 264 (394)
T ss_dssp ECCTTC------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cccCCC------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 764432 22345689999999998765 58999999999999999999999997643221110000 0000000
Q ss_pred c---cc-----ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 456 D---SG-----TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 456 ~---~~-----~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. .. .....+....+...++...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0 00 00000000000001122234458899999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=333.04 Aligned_cols=260 Identities=25% Similarity=0.385 Sum_probs=194.6
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeecc-------
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR------- 294 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------- 294 (631)
.++|...+.||+|+||.||+|+.. +|+.||||++... ......+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 467889999999999999999975 6899999999643 233456899999999999999999999986532
Q ss_pred --CCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEe
Q 006785 295 --GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 372 (631)
Q Consensus 295 --~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~ 372 (631)
......|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 12457899999999999999997532 34788999999999999999999998 9999999999999999999999
Q ss_pred ccCceeecccCCC---------CCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccc
Q 006785 373 DLGMAKRLKADGL---------PSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKG 442 (631)
Q Consensus 373 DFGla~~~~~~~~---------~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~ 442 (631)
|||++........ ...........||+.|+|||++.+. .++.++||||||+++|||++ ||.......
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~ 235 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV 235 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence 9999986543210 0001123345699999999999864 78999999999999999998 553221110
Q ss_pred cchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 443 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. .... +.. ....+...++...+..+.+|+.+||+.||.+|||+.++++.
T Consensus 236 ~--~~~~-----------~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 236 N--ILKK-----------LRS-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp H--HHHH-----------HHS-TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred H--HHHh-----------ccc-cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 0 0000 000 01111222334444558899999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=337.32 Aligned_cols=265 Identities=22% Similarity=0.261 Sum_probs=202.4
Q ss_pred hcCccccceeeeeCceEEEEEEE-C-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCC------CcceeEEeeecc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQL-T-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH------VVPLVGYCSEFR 294 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~-~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~ 294 (631)
.++|.+.+.||+|+||.||+|.+ . +++.||||+++.. ......+.+|+.+++.++|+| ++++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~-- 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH-- 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE--
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc--
Confidence 46788899999999999999987 3 5889999999743 233456889999999987664 8999998876
Q ss_pred CCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC---------
Q 006785 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE--------- 365 (631)
Q Consensus 295 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~--------- 365 (631)
....++||||+ +++|.+++.......+++.++..++.|++.||+|||+++ |+||||||+|||++.
T Consensus 89 --~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 89 --HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp --TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC-
T ss_pred --CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCC
Confidence 45789999999 899999998765556899999999999999999999998 999999999999987
Q ss_pred ----------CCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCC
Q 006785 366 ----------NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 435 (631)
Q Consensus 366 ----------~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~ 435 (631)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEH--------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSC--------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccccccCCCceEeeCcccccCccc--------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 668999999999864322 23456899999999999999999999999999999999999999
Q ss_pred CCccccccchhhhhccccccc------------------------ccccccccCCCC-CCCCCCHHHHHHHHHHHHHhcc
Q 006785 436 HRSITKGEESLVLWATPRLQD------------------------SGTVISELPDPR-LKGDFPKEEMQIMAYLAKECLQ 490 (631)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~-l~~~~~~~~~~~l~~li~~cl~ 490 (631)
..................... ..........+. -....+...+..+.+|+.+||+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp CCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence 754322111100000000000 000000000000 0011234556779999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 006785 491 LDPDARPTMSEVVQI 505 (631)
Q Consensus 491 ~dP~~RPs~~evl~~ 505 (631)
.||.+|||+.|+++.
T Consensus 315 ~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 315 YDPAKRITLREALKH 329 (339)
T ss_dssp SSTTTSCCHHHHTTS
T ss_pred cCcccccCHHHHhcC
Confidence 999999999999863
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=341.65 Aligned_cols=268 Identities=22% Similarity=0.279 Sum_probs=203.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-----------CCCCcceeEEee
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-----------HCHVVPLVGYCS 291 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~ 291 (631)
++|.+.+.||+|+||.||+|+.. +++.||||++... ......+.+|+.++++++ ||||+++++++.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 57888999999999999999974 5899999999743 223455889999999886 899999999988
Q ss_pred eccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhc-CCCceeecCCCCCCeeec------
Q 006785 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLD------ 364 (631)
Q Consensus 292 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlKp~NILl~------ 364 (631)
.........++||||+ +++|.+++.......+++..+..++.||+.||+|||++ + |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence 6544455789999999 99999999876556699999999999999999999998 8 99999999999994
Q ss_pred CCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccc
Q 006785 365 ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE 444 (631)
Q Consensus 365 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~ 444 (631)
..+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH--------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TEEEEEECCCTTCEETTBC--------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CcceEEEcccccccccCCC--------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 4457999999999876432 22346899999999999999999999999999999999999999754321100
Q ss_pred ----hhhhh--ccccc--------------ccccccccccCCCC---------CCCCCCHHHHHHHHHHHHHhcccCCCC
Q 006785 445 ----SLVLW--ATPRL--------------QDSGTVISELPDPR---------LKGDFPKEEMQIMAYLAKECLQLDPDA 495 (631)
Q Consensus 445 ----~~~~~--~~~~~--------------~~~~~~~~~~~~~~---------l~~~~~~~~~~~l~~li~~cl~~dP~~ 495 (631)
.+... ..... .........+.... ....++...+..+.+|+.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 00000 00000 00000000000000 012356777888999999999999999
Q ss_pred CCCHHHHHHH
Q 006785 496 RPTMSEVVQI 505 (631)
Q Consensus 496 RPs~~evl~~ 505 (631)
|||+.|+++.
T Consensus 325 Rpt~~ell~h 334 (373)
T 1q8y_A 325 RADAGGLVNH 334 (373)
T ss_dssp CBCHHHHHTC
T ss_pred cCCHHHHhhC
Confidence 9999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=338.95 Aligned_cols=277 Identities=23% Similarity=0.289 Sum_probs=192.6
Q ss_pred HHHHHHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC
Q 006785 217 SALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 295 (631)
Q Consensus 217 ~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 295 (631)
.......++|.+.+.||+|+||.||+|++. +|+.||||++....... ..+.+++..++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR--NRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC--CHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc--HHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 345667789999999999999999999985 58999999986543322 246788999999999999999999876332
Q ss_pred ---CcceEEEEEeeCCCCChHhhhhc--cccCCCCHHHHHHHHHHHHhhhHHHH--hcCCCceeecCCCCCCeeecC-CC
Q 006785 296 ---KRAMRLLVFEFMPNGNLRDCLDG--VLVEGMNWDTRVAIAIGAARGLEYLH--EAAAPRILHRDIKSSNILLDE-NL 367 (631)
Q Consensus 296 ---~~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivHrDlKp~NILl~~-~~ 367 (631)
...+.++||||+++ +|.+.+.. .....+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCC
Confidence 23347899999975 66555532 12345899999999999999999999 888 999999999999996 89
Q ss_pred CeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCC-CCcccchhhHHHHHHHHHhCCCCCCCccccccchh
Q 006785 368 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 446 (631)
Q Consensus 368 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~ 446 (631)
.+||+|||+++...... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...........
T Consensus 170 ~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 243 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSE------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE 243 (360)
T ss_dssp EEEECCCTTCBCCCTTS------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred cEEEeeCCCceecCCCC------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH
Confidence 99999999998765432 223456899999999987654 89999999999999999999999976432211111
Q ss_pred hhhc--ccc------cccccccc-----cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 447 VLWA--TPR------LQDSGTVI-----SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 447 ~~~~--~~~------~~~~~~~~-----~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.... .+. +....... ............+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 000 00000000 00000000111222345678999999999999999999999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=328.66 Aligned_cols=253 Identities=23% Similarity=0.289 Sum_probs=200.1
Q ss_pred HHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 221 ~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
...++|.+.+.||+|+||.||+|... +++.||||++.... .......+.+|+.++++++||||+++++++.. ..
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~ 94 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED----SS 94 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SS
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC----CC
Confidence 34578999999999999999999986 58999999986542 23445668999999999999999999999875 45
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCC---CCeEEeccC
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN---LNAKITDLG 375 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~---~~~kL~DFG 375 (631)
..++||||+++++|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.+ +.+||+|||
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred eEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccC
Confidence 789999999999999998654 45899999999999999999999998 9999999999999754 469999999
Q ss_pred ceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccc
Q 006785 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 455 (631)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 455 (631)
++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||............. .
T Consensus 170 ~~~~~~~~~------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~---- 236 (287)
T 2wei_A 170 LSTCFQQNT------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE--T---- 236 (287)
T ss_dssp GGGTBCCCS------SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--H----
T ss_pred cceeecCCC------ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--c----
Confidence 998654321 2234468999999998865 58999999999999999999999997543221100000 0
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 456 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 456 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
....... ......+..+.+|+.+||+.||.+|||+.++++
T Consensus 237 -------~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 237 -------GKYAFDL--PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -------CCCCCCS--GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------CCCCCCc--hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0000000 000122345889999999999999999999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=347.63 Aligned_cols=204 Identities=25% Similarity=0.346 Sum_probs=155.8
Q ss_pred cCccc-cceeeeeCceEEEEEEEC---CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 224 DKFSG-SNIVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 224 ~~f~~-~~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
+.|.. .++||+|+||.||+|++. +++.||||++..... ...+.+|+.+|++++||||+++++++.... ...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHA--DRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETT--TTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCC--CCe
Confidence 34554 457999999999999976 478999999975432 235889999999999999999999986532 457
Q ss_pred EEEEEeeCCCCChHhhhhccc-------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeee----cCCCC
Q 006785 300 RLLVFEFMPNGNLRDCLDGVL-------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----DENLN 368 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl----~~~~~ 368 (631)
.|+||||+. |+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||| +.++.
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCc
Confidence 899999995 68988885321 124899999999999999999999999 9999999999999 77889
Q ss_pred eEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCc
Q 006785 369 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (631)
Q Consensus 369 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~ 438 (631)
+||+|||+++........ ........||+.|+|||++.+ ..++.++|||||||+||||++|+.||...
T Consensus 171 ~kl~Dfg~a~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKP--LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp EEECCTTCCC------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EEEEECCCceecCCCCcc--cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 999999999876532111 112334679999999999987 45899999999999999999999999654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=333.42 Aligned_cols=273 Identities=21% Similarity=0.328 Sum_probs=194.5
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeecc-------
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR------- 294 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------- 294 (631)
.++|.+.+.||+|+||.||+|.... |+.||||++... .......+.+|+.++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 3678889999999999999999875 899999998754 2344556899999999999999999999874321
Q ss_pred ---CCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeec-CCCCeE
Q 006785 295 ---GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAK 370 (631)
Q Consensus 295 ---~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~-~~~~~k 370 (631)
......|+||||++ |+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++ +++.+|
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 22457899999997 699999964 45899999999999999999999998 99999999999997 567899
Q ss_pred EeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh
Q 006785 371 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 449 (631)
Q Consensus 371 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~ 449 (631)
|+|||+++........ ........||..|+|||.+.. ..++.++||||||+++|||++|+.||..............
T Consensus 162 l~Dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 239 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSH--KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239 (320)
T ss_dssp ECCCTTCBCC----------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EccCccccccCCCccc--ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999876432111 122334568999999998875 6789999999999999999999999975432211111100
Q ss_pred cccccccc-cccc---------cccCCCCCC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 450 ATPRLQDS-GTVI---------SELPDPRLK-GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 450 ~~~~~~~~-~~~~---------~~~~~~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..+..... ...+ .....+... ...+...+..+.+|+.+||+.||.+|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 00000000 0000 000000000 00011223458899999999999999999999873
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=344.79 Aligned_cols=267 Identities=25% Similarity=0.329 Sum_probs=183.9
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC--Ccc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRA 298 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~~ 298 (631)
.++|...+.||+|+||.||+|.+. +|+.||||++..... ......+.+|+.+|+.++||||+++++++..... ...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 467899999999999999999875 589999999975422 2334568899999999999999999999865321 124
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..|+||||+ +++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 579999999 7899999865 45999999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh--cccc--
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPR-- 453 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~-- 453 (631)
..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. ..+.
T Consensus 181 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 181 HTADE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252 (367)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred ccccc--------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 65422 234579999999999887 6789999999999999999999999975432211110000 0000
Q ss_pred ----cccc--cccccccCC---CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 454 ----LQDS--GTVISELPD---PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 454 ----~~~~--~~~~~~~~~---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
+... ...+..+.. ..+. .........+.+|+.+||+.||.+|||+.++++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHH-HHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHH-HHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000 000000000 0000 0001123458899999999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=337.56 Aligned_cols=200 Identities=26% Similarity=0.296 Sum_probs=170.5
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCC-----CcceeEEeeecc
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCH-----VVPLVGYCSEFR 294 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~-H~n-----iv~l~g~~~~~~ 294 (631)
..++|.+.+.||+|+||+||+|.+. +++.||||+++.. ......+..|+.++..++ |+| |+++++++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 127 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-- 127 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--
Confidence 4578999999999999999999876 4889999999743 223455788999999884 554 8999998876
Q ss_pred CCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHh--cCCCceeecCCCCCCeeec--CCCCeE
Q 006785 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE--AAAPRILHRDIKSSNILLD--ENLNAK 370 (631)
Q Consensus 295 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~--~~~~~ivHrDlKp~NILl~--~~~~~k 370 (631)
....++||||++ |+|.+++.......+++..+..++.|++.||.|||. .+ |+||||||+||||+ .++.+|
T Consensus 128 --~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 128 --RNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp --TTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEE
T ss_pred --CCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEE
Confidence 457899999995 699999987655669999999999999999999994 55 99999999999994 477899
Q ss_pred EeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCcc
Q 006785 371 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (631)
Q Consensus 371 L~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~ 439 (631)
|+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 202 L~DFG~a~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 202 IVDFGSSCQLGQR--------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp ECCCTTCEETTCC--------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEeccCceecccc--------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999876432 234568999999999999999999999999999999999999997543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=333.83 Aligned_cols=264 Identities=19% Similarity=0.232 Sum_probs=199.2
Q ss_pred hcCccccceeeeeCceEEEEEEECC-C-cEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCC------CcceeEEeeecc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD-G-RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH------VVPLVGYCSEFR 294 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g-~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~ 294 (631)
.++|.+.+.||+|+||.||+|.... + +.||||+++.. ......+.+|+.++++++|++ ++.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~-- 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF-- 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE--
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee--
Confidence 4678889999999999999998753 4 78999999743 234456889999999997766 8888888775
Q ss_pred CCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeee-----------
Q 006785 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----------- 363 (631)
Q Consensus 295 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl----------- 363 (631)
....++||||+ +++|.+++.......+++.++..++.||+.||+|||+++ |+||||||+|||+
T Consensus 94 --~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 94 --HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp --TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECC
T ss_pred --CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccc
Confidence 45789999999 778888887655456999999999999999999999998 9999999999999
Q ss_pred --------cCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCC
Q 006785 364 --------DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 435 (631)
Q Consensus 364 --------~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~ 435 (631)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 239 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEH--------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSC--------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccCCCcEEEeecCcccccccc--------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 56789999999999864322 23456999999999999999999999999999999999999999
Q ss_pred CCccccccchhhhhccccccc--------c------c----------ccccccCCC-CCCCCCCHHHHHHHHHHHHHhcc
Q 006785 436 HRSITKGEESLVLWATPRLQD--------S------G----------TVISELPDP-RLKGDFPKEEMQIMAYLAKECLQ 490 (631)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~--------~------~----------~~~~~~~~~-~l~~~~~~~~~~~l~~li~~cl~ 490 (631)
..................... . + ........+ .............+.+|+.+||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 754322111000000000000 0 0 000000000 00001223445678999999999
Q ss_pred cCCCCCCCHHHHHH
Q 006785 491 LDPDARPTMSEVVQ 504 (631)
Q Consensus 491 ~dP~~RPs~~evl~ 504 (631)
.||.+|||+.|+++
T Consensus 320 ~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 320 FDPAQRITLAEALL 333 (355)
T ss_dssp SSTTTSCCHHHHTT
T ss_pred CChhhCcCHHHHhc
Confidence 99999999999976
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=339.16 Aligned_cols=267 Identities=23% Similarity=0.320 Sum_probs=195.7
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCC--cc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK--RA 298 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~--~~ 298 (631)
.++|...+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.+++.++||||+++++++...... ..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467888999999999999999876 4899999999765322 2345688999999999999999999998753321 11
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..|+||||+. ++|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 3499999996 789888743 4899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh--ccc---
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATP--- 452 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~--- 452 (631)
..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. ..+
T Consensus 193 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 193 HADAE--------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 264 (371)
T ss_dssp ---------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccccC--------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH
Confidence 65432 233568999999999987 6799999999999999999999999975432111100000 000
Q ss_pred ---cccc--ccccccccCCCCCCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 453 ---RLQD--SGTVISELPDPRLKG--DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 453 ---~~~~--~~~~~~~~~~~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+.. .......+....... ..+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000 000000000000000 0111224558899999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=332.28 Aligned_cols=246 Identities=24% Similarity=0.370 Sum_probs=191.7
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC-----hHHHHHHHHHHHHhc----CCCCCcceeE
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-----ADSVFLTEVDMLSRL----HHCHVVPLVG 288 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-----~~~~~~~E~~~l~~l----~H~niv~l~g 288 (631)
.+...++|.+.+.||+|+||.||+|... +++.||||++....... ....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3455678999999999999999999874 58999999997543221 122366899999999 8999999999
Q ss_pred EeeeccCCcceEEEEEee-CCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeec-CC
Q 006785 289 YCSEFRGKRAMRLLVFEF-MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-EN 366 (631)
Q Consensus 289 ~~~~~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~-~~ 366 (631)
++.. ....++|||| +.+++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++ .+
T Consensus 106 ~~~~----~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 106 WFET----QEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRR 176 (312)
T ss_dssp EC---------CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTT
T ss_pred EEec----CCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCC
Confidence 9875 4466999999 7899999999764 45899999999999999999999998 99999999999999 88
Q ss_pred CCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCCccccccch
Q 006785 367 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEES 445 (631)
Q Consensus 367 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~ 445 (631)
+.+||+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 177 ~~~kl~dfg~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---- 245 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEP-------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI---- 245 (312)
T ss_dssp TEEEECCCSSCEECCSSC-------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH----
T ss_pred CeEEEEEcchhhhcccCc-------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH----
Confidence 999999999998765432 233468999999999987766 45899999999999999999999642110
Q ss_pred hhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 446 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. .. .. .++...+..+.+|+.+||+.||++|||+.++++.
T Consensus 246 -~--------------~~--~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 246 -L--------------EA--EL----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -H--------------HT--CC----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -h--------------hh--cc----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00 00 1122233458899999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=344.40 Aligned_cols=254 Identities=24% Similarity=0.341 Sum_probs=186.8
Q ss_pred CccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcceEEEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+|+++ +||||+++++++.. ....|+|
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~----~~~~~lv 87 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETT----DRFLYIA 87 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC----SSEEEEE
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEec----CCeEEEE
Confidence 34556889999999998776677999999998653 234578999999987 89999999998765 5678999
Q ss_pred EeeCCCCChHhhhhccccCC-----CCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCC------------
Q 006785 304 FEFMPNGNLRDCLDGVLVEG-----MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN------------ 366 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~-----l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~------------ 366 (631)
|||++ |+|.+++....... .++..++.++.||+.||+|||+.+ |+||||||+||||+.+
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~ 163 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAE 163 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCC
Confidence 99995 69999997543211 133456789999999999999998 9999999999999754
Q ss_pred -CCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhc-------CCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 006785 367 -LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-------GRASLMSDVFSFGVVLLELIT-GRQPIHR 437 (631)
Q Consensus 367 -~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-------~~~s~ksDVwSlGviL~eLlt-G~~P~~~ 437 (631)
+.+||+|||+++......... ........||+.|+|||++.+ ..++.++||||||+++|||++ |+.||..
T Consensus 164 ~~~~kL~DFG~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 164 NLRILISDFGLCKKLDSGQSSF-RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp SCEEEECCCTTCEECCC---------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred ceEEEEcccccceecCCCCccc-eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 479999999998875432110 112234579999999999975 678999999999999999999 9999964
Q ss_pred ccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 438 SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
...... .. ... ....+......+...+..+.+|+.+||+.||.+|||+.+|++.
T Consensus 243 ~~~~~~-~i-~~~------------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 243 KYSRES-NI-IRG------------IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp TTTHHH-HH-HHT------------CCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred chhhHH-HH-hcC------------CCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 322110 00 000 0001111122345667789999999999999999999999863
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=333.06 Aligned_cols=246 Identities=23% Similarity=0.347 Sum_probs=198.0
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC-----hHHHHHHHHHHHHhcC--CCCCcceeEEe
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-----ADSVFLTEVDMLSRLH--HCHVVPLVGYC 290 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-----~~~~~~~E~~~l~~l~--H~niv~l~g~~ 290 (631)
.+...++|.+.+.||+|+||.||+|... +++.||||++....... ....+.+|+.++++++ |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 3445678999999999999999999875 58999999997543221 1233778999999995 59999999998
Q ss_pred eeccCCcceEEEEEeeCCC-CChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeec-CCCC
Q 006785 291 SEFRGKRAMRLLVFEFMPN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLN 368 (631)
Q Consensus 291 ~~~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~-~~~~ 368 (631)
.. ....++||||+.+ ++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++ +++.
T Consensus 118 ~~----~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 118 ER----PDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EC----SSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTE
T ss_pred ec----CCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCC
Confidence 76 4578999999976 8999999764 45899999999999999999999998 99999999999999 7889
Q ss_pred eEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCCccccccchhh
Q 006785 369 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 447 (631)
Q Consensus 369 ~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~ 447 (631)
+||+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... .
T Consensus 189 ~kL~Dfg~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~ 256 (320)
T 3a99_A 189 LKLIDFGSGALLKDTV-------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----I 256 (320)
T ss_dssp EEECCCTTCEECCSSC-------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-----H
T ss_pred EEEeeCcccccccccc-------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh-----h
Confidence 9999999998765321 223469999999999987765 78899999999999999999999642110 0
Q ss_pred hhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 448 LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. .. ......++ ..+.+|+.+||+.||++|||+.+|++.
T Consensus 257 ~-------------~~---~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 257 R-------------GQ---VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp H-------------CC---CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c-------------cc---ccccccCC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00 00112233 348899999999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=333.37 Aligned_cols=266 Identities=22% Similarity=0.312 Sum_probs=196.6
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCC--cc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK--RA 298 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~--~~ 298 (631)
.++|...+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.+++.++||||+++++++...... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 367888999999999999999975 5899999999764322 2345688999999999999999999998753221 12
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..|+||||+. |+|.+++.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 4599999996 699888753 4899999999999999999999998 9999999999999999999999999997
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh--ccc---
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATP--- 452 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~--- 452 (631)
..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. ..+
T Consensus 175 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 175 HADAE--------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246 (353)
T ss_dssp C----------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHH
T ss_pred CCCCC--------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 64322 233568999999999887 6789999999999999999999999975432111000000 000
Q ss_pred ---ccccc--ccc---ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 453 ---RLQDS--GTV---ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 453 ---~~~~~--~~~---~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+... ... +.....+.+. ......+..+.+|+.+||+.||++|||+.++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 000 0001111111 1122334558999999999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=325.86 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=178.5
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHH-HHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~-~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
.++|...+.||+|+||.||+|.+. +|+.||||++........... +.++..+++.++||||+++++++.. ....
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~----~~~~ 99 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT----NTDV 99 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----SSEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec----CCcE
Confidence 467888999999999999999986 589999999986544333333 4445556888899999999999876 4578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhc-CCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
++||||+ ++.+..++.. ....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++..
T Consensus 100 ~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred EEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 9999999 5555555443 345699999999999999999999995 8 99999999999999999999999999976
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhh-----cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 454 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~ 454 (631)
..... ......||+.|+|||++. ...++.++||||||+++|||++|+.||.............
T Consensus 175 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~------ 242 (318)
T 2dyl_A 175 LVDDK------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV------ 242 (318)
T ss_dssp ------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH------
T ss_pred ccCCc------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHH------
Confidence 64322 123346999999999984 5668999999999999999999999996532211100000
Q ss_pred ccccccccccCCCCCC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 455 QDSGTVISELPDPRLK--GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 455 ~~~~~~~~~~~~~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.....+.+. ..++ ..+.+|+.+||+.||.+||++.++++.
T Consensus 243 -------~~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 243 -------LQEEPPLLPGHMGFS----GDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp -------HHSCCCCCCSSSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -------hccCCCCCCccCCCC----HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 000011111 1233 348899999999999999999999863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=340.57 Aligned_cols=250 Identities=25% Similarity=0.372 Sum_probs=185.3
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
.+|...+.||+|+||+||.....+|+.||||++...... .+.+|+.+|+.+ +||||+++++++.+ ....|+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~----~~~~~l 95 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKD----RQFQYI 95 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEE----TTEEEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEec----CCEEEE
Confidence 457778999999999976655667999999999654322 257899999999 89999999998875 557899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC-----CCCeEEeccCce
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-----NLNAKITDLGMA 377 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-----~~~~kL~DFGla 377 (631)
||||++ |+|.+++.... ..+.+.++..++.||+.||+|||+.+ |+||||||+||||+. ...+||+|||++
T Consensus 96 v~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 999995 69999997643 23555567899999999999999998 999999999999943 335789999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhh---cCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPR 453 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~ 453 (631)
+........ ........||+.|+|||++. ...++.++||||||+++|||++ |..||...........
T Consensus 171 ~~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~------- 241 (432)
T 3p23_A 171 KKLAVGRHS--FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL------- 241 (432)
T ss_dssp ECC--------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH-------
T ss_pred eeccCCCcc--eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH-------
Confidence 876543211 11233457999999999997 4567889999999999999999 8999854322111000
Q ss_pred cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 454 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 454 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
......... ..+......+.+|+.+||+.||.+|||+.+|++
T Consensus 242 -------~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 242 -------LGACSLDCL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -------TTCCCCTTS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------hccCCcccc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 000000000 112334556889999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=353.29 Aligned_cols=274 Identities=25% Similarity=0.353 Sum_probs=205.3
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeecc--CCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~~~~ 300 (631)
++|.+.+.||+|+||.||+|.+. +|+.||||++...........|.+|+.+|++++||||+++++++.... ......
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 67999999999999999999875 589999999987655555667999999999999999999999875421 124567
Q ss_pred EEEEeeCCCCChHhhhhccc-cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCC---eEEeccCc
Q 006785 301 LLVFEFMPNGNLRDCLDGVL-VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN---AKITDLGM 376 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~---~kL~DFGl 376 (631)
++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997643 235899999999999999999999998 999999999999997665 89999999
Q ss_pred eeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccc--
Q 006785 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL-- 454 (631)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~-- 454 (631)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..|.....
T Consensus 171 a~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~ 239 (676)
T 3qa8_A 171 AKELDQGE------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREK 239 (676)
T ss_dssp CCBTTSCC------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC--
T ss_pred cccccccc------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcc
Confidence 98765432 223457999999999999999999999999999999999999999653211 01100000
Q ss_pred --------ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH-----HHHHhhhCC
Q 006785 455 --------QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV-----VQILSTIAP 511 (631)
Q Consensus 455 --------~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev-----l~~L~~i~~ 511 (631)
...................+...+..+.+|+..||..||++|||+.++ ++.+..+..
T Consensus 240 ~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp ----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred cchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 000000000000011223455677889999999999999999999884 455555543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=356.24 Aligned_cols=244 Identities=22% Similarity=0.387 Sum_probs=194.9
Q ss_pred hcCccccceeeeeCceEEEEEEEC--CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCC-cce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT--DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK-RAM 299 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~~~ 299 (631)
.++|.+.+.||+|+||.||+|.+. +|+.||||++...........|.+|+.+|++++||||+++++++...... ...
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999986 58999999987654445556689999999999999999999999864332 223
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.||||||++|++|.+++.. .+++.+++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 6999999999999988754 5899999999999999999999998 9999999999999986 899999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
.... ....||+.|+|||++.++. +.++||||||++||||++|..||......
T Consensus 231 ~~~~---------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------------ 282 (681)
T 2pzi_A 231 INSF---------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD------------------ 282 (681)
T ss_dssp TTCC---------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS------------------
T ss_pred cccC---------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc------------------
Confidence 6432 3346999999999987764 89999999999999999998887532110
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHhhh
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-MSEVVQILSTI 509 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~~i 509 (631)
.+.. ..........+.+|+.+||+.||.+||+ +.++.+.|..+
T Consensus 283 ---~~~~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 283 ---GLPE----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ---SCCT----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---cccc----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0000 0011123356889999999999999995 56666666544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=313.39 Aligned_cols=234 Identities=17% Similarity=0.141 Sum_probs=182.6
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCC--hHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|.+.+.||+|+||.||+|.+.. |+.||||++....... ....|.+|+.++.+++||||+++++++.. ....
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----~~~~ 106 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT----RAGG 106 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----TTEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE----CCcE
Confidence 568889999999999999999865 8999999998654332 33569999999999999999999999876 4578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||++|++|.++++.. ....++..++.|++.||+|||+++ |+||||||+|||++.++.+||+++|
T Consensus 107 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-----
Confidence 9999999999999999642 466678999999999999999999 9999999999999999999998543
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
|++ .++.++||||||+++|||++|+.||........... ....
T Consensus 175 --------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---~~~~------- 217 (286)
T 3uqc_A 175 --------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---AERD------- 217 (286)
T ss_dssp --------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---CCBC-------
T ss_pred --------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---HHHH-------
Confidence 333 368899999999999999999999975433211100 0000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 513 (631)
+.....+ ....+...+..+.+|+.+||+.||.+| |+.++++.|..+....
T Consensus 218 ~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 218 TAGQPIE--PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp TTSCBCC--HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred hccCCCC--hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 0000000 000111233458899999999999999 9999999999886543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=313.38 Aligned_cols=231 Identities=22% Similarity=0.318 Sum_probs=181.2
Q ss_pred cCcccc-ceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHH-HhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGS-NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDML-SRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|.+. +.||+|+||.||+|... +++.||||++... ..+.+|+.++ +.++||||+++++++..........
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 456666 77999999999999875 5899999999642 3478899998 5559999999999987654446678
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC---CCCeEEeccCce
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGMA 377 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~~~~kL~DFGla 377 (631)
++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 99999999999999998765557999999999999999999999998 999999999999998 788999999998
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
.... +..++.++||||||+++|||++|+.||.......... .
T Consensus 168 ~~~~---------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-------~---- 209 (299)
T 3m2w_A 168 KETT---------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------G---- 209 (299)
T ss_dssp EECT---------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-------C----
T ss_pred cccc---------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-------H----
Confidence 7542 1346778999999999999999999996533211000 0
Q ss_pred cccccccCCCCCCCCCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 458 GTVISELPDPRLKGDFP----KEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
....+..... ..+ ...+..+.+|+.+||+.||.+|||+.++++.
T Consensus 210 --~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 210 --MKTRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp --SCCSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HHHHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000000000 111 1234558899999999999999999999974
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=330.18 Aligned_cols=247 Identities=16% Similarity=0.155 Sum_probs=181.8
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCC-CCCcce---------eE
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHH-CHVVPL---------VG 288 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~~E~~~l~~l~H-~niv~l---------~g 288 (631)
.+..|...+.||+|+||.||+|.+. +|+.||||++...... ...+.|.+|+.+++.++| +|...+ +.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3455777889999999999999965 5999999998843322 234569999999999977 322111 11
Q ss_pred E------------eeec-cCCcceEEEEEeeCCCCChHhhhhc-----cccCCCCHHHHHHHHHHHHhhhHHHHhcCCCc
Q 006785 289 Y------------CSEF-RGKRAMRLLVFEFMPNGNLRDCLDG-----VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 350 (631)
Q Consensus 289 ~------------~~~~-~~~~~~~~lV~E~~~~gsL~~~l~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 350 (631)
. .... .......+++|+++ +++|.++++. .....+++..++.++.|++.||+|||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 1 1110 00022457778776 7899999852 22334788999999999999999999998
Q ss_pred eeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhh----------hcCCCCcccchhh
Q 006785 351 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA----------MVGRASLMSDVFS 420 (631)
Q Consensus 351 ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~----------~~~~~s~ksDVwS 420 (631)
|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE--------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc--------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence 999999999999999999999999999875432 223457 999999999 4455888999999
Q ss_pred HHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006785 421 FGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 500 (631)
Q Consensus 421 lGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 500 (631)
|||++|||++|+.||......... ..+... ...+| ..+.+|+.+||+.||++||++.
T Consensus 303 lGvil~elltg~~Pf~~~~~~~~~-----------------~~~~~~--~~~~~----~~~~~li~~~l~~dP~~Rpt~~ 359 (413)
T 3dzo_A 303 LGLAIYWIWCADLPNTDDAALGGS-----------------EWIFRS--CKNIP----QPVRALLEGFLRYPKEDRLLPL 359 (413)
T ss_dssp HHHHHHHHHHSSCCCCTTGGGSCS-----------------GGGGSS--CCCCC----HHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHHCCCCCCCcchhhhH-----------------HHHHhh--cccCC----HHHHHHHHHHccCChhhCcCHH
Confidence 999999999999999654322110 001000 01234 4488999999999999999998
Q ss_pred HHHH
Q 006785 501 EVVQ 504 (631)
Q Consensus 501 evl~ 504 (631)
++++
T Consensus 360 ~~l~ 363 (413)
T 3dzo_A 360 QAME 363 (413)
T ss_dssp HHTT
T ss_pred HHHh
Confidence 8865
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=310.38 Aligned_cols=246 Identities=14% Similarity=0.110 Sum_probs=187.0
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCC-------CChHHHHHHHHHHHHhcC---------CCCCcce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-------PNADSVFLTEVDMLSRLH---------HCHVVPL 286 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-------~~~~~~~~~E~~~l~~l~---------H~niv~l 286 (631)
.++|.+.+.||+|+||+||+|++ +|+.||||++..... ......+.+|+.+|+.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688899999999999999998 689999999986532 233366899999999986 8888888
Q ss_pred eEEeeecc--------------------------CCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhh
Q 006785 287 VGYCSEFR--------------------------GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 340 (631)
Q Consensus 287 ~g~~~~~~--------------------------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL 340 (631)
.+++.... ......||||||+++|+|.+.+.+ ..+++..+..++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 87754210 014578999999999987776643 4589999999999999999
Q ss_pred HHHH-hcCCCceeecCCCCCCeeecCCC--------------------CeEEeccCceeecccCCCCCCCCCCcccccCC
Q 006785 341 EYLH-EAAAPRILHRDIKSSNILLDENL--------------------NAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399 (631)
Q Consensus 341 ~yLH-~~~~~~ivHrDlKp~NILl~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~ 399 (631)
+||| +.+ |+||||||+||||+.++ .+||+|||+|+..... ...||+
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----------~~~gt~ 241 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----------IVVFCD 241 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----------EEECCC
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----------cEEEee
Confidence 9999 898 99999999999999887 8999999999876532 347999
Q ss_pred CCCCchhhhcCCCCcccchhhHHHH-HHHHHhCCCCCCCccccccchhhhhccccccccccccccc-CCCCCCCCCCHHH
Q 006785 400 GYFAPEYAMVGRASLMSDVFSFGVV-LLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL-PDPRLKGDFPKEE 477 (631)
Q Consensus 400 ~Y~APE~~~~~~~s~ksDVwSlGvi-L~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~~~~~ 477 (631)
.|+|||++.+.. +.++||||||++ .+++++|..||....... .... . ..... .........+...
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~--~~~~----~------~~~~~~~~~~~~~~~~~~~ 308 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLH--YLTD----K------MLKQMTFKTKCNTPAMKQI 308 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHH--HHHH----H------HHHTCCCSSCCCSHHHHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhh--HHHH----h------hhhhhccCcccchhhhhhc
Confidence 999999998666 899999998776 778888999984310000 0000 0 00000 0111111233467
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHH
Q 006785 478 MQIMAYLAKECLQLDPDARPTMSEVV 503 (631)
Q Consensus 478 ~~~l~~li~~cl~~dP~~RPs~~evl 503 (631)
+..+.+|+.+||+.| |+.|++
T Consensus 309 s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 309 KRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHGGGSS-----SHHHHH
T ss_pred CHHHHHHHHHHhccC-----CHHHHH
Confidence 788999999999976 999888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-30 Score=287.57 Aligned_cols=187 Identities=19% Similarity=0.147 Sum_probs=130.5
Q ss_pred eeeeeCceEEEEEEE-CCCcEEEEEEeccCCCC---------ChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcce
Q 006785 231 IVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGP---------NADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 231 ~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~---------~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 299 (631)
.++.|++|.+..++. -.|+.||||.+...... ...++|.+|+++|+++ .|+||+++++++.+ ...
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed----~~~ 316 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN----AQS 316 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC----SSE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE----CCE
Confidence 356677777766542 24889999999754211 1234599999999999 89999999999876 667
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.||||||++|++|.++|... ..++.. .|+.||+.||+|||++| ||||||||+||||++++.+||+|||+|+.
T Consensus 317 ~yLVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~ 388 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVT 388 (569)
T ss_dssp EEEEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred EEEEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCee
Confidence 89999999999999999764 446654 58899999999999999 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCC
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 435 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~ 435 (631)
...+. ......+||+.|||||++.+ .+..++|+||+|++++++.++..|+
T Consensus 389 ~~~~~-----~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 389 TPQDC-----SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CC--------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCCC-----ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 65432 23456789999999998865 4677899999999998887765544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.7e-27 Score=259.15 Aligned_cols=189 Identities=15% Similarity=0.166 Sum_probs=143.6
Q ss_pred cccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCCh-------HHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 227 SGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNA-------DSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 227 ~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
...+.||+|+||.||+|.. .++.+|+|+......... .+.|.+|+++|++++||||+++..++.. ...
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~----~~~ 413 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD----LDN 413 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE----TTT
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe----CCc
Confidence 3467899999999999955 578899998765332211 2347999999999999999965555554 234
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.||||||+++++|.+++.. +..++.|++.||+|||+++ |+||||||+|||++. .+||+|||+++.
T Consensus 414 ~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~ 478 (540)
T 3en9_A 414 KRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKI 478 (540)
T ss_dssp TEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred cEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEE
Confidence 4999999999999999875 5689999999999999998 999999999999998 999999999987
Q ss_pred cccCCCCC--CCCCCcccccCCCCCCchhhhc--CCCCcccchhhHHHHHHHHHhCCCCC
Q 006785 380 LKADGLPS--CSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPI 435 (631)
Q Consensus 380 ~~~~~~~~--~~~~~~~~~Gt~~Y~APE~~~~--~~~s~ksDVwSlGviL~eLltG~~P~ 435 (631)
........ .........||+.|||||++.. ..|+...|+||..+-.++-+.++.+|
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 64321000 0001134679999999999986 56888899999999999988888776
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.6e-24 Score=218.92 Aligned_cols=164 Identities=15% Similarity=0.044 Sum_probs=127.4
Q ss_pred HHHHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCC-----------------ChHHHHHHHHHHHHhcCC
Q 006785 218 ALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP-----------------NADSVFLTEVDMLSRLHH 280 (631)
Q Consensus 218 ~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~-----------------~~~~~~~~E~~~l~~l~H 280 (631)
.+......|...+.||+|+||.||+|.+.+|+.||||+++..... .....+.+|+.+|++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 344445667777999999999999999977999999999643211 12345899999999999
Q ss_pred CCCcceeEEeeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCC
Q 006785 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 360 (631)
Q Consensus 281 ~niv~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~N 360 (631)
| +++.+++.. ...|+||||++||+|.+ +.. .....++.|++.||.|||+.+ |+||||||+|
T Consensus 163 -~-~~v~~~~~~-----~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~N 223 (282)
T 1zar_A 163 -G-LAVPKVYAW-----EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYN 223 (282)
T ss_dssp -T-SSSCCEEEE-----ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred -C-CCcCeEEec-----cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHH
Confidence 4 666665432 23499999999999998 421 224579999999999999999 9999999999
Q ss_pred eeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhc----------CCCCcccchhh
Q 006785 361 ILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV----------GRASLMSDVFS 420 (631)
Q Consensus 361 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~----------~~~s~ksDVwS 420 (631)
||++ ++.+||+|||+|+. +..|+|||++.. ..++..+|+|.
T Consensus 224 ILl~-~~~vkl~DFG~a~~------------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVE------------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp EEEE-TTEEEECCCTTCEE------------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EEEE-CCcEEEEECCCCeE------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 9999 99999999999864 345789998753 34555666664
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.5e-19 Score=182.22 Aligned_cols=137 Identities=20% Similarity=0.231 Sum_probs=106.2
Q ss_pred ccccceeeeeCceEEEEEEE-CCCcE--EEEEEeccCCCCC-----------------------hHHHHHHHHHHHHhcC
Q 006785 226 FSGSNIVGQGGSSYVYRGQL-TDGRI--VAVKRFKTQGGPN-----------------------ADSVFLTEVDMLSRLH 279 (631)
Q Consensus 226 f~~~~~LG~G~fG~Vy~~~~-~~g~~--vAVK~l~~~~~~~-----------------------~~~~~~~E~~~l~~l~ 279 (631)
|.+.+.||+|+||.||+|.+ .+|+. ||||+++...... ....+.+|+.+|.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999998 67888 9999976432110 0124789999999998
Q ss_pred CCCC--cceeEEeeeccCCcceEEEEEeeCCC-C----ChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHH-hcCCCce
Q 006785 280 HCHV--VPLVGYCSEFRGKRAMRLLVFEFMPN-G----NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH-EAAAPRI 351 (631)
Q Consensus 280 H~ni--v~l~g~~~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~i 351 (631)
|+++ +.++++ ...+|||||+.+ | +|.+++.. .++..+..++.|++.||.||| +.+ |
T Consensus 129 ~~~i~~p~~~~~--------~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g---i 192 (258)
T 1zth_A 129 EAGVSVPQPYTY--------MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE---L 192 (258)
T ss_dssp HTTCCCCCEEEE--------ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC---E
T ss_pred hCCCCCCeEEEc--------CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 8864 444432 134899999942 4 66665432 234567889999999999999 888 9
Q ss_pred eecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 352 LHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 352 vHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
+||||||.|||+++ .++|+|||+|...
T Consensus 193 vHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 193 VHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred EeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999999998 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=2e-17 Score=174.11 Aligned_cols=143 Identities=14% Similarity=0.141 Sum_probs=104.4
Q ss_pred HHHHHhcC---ccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCC-------------ChHHH--------HHHHHH
Q 006785 218 ALEHATDK---FSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP-------------NADSV--------FLTEVD 273 (631)
Q Consensus 218 ~l~~a~~~---f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~-------------~~~~~--------~~~E~~ 273 (631)
.|....++ |.+.+.||.|+||.||+|...+|+.||||+++..... ..... ..+|..
T Consensus 86 AL~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~ 165 (397)
T 4gyi_A 86 ALHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA 165 (397)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence 34444444 8889999999999999999989999999997642100 00011 235677
Q ss_pred HHHhcCCCCCc--ceeEEeeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCce
Q 006785 274 MLSRLHHCHVV--PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351 (631)
Q Consensus 274 ~l~~l~H~niv--~l~g~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 351 (631)
.|.++.+.++. ..+++ . ..+|||||++|++|.++... .....++.|++.+|.|||+.+ |
T Consensus 166 nL~rL~~~gv~vp~p~~~--~------~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~g---I 226 (397)
T 4gyi_A 166 FMKALYEEGFPVPEPIAQ--S------RHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKHG---L 226 (397)
T ss_dssp HHHHHHHTTCSCCCEEEE--E------TTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHhcCCCCCeeeec--c------CceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHCC---C
Confidence 77777555443 22221 1 12799999999998765432 234567899999999999998 9
Q ss_pred eecCCCCCCeeecCCCC----------eEEeccCceee
Q 006785 352 LHRDIKSSNILLDENLN----------AKITDLGMAKR 379 (631)
Q Consensus 352 vHrDlKp~NILl~~~~~----------~kL~DFGla~~ 379 (631)
|||||||.||||++++. +.|+||+-+-.
T Consensus 227 VHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 227 IHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp ECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred cCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 99999999999988763 89999997654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=2.4e-11 Score=121.85 Aligned_cols=148 Identities=16% Similarity=0.103 Sum_probs=112.4
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCc
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 297 (631)
+......|.....++.|+++.||++... ++.+++|+...... .....+.+|+.+|+.+ .+..+.++++++.. .
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~----~ 82 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERH----D 82 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE----T
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEec----C
Confidence 3445567888888898999999999754 68899999875211 1112388999999999 46778899988765 3
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcC------------------------------
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA------------------------------ 347 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------ 347 (631)
...|+||||++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 83 ~~~~lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T 3tm0_A 83 GWSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp TEEEEEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred CceEEEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence 467999999999999876421 1223477889999999999811
Q ss_pred --------------------------CCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 348 --------------------------APRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 348 --------------------------~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.+.++|+|++|.|||++++..+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13489999999999998766667999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.17 E-value=6.3e-11 Score=118.11 Aligned_cols=129 Identities=16% Similarity=0.117 Sum_probs=94.5
Q ss_pred eeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCC--CcceeEEeeeccCCcceEEEEEeeCCCC
Q 006785 233 GQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH--VVPLVGYCSEFRGKRAMRLLVFEFMPNG 310 (631)
Q Consensus 233 G~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~~~~~lV~E~~~~g 310 (631)
+.|..+.||++...+|..++||+..... ...+.+|+.+|+.+.+.+ +.+++++... ....++||||++|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~----~~~~~~v~e~i~G~ 100 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTE----AGRDWLLLGEVPGQ 100 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC----SSCEEEEEECCSSE
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccC----CCCCEEEEEecCCc
Confidence 4556699999987778889999976541 123789999999995545 4568876654 23579999999998
Q ss_pred ChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcC-------------------------------------------
Q 006785 311 NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA------------------------------------------- 347 (631)
Q Consensus 311 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------- 347 (631)
+|. ... .+ ...++.+++..|..||...
T Consensus 101 ~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 101 DLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp ETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred ccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 884 221 12 2356677778888888643
Q ss_pred ------------CCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 348 ------------APRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 348 ------------~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.+.++|+|++|.|||++++..+.|+|||.+..
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.07 E-value=5.1e-10 Score=117.72 Aligned_cols=146 Identities=16% Similarity=0.195 Sum_probs=107.0
Q ss_pred ccceeeeeCceEEEEEEECCCcEEEEEEec--cCCCCChHHHHHHHHHHHHhcC--CCCCcceeEEeeeccCCcceEEEE
Q 006785 228 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFK--TQGGPNADSVFLTEVDMLSRLH--HCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 228 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~--~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
..+.|+.|.++.||+.... +..+++|+.. ..........+.+|+.+|+.|. +..++++++++.+... ....|+|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~-~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV-IGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT-TSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc-cCCeEEE
Confidence 3567899999999999875 4678888876 3321122334889999999996 4567888888765321 1346899
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcC------------------------------------
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA------------------------------------ 347 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------ 347 (631)
|||++|..|.+.. ...++..++..++.++++.|..||...
T Consensus 120 me~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 120 MEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999998875422 133788889999999999999999731
Q ss_pred -------------------CCceeecCCCCCCeeecCCCC--eEEeccCceee
Q 006785 348 -------------------APRILHRDIKSSNILLDENLN--AKITDLGMAKR 379 (631)
Q Consensus 348 -------------------~~~ivHrDlKp~NILl~~~~~--~kL~DFGla~~ 379 (631)
.+.++|+|+++.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.02 E-value=4.4e-10 Score=115.41 Aligned_cols=187 Identities=21% Similarity=0.227 Sum_probs=124.2
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCC--CcceeEEeeeccCCcceEEEEEe
Q 006785 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCH--VVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~n--iv~l~g~~~~~~~~~~~~~lV~E 305 (631)
.+.++.|.+..||+.. ..+++|+.... .....+.+|+.+|+.+ .+.. +.+++..... .......|+||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~-~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP-SETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC-CSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCC-CCCCCcceEEEc
Confidence 4568999999999864 45889986432 2345689999999988 3333 3445444322 111123489999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcC--------------------------------------
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA-------------------------------------- 347 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------- 347 (631)
|++|.+|.+... ..++..++..++.+++..|..||...
T Consensus 97 ~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 97 KIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred ccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 999988875432 23677888888999999999998621
Q ss_pred -----------------CCceeecCCCCCCeeecC--CCCeEEeccCceeecccCCCCCCCCCCcccccCCCC---CCch
Q 006785 348 -----------------APRILHRDIKSSNILLDE--NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY---FAPE 405 (631)
Q Consensus 348 -----------------~~~ivHrDlKp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y---~APE 405 (631)
.+.++|+|++|.||++++ +..+.|+||+.+...... ........+ ..|+
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~---------~Dl~~~~~~~~~~~~~ 243 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD---------NDFISLMEDDEEYGME 243 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT---------HHHHTTCCTTTSCCHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH---------HHHHHHHhhccccCHH
Confidence 245899999999999998 556789999998764221 000111111 2333
Q ss_pred hhhc-----CCC---------CcccchhhHHHHHHHHHhCCCCCC
Q 006785 406 YAMV-----GRA---------SLMSDVFSFGVVLLELITGRQPIH 436 (631)
Q Consensus 406 ~~~~-----~~~---------s~ksDVwSlGviL~eLltG~~P~~ 436 (631)
.... +.. ....+.|+++.++|.+.+|..+|.
T Consensus 244 ~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 244 FVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 2210 111 122589999999999999998873
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1e-06 Score=90.39 Aligned_cols=137 Identities=17% Similarity=0.173 Sum_probs=93.4
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCC---CCcceeEEeeeccCCcceEEEEEe
Q 006785 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC---HVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
.+.++.|....||+. |..++||+-.. ......+.+|..+|+.|.+. .+.+++.++.. .....|+|||
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~---~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR---SDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC---TTSCEEEEEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc---CCCceEEEEe
Confidence 356788888999998 56688888432 22345689999999999653 35566666542 1335689999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhc---------------------------------------
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA--------------------------------------- 346 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------- 346 (631)
|++|.+|.+..- ..++..+...++.++++.|..||..
T Consensus 94 ~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 94 KVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred ccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 999988876321 1234445555555555555555542
Q ss_pred ------------------CCCceeecCCCCCCeeecC---CCC-eEEeccCceee
Q 006785 347 ------------------AAPRILHRDIKSSNILLDE---NLN-AKITDLGMAKR 379 (631)
Q Consensus 347 ------------------~~~~ivHrDlKp~NILl~~---~~~-~kL~DFGla~~ 379 (631)
..+.++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2335799999999999987 455 48999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=2.3e-06 Score=85.58 Aligned_cols=135 Identities=19% Similarity=0.132 Sum_probs=94.7
Q ss_pred eeeeeCce-EEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCCcceeEEeeeccCCcceEEEEEeeC
Q 006785 231 IVGQGGSS-YVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLVFEFM 307 (631)
Q Consensus 231 ~LG~G~fG-~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~~lV~E~~ 307 (631)
.+..|..| .||+.... ++..++||+-... ....+.+|...|+.|. +--+.++++++.+ ....|+|||++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~----~~~~~lvme~l 102 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRT----PDDAWLLTTAI 102 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEE----TTEEEEEEECC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEE----CCeEEEEEEee
Confidence 34556655 69998765 4677999986532 3345889999999883 3346678887765 34679999999
Q ss_pred CCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcC----------------------------------------
Q 006785 308 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA---------------------------------------- 347 (631)
Q Consensus 308 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 347 (631)
+|.++.+..... ......++.+++..|..||...
T Consensus 103 ~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 103 PGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred CCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 998887765321 1223345566666666666421
Q ss_pred ---------------CCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 348 ---------------APRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 348 ---------------~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12489999999999999887778999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=3.1e-06 Score=88.40 Aligned_cols=84 Identities=7% Similarity=-0.084 Sum_probs=55.6
Q ss_pred cee-eeeCceEEEEEEEC-------CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcC-C--CCCcceeEEeeeccCC
Q 006785 230 NIV-GQGGSSYVYRGQLT-------DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLH-H--CHVVPLVGYCSEFRGK 296 (631)
Q Consensus 230 ~~L-G~G~fG~Vy~~~~~-------~g~~vAVK~l~~~~~--~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~~~ 296 (631)
+.| +.|....+|+.... +++.+++|+...... ......+.+|+.+|+.|. + -.+.++++++.....
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~- 104 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV- 104 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT-
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc-
Confidence 557 78889999998764 267789998654220 001123788999999883 3 356788877654211
Q ss_pred cceEEEEEeeCCCCChHh
Q 006785 297 RAMRLLVFEFMPNGNLRD 314 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~ 314 (631)
....|+||||++|..|.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 124589999999877654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.00 E-value=4.2e-05 Score=78.87 Aligned_cols=141 Identities=17% Similarity=0.261 Sum_probs=80.1
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCC--CCCcceeEE-----eeeccCCcceEEE
Q 006785 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH--CHVVPLVGY-----CSEFRGKRAMRLL 302 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~-----~~~~~~~~~~~~l 302 (631)
+.|+.|..+.||+....+| .+++|+.... ...+..|+.++..|.. -.+.+++.. +.. .....++
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~---~~~~~~~ 108 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSK---HGSFLFV 108 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEE---ETTEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEE---ECCEEEE
Confidence 4466677899999987655 4899998752 1234456666666531 133444421 111 1335689
Q ss_pred EEeeCCCCChH-----------hh---hhcccc------------CCCCHHHHH--------------------------
Q 006785 303 VFEFMPNGNLR-----------DC---LDGVLV------------EGMNWDTRV-------------------------- 330 (631)
Q Consensus 303 V~E~~~~gsL~-----------~~---l~~~~~------------~~l~~~~~~-------------------------- 330 (631)
||+|++|..+. .. |+.... ....|....
T Consensus 109 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 188 (346)
T 2q83_A 109 VYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLY 188 (346)
T ss_dssp EEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHH
T ss_pred EEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHH
Confidence 99999987542 11 111100 001343211
Q ss_pred -----HHHHHHHhhhHHHHh----------cCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 331 -----AIAIGAARGLEYLHE----------AAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 331 -----~i~~~ia~gL~yLH~----------~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.+...+..++.+|+. ...+.++|+|+++.|||++.++.+.|+||+.+..
T Consensus 189 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 189 LQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111123345667763 1234699999999999998888999999998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.98 E-value=7.8e-05 Score=75.31 Aligned_cols=79 Identities=24% Similarity=0.326 Sum_probs=57.5
Q ss_pred CccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCC---CCcceeEEeeeccCCcceEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC---HVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~~~~~~~~ 301 (631)
.....+.+|.|..+.||+..+.||+.|+||+..... ......|..|...|+.|.-. -+.+++++.. .+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~--------~~ 86 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGWDD--------RT 86 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEET--------TE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEeccC--------ce
Confidence 344567799999999999999999999999876443 22233588999999988422 3455555422 27
Q ss_pred EEEeeCCCCCh
Q 006785 302 LVFEFMPNGNL 312 (631)
Q Consensus 302 lV~E~~~~gsL 312 (631)
+||||++++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 99999987754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=3.4e-05 Score=81.79 Aligned_cols=76 Identities=18% Similarity=0.125 Sum_probs=48.8
Q ss_pred cceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC------CChHHHHHHHHHHHHhcCC--C-CCcceeEEeeeccCCcc
Q 006785 229 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG------PNADSVFLTEVDMLSRLHH--C-HVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~------~~~~~~~~~E~~~l~~l~H--~-niv~l~g~~~~~~~~~~ 298 (631)
.+.||.|.++.||++... +++.++||....... ......+..|.++|+.+.. + .+.+++.+.. .
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~------~ 108 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT------E 108 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET------T
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcC------C
Confidence 457899999999999754 468899998653211 1122346789999988832 3 3445654321 1
Q ss_pred eEEEEEeeCCCC
Q 006785 299 MRLLVFEFMPNG 310 (631)
Q Consensus 299 ~~~lV~E~~~~g 310 (631)
..++||||+++.
T Consensus 109 ~~~lvmE~l~g~ 120 (397)
T 2olc_A 109 MAVTVMEDLSHL 120 (397)
T ss_dssp TTEEEECCCTTS
T ss_pred ccEEEEEeCCCc
Confidence 238999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.82 E-value=0.00013 Score=74.67 Aligned_cols=137 Identities=17% Similarity=0.191 Sum_probs=89.6
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC---CCCCcceeEEeeeccCCcceEEEEEe
Q 006785 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
.+.|+.|.+..+|+... ++..++||+.... ....|..|...|+.|. ...++++++++.. ....|+|||
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~----~g~~~lvme 111 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNS----QGHSFLLLE 111 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC----SSEEEEEEE
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec----CCceEEEEE
Confidence 46689999999999986 4678899987542 2455889999999883 3567788877654 345799999
Q ss_pred eCCCCChHh--------h---hhcccc-C-------------------CCCHHHHH---HHHH--H--------------
Q 006785 306 FMPNGNLRD--------C---LDGVLV-E-------------------GMNWDTRV---AIAI--G-------------- 335 (631)
Q Consensus 306 ~~~~gsL~~--------~---l~~~~~-~-------------------~l~~~~~~---~i~~--~-------------- 335 (631)
|+++..+.. . |+.... . .-+|.... ++.. +
T Consensus 112 ~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~ 191 (312)
T 3jr1_A 112 ALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDL 191 (312)
T ss_dssp CCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHH
T ss_pred eccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHH
Confidence 999886521 1 122111 0 02455432 1111 1
Q ss_pred HHhh-hHHHHh-cCCCceeecCCCCCCeeecCCCCeEEeccC
Q 006785 336 AARG-LEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLG 375 (631)
Q Consensus 336 ia~g-L~yLH~-~~~~~ivHrDlKp~NILl~~~~~~kL~DFG 375 (631)
++.. ...|.. ...|.++|+|+.+.|++++.++ +.|.||.
T Consensus 192 l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 192 IVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1111 123321 2346799999999999999887 8899984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00031 Score=75.06 Aligned_cols=31 Identities=13% Similarity=0.393 Sum_probs=27.4
Q ss_pred CCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 348 APRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 348 ~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.+.++|+|++|.|||++.++ ++|+||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 45699999999999998876 99999998865
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00083 Score=68.09 Aligned_cols=71 Identities=8% Similarity=-0.009 Sum_probs=45.2
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCC-cceeEEeeeccCCcceEEEEEeeC
Q 006785 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGYCSEFRGKRAMRLLVFEFM 307 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~~~~~lV~E~~ 307 (631)
.+.|+.|....+|+. ..+++|+......... ...+|+.+++.+....+ .+++++..+ .-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~--~r~~E~~~l~~l~~~g~~P~~~~~~~~------~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYI--NRANEAVAAREAAKAGVSPEVLHVDPA------TGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CC--CHHHHHHHHHHHHHTTSSCCEEEECTT------TCCEEEECC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCcccee--CHHHHHHHHHHHHHcCCCCceEEEECC------CCEEEEeec
Confidence 577888999999998 4588998765321111 13578888888743333 466654321 227899999
Q ss_pred -CCCCh
Q 006785 308 -PNGNL 312 (631)
Q Consensus 308 -~~gsL 312 (631)
+|.+|
T Consensus 90 ~~g~~l 95 (301)
T 3dxq_A 90 AGAQTM 95 (301)
T ss_dssp TTCEEC
T ss_pred CCCccC
Confidence 66544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0011 Score=68.21 Aligned_cols=141 Identities=15% Similarity=0.120 Sum_probs=74.2
Q ss_pred ceeeeeCceE-EEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-C-CCCcceeEEeeeccCCcceEEEEEee
Q 006785 230 NIVGQGGSSY-VYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-H-CHVVPLVGYCSEFRGKRAMRLLVFEF 306 (631)
Q Consensus 230 ~~LG~G~fG~-Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~-H-~niv~l~g~~~~~~~~~~~~~lV~E~ 306 (631)
+.|+.|.... +|+....+|..+++|....... ..+..|+.++..+. + -.+.+++.+... .. ++|||+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~----~g--~ll~e~ 93 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHA----RG--LLLIED 93 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETT----TT--EEEECC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCC----CC--EEEEee
Confidence 3465555444 6677654467787876543321 12456778877773 2 235567765321 22 789999
Q ss_pred CCCCChHhhhhcccc------------------------CCCCHHHHHH--------H------------HHHHHhhhHH
Q 006785 307 MPNGNLRDCLDGVLV------------------------EGMNWDTRVA--------I------------AIGAARGLEY 342 (631)
Q Consensus 307 ~~~gsL~~~l~~~~~------------------------~~l~~~~~~~--------i------------~~~ia~gL~y 342 (631)
+.+..+.+++..... ..++...... + ...+...++.
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 977777654432100 0121111000 0 0011112223
Q ss_pred HHh---cCCCceeecCCCCCCeeecCC----CCeEEeccCceeec
Q 006785 343 LHE---AAAPRILHRDIKSSNILLDEN----LNAKITDLGMAKRL 380 (631)
Q Consensus 343 LH~---~~~~~ivHrDlKp~NILl~~~----~~~kL~DFGla~~~ 380 (631)
|.. ...+.++|+|+.+.|||++.+ ..+.|+||+.+...
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 311 123469999999999999874 67899999988753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0014 Score=66.86 Aligned_cols=161 Identities=9% Similarity=0.096 Sum_probs=88.0
Q ss_pred ecHHHHHHHhcCccc-----cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCC--Ccce
Q 006785 214 FSYSALEHATDKFSG-----SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH--VVPL 286 (631)
Q Consensus 214 ~s~~~l~~a~~~f~~-----~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l 286 (631)
++.+++......|.. .+.|+.|....+|+....+| .+++|+....... ..+..|+.++..|.... +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~---~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCH---HHHHHHHHHHHHHHHCCCCCCcc
Confidence 344555555555554 23466788899999987666 5889988753222 23567888888773222 3344
Q ss_pred eEEeeecc---CCcceEEEEEeeCCCCChHh-----------h---hhccc----cC---C---CCHHHHHH--------
Q 006785 287 VGYCSEFR---GKRAMRLLVFEFMPNGNLRD-----------C---LDGVL----VE---G---MNWDTRVA-------- 331 (631)
Q Consensus 287 ~g~~~~~~---~~~~~~~lV~E~~~~gsL~~-----------~---l~~~~----~~---~---l~~~~~~~-------- 331 (631)
+... +.. ......+++|+|++|..+.. . ++... .. . ..|.....
T Consensus 83 ~~~~-~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 83 LPRK-DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp CCBT-TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cCCC-CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 3210 000 00234689999998865421 0 11110 00 0 12332111
Q ss_pred ----HHHHHHhhhHHHHhc----CCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 332 ----IAIGAARGLEYLHEA----AAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 332 ----i~~~ia~gL~yLH~~----~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
+...+...+++|+.. ..+.++|+|+.+.|||++++..+.|+||+.+..
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011234455666542 124599999999999999876568999998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0034 Score=67.62 Aligned_cols=74 Identities=11% Similarity=0.067 Sum_probs=48.5
Q ss_pred cceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCC-cceeEEeeeccCCcceEEEEEee
Q 006785 229 SNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGYCSEFRGKRAMRLLVFEF 306 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~~~~~lV~E~ 306 (631)
.+.|+.|-...+|+....+ +..+++|+.......... ..+|..+++.|...++ .++++++. . .+||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id--R~~E~~vl~~L~~~gl~P~ll~~~~-----~---G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN--REREKKISCILYNKNIAKKIYVFFT-----N---GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC--HHHHHHHHHHHTTSSSBCCEEEEET-----T---EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC--HHHHHHHHHHHHhcCCCCCEEEEeC-----C---eEEEEe
Confidence 3567778889999998865 478889987543211111 2589999999965555 46776652 1 359999
Q ss_pred CCCCCh
Q 006785 307 MPNGNL 312 (631)
Q Consensus 307 ~~~gsL 312 (631)
++|.+|
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 987554
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0027 Score=67.93 Aligned_cols=73 Identities=19% Similarity=0.283 Sum_probs=50.3
Q ss_pred cceeeeeCceEEEEEEECC--------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCC-cceeEEeeeccCCcce
Q 006785 229 SNIVGQGGSSYVYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGYCSEFRGKRAM 299 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~~~ 299 (631)
.+.|+.|....||+....+ +..+++|+.... .....+..|..+++.|...++ .++++.+..
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~------- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG------- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT-------
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC-------
Confidence 4567778889999998753 578999988432 111346689999998843344 567765431
Q ss_pred EEEEEeeCCCCCh
Q 006785 300 RLLVFEFMPNGNL 312 (631)
Q Consensus 300 ~~lV~E~~~~gsL 312 (631)
.+||||++|.+|
T Consensus 148 -g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 -GRLEEYIPSRPL 159 (429)
T ss_dssp -EEEECCCCEEEC
T ss_pred -CEEEEEeCCccc
Confidence 389999986444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0045 Score=63.23 Aligned_cols=143 Identities=16% Similarity=0.150 Sum_probs=82.4
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCC--CcceeEEeeeccC---CcceEEEEE
Q 006785 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH--VVPLVGYCSEFRG---KRAMRLLVF 304 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~---~~~~~~lV~ 304 (631)
..|+ |....||+....+|+.+++|+...... ....+..|..++..|.... +++++.. +... .....++||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEE
Confidence 4566 888899998877787899999864321 2345778888888884222 4444432 1100 123568899
Q ss_pred eeCCCCChHh-----------h---hhccc-------cCCCCHHHH----HHHH---------------HHHHhhhHHHH
Q 006785 305 EFMPNGNLRD-----------C---LDGVL-------VEGMNWDTR----VAIA---------------IGAARGLEYLH 344 (631)
Q Consensus 305 E~~~~gsL~~-----------~---l~~~~-------~~~l~~~~~----~~i~---------------~~ia~gL~yLH 344 (631)
+|++|..+.. . ++... ...+++... ..+. ..+...++.+.
T Consensus 107 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~ 186 (328)
T 1zyl_A 107 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 186 (328)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 9998754321 1 11100 001232211 0110 01112233333
Q ss_pred hc----CCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 345 EA----AAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 345 ~~----~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.. ..+.++|+|+++.|||++ + .+.|+||+.+..
T Consensus 187 ~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 187 AHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 21 234589999999999999 4 899999998754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0035 Score=65.40 Aligned_cols=73 Identities=10% Similarity=0.100 Sum_probs=44.5
Q ss_pred ceeeeeCceEEEEEEECC---------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCC-CcceeEEeeeccCCcce
Q 006785 230 NIVGQGGSSYVYRGQLTD---------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH-VVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~---------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~~~ 299 (631)
..|+.|....+|+....+ +..+++|+...... .......|..+++.|...+ +.++++...
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~~~~E~~~l~~L~~~g~~P~~~~~~~-------- 108 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--ELYNTISEFEVYKTMSKYKIAPQLLNTFN-------- 108 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--GTSCHHHHHHHHHHHHHTTSSCCEEEEET--------
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--ceecHHHHHHHHHHHHhcCCCCceEEecC--------
Confidence 457778888999998754 26888888754311 1112467888888884334 446665431
Q ss_pred EEEEEeeCCCCCh
Q 006785 300 RLLVFEFMPNGNL 312 (631)
Q Consensus 300 ~~lV~E~~~~gsL 312 (631)
-++||||++|..|
T Consensus 109 ~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 GGRIEEWLYGDPL 121 (369)
T ss_dssp TEEEEECCCSEEC
T ss_pred CcEEEEEecCCcC
Confidence 1689999987544
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0081 Score=63.00 Aligned_cols=140 Identities=19% Similarity=0.211 Sum_probs=82.4
Q ss_pred ceeeeeCceEEEEEEEC--------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCCcceeEEeeeccCCcceE
Q 006785 230 NIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~ 300 (631)
+.|..|-...+|+.... +++.+++|+.... ......+.+|..+++.|. +.-..++++++..
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~-------- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE-------- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--------
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--------
Confidence 45666888889998864 2578999986332 123345679999999884 3333567765432
Q ss_pred EEEEeeCCCCChHhh--------------h---hccc---cCCCC--HHHHHHHHHHHHh-------------------h
Q 006785 301 LLVFEFMPNGNLRDC--------------L---DGVL---VEGMN--WDTRVAIAIGAAR-------------------G 339 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~--------------l---~~~~---~~~l~--~~~~~~i~~~ia~-------------------g 339 (631)
.+||||++|..|..- | +... .+... |.++.++..++.. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 289999998665321 1 1110 11122 3444444443322 1
Q ss_pred hHHHH----hcC-CCceeecCCCCCCeeecCC----CCeEEeccCceee
Q 006785 340 LEYLH----EAA-APRILHRDIKSSNILLDEN----LNAKITDLGMAKR 379 (631)
Q Consensus 340 L~yLH----~~~-~~~ivHrDlKp~NILl~~~----~~~kL~DFGla~~ 379 (631)
+..|. ... ...++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 23332 222 2358999999999999876 6899999998754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0087 Score=57.08 Aligned_cols=99 Identities=13% Similarity=0.116 Sum_probs=64.2
Q ss_pred CChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCCC
Q 006785 310 GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 389 (631)
Q Consensus 310 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 389 (631)
-+|.+.|+.. ..++++.+++.++.|.+.+|.-+-....+ ..+=+-|..|+|..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-----------
Confidence 3799999764 47899999999999999988766221111 1223346899999999887764 2111
Q ss_pred CCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh
Q 006785 390 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 430 (631)
Q Consensus 390 ~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt 430 (631)
.....+.|||... ...+.+.=|||||+++|.-+-
T Consensus 98 ------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0123466887653 345678899999999998875
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.52 E-value=0.011 Score=61.11 Aligned_cols=31 Identities=23% Similarity=0.268 Sum_probs=27.6
Q ss_pred CceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 349 PRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 349 ~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888899999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.45 E-value=0.11 Score=55.00 Aligned_cols=74 Identities=11% Similarity=0.109 Sum_probs=48.8
Q ss_pred cceeeeeCceEEEEEEECC--------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCC-CcceeEEeeeccCCcce
Q 006785 229 SNIVGQGGSSYVYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH-VVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~~~ 299 (631)
.+.|..|-...+|+....+ +..+++|+.......-. ...+|..+++.+...+ ..++++.+.
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i--dR~~E~~~l~~L~~~gi~P~l~~~~~-------- 144 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY--DSKVELDVFRYLSNINIAPNIIADFP-------- 144 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC--CHHHHHHHHHHHHHTTSSCCEEEEET--------
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc--CHHHHHHHHHHHHhcCCCCCEEEEcC--------
Confidence 3456668889999998753 57899998654321111 2468899998884333 456665332
Q ss_pred EEEEEeeCCCCCh
Q 006785 300 RLLVFEFMPNGNL 312 (631)
Q Consensus 300 ~~lV~E~~~~gsL 312 (631)
-++||||++|..|
T Consensus 145 ~~~I~efI~G~~l 157 (424)
T 3mes_A 145 EGRIEEFIDGEPL 157 (424)
T ss_dssp TEEEEECCCSEEC
T ss_pred CCEEEEEeCCccC
Confidence 1789999998764
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.16 E-value=0.062 Score=37.07 Aligned_cols=26 Identities=15% Similarity=0.092 Sum_probs=10.3
Q ss_pred EeHHHHHHHHHHHHHHHH-HhhhhccC
Q 006785 121 IVLLLCVILTTIAFLMLV-LCYVYRKG 146 (631)
Q Consensus 121 ii~i~~~~l~~l~~l~~~-~~~~~rr~ 146 (631)
|++.+++.++++++++++ ++|++||+
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 333333333343343344 34444433
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.96 E-value=0.44 Score=50.03 Aligned_cols=29 Identities=28% Similarity=0.416 Sum_probs=24.6
Q ss_pred eeecCCCCCCeee------cCCCCeEEeccCceee
Q 006785 351 ILHRDIKSSNILL------DENLNAKITDLGMAKR 379 (631)
Q Consensus 351 ivHrDlKp~NILl------~~~~~~kL~DFGla~~ 379 (631)
++|+|+.+.|||+ +++..+.++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4566799999998764
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=92.73 E-value=0.055 Score=37.20 Aligned_cols=27 Identities=15% Similarity=0.208 Sum_probs=10.6
Q ss_pred EeHHHHHHHHHHHHHHHHHhhhhccCC
Q 006785 121 IVLLLCVILTTIAFLMLVLCYVYRKGK 147 (631)
Q Consensus 121 ii~i~~~~l~~l~~l~~~~~~~~rr~k 147 (631)
++++++++++++++++.+++|++||+.
T Consensus 14 Ia~~vVGvll~vi~~l~~~~~~RRR~~ 40 (44)
T 2jwa_A 14 IISAVVGILLVVVLGVVFGILIKRRQQ 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred hHHHHHHHHHHHHHHHHHHhheehhhh
Confidence 333333333333333334444444443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.59 E-value=0.053 Score=37.32 Aligned_cols=26 Identities=15% Similarity=0.057 Sum_probs=10.0
Q ss_pred EeHHHHHHHHHHHHHHHHHhhhhccC
Q 006785 121 IVLLLCVILTTIAFLMLVLCYVYRKG 146 (631)
Q Consensus 121 ii~i~~~~l~~l~~l~~~~~~~~rr~ 146 (631)
|++.+++.++++++++++++++.||+
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRR 37 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRK 37 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhh
Confidence 33333333334344444433333333
|
| >1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.35 E-value=0.036 Score=44.75 Aligned_cols=48 Identities=21% Similarity=0.525 Sum_probs=29.9
Q ss_pred CCccceEEecCCCCCCcccccccCccCCcccC-----CCCCCCCCceeeeecCCCCCc
Q 006785 31 GQKNWKCTCSSSLQGDQSNILKLNCSRSCDCS-----PVGGSSEGKWTCICAADGLPK 83 (631)
Q Consensus 31 ~~~~~~~~c~~~~~~~~~~~~~~~c~~~~~c~-----~~~~~~~~~~~c~~~~~g~~~ 83 (631)
...+|+|.|..+|++|+ +. .+|.....|. ..-....|.|+|.|+ |+++
T Consensus 21 ~~g~y~C~C~~G~~~~~-~g--~~C~dideC~~~~C~~~C~n~~g~y~C~C~--g~~G 73 (87)
T 1z6c_A 21 IPGDFECECPEGYRYNL-KS--KSCEDIDECSENMCAQLCVNYPGGYTCYCD--GKKG 73 (87)
T ss_dssp BTTBCCCSSSTTCEEET-TT--TEEECCCHHHHSCCSSEECCCSSSCCEECC--SSSC
T ss_pred CCCCEEEECCCCceECC-CC--CcCCCcCeeCCCCCCCEEEccCCCEEEECC--CCcC
Confidence 35689999999999765 22 2565443442 111335678999985 4444
|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 | Back alignment and structure |
|---|
Probab=86.32 E-value=0.26 Score=39.50 Aligned_cols=48 Identities=21% Similarity=0.603 Sum_probs=30.0
Q ss_pred CCccceEEecCCCCCCcccccccCccCCcccCCCC--------CCCCCceeeeecCCCC
Q 006785 31 GQKNWKCTCSSSLQGDQSNILKLNCSRSCDCSPVG--------GSSEGKWTCICAADGL 81 (631)
Q Consensus 31 ~~~~~~~~c~~~~~~~~~~~~~~~c~~~~~c~~~~--------~~~~~~~~c~~~~~g~ 81 (631)
...+|+|.|..+|++++ +.. .+|....+|.... ....|.|+|.|. .|+
T Consensus 21 ~~g~y~C~C~~Gy~~~~-~~g-~~C~dideC~~~~~~C~~~~C~n~~g~y~C~C~-~G~ 76 (86)
T 1lmj_A 21 TPGDFECKCDEGYESGF-MMM-KNCMDIDECQRDPLLCRGGVCHNTEGSYRCECP-PGH 76 (86)
T ss_dssp ETTEEEECCCSSEEECT-TTS-SSEEECCHHHHCSSTTTTSEEEEETTEEEEESC-TTS
T ss_pred CCCCEEeeCCCCcCccC-CCC-CccCCcccccCCCCcCCCCEeEcCCCCEEEECc-CCc
Confidence 34589999999999875 222 3676555553211 124577888884 344
|
| >3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.48 E-value=1.1 Score=45.27 Aligned_cols=75 Identities=23% Similarity=0.576 Sum_probs=41.1
Q ss_pred hhccccccccccCCccceEEecCCCCCCcccccccCccC--CcccCCCCCCCCCceeeeecCCCCCcccccccCcccccc
Q 006785 19 QRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSR--SCDCSPVGGSSEGKWTCICAADGLPKVAANSYDTTCFAS 96 (631)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~~~~~~~c~~--~~~c~~~~~~~~~~~~c~~~~~g~~~~~~~~~~~~c~~~ 96 (631)
.++.|.+ ..++|+|.|..+|.|+.=-..-+-|.. ...|........|.|+|.|. .|+-+ ......|...
T Consensus 15 ~~g~C~~-----~~~~~~C~C~~g~~g~~C~~~~~eC~~~~~~~C~~~C~~~~g~~~C~C~-~g~~~---~~~~~~C~~~ 85 (317)
T 3h5c_B 15 HNGSCQD-----SIWGYTCTCSPGYEGSNCELAKNECHPERTDGCQHFCLPGQESYTCSCA-QGYRL---GEDHKQCVPH 85 (317)
T ss_dssp TTCCCCC-----CSSSCCCCCSSSCCSSSSCCCSSSCCTTCTTSCSSEEECCSSSCEEECC-TTEEC---CTTSSCCEEC
T ss_pred CCCEeEC-----CCCCeEEECCCCCcCCccccCcccCCCCCCCCCcCccccCCCeeEEecc-ccccc---cccccccccc
Confidence 3455644 346899999999998631111122322 01222212235688999994 45433 2335677775
Q ss_pred cccCCC
Q 006785 97 CTCTSG 102 (631)
Q Consensus 97 ~~c~~~ 102 (631)
..|..+
T Consensus 86 ~~c~cg 91 (317)
T 3h5c_B 86 DQCACG 91 (317)
T ss_dssp SSCCCC
T ss_pred cccccc
Confidence 566554
|
| >1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* | Back alignment and structure |
|---|
Probab=83.56 E-value=1.4 Score=38.98 Aligned_cols=64 Identities=17% Similarity=0.466 Sum_probs=34.1
Q ss_pred CCccceEEecCCCCCCcccccccCccCC-cccCCCC-CCCCCceeeeecCCCCCcccccccCccccccccc
Q 006785 31 GQKNWKCTCSSSLQGDQSNILKLNCSRS-CDCSPVG-GSSEGKWTCICAADGLPKVAANSYDTTCFASCTC 99 (631)
Q Consensus 31 ~~~~~~~~c~~~~~~~~~~~~~~~c~~~-~~c~~~~-~~~~~~~~c~~~~~g~~~~~~~~~~~~c~~~~~c 99 (631)
..++|+|.|..||.|.. =...+-|... +.|...- ....|.|+|.|. +|+-. ...+..|-....+
T Consensus 65 ~~~~y~C~C~~G~~G~~-C~~~deC~~~~~~C~~~C~~n~~g~y~C~C~-~Gy~l---~~dG~~C~~~~~~ 130 (146)
T 1x7a_L 65 DINSYECWCQVGFEGKN-CELDATCNIKNGRCKQFCKTGADSKVLCSCT-TGYRL---APDQKSCKPAVPF 130 (146)
T ss_dssp CSSCEEEECCSSEESTT-TCEECCTTSGGGSCSSBCCCCSSSCCCCBCC-TTEEE---CTTSSSEEECSSS
T ss_pred CCCCEEEecCCCCcCCc-CCCCccccCCCCCCcCCCCCCCCCCEEeEcC-CCcEe---CCCCCcCCCCCCC
Confidence 34589999999998842 1110223321 2232222 345688999994 45432 2334566554333
|
| >1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A | Back alignment and structure |
|---|
Probab=83.53 E-value=0.38 Score=38.09 Aligned_cols=46 Identities=20% Similarity=0.565 Sum_probs=26.2
Q ss_pred CCccceEEecCCCCCCcccccccCccCCcccC------C-CCCCCCCceeeeecCCCCC
Q 006785 31 GQKNWKCTCSSSLQGDQSNILKLNCSRSCDCS------P-VGGSSEGKWTCICAADGLP 82 (631)
Q Consensus 31 ~~~~~~~~c~~~~~~~~~~~~~~~c~~~~~c~------~-~~~~~~~~~~c~~~~~g~~ 82 (631)
...+|+|.|..+|.|+- .+|....+|. . .-....|.|+|.|. .|+-
T Consensus 22 ~~g~y~C~C~~Gy~~~g-----~~C~dideC~~~~~C~~~~C~n~~g~y~C~C~-~G~~ 74 (82)
T 1emn_A 22 TDGSYRCECPFGYILAG-----NECVDTDECSVGNPCGNGTCKNVIGGFECTCE-EGFE 74 (82)
T ss_dssp CSSCCCEECCTTEEEET-----TEEEECCGGGTCCTTSSSCEEECSSSEEECCS-SSSC
T ss_pred cCCCEEEECCCCeECCC-----CccCCcccccCCCCCCCCEeECCCCCEEeECC-CCeE
Confidence 35689999999997422 2343333332 1 01124577888884 4443
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.17 E-value=0.13 Score=55.31 Aligned_cols=61 Identities=8% Similarity=0.004 Sum_probs=18.2
Q ss_pred cceeeeeCceEEEEEEECC-CcEEEE------EEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeee
Q 006785 229 SNIVGQGGSSYVYRGQLTD-GRIVAV------KRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 292 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~~-g~~vAV------K~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 292 (631)
.+.|| ||.||+|.+.. ..+||| |..+... ..+....|.+|..+++.++|||+++.+++...
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 45676 99999999864 467899 7766432 22333458899999999999999999887654
|
| >1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* | Back alignment and structure |
|---|
Probab=82.67 E-value=0.73 Score=38.95 Aligned_cols=50 Identities=30% Similarity=0.642 Sum_probs=30.6
Q ss_pred hhccccccccccCCccceEEecCCCCCCcccccccCccCCcc---cCC-------CCCCCCCceeeeecCCCC
Q 006785 19 QRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD---CSP-------VGGSSEGKWTCICAADGL 81 (631)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~~~~~~~c~~~~~---c~~-------~~~~~~~~~~c~~~~~g~ 81 (631)
.++.|.+ ..++|+|.|..+|.|+. |+...+ |.. .-....|.|+|.|. .|+
T Consensus 24 ~~g~C~~-----~~~~y~C~C~~G~~G~~-------C~~~~~~~~C~~~~~~C~~~C~n~~g~y~C~C~-~G~ 83 (114)
T 1aut_L 24 GHGTCID-----GIGSFSCDCRSGWEGRF-------CQREVSFLNCSLDNGGCTHYCLEEVGWRRCSCA-PGY 83 (114)
T ss_dssp TSEEECC-----CSSCCCEEECTTEESTT-------SCEECCSSSSSSGGGGCSSEEEECSSSEEEECC-TTE
T ss_pred CcCCCCC-----CCCCcEeeCCCCCcCCC-------cCcCCcCCcCcCCCCCCCCEeECCCCCEEeECC-CCe
Confidence 4556654 45689999999998863 433211 321 11235688999994 444
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=82.61 E-value=0.86 Score=30.33 Aligned_cols=14 Identities=29% Similarity=0.517 Sum_probs=5.9
Q ss_pred HHHHHHHHhhhhcc
Q 006785 132 IAFLMLVLCYVYRK 145 (631)
Q Consensus 132 l~~l~~~~~~~~rr 145 (631)
+++++.+.++++||
T Consensus 24 v~li~~l~~~~~rr 37 (38)
T 2k1k_A 24 AALLLGILVFRSRR 37 (38)
T ss_dssp HHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHHeec
Confidence 33333344444444
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 631 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-64 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-61 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-58 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-55 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-54 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-54 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-53 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-53 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-45 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-17 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 1e-64
Identities = 76/291 (26%), Positives = 122/291 (41%), Gaps = 31/291 (10%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFK-TQGGPNADSVFLTEVDMLSRLHHCH 282
+ + +G G VY+G+ VAVK T P F EV +L + H +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
++ +GY + +V ++ +L L + + IA A+G++Y
Sbjct: 66 ILLFMGYSTAP-----QLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDY 119
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
LH I+HRD+KS+NI L E+L KI D G+A S S ++ G+ +
Sbjct: 120 LHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW---SGSHQFEQLSGSILWM 173
Query: 403 APEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459
APE + S SDV++FG+VL EL+TG+ P + + ++ D
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233
Query: 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510
V S P M L ECL+ D RP +++ + +A
Sbjct: 234 VRSNCPKA-------------MKRLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 4e-63
Identities = 71/297 (23%), Positives = 124/297 (41%), Gaps = 21/297 (7%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+G+G V+RG+ G VAVK F ++ E+ L H +++ + +
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA--- 348
+ G LV ++ +G+L D L+ + + + +A+ A GL +LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 349 --PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
P I HRD+KS NIL+ +N I DLG+A R + + +P GT Y APE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT-DTIDIAPNHRVGTKRYMAPEV 183
Query: 407 ------AMVGRASLMSDVFSFGVVLLELITGRQP--IHRSITKGEESLVLWATPRLQDSG 458
+ +D+++ G+V E+ IH LV +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 459 TVISELPDPRLKGDF-PKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKS 514
V + P + + E +++MA + +EC + AR T + + LS ++ +
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 203 bits (517), Expect = 4e-61
Identities = 66/309 (21%), Positives = 127/309 (41%), Gaps = 38/309 (12%)
Query: 214 FSYSALEHATDKFSGS---------NIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQG 260
F++ A +F+ ++G G V G L VA+K K+
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 261 GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL 320
FL+E ++ + H +V+ L G ++ +++ EFM NG+L D
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK----STPVMIITEFMENGSL-DSFLRQN 121
Query: 321 VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380
V + G A G++YL + +HRD+ + NIL++ NL K++D G+++ L
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178
Query: 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 440
+ D +S + + APE + + SDV+S+G+V+ E+++ + + +T
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238
Query: 441 KGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 500
+ + + + P + + L +C Q D + RP
Sbjct: 239 NQD-----------------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281
Query: 501 EVVQILSTI 509
++V L +
Sbjct: 282 QIVNTLDKM 290
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 6e-61
Identities = 66/312 (21%), Positives = 118/312 (37%), Gaps = 41/312 (13%)
Query: 219 LEHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR 277
+E D F + +G G V++ G ++A K + P + + E+ +L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 278 LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 337
+ ++V G + E M G+L L + ++I
Sbjct: 61 CNSPYIVGFYGAFYS----DGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVI 114
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
+GL YL E +I+HRD+K SNIL++ K+ D G++ +L S G
Sbjct: 115 KGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------DSMANSFVG 165
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP-----------IHRSITKGEES- 445
T Y +PE S+ SD++S G+ L+E+ GR P + +G+ +
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225
Query: 446 ---------LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLD 492
L + I EL D + PK + + ++ CL +
Sbjct: 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 285
Query: 493 PDARPTMSEVVQ 504
P R + +++
Sbjct: 286 PAERADLKQLMV 297
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 6e-60
Identities = 68/283 (24%), Positives = 125/283 (44%), Gaps = 31/283 (10%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
+ +G G V+ G VAVK K G + FL E +++ +L H +
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRL 70
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 343
V L ++ ++ E+M NG+L D L + + + +A A G+ ++
Sbjct: 71 VRLYAVVTQEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
E +HRD++++NIL+ + L+ KI D G+A+ ++ + + + + A
Sbjct: 126 EE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK----FPIKWTA 178
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 463
PE G ++ SDV+SFG++L E++T + + +T E L R+
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM--------V 230
Query: 464 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
PD + P+E + L + C + P+ RPT + +L
Sbjct: 231 RPD-----NCPEE----LYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 1e-59
Identities = 69/298 (23%), Positives = 120/298 (40%), Gaps = 29/298 (9%)
Query: 229 SNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 284
+ ++G+G VY G L D AVK S FLTE ++ H +V+
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH 344
L+G C G L+V +M +G+LR+ + + A+G+++L
Sbjct: 92 SLLGICLRSEGSP---LVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 404
+ +HRD+ + N +LDE K+ D G+A+ + S + + A
Sbjct: 148 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK-LPVKWMAL 203
Query: 405 EYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 464
E + + SDV+SFGV+L EL+T P + + + ++ L RL
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-------- 255
Query: 465 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLN 522
P+ + + +C + RP+ SE+V +S I + +N
Sbjct: 256 ---------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVN 304
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-58
Identities = 69/286 (24%), Positives = 116/286 (40%), Gaps = 35/286 (12%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
+ +G+G V G G VAVK K A FL E ++++L H ++
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNL 62
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 343
V L+G E +G +V E+M G+L D L + D + ++ +EYL
Sbjct: 63 VQLLGVIVEEKGGL---YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
+HRD+ + N+L+ E+ AK++D G+ K SS+ + + A
Sbjct: 120 EG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--------SSTQDTGKLPVKWTA 168
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 463
PE + S SDV+SFG++L E+ + + P + +
Sbjct: 169 PEALREKKFSTKSDVWSFGILLWEIYSFGRV-----------------PYPRIPLKDVVP 211
Query: 464 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
+ K D P + + K C LD RP+ ++ + L I
Sbjct: 212 RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 3e-58
Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 31/287 (10%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
+ + +G G V+ G + VA+K + G ++ F+ E +++ +L H +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKL 62
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 343
V L G C E +A LVFEFM +G L D +T + + + G+ YL
Sbjct: 63 VQLYGVCLE----QAPICLVFEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEGMAYL 117
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
E ++HRD+ + N L+ EN K++D GM + + D S + + + +
Sbjct: 118 EE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG----TKFPVKWAS 170
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 463
PE R S SDV+SFGV++ E+ + + + + + E + RL
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK------- 223
Query: 464 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510
P+ + + C + P+ RP S +++ L+ IA
Sbjct: 224 ----------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (494), Expect = 5e-58
Identities = 71/312 (22%), Positives = 129/312 (41%), Gaps = 31/312 (9%)
Query: 213 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTE 271
+Y E + + +G G VY G VAVK K + FL E
Sbjct: 6 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKE 63
Query: 272 VDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA 331
++ + H ++V L+G C+ ++ EFM GNL D L + ++ +
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTR----EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 119
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 391
+A + +EYL + +HRD+ + N L+ EN K+ D G+++ + D + + +
Sbjct: 120 MATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 176
Query: 392 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 451
+ APE + S+ SDV++FGV+L E+ T + I +
Sbjct: 177 K----FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------- 224
Query: 452 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511
+ EL + + + P+ + + L + C Q +P RP+ +E+ Q T+
Sbjct: 225 ---------VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
Query: 512 DKSRRRNISLNL 523
+ S + L
Sbjct: 276 ESSISDEVEKEL 287
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 6e-58
Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 31/283 (10%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
+ +GQG V+ G VA+K K G + FL E ++ +L H +
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKL 74
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 343
V L SE +V E+M G+L D L G + + V +A A G+ Y+
Sbjct: 75 VQLYAVVSEEP-----IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
+HRD++++NIL+ ENL K+ D G+A+ ++ + + + + A
Sbjct: 130 ER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG----AKFPIKWTA 182
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 463
PE A+ GR ++ SDV+SFG++L EL T + + + E + +
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----------------VLD 225
Query: 464 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
+ + P E + + L +C + +P+ RPT + L
Sbjct: 226 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 8e-57
Identities = 65/302 (21%), Positives = 129/302 (42%), Gaps = 32/302 (10%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTDG-----RIVAVKRFKTQGGPNADSVFLTEVDMLSRL 278
+ ++G G VY+G L VA+K K FL E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 279 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 338
H +++ L G S+++ +++ E+M NG L L + V + G A
Sbjct: 67 SHHNIIRLEGVISKYKP----MMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAA 121
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
G++YL +HRD+ + NIL++ NL K++D G+++ L+ D P + + + +
Sbjct: 122 GMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD--PEATYTTSGGKIP 176
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458
+ APE + + SDV+SFG+V+ E++T + + ++ E
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--------------- 221
Query: 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRN 518
+ + + + P + + L +C Q + RP +++V IL + +
Sbjct: 222 --VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKT 279
Query: 519 IS 520
++
Sbjct: 280 LA 281
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (482), Expect = 5e-56
Identities = 65/323 (20%), Positives = 124/323 (38%), Gaps = 55/323 (17%)
Query: 215 SYSALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVF 268
+LE+ + +G+G V++ + +VAVK K + + + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 269 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL------------ 316
E +++ + ++V L+G C+ L+FE+M G+L + L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAV----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 317 ----------DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 366
++ ++ IA A G+ YL E + +HRD+ + N L+ EN
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGEN 176
Query: 367 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLL 426
+ KI D G+++ + + + A + PE R + SDV+++GVVL
Sbjct: 177 MVVKIADFGLSRNIYSADYYKADGNDA---IPIRWMPPESIFYNRYTTESDVWAYGVVLW 233
Query: 427 ELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAK 486
E+ + + + E VI + D + P+ + L +
Sbjct: 234 EIFSYGLQPYYGMAHEE----------------VIYYVRDGNIL-ACPENCPLELYNLMR 276
Query: 487 ECLQLDPDARPTMSEVVQILSTI 509
C P RP+ + +IL +
Sbjct: 277 LCWSKLPADRPSFCSIHRILQRM 299
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 5e-56
Identities = 58/287 (20%), Positives = 109/287 (37%), Gaps = 31/287 (10%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHC 281
+ + +G G + + +DG+I+ K + ++EV++L L H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG--MNWDTRVAIAIGAARG 339
++V + +V E+ G+L + E ++ + + +
Sbjct: 64 NIVRYYDRIIDRTNTTLY--IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 340 LEYLHE--AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
L+ H +LHRD+K +N+ LD N K+ D G+A+ L D +S G
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-----TSFAKAFVG 176
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457
T Y +PE + SD++S G +L EL P + ++
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--------------FTAFSQKEL 222
Query: 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
I E R+ + E +I+ L L RP++ E+++
Sbjct: 223 AGKIREGKFRRIPYRYSDELNEII----TRMLNLKDYHRPSVEEILE 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 2e-55
Identities = 67/295 (22%), Positives = 111/295 (37%), Gaps = 32/295 (10%)
Query: 219 LEHATDKFSGSNIV-GQGGSSYVYRGQL---TDGRIVAVKRFKTQGGPNADSVFLTEVDM 274
L D ++I G G V +G VA+K K + E +
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 275 LSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 334
+ +L + ++V L+G C +LV E G L L G E + +
Sbjct: 63 MHQLDNPYIVRLIGVCQAEA-----LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLH 116
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
+ G++YL E +HRD+ + N+LL AKI+D G++K L AD + S
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--A 171
Query: 395 MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 454
+ ++APE + S SDV+S+GV + E ++ Q P
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK-----------------PYK 214
Query: 455 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
+ G + + + + P E + L +C + RP V Q +
Sbjct: 215 KMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 3e-55
Identities = 60/278 (21%), Positives = 108/278 (38%), Gaps = 30/278 (10%)
Query: 230 NIVGQGGSSYVYRGQLTD-GRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHCHVVPLV 287
+G+G VY+G T+ VA + + F E +ML L H ++V
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 288 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 347
+ +LV E M +G L+ L + M + +GL++LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHT-R 131
Query: 348 APRILHRDIKSSNILL-DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
P I+HRD+K NI + + KI DLG+A + +S + GT + APE
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-------ASFAKAVIGTPEFMAPEM 184
Query: 407 AMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 466
+ DV++FG+ +LE+ T P + + +
Sbjct: 185 YE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----------------IYRRVTS 227
Query: 467 PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
F K + + + + C++ + D R ++ +++
Sbjct: 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 5e-55
Identities = 76/338 (22%), Positives = 136/338 (40%), Gaps = 47/338 (13%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL 278
+F ++G G VY+G VA+K + P A+ L E +++ +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 279 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 338
+ HV L+G C + L+ + MP G L D + + + + + A+
Sbjct: 69 DNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 122
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
G+ YL + R++HRD+ + N+L+ + KITD G+AK L A+ + +
Sbjct: 123 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG---GKVP 176
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458
+ A E + + SDV+S+GV + EL+T + I E S +L RL
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---- 232
Query: 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRN 518
P + + +C +D D+RP E++ S +A D R
Sbjct: 233 -------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLV 279
Query: 519 ISLNLFQIFSAGGMEKEPSIERPD--NLFETLIESEEL 554
I ++ + P N + L++ E++
Sbjct: 280 IQ-----------GDERMHLPSPTDSNFYRALMDEEDM 306
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 9e-55
Identities = 70/328 (21%), Positives = 136/328 (41%), Gaps = 50/328 (15%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTDG---RIVAVKRFKTQGGPNADSVFLTEVDMLSRL-H 279
+ +++G+G V + ++ A+KR K + F E+++L +L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 280 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVEGMN 325
H +++ L+G C R L E+ P+GNL D L ++
Sbjct: 70 HPNIINLLGACE----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 326 WDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385
+ A ARG++YL + + +HRD+ + NIL+ EN AKI D G+++
Sbjct: 126 SQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR------G 176
Query: 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES 445
+ + A E + SDV+S+GV+L E+++ + +T E
Sbjct: 177 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236
Query: 446 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505
L RL + P + L ++C + P RP+ ++++
Sbjct: 237 EKLPQGYRL-----------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
Query: 506 LSTIAPDKSRRRNISLNLFQIFSAGGME 533
L+ + + R+ ++ L++ F+ G++
Sbjct: 280 LNRMLEE--RKTYVNTTLYEKFTYAGID 305
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 3e-54
Identities = 69/284 (24%), Positives = 115/284 (40%), Gaps = 33/284 (11%)
Query: 230 NIVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVP 285
+G G V +G + VAVK K + P L E +++ +L + ++V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 345
++G C +LV E G L L + + + + G++YL E
Sbjct: 73 MIGICEAES-----WMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE 125
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 405
+HRD+ + N+LL AKI+D G++K L+AD + + + ++APE
Sbjct: 126 ---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD--ENYYKAQTHGKWPVKWYAPE 180
Query: 406 YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465
+ S SDV+SFGV++ E + Q +R + E + +L R+ P
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--------GCP 232
Query: 466 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
P+E M L C D + RP + V L
Sbjct: 233 A-----GCPRE----MYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (469), Expect = 6e-54
Identities = 65/288 (22%), Positives = 106/288 (36%), Gaps = 41/288 (14%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLH 279
FS +G G VY + + + +VA+K+ G + + + EV L +L
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 280 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 339
H + + G LV E+ V + + A+ GA +G
Sbjct: 74 HPNTIQYRGCYLR----EHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQG 127
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
L YLH ++HRD+K+ NILL E K+ D G A + GT
Sbjct: 128 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---------SFVGTP 175
Query: 400 GYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456
+ APE + G+ DV+S G+ +EL + P+ ++
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-----NMNAMSALYH----- 225
Query: 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
I++ P L+ E + CLQ P RPT +++
Sbjct: 226 ----IAQNESPALQSGHWSEYFR---NFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 1e-53
Identities = 63/314 (20%), Positives = 116/314 (36%), Gaps = 49/314 (15%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSR 277
++ S +G G V VAVK K ++E+ +LS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 278 L-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVE-------------- 322
L +H ++V L+G C+ L++ E+ G+L + L
Sbjct: 83 LGNHMNIVNLLGACTI----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 323 --GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380
++ + ++ + A+G+ +L +HRD+ + NILL KI D G+A+ +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 440
K D S + + APE + SDV+S+G+ L EL + + +
Sbjct: 196 KND---SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252
Query: 441 KGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 500
+ ++ + P+ M + K C DP RPT
Sbjct: 253 VDSK----------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK 296
Query: 501 EVVQILSTIAPDKS 514
++VQ++ + +
Sbjct: 297 QIVQLIEKQISEST 310
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 1e-53
Identities = 60/311 (19%), Positives = 115/311 (36%), Gaps = 54/311 (17%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSR 277
+ ++G G V VAVK K + + ++E+ M+++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 278 L-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-------------------- 316
L H ++V L+G C+ L+FE+ G+L + L
Sbjct: 97 LGSHENIVNLLGACTL----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 317 -DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 375
+ + + ++ + A A+G+E+L +HRD+ + N+L+ KI D G
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFG 209
Query: 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 435
+A+ + +D S + + APE G ++ SDV+S+G++L E+ +
Sbjct: 210 LARDIMSD---SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266
Query: 436 HRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDA 495
+ I +L K D P + + + + C D
Sbjct: 267 YPGIPVDAN----------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRK 310
Query: 496 RPTMSEVVQIL 506
RP+ + L
Sbjct: 311 RPSFPNLTSFL 321
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 3e-53
Identities = 57/277 (20%), Positives = 109/277 (39%), Gaps = 31/277 (11%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
+G G V G+ VA+K K G ++ F+ E ++ L H +V L G
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 349
C++ + ++ E+M NG L + L + + + +EYL
Sbjct: 68 CTK----QRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLES---K 119
Query: 350 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV 409
+ LHRD+ + N L+++ K++D G+++ + D S + + PE M
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG----SKFPVRWSPPEVLMY 175
Query: 410 GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRL 469
+ S SD+++FGV++ E+ + + + T E +E L
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-----------------TAEHIAQGL 218
Query: 470 KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
+ P + + + C D RPT ++ +
Sbjct: 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 3e-53
Identities = 66/284 (23%), Positives = 104/284 (36%), Gaps = 38/284 (13%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 280
+ F +G+G VY + I+A+K A EV++ S L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 340
+++ L GY + L+ E+ P G + L + + A L
Sbjct: 66 PNILRLYGYFHD----ATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANAL 119
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
Y H R++HRDIK N+LL KI D G + SS + GT
Sbjct: 120 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-------SSRRTTLCGTLD 169
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460
Y PE D++S GV+ E + G+ P + Q++
Sbjct: 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--------------FEANTYQETYKR 215
Query: 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
IS R++ FP + L L+ +P RP + EV++
Sbjct: 216 IS-----RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 1e-51
Identities = 63/297 (21%), Positives = 114/297 (38%), Gaps = 34/297 (11%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH 279
++ +G+G V++G VA+K K + FL E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 280 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 339
H H+V L+G +E ++ E G LR V ++ + + A +
Sbjct: 67 HPHIVKLIGVITEN-----PVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTA 120
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
L YL R +HRDI + N+L+ N K+ D G+++ ++ S + +
Sbjct: 121 LAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS----KGKLPI 173
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459
+ APE R + SDV+ FGV + E++ + + + V+
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGR--------- 221
Query: 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRR 516
I + + P + L +C DP RP +E+ LSTI ++ +
Sbjct: 222 -IENGERLPMPPNCPPT----LYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 273
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 5e-51
Identities = 62/283 (21%), Positives = 103/283 (36%), Gaps = 30/283 (10%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
+ + +G+G V VAVK + + E+ + L+H +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
VV G+ + ++ L E+ G L D ++ GM G+ Y
Sbjct: 65 VVKFYGHRR----EGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVY 118
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
LH I HRDIK N+LLDE N KI+D G+A + + + M GT Y
Sbjct: 119 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK---MCGTLPYV 172
Query: 403 APEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 461
APE + DV+S G+VL ++ G P + Q+
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD------------QPSDSCQEYSDWK 220
Query: 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
+ + ++ + L +P AR T+ ++ +
Sbjct: 221 EKKTYLNPWKKIDSAPLALL----HKILVENPSARITIPDIKK 259
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 7e-51
Identities = 62/288 (21%), Positives = 109/288 (37%), Gaps = 36/288 (12%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
D + +G G VY+ Q + + A K T+ + ++ E+D+L+ H
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED-YMVEIDILASCDHP 69
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 341
++V L+ ++ EF G + + L + + L
Sbjct: 70 NIVKLLDAFYY----ENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQVVCKQTLDALN 124
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
YLH+ +I+HRD+K+ NIL + + K+ D G++ + S GT +
Sbjct: 125 YLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-----FIGTPYW 176
Query: 402 FAPEYAMVGRA-----SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456
APE M + +DV+S G+ L+E+ P H P
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL------------NPMRVL 224
Query: 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
SE P + + K+CL+ + DAR T S+++Q
Sbjct: 225 LKIAKSEPPTLAQPSRWSSNFKDFL----KKCLEKNVDARWTTSQLLQ 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 6e-50
Identities = 64/283 (22%), Positives = 119/283 (42%), Gaps = 33/283 (11%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
K++ +GQG S VY + G+ VA+++ Q P + + E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 341
++V + +V E++ G+L D + M+ A+ + LE
Sbjct: 78 NIVNYLDSYLVGD----ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALE 130
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
+LH +++HRDIKS NILL + + K+TD G ++ + S + M GT +
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-----SKRSTMVGTPYW 182
Query: 402 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 461
APE D++S G++ +E+I G P + + +I
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP--------------YLNENPLRALYLI 228
Query: 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
+ P L+ P++ I CL +D + R + E++Q
Sbjct: 229 ATNGTPELQ--NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 4e-49
Identities = 64/281 (22%), Positives = 104/281 (37%), Gaps = 33/281 (11%)
Query: 232 VGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVP 285
+G G V RG+ VAVK K +++ F+ EV+ + L H +++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 345
L G +V E P G+L D L T A+ A G+ YL
Sbjct: 76 LYGVVLTPP-----MKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 405
R +HRD+ + N+LL KI D G+ + L + + F + APE
Sbjct: 130 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPE 184
Query: 406 YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465
S SD + FGV L E+ T Q + + ++ ++
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----------------ILHKID 228
Query: 466 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
+ P++ Q + + +C P+ RPT + L
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 5e-48
Identities = 71/307 (23%), Positives = 120/307 (39%), Gaps = 46/307 (14%)
Query: 224 DKFSGSNIVGQGGSSYVYRG------QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR 277
D+ +G+G V + R VAVK K + ++E+ +L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 278 -LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVE 322
HH +VV L+G C++ G +++ EF GNL L + + +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPL---MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 323 GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382
+ + + + A+G+E+L + +HRD+ + NILL E KI D G+A+ +
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKG 442
D + + APE ++ SDV+SFGV+L E+ + + +
Sbjct: 187 DPDYVRKGD---ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 443 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 502
EE + E R E M +C +P RPT SE+
Sbjct: 244 EEFC------------RRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSEL 287
Query: 503 VQILSTI 509
V+ L +
Sbjct: 288 VEHLGNL 294
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 7e-48
Identities = 65/297 (21%), Positives = 116/297 (39%), Gaps = 41/297 (13%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSR 277
+K + S +GQG VY G VA+K FL E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 278 LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------DGVLVEGMNWDTR 329
+ HVV L+G S + L++ E M G+L+ L + ++ +
Sbjct: 80 FNCHHVVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 330 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 389
+ +A A G+ YL+ + +HRD+ + N ++ E+ KI D GM + +
Sbjct: 136 IQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 390 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 449
+ + +PE G + SDV+SFGVVL E+ T + ++ ++ + +
Sbjct: 193 G---KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249
Query: 450 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 506
L D P ++ L + C Q +P RP+ E++ +
Sbjct: 250 EGGLL-----------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-47
Identities = 68/309 (22%), Positives = 123/309 (39%), Gaps = 50/309 (16%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDML 275
D+ +G+G V + VAVK K+ S ++E++M+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 276 SRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVL 320
+ H +++ L+G C++ ++ E+ GNLR+ L
Sbjct: 73 KMIGKHKNIINLLGACTQ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 321 VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380
E ++ V+ A ARG+EYL + +HRD+ + N+L+ E+ KI D G+A+ +
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 440
+++ + + APE + SDV+SFGV+L E+ T + +
Sbjct: 186 HHIDYYKKTTN---GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242
Query: 441 KGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 500
E +L R+ D P + + ++C P RPT
Sbjct: 243 VEELFKLLKEGHRM-----------------DKPSNCTNELYMMMRDCWHAVPSQRPTFK 285
Query: 501 EVVQILSTI 509
++V+ L I
Sbjct: 286 QLVEDLDRI 294
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 164 bits (417), Expect = 4e-47
Identities = 66/290 (22%), Positives = 113/290 (38%), Gaps = 26/290 (8%)
Query: 221 HATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSR 277
H +D++ I+G GG S V+ + L R VAVK + + F E +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 278 LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 337
L+H +V + + +V E++ LRD + M + + A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADAC 121
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
+ L + H+ I+HRD+K +NI++ K+ D G+A+ + G + + A + G
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG--NSVTQTAAVIG 176
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457
T Y +PE A SDV+S G VL E++TG P + P
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI---- 232
Query: 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-TMSEVVQIL 506
P + ++ + L +P+ R T +E+ L
Sbjct: 233 -------PPSARHEGLSADLDAVV----LKALAKNPENRYQTAAEMRADL 271
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 4e-46
Identities = 69/290 (23%), Positives = 109/290 (37%), Gaps = 50/290 (17%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 280
+ F I+G+G S V + L R A+K + + + V E D++SRL H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 340
V L + + NG L + + + L
Sbjct: 68 PFFVKLYFTFQD----DEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSAL 121
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
EYLH I+HRD+K NILL+E+++ +ITD G AK L + + ++S GT
Sbjct: 122 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS---FVGTAQ 175
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWATP 452
Y +PE A SD+++ G ++ +L+ G P I + I K E P
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP 235
Query: 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 502
+ +D L ++ L LD R E+
Sbjct: 236 KARD---------------------------LVEKLLVLDATKRLGCEEM 258
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (410), Expect = 7e-46
Identities = 50/292 (17%), Positives = 92/292 (31%), Gaps = 28/292 (9%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
+++ +G G +Y G + G VA+K + E + +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK---TKHPQLHIESKIYKMMQGGV 63
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
+P + +C ++V E + + T + +A +EY
Sbjct: 64 GIPTIRWCGAEGD---YNVMVMELLGPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEY 118
Query: 343 LHEAAAPRILHRDIKSSNIL---LDENLNAKITDLGMAKRLKADGLPSCSSSPAR--MQG 397
+H +HRD+K N L + I D G+AK+ + + G
Sbjct: 119 IHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457
T Y + + S D+ S G VL+ G P + + +
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-- 233
Query: 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509
P L +P E + + C L D +P S + Q+ +
Sbjct: 234 -----STPIEVLCKGYPSEFATYLNF----CRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 162 bits (411), Expect = 2e-45
Identities = 60/284 (21%), Positives = 104/284 (36%), Gaps = 33/284 (11%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
D + +G G V+R GR+ K T P E+ ++++LHH
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPK 87
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
++ L + + +L+ EF+ G L D + M+ + A GL++
Sbjct: 88 LINLHDAFED----KYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKH 142
Query: 343 LHEAAAPRILHRDIKSSNILLD--ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
+HE I+H DIK NI+ + + + KI D G+A +L D + T
Sbjct: 143 MHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV------TTATAE 193
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460
+ APE +D+++ GV+ L++G P V
Sbjct: 194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE------- 246
Query: 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
D E + K LQ +P R T+ + ++
Sbjct: 247 ----FDEDAFSSVSPEAKDFI----KNLLQKEPRKRLTVHDALE 282
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 161 bits (409), Expect = 4e-45
Identities = 58/288 (20%), Positives = 102/288 (35%), Gaps = 33/288 (11%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL 278
+H D + +G G V+R G A K T + ++ E+ +S L
Sbjct: 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET-VRKEIQTMSVL 80
Query: 279 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 338
H +V L + ++++EFM G L + + M+ D V +
Sbjct: 81 RHPTLVNLHDAFED----DNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCK 135
Query: 339 GLEYLHEAAAPRILHRDIKSSNILL--DENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
GL ++HE +H D+K NI+ + K+ D G+ L S
Sbjct: 136 GLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK------QSVKVTT 186
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456
GT + APE A +D++S GV+ L++G P V
Sbjct: 187 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN--- 243
Query: 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
D ++ + ++ L DP+ R T+ + ++
Sbjct: 244 --------MDDSAFSGISEDGKDFI----RKLLLADPNTRMTIHQALE 279
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (398), Expect = 2e-44
Identities = 66/297 (22%), Positives = 107/297 (36%), Gaps = 46/297 (15%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--------FLTEVDM 274
+ + I+G+G SS V R + AVK GG + + L EVD+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 275 LSRLH-HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
L ++ H +++ L LVF+ M G L D L ++ I
Sbjct: 63 LRKVSGHPNIIQLKDTYET----NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIM 116
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393
+ LH+ I+HRD+K NILLD+++N K+TD G + +L
Sbjct: 117 RALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG------EKLR 167
Query: 394 RMQGTFGYFAPEYAMVGRA------SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 447
+ GT Y APE D++S GV++ L+ G P ++
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 227
Query: 448 LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
+ + P D+ ++ L + P R T E +
Sbjct: 228 MSGNYQ----------FGSPEWD-DYSDTVKDLV----SRFLVVQPQKRYTAEEALA 269
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 3e-44
Identities = 66/297 (22%), Positives = 115/297 (38%), Gaps = 23/297 (7%)
Query: 222 ATDKFSGSNIVGQGGSSYVYRGQ--LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRL 278
A ++ +G+G V++ + GR VA+KR + Q G + + EV +L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 279 ---HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG 335
H +VV L C+ R R +L + + +L LD V G+ +T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 336 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 395
RGL++LH R++HRD+K NIL+ + K+ D G+A+ + S + +
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR------IYSFQMALTSV 175
Query: 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLV 447
T Y APE + + D++S G + E+ + I
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235
Query: 448 LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
PR + F + ++ L +CL +P R + +
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (399), Expect = 4e-44
Identities = 65/320 (20%), Positives = 117/320 (36%), Gaps = 37/320 (11%)
Query: 216 YSALEHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDM 274
+ E D + +++G G S V + ++VA+K + + E+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 275 LSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 334
L ++ H ++V L L+ + + G L D + +
Sbjct: 61 LHKIKHPNIVALDDIYES----GGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIF 114
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSS 391
++YLH+ I+HRD+K N+L DE+ I+D G++K + S
Sbjct: 115 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST--- 168
Query: 392 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 451
GT GY APE S D +S GV+ L+ G P + +L A
Sbjct: 169 ---ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE 225
Query: 452 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ---ILST 508
D D + + ++ DP+ R T + +Q I
Sbjct: 226 YE-----------FDSPYWDDISDSAKDFI----RHLMEKDPEKRFTCEQALQHPWIAGD 270
Query: 509 IAPDKSRRRNISLNLFQIFS 528
A DK+ +++S + + F+
Sbjct: 271 TALDKNIHQSVSEQIKKNFA 290
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 3e-43
Identities = 58/279 (20%), Positives = 99/279 (35%), Gaps = 31/279 (11%)
Query: 231 IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVG 288
++G G + V + A+K + EV++ R H+V +V
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVD 72
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
R L+V E + G L + + I ++YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-- 130
Query: 349 PRILHRDIKSSNILLD---ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 405
I HRD+K N+L N K+TD G AK + +S T Y APE
Sbjct: 131 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH------NSLTTPCYTPYYVAPE 183
Query: 406 YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 465
+ D++S GV++ L+ G P + + + G E P
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN----HGLAISPGMKTRIRMGQY--EFP 237
Query: 466 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
+P + +E ++ + L+ +P R T++E +
Sbjct: 238 NPEWS-EVSEEVKMLI----RNLLKTEPTQRMTITEFMN 271
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 4e-43
Identities = 68/291 (23%), Positives = 114/291 (39%), Gaps = 31/291 (10%)
Query: 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSV----FLTEVDMLSRLHHCHVV 284
+ +G+G + VY+ + +IVA+K+ K A L E+ +L L H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH 344
L+ ++ LVF+FM D L + A + +GLEYLH
Sbjct: 64 GLLDAFGH----KSNISLVFDFMETDLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLH 117
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 404
+ ILHRD+K +N+LLDEN K+ D G+AK + + + T Y AP
Sbjct: 118 Q---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-----NRAYTHQVVTRWYRAP 169
Query: 405 EYAMVGRA-SLMSDVFSFGVVLLELITGRQP--------IHRSITK--GEESLVLWATPR 453
E R + D+++ G +L EL+ I + G + W
Sbjct: 170 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229
Query: 454 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
P L F ++ + +P AR T ++ ++
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQG-LFLFNPCARITATQALK 279
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 4e-43
Identities = 55/296 (18%), Positives = 104/296 (35%), Gaps = 22/296 (7%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
+++ + +G+G V + VA+K+ L E+ +L R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 341
+++ + ++ + + + +L L + ++ D RGL+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLK 123
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
Y+H A +LHRD+K SN+LL+ + KI D G+A+ D + T Y
Sbjct: 124 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH--DHTGFLTEYVATRWY 178
Query: 402 FAPEYAMVGRASLMS-DVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWATP 452
APE + + S D++S G +L E+++ R I S
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPDARPTMSEVVQ 504
+ + L P A + L +P R + + +
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 156 bits (395), Expect = 6e-43
Identities = 68/285 (23%), Positives = 109/285 (38%), Gaps = 39/285 (13%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLH- 279
+ FS I+G+GG VY + D G++ A+K + +++ L E MLS +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 280 --HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 337
+V + + + M G+L L + A
Sbjct: 64 GDCPFIVCMSYAFHT----PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEII 117
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
GLE++H +++RD+K +NILLDE+ + +I+DLG+A P G
Sbjct: 118 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS-------KKKPHASVG 167
Query: 398 TFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456
T GY APE G A +D FS G +L +L+ G P + TK + +
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---- 223
Query: 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 501
L F E ++ + LQ D + R
Sbjct: 224 --------MAVELPDSFSPELRSLL----EGLLQRDVNRRLGCLG 256
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 154 bits (389), Expect = 6e-43
Identities = 55/299 (18%), Positives = 98/299 (32%), Gaps = 34/299 (11%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G+G ++ G L + + VA+K + + E L C +P V Y
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRR---SDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 350
+ +LV + + G + L + + T A ++ +HE
Sbjct: 70 GQEGL---HNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---S 121
Query: 351 ILHRDIKSSNILLDENLN-----AKITDLGMAKRLKAD--GLPSCSSSPARMQGTFGYFA 403
+++RDIK N L+ + + D GM K + + GT Y +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 463
+ S D+ + G V + + G P + + Q
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS------- 234
Query: 464 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLN 522
P L FP+E + M Y L DA P + + S + R N + +
Sbjct: 235 TPLRELCAGFPEEFYKYMHY----ARNLAFDATPDYDYLQGLFSKVL----ERLNTTED 285
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 8e-43
Identities = 60/338 (17%), Positives = 122/338 (36%), Gaps = 48/338 (14%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
+K+ + +G+G V+R + + K K +G + E+ +L+ H +
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRN 62
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
++ L +++FEF+ ++ + ++ E +N V+ L++
Sbjct: 63 ILHLHESFES----MEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQF 117
Query: 343 LHEAAAPRILHRDIKSSNILLD--ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
LH I H DI+ NI+ + KI + G A++LK + +
Sbjct: 118 LHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK------PGDNFRLLFTAPE 168
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460
Y+APE S +D++S G ++ L++G P + ++ A
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT------- 221
Query: 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ--------------IL 506
D + E M + L + +R T SE +Q ++
Sbjct: 222 ----FDEEAFKEISIEAMDFV----DRLLVKERKSRMTASEALQHPWLKQKIERVSTKVI 273
Query: 507 STIAPDKSRRRNISLNLFQIFSAGGMEKEPSIERPDNL 544
T+ + I +L + SA + +I +
Sbjct: 274 RTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGV 311
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 8e-41
Identities = 60/295 (20%), Positives = 111/295 (37%), Gaps = 28/295 (9%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHC 281
+ F +G+G VY+ + G +VA+K+ + S + E+ +L L+H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 341
++V L+ +L + + +L+ +D + G+ + +GL
Sbjct: 62 NIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
+ H R+LHRD+K N+L++ K+ D G+A+ T Y
Sbjct: 117 FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWY 168
Query: 402 FAPE-YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460
APE S D++S G + E++T R ++ ++ ++ T D
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD-SEIDQLFRIFRTLGTPDEVVW 227
Query: 461 ISELPDPRLKGDFPKEEMQIMAY-----------LAKECLQLDPDARPTMSEVVQ 504
P K FPK Q + L + L DP+ R + +
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 146 bits (370), Expect = 2e-40
Identities = 60/292 (20%), Positives = 110/292 (37%), Gaps = 24/292 (8%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCH 282
+K+ G +G+G VY+ Q G A+K+ + + S + E+ +L L H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
+V L RL++ + +L+ LD V G+ T + + G+ Y
Sbjct: 62 IVKLYDVIHTK-----KRLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAY 115
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
H+ R+LHRD+K N+L++ KI D G+A+ + +
Sbjct: 116 CHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH----EIVTLWYRA 168
Query: 403 APEYAMVGRASLMSDVFSFGVVLLELITGRQPIH--------RSITK--GEESLVLWATP 452
+ S D++S G + E++ G I + G + W
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
+ +P F K + L + L+LDP+ R T + ++
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 4e-40
Identities = 64/295 (21%), Positives = 102/295 (34%), Gaps = 30/295 (10%)
Query: 226 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 284
++ + ++G G VY+ +L D G +VA+K+ E+ ++ +L HC++V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNIV 76
Query: 285 PLVGYCSEF--RGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLE 341
L + + LV +++P R + + R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 342 YLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
Y+H I HRDIK N+LLD + K+ D G AK+L +
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSYICSRY 187
Query: 401 YFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQP--------IHRSITK--GEESLVLW 449
Y APE + DV+S G VL EL+ G+ I K G +
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 450 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
+ ++ F L L+ P AR T E
Sbjct: 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 146 bits (368), Expect = 1e-39
Identities = 65/308 (21%), Positives = 104/308 (33%), Gaps = 62/308 (20%)
Query: 230 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPL 286
+G G V+ + +GR A+K K + V E MLS + H ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
G + ++ +++ G L L + A LEYLH
Sbjct: 70 WGTFQD----AQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHS- 122
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
I++RD+K NILLD+N + KITD G AK + + GT Y APE
Sbjct: 123 --KDIIYRDLKPENILLDKNGHIKITDFGFAKYV--------PDVTYTLCGTPDYIAPEV 172
Query: 407 AMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWATPRLQDSG 458
+ D +SFG+++ E++ G P + I E + ++D
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD-- 230
Query: 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDAR-----PTMSEVVQ--ILSTIAP 511
L + D R +V +
Sbjct: 231 -------------------------LLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 265
Query: 512 DKSRRRNI 519
+K RNI
Sbjct: 266 EKLLSRNI 273
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 64/303 (21%), Positives = 117/303 (38%), Gaps = 40/303 (13%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSV--FLTEVDMLSR-LH 279
+ F ++G+G V+ + + A+K K D V + E +LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 280 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 339
H + + + V E++ G+L + + A G
Sbjct: 62 HPFLTHMFCTFQT----KENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILG 115
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
L++LH I++RD+K NILLD++ + KI D GM K + GT
Sbjct: 116 LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-----AKTNTFCGTP 167
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459
Y APE + + + D +SFGV+L E++ G+ P H G++ L+ + R+
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH-----GQDEEELFHSIRMD---- 218
Query: 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ---ILSTIAPDKSRR 516
+P KE ++ + +P+ R + ++ + I ++ R
Sbjct: 219 ------NPFYPRWLEKEAKDLL----VKLFVREPEKRLGVRGDIRQHPLFREINWEELER 268
Query: 517 RNI 519
+ I
Sbjct: 269 KEI 271
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-39
Identities = 59/295 (20%), Positives = 109/295 (36%), Gaps = 40/295 (13%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-----FLTEVD 273
E+ D + +G G + V + + + G A K K + ++ EV
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
+L + H +V+ L + +L+ E + G L D L E + +
Sbjct: 66 ILKEIQHPNVITLHEVYEN----KTDVILILELVAGGELFDFLAEK--ESLTEEEATEFL 119
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDEN----LNAKITDLGMAKRLKADGLPSCS 389
G+ YLH +I H D+K NI+L + KI D G+A ++
Sbjct: 120 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN- 175
Query: 390 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 449
+ GT + APE L +D++S GV+ L++G P +
Sbjct: 176 -----IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--------------F 216
Query: 450 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
Q++ +S + + + ++ + + L DP R T+ + +Q
Sbjct: 217 LGDTKQETLANVSAV-NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 6e-39
Identities = 60/301 (19%), Positives = 116/301 (38%), Gaps = 26/301 (8%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRLHHC 281
K+ +GQG V++ + G+ VA+K+ + + L E+ +L L H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 282 HVVPLVGYC----SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 337
+VV L+ C S + + LVF+F + + ++ ++ RV +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
L L+ +ILHRD+K++N+L+ + K+ D G+A+ S +
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK-NSQPNRYTNRVV 183
Query: 398 TFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRS--------ITKGEESLVL 448
T Y PE + R D++ G ++ E+ T + + I++ S+
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 449 WATPRLQD----SGTVISELPDPRLKGDFPKEEMQIMAY-LAKECLQLDPDARPTMSEVV 503
P + + + + ++K A L + L LDP R + +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
Query: 504 Q 504
Sbjct: 304 N 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (344), Expect = 9e-37
Identities = 54/294 (18%), Positives = 105/294 (35%), Gaps = 26/294 (8%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHC 281
K+ +G+G V++ + IVA+KR + S L E+ +L L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 341
++V L LVFEF + ++ + + +GL
Sbjct: 62 NIVRLHDVLHS----DKKLTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLG 115
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
+ H +LHRD+K N+L++ N K+ + G+A+ A + +
Sbjct: 116 FCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV----RCYSAEVVTLWYR 168
Query: 402 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE--ESLVLWATPRLQDSGT 459
S D++S G + EL +P+ + + + ++
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228
Query: 460 VISELPDPRLKGDFPKEEMQIMAY---------LAKECLQLDPDARPTMSEVVQ 504
+++LPD + +P + L + L+ +P R + E +Q
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 7e-36
Identities = 72/355 (20%), Positives = 121/355 (34%), Gaps = 55/355 (15%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHC 281
+ VG G V G VA+K+ E+ +L + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 282 HVVPLVGYC--SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 339
+V+ L+ E LV FM + + D + +G
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE----KLGEDRIQFLVYQMLKG 133
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
L Y+H I+HRD+K N+ ++E+ KI D G+A++ S T
Sbjct: 134 LRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA--------DSEMTGYVVTR 182
Query: 400 GYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWA 450
Y APE + R + D++S G ++ E+ITG+ + I K +
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242
Query: 451 TPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPDARPTMSEVVQ-- 504
RLQ P L+ + + LA L LD + R T E +
Sbjct: 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 302
Query: 505 ILSTIAPDKSRRRNISLNLFQIFSAGGMEKEPSIERPDNLFETLIES-EELKKAT 558
++ E EP +++ D+ F+ + + +E K+ T
Sbjct: 303 YFESLHDT--------------------EDEPQVQKYDDSFDDVDRTLDEWKRVT 337
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 2e-35
Identities = 62/279 (22%), Positives = 95/279 (34%), Gaps = 36/279 (12%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 280
+ F ++G+G V + GR A+K + + D V +TE +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 340
+ L V E+ G L L + L
Sbjct: 65 PFLTALKYAFQT----HDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSAL 118
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
EYLH +++RDIK N++LD++ + KITD G+ K +DG GT
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-----TFCGTPE 170
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460
Y APE D + GVV+ E++ GR P + + L+L R
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR---- 226
Query: 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM 499
E ++ L+ DP R
Sbjct: 227 -----------TLSPEAKSLL----AGLLKKDPKQRLGG 250
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 2e-35
Identities = 58/286 (20%), Positives = 95/286 (33%), Gaps = 54/286 (18%)
Query: 231 IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-----FLTEVDMLSRLHHCH-- 282
++G GG VY G ++D VA+K + + + EV +L ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
V+ L+ + +L+ E + + + + +
Sbjct: 71 VIRLLDWFER----PDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 125
Query: 343 LHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
H +LHRDIK NIL+D N K+ D G LK GT Y
Sbjct: 126 CHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 175
Query: 402 FAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRS--ITKGEESLVLWATPRLQDSG 458
PE+ R + V+S G++L +++ G P I +G+ + Q
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH-- 233
Query: 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
L + CL L P RPT E+
Sbjct: 234 -------------------------LIRWCLALRPSDRPTFEEIQN 254
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (324), Expect = 1e-33
Identities = 54/304 (17%), Positives = 108/304 (35%), Gaps = 43/304 (14%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHC 281
D + +G+G S V+ +T+ V VK K P E+ +L L
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----PVKKKKIKREIKILENLRGGP 90
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 341
+++ L + + LVFE + N + + L + + + L+
Sbjct: 91 NIITLADIVKDPVSRTPA--LVFEHVNNTDFKQ-----LYQTLTDYDIRFYMYEILKALD 143
Query: 342 YLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
Y H I+HRD+K N+++D E+ ++ D G+A+ + +
Sbjct: 144 YCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV------RVASRY 194
Query: 401 YFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRS---------ITKGEESLVLWA 450
+ PE + D++S G +L +I ++P I K + L+
Sbjct: 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254
Query: 451 TPRLQDS------GTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPDARPTMS 500
+ ++ R + E +++ A + L+ D +R T
Sbjct: 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314
Query: 501 EVVQ 504
E ++
Sbjct: 315 EAME 318
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (317), Expect = 2e-32
Identities = 55/306 (17%), Positives = 105/306 (34%), Gaps = 46/306 (15%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 280
D+F +G G V + G A+K Q + L E +L ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 340
+V L + +V E++ G + L + + A
Sbjct: 101 PFLVKLEFSFKDNS----NLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTF 154
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
EYLH +++RD+K N+L+D+ ++TD G AKR + GT
Sbjct: 155 EYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKR--------VKGRTWTLCGTPE 203
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460
APE + + D ++ GV++ E+ G P ++ + ++
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF-----ADQPIQIYE---------- 248
Query: 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDP-----DARPTMSEVVQ--ILSTIAPDK 513
K FP + L + LQ+D + + ++++ +T
Sbjct: 249 ----KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304
Query: 514 SRRRNI 519
+R +
Sbjct: 305 IYQRKV 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 6e-32
Identities = 64/298 (21%), Positives = 112/298 (37%), Gaps = 30/298 (10%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRLHH 280
+++ + VG G V G VAVK+ + E+ +L + H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 340
+V+ L+ + R + G D + V + + D + RGL
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMG--ADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
+Y+H I+HRD+K SN+ ++E+ KI D G+A+ T
Sbjct: 135 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH--------TDDEMTGYVATRW 183
Query: 401 YFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQP-------------IHRSITKGEESL 446
Y APE + + D++S G ++ EL+TGR + T G E L
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 447 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504
++ ++ ++++P F + L K L LD D R T ++ +
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK-MLVLDSDKRITAAQALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-30
Identities = 54/308 (17%), Positives = 112/308 (36%), Gaps = 41/308 (13%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHC 281
++ +G G V R VA+K+ + E+ ++ ++H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 282 HVVPLVGYCSEFRGKRAMR--LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 339
+++ L+ + + + LV E M + V+ ++ + + G
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ-----VIQMELDHERMSYLLYQMLCG 131
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
+++LH I+HRD+K SNI++ + KI D G+A+ + + T
Sbjct: 132 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP------YVVTR 182
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWAT 451
Y APE + D++S G ++ E++ + + + +
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
Query: 452 PRLQDSGTVISELPDPRLKGDFPK-----------EEMQIMAYLAKE----CLQLDPDAR 496
+LQ + E FPK E ++ A A++ L +DP R
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302
Query: 497 PTMSEVVQ 504
++ + +Q
Sbjct: 303 ISVDDALQ 310
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 4e-29
Identities = 58/287 (20%), Positives = 99/287 (34%), Gaps = 36/287 (12%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSV---FLTEVDMLS 276
+ F ++G G V+ + G++ A+K K TE +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 277 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA 336
+ + + Y + K + L +++ G L L T + I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLIL---DYINGGELFTHL-----SQRERFTEHEVQIYV 135
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
+ L I++RDIK NILLD N + +TD G++K AD +
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD----ETERAYDFC 191
Query: 397 GTFGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 454
GT Y AP+ G + D +S GV++ EL+TG P K ++ + +
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK- 250
Query: 455 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 501
+P + ++ + L DP R
Sbjct: 251 ----------SEPPYPQEMSALAKDLI----QRLLMKDPKKRLGCGP 283
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (278), Expect = 2e-27
Identities = 56/314 (17%), Positives = 107/314 (34%), Gaps = 48/314 (15%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC--------- 281
+G G S V+ + + + VA+K + E+ +L R++
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 282 --HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 339
H++ L+ + + ++VFE + L G+ I+ G
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLG 137
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
L+Y+H I+H DIK N+L++ + + +L K T
Sbjct: 138 LDYMHRR--CGIIHTDIKPENVLMEIVDSPE--NLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH----------------------- 436
Y +PE + +D++S ++ ELITG
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253
Query: 437 ---RSITKGEESLVLWATPRLQDSGTVISELPDPRL---KGDFPKEEMQIMAYLAKECLQ 490
+ G+ + + + L + + + P + K F K+E + ++ LQ
Sbjct: 254 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 313
Query: 491 LDPDARPTMSEVVQ 504
LDP R +V
Sbjct: 314 LDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 77.5 bits (190), Expect = 5e-17
Identities = 22/168 (13%), Positives = 43/168 (25%), Gaps = 38/168 (22%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKT---------QGGPNADSVFLTE--------V 272
++G+G S V+ VK K + D F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 273 DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 332
L +L V + + ++ E + L + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNA--------VLMELIDAKELYRV---------RVENPDEV 108
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380
+ + I+H D+ N+L+ E I D + +
Sbjct: 109 LDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEV 152
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 631 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.36 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.14 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.59 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.85 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.61 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.45 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 90.12 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-53 Score=437.72 Aligned_cols=263 Identities=25% Similarity=0.393 Sum_probs=199.7
Q ss_pred cCccccceeeeeCceEEEEEEECC-C---cEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-G---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g---~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
++|.+.++||+|+||+||+|.++. + ..||||++.........+.|.+|+++|++++|||||+++|++.. ...
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~----~~~ 101 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK----STP 101 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----SSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee----CCE
Confidence 345567899999999999998753 3 36999998876665666679999999999999999999999976 446
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.|+||||+++|+|.+++... ...++|.+++.++.|||.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceE
Confidence 79999999999999998764 245999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
.................||+.|||||++.++.++.++|||||||+||||+| |+.||...........
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~------------ 245 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA------------ 245 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH------------
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHH------------
Confidence 765432221222233568999999999999999999999999999999998 8999965432211100
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
+..-. ..+.+..++..+.+|+.+||+.||++|||+.||++.|+.+..+
T Consensus 246 --i~~~~----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 246 --IEQDY----RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp --HHTTC----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --HHcCC----CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 00101 1122333445588999999999999999999999999987543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=425.88 Aligned_cols=257 Identities=24% Similarity=0.385 Sum_probs=208.8
Q ss_pred HhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
..++|++.+.||+|+||+||+|.+++++.||||+++... ...+.|.+|+++|++++|||||+++|++.+ ...|
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~~~ 83 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-----EPIY 83 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSCE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-----CCeE
Confidence 356788889999999999999999888999999997543 334569999999999999999999998754 2458
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+++|+|.+++.......++|.+++.|+.||++||+|||+++ |+||||||+||||++++.+||+|||+|+...
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEcc
Confidence 9999999999999887665556999999999999999999999998 9999999999999999999999999999875
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 461 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (631)
.... .......||+.|+|||++..+.++.++|||||||+||||+||..|+......... .. .+
T Consensus 161 ~~~~----~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~--~~-----------~i 223 (272)
T d1qpca_ 161 DNEY----TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV--IQ-----------NL 223 (272)
T ss_dssp SSCE----ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HH-----------HH
T ss_pred CCcc----ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHH--HH-----------HH
Confidence 4321 1223456899999999999999999999999999999999976665432221110 00 01
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 462 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
.....+. .|...+..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 224 ~~~~~~~----~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 224 ERGYRMV----RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp HTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcCCCC----CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 1111111 2233344588999999999999999999999999865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-53 Score=429.78 Aligned_cols=262 Identities=27% Similarity=0.447 Sum_probs=204.2
Q ss_pred HhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
..++|.+.+.||+|+||+||+|+++ ..||||+++... .....+.|.+|+.+|++++|||||+++|++.+ ...
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-----~~~ 78 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-----PQL 78 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----SSC
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-----cEE
Confidence 3567888999999999999999874 359999997543 34556679999999999999999999998753 346
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
++||||+++|+|.++|.... ..+++.+++.|+.|||+||+|||+++ ||||||||+||||+.++.+||+|||+|+..
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred EEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeec
Confidence 99999999999999997543 45999999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhc---CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~---~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
..... ........||+.|||||++.+ +.++.++|||||||+||||+||+.||..............
T Consensus 155 ~~~~~---~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~-------- 223 (276)
T d1uwha_ 155 SRWSG---SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-------- 223 (276)
T ss_dssp --------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH--------
T ss_pred cccCC---cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHh--------
Confidence 53321 122345679999999999864 3589999999999999999999999975433221111110
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
.....|.+ ...+..++..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 224 ----~~~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 224 ----RGYLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp ----HTSCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----cCCCCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 01111111 0122233445889999999999999999999999998774
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-53 Score=434.07 Aligned_cols=264 Identities=25% Similarity=0.389 Sum_probs=214.4
Q ss_pred HHHHhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 219 l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
|+...++|...+.||+|+||+||+|.+.+ |+.||||+++... ...+.|.+|+.+|++++|||||+++|++.+ .
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----~ 85 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR----E 85 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS----S
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEee----C
Confidence 34445678888999999999999999864 8899999987543 345569999999999999999999999976 4
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
...|+||||+++|+|.++|.......+++..++.|+.|||.||+|||+++ |+||||||+||||++++.+||+|||+|
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLS 162 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccce
Confidence 56799999999999999998766677999999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
+....+.. .......||+.|+|||++.++.++.++|||||||++|||++|..||.......... .
T Consensus 163 ~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~--~--------- 227 (287)
T d1opja_ 163 RLMTGDTY----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--E--------- 227 (287)
T ss_dssp TTCCSSSS----EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH--H---------
T ss_pred eecCCCCc----eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHH--H---------
Confidence 87654321 11233458999999999999999999999999999999999877765432211100 0
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
.+.. ......|...+..+.+|+.+||+.||++|||+.+|++.|+.+..+
T Consensus 228 --~i~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 228 --LLEK----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp --HHHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred --HHhc----CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 0011 111123333445589999999999999999999999999887544
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-52 Score=418.34 Aligned_cols=256 Identities=28% Similarity=0.406 Sum_probs=197.7
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
++|+..+.||+|+||+||+|.+.+++.||||+++... ...+.|.+|+++|++++|||||+++|+|.+ ....++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE----QAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS----SSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceecc----CCceEEE
Confidence 4677889999999999999999889999999997643 344569999999999999999999999976 4467999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
|||+++|+|.+++... ...++|..++.++.|||.||+|||+++ |+||||||+||||++++.+||+|||+++.....
T Consensus 79 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp EECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred EEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCC
Confidence 9999999999998764 345899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 463 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (631)
.. .......||+.|+|||++.+..++.++|||||||+||||+|+..|+........ .... +..
T Consensus 155 ~~----~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~--~~~~-----------i~~ 217 (263)
T d1sm2a_ 155 QY----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVED-----------IST 217 (263)
T ss_dssp --------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH--HHHH-----------HHH
T ss_pred Cc----eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH--HHHH-----------HHh
Confidence 22 122345699999999999999999999999999999999996544433221111 0000 000
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 464 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 464 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
...+ ..|..++..+.+|+.+||+.||++|||+.+|++.|+++.
T Consensus 218 ~~~~----~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 218 GFRL----YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp TCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCC----CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 0111 122233345889999999999999999999999998874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-52 Score=420.50 Aligned_cols=254 Identities=26% Similarity=0.324 Sum_probs=202.6
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.++|++.+.||+|+||+||+|+++ +|+.||||++......+..+.|.+|+.+|++++|||||++++++.+ ....|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~----~~~~~ 79 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE----GNIQY 79 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE----TTEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc----CceeE
Confidence 357888999999999999999985 5999999999765544445568999999999999999999999986 56789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
|||||+++|+|.++|... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 80 ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp EEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeec
Confidence 999999999999999653 45999999999999999999999999 9999999999999999999999999999875
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
.... .......+||+.|||||++.+..+ +.++|||||||+||||++|+.||............ +..
T Consensus 155 ~~~~---~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-~~~--------- 221 (271)
T d1nvra_ 155 YNNR---ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-WKE--------- 221 (271)
T ss_dssp ETTE---ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-HHT---------
T ss_pred cCCc---cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-Hhc---------
Confidence 4321 122344679999999999988775 67899999999999999999999754332211110 000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
...........+..+.+|+.+||+.||++|||+.|+++
T Consensus 222 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 222 ------KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ------TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00000111233455788999999999999999999865
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=419.98 Aligned_cols=263 Identities=25% Similarity=0.390 Sum_probs=203.5
Q ss_pred cCccccceeeeeCceEEEEEEECCC-----cEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTDG-----RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~g-----~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
+.|+..++||+|+||+||+|.++.. ..||||+++..........|.+|+.+|++++|||||+++|++.+ ..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~----~~ 82 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK----YK 82 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----SS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec----CC
Confidence 4577789999999999999987642 47999999876555556679999999999999999999999976 45
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..++||||+.+|+|.+++... ...++|.+++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred ceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhh
Confidence 679999999999999988654 356999999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
........ ........||+.|||||++.++.++.++|||||||+||||++|..|+........ ...
T Consensus 159 ~~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~--~~~---------- 224 (283)
T d1mqba_ 159 VLEDDPEA--TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMK---------- 224 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH----------
T ss_pred cccCCCcc--ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH--HHH----------
Confidence 76543211 1122345689999999999999999999999999999999997666543222111 000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 513 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 513 (631)
.+..- .+.+.|..++..+.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus 225 -~i~~~----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 225 -AINDG----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp -HHHTT----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred -HHhcc----CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 01111 111233344456899999999999999999999999998876443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=416.57 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=207.4
Q ss_pred cCccccce-eeeeCceEEEEEEEC---CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 224 DKFSGSNI-VGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 224 ~~f~~~~~-LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
++|...+. ||+|+||+||+|.++ ++..||||+++........+.|.+|+++|++++|||||+++|++.. ..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-----~~ 82 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----EA 82 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----SS
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----Ce
Confidence 44555664 999999999999864 3568999999876555556779999999999999999999999853 24
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.||||||+++|+|.+++... ...+++.+++.++.|||.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhc
Confidence 69999999999999998653 245999999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSG 458 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 458 (631)
........ .......||+.|+|||++..+.++.++|||||||++|||+| |+.||...........
T Consensus 159 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~------------ 224 (285)
T d1u59a_ 159 LGADDSYY--TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF------------ 224 (285)
T ss_dssp CTTCSCEE--CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH------------
T ss_pred cccccccc--ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHH------------
Confidence 75433211 22234568999999999999999999999999999999998 8999975432211110
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 459 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
+.....+ ..|..++..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 225 --i~~~~~~----~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 225 --IEQGKRM----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp --HHTTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHcCCCC----CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111112 22333445588999999999999999999999998765
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-51 Score=410.10 Aligned_cols=253 Identities=22% Similarity=0.361 Sum_probs=209.8
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
++|+..+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.++++++||||++++|+|.+ ....++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~----~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK----QRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEECC----SSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc--CCHHHHHHHHHHHHhcCCCceeeEEEEEee----CCceEEE
Confidence 5788899999999999999999888999999998643 334569999999999999999999999976 4568999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
|||+++|+|.+++.... ..+++..+..++.|+|+||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 78 ~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp EECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred EEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 99999999999986543 45899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccccccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
.. .......||+.|+|||.+.+..++.++||||||+++|||+| |+.||........... +.
T Consensus 154 ~~----~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~--------------i~ 215 (258)
T d1k2pa_ 154 EY----TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH--------------IA 215 (258)
T ss_dssp SC----CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH--------------HH
T ss_pred Cc----eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH--------------HH
Confidence 32 22334569999999999999999999999999999999998 8999975443211110 01
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 508 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 508 (631)
....+ ..|...+..+.+|+.+||+.||++|||+.+|++.|..
T Consensus 216 ~~~~~----~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 216 QGLRL----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred hCCCC----CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 11111 1223333558999999999999999999999998864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=412.22 Aligned_cols=246 Identities=24% Similarity=0.379 Sum_probs=204.3
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|++.+.||+|+||+||+|+++ +|+.||||++.... .......+.+|+++|++++|||||++++++.+ ....
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~~ 81 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD----ATRV 81 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE----CCEE
Confidence 46888999999999999999986 58999999986421 22344568999999999999999999999886 5678
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 82 ~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 156 (263)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred EEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeec
Confidence 9999999999999999754 45999999999999999999999998 999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
... ......||+.|||||++.+..++.++|||||||+||||++|+.||...........+.
T Consensus 157 ~~~-------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~------------ 217 (263)
T d2j4za1 157 PSS-------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------ 217 (263)
T ss_dssp CCC-------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------------
T ss_pred CCC-------cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH------------
Confidence 432 2345679999999999999999999999999999999999999996543221111000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
. ..+ .+|...+..+.+|+.+||+.||++|||+.|+++
T Consensus 218 --~-~~~----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 218 --R-VEF----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --T-TCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --c-CCC----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 0 011 123334455889999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=416.30 Aligned_cols=256 Identities=22% Similarity=0.308 Sum_probs=194.7
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
++|++.+.||+|+||+||+|+.+ +|+.||||++..... ....+.|.+|+++|++++|||||++++++.+.. ...+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~~~ 81 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT--NTTLY 81 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC------CEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC--CCEEE
Confidence 56889999999999999999875 589999999976543 233456899999999999999999999986532 34679
Q ss_pred EEEeeCCCCChHhhhhcc--ccCCCCHHHHHHHHHHHHhhhHHHHhcCC--CceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 302 LVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAA--PRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~--~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
+||||+++|+|.+++... ....+++.+++.++.|++.||+|||+++. .+|+||||||+||||+.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 999999999999999643 23569999999999999999999998752 35999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
+.+..+. .......||+.|||||++.+..++.++|||||||+||||++|+.||...........
T Consensus 162 ~~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~----------- 225 (269)
T d2java1 162 RILNHDT-----SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK----------- 225 (269)
T ss_dssp HHC----------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-----------
T ss_pred eecccCC-----CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHH-----------
Confidence 8765432 223456799999999999999999999999999999999999999965332111000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
+.....+. .|...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 226 ---i~~~~~~~----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 226 ---IREGKFRR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---HHHTCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHcCCCCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 00111111 22233445889999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=414.52 Aligned_cols=249 Identities=25% Similarity=0.409 Sum_probs=205.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++|+..+.||+|+||+||+|... +|+.||||+++..... ..+.+.+|+.+|++++|||||++++++.+ ....||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~----~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLV----GDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEE----CCEEEE
Confidence 57999999999999999999875 5999999999765333 34569999999999999999999999986 557899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||++||+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 95 vmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp EEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 9999999999998865 35999999999999999999999999 99999999999999999999999999988754
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.............. .
T Consensus 169 ~~-----~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~------------~ 231 (293)
T d1yhwa1 169 EQ-----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT------------N 231 (293)
T ss_dssp TT-----CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH------------H
T ss_pred cc-----ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHh------------C
Confidence 32 123345799999999999999999999999999999999999999965432211110000 0
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
.. +. ...+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~--~~--~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 232 GT--PE--LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CS--CC--CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CC--CC--CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 11 1223344556899999999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=426.66 Aligned_cols=259 Identities=23% Similarity=0.408 Sum_probs=205.4
Q ss_pred HhcCccccceeeeeCceEEEEEEECC-C-----cEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeecc
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLTD-G-----RIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFR 294 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~~-g-----~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 294 (631)
..++|.+.+.||+|+||+||+|++.. + ..||||++...........|.+|+.+|.++ +|||||++++++.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-- 112 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 112 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee--
Confidence 34678889999999999999998753 2 369999997765555666799999999998 89999999999976
Q ss_pred CCcceEEEEEeeCCCCChHhhhhcccc---------------------CCCCHHHHHHHHHHHHhhhHHHHhcCCCceee
Q 006785 295 GKRAMRLLVFEFMPNGNLRDCLDGVLV---------------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILH 353 (631)
Q Consensus 295 ~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 353 (631)
....|+||||+++|+|.++|+.... ..+++..++.++.||+.||+|||+++ |||
T Consensus 113 --~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiH 187 (325)
T d1rjba_ 113 --SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH 187 (325)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred --CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 4567999999999999999965421 34899999999999999999999998 999
Q ss_pred cCCCCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CC
Q 006785 354 RDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GR 432 (631)
Q Consensus 354 rDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~ 432 (631)
|||||+|||++.++.+||+|||+|+........ .......||+.|||||++.++.++.++|||||||+||||+| |+
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~ 264 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNY---VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS---EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCce---eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCC
Confidence 999999999999999999999999876543211 11234568999999999999999999999999999999998 89
Q ss_pred CCCCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 433 QPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 433 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
.||............ +.. ....+.|..++..+.+|+.+||+.||++|||+.||++.|.
T Consensus 265 ~Pf~~~~~~~~~~~~-------------~~~----~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 265 NPYPGIPVDANFYKL-------------IQN----GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSSTTCCCSHHHHHH-------------HHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHH-------------Hhc----CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 999654322111100 111 1111233344456899999999999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-51 Score=414.62 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=198.3
Q ss_pred ceeeeeCceEEEEEEECC---CcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEEe
Q 006785 230 NIVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~E 305 (631)
++||+|+||+||+|.+++ ++.||||+++.... +...+.|.+|+++|++++|||||+++|+|.. ...+||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-----~~~~lvmE 87 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----ESWMLVME 87 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-----SSEEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-----CCEEEEEE
Confidence 579999999999998753 56899999975433 3344569999999999999999999999853 24689999
Q ss_pred eCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCCC
Q 006785 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (631)
Q Consensus 306 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 385 (631)
|+++|+|.+++... ..+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 88 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 88 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred cCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 99999999999764 55999999999999999999999998 99999999999999999999999999987654321
Q ss_pred CCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccccccccc
Q 006785 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 464 (631)
Q Consensus 386 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (631)
. ........||+.|||||++.+..++.++|||||||++|||+| |+.||........... +..-
T Consensus 163 ~--~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~--------------i~~~ 226 (277)
T d1xbba_ 163 Y--YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM--------------LEKG 226 (277)
T ss_dssp E--EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH--------------HHTT
T ss_pred c--cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHH--------------HHcC
Confidence 1 112234568999999999999999999999999999999998 8999975432211110 1111
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 465 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 465 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
..+ ..|..++..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 227 ~~~----~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 227 ERM----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCC----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCC----CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 111 22333445588999999999999999999999888754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=409.79 Aligned_cols=251 Identities=25% Similarity=0.360 Sum_probs=199.1
Q ss_pred cccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEE
Q 006785 227 SGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (631)
Q Consensus 227 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~ 304 (631)
...+.||+|+||+||+|.+. +++.||||++.... .....+.|.+|+++|++++|||||++++++.........+|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 33567999999999999986 48899999987643 33344569999999999999999999999876555566789999
Q ss_pred eeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeec-CCCCeEEeccCceeecccC
Q 006785 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 305 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~-~~~~~kL~DFGla~~~~~~ 383 (631)
||+++|+|.+++... ..+++.++..++.||+.||+|||+++ ++|+||||||+||||+ +++.+||+|||+|+.....
T Consensus 92 E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 999999999999764 45999999999999999999999875 3499999999999996 5789999999999754321
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccccccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 463 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (631)
......||+.|||||++.+ .++.++|||||||+||||++|+.||.......... .. ....
T Consensus 169 -------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~--~~----------i~~~ 228 (270)
T d1t4ha_ 169 -------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY--RR----------VTSG 228 (270)
T ss_dssp -------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH--HH----------HTTT
T ss_pred -------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHH--HH----------HHcC
Confidence 2345679999999998865 69999999999999999999999996433221100 00 0000
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 464 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 464 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
...+. ++...+..+.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~~~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 229 VKPAS----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CCCGG----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCcc----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11111 11222334889999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-51 Score=416.56 Aligned_cols=259 Identities=27% Similarity=0.402 Sum_probs=205.3
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
.++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.+|++++|||||+++|++.+ ...|+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-----~~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-----EPIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEec-----CCeEE
Confidence 35788899999999999999999888899999997543 334569999999999999999999999853 24589
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++|+|..++.......++|.+++.++.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+....
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccC
Confidence 999999999999997665567999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
... .......||+.|+|||++..+.++.++||||||++||||++|..|+.......+ ...+ +.
T Consensus 166 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~~~~-----------i~ 228 (285)
T d1fmka3 166 NEY----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQ-----------VE 228 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHH-----------HH
T ss_pred CCc----eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--HHHH-----------HH
Confidence 322 122345699999999999999999999999999999999997666644322111 1100 01
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
....+ +.+..++..+.+|+.+||+.||++||++.+|++.|+.....
T Consensus 229 ~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 229 RGYRM----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred hcCCC----CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 11111 23334445689999999999999999999999999876544
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=412.19 Aligned_cols=251 Identities=24% Similarity=0.326 Sum_probs=203.2
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
+.|++.+.||+|+||+||+|++. +|+.||||++.... ....+.|.+|+++|++++|||||++++++.+ ....||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYY----ENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE----TTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee----CCeEEE
Confidence 45888899999999999999986 58999999997653 3444568999999999999999999999986 567899
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
||||+++|+|.+++... .+.+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 87 vmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp EEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred EEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 99999999999998653 356999999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhh-----cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
.. .......||+.|+|||++. ...|+.++|||||||+||||++|+.||...........+.
T Consensus 163 ~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~--------- 228 (288)
T d2jfla1 163 TI-----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA--------- 228 (288)
T ss_dssp HH-----HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH---------
T ss_pred Cc-----ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH---------
Confidence 21 1112356999999999984 4568999999999999999999999997543322111000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
....+.+ ..+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 229 -----~~~~~~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 229 -----KSEPPTL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -----HSCCCCC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----cCCCCCC--CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001111 123344556899999999999999999999976
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-51 Score=422.54 Aligned_cols=265 Identities=24% Similarity=0.365 Sum_probs=207.0
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
..++|++.+.||+|+||+||+|++. +|+.||||+++..........+.+|+.+|++++|||||++++++.+ ....
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~ 79 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS----DGEI 79 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC----SSEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----CCEE
Confidence 3578999999999999999999975 5899999999876666666779999999999999999999999986 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhc-CCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
|+||||++||+|.+++.+. ..+++..+..++.|++.||.|||++ + |+||||||+||||+.++.+||+|||+|+.
T Consensus 80 ~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154 (322)
T ss_dssp EEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccc
Confidence 9999999999999999764 4599999999999999999999974 7 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh-ccccc----
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW-ATPRL---- 454 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~-~~~~~---- 454 (631)
..... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.............. .....
T Consensus 155 ~~~~~-------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 227 (322)
T d1s9ja_ 155 LIDSM-------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227 (322)
T ss_dssp HHHHT-------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------
T ss_pred cCCCc-------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCC
Confidence 65432 2346799999999999999999999999999999999999999975432211000000 00000
Q ss_pred ---ccccc--------------------cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 455 ---QDSGT--------------------VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 455 ---~~~~~--------------------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..... .+..-..+.+. ....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP---SGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ------------------CCCCHHHHHHHHHTSCCCCCC---BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccccchhHHHHHhhhhccCCccCc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000 00000001110 01123458899999999999999999999873
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-50 Score=413.48 Aligned_cols=254 Identities=21% Similarity=0.293 Sum_probs=190.3
Q ss_pred HhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
..+.|.+.+.||+|+||+||+|+++ +|+.||||++...........+.+|+.+|++++|||||++++++.+ ....
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~ 82 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES----GGHL 82 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----CCEE
Confidence 3567899999999999999999986 5899999999765444444568899999999999999999999876 5678
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeec---CCCCeEEeccCce
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMA 377 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~---~~~~~kL~DFGla 377 (631)
||||||++||+|.++|... ..+++.++..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+|
T Consensus 83 ~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred EEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEecccee
Confidence 9999999999999999753 56999999999999999999999998 99999999999994 5788999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
+...... ......||+.|||||++.+..++.++|||||||+||||++|+.||...........+..
T Consensus 158 ~~~~~~~------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~-------- 223 (307)
T d1a06a_ 158 KMEDPGS------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK-------- 223 (307)
T ss_dssp ---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT--------
T ss_pred EEccCCC------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc--------
Confidence 8764332 23346799999999999999999999999999999999999999975432211110000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. ........+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 224 -----~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 224 -----A--EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp -----T--CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -----c--CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 0011111222334558899999999999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-49 Score=410.23 Aligned_cols=266 Identities=23% Similarity=0.382 Sum_probs=212.9
Q ss_pred HHHHHHhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEe
Q 006785 217 SALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290 (631)
Q Consensus 217 ~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 290 (631)
.+|+...++|++.+.||+|+||+||+|+++ +++.||||+++..........|.+|+++|++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 345566788999999999999999999874 35789999998766555567799999999999999999999999
Q ss_pred eeccCCcceEEEEEeeCCCCChHhhhhccc----------------------cCCCCHHHHHHHHHHHHhhhHHHHhcCC
Q 006785 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVL----------------------VEGMNWDTRVAIAIGAARGLEYLHEAAA 348 (631)
Q Consensus 291 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 348 (631)
.. ....++||||+++|+|.++|.... ...+++.+++.|+.|++.||+|||+++
T Consensus 86 ~~----~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~- 160 (301)
T d1lufa_ 86 AV----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK- 160 (301)
T ss_dssp CS----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred cc----CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC-
Confidence 76 446799999999999999996421 124899999999999999999999998
Q ss_pred CceeecCCCCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHH
Q 006785 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLEL 428 (631)
Q Consensus 349 ~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eL 428 (631)
||||||||+||||+.++.+||+|||+|+........ .......||+.|+|||.+.+..++.++|||||||++|||
T Consensus 161 --ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~el 235 (301)
T d1lufa_ 161 --FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY---KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 235 (301)
T ss_dssp --CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB---C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred --eEeeEEcccceEECCCCcEEEccchhheeccCCccc---cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHH
Confidence 999999999999999999999999999866443211 122345689999999999999999999999999999999
Q ss_pred HhCC-CCCCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006785 429 ITGR-QPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 507 (631)
Q Consensus 429 ltG~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 507 (631)
++|. +||........... +.+-..+ ..|..++..+.+|+.+||+.||.+||||.||++.|+
T Consensus 236 l~~~~~p~~~~~~~e~~~~--------------v~~~~~~----~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~ 297 (301)
T d1lufa_ 236 FSYGLQPYYGMAHEEVIYY--------------VRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297 (301)
T ss_dssp HTTTCCTTTTSCHHHHHHH--------------HHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HccCCCCCCCCCHHHHHHH--------------HHcCCCC----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 9986 46654322211110 0111111 123333445889999999999999999999999999
Q ss_pred hhC
Q 006785 508 TIA 510 (631)
Q Consensus 508 ~i~ 510 (631)
++.
T Consensus 298 ~i~ 300 (301)
T d1lufa_ 298 RMC 300 (301)
T ss_dssp HTT
T ss_pred Hhc
Confidence 874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-50 Score=409.15 Aligned_cols=251 Identities=25% Similarity=0.346 Sum_probs=202.3
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|++.+.||+|+||+||+|+.. +|+.||||++.... .......+.+|+++|++++||||+++++++.+ ....
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~ 83 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD----DEKL 83 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC----SSEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE----CCEE
Confidence 56888999999999999999985 58999999986431 22334568999999999999999999999876 5678
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||++||+|.+++... +.+++..+..++.|++.||+|||+++ |+||||||+||||++++.+||+|||+|+.+
T Consensus 84 ~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 158 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL 158 (288)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceec
Confidence 9999999999999998754 46999999999999999999999999 999999999999999999999999999877
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
..... ........||+.|+|||++.+..++.++|||||||+||||++|+.||..........
T Consensus 159 ~~~~~---~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~--------------- 220 (288)
T d1uu3a_ 159 SPESK---QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ--------------- 220 (288)
T ss_dssp C-------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---------------
T ss_pred ccCCc---ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHH---------------
Confidence 54321 112234579999999999999999999999999999999999999997543211100
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+.... ..+|...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 221 --~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 221 --KIIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp --HHHTTC--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred --HHHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 000000 11233334558899999999999999999997653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=411.26 Aligned_cols=258 Identities=26% Similarity=0.413 Sum_probs=204.3
Q ss_pred cCccccceeeeeCceEEEEEEECC-Cc----EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~----~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
.+|++.++||+|+||+||+|.+.. |+ .||||+++.....+..+.|.+|+++|++++|||||+++|+|.+ .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-----~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----S 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-----S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----C
Confidence 458889999999999999998753 43 6999999876666667789999999999999999999999975 2
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..+++|||+.+|+|.+++... ...+++..++.++.|||.||+|||+++ |+||||||+||||+.++.+||+|||+|+
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred CeeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccce
Confidence 458899999999999988764 356999999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
........ .......||+.|+|||++.++.++.++|||||||+||||+| |..||...........+
T Consensus 160 ~~~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i---------- 226 (317)
T d1xkka_ 160 LLGAEEKE---YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---------- 226 (317)
T ss_dssp HTTTTCC-----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH----------
T ss_pred eccccccc---ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH----------
Confidence 76543221 12234568999999999999999999999999999999999 78888654322111111
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
..-..+ ..|..++..+.+|+.+||+.||.+|||+.||++.|..+..
T Consensus 227 ----~~~~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 227 ----EKGERL----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ----HHTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HcCCCC----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 010111 2233344558899999999999999999999999987753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=404.07 Aligned_cols=257 Identities=24% Similarity=0.371 Sum_probs=199.3
Q ss_pred hcCccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 298 (631)
.++|.+.+.||+|+||.||+|++.. +..||||+++..........|.+|+.+|++++|||||+++|++.+ .
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-----~ 80 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-----N 80 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----S
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----C
Confidence 4678889999999999999998753 457999998766555556679999999999999999999999853 3
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..|+||||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred eEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhe
Confidence 569999999999999988653 346899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhcccccccc
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
....... .......||+.|+|||++.+..++.++|||||||+||||++ |.+||...........
T Consensus 157 ~~~~~~~----~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~----------- 221 (273)
T d1mp8a_ 157 YMEDSTY----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR----------- 221 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-----------
T ss_pred eccCCcc----eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH-----------
Confidence 7654321 12234568999999999999999999999999999999998 8889865433211110
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
+..-..+ +.|..++..+.+|+.+||..||++|||+.||++.|..+.
T Consensus 222 ---i~~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 222 ---IENGERL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp ---HHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHcCCCC----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 0011111 223334455899999999999999999999999998774
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=401.19 Aligned_cols=250 Identities=28% Similarity=0.408 Sum_probs=198.7
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
++|+..+.||+|+||.||+|+++ |+.||||+++... ..+.|.+|+++|++++||||++++|+|.+. ...+|+|
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---~~~~~lv 79 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE---KGGLYIV 79 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC-----CCEEE
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEec---CCcEEEE
Confidence 46777899999999999999985 7899999997543 345699999999999999999999998652 2346999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
|||+++|+|.++|.......++|..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC
Confidence 99999999999997654456899999999999999999999998 999999999999999999999999999865432
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccccccccc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVIS 462 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (631)
.....+|+.|+|||++.++.++.++||||||+++|||+| |++||........ ..+ +.
T Consensus 157 --------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~---~~~-----------i~ 214 (262)
T d1byga_ 157 --------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPR-----------VE 214 (262)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHH-----------HT
T ss_pred --------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH---HHH-----------HH
Confidence 223458899999999999999999999999999999998 6777764322211 110 11
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 463 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
.-..+ +++...+..+.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus 215 ~~~~~----~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 215 KGYKM----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp TTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCC----CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 11112 23333445588999999999999999999999999876
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-49 Score=409.08 Aligned_cols=246 Identities=25% Similarity=0.361 Sum_probs=198.9
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
..|+..+.||+|+||+||+|+.. +|+.||||++...... ...+.|.+|+++|++++|||||++++++.+ ....
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----~~~~ 90 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR----EHTA 90 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----TTEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE----CCEE
Confidence 34888999999999999999875 5899999999765332 233458999999999999999999999886 5678
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+|||||++|+|..++... ..+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 91 ~iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (309)
T ss_dssp EEEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EEEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeeccccccc
Confidence 9999999999998776543 56999999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhc---CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 457 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~---~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 457 (631)
... ....||+.|||||++.+ +.|+.++|||||||++|||++|+.||............
T Consensus 166 ~~~---------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i---------- 226 (309)
T d1u5ra_ 166 APA---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---------- 226 (309)
T ss_dssp SSB---------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----------
T ss_pred CCC---------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH----------
Confidence 432 23469999999999864 46899999999999999999999999654322110000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 458 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
.. ...+.+. +...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 227 ---~~-~~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 227 ---AQ-NESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ---HH-SCCCCCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---Hh-CCCCCCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 00 0111111 1122345889999999999999999999976
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-49 Score=402.02 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=204.3
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-----CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCC
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-----PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 296 (631)
.++|.+.+.||+|+||+||+|+++ +|+.||||+++.... ....+.|.+|+.+|++++|||||++++++.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---- 84 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN---- 84 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----
Confidence 467999999999999999999985 599999999865422 2235679999999999999999999999876
Q ss_pred cceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC----CeEEe
Q 006785 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL----NAKIT 372 (631)
Q Consensus 297 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~----~~kL~ 372 (631)
....|||||||++|+|.++|... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred CCEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEec
Confidence 56789999999999999999764 46999999999999999999999999 99999999999998776 49999
Q ss_pred ccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccc
Q 006785 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 452 (631)
Q Consensus 373 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 452 (631)
|||+|+...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...........+...
T Consensus 160 DfG~a~~~~~~~------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-- 231 (293)
T d1jksa_ 160 DFGLAHKIDFGN------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-- 231 (293)
T ss_dssp CCTTCEECTTSC------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT--
T ss_pred chhhhhhcCCCc------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhc--
Confidence 999998765432 233457999999999999999999999999999999999999999754322111100000
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 453 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 453 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
........+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 232 -------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 232 -------------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -------------CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -------------CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000011123345889999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-49 Score=404.02 Aligned_cols=268 Identities=27% Similarity=0.388 Sum_probs=202.8
Q ss_pred HHHHHHhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEE
Q 006785 217 SALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGY 289 (631)
Q Consensus 217 ~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~ 289 (631)
..|+...++|.+.+.||+|+||.||+|.+. +++.||||+++..........+.+|+.++.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 344445578999999999999999999864 24689999998765555566788999988888 78999999998
Q ss_pred eeeccCCcceEEEEEeeCCCCChHhhhhccc--------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecC
Q 006785 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 355 (631)
Q Consensus 290 ~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD 355 (631)
+.+. ....++|||||++|+|.++|+... ...+++.+++.++.||+.||+|||+++ |+|||
T Consensus 86 ~~~~---~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD 159 (299)
T d1ywna1 86 CTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 159 (299)
T ss_dssp ECST---TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred eccC---CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence 8652 345799999999999999996532 234899999999999999999999998 99999
Q ss_pred CCCCCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCC-CC
Q 006785 356 IKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR-QP 434 (631)
Q Consensus 356 lKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~-~P 434 (631)
|||+||||++++++||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||++|. .|
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~---~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p 236 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPD---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 236 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTT---SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCccceeECCCCcEEEccCcchhhcccccc---ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCC
Confidence 999999999999999999999987654321 12233467999999999999999999999999999999999975 56
Q ss_pred CCCccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 435 IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
|........... .+..-..+. .|...+..+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 237 ~~~~~~~~~~~~-------------~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 237 YPGVKIDEEFCR-------------RLKEGTRMR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp STTCCCSHHHHH-------------HHHHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHH-------------HHhcCCCCC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 654322211100 011111122 22333445889999999999999999999999998774
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=398.26 Aligned_cols=258 Identities=25% Similarity=0.397 Sum_probs=205.7
Q ss_pred cceeeeeCceEEEEEEECCC----cEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEEE
Q 006785 229 SNIVGQGGSSYVYRGQLTDG----RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~~g----~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV~ 304 (631)
.++||+|+||+||+|.+.++ ..||||+++..........|.+|+++|++++||||++++|++.+. +...++||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---~~~~~lv~ 108 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---EGSPLVVL 108 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET---TTEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec---CCceEEEE
Confidence 46799999999999997542 369999998655555667799999999999999999999998753 34679999
Q ss_pred eeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccCC
Q 006785 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (631)
Q Consensus 305 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~ 384 (631)
||+++|+|.+++... ...+++..++.++.|+|.||.|||+.+ |+||||||+||||++++.+||+|||+++......
T Consensus 109 E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp ECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 999999999998764 345889999999999999999999998 9999999999999999999999999998876543
Q ss_pred CCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccccccc
Q 006785 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 464 (631)
Q Consensus 385 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (631)
... ........||+.|+|||.+..+.++.++||||||++||||++|+.||............ +..-
T Consensus 185 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~-------------i~~g 250 (311)
T d1r0pa_ 185 FDS-VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-------------LLQG 250 (311)
T ss_dssp CCC-TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHH-------------HHTT
T ss_pred ccc-ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHH-------------HHcC
Confidence 322 12233457999999999999999999999999999999999988887643322111100 0001
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 465 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 465 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
..+ ..|..++..+.+|+.+||+.||++||++.||++.|+.+..
T Consensus 251 ~~~----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 251 RRL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111 1222333458899999999999999999999999998853
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.3e-48 Score=407.78 Aligned_cols=253 Identities=22% Similarity=0.269 Sum_probs=205.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+ ....|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----~~~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFED----DNEMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE----TTEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE----CCEEE
Confidence 357999999999999999999975 59999999997543 2334568999999999999999999999886 56789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC--CCCeEEeccCceee
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE--NLNAKITDLGMAKR 379 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~--~~~~kL~DFGla~~ 379 (631)
||||||+||+|.+++... ...+++.++..++.||+.||+|||+++ ||||||||+||||+. ++.+||+|||+|+.
T Consensus 100 ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp EEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 999999999999999653 245999999999999999999999999 999999999999954 67899999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
..... ......||+.|||||++.+..++.++|||||||++|||++|+.||...........+....
T Consensus 176 ~~~~~------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-------- 241 (350)
T d1koaa2 176 LDPKQ------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD-------- 241 (350)
T ss_dssp CCTTS------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--------
T ss_pred ccccc------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------
Confidence 65432 2345679999999999999999999999999999999999999996543221111110000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
...........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 242 -------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 242 -------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -------CCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001111112334458899999999999999999999874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.4e-48 Score=395.32 Aligned_cols=265 Identities=24% Similarity=0.345 Sum_probs=205.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
.++|.+.+.||+|+||+||+|++. +|+.||||+++..... .....|.+|+++|++++||||+++++++.........
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999975 5999999999765432 2345689999999999999999999999875555567
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.||||||++||+|.+++... +.+++.+++.++.||+.||+|||+++ |+||||||+||||+.++..+|+|||++..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhh
Confidence 89999999999999998754 46999999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
....... ........||+.|+|||++.+..++.++|||||||+||||+||+.||................+
T Consensus 161 ~~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~------- 231 (277)
T d1o6ya_ 161 IADSGNS--VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP------- 231 (277)
T ss_dssp CC------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-------
T ss_pred hcccccc--ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCC-------
Confidence 5433211 1233456799999999999999999999999999999999999999975432211110000000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhh
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-TMSEVVQILSTI 509 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i 509 (631)
.........++ ..+.+|+.+||+.||.+|| |++++++.|.++
T Consensus 232 ----~~~~~~~~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 232 ----IPPSARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp ----CCGGGTSSSCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----CCCchhccCCC----HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 00001112233 4488999999999999999 899999988766
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=400.94 Aligned_cols=258 Identities=25% Similarity=0.408 Sum_probs=203.5
Q ss_pred cCccccceeeeeCceEEEEEEECC-Cc--EEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcce
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD-GR--IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~--~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 299 (631)
++|++.+.||+|+||+||+|++++ |. .||||+++........+.|.+|+++|+++ +|||||+++|+|.+ ...
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~----~~~ 85 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----RGY 85 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE----TTE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec----CCe
Confidence 567888999999999999998764 43 58889887655555556699999999999 79999999999986 567
Q ss_pred EEEEEeeCCCCChHhhhhcc--------------ccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC
Q 006785 300 RLLVFEFMPNGNLRDCLDGV--------------LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 365 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~ 365 (631)
.|+||||+++|+|.++|+.. ....+++..+..++.|||.||.|||+.+ |+||||||+|||++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGE 162 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECG
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcC
Confidence 89999999999999999643 2356999999999999999999999998 999999999999999
Q ss_pred CCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCC-CCCCccccccc
Q 006785 366 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQ-PIHRSITKGEE 444 (631)
Q Consensus 366 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~-P~~~~~~~~~~ 444 (631)
++.+||+|||+++...... ......||..|+|||.+..+.++.++||||||+++|||++|.. ||.......
T Consensus 163 ~~~~kl~DfG~a~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-- 234 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYV------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-- 234 (309)
T ss_dssp GGCEEECCTTCEESSCEEC------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--
T ss_pred CCceEEccccccccccccc------cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--
Confidence 9999999999998654321 2234568999999999999999999999999999999999765 554322111
Q ss_pred hhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 445 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
+... +..-..+ +.+..++..+.+|+.+||+.||++||||.||++.|+.+...
T Consensus 235 -~~~~-----------i~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 235 -LYEK-----------LPQGYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp -HHHH-----------GGGTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -HHHH-----------HHhcCCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1100 0111111 22333445689999999999999999999999999988643
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=398.60 Aligned_cols=258 Identities=26% Similarity=0.337 Sum_probs=196.0
Q ss_pred cCccccceeeeeCceEEEEEEECC--C--cEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTD--G--RIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~--g--~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
++|++.+.||+|+||.||+|++.. + ..||||+++... ..+..+.|.+|+.+|++++||||++++|++.+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~----- 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----- 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence 458888999999999999998642 2 379999987543 23344579999999999999999999999964
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
...++||||+++|+|.+++.... ..+++..++.++.|||.||+|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLM 158 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred cchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhh
Confidence 24589999999999999887543 45999999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccchhhhhccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
+......... .......||..|+|||++.+..++.++||||||+++|||+| |+.||..........
T Consensus 159 ~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~----------- 225 (273)
T d1u46a_ 159 RALPQNDDHY--VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH----------- 225 (273)
T ss_dssp EECCC-CCEE--EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-----------
T ss_pred hhcccCCCcc--eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHH-----------
Confidence 9875432211 12234468889999999999999999999999999999998 899996543221111
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 509 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 509 (631)
.+.......+.+...+..+.+|+.+||+.||++|||+.+|++.|.+.
T Consensus 226 ------~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 226 ------KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ------HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 01011111122233344588999999999999999999999998764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5e-48 Score=405.42 Aligned_cols=253 Identities=24% Similarity=0.305 Sum_probs=205.2
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.+.|++.+.||+|+||.||+|... +|+.||||+++... ......+.+|+.+|++++|||||++++++.+ ....|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----~~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFED----KYEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC----SSEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----CCEEE
Confidence 357899999999999999999975 59999999987643 2334568899999999999999999999876 56789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeec--CCCCeEEeccCceee
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD--ENLNAKITDLGMAKR 379 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~--~~~~~kL~DFGla~~ 379 (631)
||||||+||+|.+++... ...+++.++..|+.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+.
T Consensus 103 ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp EEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeeccccee
Confidence 999999999999988653 245999999999999999999999999 99999999999997 678999999999988
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
+.... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...........+...
T Consensus 179 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--------- 243 (352)
T d1koba_ 179 LNPDE------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC--------- 243 (352)
T ss_dssp CCTTS------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC---------
T ss_pred cCCCC------ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------
Confidence 75432 234467999999999999999999999999999999999999999654322111100000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
........+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 244 ------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 244 ------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp ------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0011111222334458899999999999999999999763
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-48 Score=401.33 Aligned_cols=248 Identities=25% Similarity=0.318 Sum_probs=204.7
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|.+.+.||+|+||.||+|+.+ +|+.||||+++... .......+.+|+.+|++++||||+++++++.+ ...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~~ 80 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT----HDRL 80 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC----SSEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc----cccc
Confidence 56889999999999999999975 59999999997431 22345568999999999999999999999886 5688
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||++||+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 81 ~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred ccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccc
Confidence 9999999999999999764 45899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
.... ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.............
T Consensus 156 ~~~~-----~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~------------ 218 (337)
T d1o6la_ 156 ISDG-----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL------------ 218 (337)
T ss_dssp CCTT-----CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------------
T ss_pred ccCC-----cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh------------
Confidence 4432 22345689999999999999999999999999999999999999997543221111000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-----MSEVVQ 504 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 504 (631)
. ... .+|...+..+.+|+.+||+.||.+||+ +.|+++
T Consensus 219 -~--~~~----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 219 -M--EEI----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -H--CCC----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -c--CCC----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 0 011 123334455889999999999999995 777765
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=399.08 Aligned_cols=275 Identities=24% Similarity=0.341 Sum_probs=203.6
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHH--HHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTE--VDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E--~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
+.|...+.||+|+||.||+|++ +|+.||||+++... ...+.+| +..+..++|||||+++|+|.+.......+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 3566778999999999999997 58999999996432 2334444 445567899999999999987665556789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcC-----CCceeecCCCCCCeeecCCCCeEEeccCc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA-----APRILHRDIKSSNILLDENLNAKITDLGM 376 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDlKp~NILl~~~~~~kL~DFGl 376 (631)
+||||+++|+|.++|++. .++|..++.++.|+|.||+|||+.. .++|+||||||+||||+.++.+||+|||+
T Consensus 78 lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 999999999999999763 5899999999999999999999741 23599999999999999999999999999
Q ss_pred eeecccCCCCCCCCCCcccccCCCCCCchhhhcCC------CCcccchhhHHHHHHHHHhCCCCCCCccccccchhh-hh
Q 006785 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR------ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-LW 449 (631)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~------~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~~ 449 (631)
++........ .........||+.|+|||++.+.. ++.++|||||||+||||+||..||............ ..
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 155 AVRHDSATDT-IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp CEEEETTTTE-ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred cccccCCCcc-eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 9887543321 112334567999999999987543 577899999999999999998887543222111100 00
Q ss_pred cccccccccccccccCCCCCCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 450 ATPRLQDSGTVISELPDPRLKGDF-----PKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
..+... .....+....++..+ +.+....+.+|+.+||+.||++|||+.||++.|+++.
T Consensus 234 ~~~~~~---~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 234 SDPSVE---EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp SSCCHH---HHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchHH---HHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 000000 001111222222222 2345567899999999999999999999999998874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=398.36 Aligned_cols=260 Identities=27% Similarity=0.414 Sum_probs=206.3
Q ss_pred hcCccccceeeeeCceEEEEEEECC--------CcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeec
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 293 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 293 (631)
.++|.+.+.||+|+||.||+|+... +..||||+++..........+.+|+..+.++ +|||||+++++|.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~- 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence 4567788999999999999998632 3479999998766555667799999999999 89999999999986
Q ss_pred cCCcceEEEEEeeCCCCChHhhhhccc--------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCC
Q 006785 294 RGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359 (631)
Q Consensus 294 ~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~ 359 (631)
....++||||+++|+|.++|.... ...+++.+++.++.||+.||+|||+.+ ||||||||+
T Consensus 91 ---~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~ 164 (299)
T d1fgka_ 91 ---DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 164 (299)
T ss_dssp ---SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred ---CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccc
Confidence 456799999999999999996542 234899999999999999999999999 999999999
Q ss_pred CeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCCc
Q 006785 360 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (631)
Q Consensus 360 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~ 438 (631)
|||++.++.+||+|||+++........ .......||+.|+|||.+.++.|+.++||||||+++|||++ |.+||...
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYY---KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTT---CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceeecCCCCeEeccchhhccccccccc---cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence 999999999999999999987654322 22344678999999999999999999999999999999998 68887543
Q ss_pred cccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 439 ITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
.... ... .+..-..+ ..|...+..+.+|+.+||+.||.+|||+.||++.|+++.
T Consensus 242 ~~~~---~~~-----------~i~~~~~~----~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 242 PVEE---LFK-----------LLKEGHRM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp CHHH---HHH-----------HHHTTCCC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHH---HHH-----------HHHcCCCC----CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 3221 100 01111112 223333445899999999999999999999999998774
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=401.26 Aligned_cols=262 Identities=24% Similarity=0.348 Sum_probs=209.2
Q ss_pred HhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeecc
Q 006785 222 ATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFR 294 (631)
Q Consensus 222 a~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 294 (631)
..++|++.+.||+|+||.||+|++. +++.||||+++..........|.+|+.+++++ +|||||+++|+|.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-- 98 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee--
Confidence 3467888899999999999999863 36789999998766555666799999999999 79999999999976
Q ss_pred CCcceEEEEEeeCCCCChHhhhhccc----------------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCC
Q 006785 295 GKRAMRLLVFEFMPNGNLRDCLDGVL----------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 358 (631)
Q Consensus 295 ~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp 358 (631)
....++||||+++|+|.++|+... ...+++..+..++.||+.||+|||+++ |+||||||
T Consensus 99 --~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp 173 (311)
T d1t46a_ 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA 173 (311)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred --CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccc
Confidence 445799999999999999996532 224899999999999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCC-CCC
Q 006785 359 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP-IHR 437 (631)
Q Consensus 359 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P-~~~ 437 (631)
+|||++.++.+||+|||+++........ .......||+.|+|||++..+.++.++||||||+++|||+|+..| |..
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~ 250 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNY---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTS---EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ccccccccCcccccccchheeccCCCcc---eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999876543221 122345789999999999999999999999999999999995555 433
Q ss_pred ccccccchhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006785 438 SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 510 (631)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 510 (631)
......... .+..-..+ ..+...+..+.+|+.+||+.||.+|||+.+|++.|+++.
T Consensus 251 ~~~~~~~~~-------------~i~~~~~~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 251 MPVDSKFYK-------------MIKEGFRM----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp CCSSHHHHH-------------HHHHTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHHHHHHH-------------HHhcCCCC----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 222111100 00111111 222333455899999999999999999999999998764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-47 Score=396.64 Aligned_cols=246 Identities=26% Similarity=0.304 Sum_probs=202.7
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccC--CCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ--GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|++.+.||+|+||+||+|+.+ +|+.||||+++.. ......+.+.+|+.+|++++|||||++++++.+ ....
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----~~~~ 79 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD----AQQI 79 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC----SSEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee----CCee
Confidence 56888999999999999999985 5999999998643 122344568999999999999999999999876 5688
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
|+||||++||+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 80 ~ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 80 FMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV 154 (316)
T ss_dssp EEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred eeEeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEe
Confidence 9999999999999998754 45889999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
... .....||+.|||||++.+..++.++|||||||+||||++|+.||...........+.
T Consensus 155 ~~~--------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------------ 214 (316)
T d1fota_ 155 PDV--------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL------------ 214 (316)
T ss_dssp SSC--------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------------
T ss_pred ccc--------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHH------------
Confidence 532 234579999999999999999999999999999999999999997543221111000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 505 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 505 (631)
.. .. .+|...+..+.+++.+||..||.+|| |+.++++.
T Consensus 215 -~~--~~----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 215 -NA--EL----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -HC--CC----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -cC--CC----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 00 01 12233344588999999999999996 88888763
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=397.81 Aligned_cols=255 Identities=22% Similarity=0.262 Sum_probs=202.8
Q ss_pred hcCccccc-eeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcce
Q 006785 223 TDKFSGSN-IVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 223 ~~~f~~~~-~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 299 (631)
.++|.+.+ .||+|+||+||+|++. +|+.||||+++.. ..+.+|+.++.++ +|||||++++++.........
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 35787764 6999999999999874 5899999998642 3478999997665 899999999998765444667
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC---CCCeEEeccCc
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGM 376 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~~~~kL~DFGl 376 (631)
+|||||||+||+|.++|.......+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 899999999999999998755567999999999999999999999999 999999999999975 55799999999
Q ss_pred eeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccc
Q 006785 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
|+...... ......||+.|+|||++.+..|+.++|||||||+||||+||+.||...........
T Consensus 161 a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---------- 224 (335)
T d2ozaa1 161 AKETTSHN------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---------- 224 (335)
T ss_dssp CEECCCCC------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------
T ss_pred eeeccCCC------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH----------
Confidence 98765432 23345799999999999999999999999999999999999999965332111000
Q ss_pred ccccccccCCCCCC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 457 SGTVISELPDPRLK--GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 457 ~~~~~~~~~~~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
....+...... .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 225 ---~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 225 ---MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---HHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00111111111 11112345668999999999999999999999873
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.4e-47 Score=384.72 Aligned_cols=252 Identities=26% Similarity=0.357 Sum_probs=203.5
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC--------hHHHHHHHHHHHHhcC-CCCCcceeEEeee
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN--------ADSVFLTEVDMLSRLH-HCHVVPLVGYCSE 292 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~--------~~~~~~~E~~~l~~l~-H~niv~l~g~~~~ 292 (631)
.++|++.+.||+|+||+||+|+.. +|+.||||+++...... ..+.+.+|+.+|++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 367899999999999999999975 58999999997653221 1235889999999996 9999999999876
Q ss_pred ccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEe
Q 006785 293 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 372 (631)
Q Consensus 293 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~ 372 (631)
....||||||+++|+|.++|... ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+
T Consensus 82 ----~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~ 152 (277)
T d1phka_ 82 ----NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT 152 (277)
T ss_dssp ----SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred ----CcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEc
Confidence 56889999999999999999754 46999999999999999999999998 9999999999999999999999
Q ss_pred ccCceeecccCCCCCCCCCCcccccCCCCCCchhhhc------CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchh
Q 006785 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV------GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 446 (631)
Q Consensus 373 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~------~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~ 446 (631)
|||+++...... ......||+.|+|||++.+ ..++.++||||+||+||||++|+.||...........
T Consensus 153 DFG~a~~~~~~~------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~ 226 (277)
T d1phka_ 153 DFGFSCQLDPGE------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 226 (277)
T ss_dssp CCTTCEECCTTC------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred cchheeEccCCC------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHH
Confidence 999998875432 2244679999999999863 3468899999999999999999999975432211111
Q ss_pred hhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 447 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
+.. . ............+..+.+|+.+||+.||.+|||+.||++
T Consensus 227 i~~-------------~--~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 227 IMS-------------G--NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHH-------------T--CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHh-------------C--CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 100 0 000111122234456899999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-48 Score=397.14 Aligned_cols=264 Identities=26% Similarity=0.383 Sum_probs=210.0
Q ss_pred HHHhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeec
Q 006785 220 EHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293 (631)
Q Consensus 220 ~~a~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 293 (631)
+...++|...+.||+|+||+||+|.+. +++.||||+++..........|.+|++++++++||||++++|++..
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~- 94 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ- 94 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS-
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec-
Confidence 334567888899999999999999874 2578999999866555555669999999999999999999999975
Q ss_pred cCCcceEEEEEeeCCCCChHhhhhccc--------cCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC
Q 006785 294 RGKRAMRLLVFEFMPNGNLRDCLDGVL--------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 365 (631)
Q Consensus 294 ~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~ 365 (631)
....++||||+++|+|.+++.... ...+++..+..++.|+|+||.|||+++ |+||||||+||||++
T Consensus 95 ---~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~ 168 (308)
T d1p4oa_ 95 ---GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE 168 (308)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECT
T ss_pred ---CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecC
Confidence 446799999999999999985421 134799999999999999999999998 999999999999999
Q ss_pred CCCeEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCC-CCCCCccccccc
Q 006785 366 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR-QPIHRSITKGEE 444 (631)
Q Consensus 366 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~-~P~~~~~~~~~~ 444 (631)
++++||+|||+|+........ .......||+.|+|||.+.++.++.++||||||++||||+||. .||.........
T Consensus 169 ~~~~Kl~DFGla~~~~~~~~~---~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~ 245 (308)
T d1p4oa_ 169 DFTVKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245 (308)
T ss_dssp TCCEEECCTTCCCGGGGGGCE---EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred CceEEEeecccceeccCCcce---eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999876543221 1123346899999999999999999999999999999999985 666433221111
Q ss_pred hhhhhcccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006785 445 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 511 (631)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 511 (631)
. .+.+.. ..+.|..++..+.+|+.+||+.||++|||+.+|++.|++...
T Consensus 246 ~-----------------~i~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 246 R-----------------FVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp H-----------------HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred H-----------------HHHhCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1 000100 011223334559999999999999999999999999987643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.5e-47 Score=398.04 Aligned_cols=245 Identities=22% Similarity=0.290 Sum_probs=202.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccC--CCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ--GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 300 (631)
++|++.+.||+|+||.||+|+++ +|+.||||++... ......+.+.+|+.+|+.++|||||++++++.. ....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~~ 116 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD----NSNL 116 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc----cccc
Confidence 57899999999999999999985 5999999998642 122344568999999999999999999999876 5578
Q ss_pred EEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeec
Q 006785 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (631)
Q Consensus 301 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~ 380 (631)
++||||+.+|+|.+++... ..+++.++..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+..
T Consensus 117 ~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~ 191 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence 9999999999999999764 45999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccccccc
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 460 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (631)
... .....||+.|||||++.+..++.++|||||||+||||++|+.||...........+.
T Consensus 192 ~~~--------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------------ 251 (350)
T d1rdqe_ 192 KGR--------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV------------ 251 (350)
T ss_dssp SSC--------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------------
T ss_pred ccc--------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHh------------
Confidence 532 234579999999999999999999999999999999999999997543211111000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006785 461 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQ 504 (631)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 504 (631)
.. .+ ..|...+..+.+|+.+||+.||.+|+ |+.++++
T Consensus 252 -~~--~~----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 252 -SG--KV----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -HC--CC----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -cC--CC----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 00 01 11223344588999999999999994 8888876
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-46 Score=397.25 Aligned_cols=250 Identities=26% Similarity=0.342 Sum_probs=197.6
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHH---HHHHHhcCCCCCcceeEEeeeccCCc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTE---VDMLSRLHHCHVVPLVGYCSEFRGKR 297 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E---~~~l~~l~H~niv~l~g~~~~~~~~~ 297 (631)
++|.+.+.||+|+||.||+|+.. +|+.||||++.... .......+.+| +.+++.++|||||++++++.+ .
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~----~ 79 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----P 79 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----S
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE----C
Confidence 57899999999999999999986 59999999986321 11122234444 666777789999999999876 5
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
...|+||||++||+|.++|... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla 154 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 154 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred CEEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeecee
Confidence 5789999999999999999764 45899999999999999999999999 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccccc
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 456 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 456 (631)
+.+.... .....||+.|+|||++.. ..++.++|||||||+||||++|+.||...............
T Consensus 155 ~~~~~~~-------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~------ 221 (364)
T d1omwa3 155 CDFSKKK-------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT------ 221 (364)
T ss_dssp EECSSSC-------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS------
T ss_pred eecCCCc-------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------
Confidence 8765432 234579999999999975 56899999999999999999999999754332211111000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-----MSEVVQI 505 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 505 (631)
....+ ..+...+..+.+|+.+||+.||.+||| +.|+++.
T Consensus 222 ------~~~~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 222 ------LTMAV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ------SSCCC----CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ------ccCCC----CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 00111 122233445889999999999999999 6888763
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=393.75 Aligned_cols=248 Identities=23% Similarity=0.353 Sum_probs=200.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHH-hcCCCCCcceeEEeeeccCCcce
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLS-RLHHCHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~~~ 299 (631)
++|.+.+.||+|+||+||+|+.. +|+.||||+++... .......+..|+.++. .++|||||++++++.+ ...
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~----~~~ 77 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT----KEN 77 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC----SSE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc----CCc
Confidence 57889999999999999999986 59999999996431 2233445677777765 6899999999999886 567
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.||||||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~ 152 (320)
T d1xjda_ 78 LFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 152 (320)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred eeEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhh
Confidence 89999999999999999764 45899999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..
T Consensus 153 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~---------- 217 (320)
T d1xjda_ 153 NMLGD-----AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM---------- 217 (320)
T ss_dssp CCCTT-----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----------
T ss_pred ccccc-----ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc----------
Confidence 54332 223345799999999999999999999999999999999999999975432211110100
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS-EVVQ 504 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 504 (631)
..+ .+|...+..+.+|+.+||+.||.+||++. ++++
T Consensus 218 -----~~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 218 -----DNP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -----CCC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -----CCC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 011 12233345588999999999999999985 6654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=393.02 Aligned_cols=252 Identities=21% Similarity=0.264 Sum_probs=203.2
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++... .....+.+|+++|+.++|||||++++++.+ ...+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----~~~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFES----MEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE----TTEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE----CCEEE
Confidence 578999999999999999999986 58999999997643 233458899999999999999999999876 56789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCC--CCeEEeccCceee
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN--LNAKITDLGMAKR 379 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~--~~~kL~DFGla~~ 379 (631)
||||||+||+|.++|... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+++.
T Consensus 78 lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhc
Confidence 999999999999999754 235999999999999999999999999 9999999999999854 4799999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccccccc
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 459 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 459 (631)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+....
T Consensus 154 ~~~~~------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~-------- 219 (321)
T d1tkia_ 154 LKPGD------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE-------- 219 (321)
T ss_dssp CCTTC------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--------
T ss_pred cccCC------cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------
Confidence 64322 2334578999999999999999999999999999999999999997543221111000000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 460 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
..+........+..+.+|+.+||..||.+|||+.|+++.
T Consensus 220 -------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 220 -------YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -------CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000001223458899999999999999999999873
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=384.07 Aligned_cols=261 Identities=25% Similarity=0.319 Sum_probs=192.0
Q ss_pred cceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC----hHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEEE
Q 006785 229 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN----ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~lV 303 (631)
+++||+|+||+||+|+++ +|+.||||+++...... ....+.+|+.+|++++|||||++++++.. ....|||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~----~~~~~iv 78 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH----KSNISLV 78 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC----TTCCEEE
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc----CCceeeh
Confidence 578999999999999975 59999999987543221 12358899999999999999999999876 4567999
Q ss_pred EeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecccC
Q 006785 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (631)
Q Consensus 304 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~~ 383 (631)
|||+.++++..++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 79 mE~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp EECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred hhhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCC
Confidence 999988877766643 245899999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhh--hcccccc---cc
Q 006785 384 GLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL--WATPRLQ---DS 457 (631)
Q Consensus 384 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~--~~~~~~~---~~ 457 (631)
. .......||+.|+|||++... .++.++|||||||++|||++|..||...........+. ...+... ..
T Consensus 154 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~ 228 (299)
T d1ua2a_ 154 N-----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228 (299)
T ss_dssp C-----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred c-----ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccch
Confidence 2 223345799999999998754 57999999999999999999999996543221111000 0000000 00
Q ss_pred cccccccCCCCCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 458 GTVISELPDPRLKGDFP-----KEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 458 ~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
............ ...+ ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 229 CSLPDYVTFKSF-PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TSSTTCCCCCCC-CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccchhhhhccC-CCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000000000000 0111 122345889999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=379.34 Aligned_cols=268 Identities=22% Similarity=0.360 Sum_probs=199.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
++|++.+.||+|+||+||+|++. +|+.||||+++.... ......+.+|+++|++++|||||++++++.+ ....|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~----~~~~~ 77 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT----ENKLY 77 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE----TTEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc----cccee
Confidence 57999999999999999999975 599999999975432 2234568999999999999999999999986 56789
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||||+. |++.+++.......+++..+..++.|++.||+|||+++ ||||||||+|||++.++.+||+|||+|+...
T Consensus 78 iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 78 LVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG 153 (298)
T ss_dssp EEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred EEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceecc
Confidence 9999995 56666665545567999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCC-CCcccchhhHHHHHHHHHhCCCCCCCccccccchhhh--hccccccccc
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL--WATPRLQDSG 458 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~--~~~~~~~~~~ 458 (631)
... .......||+.|+|||.+.... ++.++|||||||++|+|++|+.||............. ...+. ....
T Consensus 154 ~~~-----~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~ 227 (298)
T d1gz8a_ 154 VPV-----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVW 227 (298)
T ss_dssp CCS-----BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC-TTTS
T ss_pred CCc-----ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCc-hhhc
Confidence 432 2234457999999999887655 5899999999999999999999997543211100000 00000 0000
Q ss_pred ccccccCC------CCCCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 459 TVISELPD------PRLKGD---FPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 459 ~~~~~~~~------~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.......+ ...... .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000000 000000 001223458899999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-45 Score=376.86 Aligned_cols=267 Identities=23% Similarity=0.326 Sum_probs=198.7
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++|...+.||+|+||+||+|++++|+.||||+++... .......|.+|+.+|++++||||+++++++.. ....++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~~~i 77 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT----KKRLVL 77 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC----SSCEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc----CCceeE
Confidence 5788999999999999999999999999999997543 22334569999999999999999999999886 557799
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeeccc
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~~ 382 (631)
+|||+.++.|..+.... +.+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||++.....
T Consensus 78 ~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (286)
T ss_dssp EEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred EEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceeccc
Confidence 99999877776665533 56999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh--cccc---ccc
Q 006785 383 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPR---LQD 456 (631)
Q Consensus 383 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~---~~~ 456 (631)
.. .......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.............. ..+. ...
T Consensus 153 ~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 153 PV-----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (286)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred Cc-----cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccc
Confidence 32 12234468999999999875 4579999999999999999999999975432111000000 0000 000
Q ss_pred ccc---cc--cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 457 SGT---VI--SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 457 ~~~---~~--~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
... .. .....+..........+..+.+|+.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00 0000000001122233455889999999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=377.98 Aligned_cols=272 Identities=23% Similarity=0.332 Sum_probs=199.9
Q ss_pred hcCccccceeeeeCceEEEEEEEC-C-CcEEEEEEeccCCC-CChHHHHHHHHHHHHhc---CCCCCcceeEEeeecc-C
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-D-GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRL---HHCHVVPLVGYCSEFR-G 295 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~-g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~-~ 295 (631)
.++|++.+.||+|+||+||+|++. + ++.||||+++.... ......+.+|+.+|+.| +||||+++++++.... .
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 3 67899999864322 22222367888887776 7999999999986432 2
Q ss_pred CcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccC
Q 006785 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 375 (631)
Q Consensus 296 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFG 375 (631)
.....+++|||+.++++..... .....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence 3457899999998776654443 33456999999999999999999999999 9999999999999999999999999
Q ss_pred ceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhc--cc-
Q 006785 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA--TP- 452 (631)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~--~~- 452 (631)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............... .+
T Consensus 162 ~~~~~~~~~------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 162 LARIYSFQM------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235 (305)
T ss_dssp SCCCCCGGG------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hhhhhcccc------cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCc
Confidence 987654322 223457999999999999999999999999999999999999999754322111110000 00
Q ss_pred --ccccc----cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 453 --RLQDS----GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 453 --~~~~~----~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.+... ....... .......++...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSK-SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGGSCTTCSSCGGGSCCC-CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcccccccchhhhhccc-cccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 0000000 0000011222334558889999999999999999999873
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=378.71 Aligned_cols=242 Identities=23% Similarity=0.355 Sum_probs=194.8
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-----ChHHHHHHHHHHHHhcC--CCCCcceeEEeeecc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-----NADSVFLTEVDMLSRLH--HCHVVPLVGYCSEFR 294 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-----~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~ 294 (631)
.++|.+.+.||+|+||+||+|+.. +|+.||||++...... .....+.+|+.+|++++ |||||++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-- 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--
Confidence 357899999999999999999975 5899999998743211 11123678999999996 9999999999876
Q ss_pred CCcceEEEEEeeCCC-CChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC-CCCeEEe
Q 006785 295 GKRAMRLLVFEFMPN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKIT 372 (631)
Q Consensus 295 ~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kL~ 372 (631)
....|+||||+.+ ++|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+||+
T Consensus 81 --~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~ 153 (273)
T d1xwsa_ 81 --PDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 153 (273)
T ss_dssp --SSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEEC
T ss_pred --CCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEEC
Confidence 5678999999976 6888888654 45999999999999999999999998 999999999999985 4789999
Q ss_pred ccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcc
Q 006785 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 451 (631)
Q Consensus 373 DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~ 451 (631)
|||+|+..... ......||+.|+|||++.+..+ +.++|||||||+||||++|+.||..... ....
T Consensus 154 DFG~a~~~~~~-------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~~- 219 (273)
T d1xwsa_ 154 DFGSGALLKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG- 219 (273)
T ss_dssp CCTTCEECCSS-------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC-
T ss_pred ccccceecccc-------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhhc-
Confidence 99999875432 2234579999999999987765 6779999999999999999999964211 0000
Q ss_pred cccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 452 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 452 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
...+...++ ..+.+|+.+||+.||++|||+.|+++.
T Consensus 220 --------------~~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 --------------QVFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp --------------CCCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------------ccCCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 001111233 448899999999999999999999863
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-44 Score=371.69 Aligned_cols=266 Identities=20% Similarity=0.270 Sum_probs=201.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~l 302 (631)
++|++.+.||+|+||.||+|++. +|+.||||++....... .+..|+++++.++|+|++.+++.+... ....++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~E~~i~~~l~~~~~i~~~~~~~~~---~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP---QLHIESKIYKMMQGGVGIPTIRWCGAE---GDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSC---CHHHHHHHHHHSTTSTTCCCEEEEEEE---TTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCH---HHHHHHHHHHHccCCCcccEEEEEEec---CCEEEE
Confidence 56889999999999999999875 58999999987653322 378999999999888777666555442 457799
Q ss_pred EEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeec---CCCCeEEeccCceee
Q 006785 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMAKR 379 (631)
Q Consensus 303 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~---~~~~~kL~DFGla~~ 379 (631)
||||+ +|+|.+.+... .+.+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.
T Consensus 81 vme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 81 VMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCccee
Confidence 99999 67777776543 356999999999999999999999999 99999999999975 456799999999998
Q ss_pred cccCCCCCC--CCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhh-hhccccccc
Q 006785 380 LKADGLPSC--SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-LWATPRLQD 456 (631)
Q Consensus 380 ~~~~~~~~~--~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~~~~~~~~~ 456 (631)
+........ ........||+.|+|||++.+..++.++|||||||++|||++|+.||............ .+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--- 232 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK--- 232 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH---
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc---
Confidence 765432211 12234567999999999999999999999999999999999999999754432211111 000000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 457 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
...+.+.+...+| ..+.+|+..||+.+|++||++.++.+.|+.+...
T Consensus 233 -----~~~~~~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 233 -----MSTPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp -----HHSCHHHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----CCCChhHhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 0011111122334 4488999999999999999999999998877543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=377.59 Aligned_cols=275 Identities=19% Similarity=0.254 Sum_probs=198.8
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
+++|.+.+.||+|+||+||+|... +|+.||||++.........+.+.+|+.+|++++||||+++++++..........+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 457889999999999999999874 6999999999765544455678999999999999999999999865322222234
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
++++|+.+|+|.+++.. +.+++..+..++.|++.||+|||+++ ||||||||+||||+.++.+||+|||+++...
T Consensus 87 ~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 44556679999999965 35999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhh-cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccc-----
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ----- 455 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~-~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~----- 455 (631)
..... ........||+.|+|||++. ...++.++||||+|+++|||++|+.||....................
T Consensus 161 ~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 161 PDHDH--TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp GGGCB--CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred CCCcc--ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 43221 12234567999999999985 45679999999999999999999999975432211111000000000
Q ss_pred -----cccccccccCCCCCC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 456 -----DSGTVISELPDPRLK--GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 456 -----~~~~~~~~~~~~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
............... .......+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000000 00001122357899999999999999999999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.6e-44 Score=365.31 Aligned_cols=266 Identities=18% Similarity=0.206 Sum_probs=207.0
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCC-CCCcceeEEeeeccCCcceEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH-CHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~~~~~ 301 (631)
++|.+.+.||+|+||+||+|++. +|+.||||++....... .+.+|+++++.|.| +|++.+++++.+ ....+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~e~~~~~~l~~~~~i~~~~~~~~~----~~~~~ 77 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTGIPNVYYFGQE----GLHNV 77 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSC---CHHHHHHHHHHTTTCTTCCCEEEEEEE----TTEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcH---HHHHHHHHHHHhcCCCCCCEEEEEeec----CCccE
Confidence 57899999999999999999976 58999999986543322 37889999999955 899999988876 55779
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecC-----CCCeEEeccCc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-----NLNAKITDLGM 376 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-----~~~~kL~DFGl 376 (631)
+||||+ +|+|.+++... ...+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 78 ~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccce
Confidence 999999 79999998753 346999999999999999999999999 999999999999964 56799999999
Q ss_pred eeecccCCCCC--CCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhccccc
Q 006785 377 AKRLKADGLPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 454 (631)
Q Consensus 377 a~~~~~~~~~~--~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~ 454 (631)
|+.+....... .........||+.|||||++.+..++.++||||||+++|||++|+.||...............
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i---- 228 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI---- 228 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH----
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH----
Confidence 99876432211 122344568999999999999999999999999999999999999999754333221111000
Q ss_pred ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006785 455 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 512 (631)
Q Consensus 455 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 512 (631)
... ......+.+...+|+ .+.+++..||..+|++||+++.+.+.|..+..+
T Consensus 229 ~~~---~~~~~~~~l~~~~p~----~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 229 GEK---KQSTPLRELCAGFPE----EFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp HHH---HHHSCHHHHTTTSCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred Hhc---cCCCChHHhcCCCCH----HHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 000 000011111223443 488899999999999999999999988877543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=376.41 Aligned_cols=267 Identities=23% Similarity=0.291 Sum_probs=193.9
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCcceeEEeeecc--CCcceEE
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKRAMRL 301 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~~~~~ 301 (631)
+|+..++||+|+||+||+|++. +|+.||||++...... +.+|+++|++++||||+++++++.... ....++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 3666789999999999999986 5999999999765322 357999999999999999999986533 2345689
Q ss_pred EEEeeCCCCChHhhhhc-cccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC-CeEEeccCceee
Q 006785 302 LVFEFMPNGNLRDCLDG-VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKR 379 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kL~DFGla~~ 379 (631)
|||||++++.+..+... .....+++.++..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+++.
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999976544433322 22346999999999999999999999998 99999999999999775 899999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhh--ccccc--
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPRL-- 454 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~~-- 454 (631)
..... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.............. ..+..
T Consensus 173 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 173 LVRGE------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp CCTTS------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccCCc------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHh
Confidence 65432 2234579999999998875 5689999999999999999999999965432211110000 00000
Q ss_pred -----cc-ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 455 -----QD-SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 455 -----~~-~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.. .....................+..+.+|+.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0000000000000001112233458899999999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=367.34 Aligned_cols=276 Identities=20% Similarity=0.250 Sum_probs=196.6
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCCcceeEEeeecc----CCc
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR----GKR 297 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~ 297 (631)
++|++.+.||+|+||+||+|++. +|+.||||++.... .......+.+|+++|++++||||+++++++.... ...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 67888999999999999999975 69999999986542 2334556899999999999999999999986532 123
Q ss_pred ceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCce
Q 006785 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (631)
Q Consensus 298 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla 377 (631)
...|+||||+.++.+..+... ...++...+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeeccee
Confidence 467999999987776655443 355899999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccc-
Q 006785 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ- 455 (631)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~- 455 (631)
+.+....... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||....................
T Consensus 165 ~~~~~~~~~~-~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 165 RAFSLAKNSQ-PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp EECCC------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eecccccccc-cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 8765433221 1233345799999999998765 689999999999999999999999975432221111100000000
Q ss_pred ccc------ccccccCCCCCCCC-CCHH-----HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 456 DSG------TVISELPDPRLKGD-FPKE-----EMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 456 ~~~------~~~~~~~~~~l~~~-~~~~-----~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
... .....+........ .+.. ....+.+|+.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000 00000000000000 0111 12346789999999999999999999874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=359.36 Aligned_cols=267 Identities=21% Similarity=0.279 Sum_probs=203.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccCCcceEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
++|++.+.||+|+||+||+|++. +|+.||||+++.... ......+.+|+.+|+.++||||+++++++.. ....+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~----~~~~~ 77 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS----DKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc----cccee
Confidence 57899999999999999999975 589999999975533 3445678999999999999999999999986 55779
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceeecc
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~~~ 381 (631)
+||+++.+++|..++... +.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++...
T Consensus 78 iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhccc
Confidence 999999999998887643 56899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCcccccCCCCCCchhhhcCC-CCcccchhhHHHHHHHHHhCCCCCCCccccccch--hh-hhccccc---
Q 006785 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRSITKGEES--LV-LWATPRL--- 454 (631)
Q Consensus 382 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~--~~-~~~~~~~--- 454 (631)
... .......+++.|+|||.+.... ++.++|||||||++|||++|+.||.......... .. .+..+..
T Consensus 153 ~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (292)
T d1unla_ 153 IPV-----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp SCC-----SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred CCC-----ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhh
Confidence 432 2223345788999999987655 6999999999999999999999985433211100 00 0000000
Q ss_pred cccc-----ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 455 QDSG-----TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 455 ~~~~-----~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
.... ......................+.+|+.+||+.||.+|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0000000011111222333455889999999999999999999976
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-43 Score=368.27 Aligned_cols=267 Identities=24% Similarity=0.300 Sum_probs=195.2
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC--Ccc
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRA 298 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~~ 298 (631)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++.... ....+.+.+|+++|+.++|||||++++++..... ...
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 467889999999999999999975 599999999975432 2334568899999999999999999999875332 233
Q ss_pred eEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCcee
Q 006785 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (631)
Q Consensus 299 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~ 378 (631)
..|+||||+ +.+|..+++. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccccee
Confidence 579999999 6788887754 45999999999999999999999999 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCcccccCCCCCCchhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccc----
Q 006785 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR---- 453 (631)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~---- 453 (631)
..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..................
T Consensus 170 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 170 QADSE--------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241 (346)
T ss_dssp ECCSS--------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccCCc--------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHH
Confidence 76432 234579999999999876 45799999999999999999999999754322111000000000
Q ss_pred ----cc-----cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 454 ----LQ-----DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 454 ----~~-----~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.. .......+.....+. .........+.+|+.+||..||.+|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 000000011111110 1112223447889999999999999999999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2e-42 Score=360.14 Aligned_cols=261 Identities=17% Similarity=0.235 Sum_probs=196.7
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCCcceeEEeeeccCCcceEE
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRL 301 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~ 301 (631)
++|++.++||+|+||+||+|++. +|+.||||+++.. ....+.+|+++|+.+ .||||+++++++.... ....+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~--~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPV--SRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT--TCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecC--CCcee
Confidence 57999999999999999999985 5899999998643 245689999999999 5999999999987532 34689
Q ss_pred EEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCC-CeEEeccCceeec
Q 006785 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKRL 380 (631)
Q Consensus 302 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kL~DFGla~~~ 380 (631)
+||||+.+++|..+. +.+++..+..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|+..
T Consensus 109 ~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceec
Confidence 999999999998764 34899999999999999999999999 99999999999998655 5899999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchh-----------hh
Q 006785 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL-----------VL 448 (631)
Q Consensus 381 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~-----------~~ 448 (631)
.... ......||+.|+|||.+.+. .++.++||||+|+++|||++|+.||........... ..
T Consensus 181 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~ 254 (328)
T d3bqca1 181 HPGQ------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254 (328)
T ss_dssp CTTC------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred cCCC------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhh
Confidence 5432 23345689999999998865 479999999999999999999999965432111000 00
Q ss_pred hcc-cccc---cccccccccCCC----CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006785 449 WAT-PRLQ---DSGTVISELPDP----RLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 504 (631)
Q Consensus 449 ~~~-~~~~---~~~~~~~~~~~~----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 504 (631)
+.. .... ............ ..........+..+.+|+.+||+.||.+|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000 000000000000 0111112223455889999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=364.40 Aligned_cols=253 Identities=25% Similarity=0.355 Sum_probs=198.1
Q ss_pred cCccccceeeeeCceEEEEEEEC----CCcEEEEEEeccCC---CCChHHHHHHHHHHHHhcCC-CCCcceeEEeeeccC
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRLHH-CHVVPLVGYCSEFRG 295 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~---~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~ 295 (631)
++|++.+.||+|+||+||+|+.. +|+.||||+++... .....+.+.+|+++|++++| |||+++++++.+
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--- 100 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--- 100 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE---
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc---
Confidence 56899999999999999999862 38899999986431 12223458899999999966 899999999876
Q ss_pred CcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccC
Q 006785 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 375 (631)
Q Consensus 296 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFG 375 (631)
....++||||+.+|+|.+++... ..+....+..++.|++.||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 101 -~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG 174 (322)
T d1vzoa_ 101 -ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG 174 (322)
T ss_dssp -TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSS
T ss_pred -CCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeecc
Confidence 55789999999999999999764 45788999999999999999999998 9999999999999999999999999
Q ss_pred ceeecccCCCCCCCCCCcccccCCCCCCchhhhcC--CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccc
Q 006785 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 453 (631)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~--~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~ 453 (631)
+++.+..... .......||+.|+|||.+.+. .++.++|||||||+||||++|+.||................
T Consensus 175 ~a~~~~~~~~----~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~-- 248 (322)
T d1vzoa_ 175 LSKEFVADET----ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI-- 248 (322)
T ss_dssp EEEECCGGGG----GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--
T ss_pred chhhhccccc----ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--
Confidence 9987644321 123345799999999999754 46889999999999999999999997543322111110000
Q ss_pred cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006785 454 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQ 504 (631)
Q Consensus 454 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 504 (631)
. ...+ ..|...+..+.+|+.+||+.||++|| |++|+++
T Consensus 249 -------~--~~~~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 249 -------L--KSEP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -------H--HCCC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -------c--cCCC----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0 0011 12334455689999999999999999 4788875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-42 Score=360.84 Aligned_cols=268 Identities=20% Similarity=0.237 Sum_probs=191.5
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC--Ccce
Q 006785 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRAM 299 (631)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~~~ 299 (631)
++|.+.++||+|+||+||+|.+. +|+.||||++...... .....+.+|+.+|++++||||+++++++..... ....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67899999999999999999986 5999999999765332 334458899999999999999999999864322 3468
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
+|+||||+.++ |.+.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhc
Confidence 89999999654 544443 34899999999999999999999999 99999999999999999999999999886
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccchhh----------hh
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV----------LW 449 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~----------~~ 449 (631)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||............ .|
T Consensus 169 ~~~~------~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 169 AGTS------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccc------cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 6543 2334557999999999999999999999999999999999999999643211100000 00
Q ss_pred c----------ccccccccccccccCCCCCCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 450 A----------TPRLQDSGTVISELPDPRLKG---DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 450 ~----------~~~~~~~~~~~~~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
. ..................... ..+...+..+.+|+.+||..||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 000000000000000000110 1123446678999999999999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=357.30 Aligned_cols=268 Identities=22% Similarity=0.308 Sum_probs=194.7
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCCcceeEEeeeccC-Ccce
Q 006785 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG-KRAM 299 (631)
Q Consensus 223 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~~~ 299 (631)
.++|++.+.||+|+||+||+|++. +|+.||||++..... ......+.+|+++|++++|||||++++++..... ....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467999999999999999999875 599999999975432 2234468899999999999999999998864321 1223
Q ss_pred EEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 300 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.++||+|+.+|+|.+++.. +.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcc
Confidence 4666777889999999964 45999999999999999999999999 99999999999999999999999999976
Q ss_pred cccCCCCCCCCCCcccccCCCCCCchhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccchhhhhcccccc---
Q 006785 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ--- 455 (631)
Q Consensus 380 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~--- 455 (631)
.... .....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||....................
T Consensus 171 ~~~~--------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 171 TDDE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp CTGG--------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cCcc--------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 5432 2335699999999987765 568999999999999999999999965432111110000000000
Q ss_pred -------cccc---cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006785 456 -------DSGT---VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 505 (631)
Q Consensus 456 -------~~~~---~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 505 (631)
.... .........+.. .....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccchhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000 000000000000 001123457899999999999999999999873
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.5e-38 Score=328.81 Aligned_cols=266 Identities=21% Similarity=0.242 Sum_probs=190.7
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-----------CCCCcceeEEeee
Q 006785 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-----------HCHVVPLVGYCSE 292 (631)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~ 292 (631)
+|.+.+.||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+.+|+.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4888999999999999999975 59999999997542 22345788999998885 5789999988865
Q ss_pred ccCCcceEEEEEeeCCCCCh-HhhhhccccCCCCHHHHHHHHHHHHhhhHHHHh-cCCCceeecCCCCCCeeecCCCC--
Q 006785 293 FRGKRAMRLLVFEFMPNGNL-RDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLN-- 368 (631)
Q Consensus 293 ~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlKp~NILl~~~~~-- 368 (631)
.. ....+++|+++..+.. ...........+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 92 KG--PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EE--TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred cc--ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccc
Confidence 33 2345666666655443 333344444568999999999999999999998 77 999999999999986654
Q ss_pred ----eEEeccCceeecccCCCCCCCCCCcccccCCCCCCchhhhcCCCCcccchhhHHHHHHHHHhCCCCCCCccccccc
Q 006785 369 ----AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE 444 (631)
Q Consensus 369 ----~kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~ 444 (631)
++++|||.+...... .....||+.|+|||++....++.++||||+|++++||++|+.||.........
T Consensus 167 ~~~~~kl~dfg~s~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~ 238 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH--------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238 (362)
T ss_dssp TEEEEEECCCTTCEETTBC--------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeeEeecccccccccc--------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence 899999999865432 23456999999999999999999999999999999999999999643221100
Q ss_pred h----hh--hhcccc--------------cccccccccccCCCC---------CCCCCCHHHHHHHHHHHHHhcccCCCC
Q 006785 445 S----LV--LWATPR--------------LQDSGTVISELPDPR---------LKGDFPKEEMQIMAYLAKECLQLDPDA 495 (631)
Q Consensus 445 ~----~~--~~~~~~--------------~~~~~~~~~~~~~~~---------l~~~~~~~~~~~l~~li~~cl~~dP~~ 495 (631)
. .. .+.... ..........+.... .....+...+..+.+|+.+||..||.+
T Consensus 239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~ 318 (362)
T d1q8ya_ 239 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 318 (362)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred chhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhH
Confidence 0 00 000000 000000000000000 122345677788999999999999999
Q ss_pred CCCHHHHHHH
Q 006785 496 RPTMSEVVQI 505 (631)
Q Consensus 496 RPs~~evl~~ 505 (631)
|||+.|+++.
T Consensus 319 Rpta~e~L~H 328 (362)
T d1q8ya_ 319 RADAGGLVNH 328 (362)
T ss_dssp CBCHHHHHTC
T ss_pred CcCHHHHhcC
Confidence 9999999863
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=2.4e-24 Score=204.90 Aligned_cols=165 Identities=15% Similarity=0.120 Sum_probs=120.8
Q ss_pred cccceeeeeCceEEEEEEECCCcEEEEEEeccCCCC-------------C----hHHHHHHHHHHHHhcCCCCCcceeEE
Q 006785 227 SGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP-------------N----ADSVFLTEVDMLSRLHHCHVVPLVGY 289 (631)
Q Consensus 227 ~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~-------------~----~~~~~~~E~~~l~~l~H~niv~l~g~ 289 (631)
.+.+.||+|+||+||+|.+.+|+.||||+++..... . ....+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 456889999999999999988999999987632110 0 01224568899999999999998765
Q ss_pred eeeccCCcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcCCCceeecCCCCCCeeecCCCCe
Q 006785 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 369 (631)
Q Consensus 290 ~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 369 (631)
.. .+++|||+++..+.+ ++......++.|++.+|+|||+++ |+||||||+|||++++ .+
T Consensus 83 ~~--------~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 83 EG--------NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp ET--------TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EE
T ss_pred cC--------CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CE
Confidence 32 179999998765543 344456789999999999999999 9999999999999965 58
Q ss_pred EEeccCceeecccCCCCCCCCCCcccccCCCCCCch-----hhhcCCCCcccchhhHHHHH
Q 006785 370 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE-----YAMVGRASLMSDVFSFGVVL 425 (631)
Q Consensus 370 kL~DFGla~~~~~~~~~~~~~~~~~~~Gt~~Y~APE-----~~~~~~~s~ksDVwSlGviL 425 (631)
+|+|||+|....... ...|+... .+..+.|+.++||||..--+
T Consensus 142 ~liDFG~a~~~~~~~-------------~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 142 WIIDFPQSVEVGEEG-------------WREILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EECCCTTCEETTSTT-------------HHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred EEEECCCcccCCCCC-------------cHHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 999999997653221 01121110 01245688899999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.36 E-value=1.4e-06 Score=84.22 Aligned_cols=150 Identities=15% Similarity=0.108 Sum_probs=99.1
Q ss_pred HHHHHHhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCCcceeEEeeeccC
Q 006785 217 SALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRG 295 (631)
Q Consensus 217 ~~l~~a~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 295 (631)
.+|......|...+..+.++...||+... +++.++||+........ ...+.+|...+..+. +--+.+++.+...
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~-~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--- 81 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT-TYDVEREKDMMLWLEGKLPVPKVLHFERH--- 81 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS-TTCHHHHHHHHHHHTTTSCCCCEEEEEEE---
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccc-hhhHHHHHHHHHHHhccCCCCcEEEEEec---
Confidence 35666667777666555455578999875 46668888876442211 123678999988873 4345677776554
Q ss_pred CcceEEEEEeeCCCCChHhhhhccccCCCCHHHHHHHHHHHHhhhHHHHhcC----------------------------
Q 006785 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA---------------------------- 347 (631)
Q Consensus 296 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------- 347 (631)
....++||++++|.++.+..... .. ...++.++++.|..||+..
T Consensus 82 -~~~~~lv~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T d1j7la_ 82 -DGWSNLLMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp -TTEEEEEEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred -CCceEEEEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhh
Confidence 34679999999998886644211 11 2234455555666666421
Q ss_pred ----------------------------CCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 348 ----------------------------APRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 348 ----------------------------~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.+.++|+|+.|.|||+++++..-|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999876677999998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.14 E-value=2.3e-06 Score=82.27 Aligned_cols=130 Identities=17% Similarity=0.114 Sum_probs=83.1
Q ss_pred eeeeCc-eEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCC--CCcceeEEeeeccCCcceEEEEEeeCC
Q 006785 232 VGQGGS-SYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC--HVVPLVGYCSEFRGKRAMRLLVFEFMP 308 (631)
Q Consensus 232 LG~G~f-G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~~~~~~~~~lV~E~~~ 308 (631)
+..|.. ..||+...+++..+++|........ .+..|...|+.+... .+.+++++... ....++||+|++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~----~l~~E~~~l~~L~~~gvpvP~v~~~~~~----~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN----ELQDEAARLSWLATTGVPCAAVLDVVTE----AGRDWLLLGEVP 89 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS----CHHHHHHHHHHHHTTTCCBCCEEEEEEC----SSCEEEEEECCS
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh----HHHHHHHHHHHHHhcCCCCCceeeeccc----ccceEEEEEeee
Confidence 344443 6899999888888999987654322 267888888888433 35567766554 346799999998
Q ss_pred CCChHhhhhccccCCCCHHHHHHHHHHHHhhh------------------------------------------------
Q 006785 309 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL------------------------------------------------ 340 (631)
Q Consensus 309 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL------------------------------------------------ 340 (631)
|-++.+.. +.. ..++.+++..|
T Consensus 90 G~~~~~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
T d1nd4a_ 90 GQDLLSSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 159 (255)
T ss_dssp SEETTTSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred cccccccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHH
Confidence 87664321 010 01111222222
Q ss_pred ---HHHHhcC----CCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 341 ---EYLHEAA----APRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 341 ---~yLH~~~----~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
..+.... .+.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 2222211 12489999999999999876678999998754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.59 E-value=0.0001 Score=75.57 Aligned_cols=77 Identities=21% Similarity=0.205 Sum_probs=48.4
Q ss_pred ceeeeeCceEEEEEEECC-CcEEEEEEecc------CCCCChHHHHHHHHHHHHhc-CC--CCCcceeEEeeeccCCcce
Q 006785 230 NIVGQGGSSYVYRGQLTD-GRIVAVKRFKT------QGGPNADSVFLTEVDMLSRL-HH--CHVVPLVGYCSEFRGKRAM 299 (631)
Q Consensus 230 ~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~------~~~~~~~~~~~~E~~~l~~l-~H--~niv~l~g~~~~~~~~~~~ 299 (631)
+.||.|....||+....+ ++.|+||.-.. ...+........|.+.|+.+ .+ ..+.+++.+..+ .
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~------~ 105 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE------M 105 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT------T
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC------C
Confidence 468999999999998654 67899996432 11122222355788888877 33 346667655322 3
Q ss_pred EEEEEeeCCCCCh
Q 006785 300 RLLVFEFMPNGNL 312 (631)
Q Consensus 300 ~~lV~E~~~~gsL 312 (631)
.++|||++++..+
T Consensus 106 ~~lvmE~L~~~~~ 118 (392)
T d2pula1 106 AVTVMEDLSHLKI 118 (392)
T ss_dssp TEEEECCCTTSEE
T ss_pred CEEEEeccCCccc
Confidence 3799999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.85 E-value=0.0024 Score=63.15 Aligned_cols=139 Identities=19% Similarity=0.204 Sum_probs=77.9
Q ss_pred ceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCCc--ceeEEe-eeccCCcceEEEEEeeCCCCChH
Q 006785 237 SSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV--PLVGYC-SEFRGKRAMRLLVFEFMPNGNLR 313 (631)
Q Consensus 237 fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~niv--~l~g~~-~~~~~~~~~~~lV~E~~~~gsL~ 313 (631)
--.||++..++|+.|++|+...... ...++..|...|..|....+. ..+... ..........+.+++|++|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 4589999999999999999875432 334578899998888433221 111100 00001144678999999765432
Q ss_pred h-----h------h---hc----cc---cCCCCHHH-------------------HHHHHHHHHhhhHHHHhc----CCC
Q 006785 314 D-----C------L---DG----VL---VEGMNWDT-------------------RVAIAIGAARGLEYLHEA----AAP 349 (631)
Q Consensus 314 ~-----~------l---~~----~~---~~~l~~~~-------------------~~~i~~~ia~gL~yLH~~----~~~ 349 (631)
. + | +. .. ...+++.. ...+...+.+.++.+... .+.
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 1 1 0 00 00 01122211 111222223333333322 234
Q ss_pred ceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 350 RILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 350 ~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.+||+|+.+.|||++++ ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 58999999999999754 46899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.61 E-value=0.0054 Score=62.17 Aligned_cols=74 Identities=19% Similarity=0.272 Sum_probs=50.4
Q ss_pred cceeeeeCceEEEEEEECC--------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCC-cceeEEeeeccCCcce
Q 006785 229 SNIVGQGGSSYVYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGYCSEFRGKRAM 299 (631)
Q Consensus 229 ~~~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~~~ 299 (631)
.+.|+.|-.-.+|+....+ ++.|.+++.... .. .....+|..+++.+.-.++ .++++++..
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~------- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET-ESHLVAESVIFTLLSERHLGPKLYGIFSG------- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT-------
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--ch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC-------
Confidence 3567778889999998754 356777766522 22 2346789999999843344 477776642
Q ss_pred EEEEEeeCCCCChH
Q 006785 300 RLLVFEFMPNGNLR 313 (631)
Q Consensus 300 ~~lV~E~~~~gsL~ 313 (631)
.+||||++|..|.
T Consensus 117 -g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 117 -GRLEEYIPSRPLS 129 (395)
T ss_dssp -EEEECCCCEEECC
T ss_pred -ceEEEEeccccCC
Confidence 6899999876543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.45 E-value=0.0071 Score=59.01 Aligned_cols=160 Identities=10% Similarity=0.035 Sum_probs=82.8
Q ss_pred ecHHHHHHHhcCcccccee-----eeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCC--cce
Q 006785 214 FSYSALEHATDKFSGSNIV-----GQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV--VPL 286 (631)
Q Consensus 214 ~s~~~l~~a~~~f~~~~~L-----G~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l 286 (631)
.+-++++....+|.+.+.. ..|---+.|+.+.++|+ +++|+........ .+..|+++|..|...++ ...
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~~---~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEKN---DLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---CC---HHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCHH---HHHHHHHHHHhhhhcccccccc
Confidence 3456778888888775443 35556788999887665 8999986543322 24567777777743222 111
Q ss_pred e----EEeeeccCCcceEEEEEeeCCCCChHhhh--------------hc----cc---cCCCCHH--------------
Q 006785 287 V----GYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DG----VL---VEGMNWD-------------- 327 (631)
Q Consensus 287 ~----g~~~~~~~~~~~~~lV~E~~~~gsL~~~l--------------~~----~~---~~~l~~~-------------- 327 (631)
+ |..... .......++.+..+......- +. .. .......
T Consensus 79 i~~~~g~~~~~--~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (316)
T d2ppqa1 79 LPRKDGELLGE--LSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 156 (316)
T ss_dssp CCBTTCCSCEE--ETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred ceecCCCccee--eecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhh
Confidence 1 100000 123456677777665432210 00 00 0000000
Q ss_pred ----HHHHHHHHHHhhhHHHHhc-CCCceeecCCCCCCeeecCCCCeEEeccCceee
Q 006785 328 ----TRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (631)
Q Consensus 328 ----~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kL~DFGla~~ 379 (631)
.....+..+...+.-.+.. -+..+||+|+.+.||+++.+...-|.||+.+..
T Consensus 157 ~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 157 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 0111111222222222211 123599999999999999887778999998753
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=90.12 E-value=0.037 Score=35.86 Aligned_cols=26 Identities=15% Similarity=0.451 Sum_probs=20.2
Q ss_pred hhhhccccccccccCCccceEEecCCCCCCc
Q 006785 17 WIQRSICDKLSERSGQKNWKCTCSSSLQGDQ 47 (631)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~ 47 (631)
+..++.|.+ ...+|+|+|..||.||=
T Consensus 9 C~~~A~C~N-----t~Gsy~C~C~~Gy~GdG 34 (40)
T d1gl4a2 9 CSVHAECRD-----YATGFCCRCVANYTGNG 34 (40)
T ss_dssp SCTTEEEEE-----CSSCEEEEECTTEEECS
T ss_pred CCCCCEeec-----CCCCeEeECCCCCcCCC
Confidence 455677765 35589999999999986
|